<SEC-DOCUMENT>0001459839-23-000063.txt : 20230502
<SEC-HEADER>0001459839-23-000063.hdr.sgml : 20230502
<ACCEPTANCE-DATETIME>20230502162417
ACCESSION NUMBER:		0001459839-23-000063
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		166
CONFORMED PERIOD OF REPORT:	20230331
FILED AS OF DATE:		20230502
DATE AS OF CHANGE:		20230502

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SI-BONE, Inc.
		CENTRAL INDEX KEY:			0001459839
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				262216351
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38701
		FILM NUMBER:		23879437

	BUSINESS ADDRESS:	
		STREET 1:		471 EL CAMINO REAL, SUITE 101
		CITY:			SANTA CLARA
		STATE:			CA
		ZIP:			95050
		BUSINESS PHONE:		4082070700

	MAIL ADDRESS:	
		STREET 1:		471 EL CAMINO REAL, SUITE 101
		CITY:			SANTA CLARA
		STATE:			CA
		ZIP:			95050

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SI-Bone Inc.
		DATE OF NAME CHANGE:	20090326
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>sibn-20230331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:b9a8bdb4-fcbc-4ee6-8fcb-5f67627ef90e,g:a1ffbe61-3b0e-45b0-8eb9-b424c3d4458b,d:928aa505a2ea46079da4e5082002267b--><html xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:sibn="http://si-bone.com/20230331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>sibn-20230331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80L2ZyYWc6ZjdlOWM4ZDZiNjgzNGI3ZWFhMWFhMTZjYTFjNWU3ZTkvdGFibGU6YmYyNmZjZjM2MGRmNDk0NTkyM2RmZDhjMmNjZjk1ZGMvdGFibGVyYW5nZTpiZjI2ZmNmMzYwZGY0OTQ1OTIzZGZkOGMyY2NmOTVkY18xLTEtMS0xLTY4MzE2_ca95f64f-b7f0-4a1e-8c9d-39515f82346b">0001459839</ix:nonNumeric><ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80L2ZyYWc6ZjdlOWM4ZDZiNjgzNGI3ZWFhMWFhMTZjYTFjNWU3ZTkvdGFibGU6YmYyNmZjZjM2MGRmNDk0NTkyM2RmZDhjMmNjZjk1ZGMvdGFibGVyYW5nZTpiZjI2ZmNmMzYwZGY0OTQ1OTIzZGZkOGMyY2NmOTVkY18yLTEtMS0xLTY4MzE2_0f2f5a2a-f77b-4d5e-b087-d75a5f38e30b">December 31</ix:nonNumeric><ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80L2ZyYWc6ZjdlOWM4ZDZiNjgzNGI3ZWFhMWFhMTZjYTFjNWU3ZTkvdGFibGU6YmYyNmZjZjM2MGRmNDk0NTkyM2RmZDhjMmNjZjk1ZGMvdGFibGVyYW5nZTpiZjI2ZmNmMzYwZGY0OTQ1OTIzZGZkOGMyY2NmOTVkY18zLTEtMS0xLTY4MzE2_d32b5c4d-a2f4-4ea0-9a8a-ee5216b18c3e">2023</ix:nonNumeric><ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80L2ZyYWc6ZjdlOWM4ZDZiNjgzNGI3ZWFhMWFhMTZjYTFjNWU3ZTkvdGFibGU6YmYyNmZjZjM2MGRmNDk0NTkyM2RmZDhjMmNjZjk1ZGMvdGFibGVyYW5nZTpiZjI2ZmNmMzYwZGY0OTQ1OTIzZGZkOGMyY2NmOTVkY180LTEtMS0xLTY4MzE2_9ba50e0d-05f7-4dff-963e-d02cec47ed74">Q1</ix:nonNumeric><ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80L2ZyYWc6ZjdlOWM4ZDZiNjgzNGI3ZWFhMWFhMTZjYTFjNWU3ZTkvdGFibGU6YmYyNmZjZjM2MGRmNDk0NTkyM2RmZDhjMmNjZjk1ZGMvdGFibGVyYW5nZTpiZjI2ZmNmMzYwZGY0OTQ1OTIzZGZkOGMyY2NmOTVkY181LTEtMS0xLTY4MzE2_ed667950-66e2-4feb-ac8f-26c60001e5c7">false</ix:nonNumeric><ix:nonNumeric contextRef="iaea4309f7d894f26aa578b17d53f7daf_D20230101-20230331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfMTEwOQ_b006b137-1392-4dc1-aa98-21e5cfe1c1eb">P2Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="sibn-20230331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e136d89ad474fdeb683220221498c6a_I20230426"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-04-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="ibc8dabdb27e24a31aa334795682f86fb_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i9dcf850d9d0446dea538750874891e18_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1ad2c138559410ba21a1f7abb1d4ffd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73f03223216c40f18e39597ffaec1ef4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib60e72c3aa6e4ad28de9ed0584387b84_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02dda049bbb449b7a4908baa63bfc3c0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0c350aefbd0469a8c27d16d7649c977_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i205f14e8b1cc49a7aedfb949e6e0c598_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd89d2d32f7e4eadb653b6c699a1da65_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb828f727d314174b2f1a4710790fde9_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i061a1d4685fa4917a427a6f03c1beeb4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64e08c97777d48b3a2279b29a42ce726_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i930a39bf4a65491ca6af24ed50e20906_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i954439b3925043e3949da7080d9256e2_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i883fe34ebc0c4092a483d977c3f8d429_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0aa2d78b45474cb8b1a7e306265bc187_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0422532f98d04beb985b3c54535d2911_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i429ed22eade94b3e88f8ed51a9a289e9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25ff20079ccb48899ea84d72b50e16e7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58ceb493d83949bb8045aa75c1c8bdc3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84b72a6f51f6449f84a5d5b3cc309664_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id37cd14c22ad42eb8a735baa4d08d8b0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie59f6758cf1b4684be0a81c20e471c4b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad9213ed4f734769974b00e30b313acc_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8247ae5acd7b41e9a09b537937c10239_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8f402bebac44ff39653d91d5f80e030_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7459a99379124552878485552b9000b8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37f453d1957c4f60a0e5d364ba1d84c7_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="activity"><xbrli:measure>sibn:activity</xbrli:measure></xbrli:unit><xbrli:context id="ie621378e8af644ff959fd17071edec6f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d986d6c5754440c896f37265133c6f7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6d7b650f421439ea4f82d9dcaa13596_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibad906d7939f45519af713f88d015ade_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6706d03c32974a768210dd2966cd849e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic034056cf84142f3a1464896584f8499_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44dd3ae16d4d45c8bb7f34c32c3afa5b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia13be74212cd4cbdac029edf9dc0a7af_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f387eb12eb641d8acf7a18c1539123f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0cbf148284f4875b34513e22dea1727_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8559cf2d961048048b5f1dcd580f39ee_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2d6675789b842e3bc0f882dee4352c3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib008684c4f9b4e4782d069220bea736d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifdfec2a876ef4b7eb0d2a97b4c97ad16_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic260793641a14f2695a83d42d27f0e29_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93f63117979e431d8fafecd7bb59dfac_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7af7e18c08648e8a31cfe8e93a21d37_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if55d28f6c32e42e4a57e446914b3a62c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i412cc8ac40b4449d8130d9a574e1630c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70c37c2527cc48178344c05517b09dbd_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05b7a065321d4879b2ff02286b48fe5d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e5ed5afd4274c968b88749c12c77e79_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ad3e05b47f148779fa5695c98e40dcf_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c92d73d84f74de3a6513213ff796c66_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0cfde19be5044c3fb1effae06f724c64_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic660e995acfe4b2a9f4faedc08362fa8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb816e01e7874d0a96715509b31cb35a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c6fdeac85ad413ca0c0dedf070a75fe_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a100bced9af4ad5bd35f338bc5a32f8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbcaeebb6db24dffb245482694bd9c7a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i402c694c2fe74b3ca22ce9842744aa6d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4f6a87d519949ebb36b48d5adde8532_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibcc50bab28c64661b1b3e2f3166b18ac_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i127926870dbf443f939ff61f15decebe_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i165bfa53062b4b66b55877948006f464_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i599fe7f797b64b16986fe58ad0b1dea9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18026ebb41a3463a83e4df8c40ad564c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a9913b7b1e5449cb00f06f2ff1eb7b7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d0dee683e5841eb84e260a32f3255fe_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d93d5c546664a5d81e0bd4ff383fd5e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i593bc48b8f4243ddb04b45abc6ea214d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2a471609df94d37a930d6f5d6e15098_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a286c1bf0564b09a30caa94533124d2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c06318063df438297ac590b6ad0fc1d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02f410de75d14cdeaee8f125e8343cbd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2648a4f0afd74ba895a75a8524bd2b05_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia89f5e43abc74a268ac2cf0241b3f413_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3ad078aff0542a4a095dda948ebfa96_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf18e06ec7af4f8894d706876e2614db_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8afde8ae10a47ca88a2373bafb3dfac_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f7ab8e31a7c40be87fc6165468887e2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c0adbda751147eea7396bd575122c5e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i386cd3185459468682f42288ddfd4237_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if245b8c2654f417395c08edfa479ab82_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d1b210afd954f47bea17adf2f027ac5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id88038b7e8b941bc8a88b3faa056a48f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59372acb82174f63bc0cbb959bab7cb7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0994310adbdc4a3fb6f259424a3dda9b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a30c099351643919a25ea1474e284b5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b6ddb9d49374251b145ed8c06d3ea23_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b54f88e74024fb4a2091106b2085b42_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib87aa61e8c5640999864db57e9a5de97_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i238fa20d4bac4223a52c0c5dd3a10b39_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e71d795db204f3b8f094023c24425b3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee9e604e937b47a2a28b7c87d255fe22_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ca79707ebe549c1bb352a2ebd78915f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20591f6aa1e240348d149ac3850df479_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95acc83c9a7845c6a6530d0b489719b9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sibn:ComputerAndOfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9201dd932d9848bdbbe7c5a345ef8038_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sibn:ComputerAndOfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if93177d48de1415e9f17d96b9723fe38_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a70cc88c75d4e89898c6b1352acaacc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ab4226e44904229bd0ee82536c2fdcd_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ef76ab501ca47529edb5647153de4b2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3464bbb971c4eefb3b4e6d7ae410bb8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sibn:ConstructionInProgressSurgicalPlacementInstrumentSetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i368a721c855a4a1190ec9dcdc696598a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sibn:ConstructionInProgressSantaClaraLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i0948ce79deee4391b59b52520a368e51_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:IndemnificationGuaranteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c1e121f074342c9bd40478fa2984c46_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:IndemnificationGuaranteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8e560c29f77458f868e82a8beb02128_I20210812"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SVBTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fe2d63d0e5c43bdbdf07781f3c546f9_I20230106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SVBTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1bf81bb780c3454a8a17edba536c3cca_D20230106-20230106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SVBAmendedTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-06</xbrli:startDate><xbrli:endDate>2023-01-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb70f81572e248629f7b7f231c74cec6_D20230106-20230106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SVBTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-06</xbrli:startDate><xbrli:endDate>2023-01-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75a6a55921b94e788965c7b88a1250c0_I20230106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SVBAmendedTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76321e3f57544d228615f7521f589bc2_I20230106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SVBAmendedTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40ef43333c0442bf888482c8ace88dd4_D20230106-20230106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SVBAmendedTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-06</xbrli:startDate><xbrli:endDate>2023-01-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id912f88617b74e8f9c3530bd836870bf_D20230106-20230106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SVBAmendedTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-06</xbrli:startDate><xbrli:endDate>2023-01-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd2e135759a24184955191e8a1e9cc3c_I20230106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SVBAmendedTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbafe1e8ab4043a896784415b82016d4_D20230106-20230106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SVBAmendedTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-06</xbrli:startDate><xbrli:endDate>2023-01-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="quick_ratio"><xbrli:measure>sibn:quick_ratio</xbrli:measure></xbrli:unit><xbrli:context id="iead9b266d2d14baba4281492cf7acebc_D20230106-20230106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SVBAmendedTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-06</xbrli:startDate><xbrli:endDate>2023-01-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia93eb97347d343fb94b99ed9c40ef16b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SVBTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d10f967602a4f5e83faefa1d251c9a3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SolarLoanAndSecurityAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a9db0b913fe48aea9fd168fc919ec8d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaea4309f7d894f26aa578b17d53f7daf_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae333c43aa6f438893c3e83047c6ba3e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafee48dbb8fc4bfc960af6aa6244917f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf9a24c75b524dfa94a49c4ab5a022c0_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac4ffd9b01074e8fa63dc6df8b863046_D20220101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sibn:A2018EmployeeStockPurchasePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73253fc85d9d4718b307a6aeea2b9c06_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5a58a2d117b40d8a0d022c115299b14_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i542cba4badbf402198062c358fb44a47_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0fd34d1ccf7c424faab3f807a548673b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idce254121fa64dda9831a0bf7d7be47d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic31c0bf439854ab39758877476c132a4_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9878b683aeef427ebf14f59132cf0f4a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2829f82cc061453792f3357c0e3b2d45_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c44b4d86d814a99aa4f0201bc819c63_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0491eac20c484a99bcfa28ef410f4825_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sibn:A2018EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78f562b20b2e4096bb55d93c2515d6b4_D20200501-20200531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sibn:A2018EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-01</xbrli:startDate><xbrli:endDate>2020-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="purchase_period"><xbrli:measure>sibn:purchase_period</xbrli:measure></xbrli:unit><xbrli:context id="i2a36228c84c94fdd90258ab5546be250_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sibn:A2018EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0b8dd5bc1a74d16976adc6fe0963e3c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sibn:A2018EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i017405027da74f35a1e9b7624aa42eb3_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibaf29913eb3446079f07610b7349c5a2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90358afa0410497b9f081e97dbf0db01_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff0a36e596f44a779c08847487b58a42_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie75cc149b1a34a578c7e33c33a5bb53e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia11934861f834ff494d0a96536ea4362_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica097e93dc6e43ceb0f401463e05eced_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d77a44aec9a441e8285b555ea83a233_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ae664fc28564f66ac4064ddbcbd566e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i727673cf2e684c87b5b941e19e9dead2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3a30c8bb4fa4da191e1db1a2cdf4ad3_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58b615af0c5645a8bab43631dc6ce435_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba2a746fe9d742cd9ce6866ca1f467ca_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">sibn:EmployeeStockPurchasePlanSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3834751827fd42c693830e07acfee079_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">sibn:EmployeeStockPurchasePlanSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i785a9d69422049969f551e00c09cd4fe_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">sibn:CommonStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5cfef6391a45463393b78121e9c5bed4_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">sibn:CommonStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42f2ba3e6b0746d58d9b74e3cf027cd7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sibn:DevelopmentAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7bf5dda5bf324c4fa4a20b1e527679ae_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sibn:DevelopmentAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e73e5a0115b4970b15363db24e13c22_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sibn:DevelopmentAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a94faa120a0446aa696de6aeda19c4b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sibn:DevelopmentAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i928aa505a2ea46079da4e5082002267b_1"></div><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES </span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:27.916%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM&#160;<ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGV4dHJlZ2lvbjplNzg5M2Y0OWYwOTE0NDU0YjQ5YTI4MTcxZmZiODJlY18yMTUx_e738e308-4ede-4992-84a6-91705df250e6">10-Q</ix:nonNumeric> </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:27.916%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Mark one)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGV4dHJlZ2lvbjplNzg5M2Y0OWYwOTE0NDU0YjQ5YTI4MTcxZmZiODJlY18yMTQy_f1e5b190-406f-42c6-881a-a0f1cd668abf">&#9746;</ix:nonNumeric> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGV4dHJlZ2lvbjplNzg5M2Y0OWYwOTE0NDU0YjQ5YTI4MTcxZmZiODJlY18yMjk_42b5efc8-49bf-42ba-81f3-ea6e325d863e">March 31, 2023</ix:nonNumeric> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">OR</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGV4dHJlZ2lvbjplNzg5M2Y0OWYwOTE0NDU0YjQ5YTI4MTcxZmZiODJlY18yMTUy_5295dec7-0899-4102-9e2c-47594d12d542">&#9744;</ix:nonNumeric> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">For the transition period from __________ to __________</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Commission File Number:  <ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGV4dHJlZ2lvbjplNzg5M2Y0OWYwOTE0NDU0YjQ5YTI4MTcxZmZiODJlY18yMTUz_137f7f41-b60d-4607-bdf6-ab2e4c046322">001-38701</ix:nonNumeric></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGV4dHJlZ2lvbjplNzg5M2Y0OWYwOTE0NDU0YjQ5YTI4MTcxZmZiODJlY18yMTQ3_e975d30c-b296-425c-a99c-bc67e518a6e8">SI-BONE,&#160;INC.</ix:nonNumeric> </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">(Exact Name of Registrant as Specified in its Charter) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:2pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:27.916%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.527%"><tr><td style="width:1.0%"></td><td style="width:41.058%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.036%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.606%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGFibGU6ZWE0MmQwYThmYTVmNGZkMGE4NmQwZTJmZWRmMWM2NjIvdGFibGVyYW5nZTplYTQyZDBhOGZhNWY0ZmQwYTg2ZDBlMmZlZGYxYzY2Ml8wLTAtMS0xLTY4MzE2_4950ccab-c645-45da-9eb3-d2753b7fbeb6">Delaware</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGFibGU6ZWE0MmQwYThmYTVmNGZkMGE4NmQwZTJmZWRmMWM2NjIvdGFibGVyYW5nZTplYTQyZDBhOGZhNWY0ZmQwYTg2ZDBlMmZlZGYxYzY2Ml8wLTItMS0xLTY4MzE2_af3d9fe8-5c49-47b0-8ff7-cb01209b46ca">26-2216351</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State&#160;or&#160;Other&#160;Jurisdiction&#160;of<br/>Incorporation or Organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer<br/>Identification Number)</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.944%"><tr><td style="width:1.0%"></td><td style="width:41.306%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.954%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.440%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGFibGU6MzVhODJlOGJiOTM5NDBjOThjMDAwNmNmZDNjNTRjYjkvdGFibGVyYW5nZTozNWE4MmU4YmI5Mzk0MGM5OGMwMDA2Y2ZkM2M1NGNiOV8wLTAtMS0xLTY4MzE2L3RleHRyZWdpb246NmE0ODRhNmVjMmMxNDUzMzk4YTEwYmQ0MTUzZGY1NWRfNA_c36327e5-6540-4358-95b3-a5dd438dbc15">471 El Camino Real</ix:nonNumeric>, <ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGFibGU6MzVhODJlOGJiOTM5NDBjOThjMDAwNmNmZDNjNTRjYjkvdGFibGVyYW5nZTozNWE4MmU4YmI5Mzk0MGM5OGMwMDA2Y2ZkM2M1NGNiOV8wLTAtMS0xLTY4MzE2L3RleHRyZWdpb246NmE0ODRhNmVjMmMxNDUzMzk4YTEwYmQ0MTUzZGY1NWRfOA_83b18137-1267-43c6-8abb-61b639f2ca25">Suite 101</ix:nonNumeric>, <ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGFibGU6MzVhODJlOGJiOTM5NDBjOThjMDAwNmNmZDNjNTRjYjkvdGFibGVyYW5nZTozNWE4MmU4YmI5Mzk0MGM5OGMwMDA2Y2ZkM2M1NGNiOV8wLTAtMS0xLTY4MzE2L3RleHRyZWdpb246NmE0ODRhNmVjMmMxNDUzMzk4YTEwYmQ0MTUzZGY1NWRfMTI_52a3107c-334b-48de-b9a5-0834c7622e4d">Santa Clara</ix:nonNumeric>, <ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGFibGU6MzVhODJlOGJiOTM5NDBjOThjMDAwNmNmZDNjNTRjYjkvdGFibGVyYW5nZTozNWE4MmU4YmI5Mzk0MGM5OGMwMDA2Y2ZkM2M1NGNiOV8wLTAtMS0xLTY4MzE2L3RleHRyZWdpb246NmE0ODRhNmVjMmMxNDUzMzk4YTEwYmQ0MTUzZGY1NWRfMTY_a84438ea-8d09-4763-a586-336645ea5601">California</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGFibGU6MzVhODJlOGJiOTM5NDBjOThjMDAwNmNmZDNjNTRjYjkvdGFibGVyYW5nZTozNWE4MmU4YmI5Mzk0MGM5OGMwMDA2Y2ZkM2M1NGNiOV8wLTItMS0xLTY4MzE2_575fe8b2-1999-4bf2-87cc-c2bedb3be137">95050</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:700;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Registrant's telephone number, including area code</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGV4dHJlZ2lvbjplNzg5M2Y0OWYwOTE0NDU0YjQ5YTI4MTcxZmZiODJlY18yMTQz_d07fddc6-78cc-4f8f-90ca-6f22dbb1ac3e">408</ix:nonNumeric>) <ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGV4dHJlZ2lvbjplNzg5M2Y0OWYwOTE0NDU0YjQ5YTI4MTcxZmZiODJlY18yMTQ0_5bbd69ea-be46-4843-ba4d-da13aa43921d">207-0700</ix:nonNumeric></span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:27.777%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act: </span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.361%"><tr><td style="width:1.0%"></td><td style="width:38.866%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.483%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Title of each class </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Trading Symbol(s) </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Name of each exchange on which registered </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGFibGU6Y2Q0OTViYWY0MWU4NGE0MWJmYzk2NTcwMzI4YjQxMjgvdGFibGVyYW5nZTpjZDQ5NWJhZjQxZTg0YTQxYmZjOTY1NzAzMjhiNDEyOF8xLTAtMS0xLTY4MzE2_2c3224e4-cf8c-4413-8f21-c2559681252d">Common Stock, par value $0.0001&#160;per share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGFibGU6Y2Q0OTViYWY0MWU4NGE0MWJmYzk2NTcwMzI4YjQxMjgvdGFibGVyYW5nZTpjZDQ5NWJhZjQxZTg0YTQxYmZjOTY1NzAzMjhiNDEyOF8xLTEtMS0xLTY4MzE2_c8250bc9-0ac7-4acb-b760-ec5de918365c">SIBN</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGFibGU6Y2Q0OTViYWY0MWU4NGE0MWJmYzk2NTcwMzI4YjQxMjgvdGFibGVyYW5nZTpjZDQ5NWJhZjQxZTg0YTQxYmZjOTY1NzAzMjhiNDEyOF8xLTItMS0xLTY4MzE2_d39b9441-bfb6-4eed-9e14-254b621a5bec">The Nasdaq Global Market</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&#160;&#160; <ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGV4dHJlZ2lvbjplNzg5M2Y0OWYwOTE0NDU0YjQ5YTI4MTcxZmZiODJlY18yMTU0_653b2098-5e9c-4a71-92f1-f97d465d33bb">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;<ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGV4dHJlZ2lvbjplNzg5M2Y0OWYwOTE0NDU0YjQ5YTI4MTcxZmZiODJlY18yMTQ4_de72f556-90ae-454c-b9b8-566204955c28">Yes</ix:nonNumeric> &#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">   No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> &#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.722%"><tr><td style="width:1.0%"></td><td style="width:23.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.803%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.405%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.803%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.405%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.808%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Large accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGFibGU6N2E0NDljZTBmZmE1NDMwMGEyZmZkMzk0MWE5ODc4YmIvdGFibGVyYW5nZTo3YTQ0OWNlMGZmYTU0MzAwYTJmZmQzOTQxYTk4NzhiYl8wLTYtMS0xLTgxNTcw_79f43289-368d-42d9-bfe2-14cd258c5f0d">Non-accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9746;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="dei:EntitySmallBusiness" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGFibGU6N2E0NDljZTBmZmE1NDMwMGEyZmZkMzk0MWE5ODc4YmIvdGFibGVyYW5nZTo3YTQ0OWNlMGZmYTU0MzAwYTJmZmQzOTQxYTk4NzhiYl8xLTEtMS0xLTY4MzE2_37ed8036-cacb-4342-a53b-1ad0cb6112a2">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Emerging growth company</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGFibGU6N2E0NDljZTBmZmE1NDMwMGEyZmZkMzk0MWE5ODc4YmIvdGFibGVyYW5nZTo3YTQ0OWNlMGZmYTU0MzAwYTJmZmQzOTQxYTk4NzhiYl8xLTQtMS0xLTY4MzE2_18c0330a-571e-49a1-bdf5-8b1d754dd7ff">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;7(a)(2)(B) of the Securities Act.&#160;&#9744; </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;&#160;Yes &#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">    No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGV4dHJlZ2lvbjplNzg5M2Y0OWYwOTE0NDU0YjQ5YTI4MTcxZmZiODJlY18yMTU1_21f3a433-9a23-4608-b6c2-69cacfa8904d">x</ix:nonNumeric></span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The number of shares outstanding of the registrant&#8217;s Common Stock was <ix:nonFraction unitRef="shares" contextRef="i0e136d89ad474fdeb683220221498c6a_I20230426" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGV4dHJlZ2lvbjplNzg5M2Y0OWYwOTE0NDU0YjQ5YTI4MTcxZmZiODJlY18yMTMx_2f87b60a-407d-43d1-8a55-58c664eeb099">35,184,049</ix:nonFraction> as of April&#160;26, 2023.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i928aa505a2ea46079da4e5082002267b_7"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-top:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.205%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.485%"></td><td style="width:0.1%"></td></tr><tr style="height:0pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART I-FINANCIAL INFORMATION</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_13">Item 1.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_13">Financial Statements </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_13">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_16">Condensed Consolidated Balance Sheets</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_13">(Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_16">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_19">Condensed Consolidated Statements of Operations and Comprehensive Loss</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_13">(Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_19">5</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_22">Condensed Consolidated Statements of Changes in Stockholders' Equity</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_13">(Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_22">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_25">Condensed Consolidated Statements of Cash Flows</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_13">(Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_25">7</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_28">Notes to Condensed Consolidated Financial Statements</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_13">(Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_28">8</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_67">Item 2.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_67">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_67">21</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_106">Item 3.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_106">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_106">31</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_109">Item 4.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_109">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_109">31</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART II-OTHER INFORMATION</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_115">Item 1.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_115">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_115">32</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_118">Item&#160;1A.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_118">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_118">33</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_121">Item 2.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_121">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_121">67</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_124">Item 3.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_124">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_124">67</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_127">Item 4.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_127">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_127">67</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_130">Item 5.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_130">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_130">67</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_133">Item 6.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_133">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_133">68</a></span></div></td></tr><tr style="height:14pt"><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_136">SIGNATURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i928aa505a2ea46079da4e5082002267b_136">69</a></span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:18pt"><span><br/></span></div><div style="margin-top:18pt"><span><br/></span></div><div style="margin-top:18pt"><span><br/></span></div><div style="margin-top:18pt"><span><br/></span></div><div style="margin-top:18pt"><span><br/></span></div><div style="margin-top:18pt"><span><br/></span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="margin-top:18pt;text-align:center"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="i928aa505a2ea46079da4e5082002267b_10"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report on Form&#160;10-Q contains forward-looking statements. All statements other than statements of historical facts contained in this Quarterly Report, including statements regarding our future results of operations and financial position, business strategy, prospective products and product candidates, sales force expansion, surgeon adoption, reimbursement determinations, clinical trial results, and U.S. Food and Drug Administration ("FDA") approvals, are forward-looking statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some cases, you can identify forward-looking statements by terms such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;could,&#8221; &#8220;intend,&#8221; &#8220;target,&#8221; &#8220;project,&#8221; &#8220;contemplate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221; &#8220;potential&#8221; or &#8220;continue&#8221; or the negative of these terms or other similar expressions, although not all forward-looking statements contain these identifying words. These forward-looking statements speak only as of the date of this Quarterly Report and are subject to a number of risks, uncertainties and assumptions, including those described under the sections in this Quarterly Report titled &#8220;Risk Factors&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.&#8221; These forward-looking statements include, but are not limited to, statements about the following:</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to continue to diversify our product mix, including identification of new opportunities and access the capital required to fund adequate new inventory of instruments and implants to address these opportunities;</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectation that a significant portion of our revenues will be derived from sales from a small family of products and a single family of procedures;</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to develop and commercialize additional revenue opportunities, including new indications for use and new devices;</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to retain and grow our sales team based on the demand for our products;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to identify, train, and retain surgeons to perform procedures using our products;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to obtain and maintain favorable coverage and reimbursement determinations from third-party payors;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our estimates of our market opportunities;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding the scope of protection from intellectual property rights covering our products;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developments or disputes concerning our intellectual property or other proprietary rights;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">timing of and results from clinical and other trials;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">marketing clearances and authorization from the FDA and regulators in other jurisdictions;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">timing of regulatory filings and feedback;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">competition in the markets we serve;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations of the reliability and performance of our products;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations of the benefits to patients, providers, and payors of our products;</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">factors impacting the supply chains we rely on, including the availability of raw materials and skilled labor serving our suppliers, and the cost of these factors of production which may in turn impact the prices we pay for our devices;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our reliance on a limited number of suppliers, including sole source suppliers, which may impact the availability of instruments and materials;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to sustain or increase demand for our products;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our estimates regarding our costs and risks associated with our international operations and expansion;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding our ability to retain and recruit key personnel;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to attract and retain employees, including those with specialized skills and experience;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to successfully manage the supply chain and operational challenges, as well as governmental responses or mandates, associated with a disease outbreak, including epidemics, pandemics or similar widespread public health concerns;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the continuing impact of COVID-19 or other disease outbreaks on the demand for, and timing of, our procedures;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to attract and retain a force of third party sales agents who sell our products in the U.S;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding acquisitions and strategic operations;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to access capital markets;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to fund our working capital requirements;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our compliance with, and the cost of, federal, state, and foreign regulatory requirements;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the factors that may impact our financial results; and</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">anticipated trends and challenges in our business and the markets in which we operate.</span></div><div style="margin-top:9pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements are based on management&#8217;s current expectations, estimates, forecasts, and projections about our business and the industry in which we operate, and management&#8217;s beliefs and assumptions are not guarantees of future performance or development and involve known and unknown risks, uncertainties, and other factors that are in some cases beyond our control. As a result, any or all of our forward-looking statements in this report may turn out to be inaccurate. Furthermore, if the forward-looking statements prove to be inaccurate, the inaccuracy may be material. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified time frame, or at all. In addition, statements that &#8220;we believe&#8221; and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this Quarterly Report on Form 10-Q, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Factors that may cause actual results to differ materially from current expectations include, among other things, those listed under &#8220;Risk Factors&#8221; and elsewhere in this report. These statements, like all statements in this report, speak only as of their date. We caution investors that our business and financial performance are subject to substantial risks and uncertainties. Except as required by law, we assume no obligation to update or revise these forward-looking statements for any reason, even if new information becomes available in the future, except as may be required by law.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i928aa505a2ea46079da4e5082002267b_13"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I-FINANCIAL INFORMATION</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Financial Statements</span></div><div><span><br/></span></div><div id="i928aa505a2ea46079da4e5082002267b_16"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SI-BONE, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands, except share and per share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.305%"><tr><td style="width:1.0%"></td><td style="width:73.865%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.067%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.069%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASSETS</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMy0xLTEtMS02ODMxNg_5c4bbb87-8272-49c6-973e-4c8fc88ab24a">22,969</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMy0zLTEtMS02ODMxNg_f3135688-e2c8-4478-b15a-45135d94f997">20,717</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfNC0xLTEtMS02ODMxNg_0cc3314d-46bc-4c8c-a543-da07ff514f2a">62,997</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfNC0zLTEtMS02ODMxNg_b568e745-2552-4ebb-ac50-f7d30ebd0f1f">76,573</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net of allowance for credit losses of $<ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfNS0wLTEtMS02ODMxNi90ZXh0cmVnaW9uOjQ0NGY4NzRkMWE4MTQ4NjY4YzAyNzkwYTE3ZmRlMjA4XzY3_91e8cd95-4e7b-4b02-9aa5-c55693376f90">450</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfNS0wLTEtMS02ODMxNi90ZXh0cmVnaW9uOjQ0NGY4NzRkMWE4MTQ4NjY4YzAyNzkwYTE3ZmRlMjA4Xzc1_cb57d70f-f5ef-4c56-a9df-0c6bef1cef2c">400</ix:nonFraction>, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfNS0xLTEtMS02ODMxNg_30509cd7-cd75-4385-8595-17d2e38a8606">22,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfNS0zLTEtMS02ODMxNg_d2251587-1132-404b-baf5-20731070c2cf">20,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfNi0xLTEtMS02ODMxNg_9b648083-b400-44a0-bc71-35c53b77b335">17,790</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfNi0zLTEtMS02ODMxNg_b764b7b2-3399-4c76-aa24-401e0b81f061">17,282</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfNy0xLTEtMS02ODMxNg_ef4b37a5-e1d6-4b3e-89d7-f04710105808">2,045</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfNy0zLTEtMS02ODMxNg_4ea9d469-7441-4d1f-925a-d9e5fb397963">2,365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfOC0xLTEtMS02ODMxNg_aa1747d7-1fcd-4b48-8b3f-3891b2e6d8ca">128,401</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfOC0zLTEtMS02ODMxNg_a83322ba-e587-4ca7-adc1-e62e10a3c17d">137,611</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMTAtMS0xLTEtNjgzMTY_f9739bfb-0ae2-4e4b-9006-a80533f4c057">16,629</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMTAtMy0xLTEtNjgzMTY_c8982c4f-235e-4f1f-8c56-4bbe76db286d">15,564</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMTEtMS0xLTEtNjgzMTY_1913a477-aa83-4d7d-878a-a73dcba477df">3,672</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMTEtMy0xLTEtNjgzMTY_bf93a173-6f12-446d-b5b6-e0acb150cb47">4,002</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMTItMS0xLTEtNjgzMTY_e65fd43b-be03-4aa6-8bb8-5856054519a9">374</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMTItMy0xLTEtNjgzMTY_0b0b52f0-4517-40c9-89ea-f5caaa2093e8">375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL ASSETS </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMTMtMS0xLTEtNjgzMTY_b7e1ccae-be59-40e4-9b02-f42fcbfc917f">149,076</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMTMtMy0xLTEtNjgzMTY_5d4ce0f1-ae14-4657-a280-70b102229aa5">157,552</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMTctMS0xLTEtNjgzMTY_a2f64653-0cc8-4b88-971d-23820e3255ef">5,331</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMTctMy0xLTEtNjgzMTY_06128036-9190-4b5f-9c6a-7b7b4bf09e03">6,279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMTgtMS0xLTEtNjgzMTY_24eda7de-f2d1-46d6-8944-5b41844b5a1a">9,896</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMTgtMy0xLTEtNjgzMTY_cb3c342f-450a-4fb0-b7da-4c33d4c463ff">13,511</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMjAtMS0xLTEtNjgzMTY_ba812f00-558e-435c-98de-d5b720d29890">1,401</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMjAtMy0xLTEtNjgzMTY_26e37e48-26cb-4d2c-9241-21d7d6265cd1">1,388</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMjEtMS0xLTEtNjgzMTY_02f1fbca-1bc4-452d-b4be-fdd569d30353">16,628</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMjEtMy0xLTEtNjgzMTY_4ab6628f-82d2-406d-9bea-54f890c62ad2">21,178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term borrowings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMjItMS0xLTEtNjgzMTY_e0ef90d5-8675-46d2-9f8e-53aa17021fe2">35,938</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMjItMy0xLTEtNjgzMTY_3413528f-822d-43d2-ac0a-4edd96d735e1">35,171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMjMtMS0xLTEtNjgzMTY_a3389924-224a-44cf-a2a8-df6ebbe1341b">2,525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMjMtMy0xLTEtNjgzMTY_5bc6972b-a0d6-4ba8-8524-e2038d9f9d64">2,871</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMjQtMS0xLTEtNjgzMTY_9e4d2748-c915-4828-b0f0-33827101c64a">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMjQtMy0xLTEtNjgzMTY_d9a1063d-9563-4139-922c-22d2bc45a8ee">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL LIABILITIES</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMjUtMS0xLTEtNjgzMTY_f7323dad-a168-4602-a945-17cb274c84ff">55,117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMjUtMy0xLTEtNjgzMTY_6a7c6bc9-346e-4adf-a525-a78575da80c3">59,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 6)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMjctMS0xLTEtNjgzMTY_cf5aa13d-3873-4574-9daa-999a6179b182"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMjctMy0xLTEtNjgzMTY_5e1c3179-1b83-4525-92e0-041a1bf670b2"></ix:nonFraction></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">STOCKHOLDERS&#8217; EQUITY</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzAtMC0xLTEtNjgzMTYvdGV4dHJlZ2lvbjpmODNmZjZiODJmYTA0ODJmYjVjZjJiYzIyMGE5OGU4Y18yMg_6c7427cf-2e2f-4d68-a6d8-15d8ee8c6a09"><ix:nonFraction unitRef="usdPerShare" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzAtMC0xLTEtNjgzMTYvdGV4dHJlZ2lvbjpmODNmZjZiODJmYTA0ODJmYjVjZjJiYzIyMGE5OGU4Y18yMg_bbf62bd9-f206-42d7-a706-bb7a0e1ed30f">0.0001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzAtMC0xLTEtNjgzMTYvdGV4dHJlZ2lvbjpmODNmZjZiODJmYTA0ODJmYjVjZjJiYzIyMGE5OGU4Y18zNg_5fcbe3bd-abb3-429c-9656-6c42349289a1"><ix:nonFraction unitRef="shares" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzAtMC0xLTEtNjgzMTYvdGV4dHJlZ2lvbjpmODNmZjZiODJmYTA0ODJmYjVjZjJiYzIyMGE5OGU4Y18zNg_87abbe23-e6d2-410e-ab32-d14a42fd1bcc">5,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzAtMC0xLTEtNjgzMTYvdGV4dHJlZ2lvbjpmODNmZjZiODJmYTA0ODJmYjVjZjJiYzIyMGE5OGU4Y181OA_2c889b7a-12b5-4adc-8996-b1e65f142825"><ix:nonFraction unitRef="shares" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzAtMC0xLTEtNjgzMTYvdGV4dHJlZ2lvbjpmODNmZjZiODJmYTA0ODJmYjVjZjJiYzIyMGE5OGU4Y181OA_3afcd7e9-d31d-448f-b406-8da5e564180d"><ix:nonFraction unitRef="shares" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzAtMC0xLTEtNjgzMTYvdGV4dHJlZ2lvbjpmODNmZjZiODJmYTA0ODJmYjVjZjJiYzIyMGE5OGU4Y181OA_e6a3a326-245a-47e2-abdd-ef516115ae18"><ix:nonFraction unitRef="shares" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzAtMC0xLTEtNjgzMTYvdGV4dHJlZ2lvbjpmODNmZjZiODJmYTA0ODJmYjVjZjJiYzIyMGE5OGU4Y181OA_f1626f23-cf96-4121-aedd-c381fee418b2">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzAtMS0xLTEtNjgzMTY_3e6c3ebe-9b9e-4728-bfae-59ba97b2a5fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzAtMy0xLTEtNjgzMTY_31b013e8-5386-465e-826c-9b4d1494f943">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzEtMC0xLTEtNjgzMTYvdGV4dHJlZ2lvbjo0ZjhkNzFkNjk4NzQ0MjU0OGViNDAwMDg4YjM4OGU5Yl8xOA_3b11cac9-9a04-4e71-9e7c-fb3ea7ababb2"><ix:nonFraction unitRef="usdPerShare" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzEtMC0xLTEtNjgzMTYvdGV4dHJlZ2lvbjo0ZjhkNzFkNjk4NzQ0MjU0OGViNDAwMDg4YjM4OGU5Yl8xOA_d81311d2-b249-4008-8e0f-78e6d68b7b87">0.0001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzEtMC0xLTEtNjgzMTYvdGV4dHJlZ2lvbjo0ZjhkNzFkNjk4NzQ0MjU0OGViNDAwMDg4YjM4OGU5Yl8zMg_1168a993-1e59-4b7a-b817-66f732f71587"><ix:nonFraction unitRef="shares" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzEtMC0xLTEtNjgzMTYvdGV4dHJlZ2lvbjo0ZjhkNzFkNjk4NzQ0MjU0OGViNDAwMDg4YjM4OGU5Yl8zMg_93a41026-b275-4589-ac2a-566342b82366">100,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzEtMC0xLTEtNjgzMTYvdGV4dHJlZ2lvbjo0ZjhkNzFkNjk4NzQ0MjU0OGViNDAwMDg4YjM4OGU5Yl81NA_091172c4-5422-45c6-b002-9aa357af6404"><ix:nonFraction unitRef="shares" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzEtMC0xLTEtNjgzMTYvdGV4dHJlZ2lvbjo0ZjhkNzFkNjk4NzQ0MjU0OGViNDAwMDg4YjM4OGU5Yl81NA_b28a15f0-80f5-411e-ad91-270863d61383">35,106,163</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzEtMC0xLTEtNjgzMTYvdGV4dHJlZ2lvbjo0ZjhkNzFkNjk4NzQ0MjU0OGViNDAwMDg4YjM4OGU5Yl82MQ_7c2e3748-05d1-4af7-ac00-b8b52ce1db52"><ix:nonFraction unitRef="shares" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzEtMC0xLTEtNjgzMTYvdGV4dHJlZ2lvbjo0ZjhkNzFkNjk4NzQ0MjU0OGViNDAwMDg4YjM4OGU5Yl82MQ_d1757cdf-ee30-47ec-90f4-492edf56f15f">34,731,577</ix:nonFraction></ix:nonFraction> shares issued and outstanding, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzEtMS0xLTEtNjgzMTY_d7f19ad7-df49-4bc6-8b62-754847bb5465">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzEtMy0xLTEtNjgzMTY_eb867319-fa09-4651-a9e0-f378abf25771">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzItMS0xLTEtNjgzMTY_7163b525-8073-4746-a471-120c6a105b87">461,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzItMy0xLTEtNjgzMTY_09e6663d-10fc-4ed8-88c0-f6d4f9c55bbe">455,172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive income</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzMtMS0xLTEtNjgzMTY_5485ae3e-04a1-4cfd-b10f-823004e9edd5">300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzMtMy0xLTEtNjgzMTY_0da1f53d-a2c2-4a42-b05c-70408d6c38e5">232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzQtMS0xLTEtNjgzMTY_d309500c-f23d-4c5d-8bae-e2f715fc4469">368,230</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzQtMy0xLTEtNjgzMTY_70ec4f6d-0ee7-4c0c-9ad6-d9c606a914c5">357,105</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzUtMS0xLTEtNjgzMTY_b9015112-72c2-412e-b97f-82497039a588">93,959</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzUtMy0xLTEtNjgzMTY_791fd52b-a751-443a-9595-244c6dded0ec">98,302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzYtMS0xLTEtNjgzMTY_9cd0a78f-6513-4eaf-a2d3-64544d31fe2a">149,076</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzYtMy0xLTEtNjgzMTY_9235377c-2baa-4347-aa8b-9f1a8a21e805">157,552</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div><div><span><br/></span></div></div></div><div id="i928aa505a2ea46079da4e5082002267b_19"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SI-BONE, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands, except share and per share amounts) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:75.555%"><tr><td style="width:1.0%"></td><td style="width:66.914%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.719%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.342%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMi0xLTEtMS02ODMxNg_2404ee11-3490-4625-8f37-f215391f791e">32,708</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMi0zLTEtMS02ODMxNg_cd8ad697-0c18-4389-80c8-1103f69f42cb">22,439</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMy0xLTEtMS02ODMxNg_31ea5a77-3cdd-435e-a0e0-dba4973d1ea8">5,924</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMy0zLTEtMS02ODMxNg_3cfefbf1-ddf0-4cbc-a941-b79160fa0689">2,983</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfNC0xLTEtMS02ODMxNg_fe4d1c44-704b-4458-9278-9548b0153aa2">26,784</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfNC0zLTEtMS02ODMxNg_b67f8b43-6fbd-41de-b9e1-186752e93f7f">19,456</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfNi0xLTEtMS02ODMxNg_620a1ba7-511e-4ff3-b752-78b229142d3d">27,313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfNi0zLTEtMS02ODMxNg_086b8601-9557-4594-bcc6-d9a0fdcbc2eb">25,605</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfNy0xLTEtMS02ODMxNg_72a1cac4-686b-4b7a-bf60-72a6e1b002c2">3,291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfNy0zLTEtMS02ODMxNg_62449af6-fb41-44d2-99d8-11ff4603b90a">3,580</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfOC0xLTEtMS02ODMxNg_1b56a693-3ab7-4c36-a269-3fc9879be236">7,473</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfOC0zLTEtMS02ODMxNg_b9701a4a-dc99-40ac-b376-6cb3aa5425eb">7,139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfOS0xLTEtMS02ODMxNg_d194d74e-b47f-4ca5-9637-4cf5321ca920">38,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfOS0zLTEtMS02ODMxNg_baf1cfde-4ed7-48cd-9e07-b308d3cd1ea1">36,324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMTAtMS0xLTEtNjgzMTY_575a8d99-2b90-4284-ba37-6e7157ea76fa">11,293</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMTAtMy0xLTEtNjgzMTY_d1bae251-0970-4471-9dc7-7bb2aac6a568">16,868</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other income (expense), net:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMTItMS0xLTEtNjgzMTY_76975a96-0762-473a-b042-6f5ed04b502c">932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMTItMy0xLTEtNjgzMTY_30ea8b4f-4175-45cb-a0e4-ab1fb6e4af75">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMTMtMS0xLTEtNjgzMTY_5e945932-89b1-42d9-959a-a7b64751569b">838</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMTMtMy0xLTEtNjgzMTY_7fd167ca-1fcb-4115-8d14-281e9443bed7">561</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMTQtMS0xLTEtNjgzMTY_8d3f61b5-7962-427c-9dd1-3d0ff5b0c961">74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMTQtMy0xLTEtNjgzMTY_af7b5b4e-1e82-49f1-a34e-f277490ed51b">54</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMTUtMS0xLTEtNjgzMTY_c659b1dd-58c3-4035-9c61-fd009f3c7a49">11,125</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMTUtMy0xLTEtNjgzMTY_790808bf-ea33-4870-9f96-753e4492d563">17,410</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss):</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in foreign currency translation</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMTctMS0xLTEtNjgzMTY_a6a1a371-b582-4442-8db6-0540595f5151">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMTctMy0xLTEtNjgzMTY_74452b3c-ab53-4137-b9f2-33818adce841">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain (loss) on marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMTgtMS0xLTEtNjgzMTY_41c7b522-6cdd-4b9c-b0ee-551d131c6259">90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMTgtMy0xLTEtNjgzMTY_712c889a-4190-40b9-bdd7-3bca123a3394">248</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMTktMS0xLTEtNjgzMTY_0324ac71-e465-4d78-95dc-18df2e62d94f">11,057</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMTktMy0xLTEtNjgzMTY_7a0ff8b6-0cd8-4e09-ab50-cba2cbcdd813">17,658</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share, basic and diluted</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMjEtMS0xLTEtNjgzMTY_4bdef36a-9d62-40c3-8760-dfd8bd535a5a"><ix:nonFraction unitRef="usdPerShare" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMjEtMS0xLTEtNjgzMTY_b2a1e2f8-b646-4ddc-9b5f-8a5b2108cf6c">0.32</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMjEtMy0xLTEtNjgzMTY_9b67ed2f-2bb1-4372-b80a-49b761f9afe5"><ix:nonFraction unitRef="usdPerShare" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMjEtMy0xLTEtNjgzMTY_f7c53151-bad7-43f9-a148-29f999bac2e7">0.52</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares used to compute basic and diluted net loss per share</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMjMtMS0xLTEtNjgzMTY_a180c728-3f47-486d-995e-be86a427d55d"><ix:nonFraction unitRef="shares" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMjMtMS0xLTEtNjgzMTY_d61bfe58-9ae2-48c9-8282-becaee9d4a90">34,916,106</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMjMtMy0xLTEtNjgzMTY_82428667-fad5-4bb0-9c80-2bd78af9ec12"><ix:nonFraction unitRef="shares" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMjMtMy0xLTEtNjgzMTY_ebf0e2e3-a8f1-4a90-85bb-56254b0f281c">33,792,326</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i928aa505a2ea46079da4e5082002267b_22"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">SI-BONE, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">(In thousands, except share amounts)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.375%"><tr><td style="width:1.0%"></td><td style="width:45.545%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.866%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.866%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.290%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:33pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additional</span></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Paid-in  </span></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Capital</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated</span></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other  </span></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Comprehensive  </span></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated</span></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Deficit</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stockholders&#8217; Equity</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia1ad2c138559410ba21a1f7abb1d4ffd_I20221231" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMi0yLTEtMS02ODMxNg_8e9b8e5b-bd51-4c50-aa2e-b91aa23a38b4">34,731,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1ad2c138559410ba21a1f7abb1d4ffd_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMi00LTEtMS02ODMxNg_2c01a858-b43d-4190-858e-e75c7d1844b6">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73f03223216c40f18e39597ffaec1ef4_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMi02LTEtMS02ODMxNg_d2299e22-4656-4edf-999a-b88a4363f268">455,172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib60e72c3aa6e4ad28de9ed0584387b84_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMi04LTEtMS02ODMxNg_713aa2a8-30f2-4ddb-b5d4-8a18bd2c0abe">232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02dda049bbb449b7a4908baa63bfc3c0_I20221231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMi0xMC0xLTEtNjgzMTY_8ef24a24-c5eb-437a-ba93-9199de828bd9">357,105</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMi0xMi0xLTEtNjgzMTY_9c5b8b91-5a45-4259-a7ef-2a22ead31ce7">98,302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock upon exercise of stock options, net of shares withheld</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id0c350aefbd0469a8c27d16d7649c977_D20230101-20230331" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMy0yLTEtMS02ODMxNg_516b6943-d91d-43ec-817d-603e0dd8b601">120,266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i205f14e8b1cc49a7aedfb949e6e0c598_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMy02LTEtMS02ODMxNg_af17e3d3-9f15-4f37-88cc-bba15284088a">520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMy0xMi0xLTEtNjgzMTY_5ae2db9f-7194-4c26-9139-8b33029de05b">520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock upon vesting of restricted stock units</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id0c350aefbd0469a8c27d16d7649c977_D20230101-20230331" decimals="0" name="sibn:StockIssuedDuringPeriodSharesRestrictedStockUnits" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfNC0yLTEtMS02ODMxNg_eb8663ed-5737-46ee-ad09-6128a51fe4f4">254,320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i205f14e8b1cc49a7aedfb949e6e0c598_D20230101-20230331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfNS02LTEtMS02ODMxNg_009c077b-96a2-4fb3-b802-e1cc3f47b8d6">6,194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfNS0xMi0xLTEtNjgzMTY_7185957a-141d-4112-8622-b82441686993">6,194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd89d2d32f7e4eadb653b6c699a1da65_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfNy04LTEtMS02ODMxNg_9d3a0d72-72fb-426c-aade-c8b8c1fe749c">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfNy0xMi0xLTEtNjgzMTY_a4e64e2d-6b83-4b90-990c-49f27cff8bde">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized gain on marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd89d2d32f7e4eadb653b6c699a1da65_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfOC04LTEtMS02ODMxNg_9592373e-fffe-46e6-bc2e-ad27ab227889">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfOC0xMi0xLTEtNjgzMTY_05ce7305-f4a7-4e0f-b941-9f29f693d106">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb828f727d314174b2f1a4710790fde9_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfOS0xMC0xLTEtNjgzMTY_8f0d4df1-49a3-4a84-b514-7dcbaeea2573">11,125</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfOS0xMi0xLTEtNjgzMTY_7b78e745-12e0-450e-a1e9-4f5669d93508">11,125</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i061a1d4685fa4917a427a6f03c1beeb4_I20230331" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMTAtMi0xLTEtNjgzMTY_2697b472-7b25-4e00-ab2b-2825cd315d29">35,106,163</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i061a1d4685fa4917a427a6f03c1beeb4_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMTAtNC0xLTEtNjgzMTY_20b107b2-7a0f-4d2f-bceb-a4a67aaf3f5a">3</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e08c97777d48b3a2279b29a42ce726_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMTAtNi0xLTEtNjgzMTY_edd66c96-21e8-4ff5-8097-6a89340c77a0">461,886</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i930a39bf4a65491ca6af24ed50e20906_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMTAtOC0xLTEtNjgzMTY_a245e2e0-c759-480f-9b4f-528418778fa5">300</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i954439b3925043e3949da7080d9256e2_I20230331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMTAtMTAtMS0xLTY4MzE2_56f6a8bd-c345-4242-9632-c2b97d53fb41">368,230</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMTAtMTItMS0xLTY4MzE2_4b0b24e2-feef-4728-a768-a51668bfb878">93,959</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:33pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additional</span></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Paid-in  </span></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Capital</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated</span></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other  </span></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Comprehensive  </span></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated</span></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Deficit</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stockholders&#8217; Equity</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i883fe34ebc0c4092a483d977c3f8d429_I20211231" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMzItMi0xLTEtNjgzMTY_95840e9e-efb1-48d6-a132-58af4f5727ad">33,674,085</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i883fe34ebc0c4092a483d977c3f8d429_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMzItNC0xLTEtNjgzMTY_547a52e3-a3ce-4fe4-9e58-aea1efe87481">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aa2d78b45474cb8b1a7e306265bc187_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMzItNi0xLTEtNjgzMTY_22a8d334-73fb-4813-97d9-d871004cd77c">429,914</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0422532f98d04beb985b3c54535d2911_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMzItOC0xLTEtNjgzMTY_ab116e70-bc5b-486b-a4cc-227045e11c5e">352</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i429ed22eade94b3e88f8ed51a9a289e9_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMzItMTAtMS0xLTY4MzE2_6746b2de-4078-4216-aa6e-b31cb325647f">295,849</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25ff20079ccb48899ea84d72b50e16e7_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMzItMTItMS0xLTY4MzE2_c25dc590-84f7-42c4-a4af-e1a49aa04cf0">134,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock upon exercise of stock options, net of shares withheld</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i58ceb493d83949bb8045aa75c1c8bdc3_D20220101-20220331" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMzMtMi0xLTEtNjgzMTY_c4046b90-cd3e-40e9-92cd-eef48f92f26f">34,798</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84b72a6f51f6449f84a5d5b3cc309664_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMzMtNi0xLTEtNjgzMTY_329e9ddb-e349-471a-bc7f-a88773596ef8">169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMzMtMTItMS0xLTY4MzE2_80c6fda3-ad63-431c-a4ec-c99b5f761231">169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock upon vesting of restricted stock units</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i58ceb493d83949bb8045aa75c1c8bdc3_D20220101-20220331" decimals="0" name="sibn:StockIssuedDuringPeriodSharesRestrictedStockUnits" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMzQtMi0xLTEtNjgzMTY_fd1ce5f5-3711-42d0-a199-7530c14cb0a3">163,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84b72a6f51f6449f84a5d5b3cc309664_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMzUtNi0xLTEtNjgzMTY_9758561b-fb28-49d7-a95a-919292884d5d">5,507</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMzUtMTItMS0xLTY4MzE2_dd82003b-11b3-465e-8983-c2d4f44de1fc">5,507</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized loss on marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id37cd14c22ad42eb8a735baa4d08d8b0_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMzgtOC0xLTEtNjgzMTY_fa90a910-dd7d-4173-8354-9c468da0cb8c">248</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMzgtMTItMS0xLTY4MzE2_13a9ac70-bff8-4422-a5ec-c6ea4d6ff967">248</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie59f6758cf1b4684be0a81c20e471c4b_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMzktMTAtMS0xLTY4MzE2_ee601db8-3bb3-499f-acb1-96e3baadfa3a">17,410</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMzktMTItMS0xLTY4MzE2_0fc05bd4-e9ef-49dc-81f3-f5584ae1b4ad">17,410</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iad9213ed4f734769974b00e30b313acc_I20220331" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfNDAtMi0xLTEtNjgzMTY_1158adb6-174a-4167-b9cc-0d5db75c4f03">33,872,363</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad9213ed4f734769974b00e30b313acc_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfNDAtNC0xLTEtNjgzMTY_c6e1871b-3a92-4a63-92f5-20381c8fb437">3</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8247ae5acd7b41e9a09b537937c10239_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfNDAtNi0xLTEtNjgzMTY_25ac893d-1136-4f4c-b0fc-8ca67599e9db">435,590</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8f402bebac44ff39653d91d5f80e030_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfNDAtOC0xLTEtNjgzMTY_6ea3507a-523e-49dd-8977-2a2184efbb6b">104</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7459a99379124552878485552b9000b8_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfNDAtMTAtMS0xLTY4MzE2_ff4a9e0c-fc86-4cda-965d-08357e309959">313,259</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37f453d1957c4f60a0e5d364ba1d84c7_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfNDAtMTItMS0xLTY4MzE2_02addfad-fe79-40bb-9432-8604e810603f">122,438</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. </span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i928aa505a2ea46079da4e5082002267b_25"></div><hr style="page-break-after:always"/><div style="min-height:27pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SI-BONE, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.388%"><tr><td style="width:1.0%"></td><td style="width:73.683%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.147%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.150%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from operating activities</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMy0xLTEtMS02ODMxNg_3327638c-cfee-4412-9343-3c2abedf4883">11,125</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMy0zLTEtMS02ODMxNg_4b3630fc-9e3a-4f5d-97eb-3f9ac293b531">17,410</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfNS0xLTEtMS02ODMxNg_a3effe8f-dad3-40d1-bbe9-497c1aa15453">6,194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfNS0zLTEtMS02ODMxNg_7e968ef2-fdec-4bb1-9cee-5bb12ac93f98">5,507</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfNi0xLTEtMS02ODMxNg_41990c3c-b9e2-4a02-b8fb-631c0d6dd0c6">1,086</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfNi0zLTEtMS02ODMxNg_c1877551-ea33-46d0-9df3-b4cb3df9a0a5">713</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable credit losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfNy0xLTEtMS02ODMxNg_a0efc564-0526-4612-820c-f9d1174d907d">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfNy0zLTEtMS02ODMxNg_a24ad7a3-ad8b-416c-8f9a-39f22deaab1e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accretion (amortization) of discount on marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfOC0xLTEtMS02ODMxNg_8cbf87e3-fe4a-4fc4-b63a-a0056f4c4680">615</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfOC0zLTEtMS02ODMxNg_f4c5b145-769c-4db8-9bdf-a1e81a611f93">244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMTAtMS0xLTEtNjgzMTY_aff00ae7-5011-43d0-bc5a-b74231aa2ec1">81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMTAtMy0xLTEtNjgzMTY_d22ef1f8-4aeb-453f-bd34-21c58541936e">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on disposal of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMTItMS0xLTEtNjgzMTY_4e08f946-3e2a-40ed-bb86-fcb13821509e">190</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMTItMy0xLTEtNjgzMTY_0e7a46cb-ad53-4488-b0c4-4337a717b87d">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMTQtMS0xLTEtNjgzMTY_f126d060-5b8f-4ea8-a350-2f622b3663e0">2,019</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMTQtMy0xLTEtNjgzMTY_f48d9f27-75e4-42f1-9a8e-44b3de4cf946">1,603</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMTUtMS0xLTEtNjgzMTY_c9e20b8c-db07-4994-a288-1feea4063a17">536</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMTUtMy0xLTEtNjgzMTY_68a1a092-85d4-4fc7-ac0b-91754d72134b">3,178</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMTYtMS0xLTEtNjgzMTY_3431e226-54e2-4605-b075-806a3a359046">311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMTYtMy0xLTEtNjgzMTY_29f49387-a170-4265-977e-03d9322c8b1d">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMTctMS0xLTEtNjgzMTY_64e8bc35-86c2-4cc4-b497-b584e8949ad1">745</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMTctMy0xLTEtNjgzMTY_0c5f0b87-87f5-433a-9101-5556cf73190a">2,086</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued liabilities and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMTgtMS0xLTEtNjgzMTY_af502278-93f2-49e0-a366-91feb1443b96">3,625</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMTgtMy0xLTEtNjgzMTY_b2883dd5-6cd1-44ac-b855-87b85b16d91d">3,171</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMTktMS0xLTEtNjgzMTY_31a56737-d723-423c-9a35-1b3eefa58d0d">10,753</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMTktMy0xLTEtNjgzMTY_7008d54e-d9c2-492b-be82-6587db3b16a2">13,512</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from investing activities</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Maturities of marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" name="sibn:ProceedsFromMaturityOfMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMjEtMS0xLTEtNjgzMTY_f39c5949-7165-4d23-84cd-1a0e4843de2a">30,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" name="sibn:ProceedsFromMaturityOfMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMjEtMy0xLTEtNjgzMTY_69ed9a54-a0b3-4af5-9db1-5e843068d853">25,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMjMtMS0xLTEtNjgzMTY_887b70a7-68e3-4c44-86bd-db3fa256ad29">15,718</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMjMtMy0xLTEtNjgzMTY_c021cdc9-a814-4c51-9a81-5614e42e6666">45,334</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMjQtMS0xLTEtNjgzMTY_aed40589-b40a-45dd-bbce-580bb4f279a2">2,579</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMjQtMy0xLTEtNjgzMTY_9c8abf9c-2c28-47f1-bed7-58224882a89c">2,274</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by (used in) investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMjUtMS0xLTEtNjgzMTY_3c7b6294-573a-4d5c-93ac-605016d1e7b8">11,703</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMjUtMy0xLTEtNjgzMTY_6d771cb3-4a7c-4ded-9d94-a49af51f1b92">22,608</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from financing activities</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from debt financing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMjgtMS0xLTEtNjgzMTY_5251325d-61ae-43c9-a605-b4646c386964">36,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMjgtMy0xLTEtNjgzMTY_607054c3-367f-4f51-b0d4-b6bf31f9c781">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayments of debt financing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMjktMS0xLTEtNjgzMTY_fee74b5c-5632-4817-9a8c-f2fe2c3a8a56">35,275</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMjktMy0xLTEtNjgzMTY_70f36e1c-6589-4337-a63e-5df2bf0e4e5e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments of debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMzAtMS0xLTEtNjgzMTY_98e643c6-17a8-4a21-8482-9f37aa9906a8">40</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMzAtMy0xLTEtNjgzMTY_9f5cc358-c22a-44fb-8a42-166806ad7ea3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from the exercise of stock options </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMzMtMS0xLTEtNjgzMTY_046a6e65-7735-49f6-8b5e-931badc5f078">520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMzMtMy0xLTEtNjgzMTY_4e21d307-f182-4dfc-b225-b36fde10a1c0">169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMzYtMS0xLTEtNjgzMTY_092e8926-c08b-42d2-aad1-1b5e83e51fb3">1,205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMzYtMy0xLTEtNjgzMTY_18ac6acb-6325-4890-8879-04aacf3edf52">169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:17.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMzctMS0xLTEtNjgzMTY_f9c436c4-fd0d-43e1-a782-51807b3297f7">97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMzctMy0xLTEtNjgzMTY_a65ad3e0-cd75-4ca1-8d3d-1ef99e0dca1d">139</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net increase (decrease) in cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMzgtMS0xLTEtNjgzMTY_a36b2732-8c31-474a-8fa0-6856c8b5233e">2,252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMzgtMy0xLTEtNjgzMTY_bc5055e3-cfda-4941-9d60-fcd5bcf09d0a">36,090</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and cash equivalents at</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning of period</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfNDAtMS0xLTEtNjgzMTY_fb14c958-63cd-442c-af17-5ef27e6e955a">20,717</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25ff20079ccb48899ea84d72b50e16e7_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfNDAtMy0xLTEtNjgzMTY_4341f613-74d2-4561-99bb-39b85ea5dd0b">63,419</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">End of period</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfNDEtMS0xLTEtNjgzMTY_f2e89c15-9bf6-41c6-bbb8-6d8cdc6eaad4">22,969</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37f453d1957c4f60a0e5d364ba1d84c7_I20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfNDEtMy0xLTEtNjgzMTY_15347db3-9948-4fe1-aea5-02d29f326cbd">27,329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supplemental disclosure of non-cash information</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unpaid purchases of property and equipment </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfNDctMS0xLTEtNjgzMTY_9f300a74-ebca-4392-b036-cea01e195f13">887</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfNDctMy0xLTEtNjgzMTY_a38854a8-aa16-4766-b1a9-54618c67dbe6">241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. </span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div><div><span><br/></span></div></div></div><div id="i928aa505a2ea46079da4e5082002267b_28"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SI-BONE, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) </span></div><div style="text-align:center"><span><br/></span></div></div><div><span><br/></span></div><div id="i928aa505a2ea46079da4e5082002267b_31"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. <ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="us-gaap:NatureOfOperations" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zMS9mcmFnOmRkZjEzNWUzODVmNDQ5OGQ4MzIxZTczYjFlYTEzMDhmL3RleHRyZWdpb246ZGRmMTM1ZTM4NWY0NDk4ZDgzMjFlNzNiMWVhMTMwOGZfMjI3OQ_09adfe0d-2885-4a30-9ae5-d52c1146c3d3" continuedAt="i5bb884e1e0ab4a5f991673cabd96b126" escape="true">The Company and Nature of Business</ix:nonNumeric></span></div><ix:continuation id="i5bb884e1e0ab4a5f991673cabd96b126"><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SI-BONE, Inc. (the &#8220;Company&#8221;) was incorporated in the state of Delaware on March&#160;18, 2008 and is headquartered in Santa Clara, California. The Company is a medical device company that has pioneered a proprietary minimally invasive surgical implant system to fuse the sacroiliac joint for treatment of musculoskeletal disorders of the sacropelvic anatomy. The Company introduced its first generation iFuse implant in 2009 in the U.S., in 2010 in certain countries in the European Union, and in 2015 in certain countries in the rest of the world. The second generation iFuse implant, iFuse-3D, was introduced in 2017 followed by iFuse-TORQ in 2021 and iFuse Bedrock Granite in 2022.</span></div><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks and Uncertainties</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company is subject to uncertainties related to liquidity, the ability to meet covenants and access to funding for its capital needs as the financial service industry has experienced disruptions characterized by the bankruptcy, failure, collapse or sale of various financial institutions. The Company&#8217;s cash and cash equivalents are primarily invested in deposits and money market accounts with two major financial institutions in the U.S. Deposits in these banks may exceed the federally insured limits or any other insurance provided on such deposits, if any. The Company had accounts with Silicon Valley Bank (&#8220;SVB&#8221;). On March 10, 2023, California regulators shut down SVB and the FDIC was appointed as SVB&#8217;s receiver. On March 26, 2023, the FDIC announced that it had entered into a purchase and assumption agreement with First-Citizens Bank &amp; Trust Company (&#8220;First-Citizens&#8221;) under which all deposits of the former Silicon Valley Bank were assumed by First-Citizens.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">First-Citizens acquired the rights as lender under the Company&#8217;s Loan and Security Agreement as amended. To date, the Company has not experienced any losses on its deposits of cash, cash equivalents and marketable securities and continues to have access to these funds.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company is subject to continuing risk and uncertainties resulting from the COVID-19 pandemic. The COVID-19 pandemic has impacted our supply chain and also caused delays or cancellations of our procedures. Continuing or future outbreaks of COVID-19 or other public health concerns could contribute to health systems diverting resources to respond to COVID-19 which could lead to scheduling delays or cancellations of our procedures. Continuing or future outbreaks could also cause or exacerbate supply chain shortages.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As such the Company's future results of operations and liquidity could be adversely impacted by a variety of factors related to uncertainties in the financial services industry and new or ongoing impacts of the COVID-19 pandemic, including those discussed in the section titled "Risk Factors" in this report. As of the date of issuance of these condensed consolidated financial statements, the extent to which the COVID-19 pandemic, economic disruption that has resulted from the pandemic and measures taken to stabilize economies during the pandemic, global supply chain issues and uncertainties of the financial services industry may materially impact the Company's financial condition, liquidity, or results of operations remains uncertain.</span></div></ix:continuation><div id="i928aa505a2ea46079da4e5082002267b_34"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. <ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNC9mcmFnOmQzZTgyM2VlNTNhMTRkYjc5ODNhZDFhYTIzNmQyZTMzL3RleHRyZWdpb246ZDNlODIzZWU1M2ExNGRiNzk4M2FkMWFhMjM2ZDJlMzNfMTA0NDE_cce14ca6-d9ca-4db4-b12b-ad3479f2bf46" continuedAt="i0d467098f8fe4dddb151ba2e69c10ed1" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="i0d467098f8fe4dddb151ba2e69c10ed1" continuedAt="i1c0dafe98aa646ca84c7a01e9b1ebe7a"><div style="margin-bottom:12pt;margin-top:9pt;padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Principles of Consolidation</span></div><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNC9mcmFnOmQzZTgyM2VlNTNhMTRkYjc5ODNhZDFhYTIzNmQyZTMzL3RleHRyZWdpb246ZDNlODIzZWU1M2ExNGRiNzk4M2FkMWFhMjM2ZDJlMzNfMTA0NDI_145fdeae-d8de-48c5-8d3c-a94cc871b2e9" escape="true">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (&#8220;U.S. GAAP&#8221;) and applicable rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;) regarding interim financial reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP have been condensed or omitted, and accordingly the balance sheet as of December 31, 2022 has been derived from the audited consolidated financial statements at that date but does not include all of the information required by GAAP for complete financial statements.</ix:nonNumeric> <ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNC9mcmFnOmQzZTgyM2VlNTNhMTRkYjc5ODNhZDFhYTIzNmQyZTMzL3RleHRyZWdpb246ZDNlODIzZWU1M2ExNGRiNzk4M2FkMWFhMjM2ZDJlMzNfMTA0NDM_63bf4a8b-2a2c-422e-b699-aa13bce07db3" escape="true">These unaudited interim condensed consolidated financial statements have been prepared on the same basis as the Company&#8217;s annual financial statements and, in the opinion of management, reflect all adjustments that are necessary for a fair statement of the Company&#8217;s consolidated financial information. The results of operations for the three months ended March 31, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any other interim period or for any other future year.</ix:nonNumeric> </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements should be read in conjunction with the audited financial statements and related notes thereto for the year ended December 31, 2022 contained in the Company&#8217;s Annual Report on Form 10-K filed with the SEC on March 2, 2023.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SI-BONE, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) </span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="i1c0dafe98aa646ca84c7a01e9b1ebe7a" continuedAt="i33889b159c8249ef90b2c174a0f5f2a9"><div style="margin-bottom:12pt;margin-top:9pt;padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNC9mcmFnOmQzZTgyM2VlNTNhMTRkYjc5ODNhZDFhYTIzNmQyZTMzL3RleHRyZWdpb246ZDNlODIzZWU1M2ExNGRiNzk4M2FkMWFhMjM2ZDJlMzNfMTA0NDY_30671c4e-b645-4a05-97c6-3ed901c56643" continuedAt="icb6cd4d01dc44f26bd1a79cf8bee5752" escape="true">Use of Estimates </ix:nonNumeric></span></div><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="icb6cd4d01dc44f26bd1a79cf8bee5752">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Significant accounting estimates and management judgments reflected in the condensed consolidated financial statements primarily includes the fair value of performance-based restricted stock unit awards. Estimates are based on historical experience, where applicable and other assumptions believed to be reasonable by the management. Actual results could differ from those estimates.</ix:continuation> </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s significant accounting policies are disclosed in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2022. The Company updated the accounting policies related to the property and equipment and revenue recognition, as follows:</span></div><ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNC9mcmFnOmQzZTgyM2VlNTNhMTRkYjc5ODNhZDFhYTIzNmQyZTMzL3RleHRyZWdpb246ZDNlODIzZWU1M2ExNGRiNzk4M2FkMWFhMjM2ZDJlMzNfNTQ5NzU1ODQ2NzA5_9f9d5ec1-1ef8-4066-a718-a1f90f80be7d" escape="true"><div style="padding-left:72pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Property and Equipment </span></div><div style="padding-left:72pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Construction in progress includes assets that have not yet been placed into service including the cost of individual components of an instrument tray. Once an instrument tray is placed into service, the Company transfers its carrying value into machinery and equipment and begins depreciating the cost of the instrument tray over its useful life. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Leasehold improvements are amortized over the lesser of their useful lives or the life of the lease.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Upon the sale or retirement of these assets, the cost and related accumulated depreciation are removed from the consolidated balance sheet and the resulting gain or loss is recognized in the consolidated statement of operations. Maintenance and repairs are charged to operations as incurred.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNC9mcmFnOmQzZTgyM2VlNTNhMTRkYjc5ODNhZDFhYTIzNmQyZTMzL3RleHRyZWdpb246ZDNlODIzZWU1M2ExNGRiNzk4M2FkMWFhMjM2ZDJlMzNfNTQ5NzU1ODQ2NzEw_aad9eaf8-71c9-4958-ba15-14d3969ff89f" escape="true"><div style="padding-left:72pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Revenue Recognition</span></div><div style="padding-left:72pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company&#8217;s revenue is derived from the sale of its products to medical groups and hospitals through its direct sales force and third-party sales agents and resellers throughout the U.S. and Europe. The Company receives payment for its implants consumed during the surgery and does not receive additional or separate consideration for the use of the instrument tray furnished by the Company for the surgeon&#8217;s use. The Company identifies the instrument trays as a lease component and the implants as a non-lease component in its arrangements with its customers. The Company determines that the non-lease component is qualitatively predominant, and as such, elected the practical expedient to not separate the lease and non-lease components. Therefore, the overall arrangement is accounted for under Accounting Standards Codification (&#8220;ASC&#8221;) 606, Revenue from Contracts with Customers (&#8220;ASC 606&#8221;).</span></div><div style="padding-left:72pt;text-align:justify"><span><br/></span></div><div style="padding-left:72pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In accordance with ASC 606, the Company recognizes revenue when control is transferred to the customer, in an amount that reflects the consideration the Company expects to be entitled to in exchange for the goods or services. Under the revenue recognition standard, the Company applies the following five step approach: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when a performance obligation is satisfied. As it relates to product sales where the Company's sales representative delivers the product at the point of implantation at the hospital or medical facilities, the Company continues to recognize the revenue upon completion of the procedure and authorization by the customer, net of rebates and price discounts. This represents the majority of the Company's consolidated revenue. The Company also generates a small portion of revenue from the sale of products through distributors and to certain hospital or medical facilities where the products are ordered in advance of a procedure. The performance obligation is the delivery of the products and therefore, revenue is recognized upon shipment to the customers, net of rebates and price discounts. The Company accounts for rebates and price discounts as a reduction to revenue, calculated based on the terms agreed to with the customer. Historically, there had been no significant price discounts. Sales prices are specified in either the customer contract or agreed price list, which is executed prior to the transfer of control to the customer. For certain hospitals and medical facilities, the Company has agreements in place consists of either a master services agreement or an agreed price list, which defines the terms and conditions of the arrangement, including the pricing information, payment terms and pertinent aspects of the relationship between the parties. The Company also has agreements in place with its distributors, which include standard terms that do not allow for payment contingent on resale of the product, obtaining financing, or other terms that could impact the distributor&#8217;s payment obligation. The Company's standard payment terms are generally net 30 to 90 days.</span></div></ix:nonNumeric><div style="padding-left:72pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNC9mcmFnOmQzZTgyM2VlNTNhMTRkYjc5ODNhZDFhYTIzNmQyZTMzL3RleHRyZWdpb246ZDNlODIzZWU1M2ExNGRiNzk4M2FkMWFhMjM2ZDJlMzNfMTA0Mzg_2fa2e9d5-e36f-4960-9a5a-3094e1948748" continuedAt="i18026a3f6579445da50b34e76b42f5ce" escape="true">Segments</ix:nonNumeric></span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SI-BONE, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) </span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="i33889b159c8249ef90b2c174a0f5f2a9"><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><ix:continuation id="i18026a3f6579445da50b34e76b42f5ce" continuedAt="i34de569680164d869c8108d2a1630072"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's chief operating decision makers are the Chief Executive Officer (&#8220;CEO&#8221;) and Chief Financial Officer (&#8220;CFO&#8221;). The CEO and the CFO review financial information presented on a consolidated basis, accompanied by information about revenue by geographic region, for purposes of evaluating financial performance. The Company has <ix:nonFraction unitRef="activity" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="INF" name="sibn:NumberOfBusinessActivities" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNC9mcmFnOmQzZTgyM2VlNTNhMTRkYjc5ODNhZDFhYTIzNmQyZTMzL3RleHRyZWdpb246ZDNlODIzZWU1M2ExNGRiNzk4M2FkMWFhMjM2ZDJlMzNfNDAxMw_e0477b33-eca7-45c8-b8e1-277ff3fe41d9">one</ix:nonFraction> business activity and there are no segment managers who are held accountable for operations, operating results or plans for levels or components below the consolidated unit level. Accordingly, the Company has determined that it has a single reportable and operating segment structure</span><span style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</span></ix:continuation></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i34de569680164d869c8108d2a1630072">The Company derives substantially all of its revenue from sales to customers in the U.S. Revenue by geography is based on billing address of the customer. International revenue accounted for less than 10% of the total revenue during the periods presented. Long-lived assets held outside the U.S. are immaterial.</ix:continuation> <ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNC9mcmFnOmQzZTgyM2VlNTNhMTRkYjc5ODNhZDFhYTIzNmQyZTMzL3RleHRyZWdpb246ZDNlODIzZWU1M2ExNGRiNzk4M2FkMWFhMjM2ZDJlMzNfMTA0Mzk_0f086fab-1237-42de-bd85-95e778c7d76a" continuedAt="i62588f32e0514b88b00143ca3aab8b3e" escape="true">Following table summarizes the Company's revenue by geography:</ix:nonNumeric></span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><ix:continuation id="i62588f32e0514b88b00143ca3aab8b3e"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.527%"><tr><td style="width:1.0%"></td><td style="width:64.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.392%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.843%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.395%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie621378e8af644ff959fd17071edec6f_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNC9mcmFnOmQzZTgyM2VlNTNhMTRkYjc5ODNhZDFhYTIzNmQyZTMzL3RhYmxlOjkxZTZhMmNiYTIyMTQ2MWU5ZmVjMDRjYzgyNjg3NWZjL3RhYmxlcmFuZ2U6OTFlNmEyY2JhMjIxNDYxZTlmZWMwNGNjODI2ODc1ZmNfMy0xLTEtMS02ODMxNg_f9c1cbe7-c9a6-42c1-a32b-d6e489655e2e">30,450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d986d6c5754440c896f37265133c6f7_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNC9mcmFnOmQzZTgyM2VlNTNhMTRkYjc5ODNhZDFhYTIzNmQyZTMzL3RhYmxlOjkxZTZhMmNiYTIyMTQ2MWU5ZmVjMDRjYzgyNjg3NWZjL3RhYmxlcmFuZ2U6OTFlNmEyY2JhMjIxNDYxZTlmZWMwNGNjODI2ODc1ZmNfMy0zLTEtMS02ODMxNg_a3f71fab-b38c-49d5-af21-1dcc62d47588">20,367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d7b650f421439ea4f82d9dcaa13596_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNC9mcmFnOmQzZTgyM2VlNTNhMTRkYjc5ODNhZDFhYTIzNmQyZTMzL3RhYmxlOjkxZTZhMmNiYTIyMTQ2MWU5ZmVjMDRjYzgyNjg3NWZjL3RhYmxlcmFuZ2U6OTFlNmEyY2JhMjIxNDYxZTlmZWMwNGNjODI2ODc1ZmNfNC0xLTEtMS02ODMxNg_2bbb215e-c1e4-4d9f-b7cb-1ddcec6f34aa">2,258</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibad906d7939f45519af713f88d015ade_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNC9mcmFnOmQzZTgyM2VlNTNhMTRkYjc5ODNhZDFhYTIzNmQyZTMzL3RhYmxlOjkxZTZhMmNiYTIyMTQ2MWU5ZmVjMDRjYzgyNjg3NWZjL3RhYmxlcmFuZ2U6OTFlNmEyY2JhMjIxNDYxZTlmZWMwNGNjODI2ODc1ZmNfNC0zLTEtMS02ODMxNg_a69a34e6-43ca-4407-9830-2e86cd37b952">2,072</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNC9mcmFnOmQzZTgyM2VlNTNhMTRkYjc5ODNhZDFhYTIzNmQyZTMzL3RhYmxlOjkxZTZhMmNiYTIyMTQ2MWU5ZmVjMDRjYzgyNjg3NWZjL3RhYmxlcmFuZ2U6OTFlNmEyY2JhMjIxNDYxZTlmZWMwNGNjODI2ODc1ZmNfNS0xLTEtMS02ODMxNg_0afe52be-7b95-4177-bbb4-f5b18050ac44">32,708</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNC9mcmFnOmQzZTgyM2VlNTNhMTRkYjc5ODNhZDFhYTIzNmQyZTMzL3RhYmxlOjkxZTZhMmNiYTIyMTQ2MWU5ZmVjMDRjYzgyNjg3NWZjL3RhYmxlcmFuZ2U6OTFlNmEyY2JhMjIxNDYxZTlmZWMwNGNjODI2ODc1ZmNfNS0zLTEtMS02ODMxNg_901e7c1a-9b2d-40b1-8568-eb1d9d2e7e5f">22,439</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNC9mcmFnOmQzZTgyM2VlNTNhMTRkYjc5ODNhZDFhYTIzNmQyZTMzL3RleHRyZWdpb246ZDNlODIzZWU1M2ExNGRiNzk4M2FkMWFhMjM2ZDJlMzNfMTA0NDg_7ec9271c-623b-4db9-b3f7-de5dea4f637d" escape="true"><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No recently issued accounting standards are expected to have a material impact on the Company&#8217;s consolidated financial statements.</span></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div><div><span><br/></span></div></div></div><div id="i928aa505a2ea46079da4e5082002267b_37"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SI-BONE, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) </span></div><div style="text-align:justify"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3. <ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RleHRyZWdpb246NjU3MWQxNzBhMzg2NDZmODg0YWExYmM3YWE1ZThiNmJfMjAzNQ_5e6317c7-b57c-40eb-96e6-e02bfc8b656e" continuedAt="i1bc398aa5de441778f3f7dc613d09ba7" escape="true">Marketable Securities</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i1bc398aa5de441778f3f7dc613d09ba7"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company's marketable securities were available-for-sale and were classified based on their maturities. Marketable securities with remaining maturities at the date of purchase of three months or less are classified as cash equivalents. Short-term investments are securities that original maturity or remaining maturity is greater than three months and not more than twelve months. Long-term investments are securities for which the original maturity or remaining maturity is greater than twelve months.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="us-gaap:MarketableSecuritiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RleHRyZWdpb246NjU3MWQxNzBhMzg2NDZmODg0YWExYmM3YWE1ZThiNmJfMjAzNg_31f65b63-8939-4bbf-b58f-71eeee2216e0" escape="true"><div style="margin-bottom:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the marketable securities:</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.666%"><tr><td style="width:1.0%"></td><td style="width:36.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.483%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.242%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.483%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.242%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.483%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.921%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.486%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6706d03c32974a768210dd2966cd849e_I20230331" decimals="-3" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfMy0xLTEtMS02ODMxNg_c2ab2fd1-f718-4713-ac94-aae5f989dd58">15,602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6706d03c32974a768210dd2966cd849e_I20230331" decimals="-3" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfMy03LTEtMS02ODMxNg_6adeed34-d8ce-4a1c-b63d-44810729aee9">15,602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfNi0xLTEtMS02ODMxNg_7fcdef46-448c-4630-b34e-0bd4ec3d3599">15,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfNi03LTEtMS02ODMxNg_8bfc4c0e-8536-477a-8877-3f768a31f8b6">15,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic034056cf84142f3a1464896584f8499_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfOC0xLTEtMS02ODMxNg_bba76562-33d7-4b13-b17a-772bf734db80">35,978</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic034056cf84142f3a1464896584f8499_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfOC0zLTEtMS02ODMxNg_217f82a4-7022-4e88-87ae-310f398bf810">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic034056cf84142f3a1464896584f8499_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfOC01LTEtMS02ODMxNg_26d8eb29-92ea-4744-a06f-1ea940588895">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic034056cf84142f3a1464896584f8499_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfOC03LTEtMS02ODMxNg_a8c4393f-0db0-4e07-9d0b-f61de643a112">35,964</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44dd3ae16d4d45c8bb7f34c32c3afa5b_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfOS0xLTEtMS02ODMxNg_2e8ce314-6772-4889-842e-1ce57dfe1591">2,945</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44dd3ae16d4d45c8bb7f34c32c3afa5b_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfOS0zLTEtMS02ODMxNg_b219d6ec-81b4-4943-900d-a0a0248854c6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i44dd3ae16d4d45c8bb7f34c32c3afa5b_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfOS01LTEtMS02ODMxNg_681e318a-6853-48ab-9b40-a6f75af21701">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44dd3ae16d4d45c8bb7f34c32c3afa5b_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfOS03LTEtMS02ODMxNg_1363533b-5714-4beb-bd1b-318e1fef0134">2,938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia13be74212cd4cbdac029edf9dc0a7af_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfMTAtMS0xLTEtNjgzMTY_4341b131-64af-4d32-b59a-8009bc66ee75">18,265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia13be74212cd4cbdac029edf9dc0a7af_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfMTAtMy0xLTEtNjgzMTY_823fece8-501e-4778-a993-d520c7371077">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia13be74212cd4cbdac029edf9dc0a7af_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfMTAtNS0xLTEtNjgzMTY_583e0ee4-0e4b-480f-a35a-030360f8e463">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia13be74212cd4cbdac029edf9dc0a7af_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfMTAtNy0xLTEtNjgzMTY_5aa3fa1d-ee9c-41f0-8530-cd25ab90f050">18,265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f387eb12eb641d8acf7a18c1539123f_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfMTEtMS0xLTEtNzY0OTc_bed85484-e396-495b-a8f2-f542d6cd0c71">5,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f387eb12eb641d8acf7a18c1539123f_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfMTEtMy0xLTEtNzY1MDQ_b7106117-55ed-4532-9864-b23d78e301ac">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f387eb12eb641d8acf7a18c1539123f_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfMTEtNS0xLTEtNzY1MTI_c8badb0d-793e-4acf-90ca-22af4802768d">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f387eb12eb641d8acf7a18c1539123f_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfMTEtNy0xLTEtNzY1MTk_8cd14dfb-e665-40a7-82c9-61bd123511ab">5,830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfMTEtMS0xLTEtNjgzMTY_0c659509-5617-4e96-a232-2cb9b628f0b5">63,008</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfMTEtMy0xLTEtNjgzMTY_67a30989-43a6-4fd3-b80e-ddf011d51252">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfMTEtNS0xLTEtNjgzMTY_e3e32550-75f6-47ae-bb07-206cc75a3e75">29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfMTEtNy0xLTEtNjgzMTY_36532f56-8052-4745-b6d5-e737f19de915">62,997</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="sibn:MarketableSecuritiesAmortizedCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfMTUtMS0xLTEtNjgzMTY_c90e6ec1-1d4f-47b7-b7a1-b084fb5046ec">78,610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfMTUtMy0xLTEtNjgzMTY_f1ed1d8a-d42e-4c73-a8a3-79309774d8c3">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfMTUtNS0xLTEtNjgzMTY_65e1ae79-d2d2-480f-994e-f3956afa8019">29</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfMTUtNy0xLTEtNjgzMTY_0debcf1f-b8eb-4b6c-92c2-979770b0f1bc">78,599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.527%"><tr><td style="width:1.0%"></td><td style="width:36.620%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.506%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.244%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.506%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.244%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.667%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.084%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.029%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0cbf148284f4875b34513e22dea1727_I20221231" decimals="-3" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfMy0xLTEtMS02ODMxNg_c8a561cb-db30-4f10-9faa-2cb5dd85d77b">8,002</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0cbf148284f4875b34513e22dea1727_I20221231" decimals="-3" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfMy03LTEtMS02ODMxNg_1f0fa78c-c8e1-45e1-97e4-80dafd41a9df">8,002</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfNS0xLTEtMS02ODMxNg_7be93a11-51b2-4a59-9e6e-f6aea08eedde">8,002</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfNS03LTEtMS02ODMxNg_48c159af-a73b-425a-8fa6-e4cd57b05b60">8,002</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8559cf2d961048048b5f1dcd580f39ee_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfNy0xLTEtMS02ODMxNg_e3f0e871-f0fe-4fad-acbf-785177c853f4">48,636</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8559cf2d961048048b5f1dcd580f39ee_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfNy0zLTEtMS02ODMxNg_78278715-8d63-48de-b8e9-69083148e5fd">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8559cf2d961048048b5f1dcd580f39ee_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfNy01LTEtMS02ODMxNg_d1412a7f-db79-4f89-8005-1c3debfc5566">105</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8559cf2d961048048b5f1dcd580f39ee_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfNy03LTEtMS02ODMxNg_264f3d8f-90c4-4762-95ba-00a13b133a65">48,535</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2d6675789b842e3bc0f882dee4352c3_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfOC0xLTEtMS03Mjg3NQ_9f3bbd79-aacb-4ad8-9f8f-5ae0d176721c">2,918</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2d6675789b842e3bc0f882dee4352c3_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfOC0zLTEtMS03Mjg4Mw_9b41a286-ccf8-41ea-b50d-3fc23faca45f">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2d6675789b842e3bc0f882dee4352c3_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfOC01LTEtMS03Mjg5MA_beec5929-3410-4dde-a7a3-704024d2fe98">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2d6675789b842e3bc0f882dee4352c3_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfOC03LTEtMS03MzUxMg_182d5650-edb4-48e1-9fb6-3e598721f15c">2,921</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib008684c4f9b4e4782d069220bea736d_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfOC0xLTEtMS02ODMxNg_2e130ee1-6ae1-4f3a-95c5-487a447823fc">2,914</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib008684c4f9b4e4782d069220bea736d_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfOC0zLTEtMS02ODMxNg_0e3995fb-4eed-4b86-b825-178ed96ef139">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib008684c4f9b4e4782d069220bea736d_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfOC01LTEtMS02ODMxNg_b2efc6ae-e798-45b2-9765-b5d06a6e03f7">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib008684c4f9b4e4782d069220bea736d_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfOC03LTEtMS02ODMxNg_ae98fa82-495f-41f4-ad8e-1adb261811a0">2,911</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfec2a876ef4b7eb0d2a97b4c97ad16_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfOS0xLTEtMS02ODMxNg_4cd999da-94c6-4971-9de8-81e7621bac3a">22,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfec2a876ef4b7eb0d2a97b4c97ad16_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfOS0zLTEtMS02ODMxNg_dc20d3d1-bfea-441a-9a1d-41e7aff7f570">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfec2a876ef4b7eb0d2a97b4c97ad16_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfOS01LTEtMS02ODMxNg_e4d12e99-b886-46a9-b0c3-b16fdae16194">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfec2a876ef4b7eb0d2a97b4c97ad16_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfOS03LTEtMS02ODMxNg_947297ee-23af-4b9a-848d-bbe6a31132bd">22,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfMTAtMS0xLTEtNjgzMTY_742682bd-ac19-4483-a7c7-b52a09604c0e">76,674</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfMTAtMy0xLTEtNjgzMTY_04175ca1-57b1-4e69-a558-f8bf033e1cb2">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfMTAtNS0xLTEtNjgzMTY_09e74a5c-5d39-48ad-84ce-2a2ffe0bba38">108</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfMTAtNy0xLTEtNjgzMTY_09a1ebb8-ed14-4440-a4f5-59a0bbfdb5e6">76,573</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="sibn:MarketableSecuritiesAmortizedCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfMTQtMS0xLTEtNjgzMTY_b3fb3fc5-b74a-4c9d-8dee-2dbb630e5629">84,676</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfMTQtMy0xLTEtNjgzMTY_825fff2e-5459-497d-adb1-aff5badd11b2">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfMTQtNS0xLTEtNjgzMTY_91a9c24a-ddcd-4d6b-b0d3-cdaba9e57f32">108</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfMTQtNy0xLTEtNjgzMTY_2650619a-ff6c-491a-8ca1-3fd9ab034e34">84,575</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost of the Company's available-for-sale securities approximates their fair value. Unrealized losses are generally due to interest rate fluctuations, as opposed to credit quality. However, the Company reviews individual securities that are in an unrealized loss position in order to evaluate whether or not they have experienced or are expected to experience credit losses. During the three months ended March 31, 2023 and 2022, unrealized gains and losses from the investments were not material and were not the result of a decline in credit quality. As a result, the Company did <ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RleHRyZWdpb246NjU3MWQxNzBhMzg2NDZmODg0YWExYmM3YWE1ZThiNmJfMTE3Ng_0c4d2210-5f12-45dc-96f8-904ddcb6931c"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RleHRyZWdpb246NjU3MWQxNzBhMzg2NDZmODg0YWExYmM3YWE1ZThiNmJfMTE3Ng_d6cbf766-0380-47f7-85fa-99ff44965bf4">not</ix:nonFraction></ix:nonFraction> recognize any credit losses related to its investments and that all unrealized gains and losses on available-for-sale securities are recorded in accumulated other comprehensive income (loss) on the condensed consolidated balance sheets as of March 31, 2023 and December 31, 2022.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company elected to present accrued interest receivable separately from short-term and long-term investments on its condensed consolidated balance sheets. Accrued interest receivable was $<ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RleHRyZWdpb246NjU3MWQxNzBhMzg2NDZmODg0YWExYmM3YWE1ZThiNmJfMTYyMg_1d568e93-b0a9-453a-99ec-091e71f8ac6b">0.1</ix:nonFraction>&#160;million as of March 31, 2023, and was recorded in prepaid expenses and other current assets. The Company also elected to exclude accrued interest receivable from the estimation of expected credit losses on its marketable securities and reverse accrued interest receivable through interest income (expense) when amounts are determined to be uncollectible. The Company did <ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestWriteoff" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RleHRyZWdpb246NjU3MWQxNzBhMzg2NDZmODg0YWExYmM3YWE1ZThiNmJfMTk3Ng_95b54ce0-8454-4e8d-a85c-9af201206e7d"><ix:nonFraction unitRef="usd" contextRef="ic260793641a14f2695a83d42d27f0e29_D20220101-20221231" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestWriteoff" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RleHRyZWdpb246NjU3MWQxNzBhMzg2NDZmODg0YWExYmM3YWE1ZThiNmJfMTk3Ng_95bd4262-ff71-4ef6-ad63-db4551f5b93c">not</ix:nonFraction></ix:nonFraction> write off any accrued interest receivable as of March 31, 2023 or December 31, 2022.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div><div><span><br/></span></div></div></div><div id="i928aa505a2ea46079da4e5082002267b_40"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SI-BONE, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) </span></div><div style="text-align:justify"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. <ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RleHRyZWdpb246ODAyZTVhMmUyMmUyNDVkNzlkNjQ2NDE0NGQyNTQ5NGZfODA0_af0ca707-0aae-43af-aae9-cf576431686f" continuedAt="i800d0b87303c4b7d8446fa53e1bb77f9" escape="true">Fair Value Measurement</ix:nonNumeric></span></div><ix:continuation id="i800d0b87303c4b7d8446fa53e1bb77f9"><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Carrying amounts of certain of the Company&#8217;s financial instruments, including cash equivalents, accounts receivable, accounts payable and accrued liabilities, approximate fair value due to their relatively short maturities and market interest rates, if applicable. The carrying value of the Company&#8217;s long-term debt also approximates fair value based on management&#8217;s estimation that a current interest rate would not differ materially from the stated rate. There were no other financial assets and liabilities that require fair value hierarchy measurements and disclosures for the periods presented. </span></div><ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RleHRyZWdpb246ODAyZTVhMmUyMmUyNDVkNzlkNjQ2NDE0NGQyNTQ5NGZfODA1_674cb34c-b8a2-4c18-b2b9-95b989493999" escape="true"><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the fair value of the Company&#8217;s marketable securities measured at fair value on a recurring basis based on the three-tier fair value hierarchy:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.888%"><tr><td style="width:1.0%"></td><td style="width:45.201%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.769%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.769%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.769%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.775%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Marketable securities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93f63117979e431d8fafecd7bb59dfac_I20230331" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfNC0xLTEtMS02ODMxNg_42128dad-2fac-48af-9c68-9d695c4afda6">15,602</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7af7e18c08648e8a31cfe8e93a21d37_I20230331" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfNC0zLTEtMS02ODMxNg_943d2687-512d-4a45-8d61-428c11ef4105">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if55d28f6c32e42e4a57e446914b3a62c_I20230331" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfNC01LTEtMS02ODMxNg_760a9e52-3833-49c9-a0b5-d25b85459e9c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i412cc8ac40b4449d8130d9a574e1630c_I20230331" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfNC03LTEtMS02ODMxNg_4ac75fe3-186b-4cf2-9182-b88495d2a207">15,602</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70c37c2527cc48178344c05517b09dbd_I20230331" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfNS0xLTEtMS02ODMxNg_c90a40f8-7313-4dc9-b340-096370986d1d">35,964</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7a065321d4879b2ff02286b48fe5d_I20230331" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfNS0zLTEtMS02ODMxNg_60be0c3e-836b-47c0-bd22-730607fddc57">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e5ed5afd4274c968b88749c12c77e79_I20230331" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfNS01LTEtMS02ODMxNg_015a622c-dc7f-4e99-9b38-2bec391927fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad3e05b47f148779fa5695c98e40dcf_I20230331" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfNS03LTEtMS02ODMxNg_a86f4219-45d3-456e-8857-9e0920027ee8">35,964</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c92d73d84f74de3a6513213ff796c66_I20230331" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfNi0xLTEtMS02ODMxNg_06093f00-0bf2-404c-9f14-35e19b51cc2f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cfde19be5044c3fb1effae06f724c64_I20230331" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfNi0zLTEtMS02ODMxNg_a42bf910-9361-40b6-85ba-fedb04340954">2,938</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic660e995acfe4b2a9f4faedc08362fa8_I20230331" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfNi01LTEtMS02ODMxNg_be788c12-727a-4687-948e-0243c7a6ef97">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb816e01e7874d0a96715509b31cb35a_I20230331" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfNi03LTEtMS02ODMxNg_0c687d18-9856-4926-a80e-cc9cd9cc04d1">2,938</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c6fdeac85ad413ca0c0dedf070a75fe_I20230331" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfNy0xLTEtMS03NjY1Mg_cf3e04dd-cd83-4548-af70-e2c5bad419ab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a100bced9af4ad5bd35f338bc5a32f8_I20230331" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfNy0zLTEtMS03NjY1OA_fe98ffe2-babb-4f4e-b12d-6baa9b2a03ac">5,830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbcaeebb6db24dffb245482694bd9c7a_I20230331" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfNy01LTEtMS03NjY2MQ_65634cd1-0f6c-429e-9305-5b36303c9ff6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i402c694c2fe74b3ca22ce9842744aa6d_I20230331" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfNy03LTEtMS03NjY2NA_542cd3bd-7d19-4397-b041-91a962d836fd">5,830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f6a87d519949ebb36b48d5adde8532_I20230331" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfNy0xLTEtMS02ODMxNg_1fb19a7b-59c7-4c53-8b93-ef940d502fa8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcc50bab28c64661b1b3e2f3166b18ac_I20230331" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfNy0zLTEtMS02ODMxNg_9a275b71-ce6a-49c9-a657-8b06c58b73c4">18,265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i127926870dbf443f939ff61f15decebe_I20230331" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfNy01LTEtMS02ODMxNg_979df010-8841-4a02-a2b4-dd909b88e2e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i165bfa53062b4b66b55877948006f464_I20230331" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfNy03LTEtMS02ODMxNg_bdaba7dc-3328-4246-8173-6c0846f73b0d">18,265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i599fe7f797b64b16986fe58ad0b1dea9_I20230331" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfOC0xLTEtMS02ODMxNg_36f11580-f24f-4c74-99bf-2d3a1f670bf0">51,566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18026ebb41a3463a83e4df8c40ad564c_I20230331" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfOC0zLTEtMS02ODMxNg_5237f28d-a77e-4e8c-86a0-7ef44f00d37a">27,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a9913b7b1e5449cb00f06f2ff1eb7b7_I20230331" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfOC01LTEtMS02ODMxNg_b0bf1d77-5348-4cf1-8c12-40f484fd95d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d0dee683e5841eb84e260a32f3255fe_I20230331" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfOC03LTEtMS02ODMxNg_e5556894-db7d-44a0-bb67-57787034bc57">78,599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Marketable securities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d93d5c546664a5d81e0bd4ff383fd5e_I20221231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfMTQtMS0xLTEtNjgzMTY_fc4b5074-7d76-472d-98a8-7e55da3566fd">8,002</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i593bc48b8f4243ddb04b45abc6ea214d_I20221231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfMTQtMy0xLTEtNjgzMTY_3a7ed1c0-e563-469e-8630-88a64e46fe3b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2a471609df94d37a930d6f5d6e15098_I20221231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfMTQtNS0xLTEtNjgzMTY_7959a18d-6dfc-48ad-bb20-5b13ded86363">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a286c1bf0564b09a30caa94533124d2_I20221231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfMTQtNy0xLTEtNjgzMTY_1dd05afa-49d7-4505-bf17-119583e2ece8">8,002</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c06318063df438297ac590b6ad0fc1d_I20221231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfMTUtMS0xLTEtNjgzMTY_2402b7f8-65c5-40ca-ba3c-bca7d7a4618d">48,535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02f410de75d14cdeaee8f125e8343cbd_I20221231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfMTUtMy0xLTEtNjgzMTY_5926c1d8-bc47-48cd-8a8a-8a0f8bbdeedd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2648a4f0afd74ba895a75a8524bd2b05_I20221231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfMTUtNS0xLTEtNjgzMTY_745d8d26-0d07-4e89-8174-6de51d912986">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia89f5e43abc74a268ac2cf0241b3f413_I20221231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfMTUtNy0xLTEtNjgzMTY_fb6e4bd6-4659-4215-b3b9-e0ff411248e2">48,535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency bonds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3ad078aff0542a4a095dda948ebfa96_I20221231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfMTYtMS0xLTEtNzI5OTk_fc4e6027-8b0a-4544-90aa-70995b9dcebd">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf18e06ec7af4f8894d706876e2614db_I20221231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfMTYtMy0xLTEtNzMwMDc_dab73579-5be3-4d5d-a55e-cb31b42fa3bf">2,921</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8afde8ae10a47ca88a2373bafb3dfac_I20221231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfMTYtNS0xLTEtNzMwMjI_156e8d28-3393-4b57-b76e-cb489388c777">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f7ab8e31a7c40be87fc6165468887e2_I20221231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfMTYtNy0xLTEtNzMwMzY_ce2f7a79-f348-4cae-994f-c2dde054ebf7">2,921</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c0adbda751147eea7396bd575122c5e_I20221231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfMTYtMS0xLTEtNjgzMTY_6bb51a64-9086-4284-acd8-85d8cb8c10ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i386cd3185459468682f42288ddfd4237_I20221231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfMTYtMy0xLTEtNjgzMTY_baae9988-504e-426a-afe2-109cc898e90f">2,911</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if245b8c2654f417395c08edfa479ab82_I20221231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfMTYtNS0xLTEtNjgzMTY_128caad0-28c5-4ec9-8326-af0e8131993b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d1b210afd954f47bea17adf2f027ac5_I20221231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfMTYtNy0xLTEtNjgzMTY_64d54764-bd62-4176-9e52-4c1f5542b0e9">2,911</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id88038b7e8b941bc8a88b3faa056a48f_I20221231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfMTctMS0xLTEtNjgzMTY_53f78d8e-dcbf-4a19-838c-076277772d55">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59372acb82174f63bc0cbb959bab7cb7_I20221231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfMTctMy0xLTEtNjgzMTY_5a02c3db-95d4-4dee-aed7-ee22c0144c77">22,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0994310adbdc4a3fb6f259424a3dda9b_I20221231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfMTctNS0xLTEtNjgzMTY_b9d27be8-5ac0-40cb-9da7-64b0081282e7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a30c099351643919a25ea1474e284b5_I20221231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfMTctNy0xLTEtNjgzMTY_ab297aca-5fe9-48c4-83df-e9824e981fd9">22,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b6ddb9d49374251b145ed8c06d3ea23_I20221231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfMTgtMS0xLTEtNjgzMTY_df2d81da-1ea2-4208-bbde-b8414423fa12">56,537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b54f88e74024fb4a2091106b2085b42_I20221231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfMTgtMy0xLTEtNjgzMTY_ea11cc1a-9558-441b-b05c-e84b524ad0b5">28,038</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib87aa61e8c5640999864db57e9a5de97_I20221231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfMTgtNS0xLTEtNjgzMTY_85a9f726-32a5-490a-b914-2e022567229a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i238fa20d4bac4223a52c0c5dd3a10b39_I20221231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfMTgtNy0xLTEtNjgzMTY_64cecdc8-97ec-49bb-875e-e5b7ef6824cb">84,575</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div><div><span><br/></span></div></div></div><div id="i928aa505a2ea46079da4e5082002267b_43"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SI-BONE, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) </span></div><div style="text-align:justify"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RleHRyZWdpb246NThjZmNhNzJmMzk5NGQ5NWJkYjAxNGIyNzgyMWY1ZmRfNzk5_6f1de833-6a1c-4a29-8d83-9b70d25a5d29" continuedAt="i14c29b062d47401ba0520d550ef8de9e" escape="true">Balance Sheet Components</ix:nonNumeric></span></div><ix:continuation id="i14c29b062d47401ba0520d550ef8de9e"><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023, inventory consisted of finished goods of $<ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-5" name="us-gaap:InventoryFinishedGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RleHRyZWdpb246NThjZmNhNzJmMzk5NGQ5NWJkYjAxNGIyNzgyMWY1ZmRfOTQ_b627b33a-f1a5-4012-b798-122214e48bdc">16.3</ix:nonFraction>&#160;million and work-in-progress of $<ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-5" name="us-gaap:InventoryWorkInProcess" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RleHRyZWdpb246NThjZmNhNzJmMzk5NGQ5NWJkYjAxNGIyNzgyMWY1ZmRfMTIx_5c8319b1-22aa-497e-91a1-9882441238ed">1.5</ix:nonFraction>&#160;million. As of December 31, 2022,  inventory consisted of finished goods of $<ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-5" name="us-gaap:InventoryFinishedGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RleHRyZWdpb246NThjZmNhNzJmMzk5NGQ5NWJkYjAxNGIyNzgyMWY1ZmRfNTQ5NzU1ODE0OTA2_12814891-fe1c-46b8-9962-da8ccfcc77a9">15.6</ix:nonFraction>&#160;million and work-in-progress and components of $<ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-5" name="us-gaap:InventoryWorkInProcess" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RleHRyZWdpb246NThjZmNhNzJmMzk5NGQ5NWJkYjAxNGIyNzgyMWY1ZmRfNTQ5NzU1ODE0OTIx_4bfdb5cd-95e5-427c-a73b-05c4a4f277dc">1.7</ix:nonFraction>&#160;million.</span></div><div style="margin-bottom:9pt;margin-top:12pt;text-indent:24.75pt"><ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RleHRyZWdpb246NThjZmNhNzJmMzk5NGQ5NWJkYjAxNGIyNzgyMWY1ZmRfODAw_31ab423f-27db-4361-9abf-f82651328eef" continuedAt="i577c54d6dc2e4519b0b651e5c9c5ff30" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment, net:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></ix:nonNumeric></div><div style="margin-bottom:9pt;margin-top:12pt;padding-left:36pt"><ix:continuation id="i577c54d6dc2e4519b0b651e5c9c5ff30"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.916%"><tr><td style="width:1.0%"></td><td style="width:66.514%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.697%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.589%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.700%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e71d795db204f3b8f094023c24425b3_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmI2ZjQ0YjVkNDhjNDRmNzBiNDQ5YmM5ZTVkZGQ2ZDhmL3RhYmxlcmFuZ2U6YjZmNDRiNWQ0OGM0NGY3MGI0NDliYzllNWRkZDZkOGZfMi0xLTEtMS02ODMxNg_b2380bbb-0c3d-4d36-a566-09410f062189">17,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee9e604e937b47a2a28b7c87d255fe22_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmI2ZjQ0YjVkNDhjNDRmNzBiNDQ5YmM5ZTVkZGQ2ZDhmL3RhYmxlcmFuZ2U6YjZmNDRiNWQ0OGM0NGY3MGI0NDliYzllNWRkZDZkOGZfMi0zLTEtMS02ODMxNg_5c0614b8-2cc0-47fd-8fa8-e5ed8beab124">14,920</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ca79707ebe549c1bb352a2ebd78915f_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmI2ZjQ0YjVkNDhjNDRmNzBiNDQ5YmM5ZTVkZGQ2ZDhmL3RhYmxlcmFuZ2U6YjZmNDRiNWQ0OGM0NGY3MGI0NDliYzllNWRkZDZkOGZfMy0xLTEtMS02ODMxNg_f0eba209-e021-4699-8262-3c33000ab0d1">7,682</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20591f6aa1e240348d149ac3850df479_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmI2ZjQ0YjVkNDhjNDRmNzBiNDQ5YmM5ZTVkZGQ2ZDhmL3RhYmxlcmFuZ2U6YjZmNDRiNWQ0OGM0NGY3MGI0NDliYzllNWRkZDZkOGZfMy0zLTEtMS02ODMxNg_b34d1037-a901-40da-963c-1647050c2dad">7,854</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer and office equipment</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95acc83c9a7845c6a6530d0b489719b9_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmI2ZjQ0YjVkNDhjNDRmNzBiNDQ5YmM5ZTVkZGQ2ZDhmL3RhYmxlcmFuZ2U6YjZmNDRiNWQ0OGM0NGY3MGI0NDliYzllNWRkZDZkOGZfNC0xLTEtMS02ODMxNg_7c8d6bfb-24b0-4917-a318-aadc87e69e39">1,139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9201dd932d9848bdbbe7c5a345ef8038_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmI2ZjQ0YjVkNDhjNDRmNzBiNDQ5YmM5ZTVkZGQ2ZDhmL3RhYmxlcmFuZ2U6YjZmNDRiNWQ0OGM0NGY3MGI0NDliYzllNWRkZDZkOGZfNC0zLTEtMS02ODMxNg_35246d50-fca4-431c-831c-d23c955acdb9">976</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if93177d48de1415e9f17d96b9723fe38_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmI2ZjQ0YjVkNDhjNDRmNzBiNDQ5YmM5ZTVkZGQ2ZDhmL3RhYmxlcmFuZ2U6YjZmNDRiNWQ0OGM0NGY3MGI0NDliYzllNWRkZDZkOGZfNS0xLTEtMS02ODMxNg_514a951b-c0c8-4dda-9af2-a7c25ec95c22">1,631</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a70cc88c75d4e89898c6b1352acaacc_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmI2ZjQ0YjVkNDhjNDRmNzBiNDQ5YmM5ZTVkZGQ2ZDhmL3RhYmxlcmFuZ2U6YjZmNDRiNWQ0OGM0NGY3MGI0NDliYzllNWRkZDZkOGZfNS0zLTEtMS02ODMxNg_e6beb51a-f750-4b69-98e1-c71b528a4e75">1,631</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ab4226e44904229bd0ee82536c2fdcd_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmI2ZjQ0YjVkNDhjNDRmNzBiNDQ5YmM5ZTVkZGQ2ZDhmL3RhYmxlcmFuZ2U6YjZmNDRiNWQ0OGM0NGY3MGI0NDliYzllNWRkZDZkOGZfNi0xLTEtMS02ODMxNg_f6f8bc14-1868-4c5f-8185-d1f58e747180">390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ef76ab501ca47529edb5647153de4b2_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmI2ZjQ0YjVkNDhjNDRmNzBiNDQ5YmM5ZTVkZGQ2ZDhmL3RhYmxlcmFuZ2U6YjZmNDRiNWQ0OGM0NGY3MGI0NDliYzllNWRkZDZkOGZfNi0zLTEtMS02ODMxNg_c78c614b-eeac-4aa6-bc0b-a9815b34612c">390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmI2ZjQ0YjVkNDhjNDRmNzBiNDQ5YmM5ZTVkZGQ2ZDhmL3RhYmxlcmFuZ2U6YjZmNDRiNWQ0OGM0NGY3MGI0NDliYzllNWRkZDZkOGZfNy0xLTEtMS02ODMxNg_cfaabbb4-9522-48c5-91d5-52304d29a9ea">27,912</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmI2ZjQ0YjVkNDhjNDRmNzBiNDQ5YmM5ZTVkZGQ2ZDhmL3RhYmxlcmFuZ2U6YjZmNDRiNWQ0OGM0NGY3MGI0NDliYzllNWRkZDZkOGZfNy0zLTEtMS02ODMxNg_c695f151-e584-45a1-94af-ecbd6e3c952e">25,771</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation and amortization</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmI2ZjQ0YjVkNDhjNDRmNzBiNDQ5YmM5ZTVkZGQ2ZDhmL3RhYmxlcmFuZ2U6YjZmNDRiNWQ0OGM0NGY3MGI0NDliYzllNWRkZDZkOGZfOC0xLTEtMS02ODMxNg_5039b973-1340-4c25-9a3b-94ef46f923de">11,283</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmI2ZjQ0YjVkNDhjNDRmNzBiNDQ5YmM5ZTVkZGQ2ZDhmL3RhYmxlcmFuZ2U6YjZmNDRiNWQ0OGM0NGY3MGI0NDliYzllNWRkZDZkOGZfOC0zLTEtMS02ODMxNg_87878a74-a11b-4b2e-82ee-476d0983dcfb">10,207</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmI2ZjQ0YjVkNDhjNDRmNzBiNDQ5YmM5ZTVkZGQ2ZDhmL3RhYmxlcmFuZ2U6YjZmNDRiNWQ0OGM0NGY3MGI0NDliYzllNWRkZDZkOGZfOS0xLTEtMS02ODMxNg_8de07f30-6423-4877-b326-1dd6349b4c66">16,629</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmI2ZjQ0YjVkNDhjNDRmNzBiNDQ5YmM5ZTVkZGQ2ZDhmL3RhYmxlcmFuZ2U6YjZmNDRiNWQ0OGM0NGY3MGI0NDliYzllNWRkZDZkOGZfOS0zLTEtMS02ODMxNg_b9a91b62-d3be-4b9a-b8f6-9de989f4c1b1">15,564</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023, construction in progress pertains to the cost of individual components of a custom instrument set used for surgical placement of the Company's products that have not yet been placed into service of $<ix:nonFraction unitRef="usd" contextRef="if3464bbb971c4eefb3b4e6d7ae410bb8_I20230331" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RleHRyZWdpb246NThjZmNhNzJmMzk5NGQ5NWJkYjAxNGIyNzgyMWY1ZmRfNDE3_eaa1676a-c424-4390-8dcd-08c7edb1fe26">4.0</ix:nonFraction> million and construction costs related to the Company's lease for research and development and warehouse space in Santa Clara and software costs of $<ix:nonFraction unitRef="usd" contextRef="i368a721c855a4a1190ec9dcdc696598a_I20230331" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RleHRyZWdpb246NThjZmNhNzJmMzk5NGQ5NWJkYjAxNGIyNzgyMWY1ZmRfNTEz_d0926211-95e3-4314-a7ca-9ea443bee339">3.7</ix:nonFraction> million. Depreciation expense was $<ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RleHRyZWdpb246NThjZmNhNzJmMzk5NGQ5NWJkYjAxNGIyNzgyMWY1ZmRfMTA5OTUxMTYyODczOQ_88dceaf6-7c71-4cb7-b9ed-cfc299bd469f">1.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RleHRyZWdpb246NThjZmNhNzJmMzk5NGQ5NWJkYjAxNGIyNzgyMWY1ZmRfMTA5OTUxMTYyODczMA_48a77428-60a1-4f5a-9481-6f3d04563a73">0.7</ix:nonFraction> million for the three months ended March 31, 2023 and 2022, respectively.</span></div><ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RleHRyZWdpb246NThjZmNhNzJmMzk5NGQ5NWJkYjAxNGIyNzgyMWY1ZmRfNzk3_effed613-03ad-43d6-bfa9-9c2d3f341c39" escape="true"><div style="margin-bottom:9pt;margin-top:12pt;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accrued Liabilities and Other</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:9pt;margin-top:12pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.916%"><tr><td style="width:1.0%"></td><td style="width:66.514%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.697%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.589%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.700%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and related expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmJjYjZjNWYyODljNTQ5ODU4NmQyNWU2YTgwNGY2NGQ5L3RhYmxlcmFuZ2U6YmNiNmM1ZjI4OWM1NDk4NTg2ZDI1ZTZhODA0ZjY0ZDlfMi0xLTEtMS02ODMxNg_9d70bcfc-4f0a-47e9-becb-735e268b7b73">7,487</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmJjYjZjNWYyODljNTQ5ODU4NmQyNWU2YTgwNGY2NGQ5L3RhYmxlcmFuZ2U6YmNiNmM1ZjI4OWM1NDk4NTg2ZDI1ZTZhODA0ZjY0ZDlfMi0zLTEtMS02ODMxNg_fb9c4802-e6ba-47c9-b912-f981f29c8698">11,365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued royalty</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:AccruedRoyaltiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmJjYjZjNWYyODljNTQ5ODU4NmQyNWU2YTgwNGY2NGQ5L3RhYmxlcmFuZ2U6YmNiNmM1ZjI4OWM1NDk4NTg2ZDI1ZTZhODA0ZjY0ZDlfNC0xLTEtMS03NjgxMQ_2295bc35-f641-47ee-9e25-9a236acea697">996</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:AccruedRoyaltiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmJjYjZjNWYyODljNTQ5ODU4NmQyNWU2YTgwNGY2NGQ5L3RhYmxlcmFuZ2U6YmNiNmM1ZjI4OWM1NDk4NTg2ZDI1ZTZhODA0ZjY0ZDlfNC0zLTEtMS03NjgxOA_edf931e1-9781-4fe2-ade4-5269e71d84b3">818</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Accrued professional services </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmJjYjZjNWYyODljNTQ5ODU4NmQyNWU2YTgwNGY2NGQ5L3RhYmxlcmFuZ2U6YmNiNmM1ZjI4OWM1NDk4NTg2ZDI1ZTZhODA0ZjY0ZDlfNC0xLTEtMS02ODMxNg_f47291f0-42e1-470d-8234-d42cff89ab31">652</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmJjYjZjNWYyODljNTQ5ODU4NmQyNWU2YTgwNGY2NGQ5L3RhYmxlcmFuZ2U6YmNiNmM1ZjI4OWM1NDk4NTg2ZDI1ZTZhODA0ZjY0ZDlfNC0zLTEtMS02ODMxNg_f93d3af1-7b96-4ecc-9574-341b4ad5511b">355</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Others</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmJjYjZjNWYyODljNTQ5ODU4NmQyNWU2YTgwNGY2NGQ5L3RhYmxlcmFuZ2U6YmNiNmM1ZjI4OWM1NDk4NTg2ZDI1ZTZhODA0ZjY0ZDlfNi0xLTEtMS02ODMxNg_01c43c2e-2d1b-4bfa-8144-a4692c5c3b37">761</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmJjYjZjNWYyODljNTQ5ODU4NmQyNWU2YTgwNGY2NGQ5L3RhYmxlcmFuZ2U6YmNiNmM1ZjI4OWM1NDk4NTg2ZDI1ZTZhODA0ZjY0ZDlfNi0zLTEtMS02ODMxNg_934978ce-bd75-41c4-b700-e2a960da1887">973</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmJjYjZjNWYyODljNTQ5ODU4NmQyNWU2YTgwNGY2NGQ5L3RhYmxlcmFuZ2U6YmNiNmM1ZjI4OWM1NDk4NTg2ZDI1ZTZhODA0ZjY0ZDlfNy0xLTEtMS02ODMxNg_64d6899a-5367-4a65-8cc6-177bc2162fad">9,896</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmJjYjZjNWYyODljNTQ5ODU4NmQyNWU2YTgwNGY2NGQ5L3RhYmxlcmFuZ2U6YmNiNmM1ZjI4OWM1NDk4NTg2ZDI1ZTZhODA0ZjY0ZDlfNy0zLTEtMS02ODMxNg_a63ee103-7fde-45e4-86d2-0895782d0677">13,511</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">        Accounts Receivable and Allowance for Credit Losses:</span></div><ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RleHRyZWdpb246NThjZmNhNzJmMzk5NGQ5NWJkYjAxNGIyNzgyMWY1ZmRfNzk4_c78258f4-dc55-424e-9591-690a0df70599" escape="true"><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The movement in the allowance for credit losses was as follows:</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.916%"><tr><td style="width:1.0%"></td><td style="width:66.514%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.697%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.589%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.700%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOjUyMjI4YzE2MTI5MjQwMjViMmVmOTU3ZjQ4ZGRmNjg4L3RhYmxlcmFuZ2U6NTIyMjhjMTYxMjkyNDAyNWIyZWY5NTdmNDhkZGY2ODhfMi0xLTEtMS02ODMxNg_a2d419c1-66c8-4916-b98b-ddae14c84f06">400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25ff20079ccb48899ea84d72b50e16e7_I20211231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOjUyMjI4YzE2MTI5MjQwMjViMmVmOTU3ZjQ4ZGRmNjg4L3RhYmxlcmFuZ2U6NTIyMjhjMTYxMjkyNDAyNWIyZWY5NTdmNDhkZGY2ODhfMi0zLTEtMS02ODMxNg_919c8edc-d574-4eb4-a446-de8e8e87604b">264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOjUyMjI4YzE2MTI5MjQwMjViMmVmOTU3ZjQ4ZGRmNjg4L3RhYmxlcmFuZ2U6NTIyMjhjMTYxMjkyNDAyNWIyZWY5NTdmNDhkZGY2ODhfMy0xLTEtMS02ODMxNg_7fab38a0-3fda-4437-ac2e-88a32836c76a">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic260793641a14f2695a83d42d27f0e29_D20220101-20221231" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOjUyMjI4YzE2MTI5MjQwMjViMmVmOTU3ZjQ4ZGRmNjg4L3RhYmxlcmFuZ2U6NTIyMjhjMTYxMjkyNDAyNWIyZWY5NTdmNDhkZGY2ODhfMy0zLTEtMS02ODMxNg_ccd55c25-0f94-45f5-8a7f-981ee74b8640">150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOjUyMjI4YzE2MTI5MjQwMjViMmVmOTU3ZjQ4ZGRmNjg4L3RhYmxlcmFuZ2U6NTIyMjhjMTYxMjkyNDAyNWIyZWY5NTdmNDhkZGY2ODhfNC0xLTEtMS02ODMxNg_0557ac33-9996-4e97-8fc4-291ba87ad72a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic260793641a14f2695a83d42d27f0e29_D20220101-20221231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOjUyMjI4YzE2MTI5MjQwMjViMmVmOTU3ZjQ4ZGRmNjg4L3RhYmxlcmFuZ2U6NTIyMjhjMTYxMjkyNDAyNWIyZWY5NTdmNDhkZGY2ODhfNC0zLTEtMS02ODMxNg_522e2979-24f0-43ce-a952-be1e01ef1eea">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOjUyMjI4YzE2MTI5MjQwMjViMmVmOTU3ZjQ4ZGRmNjg4L3RhYmxlcmFuZ2U6NTIyMjhjMTYxMjkyNDAyNWIyZWY5NTdmNDhkZGY2ODhfNS0xLTEtMS02ODMxNg_7f5ada53-437a-4cbc-ae50-abfb0ed56531">450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOjUyMjI4YzE2MTI5MjQwMjViMmVmOTU3ZjQ4ZGRmNjg4L3RhYmxlcmFuZ2U6NTIyMjhjMTYxMjkyNDAyNWIyZWY5NTdmNDhkZGY2ODhfNS0zLTEtMS02ODMxNg_fa5116e1-70bf-4c58-a323-ec215481e8a4">400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i928aa505a2ea46079da4e5082002267b_46"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. <ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RleHRyZWdpb246YjEzZTdjNDg3MjczNDdhN2I3MjgyZmJjNjFlOGY0ZThfMzE2Nw_2e5a732a-01dc-4a64-91ff-3f1e92f3fcf8" continuedAt="i6350ea63d2a74d2b87830e060c1c3998" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="i6350ea63d2a74d2b87830e060c1c3998" continuedAt="i5f5f3ff28ec844fda8fa63ceeddceb5a"><div style="margin-top:9pt;padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Leases</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a non-cancelable operating lease for an office building space, located in Santa Clara, California which expires in May 2025 and a building used for research and development and warehouse space in Santa Clara, California which expires in </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SI-BONE, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) </span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="i5f5f3ff28ec844fda8fa63ceeddceb5a" continuedAt="ie728e359a0ea4693abe09aaed9f303ea"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">October 2026. The Company also has non-cancelable operating leases for its office building spaces in Gallarate, Italy and Knaresborough, United Kingdom, which expire in August 2027 and December 2025, respectively. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company also leases vehicles under operating lease arrangements for certain of its personnel in Europe which expire at various times throughout 2023 to 2027.</span></div><ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RleHRyZWdpb246YjEzZTdjNDg3MjczNDdhN2I3MjgyZmJjNjFlOGY0ZThfMzE2OA_502d5c3c-e8b9-4366-8214-48384cc1aa4f" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental information related to lease expense and valuation of the lease assets and lease liabilit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ies are as follows:</span></div><div><span><br/></span></div><div style="padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:60.833%"><tr><td style="width:1.0%"></td><td style="width:56.662%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.763%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.311%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.764%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Operating lease expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RhYmxlOjI3YmY3MzkxYjk3NjQwOWRhYTA4MDlhZTRhZTdiNzFmL3RhYmxlcmFuZ2U6MjdiZjczOTFiOTc2NDA5ZGFhMDgwOWFlNGFlN2I3MWZfMi0xLTEtMS02ODMxNg_aaddb893-6815-430e-8630-294c92251620">394</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RhYmxlOjI3YmY3MzkxYjk3NjQwOWRhYTA4MDlhZTRhZTdiNzFmL3RhYmxlcmFuZ2U6MjdiZjczOTFiOTc2NDA5ZGFhMDgwOWFlNGFlN2I3MWZfMi0zLTEtMS02ODMxNg_893d59e0-0a9a-42ca-afd2-00f24827a401">409</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Variable lease expense</span></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RhYmxlOjI3YmY3MzkxYjk3NjQwOWRhYTA4MDlhZTRhZTdiNzFmL3RhYmxlcmFuZ2U6MjdiZjczOTFiOTc2NDA5ZGFhMDgwOWFlNGFlN2I3MWZfMy0xLTEtMS02ODMxNg_ccd18e87-3055-454f-9649-3455ffe11a43">76</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RhYmxlOjI3YmY3MzkxYjk3NjQwOWRhYTA4MDlhZTRhZTdiNzFmL3RhYmxlcmFuZ2U6MjdiZjczOTFiOTc2NDA5ZGFhMDgwOWFlNGFlN2I3MWZfMy0zLTEtMS02ODMxNg_5b81dd7b-ce80-4888-a4c7-02e412a0fefd">104</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" name="us-gaap:LeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RhYmxlOjI3YmY3MzkxYjk3NjQwOWRhYTA4MDlhZTRhZTdiNzFmL3RhYmxlcmFuZ2U6MjdiZjczOTFiOTc2NDA5ZGFhMDgwOWFlNGFlN2I3MWZfNC0xLTEtMS02ODMxNg_d2130155-5fb2-4c23-9b16-54077f9ee9e1">470</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" name="us-gaap:LeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RhYmxlOjI3YmY3MzkxYjk3NjQwOWRhYTA4MDlhZTRhZTdiNzFmL3RhYmxlcmFuZ2U6MjdiZjczOTFiOTc2NDA5ZGFhMDgwOWFlNGFlN2I3MWZfNC0zLTEtMS02ODMxNg_142170c5-af16-42d6-ada9-7cddc6836914">513</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cash paid for amounts included in the measurement of operating lease liabilities</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RhYmxlOjI3YmY3MzkxYjk3NjQwOWRhYTA4MDlhZTRhZTdiNzFmL3RhYmxlcmFuZ2U6MjdiZjczOTFiOTc2NDA5ZGFhMDgwOWFlNGFlN2I3MWZfNi0xLTEtMS02ODMxNg_2ee8d62c-38cb-44b6-bf85-343f9aa4af0f">398</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RhYmxlOjI3YmY3MzkxYjk3NjQwOWRhYTA4MDlhZTRhZTdiNzFmL3RhYmxlcmFuZ2U6MjdiZjczOTFiOTc2NDA5ZGFhMDgwOWFlNGFlN2I3MWZfNi0zLTEtMS02ODMxNg_30ab6905-8e48-430a-afd8-9a9026a5c73c">408</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Leased assets obtained in exchange for new operating lease liabilities</span></div><div><span><br/></span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RhYmxlOjI3YmY3MzkxYjk3NjQwOWRhYTA4MDlhZTRhZTdiNzFmL3RhYmxlcmFuZ2U6MjdiZjczOTFiOTc2NDA5ZGFhMDgwOWFlNGFlN2I3MWZfNy0xLTEtMS02ODMxNg_a9976fca-7fa4-41c3-a647-418ae2e2a9a2">21</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RhYmxlOjI3YmY3MzkxYjk3NjQwOWRhYTA4MDlhZTRhZTdiNzFmL3RhYmxlcmFuZ2U6MjdiZjczOTFiOTc2NDA5ZGFhMDgwOWFlNGFlN2I3MWZfNy0zLTEtMS02ODMxNg_7265b068-9e47-4d44-822f-129bcc08f8d7">&#8212;</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Weighted average remaining lease term (in years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RhYmxlOjI3YmY3MzkxYjk3NjQwOWRhYTA4MDlhZTRhZTdiNzFmL3RhYmxlcmFuZ2U6MjdiZjczOTFiOTc2NDA5ZGFhMDgwOWFlNGFlN2I3MWZfMTAtMS0xLTEtNjgzMTY_dc5c189c-b194-4cc0-a911-b745fb531968">2.83</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RhYmxlOjI3YmY3MzkxYjk3NjQwOWRhYTA4MDlhZTRhZTdiNzFmL3RhYmxlcmFuZ2U6MjdiZjczOTFiOTc2NDA5ZGFhMDgwOWFlNGFlN2I3MWZfMTAtMy0xLTEtNjgzMTY_98294459-d168-44c8-9e73-94d152050b22">3.05</ix:nonNumeric></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RhYmxlOjI3YmY3MzkxYjk3NjQwOWRhYTA4MDlhZTRhZTdiNzFmL3RhYmxlcmFuZ2U6MjdiZjczOTFiOTc2NDA5ZGFhMDgwOWFlNGFlN2I3MWZfMTEtMS0xLTEtNjgzMTY_55835157-4608-4d51-9d57-0dfabf214b1c">5.77</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RhYmxlOjI3YmY3MzkxYjk3NjQwOWRhYTA4MDlhZTRhZTdiNzFmL3RhYmxlcmFuZ2U6MjdiZjczOTFiOTc2NDA5ZGFhMDgwOWFlNGFlN2I3MWZfMTEtMy0xLTEtNjgzMTY_59fd8934-50e1-46d0-a2f3-d06f2673ede8">5.77</ix:nonFraction>%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RleHRyZWdpb246YjEzZTdjNDg3MjczNDdhN2I3MjgyZmJjNjFlOGY0ZThfMzE2Ng_a1fee7c8-a78e-47d8-8042-de34154fd271" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments under non-cancelable operating leases as of March 31, 2023 was as follows:</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.861%"><tr><td style="width:1.0%"></td><td style="width:71.044%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.756%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:4.5pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RhYmxlOjA1OTg0YmRkMDNjNTRmNDNiY2IxNDBkMjBiZjY1NGYzL3RhYmxlcmFuZ2U6MDU5ODRiZGQwM2M1NGY0M2JjYjE0MGQyMGJmNjU0ZjNfMS0xLTEtMS02ODMxNg_66e0f960-6b15-4570-8880-900ae6d20029">1,195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RhYmxlOjA1OTg0YmRkMDNjNTRmNDNiY2IxNDBkMjBiZjY1NGYzL3RhYmxlcmFuZ2U6MDU5ODRiZGQwM2M1NGY0M2JjYjE0MGQyMGJmNjU0ZjNfMi0xLTEtMS02ODMxNg_796b2dd0-31ac-4318-b372-c1945653cb62">1,517</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RhYmxlOjA1OTg0YmRkMDNjNTRmNDNiY2IxNDBkMjBiZjY1NGYzL3RhYmxlcmFuZ2U6MDU5ODRiZGQwM2M1NGY0M2JjYjE0MGQyMGJmNjU0ZjNfMy0xLTEtMS02ODMxNg_5c5df93a-a1cf-4c1e-aaf9-284e217fd147">1,005</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RhYmxlOjA1OTg0YmRkMDNjNTRmNDNiY2IxNDBkMjBiZjY1NGYzL3RhYmxlcmFuZ2U6MDU5ODRiZGQwM2M1NGY0M2JjYjE0MGQyMGJmNjU0ZjNfNC0xLTEtMS02ODMxNg_8eb2b002-6975-49e6-9d4f-b05f3c9ddbeb">530</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RhYmxlOjA1OTg0YmRkMDNjNTRmNDNiY2IxNDBkMjBiZjY1NGYzL3RhYmxlcmFuZ2U6MDU5ODRiZGQwM2M1NGY0M2JjYjE0MGQyMGJmNjU0ZjNfNS0xLTEtMS02ODMxNg_16685a58-3da3-44b9-9543-fc886590cb12">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="sibn:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RhYmxlOjA1OTg0YmRkMDNjNTRmNDNiY2IxNDBkMjBiZjY1NGYzL3RhYmxlcmFuZ2U6MDU5ODRiZGQwM2M1NGY0M2JjYjE0MGQyMGJmNjU0ZjNfNi0xLTEtMS02ODMxNg_ce23f90f-b1e9-4306-b82e-b80a7d148e09">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RhYmxlOjA1OTg0YmRkMDNjNTRmNDNiY2IxNDBkMjBiZjY1NGYzL3RhYmxlcmFuZ2U6MDU5ODRiZGQwM2M1NGY0M2JjYjE0MGQyMGJmNjU0ZjNfNy0xLTEtMS02ODMxNg_ca90a65c-f743-441e-9621-61b2c069eaa7">4,256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RhYmxlOjA1OTg0YmRkMDNjNTRmNDNiY2IxNDBkMjBiZjY1NGYzL3RhYmxlcmFuZ2U6MDU5ODRiZGQwM2M1NGY0M2JjYjE0MGQyMGJmNjU0ZjNfOC0xLTEtMS02ODMxNg_4d76a572-08ad-4c47-a0e2-58746a9d478f">330</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RhYmxlOjA1OTg0YmRkMDNjNTRmNDNiY2IxNDBkMjBiZjY1NGYzL3RhYmxlcmFuZ2U6MDU5ODRiZGQwM2M1NGY0M2JjYjE0MGQyMGJmNjU0ZjNfOS0xLTEtMS02ODMxNg_458ae51a-a070-4384-9676-02ae6476169c">3,926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023, the Company had <ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="sibn:LesseeOperatingLeaseLeaseNotYetCommencedLiability" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RleHRyZWdpb246YjEzZTdjNDg3MjczNDdhN2I3MjgyZmJjNjFlOGY0ZThfOTMz_6f2ac838-ba47-487d-90ff-bffba944cf9d">no</ix:nonFraction> operating lease liabilities that had not commenced.</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purchase Commitments and Obligations</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has certain purchase commitments related to its inventory management with certain manufacturing suppliers wherein the Company is required to purchase the amounts forecasted in a blanket purchase order. The contractual obligations represent future cash commitments and liabilities under agreements with third parties and exclude orders for goods and services entered into in the normal course of business that are not enforceable or legally binding. These outstanding commitments amounted to $<ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-5" name="us-gaap:PurchaseObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RleHRyZWdpb246YjEzZTdjNDg3MjczNDdhN2I3MjgyZmJjNjFlOGY0ZThfMTUyOA_6d294686-29aa-46f6-b5fc-1534bb4dca81">1.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-5" name="us-gaap:PurchaseObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RleHRyZWdpb246YjEzZTdjNDg3MjczNDdhN2I3MjgyZmJjNjFlOGY0ZThfMTUzNQ_a3a8fe57-e3d0-4d27-aa39-bd1fd9758ec8">0.8</ix:nonFraction> million as of March 31, 2023 and December 31, 2022, respectively.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indemnification</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SI-BONE, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) </span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="ie728e359a0ea4693abe09aaed9f303ea" continuedAt="if182744a96a54eeab82499daecfdbfe9"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into standard indemnification arrangements in the ordinary course of business. Pursuant to these arrangements, the Company indemnifies, holds harmless, and agrees to reimburse the indemnified parties for losses suffered or incurred by the indemnified party, in connection with any trade secret, copyright, patent or other intellectual property infringement claim by any third-party with respect to the Company&#8217;s technology. The term of these indemnification agreements is generally perpetual. The maximum potential amount of future payments the Company could be required to make under these agreements is not determinable because it involves claims that may be made against the Company in the future, but have not yet been made.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into indemnification agreements with its directors and officers that may require the Company to indemnify its directors and officers against liabilities that may arise by reason of their status or service as directors or officers, other than liabilities arising from willful misconduct of the individual.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has <ix:nonFraction unitRef="usd" contextRef="i0948ce79deee4391b59b52520a368e51_D20230101-20230331" decimals="INF" name="us-gaap:LitigationSettlementExpense" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RleHRyZWdpb246YjEzZTdjNDg3MjczNDdhN2I3MjgyZmJjNjFlOGY0ZThfMjY3OQ_811adb18-d357-4600-bba3-8fe317376d8a">no</ix:nonFraction>t incurred costs to defend lawsuits or settle claims related to these indemnification agreements. <ix:nonFraction unitRef="usd" contextRef="i8c1e121f074342c9bd40478fa2984c46_I20230331" decimals="INF" name="us-gaap:LitigationReserve" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RleHRyZWdpb246YjEzZTdjNDg3MjczNDdhN2I3MjgyZmJjNjFlOGY0ZThfMjc3OQ_b5b7aa76-f7a5-4735-b587-05be6e979ff1">No</ix:nonFraction> liability associated with such indemnifications has been recorded to date.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Contingencies</span></div></ix:continuation><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if182744a96a54eeab82499daecfdbfe9">From time to time, the Company may become involved in legal proceedings arising in the ordinary course of its business. The Company is not presently a party to any material legal proceedings that, if determined adversely to the Company, would have a material adverse effect on the Company.</ix:continuation> </span></div><div id="i928aa505a2ea46079da4e5082002267b_49"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7. <ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RleHRyZWdpb246OGViMzFkNTMyOTA1NGYxOTk0YzkzNzE3MzdmYWViNjdfNTk5Mw_0a60ed76-8df4-4b4e-8793-f52629961330" continuedAt="i795534f4c5d44117be883098b3d7f65c" escape="true">Borrowings</ix:nonNumeric></span></div><ix:continuation id="i795534f4c5d44117be883098b3d7f65c" continuedAt="i3b247e6800964f6e825a7a9700976f1d"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Term Loan</span></div><ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RleHRyZWdpb246OGViMzFkNTMyOTA1NGYxOTk0YzkzNzE3MzdmYWViNjdfNTk5NQ_03ac9479-494d-4937-b0a3-b07f9e9c1607" escape="true"><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the outstanding borrowings from the term loan as of periods presented:</span></div><div style="margin-bottom:12pt;margin-top:9pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.583%"><tr><td style="width:1.0%"></td><td style="width:66.962%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.575%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.405%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal outstanding and final fee</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RhYmxlOmFiY2M3Y2JlODkxNjQ2NTJiMzlhODcyMTNiZTZlNDk2L3RhYmxlcmFuZ2U6YWJjYzdjYmU4OTE2NDY1MmIzOWE4NzIxM2JlNmU0OTZfMi0xLTEtMS02ODMxNg_9afcefdf-8e06-453c-b16a-749ad3325d2a">36,720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RhYmxlOmFiY2M3Y2JlODkxNjQ2NTJiMzlhODcyMTNiZTZlNDk2L3RhYmxlcmFuZ2U6YWJjYzdjYmU4OTE2NDY1MmIzOWE4NzIxM2JlNmU0OTZfMi0zLTEtMS02ODMxNg_1498691a-5890-416e-b57a-2ed9be174ebb">35,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RhYmxlOmFiY2M3Y2JlODkxNjQ2NTJiMzlhODcyMTNiZTZlNDk2L3RhYmxlcmFuZ2U6YWJjYzdjYmU4OTE2NDY1MmIzOWE4NzIxM2JlNmU0OTZfMy0xLTEtMS02ODMxNg_29fa9ed6-7677-49e3-aa4e-2fce7a97fa68">99</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RhYmxlOmFiY2M3Y2JlODkxNjQ2NTJiMzlhODcyMTNiZTZlNDk2L3RhYmxlcmFuZ2U6YWJjYzdjYmU4OTE2NDY1MmIzOWE4NzIxM2JlNmU0OTZfMy0zLTEtMS02ODMxNg_90d4b1d3-7005-41e2-94d7-ea12c923aabf">73</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Unaccreted value of final fee</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:DebtInstrumentFeeAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RhYmxlOmFiY2M3Y2JlODkxNjQ2NTJiMzlhODcyMTNiZTZlNDk2L3RhYmxlcmFuZ2U6YWJjYzdjYmU4OTE2NDY1MmIzOWE4NzIxM2JlNmU0OTZfNC0xLTEtMS02ODMxNg_f9f166ca-fa15-4c6a-9777-369b65d14013">683</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:DebtInstrumentFeeAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RhYmxlOmFiY2M3Y2JlODkxNjQ2NTJiMzlhODcyMTNiZTZlNDk2L3RhYmxlcmFuZ2U6YWJjYzdjYmU4OTE2NDY1MmIzOWE4NzIxM2JlNmU0OTZfNC0zLTEtMS02ODMxNg_6b58161d-e8b7-4cb0-b42e-d492eb5862bf">456</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding debt, net of debt issuance costs and unaccreted value of final fee</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RhYmxlOmFiY2M3Y2JlODkxNjQ2NTJiMzlhODcyMTNiZTZlNDk2L3RhYmxlcmFuZ2U6YWJjYzdjYmU4OTE2NDY1MmIzOWE4NzIxM2JlNmU0OTZfNS0xLTEtMS02ODMxNg_7b574425-71f6-448d-a5fb-c8af9c16e2a8">35,938</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RhYmxlOmFiY2M3Y2JlODkxNjQ2NTJiMzlhODcyMTNiZTZlNDk2L3RhYmxlcmFuZ2U6YWJjYzdjYmU4OTE2NDY1MmIzOWE4NzIxM2JlNmU0OTZfNS0zLTEtMS02ODMxNg_2774bd0a-d2ed-487d-b939-9c1fd0514fea">35,171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Classified as:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term borrowings</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RhYmxlOmFiY2M3Y2JlODkxNjQ2NTJiMzlhODcyMTNiZTZlNDk2L3RhYmxlcmFuZ2U6YWJjYzdjYmU4OTE2NDY1MmIzOWE4NzIxM2JlNmU0OTZfOC0xLTEtMS02ODMxNg_6b8a35b2-afe2-4d93-82e5-9c1f5ae3d8dd">35,938</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RhYmxlOmFiY2M3Y2JlODkxNjQ2NTJiMzlhODcyMTNiZTZlNDk2L3RhYmxlcmFuZ2U6YWJjYzdjYmU4OTE2NDY1MmIzOWE4NzIxM2JlNmU0OTZfOC0zLTEtMS02ODMxNg_f6255995-a6cb-42b3-a01a-3cdcec28bd67">35,171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The outstanding debt is related to a term loan pursuant to the Loan and Security Agreement dated August 12, 2021 (the &#8220;Effective Date&#8221;), entered into by the Company with Silicon Valley Bank (&#8220;SVB&#8221;). Pursuant the agreement, SVB provided an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="if8e560c29f77458f868e82a8beb02128_I20210812" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RleHRyZWdpb246OGViMzFkNTMyOTA1NGYxOTk0YzkzNzE3MzdmYWViNjdfMTcwMg_606146a7-7c61-437e-b50b-6724254fd321">35.0</ix:nonFraction>&#160;million to the Company (the &#8220;SVB Term Loan&#8221;). </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 6, 2023, the Company entered into a First Amendment to Loan and Security Agreement (the &#8220;Amendment&#8221;) with SVB, which amended the Company's SVB Term Loan pursuant to which the Company had a term loan facility in an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i7fe2d63d0e5c43bdbdf07781f3c546f9_I20230106" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RleHRyZWdpb246OGViMzFkNTMyOTA1NGYxOTk0YzkzNzE3MzdmYWViNjdfMTA5OTUxMTY0MTIxMg_5a491a40-7350-4fb3-9394-91e114f4d19d">35.0</ix:nonFraction>&#160;million (the &#8220;Original Loan Agreement&#8221; and with the Amendment, collectively the &#8220;Amended Loan Agreement&#8221;).  Upon entry into the Amended Loan Agreement, the Company borrowed $<ix:nonFraction unitRef="usd" contextRef="i1bf81bb780c3454a8a17edba536c3cca_D20230106-20230106" decimals="-5" name="us-gaap:ProceedsFromRepaymentsOfSecuredDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RleHRyZWdpb246OGViMzFkNTMyOTA1NGYxOTk0YzkzNzE3MzdmYWViNjdfMTA5OTUxMTY0MTMzNg_5beaf468-844a-430c-a9cc-5379fd838cbd">36.0</ix:nonFraction>&#160;million pursuant to a term loan (the "Term Loan"), which was substantially used to repay in full the $<ix:nonFraction unitRef="usd" contextRef="icb70f81572e248629f7b7f231c74cec6_D20230106-20230106" decimals="-5" sign="-" name="us-gaap:ProceedsFromRepaymentsOfSecuredDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RleHRyZWdpb246OGViMzFkNTMyOTA1NGYxOTk0YzkzNzE3MzdmYWViNjdfNTQ5NzU1ODI4MTU3_4ef0a0d8-8305-454d-95fb-0c6ce826a501">35.0</ix:nonFraction>&#160;million term loan facility outstanding under the Original Loan Agreement and secured a revolving credit facility in an aggregate principal amount of up to $<ix:nonFraction unitRef="usd" contextRef="i75a6a55921b94e788965c7b88a1250c0_I20230106" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RleHRyZWdpb246OGViMzFkNTMyOTA1NGYxOTk0YzkzNzE3MzdmYWViNjdfNTQ5NzU1ODI4MTcy_71a76ae9-c579-4f60-abeb-3388e4abb460">15.0</ix:nonFraction>&#160;million (the "Revolver"). On March 14, 2023 all of SVB&#8217;s assets and liabilities, including all of SVB&#8217;s rights as the lender pursuant to the Amended Loan Agreement, were assigned to Silicon Valley Bridge Bank.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 27, 2023, all of Silicon Valley Bridge Bank&#8217;s assets and liabilities were assigned and assumed by First-Citizens Bank &amp; Trust Company (&#8220;First-Citizens&#8221;). The Amended Loan Agreement also includes an uncommitted accordion term loan in an aggregate principal amount of up to $<ix:nonFraction unitRef="usd" contextRef="i76321e3f57544d228615f7521f589bc2_I20230106" decimals="-5" name="sibn:LineOfCreditFacilityAccordionFeatureIncreaseLimit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RleHRyZWdpb246OGViMzFkNTMyOTA1NGYxOTk0YzkzNzE3MzdmYWViNjdfMTA5OTUxMTY0MTM1MQ_6e6c4d4f-db88-4847-bac9-017f0fe5e05d">15.0</ix:nonFraction>&#160;million, which accordion may be approved by First-Citizens solely in its discretion, upon the Company&#8217;s request. The Term Loan matures on December 1, 2027 (the &#8220;Term Loan Maturity Date&#8221;). Interest on the Term Loan will be payable monthly at a floating annual rate set at the greater of the prime rate as published in the Wall Street Journal plus <ix:nonFraction unitRef="number" contextRef="i40ef43333c0442bf888482c8ace88dd4_D20230106-20230106" decimals="3" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RleHRyZWdpb246OGViMzFkNTMyOTA1NGYxOTk0YzkzNzE3MzdmYWViNjdfMTA5OTUxMTY0MTM2Ng_23a99057-a28b-453c-a33a-a0349e5524fa">0.5</ix:nonFraction>% or <ix:nonFraction unitRef="number" contextRef="id912f88617b74e8f9c3530bd836870bf_D20230106-20230106" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RleHRyZWdpb246OGViMzFkNTMyOTA1NGYxOTk0YzkzNzE3MzdmYWViNjdfMTA5OTUxMTY0MTM3Mg_fb5bf095-0b45-4023-96b2-7936ddd9b490">6.75</ix:nonFraction>%. Commencing on July 1, 2025, the Company will be required to make monthly principal Term Loan amortization payments. A final fee payment of <ix:nonFraction unitRef="number" contextRef="ibd2e135759a24184955191e8a1e9cc3c_I20230106" decimals="2" name="sibn:DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RleHRyZWdpb246OGViMzFkNTMyOTA1NGYxOTk0YzkzNzE3MzdmYWViNjdfNTQ5NzU1ODI4MTk2_1d015cfb-6e4d-4b36-968a-b629d5c57ab3">2</ix:nonFraction>% of the original principal amount of the Term Loan is due upon the earlier of the Term Loan Maturity Date, termination, acceleration by First-Citizens following an event of default, or prepayment of the Term Loan. The Company may elect to prepay the Term Loan in whole prior to the Term Loan Maturity Date subject to a prepayment fee equal to <ix:nonFraction unitRef="number" contextRef="ibd2e135759a24184955191e8a1e9cc3c_I20230106" decimals="2" name="sibn:DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RleHRyZWdpb246OGViMzFkNTMyOTA1NGYxOTk0YzkzNzE3MzdmYWViNjdfMTA5OTUxMTY0MTM4MA_13f38c3b-2554-47e1-b06a-b7f34a2eebe3">2</ix:nonFraction>% of the principal amount of the Term Loan prepaid at such time. No prepayment fee would be due if the Term Loan is refinanced by First-Citizens. Pursuant to the terms of the Amended Loan Agreement, revolving loans may be </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SI-BONE, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) </span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="i3b247e6800964f6e825a7a9700976f1d" continuedAt="i0a3e00d8388d4cedb5c1adb471b79ecd"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">borrowed, repaid and reborrowed until the maturity date, which will be July 6, 2025 (the "Revolver Maturity Date"). Borrowings under the Revolver are based on <ix:nonFraction unitRef="number" contextRef="idbafe1e8ab4043a896784415b82016d4_D20230106-20230106" decimals="2" name="sibn:DebtInstrumentAccountsReceivableBorrowingBase" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RleHRyZWdpb246OGViMzFkNTMyOTA1NGYxOTk0YzkzNzE3MzdmYWViNjdfMTA5OTUxMTY0MTM4NA_81932a3d-f917-4fea-86b0-57c1c01295bf">80</ix:nonFraction>% of eligible domestic accounts receivable borrowing base. Interest on the outstanding balance of the Revolver will be payable monthly at a floating annual rate set at the greater of the prime rate as published in the Wall Street Journal or <ix:nonFraction unitRef="number" contextRef="i76321e3f57544d228615f7521f589bc2_I20230106" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RleHRyZWdpb246OGViMzFkNTMyOTA1NGYxOTk0YzkzNzE3MzdmYWViNjdfMTA5OTUxMTY0MTM4OQ_d5d06836-ff88-4455-ac10-7050a7e7f19f">6.25</ix:nonFraction>%. Interest on borrowings is due monthly and any principal balance is due on the Revolver Maturity Date, provided that when Revolver Advances are outstanding, in the event the Company does not maintain an adjusted quick ratio of at least <ix:nonFraction unitRef="quick_ratio" contextRef="idbafe1e8ab4043a896784415b82016d4_D20230106-20230106" decimals="INF" name="sibn:DebtInstrumentCovenantAdjustedQuickRatioMinimum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RleHRyZWdpb246OGViMzFkNTMyOTA1NGYxOTk0YzkzNzE3MzdmYWViNjdfMTA5OTUxMTY0MTQxNA_321d5a90-c167-4b4f-9fc5-a19ae76a6b55">1.5</ix:nonFraction> to 1.0, then falling below such threshold will allow First-Citizens to apply accounts receivable collections to outstanding Revolver borrowings. The Company will pay a total commitment fee of $<ix:nonFraction unitRef="usd" contextRef="iead9b266d2d14baba4281492cf7acebc_D20230106-20230106" decimals="-2" name="us-gaap:LineOfCreditFacilityCommitmentFeeAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RleHRyZWdpb246OGViMzFkNTMyOTA1NGYxOTk0YzkzNzE3MzdmYWViNjdfMTA5OTUxMTY0MTM5Ng_e748cdfd-cb8e-43f9-a7ce-7bfddba39bee">187,500</ix:nonFraction> on account of the Revolver payable in installments, but fully earned at close. The Company will also be required to pay a fee of $<ix:nonFraction unitRef="usd" contextRef="iead9b266d2d14baba4281492cf7acebc_D20230106-20230106" decimals="-4" name="sibn:LineOfCreditFacilityContingentCommitmentFeeAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RleHRyZWdpb246OGViMzFkNTMyOTA1NGYxOTk0YzkzNzE3MzdmYWViNjdfMTA5OTUxMTY0MTQwNQ_faa4031a-307d-41b6-9594-c25319d9da6e">150,000</ix:nonFraction> if it terminates the Amended Loan Agreement or Revolver prior to Revolver Maturity Date. No termination fee would be due if the Revolver is replaced with a new facility with First-Citizens. No amounts were outstanding under the Revolver as of March 31, 2023.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounted for the Amended Loan Agreement as a debt modification. Accordingly, the remaining unamortized debt issuance costs related to the Original Loan Agreement together with any lender fees incurred in connection with the entry of the Amended Loan Agreement are amortized to interest expense using the straight-line method over the new term of the loan through December 2027.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective interest rate related to the First-Citizens Term Loan for the three months ended March 31, 2023 and March 31, 2022 was <ix:nonFraction unitRef="number" contextRef="ia93eb97347d343fb94b99ed9c40ef16b_D20230101-20230331" decimals="3" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RleHRyZWdpb246OGViMzFkNTMyOTA1NGYxOTk0YzkzNzE3MzdmYWViNjdfNDU3MA_3d45719a-c956-4a2d-9b72-8d64ed3ce6e2">8.6</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i7d10f967602a4f5e83faefa1d251c9a3_D20220101-20220331" decimals="3" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RleHRyZWdpb246OGViMzFkNTMyOTA1NGYxOTk0YzkzNzE3MzdmYWViNjdfNDU3Nw_2b89edf2-3093-48ee-a5f2-8747ea409590">6.3</ix:nonFraction>%, respectively. </span></div><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">         <ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RleHRyZWdpb246OGViMzFkNTMyOTA1NGYxOTk0YzkzNzE3MzdmYWViNjdfNTk5Ng_0fa17355-610d-4daa-a44d-cb1773576813" continuedAt="i90858a3877de4905a53d1e624903b2f2" escape="true">The table below summarizes the future principal and final fee payments under the Fist-Citizens Term Loan as of March 31, 2023:</ix:nonNumeric></span></div><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:36pt"><ix:continuation id="i90858a3877de4905a53d1e624903b2f2"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.388%"><tr><td style="width:1.0%"></td><td style="width:84.912%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.888%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RhYmxlOmUwOWYzZGIxNjdhNTQ3YTlhYWFmN2FjNjkxZDg3YWY2L3RhYmxlcmFuZ2U6ZTA5ZjNkYjE2N2E1NDdhOWFhYWY3YWM2OTFkODdhZjZfMS0xLTEtMS02ODMxNg_6e2ff7d6-1c3f-4bf8-b484-7486fb7587ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RhYmxlOmUwOWYzZGIxNjdhNTQ3YTlhYWFmN2FjNjkxZDg3YWY2L3RhYmxlcmFuZ2U6ZTA5ZjNkYjE2N2E1NDdhOWFhYWY3YWM2OTFkODdhZjZfMi0xLTEtMS02ODMxNg_3f8218f6-106d-47e1-a8c2-3c55f7cb8a1d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RhYmxlOmUwOWYzZGIxNjdhNTQ3YTlhYWFmN2FjNjkxZDg3YWY2L3RhYmxlcmFuZ2U6ZTA5ZjNkYjE2N2E1NDdhOWFhYWY3YWM2OTFkODdhZjZfMy0xLTEtMS02ODMxNg_d253af3a-ed04-4781-9f60-62ccab8532af">8,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RhYmxlOmUwOWYzZGIxNjdhNTQ3YTlhYWFmN2FjNjkxZDg3YWY2L3RhYmxlcmFuZ2U6ZTA5ZjNkYjE2N2E1NDdhOWFhYWY3YWM2OTFkODdhZjZfNC0xLTEtMS02ODMxNg_7ca7da02-4099-4561-92f9-7eab57c0bac2">14,400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RhYmxlOmUwOWYzZGIxNjdhNTQ3YTlhYWFmN2FjNjkxZDg3YWY2L3RhYmxlcmFuZ2U6ZTA5ZjNkYjE2N2E1NDdhOWFhYWY3YWM2OTFkODdhZjZfNS0xLTEtMS02ODMxNg_1e05d167-7de0-48e2-addc-1a0c8f447089">13,920</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total principal and final fee payments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RhYmxlOmUwOWYzZGIxNjdhNTQ3YTlhYWFmN2FjNjkxZDg3YWY2L3RhYmxlcmFuZ2U6ZTA5ZjNkYjE2N2E1NDdhOWFhYWY3YWM2OTFkODdhZjZfNy0xLTEtMS02ODMxNg_3a58e74f-6210-484d-8685-fefdd9766d07">36,720</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Amended Loan Agreement contains customary events of default, including bankruptcy, the failure to make payments when due, the occurrence of a material impairment on First-Citizens's security interest over the collateral, a material adverse change, the occurrence of a default under certain other indebtedness of the Company and its subsidiaries, the rendering of certain types of judgments against the Company and its subsidiaries, the revocation of certain government approvals, violation of covenants, and incorrectness of representations and warranties in any material respect. In addition, the Amended Loan Agreement contains a financial covenant which requires the Company to maintain, at all times when the Financial Covenant Measuring Period is in effect, certain net revenue levels as agreed upon by the Company and First-Citizens. If the Company does not comply with the various covenants under the Amended Loan Agreement and an event of default occurs under the Amended Loan Agreement, the interest rate on outstanding amounts can increase by <ix:nonFraction unitRef="number" contextRef="ia93eb97347d343fb94b99ed9c40ef16b_D20230101-20230331" decimals="3" name="sibn:DebtInstrumentInterestRateIncreaseDueToDefault" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RleHRyZWdpb246OGViMzFkNTMyOTA1NGYxOTk0YzkzNzE3MzdmYWViNjdfNTQ5NzU1ODI4MTQy_c6b78ed2-3867-41f1-a0de-35a785c6ddba">3</ix:nonFraction>% and First-Citizens may, subject to various customary cure rights, decline to provide additional advances under the Revolver, require the immediate payment of all amounts outstanding under the Amended Loan Agreement, and foreclose on all collateral. </span></div></ix:continuation><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:continuation id="i0a3e00d8388d4cedb5c1adb471b79ecd">On March 10, 2023, the Company violated one of the terms of the credit facility by opening bank accounts with another financial institution and transferring funds from SVB. The Company entered into a letter agreement with Silicon Valley Bridge Bank waiving enforcement of this covenant and providing the Company the right to hold a portion of its cash at other financial institutions. A future violation of any covenants could result in a default under the Amended Loan Agreement that would permit First-Citizens to restrict the Company&#8217;s ability to further access the Revolving Line of Credit for loans and require the immediate repayment of any outstanding loans under the agreement. As of March 31, 2023, the Company was in compliance with all debt covenants, provided, however, that in order to access future credit advances under the Revolving Line of Credit, the Company will be required to transfer certain cash management accounts back to First-Citizens.  As of March 31, 2023, the Company had cash management accounts with a financial institution other than First-Citizens and instructed its customers to direct payments to these separate operating accounts. Until such operating accounts are closed and the funds moved back to cash collateral accounts held at First-Citizens, the Company will be unable to obtain credit advances under the Revolver.</ix:continuation> </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div><div><span><br/></span></div></div></div><div id="i928aa505a2ea46079da4e5082002267b_52"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SI-BONE, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) </span></div><div style="text-align:justify"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8. <ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfNDAyNg_d7d47278-68c2-47d2-9775-eb00d1c2dbaa" continuedAt="id4f260a760be4776991b3cf498947bf8" escape="true">Stock-Based Incentive Compensation Plans </ix:nonNumeric></span></div><ix:continuation id="id4f260a760be4776991b3cf498947bf8" continuedAt="ifcef3889eff9467dae6eda46726277de"><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfNDAyOA_b54e8933-e5bf-4a97-a807-a3891cdb6a68" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the stock option activity for the three months ended March 31, 2023:</span></div><div style="margin-bottom:9pt;padding-left:72pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.444%"><tr><td style="width:1.0%"></td><td style="width:62.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of <br/>Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted- <br/>Average <br/>Exercise <br/>Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOjRjNzUxYjQ1NWMzZTRmNzdhYjczNjE0NGU2MWFiZWU4L3RhYmxlcmFuZ2U6NGM3NTFiNDU1YzNlNGY3N2FiNzM2MTQ0ZTYxYWJlZThfMS0yLTEtMS02ODMxNg_7e8544c7-c354-41d3-ac2c-aa2823d440f9">1,903,341</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOjRjNzUxYjQ1NWMzZTRmNzdhYjczNjE0NGU2MWFiZWU4L3RhYmxlcmFuZ2U6NGM3NTFiNDU1YzNlNGY3N2FiNzM2MTQ0ZTYxYWJlZThfMS00LTEtMS02ODMxNg_827b7e64-faae-4a2b-9443-9209cdc98e89">8.82</ix:nonFraction></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOjRjNzUxYjQ1NWMzZTRmNzdhYjczNjE0NGU2MWFiZWU4L3RhYmxlcmFuZ2U6NGM3NTFiNDU1YzNlNGY3N2FiNzM2MTQ0ZTYxYWJlZThfMy0yLTEtMS02ODMxNg_ffb989b1-ec66-4069-8b7c-d0e9683ca8e4">120,266</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOjRjNzUxYjQ1NWMzZTRmNzdhYjczNjE0NGU2MWFiZWU4L3RhYmxlcmFuZ2U6NGM3NTFiNDU1YzNlNGY3N2FiNzM2MTQ0ZTYxYWJlZThfMy00LTEtMS02ODMxNg_8463f5fd-d08a-4c9b-b76a-a1faeb92bf50">4.33</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled and forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOjRjNzUxYjQ1NWMzZTRmNzdhYjczNjE0NGU2MWFiZWU4L3RhYmxlcmFuZ2U6NGM3NTFiNDU1YzNlNGY3N2FiNzM2MTQ0ZTYxYWJlZThfNC0yLTEtMS02ODMxNg_a46354fc-d99a-4dea-869c-7fe2b46ce8a5">15,284</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOjRjNzUxYjQ1NWMzZTRmNzdhYjczNjE0NGU2MWFiZWU4L3RhYmxlcmFuZ2U6NGM3NTFiNDU1YzNlNGY3N2FiNzM2MTQ0ZTYxYWJlZThfNC00LTEtMS02ODMxNg_aa1e9203-19c2-4ab3-865d-8e22468e5830">21.36</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOjRjNzUxYjQ1NWMzZTRmNzdhYjczNjE0NGU2MWFiZWU4L3RhYmxlcmFuZ2U6NGM3NTFiNDU1YzNlNGY3N2FiNzM2MTQ0ZTYxYWJlZThfNS0yLTEtMS02ODMxNg_31c353c2-d087-49c3-a7d1-e436850d69f4">1,767,791</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOjRjNzUxYjQ1NWMzZTRmNzdhYjczNjE0NGU2MWFiZWU4L3RhYmxlcmFuZ2U6NGM3NTFiNDU1YzNlNGY3N2FiNzM2MTQ0ZTYxYWJlZThfNS00LTEtMS02ODMxNg_8fa139b2-8074-4265-9398-4d5db9b49333">10.23</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023, the unrecognized compensation cost related to stock options is insignificant and is expected to be recognized over a period of approximately <ix:nonNumeric contextRef="i6a9db0b913fe48aea9fd168fc919ec8d_D20230101-20230331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfMjc5_a8aef1dd-5689-436f-ac0a-97a78c52ee86">0.4</ix:nonNumeric> years.</span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="shares" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfMjk1_43447d02-bf2e-4929-bd4c-6036949e8d2a"><ix:nonFraction unitRef="shares" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfMjk1_b205a52b-b3af-44dc-a46d-2fa410a6967c">no</ix:nonFraction></ix:nonFraction> stock options granted during the three months ended March 31, 2023 and 2022. </span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Early Exercise of Unvested Stock Options</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Early exercises of stock options under the Company's 2008 Stock Option Plan are subject to a right of repurchase by the Company of any unvested shares. The repurchase rights lapse over the original vesting period of the options. The Company accounts for the cash received in consideration for the early exercised options as a liability included in accrued liabilities, which is then reclassified to stockholders&#8217; equity as the options vest. As of March 31, 2023 and December 31, 2022, the Company had <ix:nonFraction unitRef="shares" contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331" decimals="INF" name="sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfODc2_4943d8fd-70f0-4137-9514-c6eef222210c"><ix:nonFraction unitRef="shares" contextRef="i9dcf850d9d0446dea538750874891e18_I20221231" decimals="INF" name="sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfODc2_66680961-7825-425a-b076-60bc7be612ae">no</ix:nonFraction></ix:nonFraction> shares subject to repurchase. </span></div><div style="margin-top:18pt;padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Units (&#8220;RSUs&#8221;)</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs are share awards that entitle the holder to receive freely tradable shares of the Company&#8217;s common stock upon vesting. RSUs generally vest over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfMTEwOQ_b006b137-1392-4dc1-aa98-21e5cfe1c1eb">two</span> to <ix:nonNumeric contextRef="iae333c43aa6f438893c3e83047c6ba3e_D20230101-20230331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfMTExNQ_be506648-2bdb-4a78-b2c6-25dbd934e492">four years</ix:nonNumeric> based upon continued services and are settled at vesting in shares of the Company's common stock. Certain RSUs vest based upon continued services and the achievement of financial milestones. The grant date fair value of the RSUs is equal to the closing price of the Company&#8217;s common stock on the grant date. As of March 31, 2023, the unr</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ecognized compensation cost related to the RSUs was $<ix:nonFraction unitRef="usd" contextRef="iafee48dbb8fc4bfc960af6aa6244917f_I20230331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfMTA5OTUxMTYzODUyNQ_463185be-7545-4208-afb7-baf42b7f4202">41.5</ix:nonFraction> million, which is expected to be recognized over a period of approximately <ix:nonNumeric contextRef="iaf9a24c75b524dfa94a49c4ab5a022c0_D20230101-20230331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfMTA5OTUxMTYzODU5Ng_8ebb04cf-b0f5-4c54-9f87-023db060447d">2.8</ix:nonNumeric> years. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company granted performance-based restricted stock unit awards subject to market and service vesting conditions to certain executive officers under SI-BONE's 2018 Equity Incentive Plan (&#8220;PSUs&#8221;). The shares subject to PSUs vest over a <ix:nonNumeric contextRef="iac4ffd9b01074e8fa63dc6df8b863046_D20220101-20220131" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfNDAyOQ_2be96ab5-77f8-4ea9-91fc-0d3f4aa4b46d">three-year</ix:nonNumeric> performance period. The actual number of PSUs that will vest in each measurement period will be determined by the Compensation Committee based on the Company&#8217;s total shareholder return (&#8220;TSR&#8221;) relative to the TSR of the Median Peer Companies (as defined in the award agreement).  The grant date fair value of each stock award with a market condition was determined using the Monte Carlo valuation model. <ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="sibn:ScheduleOfShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfNDAzMA_aaebd7de-6ad9-4c32-8bb2-06d5c41821e0" continuedAt="id1b387f83ef7474aa301a88dccb7de9f" escape="true">The table below summarizes the assumptions used to estimate the grant date fair value of the PSUs granted:</ix:nonNumeric></span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><ix:continuation id="id1b387f83ef7474aa301a88dccb7de9f"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.833%"><tr><td style="width:1.0%"></td><td style="width:41.073%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.379%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.320%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.324%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility of common stock</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i73253fc85d9d4718b307a6aeea2b9c06_D20230101-20230331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmZjNjRjNWI2MDI2YzRkOGFhOWI1MTRkNGVlOWQxYThlL3RhYmxlcmFuZ2U6ZmM2NGM1YjYwMjZjNGQ4YWE5YjUxNGQ0ZWU5ZDFhOGVfMS0xMy0xLTEtNjgzMTY_6279dd35-18e3-4c0d-ad7e-24338c6bf67c">58.0</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i73253fc85d9d4718b307a6aeea2b9c06_D20230101-20230331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmZjNjRjNWI2MDI2YzRkOGFhOWI1MTRkNGVlOWQxYThlL3RhYmxlcmFuZ2U6ZmM2NGM1YjYwMjZjNGQ4YWE5YjUxNGQ0ZWU5ZDFhOGVfMS0xNS0xLTEtNjgzMTY_49062d06-8581-42b4-aab7-0ea135e5ce9c">73.0</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if5a58a2d117b40d8a0d022c115299b14_D20220101-20220331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmZjNjRjNWI2MDI2YzRkOGFhOWI1MTRkNGVlOWQxYThlL3RhYmxlcmFuZ2U6ZmM2NGM1YjYwMjZjNGQ4YWE5YjUxNGQ0ZWU5ZDFhOGVfMi0xNy0xLTEtNzk1NDg_5f151f95-5eb9-4aa3-a87b-8da0d35dc8c4">48.9</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if5a58a2d117b40d8a0d022c115299b14_D20220101-20220331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmZjNjRjNWI2MDI2YzRkOGFhOWI1MTRkNGVlOWQxYThlL3RhYmxlcmFuZ2U6ZmM2NGM1YjYwMjZjNGQ4YWE5YjUxNGQ0ZWU5ZDFhOGVfMi0xOS0xLTEtNzk1NTE_53b91c4e-23c9-4066-8f42-0d6eed039a7b">58.7</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility of peer companies</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i73253fc85d9d4718b307a6aeea2b9c06_D20230101-20230331" decimals="3" name="sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmZjNjRjNWI2MDI2YzRkOGFhOWI1MTRkNGVlOWQxYThlL3RhYmxlcmFuZ2U6ZmM2NGM1YjYwMjZjNGQ4YWE5YjUxNGQ0ZWU5ZDFhOGVfMi0xMy0xLTEtNjgzMTY_7efa34d1-01b0-486d-a582-93f6441dfb8b">33.0</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i73253fc85d9d4718b307a6aeea2b9c06_D20230101-20230331" decimals="3" name="sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmZjNjRjNWI2MDI2YzRkOGFhOWI1MTRkNGVlOWQxYThlL3RhYmxlcmFuZ2U6ZmM2NGM1YjYwMjZjNGQ4YWE5YjUxNGQ0ZWU5ZDFhOGVfMi0xNS0xLTEtNjgzMTY_90f80049-5402-430e-8217-90e2b7b80106">141.0</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if5a58a2d117b40d8a0d022c115299b14_D20220101-20220331" decimals="3" name="sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmZjNjRjNWI2MDI2YzRkOGFhOWI1MTRkNGVlOWQxYThlL3RhYmxlcmFuZ2U6ZmM2NGM1YjYwMjZjNGQ4YWE5YjUxNGQ0ZWU5ZDFhOGVfMy0xNy0xLTEtNzk1NDg_89b5f8fa-15a1-4816-ad81-ce42575fe225">24.2</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if5a58a2d117b40d8a0d022c115299b14_D20220101-20220331" decimals="3" name="sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmZjNjRjNWI2MDI2YzRkOGFhOWI1MTRkNGVlOWQxYThlL3RhYmxlcmFuZ2U6ZmM2NGM1YjYwMjZjNGQ4YWE5YjUxNGQ0ZWU5ZDFhOGVfMy0xOS0xLTEtNzk1NTE_b38a832b-289b-43bb-be2a-4a7812ac66d7">152.5</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Correlation coefficient of peer companies</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i73253fc85d9d4718b307a6aeea2b9c06_D20230101-20230331" decimals="2" sign="-" name="sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMinimum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmZjNjRjNWI2MDI2YzRkOGFhOWI1MTRkNGVlOWQxYThlL3RhYmxlcmFuZ2U6ZmM2NGM1YjYwMjZjNGQ4YWE5YjUxNGQ0ZWU5ZDFhOGVfMy0xMy0xLTEtNjgzMTY_17083d61-e1a5-4b99-aad9-10530407ec02">0.15</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i73253fc85d9d4718b307a6aeea2b9c06_D20230101-20230331" decimals="2" name="sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMaximum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmZjNjRjNWI2MDI2YzRkOGFhOWI1MTRkNGVlOWQxYThlL3RhYmxlcmFuZ2U6ZmM2NGM1YjYwMjZjNGQ4YWE5YjUxNGQ0ZWU5ZDFhOGVfMy0xNS0xLTEtNjgzMTY_ae6581e4-775b-4a1b-bcf3-9de3a8c4147b">1.00</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="if5a58a2d117b40d8a0d022c115299b14_D20220101-20220331" decimals="2" sign="-" name="sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMinimum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmZjNjRjNWI2MDI2YzRkOGFhOWI1MTRkNGVlOWQxYThlL3RhYmxlcmFuZ2U6ZmM2NGM1YjYwMjZjNGQ4YWE5YjUxNGQ0ZWU5ZDFhOGVfNC0xNy0xLTEtNzk1NDg_05758aba-b142-48d3-b4de-fff77473712c">0.13</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if5a58a2d117b40d8a0d022c115299b14_D20220101-20220331" decimals="2" name="sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMaximum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmZjNjRjNWI2MDI2YzRkOGFhOWI1MTRkNGVlOWQxYThlL3RhYmxlcmFuZ2U6ZmM2NGM1YjYwMjZjNGQ4YWE5YjUxNGQ0ZWU5ZDFhOGVfNC0xOS0xLTEtNzk1NTE_b4e45f41-84cb-4a5d-b189-64ec37b4accb">1.00</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i73253fc85d9d4718b307a6aeea2b9c06_D20230101-20230331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmZjNjRjNWI2MDI2YzRkOGFhOWI1MTRkNGVlOWQxYThlL3RhYmxlcmFuZ2U6ZmM2NGM1YjYwMjZjNGQ4YWE5YjUxNGQ0ZWU5ZDFhOGVfNC0xMy0xLTEtNjgzMTY_25a34dcc-9435-4777-85d9-096292110a3d">3.9</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i73253fc85d9d4718b307a6aeea2b9c06_D20230101-20230331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmZjNjRjNWI2MDI2YzRkOGFhOWI1MTRkNGVlOWQxYThlL3RhYmxlcmFuZ2U6ZmM2NGM1YjYwMjZjNGQ4YWE5YjUxNGQ0ZWU5ZDFhOGVfNC0xNS0xLTEtNjgzMTY_0bbeef21-fd68-43b4-9be6-6d46b602f1ce">5.0</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if5a58a2d117b40d8a0d022c115299b14_D20220101-20220331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmZjNjRjNWI2MDI2YzRkOGFhOWI1MTRkNGVlOWQxYThlL3RhYmxlcmFuZ2U6ZmM2NGM1YjYwMjZjNGQ4YWE5YjUxNGQ0ZWU5ZDFhOGVfNS0xNy0xLTEtNzk1NDg_a0a44856-29ac-4dd9-a6cb-8e56b91958a4">0.4</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if5a58a2d117b40d8a0d022c115299b14_D20220101-20220331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmZjNjRjNWI2MDI2YzRkOGFhOWI1MTRkNGVlOWQxYThlL3RhYmxlcmFuZ2U6ZmM2NGM1YjYwMjZjNGQ4YWE5YjUxNGQ0ZWU5ZDFhOGVfNS0xOS0xLTEtNzk1NTE_0f129aee-ceae-41af-92ea-59fffafdd1c7">1.2</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i542cba4badbf402198062c358fb44a47_D20230101-20230331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmZjNjRjNWI2MDI2YzRkOGFhOWI1MTRkNGVlOWQxYThlL3RhYmxlcmFuZ2U6ZmM2NGM1YjYwMjZjNGQ4YWE5YjUxNGQ0ZWU5ZDFhOGVfNS0xMy0xLTEtNjgzMTY_31204922-ae1c-4735-a10c-76c3a4d76cc4">&#8212;</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0fd34d1ccf7c424faab3f807a548673b_D20230101-20230331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmZjNjRjNWI2MDI2YzRkOGFhOWI1MTRkNGVlOWQxYThlL3RhYmxlcmFuZ2U6ZmM2NGM1YjYwMjZjNGQ4YWE5YjUxNGQ0ZWU5ZDFhOGVfNS0xNS0xLTEtNjgzMTY_df180238-e292-4ce0-a06f-39bb84341e8b">1.3</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idce254121fa64dda9831a0bf7d7be47d_D20220101-20220331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmZjNjRjNWI2MDI2YzRkOGFhOWI1MTRkNGVlOWQxYThlL3RhYmxlcmFuZ2U6ZmM2NGM1YjYwMjZjNGQ4YWE5YjUxNGQ0ZWU5ZDFhOGVfNi0xNy0xLTEtNzk1NDg_a1fb451e-ac87-4be5-91ed-814f11766990">&#8212;</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic31c0bf439854ab39758877476c132a4_D20220101-20220331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmZjNjRjNWI2MDI2YzRkOGFhOWI1MTRkNGVlOWQxYThlL3RhYmxlcmFuZ2U6ZmM2NGM1YjYwMjZjNGQ4YWE5YjUxNGQ0ZWU5ZDFhOGVfNi0xOS0xLTEtNzk1NTE_542b1e23-0f21-43bb-9e32-28df85ff7cc5">1.0</ix:nonFraction>%</span></td></tr></table></ix:continuation></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023, the unrecognized compensation cost related to the PSUs was $<ix:nonFraction unitRef="usd" contextRef="i9878b683aeef427ebf14f59132cf0f4a_I20230331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfMzg0ODI5MDcxMjk5NA_b5cc05bd-2d8e-4b2e-b36b-4218e88a8dab">4.1</ix:nonFraction> million, which is expected to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">be recognized over a period of approximately <ix:nonNumeric contextRef="i73253fc85d9d4718b307a6aeea2b9c06_D20230101-20230331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfMzg0ODI5MDcxMzA2NQ_4846fa77-2186-48fa-b375-edd6ffa8fd00">2.4</ix:nonNumeric> years.</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="us-gaap:ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfNDAzNA_398517f9-8f04-45a4-a505-35561478bf27" continuedAt="if4eed703a8234f28a221fe9cc2304aff" escape="true"><ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfNDAzNA_5147c52e-c22c-42c2-a6a0-e0865c551406" continuedAt="iebc33e80d7b34184bbbc6144128c8f3b" escape="true">The table below summarizes RSU and PSU activity for the three months ended March 31, 2023:</ix:nonNumeric></ix:nonNumeric></span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SI-BONE, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) </span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="ifcef3889eff9467dae6eda46726277de"><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:24.75pt"><ix:continuation id="if4eed703a8234f28a221fe9cc2304aff"><ix:continuation id="iebc33e80d7b34184bbbc6144128c8f3b"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.222%"><tr><td style="width:1.0%"></td><td style="width:38.258%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.258%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.258%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.258%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.982%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.261%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">RSUs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PSUs</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2829f82cc061453792f3357c0e3b2d45_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmE2MGEzYzg4MGNlZjQzMjM5MTU4MzMyMjI4OTFjNGRjL3RhYmxlcmFuZ2U6YTYwYTNjODgwY2VmNDMyMzkxNTgzMzIyMjg5MWM0ZGNfMi0yLTEtMS02ODMxNg_38ae9fc6-3f8d-47c7-84be-bc46a8733994">1,794,928</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i2829f82cc061453792f3357c0e3b2d45_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmE2MGEzYzg4MGNlZjQzMjM5MTU4MzMyMjI4OTFjNGRjL3RhYmxlcmFuZ2U6YTYwYTNjODgwY2VmNDMyMzkxNTgzMzIyMjg5MWM0ZGNfMi00LTEtMS02ODMxNg_56f7ac1c-f373-4bfa-9469-cb34d179725d">22.72</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0c44b4d86d814a99aa4f0201bc819c63_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmE2MGEzYzg4MGNlZjQzMjM5MTU4MzMyMjI4OTFjNGRjL3RhYmxlcmFuZ2U6YTYwYTNjODgwY2VmNDMyMzkxNTgzMzIyMjg5MWM0ZGNfMi02LTEtMS02ODMxNg_938aabce-5dc8-4b5d-9bba-b99e7a96f9c2">155,596</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i0c44b4d86d814a99aa4f0201bc819c63_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmE2MGEzYzg4MGNlZjQzMjM5MTU4MzMyMjI4OTFjNGRjL3RhYmxlcmFuZ2U6YTYwYTNjODgwY2VmNDMyMzkxNTgzMzIyMjg5MWM0ZGNfMi04LTEtMS02ODMxNg_9032f142-3f8c-4410-982e-0d1cf01d83c8">19.50</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaf9a24c75b524dfa94a49c4ab5a022c0_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmE2MGEzYzg4MGNlZjQzMjM5MTU4MzMyMjI4OTFjNGRjL3RhYmxlcmFuZ2U6YTYwYTNjODgwY2VmNDMyMzkxNTgzMzIyMjg5MWM0ZGNfMy0yLTEtMS02ODMxNg_46c0615c-2c4a-416c-924e-6c05774e4346">1,044,344</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iaf9a24c75b524dfa94a49c4ab5a022c0_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmE2MGEzYzg4MGNlZjQzMjM5MTU4MzMyMjI4OTFjNGRjL3RhYmxlcmFuZ2U6YTYwYTNjODgwY2VmNDMyMzkxNTgzMzIyMjg5MWM0ZGNfMy00LTEtMS02ODMxNg_8a3cd8f4-b1a3-4215-bf0f-705cf9cf1c9c">15.69</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i73253fc85d9d4718b307a6aeea2b9c06_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmE2MGEzYzg4MGNlZjQzMjM5MTU4MzMyMjI4OTFjNGRjL3RhYmxlcmFuZ2U6YTYwYTNjODgwY2VmNDMyMzkxNTgzMzIyMjg5MWM0ZGNfMy02LTEtMS02ODMxNg_644f05c1-070b-4f46-8564-b43459bc23d4">255,458</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i73253fc85d9d4718b307a6aeea2b9c06_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmE2MGEzYzg4MGNlZjQzMjM5MTU4MzMyMjI4OTFjNGRjL3RhYmxlcmFuZ2U6YTYwYTNjODgwY2VmNDMyMzkxNTgzMzIyMjg5MWM0ZGNfMy04LTEtMS02ODMxNg_cfbb8f86-a290-4b7a-9ab2-c4bd0a08f958">12.33</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iaf9a24c75b524dfa94a49c4ab5a022c0_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmE2MGEzYzg4MGNlZjQzMjM5MTU4MzMyMjI4OTFjNGRjL3RhYmxlcmFuZ2U6YTYwYTNjODgwY2VmNDMyMzkxNTgzMzIyMjg5MWM0ZGNfNC0yLTEtMS02ODMxNg_885e8ee8-663e-410e-8e15-961789ea44c6">228,388</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iaf9a24c75b524dfa94a49c4ab5a022c0_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmE2MGEzYzg4MGNlZjQzMjM5MTU4MzMyMjI4OTFjNGRjL3RhYmxlcmFuZ2U6YTYwYTNjODgwY2VmNDMyMzkxNTgzMzIyMjg5MWM0ZGNfNC00LTEtMS02ODMxNg_e265b819-0d47-42c2-980d-db4e1dd490e9">22.97</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i73253fc85d9d4718b307a6aeea2b9c06_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmE2MGEzYzg4MGNlZjQzMjM5MTU4MzMyMjI4OTFjNGRjL3RhYmxlcmFuZ2U6YTYwYTNjODgwY2VmNDMyMzkxNTgzMzIyMjg5MWM0ZGNfNC02LTEtMS02ODMxNg_4c8ceffd-eb98-4be4-945c-bb1b03671712">25,932</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i73253fc85d9d4718b307a6aeea2b9c06_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmE2MGEzYzg4MGNlZjQzMjM5MTU4MzMyMjI4OTFjNGRjL3RhYmxlcmFuZ2U6YTYwYTNjODgwY2VmNDMyMzkxNTgzMzIyMjg5MWM0ZGNfNC04LTEtMS02ODMxNg_724b49c5-ef4a-461a-bc2a-d3ed6666fa80">19.50</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled and forfeited</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iaf9a24c75b524dfa94a49c4ab5a022c0_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmE2MGEzYzg4MGNlZjQzMjM5MTU4MzMyMjI4OTFjNGRjL3RhYmxlcmFuZ2U6YTYwYTNjODgwY2VmNDMyMzkxNTgzMzIyMjg5MWM0ZGNfNS0yLTEtMS02ODMxNg_a63fb141-48ba-4f12-9e70-272927c63810">86,107</ix:nonFraction>)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iaf9a24c75b524dfa94a49c4ab5a022c0_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmE2MGEzYzg4MGNlZjQzMjM5MTU4MzMyMjI4OTFjNGRjL3RhYmxlcmFuZ2U6YTYwYTNjODgwY2VmNDMyMzkxNTgzMzIyMjg5MWM0ZGNfNS00LTEtMS02ODMxNg_26378df8-9223-472e-9817-aeba3f6837d0">21.70</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i73253fc85d9d4718b307a6aeea2b9c06_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmE2MGEzYzg4MGNlZjQzMjM5MTU4MzMyMjI4OTFjNGRjL3RhYmxlcmFuZ2U6YTYwYTNjODgwY2VmNDMyMzkxNTgzMzIyMjg5MWM0ZGNfNS02LTEtMS02ODMxNg_2f8448be-3cd9-4769-be19-741d82fe04f2">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i73253fc85d9d4718b307a6aeea2b9c06_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmE2MGEzYzg4MGNlZjQzMjM5MTU4MzMyMjI4OTFjNGRjL3RhYmxlcmFuZ2U6YTYwYTNjODgwY2VmNDMyMzkxNTgzMzIyMjg5MWM0ZGNfNS04LTEtMS02ODMxNg_b25ed0c0-6be7-454b-8479-6cf203c24d1b">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iafee48dbb8fc4bfc960af6aa6244917f_I20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmE2MGEzYzg4MGNlZjQzMjM5MTU4MzMyMjI4OTFjNGRjL3RhYmxlcmFuZ2U6YTYwYTNjODgwY2VmNDMyMzkxNTgzMzIyMjg5MWM0ZGNfNi0yLTEtMS02ODMxNg_418e381d-2bc7-4191-ae97-dd971906a9ed">2,524,777</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iafee48dbb8fc4bfc960af6aa6244917f_I20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmE2MGEzYzg4MGNlZjQzMjM5MTU4MzMyMjI4OTFjNGRjL3RhYmxlcmFuZ2U6YTYwYTNjODgwY2VmNDMyMzkxNTgzMzIyMjg5MWM0ZGNfNi00LTEtMS02ODMxNg_d4875571-0bc9-4b16-8a2d-876fe52f4710">19.82</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9878b683aeef427ebf14f59132cf0f4a_I20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmE2MGEzYzg4MGNlZjQzMjM5MTU4MzMyMjI4OTFjNGRjL3RhYmxlcmFuZ2U6YTYwYTNjODgwY2VmNDMyMzkxNTgzMzIyMjg5MWM0ZGNfNi02LTEtMS02ODMxNg_50d868ae-cce9-4c3d-aa3d-c60a6a699c9d">385,122</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9878b683aeef427ebf14f59132cf0f4a_I20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmE2MGEzYzg4MGNlZjQzMjM5MTU4MzMyMjI4OTFjNGRjL3RhYmxlcmFuZ2U6YTYwYTNjODgwY2VmNDMyMzkxNTgzMzIyMjg5MWM0ZGNfNi04LTEtMS02ODMxNg_0d7ab66f-9d7d-43c1-80e6-c97f419b3c6c">14.74</ix:nonFraction></span></td></tr></table></ix:continuation></ix:continuation></div><div style="margin-top:18pt;padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s 2018 Employee Stock Purchase Plan (the &#8220;ESPP&#8221;) allows eligible employees to purchase shares of the Company's common stock through payroll deductions at the price equal to <ix:nonFraction unitRef="number" contextRef="i0491eac20c484a99bcfa28ef410f4825_D20230101-20230331" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfMjc0MA_a6ca75e5-17b8-4599-b258-61d6c085b586">85</ix:nonFraction>% of the lesser of the fair market value of the stock as of the first date or the ending date of each <ix:nonNumeric contextRef="i0491eac20c484a99bcfa28ef410f4825_D20230101-20230331" name="sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfNDAzNQ_fc2dde6d-97c4-44dc-82a3-9a827ca49e66">six month</ix:nonNumeric> offering period. The offering period generally commences in May and November. On March 26, 2020, the Company's Compensation Committee approved the amendment of the terms of future offerings under the ESPP which, among other things, increased the maximum number of shares that may be purchased on any single purchase date, provided for automatic enrollment in a new offering, and provided that the offering which commenced in May 2020 be <ix:nonNumeric contextRef="i78f562b20b2e4096bb55d93c2515d6b4_D20200501-20200531" name="sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfMzI4OQ_e29e798d-7d11-4cb1-a0db-6e983e40cf7f">twelve months</ix:nonNumeric> in duration and consist of <ix:nonFraction unitRef="purchase_period" contextRef="i78f562b20b2e4096bb55d93c2515d6b4_D20200501-20200531" decimals="INF" name="sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfMzMxOQ_d07ba8b3-9de4-452d-95e3-3eac62331505">two</ix:nonFraction> purchase periods. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the ESPP shares is estimated using the Black-Scholes option pricing model, which is being amortized over the requisite service period. The Company did not issue any shares under ESPP for the three months ended March 31, 2023 and 2022. As of March 31, 2023 and December 31, 2022, total accumulated ESPP related employee payroll deductions amounted to </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i2a36228c84c94fdd90258ab5546be250_I20230331" decimals="-5" name="us-gaap:OtherEmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfMzcxMg_f9a5889d-e446-48a7-8157-f9df87fcc6cb">1.2</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $<ix:nonFraction unitRef="usd" contextRef="id0b8dd5bc1a74d16976adc6fe0963e3c_I20221231" decimals="-5" name="us-gaap:OtherEmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfMzcxOQ_22f346c0-7a1d-422d-a3b4-182d7af91603">0.3</ix:nonFraction> million, respectively, which were included within accrued compensation and related expenses in the condensed consolidated balance sheets. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation </span></div><ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfNDAzMQ_2cd55a1d-d6e3-44d0-b579-d406ea2f86aa" escape="true"><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the detail of stock-based compensation expense amounts included in the condensed consolidated statements of operations:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.305%"><tr><td style="width:1.0%"></td><td style="width:59.159%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.879%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.690%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.879%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.693%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i017405027da74f35a1e9b7624aa42eb3_D20230101-20230331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmRiYzQwNDFjMzEyYjRjYTU4MTczYjViZmMyYmE5YjM3L3RhYmxlcmFuZ2U6ZGJjNDA0MWMzMTJiNGNhNTgxNzNiNWJmYzJiYTliMzdfMy0yLTEtMS02ODMxNg_7ad0a5a7-1fed-44c9-ac70-6a855c8bcaa3">137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaf29913eb3446079f07610b7349c5a2_D20220101-20220331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmRiYzQwNDFjMzEyYjRjYTU4MTczYjViZmMyYmE5YjM3L3RhYmxlcmFuZ2U6ZGJjNDA0MWMzMTJiNGNhNTgxNzNiNWJmYzJiYTliMzdfMy00LTEtMS02ODMxNg_2ea6b2f2-78d1-403c-b1de-640805b53e31">123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90358afa0410497b9f081e97dbf0db01_D20230101-20230331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmRiYzQwNDFjMzEyYjRjYTU4MTczYjViZmMyYmE5YjM3L3RhYmxlcmFuZ2U6ZGJjNDA0MWMzMTJiNGNhNTgxNzNiNWJmYzJiYTliMzdfNC0yLTEtMS02ODMxNg_438e1e29-2bd7-4e57-9c5f-b5b0041a337c">2,910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff0a36e596f44a779c08847487b58a42_D20220101-20220331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmRiYzQwNDFjMzEyYjRjYTU4MTczYjViZmMyYmE5YjM3L3RhYmxlcmFuZ2U6ZGJjNDA0MWMzMTJiNGNhNTgxNzNiNWJmYzJiYTliMzdfNC00LTEtMS02ODMxNg_4da9be45-212b-45f0-b254-a2a057620607">2,594</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie75cc149b1a34a578c7e33c33a5bb53e_D20230101-20230331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmRiYzQwNDFjMzEyYjRjYTU4MTczYjViZmMyYmE5YjM3L3RhYmxlcmFuZ2U6ZGJjNDA0MWMzMTJiNGNhNTgxNzNiNWJmYzJiYTliMzdfNS0yLTEtMS02ODMxNg_0814a797-b6fe-475f-9cf1-134eb16d7d02">752</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia11934861f834ff494d0a96536ea4362_D20220101-20220331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmRiYzQwNDFjMzEyYjRjYTU4MTczYjViZmMyYmE5YjM3L3RhYmxlcmFuZ2U6ZGJjNDA0MWMzMTJiNGNhNTgxNzNiNWJmYzJiYTliMzdfNS00LTEtMS02ODMxNg_89e4a118-56e3-4c5e-a5bf-0d7a53412a59">633</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica097e93dc6e43ceb0f401463e05eced_D20230101-20230331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmRiYzQwNDFjMzEyYjRjYTU4MTczYjViZmMyYmE5YjM3L3RhYmxlcmFuZ2U6ZGJjNDA0MWMzMTJiNGNhNTgxNzNiNWJmYzJiYTliMzdfNi0yLTEtMS02ODMxNg_690a5c67-1e3b-4f95-b968-f240fab135b0">2,395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d77a44aec9a441e8285b555ea83a233_D20220101-20220331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmRiYzQwNDFjMzEyYjRjYTU4MTczYjViZmMyYmE5YjM3L3RhYmxlcmFuZ2U6ZGJjNDA0MWMzMTJiNGNhNTgxNzNiNWJmYzJiYTliMzdfNi00LTEtMS02ODMxNg_efc79a26-be55-4e56-9654-d8817c2a1672">2,157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmRiYzQwNDFjMzEyYjRjYTU4MTczYjViZmMyYmE5YjM3L3RhYmxlcmFuZ2U6ZGJjNDA0MWMzMTJiNGNhNTgxNzNiNWJmYzJiYTliMzdfNy0yLTEtMS02ODMxNg_3005aed0-6133-417d-b3d7-37d6400adaa6">6,194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmRiYzQwNDFjMzEyYjRjYTU4MTczYjViZmMyYmE5YjM3L3RhYmxlcmFuZ2U6ZGJjNDA0MWMzMTJiNGNhNTgxNzNiNWJmYzJiYTliMzdfNy00LTEtMS02ODMxNg_12313a37-71f9-46df-99c6-315a2186678c">5,507</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div><div><span><br/></span></div></div></div><div id="i928aa505a2ea46079da4e5082002267b_55"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SI-BONE, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) </span></div><div style="text-align:justify"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9. <ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81NS9mcmFnOjk5MTU2Yjk5YWQ0ZTRlOTU4NTFkMDVkYjVlZjhkZTVmL3RleHRyZWdpb246OTkxNTZiOTlhZDRlNGU5NTg1MWQwNWRiNWVmOGRlNWZfNjI5_4cc6bedc-d7db-4bf0-b715-221441f1cc44" continuedAt="ifedb1d66fd6f44bb9b078a3d26207e1b" escape="true">Net Loss Per Share of Common Stock</ix:nonNumeric></span></div><ix:continuation id="ifedb1d66fd6f44bb9b078a3d26207e1b"><ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81NS9mcmFnOjk5MTU2Yjk5YWQ0ZTRlOTU4NTFkMDVkYjVlZjhkZTVmL3RleHRyZWdpb246OTkxNTZiOTlhZDRlNGU5NTg1MWQwNWRiNWVmOGRlNWZfNjI3_184481ec-e012-4676-90bd-918ddc7e1108" escape="true"><div style="margin-bottom:12pt;margin-top:12pt;padding-left:24.75pt;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the computation of basic and diluted net loss per share:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:61.388%"><tr><td style="width:1.0%"></td><td style="width:55.687%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.931%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.942%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except share and per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81NS9mcmFnOjk5MTU2Yjk5YWQ0ZTRlOTU4NTFkMDVkYjVlZjhkZTVmL3RhYmxlOjNiNDg0Yjg2NjVjMzQ2MTk5NjRkZGNjMjQ5MWYyOWQzL3RhYmxlcmFuZ2U6M2I0ODRiODY2NWMzNDYxOTk2NGRkY2MyNDkxZjI5ZDNfMy0xLTEtMS02ODMxNg_d9b8f20c-fd61-418d-970a-f1c5716c8b41">11,125</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81NS9mcmFnOjk5MTU2Yjk5YWQ0ZTRlOTU4NTFkMDVkYjVlZjhkZTVmL3RhYmxlOjNiNDg0Yjg2NjVjMzQ2MTk5NjRkZGNjMjQ5MWYyOWQzL3RhYmxlcmFuZ2U6M2I0ODRiODY2NWMzNDYxOTk2NGRkY2MyNDkxZjI5ZDNfMy0zLTEtMS02ODMxNg_30919542-3fc0-4728-a7b3-aec7be63f83a">17,410</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares used to compute basic and diluted net loss per share</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81NS9mcmFnOjk5MTU2Yjk5YWQ0ZTRlOTU4NTFkMDVkYjVlZjhkZTVmL3RhYmxlOjNiNDg0Yjg2NjVjMzQ2MTk5NjRkZGNjMjQ5MWYyOWQzL3RhYmxlcmFuZ2U6M2I0ODRiODY2NWMzNDYxOTk2NGRkY2MyNDkxZjI5ZDNfNS0xLTEtMS02ODMxNg_4dffa458-7720-46db-b3f7-646ac481778d"><ix:nonFraction unitRef="shares" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81NS9mcmFnOjk5MTU2Yjk5YWQ0ZTRlOTU4NTFkMDVkYjVlZjhkZTVmL3RhYmxlOjNiNDg0Yjg2NjVjMzQ2MTk5NjRkZGNjMjQ5MWYyOWQzL3RhYmxlcmFuZ2U6M2I0ODRiODY2NWMzNDYxOTk2NGRkY2MyNDkxZjI5ZDNfNS0xLTEtMS02ODMxNg_e5946455-a44b-49ce-9262-66b4addbf777">34,916,106</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81NS9mcmFnOjk5MTU2Yjk5YWQ0ZTRlOTU4NTFkMDVkYjVlZjhkZTVmL3RhYmxlOjNiNDg0Yjg2NjVjMzQ2MTk5NjRkZGNjMjQ5MWYyOWQzL3RhYmxlcmFuZ2U6M2I0ODRiODY2NWMzNDYxOTk2NGRkY2MyNDkxZjI5ZDNfNS0zLTEtMS02ODMxNg_2d51b2b4-b9da-4988-be1b-6e7f5c188b27"><ix:nonFraction unitRef="shares" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81NS9mcmFnOjk5MTU2Yjk5YWQ0ZTRlOTU4NTFkMDVkYjVlZjhkZTVmL3RhYmxlOjNiNDg0Yjg2NjVjMzQ2MTk5NjRkZGNjMjQ5MWYyOWQzL3RhYmxlcmFuZ2U6M2I0ODRiODY2NWMzNDYxOTk2NGRkY2MyNDkxZjI5ZDNfNS0zLTEtMS02ODMxNg_4d4755d7-6518-4465-8213-b05de271c3c6">33,792,326</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share, basic and diluted</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81NS9mcmFnOjk5MTU2Yjk5YWQ0ZTRlOTU4NTFkMDVkYjVlZjhkZTVmL3RhYmxlOjNiNDg0Yjg2NjVjMzQ2MTk5NjRkZGNjMjQ5MWYyOWQzL3RhYmxlcmFuZ2U6M2I0ODRiODY2NWMzNDYxOTk2NGRkY2MyNDkxZjI5ZDNfNy0xLTEtMS02ODMxNg_20a9feb2-a793-4d2d-b2fa-91f13ba162cf"><ix:nonFraction unitRef="usdPerShare" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81NS9mcmFnOjk5MTU2Yjk5YWQ0ZTRlOTU4NTFkMDVkYjVlZjhkZTVmL3RhYmxlOjNiNDg0Yjg2NjVjMzQ2MTk5NjRkZGNjMjQ5MWYyOWQzL3RhYmxlcmFuZ2U6M2I0ODRiODY2NWMzNDYxOTk2NGRkY2MyNDkxZjI5ZDNfNy0xLTEtMS02ODMxNg_899498eb-858e-49f3-8bb7-2a199de5573a">0.32</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81NS9mcmFnOjk5MTU2Yjk5YWQ0ZTRlOTU4NTFkMDVkYjVlZjhkZTVmL3RhYmxlOjNiNDg0Yjg2NjVjMzQ2MTk5NjRkZGNjMjQ5MWYyOWQzL3RhYmxlcmFuZ2U6M2I0ODRiODY2NWMzNDYxOTk2NGRkY2MyNDkxZjI5ZDNfNy0zLTEtMS02ODMxNg_031c3b0a-f332-40bf-8e4e-1799b524ab4f"><ix:nonFraction unitRef="usdPerShare" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81NS9mcmFnOjk5MTU2Yjk5YWQ0ZTRlOTU4NTFkMDVkYjVlZjhkZTVmL3RhYmxlOjNiNDg0Yjg2NjVjMzQ2MTk5NjRkZGNjMjQ5MWYyOWQzL3RhYmxlcmFuZ2U6M2I0ODRiODY2NWMzNDYxOTk2NGRkY2MyNDkxZjI5ZDNfNy0zLTEtMS02ODMxNg_e8b6fd90-3af6-4a01-8b02-79088d2e9dc9">0.52</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because the Company has reported a net loss in all periods presented, outstanding stock options, restricted stock units, ESPP purchase rights and common stock warrants are anti-dilutive and therefore diluted net loss per common share is the same as basic net loss per common share for the periods presented. <ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81NS9mcmFnOjk5MTU2Yjk5YWQ0ZTRlOTU4NTFkMDVkYjVlZjhkZTVmL3RleHRyZWdpb246OTkxNTZiOTlhZDRlNGU5NTg1MWQwNWRiNWVmOGRlNWZfNjI4_fc229622-073b-4bc8-a634-cf76ff7ead1b" continuedAt="i8a3172793f5c4702bda570829228bb92" escape="true">The following anti-dilutive common stock equivalents were excluded from the computation of diluted net loss per share for the periods presented:</ix:nonNumeric></span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><ix:continuation id="i8a3172793f5c4702bda570829228bb92"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">            </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.527%"><tr><td style="width:1.0%"></td><td style="width:59.025%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.843%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.317%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3ae664fc28564f66ac4064ddbcbd566e_D20230101-20230331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81NS9mcmFnOjk5MTU2Yjk5YWQ0ZTRlOTU4NTFkMDVkYjVlZjhkZTVmL3RhYmxlOjllNDM0YWZjOGY5OTQ0OGE4ZmM1MWU1YzMwNGRkMmRiL3RhYmxlcmFuZ2U6OWU0MzRhZmM4Zjk5NDQ4YThmYzUxZTVjMzA0ZGQyZGJfMi0xLTEtMS02ODMxNg_04e17424-f602-4cb0-842f-b22e33c9f03f">1,767,791</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i727673cf2e684c87b5b941e19e9dead2_D20220101-20220331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81NS9mcmFnOjk5MTU2Yjk5YWQ0ZTRlOTU4NTFkMDVkYjVlZjhkZTVmL3RhYmxlOjllNDM0YWZjOGY5OTQ0OGE4ZmM1MWU1YzMwNGRkMmRiL3RhYmxlcmFuZ2U6OWU0MzRhZmM4Zjk5NDQ4YThmYzUxZTVjMzA0ZGQyZGJfMi0zLTEtMS02ODMxNg_66667e4c-a498-4980-b1fb-9150301a56d7">1,963,360</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib3a30c8bb4fa4da191e1db1a2cdf4ad3_D20230101-20230331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81NS9mcmFnOjk5MTU2Yjk5YWQ0ZTRlOTU4NTFkMDVkYjVlZjhkZTVmL3RhYmxlOjllNDM0YWZjOGY5OTQ0OGE4ZmM1MWU1YzMwNGRkMmRiL3RhYmxlcmFuZ2U6OWU0MzRhZmM4Zjk5NDQ4YThmYzUxZTVjMzA0ZGQyZGJfMy0xLTEtMS02ODMxNg_bcbe3a8b-3677-4521-a08f-3117367c12ad">2,909,899</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i58b615af0c5645a8bab43631dc6ce435_D20220101-20220331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81NS9mcmFnOjk5MTU2Yjk5YWQ0ZTRlOTU4NTFkMDVkYjVlZjhkZTVmL3RhYmxlOjllNDM0YWZjOGY5OTQ0OGE4ZmM1MWU1YzMwNGRkMmRiL3RhYmxlcmFuZ2U6OWU0MzRhZmM4Zjk5NDQ4YThmYzUxZTVjMzA0ZGQyZGJfMy0zLTEtMS02ODMxNg_fdab15d1-4a0e-4ff6-a62d-19c354a9cae7">2,309,284</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESPP purchase rights</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iba2a746fe9d742cd9ce6866ca1f467ca_D20230101-20230331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81NS9mcmFnOjk5MTU2Yjk5YWQ0ZTRlOTU4NTFkMDVkYjVlZjhkZTVmL3RhYmxlOjllNDM0YWZjOGY5OTQ0OGE4ZmM1MWU1YzMwNGRkMmRiL3RhYmxlcmFuZ2U6OWU0MzRhZmM4Zjk5NDQ4YThmYzUxZTVjMzA0ZGQyZGJfNS0xLTEtMS02ODMxNg_2e777825-9a0c-42cf-be46-e757977f8dbe">134,226</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3834751827fd42c693830e07acfee079_D20220101-20220331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81NS9mcmFnOjk5MTU2Yjk5YWQ0ZTRlOTU4NTFkMDVkYjVlZjhkZTVmL3RhYmxlOjllNDM0YWZjOGY5OTQ0OGE4ZmM1MWU1YzMwNGRkMmRiL3RhYmxlcmFuZ2U6OWU0MzRhZmM4Zjk5NDQ4YThmYzUxZTVjMzA0ZGQyZGJfNS0zLTEtMS02ODMxNg_b3b2d313-67d8-4dea-88f1-5183ad92e266">61,264</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock warrants</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i785a9d69422049969f551e00c09cd4fe_D20230101-20230331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81NS9mcmFnOjk5MTU2Yjk5YWQ0ZTRlOTU4NTFkMDVkYjVlZjhkZTVmL3RhYmxlOjllNDM0YWZjOGY5OTQ0OGE4ZmM1MWU1YzMwNGRkMmRiL3RhYmxlcmFuZ2U6OWU0MzRhZmM4Zjk5NDQ4YThmYzUxZTVjMzA0ZGQyZGJfNi0xLTEtMS02ODMxNg_c1543bac-0b7a-41cc-b429-9c67d2dde01a">118,122</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5cfef6391a45463393b78121e9c5bed4_D20220101-20220331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81NS9mcmFnOjk5MTU2Yjk5YWQ0ZTRlOTU4NTFkMDVkYjVlZjhkZTVmL3RhYmxlOjllNDM0YWZjOGY5OTQ0OGE4ZmM1MWU1YzMwNGRkMmRiL3RhYmxlcmFuZ2U6OWU0MzRhZmM4Zjk5NDQ4YThmYzUxZTVjMzA0ZGQyZGJfNi0zLTEtMS02ODMxNg_b1eb7dcf-13e5-44bf-9114-f47aaa31de52">118,122</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81NS9mcmFnOjk5MTU2Yjk5YWQ0ZTRlOTU4NTFkMDVkYjVlZjhkZTVmL3RhYmxlOjllNDM0YWZjOGY5OTQ0OGE4ZmM1MWU1YzMwNGRkMmRiL3RhYmxlcmFuZ2U6OWU0MzRhZmM4Zjk5NDQ4YThmYzUxZTVjMzA0ZGQyZGJfNy0xLTEtMS02ODMxNg_4a7f4bc1-ada2-4331-8967-5010a323ad2c">4,930,038</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81NS9mcmFnOjk5MTU2Yjk5YWQ0ZTRlOTU4NTFkMDVkYjVlZjhkZTVmL3RhYmxlOjllNDM0YWZjOGY5OTQ0OGE4ZmM1MWU1YzMwNGRkMmRiL3RhYmxlcmFuZ2U6OWU0MzRhZmM4Zjk5NDQ4YThmYzUxZTVjMzA0ZGQyZGJfNy0zLTEtMS02ODMxNg_d9adeb17-ed08-4625-bcfb-3384cd582ba4">4,452,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div></ix:continuation><div style="margin-top:6pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div><div><span><br/></span></div></div></div><div id="i928aa505a2ea46079da4e5082002267b_58"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SI-BONE, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) </span></div><div style="text-align:justify"><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10. <ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81OC9mcmFnOjJmZjdiMzc2YmI5ZjRhYzU5MGMzZTQ3NDBhYzNjYWJjL3RleHRyZWdpb246MmZmN2IzNzZiYjlmNGFjNTkwYzNlNDc0MGFjM2NhYmNfMjgwMA_6db20705-36b1-421e-90e0-0520167b824f" continuedAt="icdabd529b84f4483ab896e9c45a90ea0" escape="true">Related Party Transaction </ix:nonNumeric></span></div><ix:continuation id="icdabd529b84f4483ab896e9c45a90ea0" continuedAt="ia6cd250e01f54b388162ff2113650baa"><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 24, 2020, the Company entered into a joint development agreement (the &#8220;Development Agreement&#8221;) with SeaSpine Orthopedics Corporation (&#8220;SeaSpine&#8221;), which merged with Orthofix Medical, Inc., to develop a next generation device for sacropelvic fixation. Mr. Keith Valentine, who serves as the President, Chief Executive Officer and a member of the board of directors of SeaSpine, also serves as a member of the Company's Board of Directors since August 2015. On April 27, 2021, Addendum No.1 to the Development Agreement was entered into by and between the Company and SeaSpine to extend certain obligations as described under the Development Agreement to a consultant of the Company.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the development plan, SeaSpine shall use reasonable efforts to assist in the development of the potential product offering, including licensing certain existing intellectual property to be incorporated into such product. Under the terms of the&#160;Development Agreement, the Company agreed to make monthly payments to SeaSpine to reimburse for full time resources employed by SeaSpine responsible to conduct the development activities. For the three months ended March 31, 2023, the Company did not incur any</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> reimbursement charges from SeaSpine. For the three months ended March 31, 2022, the Company expensed approximately $<ix:nonFraction unitRef="usd" contextRef="i42f2ba3e6b0746d58d9b74e3cf027cd7_D20220101-20220331" decimals="-3" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81OC9mcmFnOjJmZjdiMzc2YmI5ZjRhYzU5MGMzZTQ3NDBhYzNjYWJjL3RleHRyZWdpb246MmZmN2IzNzZiYjlmNGFjNTkwYzNlNDc0MGFjM2NhYmNfMTMyMg_a5011924-a32b-4ad9-96d0-6b84a9ca09a4">6,000</ix:nonFraction> of the reimbursement charges from SeaSpine. The reimbursement charges were recorded within research and development expense in the condensed consolidated statements of operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain intellectual property developed pursuant to the project plan will be owned by the Company, certain intellectual property developed pursuant to the project plan will be owned by SeaSpine, and other intellectual property developed pursuant to the project plan will be jointly owned by SeaSpine and the Company. The Company also agreed to provide SeaSpine a royalty-free, worldwide, perpetual, non-exclusive license of certain of the Company's intellectual property incorporated into the product to be developed. The Company also agreed to pay SeaSpine a product royalty, in an amount specified in the Development Agreement, for each resulting product sold for a period of <ix:nonNumeric contextRef="i7bf5dda5bf324c4fa4a20b1e527679ae_D20230101-20230331" name="sibn:RelatedPartyTransactionTermOfAgreement" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81OC9mcmFnOjJmZjdiMzc2YmI5ZjRhYzU5MGMzZTQ3NDBhYzNjYWJjL3RleHRyZWdpb246MmZmN2IzNzZiYjlmNGFjNTkwYzNlNDc0MGFjM2NhYmNfMjE5OQ_73b16295-e0f0-4185-b383-e25499ba96bc">10</ix:nonNumeric> years beginning on the initial market launch. The term of the Development Agreement shall continue until the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expiration of all royalty terms, unless earlier terminated by either party, as provided for by the Development Agreement. The Company recorded $<ix:nonFraction unitRef="usd" contextRef="i5e73e5a0115b4970b15363db24e13c22_I20230331" decimals="-4" name="us-gaap:DueToAffiliateCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81OC9mcmFnOjJmZjdiMzc2YmI5ZjRhYzU5MGMzZTQ3NDBhYzNjYWJjL3RleHRyZWdpb246MmZmN2IzNzZiYjlmNGFjNTkwYzNlNDc0MGFjM2NhYmNfMTA5OTUxMTYzMDkzOQ_1fa0bc52-4e8d-4f7b-a7b7-170cacedacf3">0.06</ix:nonFraction> million of royalty for the three months ended March 31, 2023. <ix:nonFraction unitRef="usd" contextRef="i42f2ba3e6b0746d58d9b74e3cf027cd7_D20220101-20220331" decimals="-5" name="us-gaap:RoyaltyExpense" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81OC9mcmFnOjJmZjdiMzc2YmI5ZjRhYzU5MGMzZTQ3NDBhYzNjYWJjL3RleHRyZWdpb246MmZmN2IzNzZiYjlmNGFjNTkwYzNlNDc0MGFjM2NhYmNfMjUyOA_cd76ef3e-65cb-40ae-bc64-b91db02893eb">No</ix:nonFraction> royalties were recorded for three months ended March 31, 2022.</span></div></ix:continuation><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia6cd250e01f54b388162ff2113650baa" continuedAt="i3225ca1203714e6690c2cb413fc008ed">The outstanding liability to SeaSpine as of March 31, 2023 and December 31, 2022 was approximately $<ix:nonFraction unitRef="usd" contextRef="i5e73e5a0115b4970b15363db24e13c22_I20230331" decimals="-4" name="us-gaap:DueToAffiliateCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81OC9mcmFnOjJmZjdiMzc2YmI5ZjRhYzU5MGMzZTQ3NDBhYzNjYWJjL3RleHRyZWdpb246MmZmN2IzNzZiYjlmNGFjNTkwYzNlNDc0MGFjM2NhYmNfMjY0MQ_1fa0bc52-4e8d-4f7b-a7b7-170cacedacf3">0.06</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i7a94faa120a0446aa696de6aeda19c4b_I20221231" decimals="-5" name="us-gaap:DueToAffiliateCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81OC9mcmFnOjJmZjdiMzc2YmI5ZjRhYzU5MGMzZTQ3NDBhYzNjYWJjL3RleHRyZWdpb246MmZmN2IzNzZiYjlmNGFjNTkwYzNlNDc0MGFjM2NhYmNfNTQ5NzU1ODE2ODgx_780dde2a-1108-4672-b4f1-ba1bc273782a">0.1</ix:nonFraction>&#160;million, respectively, and was recorded</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3225ca1203714e6690c2cb413fc008ed"> within accrued liabilities and other in the condensed consolidated balance sheet.</ix:continuation> </span></div><div><span><br/></span></div><div id="i928aa505a2ea46079da4e5082002267b_61"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11. <ix:nonNumeric contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl82MS9mcmFnOmQyOGUyMzliY2IyMzQyN2I5MzIyYTIzYzYwM2QwOGRmL3RleHRyZWdpb246ZDI4ZTIzOWJjYjIzNDI3YjkzMjJhMjNjNjAzZDA4ZGZfMjQzOA_ce65716f-3018-469c-9b0b-3c492b9ee61e" continuedAt="i970906b84a744774a2c5bafefbdfa8a0" escape="true">Income Taxes</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i970906b84a744774a2c5bafefbdfa8a0" continuedAt="ibf2c833db69348d6b35c234d3eb5f198">In determining quarterly provisions for income taxes, the Company uses the annual estimated effective tax rate applied to the actual year-to-date profit or loss, adjusted for discrete items arising in that quarter. The Company updates its estimate of its annual effective tax rate at the end of each quarterly period. The estimate takes into account annual forecasted income (loss) before income taxes, the geographic mix of income (loss) before income taxes and any significant permanent tax items. The Company did <ix:nonFraction unitRef="usd" contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331" decimals="0" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl82MS9mcmFnOmQyOGUyMzliY2IyMzQyN2I5MzIyYTIzYzYwM2QwOGRmL3RleHRyZWdpb246ZDI4ZTIzOWJjYjIzNDI3YjkzMjJhMjNjNjAzZDA4ZGZfNTM5_2bc03212-876e-457f-98af-303df4e8d1e0"><ix:nonFraction unitRef="usd" contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331" decimals="0" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl82MS9mcmFnOmQyOGUyMzliY2IyMzQyN2I5MzIyYTIzYzYwM2QwOGRmL3RleHRyZWdpb246ZDI4ZTIzOWJjYjIzNDI3YjkzMjJhMjNjNjAzZDA4ZGZfNTM5_f6e6f6ca-95ee-416d-9894-04980c11a8d6">not</ix:nonFraction></ix:nonFraction> have provision for income taxes for the three months ended March 31, 2023 and 2022. The Company continues to maintain a full valuation allowance against its net deferred tax assets due to the uncertainty surrounding realization of such assets.</ix:continuation></span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><ix:continuation id="ibf2c833db69348d6b35c234d3eb5f198" continuedAt="iee6aa54784424db5803c4dd4c13dce76"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for the uncertainty in income taxes by utilizing a comprehensive model for the recognition, measurement, presentation and disclosure in financial statements of any uncertain tax positions that have been taken or are expected to be taken on an income tax return. There had been no changes in the estimated uncertain tax benefits recorded as of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 31, 2023</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iee6aa54784424db5803c4dd4c13dce76"> compared to December 31, 2022.</ix:continuation> </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div><div><span><br/></span></div></div></div><div id="i928aa505a2ea46079da4e5082002267b_67"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our condensed consolidated financial statements and the related notes to those statements included elsewhere in this Quarterly Report on Form 10-Q, and with the consolidated financial statements and management&#8217;s discussion and analysis of our financial condition and results of operations in our Annual Report on Form 10-K filed with the SEC on March 2, 2023. Some of the information contained in this discussion and analysis, or set forth elsewhere in this Quarterly Report on Form 10-Q, including information with respect to our plans and strategy for our business, includes forward-looking statements that involve risks and uncertainties. As a result of many important factors, including those set forth in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> section of this Quarterly Report on Form 10-Q, our actual results could differ materially from the results described in, or implied, by these forward-looking statements.</span></div><div id="i928aa505a2ea46079da4e5082002267b_70"></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We are a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy. Leveraging our knowledge of pelvic anatomy and biomechanics, we have pioneered proprietary minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. Our products include a series of patented titanium implants and the instruments used to implant them. Since launching our first generation iFuse in 2009, we have launched three new implant product lines, iFuse-3D in 2017, iFuse-TORQ in 2021 and iFuse Bedrock Granite in 2022. Within the United States, our iFuse, iFuse-3D and iFuse-TORQ have clearances for applications across sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma. </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We market our products primarily with a direct sales force as well as a number of third-party sales agents in the U.S., and with a combination of a direct sales force, and sales agents and resellers in other countries. As of March 31, 2023, more than 80,000 procedures have been performed by over 3,000 surgeons in the United States and 38 other countries since we introduced iFuse in 2009. </span></div><div id="i928aa505a2ea46079da4e5082002267b_73"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impact of COVID-19</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The global COVID-19 pandemic, and the healthcare and economic disruptions it caused, may continue to pose future risks with the emergence of new variants. Even with the public health actions that have been taken to reduce the spread of the virus, the market could experience disruptions with respect to demand for our procedures, or the ability of healthcare facilities to provide our elective procedures to patients.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Elevated infection rates and measures taken to reduce infection have also impacted, and may continue to impact, our third-party manufacturers and suppliers, and could in turn adversely impact the availability or cost of materials, which could disrupt our supply chain. Periodic resurgence of the COVID-19 pandemic negatively impacted our revenues at various periods throughout 2022 as evidenced by case deferrals attributed to COVID-19. This effect could continue in 2023.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The existence and further duration of the COVID-19 pandemic may also further exacerbate certain risks as described in &#8220;Part II- Item 1A - Risk Factors&#8221; below.</span></div><div id="i928aa505a2ea46079da4e5082002267b_76"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Factors Affecting Results of Operations and Key Performance Indicators</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We monitor certain key performance indicators that we believe provide us and our investors indications of conditions that may affect results of our operations. Our revenue growth rate and commercial progress is impacted by, among other things, our key performance indicators, including our ability to expand access to solutions, increase surgeon penetration, launch new products, address human capital needs and gain operational efficiencies.  </span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Expand Access to Solutions</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we expand our portfolio, the experience, caliber, and strong clinician relationships of our sales force, including our network of third-party sales agents, will be crucial to drive adoption of our future products and procedures. Since our initial public offering in 2018, we have made significant investments in our commercial infrastructure to build a valuable sales team to expand the market, drive surgeon engagement and deliver revenue growth.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we will continue to selectively expand our sales force, we are also focused on increasing our sales managers capacity and driving sales force productivity by adding more clinical support specialists and implementing hybrid models, including selectively adding third-party sales agents for case coverage and by consigning instrument trays and implants at selective sites of service.  This expansion of our sales force is one aspect of increasing the overall number of procedures in a given period that we can support with products, which is what we call &#8220;surgical capacity.&#8221; Our surgical capacity is also limited by the volume of implant inventory and the number of instrument trays held ready for surgery, either at our headquarters facility, forward deployed with our sales force or consigned to customer facilities. As we grow, and as adoption of our solutions continues to mature, our overall surgical capacity may become an important driver of the amount of revenue that we can generate.  </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023, our U.S. sales force consisted of 87 territory sales managers and 67 clinical support specialists directly employed by us and 126 third-party sales agents, compared to 88 territory sales managers and 66 clinical support specialists directly employed by us and 66 third-party sales agents as of March 31, 2022. As of March 31, 2023, our international sales force consisted of 12 sales representatives directly employed by us and a total of 31 third-party sales agents and resellers, compared to 18 sales representatives directly employed by us and a total of 31 third-party sales agents and resellers as of March 31, 2022. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With the steady increase in the numbers of minimally invasive procedures, including sacroiliac joint fusion procedures, being performed at ASCs, we continue to actively engage the ASCs to educate them on our clinical evidence, exclusive commercial payor coverage and focus on driving improved education and pathways between pain physicians and surgeons. As of March 31, 2023, over 20 percent of procedures for sacroiliac joint dysfunction using our products were performed at ASCs.  </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have been making targeted investments in digital marketing initiatives to drive patient awareness, to empower and educate patients as they manage their sacroiliac joint dysfunction and associated pain. These marketing programs are targeted at patients in chronic, severe sacroiliac joint pain who have been in conservative care for an extended period of time. We are focused on connecting patients with surgeons in their area who perform minimally invasive SI-Joint procedures through our Find-a-Doctor website tool.  Through a variety of channels, including search, social and display, we have deployed a number of campaigns and are continually optimizing to maximize patient awareness and to connect patients with surgeons.  Our data-driven approach enables us to focus our investment on the most cost-effective programs. </span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Surgeon Engagement</span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Engaging and educating surgeons and other healthcare professionals about the clinical merits and patient benefits of our solutions will be important to grow surgeon adoption. Our medical affairs team works closely with our sales team to increase surgeon engagement and activation. Surgeon activity includes both the number of surgeons performing our procedures as well as the number of procedures performed per surgeon. In addition to training new surgeons, we have several initiatives to re-engage inactive surgeons. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We utilize a combination of hands-on cadaveric and dry-lab training, as well as SI-BONE SImulator - a portable, radiation-free, haptics and computer-based simulator for training purposes, and optimize our programs to improve adoption rate, time to first case and ultimately surgeon productivity.  </span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023 and 2022, in the U.S. more than 2,300 surgeons and 1,800 surgeons, respectively, have been trained on iFuse and have treated at least one patient. Outside the U.S., as of March 31, 2023 and 2022, more than 900 surgeons and 700 surgeons, respectively, have been trained on iFuse and have treated at least one patient. We will continue to pursue approximately 5,200 target surgeons in the U.S., as well as international surgeons to train and retrain in the future. Since launching our academic training program in August 2018, we have trained residents and fellows in over 215 academic programs in the U.S., resulting in the training of over 1300 surgical residents and fellows. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Expand Addressable Markets</span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expanding our platform of sacropelvic solutions to address sacroiliac joint dysfunction, pelvic fixation and pelvic trauma has been a key tenet of our strategy, and we have made substantial progress on this mission. With iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite, we believe that the value of our innovative, versatile, and complementary product portfolio provides surgeons with a comprehensive set of alternatives, and positions us as the top choice for surgeons for sacropelvic solutions.  </span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, we completed enrollment in SILVIA, a two-year prospective international multi center randomized controlled trial of two different methods for pelvic fixation in adult patients undergoing long-construct spinal fusion. We anticipate the results for the primary endpoint in 2024. In September 2022 we enrolled the first of the targeted 120 patients in our SAFFRON study, a prospective randomized controlled trial of surgery using our iFuse-TORQ device vs. non-surgical management in patients with debilitating sacral fragility or insufficiency fractures. We anticipate results to be available in late 2024.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to invest in R&amp;D initiatives to bring new and differentiated solutions to the market that deliver on our vision of improving patient quality of life through differentiated solutions to target segments with a clear unmet clinical need. Robust clinical evidence is central to drive adoption and favorable reimbursement, and we remain focused on continuing to set the industry standard in delivering evidence-based care through best-in-class clinical trials that demonstrate the efficacy, safety, and economic benefit of our solutions.  During three months ended March 31, 2023, we spent $3.3 million on R&amp;D, equating to 10% of our revenue.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Enhance Employee Experience and Engagement</span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to recruit, develop and retain highly skilled talent is a significant determinant of our success. To facilitate talent attraction, retention, and development, we strive to make SI-BONE an inclusive, diverse, and safe workplace with opportunities for our employees to grow and develop in their careers, supported by strong compensation, benefits, and health and wellness programs, as well as by programs that build connections between our employees and the communities in which they live and work.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to ensuring workforce diversity as well as fair and equitable pay to our employees, we remain focused on enhancing employee retention and job satisfaction. To that effect, we have created a feedback framework to monitor and respond to employee sentiment on an ongoing basis. Leveraging the insights from this feedback, we are focused on implementing strategies to enhance productivity and increase employee empowerment to drive quick decision making and prioritization across the organization.  Additionally, we offer ongoing learning and leadership training opportunities that support growth and development. In 2022 we conducted a formal management training program and implemented a new career development program which includes a formalized framework that reflects how an employee can advance their career within the company. Through our engagement programs and voluntary and giving activities, we are also focused on building connections between our employees, their families, and our communities to create a more meaningful and fulfilling workplace. We experienced a decrease in voluntary employee attrition during 2022, which we believe was at least in part to due to our actions to improve employee experience.  </span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gain operational efficiency</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To support our growing portfolio of solutions, we continue to evolve our business processes to identify, measure and improve operational efficiency. The information developed will allow us to optimize processes, increase sales force productivity and improve asset utilization.  </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are focused on increasing our sales managers and sales representatives capacity, efficiency and productivity.  We may do this by adding more clinical support specialists and third-party sales agents as part of hybrid arrangements for case coverage, and by consigning instrument trays and implants at selective sites of service. At the end of March 31, 2023, our trailing twelve months average revenue per territory in the U.S. was $1.3 million dollars.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have made significant investments in instrument sets used to perform surgeries.  Our goal is to deploy instrument sets to the market where the demand exists to increase our asset utilization rates over time and use capital more effectively, by having our instrument sets used in more surgeries in any given time period. Given supply chain disruptions impacting the industry, we are working closely with our suppliers to reduce lead time for our implants to ensure we can support our expanding surgeon footprint and over time build the resilience in our supply chain to reduce our cash investment in inventory. Additionally, we are partnering with our suppliers around design for manufacturing, specifically for newer products, to reduce the overall cost of the implants as we scale, and reduce waste and rework.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lastly, we are integrating our demand planning and manufacturing systems, to ensure we leverage actual usage trends as we build surgical capacity to support our growth.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><div id="i928aa505a2ea46079da4e5082002267b_79"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Components of Results of Operations</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue from sales of implants fluctuate based on volume of cases (procedures performed), discounts, mix of international and U.S. sales, different implant pricing and the number of implants used for a particular patient. Similar to other orthopedic companies, our case volume can vary from quarter to quarter due to a variety of factors including reimbursement, sales force changes, physician activities, seasonality, and the impact of COVID-19.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our revenue is impacted by changes in average selling price as we respond to the competitive landscape and price differences at different medical facilities, such as hospitals and ambulatory surgical centers, or ASCs. Further, revenue results can differ based upon the mix of business between U.S. and international sales mix of our products used, and the sales channel through which each procedure is supported. Our revenue from international sales is impacted by fluctuations in foreign currency exchange rates between the U.S. dollar (our reporting currency) and the local currency.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is affected by seasonal variations. For instance, we have historically experienced lower sales in the summer months and higher sales in the last quarter of the fiscal year as patients have more time in the winter months to have the procedure completed or want to take advantage of their annual insurance coverage limits. However, taken as a whole, seasonality does not have a material impact on our financial results from year to year.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Starting March 2020, the impact of COVID-19 on our revenue has varied by period and region based on various factors, including stage of containment, resurgence of variants, success of regional vaccination campaigns, and associated government and hospital actions around elective procedures, and the direct and indirect impacts of economic and financial measures taken to mitigate the economic impacts of the pandemic. </span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Goods Sold, Gross Profit, and Gross Margin</span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We utilize third-party manufacturers for production of our implants and instrument sets. Cost of goods sold consists primarily of costs of the components of implants and instruments, instrument set depreciation, royalties, scrap and inventory obsolescence, as well as distribution-related expenses such as logistics and shipping costs. Our cost of goods sold has historically increased as case levels increase. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our gross profit and gross margin are affected by factors impacting revenue and cost of goods sold. In addition, our gross margins are typically higher on products we sell directly as compared to products we sell through third-party sales agents. As a result, changes in the mix of direct versus third-party sales agents sales can directly influence our gross margins. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating expenses consist of sales and marketing, research and development, and general and administrative expenses. Personnel costs are the most significant component of operating expenses and consist of salaries, sales commissions and other cash and stock-based compensation related expenses. We intend to make investments to execute our strategic plans and operational initiatives. We anticipate certain operating expenses will continue to increase to support our growth.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">    </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sales and Marketing Expenses</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales and marketing expenses primarily consist of salaries, stock-based compensation expense, and other compensation related costs, for personnel employed in sales, marketing, medical affairs, reimbursement and professional education departments. In addition, our sales and marketing expenses include commissions and bonuses, generally based on a percentage of sales, as well as certain commission guarantees paid to our senior sales management, direct territory sales managers, clinical support specialists and third-party sales agents. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Expenses</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our research and development expenses primarily consist of engineering, product development, clinical and regulatory expenses (including clinical study expenses), consulting services, outside prototyping services, outside research activities, materials, depreciation, and other costs associated with development of our products. Research and development expenses also include related personnel compensation and stock-based compensation expense. We expense research and development costs as they are incurred. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses for engineering projects fluctuate with project timing. Based upon our broader set of product development initiatives and the stage of the underlying projects, we expect to continue to make investments in research and development. As such, we anticipate that research and development expenses will continue to increase in the future.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and Administrative Expenses</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses primarily consist of salaries, stock-based compensation expense, and other costs for finance, accounting, legal, insurance, compliance, and administrative matters. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Income</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income is primarily related to our investments of excess cash in money market funds and marketable securities.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> Interest Expense</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Interest expense is primarily related to borrowings, amortization of debt issuance costs, and accretion of final fees on the First-Citizens Term Loan. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income (Expense), Net</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net consists primarily of net foreign exchange gains and losses on foreign transactions.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div id="i928aa505a2ea46079da4e5082002267b_82"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manage and operate as one reportable segment. The table below summarizes our results of operations for the periods presented (percentages are amounts as a percentage of revenue), which we derived from the accompanying condensed consolidated financial statements:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:72.638%"><tr><td style="width:1.0%"></td><td style="width:50.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.372%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.372%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.372%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.374%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except for percentages)</span></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statements of Operations Data:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,708&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,439&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,924&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,983&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,784&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,456&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,605&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,291&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,580&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,473&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,077&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,324&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,293)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,868)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other income (expense), net:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(838)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(561)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,125)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,410)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We derive the majority of our revenue from sales to customers in the U.S. Revenue by geography is based on billing address of the customer. The table below summarizes our revenue by geography:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:61.666%"><tr><td style="width:1.0%"></td><td style="width:41.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.413%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.926%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.413%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.926%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.413%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.926%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.416%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands except for percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,258&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,072&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,708&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,439&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:18pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Comparison of the Three Months Ended March 31, 2023 and 2022 </span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue, Cost of Goods Sold, Gross Profit, and Gross Margin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.111%"><tr><td style="width:1.0%"></td><td style="width:41.241%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.772%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.772%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.772%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.777%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#160;Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%&#160;Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except for percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,708&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,439&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,269&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,924&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,983&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,941&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,784&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,456&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,328&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin</span></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Revenue. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The increase in revenue for the three months ended March 31, 2023 as compared to the three months ended March 31, 2022 comprised a $10.1 million increase in our U.S. revenue and an increase of $0.2 million in our international revenue. The increase in revenue is due to the increase in case volumes and higher domestic average selling prices.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gross Profit and Gross Margin.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Gross profit increased $7.3 million for the three months ended March 31, 2023 as compared to the three months ended March 31, 2022, mainly driven by higher revenue. The gross margin was 82% for the three months ended March 31, 2023 as compared to 87% for the three months ended March 31, 2022. Gross margin decreased in the first quarter 2023 due to procedure and product mix given the higher total costs of the newly launched implants, and the increase in depreciation and freight costs to support the growth of the business. Gross margins also include the impact of foreign exchange on our international revenue. </span></div><div><span><br/></span></div><div style="margin-bottom:12pt;padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.111%"><tr><td style="width:1.0%"></td><td style="width:41.241%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.772%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.772%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.772%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.777%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#160;Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%&#160;Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except for percentages)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,605&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,708&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,291&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,580&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(289)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,473&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></div></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,077&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,324&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,753&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sales and Marketing Expenses. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in sales and marketing expenses for the three months ended March 31, 2023 as compared to the three months ended March 31, 2022 was primarily due to (a) increases in employee related costs, commissions and stock-based compensation of $1.7 million driven by headcount changes and higher revenues, and (b) higher levels of travel resulting in an increase of $0.2 million, partially offset by (c) lower consulting and training fees of $0.2 million associated with more targeted surgeon training programs. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Expenses. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in research and development expenses for the three months ended March 31, 2023 compared to the three months ended March 31, 2022 was primarily due to a decrease of $0.5 million in consulting and research and development activities related to the timing of new product development, partially offset by an increase of $0.2 million in employee related costs and stock-based compensation.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and Administrative Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The increase in general and administrative expenses for the three months ended March 31, 2023 compared to the three months ended March 31, 2022 was primarily due to an increase of $0.3 million in employee related costs and stock-based compensation driven by higher headcount.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:15pt;padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest and Other Income (Expense), Net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.305%"><tr><td style="width:1.0%"></td><td style="width:42.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.886%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.329%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$&#160;Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except for percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">859&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1177&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(838)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(561)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(277)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total interest and other expense, net</span></div></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(542)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">710&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Income.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The increase in interest income for the three months ended March 31, 2023 as compared to the three months ended March 31, 2022 was mainly due to higher interest earned on our investments in marketable securities, primarily as a result of higher interest rates.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The increase in interest expense for the three months ended March 31, 2023 as compared to the three months ended March 31, 2022 was primarily due to higher interest rates associated with the First-Citizens Term Loan.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Income (Expense), Net. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in other income (expense), net for the three months ended March 31, 2023 compared to the three months ended March 31, 2022 was due to foreign currency fluctuations.</span></div><div id="i928aa505a2ea46079da4e5082002267b_85"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023, we had cash and marketable securities of $86.0 million compared to $97.3 million as of December 31, 2022. We have financed our operations primarily through our public offerings and debt financing arrangements. As of March 31, 2023, we had $35.9 million in outstanding debt, compared to $35.2 million as of December 31, 2022 .</span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023, we had an accumulated deficit of $368.2 million, compared to $357.1 million as of December 31, 2022. During the three months ended March 31, 2023, we incurred a net loss of $11.1 million. During the years ended December 31, 2022 and 2021, we incurred a net loss of $61.3 million and $56.6 million, respectively, and expect to incur additional losses in the future. We have not achieved positive cash flow from operations to date.  </span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based upon our current operating plan, we believe that our existing cash and marketable securities will enable us to fund our operating expenses and capital expenditure requirements over the next 12 months and beyond. However, the economic impact of the duration and potential resurgence of the COVID-19 pandemic and uncertainties affecting the economic and capital markets environment and the financial services industry pose risks and uncertainties in our future available capital resources. Further, we may face challenges and uncertainties and, as a result, may need to raise additional capital as our available capital resources may be consumed more rapidly than currently expected due to, but not limited to, the following as a result of the COVID-19 pandemic or otherwise: (a) decreases in sales of our products and the uncertainty of future revenues from new products; (b) changes we may make to the business that affect ongoing operating expenses; (c) changes we may make in our business strategy; (d) regulatory and reimbursement developments affecting our existing products; (e) changes we may make in our research and development spending plans; and (f) other items affecting our forecasted level of expenditures and use of cash resources.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as we seek to deploy new product offerings, the need for additional capital to fund the purchase of inventories of implants and instrument sets may become more acute and may limit the number of revenue opportunities that we pursue.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each new product family introduced typically requires the purchase of consumable implant inventory as well as investment in a fleet of instrument sets required to support procedures nationwide. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Term Loan</span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The outstanding debt is related to a term loan pursuant to the Loan and Security Agreement dated August 12, 2021 (the &#8220;Effective Date&#8221;), entered into by us and Silicon Valley Bank (&#8220;SVB&#8221;). Pursuant the agreement, SVB provided an aggregate principal amount of $35.0&#160;million to us (the &#8220;SVB Term Loan&#8221;). </span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 6, 2023, we entered into a First Amendment to Loan and Security Agreement (the &#8220;Amendment&#8221;) with SVB, which amends our SVB Term Loan pursuant to which we had a term loan facility in an aggregate principal amount of $35.0 million (the &#8220;Original Loan Agreement&#8221; and with the Amendment, collectively the &#8220;Amended Loan Agreement&#8221;). Upon entry into the Amended Loan Agreement, we borrowed $36.0 million pursuant to a term loan (the "Term Loan"), which was substantially used to repay in full the $35.0 million term loan facility outstanding under the Original Loan Agreement and secured a revolving credit facility in an aggregate principal amount of up to $15.0 million (the &#8220;Revolver"). On March 14, 2023 all of SVB&#8217;s assets and liabilities, including </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">all of SVB&#8217;s rights as the lender pursuant to the Amended Loan Agreement, were assigned to Silicon Valley Bridge Bank.  On March 27, 2023, all of Silicon Valley Bridge Bank&#8217;s assets and liabilities were assigned and assumed by First-Citizens Bank &amp; Trust Company (&#8220;First-Citizens&#8221;). The Amended Loan Agreement also includes an uncommitted accordion term loan in an aggregate principal amount of up to $15.0 million, which accordion may be approved by First-Citizens, solely in its discretion, upon our request. The Term Loan matures on December 1, 2027 (the &#8220;Term Loan Maturity Date&#8221;). Interest on the Term Loan will be payable monthly at a floating annual rate set at the greater of the prime rate as published in the Wall Street Journal plus 0.5% or 6.75%. Commencing on July 1, 2025, we will be required to make monthly principal Term Loan amortization payments. A final fee payment of 2% of the original principal amount of the Term Loan is due upon the earlier of the Term Loan Maturity Date, termination, acceleration by First-Citizens following an event of default, or prepayment of the Term Loan. We may elect to prepay the Term Loan in whole prior to the Term Loan Maturity Date subject to a prepayment fee equal to 2% of the principal amount of the Term Loan prepaid at such time. No prepayment fee would be due if the Term Loan is refinanced by First-Citizens. Pursuant to the terms of the Amended Loan Agreement, revolving loans may be borrowed, repaid and reborrowed until the maturity date, which will be July 6, 2025 (the &#8220;Revolver Maturity Date&#8221;). Borrowings under the Revolver are based on 80% of eligible domestic accounts receivable borrowing base. Interest on the outstanding balance of the Revolver will be payable monthly at a floating annual rate set at the greater of the prime rate as published in the Wall Street Journal or 6.25%. Interest on borrowings is due monthly and any principal balance is due on the Revolver Maturity Date, provided that when Revolver Advances are outstanding, in the event we do not maintain an adjusted quick ratio of at least 1.5 to 1.0, then falling below such threshold will allow First-Citizens to apply accounts receivable collections to outstanding Revolver borrowings. We will pay a total commitment fee of $187,500 on account of the Revolver payable in installments, but fully earned at close. We will also be required to pay a fee of $150,000 if it terminates the Amended Loan Agreement or Revolver prior to Revolver Maturity Date. No termination fee would be due if the Revolver is replaced with a new facility with First-Citizens. No amounts were outstanding under the Revolver as of March 31, 2023. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On March 10, 2023, we violated one of the terms of the credit facility by opening bank accounts with another financial institution and transferring funds from SVB. We entered into a letter agreement with Silicon Valley Bridge Bank waiving enforcement of this covenant and providing us the right to hold a portion of our cash at other financial institutions. A future violation of any covenants could result in a default under the Amended Loan Agreement that would permit First-Citizens to restrict our ability to further access the Revolving Line of Credit for loans and require the immediate repayment of any outstanding loans under the agreement. As of March 31, 2023, we were in compliance with all debt covenants, provided, however, that in order to access future credit advances under the Revolving Line of Credit, we will be required to transfer certain cash management accounts back to First-Citizens. As of March 31, 2023, we had cash management accounts with a financial institution other than First-Citizens and instructed our customers to direct payments to us to these separate operating accounts. Until such operating accounts are closed and the funds moved back to cash collateral accounts held at First-Citizens, we will be unable to obtain credit advances under the Revolver. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Amended Loan Agreement contains customary events of default, including bankruptcy, the failure to make payments when due, the occurrence of a material impairment on First-Citizens's security interest over the collateral, a material adverse change, the occurrence of a default under certain other indebtedness of our company and our subsidiaries, the rendering of certain types of judgments against us and our subsidiaries, the revocation of certain government approvals, violation of covenants, and incorrectness of representations and warranties in any material respect. In addition, the Amended Loan Agreement contains a financial covenant which requires us to maintain, at all times when the Financial Covenant Measuring Period is in effect, certain net revenue levels as agreed upon by us and First-Citizens. If we do not comply with the various covenants under the Amended Loan Agreement and an event of default occurs under the Amended Loan Agreement, the interest rate on outstanding amounts can increase by 3% and First-Citizens may, subject to various customary cure rights, decline to provide additional advances under the Revolver, require the immediate payment of all amounts outstanding under the Amended Loan Agreement, and foreclose on all collateral. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our material cash requirements include various contractual and other obligations consisting of long-term debt obligations with First-Citizens, operating lease obligations and purchase obligations with some of our suppliers and have not changed materially since the Form 10-K filed with the SEC on March 2, 2023. As of March 31, 2023, expected timing of those payments are as follows: </span></div><div style="text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.972%"><tr><td style="width:1.0%"></td><td style="width:39.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.753%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.813%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.753%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.753%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.813%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.759%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payments Due By Period</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less than 1 year</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1-3 years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4-5 years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">More than 5 years</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal obligations and final fee on debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,720&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest obligations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,338&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,031&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,195&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">539&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase obligations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,837&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,837&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,555&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,370&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,953&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,232&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:24.305%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents the principal obligations and the final fee at maturities of our First-Citizens Term Loan.</span></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents the future interest obligations on our First-Citizens Term Loan estimated using an interest rate of 8.50% as of March 31, 2023.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This compared to $48.7&#160;million of contractual obligations as of December 31, 2022.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the primary sources and uses of cash for each of the periods presented below:  </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.222%"><tr><td style="width:1.0%"></td><td style="width:54.773%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.357%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.357%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.607%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#160;Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash provided by (used in):</span></div></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,753)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,512)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,759&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,703&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,608)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,311&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,036&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of exchange rate changes on cash and cash equivalents</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(139)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in cash and cash equivalents</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,252&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,090)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,342&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Used in Operating Activities  </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in operating activities for the three months ended March 31, 2023 of $10.7&#160;million resulted from cash outflows due to a net loss of $11.1 million, adjusted for $7.0 million of non-cash items, and cash outflows from net changes in operating assets and liabilities of $6.6 million. Net cash used in operating activities for the three months ended March 31, 2022 of $13.5 million resulted from cash outflows due to a net loss of $17.4 million, adjusted for $6.5 million of non-cash items, and cash outflows from changes in operating assets and liabilities of $2.6 million. The decrease in net loss, net of non-cash items for the three months ended March 31, 2023 compared to the three months ended March 31, 2022 was mainly due to increased revenues. Net cash outflows from changes in operating assets and liabilities for the three months ended March 31, 2023 were primarily due to higher accounts receivable due to timing of collections, higher inventory due to the inventory build-up related to our implants, lower accounts payable, accrued liabilities and prepaid expenses attributable to the normal course timing of expenses. Net cash outflows from changes in operating assets and liabilities for the three months ended March 31, 2022 were primarily due to higher inventory due to the timing of inventory build-up related to our iFuse-TORQ implants and higher accrued liabilities and others due to timing of other third-party payments and higher compensation and benefit accruals, partially offset by a decrease in accounts receivable due to timing of collections and an increase in accounts payable due to timing of vendor payments.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flows From Investing Activities</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by investing activities in the three months ended March 31, 2023 was $11.7 million compared to cash used in investing activities of $22.6 million in the three months ended March 31, 2022. Net cash provided by investing activities for the three months ended March 31, 2023 consisted of maturities of our marketable securities net of purchases of $14.3 million, partially offset by purchases of property and equipment of $2.6 million primarily related to individual components in instrument sets to support revenue growth, as well as leasehold improvements made to the building used for research and development and warehouse space in Santa Clara. We will continue to invest in instruments trays to support our products. Net cash provided by investing activities for the three months ended March 31, 2022 consisted of purchases of marketable securities, net of maturities of $20.3 million, and purchases of property and equipment of $2.3 million primarily related to individual components in instrument sets as we anticipated increased case volumes.</span></div><div style="margin-top:12pt;padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Provided by Financing Activities</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash provided by financing activities in the three months ended March 31, 2023 was $1.2 million resulting from net proceeds of $0.7 million from the refinancing of our term loan with First-Citizens and proceeds of $0.5 million from the issuance of common stock under our stock-based incentive compensation plans. This compares to $0.2 million provided by financing activities in the three months ended March 31, 2022, which consisted solely of proceeds from the issuance of common stock under our stock-based incentive compensation plans.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div id="i928aa505a2ea46079da4e5082002267b_88"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies, Significant Judgments, and Use of Estimates</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This discussion and analysis of our financial condition and results of operations is based on our consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of these consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, as well as the reported revenue generated, and expenses incurred during the reporting periods. Our estimates are based on our historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates. </span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our critical accounting policies and estimates are described in &#8220;Management's Discussion and Analysis of Financial Condition and Results of Operations - Critical Accounting Policies, Significant Judgments, and Use of Estimates&#8221; in our Annual Report on Form 10-K filed with the SEC on March 2, 2023. There had been no material changes to the descriptions of these accounting policies, judgments and estimates.</span></div><div id="i928aa505a2ea46079da4e5082002267b_100"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Seasonality</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is affected by seasonal variations. For instance, we have historically experienced lower sales in the summer months and higher sales in the last quarter of the fiscal year. However, taken as a whole, seasonality does not have a material impact on our financial results.</span></div><div id="i928aa505a2ea46079da4e5082002267b_106"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Quantitative and Qualitative Disclosures about Market Risk</span></div><div style="text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As a "small reporting company", we are not required to provide the information otherwise required by this Item.</span></div><div id="i928aa505a2ea46079da4e5082002267b_109"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Controls and Procedures</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%">We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in the reports that we file or submit under the Securities and Exchange Act of 1934 is (i) recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms and (ii) accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%">The effectiveness of any system of internal control over financial reporting, including ours, is subject to inherent limitations, including the exercise of judgment in designing, implementing, operating, and evaluating the controls and procedures, and the inability to eliminate misconduct completely. Accordingly, any system of internal control over financial reporting, including ours, no matter how well designed and operated, can only provide reasonable, not absolute assurances. In addition, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. We intend to continue to monitor and upgrade our internal controls as necessary or appropriate for our business but cannot assure you that such improvements will be sufficient to provide us with effective internal control over financial reporting.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023, our management, with the participation of our Chief Executive Officer (&#8220;CEO&#8221;) and our Chief Financial Officer (&#8220;CFO&#8221;), have evaluated our disclosure controls and procedures (as defined in Rules&#160;13a&#8209;15(e)&#160;and 15d&#8209;15(e)&#160;under the Securities Exchange Act of 1934). Based on that evaluation, our CEO and our CFO have concluded that, as of March 31, 2023, our disclosure controls and procedures were effective at the reasonable assurance level. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in internal control over financial reporting</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the quarter ended March 31, 2023, there were no changes in our internal controls over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div id="i928aa505a2ea46079da4e5082002267b_112"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II&#8212;OTHER INFORMATION</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><div id="i928aa505a2ea46079da4e5082002267b_115"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Legal Proceedings</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved in various claims, complaints, investigations and legal actions that arise from time to time in the normal course of business, including commercial and employment matters. There are no matters pending that we currently believe are material. There can be no assurance that existing or future legal proceedings arising in the ordinary course of business or otherwise will not have a material adverse effect on our business, financial condition or results of operations.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:27pt"><span><br/></span></div><div id="i928aa505a2ea46079da4e5082002267b_118"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item 1A. Risk Factors</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Investing in our common stock involves a high degree of risk. Investors should carefully consider the risks described below, as well as the other information in this Quarterly Report on Form 10-Q, including our condensed consolidated financial statements and the related notes and the section &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations,&#8221; before deciding whether to invest in our common stock. The occurrence of any of the events or developments described below could materially and adversely affect our business, financial condition, results of operations, and growth prospects. In such an event, the market price of our common stock could decline, and our stockholders may lose all or part of their investment. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also impair our business operations.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Risk Factor Summary</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">We have incurred significant operating losses since inception, we expect to continue to incur operating losses in the future, and we may not be able to achieve or sustain future profitability;</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Prolonged inflation and supply chain disruptions could result in delayed product launches, lost revenue, higher costs and decreased profit margins;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Disruptions in the supply of the materials and components used in manufacturing our products or the sterilization of our products by third-party suppliers could adversely affect our business, financial condition and results of operations;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">If hospitals, surgeons, and other healthcare providers are unable to obtain and maintain adequate or any coverage and reimbursement from third-party payors for procedures performed using our products, further adoption of our products may be delayed, and it is unlikely that they will gain further acceptance, and the prices paid for our implants may decline;</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt">If healthcare payors reverse decisions to cover minimally invasive sacroiliac joint fusion exclusively when performed with iFuse and choose to reimburse for procedures performed with competitive products, our market share could decline, adversely affecting our revenues;</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Epidemic diseases, or the perception of their effects, may continue to adversely affect our business, financial condition, results of operations, or cash flows;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">We may not be able to convince physicians that our products are attractive alternatives to our competitors&#8217; products and that our procedures are attractive alternatives to existing surgical and non-surgical treatments for their respective indications;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Surgeons and payors may not find the clinical evidence supporting our more recent products to be compelling, which could limit our sales and revenue, and on-going and future research may prove our products to be less safe and effective than currently thought;</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt">Pricing pressure from our competitors, changes in third-party coverage and reimbursement, healthcare provider consolidation, payor consolidation and the presence of &#8220;physician-owned distributorships&#8221; may impact our ability to sell our product at prices necessary to support our current business strategies;</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt">Practice trends or other factors, including the COVID-19 pandemic, have caused and may continue to cause procedures to shift from the hospital environment to ambulatory surgical centers, or ASCs, where pressure on the prices of our products is generally more acute;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">We operate in a very competitive business environment and if we are unable to compete successfully against our existing or potential competitors, our sales and operating results may be adversely affected;</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt">We are highly dependent on revenue from the sale of a single family of products focused on procedures, the goal of which is to stabilize and fuse the sacroiliac joint. Reliance on a single family of products and single family of procedures could negatively affect our results of operations and financial condition;</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt">If clinical experience with our iFuse Bedrock technique or our iFuse Bedrock Granite product does not result in positive outcomes for patients, or if clinical trials involving the use of iFuse Bedrock and/or iFuse Bedrock Granite fail to show </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">meaningful patient benefit, sales of our iFuse, iFuse-3D, iFuse-TORQ, and/or iFuse Bedrock Granite implants could be adversely impacted;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">If we are unable to maintain our network of direct sales representatives, third-party sales agents, and resellers, we may not be able to generate anticipated sales;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Our business could suffer if we lose the services of key members of our senior management, key advisors or personnel;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">If use of our products results in adverse events, this may require them to be taken off the market, require them to include safety warnings or otherwise limit their sales;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Various factors outside our direct control may adversely affect manufacturing, sterilization, and distribution of our products;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">We are dependent on a limited number of third-party suppliers, some of them single-source and some of them in single locations, for most of our products and components, and the loss of any of these suppliers, or their inability to provide us with an adequate supply of materials in a timely and cost-effective manner, could materially adversely affect our business;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">We, our suppliers, and our third-party manufacturers are subject to extensive governmental regulation both in the U.S. and abroad, and failure to comply with applicable requirements could cause our business to suffer;</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt">We and our sales representatives must comply with U.S. federal and state fraud and abuse laws, including those relating to healthcare provider kickbacks and false claims for reimbursement, and other applicable federal and state healthcare laws, as well as equivalent foreign laws, and failure to comply could negatively affect our business;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">If we or our licensors fail to adequately protect or enforce our intellectual property rights or secure rights to patents of others, the value of our intellectual property rights would diminish and our ability to successfully commercialize our products may be impaired;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Adverse developments affecting the banking industry or the broader financial services industry, such as actual events or concerns involving liquidity, defaults or non-performance, could adversely affect our operations and liquidity; and</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to access credit on favorable terms, if necessary, for the funding of our operations and capital projects may be limited due to changes in credit markets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Risks Related to Our Business and Our Industry</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We have incurred significant operating losses since inception, we expect to continue to incur operating losses in the future, and we may not be able to achieve or sustain future profitability.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have incurred net losses since our inception in 2008. For the three months ended March 31, 2023, we had a net loss of $11.1 million. For the years ended December 31, 2022 and 2021, we had net losses of $61.3 million and $56.6 million, respectively. As of March 31, 2023, we had an accumulated deficit of $368.2 million. We have financed our operations primarily through the net proceeds of our public offerings of our common stock, private placements of equity securities, certain debt-related financing arrangements, and from sales of our products. We have devoted substantially all of our resources to research and development of our products, sales and marketing activities, investments in training and educating surgeons and other healthcare providers, and clinical and regulatory matters for our products. There can be no assurances that we will be able to generate sufficient revenue from our existing products or from any of our product candidates in development, and to transition to profitability and generate consistent positive cash flows, and even if we are able to do so, our ability to do so has been delayed by the COVID-19 pandemic. We expect that our operating expenses will continue to increase as we continue to build our commercial infrastructure, develop, enhance, and commercialize our existing and new products. As a result, we expect to continue to incur operating losses for the foreseeable future and may never achieve profitability. Furthermore, even if we do achieve profitability, we may not be able to sustain or increase profitability on an ongoing basis. If we do not achieve profitability, it will be more difficult for us to finance our business and accomplish our strategic objectives.</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our expected future capital requirements depend on many factors including expanding our surgeon base, the expansion of our sales force, investment in implants and instruments, and the timing and extent of spending on the development of our technology to increase our product offerings, and potential investment in additional product and service offerings through the acquisition of other businesses. We may need additional funding for our operations, but additional funds may not be available to us on acceptable terms on a timely basis, if at all. We may seek funds through borrowings or through additional rounds of financing, including private or public equity or debt offerings. If we raise additional funds by issuing equity securities, our stockholders may experience dilution. Any future debt financing into which we enter may impose upon us additional covenants that restrict our operations, including limitations on our </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">ability to incur liens or additional debt, pay dividends, repurchase our common stock, make certain investments, and engage in certain merger, consolidation or asset sale transactions. Any future debt financing or additional equity that we raise may contain terms that are not favorable to us or our stockholders. Furthermore, we cannot be certain that additional funding will be available on acceptable terms, if at all. The capital markets have deteriorated substantially since the beginning of 2022, especially with respect to securities issued by companies in the medical device and technology sectors. Equity and debt capital have become substantially more expensive and difficult to raise on attractive terms. If we are unable to raise additional capital or generate sufficient cash from operations to adequately fund our operations, we will need to curtail planned activities to reduce costs, which will likely harm our ability to execute on our business plan and continue operations</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Prolonged inflation and supply chain disruptions could result in delayed product launches, lost revenue, higher costs and decreased profit margins. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A majority of our products are manufactured and sold inside of the United States, which increases our exposure to domestic inflation and fuel price increases. Recent inflationary pressures have resulted in increased fuel, raw materials and other costs which, if they continue for a prolonged period, may adversely affect our results of operations. We have experienced shortages in certain raw materials and component inputs of our products, primarily surgical instruments, as suppliers have been unable to meet delivery schedules due to excess demand and labor shortages, and lead times have lengthened throughout our supply chain. Our efforts to mitigate supply chain weaknesses may not be successful or may have unfavorable effects. For example, efforts to purchase raw materials in advance for product manufacturing may result in increased storage costs or excess supply. If our costs rise due to continuing significant inflationary pressures or supply chain disruptions, we may not be able to fully offset such higher costs through price increases. In addition, delays in obtaining materials, components or instruments from our suppliers could delay product launches or result in lost opportunities to sell our products due to their availability. Increased costs and decreased product availability due to supply chain issues could adversely impact our revenue and/or gross margin, and could thereby harm our business, financial condition, and results of operation.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Disruptions in the supply of the materials and components used in manufacturing our products or the sterilization of our products by third-party suppliers could adversely affect our business, financial condition and results of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our suppliers purchase many of the materials and components used in the manufacture of our products from third-party suppliers. Certain of these materials and components can only be obtained from a single source or a limited number of sources due to quality considerations, expertise, costs or constraints resulting from regulatory requirements. In certain cases, our suppliers may not be able to establish additional or replacement suppliers for such materials or components or outsourced activities in a timely or cost effective manner. A reduction or interruption in the supply of materials or components used in manufacturing our products, such as due to one or more suppliers experiencing reductions in operations and/or worker absences due to COVID-19 or other health epidemics, an inability to timely develop and validate alternative sources if required, or a significant increase in the price of such materials or components, such as that caused by inflation and rising interest rates, could adversely affect our business, financial condition and results of operations. For example, certain of our products require titanium, which is sourced from third-party suppliers. While the titanium required for such products is not directly sourced from Russia, the current geopolitical events involving Russia and Ukraine are negatively impacting the wider titanium supply chain and such geopolitical events and factors relating thereto or resulting therefrom, including related sanctions, may negatively impact the ability of our suppliers&#8217; third-party supply sources to timely supply titanium to our suppliers and may increase or result in additional costs to us.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, many of our products require sterilization prior to sale, and our suppliers use contract sterilizers to perform this service. To the extent that these contract sterilizers are unable to sterilize our products, whether due to capacity, availability of materials for sterilization, regulatory or other constraints, including reductions in operations and/or worker absences due to COVID-19 or other health epidemics, we may be unable to transition to other contract sterilizers, sterilizer locations or sterilization methods in a timely or cost effective manner or at all, which could have a material impact on our results of operations and financial condition.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">If hospitals, surgeons, and other healthcare providers are unable to obtain and maintain adequate or any coverage and reimbursement from third-party payors for procedures performed using our products, further adoption of our products may be delayed, and it is unlikely that they will gain further acceptance, and the prices paid for our implants may decline.</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Maintaining and growing sales of our products depends on the availability of adequate coverage and reimbursement from third-party payors, including government programs such as Medicare and Medicaid, private insurance plans, and managed care programs. Hospitals, surgeons, and other healthcare providers that purchase or use medical devices generally rely on third-party payors to pay for all or part of the costs and fees associated with the procedures performed with these devices. When a procedure using our implants is performed, both the surgeon and the healthcare facility, either a hospital or ambulatory surgical center, submit claims for reimbursement to the healthcare payor. We may be unable to sell our products on a profitable basis if third-party payors deny coverage, or if reimbursement levels are insufficient to support use of our products by healthcare facilities or to compensate surgeons for their time spent diagnosing patients and performing procedures using our products.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">While all Medicare Administrative Contractors are regularly reimbursing for minimally invasive sacroiliac joint fusion utilizing laterally placed transfixing devices, a small number of private payors still have policies that treat the procedure as experimental or </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">investigational and do not regularly reimburse for the procedure. Future action by the Centers for Medicare and Medicaid Services (&#8220;CMS&#8221;) or third-party payors may further reduce the availability of payments to physicians, outpatient surgery centers, and/or hospitals for procedures using our products. Volatility in the payment rates that physicians and hospitals receive from CMS may have a material impact on their willingness to perform procedures including our products, as well as place additional pressure on pricing of our implants.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The healthcare industry in the United States has experienced a trend toward cost containment as government and private insurers seek to control healthcare costs. Payors are imposing lower payment rates and negotiating reduced contract rates with service providers and being increasingly selective about the technologies and procedures they choose to cover. Payors may adopt policies in the future restricting access to medical technologies like ours and/or the procedures performed using such technologies. Therefore, we cannot be certain that the procedures performed with each of our products will be reimbursed. There can be no guarantee that, should we introduce additional products in the future, payors will cover those products or the procedures in which they are used.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Effective January 1, 2023, the Medicare physician fee reimbursement for minimally invasive fusion with our laterally placed transfixing iFuse implants, described as Current Procedural Terminology (&#8220;CPT&#8221;) Code 27279, is $827. Commercial payors generally set their physician fee reimbursement with reference to Medicare reimbursement rates. We believe that some surgeons may continue to view the Medicare and commercial reimbursement amounts as insufficient for the procedure, given the work effort involved with the procedure, including the time to diagnose the patient and obtain prior authorization from the patient&#8217;s health insurer if necessary. We believe that some private payors apply their own coverage policies and criteria inconsistently, and surgeons may not be able to consistently have minimally invasive sacroiliac fusion procedures utilizing laterally placed transfixing devices approved and covered. The perception by physicians that the reimbursement for minimally invasive sacroiliac joint fusion is insufficient to compensate them for the work required, including diagnosis, documentation, obtaining payor approval for the procedure, and burden on their office staff, may negatively affect the number of procedures performed and may therefore adversely affect our revenues.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The American Medical Association (AMA) develops and maintains CPT codes that are used by third-party payors to determine the amount of reimbursement that a healthcare provider and facility will receive for a particular service. CPT codes are divided into three categories: Category I codes represent existing services or procedures that are widely used.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Category II codes are supplemental tracking codes, and Category III codes are temporary codes that represent new technologies, services, and procedures. A Category III code does not have a payment rate established and reimbursement is at the payor&#8217;s discretion. CPT Code 27279, which describes minimally-invasive surgical fusion of the sacroiliac joint performed with our laterally placed transfixing iFuse implants, is a Category I CPT code. As the number of products and surgical procedures to address sacroiliac joint dysfunction has expanded and diversified, certain medical societies requested that the AMA create additional codes representing some of these newer, and different procedures utilizing non-transfixing technologies. In May 2022, the AMA CPT Editorial Panel adopted a proposal for a new Category III code to become effective January 1, 2023, describing a different sacroiliac joint procedure to place interpositional, intra-articular and non-transfixing implants typically using a dorsal, or posterior, approach. In September 2022, the AMA CPT Editorial Panel subsequently  voted to convert the Category III Code to describe procedures to implant the newer, non-transfixing (dorsally placed) implants to a Category I Code effective January 1, 2024.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If the levels of reimbursement for, and consistency of coverage associated with, procedures performed with our medical devices under the existing Category I CPT Code decrease as a result of or in connection with these coding changes, it could make the procedures in which our implants are used less attractive to healthcare professionals, decreasing the number of devices we are able to sell and adversely affecting our business, results of operations and financial condition. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Recent political, economic, and regulatory influences are subjecting the healthcare industry to fundamental changes that can impact coverage and reimbursement from third-party payors. We expect that the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2011, as currently enacted or as it may be amended in the future, and other healthcare reform measures that may be adopted in the future, could have a material adverse effect on our industry generally and on our ability to maintain or increase sales of our existing products. CMS budget neutrality requirements may impose cuts to the Medicare physician fee schedule, which may be mitigated by acts of Congress or other changes to regulations. Other federal laws, known as budget sequestration, further reduce Medicare&#8217;s payments to providers. Under current legislation, the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">reduction in Medicare payments will vary from 2% under the Budget Control Act of 2011 (currently set to expire in 2031) to 4% if budget sequestration is triggered under the Statutory Pay-As-You-Go Act of 2010. These reductions may reduce reimbursement for procedures performed using our products, which could potentially negatively impact our revenue, and may reduce providers&#8217; revenues or profits, which could affect their ability to purchase new technologies. Both the federal and state governments in the U.S. and foreign governments continue to propose and pass new legislation and regulations designed to contain or reduce the cost of healthcare. Such legislation and regulations may result in decreased reimbursement for medical devices, which may further exacerbate industry-wide pressure to reduce the prices charged for medical devices. This could harm our ability to market our products and generate sales, which could adversely affect our business, results of operations and financial condition.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Market acceptance of our products in foreign markets may depend, in part, upon the availability of coverage and reimbursement within prevailing healthcare payment systems. Reimbursement and healthcare payment systems in international markets vary significantly by country and include both government-sponsored healthcare and private insurance. We may not obtain additional international coverage and reimbursement approvals in a timely manner, if at all. Our failure to receive such approvals would negatively impact market acceptance of our products in the international markets in which those approvals are sought.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">If healthcare payors reverse decisions to cover minimally invasive sacroiliac joint fusion exclusively when performed with iFuse and choose to reimburse for procedures performed with competitive products, our market share could decline, adversely affecting our revenues.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of March 31, 2023, a significant number of the largest U.S. payors that we track and target have issued positive coverage policies covering the patented design of our triangular iFuse implants and excluding coverage of other products that are intended to fuse the sacroiliac joint because of the clinical evidence supporting the use of triangular titanium implants and the lack of clinical evidence supporting the use of other products. We believe that payors have adopted these exclusive coverage decisions due to the strength of our clinical evidence and in part due to recommendations of specialty benefit managers and healthcare technology assessment organizations. Clinical trials of the type and size necessary to offer evidence of the safety and efficacy of competing products could be performed and could show that other products for sacroiliac joint fusion are as effective as, or more effective than, our triangular iFuse implants. Payors could also abandon their decisions to cover triangular implants exclusively for other reasons.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Healthcare payors which have adopted sacroiliac joint fusion coverage policies exclusive to titanium triangular implants could reverse the exclusive nature of their policies and allow surgeons to use other types of products when performing sacroiliac fusion procedures.  For example, AIM, a clinical evidence evaluation organization which influences Anthem, among other payors, promulgated such a policy, effective September 11, 2022, that is no longer exclusive to titanium triangles. If healthcare payors covering a significant number of covered lives reverse their policies of covering minimally invasive sacroiliac joint fusion exclusively when performed with triangular titanium implants, sales of our triangular iFuse implants could decline or </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">fail to grow, which could adversely affect our business, results of operations and financial condition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Epidemic diseases, or the perception of their effects, may continue to adversely affect our business, financial condition, results of operations, or cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As the COVID-19 global pandemic enters its fourth year, the impact of COVID-19 on our business remains highly dependent on future developments, which are uncertain and unpredictable. An outbreak of an infectious disease, or an escalation of COVID-19 infection rates could continue to divert medical resources toward the treatment of that disease, and negatively affect hospital admission rates and the decision by patients to undergo elective surgery, which could decrease demand for procedures using our implants and cause other disruptions to our business. Business disruptions have included, and could continue to include, disruptions or restrictions on our ability to travel or to distribute our products, government orders suspending the performance of elective surgical procedures, inability of our customers to meet their financial commitments due to strain on the healthcare system, as well as temporary closures of our facilities or the facilities of our suppliers and their contract manufacturers, and a reduction in the business hours of hospitals and ambulatory surgery centers. Any disruption of our suppliers and their contract manufacturers or our customers would likely impact our sales and operating results. In addition, a significant outbreak of an infectious disease in the human population could result in a widespread health crisis that could adversely affect the economies and financial markets of many countries, resulting in an economic downturn that could affect demand for our products. Any of these events could negatively impact the number of procedures using our implants that are performed and have a material adverse effect on our business, financial condition, results of operations, or cash flows.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, COVID-19 has adversely affected, and may continue to adversely affect, the economies and financial markets of many countries, which may result in a period of regional, national, and global economic slowdown or regional, national, or global recessions that could curtail or delay spending by hospitals and affect demand for our products as well as increase risk of customer defaults or delays in payments. These market disruptions could impair our ability to raise capital, should our business experience a prolonged period of reduced revenue requiring additional capital to sustain the business. COVID-19 and the current financial, economic, and capital markets environment, and future developments in these and other areas present material uncertainty and risk with respect to our performance, financial condition, results of operations, and cash flows. Due to the uncertain scope and duration of the pandemic and uncertain timing of global recovery and economic normalization, we are unable to estimate the long-term impacts on our operations and financial results. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The existence and further duration of the COVID-19 pandemic may also further exacerbate certain of the risks described herein.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We may not be able to convince physicians that our products are attractive alternatives to our competitors&#8217; products and that our procedures are attractive alternatives to existing surgical and non-surgical treatments for their respective indications.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Surgeons, in consultation with their patients, play the primary role in determining the course of treatment and, ultimately, any product that will be used in treatment. In order for us to sell our products successfully, we must demonstrate to surgeons through education and training that treatment with iFuse is beneficial, safe, and cost-effective for patients as compared to our competitors&#8217; products. If we are not successful in demonstrating the merits of our products to surgeons, their use of our products may decline, adversely affecting our revenues and profitability.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Historically, most spine surgeons did not include an evaluation of the sacroiliac joint in their diagnostic work-up because they did not have an adequate surgical procedure to perform for patients diagnosed with sacroiliac joint dysfunction. We believe that </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">educating surgeons and other healthcare professionals about the clinical merits and patient benefits of iFuse is an important element of building our business. If we fail to effectively educate surgeons and other medical professionals, they may not include a sacroiliac joint evaluation as part of their diagnosis and, as a result, those patients may continue to receive unnecessary surgical procedures or only non-surgical treatment.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Surgeons may also hesitate to change their medical treatment practices for other reasons, including the following:</span></div><div style="text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">       </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">lack of experience with minimally invasive procedures;</span></div><div style="text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">       </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">perceived liability risks generally associated with the use of new products and procedures;</span></div><div style="text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">       </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">costs associated with the purchase of new products; and </span></div><div style="text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">       </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">time commitment that may be required for training.</span></div><div style="text-indent:49.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Furthermore, we believe surgeons will not widely use our products unless they determine, based on experience, clinical data, and published peer-reviewed publications, that surgical intervention provides benefits or is an attractive alternative to non-surgical treatments of sacroiliac joint dysfunction. In addition, we believe support of our products relies heavily on long-term data showing their benefits. If we are unable to provide that data, surgeons may not use our products. In such circumstances, we may not achieve expected sales and may be unable to achieve profitability.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Many patients with sacroiliac joint dysfunction are cared for by pain physicians and other interventionalists, who are generally trained as anesthesiologists, interventional radiologists, or physical medicine and rehabilitation specialists. These physicians often offer a variety of non-surgical and surgical interventions to sacroiliac joint dysfunction patients, including, but not limited to, steroid injections, radiofrequency ablation of the nerves serving the sacroiliac joint and implantation of neurostimulation devices, allografts, and other products intended to treat the sacroiliac joint or the pain it can cause. Our professional education program seeks to teach these physicians, and other health care providers, about the benefits of our iFuse products, in order to prompt these providers to refer their patients with sacroiliac joint dysfunction to surgeons who have been trained to perform the iFuse procedure. These providers may, however, prefer to continue to treat these patients with the interventions they offer because they feel that these interventions are superior or because they have a financial interest in offering additional treatments to these patients. If we are unable to demonstrate to potential referring health care providers the comparative benefits of iFuse, and we are therefore unable to prompt sufficient numbers of these providers to refer their patients with sacroiliac joint dysfunction for treatment by surgeons trained to perform the iFuse procedure, sales of our iFuse implants could decline or fail to grow, which could adversely affect our business, results of operations and financial condition.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Surgeons and payors may not find the clinical evidence supporting our more recent products to be compelling, which could limit our sales and revenue, and on-going and future research may prove our products to be less safe and effective than currently thought.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The products we currently market in the United States have either received premarket clearance under Section 510(k) of the United States Federal Food, Drug, and Cosmetic Act (&#8220;FDCA&#8221;), or are exempt from premarket review. Those marketed in the European Union (&#8220;EU&#8221;) have been the subject of a CE Certificate of Conformity. The 510(k) clearance process of the U.S. Food and Drug Administration (&#8220;FDA&#8221;) requires us to document that our product is &#8220;substantially equivalent&#8221; to another 510(k)-cleared product. The 510(k) process is shorter and typically requires the submission of less supporting documentation than other FDA approval processes, such as a premarket approval (&#8220;PMA&#8221;), and does not usually require pre-clinical or clinical studies. As a result, iFuse-TORQ and iFuse Bedrock Granite have been launched prior to gathering substantial prospective clinical trial evidence, and our post-market clinical studies may lack the size and scope of randomized controlled clinical trials required to support approval of a PMA. For these reasons, surgeons may be slow to adopt our products, third-party payors may be slow to provide coverage, and we may be subject to greater regulatory and product liability risks. Further, future patient studies or clinical experience may indicate that treatment with our products does not improve patient outcomes. Such results would slow the adoption of our products by surgeons, significantly reduce our ability to achieve expected sales, and could prevent us from achieving profitability. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Pricing pressure from our competitors, changes in third-party coverage and reimbursement, healthcare provider consolidation, payor consolidation and the presence of &#8220;physician-owned distributorships&#8221; may impact our ability to sell our product at prices necessary to support our current business strategies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If competitive forces drive down the prices we are able to charge for our product, our profit margins will shrink, which will adversely affect our ability to invest in and maintain and grow our market share. The sacroiliac joint fusion market has attracted numerous new companies and technologies. As a result of this increased competition, we believe there will be continuing increased pricing pressure, resulting in lower gross margins, with respect to our products.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Even to the extent our product and procedures using our product are currently covered and reimbursed by third-party private and public payors, adverse changes in coverage and reimbursement policies that affect our products, discounts, and number of implants used may also drive our prices and revenue down and harm our ability to market and sell our products.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Consolidation in the healthcare industry, including both third-party payors and healthcare providers, could lead to demands for price concessions or to the exclusion of some suppliers from certain of our markets, which could have an adverse effect on our business, results of operations, or financial condition. Because healthcare costs have risen significantly over the past several years, numerous initiatives and reforms initiated by legislators, regulators, and third-party payors to curb these costs have resulted in a consolidation trend in the healthcare industry to aggregate purchasing power. As the healthcare industry consolidates, competition to provide products and services to industry participants has become and will continue to become more intense. This in turn has resulted and will likely continue to result in greater pricing pressures and the exclusion of certain suppliers from important market segments as group purchasing organizations, independent delivery networks, and large single accounts continue to use their market power to consolidate purchasing decisions for hospitals. We expect that market demand, government regulation, third-party coverage, and reimbursement policies and societal pressures will continue to change the worldwide healthcare industry, resulting in further business consolidations and alliances among our customers, which may reduce competition, exert further downward pressure on the prices of our products, and adversely impact our business, results of operations, or financial condition. As we continue to expand into international markets, we will face similar risks relating to adverse changes in coverage and reimbursement procedures and policies in those markets. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Practice trends or other factors, including the COVID-19 pandemic, have caused and may continue to cause procedures to shift from the hospital environment to ambulatory surgical centers, or ASCs, where pressure on the prices of our products is generally more acute.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We anticipate that more outpatient eligible procedures will be performed in ASCs as a cost control measure within the healthcare system. This shift accelerated during the COVID-19 pandemic, and we expect it to continue because ASCs are generally a more economically favorable site of service, and surgeons performing the procedures sometimes have ownership interests in the ASC. Because ASC facility fee reimbursement is typically less than facility fee reimbursement for hospitals and due to surgeons&#8217; economic interest in ASCs, we typically experience more pressure on the pricing of our products by ASCs than by hospitals, and the average price for which we sell our products to ASCs is less than the average prices we charge to hospitals. In addition, some surgeons may choose to use fewer implants due to their interest in the profitability of the ASC. An accelerated shift of procedures using our products to ASCs could adversely impact the average selling prices of our products and our revenues could suffer as a result.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">   </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We operate in a very competitive business environment and if we are unable to compete successfully against our existing or potential competitors, our sales and operating results may be adversely affected.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our currently marketed products are, and any future products we commercialize will likely be, subject to intense competition. Our field is subject to rapid change and is highly sensitive to the introduction of new products or other market activities of industry participants. Our ability to compete successfully will depend on our ability to develop proprietary products that reach the market in a timely manner, receive adequate coverage and reimbursement from third-party payors, and are viewed as safer, less invasive, and more effective than alternatives available for similar purposes as demonstrated in peer-reviewed clinical publications. Because of the size of the potential market, other companies have dedicated, and likely will continue to dedicate, significant resources to developing competing products.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The number of competitors that we are aware of marketing sacroiliac joint fusion products in the United States has grown since 2008. Some of our current and potential competitors are major medical device companies that have substantially greater financial, technical, and marketing resources than we do, and they may succeed in developing products that would render our products obsolete or noncompetitive. In addition, many of these competitors have significantly longer operating history and more established reputations than we do. Some of these companies sell a broad suite of products that can be used together in the operating room in order to facilitate surgery, such as surgical imaging, navigation and robotic systems, or a large number of implants intended to treat different conditions affecting the spine and pelvis. The ability of these competitors to sell these products together or as part of larger purchasing arrangements may put us at a disadvantage. In addition, if these competitors use technology, contracts, or intellectual property measures to limit or eliminate the compatibility of their surgical imaging, navigation and robotic systems with our products, sales of our products could decline or fail to grow, which could adversely affect our business and results of operations. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the United States, we believe that our primary competitors marketing implantable devices currently are Globus Medical, Inc. and Medtronic plc. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our primary competitors in Europe are Globus Medical, Inc. and SIGNUS Medizintechnik GmbH. At any time, these or other industry participants may develop alternative treatments, products or procedures for the treatment of the sacroiliac joint that compete directly or indirectly with our products. They may also develop and patent processes or products earlier than we can, or obtain domestic and international regulatory clearances or approvals and CE Certificates of Conformity for competing products in the European Economic Area (&#8220;EEA&#8221;), more rapidly than we can, which could impair our ability to develop and commercialize similar processes or products. If alternative treatments are, or are perceived to be, superior to our products, sales of our products and our results of operations could be negatively affected.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:115%"> </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">New participants have increasingly entered the medical device industry. Many of these new competitors specialize in a specific product or focus on a particular market segment, making it more difficult for us to increase our overall market position. The frequent introduction by competitors of products that are or claim to be superior to our current or planned future products may make it difficult </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">to differentiate the benefits of our products over competing products. In addition, the entry of multiple new products and competitors may lead some of our competitors to employ pricing strategies that could adversely affect the pricing of our products and pricing in the market generally.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, a number of companies selling allograft implants for use by a variety of physicians have collectively become a much larger presence in our market. If customers view allograft implants and our products as interchangeable, we risk increased pricing pressure on our products. It is unclear how the creation of the Category III code for these procedures effective January 1, 2023, and the conversion of the Category III Code to a Category I Code effective January 1, 2024, will impact the market for these products and procedures. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As a result, without the timely introduction of new products and enhancements, our products may become obsolete over time. If we are unable to develop innovative new products, maintain competitive pricing, and offer products that surgeons and other physicians perceive to be as reliable as those of our competitors, our market share or product margins could decrease, thereby harming our business.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We are highly dependent on revenue from the sale of a single family of products focused on procedures, the goal of which is to stabilize and fuse the sacroiliac joint. Reliance on a single family of products and single family of procedures could negatively affect our results of operations and financial condition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Substantially all of our revenue comes from the sale of iFuse, iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite implants, and related tools and instruments. Therefore, we are dependent on widespread market adoption of iFuse and we will continue to be dependent on the success of this single product family for some time. There can be no assurance that iFuse will maintain a substantial degree of market acceptance among surgeons, patients or healthcare providers. Our failure to successfully grow the market for iFuse and increase our share within that market or any other event impeding our ability to sell iFuse, could adversely affect our results of operations, financial condition and continuing operations.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">If clinical experience with our iFuse Bedrock technique or our iFuse Bedrock Granite product does not result in positive outcomes for patients, or if clinical trials involving the use of iFuse Bedrock and/or iFuse Bedrock Granite fail to show meaningful patient benefit, sales of our iFuse, iFuse-3D, iFuse-TORQ, and/or iFuse Bedrock Granite implants could be adversely impacted.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In November 2018, we introduced our iFuse Bedrock technique, in which spine surgeons place iFuse triangular implants across the sacroiliac joint using a different surgical approach to treat sacroiliac joint dysfunction at the same time they are fusing multiple levels of the spine above and affixing those spinal fusion devices to the pelvis.  In April 2019, the FDA cleared promotion of iFuse Bedrock for a broader and more general purpose, to provide additional stability and immobilization of the sacroiliac joint in connection with a thoracolumbar fusion procedure. In May 2022, we introduced iFuse Bedrock Granite, an implant which fuses the sacroiliac joint and attaches to the rods placed in a multi-segment spinal fusion construct, and which is used in substantially similar procedures as the iFuse Bedrock technique. To date, clinical experience with the iFuse Bedrock technique and with iFuse Bedrock Granite is limited and we have yet to complete a clinical trial to evaluate the iFuse Bedrock technique or the iFuse Bedrock Granite implant. Surgeons do not know if the addition of sacroiliac fusion devices to the implants used to fuse multiple levels of the lumbar spine will result in patient benefit. If surgeons' clinical experience with our implants in these procedures is not positive, or if our clinical trials do not show meaningful benefits to the patients undergoing this procedure, sale of our iFuse implants for this indication could be adversely impacted, which could negatively affect our operations and financial condition.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">If we are unable to maintain our network of direct sales representatives, third-party sales agents, and resellers, we may not be able to generate anticipated sales.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of March 31, 2023, our U.S. sales force consisted of 87 territory sales managers and 67 clinical support specialists directly employed by us, and 126 third-party sales agents. As of March 31, 2023, our international sales force consisted of 12 sales representatives directly employed by us and a total of 31 third-party sales agents and resellers, which together have had sales in 39 countries through March 31, 2023. Our operating results are directly dependent upon the sales and marketing efforts of both our direct sales force and of our third-party sales agents and resellers.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As we launch new products and increase our marketing efforts with respect to existing products, we will need to expand the reach of our marketing and sales networks. Our future success will depend largely on our ability to continue to hire, train, retain and motivate skilled direct sales representatives and third-party sales agents and resellers with significant technical knowledge in various areas, such as spine and pelvic health and treatment. New hires require training and take time to achieve full productivity. If we fail to train new hires adequately, or if we experience high turnover in our sales force in the future, we cannot be certain that new hires will become as productive as may be necessary to maintain or increase our sales. If a direct sales representative or third-party sales agent or reseller departs and is retained by one of our competitors, we may be unable to prevent them from helping competitors solicit business from our existing customers, which could further adversely affect our sales. The launch of new products or entrance into new markets could distract our sales representatives from existing customers and markets and redirect resources from existing to novel markets. Furthermore, any such change affects our ability to hire, contract with and retain members of our direct sales force and third-party </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">sales agents and resellers. Because of the intense competition for their services, we may be unable to recruit or retain additional qualified third-party sales agents and resellers or to hire additional direct sales representatives to work with us. Furthermore, we may not be able to enter into agreements with them on favorable or commercially reasonable terms, if at all. Failure to hire or retain qualified direct sales representatives or third-party sales agents and resellers would prevent us from expanding our business and generating sales. If our direct sales representatives or third-party sales agents and resellers fail to adequately promote, market and sell our products or decide to leave or cease to do business with us, our sales could significantly decrease.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If we are unable to expand our sales and marketing capabilities domestically and internationally, we may not be able to effectively commercialize our products, which would adversely affect our business, results of operations and financial condition.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Our business could suffer if we lose the services of key members of our senior management, key advisors or personnel.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We are dependent upon the continued services of key members of our senior management and a limited number of key advisors and personnel. The loss of members of our senior management team, key advisors or personnel, or our inability to attract or retain other qualified personnel or advisors, could have a material adverse effect on our business, results of operations, and financial condition. We do not maintain &#8220;key person&#8221; insurance for any of our executives or employees. In addition, several of the members of our executive management team are not subject to non-competition agreements that restrict their ability to compete with us. Accordingly, the adverse effect resulting from the loss of certain executives could be compounded by our inability to prevent them from competing with us.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our business is highly reliant on a base of skilled employees, including those serving in engineering, information technology, operational, strategic marketing and sales functions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Many of these employees have developed specialized skills which are valuable within the medical device and life sciences industry, and, in some cases, in a broader variety of industries.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Competition for skilled employees is significant, and some of the labor markets we compete in have experienced tightening in the past year.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, rates of employee turnover have increased among our employees, consistent with the rates experienced by other companies in these industries.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If these conditions persist, we could experience further turnover among our employees which could become difficult and more costly to manage, adversely impacting our results of operation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Sustained pressure in these labor markets could also cause prevailing wages to rise, which could adversely impact our business, results of operation and financial condition.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:115%"> </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">If use of our products results in adverse events, this may require them to be taken off the market, require them to include safety warnings or otherwise limit their sales.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Unforeseen adverse events related to our products could arise either during clinical development or, if cleared, approved, or subject to CE Certificate of Conformity, after the product has been marketed. In clinical research, the most common adverse event related to our implant was leg pain resulting from misplacement. The most common adverse event for our implant procedure has been minor wound infections. Additional adverse effects from iFuse or any of our other products could arise either during clinical development or, if approved, cleared, or subject to CE Certificate of Conformity, after the product has been marketed.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If we or others later identify adverse events caused by our products:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;sales of the product may decrease significantly, and we may not achieve the anticipated market share;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;regulatory authorities or our Notified Body may require changes to the labeling of our product. This may include the addition of labeling statements, specific warnings, and contraindications and issuing field alerts to physicians and patients;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;we may be required to change instructions regarding the way the product is implanted or conduct additional clinical trials;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;we may be subject to limitations on how we may promote the product;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;regulatory authorities may require us to temporarily or permanently take our approved product off the market or to conduct other field safety corrective actions;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;we may be required to modify our product;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;we may be subject to litigation fines or product liability claims; and</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;our reputation may suffer.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Any of these events could prevent us from achieving or maintaining market acceptance of the affected product or could substantially increase commercialization costs and expenses, which in turn could delay or prevent us from generating significant revenue from the sale of our products.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Unfavorable media reports or other negative publicity concerning both alleged improper methods of tissue recovery from donors and disease transmission from donated tissue could limit widespread acceptance of some of our products.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We introduced iFuse Bone, an implantable bone product manufactured from sterilized recovered cadaveric bone tissue, to meet the demand of some of our surgeon customers to use implantable bone products to support and augment the patient's own bone tissue in orthopedic procedures. Unfavorable reports of improper or illegal tissue recovery practices, both in the United States and internationally, as well as incidents of improperly processed tissue leading to the transmission of disease, may affect the rate of future tissue donation and market acceptance of technologies incorporating human tissue. In addition, negative publicity could cause the families of potential donors to become reluctant to donate tissue to for-profit tissue processors. These reports could have a negative effect on sales of iFuse Bone.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Various factors outside our direct control may adversely affect manufacturing, sterilization, and distribution of our products.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The manufacture, sterilization, and distribution of our products is challenging. Changes that our suppliers may make outside the purview of our direct control can have an impact on our processes, quality of our products, and the successful delivery of products to our customers. Mistakes and mishandling are not uncommon and can affect supply and delivery. Some of these risks include:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;failure to complete sterilization on time or in compliance with the required regulatory standards;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;transportation and import and export risk;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;delays in analytical results or failure of analytical techniques that we depend on for quality control and release of products;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;large-scale epidemics of communicable diseases such as COVID-19;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;supply chain disruptions, including those caused by material and labor supply shortages in the wake of COVID-19;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;natural disasters, labor disputes, financial distress, raw material availability, issues with facilities and equipment, or other forms of disruption to business operations affecting our manufacturers or suppliers; and</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;latent defects that may become apparent after products have been released and that may result in a recall or field safety corrective action with respect to such products.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If any of these risks were to materialize, our ability to provide our products to customers on a timely basis could be adversely impacted.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:115%">&#160;</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We are dependent on a limited number of third-party suppliers, some of them single-source and some of them in single locations, for most of our products and components, and the loss of any of these suppliers, or their inability to provide us with an adequate supply of materials in a timely and cost-effective manner, could materially adversely affect our business.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We rely on third-party suppliers to manufacture and supply substantially all of our products. For us to be successful, our suppliers must be able to provide us with products and components in substantial quantities, in compliance with regulatory requirements, in accordance with agreed upon specifications, at acceptable prices, and on a timely basis. We do not have long-term supply contracts for some of our suppliers, and in some cases, even where we do have agreements in place, we purchase important parts of the iFuse Implant System, including our implants, from a single supplier. Therefore, we cannot assure investors that we will be able to obtain sufficient quantities of product in the future.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, future growth could strain the ability of our suppliers to deliver products, materials, and components. Suppliers often experience difficulties in scaling up production, including financial issues, or problems with production yields and quality control and assurance. For example, from time to time, we have experienced certain delays and may experience delays from our suppliers in the future.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We generally use a small number of suppliers for our instruments and currently rely on RMS for iFuse-3D implants and Orchid for iFuse implants. Our dependence on such a limited number of suppliers exposes us to risks, including, among other things:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;third-party contract manufacturers or suppliers may fail to comply with regulatory requirements or make errors in manufacturing that could negatively affect the safety or effectiveness of our products or cause delays in shipments of our products;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;third-party contract manufacturers or suppliers may fail to maintain good manufacturing practices, leading to quality control problems or regulatory findings that could cause disruptions in their manufacturing processes and lead to delays in shipments of our products;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;we or our third-party manufacturers and suppliers may not be able to respond to unanticipated changes in customer orders, and if orders do not match forecasts, we or our suppliers may have excess or inadequate inventory of materials and components;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;we or our third-party manufacturers and suppliers may be subject to price fluctuations due to a lack of long-term supply arrangements for key components;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;we or our third-party manufacturers and suppliers may lose access to critical services, raw materials and components, or experience significant delays in obtaining them, resulting in an interruption in the manufacture, assembly and shipment of our systems;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;we or our third-party manufacturers could experience plant closures due to local epidemics of communicable diseases, such as COVID-19, or local outbreaks of such diseases among their workforce, thereby shuttering a plant in which our products are manufactured;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;we may experience delays in delivery by our third-party manufacturers and suppliers due to changes in demand from us or their other customers;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;fluctuations in demand for products that our third-party manufacturers and suppliers manufacture for others may affect their ability or willingness to deliver components to us in a timely manner;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;our third-party manufacturers and suppliers may wish to discontinue supplying components or services to us for risk management reasons;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;we may not be able to find new or alternative components or reconfigure our system and manufacturing processes in a timely manner if the necessary components become unavailable; and</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;our third-party manufacturers and suppliers may encounter financial hardships unrelated to our demand, which could inhibit their ability to fulfill our orders and meet our requirements.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If any one or more of these risks materialize, it could significantly increase our costs and impact our ability to meet demand for our products and to launch new products. If we are unable to satisfy commercial demand for our system in a timely manner, our ability to generate revenue would be impaired, market acceptance of our products could be adversely affected, and customers may instead purchase or use our competitors&#8217; products. Additionally, we could be forced to seek alternative sources of supply.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:115%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, most of our supply and manufacturing agreements do not have minimum manufacturing or purchase obligations. As such, with many of our suppliers, we have no obligation to buy any given quantity of products, and the suppliers have no obligation to sell us or to manufacture for us any given quantity of components or products. As a result, our ability to purchase adequate quantities of components or our products may be limited and we may not be able to convince suppliers to make components and products available to us in some instances. Our suppliers may also encounter problems that limit their ability to supply components or manufacture products for us, including financial difficulties, damage to their manufacturing equipment or facilities, product discontinuations or adverse findings in quality audits. As a result, there is a risk that certain components could be discontinued and no longer available to us. We may be required to make significant &#8220;last time&#8221; purchases of component inventory that is being discontinued by the supplier to ensure supply continuity. If we fail to obtain sufficient quantities of high quality components to meet demand for our products in a timely manner or on terms acceptable to us, we would have to seek alternative sources of supply. Securing a replacement third-party manufacturer or supplier could be difficult. The introduction of new or alternative manufacturers or suppliers also may require design changes to our iFuse system that are subject to domestic and international regulatory clearances or approvals and the review of our Notified Body.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Because of the nature of our internal quality control requirements, regulatory requirements, and the custom and proprietary nature of the parts, we may not be able to quickly engage additional or replacement suppliers for many of our critical components. We may also be required to assess any potential new manufacturer&#8217;s compliance with all applicable regulations and guidelines, which could further impede our ability to manufacture our products in a timely manner. As a result, we could incur increased production costs, experience delays in deliveries of our products, suffer damage to our reputation, and experience an adverse effect on our business and financial results. Failure of any of our third-party suppliers to meet our product demand level would limit our ability to meet our sales commitments to our customers and could have a material adverse effect on our business.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We may also have difficulty obtaining similar components from other suppliers that are acceptable to the FDA, our Notified Body and the competent authorities in the countries of the EEA, or other foreign regulatory authorities, and the failure of our suppliers to comply with strictly enforced regulatory requirements could expose us to delays in obtaining clearances or approvals, regulatory action including warning letters, product recalls, termination of distribution, product seizures, civil, administrative, or criminal penalties and the suspension, variation, or withdrawal of our CE Certificates of Conformity. We could incur delays while we locate and engage qualified alternative suppliers, and we may be unable to engage alternative suppliers on favorable terms or at all. Any such disruption or increased expenses could harm our commercialization efforts and adversely affect our ability to generate sales.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, each of our third-party suppliers operates at a facility in a single location and substantially all of our inventory of component supplies and finished goods is held at these locations. A local outbreak of COVID-19 cases, vandalism, terrorism, or a natural or other disaster, such as an earthquake, fire, or flood, could damage or destroy equipment or our inventory of component supplies or finished products, cause substantial delays in our operations, result in the loss of key information, and cause us to incur additional expenses. Our insurance may not cover our losses in any particular case. In addition, regardless of the level of insurance coverage, damage to our or our suppliers&#8217; facilities could harm our business, financial condition, and operating results.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We may encounter problems or delays in the assembly of our products or fail to meet certain regulatory requirements which could result in an adverse effect on our business and financial results.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">To become profitable we must assemble our products in adequate quantities in compliance with regulatory requirements and at an acceptable cost. Increasing our capacity to assemble and test our products will require us to improve internal efficiencies. We may encounter a number of difficulties in increasing our assembly and testing capacity, including:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;managing production yields;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:115%">&#160;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;maintaining quality control and assurance;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;providing component and service availability;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;maintaining adequate control policies and procedures;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;hiring and retaining qualified personnel; and</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;complying with state, federal, and foreign regulations.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If we are unable to satisfy commercial demand for our products due to our inability to assemble and test, our ability to generate revenue would be impaired, market acceptance of our products could be adversely affected and customers may instead purchase or use our competitors&#8217; products.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">If we do not enhance and broaden our product offerings through our research and development efforts, we may be unable to compete effectively.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In order to increase our market share in the sacroiliac joint fusion and related markets, we must enhance and broaden our product offerings in response to customer demands and competitive pressures and technologies. We might not be able to successfully develop, obtain domestic and international regulatory clearances or approvals, or CE Certificates of Conformity for, or market new products, and our future products might not be accepted by the surgeons or the third-party payors who reimburse for many of the procedures performed with our products. The success of any new product offering or enhancement to an existing product will depend on numerous factors, including our ability to:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;properly identify and anticipate surgeon and patient needs;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;develop and introduce new products or product enhancements in a timely manner;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;create sufficient product differentiation to expand overall market share and minimize cannibalization of existing product markets;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;adequately protect our intellectual property and avoid infringing upon the intellectual property rights of third parties;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;demonstrate the safety and effectiveness of new products; and</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;obtain the necessary domestic and international regulatory clearances or approvals and CE Certificates of Conformity for new products or product enhancements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If we do not develop and obtain domestic and international regulatory clearances or approvals and CE Certificates of Conformity for new products or product enhancements in time to meet market demand, or if there is insufficient demand for these products or enhancements, our business could be adversely affected. Our research and development efforts may require a substantial investment of time and resources before we are adequately able to determine the commercial viability of a new product, technology, material, or other innovation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In some cases, following a successful product development effort, we may need to invest substantial resources in surgical instrumentation and implant inventory, prior to launch of the product, and before we understand the demand for such product.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If we overestimate the demand for such products and invest too heavily in inventory to support the product line, the additional revenue and product margins may not produce a positive return on such investments, which could cause our financial results to suffer. In addition, even if we are able to successfully develop enhancements or new generations of our products, these enhancements or new generations of products may not produce sales in excess of the costs of development and they may be quickly rendered obsolete by changing customer preferences or the introduction by our competitors of products embodying new technologies or features.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We are required to maintain adequate levels of inventory, the failure of which could consume our resources and reduce our cash flows.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As a result of the need to maintain adequate levels of inventory, we are subject to the risk of inventory obsolescence. Many of our products come in sets, which feature components in a variety of sizes so that the implant or device may be chosen for size based on the patient&#8217;s needs. In order to market our products effectively, we often maintain and provide surgeons and hospitals with back-up products and products of different sizes. For each surgery, fewer than all of the components of the set are used, and therefore certain portions of the set may become obsolete before they can be used. In addition, as we introduce new implants and instruments with the same intended uses as existing products, the older products may fall out of favor with our customers, causing them to become obsolete. In the event that a substantial portion of our inventory becomes obsolete, it could have a material adverse effect on our earnings and cash flows due to the resulting costs associated with the inventory impairment charges and costs required to replace such inventory.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">The size and future growth in the market for minimally invasive sacroiliac fusion performed with a lateral approach, such as the iFuse procedure, has not been established with precision and may be smaller than we estimate, possibly materially. In addition, we estimate cost savings to the economy and healthcare system as a result of the iFuse procedure based on our market research. If our estimates and projections overestimate the size of this market or these benefits and cost savings, our sales growth may be adversely affected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We are not aware of an independent third-party study that reliably reports the potential market size for minimally invasive sacroiliac fusion performed using a lateral approach or cost savings as a result of the procedure. Therefore, our estimates of the size and potential for future growth in the market for our iFuse products, cost savings to patients, the healthcare system and the economy overall from its use, and the number of people currently suffering from lower back pain who may benefit from and be amenable to our iFuse procedure, is based on a number of internal and third-party studies, surveys, reports, and estimates. While we believe these factors have historically provided and may continue to provide us with effective tools in estimating the total market for our iFuse products and procedures and health cost savings, these estimates may not be correct and the conditions supporting our estimates may change at any time, thereby reducing the predictive accuracy of these underlying factors. The actual incidence of lower back pain, and the actual demand for our products or competitive products, could differ materially from our projections if our assumptions and estimates are incorrect. As a result, our estimates of the size and future growth in the market for our iFuse products may prove to be incorrect. In addition, actual health cost savings to the healthcare system as a result of the iFuse procedure may materially differ from those we expect. If the actual number of people with lower back pain who would benefit from our iFuse products and the size and future growth in the market for iFuse products and related costs savings to the healthcare system is smaller than we have estimated, it may impair our sales growth and have an adverse impact on our business.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Our results of operations could suffer if we are unable to manage our international business effectively.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Expansion into international markets is an element of our business strategy and involves risk. The sale and shipment of our products across international borders, as well as the purchase of components and products from international sources, subject us to extensive U.S. and foreign governmental trade, import, and export and customs regulations and laws. Compliance with these regulations and laws is costly and exposes us to penalties for non-compliance. Other laws and regulations that can significantly affect us include various anti-bribery laws, including the U.S. Foreign Corrupt Practices Act (&#8220;FCPA&#8221;), and the United Kingdom Bribery Act (&#8220;UKBA&#8221;), anti-boycott laws, anti-money laundering laws, and regulations relating to economic sanctions imposed by the U.S., including the Office of Foreign Asset Control of the U.S. Treasury. Any failure to comply with applicable legal and regulatory obligations in the U.S. or abroad could adversely affect us in a variety of ways that include, but are not limited to, significant criminal, civil and administrative penalties, including imprisonment of individuals, fines and penalties, denial of export privileges, seizure of shipments and restrictions on certain business activities. Also, the failure to comply with applicable legal and regulatory obligations could result in the disruption of our distribution and sales activities.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, some of the countries in which we sell or plan to sell our products are, to some degree, subject to various risks, including:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;exposure to different legal and regulatory standards;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;lack of stringent protection of intellectual property;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;inability of the local healthcare system to absorb prices for our product that would enable our business to become profitable in those markets;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;obstacles to obtaining domestic and foreign export, import, and other governmental approvals, permits, and licenses and compliance with foreign laws;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">lower average selling prices of our implants in most foreign markets;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">reliance on a more concentrated surgeon base in international markets due to the surgeon acquisition costs relative to the selling price of our implants;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;potentially adverse tax consequences and the complexities of foreign value-added tax systems;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;adverse changes in tariffs and trade restrictions;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:115%">&#160;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;limitations on the repatriation of earnings;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;difficulties in staffing and managing foreign operations;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;insufficient numbers of patients requiring procedures that use our products;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;transportation delays and difficulties of managing international distribution channels;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;longer collection periods and difficulties in collecting receivables from foreign entities;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;increased financing costs;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;currency risks; and</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;political, social, and economic instability and increased security concerns.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">These risks may limit or disrupt our expansion, restrict the movement of funds or result in the deprivation of contractual rights or the taking of property by nationalization or expropriation without fair compensation.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our successful conduct of our international business depends, in part, on our ability to develop and implement policies and strategies that are effective in anticipating and managing these and other risks in the countries in which we plan to do business. Failure to manage these and other risks may have a material adverse effect on our operations in any particular country and on our business as a whole.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">In the future our products may become obsolete, which would negatively affect operations and financial condition.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The medical device industry is characterized by rapid and significant change. There can be no assurance that other companies will not succeed in developing or marketing devices, and products that are more effective than our iFuse system or that would render the iFuse system obsolete or noncompetitive. Additionally, new surgical procedures, medications and other therapies could be developed that replace or reduce the importance of our product. Accordingly, our success will depend in part on our ability to respond quickly to changes in technology and the practice of medicine through the development and introduction of new products. Product development involves a high degree of risk and there can be no assurance that our new product development efforts will result in any commercially successful products.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">If we experience significant disruptions in our information technology systems, our business, results of operations, and financial condition could be adversely affected.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The efficient operation of our business depends on our information technology systems. We rely on our information technology systems to effectively manage:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;sales and marketing, accounting, and financial functions;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;customer relationship management;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;inventory management;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;compliance and regulatory reporting requirements;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;engineering and product development tasks; and</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;our research and development data.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our information technology systems are vulnerable to damage or interruption from:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;earthquakes, fires, floods, and other natural disasters;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;terrorist attacks and attacks by computer viruses or hackers or internal or external breaches of our cybersecurity;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;power losses; and</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;computer systems, internet, telecommunications, or data network failures.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:115%">&#160;</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The failure of our information technology systems to perform as we anticipate or our failure to effectively implement new systems could disrupt our entire operation and could result in decreased sales, increased overhead costs, excess inventory and product shortages, and legal liability issues, all of which could have a material adverse effect on our reputation, business, results of operations, and financial condition.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Like other public companies, we have in the past, and in the future, could be subject to instances of phishing attacks on our email systems, other cyber-attacks, industrial espionage, insider threats, computer denial-of-service attacks, computer viruses, ransomware and other malware, wire fraud or other cyber incidents. The techniques used to obtain unauthorized access, or to sabotage systems, are becoming more sophisticated, frequent and adaptive, and therefore we may be unable to anticipate these techniques or to implement adequate preventative measures. Any security breach could result in: the unauthorized publication of our confidential business or proprietary information; the unauthorized release of employee, customer or vendor data and payment information; a loss of confidence by our customers; damage to our reputation; a disruption to our business; litigation and legal liability; and a negative impact on our future sales. In addition, the cost and operational consequences of implementing further data protection or data restoration measures could be significant.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, we accept payments for many of our sales through credit card transactions, which are handled through third-party payment processors. As a result, we are subject to a number of risks related to credit card payments. As a result of these transactions, we pay interchange and other fees, which may increase over time and could require us to either increase the prices we charge for our products or experience an increase in our costs and expenses. In addition, as part of the payment processing process, we transmit our customers&#8217; credit card information to our third-party payment processor. We may in the future become subject to lawsuits or other proceedings for purportedly fraudulent transactions arising out of the actual or alleged theft of our customers&#8217; credit card information if the security of our third-party credit card payment processors are breached. We and our third-party credit card payment processors are also subject to payment card association operating rules, certification requirements and rules governing electronic funds transfers, which could change or be reinterpreted to make it difficult or impossible for us to comply. If we or our third-party credit card payment processors fail to comply with these rules or requirements, we may be subject to fines and higher transaction fees and lose our ability to accept credit card payments from our customers, and there may be an adverse impact on our business.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We may seek to grow our business through acquisitions of or investments in new or complementary businesses, products or technologies, and the failure to manage acquisitions or investments, or the failure to integrate them with our existing business, could have a material adverse effect on us.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">From time to time, we expect to consider opportunities to acquire or make investments in other technologies, products, and businesses that may enhance our capabilities, complement our current products, or expand the breadth of our markets or customer base. Potential and completed acquisitions and strategic investments involve numerous risks, including:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;problems assimilating the purchased technologies, products, or business operations;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;issues maintaining uniform standards, procedures, controls, and policies;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;unanticipated costs and liabilities associated with acquisitions;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;diversion of management&#8217;s attention from our core business;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;adverse effects on existing business relationships with suppliers and customers;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;risks associated with entering new markets in which we have limited or no experience;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;potential loss of key employees of acquired businesses; and</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;increased legal and accounting compliance costs.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have no current commitments with respect to any acquisition or investment. We do not know if we will be able to identify acquisitions we deem suitable, whether we will be able to successfully complete any such acquisitions on favorable terms or at all, or whether we will be able to successfully integrate any acquired business, product, or technology into our business or retain any key personnel, suppliers, or third-party sales agents and resellers. Our ability to successfully grow through acquisitions depends upon our ability to identify, negotiate, complete, and integrate suitable target businesses and to obtain any necessary financing. These efforts could be expensive and time consuming, and may disrupt our ongoing business and prevent management from focusing on our operations. If we are unable to successfully integrate any acquired businesses, products, or technologies effectively, our business, results of operations, and financial condition will be materially adversely affected.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:115%"> </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We may enter into collaborations, in-licensing arrangements, joint ventures, strategic alliances, or partnerships with third-parties that may not result in the development of commercially viable products or the generation of significant future revenue.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the ordinary course of our business, we may enter into collaborations, in-licensing arrangements, joint ventures, strategic alliances, partnerships, or other arrangements to develop products and to pursue new markets. Proposing, negotiating, and implementing collaborations, in-licensing arrangements, joint ventures, strategic alliances, or partnerships may be a lengthy and complex process. Other companies, including those with substantially greater financial, marketing, sales, technology, or other business resources, may compete with us for these opportunities or arrangements. We may not identify, secure, or complete any such transactions or arrangements in a timely manner, on a cost-effective basis, on acceptable terms or at all. We have limited institutional knowledge and experience with respect to these business development activities, and we may also not realize the anticipated benefits of any such transaction or arrangement. In particular, these collaborations may not result in the development of products that achieve commercial success or result in significant revenue and could be terminated prior to developing any products.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Additionally, we may not be in a position to exercise sole decision-making authority regarding the transaction or arrangement, which could create the potential risk of creating impasses on decisions, and our future collaborators may have economic or business interests or goals that are, or that may become, inconsistent with our business interests or goals. It is possible that conflicts may arise with our collaborators, such as conflicts concerning the achievement of performance milestones, or the interpretation of significant terms under any agreement, such as those related to financial obligations or the ownership or control of intellectual property developed during the collaboration. If any conflicts arise with any collaborators, they may act in their self-interest, which may be adverse to our best interest, and they may breach their obligations to us. In addition, we may have limited control over the amount and timing of resources that any future collaborators devote to our or their future products.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Disputes between us and our collaborators may result in litigation or arbitration which would increase our expenses and divert the attention of our management. Further, these transactions and arrangements will be contractual in nature and will generally be terminable under the terms of the applicable agreements and, in such event, we may not continue to have rights to the products relating to such transaction or arrangement or may need to purchase such rights at a premium. If we enter into in-bound intellectual property license agreements, we may not be able to fully protect the licensed intellectual property rights or maintain those licenses. Future licensors could retain the right to prosecute and defend the intellectual property rights licensed to us, in which case we would depend on the ability of our licensors to obtain, maintain and enforce intellectual property protection for the licensed intellectual property. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">These licensors may determine not to pursue litigation against other companies or may pursue such litigation less aggressively than we would. Further, entering into such license agreements could impose various diligence, commercialization, royalty, or other obligations on us. Future licensors may allege that we have breached our license agreement with them, and accordingly seek to terminate our license, which could adversely affect our competitive business position and harm our business prospects.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Risks Related to Our Legal and Regulatory Environment</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We, our suppliers, and our third-party manufacturers are subject to extensive governmental regulation both in the U.S. and abroad, and failure to comply with applicable requirements could cause our business to suffer.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The medical device industry is regulated extensively by governmental authorities, principally the FDA and corresponding state and foreign regulatory agencies. The FDA and other U.S. and foreign governmental agencies regulate, among other things, with respect to medical devices:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;design, development, and manufacturing;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;testing, labeling, content, and language of instructions for use and storage;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:115%">&#160;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;clinical trials;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;product safety;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;marketing, sales, and distribution;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;premarket clearance and approval;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;conformity assessment procedures;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;record keeping procedures;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;advertising and promotion;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;compliance with good manufacturing practices requirements;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;recalls and field safety corrective actions;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;post-market surveillance, including reporting of deaths or serious injuries and malfunctions that, if they were to recur, could lead to death or serious injury;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;post-market approval studies; and</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;product import and export.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The regulations to which we are subject are complex and have tended to become more stringent over time. Regulatory changes could result in restrictions on our ability to carry on or expand our operations, difficulties achieving new product clearances, higher than anticipated costs or lower than anticipated sales.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Before we can market or sell a new regulated product or make a significant modification to an existing product in the U.S., with limited exceptions, we must obtain either clearance under Section&#160;510(k) of the FDCA for Class&#160;II devices or approval of a PMA application from the FDA for a Class&#160;III device. In the 510(k) clearance process, the FDA must determine that a proposed device is &#8220;substantially equivalent&#8221; to a device legally on the market, known as a &#8220;predicate&#8221; device, with respect to intended use, technology, and safety and effectiveness, in order to clear the proposed device for marketing. Clinical data is sometimes required to support substantial equivalence. The PMA pathway requires an applicant to demonstrate the safety and effectiveness of the device based, in part, on extensive data, including, but not limited to, technical, pre-clinical, clinical trial, manufacturing, and labeling data. The PMA process is typically required for devices that are deemed to pose the greatest risk, such as life-sustaining, life-supporting, or implantable devices. Products that are approved through a PMA application generally need FDA approval before they can be modified. Similarly, some modifications made to products cleared through a 510(k) may require a new 510(k). Both the 510(k) and PMA processes can be expensive and lengthy and require the payment of significant fees, unless exempt. The FDA&#8217;s 510(k) clearance process usually takes from three to 12 months, but may last longer. The process of obtaining a PMA is much more costly and uncertain than the 510(k) clearance process and generally takes from one to three years, or even longer, from the time the application is submitted to the FDA until an approval is obtained. The process of obtaining domestic and international regulatory clearances or approvals to market a medical device can be costly and time consuming, and we may not be able to obtain these clearances or approvals on a timely basis, if at all.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the U.S., our currently commercialized products have either received premarket clearance under Section&#160;510(k) of the FDCA or are exempt from premarket review. If the FDA requires us to go through a lengthier, more rigorous examination for future products or modifications to existing products than we expect, our product introductions or modifications could be delayed or canceled, which could cause our sales to decline. In addition, the FDA may determine that future products will require the more costly, lengthy, and uncertain PMA process. Although we do not currently market any devices under PMA, the FDA may demand that we obtain a PMA prior to marketing certain of our future products. In addition, if the FDA disagrees with our determination that a product we currently market is subject to an exemption from premarket review, the FDA may require us to submit a 510(k) or PMA in order to continue marketing the product. Further, even with respect to those future products where a PMA is not required, we cannot assure investors that we will be able to obtain the 510(k) clearances with respect to those products.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The FDA can delay, limit or deny clearance or approval of a device for many reasons, including:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;we may not be able to demonstrate to the FDA&#8217;s satisfaction that our products are safe and effective for their intended uses;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;the data from our pre-clinical studies and clinical trials may be insufficient to support clearance or approval, where required; and</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;the manufacturing process or facilities we use may not meet applicable requirements.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, the FDA may change its clearance and approval policies, adopt additional regulations or revise existing regulations, or take other actions which may prevent or delay clearance or approval of our products under development or impact our ability to modify our currently approved or cleared products on a timely basis.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Any delay in, or failure to receive or maintain, clearance or approval for our products under development could prevent us from generating revenue from these products or achieving profitability.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, even after we have obtained the proper regulatory clearance or approval to market a product, the FDA has the power to require us to conduct post-marketing studies. These studies can be very expensive and time consuming to conduct. Failure to comply with those studies in a timely manner could result in the revocation of the 510(k) clearance for a product that is subject to such a 522 Order and the recall or withdrawal of the product, which could prevent us from generating sales from that product in the U.S.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the EEA, a single regulatory approval process exists, and conformity with its requirements is required to affix a CE mark to our medical devices, without which they cannot be marketed or sold in the EEA.  To obtain a CE mark, defined products must meet minimum standards of performance, safety, and quality, and then, according to their classification, undergo a conformity assessment procedure. Except for low risk medical devices, a conformity assessment procedure requires the intervention of a third-party organization designated by the competent authorities of a EEA country, known as a Notified Body. The competent authorities of the E.U. countries separately regulate the clinical research for medical devices and the market surveillance of products once they are placed on the market. A new Medical Device Regulation was published by the E.U. in 2017 and became effective on May 26, 2021. Medical devices marketed in the EEA will require certification according to these new requirements, except that devices with valid CE certificates, issued pursuant to the Medical Device Directives before May 2020, can be placed on the market until May 2024. The new EU MDR includes significant additional premarket and post-market requirements. Penalties for regulatory non-compliance could be severe, including fines and revocation or suspension of a company&#8217;s business license, mandatory price reductions and criminal sanctions.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The FDA and other regulatory authorities, including foreign authorities, have broad enforcement powers. Regulatory enforcement or inquiries, or other increased scrutiny on us, could dissuade some surgeons from using our products and adversely affect our reputation and the perceived safety and effectiveness of our products.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Failure to comply with applicable regulations could jeopardize our ability to sell our products and result in enforcement actions such as:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;warning letters;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;fines;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;injunctions;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;civil penalties;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;termination of distribution;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;recalls or seizures of products;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;delays in the introduction of products into the market;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;total or partial suspension of production;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;facility closures;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;refusal of the FDA or our Notified Body or other regulator to grant future clearances or approvals or to issue CE Certificates of Conformity;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;withdrawals, variation, or suspensions of current clearances or approvals and CE Certificates of Conformity, resulting in prohibitions on sales of our products; and</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;in the most serious cases, criminal penalties.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Adverse action by an applicable regulatory agency, our Notified Body or the FDA could result in inability to produce our products in a cost-effective and timely manner, or at all, decreased sales, higher prices, lower margins, additional unplanned costs or actions, damage to our reputation, and could have material adverse effect on our reputation, business, results of operations, and financial condition. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We and our sales representatives must comply with U.S. federal and state fraud and abuse laws, including those relating to healthcare provider kickbacks and false claims for reimbursement, and other applicable federal and state healthcare laws, as well as equivalent foreign laws, and failure to comply could negatively affect our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Healthcare providers, third-party sales agents and resellers and third-party payors play a primary role in the distribution, recommendation, ordering, and purchasing of any implant or other medical device for which we have or obtain marketing clearance or approval. Through our arrangements with customers and third-party payors, we are exposed to the risk that our employees, independent contractors, principal investigators, consultants, vendors, or third-party sales agents and resellers may engage in fraudulent or other illegal activity. Misconduct by these parties could include, among other infractions or violations, intentional, reckless and/or negligent conduct or unauthorized activity that violates FDA regulations, manufacturing standards, federal and state healthcare fraud and abuse laws and regulations, laws that require the true, complete, and accurate reporting of financial information or data, other commercial or regulatory laws or requirements, and equivalent foreign rules. It is not always possible to identify and deter misconduct by our employees and other third parties, and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to comply with such laws or regulations, and government authorities may conclude that our business practices do not comply with applicable fraud and abuse or other healthcare laws and regulations or guidance despite our good faith efforts to comply.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are numerous U.S. federal and state laws pertaining to healthcare fraud and abuse, including anti-kickback and false claims laws. Our relationships and our third-party sales agents and resellers&#8217; relationships with surgeons, other healthcare professionals, and hospitals are subject to scrutiny under these laws. For example, we are subject to the federal health care Anti-Kickback Statute, the federal civil False Claims Act, the Health Insurance Portability and Accountability Act (&#8220;HIPAA&#8221;) and the </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">federal Physician Payment Sunshine Act, each of which is described in detail in Item 1 Business - Healthcare Fraud and Abuse&#8221; and &#8220;-Data Privacy and Security Laws&#8221; in our Annual Report on Form 10-K filed with the SEC on March 2, 2023.  </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Certain states and countries also have enacted analogous state and foreign law equivalents of each of the above federal laws and may also mandate implementation of corporate compliance programs, require compliance with the industry&#8217;s voluntary compliance guidelines, impose restrictions on device manufacturer marketing practices, and/or require tracking and reporting of gifts, compensation, and other remuneration to healthcare professionals and entities. Many of these state and foreign laws differ from each other in significant ways and may not have the same effect, thus complicating compliance efforts. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If we or our employees are found to have violated any of the above laws we may be subject to significant administrative, civil and criminal penalties, including imprisonment, exclusion from participation in federal healthcare programs, such as Medicare, Medicaid, and equivalent foreign programs, significant fines, monetary penalties and damages, imposition of compliance obligations and monitoring, the curtailment or restructuring of our operations, and damage to our reputation.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have entered into consulting agreements and royalty agreements with physicians and healthcare executives, including some who are customers. We also engage in co-marketing arrangements with certain surgeons who use our products. In addition, prior to our IPO, a small number of our current customer surgeons acquired from us less than 1.0% of our current outstanding common stock, which they either purchased in an arm&#8217;s length transaction on terms identical to those offered to others or received from us as fair market value consideration for consulting services performed. While all of these transactions were structured to comply with applicable laws, including the federal Anti-Kickback Statute, state anti-kickback laws and other applicable laws, it is possible that regulatory agencies may view these transactions as prohibited arrangements that must be restructured, or discontinued, or for which we could be subject to significant penalties and criminal, civil and administrative liability. We would be materially and adversely affected if regulatory agencies interpret our financial relationships with surgeons who order our products to be in violation of applicable laws and we were unable to comply with such laws, which could subject us to, among other things, monetary penalties for non-compliance, the cost of which could be substantial.</span></div><div style="text-align:justify;text-indent:25pt"><span><br/></span></div><div style="text-align:justify;text-indent:25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Various state and federal regulatory and enforcement agencies continue actively to investigate violations of health care laws and regulations, and the U.S. Congress continues to strengthen the arsenal of enforcement tools. To enforce compliance with the federal laws, the U.S. Department of Justice has continued its scrutiny of interactions between healthcare companies and healthcare providers, which has led to a number of investigations, prosecutions, convictions and settlements in the healthcare industry. Dealing with investigations can be time- and resource-consuming and can divert management&#8217;s attention from the business. Additionally, if a healthcare company settles an investigation with the Department of Justice or other law enforcement agencies, it may need to agree to additional onerous compliance and reporting requirements as part of a consent decree, deferred or non-prosecution agreement, or corporate integrity agreement. Any such investigation or settlement could increase our costs or otherwise have an adverse effect on our business. Even if we are not determined to have violated these laws, government investigations into these issues typically require the expenditure of significant resources and generate negative publicity, which could harm our financial condition and divert resources and the attention of our management from operating our business.</span></div><div style="text-align:justify;text-indent:25pt"><span><br/></span></div><div style="text-align:justify;text-indent:25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The scope and enforcement of these laws is uncertain and subject to rapid change. The shifting compliance environment and the need to build and maintain robust and expandable systems and processes to comply with different compliance and/or reporting requirements in multiple jurisdictions increase the possibility that we may run afoul of one or more of the requirements or that federal or state regulatory authorities might challenge our current or future activities under these laws. Additionally, we cannot predict the impact of any changes in these laws, whether or not retroactive.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:115%"> </span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Our failure to adequately protect personal information in compliance with evolving legal requirements could harm our business.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of our business, we collect and store sensitive data, including legally protected personally identifiable information. We collect this kind of information for billing, reimbursement support, marketing purposes, post-marketing safety vigilance, servicing potential warranty claims and during the course of clinical trials. In doing so, we are subject to various federal, state and foreign laws that protect the confidentiality of certain patient health information, including patient medical records, and restrict the use and disclosure of patient health information by healthcare providers, such as HIPAA in the U.S. and regulations in the European Union (&#8220;EU&#8221;), which are described in detail in Item 1 Business - Data Privacy and Security Laws&#8221; in our Annual Report on Form 10-K filed with the SEC on March 2, 2023.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The California Consumer Privacy Act, which became effective on January 1, 2020, as amended by the California Privacy Rights Act (&#8220;CCPA&#8221;), requires a broad range of businesses to honor the requests of California residents to access and require deletion of their personal information, opt out of certain personal information sharing, receive detailed information about how their personal information is used and shared, correct inaccurate personal information, and limit the use and disclosure of certain sensitive personal information. The CCPA provides for civil penalties of up to $7,500 for intentional violations, and a private right of action for data breaches that allows private plaintiffs to seek the greater of actual damages or statutory damages of up to $750 per consumer per data breach.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">These remedies are expected to increase data breach litigation. Although the CCPA includes exemptions for certain clinical trials data, and protected health information governed by HIPAA, the law may increase our compliance costs and potential liability </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">with respect to other personal information we collect about California residents. Our compliance costs and potential liability with respect to personal information may also increase in response to other states adopting and considering initiative regarding protection of personal information. In March 2021, Virginia passed the Consumer Data Protection Act (&#8220;CDPA&#8221;) which will take effect on January 1, 2023. Virginia is the second state to pass comprehensive privacy litigation. Colorado passed the Colorado Privacy Act (&#8220;CPA&#8221;) on July 7, 2021 with enforcement to begin on July 1, 2023. In 2022, both Utah and Connecticut also enacted comprehensive data privacy legislation. While these laws are similar in certain respects, the laws differ and compliance with one law does not equate to compliance with the other laws. Several other states (including Washington, New York, and Minnesota) also are considering comprehensive privacy legislation that could further complicate and increase the cost of complying with various state privacy laws. If states pass a patchwork of privacy laws, this also could increase pressure on the U.S. Congress to harmonize privacy laws through federal legislation.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have in the past, and could be in the future, subject to data breaches. Our failure to comply with applicable laws and regulations, or to protect such data, could result in enforcement actions against us, including fines, imprisonment of company officials and public censure, claims for damages by end-customers, and other affected individuals, and the imposition of integrity obligations and agency oversight, damage to our reputation, and loss of goodwill, any of which could harm our operations, financial performance, and business. Evolving and changing definitions of personal data and personal information, within the European Union, the U.S., and elsewhere, may limit or inhibit our ability to operate or expand our business, including limiting strategic partnerships that may involve the sharing of data. Moreover, if the relevant laws and regulations change, or are interpreted and applied in a manner that is inconsistent with our data practices or the operation of our products, or if we expand into new regions and are required to comply with new requirements, we may need to expend resources in order to change our business operations, data practices, or the manner in which our products operate. Even the perception of privacy concerns, whether or not valid, may harm our reputation and inhibit adoption of our products.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We are subject to risks associated with our non-U.S. operations.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The FCPA prohibits companies and their intermediaries from making improper payments to foreign officials for the purpose of obtaining or retaining business. Other anti-corruption or anti-bribery laws, such as the UKBA, prohibit companies and their intermediaries from making improper payments for the purpose of obtaining or retaining business in foreign countries. The FCPA also imposes accounting standards and requirements on publicly traded U.S. corporations and their foreign affiliates, which are intended to prevent the diversion of corporate funds to the payment of bribes and other improper payments, and to prevent the establishment of slush funds from which such improper payments can be made. Because of the predominance of government-sponsored healthcare systems around the world, many of our customer relationships outside of the U.S. are with governmental entities and are therefore subject to such anti-bribery laws. Our internal control policies and procedures may not always protect us from reckless or criminal acts committed by our employees or agents. Violations of these laws, or allegations of such violations, could disrupt our operations, involve significant management distraction, and result in a material adverse effect on our business, results of operations, and financial condition. We also could suffer severe penalties, including criminal and civil penalties, disgorgement, and other remedial measures, including further changes or enhancements to our procedures, policies, and controls, as well as potential personnel changes and disciplinary actions.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Furthermore, we are subject to anti-boycott laws, anti-money laundering laws, and the export controls and economic embargo rules and regulations of the U.S., including, but not limited to, the Export Administration Regulations and trade sanctions against embargoed countries, which are administered by the Office of Foreign Assets Control within the Department of the Treasury, as well as the laws and regulations administered by the Department of Commerce. These regulations limit our ability to market, sell, distribute, or otherwise transfer our products or technology to prohibited countries or persons. A determination that we have failed to comply, whether knowingly or inadvertently, may result in substantial penalties, including fines and enforcement actions and civil and/or criminal sanctions, the disgorgement of profits, and the imposition of a court-appointed monitor, as well as the denial of export privileges, and may have an adverse effect on our reputation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:115%"> </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Even if our products are approved by regulatory authorities or CE marked, if we, our contractors, or our suppliers fail to comply with ongoing FDA or other foreign regulatory requirements, or if we experience unanticipated problems with our products, these products could be subject to restrictions or withdrawal from the market.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For any product for which we obtain regulatory clearance or approval, or a CE Certificate of Conformity, the manufacturing processes, reporting requirements, post-approval clinical data, and promotional activities for such product will be subject to continued regulatory review, oversight and periodic inspections by the FDA, our Notified Body and other domestic and foreign regulatory bodies. In particular, we and our suppliers are required to comply with FDA&#8217;s Quality System Regulations (&#8220;QSR&#8221;) and International Standards Organization (&#8220;ISO&#8221;) regulations for the manufacture of our products and other regulations which cover the methods and documentation of the design, testing, production, control, quality assurance, labeling, packaging, storage, and shipping of any product for which we obtain regulatory clearance or approval, or a CE Certificate of Conformity.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The failure by us or one of our suppliers to comply with applicable statutes and regulations, or the failure to timely and adequately respond to any adverse inspectional observations or product safety issues, could result in, among other things, any of the following enforcement actions:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;untitled letters, warning letters, fines, injunctions, consent, and civil penalties;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;unanticipated expenditures to address or defend such actions;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;customer notifications for repair, replacement, refunds;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;recall, detention, or seizure of our products;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;operating restrictions or partial suspension or total shutdown of production;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;refusing or delaying our requests for 510(k) clearance or premarket approval and conformity assessments of new products or modified products;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;limitations on the intended uses for which the product may be marketed;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;operating restrictions;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;withdrawing 510(k) clearances or PMA approvals that have already been granted;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;suspension, variation or withdrawal of CE Certificates of Conformity;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;refusal to grant export approval for our products; and</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;criminal prosecution.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, we are required to conduct costly post-market testing and surveillance to monitor the safety or effectiveness of our products, and we must comply with medical device reporting requirements, including the reporting of adverse events and malfunctions related to our products. Later discovery of previously unknown problems with our products, including unanticipated adverse events or adverse events of unanticipated severity or frequency, manufacturing problems, or failure to comply with regulatory requirements such as QSR, may result in changes to labeling, restrictions on such products or manufacturing processes, withdrawal of the products from the market, voluntary or mandatory recalls, a requirement to repair, replace, or refund the cost of any medical device we manufacture or distribute, fines, suspension, variation, or withdrawal of regulatory approvals or CE Certificates of Conformity, product seizures, injunctions, or the imposition of civil, administrative, or criminal penalties which would adversely affect our business, operating results, and prospects.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If the FDA determines that our promotional materials, labeling, training or other marketing or educational activities constitute promotion of an unapproved use, it could request that we cease or modify our training or promotional materials or subject us to regulatory enforcement actions. It is also possible that other federal, state or foreign enforcement authorities might take action if they consider our training or other promotional materials to constitute promotion of an unapproved use, which could result in significant fines or penalties under other statutory authorities, such as laws prohibiting false or fraudulent claims for payment of government funds. Any of these actions would harm our reputation and cause our product sales and profitability to suffer and may prevent us from generating revenue.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Our employees, independent contractors, consultants, manufacturers, and third-party sales agents and resellers may engage in misconduct or other improper activities, relating to regulatory standards and requirements. </span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We are exposed to the risk that our employees, independent contractors, consultants, manufacturers, third-party sales agents and resellers may engage in fraudulent conduct or other illegal activity. Misconduct by these parties could include intentional, reckless and/or negligent conduct that violates applicable laws and regulations, such as FDA reporting requirements, manufacturing standards, federal, state and foreign healthcare laws and regulations, data privacy laws and laws that require the true, complete and accurate reporting of financial information or data. These laws and regulations may restrict or prohibit a wide range of pricing, discounting, marketing and promotion, sales commission, customer incentive programs, and other business arrangements. Misconduct by these parties could also involve the improper use of individually identifiable information which could result in regulatory sanctions and serious harm to our reputation. It is not always possible to identify and deter misconduct, and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to be in compliance with such laws or regulations. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business, including the imposition of significant civil, criminal, and administrative penalties, including, without limitation, damages, fines, disgorgement of profits, imprisonment, exclusion from participation in government healthcare programs, such as Medicare and Medicaid, and the curtailment or restructuring of our operations.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We may be subject to enforcement action, including fines, penalties or injunctions, if we are determined to be engaging in the off-label promotion of our products.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our promotional materials and training methods must comply with FDA and other applicable national and foreign laws and regulations, including the prohibition of the promotion of off-label use. Physicians may use our products off-label, as the FDA and equivalent third country authorities do not restrict or regulate a physician&#8217;s choice of treatment within the practice of medicine. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We believe that the specific surgical procedures for which our products are marketed fall within the scope of the surgical applications that have been cleared by the FDA and our notified body. However, if the FDA or an equivalent third country authority determines that our promotional materials or training constitutes promotion of an off-label use, it could request that we modify our training or promotional materials, require us to stop promoting our products for those specific procedures until we obtain FDA or third country authority clearance or approval for them, or subject us to regulatory or enforcement actions, including the issuance of an untitled letter, a warning letter, injunction, seizure, civil fines, and criminal penalties. It is also possible that other federal, state or foreign enforcement authorities might take action if they consider our promotional or training materials to constitute promotion of an unapproved use, which could result in significant fines or penalties under other statutory authorities, such as laws prohibiting false or fraudulent claims for payment of government fund. In that event, our reputation could be damaged and adoption of the products would be impaired. Although our policy is to refrain from statements that could be considered off-label promotion of our products, the FDA or another regulatory agency could disagree and conclude that we have engaged in off-label promotion. In addition, the off-label use of our products may increase the risk of injury to patients, and, in turn, the risk of product liability claims. Product liability claims are expensive to defend and could divert our management&#8217;s attention, result in substantial damage awards against us and harm our reputation.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We are required to report certain malfunctions, deaths, and serious injuries associated with our products, which can result in voluntary corrective actions or agency enforcement actions.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Under the FDA&#8217;s medical device reporting, regulations, and equivalent rules of other countries we are required to report to the FDA or a similar authority in such other country, any information that our product may have caused or contributed to a death or serious injury or in which our product malfunctioned and, if the malfunction were to recur, would likely cause or contribute to death or serious injury. In the EEA, we must report serious incidents and field safety corrective actions through the Commission&#8217;s electronic system on vigilance and post-market surveillance, which reports are transmitted to the competent authority of the Member State in which the incident occurred. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If we fail to report these events to the FDA or applicable authority in another country within the required timeframes, or at all, FDA, or the applicable authority in the other country could take enforcement action against us. Any such adverse event involving our products or repeated product malfunctions may result in voluntary or involuntary corrective actions, such as recalls or customer notifications, or agency action, such as inspection or enforcement action. Any corrective action, whether voluntary or involuntary, as well as defending ourselves in a lawsuit, could divert managerial and financial resources, impair our ability to manufacture our products in a cost-effective and timely manner, and have an adverse effect on our reputation, results of operations, and financial condition.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Any adverse event involving our products, whether in the U.S. or abroad could result in future voluntary corrective actions, such as recalls, including corrections, or customer notifications, or agency action, such as inspection or enforcement actions. If malfunctions do occur, we may be unable to correct the malfunctions adequately or prevent further malfunctions, in which case we may need to cease manufacture and distribution of the affected products, initiate voluntary recalls, and redesign the products. Regulatory authorities may also take actions against us, such as ordering recalls, imposing fines, or seizing the affected products. Any corrective action, whether voluntary or involuntary, will require the dedication of our time and capital, distract management from operating our business, and may harm our reputation and financial results.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:115%">&#160;</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">A recall of our products, either voluntarily or at the direction of the FDA or another governmental authority, including foreign governmental authorities, or the discovery of serious safety issues or malfunctions with our products, can result in voluntary corrective actions or agency enforcement actions, which could have a significant adverse impact on us.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The FDA and similar foreign governmental authorities have the authority to require the recall of commercialized products in the event of material deficiencies or defects in design or manufacture or in the event that a product poses an unacceptable risk to health. Manufacturers may, under their own initiative, recall a product if any material deficiency in a device is found.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the case of the FDA, the authority to require a recall must be based on an FDA finding that there is an unreasonable risk of substantial public harm. In addition, foreign governmental bodies have the authority to require the recall of our products in the event of material deficiencies or defects in design or manufacture. A government-mandated or voluntary recall by us or one of our third-party sales agents or resellers could occur as a result of an unacceptable risk to health, component failures, manufacturing errors, design or labeling defects, or other deficiencies and issues. Recalls of any of our products would divert managerial and financial resources and have an adverse effect on our reputation, results of operations, and financial condition, which could impair our ability to produce our products in a cost-effective and timely manner in order to meet our customers&#8217; demands. We may also be required to bear other costs or take other actions that may have a negative impact on our future sales and our ability to generate profits.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The FDA requires that certain classifications of recalls be reported to FDA within 10 working days after the recall is initiated. Companies are required to maintain certain records of recalls, even if they are not reportable to the FDA. We have in the past, and may in the future, initiate voluntary recalls involving our products in the future that we determine do not require notification of the FDA. If the FDA disagrees with our determinations, they could require us to report those actions as recalls. A future recall announcement could harm our reputation with customers and negatively affect our sales. In addition, the FDA could take enforcement action for failing to report the recalls when they were conducted. Equivalent procedures and penalties have been established in other countries including EU Member States.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Modifications to our products may require new 510(k) clearances or premarket approvals and new conformity assessment by our Notified Body, or may require us to cease marketing or recall the modified products until clearances, approvals, or CE Certificates of Conformity are obtained.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Any modification to a 510(k)-cleared device that could significantly affect its safety or effectiveness, or that would constitute a major change in its intended use, design, or manufacture, requires a new 510(k) clearance or, possibly, a PMA. The FDA requires every manufacturer to make and document this determination in the first instance. A manufacturer may determine that a modification could not significantly affect safety or effectiveness and does not represent a major change in its intended use, so that no new 510(k) clearance is necessary. FDA may review any manufacturer&#8217;s decision and may not agree with our decisions regarding whether new clearances or approvals are necessary. The FDA may also on its own initiative determine that a new clearance or approval is required.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have modified some of our 510(k) cleared products and have determined based on our review of the applicable FDA guidance that in certain instances new 510(k) clearances or PMAs are not required. If the FDA disagrees with our determination and requires us to submit new 510(k) clearances or PMAs for modifications to our previously cleared products for which we have concluded that new clearances or approvals are unnecessary, we may be required to cease marketing or to recall the modified product until we obtain clearance or approval. In these circumstances, we may be subject to significant enforcement actions, regulatory fines, or penalties, which could require us to redesign our products and harm our operating results.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If a manufacturer determines that a modification to an FDA-cleared device could significantly affect its safety or effectiveness, or would constitute a major change in its intended use, then the manufacturer must file for a new 510(k) clearance or possibly a premarket approval application. Where we determine that modifications to our products require a new 510(k) clearance or premarket approval application, we may not be able to obtain those additional clearances or approvals for the modifications or additional indications in a timely manner, or at all. FDA&#8217;s ongoing review of the 510(k) program may make it more difficult for us to make modifications to our previously cleared products, either by imposing more strict requirements on when a new 510(k) for a modification to a previously cleared product must be submitted, or applying more onerous review criteria to such submissions.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the EEA, we must inform the Notified Body that carried out the conformity assessment of the medical devices we market or sell in the EEA of any planned substantial changes to our quality system, manufacturing process, or changes to our devices which could affect compliance with the essential requirements or the devices&#8217; intended use. The Notified Body will then assess the changes </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">and verify whether they affect the products&#8217; conformity with Essential Requirements and related applicable laws. There can be no assurances that the assessment will be favorable and that the Notified Body will attest to our compliance with the essential requirements, which will prevent us from selling our products in the EEA. Moreover, any substantial changes that take place in the coming years may impact the continuing effectiveness of our CE Certificates of Conformity that were issued on the basis of the Medical Device Directive.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">There is no guarantee that the FDA will grant 510(k) clearance or premarket approval of our future products or that our Notified Body will issue the required CE Certificate of Conformity, and failure to obtain necessary clearances or approvals for our future products would adversely affect our business prospects.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We are in the process of developing our regulatory strategies for obtaining clearance or approval for future products. Some of them may require 510(k) clearance by the FDA or a new CE Certificate of Conformity. Other future products may require premarket approval. In addition, some of our new products may require clinical trials or significant clinical evidence to support regulatory approval and we may not successfully complete these clinical trials. Obtaining regulatory clearances or approvals and CE Certificates of Conformity can be a time-consuming process, and delays in obtaining required future regulatory clearances or approvals, and CE Certificates of Conformity would adversely affect our ability to introduce new or enhanced products in a timely manner, which in turn would adversely affect our business prospects. The FDA may not approve or clear these products or our Notified Body may not issue CE Certificate of Conformity for the indications that are necessary or desirable for successful commercialization. Indeed, the FDA may refuse our requests for 510(k) clearance or premarket approval of new products, new intended uses, or modifications to existing products and our Notified Body may refuse to issue new CE Certificates of Conformity. Failure to receive clearance, approval, or Certificates of Conformity for our new products would have an adverse effect on our ability to expand our business.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We may fail to obtain or maintain foreign regulatory approvals to market our products in other countries.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We currently market our products internationally and intend to expand our international marketing. International jurisdictions require separate regulatory approvals and compliance with numerous and varying regulatory requirements. For example, we intend to continue to seek domestic and international regulatory clearance to market our primary products Asia, the Middle East and other key markets. The approval procedures vary among countries and may involve requirements for substantial additional testing, and the time required to obtain approval may differ from country to country and from that required to obtain FDA clearance or approval or to obtain CE Certificates of Conformity.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Clearance or approval by the FDA or obtaining a CE Certificate of Conformity does not ensure approval or certification by regulatory authorities in other countries or jurisdictions, and approval or certification by one foreign regulatory authority does not ensure approval or certification by regulatory authorities in other foreign countries or by the FDA. The foreign regulatory approval or certification process may include all of the risks associated with obtaining FDA clearance or approval, or a CE Certificate of Conformity for a medical device in the EEA, in addition to other risks. In addition, the time required to obtain foreign approval may differ from that required to obtain FDA clearance or approval, or a CE Certificate of Conformity in the EEA, and we may not obtain foreign regulatory approvals on a timely basis, if at all. We may not be able to file for regulatory approvals or certifications and may not receive necessary approvals to commercialize our products in any market. If we fail to receive necessary approvals or certifications to commercialize our products in foreign jurisdictions on a timely basis, or at all, our business, results of operations, and financial condition could be adversely affected.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Clinical trials necessary to support a De Novo 510(k) or PMA application or a conformity assessment procedure will be expensive and may require the enrollment of large numbers of patients, and suitable patients may be difficult to identify and recruit. Delays or failures in our clinical trials will prevent us from commercializing any modified or new products, or new indications for use for existing products, and will adversely affect our business, operating results and prospects.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Initiating and completing clinical trials necessary to support a De Novo 510(k) or PMA application for our possible future products or to support a conformity assessment procedure for a new CE Certificate of Conformity would be time consuming and expensive and the outcome uncertain. Moreover, the results of early clinical trials are not necessarily predictive of future results, and any product, or new indication for use, we advance into clinical trials may not have favorable results in later clinical trials.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Conducting successful clinical studies may require the enrollment of large numbers of patients, and suitable patients may be difficult to identify and recruit. Patient enrollment in clinical trials and completion of patient participation and follow-up depends on many factors, including the size of the patient population, the nature of the trial protocol, the attractiveness of, or the discomforts and risks associated with, the treatments received by enrolled subjects, the availability of appropriate clinical trial investigators and support staff,  the proximity of patients to clinical sites, and the ability to comply with the inclusion and exclusion criteria for participation in the clinical trial and patient compliance. Development of sufficient and appropriate clinical protocols to demonstrate safety and effectiveness are required and we may not adequately develop such protocols to support clearance and approval. Further, the FDA or our Notified Body may require us to submit data on a greater number of patients than we originally anticipated and/or for a longer follow-up period or change the data collection requirements or data analysis applicable to our clinical trials. Delays in patient enrollment or failure of patients to continue to participate in a clinical trial may cause an increase in costs and delays in the approval and attempted commercialization of our products or result in the failure of the clinical trial. For example, COVID-19 caused substantial delays in site initiation and patient enrollment in our SILVIA trial designed to assess the safety and efficacy of our Bedrock technique. In addition, despite considerable time and expense invested in our clinical trials, the FDA or our Notified Body may not consider our data adequate to demonstrate safety and effectiveness. Such increased costs and delays or failures could adversely affect our business, operating results and prospects.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our facility and our clinical investigational sites operate under procedures that govern the conduct and management of FDA-regulated clinical studies under 21 CFR Parts 50 and 812, and Good Clinical Practices. The FDA may conduct Bioresearch Monitoring inspections of us and/or our clinical sites to assess compliance with 21 CFR Parts 50 and 812, our procedures, and the clinical protocol. If the FDA were to find that we or our clinical investigators are not operating in compliance with applicable regulations, we could be subject to the above FDA enforcement action, as well as refusal to accept all or part of our data in support of our 510(k) or PMA, or we may need to conduct additional studies.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">The results of our clinical trials may not support our product candidate claims or may result in the occurrence of adverse events.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Even if our clinical trials are completed as planned, or on a delayed basis, we cannot be certain that their results will support our product candidate claims or that the FDA, foreign authorities, or our Notified Body will agree with our conclusions regarding them. Success in pre-clinical studies and early clinical trials does not ensure that later clinical trials will be successful, and we cannot be sure that the later trials will replicate the results of prior trials and pre-clinical studies. The clinical trial process may fail to demonstrate that our product candidates are safe and effective for the proposed indicated uses, which could cause us to abandon a product candidate and may delay development of others. Any delay or termination of our clinical trials will delay the filing of our product submissions and, ultimately, our ability to commercialize our product candidates and generate revenue. It is also possible that patients enrolled in clinical trials will experience adverse events that are not currently part of the product candidate&#8217;s profile.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">U.S. legislative or FDA or foreign regulatory reforms may make it more difficult and costly for us to obtain regulatory clearances or approvals, or CE Certificates of Conformity for our product candidates and to manufacture, market, and distribute our products after approval is obtained.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">From time to time, Congress introduces legislation that could significantly change the statutory provisions governing the regulatory approval, manufacture, and marketing of regulated products or the reimbursement thereof. In addition, FDA regulations and guidance are often revised or reinterpreted by the FDA in ways that may significantly affect our business and our products. Moreover, the new Medical Device Regulation entered into application on May 26, 2021. Any new regulations or revisions or reinterpretations of existing regulations may impose additional costs or lengthen review times of future products. It is impossible to predict whether legislative changes will be enacted or FDA regulations, guidance, or interpretations changed, and what the impact of such changes, if any, may be.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Leadership, personnel and structural changes within the FDA as well as recent federal election outcomes could result in significant legislative and regulatory reforms impacting the FDA's regulation of our products. Any change in the laws or regulations that govern the clearance and approval processes relating to our current and future products could make it more difficult and costly to obtain clearance or approval for new products, or to produce, market and distribute existing products. Significant delays in receiving clearance or approval, or the failure to receive clearance or approval for our new products would have an adverse effect on our ability to expand our business.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Another example can be found in the EEA. The Medical Devices Regulation (&#8220;MDR&#8221;) entered into application on May 26, 2021. MDR introduced substantial changes to the obligations with which medical device manufacturers must comply in the EEA. Examples of the changes which will be introduced by these regulations include the following:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;additional scrutiny during the conformity assessment procedure for high risk medical devices;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;strengthening of the clinical data requirements related to medical devices;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;strengthening of the designation and monitoring processes governing notified bodies;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;the obligation for manufacturers and authorized representative to have a person responsible for regulatory compliance continuously at their disposal;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:115%">&#160;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;authorized representatives held legally responsible and liable for defective products placed on the EU market;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;increased traceability of medical devices following the introduction of a Unique Device Identification (&#8220;UDI&#8221;), system;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;new rules governing the reprocessing of medical devices; and</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;increased transparency with the establishment of European database on medical devices (&#8220;EUDAMED&#8221;) III as information from several databases concerning economic operators, CE Certificates of Conformity, conformity assessment, clinical investigations, the UDI system, adverse event reporting and market surveillance would be available to the public.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Medical Device Regulation also substantially impacts clinical investigations of medical devices. Among other things, it imposes specific obligations concerning incapacitated subjects, minors, pregnant or breastfeeding women and clinical investigations in emergency situations. In addition to detailed provisions concerning the authorization and conduct of clinical investigations, the Regulation imposes on non-EU sponsors a responsibility to appoint a legal representative established in the EU and an obligation on EU Member States to ensure that systems for compensation for any damage suffered by a subject resulting from participation in a clinical investigation conducted on their territory are in place and places on sponsors and investigators the obligation to ensure they make use of these systems.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Transition from the regulation of our products under the Medical Device Directive, and implementing legislation in each EU Member State, to regulation under the Medical Devices Regulation has required and will continue to require a substantial transition effort by us.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">In addition, detail as to how certain aspects of the Medical Devices Regulation will be applied remains unclear. Failure to update our quality system and regulatory documentation could delay our transition to compliance with the Medical Devices Regulation and delay or prevent us from obtaining new CE Certificates of Conformity under the Regulation. Transition from compliance with the Medical Device Directive to the Medical Devices Regulation could result in disruption to our business in the EEA which could adversely affect our business, results of operation and financial condition. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">In addition, any changes to the membership of the European Union, such as the departure of the United Kingdom from the EU, may impact the regulatory requirements for the impacted countries and impair our business operations and our ability to market products in such countries. For example, pursuant to guidance issued by the UK Government as a result of the UK formally withdrawing from the European Union, the Medicines and Healthcare products Regulatory Agency (&#8220;MHRA&#8221;) became the standalone medicines and medical devices regulator for the UK as of January 1, 2021. A new mark referred to as &#8220;UKCA&#8221; (UK Conformity Assessed) has also been introduced and will replace the CE conformity mark. Although CE conformity marketing and certificates issued by Notified Bodies will continue to be recognized in the UK through June 2023, all medical devices must be registered with the MHRA as of January 1, 2021. Complying with this new regulatory framework will require us to invest in additional resources and could be expensive, time-consuming and disruptive to our existing operations in the UK.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We may incur product liability losses, and insurance coverage may be inadequate or unavailable to cover these losses.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our business exposes us to potential product liability claims that are inherent in the testing, design, manufacture, and sale of surgical devices. Sacroiliac joint and other orthopedic spine surgeries involve significant risk of serious complications, including bleeding, nerve injury, paralysis, and even death. Physicians may misuse or ineffectively use our products, which may result in unsatisfactory patient outcomes or patient injury. In addition, if longer-term patient results and experience indicate that our products or any component of a product cause tissue damage, motor impairment, or other adverse effects, we could be subject to significant liability. We could become the subject of product liability lawsuits alleging that component failures, manufacturing flaws, design defects, or inadequate disclosure of product-related risks or product-related information resulted in an unsafe condition or injury to patients. Product liability lawsuits and claims, safety alerts, or product recalls, regardless of their ultimate outcome, could have a material adverse effect on our business and reputation, our ability to attract and retain customers and our results of operations or financial condition.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Although we maintain third-party product liability insurance coverage, it is possible that claims against us may exceed the coverage limits of our insurance policies or cause us to record a self-insured loss. Even if any product liability loss is covered by an insurance policy, these policies typically have substantial retentions or deductibles that we are responsible for. Product liability claims in excess of applicable insurance coverage could have a material adverse effect on our business, results of operations, and financial condition.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, any product liability claim brought against us, with or without merit, could result in an increase of our product liability insurance rates. Insurance coverage varies in cost and can be difficult to obtain, and we cannot guarantee that we will be able to obtain insurance coverage in the future on terms acceptable to us or at all.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We are subject to environmental laws and regulations that can impose significant costs and expose us to potential financial liabilities.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The manufacture of certain of our products, including our implants and products, and the handling of materials used in the product testing process involve the use of biological, hazardous and/or radioactive materials and wastes. Our business and facilities and those of our suppliers are subject to foreign, federal, state, and local laws and regulations relating to the protection of human health and the environment, including those governing the use, manufacture, storage, handling, and disposal of, and exposure to, such materials and wastes. We own and operate certain x-ray equipment at our facilities which requires adoption of a radiation safety plan.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our failure to follow such safety plan or otherwise use this equipment properly could be hazardous to our employees and expose us to liability as the employer. In addition, under some environmental laws and regulations, we could be held responsible for costs relating to any contamination at our past or present facilities and at third-party waste disposal sites even if such contamination was not caused by us. A failure to comply with current or future environmental laws and regulations could result in severe fines or penalties. Any such expenses or liability could have a significant negative impact on our business, results of operations, and financial condition.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Certain of our products are derived from human tissue and are or could be subject to additional regulations and requirements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our iFuse Bone product is derived from human bone tissue, and as a result is subject to FDA and certain state regulations regarding human cells, tissues and cellular or tissue-based products, or HCT/Ps. To date, iFuse Bone is our only HCT/P product, and as a product regulated under Section 361 of the Public Health Service Act, we have not been required to file a 510(k) with respect to iFuse Bone. However, the FDA could require us to obtain a 510(k) clearance for future tissue products not regulated as 361 HCT/Ps. The process of obtaining a 510(k) clearance could take time and consume resources, and failing to receive such a clearance would render us unable to market and sell such products, which could have a material and adverse effect on our business.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Risks Related to Our Intellectual Property</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">If we or our licensors fail to adequately protect or enforce our intellectual property rights or secure rights to patents of others, the value of our intellectual property rights would diminish and our ability to successfully commercialize our products may be impaired.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We rely primarily on patent, copyright, trademark and trade secret laws, as well as confidentiality and nondisclosure agreements and other methods, to protect our proprietary technologies and know-how. As of March 31, 2023, we owned 52 issued U.S. patents and had 29 pending U.S. patent applications, and we owned 16 issued foreign patents and had 18 pending foreign patent applications. We have focused the majority of our foreign patent efforts in China, Europe, and Japan. Our current U.S. patents on iFuse, including the triangular shape, expire in November 2024. Competitors may market similar triangular shaped devices upon the expiration of the patents in late 2024. Our current U.S. patents on iFuse-3D, including the fenestrated design, expire in September 2035. Our foreign patents will expire between August 2025 and September 2035.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of March 31, 2023, we have 19 registered trademarks in the U.S. and have filed for four more. We have sought protection for at least two of these trademarks in 60 countries including the 27 European member countries of the Madrid Protocol.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have applied for patent protection relating to certain existing and proposed products and processes. While we generally apply for patents in those countries where we intend to make, have made, use, or sell our products, we may not accurately predict all of the countries where patent protection will ultimately be desirable. If we fail to timely file a patent application in any such country, we may be precluded from doing so at a later date. Furthermore, we cannot assure investors that any of our patent applications will be approved. The rights granted to us under our patents, including prospective rights sought in our pending patent applications, may not be meaningful or provide us with any commercial advantage. In addition, those rights could be opposed, contested, or circumvented by our competitors or be declared invalid or unenforceable in judicial or administrative proceedings. The failure of our patents to adequately protect our technology might make it easier for our competitors to offer the same or similar products or technologies. Competitors may be able to design around our patents or develop products that provide outcomes that are comparable to ours without infringing on our intellectual property rights. Due to differences between foreign and U.S. patent laws, our patented intellectual property rights may not receive the same degree of protection in foreign countries as they would in the U.S. Even if patents are granted outside the U.S., effective enforcement in those countries may not be available. Since most of our issued patents are for the U.S. only, we lack a corresponding scope of patent protection in other countries. In countries where we do not have significant patent protection, we may not be able to stop a competitor from marketing products in such countries that are the same as or similar to our products.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We rely on our trademarks, trade names and brand names to distinguish our products from the products of our competitors and have registered or applied to register many of these trademarks. We cannot assure investors that our trademark applications will be approved. Third parties may also oppose our trademark applications, or otherwise challenge our use of the trademarks. In the event that our trademarks are successfully challenged, we could be forced to rebrand our products, which could result in loss of brand recognition, and could require us to devote resources to advertising and marketing new brands. Further, we cannot assure investors that competitors will not infringe upon our trademarks, or that we will have adequate resources to enforce our trademarks.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We also rely on trade secrets, know-how, and technology, which are not protected by patents, to maintain our competitive position. We try to protect this information by entering into confidentiality and intellectual property assignment agreements with parties that develop intellectual property for us and/or have access to it, such as our officers, employees, consultants, and advisors. However, in the event of unauthorized use or disclosure or other breaches of such agreements, we may not be provided with meaningful protection for our trade secrets or other proprietary information. In addition, our trade secrets may otherwise become known or be independently discovered by competitors. To the extent that our commercial partners, collaborators, employees, and consultants use intellectual property owned by others in their work for us, disputes may arise as to the rights in related or resulting know-how and inventions. If any of our trade secrets, know-how or other technologies not protected by a patent were to be disclosed to or independently developed by a competitor, our business, financial condition, and results of operations could be materially adversely affected.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the future, we may enter into licensing agreements to maintain our competitive position. If we enter into in-bound intellectual property license agreements, we may not be able to fully protect the licensed intellectual property rights or maintain those licenses. Future licensors could retain the right to prosecute and defend the intellectual property rights licensed to us, in which case we would depend on the ability of our licensors to obtain, maintain and enforce intellectual property protection for the licensed intellectual property. These licensors may determine not to pursue litigation against other companies or may pursue such litigation less aggressively than we would. Further, entering into such license agreements could impose various diligence, commercialization, royalty, or other obligations on us. Future licensors may allege that we have breached our license agreement with them, and accordingly seek damages or to terminate our license, which could adversely affect our competitive business position and harm our business prospects.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If a competitor infringes upon one of our patents, trademarks, or other intellectual property rights, enforcing those patents, trademarks, and other rights may be difficult and time consuming. Even if successful, litigation to defend our patents and trademarks against challenges or to enforce our intellectual property rights could be expensive and time consuming and could divert management&#8217;s attention from managing our business. Moreover, we may not have sufficient resources to defend our patents or trademarks against challenges or to enforce our intellectual property rights. In addition, if third parties infringe any intellectual property that is not material to the products that we make, have made, use, or sell, it may be impractical for us to enforce this intellectual property against those third parties.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We may be subject to damages resulting from claims that we, our employees, our third-party sales agents or resellers have wrongfully used or disclosed alleged trade secrets of our competitors or are in breach of non-competition or non-solicitation agreements with our competitors.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Many of our employees were previously employed at other medical device companies, including our competitors or potential competitors, in some cases until recently. Some of our third-party sales agents or resellers sell, or in the past have sold, products of our competitors. We may be subject to claims that we, our employees, our third-party sales agents or resellers have inadvertently or otherwise used or disclosed trade secrets or other proprietary information of these former employers or competitors. In addition, we have been and may in the future be subject to claims that we caused an employee to breach the terms of his or her non-competition or non-solicitation agreement. Even if we are successful in defending against these claims, litigation could result in substantial costs, divert the attention of management from our core business and harm our reputation. If our defense to those claims fails, in addition to paying monetary damages, we may lose valuable intellectual property rights or personnel. There can be no assurance that this type of litigation will not occur, and any future litigation or the threat thereof may adversely affect our ability to hire additional direct sales representatives. A loss of key personnel or their work product could hamper or prevent our ability to commercialize product candidates, which could have an adverse effect on our business, results of operations, and financial condition.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">The medical device industry is characterized by patent litigation and we could become subject to litigation that could be costly, result in the diversion of management&#8217;s time and efforts, require us to pay damages, and/or prevent us from developing or marketing our existing or future products.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our commercial success will depend in part on not infringing the patents or violating the other proprietary rights of third parties. Significant litigation regarding patent rights exists in our industry. Our competitors in both the U.S. and abroad, many of which have substantially greater resources and have made substantial investments in competing technologies, may have applied for or obtained or may in the future apply for and obtain, patents that will prevent, limit, or otherwise interfere with our ability to make and sell our products. We have conducted a limited review of patents issued to third parties. The large number of patents, the rapid rate of new patent issuances, the complexities of the technology involved, and the uncertainty of litigation increase the risk of management&#8217;s attention being diverted to patent litigation. Any litigation or claim against us, even those without merit, may cause us to incur substantial costs, and could place a significant strain on our financial resources, divert the attention of management from our core business, and harm our reputation. Further, as the number of participants in the medical device industry grows, the possibility of intellectual property infringement claims against us increases. If we are found to infringe the intellectual property rights of third parties, we could be required to pay substantial damages, including treble, or triple, damages if an infringement is found to be willful, and/or royalties and could be prevented from selling our products unless we obtain a license or are able to redesign our products to avoid infringement. Any such license may not be available on reasonable terms, if at all, and there can be no assurance that we would be able to redesign our products in a way that would not infringe the intellectual property rights of others. If we fail to obtain any required licenses or make any necessary changes to our products or technologies, we may have to withdraw existing products from the market or may be unable to commercialize one or more of our products, all of which could have a material adverse effect on our business, results of operations, and financial condition. If passed into law, patent reform legislation currently pending in the U.S. Congress could significantly change the risks associated with bringing or defending a patent infringement lawsuit. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, we generally indemnify our customers and third-party sales agents and resellers with respect to infringement by our products of the proprietary rights of third parties. Third parties may assert infringement claims against our customers or third-party sales agents and resellers. These claims may require us to initiate or defend protracted and costly litigation on behalf of our customers or third-party sales agents and resellers, regardless of the merits of these claims. If any of these claims succeed, we may be forced to pay damages on behalf of our customers or third-party sales agents and resellers or may be required to obtain licenses to intellectual property owned by such third parties. If we cannot obtain all necessary licenses on commercially reasonable terms, our customers and third-party sales agents and resellers may be forced to stop using or selling our products.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Risks Related to Ownership of Our Common Stock </span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">The price of our common stock may be volatile, and the value of an investment in our common stock could decline.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Medical device stocks have historically experienced volatility, and the trading price of our common stock may fluctuate substantially. These fluctuations could cause our stockholders to lose all or part of their investment in our common stock. Factors that could cause fluctuations in the trading price of our common stock include the following:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">changes in interest rates, investor risk appetite and other macroeconomic factors impacting the market for securities issued by medical device companies;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">the risk of inflation, interest rate increases and other macroeconomic factors impacting patients&#8217; economic ability and likelihood of undergoing elective procedures, whether real or as perceived by investors;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">actual or anticipated changes or fluctuations in our results of operations;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">the impact of infectious diseases, and measures taken to combat them, on our business;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;results of our clinical trials and that of our competitors&#8217; products;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;regulatory actions with respect to our products or our competitor&#8217;s products;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;announcements of new offerings, products, services or technologies, commercial relationships, acquisitions, or other events by us or our competitors;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;price and volume fluctuations in the overall stock market from time to time; </span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;significant volatility in the market price and trading volume of healthcare companies, in general, and of companies in the medical device industry in particular;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;fluctuations in the trading volume of our shares or the size of our public float;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;negative publicity;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;whether our results of operations meet the expectations of securities analysts or investors or those expectations change;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;litigation involving us, our industry, or both;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;regulatory developments in the U.S., foreign countries, or both;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;lock-up releases and sales of large blocks of our common stock;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:115%">&#160;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;additions or departures of key employees or scientific personnel; and</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;general economic conditions and trends.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, if the market for healthcare stocks or the stock market, in general, experience a further loss of investor confidence, the trading price of our common stock could decline for reasons unrelated to our business, results of operations, or financial condition. The trading price of our common stock might also decline in reaction to events that affect other companies in our industry even if these events do not directly affect us. In the past, following periods of volatility in the market price of a company&#8217;s securities, securities class action litigation has often been brought against that company. If our stock price is volatile, we may become the target of securities litigation. Securities litigation could result in substantial costs and divert our management&#8217;s attention and resources from our business. This could have a material adverse effect on our business, results of operations, and financial condition.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Our sales volumes and our operating results may fluctuate over the course of the year, which could affect the price of our common stock.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have experienced and continue to experience meaningful variability in our sales and gross profit from quarter to quarter, as well as within each quarter. Our sales and results of operations will be affected by numerous factors, including, among other things:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">payor coverage and reimbursement;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">the number of products sold in the quarter and our ability to drive increased sales of our products;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">our ability to establish and maintain an effective and dedicated sales force;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">pricing pressure applicable to our products, including adverse third-party coverage and reimbursement outcomes;</span></div><div style="padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:19pt">the impact of COVID-19 or other infectious disease outbreaks on our business;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">results of clinical research and trials on our existing products and products in development;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">the mix of our products sold because profit margins differ amongst our products;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">timing of new product offerings, acquisitions, licenses or other significant events by us or our competitors;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">the ability of our suppliers to timely provide us with an adequate supply of materials and components;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">the evolving product offerings of our competitors;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">the demand for, and pricing of, our products and the products of our competitors;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">factors that may affect the sale of our products, including seasonality and budgets of our customers;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">domestic and international regulatory clearances or approvals, or CE Certificates of Conformity, and legislative changes affecting the products we may offer or those of our competitors;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">interruption in the manufacturing or distribution of our products;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">the effect of competing technological, industry and market developments;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">our ability to expand the geographic reach of our sales and marketing efforts;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">the costs of maintaining adequate insurance coverage, including product liability insurance;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">the availability and cost of components and materials;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">the number of selling days in the quarter;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">fluctuation in foreign currency exchange rates; and</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">impairment and other special charges.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Some of the products we may seek to develop and introduce in the future will require FDA clearance or approval before commercialization in the U.S., and commercialization of such products outside of the U.S. would likely require additional regulatory approvals, or Certificates of Conformity and import licenses. As a result, it will be difficult for us to forecast demand for these products with any degree of certainty. In addition, we will be increasing our operating expenses as we expand our commercial capabilities. Accordingly, we may experience significant, unanticipated losses. If our quarterly or annual operating results fall below the expectations of investors or securities analysts, the price of our common stock could decline substantially. Furthermore, any quarterly or annual fluctuations in our operating results may, in turn, cause the price of our common stock to fluctuate substantially. Quarterly comparisons of our financial results may not always be meaningful and should not be relied upon as an indication of our future performance.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We may be unable to utilize our federal and state net operating loss carryforwards to reduce our income taxes.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, we had net operating loss (&#8220;NOL&#8221;) carryforwards of $298.6 million and $238.7 million available to reduce future taxable income, if any, for U.S. federal income tax and state income tax purposes, respectively. If not utilized, our federal and state NOL carryforwards begin to expire in 2029 and 2022, respectively, subject to the recent California franchise tax law change affecting California state NOLs mentioned below. Portions of these NOL carryforwards could expire unused and be unavailable to offset future income tax liabilities. Under legislation enacted in 2017, as modified by legislation enacted in 2020, unused U.S. federal NOLs generated in tax years beginning after December 31, 2017</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">will not expire and may be carried forward indefinitely, but the deductibility of such federal NOLs in taxable years beginning after December 31, 2020, is limited to 80% of taxable income. At the state level, there may be periods during which the use of NOLs is suspended or otherwise limited. In addition, under Section 382 of the Code, and corresponding provisions of state law, if a corporation undergoes an &#8220;ownership change,&#8221; which generally occurs if the percentage of the corporation&#8217;s stock owned by 5% stockholders increases by more than 50% over a three-year period, the corporation&#8217;s ability to use its pre-change NOL carryforwards and other pre-change tax attributes to offset its post-change income may be limited. We updated our Section 382 ownership change analysis through December 31, 2020. The analysis determined that we have experienced Section 382 ownership changes in 2010 and 2020. A total of $1.4 million of our NOLs and tax credit carryforwards are subject to limitation as a result of the ownership change. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The California Assembly Bill 85 (AB 85) was signed into law by Governor Gavin Newsom on June 29, 2020. The legislation suspends the California NOL deductions for 2020, 2021 and 2022 for certain taxpayers and imposes a limitation of certain California Tax Credits for 2020, 2021 and 2022. The legislation disallows the use of California NOL deductions if the taxpayer recognizes business income and its adjusted gross income is greater than $1.0 million. The carryover periods for NOL deductions disallowed by this provision will be extended. On February 9, 2022, California Senate Bill 133 (SB 133) was signed into law. The new bill lifted the limitation for California NOL and credit utilization disallowed by AB 85. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will continue to monitor the possible California NOLs and credit limitation in future periods.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Our charter documents and Delaware law could discourage takeover attempts and lead to management entrenchment.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our amended and restated certificate of incorporation and amended and restated bylaws contain provisions that could delay or prevent a change in control of our company. These provisions could also make it difficult for stockholders to elect directors that are not nominated by the current members of our board of directors or take other corporate actions, including effecting changes in our management. These provisions include:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;a classified board of directors with three-year staggered terms, which could delay the ability of stockholders to change the membership of a majority of our board of directors;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;the ability of our board of directors to issue shares of preferred stock and to determine the price and other terms of those shares, including preferences and voting rights, without stockholder approval, which could be used to significantly dilute the ownership of a hostile acquiror;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;the exclusive right of our board of directors to elect a director to fill a vacancy created by the expansion of our board of directors or the resignation, death or removal of a director, which prevents stockholders from being able to fill vacancies on our board of directors;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;a prohibition on stockholder action by written consent, which forces stockholder action to be taken at an annual or special meeting of our stockholders;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;the requirement that a special meeting of stockholders may be called only by a majority vote of our entire board of directors, the chairman of our board of directors, or our chief executive officer, which could delay the ability of our stockholders to force consideration of a proposal or to take action, including the removal of directors;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;the requirement for the affirmative vote of holders of at least 66&#160;2/3% of the voting power of all of the then-outstanding shares of the voting stock, voting together as a single class, to amend the provisions of our amended and restated certificate of incorporation relating to the management of our business or our amended and restated bylaws, which may inhibit the ability of an acquiror to effect such amendments to facilitate an unsolicited takeover attempt; and</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;advance notice procedures with which stockholders must comply to nominate candidates to our board of directors or to propose matters to be acted upon at a stockholders&#8217; meeting, which may discourage or deter a potential acquiror from conducting a solicitation of proxies to elect the acquiror&#8217;s own slate of directors or otherwise attempting to obtain control of us.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:115%">&#160;</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, as a Delaware corporation, we are subject to Section&#160;203 of the Delaware General Corporation Law. These provisions may prohibit large stockholders, in particular those owning 15% or more of our outstanding voting stock, from merging or combining with us for a certain period of time.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A Delaware corporation may opt out of this provision by express provision in its original certificate of incorporation or by amendment to its certificate of incorporation or bylaws approved by its stockholders. However, we have not opted out of, and do not currently intend to opt out of, this provision.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">These and other provisions in our amended and restated certificate of incorporation, amended and restated bylaws and Delaware law could make it more difficult for stockholders or potential acquirers to obtain control of our board of directors or initiate actions that are opposed by our then-current board of directors, including delay or impede a merger, tender offer, or proxy contest involving our company. The existence of these provisions could negatively affect the price of our common stock and limit opportunities for our stockholders to realize value in a corporate transaction.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Our amended and restated certificate of incorporation provides that the Court of Chancery of the State of Delaware and the U.S. federal district courts are the exclusive forums for substantially all disputes between us and our stockholders, which restricts our stockholders&#8217; ability to bring a lawsuit against us or our directors, officers, or employees in jurisdictions other than Delaware and federal district courts.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our amended and restated certificate of incorporation provides that the Court of Chancery of the State of Delaware is the exclusive forum for any derivative action or proceeding brought on our behalf; any action asserting a breach of a fiduciary duty; any action asserting a claim against us arising pursuant to the Delaware General Corporation Law, our amended and restated certificate of incorporation, or our amended and restated bylaws; or any action asserting a claim against us that is governed by the internal affairs doctrine. The provision would not apply to suits brought to enforce a duty or liability created by the Exchange Act. This choice of forum provision may limit a stockholder's ability to bring a claim in a judicial forum that it finds favorable for these types of disputes with us or our directors, officers, or other employees.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our amended and restated certificate of incorporation also provides that the U.S. federal district courts are the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Adverse developments affecting the banking industry or the broader financial services industry, such as actual events or concerns involving liquidity, defaults or non-performance, could adversely affect our operations and liquidity.</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actual events involving limited liquidity, defaults, non-performance or other adverse developments that affect financial institutions or other companies in the financial services industry or the financial services industry generally, or concerns or rumors about any events of these kinds, have in the past and may in the future lead to market-wide liquidity problems. For example, on March 10, 2023, Silicon Valley Bank, or SVB, was closed by the California Department of Financial Protection and Innovation, which appointed the Federal Deposit Insurance Corporation, or the FDIC, as receiver.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although a statement by the U.S. Department of the Treasury, the Federal Reserve and the FDIC stated that all depositors of SVB would have access to all of their money after only one business day following the date of closure and we and other depositors with SVB received such access on March 13, 2023, uncertainty and liquidity concerns in the broader financial services industry remain. Inflation and rapid increases in interest rates have led to a decline in the trading value of previously issued government securities with interest rates below current market interest rates. The U.S. Department of Treasury, FDIC and Federal Reserve Board have announced a program to provide up to $25 billion of loans to financial institutions secured by such government securities held by financial institutions to mitigate the risk of potential losses on the sale of such instruments. However, widespread demands for customer withdrawals or other needs of financial institutions for immediate liquidity may exceed the capacity of such program. There is no guarantee that the U.S. Department of Treasury, FDIC and Federal Reserve Board will provide access to uninsured funds in the future in the event of the closure of other banks or financial institutions in a timely fashion or at all.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our access to our cash and cash equivalents in amounts adequate to finance our operations could be significantly impaired by the financial institutions with which we have arrangements directly facing liquidity constraints or failures. In addition, investor concerns regarding the U.S. or international financial systems could result in less favorable commercial financing terms, including higher interest rates or costs and tighter financial and operating covenants, or systemic limitations on access to credit and liquidity sources, thereby making it more difficult for us to acquire financing on acceptable terms or at all. Any material decline in available funding or our ability to access our cash and cash equivalents could adversely impact our ability to meet our operating expenses, result in breaches of our contractual obligations or result in violations of federal or state wage and hour laws, any of which could have material adverse impacts on our operations and liquidity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, if any parties with whom we conduct business are unable to access funds held in uninsured deposit accounts or pursuant to lending arrangements with a financial institution that is placed in receivership by the FDIC, such parties&#8217; ability to pay their obligations to us or to enter into new commercial arrangements requiring additional payments to us could be adversely affected.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our term loan contains covenants that may restrict our business and financing activities.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our Loan and Security Agreement (as amended, the "Amended Loan Agreement") with First-Citizens Bank &amp; Trust Company (&#8220;First-Citizens&#8221;) contains customary events of default, including bankruptcy, the failure to make payments when due, the occurrence of a material impairment on First-Citizens security interest over the collateral, a material adverse change, the occurrence of a default under certain other indebtedness incurred by us or our subsidiaries, the rendering of certain types of judgments against us and our subsidiaries, the revocation of certain government approvals, violation of covenants, and incorrectness of representations and warranties in any material respect.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Amended Loan Agreement is secured by substantially all our assets other than our intellectual property. The Amended Loan Agreement includes affirmative and negative covenants applicable to us and certain of our foreign subsidiaries. The affirmative covenants include, among others, covenants requiring us to maintain our legal existence and governmental compliance, deliver certain financial reports, and maintain insurance coverage. The negative covenants include, among others, restrictions regarding transferring collateral, pledging our intellectual property to other parties, engaging in mergers or acquisitions, paying dividends or making other distributions, incurring indebtedness, transacting with affiliates, and entering into certain investments, in each case subject to certain exceptions.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The covenants in the Amended Loan Agreement, as well as any future financing agreements that we may enter into, may restrict our ability to finance our operations, engage in, expand, or otherwise pursue our business activities and strategies. Our ability to comply with these covenants may be affected by events beyond our control, and future breaches of any of these covenants could result in a default under our credit facility agreements. If not waived, future defaults could cause all of the outstanding indebtedness under the Amended Loan Agreement to become immediately due and payable.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If we do not have or are unable to generate sufficient cash available to repay our debt obligations when they become due and payable, either upon maturity or in the event of a default, we may not be able to obtain additional debt or equity financing on favorable terms, if at all, which may negatively impact our ability to operate our business.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to access credit on favorable terms, if necessary, for the funding of our operations and capital projects may be limited due to changes in credit markets.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our Amended Loan Agreement with First-Citizens provides for a secured revolving credit facility, or Revolver, in an aggregate principal amount of up to $15.0 million. The Revolver matures on July 6, 2025. As of March 31, 2023, we had not drawn on this credit facility. On March 10, 2023, we violated one of the terms of the Amended Loan Agreement by opening bank accounts with another financial institution and transferring funds from SVB. We entered into a letter agreement with Silicon Valley Bridge Bank waiving enforcement of this covenant and providing us the right to hold a portion of our cash at other financial institutions. Any future violation of any of the covenants could result in a default under the Amended Loan Agreement that would permit First-Citizens to restrict our ability to further access the Revolver for loans and require the immediate repayment of any outstanding loans under the </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">agreement. In addition, certain provisions in the these covenants are subject to renegotiation at the beginning of each fiscal year, which further reduces our ability to anticipate whether this source of capital will continue to be available in the near term. As of March 31, 2023, we had cash management accounts with a financial institution other than First-Citizens and instructed our customers to direct payments to us to these separate operating accounts. Until such operating accounts are closed and the funds moved back to cash collateral accounts held at First-Citizens, we will be unable to obtain credit advances under the Revolver. See &#8220;Note 7. Borrowings&#8221; to the &#8220;Notes to Condensed Consolidated Financial Statements&#8221; included in this report.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Additionally, in the past, the credit markets and the financial services industry have experienced disruption characterized by the bankruptcy, failure, collapse or sale of various financial institutions, increased volatility in securities prices, diminished liquidity and credit availability and intervention from the U.S. and other governments. Continued concerns about the systemic impact of potential long-term or widespread downturn, energy costs, geopolitical issues, the availability and cost of credit, the global commercial and residential real estate markets and related mortgage markets and reduced consumer confidence have contributed to increased market volatility. The cost and availability of credit has been and may continue to be adversely affected by these conditions. We cannot be certain that funding for our capital needs will be available from our existing financial institutions and the credit markets if needed, and if available, to the extent required and on acceptable terms. The Amended Loan Agreement terminates on December 1, 2027 and if we cannot renew or refinance this facility or obtain funding when needed, in each case on acceptable terms, such conditions may have an adverse effect on our ability to operate our business.</span></div><div style="margin-top:12pt"><span><br/></span></div><div id="i928aa505a2ea46079da4e5082002267b_121"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nothing to report.</span></div><div id="i928aa505a2ea46079da4e5082002267b_124"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Defaults Upon Senior Securities</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i928aa505a2ea46079da4e5082002267b_127"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Mine Safety Disclosures</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not Applicable.</span></div><div id="i928aa505a2ea46079da4e5082002267b_130"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5. Other Information</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 10, 2023, we violated one of the terms of the credit facility by opening bank accounts with another financial institution and transferring funds from SVB. On March 24, 2023, we entered into a letter agreement with Silicon Valley Bridge Bank waiving enforcement of this covenant and providing us the right to hold a portion of our cash at other financial institutions. A future violation of any covenants could result in a default under the Amended Loan Agreement that would permit First-Citizens to restrict our ability to further access our revolving line of credit for loans and require the immediate repayment of any outstanding loans under the agreement. As of March 31, 2023, we were in compliance with all debt covenants, provided, however, that in order to access future credit advances under our revolving line of credit, we will be required to transfer certain cash management accounts back to First-Citizens.  As of March 31, 2023, we had cash management accounts with a financial institution other than First-Citizens and instructed our customers to direct payments to these separate operating accounts. Until such operating accounts are closed and the funds moved back to cash collateral accounts held at First-Citizens, we will be unable to obtain credit advances under our revolving line of credit.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><div id="i928aa505a2ea46079da4e5082002267b_133"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. Exhibits </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"></td><td style="width:8.802%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.785%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.826%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.499%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.802%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.922%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporation&#160;By&#160;Reference</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SEC&#160;File&#160;No.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit/<br/>Reference</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filing&#160;Date</span></td></tr><tr style="height:0pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1459839/000119312518303020/d641574dex31.htm">Amended and Restated Certificate of Incorporation.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-38701</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/19/2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1459839/000119312518293978/d452987dex34.htm">Amended and Restated Bylaws.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-227445</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/5/2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1459839/000119312518293978/d452987dex41.htm">Form of Common Stock Certificate of the Company.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-227445</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/5/2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reference is made to Exhibits </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1459839/000119312518303020/d641574dex31.htm">3.1</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> and </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1459839/000119312518293978/d452987dex34.htm">3.2</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a-confidentialmarkupxsvb_x.htm">First Amendment to Loan and Security Agreement, dated January 6, 2023, between SI-BONE, Inc. and Silicon Valley Bank </a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="letteragreement.htm">Letter Agreement, dated March 24, 2023 between SI-BONE, Inc. and  Silicon Valley Bridge Bank. </a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="sibn-ex311_331202310xq.htm">Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="sibn-ex312_331202310xq.htm">Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="sibn-ex321_331202310xq.htm">Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;&#160;Filed herewith.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**&#160;&#160;&#160;Furnished herewith.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit 32.1 is being furnished and shall not be deemed to be &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liability of that section, nor shall such exhibit be deemed to be incorporated by reference in any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise specifically stated in such filing.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><div id="i928aa505a2ea46079da4e5082002267b_136"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES </span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section&#160;13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized, in Santa Clara, California, on May&#160;2, 2023.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.166%"><tr><td style="width:1.0%"></td><td style="width:5.665%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.126%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SI-BONE, Inc.</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Laura A. Francis</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Laura A. Francis</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Duly Authorized Officer and Principal Executive Officer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">) </span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SI-BONE, Inc.</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Anshul Maheshwari</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Anshul Maheshwari</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Financial Officer</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Duly Authorized Officer and Principal Financial and Accounting Officer)</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>a-confidentialmarkupxsvb_x.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i37efde9015094164b274aef726ee5ee2_1"></div><div style="min-height:35.28pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EXHIBIT 10.1</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CERTAIN INFORMATION IDENTIFIED BY &#8220;&#91;***&#93;&#8221; HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE OF INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="padding-left:183.5pt;padding-right:179.55pt;text-indent:32.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:48.05pt;padding-right:39.1pt;text-align:justify;text-indent:33.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This First Amendment to Loan and Security Agreement (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) is entered into as of January 6, 2023, by and between (i) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">SILICON VALLEY BANK</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, a California corporation (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Bank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), and</font></div><div style="margin-top:0.15pt;padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">SI-BONE, INC.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, a Delaware corporation (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:19.3pt;padding-right:19.3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Recitals</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.34pt">Bank and Borrower have entered into that certain Loan and Security Agreement dated as of August 12, 2021 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Existing Loan Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;&#59; the Existing Loan Agreement, as amended, restated, amended and restated, modified, or supplemented from time to time, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Loan Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25pt">Bank has extended credit to Borrower for the purposes permitted in the Loan Agreement.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">C.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:14.34pt">Borrower has requested that Bank amend the Loan Agreement to make certain revisions to the Loan Agreement as more fully set forth herein.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">D.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.34pt">Bank has agreed to so amend certain provisions of the Loan Agreement, but only to the extent, in accordance with the terms, subject to the conditions and in reliance upon the representations and warranties set forth below.</font></div><div style="padding-left:19.32pt;padding-right:19.32pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Agreement</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Now, Therefore, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">in consideration of the foregoing recitals and other good and valuable consideration, the receipt and adequacy of which is hereby acknowledged, and intending to be legally bound, the parties hereto agree as follows&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:17.75pt">Definitions. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Capitalized terms used but not defined in this Amendment shall have the meanings given to them in the Loan Agreement.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:27.75pt">Amendments to Loan Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> attached hereto, sets forth a clean copy of the Loan Agreement as amended hereby.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> attached hereto, shows deletions of the text in the Existing Loan Agreement pursuant to this Amendment (including, to the extent included in such </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, each Schedule or Exhibit to the Existing Loan Agreement), which are indicated by </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">struck-through text</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, and insertions of text, which are indicated by </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">bold, double-underlined text</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:41.8pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:17.75pt">Representations and Warranties.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">To induce Bank to enter into this Amendment, Borrower hereby represents and warrants to Bank as follows&#58;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:117%">3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;padding-left:12.25pt">Immediately after giving effect to this Amendment (a) the representations and warranties contained in the Loan Documents are true, accurate and complete in all material respects as of the date hereof (except to the extent such representations and warranties relate to an earlier date, in which case they are true and correct as of such date), and (b) no Event of Default has occurred and is continuing&#59;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.85pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">3.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Borrower has the power and authority to execute and deliver this Amendment and to perform its obligations under the Loan Agreement, as affected by this Amendment&#59;</font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:117%">3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;padding-left:12.25pt">The organizational documents of Borrower delivered to Bank on the Effective Date remain true, accurate and complete and have not been amended, supplemented or restated and are and continue to be in full force and effect&#59;</font></div><div style="height:58.32pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">3.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">The execution and delivery by Borrower of this Amendment and the performance by Borrower of its obligations under the Loan Agreement, as affected by this Amendment, have been duly authorized&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">The execution and delivery by Borrower of this Amendment and the performance by Borrower of its obligations under the Loan Agreement, as affected by this Amendment, do not and will not contravene (a) any law or regulation binding on or affecting Borrower, (b) any contractual restriction with a Person binding on Borrower, (c) any order, judgment or decree of any court or other governmental or public body or authority, or subdivision thereof, binding on Borrower, or (d) the organizational documents of Borrower, or applicable consents or waivers have been obtained&#59;</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">The execution and delivery by Borrower of this Amendment and the performance by Borrower of its obligations under the Loan Agreement, as affected by this Amendment, do not require any order, consent, approval, license, authorization or validation of, or filing, recording or registration with, or exemption by any governmental or public body or authority, or subdivision thereof, binding on Borrower, except as already has been obtained or made&#59; and</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">3.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">This Amendment has been duly executed and delivered by Borrower and is the binding obligation of Borrower, enforceable against Borrower in accordance with its terms, except as such enforceability may be limited by bankruptcy, insolvency, reorganization, liquidation, moratorium or other similar laws of general application and equitable principles relating to or affecting creditors&#8217; rights.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:17.75pt">Updated Perfection Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Borrower has delivered an updated Perfection Certificate dated as of the date hereof in connection with this Amendment (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Updated Perfection Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), which Updated Perfection Certificate shall supersede in all respects that certain Perfection Certificate delivered to Bank on the Effective Date. Borrower and Bank acknowledge and agree that all references in the Loan Agreement to the &#8220;Perfection Certificate&#8221; shall hereinafter be deemed to be a reference to the Updated Perfection Certificate.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:17.75pt">Integration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Amendment and the Loan Documents represent the entire agreement about this subject matter and supersede prior negotiations or agreements. All prior agreements, understandings, representations, warranties, and negotiations between the parties about the subject matter of this Amendment and the Loan Documents merge into this Amendment and the Loan Documents.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:17.75pt">Counterparts. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Amendment may be executed in any number of counterparts and all of such counterparts taken together shall be deemed to constitute one and the same instrument.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:17.75pt">Effectiveness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. As a condition precedent to the effectiveness of this Amendment and Bank&#8217;s obligation to make further Credit Extensions, Bank shall have received the following prior to or concurrently with this Amendment, each in form and substance satisfactory to Bank&#58;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">The due execution and delivery to Bank of this Amendment by each party</font></div><div style="margin-top:0.1pt;padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">thereto&#59;</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">7.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">copies, certified in a certificate executed by a duly authorized officer of Borrower, to be true and complete as of the date of such certificate, of each of (i) the governing documents of Borrower, as in effect on the date of such certificate, (ii) the resolutions of Borrower authorizing the execution and delivery of this Amendment, all documents executed by it in connection herewith, and Borrower&#8217;s performance of all of the transactions contemplated hereby, and (iii) an incumbency certificate giving the name and bearing a specimen signature of each individual who shall be so authorized&#59;</font></div><div style="padding-left:10pt;padding-right:41.75pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">7.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">a good standing certificate of Borrower, certified by the Secretary of State of the state of formation of Borrower, and each jurisdiction in which Borrower is qualified to do business required by Bank, dated as of a date no earlier than thirty (30) days prior to the date hereof&#59;</font></div><div style="padding-left:10pt;padding-right:41.75pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">7.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">repayment of all Obligations constituting Term Loan Advances (as defined in the Existing Loan Agreement) outstanding immediately prior to the First Amendment Effective Date&#59;</font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">7.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">certified copies, dated as of a recent date, of UCC and other lien searches of Borrower, as Bank may request and which shall be obtained by Bank, accompanied by written evidence (including any UCC termination statements) that the Liens revealed in any such searched either (i) will be terminated prior to or in connection with this Amendment, or (ii) will constitute Permitted Liens&#59;</font></div><div style="height:58.32pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><font><br></font></div></div><div style="padding-left:10pt;padding-right:41.75pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">7.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">the Updated Perfection Certificate of Borrower&#59;</font></div><div style="padding-left:10pt;padding-right:41.75pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">7.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Borrower&#8217;s payment of Bank&#8217;s legal fees and expenses incurred in connection with this Amendment&#59; and</font></div><div style="padding-left:10pt;padding-right:41.75pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">7.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">such other documents as Bank may reasonably request to effectuate the terms of this Amendment.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:17.75pt">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Amendment and any claim, controversy, dispute or cause of action (whether in contract or tort or otherwise) based upon, arising out of or relating to this Amendment and the transactions contemplated hereby and thereby shall be governed by, and construed in accordance with, the laws of the State of California, without giving effect to any choice or conflict of law provision or rule (whether of the State of California or any other jurisdiction).</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:19.35pt;padding-right:19.35pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Signature page follows.&#93;</font></div><div style="text-align:center"><font><br></font></div><div style="height:58.32pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:46pt;padding-right:39.65pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">In Witness Whereof, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the parties hereto have caused this Amendment to be duly executed and delivered as of the date first written above.</font></div><div><font><br></font></div><div style="padding-left:40.85pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.196%"><tr><td style="width:1.0%"></td><td style="width:45.053%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.055%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:0.5pt dotted #000000;border-top:0.5pt dotted #000000;padding:2px 1pt 2px 6.35pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">BANK&#58;</font></td><td colspan="3" rowspan="3" style="border-bottom:0.5pt dotted #000000;border-left:0.5pt dotted #000000;border-top:0.5pt dotted #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt dotted #000000;border-right:0.5pt dotted #000000;border-top:0.5pt dotted #000000;padding:2px 1pt 2px 6.35pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">BORROWER&#58;</font></td></tr><tr style="height:32pt"><td colspan="3" style="border-left:0.5pt dotted #000000;border-right:0.5pt dotted #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:5.85pt;padding-left:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SILICON VALLEY BANK</font></div></td><td colspan="3" style="border-left:0.5pt dotted #000000;border-right:0.5pt dotted #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:5.85pt;padding-left:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SI-BONE, INC.</font></div></td></tr><tr style="height:47pt"><td colspan="3" style="border-bottom:0.5pt dotted #000000;border-left:0.5pt dotted #000000;border-right:0.5pt dotted #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:5.35pt;padding-right:2.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58; &#47;s&#47; Mark Davis</font></div><div style="padding-left:5.35pt;padding-right:2.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58; Mark Davis</font></div><div style="margin-top:0.05pt;padding-left:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58; Senior Vice President</font></div></td><td colspan="3" style="border-bottom:0.5pt dotted #000000;border-left:0.5pt dotted #000000;border-right:0.5pt dotted #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:5.35pt;padding-right:2.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58; &#47;s&#47; Anshul Maheshwari</font></div><div style="padding-left:5.35pt;padding-right:2.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58; Anshul Maheshwari</font></div><div style="margin-top:0.05pt;padding-left:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58; CFO</font></div></td></tr></table></div><div><font><br></font></div><div style="height:58.32pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:19.4pt;padding-right:19.4pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">EXHIBIT A</font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:19.27pt;padding-right:19.27pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;Attached.&#93;</font></div><div style="height:58.32pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i37efde9015094164b274aef726ee5ee2_4"></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:19.3pt;padding-right:19.3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LOAN AND SECURITY AGREEMENT</font></div><div><font><br></font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LOAN AND SECURITY AGREEMENT </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) is dated as of the Effective Date between </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SILICON VALLEY BANK</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, a California corporation (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Bank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), and the borrower listed on Schedule I hereto (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;). The parties agree as follows&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:28.5pt;text-decoration:underline">LOAN AND TERMS OF PAYMENT</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Term Loan Advance.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt;text-decoration:underline">Availability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Subject to the terms and conditions of this Agreement, on or about the First Amendment Effective Date or, Bank shall make one (1) term loan advance to Borrower in an original principal amount equal to the Term Loan Availability Amount (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Term Loan Advance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) which shall be used to (i) refinance the Term Loan Advance (as defined in the Agreement prior to the First Amendment Effective Date) outstanding as of the First Amendment Effective Date, (ii) satisfy the Final Payment (as defined in the Agreement prior to the First Amendment Effective Date), which is with respect to the Term Loan Advance (as defined in the Agreement prior to the First Amendment Effective Date), and (iii) thereafter, used for working capital purposes. Bank and Borrower acknowledge and agree that prior to the First Amendment Effective Date, the amount Borrower accrued and owed to Bank in connection with the Final Payment (as defined in the Agreement prior to the First Amendment Effective Date) was Two Hundred Seventy Four Thousand Nine Hundred Ninety Dollars and 88&#47;100 ($274,990.88). After repayment (in whole or in part), the Term Loan Advance may not be reborrowed.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additionally, at any time during the applicable draw period agreed to by Borrower and Bank, Borrower may request that Bank make additional term loan advances available to Borrower in an aggregate original principal amount of up to Fifteen Million Dollars ($15,000,000) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Uncommitted Accordion</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;). Bank, in its sole and absolute discretion, may grant or deny any such request from Borrower for a term loan advance under the Uncommitted Accordion. If, and only if, Bank, in its sole discretion, agrees to provide any additional term loan advance(s) to Borrower under the Uncommitted Accordion, each such term loan advance shall each be considered a &#8220;Term Loan Advance&#8221; hereunder and added to the definition thereof&#59; provided that the terms of the making of any advance under the Uncommitted Accordion shall be outlined in an amendment to this Agreement to be entered into by the parties hereto.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:underline">Repayment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Borrower shall repay the Term Loan Advance as set forth in Schedule I hereto. All outstanding principal and accrued and unpaid interest under the Term Loan Advance, and all other outstanding Obligations with respect to such Term Loan Advance, are due and payable in full on the Term Loan Maturity Date.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt;text-decoration:underline">Permitted Prepayment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Borrower shall have the option to prepay all, but not less than all, of the Term Loan Advance, provided Borrower (i) delivers written notice to Bank of its election to prepay the Term Loan Advance at least five (5) Business Days prior to such prepayment, and (ii) pays, on the date of such prepayment</font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(A) the outstanding principal plus accrued and unpaid interest with respect to the Term Loan Advance, (B) the applicable Prepayment Fee, if any, (C) the Final Payment, and (D) all other sums, if any, that shall have become due and payable with respect to the Term Loan Advance, including interest at the Default Rate with respect to any past due amounts.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:underline">Mandatory Prepayment Upon an Acceleration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. If the Term Loan Advance is accelerated by Bank following the occurrence and during the continuance of an Event of Default, Borrower shall immediately pay to Bank an amount equal to the sum of (i) all outstanding principal plus accrued and unpaid interest with respect to the Term Loan Advance, (ii) the applicable Prepayment Fee, if any, (iii) the Final Payment, and (iv) all other sums, if any, that shall have become due and payable with respect to the Term Loan Advance, including interest at the Default Rate with respect to any past due amounts.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:117.95pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1.A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.78pt">Revolving Line.</font></div><div style="height:69.12pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i37efde9015094164b274aef726ee5ee2_7"></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt;text-decoration:underline">Availability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Subject to the terms and conditions of this Agreement and to deduction of Reserves, Bank shall make Advances under the Revolving Line upon Borrower&#8217;s request not exceeding the Availability Amount. Amounts borrowed under the Revolving Line may be prepaid or repaid as set forth on Schedule I hereto.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:underline">Termination&#59; Repayment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. The Revolving Line terminates on the Revolving Line Maturity Date, at which time the outstanding principal amount of all Advances, the accrued and unpaid interest thereon, and all other outstanding Obligations relating to the Revolving Line shall be immediately due and payable.</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1.B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:4.34pt">Overadvances. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If, at any time, the sum of the aggregate outstanding principal amount of any Advances exceeds the lesser of (i) the Revolving Line or (ii) the Borrowing Base, Borrower shall immediately pay to Bank in cash the amount of such excess (such excess, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Overadvance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;). Without limiting Borrower&#8217;s obligation to repay Bank any Overadvance, at Bank&#8217;s sole option, Borrower shall pay Bank interest on the outstanding amount of any Overadvance, on demand, at a rate per annum equal to the rate that is otherwise applicable to Advances plus three percent (3.0%).</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Payment of Interest on the Credit Extensions.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:154pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.91pt;text-decoration:underline">Interest Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:154pt;padding-right:41.75pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.57pt;text-decoration:underline">Advances</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Interest on the principal amount of each Advance is payable as set forth on Schedule I hereto.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:154pt;padding-right:41.9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt;text-decoration:underline">Term Loan Advances</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Interest on the outstanding principal amount of each Term Loan Advance is payable as set forth on Schedule I hereto.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:154pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt;text-decoration:underline">Interest Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.57pt;text-decoration:underline">Advances</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Subject to Section 1.2(c), the outstanding principal amount of any Advance shall accrue interest as set forth on Schedule I hereto.</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt;text-decoration:underline">Term Loan Advances</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Subject to Section 1.2(c), the outstanding principal amount of the Term Loan Advance shall accrue interest as set forth on Schedule I hereto.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:11.03pt;text-decoration:underline">All-In Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Notwithstanding any terms in this Agreement to the contrary, if at any time the interest rate applicable to any Obligations is less than zero percent (0.0%), such interest rate shall be deemed to be zero percent (0.0%) for all purposes of this Agreement.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt;text-decoration:underline">Default Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Immediately upon the occurrence and during the continuance of an Event of Default, the outstanding Obligations shall bear interest at a rate per annum which is three percent (3.0%) above the rate that is otherwise applicable thereto (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Default Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), unless Bank otherwise elects, in its sole discretion, to impose a lesser increase or no increase. Fees and expenses which are required to be paid by Borrower pursuant to the Loan Documents (including, without limitation, Bank Expenses) but are not paid when due shall bear interest until paid at a rate equal to the highest rate applicable to the Obligations. Payment or acceptance of the increased interest rate provided in this Section 1.2(c) is not a permitted alternative to timely payment and shall not constitute a waiver of any Event of Default or otherwise prejudice or limit any rights or remedies of Bank.</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:underline">Adjustment to Interest Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Each change in the interest rate applicable to any amounts payable under the Loan Documents based on changes to the Prime Rate shall be effective on the effective date of any change to the Prime Rate and to the extent of such change.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt;text-decoration:underline">Interest Computation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Interest shall be computed as set forth on Schedule I hereto. In computing interest, the date of the making of any Credit Extension shall be included and the date of payment shall be excluded&#59; provided, however, that if any Credit Extension is repaid on the same day on which it is made, such day shall be included in computing interest on such Credit Extension.</font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i37efde9015094164b274aef726ee5ee2_10"></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Fees and Expenses. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrower shall pay to Bank&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt;text-decoration:underline">Prepayment Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. The Prepayment Fee, if and when due hereunder, which shall be fully earned and non-refundable as of the applicable prepayment date&#59; provided, however, if Borrower refinances the Term Loan Advance with another credit facility from Bank, Bank shall waive the Prepayment Fee&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:underline">Final Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. The Final Payment, when due hereunder, which shall be fully earned and non-refundable as of such date, provided however, for the avoidance of doubt, the Final Payment due under the terms of this original Agreement with respect to the original Term Loan Advances shall be pro-rated and accrued and payable only through the date such original Term Loan Advances are repaid on or around the First Amendment Effective Date, in accordance with Section 1.1(a)&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt;text-decoration:underline">Revolving Line Commitment Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. A fully earned, as of the First Amendment Effective Date, non-refundable commitment fee as set forth on Schedule I hereto&#59; and</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:underline">Termination Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Upon termination of this Agreement or the termination of the Revolving Line for any reason prior to the Revolving Line Maturity Date, in addition to the payment of any other amounts then- owing, a termination fee in an amount equal to One Hundred Fifty Thousand Dollars ($150,000), which shall be fully earned and non-refundable as of such date&#59; provided that no termination fee shall be charged if the credit facility hereunder is replaced with a new facility from Bank&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt;text-decoration:underline">Bank Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. All Bank Expenses incurred through and after the First Amendment Effective Date, when due (or, if no stated due date, upon demand by Bank). Borrower has paid to Bank a good faith deposit of Seventy-Five Thousand Dollars ($75,000) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Good Faith Deposit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), in connection with the First Amendment, to initiate Bank&#8217;s due diligence review process. The Good Faith Deposit will be applied to Bank Expenses as of the Effective Date.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unless otherwise provided in this Agreement or in a separate writing by Bank, Borrower shall not be entitled to any credit, rebate, or repayment of any fees earned by Bank pursuant to this Agreement notwithstanding any termination of this Agreement or the suspension or termination of Bank&#8217;s obligation to make loans and advances hereunder. Bank may deduct amounts owing by Borrower under the clauses of this Section 1.3 pursuant to the terms of Section <a href="#i37efde9015094164b274aef726ee5ee2_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">1.4(c).</a> Bank shall provide Borrower written notice of deductions made pursuant to the terms of the clauses of this Section 1.3.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Payments&#59; Application of Payments&#59; Debit of Accounts.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">All payments (including prepayments) to be made by Borrower under any Loan Document shall be made in immediately available funds in Dollars, without setoff, counterclaim, or deduction, before 12&#58;00 p.m. Pacific time on the date when due. Payments of principal and&#47;or interest received after 12&#58;00 p.m. Pacific time are considered received at the opening of business on the next Business Day. When a payment is due on a day that is not a Business Day, the payment shall be due the next Business Day, and additional fees or interest, as applicable, shall continue to accrue until paid.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Subject to the payment terms of this Agreement and Section 8.4, Bank has the exclusive right in its reasonable discretion to determine the order and manner in which all payments with respect to the Obligations may be applied. Borrower shall have no right to specify the order or the accounts to which Bank shall allocate or apply any payments required to be made by Borrower to Bank or otherwise received by Bank under this Agreement when any such allocation or application is not specified elsewhere in this Agreement.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">Bank may debit the Designated Deposit Account (or if insufficient funds are contained therein, or if an Event of Default has occurred and is continuing, any of Borrower&#8217;s other accounts at Bank), for principal and interest payments or any other amounts Borrower owes Bank when as and when due under this Agreement. These debits shall not constitute a set-off.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Change in Circumstances.</font></div><div><font><br></font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt;text-decoration:underline">Increased Costs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. If any Change in Law shall&#58; (i) impose, modify or deem applicable any reserve, special deposit, compulsory loan, insurance charge or similar requirement against assets of, deposits with or for the account of, or advances, loans or other credit extended or participated in by, Bank, (ii) subject Bank to any Taxes (other than (A) Indemnified Taxes, (B) Taxes described in clauses (b) through (d) of the definition of Excluded Taxes, and (C) Connection Income Taxes) on its loans, loan principal, letters of credit, commitment, or other obligations, or its deposits, reserves, other liabilities or capital attributable thereto, or (iii) impose on Bank any other condition, cost or expense (other than Taxes) affecting this Agreement or Credit Extensions made by Bank, and the result of any of the foregoing shall be to increase the cost to Bank of making, converting to, continuing or maintaining any Credit Extension (or of maintaining its obligation to make any such Credit Extension), or to reduce the amount of any sum received or receivable by Bank hereunder (whether of principal, interest or any other amount) then, upon written request of Bank, Borrower shall promptly pay to Bank such additional amount or amounts as will compensate Bank for such additional costs incurred or reduction suffered.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:underline">Capital Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. If Bank determines that any Change in Law affecting Bank regarding capital or liquidity requirements, has or would have the effect of reducing the rate of return on Bank&#8217;s capital as a consequence of this Agreement, the Revolving Line, any term loan facility, or the Credit Extensions made by Bank to a level below that which Bank could have achieved but for such Change in Law (taking into consideration Bank&#8217;s policies with respect to capital adequacy and liquidity), then from time to time upon written request of Bank, Borrower shall promptly pay to Bank such additional amount or amounts as will compensate Bank for any such reduction suffered.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt;text-decoration:underline">Delay in Requests</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Failure or delay on the part of Bank to demand compensation pursuant to this Section 1.5 shall not constitute a waiver of Bank&#8217;s right to demand such compensation&#59; provided that Borrower compensate Bank pursuant to subsection (a) for any increased costs incurred or reductions suffered more than nine (9) months prior to the date that Bank notifies Borrower of the Change in Law giving rise to such increased costs or reductions (except that if the Change in Law giving rise to such increased costs or reductions is retroactive, then the nine (9) month period shall be extended to include the period of retroactive effect).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Taxes.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt;text-decoration:underline">Payments Free of Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Any and all payments by or on account of any obligation of Borrower under any Loan Document shall be made without deduction or withholding for any Taxes, except as required by Applicable Law. If any Applicable Law (as determined in the commercially reasonable discretion of Borrower) requires the deduction or withholding of any Tax from any such payment by Borrower, then (i) Borrower shall be entitled to make such deduction or withholding, (ii) Borrower shall timely pay the full amount deducted or withheld to the relevant Governmental Authority in accordance with Applicable Law, and (iii) if such Tax is an Indemnified Tax, the sum payable by Borrower shall be increased as necessary so that after such deduction or withholding has been made (including such deductions and withholdings applicable to additional sums payable under this Section 1.6) Bank receives an amount equal to the sum it would have received had no such deduction or withholding been made.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:underline">Payment of Other Taxes by Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Without limiting the provisions of subsection (a) above, Borrower shall timely pay any Other Taxes to the relevant Governmental Authority in accordance with Applicable Law.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt;text-decoration:underline">Tax Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Without limiting the provisions of subsections (a) and (b) above, Borrower shall, and does hereby, indemnify Bank, within ten (10) days after demand therefor, for the full amount of any Indemnified Taxes (including Indemnified Taxes imposed or asserted on or attributable to amounts payable under this Section 1.6) payable or paid by Bank or required to be withheld or deducted from a payment to Bank and any reasonable expenses arising therefrom or with respect thereto, whether or not such Indemnified Taxes were correctly or legally imposed or asserted by the relevant Governmental Authority. A certificate as to the amount of such payment or liability delivered to Borrower by Bank shall be conclusive absent manifest error.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:underline">Evidence of Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. As soon as practicable after any payment of Taxes by Borrower to a Governmental Authority pursuant to this Section 1.6, Borrower shall deliver to Bank a certified copy of a receipt</font></div><div style="text-align:justify"><font><br></font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:39.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">issued by such Governmental Authority evidencing such payment, a copy of the return reporting such payment or other evidence of such payment reasonably satisfactory to Bank.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt;text-decoration:underline">Status of Bank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. If Bank (including any assignee or successor) is entitled to an exemption from or reduction of withholding tax with respect to payments made under any Loan Document, it shall deliver to Borrower, at the time or times reasonably requested by Borrower, such properly completed and executed documentation reasonably requested by Borrower as will permit such payments to be made without withholding or at a reduced rate of withholding. In addition, Bank, if reasonably requested by Borrower, shall deliver such other documentation prescribed by Applicable Law or reasonably requested by Borrower as will enable Borrower to determine whether or not Bank is subject to backup withholding or information reporting requirements. Without limiting the generality of the foregoing, Bank shall deliver whichever of IRS Form W-9, IRS Form W-8BEN-E, IRS Form W-8ECI or IRS Form W-8IMY is applicable, as well as any applicable supporting documentation or certifications. If a payment made to Bank under any Loan Document would be subject to U.S. federal withholding Tax imposed by FATCA if Bank were to fail to comply with the applicable reporting requirements of FATCA (including those contained in Section 1471(b) or 1472(b) of the Internal Revenue Code, as applicable), Bank shall deliver to Borrower at the time or times prescribed by law and at such time or times reasonably requested by Borrower such documentation prescribed by Applicable Law (including as prescribed by Section 1471(b)(3)(C)(i) of the Internal Revenue Code) and such additional documentation reasonably requested by Borrower as may be necessary for Borrower to comply with its obligations under FATCA and to determine that Bank has complied with its obligations under FATCA or to determine the amount, if any, to deduct and withhold from such payment. Solely for purposes of the preceding sentence, &#8220;FATCA&#8221; shall include any amendments made to FATCA after the date of this Agreement.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.01pt;text-decoration:underline">Treatment of Certain Refunds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. If Bank determines, in its sole discretion exercised in good faith, that it has received a refund of any Taxes as to which it has been indemnified pursuant to this Section 1.6 (including by the payment of additional amounts pursuant to this Section 1.6), it shall pay to Borrower an amount equal to such refund (but only to the extent of indemnity payments made under this Section 1.6 with respect to the Taxes giving rise to such refund), net of all out-of-pocket expenses (including Taxes) of Bank and without interest (other than any interest paid by the relevant Governmental Authority with respect to such refund). Borrower, upon the request of Bank, shall repay to Bank the amount paid over pursuant to this paragraph (f) (plus any penalties, interest or other charges imposed by the relevant Governmental Authority) in the event that Bank is required to repay such refund to such Governmental Authority. Notwithstanding anything to the contrary in this paragraph (f), in no event will Bank be required to pay any amount to Borrower pursuant to this paragraph (f) the payment of which would place Bank in a less favorable net after-Tax position than Bank would have been in if the Tax subject to indemnification and giving rise to such refund had not been deducted, withheld or otherwise imposed and the indemnification payments or additional amounts with respect to such Tax had never been paid. This paragraph (f) shall not be construed to require Bank to make available its Tax returns (or any other information relating to its Taxes that it deems confidential) to Borrower or any other Person.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Procedures for Borrowing.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt;text-decoration:underline">Advances</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Subject to the prior satisfaction of all other applicable conditions to the making of an Advance set forth in this Agreement (which must be satisfied no later than 12&#58;00 p.m. Pacific time on the applicable Funding Date), to obtain an Advance, Borrower (via an individual duly authorized by an Administrator) shall notify Bank (which notice shall be irrevocable) by 12&#58;00 p.m. Pacific time on the Funding Date of the Advance. Such notice shall be made through Bank&#8217;s online banking program, provided, however, if Borrower is not utilizing Bank&#8217;s online banking program, then such notice shall be in a written format acceptable to Bank that is executed by an Authorized Signer. In connection with any such notification, Borrower shall deliver to Bank by electronic mail or through Bank&#8217;s online banking program such reports and information, including without limitation, accounts receivable aging reports, as Bank may reasonably request. Bank shall have received satisfactory evidence that the Board has approved that such Authorized Signer may provide such notices and request Advances (which requirement may be deemed satisfied by the prior delivery of Borrowing Resolutions or a secretary&#8217;s certificate that certifies as to such Board approval).</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:underline">Term Loan Advances</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Subject to the prior satisfaction of all other applicable conditions to the making of the Term Loan Advance set forth in this Agreement (which must be satisfied no later than 12&#58;00 p.m.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pacific time on the applicable Funding Date), to obtain the Term Loan Advance, Borrower shall notify Bank (which notice shall be irrevocable) by 12&#58;00 p.m. Pacific time on the Funding Date of the Term Loan Advance. Such notice shall be made by electronic mail or by telephone and, together with any such notification, Borrower shall deliver to Bank by electronic mail a completed Payment&#47;Advance Form executed by an Authorized Signer. Bank may rely on any telephone notice given by a person whom Bank reasonably believes is an Authorized Signer. Borrower will indemnify Bank for any loss Bank suffers due to such reasonable belief or reliance. Bank shall have received satisfactory evidence that the Board has approved that such Authorized Signer may provide such notices and request such Term Loan Advance (which requirement may be deemed satisfied by the prior delivery of Borrowing Resolutions or a secretary&#8217;s certificate that certifies as to such Board approval).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">Bank shall credit proceeds of a Credit Extension to the Designated Deposit Account. Bank may make Advances and Term Loan Advances under this Agreement based on instructions from an Authorized Signer or without instructions if such Advances or Term Loan Advances are necessary to meet Obligations which have become due.</font></div><div><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:28.5pt;text-decoration:underline">CONDITIONS OF CREDIT EXTENSIONS</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Conditions Precedent to Initial Credit Extension. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank&#8217;s obligation to make the initial Credit Extension is subject to the condition precedent that Bank shall have received, in form and substance satisfactory to Bank, such documents, and completion of such other matters, as Bank may reasonably deem necessary or appropriate, including, without limitation&#58;</font></div><div><font><br></font></div><div style="padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.91pt">duly executed Loan Documents&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">a duly executed Control Agreement with U.S. Bank&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">the Operating Documents of Borrower and its Subsidiaries and long-form good standing certificates of Borrower certified by the Secretary of State of the State of Delaware and the Secretary of State (or equivalent agency) of each other jurisdiction in which Borrower is qualified to conduct business, in each case as of a date no earlier than thirty (30) days prior to the Effective Date&#59;</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">a certificate duly executed by a Responsible Officer or secretary of Borrower with respect to Borrower&#8217;s (i) Operating Documents and (ii) Borrowing Resolutions&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.91pt">a duly executed payoff letter from Solar Capital&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.01pt">evidence that (i) the Liens securing Indebtedness owed by Borrower to Solar Capital will be terminated and (ii) the documents and&#47;or filings evidencing the perfection of such Liens, including without limitation any financing statements and&#47;or control agreements, have or will, concurrently with the initial Credit Extension, be terminated&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">certified copies, dated as of a recent date, of searches for financing statement filed in the central filing office of the State of Delaware, accompanied by written evidence (including any UCC termination statements) that the Liens indicated in any such financing statements either constitute Permitted Liens or have been or, in connection with the initial Credit Extension, will be terminated or released&#59;</font></div><div><font><br></font></div><div style="padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">a duly executed Perfection Certificate of Borrower&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.57pt">a duly executed landlord&#8217;s consent in favor of Bank for Borrower&#8217;s leased location at 471 El Camino Real, Suite 101, Santa Clara, CA 95050&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.57pt">a legal opinion of Borrower&#8217;s counsel dated as of the Effective Date&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">with respect to initial Advance, a completed Borrowing Base Certificate&#59;</font></div><div><font><br></font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.57pt">the completion of the Initial Audit with respect to the initial Advance&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:11.57pt">evidence satisfactory to Bank that the insurance policies and endorsements required by Section <a href="#i37efde9015094164b274aef726ee5ee2_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">5.8</a> hereof are in full force and effect, together with appropriate evidence showing lender loss payable and additional insured clauses or endorsements in favor of Bank&#59; and</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">payment of the fees and Bank Expenses then due as specified in Section 1.3 hereof.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Conditions Precedent to all Credit Extensions. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank&#8217;s obligation to make each Credit Extension, including the initial Credit Extension, is subject to the following conditions precedent&#58;</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:41.85pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">receipt of Borrower&#8217;s Credit Extension request and the related materials and documents as required by and in accordance with Section 1.7&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">the representations and warranties in this Agreement shall be true and correct in all material respects as of the date of any Credit Extension request and as of the Funding Date of each Credit Extension&#59; provided, however, that such materiality qualifier shall not be applicable to any representations and warranties that already are qualified or modified by materiality in the text thereof&#59; and provided, further that those representations and warranties expressly referring to a specific date shall be true and correct in all material respects as of such date, and no Default or Event of Default shall have occurred and be continuing or result from the Credit Extension. Each Credit Extension is Borrower&#8217;s representation and warranty on that date that the representations and warranties in this Agreement remain true and correct in all material respects&#59; provided, however, that such materiality qualifier shall not be applicable to any representations and warranties that already are qualified or modified by materiality in the text thereof&#59; and provided, further that those representations and warranties expressly referring to a specific date shall be true and correct in all material respects as of such date&#59; and</font></div><div><font><br></font></div><div style="padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.91pt">a Material Adverse Change shall not have occurred.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Covenant to Deliver.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)  Borrower shall deliver to Bank each item required to be delivered to Bank under this Agreement as a condition precedent to any Credit Extension. A Credit Extension made prior to the receipt by Bank of any such item shall not constitute a waiver by Bank of Borrower&#8217;s obligation to deliver such item, and the making of any Credit Extension in the absence of a required item shall be in Bank&#8217;s sole discretion.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:28.5pt;text-decoration:underline">CREATION OF SECURITY INTEREST</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Grant of Security Interest.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">Borrower hereby grants Bank, to secure the payment and performance in full of all of the Obligations, a continuing security interest in, and pledges to Bank, the Collateral, wherever located, whether now owned or hereafter acquired or arising, and all proceeds and products thereof.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Borrower acknowledges that it previously has entered, or may in the future enter, into Bank Services Agreements with Bank. Regardless of the terms of any Bank Services Agreement, Borrower agrees that any amounts Borrower owes Bank thereunder shall be deemed to be Obligations hereunder and that it is the intent of Borrower and Bank to have all such Obligations secured by the first priority perfected security interest in the Collateral granted herein (subject to Permitted Liens).</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Authorization to File Financing Statements. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrower hereby authorizes Bank to file financing statements covering the Collateral, without notice to Borrower, with all jurisdictions deemed necessary or appropriate by Bank to perfect or protect Bank&#8217;s interest or rights hereunder, including a notice that any disposition of the Collateral, by either Borrower or any other Person, in contravention of the terms of this Agreement shall be deemed to violate the rights of Bank under the Code. Such financing statements may indicate the Collateral</font></div><div style="text-align:justify"><font><br></font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. If this Agreement is terminated, Bank&#8217;s Lien in the Collateral shall continue until the Obligations (other than inchoate indemnity obligations) are repaid in full in cash. Upon payment in full in cash of the Obligations (other than inchoate indemnity obligations) and at such time as Bank&#8217;s obligation to make Credit Extensions has terminated, Bank shall, at Borrower&#8217;s sole cost and expense, promptly terminate its security interest in the Collateral and all rights therein shall automatically revert to Borrower, and Bank shall, upon request from Borrower and at Borrower&#8217;s sole cost and expense, promptly deliver to Borrower written evidence of the termination of such liens and any other documents reasonably necessary to terminate such liens. In the event (a) all Obligations (other than inchoate indemnity obligations), except for Bank Services, are satisfied in full, and (b) this Agreement is terminated, Bank shall terminate the security interest granted herein upon Borrower providing cash collateral acceptable to Bank in its commercially reasonable discretion for Bank Services, if any. In the event such Bank Services consist of outstanding Letters of Credit, Borrower shall provide to Bank cash collateral in an amount equal to at least (i) one hundred and five percent (105.0%) of the face amount of all such Letters of Credit denominated in Dollars and (ii) one hundred and fifteen percent (115.0%) of the Dollar Equivalent of the face amount of all such Letters of Credit denominated in a Foreign Currency, plus, in each case, all interest, fees, and costs due or estimated by Bank to become due in connection therewith, to secure all of the Obligations relating to such Letters of Credit.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:28.5pt;text-decoration:underline">REPRESENTATIONS AND WARRANTIES</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrower represents and warrants as follows&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Due Organization, Authorization&#59; Power and Authority.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">Borrower and each of its Subsidiaries are each duly existing and in good standing as a Registered Organization in their respective jurisdiction of formation and are qualified and licensed to do business and is in good standing in any other jurisdiction in which the conduct of their respective business or their ownership of property requires that they be qualified except where the failure to do so could not reasonably be expected to have a material adverse effect on Borrower&#8217;s business or operations.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">All information set forth on the Perfection Certificate pertaining to Borrower and each of its Subsidiaries is true and correct in all material respects (it being understood and agreed that Borrower may from time to time update certain information in the Perfection Certificate after the First Amendment Effective Date to the extent permitted by one or more specific provisions in this Agreement and the Perfection Certificate shall be deemed to be updated to the extent such notice is provided to Bank of such permitted update).</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">The execution, delivery and performance by Borrower and each of its Subsidiaries of the Loan Documents to which it is a party have been duly authorized, and do not (i) conflict with any of Borrower&#8217;s or any such Subsidiary&#8217;s organizational documents, (ii) contravene, conflict with, constitute a default under or violate any material Applicable Law, (iii) contravene, conflict with or violate any applicable order, writ, judgment, injunction, decree, determination or award of any Governmental Authority by which Borrower or any of its Subsidiaries or any of their property or assets may be bound or affected, (iv) require any action by, filing, registration, or qualification with, or Governmental Approval from, any Governmental Authority (except such Governmental Approvals which have already been obtained and are in full force and effect), or (v) conflict with, contravene, constitute a default or breach under, or result in or permit the termination or acceleration of, any material agreement by which Borrower or any of its Subsidiaries is bound, or applicable consents or waivers have been obtained. Neither Borrower nor any of its Subsidiaries are in default under any material agreement to which it is a party or by which it is bound in which the default could reasonably be expected to have a material adverse effect on Borrower&#8217;s or any of its Subsidiary&#8217;s business or operations (taken as a whole).</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Collateral.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">The security interest granted herein is and shall at all times continue to be a first priority perfected security interest in the Collateral (subject to Permitted Liens). Borrower has good title to, rights in, and the power to transfer each item of the Collateral upon which it purports to grant a Lien hereunder, free and clear of any and all Liens except Permitted Liens.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Borrower has no Collateral Accounts at or with any bank or financial institution other than Bank or Bank&#8217;s Affiliates except for the Collateral Accounts described in the Perfection Certificate delivered to Bank in connection herewith and which Borrower has taken such actions as are necessary to give Bank a perfected security interest therein, to the extent that perfection is required pursuant to the terms of Section <a href="#i37efde9015094164b274aef726ee5ee2_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">5.9(a).</a> The Accounts are bona fide, existing obligations of the Account Debtors.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">The Collateral is not in the possession of any third party bailee (such as a warehouse) except as otherwise provided in the Perfection Certificate or as permitted pursuant to Section <a href="#i37efde9015094164b274aef726ee5ee2_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">6.2</a> (other than laptops and other portable electronic items used in the ordinary course of business). None of the components of the Collateral shall be maintained at locations other than as provided in the Perfection Certificate or as permitted pursuant to Section <a href="#i37efde9015094164b274aef726ee5ee2_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">6.2</a> (other than laptops and other portable electronic items used in the ordinary course of business).</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">All Inventory is in all material respects of good and marketable quality, free from material</font></div><div style="padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">defects.</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">Borrower owns, or possesses the right to use to the extent reasonably necessary in its business, all Intellectual Property, licenses and other intangible assets that are used in the conduct of its business operations as now operated, except to the extent that such failure to own or possess the right to use such asset would not reasonably be expected to have a material adverse effect on Borrower&#8217;s business or operations, and no such asset, to the best knowledge of Borrower, conflicts with the valid Intellectual Property, license, or intangible asset of any other Person to the extent that such conflict could reasonably be expected to have a material adverse effect on Borrower&#8217;s business or operations.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.9pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.01pt">Except as noted on the Perfection Certificate (as updated from time to time in accordance with this Agreement) or for which notice has been given to Bank pursuant to and in accordance with Section <a href="#i37efde9015094164b274aef726ee5ee2_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">5.11(b),</a> Borrower is not a party to, nor is it bound by, any Restricted License.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Accounts Receivable.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">For each Account included in the most recent Borrowing Base Statement, on the date such related Advance is requested and made, such Account shall be an Eligible Account.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">All statements made and all unpaid balances appearing in all invoices, instruments and other documents evidencing the Eligible Accounts are and shall be true and correct and all such invoices, instruments and other documents, and all of Borrower&#8217;s Books are genuine and in all respects what they purport to be. All sales and other transactions underlying or giving rise to each Eligible Account shall comply in all material respects with all Applicable Law. Borrower has no knowledge of any actual or imminent Insolvency Proceeding of any Account Debtor whose accounts are Eligible Accounts in any Borrowing Base Statement. To Borrower&#8217;s knowledge, all signatures and endorsements on all documents, instruments, and agreements relating to all Eligible Accounts are genuine, and all such documents, instruments and agreements are legally enforceable in accordance with their terms.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Litigation. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other than as set forth on the Perfection Certificate delivered around the First Amendment Effective Date, and as disclosed to Bank pursuant to Section 5.3, there are no actions, investigations or proceedings pending or, to the knowledge of any Responsible Officer, threatened in writing by or against Borrower or any of its Subsidiaries that could reasonably be expected to result in liability of more than, individually or in the aggregate, Seven Hundred Fifty Thousand Dollars ($750,000).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Financial Statements&#59; Financial Condition. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All consolidated financial statements for Borrower and any of its Subsidiaries delivered to Bank by submission to the Financial Statement Repository or otherwise submitted to Bank fairly present in all material respects Borrower&#8217;s consolidated financial condition and Borrower&#8217;s consolidated results of operations as of the dates thereof and for the periods covered thereby, subject, in the case of unaudited financial statements, to normal year-end adjustments and the absence of footnote disclosures. There has not been any material deterioration in Borrower&#8217;s consolidated financial condition since the date of the most recent financial statements submitted to the Financial Statement Repository or otherwise submitted to Bank.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Solvency. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The fair salable value of Borrower&#8217;s consolidated assets (including goodwill minus disposition costs) exceeds the fair value of Borrower&#8217;s liabilities&#59; Borrower is not left with unreasonably small capital after the transactions in this Agreement&#59; and Borrower and Borrower and each of its Subsidiaries (taken as a whole) are able to pay their debts (including trade debts) as they mature.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Regulatory Compliance. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrower is not an &#8220;investment company&#8221; or a company &#8220;controlled&#8221; by an &#8220;investment company&#8221; under the Investment Company Act of 1940, as amended. Borrower is not engaged as one of its important activities in extending credit for margin stock (under Regulations X, T and U of the Federal Reserve Board of Governors). Borrower and each of its Subsidiaries (a) have complied in all material respects with all Applicable Law, and (b) have not violated any Applicable Law the violation of which could reasonably be expected to have a material adverse effect on Borrower&#8217;s business or operations. Borrower and each of its Subsidiaries have duly complied with, and their respective facilities, business, assets, property, leaseholds, real property and Equipment are in compliance with, Environmental Laws, except where the failure to do so could not reasonably be expected to have a material adverse effect on Borrower&#8217;s business or operations&#59; there have been no outstanding citations, notices or orders of non-compliance issued to Borrower or any of its Subsidiaries or relating to their respective facilities, businesses, assets, property, leaseholds, real property or Equipment under such Environmental Laws Borrower and each of its Subsidiaries have obtained all consents, approvals and authorizations of, made all declarations or filings with, and given all notices to, all Governmental Authorities that are necessary to continue their respective businesses as currently conducted, except where the failure to obtain or make or file the same would not reasonably be expected to have a material adverse effect on Borrower&#8217;s business or operations.</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Subsidiaries&#59; Investments. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrower does not own any stock, partnership, or other ownership interest or other equity securities except for Permitted Investments.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Tax Returns and Payments&#59; Pension Contributions.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">Borrower and each of its Subsidiaries have timely filed, or submitted extensions for, all required tax returns and reports, and Borrower and each of its Subsidiaries have timely paid, or submitted extensions for, all foreign, federal, state and local taxes, assessments, deposits and contributions owed by Borrower and each of its Subsidiaries except (i) to the extent such taxes are being contested in good faith by appropriate proceedings promptly instituted and diligently conducted, so long as such reserve or other appropriate provision, if any, as shall be required in conformity with GAAP shall have been made therefor, or (ii) if such taxes, assessments, deposits and contributions do not, individually or in the aggregate, exceed Fifty Thousand Dollars ($50,000). Borrower is unaware of any claims or adjustments proposed for any of Borrower&#8217;s or any of its Subsidiary&#8217;s prior tax years which could result in additional taxes becoming due and payable by Borrower or any of its Subsidiaries in excess of Fifty Thousand Dollars ($50,000) in the aggregate.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Borrower and each of its Subsidiaries have paid all amounts necessary to fund all present pension, profit sharing and deferred compensation plans in accordance with their terms, and neither Borrower nor any of its Subsidiaries has withdrawn from participation in, and has not permitted partial or complete termination of, or permitted the occurrence of any other event with respect to, any such plan which could reasonably be expected to result in any material liability of Borrower or any of its Subsidiaries, including any liability to the Pension Benefit Guaranty Corporation or its successors or any other Governmental Authority.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:8.5pt">Full Disclosure. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No written representation, warranty or other statement of Borrower or any of its Subsidiaries in any report, certificate or written statement submitted to the Financial Statement Repository or otherwise submitted to Bank, as of the date such representation, warranty, or other statement was made, taken together with all such written reports, written certificates and written statements submitted to the Financial Statement Repository or otherwise submitted to Bank, contains any untrue statement of a material fact or omits to state a material fact necessary to make the statements contained in the reports, certificates or written statements not misleading in light of the circumstances under which they were made (it being recognized by Bank that the projections and forecasts provided by Borrower or any of its Subsidiaries in good faith and based upon reasonable assumptions are not viewed as facts and that actual results during the period or periods covered by such projections and forecasts may differ from the projected or forecasted results).</font></div><div style="text-align:justify"><font><br></font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:8.5pt">Sanctions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Neither Borrower nor any of its Subsidiaries is&#58; (a) in violation of any Sanctions&#59; or (b) a Sanctioned Person. Neither Borrower nor any of its Subsidiaries, or, to Borrower&#8217;s knowledge, its directors, officers, employees, agents or Affiliates&#58; (i) conducts any business or engages in any transaction or dealing with any Sanctioned Person, including making or receiving any contribution of funds, goods or services to or for the benefit of any Sanctioned Person&#59; (ii) deals in, or otherwise engages in any transaction relating to, any property or interests in property blocked pursuant to any Sanctions&#59; (iii) engages in or conspires to engage in any transaction that evades or avoids, or has the purpose of evading or avoiding, or attempts to violate, any of the prohibitions set forth in any Sanctions&#59; or (iv) otherwise engages in any transaction that could cause Bank to violate any Sanctions.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:28.5pt;text-decoration:underline">AFFIRMATIVE COVENANTS</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrower shall do all of the following&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Use of Proceeds. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cause the proceeds of the Credit Extensions to be used solely as follows&#58; (a) for Credit Extensions that occur prior to the First Amendment Effective Date, (i) as working capital, (ii) to fund its general business purposes, or (iii) repayment and payoff of Solar Capital and not for personal, family, household or agricultural purposes, and (b) for Credit Extensions that occur on or after the First Amendment Effective Date, (x) as working capital, (y) to fund its general business purposes, or (z) repayment of all Obligations constituting Term Loan Advances (as defined in the Agreement prior to the First Amendment Effective Date) outstanding immediately prior to the First Amendment Effective Date.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Government Compliance.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">Maintain its and all of its Subsidiaries&#8217; legal existence (except as permitted under Section <a href="#i37efde9015094164b274aef726ee5ee2_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">6.3</a> with respect to Subsidiaries only) and good standing in their respective jurisdictions of formation and maintain qualification in each jurisdiction in which the failure to so qualify would reasonably be expected to have a material adverse effect on Borrower&#8217;s business or operations. Borrower shall comply, and have each Subsidiary comply, in all material respects, with all material laws, ordinances and regulations to which it is subject.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Obtain all of the Governmental Approvals necessary for the performance by Borrower and each of its Subsidiaries of their obligations under the Loan Documents to which it is a party, including any grant of a security interest in the Collateral to Bank. Borrower shall promptly provide copies of any such obtained Governmental Approvals to Bank upon Bank&#8217;s request.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Financial Statements, Reports. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deliver to Bank by submitting to the Financial Statement Repository&#58;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt;text-decoration:underline">Borrowing Base Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Only when Advances are outstanding or are being requested by Borrower, a Borrowing Base Statement (and any schedules related thereto and including any other information reasonably requested by Bank with respect to Borrower&#8217;s Accounts) (i) no later than Friday of each week when a Streamline Period is not in effect, (ii) within thirty (30) days after the end of each month when a Streamline Period is in effect, and (iii) with each request for an Advance&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:underline">Accounts Receivable Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Only when Advances are outstanding or are being requested by Borrower, within thirty (30) days after the end of each month, (i) monthly accounts receivable agings, aged by invoice date, (ii) monthly accounts payable agings, aged by invoice date, and outstanding or held check registers, if any, (iii) monthly reconciliations of accounts receivable agings (aged by invoice date), transaction reports, Deferred Revenue report, and general ledger&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt;text-decoration:underline">Quarterly Financial Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. No later than forty-five (45) days after the last day of each of the first three fiscal quarters of Borrower&#8217;s fiscal year, a company prepared consolidated and consolidating balance sheet and income statement covering Borrower&#8217;s and each of its Subsidiary&#8217;s operations for such quarter in a form reasonably acceptable to Bank (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quarterly Financial Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;)&#59; provided that year-end Quarterly Financial Statements shall be delivered no later than ninety (90) days after the last day of each fiscal year of Borrower&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:underline">Compliance Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Within forty-five (45) days after the last day of each of the first three fiscal quarters of Borrower (and no later than ninety (90) days after the last day of each fiscal year of Borrower), together with the statements set forth in Section <a href="#i37efde9015094164b274aef726ee5ee2_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">5.3</a>(c), a duly completed Compliance Statement, confirming that as of the end of such month, Borrower was in full compliance with all of the terms and conditions of this Agreement, and setting forth calculations showing compliance with the financial covenants set forth in this Agreement and such other information as Bank may reasonably request, except as noted therein&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt;text-decoration:underline">Annual Operating Budget and Financial Projections</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Within thirty (30) days after the end of each fiscal year of Borrower, and within thirty (30) days of any material updates or amendments thereto, (i) annual operating budgets (including income statements, balance sheets and cash flow statements, by month) for the then- current fiscal year of Borrower, and (ii) annual financial projections for the then-current fiscal year (on a quarterly basis), in each case as approved by the Board, together with any material related business forecasts used in the preparation of such annual financial projections&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.01pt;text-decoration:underline">Annual Audited Financial Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. As soon as available, and in any event within one hundred and eighty (180) days following the end of Borrower&#8217;s fiscal year, audited consolidated financial statements prepared under GAAP, consistently applied, together with an unqualified opinion on the financial statements from an independent certified public accounting firm reasonably acceptable to Bank&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:underline">SEC Filings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. In the event that Borrower or any of its Subsidiaries becomes subject to the reporting requirements under the Exchange Act within five (5) Business Days of filing, notification of the filing and copies of all periodic and other reports, proxy statements and other materials filed by Borrower and&#47;or any of its Subsidiaries or any Guarantor with the SEC, any Governmental Authority succeeding to any or all of the functions of the SEC or with any national securities exchange, or distributed to its shareholders, as the case may be. Documents required to be delivered pursuant to the terms hereof (to the extent any such documents are included in materials otherwise filed with the SEC) may be delivered electronically and if so delivered, shall be deemed to have been delivered on the date on which Borrower or any of its Subsidiaries posts such documents, or provides a link thereto, on Borrower&#8217;s or any of its Subsidiaries&#8217; website on the internet at Borrower&#8217;s or any of its Subsidiaries&#8217; website address&#59; provided, however, Borrower shall notify Bank in writing within five (5) Business Days (which may be by electronic mail) of the posting of any such documents&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:underline">Security Holder and Subordinated Debt Holder Reports</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Within five (5) Business Days of delivery, copies of all material statements, reports and notices made generally available to Borrower&#8217;s security holders or to any holders of Subordinated Debt (solely in their capacities as security holders or holders of Subordinated Debt and not in any other role)&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.57pt;text-decoration:underline">Beneficial Ownership Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Prompt written notice of any changes to the beneficial ownership information set out in Section 14 of the Perfection Certificate. Borrower understands and acknowledges that Bank relies on such true, accurate and up-to-date beneficial ownership information to meet Bank&#8217;s regulatory obligations to obtain, verify and record information about the beneficial owners of its legal entity customers&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.57pt;text-decoration:underline">Legal Action Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Prompt written notice upon becoming aware of any legal actions, investigations or proceedings pending or threatened in writing against Borrower or any of its Subsidiaries (not otherwise already disclosed on the Perfection Certificate delivered around the First Amendment Effective Date) that could reasonably be expected to result in damages or costs to Borrower or any of its Subsidiaries of, individually or in the aggregate, Seven Hundred Fifty Thousand Dollars ($750,000) or more&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:underline">Tort Claim Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. If Borrower shall acquire a commercial tort claim with a value that could reasonably be expected to exceed Five Hundred Thousand Dollars ($500,000), Borrower shall promptly notify Bank in a writing signed by Borrower of the general details thereof and, if so requested by Bank, grant to Bank in such writing a security interest therein and in the proceeds thereof, all upon the terms of this Agreement, with such writing to be in form and substance reasonably satisfactory to Bank&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.57pt;text-decoration:underline">Government Filings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Within five (5) Business Days after the same are sent by Borrower or received by Borrower, copies of all material correspondence, reports, documents and other filings by Borrower or</font></div><div style="text-align:justify"><font><br></font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any of its Subsidiaries with any Governmental Authority regarding compliance with or maintenance of Governmental Approvals or Applicable Law, in each case that could reasonably be expected to have a material effect on any of the Governmental Approvals material to the business of Borrower&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:11.57pt;text-decoration:underline">Registered Organization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. If Borrower is not a Registered Organization as of the Effective Date but later becomes one, promptly notify Bank of such occurrence and provide Bank with Borrower&#8217;s organizational identification number&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt;text-decoration:underline">Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Prompt written notice of the occurrence of a Default or Event of Default&#59; and</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(o)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:underline">Other Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Promptly, from time to time, such other financial information regarding Borrower or any of its Subsidiaries or compliance with the terms of any Loan Documents as reasonably requested by Bank.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any submission by Borrower of a Compliance Statement, or any other financial statement submitted to the Financial Statement Repository pursuant to this Section <a href="#i37efde9015094164b274aef726ee5ee2_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">5.3</a> or otherwise submitted to Bank shall be deemed to be a representation by Borrower that (i) as of the date of such Compliance Statement, or other financial statement, the information and calculations set forth therein are true and correct in all material respects, (ii) as of the end of the compliance period set forth in such submission, Borrower is in complete compliance with all required covenants except as noted in such Compliance Statement, or other financial statement, as applicable, except as noted in such Compliance Statement or other financial statement, as applicable&#59; (iii) as of the date of such submission, no Events of Default have occurred or are continuing, (iv) all representations and warranties other than any representations or warranties that are made as of a specific date in Section <a href="#i37efde9015094164b274aef726ee5ee2_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">4</a> remain true and correct in all material respects as of the date of such submission except as noted in such Compliance Statement, or other financial statement, as applicable, (v) as of the date of such submission, Borrower and each of its Subsidiaries has timely filed all required tax returns and reports, and Borrower has timely paid all foreign, federal, state and local taxes, assessments, deposits and contributions owed by Borrower except as otherwise permitted pursuant to the terms of Section <a href="#i37efde9015094164b274aef726ee5ee2_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">4.9,</a> and (vi) as of the date of such submission, no Liens have been levied or claims made against Borrower or any of its Subsidiaries relating to unpaid employee payroll or benefits of which Borrower has not previously provided written notification to Bank.</font></div><div><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Accounts Receivable.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt;text-decoration:underline">Schedules and Documents Relating to Accounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Only when Advances are outstanding or are being requested by Borrower, Borrower shall deliver to Bank transaction reports and schedules of collections, as provided in Section 5.3(b), on Bank&#8217;s standard forms&#59; provided, however, that Borrower&#8217;s failure to execute and deliver the same shall not affect or limit Bank&#8217;s Lien and other rights in all of Borrower&#8217;s Accounts, nor shall Bank&#8217;s failure to advance or lend against a specific Account affect or limit Bank&#8217;s Lien and other rights therein. If requested by Bank, Borrower shall furnish Bank with copies (or, at Bank&#8217;s request, originals) of all contracts, orders, invoices, and other similar documents, and all shipping instructions, delivery receipts, bills of lading, and other evidence of delivery, for any goods the sale or disposition of which gave rise to such Accounts. In addition, Borrower shall deliver to Bank, on its request, the originals of all instruments, chattel paper, security agreements, guarantees and other documents and property evidencing or securing any Accounts, in the same form as received, with all necessary indorsements, and copies of all credit memos.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:underline">Disputes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Borrower shall promptly notify Bank of all disputes or claims relating to Accounts that continue for more than thirty (30) days and are with respect to an amount in excess of Two Hundred Thousand Dollars ($200,000) in the aggregate at such time. Borrower may forgive (completely or partially), compromise, or settle any Account for less than payment in full, or agree to do any of the foregoing so long as (i) Borrower does so in good faith, in a commercially reasonable manner, in the ordinary course of business, in arm&#8217;s- length transactions, and reports the same to Bank in the regular reports provided to Bank&#59; (ii) no Event of Default has occurred and is continuing&#59; and (iii) there shall not be an Overadvance after taking into account all such discounts, settlements and forgiveness.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt;text-decoration:underline">Collection of Accounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Within sixty (60) days of the First Amendment Effective Date, Borrower shall direct Account Debtors to deliver or transmit all proceeds of Accounts into a lockbox account, or such</font></div><div style="text-align:justify"><font><br></font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">other &#8220;blocked account&#8221; as specified by Bank (either such account, the &#8220;Cash Collateral Account&#8221;). Whether or not an Event of Default has occurred and is continuing, Borrower shall immediately deliver all payments on and proceeds of Accounts to the Cash Collateral Account. Subject to Bank&#8217;s right to maintain a reserve pursuant to Section 5.4(d), all amounts received in the Cash Collateral Account shall be (i) when a Streamline Period is not in effect, applied to immediately reduce the Obligations under the Revolving Line (unless Bank, in its sole discretion, at times when an Event of Default exists, elects not to so apply such amounts), or (ii) when a Streamline Period is in effect, transferred by Bank on a daily basis to Borrower&#8217;s operating account with Bank. Borrower hereby authorizes Bank to transfer to the Cash Collateral Account any amounts that Bank reasonably determines are proceeds of the Accounts (provided that Bank is under no obligation to do so and this allowance shall in no event relieve Borrower of its obligations hereunder).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:underline">Reserves</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Notwithstanding any terms in this Agreement to the contrary, at times when a Default or an Event of Default exists, Bank may hold any proceeds of the Accounts and any amounts in the Cash Collateral Account that are not applied to the Obligations pursuant to Section 5.4(c) above (including amounts otherwise required to be transferred to Borrower&#8217;s operating account with Bank) as a reserve to be applied to any Obligations regardless of whether such Obligations are then due and payable.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt;text-decoration:underline">Returns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Provided no Event of Default has occurred and is continuing, if any Account Debtor returns any Inventory to Borrower, Borrower shall promptly (i) determine the reason for such return, (ii) issue a credit memorandum to the Account Debtor in the appropriate amount in accordance with Borrower&#8217;s customary business practices, and (iii) provide a copy of such credit memorandum to Bank, upon request from Bank. In the event any attempted return occurs after the occurrence and during the continuance of any Event of Default, Borrower shall hold the returned Inventory in trust for Bank, and immediately notify Bank of the return of the Inventory.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:154pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.01pt;text-decoration:underline">Verifications&#59; Confirmations&#59; Credit Quality&#59; Notifications</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Bank may, from time to time,</font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i) verify and confirm directly with the respective Account Debtors the validity, amount and other matters relating to the Accounts, either in the name of Borrower or Bank or such other name as Bank may choose, and notify any Account Debtor of Bank&#8217;s security interest in such Account and&#47;or (ii) conduct a credit check of any Account Debtor to approve any such Account Debtor&#8217;s credit.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:underline">No Liability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Bank shall not be responsible or liable for any shortage or discrepancy in, damage to, or loss or destruction of, any goods, the sale or other disposition of which gives rise to an Account, or for any error, act, omission, or delay of any kind occurring in the settlement, failure to settle, collection or failure to collect any Account, or for settling any Account in good faith for less than the full amount thereof, nor shall Bank be deemed to be responsible for any of Borrower&#8217;s obligations under any contract or agreement giving rise to an Account. Nothing herein shall, however, relieve Bank from liability for its own gross negligence or willful misconduct.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Remittance of Proceeds. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Except as otherwise provided in Section 5.4(c) and Section 7.1, deliver, in kind, all proceeds arising from the disposition of any Collateral to Bank in the original form in which received by Borrower not later than the following Business Day after receipt by Borrower, to be applied to the Obligations (a) prior to an Event of Default, pursuant to the terms of Section 5.4(c) hereof, and (b) after the occurrence and during the continuance of an Event of Default, pursuant to the terms of Section 8.4 hereof&#59; provided that, if no Event of Default has occurred and is continuing, Borrower shall not be obligated to remit to Bank the proceeds of the sale of worn out or obsolete Equipment disposed of by Borrower in good faith in an arm&#8217;s length transaction for an aggregate purchase price of One Hundred Thousand Dollars ($100,000) or less (for all such transactions in any fiscal year). Borrower agrees that it will not commingle proceeds of Collateral with any of Borrower&#8217;s other funds or property, but will hold such proceeds separate and apart from such other funds and property and in an express trust for Bank. Nothing in this Section 5.5 limits the restrictions on disposition of Collateral set forth elsewhere in this Agreement.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Taxes&#59; Pensions.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">Timely file, and require each of its Subsidiaries to timely file (in each case, unless subject to a valid extension), all required tax returns and reports and timely pay, and require each of its Subsidiaries to timely pay, or file extensions for, all foreign, federal, state and local taxes, assessments, deposits and contributions owed by Borrower and each of its Subsidiaries, except for (deferred payment of any taxes contested pursuant to the terms of</font></div><div style="text-align:justify"><font><br></font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section <a href="#i37efde9015094164b274aef726ee5ee2_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">4.9(a)</a> hereof, and shall deliver to Bank, on demand, appropriate certificates attesting to such payments, and pay, and require each of its Subsidiaries to pay, all amounts necessary to fund all present pension, profit sharing and deferred compensation plans in accordance with their terms.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">To the extent Borrower or any of its Subsidiaries defers payment of any contested taxes in excess of Fifty Thousand Dollars ($50,000), (i) notify Bank in writing of the commencement of, and any material development in, the proceedings, and (ii) post bonds or take any other steps required to prevent the Governmental Authority levying such contested taxes from obtaining a Lien upon any of the Collateral that is other than a &#8220;Permitted Lien.&#8221;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Access to Collateral&#59; Books and Records. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At reasonable times, on five (5) Business Days&#8217; notice (provided no notice is required if an Event of Default has occurred and is continuing), Bank, or its agents, shall have the right to inspect the Collateral and the right to audit and copy Borrower&#8217;s Books. The Initial Audit shall be completed within ninety (90) days after the First Amendment Effective Date, and Borrower shall cooperate with Bank in order to timely complete same. Thereafter, (i) when Streamline Period is in effect, such inspections and audits shall be conducted no more often than once every twelve (12) months, unless an Event of Default has occurred and is continuing, in which case such inspections and audits shall occur as often as Bank shall determine is necessary and</font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ii) when Streamline Period is not in effect, such inspections and audits shall be conducted no more often than once every six (6) months (or as frequently as Bank determines in its sole discretion that conditions warrant), unless an Event of Default has occurred and is continuing, in which case such inspections and audits shall occur as often as Bank shall determine is necessary. The foregoing inspections and audits shall be conducted at Borrower&#8217;s expense and the charge therefor shall be One Thousand Dollars ($1,000) per person per day (or such higher amount as shall represent Bank&#8217;s then-current standard charge for the same), plus reasonable out-of-pocket expenses. In the event Borrower and Bank schedule an audit more than eight (8) days in advance, and Borrower cancels or seeks to or reschedules the audit with less than eight (8) days written notice to Bank, then (without limiting any of Bank&#8217;s rights or remedies) Borrower shall pay Bank a fee of Two Thousand Dollars ($2,000) plus any out-of-pocket expenses incurred by Bank to compensate Bank for the anticipated costs and expenses of the cancellation or rescheduling.</font></div><div><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Insurance.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">Keep its business and the Collateral insured for risks and in amounts standard for companies in Borrower&#8217;s industry and location and as Bank may reasonably request. Insurance policies shall be in a form, with financially sound and reputable insurance companies that are not Affiliates of Borrower, and in amounts that are reasonably satisfactory to Bank.</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">All property policies shall have a lender&#8217;s loss payable endorsement showing Bank as lender loss payee. All liability policies shall show, or have endorsements showing, Bank as an additional insured. Bank shall be named as lender loss payee and&#47;or additional insured with respect to any such insurance providing coverage in respect of any Collateral.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">Ensure that proceeds payable under any property policy are, at Bank&#8217;s option, payable to Bank on account of the Obligations. Notwithstanding the foregoing, (a) so long as no Event of Default has occurred and is continuing, Borrower shall have the option of applying the proceeds of any casualty policy up to One Million Dollars ($1,000,000) in the aggregate for all losses under all casualty policies in any one year, toward the replacement or repair of destroyed or damaged property&#59; provided that any such replaced or repaired property (i) shall be of equal or like value as the replaced or repaired Collateral and (ii) shall be deemed Collateral in which Bank has been granted a first priority security interest, and (b) after the occurrence and during the continuance of an Event of Default, all proceeds payable under such casualty policy shall, at the option of Bank, be payable to Bank on account of the Obligations.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">At Bank&#8217;s request, Borrower shall deliver certified copies of insurance policies and evidence of all premium payments. Each provider of any such insurance required under this Section </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">5.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5 shall agree, by endorsement upon the policy or policies issued by it or by independent instruments furnished to Bank, that it will give Bank twenty (20) days (or ten (10) days&#8217; prior written notice in the event of cancellation due to non- payment of premium) prior written notice before any such policy or policies shall be materially altered or canceled.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If Borrower fails to obtain insurance as required under this Section 5.8 or to pay any amount or furnish any required proof of payment to third persons and Bank, Bank may make all or part of such payment or obtain such insurance policies required in this Section 5.8, and take any action under the policies Bank deems prudent.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Accounts.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">Maintain all of Borrower&#8217;s, any of its Subsidiaries&#8217;, and any Guarantor&#8217;s operating accounts, depository accounts and excess cash with Bank or Bank&#8217;s Affiliates, other than Borrower&#8217;s Foreign Subsidiaries may maintain accounts with third parties other than Bank, provided the aggregate value of such accounts is subject to the terms of Section 6.11 (collectively the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Permitted Foreign Subsidiary Accounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">In addition to the foregoing, Borrower, any Subsidiary of Borrower and any Guarantor, shall obtain any business credit card, Letter of Credit, FX Contract, and cash management services exclusively from Bank, except (i) third party credit cards, as permitted in the defined term &#8220;Permitted Indebtedness&#8221; part (g)&#59; (ii) Borrower&#8217;s Foreign Subsidiaries may maintain the foregoing bank services with third parties other than Bank, (iii) to the extent that Bank does not have such services in foreign locations, Borrower and its Subsidiaries may maintain the foregoing foreign banking services with third parties other than Bank, and (iv) Borrower may maintain and permit to exist online payment processors used in the ordinary course of business with third parties other than Bank.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:154pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.91pt">In addition to and without limiting the restrictions in (a), Borrower shall provide Bank five</font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5) days prior written notice before establishing any Collateral Account at or with any bank or financial institution other than Bank or Bank&#8217;s Affiliates. For each Collateral Account that Borrower at any time maintains, Borrower shall cause the applicable bank or financial institution (other than Bank) at or with which any Collateral Account is maintained to execute and deliver a Control Agreement or other appropriate instrument with respect to such Collateral Account to perfect Bank&#8217;s Lien in such Collateral Account in accordance with the terms hereunder which Control Agreement may not be terminated without the prior written consent of Bank. The provisions of the previous sentence shall not apply to (i) deposit accounts exclusively used for payroll, payroll taxes, and other employee wage and benefit payments to or for the benefit of Borrower&#8217;s employees and identified to Bank by Borrower as such, and (ii) the Permitted Foreign Subsidiary Accounts.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:8.5pt">Financial Covenant (Net Revenue). </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">When a Financial Covenant Measuring Period is in effect, Borrower shall achieve Net Revenue (measured in accordance with GAAP on a trailing six (6) month basis), tested quarterly on the last day of each calendar quarter, in an amount equal to or greater than the levels to be agreed upon between Borrower and Bank with respect to which Borrower hereby agrees&#58; (i) shall be documented in an amendment to this Agreement, in form and substance acceptable to Bank, which amendment shall be executed no later than February 28</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> of each year beginning with February 28, 2024 with Borrower&#8217;s failure to enter into such amendment to this Agreement to reset such covenant levels on or prior to February 28</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> of each year shall be an immediate and non-curable Event of Default hereunder&#59; (ii) shall be based on Borrower&#8217;s projections delivered to Bank in accordance with Section 5.3(e) hereof and acceptable to Bank in its commercially reasonable discretion with such projections for Borrower&#8217;s 2024 fiscal year showing annual Net Revenue of not less than &#91;***&#93; Dollars. Notwithstanding anything to the contrary herein, if a Financial Covenant Measuring Period is occurring at any point between January 1, 2024 and February 28, 2024, then Borrower&#8217;s Net Revenue (measured in accordance with GAAP on a trailing six (6) month basis) for the period ending December 31, 2023 shall be tested and such Net Revenue shall not be less than &#91;***&#93; Dollars.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:18.5pt">Protection of Intellectual Property Rights.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">(i) Use commercially reasonable efforts to protect, defend and maintain the validity and enforceability of Borrower&#8217;s and each Subsidiary&#8217;s Intellectual Property, except to the extent that such failure to do so would not reasonably be expected to have a material adverse effect on Borrower&#8217;s business or operations or that such Intellectual Property does not have material value&#59; (ii) promptly advise Bank in writing of infringements or any other event that could reasonably be expected to materially and adversely affect the value Borrower&#8217;s and each Subsidiary&#8217;s Intellectual Property that has material value&#59; and (iii) not allow any Intellectual Property material to Borrower&#8217;s or any Subsidiary&#8217;s business to be abandoned, forfeited or dedicated to the public without Bank&#8217;s written consent.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Provide written notice to Bank within thirty (30) days of entering or becoming bound by any Restricted License (other than over-the-counter software that is commercially available to the public). Borrower shall take such commercially reasonable steps as Bank requests to obtain the consent of, or waiver by, any person whose consent or waiver is necessary for (i) any such Restricted License to be deemed &#8220;Collateral&#8221; and for Bank to have a security interest in it that might otherwise be restricted or prohibited by law or by the terms of any such Restricted License, whether now existing or entered into in the future, and (ii) Bank to have the ability in the event of a liquidation of any Collateral to dispose of such Collateral in accordance with Bank&#8217;s rights and remedies under this Agreement and the other Loan Documents.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:8.5pt">Litigation Cooperation. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">From the date hereof and continuing through the termination of this Agreement, make available to Bank, without expense to Bank, Borrower and its officers, employees and agents and Borrower&#8217;s books and records, to the extent that Bank may deem them reasonably necessary to prosecute or defend any third-party suit or proceeding instituted by or against Bank with respect to any Collateral or relating to Borrower.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:18.5pt">Reserved.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:8.5pt">Formation or Acquisition of Subsidiaries. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notwithstanding and without limiting the negative covenants contained in Sections <a href="#i37efde9015094164b274aef726ee5ee2_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">6.3</a> and <a href="#i37efde9015094164b274aef726ee5ee2_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">6.7</a> hereof, at the time that Borrower or any Guarantor forms any Subsidiary or acquires any Subsidiary after the Effective Date (including, without limitation, pursuant to a Division), Borrower and such Guarantor shall (a) cause such new Subsidiary to provide to Bank a joinder to this Agreement to become a co-borrower hereunder or a guaranty to become a Guarantor hereunder (as determined by Bank in its sole discretion), together with documentation, all in form and substance satisfactory to Bank (including being sufficient to grant Bank a first priority Lien (subject to Permitted Liens) in and to the assets of such newly formed or acquired Subsidiary that constitute Collateral), (b) provide to Bank appropriate certificates and powers and financing statements, pledging (i) all of the direct or beneficial ownership interest in such new Subsidiary, in form and substance reasonably satisfactory to Bank&#59; and (c) provide to Bank all other documentation in form and substance reasonably satisfactory to Bank, including one or more opinions of counsel satisfactory to Bank, which in its opinion is appropriate with respect to the execution and delivery of the applicable documentation referred to above. Any document, agreement, or instrument executed or issued pursuant to this Section 5.14 shall be a Loan Document.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:8.5pt">Inventory&#59; Returns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Keep all Inventory in good and marketable condition, free from material defects. Returns and allowances between Borrower and its Account Debtors shall follow Borrower&#8217;s customary practices as they exist at the Effective Date. Borrower shall promptly notify Bank of all returns, recoveries, disputes and claims that involve more than Two Hundred Fifty Thousand Dollars ($250,000) (measured as to any single return, recovery, dispute or claim, and not in the aggregate at such time).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:8.5pt">Further Assurances. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Execute any further instruments and take such further action as Bank reasonably requests to perfect, protect, ensure the priority of or continue Bank&#8217;s Lien on the Collateral or to affect the purposes of this Agreement.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:8.5pt">Sanctions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. (a) Not, and not permit any of its Subsidiaries to, engage in any of the activities described in Section <a href="#i37efde9015094164b274aef726ee5ee2_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">4.11</a> in the future&#59; (b) not, and not permit any of its Subsidiaries to, become a Sanctioned Person&#59;</font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">ensure that the proceeds of the Obligations are not used to violate any Sanctions&#59; and (d) deliver to Bank any certification or other evidence requested from time to time by Bank in its sole discretion, confirming each such Person&#8217;s compliance with this Section 5.17. In addition, have implemented, and will consistently apply while this Agreement is in effect, reasonable procedures to ensure that the representations and warranties in Section <a href="#i37efde9015094164b274aef726ee5ee2_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">4.11</a> remain true and correct while this Agreement is in effect.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:18.5pt">Post-Closing Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">As soon as possible, but in any event not later than the date that is thirty (30) days after the First Amendment Effective Date, Borrower shall deliver to Bank evidence satisfactory to Bank that the insurance policies and endorsements required by Section <a href="#i37efde9015094164b274aef726ee5ee2_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">5.8</a> hereof are in full force and effect, together with appropriate evidence showing lender loss payable and additional insured clauses or endorsements in favor of Bank.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">As soon as possible, but in any event not later than the date that is five (5) days after the First Amendment Effective Date, Borrower shall deliver to Bank a duly executed Control Agreement with U.S. Bank.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:28.5pt;text-decoration:underline">NEGATIVE COVENANTS</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrower shall not do any of the following without Bank&#8217;s prior written consent&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Dispositions. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convey, sell, lease, transfer, assign, or otherwise dispose of (including, without limitation, pursuant to a Division) (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), or permit any of its Subsidiaries to Transfer, all or any part of its business or property, except for Transfers (a) of Inventory in the ordinary course of business&#59; (b) of worn- out, surplus or obsolete Equipment that is, in the reasonable judgment of Borrower, no longer economically practicable to maintain or useful in the ordinary course of business of Borrower&#59; (c) consisting of Permitted Liens and Permitted Investments&#59; (d) consisting of the sale or issuance of any stock, partnership, membership, or other ownership interest or other equity securities of Borrower permitted under Section <a href="#i37efde9015094164b274aef726ee5ee2_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">6.2</a> of this Agreement&#59; (e) consisting of Borrower&#8217;s or its Subsidiaries&#8217; use or transfer of money or Cash Equivalents in a manner that is not prohibited by the terms of this Agreement or the other Loan Documents, including without limitation cash returns or refunds of customer payments&#59;</font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(f) of non-exclusive licenses for the use of the property of Borrower or its Subsidiaries in the ordinary course of business, and other licenses permitted pursuant to part (h) of the defined Permitted Liens&#59; (g) other Transfers not to exceed One Hundred Thousand Dollars ($100,000) in any twelve (12) month period&#59; and (h) other Transfers in which Borrower will receive cash proceeds in an amount equal to no less than seventy-five percent (75%) of such other Transfer consideration (fixed or contingent) paid or payable to Borrower or its Subsidiary.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:39.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the avoidance of doubt, none of (a) the sale of any Permitted Convertible Indebtedness, (b) the sale of any Warrant Transaction, (c) the purchase of any Bond Hedge Transaction or (d) the performance by Borrower of its obligations under any Permitted Convertible Indebtedness, any Warrant Transaction or any Bond Hedge Transaction (including the settlement or termination of any Bond Hedge Transaction or Warrant Transaction) shall constitute a Transfer.</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Changes in Business, Management, Control, or Business Locations. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) Engage in or permit any of its Subsidiaries to engage in any business other than the businesses currently engaged in by Borrower and such Subsidiary, as applicable, or reasonably related thereto&#59; (b) liquidate or dissolve or permit any of its Subsidiaries to liquidate or dissolve (unless such Subsidiary&#8217;s assets are transferred to Borrower)&#59; (c) fail to provide notice to Bank of any Key Person departing from or ceasing to be employed by Borrower within seven (7) Business Days after such Key Person&#8217;s departure from Borrower&#59; (d) permit, allow or suffer to occur any Change in Control&#59; (e) without at least ten (10) days prior written notice to Bank, (i) add any new offices or business locations, including warehouses (unless such new offices or business locations contain less than Two Hundred Thousand Dollars ($200,000) in Borrower&#8217;s assets or property) or deliver any portion of the Collateral valued, individually or in the aggregate, in excess of Two Hundred Thousand Dollars ($200,000) to a bailee at a location other than to a bailee and at a location already disclosed in the Perfection Certificate, or (f) without at least twenty (20) days prior written notice to Bank (i) change its jurisdiction of organization, (ii) change its organizational structure or type, (iii) change its legal name, or, (iv) change any organizational number (if any) assigned by its jurisdiction of organization. If Borrower intends to add any new offices or business locations, including warehouses, containing in excess of Two Hundred Thousand Dollars ($200,000) of Borrower&#8217;s assets or property, then Borrower will cause the landlord of any such new offices or business locations, including warehouses, to execute and deliver a landlord consent in form and substance reasonably satisfactory to Bank. If Borrower intends to deliver any portion of the Collateral valued, individually or in the aggregate, in excess of Two Hundred Thousand Dollars ($200,000) to a bailee, and Bank and such bailee are not already parties to a bailee agreement governing both the Collateral and the location to which Borrower intends to deliver the Collateral, then Borrower will cause such bailee to execute and deliver a bailee agreement in form and substance reasonably satisfactory to Bank. For the avoidance of doubt, no landlord or bailee waivers shall be required for or with respect to any foreign locations of Borrower or its Subsidiaries.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Mergers or Acquisitions. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merge or consolidate, or permit any of its Subsidiaries to merge or consolidate, with any other Person, or acquire, or permit any of its Subsidiaries to acquire, all or substantially all of the stock, partnership, membership, or other ownership interest or other equity securities or property of another Person (including, without limitation, by the formation of any Subsidiary or pursuant to a Division), except (i) if (a) Borrower</font></div><div style="text-align:justify"><font><br></font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">has complied with the notice requirements applicable to prepayments hereunder, and (b) prior to or contemporaneously with the closing of such transaction, all Obligations are paid in full in cash, and all of Bank&#8217;s obligations to lend to Borrower under this Agreement are terminated, and&#47;or (iii) Permitted Acquisitions. A Subsidiary may merge or consolidate into another Subsidiary or into Borrower.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Indebtedness. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Create, incur, assume, or be liable for any Indebtedness, or permit any Subsidiary to do so, other than Permitted Indebtedness.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Encumbrance. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Create, incur, allow, or suffer to exist any Lien on any of its property, or assign or convey any right to receive income, including the sale of any Accounts, or permit any of its Subsidiaries to do so, in each case as to the foregoing except for Permitted Liens, permit any Collateral not to be subject to the first priority security interest granted herein, other than Permitted Liens, or enter into any agreement, document, instrument or other arrangement (except with or in favor of Bank) with any Person which directly or indirectly prohibits or has the effect of prohibiting Borrower or any Subsidiary from assigning, mortgaging, pledging, granting a security interest in or upon, or encumbering any of Borrower&#8217;s or any Subsidiary&#8217;s Intellectual Property, except as is otherwise permitted in Section <a href="#i37efde9015094164b274aef726ee5ee2_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">6.1</a> hereof and the definition of &#8220;Permitted Liens&#8221; herein.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Maintenance of Collateral Accounts. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maintain any Collateral Account except pursuant to the terms of Section <a href="#i37efde9015094164b274aef726ee5ee2_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">5.9(a).</a></font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Distributions&#59; Investments. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) Pay any dividends or make any distribution or payment or redeem, retire or purchase any stock, partnership, membership, or other ownership interest or other equity securities, provided that Borrower may (i) convert any of its convertible securities into other securities pursuant to the terms of such convertible securities or otherwise in exchange thereof, (ii) pay dividends solely in common stock or equity interests,</font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(iii) repurchase the stock of former employees, officers, directors or consultants pursuant to stock repurchase agreements or termination of employment or service or repurchases pursuant to rights of first refusal in Borrower&#8217;s bylaws, so long as an Event of Default does not exist at the time of any such repurchase and would not exist after giving effect to any such repurchase&#59; provided the aggregate amount of all such repurchases shall not exceed Five Hundred Thousand Dollars ($500,000) per fiscal year, (iv) pay cash distributions in lieu of issuing fractional shares&#59; provided the aggregate amount of all such payments shall not exceed Two Hundred Thousand Dollars ($200,000) per fiscal year , (v) distribute equity securities to former or current employees, officers, consultants or directors pursuant to the exercise of employee stock options approved by the Board, (vi) pay, in connection with any Permitted Acquisition by Borrower or any of its Subsidiaries, (A) the receipt or acceptance of the return to Borrower or any of its Subsidiaries of stock or equity interests of Borrower constituting a portion of the purchase price consideration in settlement of indemnification claims, or as a result of a purchase price adjustment (including earn-outs or similar obligations) and (B) payments or distributions to equity holders pursuant to appraisal rights required under requirements of law&#59; (vii) the distribution of rights pursuant to any shareholder rights plan or the redemption of such rights for nominal consideration in accordance with the terms of any shareholder rights plan, and (viii) for the avoidance of doubt, Subsidiaries of Borrower shall be permitted to, directly or indirectly, pay dividends or make distributions to other Subsidiaries or to Borrower, or (b) directly or indirectly make any Investment (including, without limitation, by the formation of any Subsidiary) other than Permitted Investments, or permit any of its Subsidiaries to do so.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, or anything to the contrary herein, and for the avoidance of doubt, this Section 6.7 shall not prohibit (i) the conversion by holders of (including any cash payment upon conversion), or required payment of any principal or premium on, or required payment of any interest with respect to, any Permitted Convertible Debt, in each case, in accordance with the terms of the indenture governing such Permitted Convertible Debt&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">that the preceding sentence shall only allow principal payments with respect to any repurchase in connection with the redemption of Permitted Convertible Debt upon satisfaction of a condition related to the stock price of the Borrower&#8217;s common stock if the Redemption Conditions are satisfied in respect of such redemption&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">provided further </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">that, to the extent both (a) the aggregate amount of cash payable upon conversion or redemption of any Permitted Convertible Debt (excluding any required payment of interest with respect to such Permitted Convertible Debt and excluding any payment of cash in lieu of a fractional share due upon conversion thereof) exceeds the aggregate principal amount thereof and (b) such conversion or redemption does not trigger or correspond to an exercise or early unwind or settlement of a corresponding portion of the Bond Hedge Transactions constituting Permitted Call Spread Agreements</font></div><div style="text-align:justify"><font><br></font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">relating to such Permitted Convertible Debt (including, for the avoidance of doubt, the case where there is no Bond Hedge Transaction constituting a Permitted Call Spread Agreement relating to such Permitted Convertible Debt), the payment of such excess cash (any such payment, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Excess Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) shall not be permitted by this clause (i)&#59; and (ii) any required payment with respect to (including, for the avoidance of doubt, the payment of the relevant premium for the purchase thereof), or required early unwind or settlement of, any Permitted Call Spread Agreement, in each case, in accordance with the terms of the agreement governing such Permitted Call Spread Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">that, to the extent cash is required to be paid under a Warrant Transaction as a result of the election of &#8220;cash settlement&#8221; (or substantially equivalent term) as the &#8220;settlement method&#8221; (or substantially equivalent term) thereunder by the Borrower (or its Affiliate) (including in connection with the exercise and&#47;or early unwind or settlement thereof), the payment of such cash shall not be permitted by this clause (ii). Notwithstanding the foregoing, the Borrower may repurchase, exchange or induce the conversion of Permitted Convertible Debt by delivery of shares of the Borrower&#8217;s common stock and&#47;or a different series of Permitted Convertible Debt (which series (I) matures after, and does not require any scheduled amortization or other scheduled payments of principal prior to, the analogous date under the indenture governing the Permitted Convertible Debt that are so repurchased, exchanged or converted and (II) has terms, conditions and covenants that are commercially reasonable to the Borrower (as determined by the Borrower in good faith) (any such series of Permitted Convertible Debt, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Refinancing Convertible Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) and&#47;or by payment of cash (x) in lieu of any fractional shares, (y) in respect of accrued and unpaid interest of such Permitted Convertible Debt and (z) additional cash in an amount that does not exceed the proceeds received by the Borrower from the substantially concurrent issuance of shares of the Borrower&#8217;s common stock and&#47;or a Refinancing Convertible Debt plus the net cash proceeds, if any, received by the Borrower pursuant to the related exercise or early unwind or termination of the related Permitted Call Spread Agreements pursuant to the immediately following proviso&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">that, substantially concurrently with, or a commercially reasonable period of time before or after, the related settlement date for the Permitted Convertible Debt that is so repurchased, exchanged or converted, the Borrower shall (and, for the avoidance of doubt, shall be permitted under this Section 7.7 to) exercise or unwind or terminate early (whether in cash, shares or any combination thereof) the portion of the Permitted Call Spread Agreements, if any, corresponding to such Permitted Convertible Debt that is so repurchased, exchanged or converted.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Transactions with Affiliates. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Directly or indirectly enter into or permit to exist any material transaction with any Affiliate of Borrower, except for (a) transactions that are in the ordinary course of Borrower&#8217;s business, upon fair and reasonable terms that are no less favorable to Borrower than would be obtained in an arm&#8217;s length transaction with a non-affiliated Person&#59; (b) sales of Borrower&#8217;s equity securities to the then-existing investors of Borrower in connection with a bona fide equity financing by the Board so long as such sale shall not result in a violation of the Change of Control provision in Section 6.2, (c) debt financings from Borrower&#8217;s investors so long as all such Indebtedness shall constitute Subordinated Debt, (d) reasonable and customary compensation arrangements and benefit plans for officers, and other employees of Borrower approved by the Board, (e) reasonable and customary compensation arrangements for fees and costs paid to members of the Board in the ordinary course of business, and</font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.85pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(f) Investments of the type described in and permitted under clauses (g) and&#47;or (h) of the definition of &#8220;Permitted Investments&#8221; herein.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Subordinated Debt. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Except as expressly permitted under the terms of the subordination, intercreditor, or other similar agreement to which any Subordinated Debt is subject&#58; (a) make or permit any payment on such Subordinated Debt&#59; (b) amend any provision in any document relating to such Subordinated Debt which would increase the amount thereof, or (c) provide for earlier or greater principal, interest, or other payments thereon, or adversely affect the subordination thereof to Obligations owed to Bank in contravention of the terms of such the subordination, intercreditor, or other similar agreement.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:8.5pt">Compliance. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) Become an &#8220;investment company&#8221; or a company controlled by an &#8220;investment company&#8221;, under the Investment Company Act of 1940, as amended, or undertake as one of its important activities extending credit to purchase or carry margin stock (as defined in Regulation U of the Board of Governors of the Federal Reserve System), or use the proceeds of any Credit Extension for that purpose&#59; (b)(i) fail to meet the minimum funding requirements of ERISA, (ii) permit a Reportable Event or Prohibited Transaction, as defined in ERISA, to occur, (iii) fail to comply with the Federal Fair Labor Standards Act or (iv) violate any other law or regulation, if the foregoing subclauses (i) through (iv), individually or in the aggregate, could reasonably be expected to have a material adverse effect on Borrower&#8217;s business or operations, or permit any of its Subsidiaries to do so&#59; or (c) withdraw or permit any Subsidiary to withdraw from participation in, permit partial or complete termination of, or permit the</font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i37efde9015094164b274aef726ee5ee2_13"></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">occurrence of any other event with respect to, any present pension, profit sharing and deferred compensation plan which could reasonably be expected to result in any material liability of Borrower, including any material liability to the Pension Benefit Guaranty Corporation or its successors or any other Governmental Authority.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:8.5pt">Cash and Cash Equivalents held by Foreign Subsidiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. The aggregate value of cash and Cash Equivalents held by all Foreign Subsidiaries of Borrower to exceed Two Million Five Hundred Thousand Dollars ($2,500,000) for more than five (5) Business Days in each calendar month.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:8.5pt">Value of Assets held by Foreign Subsidiaries. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The aggregate value of the assets owned by the Foreign Subsidiaries of Borrower shall not exceed twenty percent (20%) of the aggregate value of all assets owned by the Borrower and its Subsidiaries.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:8.5pt">Redemption of Permitted Convertible Debt. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise any redemption right with respect to any Permitted Convertible Debt upon satisfaction of a condition related to the stock price of the Borrower&#8217;s common stock, unless the Redemption Conditions are satisfied in respect of such redemption.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:28.5pt;text-decoration:underline">EVENTS OF DEFAULT</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any one of the following shall constitute an event of default (an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Event of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) under this Agreement&#58;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Payment Default. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrower fails to (a) make any payment of principal or interest on any Credit Extension on its due date, or (b) pay any other Obligations within three (3) Business Days after such Obligations are due and payable (which three (3) Business Day cure period shall not apply to payments due on the Revolving Line Maturity Date or Term Loan Maturity Date), in each unless such late payment is due to Bank&#8217;s failure to auto-debit such payment when sufficient funds were contained in the Designated Deposit Account (or if insufficient funds are contained therein, or if an Event of Default has occurred and is continuing, any of Borrower&#8217;s other accounts at Bank). During the cure period, the failure to make or pay any payment specified under clause (b) hereunder is not an Event of Default (but no Credit Extension will be made during the cure period)&#59;</font></div><div><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Covenant Default.</font></div><div style="padding-left:82pt;text-indent:-18pt"><font><br></font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">Borrower fails or neglects to perform any obligation in Section <a href="#i37efde9015094164b274aef726ee5ee2_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">5</a> (other than Sections <a href="#i37efde9015094164b274aef726ee5ee2_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">5.2</a> (Government Compliance), 5.12 (Litigation Cooperation), 5.15 (Inventory&#59; Returns) and 5.16 (Further Assurances)) or violates any covenant in Section <a href="#i37efde9015094164b274aef726ee5ee2_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">6&#59;</a> or</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Borrower fails or neglects to perform, keep, or observe any other term, provision, condition, covenant or agreement contained in this Agreement or any Loan Documents, and as to any default (other than those specified in this Section <a href="#i37efde9015094164b274aef726ee5ee2_13" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">6.11</a>) under such other term, provision, condition, covenant or agreement that can be cured, has failed to cure the default within ten (10) days after the occurrence thereof&#59; provided, however, that if the default cannot by its nature be cured within the ten (10) day period or cannot after diligent attempts by Borrower be cured within such ten (10) day period, and such default is likely to be cured within a reasonable time, then Borrower shall have an additional period (which shall not in any case exceed thirty (30) days) to attempt to cure such default, and within such reasonable time period the failure to cure the default shall not be deemed an Event of Default (but no Credit Extensions shall be made during such cure period). Cure periods provided under this section shall not apply, among other things, to financial covenants or any other covenants that are required to be satisfied, completed or tested by a date certain or any covenants set forth in clause (a) above&#59;</font></div><div style="padding-left:10pt;padding-right:41.7pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.3  Material Adverse Change. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A Material Adverse Change occurs&#59;</font></div><div style="padding-left:0.46pt;padding-right:41.7pt;text-align:justify;text-indent:0.72pt"><font><br></font></div><div style="padding-left:1.18pt;padding-right:41.7pt;text-indent:-0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">                                7.4 Attachment&#59; Levy&#59; Restraint on Business.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">(i) The service of process seeking to attach, by trustee or similar process, any funds of Borrower or any Subsidiary with a value in excess of Two Hundred Thousand Dollars ($200,000), or (ii) a notice of lien or levy in an amount in excess of Two Hundred Thousand Dollars ($200,000), is filed against any of Borrower&#8217;s or any of its Subsidiaries&#8217; assets by any Governmental Authority, and the same under subclauses (i) and (ii) hereof</font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i37efde9015094164b274aef726ee5ee2_16"></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">are not, within fifteen (15) days after the occurrence thereof, discharged or stayed (whether through the posting of a bond or otherwise)&#59; provided, however, no Credit Extensions shall be made during any fifteen (15) day cure period&#59; or</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">(i) any material portion of Borrower&#8217;s or any of its Subsidiaries&#8217; assets with a value in excess of Two Hundred Thousand Dollars ($200,000), is attached, seized, levied on, or comes into possession of a trustee or receiver, or (ii) any court order enjoins, restrains, or prevents Borrower or any of its Subsidiaries from conducting all or any material part of its business&#59;</font></div><div style="padding-left:10pt;padding-right:41.7pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="padding-left:36pt;padding-right:41.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.5  Insolvency.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> (a) Borrower or Borrower and of its Subsidiaries (taken as a whole) is unable to pay its debts &#160;&#160;&#160;&#160;(including trade debts) as they become due or otherwise becomes insolvent&#59; (b) Borrower or any of its Subsidiaries begins an Insolvency Proceeding&#59; or (c) an Insolvency Proceeding is begun against Borrower or any of its Subsidiaries and is not dismissed or stayed within forty-five (45) days (but no Credit Extensions shall be made while any of the conditions described in clause (a) exist and&#47;or until any Insolvency Proceeding is dismissed)&#59;</font></div><div style="padding-left:0.46pt;padding-right:41.7pt;text-align:justify;text-indent:0.72pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:0.72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.6 Other Agreements.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> There is, under any agreement to which Borrower, any of Borrower&#8217;s Subsidiaries, or any Guarantor is a party with a third party or parties, (a) any default by Borrower (after applicable grace and&#47;or cure periods) resulting in a right by such third party or parties, whether or not exercised, to accelerate the maturity of any Indebtedness in an amount individually or in the aggregate in excess of Five Hundred Thousand Dollars ($500,000)&#59; or (b) any breach or default by Borrower, any of Borrower&#8217;s Subsidiaries, or Guarantor the result of which could reasonably be expected to have a material adverse effect on Borrower&#8217;s, any of Borrower&#8217;s Subsidiaries&#8217;, or any Guarantor&#8217;s business or operations (taken as a whole)</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:0.72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">         7.7 Judgments&#59; Penalties. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One or more fines, penalties or final judgments, orders or decrees for the payment of money in an amount, individually or in the aggregate, of at least Five Hundred Thousand Dollars ($500,000)(not covered by independent third-party insurance as to which liability has been accepted by such insurance carrier) shall be rendered against Borrower or any of its Subsidiaries by any Governmental Authority, and the same are not, within ten (10) days after the entry, assessment or issuance thereof, discharged, satisfied or paid, or after execution thereof, or stayed pending appeal, or such judgments are not discharged, satisfied or paid prior to the expiration of any such stay (provided that no Credit Extensions will be made prior to the discharge, satisfaction, payment, or stay of such fine, penalty, judgment, order or decree)&#59;</font></div><div style="padding-left:0.46pt;padding-right:41.75pt;text-align:justify;text-indent:0.72pt"><font><br></font></div><div style="padding-left:36pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.8 Misrepresentations. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrower or any of its Subsidiaries or any Responsible Person acting for Borrower or any of its Subsidiaries knowingly makes any representation, warranty, or other statement now or later in this Agreement, any Loan Document or in any writing delivered to Bank or to induce Bank to enter this Agreement or any Loan Document, and such representation, warranty, or other statement is incorrect in any material respect when made (it being agreed and acknowledged by Bank that the projections and forecasts provided by Borrower or any of its Subsidiaries in good faith and based upon reasonable assumptions are not viewed as facts and that actual results during the period or periods covered by such projections and forecasts may differ from the projected or forecasted results)&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.9 Subordinated Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. If&#58; (a) any document, instrument, or agreement evidencing any Subordinated Debt &#160;&#160;&#160;&#160;shall for any reason be revoked or invalidated or otherwise cease to be in full force and effect (other than in accordance with the terms of such document, instrument or agreement) or any Person (other than Bank)) shall be in breach thereof or contest in any manner the validity or enforceability thereof or deny that it has any further liability or obligation thereunder&#59; (b) a default or event of default (however defined) has occurred under any document, instrument, or agreement evidencing any Subordinated Debt, which default shall not have been cured or waived within any applicable grace period&#59; or (c) the Obligations shall for any reason be subordinated or shall not have the priority contemplated by the applicable subordination or intercreditor agreement&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:0.46pt;text-align:justify;text-indent:0.72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">                      </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.10 Lien Priority. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">There is a material impairment in the perfection or priority of Bank&#8217;s security interest in the Collateral (unless such failure is caused by Bank&#8217;s gross negligence or willful misconduct)&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> 7.11 Guaranty.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> (a) Any guaranty of any Obligations terminates or ceases for any reason to be in full force and &#160;&#160;&#160;&#160;effect (except due to termination in accordance with the terms of such guaranty)&#59; (b) any Guarantor does</font></div><div style="text-align:justify"><font><br></font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">not perform any material obligation or covenant under any guaranty of the Obligations&#59; (c) any circumstance described in Sections 7.3, 7.4, 7.5, 7.6, 7.7, or 7.8 of this Agreement occurs with respect to any Guarantor (subject to the applicable cure and grace periods herein), (d) the death, liquidation, winding up, or termination of existence of any Guarantor&#59; or (e)a material impairment in the perfection or priority of Bank&#8217;s Lien in the collateral provided by Guarantor or in the value of such collateral &#59; or</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.12 Governmental Approvals. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any Governmental Approval shall have been (a) revoked, rescinded, suspended, modified in an adverse manner or not renewed in the ordinary course for a full term or (b) subject to any decision by a Governmental Authority that designates a hearing with respect to any applications for renewal of any of such Governmental Approval or that could result in the Governmental Authority taking any of the actions described in clause (a) above, and such decision or such revocation, rescission, suspension, modification or non-renewal (i) causes, or could reasonably be expected to cause, a Material Adverse Change, or (ii) materially and adversely affects the legal qualifications of Borrower or any of its Subsidiaries to hold such Governmental Approval in any applicable jurisdiction and such revocation, rescission, suspension, modification or non-renewal could reasonably be expected to materially and adversely affect the status of or legal qualifications of Borrower or any of its Subsidiaries to hold any Governmental Approval in any other jurisdiction that is material to the operation of Borrower&#8217;s business.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:28.5pt;text-decoration:underline">BANK&#8217;S RIGHTS AND REMEDIES</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:41.85pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Rights and Remedies. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upon the occurrence and during the continuance of an Event of Default, Bank may, without notice or demand, do any or all of the following&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">declare all Obligations immediately due and payable (but if an Event of Default described in Section <a href="#i37efde9015094164b274aef726ee5ee2_16" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">7.5</a> occurs all Obligations are immediately due and payable without any action by Bank)&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">stop advancing money or extending credit for Borrower&#8217;s benefit under this Agreement or under any other agreement between Borrower and Bank&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">demand that Borrower (i) deposit cash with Bank in an amount equal to at least (A) one hundred and five percent (105.0%) of the aggregate face amount of any Letters of Credit denominated in Dollars remaining undrawn, and (B) one hundred and fifteen percent (115.0%) of the Dollar Equivalent of the aggregate face amount of any Letters of Credit denominated in a Foreign Currency remaining undrawn (plus, in each case, all interest, fees, and costs due or estimated by Bank to become due in connection therewith), to secure all of the Obligations relating to such Letters of Credit, as collateral security for the repayment of any future drawings under such Letters of Credit, and Borrower shall forthwith deposit and pay such amounts, and (ii) pay in advance all letter of credit fees scheduled to be paid or payable over the remaining term of any Letters of Credit&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">terminate any FX Contracts (it being understood and agreed that (i) Bank is not obligated to deliver the currency which Borrower has contracted to receive under any FX Contract, and Bank may cover its exposure for any FX Contracts by purchasing or selling currency in the interbank market as Bank deems appropriate&#59;</font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ii) Borrower shall be liable for all losses, damages, costs, margin obligations and expenses incurred by Bank arising from Borrower&#8217;s failure to satisfy its obligations under any FX Contract or the execution of any FX Contract&#59; and (iii) Bank shall not be liable to Borrower for any gain in value of a FX Contract that Bank may obtain in covering Borrower&#8217;s breach)&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">verify the amount of, demand payment of and performance under, and collect any Accounts and General Intangibles, settle or adjust disputes and claims directly with Account Debtors for amounts on terms and in any order that Bank considers advisable, and notify any Person owing Borrower money of Bank&#8217;s security interest in such funds&#59;</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.01pt">make any payments and do any acts it considers necessary or reasonable to protect the Collateral and&#47;or its security interest in the Collateral. Borrower shall assemble the Collateral if Bank requests and make it available as Bank designates. Bank may enter premises where the Collateral is located, take and maintain possession of any part of the Collateral, and pay, purchase, contest, or compromise any Lien which appears to be prior</font></div><div style="text-align:justify"><font><br></font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:39.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">or superior to its security interest and pay all expenses incurred. Borrower grants Bank a license to enter and occupy any of its premises, without charge, to exercise any of Bank&#8217;s rights or remedies&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">apply to the Obligations any (i) balances and deposits of Borrower it holds, or (ii) amount held by Bank owing to or for the credit or the account of Borrower&#59;</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">ship, reclaim, recover, store, finish, maintain, repair, prepare for sale, advertise for sale, and sell the Collateral. For use solely upon the occurrence and during the continuation of an Event of Default, Bank is hereby granted a non-exclusive, royalty-free license or other right to use, without charge, Borrower&#8217;s labels, Patents, Copyrights, mask works, rights of use of any name, trade secrets, trade names, Trademarks, and advertising matter, or any similar property as it pertains to the Collateral, in completing production of, advertising for sale, and selling any Collateral and, in connection with Bank&#8217;s exercise of its rights under this Section <a href="#i37efde9015094164b274aef726ee5ee2_16" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">8.1,</a> Borrower&#8217;s rights under all licenses and all franchise agreements inure to Bank&#8217;s benefit&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.57pt">place a &#8220;hold&#8221; on any account maintained with Bank and&#47;or deliver a notice of exclusive control, any entitlement order, or other directions or instructions pursuant to any Control Agreement or similar agreements providing control of any Collateral&#59;</font></div><div><font><br></font></div><div style="padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.57pt">demand and receive possession of Borrower&#8217;s Books&#59; and</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">exercise all rights and remedies available to Bank under the Loan Documents or at law or equity, including all remedies provided under the Code or any Applicable Law (including disposal of the Collateral pursuant to the terms thereof).</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Power of Attorney. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrower hereby irrevocably appoints Bank as its true and lawful attorney-in- fact, (a) exercisable only following the occurrence and during the continuance of an Event of Default, to&#58; (i) endorse Borrower&#8217;s name on any checks, payment instruments, or other forms of payment or security&#59; (ii) sign Borrower&#8217;s name on any invoice or bill of lading for any Account or drafts against Account Debtors&#59; (iii) demand, collect, sue, and give releases to any Account Debtor for monies due, settle and adjust disputes and claims about the Accounts directly with Account Debtors, and compromise, prosecute, or defend any action, claim, case, or proceeding about any Collateral (including filing a claim or voting a claim in any bankruptcy case in Bank&#8217;s or Borrower&#8217;s name, as Bank chooses)&#59; (iv) make, settle, and adjust all claims under Borrower&#8217;s insurance policies&#59; (v) pay, contest or settle any Lien, charge, encumbrance, security interest, or other claim in or to the Collateral, or any judgment based thereon, or otherwise take any action to terminate or discharge the same&#59; and (vi) transfer the Collateral into the name of Bank or a third party as the Code permits&#59; and (b) regardless of whether an Event of Default has occurred, to sign Borrower&#8217;s name on any documents necessary to perfect or continue the perfection of Bank&#8217;s security interest in the Collateral. Bank&#8217;s foregoing appointment as Borrower&#8217;s attorney in fact, and all of Bank&#8217;s rights and powers, coupled with an interest, are irrevocable until such time as all Obligations (other than inchoate indemnity obligations) have been paid in full in cash, Bank is under no further obligation to make Credit Extensions and the Loan Documents have been terminated. Bank shall not incur any liability in connection with or arising from the exercise of such power of attorney and shall have no obligation to exercise any of the foregoing rights and remedies.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Protective Payments. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If Borrower fails to obtain the insurance called for by Section <a href="#i37efde9015094164b274aef726ee5ee2_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">5.8</a> or fails to pay any premium thereon or fails to pay any other amount which Borrower is obligated to pay under this Agreement or any other Loan Document or which may be required to preserve the Collateral, Bank may obtain such insurance or make such payment, and all amounts so paid by Bank are Bank Expenses and immediately due and payable, bearing interest at the then highest rate applicable to the Obligations, and secured by the Collateral. Bank will make reasonable efforts to provide Borrower with notice of Bank obtaining such insurance at the time it is obtained or within a reasonable time thereafter. No payments by Bank are deemed an agreement to make similar payments in the future or Bank&#8217;s waiver of any Event of Default.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Application of Payments and Proceeds. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If an Event of Default has occurred and is continuing, Bank shall have the right to apply in any order any funds in its possession, whether from Borrower account balances, payments, proceeds realized as the result of any collection of Accounts or other disposition of the Collateral, or otherwise, to the Obligations in such order as Bank shall determine in its sole discretion. Any surplus shall be paid to</font></div><div style="text-align:justify"><font><br></font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrower or other Persons legally entitled thereto&#59; Borrower shall remain liable to Bank for any deficiency. Following the occurrence and during the continuation of an Event of Default, if Bank, in its commercially reasonable discretion, directly or indirectly, enters into a deferred payment or other credit transaction with any purchaser at any sale of Collateral, Bank shall have the option, exercisable at any time, of either reducing the Obligations by the principal amount of the purchase price or deferring the reduction of the Obligations until the actual receipt by Bank of cash therefor.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Bank&#8217;s Liability for Collateral. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank&#8217;s sole duty with respect to the custody, safekeeping and physical preservation of the Collateral in its possession or under its control, under Section 9-207 of the Code or otherwise, shall be to deal with it in the same manner as Bank deals with its own property consisting of similar instruments or interests. Borrower bears all risk of loss, damage or destruction of the Collateral.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">No Waiver&#59; Remedies Cumulative. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank&#8217;s failure, at any time or times, to require strict performance by Borrower of any provision of this Agreement or any other Loan Document shall not waive, affect, or diminish any right of Bank thereafter to demand strict performance and compliance herewith or therewith. No waiver hereunder shall be effective unless signed by the party granting the waiver and then is only effective for the specific instance and purpose for which it is given. Bank&#8217;s rights and remedies under this Agreement and the other Loan Documents are cumulative. Bank has all rights and remedies provided under the Code, by law, or in equity. Bank&#8217;s exercise of one right or remedy is not an election and shall not preclude Bank from exercising any other remedy under this Agreement or other remedy available at law or in equity, and Bank&#8217;s waiver of any Event of Default is not a continuing waiver. Bank&#8217;s delay in exercising any remedy is not a waiver, election, or acquiescence.</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Demand Waiver. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrower waives demand, notice of default or dishonor, notice of payment and nonpayment, notice of any default, nonpayment at maturity, release, compromise, settlement, extension, or renewal of accounts, documents, instruments, chattel paper, and guarantees held by Bank on which Borrower is liable.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:28.5pt;text-decoration:underline">NOTICES</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All notices, consents, requests, approvals, demands, or other communication by any party to this Agreement or any other Loan Document must be in writing and shall be deemed to have been validly served, given, or delivered&#58;</font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) upon the earlier of actual receipt and three (3) Business Days after deposit in the U.S. mail, first class, registered or certified mail return receipt requested, with proper postage prepaid&#59; (b) upon transmission, when sent by electronic mail&#59; (c) one (1) Business Day after deposit with a reputable overnight courier with all charges prepaid&#59; or (d) when delivered, if hand-delivered by messenger, all of which shall be addressed to the party to be notified and sent to the address or email address indicated below&#59; provided that, for clause (b), if such notice, consent, request, approval, demand or other communication is not sent during the normal business hours of the recipient, it shall be deemed to have been sent at the opening of business on the next Business Day of the recipient. Bank or Borrower may change its mailing or electronic mail address by giving the other party written notice thereof in accordance with the terms of this Section <a href="#i37efde9015094164b274aef726ee5ee2_16" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">9.</a></font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:118pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If to Borrower&#58;&#160;&#160;&#160;&#160;SI-Bone, Inc.</font></div><div style="padding-left:226pt;padding-right:190.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">471 El Camino Real, Suite 101 Santa Clara, CA 95050</font></div><div style="padding-left:226pt;padding-right:190.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Attn&#58; Laura Francis, CEO&#59; and Anshul Maheshwari, CFO</font></div><div style="padding-left:226pt;padding-right:190.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Email&#58; lfrancis&#64;si-bone.com&#59; and Anshul.Maheshwari&#64;si-bone.com</font></div><div style="margin-top:6pt;padding-left:118pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">with a copy to (which shall not constitute notice)&#58;</font></div><div style="margin-top:5.9pt;padding-left:226pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cooley LLP</font></div><div style="margin-top:0.05pt;padding-left:226pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 Hudson Yards</font></div><div style="padding-left:226pt;padding-right:170.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York, New York, 10001-2157 Attn&#58; Patrick Flanagan</font></div><div style="margin-top:0.05pt;padding-left:226pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Email&#58; pflanagan&#64;cooley.com</font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i37efde9015094164b274aef726ee5ee2_19"></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:118pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If to Bank&#58;&#160;&#160;&#160;&#160;Silicon Valley Bank</font></div><div style="padding-left:226pt;padding-right:214.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505 Howard Street, Floor 3 San Francisco, CA 94105 Attn&#58; Mark Davis</font></div><div style="padding-left:226pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Email&#58; mdavis&#64;svb.com</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:118pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">with a copy to (which shall not constitute notice)&#58;</font></div><div style="margin-top:6.05pt;padding-left:226pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DLA Piper LLP (US)</font></div><div style="padding-left:226pt;padding-right:214.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401 B Street, Suite 1700 San Diego, California 92101 Attn&#58; Matt Schwartz, Esq.</font></div><div style="padding-left:226pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Email&#58; matt.schwartz&#64;us.dlapiper.com</font></div><div><font><br></font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt;text-decoration:underline">CHOICE OF LAW, VENUE AND JURY TRIAL WAIVER&#59; JUDICIAL REFERENCE</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Except as otherwise expressly provided in any of the Loan Documents, California law governs the Loan Documents without regard to principles of conflicts of law that would require the application of the laws of another jurisdiction. Borrower and Bank each irrevocably and unconditionally submit to the exclusive jurisdiction of the State and Federal courts in Santa Clara County, California&#59; provided, however, that nothing in this Agreement shall be deemed to operate to preclude Bank from bringing suit or taking other legal action in any other jurisdiction with respect to the Loan Documents or to realize on the Collateral or any other security for the Obligations, or to enforce a judgment or other court order in favor of Bank. Borrower expressly, irrevocably and unconditionally submits and consents in advance to such jurisdiction in any action or suit commenced in any such court, and Borrower hereby irrevocably and unconditionally waives, to the fullest extent permitted by Applicable Law, any objection that it may have based upon lack of personal jurisdiction, improper venue, or forum non conveniens and hereby irrevocably and unconditionally consents to the granting of such legal or equitable relief as is deemed appropriate by such court. Borrower hereby waives personal service of the summons, complaints, and other process issued in such action or suit and agrees that service of such summons, complaints, and other process may be made by registered or certified mail addressed to Borrower at the address set forth in, or subsequently provided by Borrower in accordance with, Section <a href="#i37efde9015094164b274aef726ee5ee2_16" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">9</a> of this Agreement and that service so made shall be deemed completed upon the earlier to occur of Borrower&#8217;s actual receipt thereof or three (3) days after deposit in the U.S. mails, proper postage prepaid.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, BORROWER AND BANK EACH WAIVES ITS RIGHT TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION ARISING OUT OF OR BASED UPON THIS AGREEMENT, THE LOAN DOCUMENTS OR ANY CONTEMPLATED TRANSACTION UNDER THIS AGREEMENT, INCLUDING CONTRACT, TORT, BREACH OF DUTY AND ALL OTHER CLAIMS. THIS WAIVER IS A MATERIAL INDUCEMENT FOR THE PARTIES HERETO TO ENTER INTO THIS AGREEMENT. EACH PARTY HERETO HAS REVIEWED THIS WAIVER WITH ITS COUNSEL.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:82pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">WITHOUT INTENDING IN ANY WAY TO LIMIT THE PARTIES&#8217; AGREEMENT TO WAIVE THEIR</font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RESPECTIVE RIGHT TO A TRIAL BY JURY, if the above waiver of the right to a trial by jury is not enforceable, the parties hereto agree that any and all disputes or controversies of any nature between them arising at any time shall be decided by a reference to a private judge, mutually selected by the parties (or, if they cannot agree, by the Presiding Judge of the Santa Clara County, California Superior Court) appointed in accordance with California Code of Civil Procedure Section 638 (or pursuant to comparable provisions of federal law if the dispute falls within the exclusive jurisdiction of the federal courts), sitting without a jury, in Santa Clara County, California&#59; and the parties hereby submit to the jurisdiction of such court. The reference proceedings shall be conducted pursuant to and in accordance with the provisions of California Code of Civil Procedure Sections 638 through 645.1, inclusive. The private judge shall have the power, among others, to grant provisional relief, including without limitation, entering temporary restraining orders, issuing preliminary and permanent injunctions and appointing receivers. All such proceedings shall be closed to the public and confidential and all records relating thereto shall be permanently sealed. If during the course of any dispute, a party desires to seek provisional relief, but a judge has not been appointed at that point pursuant to the judicial reference procedures, then such party may apply to the Santa Clara County, California Superior Court</font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i37efde9015094164b274aef726ee5ee2_22"></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">for such relief. The proceeding before the private judge shall be conducted in the same manner as it would be before a court under the rules of evidence applicable to judicial proceedings. The parties shall be entitled to discovery which shall be conducted in the same manner as it would be before a court under the rules of discovery applicable to judicial proceedings. The private judge shall oversee discovery and may enforce all discovery rules and orders applicable to judicial proceedings in the same manner as a trial court judge. The parties agree that the selected or appointed private judge shall have the power to decide all issues in the action or proceeding, whether of fact or of law, and shall report a statement of decision thereon pursuant to California Code of Civil Procedure Section 644(a). Nothing in this paragraph shall limit the right of any party at any time to exercise self-help remedies, foreclose against collateral, or obtain provisional remedies. The private judge shall also determine all issues relating to the applicability, interpretation, and enforceability of this paragraph.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:24.17pt;padding-right:24.17pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This Section <a href="#i37efde9015094164b274aef726ee5ee2_19" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">10</a> shall survive the termination of this Agreement and the repayment of all Obligations.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt;text-decoration:underline">GENERAL PROVISIONS</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:8.5pt">Termination Prior to Revolving Line Maturity Date or Term Loan Maturity Date&#59; Survival. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All covenants, representations and warranties made in this Agreement shall continue in full force until this Agreement has terminated pursuant to its terms and all Obligations (other than inchoate indemnity obligations) have been satisfied. So long as Borrower has satisfied the Obligations (other than inchoate indemnity obligations, and any other obligations which, by their terms, are to survive the termination of this Agreement and the repayment of all Obligations, and any Obligations under Bank Services Agreements that are cash collateralized in accordance with Section <a href="#i37efde9015094164b274aef726ee5ee2_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">3.1</a> of this Agreement), this Agreement may be terminated prior to the Revolving Line Maturity Date and the Term Loan Maturity Date by Borrower, effective three (3) Business Days after written notice of termination is given to Bank. Those obligations that are expressly specified in this Agreement as surviving this Agreement&#8217;s termination and the repayment of all Obligations shall continue to survive notwithstanding this Agreement&#8217;s termination and the repayment of all Obligations.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:8.5pt">Successors and Assigns. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This Agreement binds and is for the benefit of the successors and permitted assigns of each party. Borrower may not assign or transfer this Agreement or any rights or obligations under it without Bank&#8217;s prior written consent (which may be granted or withheld in Bank&#8217;s sole discretion) and any other attempted assignment or transfer by Borrower shall be null and void. Bank has the right, without the consent of or notice to Borrower, to sell, transfer, assign, negotiate, or grant participation in all or any part of, or any interest in, Bank&#8217;s obligations, rights, and benefits under this Agreement and the other Loan Documents. Notwithstanding the foregoing, or anything to the contrary herein, so long as no Event of Default shall have occurred and is continuing, Bank shall not assign its interest in the Loan Documents to any Person who is (a) a competitor of Borrower, whether as an operating company or direct or indirect parent with voting control over such operating company, or (b) a vulture fund or distressed debt fund.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:18.5pt">Indemnification.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt;text-decoration:underline">General Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Borrower shall indemnify, defend and hold Bank and its Affiliates and the partners, directors, officers, employees, agents, trustees, administrators, managers, advisors and representatives of Bank and its Affiliates (each, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indemnified Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) harmless against&#58; all losses, claims, damages, liabilities and related expenses (including Bank Expenses and the reasonable fees, charges and disbursements of any counsel for any Indemnified Person) (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Claims</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) arising out of, in connection with, or as a result of (i) the execution or delivery of this Agreement, any other Loan Document or any agreement or instrument contemplated hereby or thereby, the performance by the parties hereto of their respective obligations hereunder or thereunder or the consummation of the transactions contemplated hereby or thereby, (ii) any Credit Extension or the use or proposed use of the proceeds therefrom, (iii) any actual or alleged presence or release of hazardous materials on or from any property owned or operated by Borrower or any of its Subsidiaries, or any environmental liability related in any way to Borrower or any of its Subsidiaries, or (iv) any actual or prospective claim, litigation, investigation or proceeding relating to any of the foregoing, whether based on contract, tort or any other theory, whether brought by a third party or by Borrower, and regardless of whether any Indemnified Person is a party thereto&#59; provided that such indemnity shall not, as to any Indemnified Person, be available to the extent that such losses, claims, damages, liabilities or related expenses are determined by a court of competent jurisdiction by final</font></div><div style="text-align:justify"><font><br></font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:39.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">and nonappealable judgment to have resulted from the gross negligence or willful misconduct of such Indemnified Person. All amounts due under this Section <a href="#i37efde9015094164b274aef726ee5ee2_22" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">11.3</a> shall be payable promptly after demand therefor.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:underline">Waiver of Consequential Damages, Etc.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> To the fullest extent permitted by Applicable Law, Borrower shall not assert, and hereby waives, any claim against any Indemnified Person, on any theory of liability, for special, indirect, consequential or punitive damages (as opposed to direct or actual damages) or any loss of profits arising out of, in connection with, or as a result of, this Agreement, any other Loan Document or any agreement or instrument contemplated hereby, the transactions contemplated hereby or thereby, any Credit Extension, or the use of the proceeds thereof. No Indemnified Person shall be liable for any damages arising from the use by unintended recipients of any information or other materials distributed by it through telecommunications, electronic or other information transmission systems in connection with this Agreement or the other Loan Documents or the transactions contemplated hereby or thereby.</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:39.65pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This Section <a href="#i37efde9015094164b274aef726ee5ee2_22" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">11.3</a> shall survive the termination of this Agreement and the repayment of all Obligations until all statutes of limitation with respect to the Claims, losses, and expenses for which indemnity is given shall have run.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.4  Time of Essence. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time is of the essence for the performance of all Obligations in this Agreement.</font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.5 Severability of Provisions. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Each provision of this Agreement is severable from every other provision in determining the enforceability of any provision.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.6    Amendments in Writing&#59; Waiver&#59; Integration.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> No purported amendment or modification of any Loan Document, or waiver, discharge or termination of any obligation under any Loan Document, shall be effective unless, and only to the extent, expressly set forth in a writing signed by each party hereto. Without limiting the generality of the foregoing, no oral promise or statement, nor any action, inaction, delay, failure to require performance or course of conduct shall operate as, or evidence, an amendment, supplement or waiver or have any other effect on any Loan Document. Any waiver granted shall be limited to the specific circumstance expressly described in it, and shall not apply to any subsequent or other circumstance, whether similar or dissimilar, or give rise to, or evidence, any obligation or commitment to grant any further waiver. The Loan Documents represent the entire agreement about this subject matter and supersede prior negotiations or agreements. All prior agreements, understandings, representations, warranties, and negotiations between the parties about the subject matter of the Loan Documents merge into the Loan Documents.</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.7 Counterparts. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This Agreement may be executed in any number of counterparts and by different parties on separate counterparts, each of which, when executed and delivered, is an original, and all taken together, constitute one Agreement. Delivery of an executed signature page of this Agreement by electronic mail transmission shall be effective as delivery of a manually executed counterpart hereof.</font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.8 Confidentiality. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank agrees to maintain the confidentiality of Information (as defined below), except that Information may be disclosed (a) to Bank&#8217;s Subsidiaries and Affiliates and their respective employees, directors, agents, attorneys, accountants and other professional advisors (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Representatives</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; and, together with Bank, collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Bank Entities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), provided that such Bank Entities are subject to the same confidentiality provisions herein&#59; (b) to prospective transferees, assignees, credit providers or purchasers of Bank&#8217;s interests under or in connection with this Agreement and their Representatives (provided, however, Bank shall use obtain any such prospective transferee&#8217;s, assignee&#8217;s, credit provider&#8217;s, purchaser&#8217;s or their Representatives&#8217; agreement to the terms of this provision or substantially similar terms)&#59; (c) as required by law, regulation, subpoena, or other order&#59; (d) to Bank&#8217;s regulators or as otherwise required or requested in connection with Bank&#8217;s examination or audit&#59;</font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e) in connection with the exercise of remedies under the Loan Documents or any action or proceeding relating to this Agreement or any other Loan Document or the enforcement of rights hereunder or thereunder&#59; and (f) to third-party service providers of Bank so long as such service providers have executed a confidentiality agreement with Bank with terms no less restrictive than those contained herein. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means all information received from Borrower and its agents regarding Borrower or its business, in each case other than information that is either&#58; (i) in the public domain or in Bank&#8217;s possession when disclosed to Bank, or becomes part of the public domain (other than as a result of its disclosure by Bank in violation of this Agreement) after disclosure to Bank&#59; or (ii) disclosed to Bank by a third party, if Bank does not know that the third party is prohibited from disclosing the information.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.9 Electronic Execution of Documents. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The words &#8220;execution,&#8221; &#8220;signed,&#8221; &#8220;signature&#8221; and words of like import in any Loan Document shall be deemed to include electronic signatures, or the keeping of records in electronic form, each of which shall be of the same legal effect, validity and enforceability as a manually executed signature or the use of a paper-based recordkeeping systems, as the case may be, to the extent and as provided for in any Applicable Law, including, without limitation, any state law based on the Uniform Electronic Transactions Act.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.10 Right of Setoff. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrower hereby grants to Bank a Lien and a right of setoff as security for all Obligations to Bank, whether now existing or hereafter arising upon and against all deposits, credits, collateral and property, now or hereafter in the possession, custody, safekeeping or control of Bank or any entity under the control of Bank (including a subsidiary of Bank) or in transit to any of them, and other obligations owing to Bank or any such entity. At any time after the occurrence and during the continuance of an Event of Default, without demand or notice, Bank may setoff the same or any part thereof and apply the same to any liability or Obligation of Borrower even though unmatured and regardless of the adequacy of any other collateral securing the Obligations. ANY AND ALL RIGHTS TO REQUIRE BANK TO EXERCISE ITS RIGHTS OR REMEDIES WITH RESPECT TO ANY OTHER COLLATERAL WHICH SECURES THE OBLIGATIONS, PRIOR TO EXERCISING ITS RIGHT OF SETOFF WITH RESPECT TO SUCH DEPOSITS, CREDITS OR OTHER PROPERTY OF BORROWER, ARE HEREBY KNOWINGLY, VOLUNTARILY AND IRREVOCABLY WAIVED.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:10pt;padding-right:41.8pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.11 Captions and Section References. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The headings used in this Agreement are for convenience only and shall not affect the interpretation of this Agreement. Unless indicated otherwise, section references herein are to sections of this Agreement.</font></div><div><font><br></font></div><div style="padding-left:10pt;padding-right:41.8pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.12 Construction of Agreement. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The parties hereto mutually acknowledge that they and their attorneys have participated in the preparation and negotiation of this Agreement. In cases of uncertainty this Agreement shall be construed without regard to which of the parties caused the uncertainty to exist.</font></div><div style="padding-left:10pt;padding-right:41.8pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="padding-left:10pt;padding-right:41.8pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.13 Relationship. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The relationship of the parties to this Agreement is determined solely by the provisions of this Agreement. The parties do not intend to create any agency, partnership, joint venture, trust, fiduciary or other relationship with duties or incidents different from those of parties to an arm&#8217;s-length contract.</font></div><div style="padding-left:10pt;padding-right:41.8pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="padding-left:10pt;padding-right:41.8pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.14 Third Parties. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nothing in this Agreement, whether express or implied, is intended to&#58; (a) confer any benefits, rights or remedies under or by reason of this Agreement on any Persons other than the express parties to it and their respective permitted successors and assigns&#59; (b) relieve or discharge the obligation or liability of any Person not an express party to this Agreement&#59; or (c) give any Person not an express party to this Agreement any right of subrogation or action against any party to this Agreement.</font></div><div style="padding-left:10pt;padding-right:41.8pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="padding-left:10pt;padding-right:41.8pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.15 Anti-Terrorism Law. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank hereby notifies Borrower that, pursuant to the requirements of Anti- Terrorism Law, Bank may be required to obtain, verify and record information that identifies Borrower, which information may include the name and address of Borrower and other information that will allow Bank to identify Borrower in accordance with Anti-Terrorism Law. Borrower hereby agrees to take any action necessary to enable Bank to comply with the requirements of Anti-Terrorism Law.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt;text-decoration:underline">ACCOUNTING TERMS AND OTHER DEFINITIONS</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:18.5pt">Accounting and Other Terms.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">Accounting terms not defined in this Agreement shall be construed following GAAP, except for non-compliance with FAS 123R with respect to monthly financial statements. Calculations and determinations must be made following GAAP (except for (a) non-compliance with FAS 123R with respect to monthly financial statement), provided that if at any time any change in GAAP would affect the computation of any financial ratio or requirement set forth in any Loan Document, and either Borrower or Bank shall so request, Borrower and Bank shall negotiate in good faith to amend such ratio or requirement to preserve the original intent thereof in light of such change in GAAP&#59; provided, further, that, until so amended, (i) such ratio or requirement shall continue to be computed in accordance with GAAP prior to such change therein and (ii) Borrower shall provide Bank financial statements and other documents required under this Agreement or as reasonably requested hereunder setting forth a</font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i37efde9015094164b274aef726ee5ee2_25"></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:39.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">reconciliation between calculations of such ratio or requirement made before and after giving effect to such change in GAAP.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">As used in the Loan Documents&#58; (i) the words &#8220;shall&#8221; or &#8220;will&#8221; are mandatory, the word &#8220;may&#8221; is permissive, the word &#8220;or&#8221; is not exclusive, the words &#8220;includes&#8221; and &#8220;including&#8221; are not limiting, the singular includes the plural, and numbers denoting amounts that are set off in brackets are negative&#59; (ii) the term &#8220;continuing&#8221; in the context of an Event of Default means that the Event of Default has not been remedied (if capable of being remedied) or waived&#59; and (iii) whenever a representation or warranty is made to Borrower&#8217;s knowledge or awareness, to the &#8220;best of&#8221; Borrower&#8217;s knowledge, or with a similar qualification, knowledge or awareness means the actual knowledge, after reasonable investigation, of any Responsible Officer.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:8.5pt">Definitions. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized terms not otherwise defined in this Agreement shall have the meanings set forth in this Section <a href="#i37efde9015094164b274aef726ee5ee2_25" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">12.2.</a> All other terms contained in this Agreement, unless otherwise indicated, shall have the meaning provided by the Code to the extent such terms are defined therein. As used in this Agreement, the following capitalized terms have the following meanings&#58;</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is, as to any Person, any &#8220;account&#8221; of such Person as &#8220;account&#8221; is defined in the Code with such additions to such term as may hereafter be made, and includes, without limitation, all accounts receivable and other sums owing to such Person.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Account Debtor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is any &#8220;account debtor&#8221; as defined in the Code with such additions to such term as may hereafter be made.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted EBITDA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; shall mean, for Borrower and its Subsidiaries, with respect to any period, the sum of (a) Net Income, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">plus </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b) to the extent deducted or added to the calculation of Net Income, (i) Interest income, Interest Expenses, (ii) depreciation expense and amortization expense, (iii) income tax expense, (iv) non-cash stock compensation, and (v) any other one-time restructuring or non-cash charges.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted Quick Ratio</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is the ratio of (a) Quick Assets to (b) the sum of (i) Current Liabilities minus (ii) the current portion of Deferred Revenue.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:84.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Administrator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is an individual that is named&#58;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:82pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">as an &#8220;Administrator&#8221; in the &#8220;SVB Online Services&#8221; form completed by Borrower with the authority to determine who will be authorized to use SVB Online Services (as defined in Bank&#8217;s Online Banking Agreement as in effect from time to time) on behalf of Borrower&#59; and</font></div><div><font><br></font></div><div style="padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">as an Authorized Signer of Borrower in an approval by the Board.</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Advance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Advances</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means a revolving credit loan (or revolving credit loans) under the Revolving</font></div><div style="padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Line.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is, with respect to any Person, each other Person that owns or controls directly or indirectly the Person, any Person that controls or is controlled by or is under common control with the Person, and each of that Person&#8217;s senior executive officers, directors, partners and, for any Person that is a limited liability company, that Person&#8217;s managers and members.</font></div><div><font><br></font></div><div style="padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is defined in the preamble hereof.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Anti-Terrorism Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means any law relating to terrorism or money-laundering, including Executive Order No. 13224 and the USA Patriot Act.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means all applicable provisions of constitutions, laws, statutes, ordinances, rules, treaties, regulations, permits, licenses, approvals, interpretations and orders of courts or Governmental Authorities and all orders and decrees of all courts and arbitrators.</font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i37efde9015094164b274aef726ee5ee2_28"></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Authorized Signer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means any individual listed in Borrower&#8217;s Borrowing Resolution who is authorized to execute the Loan Documents, including making (and executing if applicable) any Credit Extension request, on behalf of Borrower.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Availability Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is the lesser of (a) the Revolving Line or (b) the Borrowing Base, minus the sum of all outstanding principal amounts of any Advances.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:82pt;padding-right:279.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:237%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:237%">Bank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:237%">&#8221; is defined in the preamble hereof. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:237%">Bank Entities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:237%">&#8221; is defined in Section <a href="#i37efde9015094164b274aef726ee5ee2_22" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:237%;text-decoration:none">11.8.</a></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Bank Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; are all reasonable audit fees, costs and reasonable expenses (including reasonable, out-of- pocket and documented attorneys&#8217; fees and expenses) for preparing, amending, negotiating, administering, defending and enforcing the Loan Documents (including, without limitation, those incurred in connection with appeals or Insolvency Proceedings) or otherwise incurred with respect to Borrower or any Guarantor.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Bank Services</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; are any products, credit services, and&#47;or financial accommodations previously, now, or hereafter provided to Borrower or any of its Subsidiaries by Bank or any Bank Affiliate, including, without limitation, any letters of credit, cash management services (including, without limitation, merchant services, direct deposit of payroll, business credit cards, and check cashing services), interest rate swap arrangements, and foreign exchange services as any such products or services may be identified in Bank&#8217;s various agreements related thereto (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Bank Services Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:82pt;padding-right:170.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:237%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:237%">Bank Services Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:237%">&#8221; is defined in the definition of Bank Services. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:237%">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:237%">&#8221; is Borrower&#8217;s board of directors or equivalent governing body. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:237%">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:237%">&#8221; is set forth on Schedule I hereto.</font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Borrower&#8217;s Books</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; are all Borrower&#8217;s books and records including ledgers, federal and state tax returns, records regarding Borrower&#8217;s assets or liabilities, the Collateral, business operations or financial condition, and all computer programs or storage or any equipment containing such information.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:38.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Borrowing Base</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is eighty percent (80%) of Eligible Accounts, as determined by Bank from Borrower&#8217;s most recent Borrowing Base Statement&#59; provided, however, that Bank has the right to decrease the foregoing percentages in its commercially reasonable discretion to mitigate the impact of events, conditions, contingencies, or risks which would reasonably be expected to adversely affect the Collateral or its value, following thirty (30) days prior written notice to Borrower.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Borrowing Base Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is that certain statement of the value of certain Collateral in the form specified by Bank to Borrower from time to time.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Borrowing Resolutions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; are, with respect to any Person, those resolutions adopted by such Person&#8217;s board of directors (and, if required under the terms of such Person&#8217;s Operating Documents, stockholders) and delivered by such Person to Bank approving the Loan Documents to which such Person is a party and the transactions contemplated thereby, together with a certificate executed by its secretary on behalf of such Person certifying (a) such Person has the authority to execute, deliver, and perform its obligations under each of the Loan Documents to which it is a party,</font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b) that set forth as a part of or attached as an exhibit to such certificate is a true, correct, and complete copy of the applicable resolutions then in full force and effect authorizing and ratifying the execution, delivery, and performance by such Person of the Loan Documents to which it is a party, (c) the name(s) of the Person(s) authorized to execute the Loan Documents, including making (and executing if applicable) any Credit Extension request, on behalf of such Person, together with a sample of the true signature(s) of such Person(s), and (d) that Bank may conclusively rely on such certificate unless and until such Person shall have delivered to Bank a further certificate canceling or amending such prior certificate.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Business Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is a day other than a Saturday, Sunday or other day on which commercial banks in the State of California are authorized or required by law to close, except that if any determination of a &#8220;Business Day&#8221; shall relate to an FX Contract, the term &#8220;Business Day&#8221; shall be a FX Business Day.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Collateral Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is defined in Section 5.4(c).</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; are (a) marketable direct obligations issued or unconditionally guaranteed by the United States or any agency or any State thereof having maturities of not more than one (1) year from the date of acquisition&#59;</font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b) commercial paper maturing no more than one (1) year after its creation and having the highest rating from either Standard &#38; Poor&#8217;s Ratings Group or Moody&#8217;s Investors Service, Inc.&#59; (c) Bank&#8217;s certificates of deposit issued maturing no more than one (1) year after issue&#59; (d) long-term securities having a rating minimum of A-&#47;A3 from either Standard &#38; Poor&#8217;s Ratings Group or Moody&#8217;s Investors Service, Inc.&#59; and (e) money market funds at least ninety-five percent (95.0%) of the assets of which constitute Cash Equivalents of the kinds described in clauses (a) through (d) of this definition.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:38.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means (a) at any time, any &#8220;person&#8221; or &#8220;group&#8221; (as such terms are used in Sections 13(d) and 14(d) of the Exchange Act), shall become, or obtain rights (whether by means of warrants, options or otherwise) to become, the &#8220;beneficial owner&#8221; (as defined in Rules 13(d)-3 and 13(d)-5 under the Exchange Act), directly or indirectly, of forty-nine percent (49.0%) or more of the ordinary voting power for the election of directors, partners, managers and members, as applicable, of Borrower (determined on a fully diluted basis) other than by the sale of Borrower&#8217;s equity securities in a public offering or to venture capital or private equity investors so long as Borrower identifies to Bank the venture capital or private equity investors at least seven (7) Business Days prior to the closing of the transaction and provides to Bank a description of the material terms of the transaction&#59; (b) during any period of twelve (12) consecutive months, a majority of the members of the Board of Borrower cease to be composed of individuals (i) who were members of that board or equivalent governing body on the first (1st) day of such period, (ii) whose election or nomination to that board or equivalent governing body was approved by individuals referred to in clause (i) above constituting at the time of such election or nomination at least a majority of that board or equivalent governing body or (iii) whose election or nomination to that board or other equivalent governing body was approved by individuals referred to in clauses (i) and (ii) above constituting at the time of such election or nomination at least a majority of that board or equivalent governing body&#59; or (c) at any time, Borrower shall cease to own and control, of record and beneficially, directly or indirectly, one hundred percent (100.0%) of each class of outstanding stock, partnership, membership, or other ownership interest or other equity securities of each Subsidiary of Borrower free and clear of all Liens (except Permitted Liens and except dissolutions or transfers permitted pursuant to Sections 6.2 and 6.3 of this Agreement).</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means the occurrence, after the Effective Date, of&#58; (a) the adoption or taking effect of any law, rule, regulation or treaty&#59; (b) any change in Applicable Law or in the administration, interpretation, implementation or application thereof by any Governmental Authority&#59; or (c) the making or issuance of any request, rule, guideline or directive (whether or not having the force of law) by any Governmental Authority&#59; provided that notwithstanding anything herein to the contrary, (i) the Dodd-Frank Wall Street Reform and Consumer Protection Act and all requests, rules, guidelines or directives thereunder or issued in connection therewith and (ii) all requests, rules, guidelines or directives promulgated by Bank for International Settlements, the Basel Committee on Banking Supervision (or any successor or similar authority) or the United States or foreign regulatory authorities, in each case pursuant to Basel III, shall in each case be deemed to be a &#8220;Change in Law&#8221;, regardless of the date enacted, adopted or issued.</font></div><div><font><br></font></div><div style="padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Claims</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is defined in Section <a href="#i37efde9015094164b274aef726ee5ee2_22" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">11.3.</a></font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is the Uniform Commercial Code, as the same may, from time to time, be enacted and in effect in the State of California&#59; provided, that, to the extent that the Code is used to define any term herein or in any Loan Document and such term is defined differently in different Articles or Divisions of the Code, the definition of such term contained in Article or Division 9 shall govern&#59; provided further, that in the event that, by reason of mandatory provisions of law, any or all of the attachment, perfection, or priority of, or remedies with respect to, Bank&#8217;s Lien on any Collateral is governed by the Uniform Commercial Code in effect in a jurisdiction other than the State of California, the term &#8220;Code&#8221; shall mean the Uniform Commercial Code as enacted and in effect in such other</font></div><div style="text-align:justify"><font><br></font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:39.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">jurisdiction solely for purposes of the provisions thereof relating to such attachment, perfection, priority, or remedies and for purposes of definitions relating to such provisions.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Collateral</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; consists of all of Borrower&#8217;s right, title and interest in and to the following personal property&#58;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">(i) all goods, Accounts (including health-care receivables), Equipment, Inventory, contract rights or rights to payment of money, leases, license agreements, franchise agreements, General Intangibles (except as provided below), commercial tort claims, documents, instruments (including any promissory notes), chattel paper (whether tangible or electronic), cash, deposit accounts, certificates of deposit, fixtures, letters of credit rights (whether or not the letter of credit is evidenced by a writing), securities, securities accounts, securities entitlements and all other investment property, supporting obligations, and financial assets, whether now owned or hereafter acquired, wherever located&#59; and (ii) all Borrower&#8217;s Books relating to the foregoing, and any and all claims, rights and interests in any of the above and all substitutions for, additions, attachments, accessories, accessions and improvements to and replacements, products, proceeds and insurance proceeds of any or all of the foregoing.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Notwithstanding the foregoing, the Collateral does not include any of the following (now existing or hereafter arising, owned or created)&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:118pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.57pt">any Intellectual Property&#59; provided, however, the Collateral shall include all Accounts and all proceeds of Intellectual Property. If a judicial authority (including a U.S. Bankruptcy Court) would hold that a security interest in the underlying Intellectual Property is necessary to have a security interest in such Accounts and such property that are proceeds of Intellectual Property, then the Collateral shall automatically, and effective as of the Effective Date, include the Intellectual Property to the extent necessary to permit perfection of Bank&#8217;s security interest in such Accounts and such other property of Borrower that are proceeds of the Intellectual Property&#59; and</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:118pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">any interest of Borrower as a lessee or sublessee under a real property lease or an Equipment lease if Borrower is prohibited by the terms of such lease from granting a security interest in such lease or under which such an assignment or Lien would cause a default to occur under such lease (but only to the extent that such prohibition is enforceable under all applicable laws including, without limitation, the Code)&#59; provided, however, that upon termination of such prohibition, such interest shall immediately become Collateral without any action by Borrower or Bank.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">Pursuant to the terms of a certain negative pledge arrangement with Bank, Borrower has agreed not to encumber any of its Intellectual Property in contravention of the terms of such pledge agreement without Bank&#8217;s prior written consent.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Collateral Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is any Deposit Account, Securities Account, or Commodity Account.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46pt;padding-right:39.65pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commodity Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is any &#8220;commodity account&#8221; as defined in the Code with such additions to such term as may hereafter be made.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Compliance Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is that certain statement in the form attached hereto as Exhibit A.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:39.65pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Connection Income Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means Other Connection Taxes that are imposed on or measured by net income (however denominated) or that are franchise Taxes or branch profits Taxes.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:44.25pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent Obligation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is, for any Person, any direct or indirect liability of that Person for (a) any direct or indirect guaranty by such Person of any indebtedness, lease, dividend, letter of credit, credit card or other obligation of another, (b) any other obligation endorsed, co-made, discounted or sold with recourse by that Person, or for which that Person is directly or indirectly liable&#59; (c) any obligations for undrawn letters of credit for the account of that Person&#59; and (d) all obligations from any interest rate, currency or commodity swap agreement, interest rate cap or collar agreement, or other agreement or arrangement designated to protect a Person against fluctuation in interest rates, currency exchange rates or commodity prices&#59; but &#8220;Contingent Obligation&#8221; does not</font></div><div><font><br></font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:43.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">include endorsements in the ordinary course of business or any Permitted Call Spread Agreement(s). The amount of a Contingent Obligation is the stated or determined amount of the primary obligation for which the Contingent Obligation is made or, if not determinable, the maximum reasonably anticipated liability for it determined by the Person in good faith&#59; but the amount may not exceed the maximum of the obligations under any guarantee or other support arrangement.</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Control Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is any control agreement entered into among the depository institution at which Borrower maintains a Deposit Account or the securities intermediary or commodity intermediary at which Borrower maintains a Securities Account or a Commodity Account, Borrower, and Bank pursuant to which Bank obtains control (within the meaning of the Code) over such Deposit Account, Securities Account, or Commodity Account.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Copyrights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; are any and all copyright rights, copyright applications, copyright registrations and like protections in each work of authorship and derivative work thereof, whether published or unpublished and whether or not the same also constitutes a trade secret.</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Credit Extension</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is any Advance, Overadvance, Letter of Credit, FX Contract, amount utilized for cash management services, Term Loan Advance, or any other extension of credit under the Loan Documents by Bank for Borrower&#8217;s benefit.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is coined money and such other banknotes or other paper money as are authorized by law and circulate as a medium of exchange.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current Liabilities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; are (a) all obligations and liabilities of Borrower to Bank, plus (b) without duplication of (a) the aggregate amount of Borrower&#8217;s Total Liabilities that mature within one (1) year (including, for the avoidance of doubt, all Obligations of Borrower to Bank under the Term Loan Advances that mature within one year and Revolving Advances that mature within one year).</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means any event which with notice or passage of time or both, would constitute an Event of</font></div><div style="padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Default.</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Default Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is defined in Section <a href="#i37efde9015094164b274aef726ee5ee2_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">1.2(c).</a></font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred Revenue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is all amounts received or invoiced in advance of performance under contracts and not yet recognized as revenue.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deposit Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is any &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">deposit account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; as defined in the Code with such additions to such term as may hereafter be made.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated Deposit Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is the deposit account with account number xxx-xxxx-9905, established by Borrower with Bank for purposes of receiving Credit Extensions.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Division</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means, in reference to any Person which is an entity, the division of such Person into two (2) or more separate Persons, with the dividing Person either continuing or terminating its existence as part of such division, including, without limitation, as contemplated under Section 18-217 of the Delaware Limited Liability Company Act for limited liability companies formed under Delaware law, Section 17-220 of the Delaware Revised Uniform Limited Partnership Act for limited partnerships formed under Delaware law, or any analogous action taken pursuant to any other Applicable Law with respect to any corporation, limited liability company, partnership or other entity.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dollar Equivalent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is, at any time, (a) with respect to any amount denominated in Dollars, such amount, and (b) with respect to any amount denominated in a Foreign Currency, the equivalent amount therefor in Dollars as determined by Bank at such time on the basis of the then-prevailing rate of exchange in San Francisco, California, for sales of the Foreign Currency for transfer to the country issuing such Foreign Currency.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dollars</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">,&#8221; &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">dollars</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; or use of the sign &#8220;$&#8221; means only lawful money of the United States and not any other currency, regardless of whether that currency uses the &#8220;$&#8221; sign to denote its currency or may be readily converted into lawful money of the United States.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is set forth on Schedule I hereto.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:38.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eligible Accounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means Accounts owing to Borrower which arise in the ordinary course of Borrower&#8217;s business that meet all Borrower&#8217;s representations and warranties in Section 4.3, that have been, at the option of Bank, confirmed in accordance with Section 5.4(f) of this Agreement, and are due and owing from Account Debtors deemed creditworthy by Bank in its commercially reasonable discretion. Bank reserves the right, at any time after the First Amendment Effective Date, in its commercially reasonable discretion in each instance, to adjust any of the criteria set forth below and to establish new criteria, following thirty (30) days prior written notice to Borrower. Unless Bank otherwise agrees in writing, Eligible Accounts shall not include&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.8pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">Accounts (i) for which the Account Debtor is Borrower&#8217;s Affiliate, officer, employee, investor, or agent, or (ii) that are intercompany Accounts&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Accounts that the Account Debtor has not paid within ninety (90) days of invoice date regardless of invoice payment period terms&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.91pt">Accounts with credit balances over ninety (90) days from invoice date, to the extent of such</font></div><div style="margin-top:0.05pt;padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">credit balances&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Accounts owing from an Account Debtor that exceed Two Hundred Fifty Thousand Dollars ($250,000) if fifty percent (50.0%) or more of the Accounts owing from such Account Debtor have not been paid within ninety (90) days of invoice date&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">Accounts owing from an Account Debtor (i) which does not have its principal place of business in the United States or (ii) whose billing address (as set forth in the applicable invoice for such Account) is not in the United States, unless in the case of both (i) and (ii) such Accounts are otherwise approved by Bank in writing, provided, however, that Bank hereby approves the Accounts relating to Device Technologies Belrose which is located in Australia&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.95pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.01pt">Accounts billed from and&#47;or payable to Borrower outside of the United States (sometimes called foreign invoiced accounts)&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Accounts in which Bank does not have a first priority, perfected security interest under all Applicable Law, other than Device Technologies Belrose which is located in Australia (solely relative to any failure to obtain a first priority, perfected security interest in any foreign jurisdiction, including Australia)&#59;</font></div><div><font><br></font></div><div style="padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">Accounts billed and&#47;or payable in a Currency other than Dollars&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.57pt">Accounts owing from an Account Debtor to the extent that Borrower is indebted or obligated in any manner to the Account Debtor (as creditor, lessor, supplier or otherwise - sometimes called &#8220;contra&#8221; accounts, accounts payable, customer deposits or credit accounts), but only to the extent of such Indebtedness or obligations&#59;</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.57pt">Accounts with or in respect of accruals for marketing allowances, incentive rebates, price protection, cooperative advertising and other similar marketing credits, unless otherwise approved by Bank in writing, but only to the extent of such credits&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Accounts owing from an Account Debtor which is a United States government entity or any department, agency, or instrumentality thereof unless Borrower has assigned its payment rights to Bank and the assignment has been acknowledged under the Federal Assignment of Claims Act of 1940, as amended&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.57pt">Accounts with customer deposits and&#47;or with respect to which Borrower has received an upfront payment, to the extent of such customer deposit and&#47;or upfront payment&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:11.57pt">Accounts for demonstration or promotional equipment, or in which goods are consigned, or sold on a &#8220;sale guaranteed&#8221;, &#8220;sale or return&#8221;, &#8220;sale on approval&#8221;, or other terms if Account Debtor&#8217;s payment may be conditional&#59;</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:41.9pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Accounts owing from an Account Debtor where goods or services have not yet been rendered to the Account Debtor (sometimes called memo billings or pre-billings)&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(o)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Accounts subject to contractual arrangements between Borrower and an Account Debtor where payments shall be scheduled or due according to completion or fulfillment requirements (sometimes called contracts accounts receivable, progress billings, milestone billings, or fulfillment contracts)&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(p)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Accounts owing from an Account Debtor the amount of which may be subject to withholding based on the Account Debtor&#8217;s satisfaction of Borrower&#8217;s complete performance (but only to the extent of the amount withheld&#59; sometimes called retainage billings)&#59;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.5pt;padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(q)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">Accounts subject to trust provisions, subrogation rights of a bonding company, or a</font></div><div style="margin-top:0.05pt;padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">statutory trust&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(r)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.01pt">Accounts owing from an Account Debtor that has been invoiced for goods that have not been shipped to the Account Debtor unless Bank, Borrower, and the Account Debtor have entered into an agreement acceptable to Bank wherein the Account Debtor acknowledges that (i) it has title to and has ownership of the goods wherever located, (ii) a bona fide sale of the goods has occurred, and (iii) it owes payment for such goods in accordance with invoices from Borrower (sometimes called &#8220;bill and hold&#8221; accounts)&#59;</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(s)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:25.45pt">Accounts for which the Account Debtor has not been invoiced&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.95pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(t)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.57pt">Accounts that represent non-trade receivables or that are derived by means other than in the ordinary course of Borrower&#8217;s business&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(u)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Accounts for which Borrower has permitted Account Debtor&#8217;s payment to extend beyond ninety (90) days (including Accounts with a due date that is more than ninety (90) days from invoice date)&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">Accounts arising from chargebacks, debit memos or other payment deductions taken by an</font></div><div style="margin-top:0.05pt;padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Account Debtor&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(w)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:12.12pt">Accounts arising from product returns and&#47;or exchanges (sometimes called &#8220;warranty&#8221; or &#8220;RMA&#8221; accounts)&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(x)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Accounts in which the Account Debtor disputes liability or makes any claim (but only up to the disputed or claimed amount), or if the Account Debtor is subject to an Insolvency Proceeding (whether voluntary or involuntary), or becomes insolvent, or goes out of business&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(y)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Accounts owing from an Account Debtor, whose total obligations to Borrower exceed twenty-five percent (25.0%) of all Accounts, only for the amounts that exceed that percentage, unless Bank approves in writing&#59; and</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(z)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">Accounts for which Bank in its sole discretion determines collection to be doubtful, including, without limitation, accounts represented by &#8220;refreshed&#8221; or &#8220;recycled&#8221; invoices.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46pt;padding-right:39.65pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Environmental Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means any Applicable Law (including any permits, concessions, grants, franchises, licenses, agreements or governmental restrictions) relating to pollution or the protection of health, safety or the</font></div><div><font><br></font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:39.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">environment or the release of any materials into the environment (including those related to hazardous materials, air emissions, discharges to waste or public systems and health and safety matters).</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equipment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is all &#8220;equipment&#8221; as defined in the Code with such additions to such term as may hereafter be made, and includes without limitation all machinery, fixtures, goods, vehicles (including motor vehicles and trailers), and any interest in any of the foregoing.</font></div><div><font><br></font></div><div style="padding-left:82pt;padding-right:44.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:237%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:237%">ERISA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:237%">&#8221; is the Employee Retirement Income Security Act of 1974, as amended, and its regulations. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:237%">Event of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:237%">&#8221; is defined in Section <a href="#i37efde9015094164b274aef726ee5ee2_13" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:237%;text-decoration:none">6.11.</a></font></div><div style="padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8221; is the Securities Exchange Act of 1934, as amended.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Excluded Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means any of the following Taxes imposed on or with respect to Bank or required to be withheld or deducted from a payment to Bank, (a) Taxes imposed on or measured by net income (however denominated), franchise Taxes, and branch profits Taxes, in each case, (i) imposed as a result of Bank being organized under the laws of, or having its principal office or its applicable lending office located in, the jurisdiction imposing such Tax (or any political subdivision thereof) or (ii) that are Other Connection Taxes, (b) U.S. federal withholding Taxes imposed on amounts payable to or for the account of Bank with respect to an applicable interest in a Credit Extension pursuant to a law in effect on the date on which (i) Bank acquires such interest in the Credit Extensions or</font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ii) Bank changes its lending office, except in each case to the extent that, pursuant to Section 1.6, amounts with respect to such Taxes were payable either to Bank&#8217;s assignor immediately before Bank became a party hereto or to Bank immediately before it changed its lending office, (c) Taxes attributable to Bank&#8217;s failure to comply with Section 1.6(e) and&#47;or any reporting and delivery requirements, and (d) any withholding Taxes imposed under FATCA.</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:38.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FATCA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means Sections 1471 through 1474 of the Internal Revenue Code, as of the date of this Agreement (or any amended or successor version that is substantively comparable and not materially more onerous to comply with), any current or future regulations or official interpretations thereof, any agreements entered into pursuant to Section 1471(b)(1) of the Internal Revenue Code and any fiscal or regulatory legislation, rules or practices adopted pursuant to any intergovernmental agreement, treaty or convention among Governmental Authorities and implementing such Sections of the Internal Revenue Code.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Final Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is a payment (in addition to and not a substitution for the regular monthly payments of principal plus accrued interest) due on the earliest to occur of (a) the Term Loan Maturity Date, (b) the repayment of the Term Loan Advance in full, (c) as required pursuant to Section 1.1(c) or 1.1(d), or (d) the termination of this Agreement, in an amount equal to the original aggregate principle amount of the Term Loan Advance extended by Bank to Borrower multiplied by two percent (2.0%).</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Covenant Measuring Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is any period of time (a) commencing on the later to occur of (i) the date on which the aggregate value of the Borrower&#8217;s unrestricted and unencumbered (except for Liens in favor of Bank) cash and Cash Equivalents held at SVB and SVB&#8217;s Affiliates falls below &#91;***&#93; Dollars and (ii) January 1, 2024 and (b) terminating on the date on which Borrower has achieved two (2) consecutive quarters of Adjusted EBITDA greater than &#91;***&#93; Dollars. After the termination of a Financial Covenant Measuring Period, if both (X) Borrower&#8217;s Adjusted EBITDA is equal to or less than &#91;***&#93; Dollars any such fiscal quarter and (Y) the aggregate value of the Borrower&#8217;s unrestricted and unencumbered (except for Liens in favor of Bank) cash and Cash Equivalents held at SVB and SVB&#8217;s Affiliates is less than &#91;***&#93; Dollars, then a new Financial Covenant Measuring Period shall start and shall not terminate until Borrower again achieves Adjusted EBITDA Balance greater than &#91;***&#93; Dollars for two (2) new consecutive quarters.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Statement Repository</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is L43f1c&#64;svb.com or such other means of collecting information approved and designated by Bank after providing notice thereof to Borrower from time to time.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:81.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">First Amendment Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means January 6, 2023.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is the lawful money of a country other than the United States.</font></div><div><font><br></font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:47.3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is a Subsidiary that is not an entity organized under the laws of the United States or any territory thereof or the District of Columbia.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funding Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is any date on which a Credit Extension is made to or for the account of Borrower which shall be a Business Day.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FX Business Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is any day when (a) Bank&#8217;s Foreign Exchange Department is conducting its normal business and (b) the Foreign Currency being purchased or sold by Borrower is available to Bank from the entity from which Bank shall buy or sell such Foreign Currency.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FX Contract</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is any foreign exchange contract by and between Borrower and Bank under which Borrower commits to purchase from or sell to Bank a specific amount of Foreign Currency at a set price or on a specified date.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is generally accepted accounting principles set forth in the opinions and pronouncements of the Accounting Principles Board of the American Institute of Certified Public Accountants and statements and pronouncements of the Financial Accounting Standards Board or in such other statements by such other Person as may be approved by a significant segment of the accounting profession, which are applicable to the circumstances as of the date of determination (except for with respect to unaudited financial statements for the absence of footnotes and subject to year-end audit adjustments).</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">General Intangibles</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is all &#8220;general intangibles&#8221; as defined in the Code in effect on the date hereof with such additions to such term as may hereafter be made, and includes without limitation, all Intellectual Property, claims, income and other tax refunds, security and other deposits, payment intangibles, contract rights, options to purchase or sell real or personal property, rights in all litigation presently or hereafter pending (whether in contract, tort or otherwise), insurance policies (including without limitation key man, property damage, and business interruption insurance), payments of insurance and rights to payment of any kind.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Good Faith Deposit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is defined in Section 1.3.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Governmental Approval</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is any consent, authorization, approval, order, license, franchise, permit, certificate, accreditation, registration, filing or notice, of, issued by, from or to, or other act by or in respect of, any Governmental Authority.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Governmental Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is any nation or government, any state or other political subdivision thereof, any agency, authority, instrumentality, regulatory body, court, central bank or other entity exercising executive, legislative, judicial, taxing, regulatory or administrative functions of or pertaining to government, any securities exchange and any self-regulatory organization.</font></div><div style="margin-top:0.1pt;padding-left:82pt;padding-right:39.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:273%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:273%">Guarantor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:273%">&#8221; is any Person providing a Guaranty in favor of Bank with respect to the Obligations. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:273%">Guaranty</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:273%">&#8221; is any guarantee of all or any part of the Obligations, as the same may from time to time be</font></div><div style="padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">amended, restated, modified or otherwise supplemented.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:38.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is (a) indebtedness for borrowed money or the deferred price of property or services, such as reimbursement and other obligations for surety bonds and letters of credit, (b) obligations evidenced by notes, bonds, debentures or similar instruments, (c) capital lease obligations, (d) Contingent Obligations and (e) other short- and long-term obligations under debt agreements, lines of credit and extensions of credit, provided, however, that in no event shall obligations under any Permitted Call Spread Agreement constitute Indebtedness.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indemnified Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is defined in Section <a href="#i37efde9015094164b274aef726ee5ee2_22" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">11.3.</a></font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indemnified Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means (a) Taxes, other than Excluded Taxes, imposed on or with respect to any payment made by or on account of any obligation of Borrower under any Loan Document and (b) to the extent not otherwise described in clause (a), Other Taxes.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is defined in Section <a href="#i37efde9015094164b274aef726ee5ee2_22" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">11.8.</a></font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Initial Audit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is Bank&#8217;s inspection of Borrower&#8217;s Accounts, the Collateral, and Borrower&#8217;s Books, with results satisfactory to Bank in its sole discretion.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Insolvency Proceeding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is any proceeding by or against any Person under the United States Bankruptcy Code, or any other bankruptcy or insolvency law, including assignments for the benefit of creditors, compositions, extensions generally with its creditors, or proceedings seeking reorganization, arrangement, receivership or other relief.</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:41.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intellectual Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Person, all of such Person&#8217;s right, title, and interest in and to the following, whether now owned or hereafter acquired or created&#58;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.91pt">its Copyrights, Trademarks and Patents&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">any and all trade secrets and trade secret rights, including, without limitation, any rights to unpatented inventions, know-how and operating manuals&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.91pt">licenses any and all source code&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">any and all design rights which may be available to such Person&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">any and all claims for damages by way of past, present and future infringement of any of the foregoing, with the right, but not the obligation, to sue for and collect such damages for said use or infringement of the Intellectual Property rights identified above&#59; and</font></div><div><font><br></font></div><div style="padding-left:82pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.01pt">all amendments, renewals and extensions of any of the Copyrights, Trademarks or Patents.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest Expense</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means for any fiscal period, interest expense (whether cash or non-cash) determined in accordance with GAAP for the relevant period ending on such date, including, in any event, interest expense with respect to any Credit Extension and other Indebtedness of Borrower and its Subsidiaries, including, without limitation or duplication, all commissions, discounts, or related amortization and other fees and charges with respect to letters of credit and bankers&#8217; acceptance financing and the net costs associated with interest rate swap, cap, and similar arrangements, and the interest portion of any deferred payment obligation (including leases of all types).</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Internal Revenue Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means the U.S. Internal Revenue Code of 1986, and the rules and regulations promulgated thereunder, each as amended or modified from time to time.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inventory</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is all &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">inventory</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; as defined in the Code in effect on the date hereof with such additions to such term as may hereafter be made, and includes without limitation all merchandise, raw materials, parts, supplies, packing and shipping materials, work in process and finished products, including without limitation such inventory as is temporarily out of Borrower&#8217;s custody or possession or in transit and including any returned goods and any documents of title representing any of the above.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is any beneficial ownership interest in any Person (including stock, partnership, membership, or other ownership interest or other equity securities), and any loan, advance or capital contribution to any Person.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Key Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is each of Borrower&#8217;s (i) Chief Executive Officer, and (ii) Chief Financial Officer, as of the Effective Date.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Letter of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is a standby or commercial letter of credit issued by Bank upon request of Borrower based upon an application, guarantee, indemnity, or similar agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lien</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is a claim, mortgage, deed of trust, levy, attachment charge, pledge, hypothecation, security interest or other encumbrance of any kind, whether voluntarily incurred or arising by operation of law or otherwise against any property.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loan Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; are, collectively, this Agreement and any schedules, exhibits, certificates, notices, and any other documents related to this Agreement, the Perfection Certificate, the Control Agreement, any Bank Services Agreement, any subordination agreement, any note, or notes or guaranties executed by Borrower or any Guarantor, landlord waivers and consents, bailee waivers and consents, and any other present or future agreement by Borrower and&#47;or any Guarantor with or for the benefit of Bank in connection with this Agreement or Bank Services, all as amended, restated, or otherwise modified in accordance with the terms thereof.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Material Adverse Change</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is (a) a material impairment in the perfection or priority of Bank&#8217;s Lien in the Collateral or in the value of such Collateral&#59; (b) a material adverse change in the business, operations, or condition (financial or otherwise) of Borrower&#59; or (c) a material impairment of the prospect of repayment of any portion of the Obligations when such Obligations are due.</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8220;Net Income</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means, as calculated on a consolidated basis for Borrower and its Subsidiaries for any period as at any date of determination, the net profit (or loss), after provision for taxes, of Borrower and its Subsidiaries for such period taken as a single accounting period.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Revenue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means, for any period as of any date of determination, Borrower&#8217;s net revenue calculated in accordance with GAAP.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; are Borrower&#8217;s obligations to pay when due any debts, principal, interest, fees, Bank Expenses, the Termination Fee (if applicable), the Revolving Line Commitment Fee, the Prepayment Fee (if applicable), the Final Payment, and other amounts Borrower owes Bank now or later, whether under this Agreement, or the other Loan Documents, or otherwise, including, without limitation, all obligations relating to Bank Services and interest accruing after Insolvency Proceedings begin and debts, liabilities, or obligations of Borrower assigned to Bank, and to perform Borrower&#8217;s duties under the Loan Documents (but in all cases excluding any equity interests of Bank and&#47;or its Affiliates in Borrower).</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OFAC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is the Office of Foreign Assets Control of the United States Department of the Treasury and any successor thereto.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; are, for any Person, such Person&#8217;s formation documents, as certified by the Secretary of State (or equivalent agency) of such Person&#8217;s jurisdiction of organization on a date that is no earlier than thirty (30) days prior to the First Amendment Effective Date, and, (a) if such Person is a corporation, its bylaws in current form, (b) if such Person is a limited liability company, its limited liability company agreement (or similar agreement), and (c) if such Person is a partnership or limited partnership, its partnership agreement or limited partnership agreement (or similar agreement), each of the foregoing with all current amendments or modifications thereto.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Connection Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means, with respect to Bank, Taxes imposed as a result of a present or former connection between Bank and the jurisdiction imposing such Tax (other than connections arising from Bank having executed, delivered, become a party to, performed its obligations under, received payments under, received or perfected a security interest under, engaged in any other transaction pursuant to or enforced any Loan Document, or sold or assigned an interest in any Credit Extension or Loan Document).</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means all present or future stamp, court, documentary, intangible, recording, filing or similar Taxes that arise from any payment made under, from the execution, delivery, performance, enforcement or registration of, from the receipt or perfection of a security interest under, or otherwise with respect to, any Loan Document, except any such Taxes that are Other Connection Taxes imposed with respect to an assignment.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Overadvance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is defined in Section 1.1.B.</font></div><div><font><br></font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Patents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means all patents, patent applications and like protections including without limitation improvements, divisions, continuations, renewals, reissues, extensions and continuations-in-part of the same.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:82pt;padding-right:80.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:236%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:236%">Payment&#47;Advance Form</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:236%">&#8221; is that certain form in the form attached hereto as Exhibit B. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:236%">Payment Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:236%">&#8221; is set forth on Schedule I hereto.</font></div><div style="padding-left:46pt;padding-right:41.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Perfection Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is the updated Perfection Certificate delivered by Borrower on or around the First Amendment Effective Date in connection with this Agreement.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8220;Permitted Acquisition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Permitted Acquisitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means an acquisition by Borrower or any Subsidiary of any Intellectual Property or all or substantially all of the assets of, all of the ownership interests in, or a business line, product line (including rights in respect of any medical device) or unit or division of another Person (including any foreign corporations) for cash consideration (including any purchase price adjustments, indemnity payments and earn-out obligations in connection therewith) up to Ten Million Dollars ($10,000,000) in any fiscal year (or such greater amount as may be agreed with the prior written consent of Bank)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">that, with respect to each such acquisition, each of the following conditions shall have been satisfied (or waived by Bank, acting in its commercially reasonable discretion)&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">no Event of Default shall have occurred and be continuing or would result from the consummation of the proposed acquisition and Bank has received evidence that Borrower is in compliance with all terms and conditions of this Agreement on a pro forma basis after giving effect to such acquisition,</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">such acquired Person or assets shall be in a similar line of business as is conducted by Borrower as of the Effective Date (or a line of business reasonably related thereto),</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">such acquisition shall not cause the focus or locations of Borrower&#8217;s and its Subsidiaries&#8217; operations (when taken as a whole) to be located outside of the United States,</font></div><div><font><br></font></div><div style="padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">such acquisition shall not constitute a hostile acquisition,</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">any Person acquired as a result of such acquisition shall become a secured Guarantor (or co-borrower) subject to the terms herein, within fifteen (15) Business Days of the consummation of such acquisition,</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.01pt">in connection with such acquisition, neither Borrower nor any of its subsidiaries (including for this purpose, the target of the acquisition) shall acquire or be subject to any Indebtedness or Liens that are not otherwise permitted hereunder&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">Borrower shall provide Bank with written notice of the proposed acquisition at least five</font></div><div style="padding-left:46pt;padding-right:39.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5) Business Days prior to the anticipated signing, commitment, or closing date of the proposed acquisition, whichever occurs first&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.9pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Borrower shall provide to the Bank not later than five (5) Business Days after the execution thereof, a copy of the executed purchase agreement or similar agreement with respect to any such acquisition&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.57pt">such acquisition has been approved by the board of directors (or other equivalent legally governing body) of the Person to be acquired,</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.57pt">the entity or assets to be acquired in such acquisition shall not be subject to any Lien other</font></div><div style="margin-top:0.05pt;padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(x) the first priority Liens granted in favor of Bank and (y) Permitted Liens&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.9pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">all transactions related to such acquisition shall be consummated in all material respects in accordance with applicable law&#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.57pt">Borrower shall provide to the Bank as soon as available but in any event not later than five</font></div><div style="padding-left:46pt;padding-right:39.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5) Business Days after the execution thereof, a copy of the executed purchase agreement or similar agreement with respect to any such acquisition.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrower shall provide to the Bank as soon as available but in any event not later than five (5) Business Days after the execution thereof a certificate of a Responsible Officer of Borrower, in form and substance reasonably satisfactory to Bank, certifying that all of the requirements set forth in this definition have been satisfied or will be satisfied on or prior to the consummation of such acquisition. Notwithstanding the foregoing and for the avoidance of doubt, in no event shall Borrower or any of its Subsidiaries assume any liabilities with respect to any acquisition, including without limitation, any Permitted Indebtedness, in excess of Fifteen Million Dollars ($15,000,000) in aggregate outstanding at any time for such Permitted Acquisitions.</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Permitted Call Spread Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means (a) any call option transaction (including, but not limited to, any bond hedge transaction or capped call transaction) pursuant to which the Borrower acquires an option requiring the counterparty thereto to deliver to the Borrower shares of common stock of the Borrower (or other securities or property following a merger event or other change of the common stock of the Borrower), the cash value thereof or a combination thereof from time to time upon exercise of such option entered into by the Borrower in connection with the issuance of Permitted Convertible Debt (such transaction, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Bond Hedge Transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) and (b) any issued warrants to acquire common stock of the Borrower (or other securities or property following a merger event or other change of the common stock of the Borrower) (whether such warrant is settled in shares, cash or a combination thereof) issued by the Borrower in connection with the issuance of Permitted Convertible Debt and sold by Borrower substantially concurrently with any purchase by Borrower of a Bond Hedge Transaction and settled in (such transaction, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Warrant Transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">that (i) the terms, conditions and covenants of each such call option transaction are customary for agreements of such type, as determined by the Board (or a committee thereof) in good faith, (ii) the purchase price for such Bond Hedge Transaction, less the proceeds received by the Borrower from the sale of any related Warrant Transaction, does not exceed the net proceeds received by the Borrower from the issuance of the related Permitted Convertible Indebtedness at the time of such purchase, and (iii) in the case of clause (b) above, such warrants would be classified as an equity instrument in accordance with GAAP.</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:50.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Permitted Convertible Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means any unsecured notes issued by the Borrower that are convertible into a fixed number (subject to customary anti-dilution adjustments, &#8220;make-whole&#8221; increases and other customary changes thereto) of shares of common stock of the Borrower (or other securities or property following a merger event or other change of the common stock of the Borrower), cash or any combination thereof (with the amount of such cash or such combination determined by reference to the market price of such common stock or such other securities)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">that such Indebtedness must satisfy each of the following conditions&#58; (i) both immediately prior to and after giving effect (including pro forma effect) to the issuance thereof, no Default or Event of Default shall exist or result therefrom, (ii) such Indebtedness matures after, and does not require any scheduled amortization or other scheduled or otherwise required payments of principal prior to, or have a scheduled maturity date earlier than, the date that is ninety one (91) calendar days after the Term Loan Maturity Date and prior to that date, does not provide for or require any payments of principal or any other payments with the exception of semi-annual interest payments, obligations to settle conversions, redemption rights (which, for the avoidance of doubt, will be subject to Section 6.7) and customary obligations to offer to repurchase the notes upon the occurrence of a &#8220;fundamental change&#8221;, (iii) any cross-default or cross-acceleration event of default (each howsoever defined) provision contained therein that relates to indebtedness or other payment obligations of Borrower (or any of its Subsidiaries) (such indebtedness or other payment obligations, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cross-Default Reference Obligation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) contains a cure period of at least thirty (30) calendar days (after written notice to the issuer of such Indebtedness by the trustee or to such issuer and such trustee by holders of at least 25% in aggregate principal amount of such Indebtedness then outstanding) before a default, event of default, acceleration or other event or condition under such Cross-Default Reference Obligation results in an event of default under such cross-default or cross-acceleration provision, (iv) the terms, conditions and covenants (other than pricing terms determined through a customary marketing process) of such Indebtedness must be customary for convertible Indebtedness of such type at the time of issuance (as determined by the Board, or a committee thereof, in good faith) and, (v) such Indebtedness is not guaranteed by any Subsidiary of the Borrower unless the Obligations are guaranteed by such Subsidiary on a secured basis. For the avoidance of doubt, and without limitation of the foregoing, Permitted Convertible Debt shall at all</font></div><div style="text-align:justify"><font><br></font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:44.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">times be valued at the full stated principle amount thereof and shall not include any reduction or appreciation in value of the shares deliverable upon conversion thereof.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Permitted Foreign Subsidiary Accounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is defined in Section 5.9(a).</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Permitted Hedging Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means any currency agreement, all rate swap transactions or other contract or arrangement designed solely to protect a Person against fluctuations in currency exchange rates and interest rate risk, and any confirmation executed in connection with any such agreement, contract, or arrangement, in each case, entered into by Borrower or any of its Subsidiaries solely to hedge or mitigate the risks of foreign exchange rate fluctuations and interest rate risk and not for any speculative or other purposes&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">that such agreement, contract or arrangement shall comply in all respects with the hedging policies or guidelines as are approved by the Board or as are approved by Bank (such approval not to be unreasonably withheld, delayed or conditioned)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">provided further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, that all accrued and reasonably expected liabilities of Borrower or its Subsidiaries arising under Permitted Hedging Agreements shall not exceed One Million Dollars ($1,000,000) in the aggregate at any time. For the avoidance of doubt, no Permitted Call Spread Agreement shall constitute a Permitted Hedging Agreement.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Permitted Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">Borrower&#8217;s Indebtedness to Bank under this Agreement, the other Loan Documents and under any other agreement with Bank&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">Indebtedness existing on the Effective Date which is shown on the Perfection Certificate&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.91pt">Subordinated Debt&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">unsecured Indebtedness to trade creditors incurred in the ordinary course of business&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">Indebtedness incurred as a result of endorsing negotiable instruments received in the ordinary course of business&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.01pt">Indebtedness secured by Liens permitted under clauses (a) and (c) of the definition of &#8220;Permitted Liens&#8221; hereunder&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">other unsecured Indebtedness not otherwise permitted by Section 6.4 not exceeding Two Hundred Fifty Thousand Dollars ($250,000.00) in the aggregate outstanding at any time&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Indebtedness with respect to credit cards maintained with American Express, not to exceed Five Hundred Thousand Dollars ($500,000) outstanding at any time&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.57pt">Permitted Hedging Agreements&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:42.05pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.57pt">intercompany Indebtedness by and among Borrower and its Subsidiaries (subject to &#8220;Permitted Investments&#8221; part (g)(i)&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Indebtedness in respect of letters of credit, bank guarantees and similar instruments issued for the account of Borrower and&#47;or its Subsidiaries in the ordinary course of business not to exceed Seven Hundred Fifty Thousand Dollars ($750,000) outstanding at any time&#59;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.57pt">advances or deposits received in the ordinary course of business from customers or</font></div><div style="padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">vendors&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:11.57pt">Indebtedness in respect of netting services, overdraft protections, payment processing, automatic clearinghouse arrangements, arrangements in respect of pooled deposit or sweep accounts, check endorsement guarantees, and otherwise in connection with deposit accounts or cash management services and</font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i37efde9015094164b274aef726ee5ee2_31"></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:39.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indebtedness arising in connection with automated clearing house transfer of funds or the use of other payment processing services&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Indebtedness arising in connection with the financing of insurance premiums in the ordinary course of business not to exceed Seven Hundred Fifty Thousand Dollars ($750,000) outstanding at any time&#59;</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(o)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Indebtedness in respect of performance bonds, bid bonds, appeal bonds, surety bonds, completion guarantees and similar obligations arising in the ordinary course of business not to exceed Seven Hundred Fifty Thousand Dollars ($750,000) in the aggregate outstanding at any time&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.85pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(p)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Unsecured Indebtedness in connection with Permitted Acquisitions, not to exceed Fifteen Million Dollars ($15,000,000) in aggregate outstanding at any time&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(q)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Permitted Convertible Debt in aggregate principal amount not to exceed Two Hundred Fifty Million Dollars ($250,000,000) in principal amount at any time outstanding&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(r)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.01pt">Indebtedness of Borrower&#8217;s Subsidiaries in connection with the sale of Inventory by Borrower to its Subsidiaries in the ordinary course of business, which may from time to time be forgiven by Borrower&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(s)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:15.45pt">purchase price adjustments, indemnity payments and earn-out obligations in connection with any Permitted Acquisition (to the extent not in excess of the consideration limitations set forth in the definition thereof)&#59; and</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(t)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.57pt">extensions, refinancings, modifications, amendments and restatements of any items of Permitted Indebtedness (a) through (s) above, provided that the principal amount thereof is not increased or the terms thereof are not modified to impose more burdensome terms upon Borrower or its Subsidiary, as the case may be.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Permitted Investments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; are&#58;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">Investments (including, without limitation, Subsidiaries) existing on the Effective Date which are shown on the Perfection Certificate&#59;</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">(i) Investments consisting of cash and Cash Equivalents, and (ii) any other Investments permitted by Borrower&#8217;s investment policy, as amended from time to time, provided that such investment policy (and any such amendment thereto) has been approved in writing by Bank, further provided that Bank hereby confirms approval of such investment policy delivered to Bank around the Effective Date&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">Investments consisting of the endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of Borrower&#8217;s business&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Investments consisting of deposit and securities accounts (but only to the extent that Borrower or its Subsidiaries is permitted to maintain such accounts pursuant to Section 5.9 of this Agreement) in which Bank has a first priority perfected security interest (only if and to the extent required pursuant to Section 5.9 of this Agreement)&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.91pt">Investments accepted in connection with Transfers permitted by Section <a href="#i37efde9015094164b274aef726ee5ee2_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">6.1</a>&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.01pt">Investments consisting of the creation of a Subsidiary for the purpose of consummating a merger transactions and Permitted Acquisitions permitted by Section <a href="#i37efde9015094164b274aef726ee5ee2_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">6.3</a> of this Agreement, which is otherwise a Permitted Investment&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Investments by Borrower in Subsidiaries that are not borrowers hereunder (or Guarantors), not to exceed (i) (x) Seven Million Five Hundred Thousand Dollars ($7,500,000) in the aggregate in any fiscal year&#59; and (y) Three Million Dollars ($3,000,000) in any fiscal quarter, plus (ii) the ongoing day-to-day operations of such Subsidiaries in the ordinary course of business, so long as such (part (ii)) Investments are (A) made on a cost-plus</font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i37efde9015094164b274aef726ee5ee2_34"></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:39.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">basis, or (B) otherwise in accordance with transfer pricing arrangements, or (C) are otherwise approved in advance in writing by Bank&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">Investments by Borrower in any other co-borrower under this Agreement or Guarantor&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.57pt">Investments consisting of (i) travel advances and employee relocation loans and other employee loans and advances in the ordinary course of business, and (ii) loans to employees, officers, directors, partners, managers and members relating to the purchase of equity securities of Borrower or its Subsidiaries pursuant to employee equity purchase plans or similar agreements approved by the Board&#59;</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.57pt">Investments (including debt obligations) received in connection with the bankruptcy or reorganization of customers or suppliers and in settlement of delinquent obligations of, and other disputes with, customers or suppliers arising in the ordinary course of business&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Investments consisting of notes receivable of, or prepaid royalties and other credit extensions, to customers and suppliers who are not Affiliates, in the ordinary course of business&#59; provided that this paragraph (j) shall not apply to Investments of Borrower in any Subsidiary&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.57pt">Cash investments of up to One Million Dollars ($1,000,000) per fiscal year, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> non-cash Investments in joint ventures or strategic alliances in the ordinary course of Borrower&#8217;s business consisting of the non- exclusive licensing of technology, the development of technology or the providing of technical support&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:21.57pt">any Permitted Call Spread Agreements&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">Permitted Acquisitions&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(o)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Investments not to exceed Five Million Dollars ($5,000,000) per fiscal year to fund the expansion of Borrower and&#47;or its Subsidiaries in (i) Japan, and&#47;or (ii) any other jurisdiction as may be agreed by Bank (in its commercially reasonable discretion) and Borrower&#59; and</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(p)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">other Investments not otherwise enumerated in this defined term &#8220;Permitted Investments&#8221; not exceeding Five Hundred Thousand Dollars ($500,000) in the aggregate during any fiscal year.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Permitted Liens</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; are&#58;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.9pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">Liens existing on the Effective Date which are shown on the Perfection Certificate or arising under this Agreement or the other Loan Documents&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Liens for taxes, fees, assessments or other government charges or levies, either (i) not due and payable or (ii) being contested in good faith and for which Borrower maintains adequate reserves on Borrower&#8217;s Books, provided that no notice of any such Lien has been filed or recorded under the Internal Revenue Code&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">purchase money Liens and equipment liens (i) on Equipment or software acquired or held by Borrower incurred for financing the acquisition of the Equipment or software securing no more than One Million Dollars ($1,000,000) in the aggregate amount outstanding, or (ii) existing on Equipment or software when acquired, if the Lien is confined to the property and improvements and the proceeds of the Equipment or software&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Liens of carriers, warehousemen, suppliers, or other Persons that are possessory in nature arising in the ordinary course of business so long as such Liens attach only to Inventory, securing liabilities in the aggregate amount not to exceed Two Hundred Fifty Thousand Dollars ($250,000), and which are not delinquent or remain payable without penalty or which are being contested in good faith and by appropriate proceedings which proceedings have the effect of preventing the forfeiture or sale of the property subject thereto&#59;</font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i37efde9015094164b274aef726ee5ee2_37"></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">Liens to secure payment of workers&#8217; compensation, employment insurance, old-age pensions, social security and other like obligations incurred in the ordinary course of business (other than Liens imposed by ERISA)&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.01pt">Liens incurred in the extension, renewal or refinancing of the Indebtedness secured by Liens described in (a) through (c), but any extension, renewal or replacement Lien must be limited to the property encumbered by the existing Lien and the principal amount of the indebtedness may not increase&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">leases or subleases of real property granted in the ordinary course of Borrower&#8217;s business (or, if referring to another Person, in the ordinary course of such Person&#8217;s business), and leases, subleases, non- exclusive licenses or sublicenses of personal property (other than Intellectual Property) granted in the ordinary course of Borrower&#8217;s business (or, if referring to another Person, in the ordinary course of such Person&#8217;s business), if the leases, subleases, licenses and sublicenses do not prohibit granting Bank a security interest therein&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">(i) non-exclusive licenses of Intellectual Property granted to third parties in the ordinary course of business, (ii) licenses of Intellectual Property that could not reasonably be expected to result in a legal transfer of title of the licensed property that may be exclusive in respects of territory (as to discreet geographical areas inside and outside of the United States), and (iii) licenses existing on the Effective Date and disclosed on the Perfection Certificate&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.57pt">customary Liens of any bank in connection with statutory, common law and contractual rights of setoff and recoupment with respect to any deposit account or securities account of Borrower, provided that</font></div><div style="padding-left:46pt;padding-right:39.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i) Bank has a first priority perfected security interest in such account (if perfection is required pursuant to Section 5.9 of this Agreement), and (ii) such account is permitted to be maintained pursuant to Section <a href="#i37efde9015094164b274aef726ee5ee2_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">5.9</a> of this Agreement&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.57pt">Liens arising from attachments or judgments, orders, or decrees in circumstances not constituting an Event of Default under Sections and <a href="#i37efde9015094164b274aef726ee5ee2_16" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">7.7&#59;</a></font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.85pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">deposits under real property leases that are made in the ordinary course of business not to exceed Seven Hundred Fifty Thousand Dollars ($750,000) at any time&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.57pt">easements, rights-of-way, restrictions and other similar encumbrances affecting real property which, in the aggregate, are not substantial in amount, and which do not in any case materially detract from the value of the property subject thereto or materially interfere with the ordinary conduct of the business of the applicable Person&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.85pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:11.57pt">other Liens (not otherwise enumerated in this defined term) not exceeding One Hundred Thousand Dollars ($100,000) in the aggregate outstanding at any time&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Liens in respect of performance bonds, bid bonds, appeal bonds, surety bonds, completion guarantees and similar obligations arising in the ordinary course of business not to exceed Seven Hundred Fifty Thousand Dollars ($750,000) in the aggregate outstanding at any time&#59; and</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(o)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">Liens on cash and Cash Equivalents securing obligations under Permitted Hedging</font></div><div style="padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agreements.</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is any individual, sole proprietorship, partnership, limited liability company, joint venture, company, trust, unincorporated organization, association, corporation, institution, public benefit corporation, firm, joint stock company, estate, entity or government agency.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prepayment Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is a fee due upon prepayment (whether voluntary or otherwise) of the Term Loan Advance in full prior to the Term Loan Maturity Date equal to two percent (2.00%) of the aggregate l principal amount of the Term Loan Advance being prepaid on such date, provided, however, that no such Prepayment Fee is accrued or payable to Bank, and such Prepayment Fee is waived by Bank (i) with respect to the Term Loan Advance (as defined in the Agreement prior to the First Amendment Effective Date) prepaid on or around the First Amendment</font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i37efde9015094164b274aef726ee5ee2_40"></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:39.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective Date, and (ii) if any such prepaid Term Loan Advance is refinanced through a new credit facility provided by Bank.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prime Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is set forth on Schedule I hereto.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prime Rate Margin</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is set forth on Schedule I hereto.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Qualified Cash</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means the amount of the Borrower and its Subsidiaries cash and Cash Equivalents held with Bank and&#47;or Banks&#8217; Affiliates and&#47;or in accounts subject to a Control Agreement in favor of Bank&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quarterly Financial Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is defined in Section 5.3(c).</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quick Assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is, on any date, Borrower&#8217;s unrestricted and unencumbered cash and Cash Equivalents, including, for the avoidance of doubt, balances in the Cash Collateral Account, and Eligible Accounts.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redemption Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means, with respect to any redemption by the Borrower of any Permitted Convertible Debt, satisfaction of each of the following events&#58; (a) no Event of Default shall exist or result therefrom,</font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b) both immediately before and after such redemption, Borrower&#8217;s Qualified Cash shall be no less than the amount required to prepay the outstanding Obligations in full at the time of such redemption, including all outstanding principal of the Term Loans, the accrued and unpaid interest thereon, the Final Payment, and the Prepayment Fee (provided, however, for the avoidance of doubt no such prepayment is required at such time), and (c) both immediately before and after such redemption, Borrower&#8217;s Remaining Months Liquidity shall be no less than twelve (12).</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Registered Organization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is any &#8220;registered organization&#8221; as defined in the Code with such additions to such term as may hereafter be made.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Remaining Months Liquidity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means Qualified Cash divided by Adjusted EBITDA (measured on a trailing twelve (12) month basis).</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Representatives</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is defined in Section <a href="#i37efde9015094164b274aef726ee5ee2_22" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">11.8.</a></font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reserves</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means, as of any date of determination, such amounts as Bank may from time to time establish and revise in its commercially reasonable discretion, reducing the amount of Advances and other financial accommodations which would otherwise be available to Borrower (a) to reflect events, conditions, contingencies or risks which, as determined by Bank in its commercially reasonable discretion, do or may adversely affect (i) the Collateral or any other property which is security for the Obligations or its value (including without limitation any increase in delinquencies of Accounts), (ii) the assets, business or prospects of Borrower or any Guarantor, or (iii) the security interests and other rights of Bank in the Collateral (including the enforceability, perfection and priority thereof)&#59; or (b) to reflect Bank's reasonable belief that any collateral report or financial information furnished by or on behalf of Borrower or any Guarantor to Bank is or may have been incomplete, inaccurate or misleading in any material respect&#59; or (c) in respect of any state of facts which Bank determines in its commercially reasonable discretion constitutes a Default or an Event of Default.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Responsible Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is any of the Chief Executive Officer, President, Chief Financial Officer, Chief Legal Officer, and Controller of Borrower.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restricted License</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is any material license or other material agreement with respect to which Borrower is the licensee (a) that prohibits or otherwise restricts Borrower from granting a security interest in Borrower&#8217;s interest in such license or agreement or any other property, or (b) for which a default under or termination of could interfere with Bank&#8217;s right to sell any material Collateral.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revolving Line</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is set forth on Schedule I hereto.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revolving Line Maturity Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is set forth on Schedule I hereto.</font></div><div><font><br></font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sanctioned Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means a Person that&#58; (a) is listed on any Sanctions list maintained by OFAC or any similar Sanctions list maintained by any other Governmental Authority having jurisdiction over Borrower&#59; (b) is located, organized, or resident in any country, territory, or region that is the subject or target of Sanctions&#59; or (c) is fifty percent (50.0%) or more owned or controlled by one (1) or more Persons described in clauses (a) and (b) hereof.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sanctions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means the economic sanctions laws, regulations, embargoes or restrictive measures administered, enacted or enforced by the United States government and any of its agencies, including, without limitation, OFAC and the U.S. State Department, or any other Governmental Authority having jurisdiction over Borrower.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SEC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is the Securities and Exchange Commission, any successor thereto, and any analogous Governmental Authority.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Securities Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is any &#8220;securities account&#8221; as defined in the Code with such additions to such term as may hereafter be made.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Streamline Balance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is defined in the definition of Streamline Period.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:38.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Streamline Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is, on and after the First Amendment Effective Date, provided no Event of Default has occurred and is continuing, the period (a) commencing on the first (1st) day of the month following the day that Borrower provides to Bank a written report that Borrower has, for the immediately preceding month, measured at month-end (only when Advances are outstanding or are being requested by Borrower), as determined by Bank in its commercially reasonable discretion, an Adjusted Quick Ratio in an amount as of such measurement date of greater than or equal to 1.50 to 1.00 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Streamline Balance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;)&#59; and (b) terminating on the earlier to occur of (i) the occurrence of an Event of Default, and (ii) the first month-end measured thereafter in which Borrower fails to maintain the Streamline Balance, as determined by Bank in its commercially reasonable discretion. Upon the termination of a Streamline Period, Borrower shall maintain the Streamline Balance each month end for one (1) fiscal quarter, as determined by Bank in its commercially reasonable discretion, prior to entering into a subsequent Streamline Period. Borrower shall give Bank prior written notice of Borrower&#8217;s election to enter into any such Streamline Period, and each such Streamline Period shall commence on the first (1st) day of the monthly period following the date Bank determines, in its commercially reasonable discretion, that the Streamline Balance has been achieved.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Subordinated Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is indebtedness incurred by Borrower or any of its Subsidiaries subordinated to all of Borrower&#8217;s or any of its Subsidiaries&#8217; now or hereafter indebtedness to Bank (pursuant to a subordination, intercreditor, or other similar agreement in form and substance satisfactory to Bank entered into between Bank and the other creditor), on terms acceptable to Bank. For the avoidance of doubt, Permitted Convertible Debt shall not constitute Subordinated Debt.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is, as to any Person, a corporation, partnership, limited liability company or other entity of which shares of stock, partnership, membership, or other ownership interest or other equity securities having ordinary voting power (other than stock, partnership, membership, or other ownership interest or other equity securities having such power only by reason of the happening of a contingency) to elect a majority of the board of directors or other managers of such corporation, partnership or other entity are at the time owned, or the management of which is otherwise controlled, directly or indirectly through one or more intermediaries, or both, by such Person. Unless the context otherwise requires, each reference to a Subsidiary herein shall be a reference to a Subsidiary of Borrower or Guarantor.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means all present or future taxes, levies, imposts, duties, deductions, withholdings (including backup withholding), assessments, fees or other charges imposed by any Governmental Authority, including any interest, additions to tax or penalties applicable thereto.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:82pt;padding-right:170.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:236%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:236%">Term Loan Advance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:236%">&#8221; is defined in Section <a href="#i37efde9015094164b274aef726ee5ee2_4" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:236%;text-decoration:none">1.1</a>(a) of this Agreement. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:236%">Term Loan Amortization Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:236%">&#8221; is set forth on Schedule I hereto.</font></div><div><font><br></font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:82pt;padding-right:190.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:237%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:237%">Term Loan Availability Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:237%">&#8221; is set forth on Schedule I hereto. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:237%">Term Loan Maturity Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:237%">&#8221; is set forth on Schedule I hereto. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:237%">Termination Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:237%">&#8221; is defined in Section 1.3(c).</font></div><div style="padding-left:46pt;padding-right:41.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Liabilities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is on any day, obligations that should, under GAAP, be classified as liabilities on Borrower&#8217;s consolidated balance sheet, including all Indebtedness, but excluding all Subordinated Debt.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trademarks</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Person, any trademark and servicemark rights, whether registered or not, applications to register and registrations of the same and like protections, and the entire goodwill of the business of such Person connected with and symbolized by such trademarks.</font></div><div><font><br></font></div><div style="padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is defined in Section <a href="#i37efde9015094164b274aef726ee5ee2_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">6.1.</a></font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Uncommitted Accordion</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is defined in Section 1.1(a) of this Agreement.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">USA Patriot Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means the &#8220;Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001&#8221; (Public Law 107-56, signed into law on October 26, 2001), as amended from time to time.</font></div><div><font><br></font></div><div style="padding-left:20.57pt;padding-right:20.57pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Signature page follows</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#93;</font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i37efde9015094164b274aef726ee5ee2_43"></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">IN WITNESS WHEREOF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, the parties hereto have caused this Agreement to be executed as of the Effective</font></div><div style="padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date.</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:298pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BORROWER&#58;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:298pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SI-BONE, INC.</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:298pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58; &#47;s&#47; Anshul Maheshwari</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:298pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Anshul Maheshwari</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:298pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Chief Financial Officer</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:298pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BANK&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:298pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SILICON VALLEY BANK</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:298pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58; &#47;s&#47; Mark Davis</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:298pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Mark Davis</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:298pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Vice President</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:19.45pt;padding-right:19.45pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Signature Page to Loan and Security Agreement</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="height:41.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div></div><div id="i37efde9015094164b274aef726ee5ee2_46"></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:19.35pt;padding-right:19.35pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">SCHEDULE I</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:19.35pt;padding-right:19.35pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">LSA PROVISIONS</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46.6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.387%"><tr><td style="width:1.0%"></td><td style="width:32.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:65.244%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.1pt;padding-left:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">LSA Section</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.1pt;padding-left:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">LSA Provision</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1A(a) &#8211; Revolving Line - Availability</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt;padding-right:4.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts borrowed under the Revolving Line may be prepaid or repaid and, prior to the Revolving Line Maturity Date, reborrowed, subject to the applicable terms and conditions precedent herein, without penalty or premium.</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i37efde9015094164b274aef726ee5ee2_4" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">1.1(a)</a> &#8211; Term Loan &#8211; Availability</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt;padding-right:4.65pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The initial Term Loan Advance must be in an amount equal to the initial Term Loan Availability Amount available on the First Amendment Effective Date (excluding the Uncommitted Accordion, for the avoidance of doubt). After repayment, the Term Loan Advance (or any portion thereof) may not be reborrowed.</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i37efde9015094164b274aef726ee5ee2_4" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">1.1(b)</a> &#8211; Term Loan &#8211; Repayment</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt;padding-right:4.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commencing on the Term Loan Amortization Date, and continuing on each Payment Date thereafter until the Term Loan Advance is paid in full, Borrower shall repay the outstanding Term Loan Advance in (i) thirty (30) equal monthly installments of principal, plus (ii) monthly payments of accrued interest in accordance with Section 1.2(a)(ii) at the rate set forth in Section <a href="#i37efde9015094164b274aef726ee5ee2_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">1.2(b)(iii).</a></font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2(a)(i) &#8211; Interest Payments - Advances</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt;padding-right:4.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on the outstanding principal amount of each Advance is payable in arrears monthly (A) on each Payment Date, (B) on the date of any prepayment and (C) on the Revolving Line Maturity Date.</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt;padding-right:6.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2(a)(ii) &#8211; Interest Payments &#8211; Term Loan Advances</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt;padding-right:4.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on the outstanding principal amount of the Term Loan Advance is payable in arrears monthly (i) on each Payment Date commencing on the first Payment Date following the Funding Date of each such Term Loan Advance, (ii) on the date of any prepayment of the Term Loan Advance, and (iii) on the Term Loan Maturity Date.</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2(b)(i) &#8211; Interest Rate - Advances</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt;padding-right:4.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The outstanding principal amount of any Advance shall accrue interest at a floating rate per annum equal to the greater of (A) six and one quarter of one percent (6.25%) and (B) the Prime Rate plus the applicable Prime Rate Margin, which interest shall be payable in accordance with Section 1.2(a)(i).</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt;padding-right:6.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2(b)(ii) &#8211; Interest Rate &#8211; Term Loan Advances</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt;padding-right:4.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The outstanding principal amount of the Term Loan Advance shall accrue interest at a floating rate per annum equal to the greater of (A) six and three quarters of one percent (6.75%) and (B) the Prime Rate plus the applicable Prime Rate Margin, which interest shall be payable in accordance with Section <a href="#i37efde9015094164b274aef726ee5ee2_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">1.2(a)</a>(ii).</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2(e) &#8211; Interest Computation</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt;padding-right:4.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest shall be computed on the basis of the actual number of days elapsed and a 360-day year for any Credit Extension outstanding.</font></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt;padding-right:6.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3(c) &#8211; Revolving Line Commitment Fee</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A fully earned, non-refundable commitment fee of (i) Seventy-Five Thousand Dollars ($75,000) on the First Amendment Effective Date, (ii)</font></div><div style="padding-left:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Seventy-Five Thousand Dollars ($75,000) on the first anniversary of the</font></div></td></tr></table></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:19.35pt;padding-right:19.35pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I-1</font></div><div style="height:43.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div></div><div id="i37efde9015094164b274aef726ee5ee2_49"></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46.6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.387%"><tr><td style="width:1.0%"></td><td style="width:32.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:65.244%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">LSA Section</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">LSA Provision</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt;padding-right:4.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Amendment Effective Date, and (iii) Thirty-Seven Thousand Five Hundred ($37,500) on the second anniversary of the First Amendment Effective Date.</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i37efde9015094164b274aef726ee5ee2_25" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">12.2</a> &#8211; &#8220;Borrower&#8221;</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means (i) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SI-BONE, INC.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, a Delaware corporation.</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i37efde9015094164b274aef726ee5ee2_25" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">12.2</a> &#8211; &#8220;Effective Date&#8221;</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is August 12, 2021.</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i37efde9015094164b274aef726ee5ee2_25" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">12.2</a> &#8211; &#8220;Payment Date&#8221;</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt;padding-right:4.65pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Payment Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is (a) with respect to Term Loan Advances, the first (1st) calendar day of each month and (b) with respect to Advances, the last calendar day of each month.</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i37efde9015094164b274aef726ee5ee2_25" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">12.2</a> &#8211; &#8220;Prime Rate&#8221;</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt;padding-right:4.65pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prime Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is the rate of interest per annum from time to time published in the money rates section of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">The Wall Street Journal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> or any successor publication thereto as the &#8220;prime rate&#8221; then in effect&#59; provided that if such rate of interest, as set forth from time to time in the money rates section of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">The Wall Street Journal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, becomes unavailable for any reason as determined by Bank, the &#8220;Prime Rate&#8221; shall mean the rate of interest per annum announced by Bank as its prime rate in effect at its principal office in the State of California (such Bank announced Prime Rate not being intended to be the lowest rate of interest charged by Bank in connection with extensions of credit to debtors)&#59; provided that, in the event such rate of interest is less than zero percent (0.0%) per annum, such rate shall be deemed to be zero percent (0.0%) per annum for purposes of this Agreement.</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i37efde9015094164b274aef726ee5ee2_25" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">12.2</a> &#8211; &#8220;Prime Rate Margin&#8221;</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prime Rate Margin</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is (a) for Advances, (i) zero percent (0.00%), and</font></div><div style="padding-left:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b) for Term Loan Advances, one half of one percent (0.50%).</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 &#8211; &#8220;Revolving Line&#8221;</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revolving Line</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is an aggregate principal amount equal to Fifteen Million Dollars ($15,000,000).</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 &#8211; &#8220;Term Loan Amortization Date&#8221;</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Term Loan Amortization Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is July 1, 2025.</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 &#8211; &#8220;Revolving Line Maturity Date&#8221;</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revolving Line Maturity Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is the date that is thirty (30) months after the First Amendment Effective Date.</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 &#8211; &#8220;Term Loan Availability Amount&#8221;</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt;padding-right:4.65pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Term Loan Availability Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is Thirty-Six Million Dollars ($36,000,000)&#59; provided however, upon Borrower&#8217;s request, if Bank, in its sole and absolute discretion, grant Borrower&#8217;s request to make the Uncommitted Accordion available to Borrower, then &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Term Loan Availability Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; shall mean an aggregate principal amount equal to Fifty-One Million Dollars ($51,000,000).</font></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i37efde9015094164b274aef726ee5ee2_25" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">12.2</a> &#8211; &#8220;Term Loan Maturity Date&#8221;</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Term Loan Maturity Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is December 1, 2027.</font></div></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:19.35pt;padding-right:19.35pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I-2</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="height:41.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div></div><div id="i37efde9015094164b274aef726ee5ee2_52"></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:19.32pt;padding-right:19.32pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">EXHIBIT A</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:19.37pt;padding-right:19.37pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">COMPLIANCE STATEMENT</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:39.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TO&#58;&#160;&#160;&#160;&#160;SILICON VALLEY BANK&#160;&#160;&#160;&#160;Date&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> FROM&#58;&#160;&#160;&#160;&#160;SI-BONE, INC.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:41.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under the terms and conditions of the Loan and Security Agreement between Borrower and Bank (as amended, modified, supplemented and&#47;or restated from time to time, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), Borrower is in complete compliance for the period ending </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">with all required covenants except as noted below. Attached are the required documents evidencing such compliance, setting forth calculations prepared in accordance with GAAP consistently applied from one period to the next except as explained in an accompanying letter or footnotes (and except for with respect to unaudited financial statements for the absence of footnotes and subject to year-end audit adjustments). Capitalized terms used but not otherwise defined herein shall have the meanings given them in the Agreement.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:51.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Please indicate compliance status by circling Yes&#47;No under &#8220;Complies&#8221; column.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:46.35pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.355%"><tr><td style="width:1.0%"></td><td style="width:41.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.432%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:57pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:95%">Reporting Covenants</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:45.2pt;padding-right:45.2pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:95%">Required</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:42.32pt;padding-right:42.32pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:95%">Complies</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:2pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%">Quarterly Financial Statements with</font></div><div style="padding-left:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compliance Statement</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:2pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%">Quarterly within 45 days and</font></div><div style="padding-left:5.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FYE within 90 days</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:2pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:42.32pt;padding-right:42.32pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%">Yes No</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annual financial statements (CPA Audited)</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FYE within 180 days</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:42.32pt;padding-right:42.32pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yes No</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q, 10-K and 8-K</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Within 5 Business Days after filing with SEC</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:42.37pt;padding-right:42.37pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yes No N&#47;A</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Board approved projections</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.4pt;padding-right:7.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FYE within 30 days and within 30 days, as amended&#47;updated, in each case as approved by the</font></div><div style="padding-left:5.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%">Board</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:42.32pt;padding-right:42.32pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yes No</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrowing Base Reports</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.25pt;padding-left:5.4pt;padding-right:2.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When Advances are outstanding or are being requested, weekly on Friday of each week if an Streamline Period is not in effect&#59; monthly within 30 days of month</font></div><div style="margin-top:0.3pt;padding-left:5.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End if and Streamline Period</font></div><div style="padding-left:5.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">is in effect&#59; and with each Advance</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:42.32pt;padding-right:42.32pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yes No</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt;padding-right:7.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A&#47;R &#38; A&#47;P Agings and Deferred Revenue reports</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.4pt;padding-right:7.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When Advances are outstanding or are being requested, monthly within 30 days</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:42.32pt;padding-right:42.32pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yes No</font></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt;padding-right:7.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Have there been any material amendments to the Operating Documents of Borrower&#63; If yes,</font></div><div style="padding-left:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">provide copies of any such amendments or changes with this Compliance Statement</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 6.4pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:42.32pt;padding-right:42.32pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yes No</font></div></td></tr></table></div><div><font><br></font></div><div style="padding-left:46.8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.147%"><tr><td style="width:1.0%"></td><td style="width:58.942%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.858%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.35pt;padding-left:78.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Streamline Period</font></div><div style="padding-left:31.2pt;padding-right:4.15pt;text-indent:-24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(Measured only when Advances are outstanding or are being requested by Borrower)</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 55.1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Applies</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.25pt;padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Adjusted Quick Ratio &#62; 1.50 to 1.00</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.25pt;padding-left:52.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Yes No</font></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.25pt;padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Adjusted Quick Ratio &#60; 1.50 to 1.00</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.25pt;padding-left:52.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Yes No</font></div></td></tr></table></div><div><font><br></font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="height:43.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div></div><div id="i37efde9015094164b274aef726ee5ee2_58"></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:39.65pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following financial covenant analyses and information set forth in Schedule 1 attached hereto are true and correct as of the date of this Compliance Statement.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46pt;padding-right:39.65pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following are the exceptions with respect to the statements above&#58; (If no exceptions exist, state &#8220;No exceptions to note.&#8221;)</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:49.806%"><div style="margin-top:0.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SI-Bone, INC.</font></div><div><font><br></font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:51.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Name&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Title&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.25pt"><font><br></font></div></div><div style="display:inline-block;max-width:0.386%;min-width:0.000%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:49.808%"><div><font><br></font></div><div style="padding-left:51.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BANK USE ONLY</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:51.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Received by&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-top:2.35pt;padding-left:115.42pt;padding-right:115.42pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AUTHORIZED SIGNER</font></div><div style="margin-top:0.95pt;padding-left:51.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:51.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Verified&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-top:2.4pt;padding-left:115.42pt;padding-right:115.42pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AUTHORIZED SIGNER</font></div><div style="margin-top:0.9pt;padding-left:51.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div></div></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:293.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compliance Status&#58;&#160;&#160;&#160;&#160;Yes&#160;&#160;&#160;&#160;No</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:41.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div></div><div id="i37efde9015094164b274aef726ee5ee2_64"></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:19.37pt;padding-right:19.37pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Schedule 1 to Compliance Statement</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:19.37pt;padding-right:19.37pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Financial Covenants of Borrower</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In the event of a conflict between this Schedule and the Agreement, the terms of the Agreement shall govern.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Minimum Net Revenue </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Section 5.10)</font></div><div><font><br></font></div><div style="padding-left:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Required&#58;&#160;&#160;&#160;&#160;When a Financial Covenant Measuring Period is in effect, Borrower shall achieve Net Revenue as required by Section</font></div><div style="margin-top:0.05pt;padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.10 and set forth below (pursuant to the amendment(s) required under Section 5.10)&#58;</font></div><div><font><br></font></div><div style="padding-left:77.8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:65.846%"><tr><td style="width:1.0%"></td><td style="width:23.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.491%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:34.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Measuring Period Ending</font></div></td><td colspan="6" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9.8pt;text-indent:32.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Minimum Net Revenue (measured on a trailing 6 month basis)</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.1pt;padding-right:7.2pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;</font></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 8.8pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.1pt;padding-right:8.4pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;</font></div></td><td colspan="3" style="border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#93;</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.1pt;padding-right:7.2pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;</font></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 8.8pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.1pt;padding-right:8.4pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;</font></div></td><td colspan="3" style="border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#93;</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.1pt;padding-right:7.2pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;</font></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 8.8pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.1pt;padding-right:8.4pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;</font></div></td><td colspan="3" style="border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#93;</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.1pt;padding-right:7.2pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 8.8pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#93;</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.1pt;padding-right:8.4pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#93;</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual&#58; $</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Is Borrower&#8217;s Net Revenue (measured on a trailing 6 month basis) greater than or equal to the required amount for the corresponding measuring period set forth in the chart above&#63;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> No, not in compliance&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Yes, in compliance</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="height:43.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div></div><div id="i37efde9015094164b274aef726ee5ee2_67"></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:235.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">EXHIBIT B</font></div><div style="margin-top:6pt;padding-left:136.2pt;padding-right:148.2pt;text-indent:13.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:176%;text-decoration:underline">LOAN PAYMENT&#47;ADVANCE REQUEST FORM</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:176%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:176%;text-decoration:underline">Deadline for same day processing is Noon Pacific Time</font></div><div style="padding-left:50.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:127%">FAX TO</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">&#58;&#160;&#160;&#160;&#160;Date&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.5pt"><img alt="image_22.jpg" src="image_22.jpg" style="height:148px;margin-bottom:5pt;vertical-align:text-bottom;width:696px"><img alt="image_23.jpg" src="image_23.jpg" style="height:257px;margin-bottom:5pt;vertical-align:text-bottom;width:696px"></div><div style="height:54.72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.493%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:1.45pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div></div><div id="i37efde9015094164b274aef726ee5ee2_73"></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:19.47pt;padding-right:19.47pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">EXHIBIT B</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:19.35pt;padding-right:19.35pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;Attached&#93;</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.75pt;padding-left:46pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">278639749 v2</font></div><div style="margin-top:3.95pt;padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">WEST&#92;300647616.3</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i37efde9015094164b274aef726ee5ee2_76"></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:19.32pt;padding-right:19.32pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LOAN AND SECURITY AGREEMENT</font></div><div><font><br></font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:45.95pt;padding-right:45pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LOAN AND SECURITY AGREEMENT </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) is dated as of the Effective Date between </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SILICON VALLEY BANK</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, a California corporation (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Bank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), and the borrower listed on Schedule I hereto (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;). The parties agree as follows&#58;</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:28.5pt;text-decoration:underline">LOAN AND TERMS OF PAYMENT</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Term Loan Advance.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:45.15pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt;text-decoration:underline">Availability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Subject to the terms and conditions of this Agreement, on </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">or about</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">First</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Amendment</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective Date or</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through"> soon thereafter as all conditions precedent to the making thereof have been met</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, Bank shall make one (1) term loan advance to Borrower in an original principal amount equal to the Term Loan Availability Amount (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Term Loan Advance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"> which shall be used to (i) refinance the Term Loan Advance (as</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">defined in the Agreement prior to the First Amendment Effective Date) outstanding as of the First Amendment</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Effective Date, (ii) satisfy the Final Payment (as defined in the Agreement prior to the First Amendment Effective</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Date), which is with respect to the Term Loan Advance (as defined in the Agreement prior to the First Amendment</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Effective Date), and (iii) thereafter, used for working capital purposes. Bank and Borrower acknowledge and agree</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">that prior to the First Amendment Effective Date, the amount Borrower accrued and owed to Bank in connection</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">with the Final Payment (as defined in the Agreement prior to the First Amendment Effective Date) was Two</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Hundred Seventy Four Thousand Nine Hundred Ninety Dollars and 88&#47;100 ($274,990.88)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. After repayment (in whole or in part), the Term Loan Advance may not be reborrowed.</font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:45.15pt;text-align:justify;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Additionally, at any time during the applicable draw period agreed to by Borrower and Bank, Borrower</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">may request that Bank make additional term loan advances available to Borrower in an aggregate original principal</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">amount of up to Fifteen Million Dollars ($15,000,000) (the &#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Uncommitted Accordion</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8221;). Bank, in its sole and</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">absolute discretion, may grant or deny any such request from Borrower for a term loan advance under the</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Uncommitted Accordion. If, and only if, Bank, in its sole discretion, agrees to provide any additional term loan</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">advance(s) to Borrower under the Uncommitted Accordion, each such term loan advance shall each be considered a</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;Term Loan Advance&#8221; hereunder and added to the definition thereof&#59; provided that the terms of the making of any</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">advance under the Uncommitted Accordion shall be outlined in an amendment to this Agreement to be entered into</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">by the parties hereto.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:4.5pt;padding-left:45.95pt;padding-right:45.15pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.39pt;text-decoration:underline">Repayment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Borrower shall repay the Term Loan Advance as set forth in Schedule I hereto. All outstanding principal and accrued and unpaid interest under the Term Loan Advance, and all other outstanding Obligations with respect to such Term Loan Advance, are due and payable in full on the Term Loan Maturity Date.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:45.95pt;padding-right:44.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.96pt;text-decoration:underline">Permitted Prepayment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Borrower shall have the option to prepay all, but not less than all, of the Term Loan Advance, provided Borrower (i) delivers written notice to Bank of its election to prepay the Term Loan Advance at least five (5) Business Days prior to such prepayment, and (ii) pays, on the date of such prepayment (A) the outstanding principal plus accrued and unpaid interest with respect to the Term Loan Advance,</font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:45.25pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(B) the applicable Prepayment Fee, if any, (C) the Final Payment, and (D) all other sums, if any, that shall have become due and payable with respect to the Term Loan Advance, including interest at the Default Rate with respect to any past due amounts.</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:45.2pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><img alt="image_45.jpg" src="image_45.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:3px"><img alt="image_172.jpg" src="image_172.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:underline">Mandatory Prepayment Upon an Acceleration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. If the Term Loan Advance is accelerated by Bank following the occurrence and during the continuance of an Event of Default, Borrower shall immediately pay to Bank an amount equal to the sum of (i) all outstanding principal plus accrued and unpaid interest with respect to the Term Loan Advance, (ii) the applicable Prepayment Fee, if any</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(iii) the Final Payment, and (iv) all other sums, if any, that shall have become due and payable with respect to the Term Loan Advance, including interest at the Default Rate with respect to any past due amounts.</font></div><div><font><br></font></div><div style="margin-top:4.75pt;padding-left:46pt"><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt"><img alt="image_48.jpg" src="image_48.jpg" style="height:27px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font></div><div style="height:41.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:10.794%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><div id="i37efde9015094164b274aef726ee5ee2_79"></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">1.1.A</font><img alt="image_172.jpg" src="image_172.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.78pt;text-decoration:underline">Revolving Line.</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:45.15pt;text-align:justify;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><img alt="image_169.jpg" src="image_169.jpg" style="height:61px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt;text-decoration:underline">Availability. Subject to the terms and conditions of this Agreement and to deduction of</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Reserves, Bank shall make Advances under the Revolving Line upon Borrower&#8217;s request not exceeding the</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Availability Amount. Amounts borrowed under the Revolving Line may be prepaid or repaid as set forth on</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule I hereto.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:44.9pt;text-align:justify;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><img alt="image_214.jpg" src="image_214.jpg" style="height:46px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:underline">Termination&#59; Repayment. The Revolving Line terminates on the Revolving Line</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Maturity Date, at which time the outstanding principal amount of all Advances, the accrued and unpaid interest</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">thereon, and all other outstanding Obligations relating to the Revolving Line shall be immediately due and payable.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:43.55pt;text-align:justify;text-indent:36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">1.1.B</font><img alt="image_53.jpg" src="image_53.jpg" style="height:92px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:4.34pt;text-decoration:underline">Overadvances. </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">If, at any time, the sum of the aggregate outstanding principal amount of any</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Advances exceeds the lesser of (i) the Revolving Line or (ii) the Borrowing Base, Borrower shall immediately pay to</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Bank in cash the amount of such excess (such excess, the &#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Overadvance</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8221;). Without limiting Borrower&#8217;s obligation</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">to repay Bank any Overadvance, at Bank&#8217;s sole option, Borrower shall pay Bank interest on the outstanding amount</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">of any Overadvance, on demand, at a rate per annum equal to the rate that is otherwise applicable to Advances plus</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">three percent (3.0%).</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Payment of Interest on the Credit Extensions.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:154pt;text-indent:-36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><img alt="image_54.jpg" src="image_54.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:97px"><img alt="image_172.jpg" src="image_172.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.91pt;text-decoration:underline">Interest Payments.</font></div><div style="padding-left:117.7pt"><img alt="image_56.jpg" src="image_56.jpg" style="height:2px;margin-bottom:5pt;vertical-align:text-bottom;width:14px"></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:154pt;padding-right:44.05pt;text-indent:36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(i)</font><img alt="image_171.jpg" src="image_171.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.57pt;text-decoration:underline">Advances. Interest on the principal amount of each Advance is payable</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">as set forth on Schedule I hereto.</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:154pt;padding-right:44.95pt;text-align:justify;text-indent:36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(ii)</font><img alt="image_58.jpg" src="image_58.jpg" style="height:2px;margin-bottom:5pt;vertical-align:text-bottom;width:209px"><img alt="image_171.jpg" src="image_171.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt;text-decoration:line-through">(a) Interest Payments</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan Advances</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Interest on the outstanding principal amount of </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">the</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">each</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan Advance is payable as set forth on Schedule I hereto.</font></div><div><font><br></font></div><div style="padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt;text-decoration:underline">Interest Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.05pt;text-indent:144pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(i)</font><img alt="image_171.jpg" src="image_171.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.57pt;text-decoration:underline">Advances. Subject to Section 1.2(c), the outstanding principal amount</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">of any Advance shall accrue interest as set forth on Schedule I hereto.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:45.2pt;text-align:justify;text-indent:144pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(ii)</font><img alt="image_61.jpg" src="image_61.jpg" style="height:2px;margin-bottom:5pt;vertical-align:text-bottom;width:99px"><img alt="image_172.jpg" src="image_172.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt;text-decoration:line-through">(i)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Term Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">Advance</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advances</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Subject to Section 1.2</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">(c)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, the outstanding principal amount of the Term Loan Advance shall accrue interest as set forth on Schedule I hereto.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:44.85pt;text-align:justify;text-indent:144pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(iii)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:11.03pt;text-decoration:line-through">(ii)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">All-In Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Notwithstanding any terms in this Agreement to the contrary, if at any time the interest rate applicable to any Obligations is less than zero percent (0.0%), such interest rate shall be deemed to be zero percent (0.0%) for all purposes of this Agreement.</font></div><div><font><br></font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="padding-left:46pt;padding-right:44.45pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><img alt="image_172.jpg" src="image_172.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt;text-decoration:underline">Default Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Immediately upon the occurrence and during the continuance of an Event of Default, the outstanding Obligations shall bear interest at a rate per annum which is three percent (3.0%) above the rate that is otherwise applicable thereto (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Default Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), unless Bank otherwise elects, in its sole discretion, to impose a lesser increase or no increase. Fees and expenses which are required to be paid by Borrower pursuant to the Loan Documents (including, without limitation, Bank Expenses) but are not paid when due shall bear interest until paid at a rate equal to the highest rate applicable to the Obligations. Payment or acceptance of the increased interest rate provided in this Section 1.2</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">(c)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(c)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">is not a permitted alternative to timely payment and shall not constitute a waiver of any Event of Default or otherwise prejudice or limit any rights or reme</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.25pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:underline">Adjustment to Interest Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Each change in the interest rate applicable to any amounts payable under the Loan Documents based on changes to the Prime Rate shall be effective on the effective date of any change to the Prime Rate and to the extent of such change.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:43.15pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt;text-decoration:underline">Interest Computation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Interest shall be computed as set forth on Schedule I hereto. In computing interest, the date of the making of any Credit Extension shall be included and the date of payment shall be excluded&#59; provided, however, that if any Credit Extension is repaid on the same day on which it is made, such day shall be included in computing interest on such Credit Extension.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Fees and Expenses. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrower shall pay to Bank&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:44.95pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt;text-decoration:underline">Prepayment Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. The Prepayment Fee, if and when due hereunder, which shall be fully earned and non-refundable as of the applicable prepayment date&#59; provided, however, if Borrower refinances the Term Loan Advance with another credit facility from Bank, Bank shall waive the Prepayment Fee&#59;</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:45.05pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><img alt="image_169.jpg" src="image_169.jpg" style="height:61px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><img alt="image_163.jpg" src="image_163.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:619px"><img alt="image_241.jpg" src="image_241.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:619px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:underline">Final Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. The Final Payment, when due hereunder, which shall be fully earned and non-refundable as of such date</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">&#59; and</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">, provided however, for the avoidance of doubt, the Final Payment due under the</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">terms of this original Agreement with respect to the original Term Loan Advances shall be pro-rated and accrued</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">and payable only through the date such original Term Loan Advances are repaid on or around the First Amendment</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Effective Date, in accordance with Section 1.1(a)&#59;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:45.05pt;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><img alt="image_171.jpg" src="image_171.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt;text-decoration:underline">Revolving Line Commitment Fee. A fully earned, as of the First Amendment Effective</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Date, non-refundable commitment fee as set forth on Schedule I hereto&#59; and</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:45.05pt;text-align:justify;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><img alt="image_126.jpg" src="image_126.jpg" style="height:76px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:underline">Termination Fee. Upon termination of this Agreement or the termination of the</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Line for any reason prior to the Revolving Line Maturity Date, in addition to the payment of any other</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">amounts then-owing, a termination fee in an amount equal to One Hundred Fifty Thousand Dollars ($150,000),</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">which shall be fully earned and non-refundable as of such date&#59; provided that no termination fee shall be charged if</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">the credit facility hereunder is replaced with a new facility from Bank&#59;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:42.95pt;text-align:justify;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e)</font><img alt="image_172.jpg" src="image_172.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><img alt="image_166.jpg" src="image_166.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt;text-decoration:line-through">(c)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Bank Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. All Bank Expenses incurred through and after the </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">First Amendment</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective Date, when due (or, if no stated due date, upon demand by Bank). Borrower has paid to Bank a good faith deposit of </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">Fifty</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Seventy-Five</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thousand Dollars ($</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">50,000</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">75,000</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Good Faith Deposit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">, in connection with the</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">First Amendment,</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to initiate Bank&#8217;s due diligence review process. The Good Faith Deposit will be applied to Bank Expenses as of the Effective Date.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:46pt;padding-right:44.3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unless otherwise provided in this Agreement or in a separate writing by Bank, Borrower shall not be entitled to any credit, rebate, or repayment of any fees earned by Bank pursuant to this Agreement notwithstanding any termination of this Agreement or the suspension or termination of Bank&#8217;s obligation to make loans and advances hereunder. Bank may deduct amounts owing by Borrower under the clauses of this Section 1.3 pursuant to </font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="padding-left:46pt;padding-right:44.3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the terms of Section 1.4(c). Bank shall provide Borrower written notice of deductions made pursuant to the terms of the clauses of this Section 1.3.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Payments&#59; Application of Payments&#59; Debit of Accounts.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:44.05pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">All payments (including prepayments) to be made by Borrower under any Loan Document shall be made in immediately available funds in Dollars, without setoff, counterclaim, or deduction, before 12&#58;00 p.m. Pacific time on the date when due. Payments of principal and&#47;or interest received after 12&#58;00 p.m. Pacific time are considered received at the opening of business on the next Business Day. When a payment is due on a day that is not a Business Day, the payment shall be due the next Business Day, and additional fees or interest, as applicable, shall continue to accrue until paid.</font></div><div style="padding-left:46pt;padding-right:45.1pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><img alt="image_172.jpg" src="image_172.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"> Subject to the payment terms of this Agreement and Section 8.4,</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank has the exclusive right in its reasonable discretion to determine the order and manner in which all payments with respect to the Obligations may be applied. Borrower shall have no right to specify the order or the accounts to which Bank shall allocate or apply any payments required to be made by Borrower to Bank or otherwise received by Bank under this Agreement when any such allocation or application is not specified elsewhere in this Agreement.</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:45.25pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">Bank may debit the Designated Deposit Account (or if insufficient funds are contained therein, or if an Event of Default has occurred and is continuing, any of Borrower&#8217;s other accounts at Bank), for principal and interest payments or any other amounts Borrower owes Bank when as and when due under this Agreement. These debits shall not constitute a set-off.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Change in Circumstances.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:43.15pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt;text-decoration:underline">Increased Costs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. If any Change in Law shall&#58; (i) impose, modify or deem applicable any reserve, special deposit, compulsory loan, insurance charge or similar requirement against assets of, deposits with or for the account of, or advances, loans or other credit extended or participated in by, Bank, (ii) subject Bank to any Taxes (other than (A) Indemnified Taxes, (B) Taxes described in clauses (b) through (d) of the definition of Excluded Taxes, and (C) Connection Income Taxes) on its loans, loan principal, letters of credit, commitment, or other obligations, or its deposits, reserves, other liabilities or capital attributable thereto, or (iii) impose on Bank any other condition, cost or expense (other than Taxes) affecting this Agreement or Credit Extensions made by Bank, and the result of any of the foregoing shall be to increase the cost to Bank of making, converting to, continuing or maintaining any Credit Extension (or of maintaining its obligation to make any such Credit Extension), or to reduce the amount of any sum received or receivable by Bank hereunder (whether of principal, interest or any other amount) then, upon written request of Bank, Borrower shall promptly pay to Bank such additional amount or amounts as will compensate Bank for such additional costs incurred or reduction suffered.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:46pt;padding-right:44.95pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><img alt="image_172.jpg" src="image_172.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:underline">Capital Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. If Bank determines that any Change in Law affecting Bank regarding capital or liquidity requirements, has or would have the effect of reducing the rate of return on Bank&#8217;s capital as a consequence of this Agreement, </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">the Revolving Line,</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any term loan facility, or the Credit Extensions made by Bank to a level below that which Bank could have achieved but for such Change in Law (taking into consideration Bank&#8217;s policies with respect to capital adequacy and liquidity), then from time to time upon written request of Bank, Borrower shall promptly pay to Bank such additional amount or amounts as will compensate Bank for any such reduction suffered.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:46pt;padding-right:42.95pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt;text-decoration:underline">Delay in Requests</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Failure or delay on the part of Bank to demand compensation pursuant to this Section 1.5 shall not constitute a waiver of Bank&#8217;s right to demand such compensation&#59; provided that Borrower compensate Bank pursuant to subsection (a) for any increased costs incurred or reductions suffered more than nine (9) months prior to the date that Bank notifies Borrower of the Change in Law giving rise to such increased costs or reductions (except that if the Change in Law giving rise to such increased costs or reductions is retroactive, then the nine (9) month period shall be extended to include the period of retroactive effect).</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Taxes.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.15pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><img alt="image_172.jpg" src="image_172.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt;text-decoration:underline">Payments Free of Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Any and all payments by or on account of any obligation of Borrower under any Loan Document shall be made without deduction or withholding for any Taxes, except as required by Applicable Law. If any Applicable Law (as determined in the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">good faith</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">commercially reasonable</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">discretion of Borrower) requires the deduction or withholding of any Tax from any such payment by Borrower, then</font></div><div style="margin-top:0.1pt;padding-left:46pt;padding-right:44.05pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i) Borrower shall be entitled to make such deduction or withholding, (ii) Borrower shall timely pay the full amount deducted or withheld to the relevant Governmental Authority in accordance with Applicable Law, and (iii) if such Tax is an Indemnified Tax, the sum payable by Borrower shall be increased as necessary so that after such deduction or withholding has been made (including such deductions and withholdings applicable to additional sums payable</font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="padding-left:46pt;padding-right:39.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">under this Section 1.6) Bank receives an amount equal to the sum it would have received had no such deduction or withholding been made.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:45.15pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:underline">Payment of Other Taxes by Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Without limiting the provisions of subsection (a) above, Borrower shall timely pay any Other Taxes to the relevant Governmental Authority in accordance with Applicable Law.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.15pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt;text-decoration:underline">Tax Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Without limiting the provisions of subsections (a) and (b) above, Borrower shall, and does hereby, indemnify Bank, within ten (10) days after demand therefor, for the full amount of any Indemnified Taxes (including Indemnified Taxes imposed or asserted on or attributable to amounts payable under this Section 1.6) payable or paid by Bank or required to be withheld or deducted from a payment to Bank and any reasonable expenses arising therefrom or with respect thereto, whether or not such Indemnified Taxes were correctly or legally imposed or asserted by the relevant Governmental Authority. A certificate as to the amount of such payment or liability delivered to Borrower by Bank shall be conclusive absent manifest error.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.3pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:underline">Evidence of Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. As soon as practicable after any payment of Taxes by Borrower to a Governmental Authority pursuant to this Section 1.6, Borrower shall deliver to Bank a certified copy of a receipt issued by such Governmental Authority evidencing such payment, a copy of the return reporting such payment or other evidence of such payment reasonably satisfactory to Bank.</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:45.95pt;padding-right:43.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.96pt;text-decoration:underline">Status of Bank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. If Bank (including any assignee or successor) is entitled to an exemption from or reduction of withholding tax with respect to payments made under any Loan Document, it shall deliver to Borrower, at the time or times reasonably requested by Borrower, such properly completed and executed documentation reasonably requested by Borrower as will permit such payments to be made without withholding or at a reduced rate of withholding. In addition, Bank, if reasonably requested by Borrower, shall deliver such other documentation prescribed by Applicable Law or reasonably requested by Borrower as will enable Borrower to determine whether or not Bank is subject to backup withholding or information reporting requirements. Without limiting the generality of the foregoing, Bank shall deliver whichever of IRS Form W-9, IRS Form W-8BEN-E, IRS Form W-8ECI or IRS Form W-8IMY is applicable, as well as any applicable supporting documentation or certifications. If a payment made to Bank under any Loan Document would be subject to U.S. federal withholding Tax imposed by FATCA if Bank were to fail to comply with the applicable reporting requirements of FATCA (including those contained in Section 1471(b) or 1472(b) of the Internal Revenue Code, as applicable), Bank shall deliver to Borrower at the time or times prescribed by law and at such time or times reasonably requested by Borrower such documentation prescribed by Applicable Law (including as prescribed by Section 1471(b)(3)(C)(i) of the Internal Revenue Code) and such additional documentation reasonably requested by Borrower as may be necessary for Borrower to comply with its obligations under FATCA and to determine that Bank has complied with its obligations under FATCA or to determine the amount, if any, to deduct and withhold from such payment. Solely for purposes of the preceding sentence, &#8220;FATCA&#8221; shall include any amendments made to FATCA after the date of this Agreement.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.05pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.01pt;text-decoration:underline">Treatment of Certain Refunds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. If Bank determines, in its sole discretion exercised in good faith, that it has received a refund of any Taxes as to which it has been indemnified pursuant to this Section 1.6 (including by the payment of additional amounts pursuant to this Section 1.6), it shall pay to Borrower an amount equal to such refund (but only to the extent of indemnity payments made under this Section 1.6 with respect to the Taxes giving rise to such refund), net of all out-of-pocket expenses (including Taxes) of Bank and without interest (other than any interest paid by the relevant Governmental Authority with respect to such refund). Borrower, upon the request of Bank, shall repay to Bank the amount paid over pursuant to this paragraph (f) (plus any penalties, interest or other charges imposed by the relevant Governmental Authority) in the event that Bank is required to repay such refund to such Governmental Authority. Notwithstanding anything to the contrary in this paragraph (f), in no event will Bank be required to pay any amount to Borrower pursuant to this paragraph (f) the payment of which would place Bank in a less favorable net after-Tax position than Bank would have been in if the Tax subject to indemnification and giving rise to such refund had not been deducted, withheld or otherwise imposed and the indemnification payments or additional amounts with respect to such Tax had never been paid. This paragraph (f)</font></div><div style="text-align:justify"><font><br></font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:39.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">shall not be construed to require Bank to make available its Tax returns (or any other information relating to its Taxes that it deems confidential) to Borrower or any other Person.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Procedures for Borrowing.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:44.05pt;text-align:justify;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><img alt="image_76.jpg" src="image_76.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:475px"><img alt="image_77.jpg" src="image_77.jpg" style="height:184px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt;text-decoration:underline">Advances. Subject to the prior satisfaction of all other applicable conditions to the</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">making of an Advance set forth in this Agreement (which must be satisfied no later than 12&#58;00 p.m. Pacific time on</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">the applicable Funding Date), to obtain an Advance, Borrower (via an individual duly authorized by an</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Administrator) shall notify Bank (which notice shall be irrevocable) by 12&#58;00 p.m. Pacific time on the Funding Date</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">of the Advance. Such notice shall be made through Bank&#8217;s online banking program, provided, however, if Borrower</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">is not utilizing Bank&#8217;s online banking program, then such notice shall be in a written format acceptable to Bank that</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">is executed by an Authorized Signer. In connection with any such notification, Borrower shall deliver to Bank by</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">electronic mail or through Bank&#8217;s online banking program such reports and information, including without</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">limitation, accounts receivable aging reports, as Bank may reasonably request. Bank shall have received satisfactory</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">evidence that the Board has approved that such Authorized Signer may provide such notices and request Advances</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(which requirement may be deemed satisfied by the prior delivery of Borrowing Resolutions or a secretary&#8217;s</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">certificate that certifies as to such Board approval).</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:4.5pt;padding-left:46pt;padding-right:45.25pt;text-align:justify;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><img alt="image_172.jpg" src="image_172.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:line-through">(a) </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Term Loan Advances. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subject to the prior satisfaction of all other applicable conditions to the making of the Term Loan Advance set forth in this Agreement (which must be satisfied no later than 12&#58;00 p.m. Pacific time on the applicable Funding Date), to obtain the Term Loan Advance, Borrower shall notify Bank (which notice shall be irrevocable) by 12&#58;00 p.m. Pacific time on the Funding Date of the Term Loan Advance. Such notice shall be made by electronic mail or by telephone and, together with any such notification, Borrower shall deliver to Bank by electronic mail a completed Payment&#47;Advance Form executed by an Authorized Signer. Bank may rely on any telephone notice given by a person whom Bank reasonably believes is an Authorized Signer. Borrower will indemnify Bank for any loss Bank suffers due to such reasonable belief or reliance. Bank shall have received satisfactory evidence that the Board has approved that such Authorized Signer may provide such notices and request such Term Loan Advance (which requirement may be deemed satisfied by the prior delivery of Borrowing Resolutions or a secretary&#8217;s certificate that certifies as to such Board approval).</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:45.35pt;text-align:justify;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><img alt="image_166.jpg" src="image_166.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt;text-decoration:line-through">(b)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank shall credit proceeds of a Credit Extension to the Designated Deposit Account. Bank may make </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">the</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Advances and</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">Advance</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Advances</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">under this Agreement based on instructions from an Authorized Signer or without instructions if such </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Advances or</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">Advance is</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Advances are</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">necessary to meet Obligations which have become due.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:28.5pt;text-decoration:underline">CONDITIONS OF CREDIT EXTENSIONS</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:44.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Conditions Precedent to Initial Credit Extension. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank&#8217;s obligation to make the initial Credit Extension is subject to the condition precedent that Bank shall have received, in form and substance satisfactory to Bank, such documents, and completion of such other matters, as Bank may reasonably deem necessary or appropriate, including, without limitation&#58;</font></div><div><font><br></font></div><div style="padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.91pt">duly executed Loan Documents&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">a duly executed Control Agreement with U.S. Bank&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:45.05pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">the Operating Documents of Borrower and its Subsidiaries and long-form good standing certificates of Borrower certified by the Secretary of State of the State of Delaware and the Secretary of State (or equivalent agency) of each other jurisdiction in which Borrower is qualified to conduct business, in each case as of a date no earlier than thirty (30) days prior to the Effective Date&#59;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:43.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">a certificate duly executed by a Responsible Officer or secretary of Borrower with respect to Borrower&#8217;s (i) Operating Documents and (ii) Borrowing Resolutions&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.91pt">a duly executed payoff letter from Solar Capital&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.1pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.01pt">evidence that (i) the Liens securing Indebtedness owed by Borrower to Solar Capital will be terminated and (ii) the documents and&#47;or filings evidencing the perfection of such Liens, including without limitation any financing statements and&#47;or control agreements, have or will, concurrently with the initial Credit Extension, be terminated&#59;</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:45.25pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">certified copies, dated as of a recent date, of searches for financing statement filed in the central filing office of the State of Delaware, accompanied by written evidence (including any UCC termination statements) that the Liens indicated in any such financing statements either constitute Permitted Liens or have been or, in connection with the initial Credit Extension, will be terminated or released&#59;</font></div><div><font><br></font></div><div style="padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">a duly executed Perfection Certificate of Borrower&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:43.95pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.57pt">a duly executed landlord&#8217;s consent in favor of Bank for Borrower&#8217;s leased location at 471 El Camino Real, Suite 101, Santa Clara, CA 95050&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.57pt">a legal opinion of Borrower&#8217;s counsel dated as of the Effective Date&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:154pt;text-indent:-36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(k)</font><img alt="image_90.jpg" src="image_90.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:387px"><img alt="image_91.jpg" src="image_91.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:15px"><img alt="image_172.jpg" src="image_172.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt;text-decoration:underline">with respect to initial Advance, a completed Borrowing Base Certificate&#59;</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:154pt;text-indent:-36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(l)</font><img alt="image_93.jpg" src="image_93.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:370px"><img alt="image_172.jpg" src="image_172.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.57pt;text-decoration:underline">the completion of the Initial Audit with respect to the initial Advance&#59;</font></div><div style="padding-left:117.7pt"><img alt="image_95.jpg" src="image_95.jpg" style="height:2px;margin-bottom:5pt;vertical-align:text-bottom;width:12px"></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:45.35pt;text-align:justify;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(m)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:11.57pt;text-decoration:line-through">(k)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">evidence satisfactory to Bank that the insurance policies and endorsements required by Section 5.8 hereof are in full force and effect, together with appropriate evidence showing lender loss payable and additional insured clauses or endorsements in favor of Bank&#59; and</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:154pt;text-indent:-36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(n)</font><img alt="image_96.jpg" src="image_96.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:16px"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt;text-decoration:underline line-through">(l)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">payment of the fees and Bank Expenses then due as specified in Section 1.3 hereof.</font></div><div style="padding-left:117.7pt"><img alt="image_97.jpg" src="image_97.jpg" style="height:2px;margin-bottom:5pt;vertical-align:text-bottom;width:15px"></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.1pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Conditions Precedent to all Credit Extensions.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank&#8217;s obligation to make each Credit Extension, including the initial Credit Extension, is subject to the following conditions precedent&#58;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.2pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">receipt of Borrower&#8217;s Credit Extension request and the related materials and documents as required by and in accordance with Section 1.7&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.1pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">the representations and warranties in this Agreement shall be true and correct in all material respects as of the date of any Credit Extension request and as of the Funding Date of each Credit Extension&#59; provided, however, that such materiality qualifier shall not be applicable to any representations and warranties that already are qualified or modified by materiality in the text thereof&#59; and provided, further that those representations and warranties expressly referring to a specific date shall be true and correct in all material respects as of such date, and no Default or Event of Default shall have occurred and be continuing or result from the Credit Extension. Each Credit Extension is Borrower&#8217;s representation and warranty on that date that the representations and warranties in this Agreement remain true and correct in all material respects&#59; provided, however, that such materiality qualifier shall not be applicable to any representations and warranties that already are qualified or modified by materiality in the text thereof&#59; and provided, further that those representations and warranties expressly referring to a specific date shall be true and correct in all material respects as of such date&#59; and</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.91pt">a Material Adverse Change shall not have occurred.</font></div><div><font><br></font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Covenant to Deliver.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:45.1pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">Borrower shall deliver to Bank each item required to be delivered to Bank under this Agreement as a condition precedent to any Credit Extension. A Credit Extension made prior to the receipt by Bank of any such item shall not constitute a waiver by Bank of Borrower&#8217;s obligation to deliver such item, and the making of any Credit Extension in the absence of a required item shall be in Bank&#8217;s sole discretion.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:28.5pt;text-decoration:underline">CREATION OF SECURITY INTEREST</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Grant of Security Interest.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.05pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">Borrower hereby grants Bank, to secure the payment and performance in full of all of the Obligations, a continuing security interest in, and pledges to Bank, the Collateral, wherever located, whether now owned or hereafter acquired or arising, and all proceeds and products thereof.</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:45.1pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Borrower acknowledges that it previously has entered, or may in the future enter, into Bank Services Agreements with Bank. Regardless of the terms of any Bank Services Agreement, Borrower agrees that any amounts Borrower owes Bank thereunder shall be deemed to be Obligations hereunder and that it is the intent of Borrower and Bank to have all such Obligations secured by the first priority perfected security interest in the Collateral granted herein (subject to Permitted Liens).</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:45.95pt;padding-right:45.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.55pt">Authorization to File Financing Statements. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrower hereby authorizes Bank to file financing statements covering the Collateral, without notice to Borrower, with all jurisdictions deemed necessary or appropriate by Bank to perfect or protect Bank&#8217;s interest or rights hereunder, including a notice that any disposition of the Collateral, by either Borrower or any other Person, in contravention of the terms of this Agreement shall be deemed to violate the rights of Bank under the Code. Such financing statements may indicate the Collateral</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:45.95pt;padding-right:43.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.55pt">Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. If this Agreement is terminated, Bank&#8217;s Lien in the Collateral shall continue until the Obligations (other than inchoate indemnity obligations) are repaid in full in cash. Upon payment in full in cash of the Obligations (other than inchoate indemnity obligations) and at such time as Bank&#8217;s obligation to make Credit Extensions has terminated, Bank shall, at Borrower&#8217;s sole cost and expense, promptly terminate its security interest in the Collateral and all rights therein shall automatically revert to Borrower, and Bank shall, upon request from Borrower and at Borrower&#8217;s sole cost and expense, promptly deliver to Borrower written evidence of the termination of such liens and any other documents reasonably necessary to terminate such liens. In the event (a) all Obligations (other than inchoate indemnity obligations), except for Bank Services, are satisfied in full, and (b) this Agreement is terminated, Bank shall terminate the security interest granted herein upon Borrower providing cash collateral acceptable to Bank in its commercially reasonable discretion for Bank Services, if any. In the event such Bank Services consist of outstanding Letters of Credit, Borrower shall provide to Bank cash collateral in an amount equal to at least (i) one hundred and five percent (105.0%) of the face amount of all such Letters of Credit denominated in Dollars and (ii) one hundred and fifteen percent (115.0%) of the Dollar Equivalent of the face amount of all such Letters of Credit denominated in a Foreign Currency, plus, in each case, all interest, fees, and costs due or estimated by Bank to become due in connection therewith, to secure all of the Obligations relating to such Letters of Credit.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:28.5pt;text-decoration:underline">REPRESENTATIONS AND WARRANTIES</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrower represents and warrants as follows&#58;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Due Organization, Authorization&#59; Power and Authority.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:45.25pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">Borrower and each of its Subsidiaries are each duly existing and in good standing as a Registered Organization in their respective jurisdiction of formation and are qualified and licensed to do business and is in good standing in any other jurisdiction in which the conduct of their respective business or their ownership</font></div><div style="text-align:justify"><font><br></font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:44.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">of property requires that they be qualified except where the failure to do so could not reasonably be expected to have a material adverse effect on Borrower&#8217;s business or operations.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:44.55pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><img alt="image_172.jpg" src="image_172.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">All information set forth on the Perfection Certificate pertaining to Borrower and each of its Subsidiaries is true and correct in all material respects (it being understood and agreed that Borrower may from time to time update certain information in the Perfection Certificate after the </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">First Amendment</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective Date to the extent permitted by one or more specific provisions in this Agreement and the Perfection Certificate shall be deemed to be updated to the extent such notice is provided to Bank of such permitted update).</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:42.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">The execution, delivery and performance by Borrower and each of its Subsidiaries of the Loan Documents to which it is a party have been duly authorized, and do not (i) conflict with any of Borrower&#8217;s or any such Subsidiary&#8217;s organizational documents, (ii) contravene, conflict with, constitute a default under or violate any material Applicable Law, (iii) contravene, conflict with or violate any applicable order, writ, judgment, injunction, decree, determination or award of any Governmental Authority by which Borrower or any of its Subsidiaries or any of their property or assets may be bound or affected, (iv) require any action by, filing, registration, or qualification with, or Governmental Approval from, any Governmental Authority (except such Governmental Approvals which have already been obtained and are in full force and effect), or (v) conflict with, contravene, constitute a default or breach under, or result in or permit the termination or acceleration of, any material agreement by which Borrower or any of its Subsidiaries is bound, or applicable consents or waivers have been obtained. Neither Borrower nor any of its Subsidiaries are in default under any material agreement to which it is a party or by which it is bound in which the default could reasonably be expected to have a material adverse effect on Borrower&#8217;s or any of its Subsidiary&#8217;s business or operations (taken as a whole).</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Collateral.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:44.9pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">The security interest granted herein is and shall at all times continue to be a first priority perfected security interest in the Collateral (subject to Permitted Liens). Borrower has good title to, rights in, and the power to transfer each item of the Collateral upon which it purports to grant a Lien hereunder, free and clear of any and all Liens except Permitted Liens.</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:45.05pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Borrower has no Collateral Accounts at or with any bank or financial institution other than Bank or Bank&#8217;s Affiliates except for the Collateral Accounts described in the Perfection Certificate delivered to Bank in connection herewith and which Borrower has taken such actions as are necessary to give Bank a perfected security interest therein, to the extent that perfection is required pursuant to the terms of Section 5.9(c). The Accounts are bona fide, existing obligations of the Account Debtors.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:45.95pt;padding-right:45.25pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.96pt">The Collateral is not in the possession of any third party bailee (such as a warehouse) except as otherwise provided in the Perfection Certificate or as permitted pursuant to Section 6.2 (other than laptops and other portable electronic items used in the ordinary course of business). None of the components of the Collateral shall be maintained at locations other than as provided in the Perfection Certificate or as permitted pursuant to Section 6.2 (other than laptops and other portable electronic items used in the ordinary course of business).</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">All Inventory is in all material respects of good and marketable quality, free from</font></div><div style="padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">material defects.</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:42.9pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">Borrower owns, or possesses the right to use to the extent reasonably necessary in its business, all Intellectual Property, licenses and other intangible assets that are used in the conduct of its business operations as now operated, except to the extent that such failure to own or possess the right to use such asset would not reasonably be expected to have a material adverse effect on Borrower&#8217;s business or operations, and no such asset, to the best knowledge of Borrower, conflicts with the valid Intellectual Property, license, or intangible asset of</font></div><div style="text-align:justify"><font><br></font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:39.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any other Person to the extent that such conflict could reasonably be expected to have a material adverse effect on Borrower&#8217;s business or operations.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:45.95pt;padding-right:43.6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.06pt">Except as noted on the Perfection Certificate (as updated from time to time in accordance with this Agreement) or for which notice has been given to Bank pursuant to and in accordance with Section 5.11(b), Borrower is not a party to, nor is it bound by, any Restricted License.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.3</font><img alt="image_143.jpg" src="image_143.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt;text-decoration:line-through">Reserved</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Accounts Receivable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">.</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:45.1pt;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(a)</font><img alt="image_171.jpg" src="image_171.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt;text-decoration:underline">For each Account included in the most recent Borrowing Base Statement, on the date</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">such related Advance is requested and made, such Account shall be an Eligible Account.</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:45.25pt;text-align:justify;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(b)</font><img alt="image_101.jpg" src="image_101.jpg" style="height:138px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:underline">All statements made and all unpaid balances appearing in all invoices, instruments and</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">other documents evidencing the Eligible Accounts are and shall be true and correct and all such invoices,</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">instruments and other documents, and all of Borrower&#8217;s Books are genuine and in all respects what they purport to</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">be. All sales and other transactions underlying or giving rise to each Eligible Account shall comply in all material</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">respects with all Applicable Law. Borrower has no knowledge of any actual or imminent Insolvency Proceeding of</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">any Account Debtor whose accounts are Eligible Accounts in any Borrowing Base Statement. To Borrower&#8217;s</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">knowledge, all signatures and endorsements on all documents, instruments, and agreements relating to all Eligible</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Accounts are genuine, and all such documents, instruments and agreements are legally enforceable in accordance</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">with their terms.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:45.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.4</font><img alt="image_103.jpg" src="image_103.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Litigation. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other than as set forth on the Perfection Certificate delivered around the </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">First</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Amendment</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective Date, and as disclosed to Bank pursuant to Section 5.3, there are no actions, investigations or proceedings pending or, to the knowledge of any Responsible Officer, threatened in writing by or against Borrower or any of its Subsidiaries that could reasonably be expected to result in liability of more than, individually or in the aggregate, Seven Hundred Fifty Thousand Dollars ($750,000).</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.25pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Financial Statements&#59; Financial Condition. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All consolidated financial statements for Borrower and any of its Subsidiaries delivered to Bank by submission to the Financial Statement Repository or otherwise submitted to Bank fairly present in all material respects Borrower&#8217;s consolidated financial condition and Borrower&#8217;s consolidated results of operations as of the dates thereof and for the periods covered thereby, subject, in the case of unaudited financial statements, to normal year-end adjustments and the absence of footnote disclosures. There has not been any material deterioration in Borrower&#8217;s consolidated financial condition since the date of the most recent financial statements submitted to the Financial Statement Repository or otherwise submitted to Bank.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:45.95pt;padding-right:45.35pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.55pt">Solvency. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The fair salable value of Borrower&#8217;s consolidated assets (including goodwill minus disposition costs) exceeds the fair value of Borrower&#8217;s liabilities&#59; Borrower is not left with unreasonably small capital after the transactions in this Agreement&#59; and Borrower and Borrower and each of its Subsidiaries (taken as a whole) are able to pay their debts (including trade debts) as they mature.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:46pt;padding-right:44.2pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Regulatory Compliance. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrower is not an &#8220;investment company&#8221; or a company &#8220;controlled&#8221; by an &#8220;investment company&#8221; under the Investment Company Act of 1940, as amended. Borrower is not engaged as one of its important activities in extending credit for margin stock (under Regulations X, T and U of the Federal Reserve Board of Governors). Borrower and each of its Subsidiaries (a) have complied in all material respects with all Applicable Law, and (b) have not violated any Applicable Law the violation of which could reasonably be expected to have a material adverse effect on Borrower&#8217;s business or operations. Borrower and each of its Subsidiaries have </font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="padding-left:46pt;padding-right:44.2pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">duly complied with, and their respective facilities, business, assets, property, leaseholds, real property and Equipment are in compliance with, Environmental Laws, except where the failure to do so could not reasonably be expected to have a material adverse effect on Borrower&#8217;s business or operations&#59; there have been no outstanding citations, notices or orders of non-compliance issued to Borrower or any of its Subsidiaries or relating to their respective facilities, businesses, assets, property, leaseholds, real property or Equipment under such Environmental Laws Borrower and each of its Subsidiaries have obtained all consents, approvals and authorizations</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.55pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">of, made all declarations or filings with, and given all notices to, all Governmental Authorities that are necessary to continue their respective businesses as currently conducted, except where the failure to obtain or make or file the same would not reasonably be expected to have a material adverse effect on Borrower&#8217;s business or operations.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.35pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Subsidiaries&#59; Investments. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrower does not own any stock, partnership, or other ownership interest or other equity securities except for Permitted Investments.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:118pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Tax Returns and Payments&#59; Pension Contributions.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:44.45pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">Borrower and each of its Subsidiaries have timely filed, or submitted extensions for, all required tax returns and reports, and Borrower and each of its Subsidiaries have timely paid, or submitted extensions for, all foreign, federal, state and local taxes, assessments, deposits and contributions owed by Borrower and each of its Subsidiaries except (i) to the extent such taxes are being contested in good faith by appropriate proceedings promptly instituted and diligently conducted, so long as such reserve or other appropriate provision, if any, as shall be required in conformity with GAAP shall have been made therefor, or (ii) if such taxes, assessments, deposits and contributions do not, individually or in the aggregate, exceed Fifty Thousand Dollars ($50,000). Borrower is unaware of any claims or adjustments proposed for any of Borrower&#8217;s or any of its Subsidiary&#8217;s prior tax years which could result in additional taxes becoming due and payable by Borrower or any of its Subsidiaries in excess of Fifty Thousand Dollars ($50,000) in the aggregate.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:45.95pt;padding-right:45.2pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.39pt">Borrower and each of its Subsidiaries have paid all amounts necessary to fund all present pension, profit sharing and deferred compensation plans in accordance with their terms, and neither Borrower nor any of its Subsidiaries has withdrawn from participation in, and has not permitted partial or complete termination of, or permitted the occurrence of any other event with respect to, any such plan which could reasonably be expected to result in any material liability of Borrower or any of its Subsidiaries, including any liability to the Pension Benefit Guaranty Corporation or its successors or any other Governmental Authority.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:46pt;padding-right:44.3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:8.5pt">Full Disclosure. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No written representation, warranty or other statement of Borrower or any of its Subsidiaries in any report, certificate or written statement submitted to the Financial Statement Repository or otherwise submitted to Bank, as of the date such representation, warranty, or other statement was made, taken together with all such written reports, written certificates and written statements submitted to the Financial Statement Repository or otherwise submitted to Bank, contains any untrue statement of a material fact or omits to state a material fact necessary to make the statements contained in the reports, certificates or written statements not misleading in light of the circumstances under which they were made (it being recognized by Bank that the projections and forecasts provided by Borrower or any of its Subsidiaries in good faith and based upon reasonable assumptions are not viewed as facts and that actual results during the period or periods covered by such projections and forecasts may differ from the projected or forecasted results).</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:118pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:18.5pt">Sanctions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Neither Borrower nor any of its Subsidiaries is&#58; (a) in violation of any Sanctions&#59; or</font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:45.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">a Sanctioned Person. Neither Borrower nor any of its Subsidiaries, or, to Borrower&#8217;s knowledge, its directors, officers, employees, agents or Affiliates&#58; (i) conducts any business or engages in any transaction or dealing with any Sanctioned Person, including making or receiving any contribution of funds, goods or services to or for the benefit of any Sanctioned Person&#59; (ii) deals in, or otherwise engages in any transaction relating to, any property or interests in property blocked pursuant to any Sanctions&#59; (iii) engages in or conspires to engage in any transaction that evades or avoids, or has the purpose of evading or avoiding, or attempts to violate, any of the prohibitions set forth in any Sanctions&#59; or (iv) otherwise engages in any transaction that could cause Bank to violate any Sanctions.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:118pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:28.5pt;text-decoration:underline">AFFIRMATIVE COVENANTS</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrower shall do all of the following&#58;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.25pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.1</font><img alt="image_103.jpg" src="image_103.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Use of Proceeds. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cause the proceeds of the Credit Extensions to be used solely </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">(a)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">as follows&#58; (a)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">for Credit Extensions that occur prior to the First Amendment Effective Date, (i)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">as working capital, (</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">b</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">ii</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">) to fund its</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="padding-left:46pt;padding-right:45.15pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">general business purposes, or (</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">c</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">iii</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">) repayment and payoff of Solar Capital and not for personal, family, household or agricultural purposes</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">, and (b) for Credit Extensions that occur on or after the First Amendment Effective Date, (x)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">as working capital, (y) to fund its general business purposes, or (z) repayment of all Obligations constituting Term</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Loan Advances (as defined in the Agreement prior to the First Amendment Effective Date) outstanding immediately</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">prior to the First Amendment Effective Date.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Government Compliance.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.25pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">Maintain its and all of its Subsidiaries&#8217; legal existence (except as permitted under Section 6.3 with respect to Subsidiaries only) and good standing in their respective jurisdictions of formation and maintain qualification in each jurisdiction in which the failure to so qualify would reasonably be expected to have a material adverse effect on Borrower&#8217;s business or operations. Borrower shall comply, and have each Subsidiary comply, in all material respects, with all material laws, ordinances and regulations to which it is subject.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:45.95pt;padding-right:45.25pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.39pt">Obtain all of the Governmental Approvals necessary for the performance by Borrower and each of its Subsidiaries of their obligations under the Loan Documents to which it is a party, including any grant of a security interest in the Collateral to Bank. Borrower shall promptly provide copies of any such obtained Governmental Approvals to Bank upon Bank&#8217;s request.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Financial Statements, Reports.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deliver to Bank by submitting to the Financial Statement Repository&#58;</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:43.9pt;text-align:justify;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><img alt="image_107.jpg" src="image_107.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:475px"><img alt="image_126.jpg" src="image_126.jpg" style="height:76px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><img alt="image_130.jpg" src="image_130.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:619px"><img alt="image_241.jpg" src="image_241.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:619px"><img alt="image_111.jpg" src="image_111.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:621px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt;text-decoration:underline">Borrowing Base Statement. Only when Advances are outstanding or are being requested</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">by Borrower, a Borrowing Base Statement (and any schedules related thereto and including any other information</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">reasonably requested by Bank with respect to Borrower&#8217;s Accounts) (i) no later than Friday of each week when a</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Streamline Period is not in effect, (ii) within thirty (30) days after the end of each month when a Streamline Period is</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">in effect, and (iii) with each request for an Advance&#59;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:45.05pt;text-align:justify;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><img alt="image_126.jpg" src="image_126.jpg" style="height:76px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:underline">Accounts Receivable Information. Only when Advances are outstanding or are being</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">requested by Borrower, within thirty (30) days after the end of each month, (i) monthly accounts receivable agings,</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">aged by invoice date, (ii) monthly accounts payable agings, aged by invoice date, and outstanding or held check</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">registers, if any, (iii) monthly reconciliations of accounts receivable agings (aged by invoice date), transaction</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">reports, Deferred Revenue report, and general ledger&#59;</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:45.95pt;padding-right:45pt;text-align:justify;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.96pt;text-decoration:line-through">(a)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Quarterly Financial Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. No later than forty-five (45) days after the last day of each of the first three fiscal quarters of Borrower&#8217;s fiscal year, a company prepared consolidated and consolidating balance sheet and income statement covering Borrower&#8217;s and each of its Subsidiary&#8217;s operations for such quarter in a form reasonably acceptable to Bank (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quarterly Financial Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;)&#59; provided that year-end Quarterly Financial Statements shall be delivered no later than ninety (90) days after the last day of each fiscal year of Borrower&#59;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.25pt;text-align:justify;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><img alt="image_172.jpg" src="image_172.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><img alt="image_166.jpg" src="image_166.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:line-through">(b)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Compliance Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Within forty-five (45) days after the last day of each of the first three fiscal quarters of Borrower (and no later than ninety (90) days after the last day of each fiscal year of Borrower), together with the statements set forth in Section 5.3(</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">a</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">c</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">), a duly completed Compliance Statement, confirming that as of the end of such month, Borrower was in full compliance with all of the terms and conditions of this Agreement, </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">and setting forth calculations showing compliance with the financial covenants set forth in this</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement and such other information as Bank may reasonably request,</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">except as noted therein&#59;</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:45.1pt;text-align:justify;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt;text-decoration:line-through">(c)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Annual Operating Budget and Financial Projections</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Within thirty (30) days after the end of each fiscal year of Borrower, and within thirty (30) days of any material updates or amendments thereto, (i) annual operating budgets (including income statements, balance sheets and cash flow statements, by month) for the then-current fiscal year of Borrower, and (ii) annual financial projections for the then-current fiscal year (on a</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:46pt;padding-right:39.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">quarterly basis), in each case as approved by the Board, together with any material related business forecasts used in the preparation of such annual financial projections&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:45.05pt;text-align:justify;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(f)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.01pt;text-decoration:line-through">(d)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Annual Audited Financial Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. As soon as available, and in any event within one hundred and eighty (180) days following the end of Borrower&#8217;s fiscal year, audited consolidated financial statements prepared under GAAP, consistently applied, together with an unqualified opinion on the financial statements from an independent certified public accounting firm reasonably acceptable to Bank&#59;</font></div><div><font><br></font></div><div style="padding-left:45.95pt;padding-right:43.2pt;text-align:justify;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(g)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.39pt;text-decoration:line-through">(e)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">SEC Filings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. In the event that Borrower or any of its Subsidiaries becomes subject to the reporting requirements under the Exchange Act within five (5) Business Days of filing, notification of the filing and copies of all periodic and other reports, proxy statements and other materials filed by Borrower and&#47;or any of its Subsidiaries or any Guarantor with the SEC, any Governmental Authority succeeding to any or all of the functions of the SEC or with any national securities exchange, or distributed to its shareholders, as the case may be. Documents required to be delivered pursuant to the terms hereof (to the extent any such documents are included in materials otherwise filed with the SEC) may be delivered electronically and if so delivered, shall be deemed to have been delivered on the date on which Borrower or any of its Subsidiaries posts such documents, or provides a link thereto, on Borrower&#8217;s or any of its Subsidiaries&#8217; website on the internet at Borrower&#8217;s or any of its Subsidiaries&#8217; website address&#59; provided, however, Borrower shall notify Bank in writing within five (5) Business Days (which may be by electronic mail) of the posting of any such documents&#59;</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.1pt;text-align:justify;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(h)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:line-through">(f)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Security Holder and Subordinated Debt Holder Reports</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Within five (5) Business Days of delivery, copies of all material statements, reports and notices made generally available to Borrower&#8217;s security holders or to any holders of Subordinated Debt (solely in their capacities as security holders or holders of Subordinated Debt and not in any other role)&#59;</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:45.05pt;text-align:justify;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.57pt;text-decoration:line-through">(g)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Beneficial Ownership Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Prompt written notice of any changes to the beneficial ownership information set out in Section 14 of the Perfection Certificate. Borrower understands and acknowledges that Bank relies on such true, accurate and up-to-date beneficial ownership information to meet Bank&#8217;s regulatory obligations to obtain, verify and record information about the beneficial owners of its legal entity customers&#59;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45pt;text-align:justify;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(j)</font><img alt="image_172.jpg" src="image_172.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.57pt;text-decoration:line-through">(h)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Legal Action Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Prompt written notice upon becoming aware of any legal actions, investigations or proceedings pending or threatened in writing against Borrower or any of its Subsidiaries (not otherwise already disclosed on the Perfection Certificate delivered around the </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">First Amendment</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective Date) that could reasonably be expected to result in damages or costs to Borrower or any of its Subsidiaries of, individually or in the aggregate, Seven Hundred Fifty Thousand Dollars ($750,000) or more&#59;</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:42.95pt;text-align:justify;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(k)</font><img alt="image_116.jpg" src="image_116.jpg" style="height:2px;margin-bottom:5pt;vertical-align:text-bottom;width:113px"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:line-through">(i)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tort Claim Notice. If Borrower shall acquire a commercial tort claim with a value that could reasonably be expected to exceed Five Hundred Thousand Dollars ($500,000), Borrower shall promptly notify Bank in a writing signed by Borrower of the general details thereof and, if so requested by Bank, grant to Bank in such writing a security interest therein and in the proceeds thereof, all upon the terms of this Agreement, with such writing to be in form and substance reasonably satisfactory to Bank&#59;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:46pt;padding-right:44.8pt;text-align:justify;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(l)</font><img alt="image_117.jpg" src="image_117.jpg" style="height:2px;margin-bottom:5pt;vertical-align:text-bottom;width:128px"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.57pt;text-decoration:line-through">(j) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government Filings. Within five (5) Business Days after the same are sent by Borrower or received by Borrower, copies of all material correspondence, reports, documents and other filings by Borrower or any of its Subsidiaries with any Governmental Authority regarding compliance with or maintenance of Governmental Approvals or Applicable Law, in each case that could reasonably be expected to have a material effect on any of the Governmental Approvals material to the business of Borrower&#59;</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:45.05pt;text-align:justify;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(m)</font><img alt="image_118.jpg" src="image_118.jpg" style="height:2px;margin-bottom:5pt;vertical-align:text-bottom;width:153px"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:11.57pt;text-decoration:line-through">(k)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Registered Organization. If Borrower is not a Registered Organization as of the Effective Date but later becomes one, promptly notify Bank of such occurrence and provide Bank with Borrower&#8217;s organizational identification number&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:154pt;text-indent:-36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(n)</font><img alt="image_91.jpg" src="image_91.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:15px"><img alt="image_120.jpg" src="image_120.jpg" style="height:2px;margin-bottom:5pt;vertical-align:text-bottom;width:55px"><img alt="image_121.jpg" src="image_121.jpg" style="height:2px;margin-bottom:5pt;vertical-align:text-bottom;width:122px"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt;text-decoration:line-through">(l)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Default. Prompt written notice of the occurrence of a Default or Event of Default&#59; and</font></div><div style="margin-top:9.25pt;padding-left:46pt;padding-right:44.85pt;text-align:justify;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(o)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:line-through">(m)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Information. Promptly, from time to time, such other financial information regarding Borrower or any of its Subsidiaries or compliance with the terms of any Loan Documents as reasonably requested by Bank.</font></div><div><font><br></font></div><div style="padding-left:45.95pt;padding-right:45.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any submission by Borrower of a Compliance Statement, or any other financial statement submitted to the Financial Statement Repository pursuant to this Section 5.3 or otherwise submitted to Bank shall be deemed to be a representation by Borrower that (i) as of the date of such Compliance Statement, or other financial statement, the information and calculations set forth therein are true and correct in all material respects, (ii) as of the end of the compliance period set forth in such submission, Borrower is in complete compliance with all required covenants except as noted in such Compliance Statement, or other financial statement, as applicable, except as noted in such Compliance Statement or other financial statement, as applicable&#59; (iii) as of the date of such submission, no Events of Default have occurred or are continuing, (iv) all representations and warranties other than any representations or warranties that are made as of a specific date in Section 4 remain true and correct in all material respects as of the date of such submission except as noted in such Compliance Statement, or other financial statement, as applicable,</font></div><div style="margin-top:0.2pt;padding-left:46pt;padding-right:45.3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(v) as of the date of such submission, Borrower and each of its Subsidiaries has timely filed all required tax returns and reports, and Borrower has timely paid all foreign, federal, state and local taxes, assessments, deposits and contributions owed by Borrower except as otherwise permitted pursuant to the terms of Section 4.9, and (vi) as of the date of such submission, no Liens have been levied or claims made against Borrower or any of its Subsidiaries relating to unpaid employee payroll or benefits of which Borrower has not previously provided written notification to Bank.</font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.4</font><img alt="image_143.jpg" src="image_143.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt;text-decoration:line-through">Reserved</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Accounts Receivable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:97.1pt;text-indent:-15.15pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.5</font><img alt="image_143.jpg" src="image_143.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:2.65pt;text-decoration:line-through">Reserved.</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:43.05pt;text-align:justify;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><img alt="image_124.jpg" src="image_124.jpg" style="height:169px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt;text-decoration:underline">Schedules and Documents Relating to Accounts. Only when Advances are outstanding or</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">are being requested by Borrower, Borrower shall deliver to Bank transaction reports and schedules of collections, as</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">provided in Section 5.3(b), on Bank&#8217;s standard forms&#59; provided, however, that Borrower&#8217;s failure to execute and</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">deliver the same shall not affect or limit Bank&#8217;s Lien and other rights in all of Borrower&#8217;s Accounts, nor shall Bank&#8217;s</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">failure to advance or lend against a specific Account affect or limit Bank&#8217;s Lien and other rights therein. If</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">requested by Bank, Borrower shall furnish Bank with copies (or, at Bank&#8217;s request, originals) of all contracts, orders,</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">invoices, and other similar documents, and all shipping instructions, delivery receipts, bills of lading, and other</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">evidence of delivery, for any goods the sale or disposition of which gave rise to such Accounts. In addition,</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower shall deliver to Bank, on its request, the originals of all instruments, chattel paper, security agreements,</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">guarantees and other documents and property evidencing or securing any Accounts, in the same form as received,</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">with all necessary indorsements, and copies of all credit memos.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:45.05pt;text-align:justify;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><img alt="image_144.jpg" src="image_144.jpg" style="height:122px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:underline">Disputes. Borrower shall promptly notify Bank of all disputes or claims relating to</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Accounts that continue for more than thirty (30) days and are with respect to an amount in excess of Two Hundred</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Thousand Dollars ($200,000) in the aggregate at such time. Borrower may forgive (completely or partially),</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">compromise, or settle any Account for less than payment in full, or agree to do any of the foregoing so long as (i)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower does so in good faith, in a commercially reasonable manner, in the ordinary course of business, in</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">arm&#8217;s-length transactions, and reports the same to Bank in the regular reports provided to Bank&#59; (ii) no Event of</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Default has occurred and is continuing&#59; and (iii) there shall not be an Overadvance after taking into account all such</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">discounts, settlements and forgiveness.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:45.25pt;text-align:justify;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><img alt="image_126.jpg" src="image_126.jpg" style="height:76px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt;text-decoration:underline">Collection of Accounts. Within sixty (60) days of the First Amendment Effective Date,</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower shall direct Account Debtors to deliver or transmit all proceeds of Accounts into a lockbox account, or</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">such other &#8220;blocked account&#8221; as specified by Bank (either such account, the &#8220;Cash Collateral Account&#8221;). Whether</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">or not an Event of Default has occurred and is continuing, Borrower shall immediately deliver all payments on and</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">proceeds of Accounts to the Cash Collateral Account. Subject to Bank&#8217;s right to maintain a reserve pursuant to</font></div><div style="text-align:justify"><font><br></font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.3pt;text-align:justify"><img alt="image_241.jpg" src="image_241.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:619px"><img alt="image_128.jpg" src="image_128.jpg" style="height:107px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><img alt="image_241.jpg" src="image_241.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:619px"><img alt="image_130.jpg" src="image_130.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:619px"><img alt="image_241.jpg" src="image_241.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:619px"><img alt="image_163.jpg" src="image_163.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:619px"><img alt="image_241.jpg" src="image_241.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:619px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.4(d), all amounts received in the Cash Collateral Account shall be (i) when a Streamline Period is not in</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">effect, applied to immediately reduce the Obligations under the Revolving Line (unless Bank, in its sole discretion,</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">at times when an Event of Default exists, elects not to so apply such amounts), or (ii) when a Streamline Period is in</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">effect, transferred by Bank on a daily basis to Borrower&#8217;s operating account with Bank. Borrower hereby authorizes</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Bank to transfer to the Cash Collateral Account any amounts that Bank reasonably determines are proceeds of the</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Accounts (provided that Bank is under no obligation to do so and this allowance shall in no event relieve Borrower</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">of its obligations hereunder).</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:45pt;text-align:justify;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><img alt="image_126.jpg" src="image_126.jpg" style="height:76px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:underline">Reserves. Notwithstanding any terms in this Agreement to the contrary, at times when a</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Default or an Event of Default exists, Bank may hold any proceeds of the Accounts and any amounts in the Cash</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Collateral Account that are not applied to the Obligations pursuant to Section 5.4(c) above (including amounts</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">otherwise required to be transferred to Borrower&#8217;s operating account with Bank) as a reserve to be applied to any</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Obligations regardless of whether such Obligations are then due and payable.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:43.55pt;text-align:justify;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e)</font><img alt="image_128.jpg" src="image_128.jpg" style="height:107px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt;text-decoration:underline">Returns. Provided no Event of Default has occurred and is continuing, if any Account</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Debtor returns any Inventory to Borrower, Borrower shall promptly (i) determine the reason for such return, (ii)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">issue a credit memorandum to the Account Debtor in the appropriate amount in accordance with Borrower&#8217;s</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">customary business practices, and (iii) provide a copy of such credit memorandum to Bank, upon request from Bank.</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">In the event any attempted return occurs after the occurrence and during the continuance of any Event of Default,</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower shall hold the returned Inventory in trust for Bank, and immediately notify Bank of the return of the</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Inventory.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:154pt;text-align:justify;text-indent:-36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(f)</font><img alt="image_136.jpg" src="image_136.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:478px"><img alt="image_126.jpg" src="image_126.jpg" style="height:76px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><img alt="image_130.jpg" src="image_130.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:619px"><img alt="image_130.jpg" src="image_130.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:619px"><img alt="image_156.jpg" src="image_156.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:622px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.01pt;text-decoration:underline">Verifications&#59; Confirmations&#59; Credit Quality&#59; Notifications. Bank may, from time to time,</font></div><div style="padding-left:46pt;padding-right:43.05pt;text-align:justify"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(i) verify and confirm directly with the respective Account Debtors the validity, amount and other matters relating to</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">the Accounts, either in the name of Borrower or Bank or such other name as Bank may choose, and notify any</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Account Debtor of Bank&#8217;s security interest in such Account and&#47;or (ii) conduct a credit check of any Account Debtor</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">to approve any such Account Debtor&#8217;s credit.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:44.2pt;text-align:justify;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(g)</font><img alt="image_128.jpg" src="image_128.jpg" style="height:107px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:underline">No Liability. Bank shall not be responsible or liable for any shortage or discrepancy in,</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">damage to, or loss or destruction of, any goods, the sale or other disposition of which gives rise to an Account, or for</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">any error, act, omission, or delay of any kind occurring in the settlement, failure to settle, collection or failure to</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">collect any Account, or for settling any Account in good faith for less than the full amount thereof, nor shall Bank be</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">deemed to be responsible for any of Borrower&#8217;s obligations under any contract or agreement giving rise to an</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Account. Nothing herein shall, however, relieve Bank from liability for its own gross negligence or willful</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">misconduct.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:43.75pt;text-align:justify;text-indent:36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.5</font><img alt="image_142.jpg" src="image_142.jpg" style="height:184px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt;text-decoration:underline">Remittance of Proceeds. </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Except as otherwise provided in Section 5.4(c) and Section 7.1, deliver,</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">in kind, all proceeds arising from the disposition of any Collateral to Bank in the original form in which received by</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower not later than the following Business Day after receipt by Borrower, to be applied to the Obligations (a)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">prior to an Event of Default, pursuant to the terms of Section 5.4(c) hereof, and (b) after the occurrence and during</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">the continuance of an Event of Default, pursuant to the terms of Section 8.4 hereof&#59; provided that, if no Event of</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Default has occurred and is continuing, Borrower shall not be obligated to remit to Bank the proceeds of the sale of</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">worn out or obsolete Equipment disposed of by Borrower in good faith in an arm&#8217;s length transaction for an</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">aggregate purchase price of One Hundred Thousand Dollars ($100,000) or less (for all such transactions in any</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">fiscal year). Borrower agrees that it will not commingle proceeds of Collateral with any of Borrower&#8217;s other funds</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">or property, but will hold such proceeds separate and apart from such other funds and property and in an express</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">trust for Bank. Nothing in this Section 5.5 limits the restrictions on disposition of Collateral set forth elsewhere in</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">this Agreement.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Taxes&#59; Pensions.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:44.35pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">Timely file, and require each of its Subsidiaries to timely file (in each case, unless subject to a valid extension), all required tax returns and reports and timely pay, and require each of its Subsidiaries to</font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">timely pay, or file extensions for, all foreign, federal, state and local taxes, assessments, deposits and contributions owed by Borrower and each of its Subsidiaries, except for (deferred payment of any taxes contested pursuant to the terms of Section 4.9(a) hereof, and shall deliver to Bank, on demand, appropriate certificates attesting to such payments, and pay, and require each of its Subsidiaries to pay, all amounts necessary to fund all present pension, profit sharing and deferred compensation plans in accordance with their terms.</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:42.6pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">To the extent Borrower or any of its Subsidiaries defers payment of any contested taxes in excess of Fifty Thousand Dollars ($50,000), (i) notify Bank in writing of the commencement of, and any material development in, the proceedings, and (ii) post bonds or take any other steps required to prevent the Governmental Authority levying such contested taxes from obtaining a Lien upon any of the Collateral that is other than a &#8220;Permitted Lien.&#8221;</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="padding-left:46pt;padding-right:43.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.7</font><img alt="image_143.jpg" src="image_143.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><img alt="image_144.jpg" src="image_144.jpg" style="height:122px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><img alt="image_130.jpg" src="image_130.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:619px"><img alt="image_146.jpg" src="image_146.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:622px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Access to Collateral&#59; Books and Records. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At reasonable times, on </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">three</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">five</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">3)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">) Business Days&#8217; notice (provided no notice is required if an Event of Default has occurred and is continuing), Bank, or its agents, shall have the right to inspect the Collateral and the right to audit and copy Borrower&#8217;s Books. </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">Such</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">The</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Initial Audit shall be completed within ninety (90) days after the First Amendment Effective Date, and Borrower</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">shall cooperate with Bank in order to timely complete same. Thereafter, (i) when Streamline Period is in effect, such</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">inspections and audits shall be conducted </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">during Borrower&#8217;s business hours</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">no more often than once every twelve</font></div><div style="margin-top:0.15pt;padding-left:46pt;padding-right:45.15pt;text-align:justify"><img alt="image_241.jpg" src="image_241.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:619px"><img alt="image_163.jpg" src="image_163.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:619px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12) months</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">, unless an Event of Default has occurred and is continuing, in which case such inspections and audits</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">shall occur as often as Bank shall determine is necessary and (ii) when Streamline Period is not in effect, such</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">inspections and audits shall be conducted no more often than once every six (6) months (or as frequently as Bank</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">determines in its sole discretion that conditions warrant)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, unless an Event of Default has occurred and is continuing, in which case such inspections and audits shall occur as often as Bank shall determine is necessary. The foregoing inspections and audits shall be conducted at Borrower&#8217;s expense and the charge therefor shall be One Thousand Dollars ($1,000) per person per day (or such higher amount as shall represent Bank&#8217;s then-current standard charge for the same), plus reasonable out-of-pocket expenses. In the event Borrower and Bank schedule an audit more than eight (8) days in advance, and Borrower cancels or seeks to or reschedules the audit with less than eight (8) days written notice to Bank, then (without limiting any of Bank&#8217;s rights or remedies) Borrower shall pay Bank a fee of Two Thousand Dollars ($2,000) plus any out-of-pocket expenses incurred by Bank to compensate Bank for the anticipated costs and expenses of the cancellation or rescheduling.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Insurance.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">Keep its business and the Collateral insured for risks and in amounts standard for companies in Borrower&#8217;s industry and location and as Bank may reasonably request. Insurance policies shall be in a form, with financially sound and reputable insurance companies that are not Affiliates of Borrower, and in amounts that are reasonably satisfactory to Bank.</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:45.2pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">All property policies shall have a lender&#8217;s loss payable endorsement showing Bank as lender loss payee. All liability policies shall show, or have endorsements showing, Bank as an additional insured. Bank shall be named as lender loss payee and&#47;or additional insured with respect to any such insurance providing coverage in respect of any Collateral.</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:44pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">Ensure that proceeds payable under any property policy are, at Bank&#8217;s option, payable to Bank on account of the Obligations. Notwithstanding the foregoing, (a) so long as no Event of Default has occurred and is continuing, Borrower shall have the option of applying the proceeds of any casualty policy up to One Million Dollars ($1,000,000) in the aggregate for all losses under all casualty policies in any one year, toward the replacement or repair of destroyed or damaged property&#59; provided that any such replaced or repaired property (i) shall be of equal or like value as the replaced or repaired Collateral and (ii) shall be deemed Collateral in which Bank has been granted a first priority security interest, and (b) after the occurrence and during the continuance of an Event of Default, all proceeds payable under such casualty policy shall, at the option of Bank, be payable to Bank on account of the Obligations.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.25pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">At Bank&#8217;s request, Borrower shall deliver certified copies of insurance policies and evidence of all premium payments. Each provider of any such insurance required under this Section </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">5.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5 shall agree, by endorsement upon the policy or policies issued by it or by independent instruments furnished to Bank, that it will give Bank twenty (20) days (or ten (10) days&#8217; prior written notice in the event of cancellation due to non-payment of premium) prior written notice before any such policy or policies shall be materially altered or canceled. If Borrower fails to obtain insurance as required under this Section 5.8 or to pay any amount or furnish any required proof of payment to third persons and Bank, Bank may make all or part of such payment or obtain such insurance policies required in this Section 5.8, and take any action under the policies Bank deems prudent.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Accounts.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="padding-left:46pt;padding-right:45.05pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">Maintain all of Borrower&#8217;s, any of its Subsidiaries&#8217;, and any Guarantor&#8217;s operating accounts, depository accounts and excess cash with Bank or Bank&#8217;s Affiliates, other than Borrower&#8217;s Foreign Subsidiaries may maintain accounts with third parties other than Bank, provided the aggregate value of such accounts is subject to the terms of Section 6.11 (collectively the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Permitted Foreign Subsidiary Accounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;).</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:43.1pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">In addition to the foregoing, Borrower, any Subsidiary of Borrower and any Guarantor, shall obtain any business credit card, Letter of Credit, FX Contract, and cash management services exclusively from Bank, except (i) third party credit cards, as permitted in the defined term &#8220;Permitted Indebtedness&#8221; part (g)&#59; (ii) Borrower&#8217;s Foreign Subsidiaries may maintain the foregoing bank services with third parties other than Bank, (iii) to the extent that Bank does not have such services in foreign locations, Borrower and its Subsidiaries may maintain the foregoing foreign banking services with third parties other than Bank, and (iv) Borrower may maintain and permit to exist online payment processors used in the ordinary course of business with third parties other than Bank.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:46pt;padding-right:44.85pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">In addition to and without limiting the restrictions in (a), Borrower shall provide Bank five (5) days prior written notice before establishing any Collateral Account at or with any bank or financial institution other than Bank or Bank&#8217;s Affiliates. For each Collateral Account that Borrower at any time maintains, Borrower shall cause the applicable bank or financial institution (other than Bank) at or with which any Collateral Account is maintained to execute and deliver a Control Agreement or other appropriate instrument with respect to such Collateral Account to perfect Bank&#8217;s Lien in such Collateral Account in accordance with the terms hereunder which Control Agreement may not be terminated without the prior written consent of Bank. The provisions of the previous sentence shall not apply to (i) deposit accounts exclusively used for payroll, payroll taxes, and other employee wage and benefit payments to or for the benefit of Borrower&#8217;s employees and identified to Bank by Borrower as such, and (ii) the Permitted Foreign Subsidiary Accounts.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:0.4pt;padding-left:46pt;padding-right:42.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">5.10</font><img alt="image_149.jpg" src="image_149.jpg" style="height:215px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><img alt="image_130.jpg" src="image_130.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:619px"><img alt="image_163.jpg" src="image_163.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:619px"><img alt="image_241.jpg" src="image_241.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:619px"><img alt="image_241.jpg" src="image_241.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:619px"><img alt="image_154.jpg" src="image_154.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:619px"><img alt="image_160.jpg" src="image_160.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:619px"><img alt="image_156.jpg" src="image_156.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:622px"><img alt="image_159.jpg" src="image_159.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:619px"><img alt="image_158.jpg" src="image_158.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:619px"><img alt="image_159.jpg" src="image_159.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:619px"><img alt="image_160.jpg" src="image_160.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:619px"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:14.63pt;text-decoration:line-through">Reserved.</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Financial Covenant (Net Revenue). </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">When a Financial Covenant Measuring Period is</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">in effect, Borrower shall achieve Net Revenue (measured in accordance with GAAP on a trailing six (6) month</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">basis), tested quarterly on the last day of each calendar quarter, in an amount equal to or greater than the levels to be</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">agreed upon between Borrower and Bank with respect to which Borrower hereby agrees&#58; (i) shall be documented in</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">an amendment to this Agreement, in form and substance acceptable to Bank, which amendment shall be executed no</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">later than February 28</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">th</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"> of each year beginning with February 28, 2024 with Borrower&#8217;s failure to enter into such</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> amendment to this Agreement to reset such covenant levels on or prior to February 28</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">th </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">of each year shall be an immediate and non-curable Event of Default hereunder&#59; (ii) shall be based on Borrower&#8217;s projections delivered to </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Bank in accordance with Section 5.3(e) hereof and acceptable to Bank in its commercially reasonable discretion with</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> such projections for Borrower&#8217;s 2024 fiscal year showing annual Net Revenue of not less than </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;***&#93;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Notwithstanding anything to the contrary herein, if a Financial Covenant Measuring Period is occurring at any point between January 1, 2024 and February 28, 2024, then Borrower&#8217;s Net Revenue (measured in accordance with GAAP on a trailing six (6) month basis) for the period ending December 31, </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2023 shall be tested and such Net Revenue shall not be less than </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;***&#93;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Dollars.</font></div><div style="margin-top:4.55pt;padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:18.5pt">Protection of Intellectual Property Rights.</font></div><div><font><br></font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:43.2pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">(i) Use commercially reasonable efforts to protect, defend and maintain the validity and enforceability of Borrower&#8217;s and each Subsidiary&#8217;s Intellectual Property, except to the extent that such failure to do so would not reasonably be expected to have a material adverse effect on Borrower&#8217;s business or operations or that such Intellectual Property does not have material value&#59; (ii) promptly advise Bank in writing of infringements or any other event that could reasonably be expected to materially and adversely affect the value Borrower&#8217;s and each Subsidiary&#8217;s Intellectual Property that has material value&#59; and (iii) not allow any Intellectual Property material to Borrower&#8217;s or any Subsidiary&#8217;s business to be abandoned, forfeited or dedicated to the public without Bank&#8217;s written consent.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:44.4pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Provide written notice to Bank within thirty (30) days of entering or becoming bound by any Restricted License (other than over-the-counter software that is commercially available to the public). Borrower shall take such commercially reasonable steps as Bank requests to obtain the consent of, or waiver by, any person whose consent or waiver is necessary for (i) any such Restricted License to be deemed &#8220;Collateral&#8221; and for Bank to have a security interest in it that might otherwise be restricted or prohibited by law or by the terms of any such Restricted License, whether now existing or entered into in the future, and (ii) Bank to have the ability in the event of a liquidation of any Collateral to dispose of such Collateral in accordance with Bank&#8217;s rights and remedies under this Agreement and the other Loan Documents.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:8.5pt">Litigation Cooperation. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">From the date hereof and continuing through the termination of this Agreement, make available to Bank, without expense to Bank, Borrower and its officers, employees and agents and Borrower&#8217;s books and records, to the extent that Bank may deem them reasonably necessary to prosecute or defend any third-party suit or proceeding instituted by or against Bank with respect to any Collateral or relating to Borrower.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:18.5pt">Reserved.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:46pt;padding-right:44.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:8.5pt">Formation or Acquisition of Subsidiaries. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notwithstanding and without limiting the negative covenants contained in Sections 6.3 and 6.7 hereof, at the time that Borrower or any Guarantor forms any Subsidiary or acquires any Subsidiary after the Effective Date (including, without limitation, pursuant to a Division), Borrower and such Guarantor shall (a) cause such new Subsidiary to provide to Bank a joinder to this Agreement to become a co-borrower hereunder or a guaranty to become a Guarantor hereunder (as determined by Bank in its sole discretion), together with documentation, all in form and substance satisfactory to Bank (including being sufficient to grant Bank a first priority Lien (subject to Permitted Liens) in and to the assets of such newly formed or acquired Subsidiary that constitute Collateral), (b) provide to Bank appropriate certificates and powers and financing statements, pledging (i) all of the direct or beneficial ownership interest in such new Subsidiary, in form and substance reasonably satisfactory to Bank&#59; and (c) provide to Bank all other documentation in form and substance reasonably satisfactory to Bank, including one or more opinions of counsel satisfactory to Bank, which in its opinion is appropriate with respect to the execution and delivery of the applicable documentation referred to above. Any document, agreement, or instrument executed or issued pursuant to this Section 5.14 shall be a Loan Document.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:45.2pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:8.5pt">Inventory&#59; Returns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Keep all Inventory in good and marketable condition, free from material defects. Returns and allowances between Borrower and its Account Debtors shall follow Borrower&#8217;s customary practices as they exist at the Effective Date. Borrower shall promptly notify Bank of all returns, recoveries, disputes and claims that involve more than Two Hundred Fifty Thousand Dollars ($250,000) (measured as to any single return, recovery, dispute or claim, and not in the aggregate at such time).</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:45.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:8.5pt">Further Assurances. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Execute any further instruments and take such further action as Bank reasonably requests to perfect, protect, ensure the priority of or continue Bank&#8217;s Lien on the Collateral or to affect the purposes of this Agreement.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:8.5pt">Sanctions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. (a) Not, and not permit any of its Subsidiaries to, engage in any of the activities described in Section 4.11 in the future&#59; (b) not, and not permit any of its Subsidiaries to, become a Sanctioned Person&#59; (c) ensure that the proceeds of the Obligations are not used to violate any Sanctions&#59; and (d) deliver to Bank</font></div><div style="text-align:justify"><font><br></font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any certification or other evidence requested from time to time by Bank in its sole discretion, confirming each such Person&#8217;s compliance with this Section 5.17. In addition, have implemented, and will consistently apply while this Agreement is in effect, reasonable procedures to ensure that the representations and warranties in Section 4.11 remain true and correct while this Agreement is in effect.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:18.5pt">Post-Closing Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:44.35pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><img alt="image_53.jpg" src="image_53.jpg" style="height:92px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><img alt="image_162.jpg" src="image_162.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:619px"><img alt="image_163.jpg" src="image_163.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:619px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">As soon as possible, but in any event not later than the date that is </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">fifteen</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">thirty</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">15</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">30</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">) days after the </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">First Amendment</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective Date, Borrower shall deliver to Bank </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">a duly executed landlord&#8217;s consent in</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">favor of Bank for Borrower&#8217;s leased location at 2380-2390 Owen Street, Santa Clara, CA 95954</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">evidence</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">satisfactory to Bank that the insurance policies and endorsements required by Section 5.8 hereof are in full force and</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">effect, together with appropriate evidence showing lender loss payable and additional insured clauses or</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">endorsements in favor of Bank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:43.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(b)</font><img alt="image_164.jpg" src="image_164.jpg" style="height:61px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.78pt">As soon as possible, but in any event not later than the date that is </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">thirty</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">five</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">30</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">) days after the </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">First Amendment</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective Date, Borrower shall deliver to Bank a duly executed </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">bailee&#8217;s waiver in favor of</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">Bank for the bailee location at 1125 W. Pinnacle Peak Road, Phoenix, AZ 85027, where Borrower maintains</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">property with a third party</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Control Agreement with U.S. Bank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:28.5pt;text-decoration:underline">NEGATIVE COVENANTS</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrower shall not do any of the following without Bank&#8217;s prior written consent&#58;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Dispositions. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convey, sell, lease, transfer, assign, or otherwise dispose of (including, without limitation, pursuant to a Division) (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), or permit any of its Subsidiaries to Transfer, all or any part of its business or property, except for Transfers (a) of Inventory in the ordinary course of business&#59; (b) of worn-out, surplus or obsolete Equipment that is, in the reasonable judgment of Borrower, no longer economically practicable to maintain or useful in the ordinary course of business of Borrower&#59; (c) consisting of Permitted Liens and Permitted Investments&#59; (d) consisting of the sale or issuance of any stock, partnership, membership, or other ownership interest or other equity securities of Borrower permitted under Section 6.2 of this Agreement&#59; (e) consisting of Borrower&#8217;s or its Subsidiaries&#8217; use or transfer of money or Cash Equivalents in a manner that is not prohibited by the terms of this Agreement or the other Loan Documents, including without limitation cash returns or refunds of customer payments&#59; (f) of non-exclusive licenses for the use of the property of Borrower or its Subsidiaries in the ordinary course of business, and other licenses permitted pursuant to part (h) of the defined Permitted Liens&#59; (g) other Transfers not to exceed One Hundred Thousand Dollars ($100,000) in any twelve (12) month period&#59; and (h) other Transfers in which Borrower will receive cash proceeds in an amount equal to no less than seventy-five percent (75%) of such other Transfer consideration (fixed or contingent) paid or payable to Borrower or its Subsidiary.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:46pt;padding-right:39.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the avoidance of doubt, none of (a) the sale of any Permitted Convertible Indebtedness, (b) the sale of any Warrant Transaction, (c) the purchase of any Bond Hedge Transaction or (d) the performance by Borrower of its obligations under any Permitted Convertible Indebtedness, any Warrant Transaction or any Bond Hedge Transaction (including the settlement or termination of any Bond Hedge Transaction or Warrant Transaction) shall constitute a Transfer.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:45.95pt;padding-right:45.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.55pt">Changes in Business, Management, Control, or Business Locations. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) Engage in or permit any of its Subsidiaries to engage in any business other than the businesses currently engaged in by Borrower and such Subsidiary, as applicable, or reasonably related thereto&#59; (b) liquidate or dissolve or permit any of its Subsidiaries to </font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="padding-left:45.95pt;padding-right:45.15pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">liquidate or dissolve (unless such Subsidiary&#8217;s assets are transferred to Borrower)&#59; (c) fail to provide notice to Bank of any Key Person departing from or ceasing to be employed by Borrower within seven (7) Business Days after such Key Person&#8217;s departure from Borrower&#59; (d) permit, allow or suffer to occur any Change in Control&#59;</font></div><div style="margin-top:0.1pt;padding-left:46pt;padding-right:42.9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e) without at least ten (10) days prior written notice to Bank, (i) add any new offices or business locations, including warehouses (unless such new offices or business locations contain less than Two Hundred Thousand Dollars</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($200,000) in Borrower&#8217;s assets or property) or deliver any portion of the Collateral valued, individually or in the aggregate, in excess of Two Hundred Thousand Dollars ($200,000) to a bailee at a location other than to a bailee and at a location already disclosed in the Perfection Certificate, or (f) without at least twenty (20) days prior written notice to Bank (i) change its jurisdiction of organization, (ii) change its organizational structure or type, (iii) change its legal name, or, (iv) change any organizational number (if any) assigned by its jurisdiction of organization. If Borrower intends to add any new offices or business locations, including warehouses, containing in excess of Two Hundred Thousand Dollars ($200,000) of Borrower&#8217;s assets or property, then Borrower will cause the landlord of any such new offices or business locations, including warehouses, to execute and deliver a landlord consent in form and substance reasonably satisfactory to Bank. If Borrower intends to deliver any portion of the Collateral valued, individually or in the aggregate, in excess of Two Hundred Thousand Dollars ($200,000) to a bailee, and Bank and such bailee are not already parties to a bailee agreement governing both the Collateral and the location to which Borrower intends to deliver the Collateral, then Borrower will cause such bailee to execute and deliver a bailee agreement in form and substance reasonably satisfactory to Bank. For the avoidance of doubt, no landlord or bailee waivers shall be required for or with respect to any foreign locations of Borrower or its Subsidiaries.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:45.95pt;padding-right:45.2pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.55pt">Mergers or Acquisitions. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merge or consolidate, or permit any of its Subsidiaries to merge or consolidate, with any other Person, or acquire, or permit any of its Subsidiaries to acquire, all or substantially all of the stock, partnership, membership, or other ownership interest or other equity securities or property of another Person (including, without limitation, by the formation of any Subsidiary or pursuant to a Division), except (i) if (a) Borrower has complied with the notice requirements applicable to prepayments hereunder, and (b) prior to or contemporaneously with the closing of such transaction, all Obligations are paid in full in cash, and all of Bank&#8217;s obligations to lend to Borrower under this Agreement are terminated, and&#47;or (iii) Permitted Acquisitions. A Subsidiary may merge or consolidate into another Subsidiary or into Borrower.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Indebtedness. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Create, incur, assume, or be liable for any Indebtedness, or permit any Subsidiary to do so, other than Permitted Indebtedness.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:43.3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Encumbrance. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Create, incur, allow, or suffer to exist any Lien on any of its property, or assign or convey any right to receive income, including the sale of any Accounts, or permit any of its Subsidiaries to do so, in each case as to the foregoing except for Permitted Liens, permit any Collateral not to be subject to the first priority security interest granted herein, other than Permitted Liens, or enter into any agreement, document, instrument or other arrangement (except with or in favor of Bank) with any Person which directly or indirectly prohibits or has the effect of prohibiting Borrower or any Subsidiary from assigning, mortgaging, pledging, granting a security interest in or upon, or encumbering any of Borrower&#8217;s or any Subsidiary&#8217;s Intellectual Property, except as is otherwise permitted in Section 6.1 hereof and the definition of &#8220;Permitted Liens&#8221; herein.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Maintenance of Collateral Accounts. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maintain any Collateral Account except pursuant to the terms of Section 5.9(c).</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:45.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Distributions&#59; Investments. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) Pay any dividends or make any distribution or payment or redeem, retire or purchase any stock, partnership, membership, or other ownership interest or other equity securities, provided that Borrower may (i) convert any of its convertible securities into other securities pursuant to the terms of such convertible securities or otherwise in exchange thereof, (ii) pay dividends solely in common stock or equity interests, (iii) repurchase the stock of former employees, officers, directors or consultants pursuant to stock repurchase agreements or termination of employment or service or repurchases pursuant to rights of first refusal in Borrower&#8217;s bylaws, so long as an Event of Default does not exist at the time of any such repurchase and would not exist after giving effect to any such repurchase&#59; provided the aggregate amount of all such repurchases shall not exceed Five Hundred Thousand Dollars ($500,000) per fiscal year, (iv) pay cash distributions in lieu of issuing fractional shares&#59; provided the aggregate amount of all such payments shall not exceed Two Hundred Thousand Dollars ($200,000) per fiscal year , (v) distribute equity securities to former or current employees, officers, consultants or directors pursuant to the exercise of employee stock options approved by the Board, (vi) pay, in connection with any Permitted Acquisition by Borrower or any of its Subsidiaries, (A) the receipt or acceptance of the return to Borrower or any of its Subsidiaries of stock or equity interests of Borrower constituting a portion of the</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.15pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">purchase price consideration in settlement of indemnification claims, or as a result of a purchase price adjustment (including earn-outs or similar obligations) and (B) payments or distributions to equity holders pursuant to appraisal </font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="padding-left:46pt;padding-right:45.15pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">rights required under requirements of law&#59; (vii) the distribution of rights pursuant to any shareholder rights plan or the redemption of such rights for nominal consideration in accordance with the terms of any shareholder rights plan, and (viii) for the avoidance of doubt, Subsidiaries of Borrower shall be permitted to, directly or indirectly, pay dividends or make distributions to other Subsidiaries or to Borrower, or (b) directly or indirectly make any Investment (including, without limitation, by the formation of any Subsidiary) other than Permitted Investments, or permit any of its Subsidiaries to do so.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:45.95pt;padding-right:43.05pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, or anything to the contrary herein, and for the avoidance of doubt, this Section 6.7 shall not prohibit (i) the conversion by holders of (including any cash payment upon conversion), or required payment of any principal or premium on, or required payment of any interest with respect to, any Permitted Convertible Debt, in each case, in accordance with the terms of the indenture governing such Permitted Convertible Debt&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">that the preceding sentence shall only allow principal payments with respect to any repurchase in connection with the redemption of Permitted Convertible Debt upon satisfaction of a condition related to the stock price of the Borrower&#8217;s common stock if the Redemption Conditions are satisfied in respect of such redemption&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">provided further </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">that, to the extent both (a) the aggregate amount of cash payable upon conversion or redemption of any Permitted Convertible Debt (excluding any required payment of interest with respect to such Permitted Convertible Debt and excluding any payment of cash in lieu of a fractional share due upon conversion thereof) exceeds the aggregate principal amount thereof and (b) such conversion or redemption does not trigger or correspond to an exercise or early unwind or settlement of a corresponding portion of the Bond Hedge Transactions constituting Permitted Call Spread Agreements relating to such Permitted Convertible Debt (including, for the avoidance of doubt, the case where there is no Bond Hedge Transaction constituting a Permitted Call Spread Agreement relating to such Permitted Convertible Debt), the payment of such excess cash (any such payment, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Excess Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) shall not be permitted by this clause (i)&#59; and (ii) any required payment with respect to (including, for the avoidance of doubt, the payment of the relevant premium for the purchase thereof), or required early unwind or settlement of, any Permitted Call Spread Agreement, in each case, in accordance with the terms of the agreement governing such Permitted Call Spread Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">that, to the extent cash is required to be paid under a Warrant Transaction as a result of the election of &#8220;cash settlement&#8221; (or substantially equivalent term) as the &#8220;settlement method&#8221; (or substantially equivalent term) thereunder by the Borrower (or its Affiliate) (including in connection with the exercise and&#47;or early unwind or settlement thereof), the payment of such cash shall not be permitted by this clause (ii). Notwithstanding the foregoing, the Borrower may repurchase, exchange or induce the conversion of Permitted Convertible Debt by delivery of shares of the Borrower&#8217;s common stock and&#47;or a different series of Permitted Convertible Debt (which series (I) matures after, and does not require any scheduled amortization or other scheduled payments of principal prior to, the analogous date under the indenture governing the Permitted Convertible Debt that are so repurchased, exchanged or converted and (II) has terms, conditions and covenants that are commercially reasonable to the Borrower (as determined by the Borrower in good faith) (any such series of Permitted Convertible Debt, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Refinancing Convertible Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) and&#47;or by payment of cash (x) in lieu of any fractional shares, (y) in respect of accrued and unpaid interest of such Permitted Convertible Debt and (z) additional cash in an amount that does not exceed the proceeds received by the Borrower from the substantially concurrent issuance of shares of the Borrower&#8217;s common stock and&#47;or a Refinancing Convertible Debt plus the net cash proceeds, if any, received by the Borrower pursuant to the related exercise or early unwind or termination of the related Permitted Call Spread Agreements pursuant to the immediately following proviso&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">that, substantially concurrently with, or a commercially reasonable period of time before or after, the related settlement date for the Permitted Convertible Debt that is so repurchased, exchanged or converted, the Borrower shall (and, for the avoidance of doubt, shall be permitted under this Section 7.7 to) exercise or unwind or terminate early (whether in cash, shares or any combination thereof) the portion of the Permitted Call Spread Agreements, if any, corresponding to such Permitted Convertible Debt that is so repurchased, exchanged or converted.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:46pt;padding-right:43.3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Transactions with Affiliates. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Directly or indirectly enter into or permit to exist any material transaction with any Affiliate of Borrower, except for (a) transactions that are in the ordinary course of Borrower&#8217;s business, upon fair and reasonable terms that are no less favorable to Borrower than would be obtained in an arm&#8217;s length transaction with a non-affiliated Person&#59; (b) sales of Borrower&#8217;s equity securities to the then-existing investors</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:46pt;padding-right:44.45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">of Borrower in connection with a bona fide equity financing by the Board so long as such sale shall not result in a violation of the Change of Control provision in Section 6.2, (c) debt financings from Borrower&#8217;s investors so long as all such Indebtedness shall constitute Subordinated Debt, (d) reasonable and customary compensation arrangements and benefit plans for officers, and other employees of Borrower approved by the Board, (e) reasonable and customary compensation arrangements for fees and costs paid to members of the Board in the ordinary course of business, and (f) Investments of the type described in and permitted under clauses (g) and&#47;or (h) of the definition of &#8220;Permitted Investments&#8221; herein.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:44.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Subordinated Debt. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Except as expressly permitted under the terms of the subordination, intercreditor, or other similar agreement to which any Subordinated Debt is subject&#58; (a) make or permit any payment on such Subordinated Debt&#59; (b) amend any provision in any document relating to such Subordinated Debt which would increase the amount thereof, or (c) provide for earlier or greater principal, interest, or other payments </font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:44.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">thereon, or adversely affect the subordination thereof to Obligations owed to Bank in contravention of the terms of such the subordination, intercreditor, or other similar agreement.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:8.5pt">Compliance. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) Become an &#8220;investment company&#8221; or a company controlled by an &#8220;investment company&#8221;, under the Investment Company Act of 1940, as amended, or undertake as one of its important activities extending credit to purchase or carry margin stock (as defined in Regulation U of the Board of Governors of the Federal Reserve System), or use the proceeds of any Credit Extension for that purpose&#59; (b)(i) fail to meet the minimum funding requirements of ERISA, (ii) permit a Reportable Event or Prohibited Transaction, as defined in ERISA, to occur, (iii) fail to comply with the Federal Fair Labor Standards Act or (iv) violate any other law or regulation, if the foregoing subclauses (i) through (iv), individually or in the aggregate, could reasonably be expected to have a material adverse effect on Borrower&#8217;s business or operations, or permit any of its Subsidiaries to do so&#59; or (c) withdraw or permit any Subsidiary to withdraw from participation in, permit partial or complete termination of, or permit the occurrence of any other event with respect to, any present pension, profit sharing and deferred compensation plan which could reasonably be expected to result in any material liability of Borrower, including any material liability to the Pension Benefit Guaranty Corporation or its successors or any other Governmental Authority.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.25pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:8.5pt">Cash and Cash Equivalents held by Foreign Subsidiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. The aggregate value of cash and Cash Equivalents held by all Foreign Subsidiaries of Borrower to exceed Two Million Five Hundred Thousand Dollars ($2,500,000) for more than five (5) Business Days in each calendar month.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:45.3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:8.5pt">Value of Assets held by Foreign Subsidiaries. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The aggregate value of the assets owned by the Foreign Subsidiaries of Borrower shall not exceed twenty percent (20%) of the aggregate value of all assets owned by the Borrower and its Subsidiaries.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:8.5pt">Redemption of Permitted Convertible Debt. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise any redemption right with respect to any Permitted Convertible Debt upon satisfaction of a condition related to the stock price of the Borrower&#8217;s common stock, unless the Redemption Conditions are satisfied in respect of such redemption.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:28.5pt;text-decoration:underline">EVENTS OF DEFAULT</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any one of the following shall constitute an event of default (an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Event of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) under this Agreement&#58;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.1</font><img alt="image_166.jpg" src="image_166.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Payment Default. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrower fails to (a) make any payment of principal or interest on any Credit Extension on its due date, or (b) pay any other Obligations within three (3) Business Days after such Obligations are due and payable (which three (3) Business Day cure period shall not apply to payments due on the </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Line</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Maturity Date or</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan Maturity Date), in each unless such late payment is due to Bank&#8217;s failure to auto-debit such payment when sufficient funds were contained in the Designated Deposit Account (or if insufficient funds are contained therein, or if an Event of Default has occurred and is continuing, any of Borrower&#8217;s other accounts at</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:46pt;padding-right:46.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank). During the cure period, the failure to make or pay any payment specified under clause (b) hereunder is not an Event of Default (but no Credit Extension will be made during the cure period)&#59;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Covenant Default.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:45.95pt;padding-right:45.15pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.96pt">Borrower fails or neglects to perform any obligation in Section 5 (other than Sections 5.2 (Government Compliance), 5.12 (Litigation Cooperation), 5.15 (Inventory&#59; Returns) and 5.16 (Further Assurances)) or violates any covenant in Section 6&#59; or</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:44.1pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><img alt="image_166.jpg" src="image_166.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Borrower fails or neglects to perform, keep, or observe any other term, provision, condition, covenant or agreement contained in this Agreement or any Loan Documents, and as to any default (other than those specified in this Section 7) under such other term, provision, condition, covenant or agreement that can be cured, has failed to cure the default within ten (10) days after the occurrence thereof&#59; provided, however, that if the default cannot by its nature be cured within the ten (10) day period or cannot after diligent attempts by Borrower be cured within such ten (10) day period, and such default is likely to be cured within a reasonable time, then Borrower shall have an additional period (which shall not in any case exceed thirty (30) days) to attempt to cure such default, and within such reasonable time period the failure to cure the default shall not be deemed an Event of Default (but no Credit Extensions shall be made during such cure period). Cure periods provided under this section shall not apply</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through"> to</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">, among other things, to financial covenants or any other covenants that are required to be satisfied,</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">completed or tested by a date certain or</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any covenants set forth in </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">Section 7.2(a)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">clause (a)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">above&#59;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="margin-top:4.55pt;padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Material Adverse Change. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A Material Adverse Change occurs&#59;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Attachment&#59; Levy&#59; Restraint on Business.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:45.95pt;padding-right:43.45pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.96pt">(i) The service of process seeking to attach, by trustee or similar process, any funds of Borrower or any Subsidiary with a value in excess of Two Hundred Thousand Dollars ($200,000), or (ii) a notice of lien or levy in an amount in excess of Two Hundred Thousand Dollars ($200,000), is filed against any of Borrower&#8217;s or any of its Subsidiaries&#8217; assets by any Governmental Authority, and the same under subclauses (i) and (ii) hereof are not, within fifteen (15) days after the occurrence thereof, discharged or stayed (whether through the posting of a bond or otherwise)&#59; provided, however, no Credit Extensions shall be made during any fifteen (15) day cure period&#59; or</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.05pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">(i) any material portion of Borrower&#8217;s or any of its Subsidiaries&#8217; assets with a value in excess of Two Hundred Thousand Dollars ($200,000), is attached, seized, levied on, or comes into possession of a trustee or receiver, or (ii) any court order enjoins, restrains, or prevents Borrower or any of its Subsidiaries from conducting all or any material part of its business&#59;</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:46pt;padding-right:44.95pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Insolvency. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) Borrower or Borrower and of its Subsidiaries (taken as a whole) is unable to pay its debts (including trade debts) as they become due or otherwise becomes insolvent&#59; (b) Borrower or any of its Subsidiaries begins an Insolvency Proceeding&#59; or (c) an Insolvency Proceeding is begun against Borrower or any of its Subsidiaries and is not dismissed or stayed within forty-five (45) days (but no Credit Extensions shall be made while any of the conditions described in clause (a) exist and&#47;or until any Insolvency Proceeding is dismissed)&#59;</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Other Agreements. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">There is, under any agreement to which Borrower, any of Borrower&#8217;s Subsidiaries, or any Guarantor is a party with a third party or parties, (a) any default by Borrower (after applicable grace and&#47;or cure periods) resulting in a right by such third party or parties, whether or not exercised, to accelerate the maturity of any Indebtedness in an amount individually or in the aggregate in excess of Five Hundred Thousand Dollars ($500,000)&#59; or (b) any breach or default by Borrower, any of Borrower&#8217;s Subsidiaries, or Guarantor the result of which could reasonably be expected to have a material adverse effect on Borrower&#8217;s, any of Borrower&#8217;s Subsidiaries&#8217;, or any Guarantor&#8217;s business or operations (taken as a whole)</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:43.2pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Judgments&#59; Penalties. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One or more fines, penalties or final judgments, orders or decrees for the payment of money in an amount, individually or in the aggregate, of at least Five Hundred Thousand Dollars ($500,000)(not covered by independent third-party insurance as to which liability has been accepted by such insurance carrier) shall be rendered against Borrower or any of its Subsidiaries by any Governmental Authority, and the same are not, within ten (10) days after the entry, assessment or issuance thereof, discharged, satisfied or paid, or after execution thereof, or stayed pending appeal, or such judgments are not discharged, satisfied or paid prior to the expiration of any such stay (provided that no Credit Extensions will be made prior to the discharge, satisfaction, payment, or stay of such fine, penalty, judgment, order or decree)&#59;</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:46pt;padding-right:44.25pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Misrepresentations. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrower or any of its Subsidiaries or any Responsible Person acting for Borrower or any of its Subsidiaries knowingly makes any representation, warranty, or other statement now or later in this Agreement, any Loan Document or in any writing delivered to Bank or to induce Bank to enter this Agreement or any Loan Document, and such representation, warranty, or other statement is incorrect in any material respect when made (it being agreed and acknowledged by Bank that the projections and forecasts provided by Borrower or any of its Subsidiaries in good faith and based upon reasonable assumptions are not viewed as facts and that actual results during the period or periods covered by such projections and forecasts may differ from the projected or forecasted results)&#59;</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:44.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Subordinated Debt. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If&#58; (a) any document, instrument, or agreement evidencing any Subordinated Debt shall for any reason be revoked or invalidated or otherwise cease to be in full force and effect (other than in accordance with the terms of such document, instrument or agreement) or any Person (other than Bank)) shall be in breach thereof or contest in any manner the validity or enforceability thereof or deny that it has any further liability or obligation thereunder&#59; (b) a default or event of default (however defined) has occurred under any document, instrument, or agreement evidencing any Subordinated Debt, which default shall not have been cured or waived within any applicable grace period&#59; or (c) the Obligations shall for any reason be subordinated or shall not have the priority contemplated by the applicable subordination or intercreditor agreement&#59;</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Lien Priority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. There is a material impairment in the perfection or priority of Bank&#8217;s security interest in the Collateral (unless such failure is caused by Bank&#8217;s gross negligence or willful misconduct)&#59;</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:45.95pt;padding-right:43.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.55pt">Guaranty. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) Any guaranty of any Obligations terminates or ceases for any reason to be in full force and effect (except due to termination in accordance with the terms of such guaranty)&#59; (b) any Guarantor does not perform any material obligation or covenant under any guaranty of the Obligations&#59; (c) any circumstance described in Sections 7.3, 7.4, 7.5, 7.6, 7.7, or 7.8 of this Agreement occurs with respect to any Guarantor (subject </font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="padding-left:45.95pt;padding-right:43.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to the applicable cure and grace periods herein), (d) the death, liquidation, winding up, or termination of existence of any Guarantor&#59; or (e)a material impairment in the perfection or priority of Bank&#8217;s Lien in the collateral provided by Guarantor or in the value of such collateral &#59; or</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:45.95pt;padding-right:45.3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.55pt">Governmental Approvals. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any Governmental Approval shall have been (a) revoked, rescinded, suspended, modified in an adverse manner or not renewed in the ordinary course for a full term or (b) subject to any decision by a Governmental Authority that designates a hearing with respect to any applications for renewal of any of such Governmental Approval or that could result in the Governmental Authority taking any of the actions described in clause (a) above, and such decision or such revocation, rescission, suspension, modification or non-renewal (i) causes, or could reasonably be expected to cause, a Material Adverse Change, or (ii) materially and adversely affects the legal qualifications of Borrower or any of its Subsidiaries to hold such Governmental Approval in any applicable jurisdiction and such revocation, rescission, suspension, modification or non-renewal could reasonably be expected to materially and adversely affect the status of or legal qualifications of Borrower or any of its Subsidiaries to hold any Governmental Approval in any other jurisdiction that is material to the operation of Borrower&#8217;s business.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:28.5pt;text-decoration:underline">BANK&#8217;S RIGHTS AND REMEDIES</font></div><div><font><br></font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:45.15pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Rights and Remedies. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upon the occurrence and during the continuance of an Event of Default, Bank may, without notice or demand, do any or all of the following&#58;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:43.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">declare all Obligations immediately due and payable (but if an Event of Default described in Section 7.5 occurs all Obligations are immediately due and payable without any action by Bank)&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:43.15pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">stop advancing money or extending credit for Borrower&#8217;s benefit under this Agreement or under any other agreement between Borrower and Bank&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:43.1pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">demand that Borrower (i) deposit cash with Bank in an amount equal to at least (A) one hundred and five percent (105.0%) of the aggregate face amount of any Letters of Credit denominated in Dollars remaining undrawn, and (B) one hundred and fifteen percent (115.0%) of the Dollar Equivalent of the aggregate face amount of any Letters of Credit denominated in a Foreign Currency remaining undrawn (plus, in each case, all interest, fees, and costs due or estimated by Bank to become due in connection therewith), to secure all of the Obligations relating to such Letters of Credit, as collateral security for the repayment of any future drawings under such Letters of Credit, and Borrower shall forthwith deposit and pay such amounts, and (ii) pay in advance all letter of credit fees scheduled to be paid or payable over the remaining term of any Letters of Credit&#59;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:43.4pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">terminate any FX Contracts (it being understood and agreed that (i) Bank is not obligated to deliver the currency which Borrower has contracted to receive under any FX Contract, and Bank may cover its exposure for any FX Contracts by purchasing or selling currency in the interbank market as Bank deems appropriate&#59;</font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:44.9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ii) Borrower shall be liable for all losses, damages, costs, margin obligations and expenses incurred by Bank arising from Borrower&#8217;s failure to satisfy its obligations under any FX Contract or the execution of any FX Contract&#59; and</font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:45.15pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(iii) Bank shall not be liable to Borrower for any gain in value of a FX Contract that Bank may obtain in covering Borrower&#8217;s breach)&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:45pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">verify the amount of, demand payment of and performance under, and collect any Accounts and General Intangibles, settle or adjust disputes and claims directly with Account Debtors for amounts on terms and in any order that Bank considers advisable, and notify any Person owing Borrower money of Bank&#8217;s security interest in such funds&#59;</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:45.3pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.01pt">make any payments and do any acts it considers necessary or reasonable to protect the Collateral and&#47;or its security interest in the Collateral. Borrower shall assemble the Collateral if Bank requests and make it available as Bank designates. Bank may enter premises where the Collateral is located, take and maintain possession of any part of the Collateral, and pay, purchase, contest, or compromise any Lien which appears to be prior or superior to its security interest and pay all expenses incurred. Borrower grants Bank a license to enter and occupy any of its premises, without charge, to exercise any of Bank&#8217;s rights or remedies&#59;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:46pt;padding-right:44pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">apply to the Obligations any (i) balances and deposits of Borrower it holds, or (ii) amount held by Bank owing to or for the credit or the account of Borrower&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:45.25pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">ship, reclaim, recover, store, finish, maintain, repair, prepare for sale, advertise for sale, and sell the Collateral. For use solely upon the occurrence and during the continuation of an Event of Default, Bank is hereby granted a non-exclusive, royalty-free license or other right to use, without charge, Borrower&#8217;s labels, </font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:45.25pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents, Copyrights, mask works, rights of use of any name, trade secrets, trade names, Trademarks, and advertising matter, or any similar property as it pertains to the Collateral, in completing production of, advertising for sale, and selling any Collateral and, in connection with Bank&#8217;s exercise of its rights under this Section 8.1, Borrower&#8217;s rights under all licenses and all franchise agreements inure to Bank&#8217;s benefit&#59;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.15pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.57pt">place a &#8220;hold&#8221; on any account maintained with Bank and&#47;or deliver a notice of exclusive control, any entitlement order, or other directions or instructions pursuant to any Control Agreement or similar agreements providing control of any Collateral&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.57pt">demand and receive possession of Borrower&#8217;s Books&#59; and</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:45.95pt;padding-right:45.1pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.39pt">exercise all rights and remedies available to Bank under the Loan Documents or at law or equity, including all remedies provided under the Code or any Applicable Law (including disposal of the Collateral pursuant to the terms thereof).</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Power of Attorney. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrower hereby irrevocably appoints Bank as its true and lawful attorney-in-fact, (a) exercisable only following the occurrence and during the continuance of an Event of Default, to&#58;</font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:45.25pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i) endorse Borrower&#8217;s name on any checks, payment instruments, or other forms of payment or security&#59; (ii) sign Borrower&#8217;s name on any invoice or bill of lading for any Account or drafts against Account Debtors&#59; (iii) demand, collect, sue, and give releases to any Account Debtor for monies due, settle and adjust disputes and claims about the Accounts directly with Account Debtors, and compromise, prosecute, or defend any action, claim, case, or proceeding about any Collateral (including filing a claim or voting a claim in any bankruptcy case in Bank&#8217;s or Borrower&#8217;s name, as Bank chooses)&#59; (iv) make, settle, and adjust all claims under Borrower&#8217;s insurance policies&#59; (v) pay, contest or settle any Lien, charge, encumbrance, security interest, or other claim in or to the Collateral, or any judgment based thereon, or otherwise take any action to terminate or discharge the same&#59; and (vi) transfer the Collateral into the name of Bank or a third party as the Code permits&#59; and (b) regardless of whether an Event of Default has occurred, to sign Borrower&#8217;s name on any documents necessary to perfect or continue the perfection of Bank&#8217;s security interest in the Collateral. Bank&#8217;s foregoing appointment as Borrower&#8217;s attorney in fact, and all of Bank&#8217;s rights and powers, coupled with an interest, are irrevocable until such time as all Obligations (other than inchoate indemnity obligations) have been paid in full in cash, Bank is under no further obligation to make Credit Extensions and the Loan Documents have been terminated. Bank shall not incur any liability in connection with or arising from the exercise of such power of attorney and shall have no obligation to exercise any of the foregoing rights and remedies.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Protective Payments. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If Borrower fails to obtain the insurance called for by Section 5.8 or fails to pay any premium thereon or fails to pay any other amount which Borrower is obligated to pay under this Agreement or any other Loan Document or which may be required to preserve the Collateral, Bank may obtain such insurance or make such payment, and all amounts so paid by Bank are Bank Expenses and immediately due and payable, bearing interest at the then highest rate applicable to the Obligations, and secured by the Collateral. Bank will make reasonable efforts to provide Borrower with notice of Bank obtaining such insurance at the time it is obtained or within a reasonable time thereafter. No payments by Bank are deemed an agreement to make similar payments in the future or Bank&#8217;s waiver of any Event of Default.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:46pt;padding-right:43.25pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Application of Payments and Proceeds. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If an Event of Default has occurred and is continuing, Bank shall have the right to apply in any order any funds in its possession, whether from Borrower account balances, payments, proceeds realized as the result of any collection of Accounts or other disposition of the Collateral, or otherwise, to the Obligations in such order as Bank shall determine in its sole discretion. Any surplus shall be paid to Borrower or other Persons legally entitled thereto&#59; Borrower shall remain liable to Bank for any deficiency. Following the occurrence and during the continuation of an Event of Default, if Bank, in its commercially reasonable discretion, directly or indirectly, enters into a deferred payment or other credit transaction with any purchaser at any sale of Collateral, Bank shall have the option, exercisable at any time, of either reducing the Obligations by the principal amount of the purchase price or deferring the reduction of the Obligations until the actual receipt by Bank of cash therefor.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Bank&#8217;s Liability for Collateral. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank&#8217;s sole duty with respect to the custody, safekeeping and physical preservation of the Collateral in its possession or under its control, under Section 9-207 of the Code or otherwise, shall be to deal with it in the same manner as Bank deals with its own property consisting of similar instruments or interests. Borrower bears all risk of loss, damage or destruction of the Collateral.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:46pt;padding-right:43.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">No Waiver&#59; Remedies Cumulative. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank&#8217;s failure, at any time or times, to require strict performance by Borrower of any provision of this Agreement or any other Loan Document shall not waive, affect, or diminish any right of Bank thereafter to demand strict performance and compliance herewith or therewith. No</font></div><div style="text-align:justify"><font><br></font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:44.05pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">waiver hereunder shall be effective unless signed by the party granting the waiver and then is only effective for the specific instance and purpose for which it is given. Bank&#8217;s rights and remedies under this Agreement and the other Loan Documents are cumulative. Bank has all rights and remedies provided under the Code, by law, or in equity. Bank&#8217;s exercise of one right or remedy is not an election and shall not preclude Bank from exercising any other remedy under this Agreement or other remedy available at law or in equity, and Bank&#8217;s waiver of any Event of Default is not a continuing waiver. Bank&#8217;s delay in exercising any remedy is not a waiver, election, or acquiescence.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.5pt">Demand Waiver. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrower waives demand, notice of default or dishonor, notice of payment and nonpayment, notice of any default, nonpayment at maturity, release, compromise, settlement, extension, or renewal of accounts, documents, instruments, chattel paper, and guarantees held by Bank on which Borrower is liable.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:28.5pt;text-decoration:underline">NOTICES</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:43.05pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All notices, consents, requests, approvals, demands, or other communication by any party to this Agreement or any other Loan Document must be in writing and shall be deemed to have been validly served, given, or delivered&#58; (a) upon the earlier of actual receipt and three (3) Business Days after deposit in the U.S. mail, first class, registered or certified mail return receipt requested, with proper postage prepaid&#59; (b) upon transmission, when sent by electronic mail&#59; (c) one (1) Business Day after deposit with a reputable overnight courier with all charges prepaid&#59; or (d) when delivered, if hand-delivered by messenger, all of which shall be addressed to the party to be notified and sent to the address or email address indicated below&#59; provided that, for clause (b), if such notice, consent, request, approval, demand or other communication is not sent during the normal business hours of the recipient, it shall be deemed to have been sent at the opening of business on the next Business Day of the recipient. Bank or Borrower may change its mailing or electronic mail address by giving the other party written notice thereof in accordance with the terms of this Section 9.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:118pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If to Borrower&#58;&#160;&#160;&#160;&#160;SI-Bone, Inc.</font></div><div style="margin-top:0.05pt;padding-left:226pt;padding-right:190.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">471 El Camino Real, Suite 101 Santa Clara, CA 95050</font></div><div style="margin-top:0.05pt;padding-left:226pt;padding-right:190.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Attn&#58; Laura Francis, CEO&#59; and Anshul Maheshwari, CFO</font></div><div style="margin-top:0.05pt;padding-left:226pt;padding-right:191pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Email&#58; lfrancis&#64;si-bone.com&#59; and Anshul.Maheshwari&#64;si-bone.com</font></div><div style="margin-top:6pt;padding-left:118pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">with a copy to (which shall not constitute notice)&#58;</font></div><div style="margin-top:6.05pt;padding-left:226pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cooley LLP</font></div><div style="padding-left:226pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 Hudson Yards</font></div><div style="margin-top:0.05pt;padding-left:226pt;padding-right:170.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York, New York, 10001-2157 Attn&#58; Patrick Flanagan</font></div><div style="padding-left:226pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Email&#58; pflanagan&#64;cooley.com</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:118pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If to Bank&#58;&#160;&#160;&#160;&#160;Silicon Valley Bank</font></div><div style="margin-top:0.05pt;padding-left:226pt;padding-right:214.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505 Howard Street, Floor 3 San Francisco, CA 94105 Attn&#58; Mark Davis</font></div><div style="margin-top:0.05pt;padding-left:226pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Email&#58; mdavis&#64;svb.com</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:118pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">with a copy to (which shall not constitute notice)&#58;</font></div><div style="margin-top:6.05pt;padding-left:226pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DLA Piper LLP (US)</font></div><div style="padding-left:226pt;padding-right:215.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401 B Street, Suite 1700 San Diego, California 92101 Attn&#58; Matt Schwartz, Esq.</font></div><div style="margin-top:0.1pt;padding-left:226pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Email&#58; matt.schwartz&#64;us.dlapiper.com</font></div><div><font><br></font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt;text-decoration:underline">CHOICE OF LAW, VENUE AND JURY TRIAL WAIVER&#59; JUDICIAL REFERENCE</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:43pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Except as otherwise expressly provided in any of the Loan Documents, California law governs the Loan Documents without regard to principles of conflicts of law that would require the application of the laws of another </font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:43pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">jurisdiction. Borrower and Bank each irrevocably and unconditionally submit to the exclusive jurisdiction of the State and Federal courts in Santa Clara County, California&#59; provided, however, that nothing in this Agreement shall be deemed to operate to preclude Bank from bringing suit or taking other legal action in any other jurisdiction with respect to the Loan Documents or to realize on the Collateral or any other security for the Obligations, or to enforce a judgment or other court order in favor of Bank. Borrower expressly, irrevocably and unconditionally submits and consents in advance to such jurisdiction in any action or suit commenced in any such court, and Borrower hereby irrevocably and unconditionally waives, to the fullest extent permitted by Applicable Law, any objection that it may have based upon lack of personal jurisdiction, improper venue, or forum non conveniens and hereby irrevocably and unconditionally consents to the granting of such legal or equitable relief as is deemed appropriate by such court. Borrower hereby waives personal service of the summons, complaints, and other process issued in such action or suit and agrees that service of such summons, complaints, and other process may be made by registered or certified mail addressed to Borrower at the address set forth in, or subsequently provided by Borrower in accordance with, Section 9 of this Agreement and that service so made shall be deemed completed upon the earlier to occur of Borrower&#8217;s actual receipt thereof or three (3) days after deposit in the U.S. mails, proper postage prepaid.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:46pt;padding-right:44.45pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, BORROWER AND BANK EACH WAIVES ITS RIGHT TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION ARISING OUT OF OR BASED UPON THIS AGREEMENT, THE LOAN DOCUMENTS OR ANY CONTEMPLATED TRANSACTION UNDER THIS AGREEMENT, INCLUDING CONTRACT, TORT, BREACH OF DUTY AND ALL OTHER CLAIMS. THIS WAIVER IS A MATERIAL INDUCEMENT FOR THE PARTIES HERETO TO ENTER INTO THIS AGREEMENT. EACH PARTY HERETO HAS REVIEWED THIS WAIVER WITH ITS COUNSEL.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WITHOUT INTENDING IN ANY WAY TO LIMIT THE PARTIES&#8217; AGREEMENT TO WAIVE THEIR</font></div><div style="padding-left:45.95pt;padding-right:43.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RESPECTIVE RIGHT TO A TRIAL BY JURY, if the above waiver of the right to a trial by jury is not enforceable, the parties hereto agree that any and all disputes or controversies of any nature between them arising at any time shall be decided by a reference to a private judge, mutually selected by the parties (or, if they cannot agree, by the Presiding Judge of the Santa Clara County, California Superior Court) appointed in accordance with California Code of Civil Procedure Section 638 (or pursuant to comparable provisions of federal law if the dispute falls within the exclusive jurisdiction of the federal courts), sitting without a jury, in Santa Clara County, California&#59; and the parties hereby submit to the jurisdiction of such court. The reference proceedings shall be conducted pursuant to and in accordance with the provisions of California Code of Civil Procedure Sections 638 through 645.1, inclusive. The private judge shall have the power, among others, to grant provisional relief, including without limitation, entering temporary restraining orders, issuing preliminary and permanent injunctions and appointing receivers. All such proceedings shall be closed to the public and confidential and all records relating thereto shall be permanently sealed. If during the course of any dispute, a party desires to seek provisional relief, but a judge has not been appointed at that point pursuant to the judicial reference procedures, then such party may apply to the Santa Clara County, California Superior Court for such relief. The proceeding before the private judge shall be conducted in the same manner as it would be before a court under the rules of evidence applicable to judicial proceedings. The parties shall be entitled to discovery which shall be conducted in the same manner as it would be before a court under the rules of discovery applicable to judicial proceedings. The private judge shall oversee discovery and may enforce all discovery rules and orders applicable to judicial proceedings in the same manner as a trial court judge. The parties agree that the selected or appointed private judge shall have the power to decide all issues in the action or proceeding, whether of fact or of law, and shall report a statement of decision thereon pursuant to California Code of Civil Procedure Section 644(a). Nothing in this paragraph shall limit the right of any party at any time to exercise self-help remedies, foreclose against collateral, or obtain provisional remedies. The private judge shall also determine all issues relating to the applicability, interpretation, and enforceability of this paragraph.</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:23pt;padding-right:23pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This Section 10 shall survive the termination of this Agreement and the repayment of all Obligations.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt;text-decoration:underline">GENERAL PROVISIONS</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:45.95pt;padding-right:42.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.1</font><img alt="image_143.jpg" src="image_143.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><img alt="image_172.jpg" src="image_172.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:8.55pt">Termination Prior to </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Revolving Line Maturity Date or</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Term Loan Maturity Date&#59; Survival. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All covenants, representations and warranties made in this Agreement shall continue in full force until this Agreement has terminated pursuant to its terms and all Obligations (other than inchoate indemnity obligations) have been satisfied. So long as Borrower has satisfied the Obligations (other than inchoate indemnity obligations, and any other obligations which, by their terms, are to survive the termination of this Agreement and the repayment of all Obligations, and any Obligations under Bank Services Agreements that are cash collateralized in accordance with Section 3.1 of this Agreement), this Agreement may be terminated prior to the </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Line Maturity Date and the</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan Maturity Date by Borrower, effective three (3) Business Days after written notice of termination is given to Bank. Those obligations that are expressly specified in this Agreement as surviving this Agreement&#8217;s</font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="margin-top:4.55pt;padding-left:45.95pt;padding-right:42.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> termination and the repayment of all Obligations shall continue to survive notwithstanding this Agreement&#8217;s termination and the repayment of all Obligations.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:8.5pt">Successors and Assigns. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This Agreement binds and is for the benefit of the successors and permitted assigns of each party. Borrower may not assign or transfer this Agreement or any rights or obligations under it without Bank&#8217;s prior written consent (which may be granted or withheld in Bank&#8217;s sole discretion) and any other attempted assignment or transfer by Borrower shall be null and void. Bank has the right, without the consent of or notice to Borrower, to sell, transfer, assign, negotiate, or grant participation in all or any part of, or any interest in, Bank&#8217;s obligations, rights, and benefits under this Agreement and the other Loan Documents. Notwithstanding the foregoing, or anything to the contrary herein, so long as no Event of Default shall have occurred and is continuing, Bank shall not assign its interest in the Loan Documents to any Person who is (a) a competitor of Borrower, whether as an operating company or direct or indirect parent with voting control over such operating company, or (b) a vulture fund or distressed debt fund.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:18.5pt">Indemnification.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:44.95pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt;text-decoration:underline">General Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Borrower shall indemnify, defend and hold Bank and its Affiliates and the partners, directors, officers, employees, agents, trustees, administrators, managers, advisors and representatives of Bank and its Affiliates (each, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indemnified Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) harmless against&#58; all losses, claims, damages, liabilities and related expenses (including Bank Expenses and the reasonable fees, charges and disbursements of any counsel for any Indemnified Person) (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Claims</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) arising out of, in connection with, or as a result of (i) the execution or delivery of this Agreement, any other Loan Document or any agreement or instrument contemplated hereby or thereby, the performance by the parties hereto of their respective obligations hereunder or thereunder or the consummation of the transactions contemplated hereby or thereby, (ii) any Credit Extension or the use or proposed use of the proceeds therefrom, (iii) any actual or alleged presence or release of hazardous materials on or from any property owned or operated by Borrower or any of its Subsidiaries, or any environmental liability related in any way to Borrower or any of its Subsidiaries, or (iv) any actual or prospective claim, litigation, investigation or proceeding relating to any of the foregoing, whether based on contract, tort or any other theory, whether brought by a third party or by Borrower, and regardless of whether any Indemnified Person is a party thereto&#59; provided that such indemnity shall not, as to any Indemnified Person, be available to the extent that such losses, claims, damages, liabilities or related expenses are determined by a court of competent jurisdiction by final and nonappealable judgment to have resulted from the gross negligence or willful misconduct of such Indemnified Person. All amounts due under this Section 11.3 shall be payable promptly after demand therefor.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:46pt;padding-right:44.4pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:underline">Waiver of Consequential Damages, Etc.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> To the fullest extent permitted by Applicable Law, Borrower shall not assert, and hereby waives, any claim against any Indemnified Person, on any theory of liability, for special, indirect, consequential or punitive damages (as opposed to direct or actual damages) or any loss of profits arising out of, in connection with, or as a result of, this Agreement, any other Loan Document or any agreement or instrument contemplated hereby, the transactions contemplated hereby or thereby, any Credit Extension, or the use of the proceeds thereof. No Indemnified Person shall be liable for any damages arising from</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.25pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the use by unintended recipients of any information or other materials distributed by it through telecommunications, electronic or other information transmission systems in connection with this Agreement or the other Loan Documents or the transactions contemplated hereby or thereby.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:39.65pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This Section 11.3 shall survive the termination of this Agreement and the repayment of all Obligations until all statutes of limitation with respect to the Claims, losses, and expenses for which indemnity is given shall have run.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:18.5pt">Time of Essence. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time is of the essence for the performance of all Obligations in this Agreement.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:8.5pt">Severability of Provisions. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Each provision of this Agreement is severable from every other provision in determining the enforceability of any provision.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:46pt;padding-right:44.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:8.5pt">Amendments in Writing&#59; Waiver&#59; Integration. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No purported amendment or modification of any Loan Document, or waiver, discharge or termination of any obligation under any Loan Document, shall be effective unless, and only to the extent, expressly set forth in a writing signed by each party hereto. Without limiting the generality of the foregoing, no oral promise or statement, nor any action, inaction, delay, failure to require performance or course of conduct shall operate as, or evidence, an amendment, supplement or waiver or have any other effect on any Loan Document. Any waiver granted shall be limited to the specific circumstance expressly described in it, and shall not apply to any subsequent or other circumstance, whether similar or dissimilar, or give rise to, or evidence, any obligation or commitment to grant any further waiver. The Loan Documents represent the entire agreement about this subject matter and supersede prior negotiations or agreements. All prior agreements, understandings, representations, warranties, and negotiations between the parties about the subject matter of the Loan Documents merge into the Loan Documents.</font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:46pt;padding-right:43.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:8.5pt">Counterparts. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This Agreement may be executed in any number of counterparts and by different parties on separate counterparts, each of which, when executed and delivered, is an original, and all taken together, constitute one Agreement. Delivery of an executed signature page of this Agreement by electronic mail transmission shall be effective as delivery of a manually executed counterpart hereof.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:46pt;padding-right:44.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:8.5pt">Confidentiality. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank agrees to maintain the confidentiality of Information (as defined below), except that Information may be disclosed (a) to Bank&#8217;s Subsidiaries and Affiliates and their respective employees, directors, agents, attorneys, accountants and other professional advisors (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Representatives</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; and, together with Bank, collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Bank Entities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), provided that such Bank Entities are subject to the same confidentiality provisions herein&#59; (b) to prospective transferees, assignees, credit providers or purchasers of Bank&#8217;s interests under or in connection with this Agreement and their Representatives (provided, however, Bank shall use obtain any such prospective transferee&#8217;s, assignee&#8217;s, credit provider&#8217;s, purchaser&#8217;s or their Representatives&#8217; agreement to the terms of this provision or substantially similar terms)&#59; (c) as required by law, regulation, subpoena, or other order&#59; (d) to Bank&#8217;s regulators or as otherwise required or requested in connection with Bank&#8217;s examination or audit&#59; (e) in connection with the exercise of remedies under the Loan Documents or any action or proceeding relating to this Agreement or any other Loan Document or the enforcement of rights hereunder or thereunder&#59; and (f) to third-party service providers of Bank so long as such service providers have executed a confidentiality agreement with Bank with terms no less restrictive than those contained herein. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means all information received from Borrower and its agents regarding Borrower or its business, in each case other than information that is either&#58;</font></div><div style="margin-top:0.3pt;padding-left:46pt;padding-right:45.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i) in the public domain or in Bank&#8217;s possession when disclosed to Bank, or becomes part of the public domain (other than as a result of its disclosure by Bank in violation of this Agreement) after disclosure to Bank&#59; or (ii) disclosed to Bank by a third party, if Bank does not know that the third party is prohibited from disclosing the information.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:46pt;padding-right:43.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:8.5pt">Electronic Execution of Documents. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The words &#8220;execution,&#8221; &#8220;signed,&#8221; &#8220;signature&#8221; and words of like import in any Loan Document shall be deemed to include electronic signatures, or the keeping of records in electronic form, each of which shall be of the same legal effect, validity and enforceability as a manually executed</font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:45.95pt;padding-right:39.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">signature or the use of a paper-based recordkeeping systems, as the case may be, to the extent and as provided for in any Applicable Law, including, without limitation, any state law based on the Uniform Electronic Transactions Act.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:44.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:3.5pt">Right of Setoff. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrower hereby grants to Bank a Lien and a right of setoff as security for all Obligations to Bank, whether now existing or hereafter arising upon and against all deposits, credits, collateral and property, now or hereafter in the possession, custody, safekeeping or control of Bank or any entity under the control of Bank (including a subsidiary of Bank) or in transit to any of them, and other obligations owing to Bank or any such entity. At any time after the occurrence and during the continuance of an Event of Default, without demand or notice, Bank may setoff the same or any part thereof and apply the same to any liability or Obligation of Borrower even though unmatured and regardless of the adequacy of any other collateral securing the Obligations. ANY AND ALL RIGHTS TO REQUIRE BANK TO EXERCISE ITS RIGHTS OR REMEDIES WITH RESPECT TO ANY OTHER COLLATERAL WHICH SECURES THE OBLIGATIONS, PRIOR TO EXERCISING ITS RIGHT OF SETOFF WITH RESPECT TO SUCH DEPOSITS, CREDITS OR OTHER PROPERTY OF BORROWER, ARE HEREBY KNOWINGLY, VOLUNTARILY AND IRREVOCABLY WAIVED.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.25pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:3.5pt">Captions and Section References. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The headings used in this Agreement are for convenience only and shall not affect the interpretation of this Agreement. Unless indicated otherwise, section references herein are to sections of this Agreement.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:3.5pt">Construction of Agreement. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The parties hereto mutually acknowledge that they and their attorneys have participated in the preparation and negotiation of this Agreement. In cases of uncertainty this Agreement shall be construed without regard to which of the parties caused the uncertainty to exist.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:3.5pt">Relationship. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The relationship of the parties to this Agreement is determined solely by the provisions of this Agreement. The parties do not intend to create any agency, partnership, joint venture, trust, fiduciary or other relationship with duties or incidents different from those of parties to an arm&#8217;s-length contract.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:45.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:3.5pt">Third Parties. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nothing in this Agreement, whether express or implied, is intended to&#58; (a) confer any benefits, rights or remedies under or by reason of this Agreement on any Persons other than the express parties to it and their respective permitted successors and assigns&#59; (b) relieve or discharge the obligation or liability of any Person not an express party to this Agreement&#59; or (c) give any Person not an express party to this Agreement any right of subrogation or action against any party to this Agreement.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:45.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:3.5pt">Anti-Terrorism Law. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank hereby notifies Borrower that, pursuant to the requirements of Anti-Terrorism Law, Bank may be required to obtain, verify and record information that identifies Borrower, which information may include the name and address of Borrower and other information that will allow Bank to identify Borrower in accordance with Anti-Terrorism Law. Borrower hereby agrees to take any action necessary to enable Bank to comply with the requirements of Anti-Terrorism Law.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt;text-decoration:underline">ACCOUNTING TERMS AND OTHER DEFINITIONS</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:118pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:18.5pt">Accounting and Other Terms.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:44.45pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">Accounting terms not defined in this Agreement shall be construed following GAAP, except for non-compliance with FAS 123R with respect to monthly financial statements. Calculations and determinations must be made following GAAP (except for (a) non-compliance with FAS 123R with respect to monthly financial statement), provided that if at any time any change in GAAP would affect the computation of any financial ratio or requirement set forth in any Loan Document, and either Borrower or Bank shall so request, Borrower and Bank shall negotiate in good faith to amend such ratio or requirement to preserve the original intent thereof in light of such change in GAAP&#59; provided, further, that, until so amended, (i) such ratio or requirement shall continue to be computed in accordance with GAAP prior to such change therein and (ii) Borrower shall provide Bank financial statements and other documents required under this Agreement or as reasonably requested hereunder</font></div><div style="text-align:justify"><font><br></font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:46pt;padding-right:39.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">setting forth a reconciliation between calculations of such ratio or requirement made before and after giving effect to such change in GAAP.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:45.05pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">As used in the Loan Documents&#58; (i) the words &#8220;shall&#8221; or &#8220;will&#8221; are mandatory, the word &#8220;may&#8221; is permissive, the word &#8220;or&#8221; is not exclusive, the words &#8220;includes&#8221; and &#8220;including&#8221; are not limiting, the singular includes the plural, and numbers denoting amounts that are set off in brackets are negative&#59; (ii) the term &#8220;continuing&#8221; in the context of an Event of Default means that the Event of Default has not been remedied (if capable of being remedied) or waived&#59; and (iii) whenever a representation or warranty is made to Borrower&#8217;s knowledge or awareness, to the &#8220;best of&#8221; Borrower&#8217;s knowledge, or with a similar qualification, knowledge or awareness means the actual knowledge, after reasonable investigation, of any Responsible Officer.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:8.5pt">Definitions. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized terms not otherwise defined in this Agreement shall have the meanings set forth in this Section 12.2. All other terms contained in this Agreement, unless otherwise indicated, shall have the meaning provided by the Code to the extent such terms are defined therein. As used in this Agreement, the following capitalized terms have the following meanings&#58;</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:44pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is, as to any Person, any &#8220;account&#8221; of such Person as &#8220;account&#8221; is defined in the Code with such additions to such term as may hereafter be made, and includes, without limitation, all accounts receivable and other sums owing to such Person.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Account Debtor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is any &#8220;account debtor&#8221; as defined in the Code with such additions to such term as may hereafter be made.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="margin-bottom:0.35pt;padding-left:82pt;text-align:justify"><img alt="image_169.jpg" src="image_169.jpg" style="height:61px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Adjusted EBITDA</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8221; shall mean, for Borrower and its Subsidiaries, with respect to any period, the sum of</font></div><div style="padding-left:81.7pt"><img alt="image_176.jpg" src="image_176.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:571px"></div><div style="padding-left:46pt;padding-right:45.55pt;text-align:justify"><font style="color:#007f00;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(a)</font><font style="color:#007f00;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt;text-decoration:underline">Net Income, </font><font style="color:#007f00;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">plus </font><font style="color:#007f00;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(b) to the extent deducted</font><font style="color:#007f00;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">or added to </font><font style="color:#007f00;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">the calculation of Net Income</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">, (i) Interest income,</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Interest Expenses</font><font style="color:#007f00;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">, (ii) depreciation expense and amortization expense, (iii) income tax expense,</font><font style="color:#007f00;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(iv) non-cash stock</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">compensation, and (v) any other one-time restructuring or non-cash charges.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:39.65pt;text-indent:36pt"><img alt="image_171.jpg" src="image_171.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Adjusted Quick Ratio</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8221; is the ratio of (a) Quick Assets to (b) the sum of (i) Current Liabilities minus (ii)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">the current portion of Deferred Revenue.</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:81.85pt"><img alt="image_172.jpg" src="image_172.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"> &#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Administrator</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8221; is an individual that is named&#58;</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:82pt;padding-right:44.95pt;text-align:justify;text-indent:36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(a)</font><img alt="image_214.jpg" src="image_214.jpg" style="height:46px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt;text-decoration:underline">as an &#8220;Administrator&#8221; in the &#8220;SVB Online Services&#8221; form completed by Borrower with</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">the authority to determine who will be authorized to use SVB Online Services (as defined in Bank&#8217;s Online</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Banking Agreement as in effect from time to time) on behalf of Borrower&#59; and</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:154pt;text-indent:-36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(b)</font><img alt="image_172.jpg" src="image_172.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt;text-decoration:underline">as an Authorized Signer of Borrower in an approval by the Board.</font></div><div><font><br></font></div><div style="margin-bottom:0.35pt;margin-top:4.55pt;padding-left:82pt"><img alt="image_171.jpg" src="image_171.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Advance</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8221; or &#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Advances</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8221; means a revolving credit loan (or revolving credit loans) under the Revolving</font></div><div style="padding-left:81.7pt"><img alt="image_176.jpg" src="image_176.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:571px"></div><div style="padding-left:46pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Line.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:45.3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is, with respect to any Person, each other Person that owns or controls directly or indirectly the Person, any Person that controls or is controlled by or is under common control with the Person, and each of that Person&#8217;s senior executive officers, directors, partners and, for any Person that is a limited liability company, that Person&#8217;s managers and members.</font></div><div><font><br></font></div><div style="padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is defined in the preamble hereof.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:45.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Anti-Terrorism Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means any law relating to terrorism or money-laundering, including Executive Order No. 13224 and the USA Patriot Act.</font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means all applicable provisions of constitutions, laws, statutes, ordinances, rules, treaties, regulations, permits, licenses, approvals, interpretations and orders of courts or Governmental Authorities and all orders and decrees of all courts and arbitrators.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Authorized Signer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means any individual listed in Borrower&#8217;s Borrowing Resolution who is authorized to execute the Loan Documents, including making (and executing if applicable) any Credit Extension request, on behalf of Borrower.</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:44.55pt;text-align:justify;text-indent:36pt"><img alt="image_177.jpg" src="image_177.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:572px"><img alt="image_171.jpg" src="image_171.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Availability Amount</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8221; is the lesser of (a) the Revolving Line or (b) the Borrowing Base, minus the sum of</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">all outstanding principal amounts of any Advances.</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:82pt;padding-right:279.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:237%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:237%">Bank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:237%">&#8221; is defined in the preamble hereof. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:237%">Bank Entities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:237%">&#8221; is defined in Section 11.8.</font></div><div style="padding-left:46pt;padding-right:45.2pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Bank Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; are all reasonable audit fees, costs and reasonable expenses (including reasonable, out-of-pocket and documented attorneys&#8217; fees and expenses) for preparing, amending, negotiating, administering, defending and enforcing the Loan Documents (including, without limitation, those incurred in connection with appeals or Insolvency Proceedings) or otherwise incurred with respect to Borrower or any Guarantor.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Bank Services</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; are any products, credit services, and&#47;or financial accommodations previously, now, or hereafter provided to Borrower or any of its Subsidiaries by Bank or any Bank Affiliate, including, without limitation, any letters of credit, cash management services (including, without limitation, merchant services, direct deposit of payroll, business credit cards, and check cashing services), interest rate swap arrangements, and foreign exchange services as any such products or services may be identified in Bank&#8217;s various agreements related thereto (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Bank Services Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:82pt;padding-right:170.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:237%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:237%">Bank Services Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:237%">&#8221; is defined in the definition of Bank Services. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:237%">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:237%">&#8221; is Borrower&#8217;s board of directors or equivalent governing body. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:237%">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:237%">&#8221; is set forth on Schedule I hereto.</font></div><div style="padding-left:45.95pt;padding-right:45.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Borrower&#8217;s Books</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; are all Borrower&#8217;s books and records including ledgers, federal and state tax returns, records regarding Borrower&#8217;s assets or liabilities, the Collateral, business operations or financial condition, and all computer programs or storage or any equipment containing such information.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.3pt;text-align:justify;text-indent:35.85pt"><img alt="image_179.jpg" src="image_179.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:571px"><img alt="image_126.jpg" src="image_126.jpg" style="height:76px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><img alt="image_130.jpg" src="image_130.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:619px"><img alt="image_163.jpg" src="image_163.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:619px"><img alt="image_241.jpg" src="image_241.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:619px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"> &#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Borrowing Base</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8221; is eighty percent (80%) of Eligible Accounts, as determined by Bank from Borrower&#8217;s</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">most recent Borrowing Base Statement&#59; provided, however, that Bank has the right to decrease the foregoing</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">percentages in its commercially reasonable discretion to mitigate the impact of events, conditions, contingencies, or</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">risks which would reasonably be expected to adversely affect the Collateral or its value, following thirty (30) days</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">prior written notice to Borrower.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:39.65pt;text-indent:36pt"><img alt="image_171.jpg" src="image_171.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Borrowing Base Statement</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8221; is that certain statement of the value of certain Collateral in the form</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">specified by Bank to Borrower from time to time.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:45.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Borrowing Resolutions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; are, with respect to any Person, those resolutions adopted by such Person&#8217;s board of directors (and, if required under the terms of such Person&#8217;s Operating Documents, stockholders) and </font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:45.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">delivered by such Person to Bank approving the Loan Documents to which such Person is a party and the transactions contemplated thereby, together with a certificate executed by its secretary on behalf of such Person certifying (a) such Person has the authority to execute, deliver, and perform its obligations under each of the Loan Documents to which it is a party, (b) that set forth as a part of or attached as an exhibit to such certificate is a true, correct, and complete copy of the applicable resolutions then in full force and effect authorizing and ratifying the</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:43.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">execution, delivery, and performance by such Person of the Loan Documents to which it is a party, (c) the name(s) of the Person(s) authorized to execute the Loan Documents, including making (and executing if applicable) any Credit Extension request, on behalf of such Person, together with a sample of the true signature(s) of such Person(s), and (d) that Bank may conclusively rely on such certificate unless and until such Person shall have delivered to Bank a further certificate canceling or amending such prior certificate.</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:45.3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Business Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is a day other than a Saturday, Sunday or other day on which commercial banks in the State of California are authorized or required by law to close, except that if any determination of a &#8220;Business Day&#8221; shall relate to an FX Contract, the term &#8220;Business Day&#8221; shall be a FX Business Day.</font></div><div><font><br></font></div><div style="padding-left:82pt"><img alt="image_172.jpg" src="image_172.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Cash Collateral Account</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8221; is defined in Section 5.4(c).</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:45.3pt;text-align:justify;text-indent:36pt"><img alt="image_166.jpg" src="image_166.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><img alt="image_172.jpg" src="image_172.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; are (a) marketable direct obligations issued or unconditionally guaranteed by the United States or any agency or any State thereof having maturities of not more than one (1) year from the date of acquisition&#59; (b) commercial paper maturing no more than one (1) year after its creation and having the highest rating from either Standard &#38; Poor&#8217;s Ratings Group or Moody&#8217;s Investors Service, Inc.&#59; (c) Bank&#8217;s certificates of deposit issued maturing no more than one (1) year after issue&#59; </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">and</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d) </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">long-term securities having a rating minimum of</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">A-&#47;A3 from either Standard &#38; Poor&#8217;s Ratings Group or Moody&#8217;s Investors Service, Inc.&#59; and (e)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">money market funds at least ninety-five percent (95.0%) of the assets of which constitute Cash Equivalents of the kinds described in clauses (a) through (</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">c</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">d</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">) of this definition.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:44.6pt;text-align:justify;text-indent:38.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means (a) at any time, any &#8220;person&#8221; or &#8220;group&#8221; (as such terms are used in Sections 13(d) and 14(d) of the Exchange Act), shall become, or obtain rights (whether by means of warrants, options or otherwise) to become, the &#8220;beneficial owner&#8221; (as defined in Rules 13(d)-3 and 13(d)-5 under the Exchange Act), directly or indirectly, of forty-nine percent (49.0%) or more of the ordinary voting power for the election of directors, partners, managers and members, as applicable, of Borrower (determined on a fully diluted basis) other than by the sale of Borrower&#8217;s equity securities in a public offering or to venture capital or private equity investors so long as Borrower identifies to Bank the venture capital or private equity investors at least seven (7) Business Days prior to the closing of the transaction and provides to Bank a description of the material terms of the transaction&#59; (b) during any period of twelve (</font><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">consecutive months, a majority of the members of the Board of Borrower cease to be composed of individuals (i) who were members of that board or equivalent governing body on the first (1st) day of such period, (ii) whose election or nomination to that board or equivalent governing body was approved by individuals referred to in clause (i) above constituting at the time of such election or nomination at least a majority of that board or equivalent governing body or (iii) whose election or nomination to that board or other equivalent governing body was approved by individuals referred to in clauses (i) and (ii) above constituting at the time of such election or nomination at least a majority of that board or equivalent governing body&#59; or (c) at any time, Borrower shall cease to own and control, of record and beneficially, directly or indirectly, one hundred percent (100.0%) of each class of outstanding stock, partnership, membership, or other ownership interest or other equity securities of each Subsidiary of Borrower free and clear of all Liens (except Permitted Liens and except dissolutions or transfers permitted pursuant to Sections 6.2 and 6.3 of this Agreement).</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:45.95pt;padding-right:43.55pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means the occurrence, after the Effective Date, of&#58; (a) the adoption or taking effect of any law, rule, regulation or treaty&#59; (b) any change in Applicable Law or in the administration, interpretation, implementation or application thereof by any Governmental Authority&#59; or (c) the making or issuance of any request, rule, guideline or directive (whether or not having the force of law) by any Governmental Authority&#59; provided that notwithstanding anything herein to the contrary, (i) the Dodd-Frank Wall Street Reform and Consumer Protection Act and all requests, rules, guidelines or directives thereunder or issued in connection therewith and (ii) all requests, rules, guidelines or directives promulgated by Bank for International Settlements, the Basel Committee on Banking Supervision (or any successor or similar authority) or the United States or foreign regulatory authorities, in each case pursuant to Basel III, shall in each case be deemed to be a &#8220;Change in Law&#8221;, regardless of the date enacted, adopted or issued.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Claims</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is defined in Section 11.3.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="padding-left:45.95pt;padding-right:43.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is the Uniform Commercial Code, as the same may, from time to time, be enacted and in effect in the State of California&#59; provided, that, to the extent that the Code is used to define any term herein or in any Loan Document and such term is defined differently in different Articles or Divisions of the Code, the definition of such term contained in Article or Division 9 shall govern&#59; provided further, that in the event that, by reason of mandatory provisions of law, any or all of the attachment, perfection, or priority of, or remedies with respect to, Bank&#8217;s Lien on any Collateral is governed by the Uniform Commercial Code in effect in a jurisdiction other than the State of California, the term &#8220;Code&#8221; shall mean the Uniform Commercial Code as enacted and in effect in such other jurisdiction solely for purposes of the provisions thereof relating to such attachment, perfection, priority, or remedies and for purposes of definitions relating to such provisions.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Collateral</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; consists of all of Borrower&#8217;s right, title and interest in and to the following personal property&#58;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:45.95pt;padding-right:44.3pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.96pt">(i) all goods, Accounts (including health-care receivables), Equipment, Inventory, contract rights or rights to payment of money, leases, license agreements, franchise agreements, General Intangibles (except as provided below), commercial tort claims, documents, instruments (including any promissory notes), chattel paper (whether tangible or electronic), cash, deposit accounts, certificates of deposit, fixtures, letters of credit rights (whether or not the letter of credit is evidenced by a writing), securities, securities accounts, securities entitlements and all other investment property, supporting obligations, and financial assets, whether now owned or hereafter acquired, wherever located&#59; and (ii) all Borrower&#8217;s Books relating to the foregoing, and any and all claims, rights and interests in any of the above and all substitutions for, additions, attachments, accessories, accessions and improvements to and replacements, products, proceeds and insurance proceeds of any or all of the foregoing.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:46pt;padding-right:44.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Notwithstanding the foregoing, the Collateral does not include any of the following (now existing or hereafter arising, owned or created)&#58;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:117.95pt;padding-right:44.2pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.62pt">any Intellectual Property&#59; provided, however, the Collateral shall include all Accounts and all proceeds of Intellectual Property. If a judicial authority (including a U.S. Bankruptcy Court) would hold that a security interest in the underlying Intellectual Property is necessary to have a security interest in such Accounts and such property that are proceeds of Intellectual Property, then the Collateral shall automatically, and effective as of the Effective Date, include the Intellectual Property to the extent necessary to permit perfection of Bank&#8217;s security interest in such Accounts and such other property of Borrower that are proceeds of the Intellectual Property&#59; and</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:118pt;padding-right:44.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">any interest of Borrower as a lessee or sublessee under a real property lease or an Equipment lease if Borrower is prohibited by the terms of such lease from granting a security interest in such lease or under which such an assignment or Lien would cause a default to occur under such lease (but only to the extent that such prohibition is enforceable under all applicable laws including, without limitation, the Code)&#59; provided, however, that upon termination of such prohibition, such interest shall immediately become Collateral without any action by Borrower or Bank.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:46pt;padding-right:44.95pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">Pursuant to the terms of a certain negative pledge arrangement with Bank, Borrower has agreed not to encumber any of its Intellectual Property in contravention of the terms of such pledge agreement without Bank&#8217;s prior written consent.</font></div><div><font><br></font></div><div style="padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Collateral Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is any Deposit Account, Securities Account, or Commodity Account.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:45.3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commodity Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is any &#8220;commodity account&#8221; as defined in the Code with such additions to such term as may hereafter be made.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Compliance Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is that certain statement in the form attached hereto as Exhibit A.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:39.65pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Connection Income Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means Other Connection Taxes that are imposed on or measured by net income (however denominated) or that are franchise Taxes or branch profits Taxes.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:44.25pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent Obligation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is, for any Person, any direct or indirect liability of that Person for (a) any direct or indirect guaranty by such Person of any indebtedness, lease, dividend, letter of credit, credit card or other obligation of another, (b) any other obligation endorsed, co-made, discounted or sold with recourse by that Person, or for which that Person is directly or indirectly liable&#59; (c) any obligations for undrawn letters of credit for the account of that Person&#59; and (d) all obligations from any interest rate, currency or commodity swap agreement, interest rate cap or collar agreement, or other agreement or arrangement designated to protect a Person against fluctuation in interest rates, currency exchange rates or commodity prices&#59; but &#8220;Contingent Obligation&#8221; does not include endorsements in the ordinary course of business or any Permitted Call Spread Agreement(s). The amount of a Contingent Obligation is the stated or determined amount of the primary obligation for which the Contingent </font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="padding-left:46pt;padding-right:44.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Obligation is made or, if not determinable, the maximum reasonably anticipated liability for it determined by the Person in good faith&#59; but the amount may not exceed the maximum of the obligations under any guarantee or other support arrangement.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.2pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Control Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is any control agreement entered into among the depository institution at which Borrower maintains a Deposit Account or the securities intermediary or commodity intermediary at which Borrower maintains a Securities Account or a Commodity Account, Borrower, and Bank pursuant to which Bank obtains control (within the meaning of the Code) over such Deposit Account, Securities Account, or Commodity Account.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Copyrights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; are any and all copyright rights, copyright applications, copyright registrations and like protections in each work of authorship and derivative work thereof, whether published or unpublished and whether or not the same also constitutes a trade secret.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.2pt;text-align:justify;text-indent:36pt"><img alt="image_172.jpg" src="image_172.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Credit Extension</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is any </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Advance, Overadvance,</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Letter of Credit, FX Contract, amount utilized for cash management services, Term Loan Advance, or any other extension of credit under the Loan Documents by Bank for Borrower&#8217;s benefit.</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:45.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is coined money and such other banknotes or other paper money as are authorized by law and circulate as a medium of exchange.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:45.1pt;text-align:justify;text-indent:36pt"><img alt="image_189.jpg" src="image_189.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:571px"><img alt="image_169.jpg" src="image_169.jpg" style="height:61px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><img alt="image_130.jpg" src="image_130.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:619px"><img alt="image_241.jpg" src="image_241.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:619px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Current Liabilities</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8221; are (a) all obligations and liabilities of Borrower to Bank, plus (b) without</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">duplication of (a) the aggregate amount of Borrower&#8217;s Total Liabilities that mature within one (1) year (including,</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">for the avoidance of doubt, all Obligations of Borrower to Bank under the Term Loan Advances that mature within</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">one year and Revolving Advances that mature within one year).</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means any event which with notice or passage of time or both, would constitute an Event of</font></div><div style="padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Default.</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Default Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is defined in Section 1.2(c).</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:44.25pt;text-indent:36pt"><img alt="image_193.jpg" src="image_193.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:571px"><img alt="image_171.jpg" src="image_171.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Deferred Revenue</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8221; is all amounts received or invoiced in advance of performance under contracts and</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">not yet recognized as revenue.</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:44.25pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deposit Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is any &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">deposit account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; as defined in the Code with such additions to such term as may hereafter be made.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:46.7pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated Deposit Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is the deposit account with account number xxx-xxxx-9905, established by Borrower with Bank for purposes of receiving Credit Extensions.</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:43.55pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Division</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means, in reference to any Person which is an entity, the division of such Person into two (2) or more separate Persons, with the dividing Person either continuing or terminating its existence as part of such division, including, without limitation, as contemplated under Section 18-217 of the Delaware Limited Liability Company Act for limited liability companies formed under Delaware law, Section 17-220 of the Delaware Revised Uniform Limited Partnership Act for limited partnerships formed under Delaware law, or any analogous action taken pursuant to any other Applicable Law with respect to any corporation, limited liability company, partnership or other entity.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:45.95pt;padding-right:45.2pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dollar Equivalent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is, at any time, (a) with respect to any amount denominated in Dollars, such amount, and (b) with respect to any amount denominated in a Foreign Currency, the equivalent amount therefor in Dollars as determined by Bank at such time on the basis of the then-prevailing rate of exchange in San Francisco, California, for sales of the Foreign Currency for transfer to the country issuing such Foreign Currency.</font></div><div><font><br></font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="padding-left:46pt;padding-right:45.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dollars</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">,&#8221; &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">dollars</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; or use of the sign &#8220;$&#8221; means only lawful money of the United States and not any other currency, regardless of whether that currency uses the &#8220;$&#8221; sign to denote its currency or may be readily converted into lawful money of the United States.</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:45.25pt;text-align:justify;text-indent:36pt"><img alt="image_214.jpg" src="image_214.jpg" style="height:46px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:line-through">EBITDA</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221; shall mean</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#007f00;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">(a) Net Income, plus (b) to the extent deducted</font><font style="color:#007f00;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">in</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#007f00;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">the calculation of Net Income</font><font style="color:#007f00;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">(i)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">Interest Expense</font><font style="color:#007f00;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">, (ii) depreciation expense and amortization expense, (iii) income tax expense,</font><font style="color:#007f00;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">and (iv) stock based</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">compensation.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is set forth on Schedule I hereto.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:44.25pt;text-indent:35.85pt"><img alt="image_196.jpg" src="image_196.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:571px"><img alt="image_128.jpg" src="image_128.jpg" style="height:107px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><img alt="image_241.jpg" src="image_241.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:619px"><img alt="image_163.jpg" src="image_163.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:619px"><img alt="image_200.jpg" src="image_200.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:614px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"> &#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Eligible Accounts</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8221; means Accounts owing to Borrower which arise in the ordinary course of Borrower&#8217;s</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">business that meet all Borrower&#8217;s representations and warranties in Section 4.3, that have been, at the option of</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Bank, confirmed in accordance with Section 5.4(f) of this Agreement, and are due and owing from Account Debtors</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">deemed creditworthy by Bank in its commercially reasonable discretion. Bank reserves the right,</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#007f00;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">at any time after</font><font style="color:#007f00;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#007f00;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">the</font><font style="color:#007f00;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">First Amendment Effective Date, in its commercially reasonable discretion in each instance, to adjust any of the</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">criteria set forth below and to establish new criteria, following thirty (30) days prior written notice to Borrower.</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Unless Bank otherwise agrees in writing, Eligible Accounts shall not include&#58;</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:45.25pt;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><img alt="image_171.jpg" src="image_171.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt;text-decoration:underline">Accounts (i) for which the Account Debtor is Borrower&#8217;s Affiliate, officer, employee,</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">investor, or agent, or (ii) that are intercompany Accounts&#59;</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:45.25pt;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><img alt="image_171.jpg" src="image_171.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:underline">Accounts that the Account Debtor has not paid within ninety (90) days of invoice date</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">regardless of invoice payment period terms&#59;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:45.15pt;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><img alt="image_171.jpg" src="image_171.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt;text-decoration:underline">Accounts with credit balances over ninety (90) days from invoice date, to the extent of</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">such credit balances&#59;</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:45.2pt;text-align:justify;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><img alt="image_214.jpg" src="image_214.jpg" style="height:46px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:underline">Accounts owing from an Account Debtor that exceed Two Hundred Fifty Thousand</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Dollars ($250,000) if fifty percent (50.0%) or more of the Accounts owing from such Account Debtor have not been</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">paid within ninety (90) days of invoice date&#59;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:45.15pt;text-align:justify;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e)</font><img alt="image_126.jpg" src="image_126.jpg" style="height:76px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt;text-decoration:underline">Accounts owing from an Account Debtor (i) which does not have its principal place of</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">business in the United States or (ii) whose billing address (as set forth in the applicable invoice for such Account) is</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">not in the United States, unless in the case of both (i) and (ii) such Accounts are otherwise approved by Bank in</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">writing, provided, however, that Bank hereby approves the Accounts relating to Device Technologies Belrose which</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">is located in Australia&#59;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:43.9pt;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(f)</font><img alt="image_171.jpg" src="image_171.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.01pt;text-decoration:underline">Accounts billed from and&#47;or payable to Borrower outside of the United States (sometimes</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">called foreign invoiced accounts)&#59;</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:43.45pt;text-align:justify;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(g)</font><img alt="image_207.jpg" src="image_207.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:477px"><img alt="image_214.jpg" src="image_214.jpg" style="height:46px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><img alt="image_163.jpg" src="image_163.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:619px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:underline">Accounts in which Bank does not have a first priority, perfected security interest under all</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Applicable Law, other than Device Technologies Belrose which is located in Australia (solely relative to any failure</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">to obtain a first priority, perfected security interest in any foreign jurisdiction, including Australia)&#59;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:154pt;text-indent:-36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(h)</font><img alt="image_210.jpg" src="image_210.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:344px"><img alt="image_172.jpg" src="image_172.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt;text-decoration:underline">Accounts billed and&#47;or payable in a Currency other than Dollars&#59;</font></div><div style="padding-left:117.7pt"><img alt="image_97.jpg" src="image_97.jpg" style="height:2px;margin-bottom:5pt;vertical-align:text-bottom;width:15px"></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:43.65pt;text-align:justify;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)</font><img alt="image_169.jpg" src="image_169.jpg" style="height:61px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.57pt;text-decoration:underline">Accounts owing from an Account Debtor to the extent that Borrower is indebted or</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">obligated in any manner to the Account Debtor (as creditor, lessor, supplier or otherwise - sometimes called &#8220;contra&#8221;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">accounts, accounts payable, customer deposits or credit accounts), but only to the extent of such Indebtedness or</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">obligations&#59;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:45.25pt;text-align:justify;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(j)</font><img alt="image_214.jpg" src="image_214.jpg" style="height:46px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.57pt;text-decoration:underline">Accounts with or in respect of accruals for marketing allowances, incentive rebates, price</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">protection, cooperative advertising and other similar marketing credits, unless otherwise approved by Bank in</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">writing, but only to the extent of such credits&#59;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:45.15pt;text-align:justify;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(k)</font><img alt="image_214.jpg" src="image_214.jpg" style="height:46px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:underline">Accounts owing from an Account Debtor which is a United States government entity or</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">any department, agency, or instrumentality thereof unless Borrower has assigned its payment rights to Bank and the</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">assignment has been acknowledged under the Federal Assignment of Claims Act of 1940, as amended&#59;</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:45.25pt;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(l)</font><img alt="image_171.jpg" src="image_171.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.57pt;text-decoration:underline">Accounts with customer deposits and&#47;or with respect to which Borrower has received an</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">upfront payment, to the extent of such customer deposit and&#47;or upfront payment&#59;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:45.1pt;text-align:justify;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(m)</font><img alt="image_214.jpg" src="image_214.jpg" style="height:46px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:11.57pt;text-decoration:underline">Accounts for demonstration or promotional equipment, or in which goods are consigned,</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">or sold on a &#8220;sale guaranteed&#8221;, &#8220;sale or return&#8221;, &#8220;sale on approval&#8221;, or other terms if Account Debtor&#8217;s payment may</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">be conditional&#59;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:45.15pt;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(n)</font><img alt="image_171.jpg" src="image_171.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:underline">Accounts owing from an Account Debtor where goods or services have not yet been</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">rendered to the Account Debtor (sometimes called memo billings or pre-billings)&#59;</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:45.35pt;text-align:justify;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(o)</font><img alt="image_214.jpg" src="image_214.jpg" style="height:46px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:underline">Accounts subject to contractual arrangements between Borrower and an Account Debtor</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">where payments shall be scheduled or due according to completion or fulfillment requirements (sometimes called</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">contracts accounts receivable, progress billings, milestone billings, or fulfillment contracts)&#59;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:45.25pt;text-align:justify;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(p)</font><img alt="image_214.jpg" src="image_214.jpg" style="height:46px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:underline">Accounts owing from an Account Debtor the amount of which may be subject to</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">withholding based on the Account Debtor&#8217;s satisfaction of Borrower&#8217;s complete performance (but only to the extent</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">of the amount withheld&#59; sometimes called retainage billings)&#59;</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:154pt;text-indent:-36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(q)</font><img alt="image_171.jpg" src="image_171.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt;text-decoration:underline">Accounts subject to trust provisions, subrogation rights of a bonding company, or a</font></div><div style="margin-top:0.05pt;padding-left:46pt"><img alt="image_222.jpg" src="image_222.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:15px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">statutory trust&#59;</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:44.5pt;text-align:justify;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(r)</font><img alt="image_126.jpg" src="image_126.jpg" style="height:76px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.01pt;text-decoration:underline">Accounts owing from an Account Debtor that has been invoiced for goods that have not</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">been shipped to the Account Debtor unless Bank, Borrower, and the Account Debtor have entered into an agreement</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">acceptable to Bank wherein the Account Debtor acknowledges that (i) it has title to and has ownership of the goods</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">wherever located, (ii) a bona fide sale of the goods has occurred, and (iii) it owes payment for such goods in</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">accordance with invoices from Borrower (sometimes called &#8220;bill and hold&#8221; accounts)&#59;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:154pt;text-indent:-36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(s)</font><img alt="image_224.jpg" src="image_224.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:334px"><img alt="image_225.jpg" src="image_225.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:14px"><img alt="image_172.jpg" src="image_172.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:25.45pt;text-decoration:underline">Accounts for which the Account Debtor has not been invoiced&#59;</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:45.25pt;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(t)</font><img alt="image_171.jpg" src="image_171.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.57pt;text-decoration:underline">Accounts that represent non-trade receivables or that are derived by means other than in</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">the ordinary course of Borrower&#8217;s business&#59;</font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.3pt;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(u)</font><img alt="image_228.jpg" src="image_228.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:475px"><img alt="image_171.jpg" src="image_171.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:underline">Accounts for which Borrower has permitted Account Debtor&#8217;s payment to extend beyond</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">ninety (90) days (including Accounts with a due date that is more than ninety (90) days from invoice date)&#59;</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:45.05pt;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(v)</font><img alt="image_171.jpg" src="image_171.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:underline">Accounts arising from chargebacks, debit memos or other payment deductions taken by</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">an Account Debtor&#59;</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:45.25pt;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(w)</font><img alt="image_171.jpg" src="image_171.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:12.12pt;text-decoration:underline">Accounts arising from product returns and&#47;or exchanges (sometimes called &#8220;warranty&#8221; or</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;RMA&#8221; accounts)&#59;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:45.15pt;text-align:justify;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(x)</font><img alt="image_214.jpg" src="image_214.jpg" style="height:46px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:underline">Accounts in which the Account Debtor disputes liability or makes any claim (but only up</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">to the disputed or claimed amount), or if the Account Debtor is subject to an Insolvency Proceeding (whether</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">voluntary or involuntary), or becomes insolvent, or goes out of business&#59;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:44.1pt;text-align:justify;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(y)</font><img alt="image_214.jpg" src="image_214.jpg" style="height:46px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:underline">Accounts owing from an Account Debtor, whose total obligations to Borrower exceed</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">twenty-five percent (25.0%) of all Accounts, only for the amounts that exceed that percentage, unless Bank approves</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">in writing&#59; and</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:45.25pt;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(z)</font><img alt="image_171.jpg" src="image_171.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt;text-decoration:underline">Accounts for which Bank in its sole discretion determines collection to be doubtful,</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">including, without limitation, accounts represented by &#8220;refreshed&#8221; or &#8220;recycled&#8221; invoices.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:43.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Environmental Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means any Applicable Law (including any permits, concessions, grants, franchises, licenses, agreements or governmental restrictions) relating to pollution or the protection of health, safety or the environment or the release of any materials into the environment (including those related to hazardous materials, air emissions, discharges to waste or public systems and health and safety matters).</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:45.25pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equipment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is all &#8220;equipment&#8221; as defined in the Code with such additions to such term as may hereafter be made, and includes without limitation all machinery, fixtures, goods, vehicles (including motor vehicles and trailers), and any interest in any of the foregoing.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:82pt;padding-right:46.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:237%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:237%">ERISA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:237%">&#8221; is the Employee Retirement Income Security Act of 1974, as amended, and its regulations. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:237%">Event of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:237%">&#8221; is defined in Section 7.</font></div><div style="padding-left:81.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8221; is the Securities Exchange Act of 1934, as amended.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:45.95pt;padding-right:44pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Excluded Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means any of the following Taxes imposed on or with respect to Bank or required to be withheld or deducted from a payment to Bank, (a) Taxes imposed on or measured by net income (however denominated), franchise Taxes, and branch profits Taxes, in each case, (i) imposed as a result of Bank being organized under the laws of, or having its principal office or its applicable lending office located in, the jurisdiction imposing such Tax (or any political subdivision thereof) or (ii) that are Other Connection Taxes, (b) U.S. federal withholding Taxes imposed on amounts payable to or for the account of Bank with respect to an applicable interest in a Credit Extension pursuant to a law in effect on the date on which (i) Bank acquires such interest in the Credit Extensions or (ii) Bank changes its lending office, except in each case to the extent that, pursuant to Section 1.6, amounts with respect to such Taxes were payable either to Bank&#8217;s assignor immediately before Bank became a party hereto or to Bank immediately before it changed its lending office, (c) Taxes attributable to Bank&#8217;s failure to comply with Section 1.6(e) and&#47;or any reporting and delivery requirements, and (d) any withholding Taxes imposed under FATCA.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.25pt;text-align:justify;text-indent:40.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FATCA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means Sections 1471 through 1474 of the Internal Revenue Code, as of the date of this Agreement (or any amended or successor version that is substantively comparable and not materially more onerous to comply with), any current or future regulations or official interpretations thereof, any agreements entered into pursuant to Section 1471(b)(1) of the Internal Revenue Code and any fiscal or regulatory legislation, rules or</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:39.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">practices adopted pursuant to any intergovernmental agreement, treaty or convention among Governmental Authorities and implementing such Sections of the Internal Revenue Code.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:44.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Final Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is a payment (in addition to and not a substitution for the regular monthly payments of principal plus accrued interest) due on the earliest to occur of (a) the Term Loan Maturity Date, (b) the repayment of the Term Loan Advance in full, (c) as required pursuant to Section 1.1(c) or 1.1(d), or (d) the termination of this Agreement, in an amount equal to the original aggregate principle amount of the Term Loan Advance extended by Bank to Borrower multiplied by two percent (2.0%).</font></div><div><font><br></font></div><div style="margin-bottom:0.35pt;padding-left:82pt;text-align:justify"><img alt="image_124.jpg" src="image_124.jpg" style="height:169px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><img alt="image_241.jpg" src="image_241.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:619px"><img alt="image_163.jpg" src="image_163.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:619px"><img alt="image_130.jpg" src="image_130.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:619px"><img alt="image_241.jpg" src="image_241.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:619px"><img alt="image_240.jpg" src="image_240.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:621px"><img alt="image_241.jpg" src="image_241.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:619px"><img alt="image_241.jpg" src="image_241.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:619px"><img alt="image_241.jpg" src="image_241.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:619px"><img alt="image_241.jpg" src="image_241.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:619px"><img alt="image_245.jpg" src="image_245.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:46px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Financial Covenant Measuring Period</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8221; is any period of time (a) commencing on the later to occur of</font></div><div style="padding-left:81.7pt"><img alt="image_176.jpg" src="image_176.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:571px"></div><div style="padding-left:46pt;padding-right:43.7pt;text-align:justify"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(i) the date on which the aggregate value of the Borrower&#8217;s unrestricted and unencumbered (except for Liens in</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">favor of Bank) cash and Cash Equivalents held at SVB and SVB&#8217;s Affiliates falls below </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;***&#93; </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Dollars, and (ii) </font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="padding-left:46pt;padding-right:43.7pt;text-align:justify"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">January 1, 2024 and (b) terminating on the date on which Borrower has achieved two (2)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">consecutive quarters of Adjusted EBITDA greater than </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;***&#93;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"> Dollars. After the termination of a Financial</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Covenant Measuring Period, if both (X) Borrower&#8217;s Adjusted EBITDA is equal to or less than </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;***&#93;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"> Dollars any</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">such fiscal quarter and (Y) the aggregate value of the Borrower&#8217;s unrestricted and unencumbered (except for Liens</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">in favor of Bank) cash and Cash Equivalents held at SVB and SVB&#8217;s Affiliates is less than </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;***&#93; </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Dollars, then a new Financial Covenant Measuring Period shall start and shall not terminate until</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower again achieves Adjusted EBITDA Balance greater than </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;***&#93;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"> Dollars for two (2) new consecutive</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> quarters.</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:39.65pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Statement Repository</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is L43f1c&#64;svb.com or such other means of collecting information approved and designated by Bank after providing notice thereof to Borrower from time to time.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:82pt"><img alt="image_172.jpg" src="image_172.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">First Amendment Effective Date</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means January 6, 2023.</font></div><div style="padding-left:81.7pt"><img alt="image_248.jpg" src="image_248.jpg" style="height:2px;margin-bottom:5pt;vertical-align:text-bottom;width:324px"></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is the lawful money of a country other than the United States.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:49pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is a Subsidiary that is not an entity organized under the laws of the United States or any territory thereof or the District of Columbia.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.2pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funding Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is any date on which a Credit Extension is made to or for the account of Borrower which shall be a Business Day.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:45.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FX Business Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is any day when (a) Bank&#8217;s Foreign Exchange Department is conducting its normal business and (b) the Foreign Currency being purchased or sold by Borrower is available to Bank from the entity from which Bank shall buy or sell such Foreign Currency.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:45.95pt;padding-right:45.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FX Contract</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is any foreign exchange contract by and between Borrower and Bank under which Borrower commits to purchase from or sell to Bank a specific amount of Foreign Currency at a set price or on a specified date.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:44.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is generally accepted accounting principles set forth in the opinions and pronouncements of the Accounting Principles Board of the American Institute of Certified Public Accountants and statements and pronouncements of the Financial Accounting Standards Board or in such other statements by such other Person as may be approvedby a significant segment of the accounting profession, which are applicable to the circumstances as of the date of determination (except for with respect to unaudited financial statements for the absence of footnotes and subject to year-end audit adjustments).</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">General Intangibles</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is all &#8220;general intangibles&#8221; as defined in the Code in effect on the date hereof with such additions to such term as may hereafter be made, and includes without limitation, all Intellectual Property, claims, income and other tax refunds, security and other deposits, payment intangibles, contract rights, options to purchase or sell real or personal property, rights in all litigation presently or hereafter pending (whether in contract,</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:46pt;padding-right:39.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">tort or otherwise), insurance policies (including without limitation key man, property damage, and business interruption insurance), payments of insurance and rights to payment of any kind.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-right:280.1pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Good Faith Deposit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is defined in Section 1.3.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Governmental Approval</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is any consent, authorization, approval, order, license, franchise, permit, certificate, accreditation, registration, filing or notice, of, issued by, from or to, or other act by or in respect of, any Governmental Authority.</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:45.3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Governmental Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is any nation or government, any state or other political subdivision thereof, any agency, authority, instrumentality, regulatory body, court, central bank or other entity exercising executive, legislative, judicial, taxing, regulatory or administrative functions of or pertaining to government, any securities exchange and any self-regulatory organization.</font></div><div style="margin-top:0.05pt;padding-left:81.95pt;padding-right:39.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:273%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:273%">Guarantor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:273%">&#8221; is any Person providing a Guaranty in favor of Bank with respect to the Obligations. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:273%">Guaranty</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:273%">&#8221; is any guarantee of all or any part of the Obligations, as the same may from time to time be</font></div><div style="margin-top:0.05pt;padding-right:284.8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">amended, restated, modified or otherwise supplemented.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.5pt;text-align:justify;text-indent:38.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is (a) indebtedness for borrowed money or the deferred price of property or services, such as reimbursement and other obligations for surety bonds and letters of credit, (b) obligations evidenced by </font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="padding-left:46pt;padding-right:45.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">notes, bonds, debentures or similar instruments, (c) capital lease obligations, (d) Contingent Obligations and (e) other short- and long-term obligations under debt agreements, lines of credit and extensions of credit, provided, however, that in no event shall obligations under any Permitted Call Spread Agreement constitute Indebtedness.</font></div><div><font><br></font></div><div style="padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indemnified Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is defined in Section 11.3.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.25pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indemnified Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means (a) Taxes, other than Excluded Taxes, imposed on or with respect to any payment made by or on account of any obligation of Borrower under any Loan Document and (b) to the extent not otherwise described in clause (a), Other Taxes.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is defined in Section 11.8.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:45.2pt;text-align:justify;text-indent:36pt"><img alt="image_196.jpg" src="image_196.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:571px"><img alt="image_171.jpg" src="image_171.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Initial Audit</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8221; is Bank&#8217;s inspection of Borrower&#8217;s Accounts, the Collateral, and Borrower&#8217;s Books, with</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">results satisfactory to Bank in its sole discretion.</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:45.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Insolvency Proceeding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is any proceeding by or against any Person under the United States Bankruptcy Code, or any other bankruptcy or insolvency law, including assignments for the benefit of creditors, compositions, extensions generally with its creditors, or proceedings seeking reorganization, arrangement, receivership or other relief.</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:45.3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intellectual Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Person, all of such Person&#8217;s right, title, and interest in and to the following, whether now owned or hereafter acquired or created&#58;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.91pt">its Copyrights, Trademarks and Patents&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:42.4pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">any and all trade secrets and trade secret rights, including, without limitation, any rights to unpatented inventions, know-how and operating manuals&#59;</font></div><div><font><br></font></div><div style="padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.91pt">licenses any and all source code&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">any and all design rights which may be available to such Person&#59;</font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">any and all claims for damages by way of past, present and future infringement of any of the foregoing, with the right, but not the obligation, to sue for and collect such damages for said use or infringement of the Intellectual Property rights identified above&#59; and</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.01pt">all amendments, renewals and extensions of any of the Copyrights, Trademarks or</font></div><div style="padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents.</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:45.4pt;text-align:justify;text-indent:36pt"><img alt="image_53.jpg" src="image_53.jpg" style="height:92px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Interest Expense</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8221; means for any fiscal period, interest expense (whether cash or non-cash)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#007f00;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">determined in</font><font style="color:#007f00;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#007f00;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">accordance with GAAP</font><font style="color:#007f00;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">for the relevant period ending on such date, including, in any event, interest expense with</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">respect to any Credit Extension and other Indebtedness of Borrower and its Subsidiaries, including, without</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">limitation or duplication, all commissions, discounts, or related amortization and other fees and charges with respect</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">to letters of credit and bankers&#8217; acceptance financing and the net costs associated with interest rate swap, cap, and</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">similar arrangements, and the interest portion of any deferred payment obligation (including leases of all types).</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:45.2pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Internal Revenue Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means the U.S. Internal Revenue Code of 1986, and the rules and regulations promulgated thereunder, each as amended or modified from time to time.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inventory</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is all &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">inventory</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; as defined in the Code in effect on the date hereof with such additions to such term as may hereafter be made, and includes without limitation all merchandise, raw materials, parts, supplies, packing and shipping materials, work in process and finished products, including without limitation such inventory as is temporarily out of Borrower&#8217;s custody or possession or in transit and including any returned goods and any documents of title representing any of the above.</font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:44.55pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is any beneficial ownership interest in any Person (including stock, partnership, membership, or other ownership interest or other equity securities), and any loan, advance or capital contribution to any Person.</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:45.35pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Key Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is each of Borrower&#8217;s (i) Chief Executive Officer, and (ii) Chief Financial Officer, as of the Effective Date.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:45.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Letter of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is a standby or commercial letter of credit issued by Bank upon request of Borrower based upon an application, guarantee, indemnity, or similar agreement.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:45.95pt;padding-right:45.2pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lien</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is a claim, mortgage, deed of trust, levy, attachment charge, pledge, hypothecation, security interest or other encumbrance of any kind, whether voluntarily incurred or arising by operation of law or otherwise against any property.</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:43.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loan Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; are, collectively, this Agreement and any schedules, exhibits, certificates, notices, and any other documents related to this Agreement, the Perfection Certificate, the Control Agreement, any Bank Services Agreement, any subordination agreement, any note, or notes or guaranties executed by Borrower or any Guarantor, landlord waivers and consents, bailee waivers and consents, and any other present or future agreement by Borrower and&#47;or any Guarantor with or for the benefit of Bank in connection with this Agreement or Bank Services, all as amended, restated, or otherwise modified in accordance with the terms thereof.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:46pt;padding-right:43.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Material Adverse Change</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is (a) a material impairment in the perfection or priority of Bank&#8217;s Lien in the Collateral or in the value of such Collateral&#59; (b) a material adverse change in the business, operations, or condition (financial or otherwise) of Borrower&#59; or (c) a material impairment of the prospect of repayment of any portion of the Obligations when such Obligations are due.</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:45.35pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8220;Net Income</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means, as calculated on a consolidated basis for Borrower and its Subsidiaries for any period as at any date of determination, the net profit (or loss), after provision for taxes, of Borrower and its Subsidiaries for such period taken as a single accounting period.</font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:39.65pt;text-indent:36pt"><img alt="image_252.jpg" src="image_252.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:573px"><img alt="image_171.jpg" src="image_171.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Net Revenue</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8221; means, for any period as of any date of determination, Borrower&#8217;s net revenue calculated in</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">accordance with GAAP.</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:43.55pt;text-align:justify;text-indent:36pt"><img alt="image_172.jpg" src="image_172.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; are Borrower&#8217;s obligations to pay when due any debts, principal, interest, fees, Bank Expenses</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">, the Termination Fee (if applicable), the Revolving Line Commitment Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, the Prepayment Fee (if applicable), the Final Payment, and other amounts Borrower owes Bank now or later, whether under this Agreement, or the other Loan Documents, or otherwise, including, without limitation, all obligations relating to Bank Services and interest accruing after Insolvency Proceedings begin and debts, liabilities, or obligations of Borrower assigned to Bank, and to perform Borrower&#8217;s duties under the Loan Documents (but in all cases excluding any equity interests of Bank and&#47;or its Affiliates in Borrower).</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:45.25pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OFAC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is the Office of Foreign Assets Control of the United States Department of the Treasury and any successor thereto.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.3pt;text-align:justify;text-indent:36pt"><img alt="image_172.jpg" src="image_172.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; are, for any Person, such Person&#8217;s formation documents, as certified by the Secretary of State (or equivalent agency) of such Person&#8217;s jurisdiction of organization on a date that is no earlier than thirty (30) days prior to the </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">First Amendment</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective Date, and, (a) if such Person is a corporation, its bylaws in current form, (b) if such Person is a limited liability company, its limited liability company agreement (or similar agreement), and (c) if such Person is a partnership or limited partnership, its partnership agreement or limited partnership agreement (or similar agreement), each of the foregoing with all current amendments or modifications thereto.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Connection Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means, with respect to Bank, Taxes imposed as a result of a present or former connection between Bank and the jurisdiction imposing such Tax (other than connections arising from Bank having executed, delivered, become a party to, performed its obligations under, received payments under, received or perfected a security interest under, engaged in any other transaction pursuant to or enforced any Loan Document, or sold or assigned an interest in any Credit Extension or Loan Document).</font></div><div><font><br></font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="padding-left:46pt;padding-right:45.3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means all present or future stamp, court, documentary, intangible, recording, filing or similar Taxes that arise from any payment made under, from the execution, delivery, performance, enforcement or registration of, from the receipt or perfection of a security interest under, or otherwise with respect to, any Loan Document, except any such Taxes that are Other Connection Taxes imposed with respect to an assignment.</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:82pt"><img alt="image_172.jpg" src="image_172.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Overadvance</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8221; is defined in Section 1.1.B.</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Patents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means all patents, patent applications and like protections including without limitation improvements, divisions, continuations, renewals, reissues, extensions and continuations-in-part of the same.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:82pt;padding-right:80.6pt"><img alt="image_166.jpg" src="image_166.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:237%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:237%">Payment&#47;Advance Form</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:237%">&#8221; is that certain form in the form attached hereto as Exhibit B. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:237%">Payment Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:237%">&#8221; is set forth on Schedule I hereto.</font></div><div style="padding-left:46pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Perfection Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is the </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">updated</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perfection Certificate delivered by Borrower </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">on or around the First</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Amendment Effective Date</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">in connection with this Agreement.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:39.65pt;text-indent:36pt"><img alt="image_169.jpg" src="image_169.jpg" style="height:61px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:line-through">Performance Milestone</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221; means Borrower&#8217;s delivery to Bank of evidence reasonably satisfactory to</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#007f00;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">Bank</font><font style="color:#007f00;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#007f00;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">in its commercially reasonable discretion,</font><font style="color:#007f00;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">confirming that Borrower has achieved revenue (</font><font style="color:#007f00;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">determined in accordance</font><font style="color:#007f00;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#007f00;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">with GAAP</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">) of at least Ninety Million Dollars ($90,000,000) for the trailing twelve (12) month period ending on</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">December 31, 2022.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:43.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8220;Permitted Acquisition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Permitted Acquisitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means an acquisition by Borrower or any Subsidiary of any Intellectual Property or all or substantially all of the assets of, all of the ownership interests in, or a business line, product line (including rights in respect of any medical device) or unit or division of another Person</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:44.7pt;text-align:justify"><img alt="image_172.jpg" src="image_172.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(including any foreign corporations) for cash consideration (including any purchase price adjustments, indemnity payments and earn-out obligations in connection therewith) up to Ten Million Dollars ($10,000,000) in any fiscal year (or such greater amount as may be agreed with the prior written consent of Bank)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">that, with respect to each such acquisition, each of the following conditions shall have been satisfied (or waived by Bank, acting in its </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">good faith business</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">commercially reasonable</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">discretion)&#58;</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:45.05pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">no Event of Default shall have occurred and be continuing or would result from the consummation of the proposed acquisition and Bank has received evidence that Borrower is in compliance with all terms and conditions of this Agreement on a pro forma basis after giving effect to such acquisition,</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:45.25pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">such acquired Person or assets shall be in a similar line of business as is conducted by Borrower as of the Effective Date (or a line of business reasonably related thereto),</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.3pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">such acquisition shall not cause the focus or locations of Borrower&#8217;s and its Subsidiaries&#8217; operations (when taken as a whole) to be located outside of the United States,</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">such acquisition shall not constitute a hostile acquisition,</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:44.85pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">any Person acquired as a result of such acquisition shall become a secured Guarantor (or co-borrower) subject to the terms herein, within fifteen (15) Business Days of the consummation of such acquisition,</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:44.95pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.01pt">in connection with such acquisition, neither Borrower nor any of its subsidiaries (including for this purpose, the target of the acquisition) shall acquire or be subject to any Indebtedness or Liens that are not otherwise permitted hereunder&#59;</font></div><div><font><br></font></div><div style="padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">Borrower shall provide Bank with written notice of the proposed acquisition at least five</font></div><div style="padding-left:46pt;padding-right:39.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5) Business Days prior to the anticipated signing, commitment, or closing date of the proposed acquisition, whichever occurs first&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="padding-left:46pt;padding-right:45.05pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Borrower shall provide to the Bank not later than five (5) Business Days after the execution thereof, a copy of the executed purchase agreement or similar agreement with respect to any such acquisition&#59;</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:45.05pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.57pt">such acquisition has been approved by the board of directors (or other equivalent legally governing body) of the Person to be acquired,</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.15pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.57pt">the entity or assets to be acquired in such acquisition shall not be subject to any Lien other (x) the first priority Liens granted in favor of Bank and (y) Permitted Liens&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:45.2pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">all transactions related to such acquisition shall be consummated in all material respects in accordance with applicable law&#59; and</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.05pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.57pt">Borrower shall provide to the Bank as soon as available but in any event not later than five (5) Business Days after the execution thereof, a copy of the executed purchase agreement or similar agreement with respect to any such acquisition.</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:45.25pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrower shall provide to the Bank as soon as available but in any event not later than five (5) Business Days after the execution thereof a certificate of a Responsible Officer of Borrower, in form and substance reasonably satisfactory to Bank, certifying that all of the requirements set forth in this definition have been satisfied or will be satisfied on or prior to the consummation of such acquisition. Notwithstanding the foregoing and for the avoidance of doubt, in no event shall Borrower or any of its Subsidiaries assume any liabilities with respect to any acquisition, including without limitation, any Permitted Indebtedness, in excess of Fifteen Million Dollars ($15,000,000) in aggregate outstanding at any time for such Permitted Acquisitions.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:45.95pt;padding-right:43.2pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Permitted Call Spread Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means (a) any call option transaction (including, but not limited to, any bond hedge transaction or capped call transaction) pursuant to which the Borrower acquires an option requiring the counterparty thereto to deliver to the Borrower shares of common stock of the Borrower (or other securities or property following a merger event or other change of the common stock of the Borrower), the cash value thereof or a combination thereof from time to time upon exercise of such option entered into by the Borrower in connection with the issuance of Permitted Convertible Debt (such transaction, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Bond Hedge Transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) and (b) any issued warrants to acquire common stock of the Borrower (or other securities or property following a merger event or other change of the common stock of the Borrower) (whether such warrant is settled in shares, cash or a combination thereof) issued by the Borrower in connection with the issuance of Permitted Convertible Debt and sold by Borrower substantially concurrently with any purchase by Borrower of a Bond Hedge Transaction and settled in (such transaction, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Warrant Transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">that (i) the terms, conditions and covenants of each such call option transaction are customary for agreements of such type, as determined by the Board (or a committee thereof) in good faith, (ii) the purchase price for such Bond Hedge Transaction, less the proceeds received by the Borrower from the sale of any related Warrant Transaction, does not exceed the net proceeds received by the Borrower from the issuance of the related Permitted Convertible Indebtedness at the time of such purchase, and (iii) in the case of clause (b) above, such warrants would be classified as an equity instrument in accordance with GAAP.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:46pt;padding-right:52pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Permitted Convertible Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means any unsecured notes issued by the Borrower that are convertible into a fixed number (subject to customary anti-dilution adjustments, &#8220;make-whole&#8221; increases and other customary changes thereto) of shares of common stock of the Borrower (or other securities or property following a merger event or other change of the common stock of the Borrower), cash or any combination thereof (with the amount of such cash or such combination determined by reference to the market price of such common stock or such other securities)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">that such Indebtedness must satisfy each of the following conditions&#58; (i) both immediately prior to and after giving effect (including pro forma effect) to the issuance thereof, no Default or Event of Default shall exist or result therefrom, (ii) such Indebtedness matures after, and does not require any scheduled amortization or other scheduled or otherwise required payments of principal prior to, or have a scheduled maturity date earlier than, the date that is ninety one (91) calendar days after the Term Loan Maturity Date and prior to that date, does not provide for or require any payments of principal or any other payments with the exception of semi-annual interest payments, obligations to settle conversions, redemption rights (which, for the avoidance of doubt, will be subject to Section 6.7) and customary obligations to offer to repurchase the notes upon the occurrence of a &#8220;fundamental change&#8221;, (iii) any cross-default or cross-acceleration event of default (each howsoever defined) provision contained therein that relates to indebtedness or other payment obligations of Borrower (or any of its Subsidiaries) (such indebtedness or other payment obligations, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cross-Default Reference Obligation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) contains a cure period of at least thirty (30) calendar days (after written notice to the issuer of such Indebtedness by the trustee or to such issuer and such trustee by holders of at least 25% in aggregate principal amount of such Indebtedness then outstanding) before a default, event of default, acceleration or other event or condition under such Cross-Default Reference Obligation results in an event of default under such cross-default or cross-acceleration provision, (iv) the terms, conditions and covenants (other than pricing terms determined through a customary marketing process) of such Indebtedness must be customary for </font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="padding-left:46pt;padding-right:52pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">convertible Indebtedness of such type at the time of issuance (as determined by the Board, or a committee thereof, in good faith) and, (v) such Indebtedness is not guaranteed by any Subsidiary of the Borrower unless the Obligations are guaranteed by such Subsidiary on a secured basis. For the avoidance of doubt, and without limitation of the foregoing, Permitted Convertible Debt shall at all times be valued at the full stated principle amount thereof and shall not include any reduction or appreciation in value of the shares deliverable upon conversion thereof.</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Permitted Foreign Subsidiary Accounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is defined in Section 5.9(a).</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:44.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Permitted Hedging Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means any currency agreement, all rate swap transactions or other contract or arrangement designed solely to protect a Person against fluctuations in currency exchange rates and interest rate risk, and any confirmation executed in connection with any such agreement, contract, or arrangement, in each case, entered into by Borrower or any of its Subsidiaries solely to hedge or mitigate the risks of foreign exchange rate fluctuations and interest rate risk and not for any speculative or other purposes&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">that such</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:45.95pt;padding-right:45.3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">agreement, contract or arrangement shall comply in all respects with the hedging policies or guidelines as are approved by the Board or as are approved by Bank (such approval not to be unreasonably withheld, delayed or conditioned)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">provided further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, that all accrued and reasonably expected liabilities of Borrower or its Subsidiaries arising under Permitted Hedging Agreements shall not exceed One Million Dollars ($1,000,000) in the aggregate at any time. For the avoidance of doubt, no Permitted Call Spread Agreement shall constitute a Permitted Hedging Agreement.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Permitted Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.25pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">Borrower&#8217;s Indebtedness to Bank under this Agreement, the other Loan Documents and under any other agreement with Bank&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">Indebtedness existing on the Effective Date which is shown on the Perfection Certificate&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.91pt">Subordinated Debt&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">unsecured Indebtedness to trade creditors incurred in the ordinary course of business&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.3pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">Indebtedness incurred as a result of endorsing negotiable instruments received in the ordinary course of business&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.15pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.01pt">Indebtedness secured by Liens permitted under clauses (a) and (c) of the definition of &#8220;Permitted Liens&#8221; hereunder&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.3pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">other unsecured Indebtedness not otherwise permitted by Section 6.4 not exceeding Two Hundred Fifty Thousand Dollars ($250,000.00) in the aggregate outstanding at any time&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.3pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Indebtedness with respect to credit cards maintained with American Express, not to exceed Five Hundred Thousand Dollars ($500,000) outstanding at any time&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.57pt">Permitted Hedging Agreements&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.3pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.57pt">intercompany Indebtedness by and among Borrower and its Subsidiaries (subject to &#8220;Permitted Investments&#8221; part (g)(i)&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.25pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Indebtedness in respect of letters of credit, bank guarantees and similar instruments issued for the account of Borrower and&#47;or its Subsidiaries in the ordinary course of business not to exceed Seven Hundred Fifty Thousand Dollars ($750,000) outstanding at any time&#59;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.57pt">advances or deposits received in the ordinary course of business from customers or</font></div><div style="padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">vendors&#59;</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:45.4pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:11.57pt">Indebtedness in respect of netting services, overdraft protections, payment processing, automatic clearinghouse arrangements, arrangements in respect of pooled deposit or sweep accounts, check endorsement guarantees, and otherwise in connection with deposit accounts or cash management services and Indebtedness arising in connection with automated clearing house transfer of funds or the use of other payment processing services&#59;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="padding-left:46pt;padding-right:45.05pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Indebtedness arising in connection with the financing of insurance premiums in the ordinary course of business not to exceed Seven Hundred Fifty Thousand Dollars ($750,000) outstanding at any time&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:46pt;padding-right:45.4pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(o)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Indebtedness in respect of performance bonds, bid bonds, appeal bonds, surety bonds, completion guarantees and similar obligations arising in the ordinary course of business not to exceed Seven Hundred Fifty Thousand Dollars ($750,000) in the aggregate outstanding at any time&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:45.95pt;padding-right:45.2pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(p)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.39pt">Unsecured Indebtedness in connection with Permitted Acquisitions, not to exceed Fifteen Million Dollars ($15,000,000) in aggregate outstanding at any time&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.2pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(q)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Permitted Convertible Debt in aggregate principal amount not to exceed Two Hundred Fifty Million Dollars ($250,000,000) in principal amount at any time outstanding&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:44.95pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(r)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.01pt">Indebtedness of Borrower&#8217;s Subsidiaries in connection with the sale of Inventory by Borrower to its Subsidiaries in the ordinary course of business, which may from time to time be forgiven by Borrower&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:45.95pt;padding-right:45.15pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(s)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:15.5pt">purchase price adjustments, indemnity payments and earn-out obligations in connection with any Permitted Acquisition (to the extent not in excess of the consideration limitations set forth in the definition thereof)&#59; and</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:45.15pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(t)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.57pt">extensions, refinancings, modifications, amendments and restatements of any items of Permitted Indebtedness (a) through (s) above, provided that the principal amount thereof is not increased or the terms thereof are not modified to impose more burdensome terms upon Borrower or its Subsidiary, as the case may be.</font></div><div><font><br></font></div><div style="padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Permitted Investments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; are&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:48.35pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">Investments (including, without limitation, Subsidiaries) existing on the Effective Date which are shown on the Perfection Certificate&#59;</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:45pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">(i) Investments consisting of cash and Cash Equivalents, and (ii) any other Investments permitted by Borrower&#8217;s investment policy, as amended from time to time, provided that such investment policy (and any such amendment thereto) has been approved in writing by Bank, further provided that Bank hereby confirms approval of such investment policy delivered to Bank around the Effective Date&#59;</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:45.15pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">Investments consisting of the endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of Borrower&#8217;s business&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.15pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Investments consisting of deposit and securities accounts (but only to the extent that Borrower or its Subsidiaries is permitted to maintain such accounts pursuant to Section 5.9 of this Agreement) in which Bank has a first priority perfected security interest (only if and to the extent required pursuant to Section 5.9 of this Agreement)&#59;</font></div><div><font><br></font></div><div style="padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.91pt">Investments accepted in connection with Transfers permitted by Section 6.1&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:45.95pt;padding-right:45.25pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.06pt">Investments consisting of the creation of a Subsidiary for the purpose of consummating a merger transactions and Permitted Acquisitions permitted by Section 6.3 of this Agreement, which is otherwise a Permitted Investment&#59;</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:45pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Investments by Borrower in Subsidiaries that are not borrowers hereunder (or Guarantors), not to exceed (i) (x) Seven Million Five Hundred Thousand Dollars ($7,500,000) in the aggregate in any fiscal year&#59; and (y) Three Million Dollars ($3,000,000) in any fiscal quarter, plus (ii) the ongoing day-to-day operations of such Subsidiaries in the ordinary course of business, so long as such (part (ii)) Investments are (A)made on a cost-plus basis, or (B) otherwise in accordance with transfer pricing arrangements, or (C) are otherwise approved in advance in writing by Bank&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">Investments by Borrower in any other co-borrower under this Agreement or Guarantor&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.3pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.57pt">Investments consisting of (i) travel advances and employee relocation loans and other employee loans and advances in the ordinary course of business, and (ii) loans to employees, officers, directors, partners, managers and members relating to the purchase of equity securities of Borrower or its Subsidiaries pursuant to employee equity purchase plans or similar agreements approved by the Board&#59;</font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:45.05pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.57pt">Investments (including debt obligations) received in connection with the bankruptcy or reorganization of customers or suppliers and in settlement of delinquent obligations of, and other disputes with, customers or suppliers arising in the ordinary course of business&#59;</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:45.2pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Investments consisting of notes receivable of, or prepaid royalties and other credit extensions, to customers and suppliers who are not Affiliates, in the ordinary course of business&#59; provided that this paragraph (j) shall not apply to Investments of Borrower in any Subsidiary&#59;</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:44.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.57pt">Cash investments of up to One Million Dollars ($1,000,000) per fiscal year, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> non-cash Investments in joint ventures or strategic alliances in the ordinary course of Borrower&#8217;s business consisting of the non-exclusive licensing of technology, the development of technology or the providing of technical support&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:21.57pt">any Permitted Call Spread Agreements&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">Permitted Acquisitions&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.3pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(o)</font><img alt="image_172.jpg" src="image_172.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Investments not to exceed Five Million Dollars ($5,000,000) per fiscal year to fund the expansion of Borrower and&#47;or its Subsidiaries in (i) Japan, and&#47;or (ii) any other jurisdiction as may be agreed by Bank (in its </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">good faith business</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">commercially reasonable</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">discretion) and Borrower&#59; and</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:45.95pt;padding-right:45.15pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(p)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.39pt">other Investments not otherwise enumerated in this defined term &#8220;Permitted Investments&#8221; not exceeding Five Hundred Thousand Dollars ($500,000) in the aggregate during any fiscal year.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:81.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Permitted Liens</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; are&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.15pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">Liens existing on the Effective Date which are shown on the Perfection Certificate or arising under this Agreement or the other Loan Documents&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:43.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Liens for taxes, fees, assessments or other government charges or levies, either (i) not due and payable or (ii) being contested in good faith and for which Borrower maintains adequate reserves on Borrower&#8217;s Books, provided that no notice of any such Lien has been filed or recorded under the Internal Revenue Code&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:44.4pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">purchase money Liens and equipment liens (i) on Equipment or software acquired or held by Borrower incurred for financing the acquisition of the Equipment or software securing no more than One Million Dollars ($1,000,000) in the aggregate amount outstanding, or (ii) existing on Equipment or software when acquired, if the Lien is confined to the property and improvements and the proceeds of the Equipment or software&#59;</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:45.25pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Liens of carriers, warehousemen, suppliers, or other Persons that are possessory in nature arising in the ordinary course of business so long as such Liens attach only to Inventory, securing liabilities in the aggregate amount not to exceed Two Hundred Fifty Thousand Dollars ($250,000), and which are not delinquent or remain payable without penalty or which are being contested in good faith and by appropriate proceedings which proceedings have the effect of preventing the forfeiture or sale of the property subject thereto&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:46pt;padding-right:45.25pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.91pt">Liens to secure payment of workers&#8217; compensation, employment insurance, old-age pensions, social security and other like obligations incurred in the ordinary course of business (other than Liens imposed by ERISA)&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:44.95pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.01pt">Liens incurred in the extension, renewal or refinancing of the Indebtedness secured by Liens described in (a) through (c), but any extension, renewal or replacement Lien must be limited to the property encumbered by the existing Lien and the principal amount of the indebtedness may not increase&#59;</font></div><div><font><br></font></div><div style="padding-left:45.95pt;padding-right:45.35pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.39pt">leases or subleases of real property granted in the ordinary course of Borrower&#8217;s business (or, if referring to another Person, in the ordinary course of such Person&#8217;s business), and leases, subleases, non-exclusive licenses or sublicenses of personal property (other than Intellectual Property) granted in the ordinary course of Borrower&#8217;s business (or, if referring to another Person, in the ordinary course of such Person&#8217;s business), if the leases, subleases, licenses and sublicenses do not prohibit granting Bank a security interest therein&#59;</font></div><div><font><br></font></div><div style="padding-left:45.95pt;padding-right:44.9pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.39pt">(i) non-exclusive licenses of Intellectual Property granted to third parties in the ordinary course of business, (ii) licenses of Intellectual Property that could not reasonably be expected to result in a legal transfer of title of the licensed property that may be exclusive in respects of territory (as to discreet geographical areas inside and outside of the United States), and (iii) licenses existing on the Effective Date and disclosed on the Perfection Certificate&#59;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="padding-left:46pt;padding-right:45pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.57pt">customary Liens of any bank in connection with statutory, common law and contractual rights of setoff and recoupment with respect to any deposit account or securities account of Borrower, provided that</font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:45.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i) Bank has a first priority perfected security interest in such account (if perfection is required pursuant to Section 5.9 of this Agreement), and (ii) such account is permitted to be maintained pursuant to Section 5.9 of this Agreement&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.15pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.57pt">Liens arising from attachments or judgments, orders, or decrees in circumstances not constituting an Event of Default under Sections and 7.7&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:45.95pt;padding-right:45.4pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.39pt">deposits under real property leases that are made in the ordinary course of business not to exceed Seven Hundred Fifty Thousand Dollars ($750,000) at any time&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.15pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.57pt">easements, rights-of-way, restrictions and other similar encumbrances affecting real property which, in the aggregate, are not substantial in amount, and which do not in any case materially detract from the value of the property subject thereto or materially interfere with the ordinary conduct of the business of the applicable Person&#59;</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:45.2pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:11.57pt">other Liens (not otherwise enumerated in this defined term) not exceeding One Hundred Thousand Dollars ($100,000) in the aggregate outstanding at any time&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.4pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.34pt">Liens in respect of performance bonds, bid bonds, appeal bonds, surety bonds, completion guarantees and similar obligations arising in the ordinary course of business not to exceed Seven Hundred Fifty Thousand Dollars ($750,000) in the aggregate outstanding at any time&#59; and</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:154pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(o)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">Liens on cash and Cash Equivalents securing obligations under Permitted Hedging</font></div><div style="padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agreements.</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:45.25pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is any individual, sole proprietorship, partnership, limited liability company, joint venture, company, trust, unincorporated organization, association, corporation, institution, public benefit corporation, firm, joint stock company, estate, entity or government agency.</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:45.15pt;text-align:justify;text-indent:36pt"><img alt="image_172.jpg" src="image_172.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prepayment Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is a fee due upon prepayment (whether voluntary or otherwise) of the Term Loan Advance in full </font><font style="color:#007f00;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">prior to the Term Loan Maturity Date</font><font style="color:#007f00;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">equal to </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">(i) one</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">two</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">percent (</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">1.00</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2.00</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%) of the aggregate</font></div><div style="text-align:justify"><img alt="image_241.jpg" src="image_241.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:619px"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">original</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">l </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">principal amount of the Term Loan Advance </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">made by Bank to Borrower hereunder, if such prepayment</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">occurs prior to the second (2nd) anniversary of the Effective Date, (ii) zero percent (0.00%) of the aggregate original</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">principal amount of</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">being prepaid on such date, provided, however, that no such Prepayment Fee is accrued or</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">payable to Bank, and such Prepayment Fee is waived by Bank (i) with respect to</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the Term Loan Advance </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">made by</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">Bank to Borrower hereunder if such prepayment occurs on or</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#007f00;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">at any time after the</font><font style="color:#007f00;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">second (2nd) anniversary of the</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">Effective Date but</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#007f00;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">prior to the Term Loan Maturity Date</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">&#59;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(as defined in the Agreement prior to the First Amendment</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Effective Date) prepaid on or around the First Amendment Effective Date, and (ii) if any such prepaid Term Loan</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Advance is refinanced through a new credit facility provided by Bank.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prime Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is set forth on Schedule I hereto.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prime Rate Margin</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is set forth on Schedule I hereto.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:39.65pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Qualified Cash</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means the amount of the Borrower and its Subsidiaries cash and Cash Equivalents held with Bank and&#47;or Banks&#8217; Affiliates and&#47;or in accounts subject to a Control Agreement in favor of Bank&#59;</font></div><div><font><br></font></div><div style="padding-left:82pt"><img alt="image_172.jpg" src="image_172.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quarterly Financial Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is defined in Section 5.3(</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">a</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">c</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">).</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:39.65pt;text-indent:36pt"><img alt="image_171.jpg" src="image_171.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Quick Assets</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8221; is, on any date, Borrower&#8217;s unrestricted and unencumbered cash and Cash Equivalents,</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">including, for the avoidance of doubt, balances in the Cash Collateral Account, and Eligible Accounts.</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:45.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redemption Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means, with respect to any redemption by the Borrower of any Permitted Convertible Debt, satisfaction of each of the following events&#58; (a) no Event of Default shall exist or result therefrom,</font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:45.2pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b) both immediately before and after such redemption, Borrower&#8217;s Qualified Cash shall be no less than the amount required to prepay the outstanding Obligations in full at the time of such redemption, including all outstanding principal of the Term Loans, the accrued and unpaid interest thereon, the Final Payment, and the Prepayment Fee (provided, however, for the avoidance of doubt no such prepayment is required at such time), and (c) both </font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:45.2pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">immediately before and after such redemption, Borrower&#8217;s Remaining Months Liquidity shall be no less than twelve (12).</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Registered Organization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is any &#8220;registered organization&#8221; as defined in the Code with such additions to such term as may hereafter be made.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.25pt;text-align:justify;text-indent:36pt"><img alt="image_172.jpg" src="image_172.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Remaining Months Liquidity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means Qualified Cash divided by </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Adjusted</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EBITDA (measured on a trailing twelve (12) month basis).</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Representatives</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is defined in Section 11.8.</font></div><div style="margin-top:0.5pt"><img alt="image_163.jpg" src="image_163.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:619px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Reserves</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8221; means, as of any date of determination, such amounts as Bank may from time to time establish</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">and revise in its commercially reasonable discretion, reducing the amount of Advances and other financial</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">accommodations which would otherwise be available to Borrower (a) to reflect events, conditions, contingencies or</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">risks which, as determined by Bank in its commercially reasonable discretion, do or may adversely affect (i) the</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Collateral or any other property which is security for the Obligations or its value (including without limitation any</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">increase in delinquencies of Accounts), (ii) the assets, business or prospects of Borrower or any Guarantor, or (iii)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">the security interests and other rights of Bank in the Collateral (including the enforceability, perfection and priority</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">thereof)&#59; or (b) to reflect Bank's reasonable belief that any collateral report or financial information furnished by or</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">on behalf of Borrower or any Guarantor to Bank is or may have been incomplete, inaccurate or misleading in any</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">material respect&#59; or (c) in respect of any state of facts which Bank determines in its commercially reasonable</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">discretion constitutes a Default or an Event of Default.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:39.65pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Responsible Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is any of the Chief Executive Officer, President, Chief Financial Officer, Chief Legal Officer, and Controller of Borrower.</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:45.2pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restricted License</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is any material license or other material agreement with respect to which Borrower is the licensee (a) that prohibits or otherwise restricts Borrower from granting a security interest in Borrower&#8217;s interest in such license or agreement or any other property, or (b) for which a default under or termination of could interfere with Bank&#8217;s right to sell any material Collateral.</font></div><div><font><br></font></div><div style="padding-left:82pt"><img alt="image_172.jpg" src="image_172.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Revolving Line</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8221; is set forth on Schedule I hereto.</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:82pt"><img alt="image_172.jpg" src="image_172.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Revolving Line Maturity Date</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8221; is set forth on Schedule I hereto.</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:45.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sanctioned Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means a Person that&#58; (a) is listed on any Sanctions list maintained by OFAC or any similar Sanctions list maintained by any other Governmental Authority having jurisdiction over Borrower&#59; (b) is located, organized, or resident in any country, territory, or region that is the subject or target of Sanctions&#59; or (c) is fifty percent (50.0%) or more owned or controlled by one (1) or more Persons described in clauses (a) and (b) hereof.</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:45.3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sanctions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means the economic sanctions laws, regulations, embargoes or restrictive measures administered, enacted or enforced by the United States government and any of its agencies, including, without limitation, OFAC and the U.S. State Department, or any other Governmental Authority having jurisdiction over Borrower.</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:45.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SEC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is the Securities and Exchange Commission, any successor thereto, and any analogous Governmental Authority.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:43.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Securities Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is any &#8220;securities account&#8221; as defined in the Code with such additions to such term as may hereafter be made.</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:45.4pt;text-align:justify;text-indent:36pt"><img alt="image_214.jpg" src="image_214.jpg" style="height:46px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:line-through">Solar Capital</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221; means Solar Capital Ltd., as collateral agent and as a lender, and the other lenders party to</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">that certain Loan and Security Agreement by and among such parties and Borrower, dated as of May 29, 2020, as</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">amended and&#47;or restated).</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:82pt"><img alt="image_172.jpg" src="image_172.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Streamline Balance</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8221; is defined in the definition of Streamline Period.</font></div><div><font><br></font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:45.25pt;text-align:justify;text-indent:35.85pt"><img alt="image_283.jpg" src="image_283.jpg" style="height:215px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"> &#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Streamline Period</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8221; is, on and after the First Amendment Effective Date, provided no Event of Default</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">has occurred and is continuing, the period (a) commencing on the first (1st) day of the month following the day that</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower provides to Bank a written report that Borrower has, for the immediately preceding month, measured at</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">month-end (only when Advances are outstanding or are being requested by Borrower), as determined by</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#007f00;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Bank in its</font><font style="color:#007f00;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#007f00;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">commercially reasonable discretion,</font><font style="color:#007f00;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">an Adjusted Quick Ratio in an amount as of such measurement date of greater</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">than or equal to 1.50 to 1.00 (the &#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Streamline Balance</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8221;)&#59; and (b) terminating on the earlier to occur of (i) the</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">occurrence of an Event of Default, and (ii) the first month-end measured thereafter in which Borrower fails to</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">maintain the Streamline Balance, as determined by Bank in its commercially reasonable discretion. Upon the</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">termination of a Streamline Period, Borrower shall maintain the Streamline Balance each month end for one (1)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">fiscal quarter, as determined by Bank in its commercially reasonable discretion, prior to entering into a subsequent</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Streamline Period. Borrower shall give Bank prior written notice of Borrower&#8217;s election to enter into any such</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Streamline Period, and each such Streamline Period shall commence on the first (1st) day of the monthly period</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">following the date Bank determines, in its commercially reasonable discretion, that the Streamline Balance has been</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">achieved.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:45.35pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Subordinated Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is indebtedness incurred by Borrower or any of its Subsidiaries subordinated to all of Borrower&#8217;s or any of its Subsidiaries&#8217; now or hereafter indebtedness to Bank (pursuant to a subordination, intercreditor, or other similar agreement in form and substance satisfactory to Bank entered into between Bank and the other creditor), on terms acceptable to Bank. For the avoidance of doubt, Permitted Convertible Debt shall not constitute Subordinated Debt.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:46pt;padding-right:45pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is, as to any Person, a corporation, partnership, limited liability company or other entity of which shares of stock, partnership, membership, or other ownership interest or other equity securities having ordinary voting power (other than stock, partnership, membership, or other ownership interest or other equity securities having such power only by reason of the happening of a contingency) to elect a majority of the board of directors or other managers of such corporation, partnership or other entity are at the time owned, or the management of which is otherwise controlled, directly or indirectly through one or more intermediaries, or both, by such Person. Unless the context otherwise requires, each reference to a Subsidiary herein shall be a reference to a Subsidiary of Borrower or Guarantor.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46pt;padding-right:45.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means all present or future taxes, levies, imposts, duties, deductions, withholdings (including backup withholding), assessments, fees or other charges imposed by any Governmental Authority, including any interest, additions to tax or penalties applicable thereto.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:81.95pt;padding-right:190.15pt"><img alt="image_172.jpg" src="image_172.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:237%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:237%">Term Loan Advance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:237%">&#8221; is defined in Section 1.1(a) of this Agreement. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:237%">Term Loan Amortization Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:237%">&#8221; is set forth on Schedule I hereto. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:237%">Term Loan Availability Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:237%">&#8221; is set forth on Schedule I hereto. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:237%">Term Loan Maturity Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:237%">&#8221; is set forth on Schedule I hereto. </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:237%;text-decoration:underline">&#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:237%;text-decoration:underline">Termination Fee</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:237%;text-decoration:underline">&#8221; is defined in Section 1.3(c).</font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="padding-left:46pt;padding-right:39.65pt;text-indent:36pt"><img alt="image_179.jpg" src="image_179.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:571px"><img alt="image_171.jpg" src="image_171.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Total Liabilities</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8221; is on any day, obligations that should, under GAAP, be classified as liabilities on</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower&#8217;s consolidated balance sheet, including all Indebtedness, but excluding all Subordinated Debt.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:45.3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trademarks</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Person, any trademark and servicemark rights, whether registered or not, applications to register and registrations of the same and like protections, and the entire goodwill of the business of such Person connected with and symbolized by such trademarks.</font></div><div><font><br></font></div><div style="padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is defined in Section 6.1.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:81.95pt"><img alt="image_172.jpg" src="image_172.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Uncommitted Accordion</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8221; is defined in Section 1.1(a) of this Agreement.</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt;padding-right:45.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">USA Patriot Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means the &#8220;Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001&#8221; (Public Law 107-56, signed into law on October 26, 2001), as amended from time to time.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:20.57pt;padding-right:20.57pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Signature page follows</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#93;</font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">295054968.4</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:line-through">354271-000499</font></div></td></tr></table></div></div></div><div id="i37efde9015094164b274aef726ee5ee2_82"></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46pt;padding-right:39.65pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">IN WITNESS WHEREOF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, the parties hereto have caused this Agreement to be executed as of the Effective Date.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:298pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BORROWER&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:298pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SI-BONE, INC.</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:298pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:298pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Anshul Maheshwari</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:298pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Chief Financial Officer</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:298pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BANK&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:298pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SILICON VALLEY BANK</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:298pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:298pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Mark Davis</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:298pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Vice President</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:19.32pt;padding-right:19.32pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Signature Page to Loan and Security Agreement</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:46pt"><img alt="image_288.jpg" src="image_288.jpg" style="height:40px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:underline">WEST&#92;300615610.6</font></div><div style="padding-left:46pt"><img alt="image_289.jpg" src="image_289.jpg" style="height:5px;margin-bottom:5pt;vertical-align:text-bottom;width:77px"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:254%">2</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:254%">23</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:254%">7</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:254%">59</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:254%">8</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:254%">45</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:254%">6</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:254%">20</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:254%">3</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:254%">75</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:254%">8</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:254%">14</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:254%">01</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:254%">-90</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:254%">9</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:254%">608</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:254%">v</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:254%">0</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:254%">5</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:254%">.499</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i37efde9015094164b274aef726ee5ee2_85"></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:19.35pt;padding-right:19.35pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">SCHEDULE I</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:19.35pt;padding-right:19.35pt;text-align:center"><img alt="image_296.jpg" src="image_296.jpg" style="height:61px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">LSA PROVISIONS</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:0.05pt;margin-top:0.4pt"><font><br></font></div><div style="padding-left:46.55pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.387%"><tr><td style="width:1.0%"></td><td style="width:32.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:65.244%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">LSA Section</font></div></td><td colspan="3" style="border-left:0.5pt solid #010101;border-right:0.75pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">LSA Provision</font></div></td></tr><tr><td colspan="3" style="background-color:#e6e6f9;border-left:0.5pt solid #010101;border-top:1pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.2pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">1.1A(a) &#8211; Revolving Line -</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Availability</font></div></td><td colspan="3" style="background-color:#e6e6f9;border-left:0.5pt solid #010101;border-right:0.75pt solid #010101;border-top:1pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.45pt;padding-right:2.15pt;text-align:justify"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Amounts borrowed under the Revolving Line may be prepaid or repaid</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">and, prior to the Revolving Line Maturity Date, reborrowed, subject to the</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">applicable terms and conditions precedent herein, without penalty or</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">premium.</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1(a) &#8211; Term Loan &#8211; Availability</font></div></td><td colspan="3" style="border-left:0.5pt solid #010101;border-right:0.75pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.45pt;padding-right:2pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">initial</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan Advance must be in an amount equal to the </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">initial</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan Availability Amount</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"> available on the First Amendment</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Effective Date (excluding the Uncommitted Accordion, for the avoidance</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">of doubt)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. After repayment, the Term Loan Advance (or any portion thereof) may not be reborrowed.</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1(b) &#8211; Term Loan &#8211; Repayment</font></div></td><td colspan="3" style="border-left:0.5pt solid #010101;border-right:0.75pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.45pt;padding-right:1.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commencing on the Term Loan Amortization Date, and continuing on each Payment Date thereafter until the Term Loan Advance is paid in full, Borrower shall repay the </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">outstanding</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan Advance in (i) </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">thirty</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">a)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">twenty-four (24</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">30</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">) equal monthly installments of principal</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through"> if the</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">Performance Milestone does not occur, or (b) thirty-six (36) equal monthly</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">installments of principal if the Performance Milestone occurs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, plus (ii) monthly payments of accrued interest in accordance with Section 1.2(a)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(ii)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">at the rate set forth in Section </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">1.2(b)(i)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">1.2(b)(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div></td></tr><tr><td colspan="3" style="background-color:#e6e6f9;border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.2pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">1.2(a)(i) &#8211; Interest Payments -</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Advances</font></div></td><td colspan="3" style="background-color:#e6e6f9;border-left:0.5pt solid #010101;border-right:0.75pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.45pt;padding-right:2pt;text-align:justify"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Interest on the outstanding principal amount of each Advance is payable in</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">arrears monthly (A) on each Payment Date, (B) on the date of any</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">prepayment and (C) on the Revolving Line Maturity Date.</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2(a)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(ii)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211; Interest Payments &#8211; Term Loan </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">Advance</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Advances</font></div></td><td colspan="3" style="border-left:0.5pt solid #010101;border-right:0.75pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.45pt;padding-right:2pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on the outstanding principal amount of the Term Loan Advance is payable in arrears monthly (i) on each Payment Date commencing on the first Payment Date following the Funding Date of each such Term Loan Advance, (ii) on the date of any prepayment of the Term Loan Advance, and (iii) on the Term Loan Maturity Date.</font></div></td></tr><tr><td colspan="3" style="background-color:#e6e6f9;border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.2pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">1.2(b)(i) &#8211; Interest Rate - Advances</font></div></td><td colspan="3" style="background-color:#e6e6f9;border-left:0.5pt solid #010101;border-right:0.75pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.45pt;padding-right:0.6pt;text-align:justify"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">The outstanding principal amount of any Advance shall accrue interest at a</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">floating rate per annum equal to the greater of (A) six and one quarter of</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">one percent (6.25%) and (B) the Prime Rate plus the applicable Prime Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Margin, which interest shall be payable in accordance with Section</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">1.2(a)(i).</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.2pt;padding-right:0.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2(b)(</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">i</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">ii</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">) &#8211; Interest Rate &#8211; Term Loan </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">Advance</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Advances</font></div></td><td colspan="3" style="border-left:0.5pt solid #010101;border-right:0.75pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.45pt;padding-right:2.15pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The outstanding principal amount of the Term Loan Advance shall accrue interest at a floating rate per annum equal to the greater of (A) </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">five</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">six</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">and three quarters of one percent (</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">5.75</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">6.75</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%) and (B) the Prime Rate plus the </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">applicable </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prime Rate Margin, which interest shall be payable in accordance with Section 1.2(a)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #010101;border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2(e) &#8211; Interest Computation</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #010101;border-left:0.5pt solid #010101;border-right:0.75pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest shall be computed on the basis of the actual number of days elapsed and a 360-day year for any Credit Extension outstanding.</font></div></td></tr></table></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:19.3pt;padding-right:19.3pt;text-align:center"><img alt="image_297.jpg" src="image_297.jpg" style="height:76px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I-1</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:46pt"><img alt="image_298.jpg" src="image_298.jpg" style="height:42px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font></div><div style="margin-top:0.05pt;padding-left:46pt"><img alt="image_299.jpg" src="image_299.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:58px"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:144%">2</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:144%">2</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:144%">7</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:144%">9</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:144%">8</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:144%">5</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:144%">6</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:144%">0</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:144%">3</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:144%">5</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:144%">8</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:144%">4</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:144%">01</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:144%">9</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:144%">9</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:144%">68</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:144%">v5</font><font style="color:#ff0000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:144%">.4</font></div><div style="padding-left:46pt"><font style="color:#ff0000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:89%;text-decoration:line-through">354271-000499</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i37efde9015094164b274aef726ee5ee2_88"></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div><img alt="image_214.jpg" src="image_214.jpg" style="height:46px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><img alt="image_302.jpg" src="image_302.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><img alt="image_303.jpg" src="image_303.jpg" style="height:92px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><img alt="image_304.jpg" src="image_304.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><img alt="image_214.jpg" src="image_214.jpg" style="height:46px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><img alt="image_53.jpg" src="image_53.jpg" style="height:92px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><img alt="image_166.jpg" src="image_166.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"></div><div><font><br></font></div><div style="margin-top:0.45pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.387%"><tr><td style="width:1.0%"></td><td style="width:32.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:65.244%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">LSA Section</font></div></td><td colspan="3" style="border-left:0.5pt solid #010101;border-right:0.75pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">LSA Provision</font></div></td></tr><tr><td colspan="3" style="background-color:#e6e6f9;border-left:0.5pt solid #010101;border-top:1pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.2pt;padding-right:-0.75pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">1.3(c) &#8211; Revolving Line Commitment</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Fee</font></div></td><td colspan="3" style="background-color:#e6e6f9;border-left:0.5pt solid #010101;border-right:0.75pt solid #010101;border-top:1pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.45pt;padding-right:2.15pt;text-align:justify"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">A fully earned, non-refundable commitment fee of (i) Seventy-Five</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Thousand Dollars ($75,000) on the First Amendment Effective Date, (ii)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Seventy-Five Thousand Dollars ($75,000) on the first anniversary of the</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">First Amendment Effective Date, and (iii) Thirty-Seven Thousand Five</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Hundred ($37,500) on the second anniversary of the First Amendment</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Effective Date.</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 &#8211; &#8220;Borrower&#8221;</font></div></td><td colspan="3" style="border-left:0.5pt solid #010101;border-right:0.75pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means (i) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SI-BONE, INC.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, a Delaware corporation.</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 &#8211; &#8220;Effective Date&#8221;</font></div></td><td colspan="3" style="border-left:0.5pt solid #010101;border-right:0.75pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is August 12, 2021.</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 &#8211; &#8220;Payment Date&#8221;</font></div></td><td colspan="3" style="border-left:0.5pt solid #010101;border-right:0.75pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.45pt;padding-right:2.25pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Payment Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(a) with respect to Term Loan Advances,</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the first (1st) calendar day of each month</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"> and (b) with respect to Advances, the last</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">calendar day of each month</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 &#8211; &#8220;Prime Rate&#8221;</font></div></td><td colspan="3" style="border-left:0.5pt solid #010101;border-right:0.75pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.45pt;padding-right:0.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prime Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is the rate of interest per annum from time to time published in the money rates section of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">The Wall Street Journal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> or any successor publication thereto as the &#8220;prime rate&#8221; then in effect&#59; provided that if such rate of interest, as set forth from time to time in the money rates section of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">The Wall Street Journal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, becomes unavailable for any reason as determined by Bank, the &#8220;Prime Rate&#8221; shall mean the rate of interest per annum announced by Bank as its prime rate in effect at its principal office in the State of California (such Bank announced Prime Rate not being intended to be the lowest rate of interest charged by Bank in connection with extensions of credit to debtors)&#59; provided that, in the event such rate of interest is less than zero percent (0.0%) per annum, such rate shall be deemed to be zero percent (0.0%) per annum for purposes of this Agreement.</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 &#8211; &#8220;Prime Rate Margin&#8221;</font></div></td><td colspan="3" style="border-left:0.5pt solid #010101;border-right:0.75pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.45pt;padding-right:2.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prime Rate Margin</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">two and</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(a) for Advances, (i) zero percent</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(0.00%), and (b) for Term Loan Advances,</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">one half of one percent (</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">2.50</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">0.50</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%).</font></div></td></tr><tr><td colspan="3" style="background-color:#e6e6f9;border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.2pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">12.2 &#8211; &#8220;Revolving Line&#8221;</font></div></td><td colspan="3" style="background-color:#e6e6f9;border-left:0.5pt solid #010101;border-right:0.75pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.45pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Revolving Line</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8221; is an aggregate principal amount equal to Fifteen</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Million Dollars ($15,000,000).</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 &#8211; &#8220;Term Loan Amortization Date&#8221;</font></div></td><td colspan="3" style="border-left:0.5pt solid #010101;border-right:0.75pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Term Loan Amortization Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">September</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">July</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1, </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">2023</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2025</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div></td></tr><tr><td colspan="3" style="background-color:#e6e6f9;border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.2pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">12.2 &#8211; &#8220;Revolving Line Maturity</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Date&#8221;</font></div></td><td colspan="3" style="background-color:#e6e6f9;border-left:0.5pt solid #010101;border-right:0.75pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.45pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Revolving Line Maturity Date</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8221; is the date that is thirty (30) months</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">after the First Amendment Effective Date.</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 &#8211; &#8220;Term Loan Availability Amount&#8221;</font></div></td><td colspan="3" style="border-left:0.5pt solid #010101;border-right:0.75pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.45pt;padding-right:1.9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Term Loan Availability Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; is </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">Thirty-Five</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Thirty-Six</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Million Dollars ($</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">35,000,000)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">36,000,000)&#59; provided however, upon Borrower&#8217;s</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">request, if Bank, in its sole and absolute discretion, grant Borrower&#8217;s</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">request to make the Uncommitted Accordion available to Borrower, then</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Term Loan Availability Amount</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8221; shall mean an aggregate principal</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">amount equal to Fifty-One Million Dollars ($51,000,000)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #010101;border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 &#8211; &#8220;Term Loan Maturity Date&#8221;</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #010101;border-left:0.5pt solid #010101;border-right:0.75pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Term Loan Maturity Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221; is </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:line-through">August</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">December</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">1, </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:line-through">2025&#59; provided,</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:line-through">however, if Borrower achieves the Performance Milestone, then the Term</font></div></td></tr></table></div><div style="height:87.84pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_309.jpg" src="image_309.jpg" style="height:41px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.103%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I-2</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font></div><div style="margin-top:0.1pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:144%">2</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:144%">2</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:144%">7</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:144%">9</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:144%">8</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:144%">5</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:144%">6</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:144%">0</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:144%">3</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:144%">5</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:144%">8</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:144%">4</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:144%">01</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:144%">9</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:144%">9</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:144%">68</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:144%">v5</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:144%">.</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">354271-000499</font></div></td></tr></table></div></div></div><div id="i37efde9015094164b274aef726ee5ee2_91"></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="padding-left:46.55pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.387%"><tr><td style="width:1.0%"></td><td style="width:32.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:65.244%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">LSA Section</font></div></td><td colspan="3" style="border-left:0.5pt solid #010101;border-right:0.75pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">LSA Provision</font></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #010101;border-left:0.5pt solid #010101;border-top:1pt solid #010101;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #010101;border-left:0.5pt solid #010101;border-right:0.75pt solid #010101;border-top:1pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.45pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">Loan Maturity Date shall automatically, with no further action required by the parties hereto, be extended through August 1, 2026</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline line-through">2027</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">.</font></div></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:19.3pt;padding-right:19.3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I-3</font></div><div style="text-align:center"><font><br></font></div><div style="height:61.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_309.jpg" src="image_309.jpg" style="height:41px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:underline">WEST&#92;300615610.6</font></div><div style="padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:143%">2</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:143%">2</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:143%">7</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:143%">9</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:143%">8</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:143%">5</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:143%">6</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:143%">0</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:143%">3</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:143%">5</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:143%">8</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:143%">4</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:143%">01</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:143%">9</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:143%">9</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:143%">68</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:143%">v5</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:143%">.</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:99%">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:4.5pt;padding-left:19.37pt;padding-right:19.37pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">EXHIBIT A</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:19.25pt;padding-right:19.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">COMPLIANCE STATEMENT</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TO&#58;&#160;&#160;&#160;&#160;SILICON VALLEY BANK&#160;&#160;&#160;&#160;Date&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.05pt;padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FROM&#58;&#160;&#160;&#160;&#160;SI-BONE, INC.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46pt;padding-right:45.2pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under the terms and conditions of the Loan and Security Agreement between Borrower and Bank (as amended, modified, supplemented and&#47;or restated from time to time, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), Borrower is in complete compliance for the period ending </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">with all required covenants except as noted below. Attached are the required documents evidencing such compliance, setting forth calculations prepared in accordance with GAAP consistently applied from one period to the next except as explained in an accompanying letter or footnotes (and except for with respect to unaudited financial statements for the absence of footnotes and subject to year-end audit adjustments). Capitalized terms used but not otherwise defined herein shall have the meanings given them in the Agreement.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:51.5pt"><img alt="image_314.jpg" src="image_314.jpg" style="height:226px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Please indicate compliance status by circling Yes&#47;No under &#8220;Complies&#8221; column.</font></div><div style="margin-bottom:0.05pt;margin-top:0.1pt"><font><br></font></div><div style="height:61.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_309.jpg" src="image_309.jpg" style="height:41px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:underline">WEST&#92;300615610.6</font></div><div style="padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:143%">2</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:143%">2</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:143%">7</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:143%">9</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:143%">8</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:143%">5</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:143%">6</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:143%">0</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:143%">3</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:143%">5</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:143%">8</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:143%">4</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:143%">01</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:143%">9</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:143%">9</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:143%">68</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:143%">v5</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:143%">.</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:99%">354271-000499</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><font><br></font></div></div><div style="padding-left:46.55pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.220%"><tr><td style="width:1.0%"></td><td style="width:31.607%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.895%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.931%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.437%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.1pt;padding-left:35.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:111%;text-decoration:underline">Reporting Covenants</font></div></td><td colspan="9" style="border-bottom:0.5pt solid #010101;border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.1pt;padding-left:86.07pt;padding-right:86.07pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:111%;text-decoration:underline">Required</font></div></td><td colspan="3" style="border-left:0.5pt solid #010101;border-right:0.75pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.1pt;padding-left:25.35pt;padding-right:25.35pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:111%;text-decoration:underline">Complies</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.2pt;padding-right:6.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quarterly Financial Statements with Compliance Statement</font></div></td><td colspan="9" style="border-bottom:0.5pt solid #010101;border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quarterly within 45 days and FYE within 90 days</font></div></td><td colspan="3" style="border-left:0.5pt solid #010101;border-right:0.75pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:25.3pt;padding-right:25.3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yes No</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.2pt;padding-right:14.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annual financial statements (CPA Audited)</font></div></td><td colspan="9" style="border-bottom:0.5pt solid #010101;border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FYE within 180 days</font></div></td><td colspan="3" style="border-left:0.5pt solid #010101;border-right:0.75pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:25.3pt;padding-right:25.3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yes No</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q, 10-K and 8-K</font></div></td><td colspan="9" style="border-bottom:0.5pt solid #010101;border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Within 5 Business Days after filing with SEC</font></div></td><td colspan="3" style="border-left:0.5pt solid #010101;border-right:0.75pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:25.45pt;padding-right:25.45pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yes No N&#47;A</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Board approved projections</font></div></td><td colspan="9" style="border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">FYE within 30 days and within 30 days, as amended&#47;updated, in each case as approved by the Board</font></div></td><td colspan="3" style="border-left:0.5pt solid #010101;border-right:0.75pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:25.3pt;padding-right:25.3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yes No</font></div></td></tr><tr style="height:41pt"><td colspan="3" rowspan="3" style="background-color:#c0c0c0;border-left:0.5pt solid #010101;border-right:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5.2pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline line-through">Other Matters</font></div><div style="margin-top:0.05pt;padding-left:5.2pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Borrowing Base Reports</font></div></td><td colspan="3" rowspan="3" style="background-color:#c0c0c0;border-left:0.5pt solid #010101;border-top:1pt solid #010101;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.45pt;padding-right:-2.2pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline">When Advances are</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> outstanding or are being</font></div></td><td colspan="3" rowspan="3" style="background-color:#ffdead;border-bottom:1pt solid #010101;border-left:0.5pt solid #010101;border-right:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:9.25pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">h</font></div></td><td colspan="3" rowspan="3" style="background-color:#c0c0c0;border-left:0.5pt solid #010101;border-right:0.75pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:39.05pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:113%;text-decoration:underline">Yes No</font></div></td></tr><tr style="height:83pt"><td colspan="3" style="background-color:#c0c0c0;border-right:0.5pt solid #010101;border-top:1.5pt double #0000ff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.45pt;padding-right:-2.2pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">requested, weekly on</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Friday of each week if</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">an Streamline Period is</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">not in effect&#59; monthly</font></div><div style="padding-left:0.45pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:98%">within 30 days of mont</font></div></td></tr><tr style="height:48pt"><td colspan="3" style="background-color:#c0c0c0;border-bottom:1pt solid #010101;border-right:0.5pt solid #010101;border-top:1.5pt double #0000ff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.15pt;padding-left:0.45pt;padding-right:-2.2pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">End if and Streamline</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Period</font></div><div style="padding-left:0.45pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:111%;text-decoration:underline">is in effect&#59; and with</font></div><div style="margin-top:0.05pt;padding-left:0.45pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:106%;text-decoration:underline">each Advance</font></div></td></tr><tr><td colspan="3" style="background-color:#e6e6f9;border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.2pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">A&#47;R &#38; A&#47;P Agings and Deferred</font></div><div style="padding-left:5.2pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:111%;text-decoration:underline">Revenue reports</font></div></td><td colspan="9" style="background-color:#e6e6f9;border-left:0.5pt solid #010101;border-top:1pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.45pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">When Advances are outstanding or are being</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> requested, monthly within 30 days</font></div></td><td colspan="3" style="background-color:#e6e6f9;border-left:0.5pt solid #010101;border-right:0.75pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:25.3pt;padding-right:25.3pt;text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Yes No</font></div></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;border-bottom:0.5pt solid #010101;border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%">Have there been any material</font></div><div style="padding-left:5.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">amendments to the Operating Documents of Borrower&#63; If yes, provide copies of any such amendments or changes with this Compliance Statement</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">.</font></div></td><td colspan="6" style="background-color:#c0c0c0;border-bottom:0.5pt solid #010101;border-left:0.5pt solid #010101;border-top:2pt double #010101;padding:2px 1pt 2px 6.45pt;text-align:left;vertical-align:top"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">N&#47;A</font></td><td colspan="3" style="background-color:#ffdead;border-left:0.5pt solid #010101;border-top:1.5pt double #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.9pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:96%;text-decoration:line-through">Yes&#160;&#160;&#160;&#160;No</font></div></td><td colspan="3" style="background-color:#c0c0c0;border-bottom:0.5pt solid #010101;border-left:0.5pt solid #010101;border-right:0.75pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:25.3pt;padding-right:25.3pt;text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;text-decoration:underline">Yes No</font></div></td></tr></table></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:46.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.331%"><tr><td style="width:1.0%"></td><td style="width:42.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.020%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.5pt;padding-left:78.85pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Streamline Period</font></div><div style="padding-left:31.45pt;text-indent:-23.3pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline">(Measured only when Advances are outstanding</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline">or are being requested by Borrower)</font></div></td><td colspan="3" style="background-color:#ffdead;border-bottom:1pt solid #010101;border-left:0.5pt solid #010101;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-left:0.5pt solid #010101;border-right:0.75pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.5pt;padding-right:49.2pt;text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Applies</font></div></td></tr><tr><td colspan="6" style="background-color:#e6e6f9;border-bottom:0.5pt solid #010101;border-left:0.5pt solid #010101;border-top:1pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.45pt;padding-left:5.8pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%;text-decoration:underline">Adjusted Quick Ratio &#62; 1.50 to 1.00</font></div></td><td colspan="3" style="background-color:#e6e6f9;border-left:0.5pt solid #010101;border-right:0.75pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.2pt;padding-right:47.15pt;text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline">Yes No</font></div></td></tr><tr><td colspan="6" style="background-color:#e6e6f9;border-bottom:0.5pt solid #010101;border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.5pt;padding-left:5.8pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%;text-decoration:underline">Adjusted Quick Ratio &#60; 1.50 to 1.00</font></div></td><td colspan="3" style="background-color:#e6e6f9;border-bottom:0.5pt solid #010101;border-left:0.5pt solid #010101;border-right:0.75pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.5pt;padding-right:47.15pt;text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%;text-decoration:underline">Yes No</font></div></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:19.35pt;padding-right:19.35pt;text-align:center"><img alt="image_315.jpg" src="image_315.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><img alt="image_316.jpg" src="image_316.jpg" style="height:23px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><img alt="image_317.jpg" src="image_317.jpg" style="height:82px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A-1</font></div><div style="height:61.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_309.jpg" src="image_309.jpg" style="height:41px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%;text-decoration:underline">WEST&#92;300615610.6</font></div><div style="padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:143%">2</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:143%">2</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:143%">7</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:143%">9</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:143%">8</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:143%">5</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:143%">6</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:143%">0</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:143%">3</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:143%">5</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:143%">8</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:143%">4</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:143%">01</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:143%">9</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:143%">9</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:143%">68</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:143%">v5</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:143%">.</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:99%">354271-000499</font></div></td></tr></table></div></div></div><div id="i37efde9015094164b274aef726ee5ee2_97"></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:4.5pt;padding-left:19.37pt;padding-right:19.37pt;text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Schedule 1 to Compliance Statement</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:19.37pt;padding-right:19.37pt;text-align:center"><img alt="image_322.jpg" src="image_322.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Financial Covenants of Borrower</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:10pt"><img alt="image_323.jpg" src="image_323.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><img alt="image_172.jpg" src="image_172.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">In the event of a conflict between this Schedule and the Agreement, the terms of the Agreement shall govern.</font></div><div><font><br></font></div><div style="margin-bottom:0.35pt;margin-top:4.55pt;padding-left:5.4pt"><img alt="image_172.jpg" src="image_172.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I.&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Minimum Net Revenue </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(Section 5.10)</font></div><div style="padding-left:54.7pt"><img alt="image_326.jpg" src="image_326.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:210px"></div><div style="padding-left:5.15pt"><img alt="image_327.jpg" src="image_327.jpg" style="height:2px;margin-bottom:5pt;vertical-align:text-bottom;width:7px"></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.5pt;padding-left:82pt;padding-right:9.3pt;text-indent:-72pt"><img alt="image_171.jpg" src="image_171.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><img alt="image_329.jpg" src="image_329.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><img alt="image_330.jpg" src="image_330.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><img alt="image_329.jpg" src="image_329.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Required&#58;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">When a Financial Covenant Measuring Period is in effect, Borrower shall achieve Net Revenue as required by</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.10 and set forth below (pursuant to the amendment(s) required under Section 5.10)&#58;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:77.6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:65.576%"><tr><td style="width:1.0%"></td><td style="width:48.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.518%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e6e6f9;border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.87pt;padding-right:2.87pt;text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Measuring Period Ending</font></div></td><td colspan="3" style="background-color:#e6e6f9;border-left:0.5pt solid #010101;border-right:0.75pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13pt;text-indent:32.5pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Minimum Net Revenue</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">(measured on a trailing 6 month basis)</font></div></td></tr><tr><td colspan="3" style="background-color:#e6e6f9;border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.8pt;padding-right:2.8pt;text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#91;&#160;&#160;&#160;&#160;&#93;</font></div></td><td colspan="3" style="background-color:#e6e6f9;border-left:0.5pt solid #010101;border-right:0.75pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:73.9pt;text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">$&#91;&#160;&#160;&#160;&#160;&#93;</font></div></td></tr><tr><td colspan="3" style="background-color:#e6e6f9;border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.8pt;padding-right:2.8pt;text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#91;&#160;&#160;&#160;&#160;&#93;</font></div></td><td colspan="3" style="background-color:#e6e6f9;border-left:0.5pt solid #010101;border-right:0.75pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:73.9pt;text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">$&#91;&#160;&#160;&#160;&#160;&#93;</font></div></td></tr><tr><td colspan="3" style="background-color:#e6e6f9;border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.8pt;padding-right:2.8pt;text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#91;&#160;&#160;&#160;&#160;&#93;</font></div></td><td colspan="3" style="background-color:#e6e6f9;border-left:0.5pt solid #010101;border-right:0.75pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:73.9pt;text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">$&#91;&#160;&#160;&#160;&#160;&#93;</font></div></td></tr><tr><td colspan="3" style="background-color:#e6e6f9;border-bottom:0.5pt solid #010101;border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.8pt;padding-right:2.8pt;text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#91;&#160;&#160;&#160;&#160;&#93;</font></div></td><td colspan="3" style="background-color:#e6e6f9;border-bottom:0.5pt solid #010101;border-left:0.5pt solid #010101;border-right:0.75pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:73.9pt;text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">$&#91;&#160;&#160;&#160;&#160;&#93;</font></div></td></tr></table></div><div><font><br></font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:10pt"><img alt="image_332.jpg" src="image_332.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><img alt="image_332.jpg" src="image_332.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><img alt="image_172.jpg" src="image_172.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Actual&#58; $&#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:10pt"><img alt="image_171.jpg" src="image_171.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><img alt="image_172.jpg" src="image_172.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Is Borrower&#8217;s Net Revenue (measured on a trailing 6 month basis) greater than or equal to the required amount for the corresponding</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">measuring period set forth in the chart above&#63;</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:8.7pt;padding-right:8.7pt;text-align:center"><img alt="image_337.jpg" src="image_337.jpg" style="height:2px;margin-bottom:5pt;vertical-align:text-bottom;width:172px"><img alt="image_338.jpg" src="image_338.jpg" style="height:2px;margin-bottom:5pt;vertical-align:text-bottom;width:156px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No, not in compliance&#160;&#160;&#160;&#160;Yes, in compliance</font></div><div style="height:66.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_339.jpg" src="image_339.jpg" style="height:44px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font></div><div style="margin-top:4.7pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">278638019 v5</font></div></td></tr></table></div></div></div><div id="i37efde9015094164b274aef726ee5ee2_100"></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div><img alt="image_289.jpg" src="image_289.jpg" style="height:5px;margin-bottom:5pt;vertical-align:text-bottom;width:77px"></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:236.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">EXHIBIT B</font></div><div style="margin-top:6pt;padding-left:140.8pt;padding-right:148.2pt;text-indent:9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:176%;text-decoration:underline">LOAN PAYMENT&#47;ADVANCE REQUEST FORM</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:176%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:176%;text-decoration:underline">Deadline for same day processing is Noon Pacific Time</font></div><div style="margin-top:0.2pt;padding-left:50.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">FAX TO</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58;&#160;&#160;&#160;&#160;Date&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.05pt"><img alt="image_342.jpg" src="image_342.jpg" style="height:302px;margin-bottom:5pt;vertical-align:text-bottom;width:699px"><img alt="image_343.jpg" src="image_343.jpg" style="height:148px;margin-bottom:5pt;vertical-align:text-bottom;width:702px"><img alt="image_344.jpg" src="image_344.jpg" style="height:263px;margin-bottom:5pt;vertical-align:text-bottom;width:702px"></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="height:66.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_345.jpg" src="image_345.jpg" style="height:41px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.6pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">WEST&#92;300615610.6</font></div><div style="margin-top:0.1pt;padding-left:1pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:144%">2</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:144%">2</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:144%">7</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:144%">9</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:144%">8</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:144%">5</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:144%">6</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:144%">0</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:144%">3</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:144%">5</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:144%">8</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:144%">4</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:144%">01</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:144%">9</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:144%">9</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:144%">68</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:144%">v5</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:144%">.</font></div><div style="padding-left:1pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:99%">354271-000499</font></div></td></tr></table></div></div></div><div id="i37efde9015094164b274aef726ee5ee2_109"></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:80.66pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.918%"><tr><td style="width:1.0%"></td><td style="width:76.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.415%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="border-bottom:0.75pt solid #010101;border-left:0.75pt solid #010101;border-right:1pt solid #010101;border-top:0.75pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:4.42pt;padding-right:4.42pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Summary report&#58;</font></div><div style="padding-left:4.55pt;padding-right:4.55pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:131%">Litera Compare for Word 11.2.0.54 Document comparison done on 1&#47;5&#47;2023 2&#58;03&#58;48 PM</font></div></td></tr><tr><td colspan="6" style="border-bottom:0.75pt solid #010101;border-left:0.75pt solid #010101;border-right:1pt solid #010101;border-top:0.75pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:106%">Style name&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">DLAPiper</font></div></td></tr><tr><td colspan="6" style="border-bottom:0.75pt solid #010101;border-left:0.75pt solid #010101;border-right:1pt solid #010101;border-top:0.75pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:5.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:106%">Intelligent Table Comparison&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">Active</font></div></td></tr><tr><td colspan="6" style="border-bottom:0.75pt solid #010101;border-left:0.75pt solid #010101;border-right:1pt solid #010101;border-top:0.75pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:5.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:106%">Original DMS&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">iw&#58;&#47;&#47;dms.us.dlapiper.com&#47;WEST&#47;300615610&#47;1</font></div></td></tr><tr><td colspan="6" style="border-bottom:0.75pt solid #010101;border-left:0.75pt solid #010101;border-right:1pt solid #010101;border-top:0.75pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:5.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:106%">Modified DMS&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">iw&#58;&#47;&#47;dms.us.dlapiper.com&#47;WEST&#47;300615610&#47;6</font></div></td></tr><tr><td colspan="6" style="border-left:0.75pt solid #010101;border-right:1pt solid #010101;border-top:0.75pt solid #010101;padding:2px 1pt 2px 6.05pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Changes&#58;</font></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #010101;border-top:0.75pt solid #010101;padding:2px 1pt 2px 6.05pt;text-align:left;vertical-align:top"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Add</font></td><td colspan="3" style="border-left:0.75pt solid #010101;border-right:1pt solid #010101;border-top:0.75pt solid #010101;padding:2px 1pt 2px 6.4pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">297</font></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #010101;border-top:0.75pt solid #010101;padding:2px 1pt 2px 6.05pt;text-align:left;vertical-align:top"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Delete</font></td><td colspan="3" style="border-left:0.75pt solid #010101;border-right:1pt solid #010101;border-top:0.75pt solid #010101;padding:2px 1pt 2px 6.4pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">136</font></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #010101;border-top:0.75pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:5.05pt"><font style="color:#007f00;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%;text-decoration:line-through">Move From</font></div></td><td colspan="3" style="border-left:0.75pt solid #010101;border-right:1pt solid #010101;border-top:0.75pt solid #010101;padding:2px 1pt 2px 6.4pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7</font></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #010101;border-top:0.75pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:5.05pt"><font style="color:#007f00;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%;text-decoration:underline">Move To</font></div></td><td colspan="3" style="border-left:0.75pt solid #010101;border-right:1pt solid #010101;border-top:0.75pt solid #010101;padding:2px 1pt 2px 6.4pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7</font></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #010101;border-top:0.75pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:5.05pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%;text-decoration:underline">Table Insert</font></div></td><td colspan="3" style="border-left:0.75pt solid #010101;border-right:1pt solid #010101;border-top:0.75pt solid #010101;padding:2px 1pt 2px 6.4pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11</font></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #010101;border-top:0.75pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:5.05pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%;text-decoration:line-through">Table Delete</font></div></td><td colspan="3" style="border-left:0.75pt solid #010101;border-right:1pt solid #010101;border-top:0.75pt solid #010101;padding:2px 1pt 2px 6.4pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6</font></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #010101;border-top:0.75pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:5.05pt"><font style="color:#007f00;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%;text-decoration:underline">Table moves to</font></div></td><td colspan="3" style="border-left:0.75pt solid #010101;border-right:1pt solid #010101;border-top:0.75pt solid #010101;padding:2px 1pt 2px 6.4pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0</font></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #010101;border-top:0.75pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:5.05pt"><font style="color:#007f00;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%;text-decoration:line-through">Table moves from</font></div></td><td colspan="3" style="border-left:0.75pt solid #010101;border-right:1pt solid #010101;border-top:0.75pt solid #010101;padding:2px 1pt 2px 6.4pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0</font></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #010101;border-top:0.75pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:5.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">Embedded Graphics (Visio, ChemDraw, Images etc.)</font></div></td><td colspan="3" style="border-left:0.75pt solid #010101;border-right:1pt solid #010101;border-top:0.75pt solid #010101;padding:2px 1pt 2px 6.4pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0</font></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #010101;border-top:0.75pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:5.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">Embedded Excel</font></div></td><td colspan="3" style="border-left:0.75pt solid #010101;border-right:1pt solid #010101;border-top:0.75pt solid #010101;padding:2px 1pt 2px 6.4pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0</font></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #010101;border-top:0.75pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:5.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">Format changes</font></div></td><td colspan="3" style="border-left:0.75pt solid #010101;border-right:1pt solid #010101;border-top:0.75pt solid #010101;padding:2px 1pt 2px 6.4pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0</font></td></tr><tr><td colspan="3" style="border-bottom:0.75pt solid #010101;border-left:0.75pt solid #010101;border-top:0.75pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:5.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:106%">Total Changes&#58;</font></div></td><td colspan="3" style="border-bottom:0.75pt solid #010101;border-left:0.75pt solid #010101;border-right:1pt solid #010101;border-top:0.75pt solid #010101;padding:2px 1pt 2px 6.4pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">464</font></td></tr></table></div><div><font><br></font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>letteragreement.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="iced1dd4bb76e4438bc7c82486e54cf68_33"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EXHIBIT 10.2</font></div><div style="padding-left:108pt;text-indent:36pt"><font><br></font></div><div style="padding-left:108pt;text-indent:36pt"><img alt="picture1.jpg" src="picture1.jpg" style="height:52px;margin-bottom:5pt;vertical-align:text-bottom;width:300px"></div><div style="padding-left:36pt;text-indent:36pt"><font><br></font></div><div style="text-align:right;text-indent:-0.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">                                                                                      </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:103%">March 24, 2023 </font></div><div><font><br></font></div><div style="text-align:center;text-indent:2.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:107%;text-decoration:underline">Letter Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:107%"> </font></div><div><font><br></font></div><div style="text-indent:35.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:103%">Reference is made to the Loan and Security Agreement dated as of August 12, 2021 by and between Silicon Valley Bank, now known as Silicon Valley Bridge Bank, N.A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:103%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:103%"> (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:103%">Bank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:103%">&#8221;) and SI-BONE, Inc., a Delaware corporation (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:103%">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:103%">&#8221;) (as amended </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:103%">modified, supplemented and&#47;or restated from time to time, including, without limitation, pursuant to that certain First Amendment to Loan and Security Agreement dated January 6, 2023, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:103%">Loan Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:103%">&#8221;).</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:103%">Capitalized terms used but not otherwise defined herein shall have the same meanings set forth in the Loan Agreement. </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:9.75pt">Bank hereby waives any Event of Default under the Loan Agreement by virtue of Borrower&#8217;s failure to comply with Sections 5.4(c), 5.9(a), and 5.9(c)of the Loan Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Depository Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;) prior to the date hereof.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Bank&#8217;s waiver of Borrower&#8217;s compliance with the Depository Covenants shall apply only to the foregoing specific period.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Except as explicitly set forth herein, Borrower shall continue to comply with requirements set forth in the Loan Agreement pertaining to accounts of Borrower maintained outside of Bank including, without limitation, those requirements pertaining to (i) notifications to Bank of the establishment of any account with a financial institution other than Bank or (ii) delivery of a fully-executed account control agreement with respect to each such account.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:9.75pt">Notwithstanding any terms in the Loan Agreement or the other Loan Documents to the contrary, Bank hereby agrees that Borrower shall have (a) for any accounts opened by Borrower with a financial institution other than Bank prior to the date of this letter agreement, 45 days from the date of this letter agreement to deliver fully-executed account control agreements with respect to such accounts, and (b) for any accounts opened by Borrower with a financial institution other than Bank on or after the date of this letter agreement, 10 days from the date that the applicable account is opened to deliver a fully executed account control agreement with respect to such account.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:9.75pt">Notwithstanding Section 5.4(c) of the Loan Agreement, or anything to the contrary therein, if, and only if, no amounts are outstanding under the Revolving Line, Borrower shall not be required to direct Account Debtors to or deliver proceeds of Accounts to the Cash Collateral Account, nor is Borrower required to sweep Account proceeds from third party accounts maintained in compliance with this letter agreement, to the Cash Collateral Account (or accounts with Bank or Bank&#8217;s Affiliates), subject to Borrower&#8217;s compliance with Section 5.9 of the Loan Agreement, as amended by this letter agreement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:9pt">At all times when any amounts are outstanding under the Revolving Line, Borrower shall maintain no more than Ten Million Dollars ($10,000,000) in aggregate in accounts with financial institutions in the United States other than the Bank or Bank&#8217;s Affiliates. </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:9.75pt">Notwithstanding the terms of the Depository Covenants in the Loan Agreement to the contrary, solely with respect to accounts of Borrower, Bank hereby agrees that Borrower shall only be required to maintain its primary operating accounts, depository accounts and excess cash with Bank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">or Bank&#8217;s Affiliates, which shall represent at least 50.0% of the Dollar value of all of Borrower&#8217;s accounts at all financial institutions.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:9.75pt">Except for the limited purpose expressly set forth herein, this letter agreement shall in no way limit, amend or waive any other provision of the Loan Agreement or any of the Loan Documents, or any of Bank&#8217;s rights stated therein.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">This letter agreement shall be deemed to be a Loan Document. </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:9.75pt">In consideration for Bank&#8217;s agreements hereunder, Borrower hereby forever relieves, releases, and discharges Bank, its predecessors in interest, and their respective present or former employees, officers, directors, agents, representatives, attorneys, and each of them, from any and all claims, debts, liabilities, demands, obligations, promises, acts, agreements, costs and expenses, actions and causes of action, of every type, kind, nature, description or character whatsoever, whether known or unknown, arising out of or in any manner whatsoever connected with or related to facts, circumstances, issues, controversies or claims existing or arising from the beginning of time through and including the date of execution of this letter agreement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Borrower expressly acknowledges and waives any and all rights under Section 1542 of the California Civil Code, which provides as follows&#58; &#8220;A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY.&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Borrower expressly, knowingly, and intentionally waive any and all rights, benefits, and protections of Section 1542 of the California Civil Code and of any other state or federal statute or common law principle limiting the scope of a general release. </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:9.75pt">This letter agreement shall be effective as of the date first written above. </font></div><div><font><br></font></div><div><font><br></font></div><div style="text-indent:-0.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">                                                                        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:103%">Sincerely, </font></div><div><font><br></font></div><div style="text-indent:-0.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">                                                               </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:107%">SILICON VALLEY BRIDGE BANK, N.A. </font></div><div><font><br></font></div><div><font><br></font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:103%">By &#47;s&#47; Mark Davis </font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:103%">Name&#58; Mark Davis </font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:103%">Title&#58; Senior Vice President </font></div><div><font><br></font></div><div><font><br></font></div><div style="text-indent:-0.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:103%">Acknowledged and agreed&#58; </font></div><div><font><br></font></div><div style="text-indent:-0.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:107%">SI-BONE, INC. </font></div><div><font><br></font></div><div><font><br></font></div><div style="text-indent:-0.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:103%">By &#47;s&#47; Anshul Maheshwari</font></div><div style="text-indent:-0.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:103%">Name&#58; Anshul Maheshwari </font></div><div style="text-indent:-0.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:103%">Title&#58; CFO </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>sibn-ex311_331202310xq.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ib4ffee46fdc24b22aad694f9aea6a143_1"></div><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div><font><br></font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Laura A. Francis, certify that&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this Form 10-Q of SI-BONE, Inc.&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.74pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-4.5pt"><font><br></font></div><div style="padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.17pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-4.5pt"><font><br></font></div><div style="padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.74pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-4.5pt"><font><br></font></div><div style="padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.17pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.74pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-4.5pt"><font><br></font></div><div style="padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.17pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.138%"><tr><td style="width:1.0%"></td><td style="width:4.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.815%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.615%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.615%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.928%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Laura A. Francis</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2, 2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laura A. Francis</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>sibn-ex312_331202310xq.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i4cffe5051e144b96a23e9fe0123f8170_1"></div><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="text-align:right"><font><br></font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Anshul Maheshwari, certify that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this Form 10-Q of SI-BONE, Inc.&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.74pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-4.5pt"><font><br></font></div><div style="padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.17pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-4.5pt"><font><br></font></div><div style="padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.74pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-4.5pt"><font><br></font></div><div style="padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.17pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.74pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-4.5pt"><font><br></font></div><div style="padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.17pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.527%"><tr><td style="width:1.0%"></td><td style="width:5.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.225%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.752%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.366%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Anshul Maheshwari</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2, 2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anshul Maheshwari</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>sibn-ex321_331202310xq.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i7e0fee34ef844cbfba8e9ffe03df52f2_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="text-align:right"><font><br></font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, (the &#8220;Exchange Act&#8221;) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. &#167;1350), Laura A. Francis, Chief Executive Officer of SI-BONE, Inc. (the &#8220;Company&#8221;), and Anshul Maheshwari, Chief Financial Officer of the Company, each hereby certify that, to the best of her or his knowledge&#58; </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. The Company&#8217;s Quarterly Report on Form 10-Q for the period ended March 31, 2023, to which this Certification is attached as Exhibit 32.1 (the &#8220;Periodic Report&#8221;), fully complies with the requirements of Section 13(a) or Section 15(d) of the Exchange Act&#59; and </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. The information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company. </font></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.857%"><tr><td style="width:1.0%"></td><td style="width:4.782%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.305%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.329%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.006%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.006%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.006%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.566%"></td><td style="width:0.1%"></td></tr><tr style="height:39pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Laura A. Francis</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2, 2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laura A. Francis</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="12" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Anshul Maheshwari</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2, 2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anshul Maheshwari</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of SI-BONE, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing. </font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>sibn-20230331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:b9a8bdb4-fcbc-4ee6-8fcb-5f67627ef90e,g:a1ffbe61-3b0e-45b0-8eb9-b424c3d4458b-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:sibn="http://si-bone.com/20230331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://si-bone.com/20230331">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sibn-20230331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sibn-20230331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sibn-20230331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sibn-20230331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://si-bone.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETS" roleURI="http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS">
        <link:definition>0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" roleURI="http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS">
        <link:definition>0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" roleURI="http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY">
        <link:definition>0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TheCompanyandNatureofBusiness" roleURI="http://si-bone.com/role/TheCompanyandNatureofBusiness">
        <link:definition>0000007 - Disclosure - The Company and Nature of Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://si-bone.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>0000008 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecurities" roleURI="http://si-bone.com/role/MarketableSecurities">
        <link:definition>0000009 - Disclosure - Marketable Securities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurement" roleURI="http://si-bone.com/role/FairValueMeasurement">
        <link:definition>0000010 - Disclosure - Fair Value Measurement</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponents" roleURI="http://si-bone.com/role/BalanceSheetComponents">
        <link:definition>0000011 - Disclosure - Balance Sheet Components</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://si-bone.com/role/CommitmentsandContingencies">
        <link:definition>0000012 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Borrowings" roleURI="http://si-bone.com/role/Borrowings">
        <link:definition>0000013 - Disclosure - Borrowings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedIncentiveCompensationPlans" roleURI="http://si-bone.com/role/StockBasedIncentiveCompensationPlans">
        <link:definition>0000014 - Disclosure - Stock-Based Incentive Compensation Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareofCommonStock" roleURI="http://si-bone.com/role/NetLossPerShareofCommonStock">
        <link:definition>0000015 - Disclosure - Net Loss Per Share of Common Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransaction" roleURI="http://si-bone.com/role/RelatedPartyTransaction">
        <link:definition>0000016 - Disclosure - Related Party Transaction</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://si-bone.com/role/IncomeTaxes">
        <link:definition>0000017 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://si-bone.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>0000018 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesTables" roleURI="http://si-bone.com/role/SummaryofSignificantAccountingPoliciesTables">
        <link:definition>0000019 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecuritiesTables" roleURI="http://si-bone.com/role/MarketableSecuritiesTables">
        <link:definition>0000020 - Disclosure - Marketable Securities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementTables" roleURI="http://si-bone.com/role/FairValueMeasurementTables">
        <link:definition>0000021 - Disclosure - Fair Value Measurement (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsTables" roleURI="http://si-bone.com/role/BalanceSheetComponentsTables">
        <link:definition>0000022 - Disclosure - Balance Sheet Components (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesTables" roleURI="http://si-bone.com/role/CommitmentsandContingenciesTables">
        <link:definition>0000023 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsTables" roleURI="http://si-bone.com/role/BorrowingsTables">
        <link:definition>0000024 - Disclosure - Borrowings (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedIncentiveCompensationPlansTables" roleURI="http://si-bone.com/role/StockBasedIncentiveCompensationPlansTables">
        <link:definition>0000025 - Disclosure - Stock-Based Incentive Compensation Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareofCommonStockTables" roleURI="http://si-bone.com/role/NetLossPerShareofCommonStockTables">
        <link:definition>0000026 - Disclosure - Net Loss Per Share of Common Stock (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesNarrativeDetails" roleURI="http://si-bone.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>0000027 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesRevenuebyGeographyDetails" roleURI="http://si-bone.com/role/SummaryofSignificantAccountingPoliciesRevenuebyGeographyDetails">
        <link:definition>0000028 - Disclosure - Summary of Significant Accounting Policies - Revenue by Geography (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecuritiesScheduleofMarketableSecuritiesDetails" roleURI="http://si-bone.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails">
        <link:definition>0000029 - Disclosure - Marketable Securities - Schedule of Marketable Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecuritiesNarrativeDetails" roleURI="http://si-bone.com/role/MarketableSecuritiesNarrativeDetails">
        <link:definition>0000030 - Disclosure - Marketable Securities - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementDetails" roleURI="http://si-bone.com/role/FairValueMeasurementDetails">
        <link:definition>0000031 - Disclosure - Fair Value Measurement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsNarrativeDetails" roleURI="http://si-bone.com/role/BalanceSheetComponentsNarrativeDetails">
        <link:definition>0000032 - Disclosure - Balance Sheet Components - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsPropertyandEquipmentNetDetails" roleURI="http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails">
        <link:definition>0000033 - Disclosure - Balance Sheet Components - Property and Equipment, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsAccruedLiabilitiesandOtherDetails" roleURI="http://si-bone.com/role/BalanceSheetComponentsAccruedLiabilitiesandOtherDetails">
        <link:definition>0000034 - Disclosure - Balance Sheet Components - Accrued Liabilities and Other (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsAccountsReceivableandAllowanceforCreditLossesDetails" roleURI="http://si-bone.com/role/BalanceSheetComponentsAccountsReceivableandAllowanceforCreditLossesDetails">
        <link:definition>0000035 - Disclosure - Balance Sheet Components - Accounts Receivable and Allowance for Credit Losses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingenciesSupplementalInformationRelatedtoLeaseExpenseDetails" roleURI="http://si-bone.com/role/CommitmentandContingenciesSupplementalInformationRelatedtoLeaseExpenseDetails">
        <link:definition>0000036 - Disclosure - Commitment and Contingencies - Supplemental Information Related to Lease Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails" roleURI="http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails">
        <link:definition>0000037 - Disclosure - Commitments and Contingencies - Aggregate Future Minimum Lease Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails_1" roleURI="http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails_1">
        <link:definition>0000037 - Disclosure - Commitments and Contingencies - Aggregate Future Minimum Lease Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesNarrativeDetails" roleURI="http://si-bone.com/role/CommitmentsandContingenciesNarrativeDetails">
        <link:definition>0000038 - Disclosure - Commitments and Contingencies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsSummaryofBorrowingsDetails" roleURI="http://si-bone.com/role/BorrowingsSummaryofBorrowingsDetails">
        <link:definition>0000039 - Disclosure - Borrowings - Summary of Borrowings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsNarrativeDetails" roleURI="http://si-bone.com/role/BorrowingsNarrativeDetails">
        <link:definition>0000040 - Disclosure - Borrowings - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsDebtMaturityDetails" roleURI="http://si-bone.com/role/BorrowingsDebtMaturityDetails">
        <link:definition>0000041 - Disclosure - Borrowings - Debt Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedIncentiveCompensationPlansStockOptionActivityDetails" roleURI="http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockOptionActivityDetails">
        <link:definition>0000042 - Disclosure - Stock-Based Incentive Compensation Plans - Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedIncentiveCompensationPlansNarrativeDetails" roleURI="http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails">
        <link:definition>0000043 - Disclosure - Stock-Based Incentive Compensation Plans - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails" roleURI="http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails">
        <link:definition>0000044 - Disclosure - Stock-Based Incentive Compensation Plans - Valuation Assumptions for Stock Options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityandPerformanceBasedRestrictedStockUnitActivityDetails" roleURI="http://si-bone.com/role/StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityandPerformanceBasedRestrictedStockUnitActivityDetails">
        <link:definition>0000045 - Disclosure - Stock-Based Incentive Compensation Plans - Restricted Stock Units Activity and Performance-Based Restricted Stock Unit Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedIncentiveCompensationPlansStockBasedCompensationExpenseDetails" roleURI="http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockBasedCompensationExpenseDetails">
        <link:definition>0000046 - Disclosure - Stock-Based Incentive Compensation Plans - Stock-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareofCommonStockComputationofEarningsPerShareDetails" roleURI="http://si-bone.com/role/NetLossPerShareofCommonStockComputationofEarningsPerShareDetails">
        <link:definition>0000047 - Disclosure - Net Loss Per Share of Common Stock - Computation of Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareofCommonStockAntidilutiveCommonStockEquivalentsExcludedfromComputationofEarningsPerShareDetails" roleURI="http://si-bone.com/role/NetLossPerShareofCommonStockAntidilutiveCommonStockEquivalentsExcludedfromComputationofEarningsPerShareDetails">
        <link:definition>0000048 - Disclosure - Net Loss Per Share of Common Stock - Antidilutive Common Stock Equivalents Excluded from Computation of Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionDetails" roleURI="http://si-bone.com/role/RelatedPartyTransactionDetails">
        <link:definition>0000049 - Disclosure - Related Party Transaction (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://si-bone.com/role/IncomeTaxesDetails">
        <link:definition>0000050 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="sibn_DebtInstrumentCovenantAdjustedQuickRatioMinimum" abstract="false" name="DebtInstrumentCovenantAdjustedQuickRatioMinimum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:decimalItemType"/>
  <xs:element id="sibn_ScheduleOfShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValuationAssumptionsTableTextBlock" abstract="false" name="ScheduleOfShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValuationAssumptionsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMinimum" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMinimum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="sibn_LesseeOperatingLeaseLeaseNotYetCommencedLiability" abstract="false" name="LesseeOperatingLeaseLeaseNotYetCommencedLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sibn_EmployeeStockPurchasePlanSharesMember" abstract="true" name="EmployeeStockPurchasePlanSharesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMinimum" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMinimum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="sibn_ComputerAndOfficeEquipmentMember" abstract="true" name="ComputerAndOfficeEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMaximum" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMaximum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="sibn_A2018EmployeeStockPurchasePlanMember" abstract="true" name="A2018EmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sibn_StockIssuedDuringPeriodSharesRestrictedStockUnits" abstract="false" name="StockIssuedDuringPeriodSharesRestrictedStockUnits" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="sibn_SVBAmendedTermLoanMember" abstract="true" name="SVBAmendedTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="sibn_LineOfCreditFacilityAccordionFeatureIncreaseLimit" abstract="false" name="LineOfCreditFacilityAccordionFeatureIncreaseLimit" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMaximum" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMaximum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="sibn_RelatedPartyTransactionTermOfAgreement" abstract="false" name="RelatedPartyTransactionTermOfAgreement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="sibn_DevelopmentAgreementMember" abstract="true" name="DevelopmentAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sibn_ConstructionInProgressSurgicalPlacementInstrumentSetMember" abstract="true" name="ConstructionInProgressSurgicalPlacementInstrumentSetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sibn_LineOfCreditFacilityContingentCommitmentFeeAmount" abstract="false" name="LineOfCreditFacilityContingentCommitmentFeeAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sibn_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" abstract="false" name="LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sibn_DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal" abstract="false" name="DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="sibn_ProceedsFromMaturityOfMarketableSecurities" abstract="false" name="ProceedsFromMaturityOfMarketableSecurities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sibn_CommonStockWarrantsMember" abstract="true" name="CommonStockWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sibn_NumberOfBusinessActivities" abstract="false" name="NumberOfBusinessActivities" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sibn_SolarLoanAndSecurityAgreementMember" abstract="true" name="SolarLoanAndSecurityAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sibn_DebtInstrumentAccountsReceivableBorrowingBase" abstract="false" name="DebtInstrumentAccountsReceivableBorrowingBase" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="sibn_DebtInstrumentInterestRateIncreaseDueToDefault" abstract="false" name="DebtInstrumentInterestRateIncreaseDueToDefault" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="sibn_ConstructionInProgressSantaClaraLeaseMember" abstract="true" name="ConstructionInProgressSantaClaraLeaseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sibn_MarketableSecuritiesAmortizedCost" abstract="false" name="MarketableSecuritiesAmortizedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sibn_SVBTermLoanMember" abstract="true" name="SVBTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>sibn-20230331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:b9a8bdb4-fcbc-4ee6-8fcb-5f67627ef90e,g:a1ffbe61-3b0e-45b0-8eb9-b424c3d4458b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="sibn-20230331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_f0834b27-b3cc-454b-858c-29bfb07f4028" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_50982a45-7784-4b9d-bc10-ec8fd5e8a63f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f0834b27-b3cc-454b-858c-29bfb07f4028" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_50982a45-7784-4b9d-bc10-ec8fd5e8a63f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent_593d6b1a-416b-4bb1-b909-d6f8bee19f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f0834b27-b3cc-454b-858c-29bfb07f4028" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent_593d6b1a-416b-4bb1-b909-d6f8bee19f4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_05863e30-6c90-4d51-8f8d-6b5ff9de11d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f0834b27-b3cc-454b-858c-29bfb07f4028" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_05863e30-6c90-4d51-8f8d-6b5ff9de11d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_46cf6afd-4eae-4b77-ad97-fcbe5c08ebc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f0834b27-b3cc-454b-858c-29bfb07f4028" xlink:to="loc_us-gaap_InventoryNet_46cf6afd-4eae-4b77-ad97-fcbe5c08ebc9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c6ca556a-ff78-47eb-a9c3-354c99950160" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f0834b27-b3cc-454b-858c-29bfb07f4028" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c6ca556a-ff78-47eb-a9c3-354c99950160" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9d1df874-a8d1-454f-9a39-1ad16abc813a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_e6b958dc-4eb6-43b7-9107-8cf086da21d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9d1df874-a8d1-454f-9a39-1ad16abc813a" xlink:to="loc_us-gaap_PreferredStockValue_e6b958dc-4eb6-43b7-9107-8cf086da21d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_e5677e1e-6763-4e15-8477-a0600b5497e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9d1df874-a8d1-454f-9a39-1ad16abc813a" xlink:to="loc_us-gaap_CommonStockValue_e5677e1e-6763-4e15-8477-a0600b5497e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_f100df9d-0bd7-4c85-83cd-48c506db4123" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9d1df874-a8d1-454f-9a39-1ad16abc813a" xlink:to="loc_us-gaap_AdditionalPaidInCapital_f100df9d-0bd7-4c85-83cd-48c506db4123" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0b1069e2-73b0-48f5-a46c-ddad838411e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9d1df874-a8d1-454f-9a39-1ad16abc813a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0b1069e2-73b0-48f5-a46c-ddad838411e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9cc5fe2c-d2fa-4362-8f3e-a40a9649b219" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9d1df874-a8d1-454f-9a39-1ad16abc813a" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9cc5fe2c-d2fa-4362-8f3e-a40a9649b219" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_9484dca8-f51b-4d28-a312-0e33b34d662c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_440b0a6d-ff4d-45a0-bb8b-73e551c3656d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_9484dca8-f51b-4d28-a312-0e33b34d662c" xlink:to="loc_us-gaap_Liabilities_440b0a6d-ff4d-45a0-bb8b-73e551c3656d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_9bd67c93-e419-42a0-82fc-2e996c06a0d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_9484dca8-f51b-4d28-a312-0e33b34d662c" xlink:to="loc_us-gaap_CommitmentsAndContingencies_9bd67c93-e419-42a0-82fc-2e996c06a0d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8f121ba7-3013-46c8-80ef-e7d5ea7ec650" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_9484dca8-f51b-4d28-a312-0e33b34d662c" xlink:to="loc_us-gaap_StockholdersEquity_8f121ba7-3013-46c8-80ef-e7d5ea7ec650" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_88cadb64-6013-4d71-a56d-4f0bffd4b843" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_26dc85e0-658d-46bf-9595-b17eaf7d0d04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_88cadb64-6013-4d71-a56d-4f0bffd4b843" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_26dc85e0-658d-46bf-9595-b17eaf7d0d04" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d004e9f7-960a-46e5-b382-97d1490641b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_88cadb64-6013-4d71-a56d-4f0bffd4b843" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d004e9f7-960a-46e5-b382-97d1490641b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_ab289093-a392-46d4-96d5-e36bdebf517b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_88cadb64-6013-4d71-a56d-4f0bffd4b843" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_ab289093-a392-46d4-96d5-e36bdebf517b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_ef7dd4cf-1da6-4da7-9667-a74a577ef61f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_88cadb64-6013-4d71-a56d-4f0bffd4b843" xlink:to="loc_us-gaap_LiabilitiesCurrent_ef7dd4cf-1da6-4da7-9667-a74a577ef61f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_0c7e13bb-37ef-4ca8-ad45-6eb54ba6c9ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_6eaaf512-3e95-4b7c-8f8c-bec25c39fa40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0c7e13bb-37ef-4ca8-ad45-6eb54ba6c9ff" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_6eaaf512-3e95-4b7c-8f8c-bec25c39fa40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_08f73fa7-7fff-41cb-8534-0a9dc8a7aec2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0c7e13bb-37ef-4ca8-ad45-6eb54ba6c9ff" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_08f73fa7-7fff-41cb-8534-0a9dc8a7aec2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_1c37198d-bcf8-49fb-81ca-50aa3b952504" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0c7e13bb-37ef-4ca8-ad45-6eb54ba6c9ff" xlink:to="loc_us-gaap_AccountsPayableCurrent_1c37198d-bcf8-49fb-81ca-50aa3b952504" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_ba6a677c-4ae5-46d6-8503-03bd9008abbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_7808f4c4-c45a-465e-a881-72c757a6eefb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ba6a677c-4ae5-46d6-8503-03bd9008abbd" xlink:to="loc_us-gaap_AssetsCurrent_7808f4c4-c45a-465e-a881-72c757a6eefb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_cfd2c492-33cd-4d37-ac51-ddce38889fcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ba6a677c-4ae5-46d6-8503-03bd9008abbd" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_cfd2c492-33cd-4d37-ac51-ddce38889fcb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_5499b1e2-64a8-4ffd-994d-21d2928e3de3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ba6a677c-4ae5-46d6-8503-03bd9008abbd" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_5499b1e2-64a8-4ffd-994d-21d2928e3de3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_c1b7d243-4618-4bdc-ad45-0d89d3f88258" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ba6a677c-4ae5-46d6-8503-03bd9008abbd" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_c1b7d243-4618-4bdc-ad45-0d89d3f88258" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="sibn-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"/>
  <link:calculationLink xlink:role="http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_5c4133a1-d39c-427e-8876-a956f7a5cce0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_75ce60c8-c7cd-4071-b468-afb4561a1a35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_5c4133a1-d39c-427e-8876-a956f7a5cce0" xlink:to="loc_us-gaap_GrossProfit_75ce60c8-c7cd-4071-b468-afb4561a1a35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_865f3200-1d0d-4954-a401-f020b42476b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_5c4133a1-d39c-427e-8876-a956f7a5cce0" xlink:to="loc_us-gaap_OperatingExpenses_865f3200-1d0d-4954-a401-f020b42476b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_97f8b312-b5f6-49e1-a23e-d417cf8f7017" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c0ba3d8d-4ae0-4262-9523-dcd7f2b74b35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_97f8b312-b5f6-49e1-a23e-d417cf8f7017" xlink:to="loc_us-gaap_OperatingIncomeLoss_c0ba3d8d-4ae0-4262-9523-dcd7f2b74b35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_7d1636cb-6c7a-421e-af58-9b4f8e23f272" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_97f8b312-b5f6-49e1-a23e-d417cf8f7017" xlink:to="loc_us-gaap_InvestmentIncomeInterest_7d1636cb-6c7a-421e-af58-9b4f8e23f272" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_f7be9ca7-8b6d-4892-8460-d30b472a13f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_97f8b312-b5f6-49e1-a23e-d417cf8f7017" xlink:to="loc_us-gaap_InterestExpense_f7be9ca7-8b6d-4892-8460-d30b472a13f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_9fff06e7-5544-498f-8801-5332c03c95be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_97f8b312-b5f6-49e1-a23e-d417cf8f7017" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_9fff06e7-5544-498f-8801-5332c03c95be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_f839deeb-455e-4b6f-b4d8-b7279e2aae68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_bde125b9-62e3-4fef-b057-bfd6f768572c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_f839deeb-455e-4b6f-b4d8-b7279e2aae68" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_bde125b9-62e3-4fef-b057-bfd6f768572c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_d452e7ca-08b7-4d62-a83b-18d1417b435c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_f839deeb-455e-4b6f-b4d8-b7279e2aae68" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_d452e7ca-08b7-4d62-a83b-18d1417b435c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_387aa17c-bb1d-4112-ab6b-35eaafc273da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_a16dc8ab-84cf-4fdc-a5ec-c4db7bfe3658" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_387aa17c-bb1d-4112-ab6b-35eaafc273da" xlink:to="loc_us-gaap_SellingAndMarketingExpense_a16dc8ab-84cf-4fdc-a5ec-c4db7bfe3658" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_e458efd1-9a5b-48e1-9886-8b8bb6e77ec9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_387aa17c-bb1d-4112-ab6b-35eaafc273da" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_e458efd1-9a5b-48e1-9886-8b8bb6e77ec9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_43927485-70e0-4f39-b0dc-0ac3d125f328" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_387aa17c-bb1d-4112-ab6b-35eaafc273da" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_43927485-70e0-4f39-b0dc-0ac3d125f328" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_34c5208f-aeed-441f-b84c-718839bb9c26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_8571dd98-783e-4c05-a748-00fa7f4c42b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_34c5208f-aeed-441f-b84c-718839bb9c26" xlink:to="loc_us-gaap_NetIncomeLoss_8571dd98-783e-4c05-a748-00fa7f4c42b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2c205152-e387-46a7-85ae-d6b12d880186" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_34c5208f-aeed-441f-b84c-718839bb9c26" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2c205152-e387-46a7-85ae-d6b12d880186" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_0328d26c-8b7f-47d0-9e83-f1a64ae6dcf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_34c5208f-aeed-441f-b84c-718839bb9c26" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_0328d26c-8b7f-47d0-9e83-f1a64ae6dcf8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="sibn-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_355acca6-4efb-42ec-80e6-d47206fc1012" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ProceedsFromMaturityOfMarketableSecurities_d5fe88de-4821-4b6c-bb9b-ade4420a65cb" xlink:href="sibn-20230331.xsd#sibn_ProceedsFromMaturityOfMarketableSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_355acca6-4efb-42ec-80e6-d47206fc1012" xlink:to="loc_sibn_ProceedsFromMaturityOfMarketableSecurities_d5fe88de-4821-4b6c-bb9b-ade4420a65cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_cb1975f4-3cd5-4b4d-9397-f89acb42317f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_355acca6-4efb-42ec-80e6-d47206fc1012" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_cb1975f4-3cd5-4b4d-9397-f89acb42317f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_985cd853-ddf1-4c8c-91e8-028d79866f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_355acca6-4efb-42ec-80e6-d47206fc1012" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_985cd853-ddf1-4c8c-91e8-028d79866f2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_db6edd6b-2cb2-4d72-bb65-bd91b4c30c44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e4294fbe-c0c3-48be-95a1-ba89fba2620a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_db6edd6b-2cb2-4d72-bb65-bd91b4c30c44" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e4294fbe-c0c3-48be-95a1-ba89fba2620a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7c4e06b1-5556-46a0-a27b-4765a655e13b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_db6edd6b-2cb2-4d72-bb65-bd91b4c30c44" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7c4e06b1-5556-46a0-a27b-4765a655e13b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_24cca72c-97a8-4f84-b918-a03b04952f4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_db6edd6b-2cb2-4d72-bb65-bd91b4c30c44" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_24cca72c-97a8-4f84-b918-a03b04952f4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_686e2611-5edd-4440-bc45-4eea0cfeec7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_db6edd6b-2cb2-4d72-bb65-bd91b4c30c44" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_686e2611-5edd-4440-bc45-4eea0cfeec7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b80e6ef2-02ae-4cad-9c8b-350d85d2a1b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_923863a3-99f9-4402-b07c-8c82c2acefd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b80e6ef2-02ae-4cad-9c8b-350d85d2a1b3" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_923863a3-99f9-4402-b07c-8c82c2acefd4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_56ed003a-715e-4371-8bc2-e32bca046759" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b80e6ef2-02ae-4cad-9c8b-350d85d2a1b3" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_56ed003a-715e-4371-8bc2-e32bca046759" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_da61454d-8dff-4a7a-8a5f-532b6478afc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b80e6ef2-02ae-4cad-9c8b-350d85d2a1b3" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_da61454d-8dff-4a7a-8a5f-532b6478afc2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_a86cca65-4069-451f-b348-083b71a790e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b80e6ef2-02ae-4cad-9c8b-350d85d2a1b3" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_a86cca65-4069-451f-b348-083b71a790e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a6e35c10-bf7b-42fb-9934-66e29e354104" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_486267d3-13ca-43f7-b8db-8783ed276113" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a6e35c10-bf7b-42fb-9934-66e29e354104" xlink:to="loc_us-gaap_NetIncomeLoss_486267d3-13ca-43f7-b8db-8783ed276113" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_ece48a4f-87a1-4d3f-9b5b-5a682b7c2731" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a6e35c10-bf7b-42fb-9934-66e29e354104" xlink:to="loc_us-gaap_ShareBasedCompensation_ece48a4f-87a1-4d3f-9b5b-5a682b7c2731" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_705a3410-c184-4967-becd-14de591521e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a6e35c10-bf7b-42fb-9934-66e29e354104" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_705a3410-c184-4967-becd-14de591521e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_9e93b171-469e-4e98-9a6a-3c107e400ffe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a6e35c10-bf7b-42fb-9934-66e29e354104" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_9e93b171-469e-4e98-9a6a-3c107e400ffe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_1963b1b1-6d09-4c5b-9a96-d4719a298a4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a6e35c10-bf7b-42fb-9934-66e29e354104" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_1963b1b1-6d09-4c5b-9a96-d4719a298a4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_81dfdb51-7a01-4341-9581-2fb9b39be91f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a6e35c10-bf7b-42fb-9934-66e29e354104" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_81dfdb51-7a01-4341-9581-2fb9b39be91f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_635186a0-1c0c-4e43-8f1f-91b5b22e4e4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a6e35c10-bf7b-42fb-9934-66e29e354104" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_635186a0-1c0c-4e43-8f1f-91b5b22e4e4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_6bc62f6b-684a-4ab5-9a70-e1b8eca16bd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a6e35c10-bf7b-42fb-9934-66e29e354104" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_6bc62f6b-684a-4ab5-9a70-e1b8eca16bd9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2c8c451f-8046-4831-a18a-3a2705f85587" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a6e35c10-bf7b-42fb-9934-66e29e354104" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2c8c451f-8046-4831-a18a-3a2705f85587" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_9afb52c8-c814-4a78-8036-988c9ef65c32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a6e35c10-bf7b-42fb-9934-66e29e354104" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_9afb52c8-c814-4a78-8036-988c9ef65c32" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_109c1c0d-2fd7-4061-83ff-0e621851b6f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a6e35c10-bf7b-42fb-9934-66e29e354104" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_109c1c0d-2fd7-4061-83ff-0e621851b6f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_aeec5039-4f25-4393-9899-068e4e5ddfd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a6e35c10-bf7b-42fb-9934-66e29e354104" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_aeec5039-4f25-4393-9899-068e4e5ddfd0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://si-bone.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails" xlink:type="simple" xlink:href="sibn-20230331.xsd#MarketableSecuritiesScheduleofMarketableSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://si-bone.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss_172b070a-f221-442e-bd4b-9392a22c3caa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_2c684c26-414e-43e7-a5cf-42ef8a8135f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss_172b070a-f221-442e-bd4b-9392a22c3caa" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_2c684c26-414e-43e7-a5cf-42ef8a8135f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4c3cc9d6-fb3e-4066-bdda-e3dba7037d80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss_172b070a-f221-442e-bd4b-9392a22c3caa" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4c3cc9d6-fb3e-4066-bdda-e3dba7037d80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_333479fd-ebd9-413d-a2ba-2fb19620799a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss_172b070a-f221-442e-bd4b-9392a22c3caa" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_333479fd-ebd9-413d-a2ba-2fb19620799a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_MarketableSecuritiesAmortizedCost_238dc49a-78c9-4860-b29e-1202010ff148" xlink:href="sibn-20230331.xsd#sibn_MarketableSecuritiesAmortizedCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss_358e7a98-450d-47af-9080-1eb4e4cbfc96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sibn_MarketableSecuritiesAmortizedCost_238dc49a-78c9-4860-b29e-1202010ff148" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss_358e7a98-450d-47af-9080-1eb4e4cbfc96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_1e833e51-2a10-4558-9a4e-2d30790ccd40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sibn_MarketableSecuritiesAmortizedCost_238dc49a-78c9-4860-b29e-1202010ff148" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_1e833e51-2a10-4558-9a4e-2d30790ccd40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_61955ac0-f8a1-4886-915d-ae5209bd2b72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_524087bf-b86e-4658-966c-4ed43cd575c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_61955ac0-f8a1-4886-915d-ae5209bd2b72" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_524087bf-b86e-4658-966c-4ed43cd575c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_86d6384f-d045-48aa-b0b0-a7f2a61371dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_61955ac0-f8a1-4886-915d-ae5209bd2b72" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_86d6384f-d045-48aa-b0b0-a7f2a61371dc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="sibn-20230331.xsd#BalanceSheetComponentsPropertyandEquipmentNetDetails"/>
  <link:calculationLink xlink:role="http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_d1411871-ad9b-45c7-9dce-0928ce68c9db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_dec92fc4-e52c-447a-98ee-e438a6bfca52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_d1411871-ad9b-45c7-9dce-0928ce68c9db" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_dec92fc4-e52c-447a-98ee-e438a6bfca52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_41999a4f-2beb-4f69-928c-180ff3334eb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_d1411871-ad9b-45c7-9dce-0928ce68c9db" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_41999a4f-2beb-4f69-928c-180ff3334eb8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://si-bone.com/role/BalanceSheetComponentsAccruedLiabilitiesandOtherDetails" xlink:type="simple" xlink:href="sibn-20230331.xsd#BalanceSheetComponentsAccruedLiabilitiesandOtherDetails"/>
  <link:calculationLink xlink:role="http://si-bone.com/role/BalanceSheetComponentsAccruedLiabilitiesandOtherDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_8ce92e98-9dda-47b3-8585-d2e53545626a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_5aba35c6-08d8-4f0f-b97e-9de2224b0fe4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_8ce92e98-9dda-47b3-8585-d2e53545626a" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_5aba35c6-08d8-4f0f-b97e-9de2224b0fe4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_256ed0b4-e177-449a-b823-7f2675746102" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_8ce92e98-9dda-47b3-8585-d2e53545626a" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_256ed0b4-e177-449a-b823-7f2675746102" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_58ebc29c-1ee7-4fb0-b661-bfd53db010a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_8ce92e98-9dda-47b3-8585-d2e53545626a" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_58ebc29c-1ee7-4fb0-b661-bfd53db010a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_491ab9e5-caff-402a-a065-8cde2bcba67f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_8ce92e98-9dda-47b3-8585-d2e53545626a" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_491ab9e5-caff-402a-a065-8cde2bcba67f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://si-bone.com/role/CommitmentandContingenciesSupplementalInformationRelatedtoLeaseExpenseDetails" xlink:type="simple" xlink:href="sibn-20230331.xsd#CommitmentandContingenciesSupplementalInformationRelatedtoLeaseExpenseDetails"/>
  <link:calculationLink xlink:role="http://si-bone.com/role/CommitmentandContingenciesSupplementalInformationRelatedtoLeaseExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_a61f7358-cb22-49dd-95ba-9e2ccc1644d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_609e6c2e-ac4d-4252-865f-8381501c89ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_a61f7358-cb22-49dd-95ba-9e2ccc1644d6" xlink:to="loc_us-gaap_OperatingLeaseCost_609e6c2e-ac4d-4252-865f-8381501c89ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_17fc03cd-aa1b-469d-94f7-9e6b823a6de4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_a61f7358-cb22-49dd-95ba-9e2ccc1644d6" xlink:to="loc_us-gaap_VariableLeaseCost_17fc03cd-aa1b-469d-94f7-9e6b823a6de4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails" xlink:type="simple" xlink:href="sibn-20230331.xsd#CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails"/>
  <link:calculationLink xlink:role="http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0acc1ed2-7ce5-4879-8f05-a4fe2ad69db4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_827f69ea-37bb-4d98-aa7b-754b8845f0ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0acc1ed2-7ce5-4879-8f05-a4fe2ad69db4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_827f69ea-37bb-4d98-aa7b-754b8845f0ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_35addd9d-7748-4db8-beaf-2b2f8ed68052" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0acc1ed2-7ce5-4879-8f05-a4fe2ad69db4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_35addd9d-7748-4db8-beaf-2b2f8ed68052" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_72c6d4ff-4598-43b4-83bb-ef97d0c8fc41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0acc1ed2-7ce5-4879-8f05-a4fe2ad69db4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_72c6d4ff-4598-43b4-83bb-ef97d0c8fc41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_124b7148-5ae5-4c72-8bcc-32f338eaa656" xlink:href="sibn-20230331.xsd#sibn_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0acc1ed2-7ce5-4879-8f05-a4fe2ad69db4" xlink:to="loc_sibn_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_124b7148-5ae5-4c72-8bcc-32f338eaa656" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_284ac3f6-fc48-41cf-9456-427d022c69b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0acc1ed2-7ce5-4879-8f05-a4fe2ad69db4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_284ac3f6-fc48-41cf-9456-427d022c69b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_9c87eb26-1f27-4b76-bd02-d8514178497d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0acc1ed2-7ce5-4879-8f05-a4fe2ad69db4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_9c87eb26-1f27-4b76-bd02-d8514178497d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails_1" xlink:type="simple" xlink:href="sibn-20230331.xsd#CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails_1"/>
  <link:calculationLink xlink:role="http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_523bfe7e-1ab4-4764-bca2-d3dec383fefb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_11d96549-b86e-485c-aa33-769ec4f01eee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_523bfe7e-1ab4-4764-bca2-d3dec383fefb" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_11d96549-b86e-485c-aa33-769ec4f01eee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_afd38540-4bed-4ed6-b900-7cc6b15356be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_523bfe7e-1ab4-4764-bca2-d3dec383fefb" xlink:to="loc_us-gaap_OperatingLeaseLiability_afd38540-4bed-4ed6-b900-7cc6b15356be" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://si-bone.com/role/BorrowingsSummaryofBorrowingsDetails" xlink:type="simple" xlink:href="sibn-20230331.xsd#BorrowingsSummaryofBorrowingsDetails"/>
  <link:calculationLink xlink:role="http://si-bone.com/role/BorrowingsSummaryofBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_98a1d45b-dc1f-4b1d-8335-df791a9457a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_0e43b556-418a-49f1-b79f-39292a14bb68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_98a1d45b-dc1f-4b1d-8335-df791a9457a8" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_0e43b556-418a-49f1-b79f-39292a14bb68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_51231b42-f402-43d1-8337-6bcff08ded8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_98a1d45b-dc1f-4b1d-8335-df791a9457a8" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_51231b42-f402-43d1-8337-6bcff08ded8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount_c5a6b5ba-e8e5-4353-abfd-b106a7dc7e53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_98a1d45b-dc1f-4b1d-8335-df791a9457a8" xlink:to="loc_us-gaap_DebtInstrumentFeeAmount_c5a6b5ba-e8e5-4353-abfd-b106a7dc7e53" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://si-bone.com/role/BorrowingsDebtMaturityDetails" xlink:type="simple" xlink:href="sibn-20230331.xsd#BorrowingsDebtMaturityDetails"/>
  <link:calculationLink xlink:role="http://si-bone.com/role/BorrowingsDebtMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_329836b4-c5f9-4dc1-bba4-5a888eebe8ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_4ea9953d-37a6-46f8-b0c3-6c17cfe5d320" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_329836b4-c5f9-4dc1-bba4-5a888eebe8ed" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_4ea9953d-37a6-46f8-b0c3-6c17cfe5d320" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_397cdfae-cd1e-440b-8cd7-70e76856a554" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_329836b4-c5f9-4dc1-bba4-5a888eebe8ed" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_397cdfae-cd1e-440b-8cd7-70e76856a554" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_a4a25ba9-9007-4394-98ac-d19dd26fadf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_329836b4-c5f9-4dc1-bba4-5a888eebe8ed" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_a4a25ba9-9007-4394-98ac-d19dd26fadf6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_4cdd0b1b-76a9-4514-a701-cb6eebe13a7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_329836b4-c5f9-4dc1-bba4-5a888eebe8ed" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_4cdd0b1b-76a9-4514-a701-cb6eebe13a7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_07556f49-4d72-4b08-b211-5b28826422c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_329836b4-c5f9-4dc1-bba4-5a888eebe8ed" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_07556f49-4d72-4b08-b211-5b28826422c3" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>sibn-20230331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:b9a8bdb4-fcbc-4ee6-8fcb-5f67627ef90e,g:a1ffbe61-3b0e-45b0-8eb9-b424c3d4458b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="sibn-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" xlink:type="extended" id="i6bf3a2de8f354a2ead281de341fe6b44_CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_3da949f8-79b9-4cfd-a2d8-c07303ae2274" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_079e8f3b-93bb-4b05-8540-edd491fe64fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3da949f8-79b9-4cfd-a2d8-c07303ae2274" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_079e8f3b-93bb-4b05-8540-edd491fe64fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_537475fd-5e16-4f19-a72f-79d7122bc848" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_079e8f3b-93bb-4b05-8540-edd491fe64fa" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_537475fd-5e16-4f19-a72f-79d7122bc848" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_84426c95-8e7b-4cb1-8553-ff6595b38f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_079e8f3b-93bb-4b05-8540-edd491fe64fa" xlink:to="loc_us-gaap_StockholdersEquity_84426c95-8e7b-4cb1-8553-ff6595b38f2a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6160ca46-ceb9-4c9a-9bd7-28a00817347d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_079e8f3b-93bb-4b05-8540-edd491fe64fa" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6160ca46-ceb9-4c9a-9bd7-28a00817347d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_3e28f91d-3f1d-4dff-9c12-259b9da1b700" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_079e8f3b-93bb-4b05-8540-edd491fe64fa" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_3e28f91d-3f1d-4dff-9c12-259b9da1b700" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_StockIssuedDuringPeriodSharesRestrictedStockUnits_9f28cdba-8908-454b-ba17-2a41979c3d02" xlink:href="sibn-20230331.xsd#sibn_StockIssuedDuringPeriodSharesRestrictedStockUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_079e8f3b-93bb-4b05-8540-edd491fe64fa" xlink:to="loc_sibn_StockIssuedDuringPeriodSharesRestrictedStockUnits_9f28cdba-8908-454b-ba17-2a41979c3d02" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_b56bacb4-b656-4164-9e41-b4286f6dfdb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_079e8f3b-93bb-4b05-8540-edd491fe64fa" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_b56bacb4-b656-4164-9e41-b4286f6dfdb4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_ab6a7594-df32-438f-a79a-0506be119657" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_079e8f3b-93bb-4b05-8540-edd491fe64fa" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_ab6a7594-df32-438f-a79a-0506be119657" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_864b9d1e-e430-4100-a5a7-5f1ee25c6301" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_079e8f3b-93bb-4b05-8540-edd491fe64fa" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_864b9d1e-e430-4100-a5a7-5f1ee25c6301" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_cab14cc4-4570-4eff-9f8a-c4abe9594e9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_079e8f3b-93bb-4b05-8540-edd491fe64fa" xlink:to="loc_us-gaap_NetIncomeLoss_cab14cc4-4570-4eff-9f8a-c4abe9594e9b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_b5a44ed4-4396-43a1-a2fa-86efb03ec7f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d44a8206-7c0e-4202-ab89-1453f15e21e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ba51b4be-b43b-4e79-ad3e-f34b3e5f9610" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_3da949f8-79b9-4cfd-a2d8-c07303ae2274" xlink:to="loc_us-gaap_StatementTable_ba51b4be-b43b-4e79-ad3e-f34b3e5f9610" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_7d6e643b-9abe-4617-85e7-003cf252ca14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_ba51b4be-b43b-4e79-ad3e-f34b3e5f9610" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_7d6e643b-9abe-4617-85e7-003cf252ca14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7d6e643b-9abe-4617-85e7-003cf252ca14_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7d6e643b-9abe-4617-85e7-003cf252ca14" xlink:to="loc_us-gaap_EquityComponentDomain_7d6e643b-9abe-4617-85e7-003cf252ca14_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9c7d00d4-d4e5-4341-bfd2-47f082e25713" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7d6e643b-9abe-4617-85e7-003cf252ca14" xlink:to="loc_us-gaap_EquityComponentDomain_9c7d00d4-d4e5-4341-bfd2-47f082e25713" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_3ff0028d-0cc6-45f2-9125-72562bf974c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9c7d00d4-d4e5-4341-bfd2-47f082e25713" xlink:to="loc_us-gaap_CommonStockMember_3ff0028d-0cc6-45f2-9125-72562bf974c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_bcbf8e9c-b271-4d3c-92b8-d3d2f3f212f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9c7d00d4-d4e5-4341-bfd2-47f082e25713" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_bcbf8e9c-b271-4d3c-92b8-d3d2f3f212f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f1c5bf6c-765a-4bfa-993a-361d774b1602" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9c7d00d4-d4e5-4341-bfd2-47f082e25713" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f1c5bf6c-765a-4bfa-993a-361d774b1602" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_eb6a452b-a32d-4847-874d-f0e57c8a5f32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9c7d00d4-d4e5-4341-bfd2-47f082e25713" xlink:to="loc_us-gaap_RetainedEarningsMember_eb6a452b-a32d-4847-874d-f0e57c8a5f32" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://si-bone.com/role/SummaryofSignificantAccountingPoliciesRevenuebyGeographyDetails" xlink:type="simple" xlink:href="sibn-20230331.xsd#SummaryofSignificantAccountingPoliciesRevenuebyGeographyDetails"/>
  <link:definitionLink xlink:role="http://si-bone.com/role/SummaryofSignificantAccountingPoliciesRevenuebyGeographyDetails" xlink:type="extended" id="i8b3946c5e98c48c2a508b737e99436cb_SummaryofSignificantAccountingPoliciesRevenuebyGeographyDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_6f932919-47e0-4e48-9f46-e6017888b783" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_bbad471a-ba9d-4071-8313-ddcdac0ef7a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_6f932919-47e0-4e48-9f46-e6017888b783" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_bbad471a-ba9d-4071-8313-ddcdac0ef7a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_6c1f863d-301c-45a9-86d9-b3e1b3c0ae44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_6f932919-47e0-4e48-9f46-e6017888b783" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_6c1f863d-301c-45a9-86d9-b3e1b3c0ae44" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_ff6d9428-12cf-4f31-95de-8a67353c32b3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_6c1f863d-301c-45a9-86d9-b3e1b3c0ae44" xlink:to="loc_srt_StatementGeographicalAxis_ff6d9428-12cf-4f31-95de-8a67353c32b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_ff6d9428-12cf-4f31-95de-8a67353c32b3_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_ff6d9428-12cf-4f31-95de-8a67353c32b3" xlink:to="loc_srt_SegmentGeographicalDomain_ff6d9428-12cf-4f31-95de-8a67353c32b3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_46e283d6-576e-4d74-80c2-32bf56c4c5d7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_ff6d9428-12cf-4f31-95de-8a67353c32b3" xlink:to="loc_srt_SegmentGeographicalDomain_46e283d6-576e-4d74-80c2-32bf56c4c5d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_a44d574f-326f-41af-8cb5-edc37dbf22f4" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_46e283d6-576e-4d74-80c2-32bf56c4c5d7" xlink:to="loc_country_US_a44d574f-326f-41af-8cb5-edc37dbf22f4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_7da4e697-4f1a-475d-b781-473ccf21f87b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_46e283d6-576e-4d74-80c2-32bf56c4c5d7" xlink:to="loc_us-gaap_NonUsMember_7da4e697-4f1a-475d-b781-473ccf21f87b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://si-bone.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails" xlink:type="simple" xlink:href="sibn-20230331.xsd#MarketableSecuritiesScheduleofMarketableSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://si-bone.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails" xlink:type="extended" id="ib9a65f3cddec42be9ac1fe22450bb2dc_MarketableSecuritiesScheduleofMarketableSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesLineItems_de639f07-ad53-4fd9-8272-713a044b52a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValueAbstract_b7a3d8bc-e01f-40ee-94f4-aa4050ecc337" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsAtCarryingValueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_de639f07-ad53-4fd9-8272-713a044b52a5" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValueAbstract_b7a3d8bc-e01f-40ee-94f4-aa4050ecc337" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_2bb2934c-fa15-47d4-83b8-1f886a5b0ce4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashEquivalentsAtCarryingValueAbstract_b7a3d8bc-e01f-40ee-94f4-aa4050ecc337" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_2bb2934c-fa15-47d4-83b8-1f886a5b0ce4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_8d0f4cd3-b002-4bee-badb-2b54032d9a42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_de639f07-ad53-4fd9-8272-713a044b52a5" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_8d0f4cd3-b002-4bee-badb-2b54032d9a42" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss_7958aab7-295b-432a-a600-54d43893e8c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_8d0f4cd3-b002-4bee-badb-2b54032d9a42" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss_7958aab7-295b-432a-a600-54d43893e8c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_a1929e5b-5e84-4751-b624-ff3a7f36ebd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_8d0f4cd3-b002-4bee-badb-2b54032d9a42" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_a1929e5b-5e84-4751-b624-ff3a7f36ebd6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_19b82346-25c2-4a8c-9626-a22c92c6cf3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_8d0f4cd3-b002-4bee-badb-2b54032d9a42" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_19b82346-25c2-4a8c-9626-a22c92c6cf3e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_f868ac28-984a-413a-9a1f-29d2ca3c6ff0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_8d0f4cd3-b002-4bee-badb-2b54032d9a42" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_f868ac28-984a-413a-9a1f-29d2ca3c6ff0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_MarketableSecuritiesAmortizedCost_aa9c4d4a-ac54-4301-8b30-a3b564cbd124" xlink:href="sibn-20230331.xsd#sibn_MarketableSecuritiesAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_de639f07-ad53-4fd9-8272-713a044b52a5" xlink:to="loc_sibn_MarketableSecuritiesAmortizedCost_aa9c4d4a-ac54-4301-8b30-a3b564cbd124" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_60c3660a-1850-44d2-a2a6-ea041e7344c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_de639f07-ad53-4fd9-8272-713a044b52a5" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_60c3660a-1850-44d2-a2a6-ea041e7344c4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTable_ec0cd58b-2a65-4892-ad16-010459bd6a5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_de639f07-ad53-4fd9-8272-713a044b52a5" xlink:to="loc_us-gaap_MarketableSecuritiesTable_ec0cd58b-2a65-4892-ad16-010459bd6a5e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_74705183-a45d-4df4-9322-e745d7975d96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MarketableSecuritiesTable_ec0cd58b-2a65-4892-ad16-010459bd6a5e" xlink:to="loc_us-gaap_FinancialInstrumentAxis_74705183-a45d-4df4-9322-e745d7975d96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_74705183-a45d-4df4-9322-e745d7975d96_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_74705183-a45d-4df4-9322-e745d7975d96" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_74705183-a45d-4df4-9322-e745d7975d96_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e1aeea70-fc0a-4f2b-b065-96d4ca045746" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_74705183-a45d-4df4-9322-e745d7975d96" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e1aeea70-fc0a-4f2b-b065-96d4ca045746" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_ab1b2be7-f2c5-4938-ad3f-0445320688b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e1aeea70-fc0a-4f2b-b065-96d4ca045746" xlink:to="loc_us-gaap_MoneyMarketFundsMember_ab1b2be7-f2c5-4938-ad3f-0445320688b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_9ec5758e-da75-4934-9841-875a6419af9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e1aeea70-fc0a-4f2b-b065-96d4ca045746" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_9ec5758e-da75-4934-9841-875a6419af9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_e003e00f-7697-4817-a72c-0c045ca273ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e1aeea70-fc0a-4f2b-b065-96d4ca045746" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_e003e00f-7697-4817-a72c-0c045ca273ee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_9d2355fa-de25-4b8c-84ba-2134731791a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e1aeea70-fc0a-4f2b-b065-96d4ca045746" xlink:to="loc_us-gaap_CommercialPaperMember_9d2355fa-de25-4b8c-84ba-2134731791a9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_1d2b3893-bc99-4cc0-a347-894dfce535b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e1aeea70-fc0a-4f2b-b065-96d4ca045746" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_1d2b3893-bc99-4cc0-a347-894dfce535b4" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://si-bone.com/role/FairValueMeasurementDetails" xlink:type="simple" xlink:href="sibn-20230331.xsd#FairValueMeasurementDetails"/>
  <link:definitionLink xlink:role="http://si-bone.com/role/FairValueMeasurementDetails" xlink:type="extended" id="i00ec8d4714dc427798711138085e5cac_FairValueMeasurementDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8075497c-9020-4b48-aa39-033eaa5edcf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_06f823f5-5a9b-4685-a135-373e1c404baa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8075497c-9020-4b48-aa39-033eaa5edcf3" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_06f823f5-5a9b-4685-a135-373e1c404baa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_e304e61c-9e67-4c6f-8011-a970cbd4c1ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_06f823f5-5a9b-4685-a135-373e1c404baa" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_e304e61c-9e67-4c6f-8011-a970cbd4c1ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f81370c7-a60e-4655-bdd2-6fcb29fb443b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8075497c-9020-4b48-aa39-033eaa5edcf3" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f81370c7-a60e-4655-bdd2-6fcb29fb443b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_9bb0688c-ad26-4e80-8bec-850136a3174c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f81370c7-a60e-4655-bdd2-6fcb29fb443b" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_9bb0688c-ad26-4e80-8bec-850136a3174c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_9bb0688c-ad26-4e80-8bec-850136a3174c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_9bb0688c-ad26-4e80-8bec-850136a3174c" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_9bb0688c-ad26-4e80-8bec-850136a3174c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_0c5f0a76-9ebc-4c38-9ec4-45e0e44b61cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_9bb0688c-ad26-4e80-8bec-850136a3174c" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_0c5f0a76-9ebc-4c38-9ec4-45e0e44b61cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_e6663e82-151b-4e8f-966f-c639fcddf1ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_0c5f0a76-9ebc-4c38-9ec4-45e0e44b61cf" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_e6663e82-151b-4e8f-966f-c639fcddf1ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a40e27e9-9c19-44f8-835a-c2a74f2ed47c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f81370c7-a60e-4655-bdd2-6fcb29fb443b" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a40e27e9-9c19-44f8-835a-c2a74f2ed47c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a40e27e9-9c19-44f8-835a-c2a74f2ed47c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a40e27e9-9c19-44f8-835a-c2a74f2ed47c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a40e27e9-9c19-44f8-835a-c2a74f2ed47c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_196555c3-9f76-4b3e-806b-c8ab8ce1143d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a40e27e9-9c19-44f8-835a-c2a74f2ed47c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_196555c3-9f76-4b3e-806b-c8ab8ce1143d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_89539c7b-2772-4ef9-998c-ec8d66243e32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_196555c3-9f76-4b3e-806b-c8ab8ce1143d" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_89539c7b-2772-4ef9-998c-ec8d66243e32" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_df2bfbe3-ead8-4ab9-90a1-83b2b35edd91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_196555c3-9f76-4b3e-806b-c8ab8ce1143d" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_df2bfbe3-ead8-4ab9-90a1-83b2b35edd91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_357b4564-975f-4ef7-8fdc-44178741fd5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_196555c3-9f76-4b3e-806b-c8ab8ce1143d" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_357b4564-975f-4ef7-8fdc-44178741fd5e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_8e801c7b-e6c4-46d1-8631-4d83897ec6f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f81370c7-a60e-4655-bdd2-6fcb29fb443b" xlink:to="loc_us-gaap_FinancialInstrumentAxis_8e801c7b-e6c4-46d1-8631-4d83897ec6f9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e801c7b-e6c4-46d1-8631-4d83897ec6f9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_8e801c7b-e6c4-46d1-8631-4d83897ec6f9" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e801c7b-e6c4-46d1-8631-4d83897ec6f9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3fed2871-5fc5-406a-afbd-dad45b7b4ba9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_8e801c7b-e6c4-46d1-8631-4d83897ec6f9" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3fed2871-5fc5-406a-afbd-dad45b7b4ba9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_ec1d1353-55d0-4037-8081-40d984b1b2ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3fed2871-5fc5-406a-afbd-dad45b7b4ba9" xlink:to="loc_us-gaap_MoneyMarketFundsMember_ec1d1353-55d0-4037-8081-40d984b1b2ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_38c23861-2d16-4249-8884-cba63c18187a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3fed2871-5fc5-406a-afbd-dad45b7b4ba9" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_38c23861-2d16-4249-8884-cba63c18187a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_88b5199c-e7de-4df8-98b5-1a17779077cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3fed2871-5fc5-406a-afbd-dad45b7b4ba9" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_88b5199c-e7de-4df8-98b5-1a17779077cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_cea0f405-be28-485a-925d-56ebc86925a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3fed2871-5fc5-406a-afbd-dad45b7b4ba9" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_cea0f405-be28-485a-925d-56ebc86925a5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_0e1b7295-d91d-4fb4-b5f7-33d7678f31cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3fed2871-5fc5-406a-afbd-dad45b7b4ba9" xlink:to="loc_us-gaap_CommercialPaperMember_0e1b7295-d91d-4fb4-b5f7-33d7678f31cf" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://si-bone.com/role/BalanceSheetComponentsNarrativeDetails" xlink:type="simple" xlink:href="sibn-20230331.xsd#BalanceSheetComponentsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://si-bone.com/role/BalanceSheetComponentsNarrativeDetails" xlink:type="extended" id="i5fce65fff56441f6ae9b63f213a80f89_BalanceSheetComponentsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7582b601-2a1f-47fd-a5cf-cd344f1b9f10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_a041566a-7f22-43c1-933b-80d74cfc53ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7582b601-2a1f-47fd-a5cf-cd344f1b9f10" xlink:to="loc_us-gaap_InventoryFinishedGoods_a041566a-7f22-43c1-933b-80d74cfc53ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess_4321511c-b32e-4f62-972a-6e4a6c929869" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7582b601-2a1f-47fd-a5cf-cd344f1b9f10" xlink:to="loc_us-gaap_InventoryWorkInProcess_4321511c-b32e-4f62-972a-6e4a6c929869" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_c287aae8-6748-461b-9b76-eea333e62b89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7582b601-2a1f-47fd-a5cf-cd344f1b9f10" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_c287aae8-6748-461b-9b76-eea333e62b89" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_188c29cf-ae4c-44de-b05d-deaf86815afb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7582b601-2a1f-47fd-a5cf-cd344f1b9f10" xlink:to="loc_us-gaap_Depreciation_188c29cf-ae4c-44de-b05d-deaf86815afb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ac0174f8-af7e-4aa2-9875-8e5f86365445" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7582b601-2a1f-47fd-a5cf-cd344f1b9f10" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ac0174f8-af7e-4aa2-9875-8e5f86365445" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d5bd59dd-9398-4f75-a277-abef42735297" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ac0174f8-af7e-4aa2-9875-8e5f86365445" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d5bd59dd-9398-4f75-a277-abef42735297" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d5bd59dd-9398-4f75-a277-abef42735297_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d5bd59dd-9398-4f75-a277-abef42735297" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d5bd59dd-9398-4f75-a277-abef42735297_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1bdbb5a5-9867-4f7c-bf8d-180e296d2a56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d5bd59dd-9398-4f75-a277-abef42735297" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1bdbb5a5-9867-4f7c-bf8d-180e296d2a56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ConstructionInProgressSurgicalPlacementInstrumentSetMember_89442908-d9d1-432b-950c-2c6312c2b5a2" xlink:href="sibn-20230331.xsd#sibn_ConstructionInProgressSurgicalPlacementInstrumentSetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1bdbb5a5-9867-4f7c-bf8d-180e296d2a56" xlink:to="loc_sibn_ConstructionInProgressSurgicalPlacementInstrumentSetMember_89442908-d9d1-432b-950c-2c6312c2b5a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ConstructionInProgressSantaClaraLeaseMember_b523971e-b666-4d65-9f25-a478da85b2f0" xlink:href="sibn-20230331.xsd#sibn_ConstructionInProgressSantaClaraLeaseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1bdbb5a5-9867-4f7c-bf8d-180e296d2a56" xlink:to="loc_sibn_ConstructionInProgressSantaClaraLeaseMember_b523971e-b666-4d65-9f25-a478da85b2f0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="sibn-20230331.xsd#BalanceSheetComponentsPropertyandEquipmentNetDetails"/>
  <link:definitionLink xlink:role="http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails" xlink:type="extended" id="ie0649b5deefc4fedb691de22ac4d943c_BalanceSheetComponentsPropertyandEquipmentNetDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8a2773ac-15b9-45da-a067-96fa282b2d6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_6cf1679e-43be-46ea-a653-890aaf45a64f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8a2773ac-15b9-45da-a067-96fa282b2d6f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_6cf1679e-43be-46ea-a653-890aaf45a64f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_9f6d417c-8a1a-4a11-9624-58534370ef09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8a2773ac-15b9-45da-a067-96fa282b2d6f" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_9f6d417c-8a1a-4a11-9624-58534370ef09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_aa9bb6eb-492a-446e-8396-57b4f0dd605d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8a2773ac-15b9-45da-a067-96fa282b2d6f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_aa9bb6eb-492a-446e-8396-57b4f0dd605d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4bd19718-a6f4-47f2-8148-c570bdfd1650" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8a2773ac-15b9-45da-a067-96fa282b2d6f" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4bd19718-a6f4-47f2-8148-c570bdfd1650" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_125de7d9-c054-44fa-9311-14d330bb72be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4bd19718-a6f4-47f2-8148-c570bdfd1650" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_125de7d9-c054-44fa-9311-14d330bb72be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_125de7d9-c054-44fa-9311-14d330bb72be_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_125de7d9-c054-44fa-9311-14d330bb72be" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_125de7d9-c054-44fa-9311-14d330bb72be_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_62a48284-8112-427a-a624-7b691daf38d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_125de7d9-c054-44fa-9311-14d330bb72be" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_62a48284-8112-427a-a624-7b691daf38d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_607842c2-36df-42a8-9fa2-45b474d280b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_62a48284-8112-427a-a624-7b691daf38d8" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_607842c2-36df-42a8-9fa2-45b474d280b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_87117d28-acf9-4282-877c-c3586b38fcd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_62a48284-8112-427a-a624-7b691daf38d8" xlink:to="loc_us-gaap_ConstructionInProgressMember_87117d28-acf9-4282-877c-c3586b38fcd8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ComputerAndOfficeEquipmentMember_c7526cb4-bb3a-434b-82b6-54400d266c14" xlink:href="sibn-20230331.xsd#sibn_ComputerAndOfficeEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_62a48284-8112-427a-a624-7b691daf38d8" xlink:to="loc_sibn_ComputerAndOfficeEquipmentMember_c7526cb4-bb3a-434b-82b6-54400d266c14" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_e8188575-0fae-44b7-9177-2cdf22c42e19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_62a48284-8112-427a-a624-7b691daf38d8" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_e8188575-0fae-44b7-9177-2cdf22c42e19" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_8b1ad121-da9e-4545-80f8-fe55682db0d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_62a48284-8112-427a-a624-7b691daf38d8" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_8b1ad121-da9e-4545-80f8-fe55682db0d2" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://si-bone.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="simple" xlink:href="sibn-20230331.xsd#CommitmentsandContingenciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://si-bone.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="extended" id="i22e0c98f4ed54912a16c315d8ebf5e1c_CommitmentsandContingenciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_4333806d-ffbc-44bc-9803-c2b5e410d6ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_LesseeOperatingLeaseLeaseNotYetCommencedLiability_a3cadbb5-3de6-42ed-9d40-313e88dbd8b5" xlink:href="sibn-20230331.xsd#sibn_LesseeOperatingLeaseLeaseNotYetCommencedLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_4333806d-ffbc-44bc-9803-c2b5e410d6ca" xlink:to="loc_sibn_LesseeOperatingLeaseLeaseNotYetCommencedLiability_a3cadbb5-3de6-42ed-9d40-313e88dbd8b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligation_fca24ce5-db40-4361-8e26-152924db3f5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PurchaseObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_4333806d-ffbc-44bc-9803-c2b5e410d6ca" xlink:to="loc_us-gaap_PurchaseObligation_fca24ce5-db40-4361-8e26-152924db3f5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_0f568204-b53a-48ba-8a2f-0b729eb65d35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_4333806d-ffbc-44bc-9803-c2b5e410d6ca" xlink:to="loc_us-gaap_LitigationSettlementExpense_0f568204-b53a-48ba-8a2f-0b729eb65d35" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_d3b9527f-fce3-4fb5-819a-2d7850184b36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_4333806d-ffbc-44bc-9803-c2b5e410d6ca" xlink:to="loc_us-gaap_LitigationReserve_d3b9527f-fce3-4fb5-819a-2d7850184b36" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_a3bd7231-2a70-4f43-9d9c-c4b5c9801028" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_4333806d-ffbc-44bc-9803-c2b5e410d6ca" xlink:to="loc_us-gaap_OtherCommitmentsTable_a3bd7231-2a70-4f43-9d9c-c4b5c9801028" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_05a70a78-8d16-4f9f-941d-733a9c83f5e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_a3bd7231-2a70-4f43-9d9c-c4b5c9801028" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_05a70a78-8d16-4f9f-941d-733a9c83f5e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_05a70a78-8d16-4f9f-941d-733a9c83f5e9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_05a70a78-8d16-4f9f-941d-733a9c83f5e9" xlink:to="loc_us-gaap_LossContingencyNatureDomain_05a70a78-8d16-4f9f-941d-733a9c83f5e9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_64fb8cc2-4021-4f6b-97c5-6368cf63f18e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_05a70a78-8d16-4f9f-941d-733a9c83f5e9" xlink:to="loc_us-gaap_LossContingencyNatureDomain_64fb8cc2-4021-4f6b-97c5-6368cf63f18e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndemnificationGuaranteeMember_cf578d42-0f8b-487e-ae34-d3bf54def76c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndemnificationGuaranteeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_64fb8cc2-4021-4f6b-97c5-6368cf63f18e" xlink:to="loc_us-gaap_IndemnificationGuaranteeMember_cf578d42-0f8b-487e-ae34-d3bf54def76c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://si-bone.com/role/BorrowingsNarrativeDetails" xlink:type="simple" xlink:href="sibn-20230331.xsd#BorrowingsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://si-bone.com/role/BorrowingsNarrativeDetails" xlink:type="extended" id="i34699f2b3a5448dbb10b30e0c2dcc204_BorrowingsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_cc46bafc-17fb-4610-b176-9ea43db1abf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_973852c0-5eb1-4b3a-a10a-ed65554af67f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cc46bafc-17fb-4610-b176-9ea43db1abf8" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_973852c0-5eb1-4b3a-a10a-ed65554af67f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfSecuredDebt_cb8db7e1-6b81-472f-9a0d-245d60789863" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfSecuredDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cc46bafc-17fb-4610-b176-9ea43db1abf8" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfSecuredDebt_cb8db7e1-6b81-472f-9a0d-245d60789863" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_87ffb6d7-9d9b-4513-a681-4d703fba1987" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cc46bafc-17fb-4610-b176-9ea43db1abf8" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_87ffb6d7-9d9b-4513-a681-4d703fba1987" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_LineOfCreditFacilityAccordionFeatureIncreaseLimit_de10a46c-b75f-42a3-9286-18e4892682c9" xlink:href="sibn-20230331.xsd#sibn_LineOfCreditFacilityAccordionFeatureIncreaseLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cc46bafc-17fb-4610-b176-9ea43db1abf8" xlink:to="loc_sibn_LineOfCreditFacilityAccordionFeatureIncreaseLimit_de10a46c-b75f-42a3-9286-18e4892682c9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_f761ac57-2429-4f7f-8a78-cbc3bc69acf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cc46bafc-17fb-4610-b176-9ea43db1abf8" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_f761ac57-2429-4f7f-8a78-cbc3bc69acf5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal_7f1bd52a-72e5-45cd-80f4-4c592a7f64ca" xlink:href="sibn-20230331.xsd#sibn_DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cc46bafc-17fb-4610-b176-9ea43db1abf8" xlink:to="loc_sibn_DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal_7f1bd52a-72e5-45cd-80f4-4c592a7f64ca" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_DebtInstrumentAccountsReceivableBorrowingBase_5a736a44-fb98-46e8-a468-c5db29e872f8" xlink:href="sibn-20230331.xsd#sibn_DebtInstrumentAccountsReceivableBorrowingBase"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cc46bafc-17fb-4610-b176-9ea43db1abf8" xlink:to="loc_sibn_DebtInstrumentAccountsReceivableBorrowingBase_5a736a44-fb98-46e8-a468-c5db29e872f8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_51fe6067-2c8c-4841-8c7a-246ac7062d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cc46bafc-17fb-4610-b176-9ea43db1abf8" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_51fe6067-2c8c-4841-8c7a-246ac7062d1c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_DebtInstrumentCovenantAdjustedQuickRatioMinimum_402ec14a-30a2-40c7-bf4a-66901e369c85" xlink:href="sibn-20230331.xsd#sibn_DebtInstrumentCovenantAdjustedQuickRatioMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cc46bafc-17fb-4610-b176-9ea43db1abf8" xlink:to="loc_sibn_DebtInstrumentCovenantAdjustedQuickRatioMinimum_402ec14a-30a2-40c7-bf4a-66901e369c85" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_8c8d2d51-a3de-4e75-a9db-da35c385e527" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cc46bafc-17fb-4610-b176-9ea43db1abf8" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_8c8d2d51-a3de-4e75-a9db-da35c385e527" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_LineOfCreditFacilityContingentCommitmentFeeAmount_bec2e3ed-b148-488c-83b7-dd2d4ad1c591" xlink:href="sibn-20230331.xsd#sibn_LineOfCreditFacilityContingentCommitmentFeeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cc46bafc-17fb-4610-b176-9ea43db1abf8" xlink:to="loc_sibn_LineOfCreditFacilityContingentCommitmentFeeAmount_bec2e3ed-b148-488c-83b7-dd2d4ad1c591" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_c57088d0-eb6a-45fb-9cf0-f5fa9102abc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cc46bafc-17fb-4610-b176-9ea43db1abf8" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_c57088d0-eb6a-45fb-9cf0-f5fa9102abc5" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_DebtInstrumentInterestRateIncreaseDueToDefault_89262a0b-fe6e-4055-9f93-5008d279a071" xlink:href="sibn-20230331.xsd#sibn_DebtInstrumentInterestRateIncreaseDueToDefault"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cc46bafc-17fb-4610-b176-9ea43db1abf8" xlink:to="loc_sibn_DebtInstrumentInterestRateIncreaseDueToDefault_89262a0b-fe6e-4055-9f93-5008d279a071" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_05b2a325-7780-4305-b1bb-182a10ba52ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cc46bafc-17fb-4610-b176-9ea43db1abf8" xlink:to="loc_us-gaap_DebtInstrumentTable_05b2a325-7780-4305-b1bb-182a10ba52ec" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8aefc798-34de-4c41-b759-b787b187f9c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_05b2a325-7780-4305-b1bb-182a10ba52ec" xlink:to="loc_us-gaap_DebtInstrumentAxis_8aefc798-34de-4c41-b759-b787b187f9c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8aefc798-34de-4c41-b759-b787b187f9c8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_8aefc798-34de-4c41-b759-b787b187f9c8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8aefc798-34de-4c41-b759-b787b187f9c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_85aabf4c-ff7f-4baa-8a73-254f4a25f376" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_8aefc798-34de-4c41-b759-b787b187f9c8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_85aabf4c-ff7f-4baa-8a73-254f4a25f376" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_SVBTermLoanMember_ea9e8227-957f-462d-8b72-746ca9f97a13" xlink:href="sibn-20230331.xsd#sibn_SVBTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_85aabf4c-ff7f-4baa-8a73-254f4a25f376" xlink:to="loc_sibn_SVBTermLoanMember_ea9e8227-957f-462d-8b72-746ca9f97a13" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_SVBAmendedTermLoanMember_650ce17d-f357-45e6-ab95-a00598550273" xlink:href="sibn-20230331.xsd#sibn_SVBAmendedTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_85aabf4c-ff7f-4baa-8a73-254f4a25f376" xlink:to="loc_sibn_SVBAmendedTermLoanMember_650ce17d-f357-45e6-ab95-a00598550273" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_SolarLoanAndSecurityAgreementMember_1054d38c-e653-4702-8508-bcbbebbae7a6" xlink:href="sibn-20230331.xsd#sibn_SolarLoanAndSecurityAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_85aabf4c-ff7f-4baa-8a73-254f4a25f376" xlink:to="loc_sibn_SolarLoanAndSecurityAgreementMember_1054d38c-e653-4702-8508-bcbbebbae7a6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_274d0f25-ba58-4860-94b8-67faad778144" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_05b2a325-7780-4305-b1bb-182a10ba52ec" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_274d0f25-ba58-4860-94b8-67faad778144" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_274d0f25-ba58-4860-94b8-67faad778144_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_274d0f25-ba58-4860-94b8-67faad778144" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_274d0f25-ba58-4860-94b8-67faad778144_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ea923f93-5ae8-4222-ba5c-9ba5e66e0811" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_274d0f25-ba58-4860-94b8-67faad778144" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ea923f93-5ae8-4222-ba5c-9ba5e66e0811" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_a9da7dab-2ba4-4f2c-bcfd-1f3796a6fdb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ea923f93-5ae8-4222-ba5c-9ba5e66e0811" xlink:to="loc_us-gaap_SecuredDebtMember_a9da7dab-2ba4-4f2c-bcfd-1f3796a6fdb8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_bb15716f-c2c4-4772-a9c0-8e1eb9ed830b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ea923f93-5ae8-4222-ba5c-9ba5e66e0811" xlink:to="loc_us-gaap_LineOfCreditMember_bb15716f-c2c4-4772-a9c0-8e1eb9ed830b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_e556c148-a08e-496f-8e72-ec09476291c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_05b2a325-7780-4305-b1bb-182a10ba52ec" xlink:to="loc_us-gaap_CreditFacilityAxis_e556c148-a08e-496f-8e72-ec09476291c7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_e556c148-a08e-496f-8e72-ec09476291c7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_e556c148-a08e-496f-8e72-ec09476291c7" xlink:to="loc_us-gaap_CreditFacilityDomain_e556c148-a08e-496f-8e72-ec09476291c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_0ed16cf6-b442-49f2-90a3-d2e52c81d114" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_e556c148-a08e-496f-8e72-ec09476291c7" xlink:to="loc_us-gaap_CreditFacilityDomain_0ed16cf6-b442-49f2-90a3-d2e52c81d114" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_431d339d-4457-4cfa-9838-363d19fab029" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_0ed16cf6-b442-49f2-90a3-d2e52c81d114" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_431d339d-4457-4cfa-9838-363d19fab029" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_dd7fd065-db5e-4d70-996b-20cadf8dc843" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_05b2a325-7780-4305-b1bb-182a10ba52ec" xlink:to="loc_srt_RangeAxis_dd7fd065-db5e-4d70-996b-20cadf8dc843" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_dd7fd065-db5e-4d70-996b-20cadf8dc843_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_dd7fd065-db5e-4d70-996b-20cadf8dc843" xlink:to="loc_srt_RangeMember_dd7fd065-db5e-4d70-996b-20cadf8dc843_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_da5ce524-6b2d-4e27-851a-86ae6c5b06c3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_dd7fd065-db5e-4d70-996b-20cadf8dc843" xlink:to="loc_srt_RangeMember_da5ce524-6b2d-4e27-851a-86ae6c5b06c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_37a6df95-93b3-43b7-a1eb-323896af3f97" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_da5ce524-6b2d-4e27-851a-86ae6c5b06c3" xlink:to="loc_srt_MinimumMember_37a6df95-93b3-43b7-a1eb-323896af3f97" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2641e5ae-2260-4aa2-aae6-d02deb39612e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_da5ce524-6b2d-4e27-851a-86ae6c5b06c3" xlink:to="loc_srt_MaximumMember_2641e5ae-2260-4aa2-aae6-d02deb39612e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails" xlink:type="simple" xlink:href="sibn-20230331.xsd#StockBasedIncentiveCompensationPlansNarrativeDetails"/>
  <link:definitionLink xlink:role="http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails" xlink:type="extended" id="i8be3694ee38f425fb1cbade3480cbb82_StockBasedIncentiveCompensationPlansNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_131e44e3-f3d3-4a86-b5de-17862fdf2628" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0ae17600-16eb-460d-b667-da5cfc2979d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_131e44e3-f3d3-4a86-b5de-17862fdf2628" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0ae17600-16eb-460d-b667-da5cfc2979d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_7b24662b-5abc-44e5-b146-288869f843ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_131e44e3-f3d3-4a86-b5de-17862fdf2628" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_7b24662b-5abc-44e5-b146-288869f843ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase_a34fc2e7-affa-4e13-992a-86a36b2fffbe" xlink:href="sibn-20230331.xsd#sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_131e44e3-f3d3-4a86-b5de-17862fdf2628" xlink:to="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase_a34fc2e7-affa-4e13-992a-86a36b2fffbe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_539c5cbd-d0f4-413d-974d-430609389545" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_131e44e3-f3d3-4a86-b5de-17862fdf2628" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_539c5cbd-d0f4-413d-974d-430609389545" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_445905cc-3d66-4cfd-8895-88c0e63608c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_131e44e3-f3d3-4a86-b5de-17862fdf2628" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_445905cc-3d66-4cfd-8895-88c0e63608c8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_148e0807-cded-4924-a69c-0062bfa703f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_131e44e3-f3d3-4a86-b5de-17862fdf2628" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_148e0807-cded-4924-a69c-0062bfa703f4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval_3d85e69a-5b90-4c83-ba3e-08dde5e624c0" xlink:href="sibn-20230331.xsd#sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_131e44e3-f3d3-4a86-b5de-17862fdf2628" xlink:to="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval_3d85e69a-5b90-4c83-ba3e-08dde5e624c0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods_1b9c9e8d-c741-4f92-892c-a51984bc7f33" xlink:href="sibn-20230331.xsd#sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_131e44e3-f3d3-4a86-b5de-17862fdf2628" xlink:to="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods_1b9c9e8d-c741-4f92-892c-a51984bc7f33" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent_0add0772-c540-4e28-bb0f-e7488f7841b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherEmployeeRelatedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_131e44e3-f3d3-4a86-b5de-17862fdf2628" xlink:to="loc_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent_0add0772-c540-4e28-bb0f-e7488f7841b4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a1a635a8-c2f5-4cd4-80a5-f2ddbbe34fea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_131e44e3-f3d3-4a86-b5de-17862fdf2628" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a1a635a8-c2f5-4cd4-80a5-f2ddbbe34fea" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_07c734b9-c597-4037-81d9-0499ccbdd6ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a1a635a8-c2f5-4cd4-80a5-f2ddbbe34fea" xlink:to="loc_us-gaap_PlanNameAxis_07c734b9-c597-4037-81d9-0499ccbdd6ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_07c734b9-c597-4037-81d9-0499ccbdd6ae_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_07c734b9-c597-4037-81d9-0499ccbdd6ae" xlink:to="loc_us-gaap_PlanNameDomain_07c734b9-c597-4037-81d9-0499ccbdd6ae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_cdb3c834-d250-4095-b984-58aa41d37495" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_07c734b9-c597-4037-81d9-0499ccbdd6ae" xlink:to="loc_us-gaap_PlanNameDomain_cdb3c834-d250-4095-b984-58aa41d37495" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_A2018EmployeeStockPurchasePlanMember_8859342f-c4f9-43eb-897b-d11545071ebb" xlink:href="sibn-20230331.xsd#sibn_A2018EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_cdb3c834-d250-4095-b984-58aa41d37495" xlink:to="loc_sibn_A2018EmployeeStockPurchasePlanMember_8859342f-c4f9-43eb-897b-d11545071ebb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_beebb42f-92f5-432d-9776-83c907d567f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a1a635a8-c2f5-4cd4-80a5-f2ddbbe34fea" xlink:to="loc_us-gaap_AwardTypeAxis_beebb42f-92f5-432d-9776-83c907d567f8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_beebb42f-92f5-432d-9776-83c907d567f8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_beebb42f-92f5-432d-9776-83c907d567f8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_beebb42f-92f5-432d-9776-83c907d567f8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6c4c4dc0-cbc4-44dd-861c-eefff6537d68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_beebb42f-92f5-432d-9776-83c907d567f8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6c4c4dc0-cbc4-44dd-861c-eefff6537d68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_9bd87c8d-e5f3-447c-93d2-684c62e114cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6c4c4dc0-cbc4-44dd-861c-eefff6537d68" xlink:to="loc_us-gaap_EmployeeStockOptionMember_9bd87c8d-e5f3-447c-93d2-684c62e114cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_59203a57-b620-4aed-938f-1240cd3b3c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6c4c4dc0-cbc4-44dd-861c-eefff6537d68" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_59203a57-b620-4aed-938f-1240cd3b3c4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_7a61f6db-0614-466d-9031-1e700fdab34e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6c4c4dc0-cbc4-44dd-861c-eefff6537d68" xlink:to="loc_us-gaap_PerformanceSharesMember_7a61f6db-0614-466d-9031-1e700fdab34e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f18f24d7-6757-43bd-a6d2-4afe80cd92c2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a1a635a8-c2f5-4cd4-80a5-f2ddbbe34fea" xlink:to="loc_srt_RangeAxis_f18f24d7-6757-43bd-a6d2-4afe80cd92c2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f18f24d7-6757-43bd-a6d2-4afe80cd92c2_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_f18f24d7-6757-43bd-a6d2-4afe80cd92c2" xlink:to="loc_srt_RangeMember_f18f24d7-6757-43bd-a6d2-4afe80cd92c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6c0b2e23-59aa-43fd-bc33-6b0ddbc662b8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_f18f24d7-6757-43bd-a6d2-4afe80cd92c2" xlink:to="loc_srt_RangeMember_6c0b2e23-59aa-43fd-bc33-6b0ddbc662b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8e63d749-ed83-4555-8e94-e56a0ff9cd8a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6c0b2e23-59aa-43fd-bc33-6b0ddbc662b8" xlink:to="loc_srt_MinimumMember_8e63d749-ed83-4555-8e94-e56a0ff9cd8a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d6a7c679-a7e4-449f-b528-3974d1b52150" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6c0b2e23-59aa-43fd-bc33-6b0ddbc662b8" xlink:to="loc_srt_MaximumMember_d6a7c679-a7e4-449f-b528-3974d1b52150" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails" xlink:type="simple" xlink:href="sibn-20230331.xsd#StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails"/>
  <link:definitionLink xlink:role="http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails" xlink:type="extended" id="i962d13309a67420c873c8adc2758a885_StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9553f8b2-57a6-43e0-98ad-02dc535eae11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_7c20a08f-5066-43f5-88e9-bc0144041907" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9553f8b2-57a6-43e0-98ad-02dc535eae11" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_7c20a08f-5066-43f5-88e9-bc0144041907" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_a60a3554-6b25-4261-bd6d-5b8428e93480" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_7c20a08f-5066-43f5-88e9-bc0144041907" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_a60a3554-6b25-4261-bd6d-5b8428e93480" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_2ed75875-7d67-4e20-94cf-08639a7948fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_7c20a08f-5066-43f5-88e9-bc0144041907" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_2ed75875-7d67-4e20-94cf-08639a7948fc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMinimum_896f8e16-91b6-4dee-a6b1-b22289b98d81" xlink:href="sibn-20230331.xsd#sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_7c20a08f-5066-43f5-88e9-bc0144041907" xlink:to="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMinimum_896f8e16-91b6-4dee-a6b1-b22289b98d81" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMaximum_4c45b926-a933-4161-832f-aef1c9b457e7" xlink:href="sibn-20230331.xsd#sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_7c20a08f-5066-43f5-88e9-bc0144041907" xlink:to="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMaximum_4c45b926-a933-4161-832f-aef1c9b457e7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMinimum_ffb13bdb-0f8b-4627-98fd-20c5dea92a1d" xlink:href="sibn-20230331.xsd#sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_7c20a08f-5066-43f5-88e9-bc0144041907" xlink:to="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMinimum_ffb13bdb-0f8b-4627-98fd-20c5dea92a1d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMaximum_30559e9e-b9e2-455f-962c-b708e509becb" xlink:href="sibn-20230331.xsd#sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_7c20a08f-5066-43f5-88e9-bc0144041907" xlink:to="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMaximum_30559e9e-b9e2-455f-962c-b708e509becb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_15e8bf90-3cfa-4af7-9ab3-ed4cab4605d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_7c20a08f-5066-43f5-88e9-bc0144041907" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_15e8bf90-3cfa-4af7-9ab3-ed4cab4605d0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_aef93d62-98e6-4f96-8cb7-1735a0691a8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_7c20a08f-5066-43f5-88e9-bc0144041907" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_aef93d62-98e6-4f96-8cb7-1735a0691a8b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1bc4a0e3-169a-43ba-b0a8-a0c6d71271b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_7c20a08f-5066-43f5-88e9-bc0144041907" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1bc4a0e3-169a-43ba-b0a8-a0c6d71271b8" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_101e1d3d-4866-4399-b241-9ee1228a50ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9553f8b2-57a6-43e0-98ad-02dc535eae11" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_101e1d3d-4866-4399-b241-9ee1228a50ff" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_eeca9c36-6a19-40e3-9a4e-8a1d4ff1a67d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_101e1d3d-4866-4399-b241-9ee1228a50ff" xlink:to="loc_us-gaap_AwardTypeAxis_eeca9c36-6a19-40e3-9a4e-8a1d4ff1a67d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_eeca9c36-6a19-40e3-9a4e-8a1d4ff1a67d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_eeca9c36-6a19-40e3-9a4e-8a1d4ff1a67d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_eeca9c36-6a19-40e3-9a4e-8a1d4ff1a67d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cd877b47-c870-4652-bf39-6879eb53698f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_eeca9c36-6a19-40e3-9a4e-8a1d4ff1a67d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cd877b47-c870-4652-bf39-6879eb53698f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_0f2343e9-12fe-481e-8bc1-99b0089d4a5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cd877b47-c870-4652-bf39-6879eb53698f" xlink:to="loc_us-gaap_PerformanceSharesMember_0f2343e9-12fe-481e-8bc1-99b0089d4a5e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a6b4ac7c-6181-4bef-a657-62c9e95cfb9b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_101e1d3d-4866-4399-b241-9ee1228a50ff" xlink:to="loc_srt_RangeAxis_a6b4ac7c-6181-4bef-a657-62c9e95cfb9b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a6b4ac7c-6181-4bef-a657-62c9e95cfb9b_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_a6b4ac7c-6181-4bef-a657-62c9e95cfb9b" xlink:to="loc_srt_RangeMember_a6b4ac7c-6181-4bef-a657-62c9e95cfb9b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6f0db6e2-d219-4bdd-b737-7fb8e7f78e72" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_a6b4ac7c-6181-4bef-a657-62c9e95cfb9b" xlink:to="loc_srt_RangeMember_6f0db6e2-d219-4bdd-b737-7fb8e7f78e72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_357b3046-7fff-44e6-8d6a-0c3fe4b0d190" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6f0db6e2-d219-4bdd-b737-7fb8e7f78e72" xlink:to="loc_srt_MinimumMember_357b3046-7fff-44e6-8d6a-0c3fe4b0d190" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_cedb9a2a-be66-499e-9648-5f8c99c9412e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6f0db6e2-d219-4bdd-b737-7fb8e7f78e72" xlink:to="loc_srt_MaximumMember_cedb9a2a-be66-499e-9648-5f8c99c9412e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://si-bone.com/role/StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityandPerformanceBasedRestrictedStockUnitActivityDetails" xlink:type="simple" xlink:href="sibn-20230331.xsd#StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityandPerformanceBasedRestrictedStockUnitActivityDetails"/>
  <link:definitionLink xlink:role="http://si-bone.com/role/StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityandPerformanceBasedRestrictedStockUnitActivityDetails" xlink:type="extended" id="i4955162043ee45f2bcf2a207664ab486_StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityandPerformanceBasedRestrictedStockUnitActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_74dca812-8bb1-4794-866c-44e01669f802" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5792a651-a9a6-495f-ab68-f948d4e3c6f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_74dca812-8bb1-4794-866c-44e01669f802" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5792a651-a9a6-495f-ab68-f948d4e3c6f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_94d4c874-0211-4943-bdaf-fcb7db966c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5792a651-a9a6-495f-ab68-f948d4e3c6f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_94d4c874-0211-4943-bdaf-fcb7db966c5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_35eec8f3-023e-4be8-b168-2a84dafe4e84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5792a651-a9a6-495f-ab68-f948d4e3c6f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_35eec8f3-023e-4be8-b168-2a84dafe4e84" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_9b3235b7-1bb8-4529-95f5-7a7ac9107a6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5792a651-a9a6-495f-ab68-f948d4e3c6f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_9b3235b7-1bb8-4529-95f5-7a7ac9107a6d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_de671f21-9005-4535-abe4-cd8a8764e561" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5792a651-a9a6-495f-ab68-f948d4e3c6f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_de671f21-9005-4535-abe4-cd8a8764e561" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_024822f9-f1d6-489d-940b-c8ece9467b69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_492f3459-73d7-49fe-9e56-c0d1d8df9124" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_74dca812-8bb1-4794-866c-44e01669f802" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_492f3459-73d7-49fe-9e56-c0d1d8df9124" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_31a1f639-86a6-4bd7-8087-f44e738321ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_492f3459-73d7-49fe-9e56-c0d1d8df9124" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_31a1f639-86a6-4bd7-8087-f44e738321ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_55d7e1b1-209e-4b4a-a544-0e20c146c969" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_492f3459-73d7-49fe-9e56-c0d1d8df9124" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_55d7e1b1-209e-4b4a-a544-0e20c146c969" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_b88c24f6-2439-44f7-8145-21c527819423" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_492f3459-73d7-49fe-9e56-c0d1d8df9124" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_b88c24f6-2439-44f7-8145-21c527819423" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_83421257-b2f2-4664-a7e8-9698e9269d0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_492f3459-73d7-49fe-9e56-c0d1d8df9124" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_83421257-b2f2-4664-a7e8-9698e9269d0d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ea33795a-7c04-4651-bcb2-6aeec198c327" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_732391ea-c2ec-4a0f-b9da-428f7701a1fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_74dca812-8bb1-4794-866c-44e01669f802" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_732391ea-c2ec-4a0f-b9da-428f7701a1fc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_ffde45d5-5734-42fe-827a-9a3c38b3de05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_732391ea-c2ec-4a0f-b9da-428f7701a1fc" xlink:to="loc_us-gaap_AwardTypeAxis_ffde45d5-5734-42fe-827a-9a3c38b3de05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ffde45d5-5734-42fe-827a-9a3c38b3de05_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_ffde45d5-5734-42fe-827a-9a3c38b3de05" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ffde45d5-5734-42fe-827a-9a3c38b3de05_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7c5875b3-7ad4-4995-975d-d5e3ab2a6910" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_ffde45d5-5734-42fe-827a-9a3c38b3de05" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7c5875b3-7ad4-4995-975d-d5e3ab2a6910" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_41923c6e-1651-4f22-8557-a08d2fe080c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7c5875b3-7ad4-4995-975d-d5e3ab2a6910" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_41923c6e-1651-4f22-8557-a08d2fe080c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_2f4c8b38-a117-4a0b-890b-1dfe81aa053f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7c5875b3-7ad4-4995-975d-d5e3ab2a6910" xlink:to="loc_us-gaap_PerformanceSharesMember_2f4c8b38-a117-4a0b-890b-1dfe81aa053f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="sibn-20230331.xsd#StockBasedIncentiveCompensationPlansStockBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockBasedCompensationExpenseDetails" xlink:type="extended" id="i9308dd6a97c8416aac885b61fa96a13b_StockBasedIncentiveCompensationPlansStockBasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d1ab7e8b-83fc-453d-acb8-35b148f8b427" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_966bb8f3-49bf-432a-bd8a-843e27c7130b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d1ab7e8b-83fc-453d-acb8-35b148f8b427" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_966bb8f3-49bf-432a-bd8a-843e27c7130b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9256da42-530a-4740-97db-a13989510b20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d1ab7e8b-83fc-453d-acb8-35b148f8b427" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9256da42-530a-4740-97db-a13989510b20" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_bc484471-837b-4b23-b8d8-a7b15cbdc585" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9256da42-530a-4740-97db-a13989510b20" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_bc484471-837b-4b23-b8d8-a7b15cbdc585" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_bc484471-837b-4b23-b8d8-a7b15cbdc585_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_bc484471-837b-4b23-b8d8-a7b15cbdc585" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_bc484471-837b-4b23-b8d8-a7b15cbdc585_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5079c327-3c5d-490f-b0cc-2d727beb3fd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_bc484471-837b-4b23-b8d8-a7b15cbdc585" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_5079c327-3c5d-490f-b0cc-2d727beb3fd2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_f2e06678-4591-42de-a55c-85e6ec9800a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5079c327-3c5d-490f-b0cc-2d727beb3fd2" xlink:to="loc_us-gaap_CostOfSalesMember_f2e06678-4591-42de-a55c-85e6ec9800a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_804b96da-4952-4b4c-8aac-2a7946ceb718" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5079c327-3c5d-490f-b0cc-2d727beb3fd2" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_804b96da-4952-4b4c-8aac-2a7946ceb718" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_9fe41d07-6b88-4fc4-8caf-e24d5ea71e43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5079c327-3c5d-490f-b0cc-2d727beb3fd2" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_9fe41d07-6b88-4fc4-8caf-e24d5ea71e43" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_04e15553-88bc-46d9-a351-8be8449fd534" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5079c327-3c5d-490f-b0cc-2d727beb3fd2" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_04e15553-88bc-46d9-a351-8be8449fd534" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://si-bone.com/role/NetLossPerShareofCommonStockAntidilutiveCommonStockEquivalentsExcludedfromComputationofEarningsPerShareDetails" xlink:type="simple" xlink:href="sibn-20230331.xsd#NetLossPerShareofCommonStockAntidilutiveCommonStockEquivalentsExcludedfromComputationofEarningsPerShareDetails"/>
  <link:definitionLink xlink:role="http://si-bone.com/role/NetLossPerShareofCommonStockAntidilutiveCommonStockEquivalentsExcludedfromComputationofEarningsPerShareDetails" xlink:type="extended" id="i2f8c7991c2584e84b1906f6388e6cd98_NetLossPerShareofCommonStockAntidilutiveCommonStockEquivalentsExcludedfromComputationofEarningsPerShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_d7c863e4-2e30-4538-b34a-bba04a6d85c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_5f8ee1e3-38f9-4bef-9a17-9af5ba093116" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_d7c863e4-2e30-4538-b34a-bba04a6d85c5" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_5f8ee1e3-38f9-4bef-9a17-9af5ba093116" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_37dc9d4a-366e-49ad-ac1a-b38d9a9110d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_d7c863e4-2e30-4538-b34a-bba04a6d85c5" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_37dc9d4a-366e-49ad-ac1a-b38d9a9110d3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e40455d0-ef04-4d68-bc29-102be82d835d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_37dc9d4a-366e-49ad-ac1a-b38d9a9110d3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e40455d0-ef04-4d68-bc29-102be82d835d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e40455d0-ef04-4d68-bc29-102be82d835d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e40455d0-ef04-4d68-bc29-102be82d835d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e40455d0-ef04-4d68-bc29-102be82d835d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_96c464c6-ed8b-4ed3-aec1-a9434be820d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e40455d0-ef04-4d68-bc29-102be82d835d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_96c464c6-ed8b-4ed3-aec1-a9434be820d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_6a696385-7759-45fa-a890-6998d1abde6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_96c464c6-ed8b-4ed3-aec1-a9434be820d1" xlink:to="loc_us-gaap_EmployeeStockOptionMember_6a696385-7759-45fa-a890-6998d1abde6b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_5ab261a5-6356-4b18-8e9d-1813a7305788" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_96c464c6-ed8b-4ed3-aec1-a9434be820d1" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_5ab261a5-6356-4b18-8e9d-1813a7305788" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_EmployeeStockPurchasePlanSharesMember_1d433f02-4b94-46d6-b0cb-e4d63492fd7c" xlink:href="sibn-20230331.xsd#sibn_EmployeeStockPurchasePlanSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_96c464c6-ed8b-4ed3-aec1-a9434be820d1" xlink:to="loc_sibn_EmployeeStockPurchasePlanSharesMember_1d433f02-4b94-46d6-b0cb-e4d63492fd7c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_CommonStockWarrantsMember_58ea6d71-8f07-4a0f-8e83-63d9cb76fee4" xlink:href="sibn-20230331.xsd#sibn_CommonStockWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_96c464c6-ed8b-4ed3-aec1-a9434be820d1" xlink:to="loc_sibn_CommonStockWarrantsMember_58ea6d71-8f07-4a0f-8e83-63d9cb76fee4" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://si-bone.com/role/RelatedPartyTransactionDetails" xlink:type="simple" xlink:href="sibn-20230331.xsd#RelatedPartyTransactionDetails"/>
  <link:definitionLink xlink:role="http://si-bone.com/role/RelatedPartyTransactionDetails" xlink:type="extended" id="i8482cabda7a848f7ae928552126d70e6_RelatedPartyTransactionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_28885571-a734-45d4-8d30-6009f4e1eb75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_18965389-1bea-4e14-9715-cc41516f9352" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_28885571-a734-45d4-8d30-6009f4e1eb75" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_18965389-1bea-4e14-9715-cc41516f9352" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_RelatedPartyTransactionTermOfAgreement_df5f7da2-4216-41c5-b812-4d8358bd2567" xlink:href="sibn-20230331.xsd#sibn_RelatedPartyTransactionTermOfAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_28885571-a734-45d4-8d30-6009f4e1eb75" xlink:to="loc_sibn_RelatedPartyTransactionTermOfAgreement_df5f7da2-4216-41c5-b812-4d8358bd2567" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense_148353e2-520f-410c-a05d-ab428b73593c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_28885571-a734-45d4-8d30-6009f4e1eb75" xlink:to="loc_us-gaap_RoyaltyExpense_148353e2-520f-410c-a05d-ab428b73593c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrent_5ee01009-d380-44d1-84ff-647b8b2ae288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToAffiliateCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_28885571-a734-45d4-8d30-6009f4e1eb75" xlink:to="loc_us-gaap_DueToAffiliateCurrent_5ee01009-d380-44d1-84ff-647b8b2ae288" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_04736edc-b879-4d28-949a-b96a029ed575" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_28885571-a734-45d4-8d30-6009f4e1eb75" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_04736edc-b879-4d28-949a-b96a029ed575" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_35850a3c-3664-48e0-b5d3-57a03b09f423" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_04736edc-b879-4d28-949a-b96a029ed575" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_35850a3c-3664-48e0-b5d3-57a03b09f423" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_35850a3c-3664-48e0-b5d3-57a03b09f423_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_35850a3c-3664-48e0-b5d3-57a03b09f423" xlink:to="loc_us-gaap_RelatedPartyDomain_35850a3c-3664-48e0-b5d3-57a03b09f423_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_b47d507d-00a4-487a-b57b-24f67eb69a7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_35850a3c-3664-48e0-b5d3-57a03b09f423" xlink:to="loc_us-gaap_RelatedPartyDomain_b47d507d-00a4-487a-b57b-24f67eb69a7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_6ab5cb50-923d-452e-b8c8-1507f7b887b2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AffiliatedEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_b47d507d-00a4-487a-b57b-24f67eb69a7f" xlink:to="loc_srt_AffiliatedEntityMember_6ab5cb50-923d-452e-b8c8-1507f7b887b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_ac0b5f75-d85e-474b-9cbe-61a2f4fb0e99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_04736edc-b879-4d28-949a-b96a029ed575" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_ac0b5f75-d85e-474b-9cbe-61a2f4fb0e99" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_ac0b5f75-d85e-474b-9cbe-61a2f4fb0e99_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_ac0b5f75-d85e-474b-9cbe-61a2f4fb0e99" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_ac0b5f75-d85e-474b-9cbe-61a2f4fb0e99_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_75072c70-f932-4bb6-9075-1cf0a684daee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_ac0b5f75-d85e-474b-9cbe-61a2f4fb0e99" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_75072c70-f932-4bb6-9075-1cf0a684daee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_DevelopmentAgreementMember_a431be9a-492b-4d2d-bea4-c306a820773c" xlink:href="sibn-20230331.xsd#sibn_DevelopmentAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_75072c70-f932-4bb6-9075-1cf0a684daee" xlink:to="loc_sibn_DevelopmentAgreementMember_a431be9a-492b-4d2d-bea4-c306a820773c" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>sibn-20230331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:b9a8bdb4-fcbc-4ee6-8fcb-5f67627ef90e,g:a1ffbe61-3b0e-45b0-8eb9-b424c3d4458b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_IndemnificationGuaranteeMember_40a51739-324b-435b-a6a8-1d04d0264a74_terseLabel_en-US" xlink:label="lab_us-gaap_IndemnificationGuaranteeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indemnification Agreement</link:label>
    <link:label id="lab_us-gaap_IndemnificationGuaranteeMember_label_en-US" xlink:label="lab_us-gaap_IndemnificationGuaranteeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indemnification Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndemnificationGuaranteeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndemnificationGuaranteeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndemnificationGuaranteeMember" xlink:to="lab_us-gaap_IndemnificationGuaranteeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03d519c3-fbf3-4042-9866-2f0482ec7f86_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4c10cd83-6c54-42aa-8e35-6f4299e9d482_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_34fabd1e-c923-4345-89f4-155660038f51_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_2958ecc5-2192-4aab-b41f-19fee35367b4_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable credit losses</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_4f6e7aa7-26fe-4755-ad95-514faa3cbc2f_verboseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_4b1ad6f9-add7-4d1e-9d57-e5aae4604189_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal outstanding and final fee</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_a3d9e385-0cd8-4900-b6c6-ff2cceaf17b1_totalLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total principal and final fee payments</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_5ac64094-9334-464c-a1ee-0f0f73e9bfeb_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_42a8f11f-ee98-4a06-a182-6000c5d363b1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on marketable securities</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_9c9d0fff-2b8d-43b1-bda9-e52f0f245a63_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized gain (loss) on marketable securities</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_b075261c-5b35-40af-9f80-39e7d92c6601_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_390dd5f7-f926-4641-99d8-60ab444a91b1_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_39b44c53-c240-4b5f-9d4e-bb33e87d2678_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_13bc7cca-5abc-4ec4-9e82-a68ba053eded_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_182c8208-4054-4a82-a12f-a4be47449dc2_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_21c7c2ed-e284-499d-8df2-44a2b55d10b1_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reimbursement charges expensed</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Expenses from Transactions with Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_8ee2e01f-4861-4e8a-a59e-ba47b937f427_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving credit facility, aggregate principal amount</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_29fb92b5-260c-47ae-8958-7d01607ffce6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_d0deaf8c-70d3-4c68-a5f5-258363f72e90_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and other income (expense), net:</link:label>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_e457eb10-a13b-4cb7-81e9-1219a2376f87_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_fbcd7da6-b587-494a-8482-9ef4dfb0b3d3_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_5854d06d-1847-4618-a60b-296052d0ea0b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_7fd25313-5b48-4cd2-bfa9-2adfb5d1e768_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_c53fc7bd-a02a-4957-8b52-f6046028ed22_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ef98c99d-b87b-4a78-8d34-4e064efe7955_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock upon exercise of stock options, net of shares withheld (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8ee365c9-d0dd-4f6a-a1d6-3cfa3fbd6a58_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaturitiesOfLongTermDebtAbstract_d4bd49b0-8a87-4737-af12-517092e25cf3_terseLabel_en-US" xlink:label="lab_us-gaap_MaturitiesOfLongTermDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future principal and final fee payments</link:label>
    <link:label id="lab_us-gaap_MaturitiesOfLongTermDebtAbstract_label_en-US" xlink:label="lab_us-gaap_MaturitiesOfLongTermDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of Long-Term Debt [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaturitiesOfLongTermDebtAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaturitiesOfLongTermDebtAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaturitiesOfLongTermDebtAbstract" xlink:to="lab_us-gaap_MaturitiesOfLongTermDebtAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_aa9571b4-8f71-44ac-a863-83b38bd05419_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed interest rate (percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_002c7bed-5e76-4894-a07a-d0a36b8756e2_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_090b8584-8f20-4e3d-b457-4a6446a3b176_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_81609603-1c01-4e51-8059-8658ac57aea7_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_2008cca2-460a-4d0f-85a9-1b3b0992a07c_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_958ee7da-ffe4-4dd2-8d52-2c06a24dc342_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c65cb019-8926-4261-949d-99253b4a5779_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock equivalents excluded from computation of diluted net loss per share (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_EmployeeStockPurchasePlanSharesMember_45fa36f5-7316-4713-8024-1c8cf720a1cf_verboseLabel_en-US" xlink:label="lab_sibn_EmployeeStockPurchasePlanSharesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP purchase rights</link:label>
    <link:label id="lab_sibn_EmployeeStockPurchasePlanSharesMember_label_en-US" xlink:label="lab_sibn_EmployeeStockPurchasePlanSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan Shares [Member]</link:label>
    <link:label id="lab_sibn_EmployeeStockPurchasePlanSharesMember_documentation_en-US" xlink:label="lab_sibn_EmployeeStockPurchasePlanSharesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_EmployeeStockPurchasePlanSharesMember" xlink:href="sibn-20230331.xsd#sibn_EmployeeStockPurchasePlanSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_EmployeeStockPurchasePlanSharesMember" xlink:to="lab_sibn_EmployeeStockPurchasePlanSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_903006da-2b54-4f99-89bd-1bc692365dcf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Principal and Final Fee Payments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-Term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_ConstructionInProgressSurgicalPlacementInstrumentSetMember_11459aa1-1dd8-46b6-951d-3c02a962c143_terseLabel_en-US" xlink:label="lab_sibn_ConstructionInProgressSurgicalPlacementInstrumentSetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress, surgical placement instrument set</link:label>
    <link:label id="lab_sibn_ConstructionInProgressSurgicalPlacementInstrumentSetMember_label_en-US" xlink:label="lab_sibn_ConstructionInProgressSurgicalPlacementInstrumentSetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress, Surgical Placement Instrument Set [Member]</link:label>
    <link:label id="lab_sibn_ConstructionInProgressSurgicalPlacementInstrumentSetMember_documentation_en-US" xlink:label="lab_sibn_ConstructionInProgressSurgicalPlacementInstrumentSetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress, Surgical Placement Instrument Set</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ConstructionInProgressSurgicalPlacementInstrumentSetMember" xlink:href="sibn-20230331.xsd#sibn_ConstructionInProgressSurgicalPlacementInstrumentSetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_ConstructionInProgressSurgicalPlacementInstrumentSetMember" xlink:to="lab_sibn_ConstructionInProgressSurgicalPlacementInstrumentSetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_8f1fbc7d-25fe-4809-b8b4-04c4aefb5acc_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_374425e3-4fe7-4736-ba81-bf9f63a2d217_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term loan</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_95574d75-cb8f-463f-bd27-ebbbf8eacc56_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_47541b9c-3f37-41ed-b001-6b4668413ad6_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_9d99de8f-f1e9-48dc-be7e-b1194d6f327e_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation cost</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_dda1669a-8c24-42be-a42a-40e39ccfb530_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_7ae974a5-4498-4517-827a-e3fd77dc37b8_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remainder of 2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_e04e7e87-bdf7-42b1-9ae3-b032c089c822_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_727dd569-db1a-45ac-8a5d-998913c50adc_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_070f17ec-c296-48ea-8384-bbd70d6d1fce_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_a02ec954-45c3-4b38-8217-c25deb1bd283_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_12230100-69b7-4a89-8ad2-986175587aa3_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_77750b78-e151-4366-8b88-86959bbd240c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a8882936-8c5e-4f39-ac63-0aefe4bd9cda_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_ccc92d4c-4305-43d8-871e-67968b85e999_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain" xlink:to="lab_us-gaap_RelatedPartyTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_a3827a4e-27e1-480a-bfbb-c5888d61437e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_86668a19-18e4-428e-a64f-6c7c2fdf174b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term borrowings</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_61527dc8-7321-415d-aff3-355a35b25720_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL LIABILITIES</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_b398b5d0-4cb0-4001-8823-4282466d1596_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term (in years)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e596dd52-5a48-4d85-8183-054455c702ec_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_908197f1-90ba-4450-8ab1-b5f1f9c89846_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d11de8d6-9d61-4085-ac50-f1d82abd5a5a_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_0005fc1b-b54e-4f99-8d06-c3967862d07f_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5b76fb35-b5c5-4854-b65d-37d1b4f75172_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_409d1a12-a92a-4672-ab41-5760765cd799_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_7e063217-9f03-423e-9a75-6ee526b72884_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_1377f1a3-abc3-42cb-9d05-258e6cf15203_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_527b63c8-e7e2-4a81-9571-ff9658afd742_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_15bd8265-2a5c-426b-ac3c-91fc6bff1e48_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4e8210c2-634b-464e-af8f-6e84d8effe77_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b2b56799-44dc-4a16-a98a-2d7f8fbb0b9c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_e2010138-8d8c-424e-8461-b49208bd5309_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canceled and forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMinimum_05bfe522-aa28-485d-a065-e69b96636158_terseLabel_en-US" xlink:label="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility of peer companies, minimum (percent)</link:label>
    <link:label id="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMinimum_label_en-US" xlink:label="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Peer Companies, Minimum</link:label>
    <link:label id="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMinimum_documentation_en-US" xlink:label="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Peer Companies, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMinimum" xlink:href="sibn-20230331.xsd#sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMinimum" xlink:to="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_ca0e0502-b76c-46d5-8478-c8daca60f3d1_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8f71721a-6dff-47e2-8b1c-57f0581eee0f_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_27ad3066-e603-4bce-b682-34d2ebc661e1_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, end of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_665d10b6-146e-4f30-9921-ae46a26f95c9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_b44fd014-5182-49e6-9cd8-42e56e0f3165_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_cf1aefad-f2be-4c7a-b7da-9864e6cf9290_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities and other</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_5fd3a530-6a7f-4abb-a07e-2ce17c77357d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_c4e36742-bd7c-4a9a-97c3-c78f7e2e5833_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_3d225385-5080-4b5a-9d26-ffe5be2ecf8b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AffiliatedEntityMember_f25895b6-672f-4b1b-84d2-a06868b6c7b1_terseLabel_en-US" xlink:label="lab_srt_AffiliatedEntityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SeaSpine</link:label>
    <link:label id="lab_srt_AffiliatedEntityMember_label_en-US" xlink:label="lab_srt_AffiliatedEntityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affiliated Entity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AffiliatedEntityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AffiliatedEntityMember" xlink:to="lab_srt_AffiliatedEntityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_5762e12e-1d31-44be-9b20-27f3fd3d6ddd_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_e495a02b-8be1-43f7-b92a-d8c20a1f0655_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL ASSETS</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_5aaea192-1b57-4b23-a6de-7bf1bdb9b318_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-offs</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Writeoff</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_b71cd306-3bb5-4f57-b7ba-fda470e0bb40_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal_c2263b3f-5c07-4d41-bb17-e730d7281508_terseLabel_en-US" xlink:label="lab_sibn_DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Final fee as percentage of aggregate principal amount (percent)</link:label>
    <link:label id="lab_sibn_DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal_label_en-US" xlink:label="lab_sibn_DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fee Amount As Percentage Of Aggregate Principal</link:label>
    <link:label id="lab_sibn_DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal_documentation_en-US" xlink:label="lab_sibn_DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fee Amount As Percentage Of Aggregate Principal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal" xlink:href="sibn-20230331.xsd#sibn_DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal" xlink:to="lab_sibn_DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_6fb7fc1e-ad2e-4b64-8fa7-32439e6d0c7a_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_deac2d00-a53c-40a8-b00b-90bc320add10_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_b8edd6fb-db20-419b-a100-5f0cf3de5d09_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Black-Scholes option-pricing model assumptions</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_01cd6512-5bbe-4c87-b9ec-5fff7a501293_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_b534b9ab-1bcc-4736-b50d-02cd41f7a639_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_21853745-b8d6-4d12-859e-0b6c053b6596_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities and other</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_169234ce-6d9b-4621-9bf2-9ec229164ae4_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities and other</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_8c9c8ec5-53e9-4d62-b9c6-b65b9d4dc0a5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_702c8fdc-4068-4f6a-aad9-13d8546fe473_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_5656fd65-566b-4f33-b4be-e159a9865dbe_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_480f703a-4fee-4032-9e5e-02d60e8efd2a_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and related expenses</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_ca2b01cd-650c-45c0-bda1-68d306fc4980_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_8fcde464-8289-4bc7-b8b0-2e57d135aa5d_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable lease expense</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_db5a75aa-0b3b-42f3-ba8e-2dafa8270d28_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f1b1e86b-cadc-4b1a-b2e9-a0630d85d155_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_15778c04-c8ad-4376-9ad8-90d71e0a1c55_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Loss Per Share of Common Stock</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValueAbstract_4be4322d-8885-4522-954a-d58537ef7e8f_terseLabel_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at</link:label>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValueAbstract_b9057bb0-c39c-4c93-bd61-7a31b2b993a6_verboseLabel_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValueAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValueAbstract_label_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents, at Carrying Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsAtCarryingValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashEquivalentsAtCarryingValueAbstract" xlink:to="lab_us-gaap_CashEquivalentsAtCarryingValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_2c75a2a5-f589-4d81-ad22-932be4c045d6_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Components</link:label>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_4d69b282-efd9-452a-ae82-c7f8d0712061_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6edff1a4-7ae2-4b96-9aab-cd0a20ea8965_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_4e0270d3-377d-4a89-b2be-3a95e29d7b98_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation cost, expected period for recognition (in years)</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_0e775878-9988-4e07-bda1-2738d6c30e80_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, finished goods, gross</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoods" xlink:to="lab_us-gaap_InventoryFinishedGoods" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_320bddc3-f5cc-4a2e-99d3-b07608b9dfcb_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_a7b50453-4d81-40bd-bea6-c40f854ce677_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesTextBlock_398c431f-be63-4204-847a-57669f56ba1e_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Marketable Securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesTextBlock_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesTextBlock" xlink:to="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_LineOfCreditFacilityAccordionFeatureIncreaseLimit_cf051813-18f0-41df-a3db-35136655dc8a_terseLabel_en-US" xlink:label="lab_sibn_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accordion feature, increase limit</link:label>
    <link:label id="lab_sibn_LineOfCreditFacilityAccordionFeatureIncreaseLimit_label_en-US" xlink:label="lab_sibn_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Accordion Feature, Increase Limit</link:label>
    <link:label id="lab_sibn_LineOfCreditFacilityAccordionFeatureIncreaseLimit_documentation_en-US" xlink:label="lab_sibn_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Accordion Feature, Increase Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:href="sibn-20230331.xsd#sibn_LineOfCreditFacilityAccordionFeatureIncreaseLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:to="lab_sibn_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_7a8c0867-8990-4445-b3e2-157d901aa0c3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield (percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_LineOfCreditFacilityContingentCommitmentFeeAmount_c71a1f5f-2c16-4a82-9744-e0e0cfdf5f93_terseLabel_en-US" xlink:label="lab_sibn_LineOfCreditFacilityContingentCommitmentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent fee, amount</link:label>
    <link:label id="lab_sibn_LineOfCreditFacilityContingentCommitmentFeeAmount_label_en-US" xlink:label="lab_sibn_LineOfCreditFacilityContingentCommitmentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Contingent Commitment Fee, Amount</link:label>
    <link:label id="lab_sibn_LineOfCreditFacilityContingentCommitmentFeeAmount_documentation_en-US" xlink:label="lab_sibn_LineOfCreditFacilityContingentCommitmentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Contingent Commitment Fee, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_LineOfCreditFacilityContingentCommitmentFeeAmount" xlink:href="sibn-20230331.xsd#sibn_LineOfCreditFacilityContingentCommitmentFeeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_LineOfCreditFacilityContingentCommitmentFeeAmount" xlink:to="lab_sibn_LineOfCreditFacilityContingentCommitmentFeeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_ConstructionInProgressSantaClaraLeaseMember_7114112b-98b1-4e63-99af-8596083561d2_terseLabel_en-US" xlink:label="lab_sibn_ConstructionInProgressSantaClaraLeaseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress, Santa Clara Lease</link:label>
    <link:label id="lab_sibn_ConstructionInProgressSantaClaraLeaseMember_label_en-US" xlink:label="lab_sibn_ConstructionInProgressSantaClaraLeaseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress, Santa Clara Lease [Member]</link:label>
    <link:label id="lab_sibn_ConstructionInProgressSantaClaraLeaseMember_documentation_en-US" xlink:label="lab_sibn_ConstructionInProgressSantaClaraLeaseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress, Santa Clara Lease</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ConstructionInProgressSantaClaraLeaseMember" xlink:href="sibn-20230331.xsd#sibn_ConstructionInProgressSantaClaraLeaseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_ConstructionInProgressSantaClaraLeaseMember" xlink:to="lab_sibn_ConstructionInProgressSantaClaraLeaseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_dd03b2b4-4f7a-4717-b251-57b51413fc23_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_e471d3a8-032f-49a0-aea5-666c380d50a0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_7dffd34a-a75a-40da-8abd-3ebe5750fcac_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_cdf0399d-cc05-46bb-a52b-8fdcc91f31f6_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_55cacd5c-b408-4945-82dc-c5783de0acbb_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_a21fbbc8-8648-4308-8725-9c8bc5f6784e_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_6491cf5a-fc43-4906-86a5-6a666a0c604e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_266f6128-bc84-4c14-a5cf-b58b174124a4_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Unamortized debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0d0c5f26-011d-4513-bd5f-5263ea9c9a3b_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_bb7533d8-72c4-42b7-b57d-b8a34b236368_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_LesseeOperatingLeaseLeaseNotYetCommencedLiability_2e3c4bbe-e1c6-4e2e-9d2b-4d7d914af178_terseLabel_en-US" xlink:label="lab_sibn_LesseeOperatingLeaseLeaseNotYetCommencedLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities that had not commenced.</link:label>
    <link:label id="lab_sibn_LesseeOperatingLeaseLeaseNotYetCommencedLiability_label_en-US" xlink:label="lab_sibn_LesseeOperatingLeaseLeaseNotYetCommencedLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Liability</link:label>
    <link:label id="lab_sibn_LesseeOperatingLeaseLeaseNotYetCommencedLiability_documentation_en-US" xlink:label="lab_sibn_LesseeOperatingLeaseLeaseNotYetCommencedLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_LesseeOperatingLeaseLeaseNotYetCommencedLiability" xlink:href="sibn-20230331.xsd#sibn_LesseeOperatingLeaseLeaseNotYetCommencedLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_LesseeOperatingLeaseLeaseNotYetCommencedLiability" xlink:to="lab_sibn_LesseeOperatingLeaseLeaseNotYetCommencedLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_5f1c0c14-19aa-4dcf-9e68-0860b89e6ecb_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_a41b6a33-2674-4000-8b4e-dcaac27d5dd4_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_SVBAmendedTermLoanMember_8710acde-ab95-4ed6-bb27-2faaaa5f17e6_terseLabel_en-US" xlink:label="lab_sibn_SVBAmendedTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SVB Amended Term Loan</link:label>
    <link:label id="lab_sibn_SVBAmendedTermLoanMember_label_en-US" xlink:label="lab_sibn_SVBAmendedTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SVB Amended Term Loan [Member]</link:label>
    <link:label id="lab_sibn_SVBAmendedTermLoanMember_documentation_en-US" xlink:label="lab_sibn_SVBAmendedTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SVB Amended Term Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_SVBAmendedTermLoanMember" xlink:href="sibn-20230331.xsd#sibn_SVBAmendedTermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_SVBAmendedTermLoanMember" xlink:to="lab_sibn_SVBAmendedTermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_d935dc8c-93be-4ea0-9ad6-44468f903872_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesLineItems_05836b74-646e-4331-a7ca-8cf9cba327e2_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities [Line Items]</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems" xlink:to="lab_us-gaap_MarketableSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_303a48f1-cedb-4a99-ac9a-0ca0022ba2dc_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_34bcbe3c-bbe4-4cc9-9684-0a1f1745467f_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_2438ff4f-51ef-4473-9e11-6f316d424682_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_099c4952-14f5-4870-9f5b-058884a26db2_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_e23ee08c-b866-4781-b95d-97e461effcd2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss):</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_ec18c093-c273-4a4a-801a-12ebfe513c53_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_7d341ba3-7a48-4635-a516-ccd4ca6bdf3c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility of common stock, maximum (percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFeeAmount_f6ed1257-6413-48ea-8d82-a737340ca8c2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFeeAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unaccreted value of final fee</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFeeAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fee Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFeeAmount" xlink:to="lab_us-gaap_DebtInstrumentFeeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_60ffe973-95a0-4df4-8db0-b8c8ec5ceaef_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_866dc499-52b5-4b58-8179-a46f30ceb087_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_4fe2996d-3689-4103-a08a-774ec14171d6_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_832fcf94-d92e-4fd6-aea2-4b2691c1c811_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share, basic (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_b559256f-e4ae-4ea6-9f56-9dc32e183a1c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods_a1bd757e-9cb8-430b-adec-a59156b44a69_terseLabel_en-US" xlink:label="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of purchase periods in offering interval</link:label>
    <link:label id="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods_label_en-US" xlink:label="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Purchase Periods</link:label>
    <link:label id="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods_documentation_en-US" xlink:label="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Purchase Periods</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" xlink:href="sibn-20230331.xsd#sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" xlink:to="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_f29e3ade-d010-4f8a-aac4-55f97ee81f6c_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense" xlink:to="lab_us-gaap_SellingAndMarketingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_5c6c9f37-37d6-489c-8401-2827159b5fc8_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_23d51988-a575-4e79-9f06-60f2953f30ec_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity, beginning of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_34549f27-47cb-45ef-b9c7-576f2240fd5b_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity, end of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DueToAffiliateCurrent_c87a23b7-061c-45c9-a2b0-2e5cc86d84b0_terseLabel_en-US" xlink:label="lab_us-gaap_DueToAffiliateCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding liability to SeaSpine</link:label>
    <link:label id="lab_us-gaap_DueToAffiliateCurrent_label_en-US" xlink:label="lab_us-gaap_DueToAffiliateCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to Affiliate, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToAffiliateCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueToAffiliateCurrent" xlink:to="lab_us-gaap_DueToAffiliateCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_58c3c697-b045-4667-8b30-8fb1802c1538_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canceled and forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_69b67d9b-8123-447a-b557-4919539efb70_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_7bb35ee7-9eb3-4928-a03a-f306f3ec6c7e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_88305130-eab2-47db-ab32-cded54a10089_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss_d5ef29cd-cee3-4d85-a2d0-a858d1777129_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest receivable</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_4f5ec9ce-a8d1-46f9-a2e0-7d6ab7d7fb42_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_18fa6e68-b727-4dd7-ba42-280350bb222e_verboseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_33df6043-c492-4064-859d-f3a8d9737ca9_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_4716574b-44cd-46db-9a0d-86d72465a304_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease expense</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_07c673e2-36a5-4a74-9199-797deb053c25_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_81e640ab-8fad-479b-a767-9f842a73f9cd_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Information Related to Lease Expense and Valuation of Lease Assets and Lease Liabilities</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_3affa171-d580-4646-85f5-f60a2ea8a6ca_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments_8012c78e-76dc-445e-9b15-a3f5210f11d0_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total marketable securities, Aggregate Fair Value</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, and Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:to="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_e0f1a5ce-9f99-460f-bca6-44fde1f02398_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_2e35aa51-8bb6-4416-bbae-0aa772e3229d_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_7d7cb291-d05f-471f-bc75-82f7f53f747b_verboseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_1907c9c5-d09f-4f76-84e0-53af624eac45_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_23dff838-0478-418f-a7f7-92370e402e1e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, net of current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_ff38e546-e7f7-4cc4-a2eb-df4a6b22da2f_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_dab707d4-53e1-4170-bc3d-4a0fb4d6ede3_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_eb9c1153-4391-4cba-a252-83cdecc68490_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_afd736b0-2f6d-42c6-b95a-bef004dac999_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Geography</link:label>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_a1260d49-f0be-4c9e-b203-28e13a8ebd22_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_bf3d920b-d093-4c56-a390-49940b3ccee1_terseLabel_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value</link:label>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_1fefa626-fb00-4479-bf43-2bf8bd7e503b_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowance for credit losses of $450 and $400, respectively</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_57a45f29-da2d-4b0c-95f4-b3fc150f5462_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of marketable securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_b5446aa8-b902-4a91-86cc-b003e371b89e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_d6458fe7-5574-4d49-afbf-e1cd1e12d517_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_91e11bcc-42f3-465d-a608-7227c51fdbe9_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_9617fdf2-74e9-4243-816c-e9a4ba097746_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_06d44227-073c-4d2b-bcb4-ce50d02b87b4_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b206b9bf-1e58-4ab9-98bc-4c010b25e7aa_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_0dc0bb53-e357-4093-8f62-8d032b1cf544_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_637a73d7-999b-4fcb-ac2e-31bb362a4bb8_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_28b1e2ac-a20f-4848-bdc5-524bf546c281_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_93b5e4b6-bef9-4436-8883-01305050d337_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent_7b2b8134-1a8a-4472-847c-7406c6a0cb29_terseLabel_en-US" xlink:label="lab_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and related expenses for employee payroll deductions</link:label>
    <link:label id="lab_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherEmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrent_4aa2d417-691a-4baf-8de8-37f3016bd65e_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued royalty</link:label>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Royalties, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedRoyaltiesCurrent" xlink:to="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_899eadba-8ec6-4026-906a-82519ee72a9e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_b46b9261-3079-4d69-99d7-bd00985810ad_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_5c08ca1e-784b-4a32-a338-448bee8625db_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_7cf5e7bb-2c9c-4e42-bd5b-badc20436738_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_8abd5231-0e98-47c2-ac30-b43dd0ea8005_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_c75e9a57-7e4a-4bc0-bee5-56a5775e6533_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Option Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_90f5484e-8307-44f6-9ae2-46d88b5e7b60_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_93eea06b-0880-4fc3-97e7-f089a131eee0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_6933cf22-1f52-49f0-ac71-0c636fd3b724_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_fc10522e-26ee-4ab0-b5ca-2ebffcafadef_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Adopted Accounting Standards and Recent Accounting Standards Not Yet Effective</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_5825d0bd-3eb7-40b2-bafd-0bf8a8a12843_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_cf33af8c-a526-4c5b-8a9c-ba838d3d83e4_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_e06d3425-91ad-45e7-ab57-5d06a67d6b0d_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity, beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_f09b8b17-b51a-48b7-8e9d-2932d788b1c0_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity, end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cdb21e92-6c0c-4d2b-9807-8106ff72da57_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_3ab7d943-b994-452e-9171-69376076422c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax provision</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_ca8882af-0f1a-4d7a-8145-a98e19373f89_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_09213ee0-6614-4b67-934e-abb49015c5ca_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_9280d1d8-b86a-469a-b16c-62f17a62a3c7_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_30795262-7f2b-4e09-ac9d-4208c019d61a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_97838104-54dd-4dbb-a82f-654d0483b6f6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMinimum_680276d5-d34d-432d-9d16-1043c66ab81b_terseLabel_en-US" xlink:label="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Correlation coefficient of peer companies, minimum</link:label>
    <link:label id="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMinimum_label_en-US" xlink:label="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Correlation Coefficient Of Peer Companies, Minimum</link:label>
    <link:label id="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMinimum_documentation_en-US" xlink:label="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Correlation Coefficient Of Peer Companies, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMinimum" xlink:href="sibn-20230331.xsd#sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMinimum" xlink:to="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d033e432-1ae5-4456-9e25-351b024e5272_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_1cbe7e90-ba89-4493-a95b-a721fe2cef68_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_9a196883-d377-494a-8169-e805f5dfefa7_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_10ad6639-7956-493a-b776-48ca832b33d5_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of goods sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_adbe42db-91bf-403b-9f9d-ec27fe142821_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average number of common shares used to compute diluted net loss per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_4911aa46-155a-4bb2-8ec8-f83b9417889a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility of common stock, minimum (percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_665996b0-1315-4051-81c5-a14be7a218bf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_def0022a-64ec-4e5f-a8e3-54649945686a_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_00ff20a1-d0ad-4b18-bffe-969280da7a1e_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_DevelopmentAgreementMember_a5090111-67df-473b-94f3-e53b8c47bdd0_terseLabel_en-US" xlink:label="lab_sibn_DevelopmentAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint development agreement</link:label>
    <link:label id="lab_sibn_DevelopmentAgreementMember_label_en-US" xlink:label="lab_sibn_DevelopmentAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development Agreement [Member]</link:label>
    <link:label id="lab_sibn_DevelopmentAgreementMember_documentation_en-US" xlink:label="lab_sibn_DevelopmentAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_DevelopmentAgreementMember" xlink:href="sibn-20230331.xsd#sibn_DevelopmentAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_DevelopmentAgreementMember" xlink:to="lab_sibn_DevelopmentAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_6482bd15-8b2b-4803-8cdf-26597128ad7e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.0001 par value; 100,000,000 shares authorized; 35,106,163 and 34,731,577 shares issued and outstanding, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_89057a60-47df-4a5a-8c6a-3af185d974ed_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_27a1c224-a8bf-4ca1-9728-d6587949518c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_cbf99b97-a821-48c3-8403-6abf89d3ef2a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Anti-dilutive Common Stock Equivalents Excluded from Computation of Diluted Net Loss per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_36361d6c-c824-4712-aa98-4215e25d8402_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Marketable Securities Measured at Fair Value on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_4befd816-ff0c-4158-bd1e-b5c643a7c1cb_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_995a9bd7-cb80-412a-9301-471ba3c2e3fc_terseLabel_en-US" xlink:label="lab_sibn_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_sibn_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_label_en-US" xlink:label="lab_sibn_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, After Year Four</link:label>
    <link:label id="lab_sibn_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_documentation_en-US" xlink:label="lab_sibn_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, After Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:href="sibn-20230331.xsd#sibn_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:to="lab_sibn_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_DebtInstrumentCovenantAdjustedQuickRatioMinimum_529f7208-bb6c-46c0-85ad-816d38c56f1e_terseLabel_en-US" xlink:label="lab_sibn_DebtInstrumentCovenantAdjustedQuickRatioMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted quick ratio threshold</link:label>
    <link:label id="lab_sibn_DebtInstrumentCovenantAdjustedQuickRatioMinimum_label_en-US" xlink:label="lab_sibn_DebtInstrumentCovenantAdjustedQuickRatioMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Adjusted Quick Ratio, Minimum</link:label>
    <link:label id="lab_sibn_DebtInstrumentCovenantAdjustedQuickRatioMinimum_documentation_en-US" xlink:label="lab_sibn_DebtInstrumentCovenantAdjustedQuickRatioMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Adjusted Quick Ratio, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_DebtInstrumentCovenantAdjustedQuickRatioMinimum" xlink:href="sibn-20230331.xsd#sibn_DebtInstrumentCovenantAdjustedQuickRatioMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_DebtInstrumentCovenantAdjustedQuickRatioMinimum" xlink:to="lab_sibn_DebtInstrumentCovenantAdjustedQuickRatioMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2e6d3c20-5973-47ae-876c-edd743a6bdc8_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_839e5c2e-341e-4cc2-8b80-f05963e09cce_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">End of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_075f6ac9-974f-4fd4-928a-251d984f2680_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_b5723c30-3271-466f-b38f-bee99174e7b3_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_b21da32c-8fa6-4dfe-a9cf-5271a3e6825a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from the exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_e158db59-eafb-4aa4-b328-6c722e40fd94_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from debt financing</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent_7f2a0498-cc48-438d-8131-c041fb364c8a_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Excluding Accrued Interest, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_d459bd22-c59d-405b-adf3-8128a3c6e12b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_869e6d9f-34f5-45a8-89c5-c9d03a9e8ca8_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unpaid purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_9c530e8e-d419-426a-b115-08066c2ea492_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9d5ffc4a-192e-4374-b355-9b2ccbf312fd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_3db9deae-40a2-414a-88b8-5ae577e82eb5_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_f811aa7e-287b-40fa-bb5f-3ff5cabd2a6e_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_ddf3cb1f-bc61-43b9-94e2-2351bbdcc1a5_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_b4e4e71f-c568-4cd9-9a53-715dc285850f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_ProceedsFromMaturityOfMarketableSecurities_2cc7961a-6151-47d2-b66d-c8a5ab040a98_terseLabel_en-US" xlink:label="lab_sibn_ProceedsFromMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of marketable securities</link:label>
    <link:label id="lab_sibn_ProceedsFromMaturityOfMarketableSecurities_label_en-US" xlink:label="lab_sibn_ProceedsFromMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Maturity Of Marketable Securities</link:label>
    <link:label id="lab_sibn_ProceedsFromMaturityOfMarketableSecurities_documentation_en-US" xlink:label="lab_sibn_ProceedsFromMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Maturity Of Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ProceedsFromMaturityOfMarketableSecurities" xlink:href="sibn-20230331.xsd#sibn_ProceedsFromMaturityOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_ProceedsFromMaturityOfMarketableSecurities" xlink:to="lab_sibn_ProceedsFromMaturityOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_93163ea8-ad52-4c6d-83b6-c7f25958f6f3_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_6f20af02-338b-4839-9098-b74b32c22b93_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_9236ef0c-55e8-483c-b68e-2f1b5a146167_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_90156f4b-097d-4b18-9a8e-118c45fdd7a6_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_DebtInstrumentInterestRateIncreaseDueToDefault_f51518cc-bc0e-43ea-9a48-f7591a8f0cac_terseLabel_en-US" xlink:label="lab_sibn_DebtInstrumentInterestRateIncreaseDueToDefault" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent interest rate increase due to default</link:label>
    <link:label id="lab_sibn_DebtInstrumentInterestRateIncreaseDueToDefault_label_en-US" xlink:label="lab_sibn_DebtInstrumentInterestRateIncreaseDueToDefault" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate Increase Due to Default</link:label>
    <link:label id="lab_sibn_DebtInstrumentInterestRateIncreaseDueToDefault_documentation_en-US" xlink:label="lab_sibn_DebtInstrumentInterestRateIncreaseDueToDefault" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate Increase Due to Default</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_DebtInstrumentInterestRateIncreaseDueToDefault" xlink:href="sibn-20230331.xsd#sibn_DebtInstrumentInterestRateIncreaseDueToDefault"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_DebtInstrumentInterestRateIncreaseDueToDefault" xlink:to="lab_sibn_DebtInstrumentInterestRateIncreaseDueToDefault" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_1b6fc870-0664-4ce3-a6cb-4af5eb5e8bff_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_fdaf756b-011f-4bc0-9be5-4adf997c884c_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_821852c0-ca6f-4702-b47a-53c3639be6c3_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price of common stock as a percent of fair market value (percent)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_853f5d5b-8293-4c75-b45f-87f80a953235_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_dbd8072d-9f06-4b50-874d-610dab3a4940_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Excluding Accrued Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_f5ea13a7-9e87-4491-8d57-a2b16f406cad_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_72f09318-2b70-4a49-8283-3e29a15087da_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_SVBTermLoanMember_a5e1db1b-ed71-408b-88b9-23c1b4cda330_terseLabel_en-US" xlink:label="lab_sibn_SVBTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SVB Term Loan</link:label>
    <link:label id="lab_sibn_SVBTermLoanMember_label_en-US" xlink:label="lab_sibn_SVBTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SVB Term Loan [Member]</link:label>
    <link:label id="lab_sibn_SVBTermLoanMember_documentation_en-US" xlink:label="lab_sibn_SVBTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SVB Term Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_SVBTermLoanMember" xlink:href="sibn-20230331.xsd#sibn_SVBTermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_SVBTermLoanMember" xlink:to="lab_sibn_SVBTermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_7edeb9c1-4c24-401a-bfbc-215b9f6d6b41_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_e9d6d1b5-f3e1-48f2-831e-eb3eea60f037_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_888adc3d-c25c-47b2-b8db-128815e90957_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_a81f7dac-84f1-471c-a5f4-56e7dd9c6d6b_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_f68cae92-726f-40ef-9f48-fa5d0d72c1cd_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_7050027f-312a-4b26-bf7d-b716a527aba9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Future Minimum Lease Payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_0f517bd9-1e33-40b7-8d25-466f6d8c1528_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for amounts included in the measurement of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval_9c154829-e624-491a-b4e9-e5eb8b0790cd_terseLabel_en-US" xlink:label="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock purchase program offering period interval (in months)</link:label>
    <link:label id="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval_label_en-US" xlink:label="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Offering Period Interval</link:label>
    <link:label id="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval_documentation_en-US" xlink:label="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Offering Period Interval</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval" xlink:href="sibn-20230331.xsd#sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval" xlink:to="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_781d95f0-7b36-48bc-821f-ca2d5de1ef87_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of debt financing</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_6043cccb-9bca-48cf-a180-008eea1228e4_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:to="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_204df9f7-9ab3-46fa-ae82-068e72cb8470_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_0a6fcb17-1f91-4caa-a1bc-74598517c468_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_44b8e08e-43db-4c2f-9c85-d496e632ea81_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_A2018EmployeeStockPurchasePlanMember_fbe8813d-b50b-4e4c-a6f1-17f2ae2b7069_terseLabel_en-US" xlink:label="lab_sibn_A2018EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 ESPP</link:label>
    <link:label id="lab_sibn_A2018EmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_sibn_A2018EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">A2018 Employee Stock Purchase Plan [Member]</link:label>
    <link:label id="lab_sibn_A2018EmployeeStockPurchasePlanMember_documentation_en-US" xlink:label="lab_sibn_A2018EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">A2018 Employee Stock Purchase Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_A2018EmployeeStockPurchasePlanMember" xlink:href="sibn-20230331.xsd#sibn_A2018EmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_A2018EmployeeStockPurchasePlanMember" xlink:to="lab_sibn_A2018EmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_ComputerAndOfficeEquipmentMember_9c9a4f2f-fc95-456a-9bb6-74653aad1147_terseLabel_en-US" xlink:label="lab_sibn_ComputerAndOfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer and office equipment</link:label>
    <link:label id="lab_sibn_ComputerAndOfficeEquipmentMember_label_en-US" xlink:label="lab_sibn_ComputerAndOfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer And Office Equipment [Member]</link:label>
    <link:label id="lab_sibn_ComputerAndOfficeEquipmentMember_documentation_en-US" xlink:label="lab_sibn_ComputerAndOfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer And Office Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ComputerAndOfficeEquipmentMember" xlink:href="sibn-20230331.xsd#sibn_ComputerAndOfficeEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_ComputerAndOfficeEquipmentMember" xlink:to="lab_sibn_ComputerAndOfficeEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_ff4f97fe-a825-427c-8315-ba6751285c8b_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock upon exercise of stock options, net of shares withheld</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_6e681da7-c651-4249-8061-70896459b76d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canceled and forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_a3433281-077b-42f2-b130-362e39f5ef5d_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding debt, net of debt issuance costs and unaccreted value of final fee</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestWriteoff_0d6cd5d0-78eb-4383-90ae-7bc5915c7d9c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestWriteoff" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest writeoff</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestWriteoff_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestWriteoff" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accrued Interest Writeoff</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestWriteoff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestWriteoff"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestWriteoff" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestWriteoff" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_6d08f39e-18e2-42a5-9ac3-a330f79d56d6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_0aa51ce1-ed55-447a-8279-f1e3aa42b4be_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_fa8af250-1928-41ba-bdfa-800d4edbfccb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_SolarLoanAndSecurityAgreementMember_f86addf7-e257-4a90-8639-956e6b129133_terseLabel_en-US" xlink:label="lab_sibn_SolarLoanAndSecurityAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Solar Term Loan</link:label>
    <link:label id="lab_sibn_SolarLoanAndSecurityAgreementMember_label_en-US" xlink:label="lab_sibn_SolarLoanAndSecurityAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Solar Loan and Security Agreement [Member]</link:label>
    <link:label id="lab_sibn_SolarLoanAndSecurityAgreementMember_documentation_en-US" xlink:label="lab_sibn_SolarLoanAndSecurityAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Solar Loan and Security Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_SolarLoanAndSecurityAgreementMember" xlink:href="sibn-20230331.xsd#sibn_SolarLoanAndSecurityAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_SolarLoanAndSecurityAgreementMember" xlink:to="lab_sibn_SolarLoanAndSecurityAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_f59c65f6-a5ed-4654-a324-2e6be86849ec_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_a4217199-1621-414e-bb54-731d10606db4_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4daa6074-f7af-4890-9269-27944fb76c2a_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_a00778e4-182e-4684-8056-18b9a3a99b06_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcess_9edc469a-31d5-42b8-be44-fa34e3c44c83_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, work in process, gross</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcess_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcess" xlink:to="lab_us-gaap_InventoryWorkInProcess" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_b4e82555-86ec-4f6f-b773-3f010fd2f3ad_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_579c318c-f69b-49e8-9a94-6323c5fdee37_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_8a750e82-351c-46d0-ae7e-f82d82b48eca_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsTable" xlink:to="lab_us-gaap_OtherCommitmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_f7688226-c333-486d-ace5-885fbc749628_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_f265d392-5858-49cb-bc6e-6554c4dc80ad_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b083aaf4-49ff-4d29-9681-206bda7b4233_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock_f0a76088-c930-44b5-bf84-deedd50e4e5a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Performance-based Restricted Stock Unit Activity Arrangement</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Performance Shares, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock" xlink:to="lab_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_db710e0e-ac73-4ff8-b27c-2c3e824afc30_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_91df51eb-6fbb-493f-a47c-04a8542c1b94_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_ab0e65c5-3533-4284-b187-09bbead546f5_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase_b83f8a98-702e-42ea-8906-268d4107c998_terseLabel_en-US" xlink:label="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Early exercise of stock options, share subject to repurchase (in shares)</link:label>
    <link:label id="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase_label_en-US" xlink:label="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Early Exercise, Common Stock Subject To Repurchase</link:label>
    <link:label id="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase_documentation_en-US" xlink:label="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Early Exercise, Common Stock Subject To Repurchase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase" xlink:href="sibn-20230331.xsd#sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase" xlink:to="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_7aa66aa4-fe3b-4890-8929-9d7303179786_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMaximum_9feb2ec1-9620-4489-a9c9-67abde80e2e1_terseLabel_en-US" xlink:label="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Correlation coefficient of peer companies, maximum</link:label>
    <link:label id="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMaximum_label_en-US" xlink:label="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Correlation Coefficient Of Peer Companies, Maximum</link:label>
    <link:label id="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMaximum_documentation_en-US" xlink:label="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Correlation Coefficient Of Peer Companies, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMaximum" xlink:href="sibn-20230331.xsd#sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMaximum" xlink:to="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_MarketableSecuritiesAmortizedCost_bba64727-44ea-461c-a736-e6ea67557f38_totalLabel_en-US" xlink:label="lab_sibn_MarketableSecuritiesAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total marketable securities, Amortized Cost</link:label>
    <link:label id="lab_sibn_MarketableSecuritiesAmortizedCost_label_en-US" xlink:label="lab_sibn_MarketableSecuritiesAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Amortized Cost</link:label>
    <link:label id="lab_sibn_MarketableSecuritiesAmortizedCost_documentation_en-US" xlink:label="lab_sibn_MarketableSecuritiesAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total amortized cost for marketable securities included in cash equivalents and investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_MarketableSecuritiesAmortizedCost" xlink:href="sibn-20230331.xsd#sibn_MarketableSecuritiesAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_MarketableSecuritiesAmortizedCost" xlink:to="lab_sibn_MarketableSecuritiesAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_59ec2b59-89f5-4f79-9ded-27f625aad62a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_d586b824-ee64-48fc-a705-4c2e2b89770f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_3f705121-aaba-4a5c-9c9b-c5a1ebf2be4f_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. agency bonds</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest_5d85852a-1e61-4dbb-820c-f055ed1836b1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit losses on investments</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Allowance for Credit Loss, Excluding Accrued Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_b69eaab3-b0a2-432b-9102-17abc59e66f1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion (amortization) of discount on marketable securities</link:label>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_label_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_bb41d5f5-70af-40c0-9116-e1ffa2b43792_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_81d8e513-12f1-49ce-858d-cafa4677c4b9_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_b8ea5166-644c-4ec8-baf3-63314b285f6e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in foreign currency translation</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_47d2cc96-8072-4e36-b39e-4eb3b8cd9366_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_0353ee26-a231-4325-8766-9f155697d1ab_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. treasury securities</link:label>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_5975987c-c6fe-4dc8-986d-1654a93c9fa1_verboseLabel_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. treasury securities</link:label>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasurySecuritiesMember" xlink:to="lab_us-gaap_USTreasurySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_45263ffc-1cf7-42d3-a2f6-96f485a40946_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_1395ef94-bcf3-426f-b2a8-21a1dde4ec50_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canceled and forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_4e02b5c5-db9d-4c27-a197-56576f34ce0b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remainder of 2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_42c99eea-571e-4c33-990c-01ac369f0948_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_d475b630-e276-4018-83bc-0797d87b85b4_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_38740a85-0cb6-44b7-acb4-a6d156875595_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfOperations_d62f5179-8359-4d34-9999-141c7cfef5aa_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The Company and Nature of Business</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_bd83a1ac-c332-4ba1-837c-4c0aeb22d40a_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a035d0a9-0e86-40e4-95c1-545ffb870ae5_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average number of common shares used to compute basic net loss per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_6d8e33f0-ce80-4673-ba26-edcd599c9a75_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfSecuredDebt_39756b8d-23ef-4a1c-86bb-74fcb905555e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfSecuredDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Secured Debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfSecuredDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfSecuredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Secured Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfSecuredDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfSecuredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfSecuredDebt" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfSecuredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_089591c5-4050-4b52-8b1e-e27c9ba071da_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities and Other</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_1d81941b-307b-4054-82d0-15a5f6431b20_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_ef6f15e6-585e-46f2-a821-fc498eae6a47_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of non-cash information</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_c7cc4c03-415a-41ab-b87d-3bff66833e08_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 6)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_8895b480-1160-4db6-b2b8-5d4ad0730d1c_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_5fc654f3-c275-411d-a740-0859a268f656_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_d0cd6340-39d5-4300-a5c1-44168f625469_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, end of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_58313cf1-f80b-49e2-a97f-176317199761_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.0001 par value; 5,000,000 shares authorized; no shares issued and outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_RelatedPartyTransactionTermOfAgreement_8f45eab2-b1a2-490e-8476-4cfef25727e1_terseLabel_en-US" xlink:label="lab_sibn_RelatedPartyTransactionTermOfAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of product royalty sales period (in years)</link:label>
    <link:label id="lab_sibn_RelatedPartyTransactionTermOfAgreement_label_en-US" xlink:label="lab_sibn_RelatedPartyTransactionTermOfAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Term Of Agreement</link:label>
    <link:label id="lab_sibn_RelatedPartyTransactionTermOfAgreement_documentation_en-US" xlink:label="lab_sibn_RelatedPartyTransactionTermOfAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Term Of Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_RelatedPartyTransactionTermOfAgreement" xlink:href="sibn-20230331.xsd#sibn_RelatedPartyTransactionTermOfAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_RelatedPartyTransactionTermOfAgreement" xlink:to="lab_sibn_RelatedPartyTransactionTermOfAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_4e07360c-9428-4ae9-9b1b-d3b52ec2fd7e_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value to Amortized Cost, after Allowance for Credit Loss [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_94f42cb8-e74e-435a-92be-7e48b8f36bc5_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_a9958315-5bec-48ce-974f-71876acbecf8_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_9e62b75a-e0a0-4532-a25e-a20cd8e37cc2_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_563c119e-e7e3-4b4e-a4bc-4ca5aa19d742_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_8c6a2fd2-9c22-47ce-afba-7c453796eaf6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_82a9e116-fd23-40b9-8ea8-5793f372d3bb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_f499913b-103b-4725-9471-19039c1c8794_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Incentive Compensation Plans</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_5f0c952f-c19e-4367-b747-4ae40d87d504_periodStartLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_5cfcd2de-38c7-462d-89a8-46a7b7c3abbf_periodEndLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RoyaltyExpense_7f5b669e-64aa-4ff9-9b81-32008662333e_terseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalties</link:label>
    <link:label id="lab_us-gaap_RoyaltyExpense_label_en-US" xlink:label="lab_us-gaap_RoyaltyExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyExpense" xlink:to="lab_us-gaap_RoyaltyExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_ScheduleOfShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValuationAssumptionsTableTextBlock_ec07edd5-cbf8-4ae8-b513-f473e37b39ef_terseLabel_en-US" xlink:label="lab_sibn_ScheduleOfShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Equity Instruments Other Than Options, Valuation Assumptions</link:label>
    <link:label id="lab_sibn_ScheduleOfShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_sibn_ScheduleOfShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Equity Instruments Other Than Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:label id="lab_sibn_ScheduleOfShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValuationAssumptionsTableTextBlock_documentation_en-US" xlink:label="lab_sibn_ScheduleOfShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Equity Instruments Other Than Options, Valuation Assumptions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ScheduleOfShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValuationAssumptionsTableTextBlock" xlink:href="sibn-20230331.xsd#sibn_ScheduleOfShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_ScheduleOfShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_sibn_ScheduleOfShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_3849ddf7-0314-4e45-9c44-6247c721fbe6_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_990a56c4-b049-498f-9c65-136a2600a894_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_cbbc6111-b748-4734-a201-d5f6458b66f2_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_68eeac2d-6624-45ae-949a-32e1d759de1c_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_StockIssuedDuringPeriodSharesRestrictedStockUnits_2be2e185-5fd7-4236-b7e7-3a8ccc54fa9e_terseLabel_en-US" xlink:label="lab_sibn_StockIssuedDuringPeriodSharesRestrictedStockUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock upon vesting of restricted stock units (in shares)</link:label>
    <link:label id="lab_sibn_StockIssuedDuringPeriodSharesRestrictedStockUnits_label_en-US" xlink:label="lab_sibn_StockIssuedDuringPeriodSharesRestrictedStockUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period Shares Restricted Stock Units</link:label>
    <link:label id="lab_sibn_StockIssuedDuringPeriodSharesRestrictedStockUnits_documentation_en-US" xlink:label="lab_sibn_StockIssuedDuringPeriodSharesRestrictedStockUnits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period Shares Restricted Stock Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_StockIssuedDuringPeriodSharesRestrictedStockUnits" xlink:href="sibn-20230331.xsd#sibn_StockIssuedDuringPeriodSharesRestrictedStockUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_StockIssuedDuringPeriodSharesRestrictedStockUnits" xlink:to="lab_sibn_StockIssuedDuringPeriodSharesRestrictedStockUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_69d06149-5af2-4fac-870a-00b061994bc3_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e4d21feb-c18a-40a4-907d-dbd6342c12d6_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_1f0184d8-461b-4172-9841-f054f312a907_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_f1c6f69b-efd1-4c73-a86b-0431a81d8b9e_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_a1a7319e-9ce0-4abb-b726-bf0bbec13259_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_6b75a78c-fb7c-4f72-9fbc-f76fa1f3eb28_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share, diluted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_72849229-2a3b-488d-b4fc-5a376c5a8468_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_e630cfc8-6780-4d87-a181-4ffb41a92185_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on disposal of property and equipment</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_fbe8d95a-036d-44d9-8d03-c6c5e2c8d600_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_b0a68a5b-8124-4237-9ac2-747cbb72d89e_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_56d5c92b-752b-429c-af23-190b666f349a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate, minimum (percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_NumberOfBusinessActivities_a2d6608c-594d-4d3c-86fa-0d5659d9e3ab_terseLabel_en-US" xlink:label="lab_sibn_NumberOfBusinessActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of business activities</link:label>
    <link:label id="lab_sibn_NumberOfBusinessActivities_label_en-US" xlink:label="lab_sibn_NumberOfBusinessActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Business Activities</link:label>
    <link:label id="lab_sibn_NumberOfBusinessActivities_documentation_en-US" xlink:label="lab_sibn_NumberOfBusinessActivities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Business Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_NumberOfBusinessActivities" xlink:href="sibn-20230331.xsd#sibn_NumberOfBusinessActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_NumberOfBusinessActivities" xlink:to="lab_sibn_NumberOfBusinessActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss_a37f1d94-35f7-4b52-94d8-4ca0eb237c3b_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_d9435177-cef5-459b-ac96-2d3f850c327a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesTable_135b74b6-62ea-42a9-a2d5-9490fefcc3ec_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities [Table]</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesTable_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesTable" xlink:to="lab_us-gaap_MarketableSecuritiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_1dd95872-303b-48b2-b138-9146adab54bd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restricted Stock Unit Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_178b7088-7c51-45ce-97ee-03be8d109c58_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate bonds</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_f037fec6-1b9b-4e0b-8a08-38f88ae57216_verboseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate bonds</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_fcba243d-80b5-4c64-84e5-7900f0b0756d_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Receivable and Allowance for Credit Losses</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:to="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_242836cb-9c9a-47e9-816d-b0374e58d043_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate, maximum (percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_21b31040-6a79-4d0e-888d-38566721f1d2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Minimum Lease Payments Under Non-Cancelable Operating Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_965ebc2f-e2eb-465f-97be-25f842a65dbe_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_08b7a550-dac1-42c4-887d-8ae28b62c3cd_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_c7bb98e7-f9f7-473a-a19d-44e1b0c4e527_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_192a9c60-b4bb-49fe-ac33-2040bb9f43ef_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_f21dccee-cf92-4a31-b50b-cbc16b569195_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_c7e416f7-fd60-4bcf-9cd8-7c3872fce07c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities and Other</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_d5ad8fad-67ce-4ff7-b9e8-2956b95e6a80_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Outstanding Borrowings</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_CommonStockWarrantsMember_80c00f47-0706-4293-900c-97731986ffc4_terseLabel_en-US" xlink:label="lab_sibn_CommonStockWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock warrants</link:label>
    <link:label id="lab_sibn_CommonStockWarrantsMember_label_en-US" xlink:label="lab_sibn_CommonStockWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Warrants [Member]</link:label>
    <link:label id="lab_sibn_CommonStockWarrantsMember_documentation_en-US" xlink:label="lab_sibn_CommonStockWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Warrants [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_CommonStockWarrantsMember" xlink:href="sibn-20230331.xsd#sibn_CommonStockWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_CommonStockWarrantsMember" xlink:to="lab_sibn_CommonStockWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_e394b7ae-2b90-431b-8a5b-716eb06faee2_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_us-gaap_MachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_9b780681-00d5-43eb-bbcd-1cb197e2d895_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_5b662560-7fa2-453b-969d-9f3fa52821fe_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMaximum_7e8c461b-7c04-431e-ada9-985cb40142e1_terseLabel_en-US" xlink:label="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility of peer companies, maximum (percent)</link:label>
    <link:label id="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMaximum_label_en-US" xlink:label="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Peer Companies, Maximum</link:label>
    <link:label id="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMaximum_documentation_en-US" xlink:label="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Peer Companies, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMaximum" xlink:href="sibn-20230331.xsd#sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMaximum" xlink:to="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_636f7590-5ea0-401f-8519-1eaeac6a3209_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective interest rate during the period (percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_2501ddfd-f12d-4d81-bcbe-de198e08a8ea_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs to defend lawsuits or settle claims</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementExpense" xlink:to="lab_us-gaap_LitigationSettlementExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_afcf88e2-b44f-44ab-a805-25ce8786efcf_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_99486ca2-553c-417c-b23b-c46d0ae775b9_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total commitment fee, amount</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_3f36bdb5-dfba-47fa-8e2b-a23813fa613f_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_7beefef5-98f4-4b7a-a568-49185fce41be_verboseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_02e99ec4-1668-4645-9f20-b2f33f309bcd_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_7bcadfc6-9774-43b4-be6a-92853ff77ba6_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_3c7b0597-c01f-441b-b2f1-4a65a5ff3d10_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_ee736b24-3bee-4969-989c-5e9ba69853d2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d1db4041-a0f3-4a14-9e3e-817110ed142e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_698210a7-bda0-48fb-844d-5ebc49186848_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_DebtInstrumentAccountsReceivableBorrowingBase_24382709-b188-41c4-901f-e86e6084ec34_terseLabel_en-US" xlink:label="lab_sibn_DebtInstrumentAccountsReceivableBorrowingBase" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable borrowing base (percent)</link:label>
    <link:label id="lab_sibn_DebtInstrumentAccountsReceivableBorrowingBase_label_en-US" xlink:label="lab_sibn_DebtInstrumentAccountsReceivableBorrowingBase" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Accounts Receivable Borrowing Base</link:label>
    <link:label id="lab_sibn_DebtInstrumentAccountsReceivableBorrowingBase_documentation_en-US" xlink:label="lab_sibn_DebtInstrumentAccountsReceivableBorrowingBase" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Accounts Receivable Borrowing Base</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_DebtInstrumentAccountsReceivableBorrowingBase" xlink:href="sibn-20230331.xsd#sibn_DebtInstrumentAccountsReceivableBorrowingBase"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_DebtInstrumentAccountsReceivableBorrowingBase" xlink:to="lab_sibn_DebtInstrumentAccountsReceivableBorrowingBase" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_5526eca3-54b0-47ae-b1c4-c8d3c34083df_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Others</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserve_2bfa4410-8214-4289-b36f-e45eebdebbfd_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability associated with indemnifications</link:label>
    <link:label id="lab_us-gaap_LitigationReserve_label_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserve" xlink:to="lab_us-gaap_LitigationReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_b1b4925d-0d6a-4ef4-9e46-3325867211ea_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_6345f7a5-2b82-4d79-8177-d95d0f8717bf_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_e307bcaf-72a9-4fb1-b8b5-74a69f95dccc_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued professional services</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_5d1a143e-cc46-4ee8-9cbc-986983acafcf_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_96d90574-d2f1-40d7-ae5b-87ae7e46bf69_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_a7d19fe0-148e-411b-ab75-4db627205f18_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligation_a7c8c693-d92a-4068-a2e7-59049fa33832_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase commitments related to inventory management and training materials</link:label>
    <link:label id="lab_us-gaap_PurchaseObligation_label_en-US" xlink:label="lab_us-gaap_PurchaseObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PurchaseObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligation" xlink:to="lab_us-gaap_PurchaseObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_970d8714-c824-43e4-86fa-2854a536f73f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsLineItems" xlink:to="lab_us-gaap_OtherCommitmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_272715fc-028c-4605-a4bc-e174f54f78c3_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d0ab613c-2c37-4d7e-83ae-e554c7aca4ed_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_53227a53-9329-4a06-84d5-5a52f356f2d1_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_09bd010c-f421-4cb9-b1d0-fc1beb589ddf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_cd03b68d-d970-416e-9128-516418a8bd9b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_426edd72-a7c2-4e74-884a-eb2d2eed0589_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_46a7c581-3759-40c7-8f82-0c42654c7eff_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_4d55147c-7316-4050-950e-80010c3862ad_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_2e012ad6-66f4-48e6-a380-c74b72b5c2a5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Computation of Basic and Diluted Net Loss per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_0ccc69c7-d6e3-4095-bcb1-7c283f5af368_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leased assets obtained in exchange for new operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_11872bd8-edc0-44c1-9045-e908a04d2efe_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of goods sold</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>sibn-20230331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:b9a8bdb4-fcbc-4ee6-8fcb-5f67627ef90e,g:a1ffbe61-3b0e-45b0-8eb9-b424c3d4458b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://si-bone.com/role/Cover" xlink:type="simple" xlink:href="sibn-20230331.xsd#Cover"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_3f44d8f7-223c-47b1-892e-6c357fae026f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_c2119f71-c620-40fb-978c-2905905dbdf4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f44d8f7-223c-47b1-892e-6c357fae026f" xlink:to="loc_dei_DocumentType_c2119f71-c620-40fb-978c-2905905dbdf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_194dbc09-34fa-4ab4-aaae-0ee3aea74134" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f44d8f7-223c-47b1-892e-6c357fae026f" xlink:to="loc_dei_DocumentQuarterlyReport_194dbc09-34fa-4ab4-aaae-0ee3aea74134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_1d03a3c1-19af-496b-8257-1555a43c82fa" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f44d8f7-223c-47b1-892e-6c357fae026f" xlink:to="loc_dei_DocumentPeriodEndDate_1d03a3c1-19af-496b-8257-1555a43c82fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_37292348-91b0-49b8-9aea-04ca2c56d8ff" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f44d8f7-223c-47b1-892e-6c357fae026f" xlink:to="loc_dei_DocumentTransitionReport_37292348-91b0-49b8-9aea-04ca2c56d8ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_a75c8d87-33c6-4196-8028-26a548f78584" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f44d8f7-223c-47b1-892e-6c357fae026f" xlink:to="loc_dei_EntityFileNumber_a75c8d87-33c6-4196-8028-26a548f78584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_b2914a99-c9d9-41c7-93b4-cf9a87e33515" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f44d8f7-223c-47b1-892e-6c357fae026f" xlink:to="loc_dei_EntityRegistrantName_b2914a99-c9d9-41c7-93b4-cf9a87e33515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_8ce2ea84-c509-4e55-9a50-09fb1ff47eba" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f44d8f7-223c-47b1-892e-6c357fae026f" xlink:to="loc_dei_EntityIncorporationStateCountryCode_8ce2ea84-c509-4e55-9a50-09fb1ff47eba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_15537ec0-4523-4e73-9289-ba7bfa1a77c1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f44d8f7-223c-47b1-892e-6c357fae026f" xlink:to="loc_dei_EntityTaxIdentificationNumber_15537ec0-4523-4e73-9289-ba7bfa1a77c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_858a7f6f-c3dc-40cf-820e-7ae80ff4f873" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f44d8f7-223c-47b1-892e-6c357fae026f" xlink:to="loc_dei_EntityAddressAddressLine1_858a7f6f-c3dc-40cf-820e-7ae80ff4f873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_801a3e05-4267-479d-9bf3-da1f88d7a544" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f44d8f7-223c-47b1-892e-6c357fae026f" xlink:to="loc_dei_EntityAddressAddressLine2_801a3e05-4267-479d-9bf3-da1f88d7a544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_471d3128-cf37-40a7-8bbc-10bf1525c6aa" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f44d8f7-223c-47b1-892e-6c357fae026f" xlink:to="loc_dei_EntityAddressCityOrTown_471d3128-cf37-40a7-8bbc-10bf1525c6aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_25ab9711-df6e-483b-a37b-1f434b246fb7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f44d8f7-223c-47b1-892e-6c357fae026f" xlink:to="loc_dei_EntityAddressStateOrProvince_25ab9711-df6e-483b-a37b-1f434b246fb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_bc79a06f-8667-40e7-a96a-1c1950791e7a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f44d8f7-223c-47b1-892e-6c357fae026f" xlink:to="loc_dei_EntityAddressPostalZipCode_bc79a06f-8667-40e7-a96a-1c1950791e7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_d8a978b7-e7cf-4bdd-8902-72e957806e39" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f44d8f7-223c-47b1-892e-6c357fae026f" xlink:to="loc_dei_CityAreaCode_d8a978b7-e7cf-4bdd-8902-72e957806e39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_895d7719-39d8-4211-bd12-429d4f734c2c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f44d8f7-223c-47b1-892e-6c357fae026f" xlink:to="loc_dei_LocalPhoneNumber_895d7719-39d8-4211-bd12-429d4f734c2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_14010c9f-dd0c-4ce0-aebb-24733dd2e1d4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f44d8f7-223c-47b1-892e-6c357fae026f" xlink:to="loc_dei_Security12bTitle_14010c9f-dd0c-4ce0-aebb-24733dd2e1d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_d1a3c6f9-064b-4dbc-bb93-82ec82d6fbb0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f44d8f7-223c-47b1-892e-6c357fae026f" xlink:to="loc_dei_TradingSymbol_d1a3c6f9-064b-4dbc-bb93-82ec82d6fbb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_2e4b84e5-5d4c-4597-ad2a-ceee98ca50f9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f44d8f7-223c-47b1-892e-6c357fae026f" xlink:to="loc_dei_SecurityExchangeName_2e4b84e5-5d4c-4597-ad2a-ceee98ca50f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_9476e6dc-9732-4194-98e2-a97c05453117" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f44d8f7-223c-47b1-892e-6c357fae026f" xlink:to="loc_dei_EntityCurrentReportingStatus_9476e6dc-9732-4194-98e2-a97c05453117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_dfa96ed0-d2c0-47b6-bf32-943a1b4581dd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f44d8f7-223c-47b1-892e-6c357fae026f" xlink:to="loc_dei_EntityInteractiveDataCurrent_dfa96ed0-d2c0-47b6-bf32-943a1b4581dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_561583d0-137e-44fa-a84a-258396299e4a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f44d8f7-223c-47b1-892e-6c357fae026f" xlink:to="loc_dei_EntitySmallBusiness_561583d0-137e-44fa-a84a-258396299e4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_3c0100ca-3d5a-44fd-883f-debdafaf8121" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f44d8f7-223c-47b1-892e-6c357fae026f" xlink:to="loc_dei_EntityEmergingGrowthCompany_3c0100ca-3d5a-44fd-883f-debdafaf8121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_8d872af6-a50e-46f7-99f6-7fdbc2c73c95" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f44d8f7-223c-47b1-892e-6c357fae026f" xlink:to="loc_dei_EntityShellCompany_8d872af6-a50e-46f7-99f6-7fdbc2c73c95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_5934baab-784a-45cc-bfaf-1c83ced3ff46" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f44d8f7-223c-47b1-892e-6c357fae026f" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_5934baab-784a-45cc-bfaf-1c83ced3ff46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_7948542c-b5b1-4c60-90dd-2c52781835c5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f44d8f7-223c-47b1-892e-6c357fae026f" xlink:to="loc_dei_EntityCentralIndexKey_7948542c-b5b1-4c60-90dd-2c52781835c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_81944501-73a1-4b83-ad2b-f553fe8cfc56" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f44d8f7-223c-47b1-892e-6c357fae026f" xlink:to="loc_dei_CurrentFiscalYearEndDate_81944501-73a1-4b83-ad2b-f553fe8cfc56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_f260ca91-5b10-4487-8b28-9ac97173a0c4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f44d8f7-223c-47b1-892e-6c357fae026f" xlink:to="loc_dei_DocumentFiscalYearFocus_f260ca91-5b10-4487-8b28-9ac97173a0c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_bcff295c-6232-49dc-a647-12e5124c99f0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f44d8f7-223c-47b1-892e-6c357fae026f" xlink:to="loc_dei_DocumentFiscalPeriodFocus_bcff295c-6232-49dc-a647-12e5124c99f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_1947728e-ba12-4fcf-a5a7-21c15c1f85cb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f44d8f7-223c-47b1-892e-6c357fae026f" xlink:to="loc_dei_AmendmentFlag_1947728e-ba12-4fcf-a5a7-21c15c1f85cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_118f5b87-ccb6-47db-a398-9f7dade4045b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f44d8f7-223c-47b1-892e-6c357fae026f" xlink:to="loc_dei_EntityFilerCategory_118f5b87-ccb6-47db-a398-9f7dade4045b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="sibn-20230331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_19591b9a-6f6c-43fb-ade0-130dee5dc3f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_3e6317e6-593f-4224-bdde-8b88035d8c26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_19591b9a-6f6c-43fb-ade0-130dee5dc3f4" xlink:to="loc_us-gaap_AssetsAbstract_3e6317e6-593f-4224-bdde-8b88035d8c26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_ba1a0ff4-bcd2-4152-91aa-8f7b62c10ac2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3e6317e6-593f-4224-bdde-8b88035d8c26" xlink:to="loc_us-gaap_AssetsCurrentAbstract_ba1a0ff4-bcd2-4152-91aa-8f7b62c10ac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3e888187-0f6d-42ca-b8d2-0cd862c2de70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ba1a0ff4-bcd2-4152-91aa-8f7b62c10ac2" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3e888187-0f6d-42ca-b8d2-0cd862c2de70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent_aadd886b-26f2-444c-ae09-83036c61fc6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ba1a0ff4-bcd2-4152-91aa-8f7b62c10ac2" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent_aadd886b-26f2-444c-ae09-83036c61fc6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_1051fadc-b1fd-4797-b6c1-2f469166d8e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ba1a0ff4-bcd2-4152-91aa-8f7b62c10ac2" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_1051fadc-b1fd-4797-b6c1-2f469166d8e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_c1716a7b-226c-4a28-85ca-f4a2caf0be94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ba1a0ff4-bcd2-4152-91aa-8f7b62c10ac2" xlink:to="loc_us-gaap_InventoryNet_c1716a7b-226c-4a28-85ca-f4a2caf0be94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_55dfd99e-593c-4a0b-a04b-9ca6637861ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ba1a0ff4-bcd2-4152-91aa-8f7b62c10ac2" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_55dfd99e-593c-4a0b-a04b-9ca6637861ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_ba9db6ad-263c-4808-bf62-d2b11840cf18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ba1a0ff4-bcd2-4152-91aa-8f7b62c10ac2" xlink:to="loc_us-gaap_AssetsCurrent_ba9db6ad-263c-4808-bf62-d2b11840cf18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_de653ef1-c0fa-4d82-920f-4c80f20a93ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3e6317e6-593f-4224-bdde-8b88035d8c26" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_de653ef1-c0fa-4d82-920f-4c80f20a93ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_b0970eca-d8eb-498a-84b5-c9f707cea613" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3e6317e6-593f-4224-bdde-8b88035d8c26" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_b0970eca-d8eb-498a-84b5-c9f707cea613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_ef287b70-9fcb-4b2a-8f45-c4352f497c14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3e6317e6-593f-4224-bdde-8b88035d8c26" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_ef287b70-9fcb-4b2a-8f45-c4352f497c14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_027ede5b-4b9e-4d3c-9103-12d55cc6d156" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3e6317e6-593f-4224-bdde-8b88035d8c26" xlink:to="loc_us-gaap_Assets_027ede5b-4b9e-4d3c-9103-12d55cc6d156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6758734f-d093-4a6b-85f2-7916e8e4c87d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_19591b9a-6f6c-43fb-ade0-130dee5dc3f4" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6758734f-d093-4a6b-85f2-7916e8e4c87d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_f2b7a264-3a39-4520-a581-254b4d0dff31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6758734f-d093-4a6b-85f2-7916e8e4c87d" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_f2b7a264-3a39-4520-a581-254b4d0dff31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_fbb29c9d-77a5-4792-94e3-ab8ec4e64051" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_f2b7a264-3a39-4520-a581-254b4d0dff31" xlink:to="loc_us-gaap_AccountsPayableCurrent_fbb29c9d-77a5-4792-94e3-ab8ec4e64051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_fa7d465d-6b60-428a-bfef-373841f53c96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_f2b7a264-3a39-4520-a581-254b4d0dff31" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_fa7d465d-6b60-428a-bfef-373841f53c96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_477df923-bcd0-4419-9053-d9592f93e786" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_f2b7a264-3a39-4520-a581-254b4d0dff31" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_477df923-bcd0-4419-9053-d9592f93e786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_6ae31655-7b95-4168-96d2-1fb77462cdb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_f2b7a264-3a39-4520-a581-254b4d0dff31" xlink:to="loc_us-gaap_LiabilitiesCurrent_6ae31655-7b95-4168-96d2-1fb77462cdb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_6d4dd545-7926-4543-bab5-dd0b71fb97ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6758734f-d093-4a6b-85f2-7916e8e4c87d" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_6d4dd545-7926-4543-bab5-dd0b71fb97ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c2f48bf1-7aee-48ee-8afd-3029b2ccb835" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6758734f-d093-4a6b-85f2-7916e8e4c87d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c2f48bf1-7aee-48ee-8afd-3029b2ccb835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_741b22fa-4703-4f7d-ae8c-8b59436563f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6758734f-d093-4a6b-85f2-7916e8e4c87d" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_741b22fa-4703-4f7d-ae8c-8b59436563f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_5f2fc940-d1e4-4a77-b802-d5742f6205e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6758734f-d093-4a6b-85f2-7916e8e4c87d" xlink:to="loc_us-gaap_Liabilities_5f2fc940-d1e4-4a77-b802-d5742f6205e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_9d398507-fe2d-407a-9e23-e01c058acd1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6758734f-d093-4a6b-85f2-7916e8e4c87d" xlink:to="loc_us-gaap_CommitmentsAndContingencies_9d398507-fe2d-407a-9e23-e01c058acd1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_dc6fb7b4-f79b-4e51-9902-a209e8bbdb6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6758734f-d093-4a6b-85f2-7916e8e4c87d" xlink:to="loc_us-gaap_StockholdersEquityAbstract_dc6fb7b4-f79b-4e51-9902-a209e8bbdb6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_f337d4b3-448e-4310-b27b-cb97e43ea73d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_dc6fb7b4-f79b-4e51-9902-a209e8bbdb6e" xlink:to="loc_us-gaap_PreferredStockValue_f337d4b3-448e-4310-b27b-cb97e43ea73d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_a94b9e75-2d59-4675-bdcc-a65e18c4a934" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_dc6fb7b4-f79b-4e51-9902-a209e8bbdb6e" xlink:to="loc_us-gaap_CommonStockValue_a94b9e75-2d59-4675-bdcc-a65e18c4a934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_5ef6635a-a854-44aa-b8fe-22f58179945b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_dc6fb7b4-f79b-4e51-9902-a209e8bbdb6e" xlink:to="loc_us-gaap_AdditionalPaidInCapital_5ef6635a-a854-44aa-b8fe-22f58179945b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9c43a3d4-3fc6-4eaa-a86a-d75178bcf8d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_dc6fb7b4-f79b-4e51-9902-a209e8bbdb6e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9c43a3d4-3fc6-4eaa-a86a-d75178bcf8d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2c020826-d00a-4f94-8d80-9fe546f09986" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_dc6fb7b4-f79b-4e51-9902-a209e8bbdb6e" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2c020826-d00a-4f94-8d80-9fe546f09986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_696e2f06-034f-48ec-b23b-4c68f87195e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_dc6fb7b4-f79b-4e51-9902-a209e8bbdb6e" xlink:to="loc_us-gaap_StockholdersEquity_696e2f06-034f-48ec-b23b-4c68f87195e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_388458ac-9248-442e-bd95-95747c619629" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6758734f-d093-4a6b-85f2-7916e8e4c87d" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_388458ac-9248-442e-bd95-95747c619629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="sibn-20230331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_52727e78-8321-48ac-b2be-bbb869f30f4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_0eea323f-1580-4705-a8f8-d0251eb40bee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_52727e78-8321-48ac-b2be-bbb869f30f4f" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_0eea323f-1580-4705-a8f8-d0251eb40bee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_00d56b43-c204-4e68-b027-d0232d145987" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_52727e78-8321-48ac-b2be-bbb869f30f4f" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_00d56b43-c204-4e68-b027-d0232d145987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_062b64e1-f13e-4858-885d-708b42a897fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_52727e78-8321-48ac-b2be-bbb869f30f4f" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_062b64e1-f13e-4858-885d-708b42a897fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_3352bdf8-b726-4a4b-a1a7-f8f2aad9f0a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_52727e78-8321-48ac-b2be-bbb869f30f4f" xlink:to="loc_us-gaap_PreferredStockSharesIssued_3352bdf8-b726-4a4b-a1a7-f8f2aad9f0a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_cf04603e-d608-4cae-a58a-49d04d57bb44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_52727e78-8321-48ac-b2be-bbb869f30f4f" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_cf04603e-d608-4cae-a58a-49d04d57bb44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_19e14b38-a846-4a45-8f80-94095287e13c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_52727e78-8321-48ac-b2be-bbb869f30f4f" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_19e14b38-a846-4a45-8f80-94095287e13c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_34b5e38e-e1d5-434a-baec-80ddcf4091e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_52727e78-8321-48ac-b2be-bbb869f30f4f" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_34b5e38e-e1d5-434a-baec-80ddcf4091e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_71b29e38-433b-4fb5-8a21-11d544d7f277" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_52727e78-8321-48ac-b2be-bbb869f30f4f" xlink:to="loc_us-gaap_CommonStockSharesIssued_71b29e38-433b-4fb5-8a21-11d544d7f277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_c9e5b2c9-c866-47c0-a5ba-15b067da96ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_52727e78-8321-48ac-b2be-bbb869f30f4f" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_c9e5b2c9-c866-47c0-a5ba-15b067da96ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="sibn-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_8870046d-2742-4fdc-9335-b79756a83263" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d6f8ced0-6225-426e-89d1-9e2145048caf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8870046d-2742-4fdc-9335-b79756a83263" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d6f8ced0-6225-426e-89d1-9e2145048caf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_5102eb80-e7b6-404e-9829-e4f1df58b2c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8870046d-2742-4fdc-9335-b79756a83263" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_5102eb80-e7b6-404e-9829-e4f1df58b2c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_d799c1e2-6be7-4c59-b3f5-01a802c3f4aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8870046d-2742-4fdc-9335-b79756a83263" xlink:to="loc_us-gaap_GrossProfit_d799c1e2-6be7-4c59-b3f5-01a802c3f4aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_75c11156-617e-453f-b669-2ed52cca58c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8870046d-2742-4fdc-9335-b79756a83263" xlink:to="loc_us-gaap_OperatingExpensesAbstract_75c11156-617e-453f-b669-2ed52cca58c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_00f29f36-0b0d-494a-8f88-4d90c8e3d80b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_75c11156-617e-453f-b669-2ed52cca58c1" xlink:to="loc_us-gaap_SellingAndMarketingExpense_00f29f36-0b0d-494a-8f88-4d90c8e3d80b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_bec88e2b-f374-4033-b8d4-41688a6eab78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_75c11156-617e-453f-b669-2ed52cca58c1" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_bec88e2b-f374-4033-b8d4-41688a6eab78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_22bb174a-0ca4-470a-93b4-2e62bd550ca3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_75c11156-617e-453f-b669-2ed52cca58c1" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_22bb174a-0ca4-470a-93b4-2e62bd550ca3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_a6dc1692-5d6f-42d9-9e14-49119d40f203" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_75c11156-617e-453f-b669-2ed52cca58c1" xlink:to="loc_us-gaap_OperatingExpenses_a6dc1692-5d6f-42d9-9e14-49119d40f203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_69da9edd-4af7-4b4c-afe5-e675599de013" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8870046d-2742-4fdc-9335-b79756a83263" xlink:to="loc_us-gaap_OperatingIncomeLoss_69da9edd-4af7-4b4c-afe5-e675599de013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_ca0ec66e-bffa-46aa-bbc2-6975a226813d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8870046d-2742-4fdc-9335-b79756a83263" xlink:to="loc_us-gaap_OtherIncomeAndExpensesAbstract_ca0ec66e-bffa-46aa-bbc2-6975a226813d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_89d37795-a172-4fee-919c-660155c03a20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_ca0ec66e-bffa-46aa-bbc2-6975a226813d" xlink:to="loc_us-gaap_InvestmentIncomeInterest_89d37795-a172-4fee-919c-660155c03a20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_81067729-e525-4322-8204-3cea98a90482" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_ca0ec66e-bffa-46aa-bbc2-6975a226813d" xlink:to="loc_us-gaap_InterestExpense_81067729-e525-4322-8204-3cea98a90482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_7bb79bb7-c6db-40a9-b536-977f16d4f1af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_ca0ec66e-bffa-46aa-bbc2-6975a226813d" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_7bb79bb7-c6db-40a9-b536-977f16d4f1af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2bb6b1b6-1d7a-47ea-a038-1600a989e9b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8870046d-2742-4fdc-9335-b79756a83263" xlink:to="loc_us-gaap_NetIncomeLoss_2bb6b1b6-1d7a-47ea-a038-1600a989e9b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_9f95709a-e7eb-4702-89db-8cd6b87426e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8870046d-2742-4fdc-9335-b79756a83263" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_9f95709a-e7eb-4702-89db-8cd6b87426e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_e64f33db-b37e-404a-9aff-e4098ee869d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_9f95709a-e7eb-4702-89db-8cd6b87426e0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_e64f33db-b37e-404a-9aff-e4098ee869d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_9b6f88da-74a5-4d35-b99d-1982bfbfec8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_9f95709a-e7eb-4702-89db-8cd6b87426e0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_9b6f88da-74a5-4d35-b99d-1982bfbfec8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_efaccc87-25ed-4bf1-b411-a557cbb84eac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8870046d-2742-4fdc-9335-b79756a83263" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_efaccc87-25ed-4bf1-b411-a557cbb84eac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_f8172c04-fadc-46e5-8085-89b845e0f91f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8870046d-2742-4fdc-9335-b79756a83263" xlink:to="loc_us-gaap_EarningsPerShareBasic_f8172c04-fadc-46e5-8085-89b845e0f91f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_4a0847d5-35c5-42d6-89d5-f8813d2c2b8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8870046d-2742-4fdc-9335-b79756a83263" xlink:to="loc_us-gaap_EarningsPerShareDiluted_4a0847d5-35c5-42d6-89d5-f8813d2c2b8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0ce41913-cb03-481d-a7b3-c84c0301d3af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8870046d-2742-4fdc-9335-b79756a83263" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0ce41913-cb03-481d-a7b3-c84c0301d3af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_94f56b58-cb08-45c4-a059-edcff7e20a42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8870046d-2742-4fdc-9335-b79756a83263" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_94f56b58-cb08-45c4-a059-edcff7e20a42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="sibn-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_261a5f72-52bf-4f56-a766-15a304ecf473" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ba51b4be-b43b-4e79-ad3e-f34b3e5f9610" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_261a5f72-52bf-4f56-a766-15a304ecf473" xlink:to="loc_us-gaap_StatementTable_ba51b4be-b43b-4e79-ad3e-f34b3e5f9610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_7d6e643b-9abe-4617-85e7-003cf252ca14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ba51b4be-b43b-4e79-ad3e-f34b3e5f9610" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_7d6e643b-9abe-4617-85e7-003cf252ca14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9c7d00d4-d4e5-4341-bfd2-47f082e25713" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7d6e643b-9abe-4617-85e7-003cf252ca14" xlink:to="loc_us-gaap_EquityComponentDomain_9c7d00d4-d4e5-4341-bfd2-47f082e25713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_3ff0028d-0cc6-45f2-9125-72562bf974c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9c7d00d4-d4e5-4341-bfd2-47f082e25713" xlink:to="loc_us-gaap_CommonStockMember_3ff0028d-0cc6-45f2-9125-72562bf974c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_bcbf8e9c-b271-4d3c-92b8-d3d2f3f212f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9c7d00d4-d4e5-4341-bfd2-47f082e25713" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_bcbf8e9c-b271-4d3c-92b8-d3d2f3f212f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f1c5bf6c-765a-4bfa-993a-361d774b1602" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9c7d00d4-d4e5-4341-bfd2-47f082e25713" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f1c5bf6c-765a-4bfa-993a-361d774b1602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_eb6a452b-a32d-4847-874d-f0e57c8a5f32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9c7d00d4-d4e5-4341-bfd2-47f082e25713" xlink:to="loc_us-gaap_RetainedEarningsMember_eb6a452b-a32d-4847-874d-f0e57c8a5f32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_3da949f8-79b9-4cfd-a2d8-c07303ae2274" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ba51b4be-b43b-4e79-ad3e-f34b3e5f9610" xlink:to="loc_us-gaap_StatementLineItems_3da949f8-79b9-4cfd-a2d8-c07303ae2274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_079e8f3b-93bb-4b05-8540-edd491fe64fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3da949f8-79b9-4cfd-a2d8-c07303ae2274" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_079e8f3b-93bb-4b05-8540-edd491fe64fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_537475fd-5e16-4f19-a72f-79d7122bc848" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_079e8f3b-93bb-4b05-8540-edd491fe64fa" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_537475fd-5e16-4f19-a72f-79d7122bc848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_84426c95-8e7b-4cb1-8553-ff6595b38f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_079e8f3b-93bb-4b05-8540-edd491fe64fa" xlink:to="loc_us-gaap_StockholdersEquity_84426c95-8e7b-4cb1-8553-ff6595b38f2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6160ca46-ceb9-4c9a-9bd7-28a00817347d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_079e8f3b-93bb-4b05-8540-edd491fe64fa" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6160ca46-ceb9-4c9a-9bd7-28a00817347d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_3e28f91d-3f1d-4dff-9c12-259b9da1b700" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_079e8f3b-93bb-4b05-8540-edd491fe64fa" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_3e28f91d-3f1d-4dff-9c12-259b9da1b700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_StockIssuedDuringPeriodSharesRestrictedStockUnits_9f28cdba-8908-454b-ba17-2a41979c3d02" xlink:href="sibn-20230331.xsd#sibn_StockIssuedDuringPeriodSharesRestrictedStockUnits"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_079e8f3b-93bb-4b05-8540-edd491fe64fa" xlink:to="loc_sibn_StockIssuedDuringPeriodSharesRestrictedStockUnits_9f28cdba-8908-454b-ba17-2a41979c3d02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_b56bacb4-b656-4164-9e41-b4286f6dfdb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_079e8f3b-93bb-4b05-8540-edd491fe64fa" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_b56bacb4-b656-4164-9e41-b4286f6dfdb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_ab6a7594-df32-438f-a79a-0506be119657" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_079e8f3b-93bb-4b05-8540-edd491fe64fa" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_ab6a7594-df32-438f-a79a-0506be119657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_864b9d1e-e430-4100-a5a7-5f1ee25c6301" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_079e8f3b-93bb-4b05-8540-edd491fe64fa" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_864b9d1e-e430-4100-a5a7-5f1ee25c6301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_cab14cc4-4570-4eff-9f8a-c4abe9594e9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_079e8f3b-93bb-4b05-8540-edd491fe64fa" xlink:to="loc_us-gaap_NetIncomeLoss_cab14cc4-4570-4eff-9f8a-c4abe9594e9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_b5a44ed4-4396-43a1-a2fa-86efb03ec7f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_079e8f3b-93bb-4b05-8540-edd491fe64fa" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_b5a44ed4-4396-43a1-a2fa-86efb03ec7f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d44a8206-7c0e-4202-ab89-1453f15e21e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_079e8f3b-93bb-4b05-8540-edd491fe64fa" xlink:to="loc_us-gaap_StockholdersEquity_d44a8206-7c0e-4202-ab89-1453f15e21e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="sibn-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_eab2a924-577f-45a9-94d0-acdc72635412" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_44c512bb-f519-4656-9f5d-0b92f46f997f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_eab2a924-577f-45a9-94d0-acdc72635412" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_44c512bb-f519-4656-9f5d-0b92f46f997f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5aa17c2d-c86b-4067-ae1e-7727a4b93a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_44c512bb-f519-4656-9f5d-0b92f46f997f" xlink:to="loc_us-gaap_NetIncomeLoss_5aa17c2d-c86b-4067-ae1e-7727a4b93a8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d2e49123-461b-4ca0-8dd8-561c06812d60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_44c512bb-f519-4656-9f5d-0b92f46f997f" xlink:to="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d2e49123-461b-4ca0-8dd8-561c06812d60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_6f4d0a8c-e285-4787-979c-40d4e57bb144" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d2e49123-461b-4ca0-8dd8-561c06812d60" xlink:to="loc_us-gaap_ShareBasedCompensation_6f4d0a8c-e285-4787-979c-40d4e57bb144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_7238cdfe-921c-484a-8cb8-bc7a4375094e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d2e49123-461b-4ca0-8dd8-561c06812d60" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_7238cdfe-921c-484a-8cb8-bc7a4375094e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_2e6bb93d-f042-4dfd-a1c4-2f0e375200e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d2e49123-461b-4ca0-8dd8-561c06812d60" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_2e6bb93d-f042-4dfd-a1c4-2f0e375200e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_4da31b54-2583-4520-8567-fdf69fdb14e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d2e49123-461b-4ca0-8dd8-561c06812d60" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_4da31b54-2583-4520-8567-fdf69fdb14e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_a9bea7b3-0888-4d91-a38a-30e99e8c641a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d2e49123-461b-4ca0-8dd8-561c06812d60" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_a9bea7b3-0888-4d91-a38a-30e99e8c641a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_171c702d-8e77-49b3-9d5d-b2dd215d6301" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d2e49123-461b-4ca0-8dd8-561c06812d60" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_171c702d-8e77-49b3-9d5d-b2dd215d6301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5b6022dd-ccec-4a23-a5de-92546c7b168e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_44c512bb-f519-4656-9f5d-0b92f46f997f" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5b6022dd-ccec-4a23-a5de-92546c7b168e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_aa73425e-a479-4084-98e9-df6f10d15970" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5b6022dd-ccec-4a23-a5de-92546c7b168e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_aa73425e-a479-4084-98e9-df6f10d15970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_2e612ddb-f394-45c1-9742-5c86fd759fba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5b6022dd-ccec-4a23-a5de-92546c7b168e" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_2e612ddb-f394-45c1-9742-5c86fd759fba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_b3b61aa0-3a9a-40e5-aafc-a750d4391a9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5b6022dd-ccec-4a23-a5de-92546c7b168e" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_b3b61aa0-3a9a-40e5-aafc-a750d4391a9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_7dc97e14-bab3-4d35-a79c-0657b0eeb695" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5b6022dd-ccec-4a23-a5de-92546c7b168e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_7dc97e14-bab3-4d35-a79c-0657b0eeb695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_2d0e1636-340d-41ae-83da-c05fcdaae9c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5b6022dd-ccec-4a23-a5de-92546c7b168e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_2d0e1636-340d-41ae-83da-c05fcdaae9c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5f6d2154-aabc-45d6-bb4e-67fb27908c90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_44c512bb-f519-4656-9f5d-0b92f46f997f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5f6d2154-aabc-45d6-bb4e-67fb27908c90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a1c284ec-33d9-4a4c-9c1e-f57ab0803e6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_eab2a924-577f-45a9-94d0-acdc72635412" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a1c284ec-33d9-4a4c-9c1e-f57ab0803e6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ProceedsFromMaturityOfMarketableSecurities_fc7ca3c8-7c85-4dc9-bc45-9813c82962e9" xlink:href="sibn-20230331.xsd#sibn_ProceedsFromMaturityOfMarketableSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a1c284ec-33d9-4a4c-9c1e-f57ab0803e6e" xlink:to="loc_sibn_ProceedsFromMaturityOfMarketableSecurities_fc7ca3c8-7c85-4dc9-bc45-9813c82962e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_00ff89cf-ab71-46d5-be9e-d8cbe8531434" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a1c284ec-33d9-4a4c-9c1e-f57ab0803e6e" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_00ff89cf-ab71-46d5-be9e-d8cbe8531434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_031ffedb-9e45-4468-a263-c53c17052776" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a1c284ec-33d9-4a4c-9c1e-f57ab0803e6e" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_031ffedb-9e45-4468-a263-c53c17052776" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e9d3a7ab-ae28-4015-922b-ee02a0c13631" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a1c284ec-33d9-4a4c-9c1e-f57ab0803e6e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e9d3a7ab-ae28-4015-922b-ee02a0c13631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_82e4d492-5fb7-4f62-b531-ed70a6a12c66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_eab2a924-577f-45a9-94d0-acdc72635412" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_82e4d492-5fb7-4f62-b531-ed70a6a12c66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_6e0a8c88-47e7-4ae8-85f2-cd87764680e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_82e4d492-5fb7-4f62-b531-ed70a6a12c66" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_6e0a8c88-47e7-4ae8-85f2-cd87764680e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_da4cc169-dbd7-4f58-a2c8-2b94767a65ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_82e4d492-5fb7-4f62-b531-ed70a6a12c66" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_da4cc169-dbd7-4f58-a2c8-2b94767a65ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_fd820944-8b04-4e78-9321-659d0052bc76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_82e4d492-5fb7-4f62-b531-ed70a6a12c66" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_fd820944-8b04-4e78-9321-659d0052bc76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_020c01eb-cdab-4b32-a3d0-140a0819cb1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_82e4d492-5fb7-4f62-b531-ed70a6a12c66" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_020c01eb-cdab-4b32-a3d0-140a0819cb1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_fff07223-783c-4013-9f74-0c00771432b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_82e4d492-5fb7-4f62-b531-ed70a6a12c66" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_fff07223-783c-4013-9f74-0c00771432b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f050b070-68ac-4f05-84aa-409aec190564" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_eab2a924-577f-45a9-94d0-acdc72635412" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f050b070-68ac-4f05-84aa-409aec190564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_850587ed-6183-4601-a8e4-7290159609d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_eab2a924-577f-45a9-94d0-acdc72635412" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_850587ed-6183-4601-a8e4-7290159609d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValueAbstract_5afc1fef-210a-4a1e-9c10-2f848b1733d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsAtCarryingValueAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_eab2a924-577f-45a9-94d0-acdc72635412" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValueAbstract_5afc1fef-210a-4a1e-9c10-2f848b1733d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_82f8d485-4d87-4387-a3d1-5ff1dc78972d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashEquivalentsAtCarryingValueAbstract_5afc1fef-210a-4a1e-9c10-2f848b1733d7" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_82f8d485-4d87-4387-a3d1-5ff1dc78972d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_42e81cea-14f7-458d-8039-5becf41f2ffb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashEquivalentsAtCarryingValueAbstract_5afc1fef-210a-4a1e-9c10-2f848b1733d7" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_42e81cea-14f7-458d-8039-5becf41f2ffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_eec7d23d-6231-4083-9bba-6b3fd6c5ebe4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_eab2a924-577f-45a9-94d0-acdc72635412" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_eec7d23d-6231-4083-9bba-6b3fd6c5ebe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_de34a065-4256-45b6-a92b-7cff6fc34132" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_eec7d23d-6231-4083-9bba-6b3fd6c5ebe4" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_de34a065-4256-45b6-a92b-7cff6fc34132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/TheCompanyandNatureofBusiness" xlink:type="simple" xlink:href="sibn-20230331.xsd#TheCompanyandNatureofBusiness"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/TheCompanyandNatureofBusiness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_20d8359d-b9bf-43fc-a692-e8d173a422e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_3ef086fa-a0f0-4263-8862-8c10fc4d645f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_20d8359d-b9bf-43fc-a692-e8d173a422e4" xlink:to="loc_us-gaap_NatureOfOperations_3ef086fa-a0f0-4263-8862-8c10fc4d645f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="sibn-20230331.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7fbe6cdb-ec78-4874-81e8-8bfa0e27b3f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_c88b2546-7b1f-4325-89cd-e144ea160804" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7fbe6cdb-ec78-4874-81e8-8bfa0e27b3f7" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_c88b2546-7b1f-4325-89cd-e144ea160804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/MarketableSecurities" xlink:type="simple" xlink:href="sibn-20230331.xsd#MarketableSecurities"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/MarketableSecurities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_8aa0ecca-0198-430c-857d-0d0eae9039d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_c01ee0f4-d0a8-4457-9516-0e0d8596ccc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_8aa0ecca-0198-430c-857d-0d0eae9039d9" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_c01ee0f4-d0a8-4457-9516-0e0d8596ccc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/FairValueMeasurement" xlink:type="simple" xlink:href="sibn-20230331.xsd#FairValueMeasurement"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/FairValueMeasurement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_8ec30a29-f7c1-49d2-9eb7-880faec2549e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_6ccb6e70-cdfb-4922-81d1-e4bcb285397c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_8ec30a29-f7c1-49d2-9eb7-880faec2549e" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_6ccb6e70-cdfb-4922-81d1-e4bcb285397c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/BalanceSheetComponents" xlink:type="simple" xlink:href="sibn-20230331.xsd#BalanceSheetComponents"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/BalanceSheetComponents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a63ca1d3-bed9-41ff-a54f-50adc06e01f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_4acd81ca-1e97-47e9-b4ab-e1f8a6068d18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a63ca1d3-bed9-41ff-a54f-50adc06e01f9" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_4acd81ca-1e97-47e9-b4ab-e1f8a6068d18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="sibn-20230331.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_80d82cac-43be-4069-992d-41e58d647fd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_e6f2f1d6-55c6-4393-b90a-21b3d11a7565" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_80d82cac-43be-4069-992d-41e58d647fd9" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_e6f2f1d6-55c6-4393-b90a-21b3d11a7565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/Borrowings" xlink:type="simple" xlink:href="sibn-20230331.xsd#Borrowings"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/Borrowings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_242f0907-df56-4fed-8461-5c12891df831" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_7c614a4d-515d-4077-b01a-f4f02cb84234" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_242f0907-df56-4fed-8461-5c12891df831" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_7c614a4d-515d-4077-b01a-f4f02cb84234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/StockBasedIncentiveCompensationPlans" xlink:type="simple" xlink:href="sibn-20230331.xsd#StockBasedIncentiveCompensationPlans"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/StockBasedIncentiveCompensationPlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ce36d49a-eec6-4189-8769-eaf4daf5b054" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_fd5d887a-8bc9-4214-a197-7f271734b5f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ce36d49a-eec6-4189-8769-eaf4daf5b054" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_fd5d887a-8bc9-4214-a197-7f271734b5f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/NetLossPerShareofCommonStock" xlink:type="simple" xlink:href="sibn-20230331.xsd#NetLossPerShareofCommonStock"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/NetLossPerShareofCommonStock" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_6fa53584-3d2d-416b-bae5-95a5d3ecd049" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_436ba7e2-70b3-4ea3-8ac6-8c7a20c45e17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6fa53584-3d2d-416b-bae5-95a5d3ecd049" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_436ba7e2-70b3-4ea3-8ac6-8c7a20c45e17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/RelatedPartyTransaction" xlink:type="simple" xlink:href="sibn-20230331.xsd#RelatedPartyTransaction"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/RelatedPartyTransaction" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_4078cf03-3fbf-4102-9b1c-efe2104948cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_ab71b456-9dec-477e-a83a-286cba0e2bd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_4078cf03-3fbf-4102-9b1c-efe2104948cb" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_ab71b456-9dec-477e-a83a-286cba0e2bd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/IncomeTaxes" xlink:type="simple" xlink:href="sibn-20230331.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_6c3c4380-2477-49ef-a628-87c714cd5aca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_d459bc27-dd2c-4c7c-ae30-e4131e5f246b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6c3c4380-2477-49ef-a628-87c714cd5aca" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_d459bc27-dd2c-4c7c-ae30-e4131e5f246b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="sibn-20230331.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6f51926b-56f2-4329-aa25-6c921a6e2f66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_63bb7ce4-2aa8-40dd-9e25-1927b9ffe5f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6f51926b-56f2-4329-aa25-6c921a6e2f66" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_63bb7ce4-2aa8-40dd-9e25-1927b9ffe5f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_b1758bdf-62b2-4103-a0f5-bade44b7a100" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6f51926b-56f2-4329-aa25-6c921a6e2f66" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_b1758bdf-62b2-4103-a0f5-bade44b7a100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_c24e71d3-a283-4a79-b013-8b946ae68feb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6f51926b-56f2-4329-aa25-6c921a6e2f66" xlink:to="loc_us-gaap_UseOfEstimates_c24e71d3-a283-4a79-b013-8b946ae68feb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_9e4964ad-4d1d-4434-9e1b-5b8fa01e855b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6f51926b-56f2-4329-aa25-6c921a6e2f66" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_9e4964ad-4d1d-4434-9e1b-5b8fa01e855b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_29515a12-06cc-418f-9d46-ccb4cf27680d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6f51926b-56f2-4329-aa25-6c921a6e2f66" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_29515a12-06cc-418f-9d46-ccb4cf27680d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_6bd26529-8043-4952-8314-dca82cccff26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6f51926b-56f2-4329-aa25-6c921a6e2f66" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_6bd26529-8043-4952-8314-dca82cccff26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_d36d0c07-d092-4fd2-9443-2524ac9a2a39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6f51926b-56f2-4329-aa25-6c921a6e2f66" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_d36d0c07-d092-4fd2-9443-2524ac9a2a39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="sibn-20230331.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_5b92cea4-9e4c-4985-ac95-7a6faf5fe0fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_693f680a-e45a-4321-bd5a-19d1dc7d92f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5b92cea4-9e4c-4985-ac95-7a6faf5fe0fe" xlink:to="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_693f680a-e45a-4321-bd5a-19d1dc7d92f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/MarketableSecuritiesTables" xlink:type="simple" xlink:href="sibn-20230331.xsd#MarketableSecuritiesTables"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/MarketableSecuritiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_a7f64547-462c-4cbd-a3e8-e02fe79e537c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock_8f550c88-8ad2-4f1e-921f-3ef15ae943bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_a7f64547-462c-4cbd-a3e8-e02fe79e537c" xlink:to="loc_us-gaap_MarketableSecuritiesTextBlock_8f550c88-8ad2-4f1e-921f-3ef15ae943bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/FairValueMeasurementTables" xlink:type="simple" xlink:href="sibn-20230331.xsd#FairValueMeasurementTables"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/FairValueMeasurementTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_f3b38c6a-6f5c-4081-aa2f-032615425759" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_0da0cf0e-df50-43a7-8980-ab3a78832c3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f3b38c6a-6f5c-4081-aa2f-032615425759" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_0da0cf0e-df50-43a7-8980-ab3a78832c3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/BalanceSheetComponentsTables" xlink:type="simple" xlink:href="sibn-20230331.xsd#BalanceSheetComponentsTables"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/BalanceSheetComponentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cc8a7d43-507d-4776-99f6-d141e4c8c115" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_3e24773e-2456-4b62-abdc-3c404bddd265" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cc8a7d43-507d-4776-99f6-d141e4c8c115" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_3e24773e-2456-4b62-abdc-3c404bddd265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_74b618ba-20e3-4d9b-a9ab-43d4b66a7a15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cc8a7d43-507d-4776-99f6-d141e4c8c115" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_74b618ba-20e3-4d9b-a9ab-43d4b66a7a15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_a458f79a-ec10-4fdd-bc27-d113ebed1006" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cc8a7d43-507d-4776-99f6-d141e4c8c115" xlink:to="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_a458f79a-ec10-4fdd-bc27-d113ebed1006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/CommitmentsandContingenciesTables" xlink:type="simple" xlink:href="sibn-20230331.xsd#CommitmentsandContingenciesTables"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/CommitmentsandContingenciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e48ad039-0440-4bcc-9bea-fb7589ca208c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_1cbfe2ec-4c20-46f9-b361-9dc921d73f53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e48ad039-0440-4bcc-9bea-fb7589ca208c" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_1cbfe2ec-4c20-46f9-b361-9dc921d73f53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_b1f8c22b-821e-4f34-a4e7-3b3ebf37cf9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e48ad039-0440-4bcc-9bea-fb7589ca208c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_b1f8c22b-821e-4f34-a4e7-3b3ebf37cf9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/BorrowingsTables" xlink:type="simple" xlink:href="sibn-20230331.xsd#BorrowingsTables"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/BorrowingsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_c1dd709a-6389-4f9c-af5a-14c0d0befef7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_d3eb26b5-58a2-443b-a4cf-cd8496754bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_c1dd709a-6389-4f9c-af5a-14c0d0befef7" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_d3eb26b5-58a2-443b-a4cf-cd8496754bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_fb0fb552-f6ce-4a7c-8c74-92e59c3cf527" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_c1dd709a-6389-4f9c-af5a-14c0d0befef7" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_fb0fb552-f6ce-4a7c-8c74-92e59c3cf527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/StockBasedIncentiveCompensationPlansTables" xlink:type="simple" xlink:href="sibn-20230331.xsd#StockBasedIncentiveCompensationPlansTables"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/StockBasedIncentiveCompensationPlansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6acf6cf2-b3a4-4f27-9d39-ca0f1192f949" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_fbf8b322-ab88-42b3-b7dd-6edaf87075e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6acf6cf2-b3a4-4f27-9d39-ca0f1192f949" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_fbf8b322-ab88-42b3-b7dd-6edaf87075e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ScheduleOfShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValuationAssumptionsTableTextBlock_b04a2a8b-27b0-453b-b030-4f6577792b64" xlink:href="sibn-20230331.xsd#sibn_ScheduleOfShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6acf6cf2-b3a4-4f27-9d39-ca0f1192f949" xlink:to="loc_sibn_ScheduleOfShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValuationAssumptionsTableTextBlock_b04a2a8b-27b0-453b-b030-4f6577792b64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_ed91787b-eb0f-45a6-9b6b-571231a5b38c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6acf6cf2-b3a4-4f27-9d39-ca0f1192f949" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_ed91787b-eb0f-45a6-9b6b-571231a5b38c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock_c6f8e48b-2a22-4fe5-9ada-8f428276317c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6acf6cf2-b3a4-4f27-9d39-ca0f1192f949" xlink:to="loc_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock_c6f8e48b-2a22-4fe5-9ada-8f428276317c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_385fb25d-4c1d-4b07-b97a-114480f076e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6acf6cf2-b3a4-4f27-9d39-ca0f1192f949" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_385fb25d-4c1d-4b07-b97a-114480f076e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/NetLossPerShareofCommonStockTables" xlink:type="simple" xlink:href="sibn-20230331.xsd#NetLossPerShareofCommonStockTables"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/NetLossPerShareofCommonStockTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_68e5e97e-1267-46d1-b626-79d4e53cebaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_24447d14-40c1-4f3c-8f10-934413d195da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_68e5e97e-1267-46d1-b626-79d4e53cebaf" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_24447d14-40c1-4f3c-8f10-934413d195da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_57466159-c715-44f7-801e-a69c0063e6d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_68e5e97e-1267-46d1-b626-79d4e53cebaf" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_57466159-c715-44f7-801e-a69c0063e6d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="sibn-20230331.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_57d7b9e8-8017-46a0-88ff-1bf32094ecce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_NumberOfBusinessActivities_01e09aca-33eb-40eb-af83-1aae4f208f65" xlink:href="sibn-20230331.xsd#sibn_NumberOfBusinessActivities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_57d7b9e8-8017-46a0-88ff-1bf32094ecce" xlink:to="loc_sibn_NumberOfBusinessActivities_01e09aca-33eb-40eb-af83-1aae4f208f65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/SummaryofSignificantAccountingPoliciesRevenuebyGeographyDetails" xlink:type="simple" xlink:href="sibn-20230331.xsd#SummaryofSignificantAccountingPoliciesRevenuebyGeographyDetails"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/SummaryofSignificantAccountingPoliciesRevenuebyGeographyDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_2c23a0f3-dbfe-41b6-b7f6-8814dc4cae91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_6c1f863d-301c-45a9-86d9-b3e1b3c0ae44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2c23a0f3-dbfe-41b6-b7f6-8814dc4cae91" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_6c1f863d-301c-45a9-86d9-b3e1b3c0ae44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_ff6d9428-12cf-4f31-95de-8a67353c32b3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_6c1f863d-301c-45a9-86d9-b3e1b3c0ae44" xlink:to="loc_srt_StatementGeographicalAxis_ff6d9428-12cf-4f31-95de-8a67353c32b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_46e283d6-576e-4d74-80c2-32bf56c4c5d7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_ff6d9428-12cf-4f31-95de-8a67353c32b3" xlink:to="loc_srt_SegmentGeographicalDomain_46e283d6-576e-4d74-80c2-32bf56c4c5d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_a44d574f-326f-41af-8cb5-edc37dbf22f4" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_46e283d6-576e-4d74-80c2-32bf56c4c5d7" xlink:to="loc_country_US_a44d574f-326f-41af-8cb5-edc37dbf22f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_7da4e697-4f1a-475d-b781-473ccf21f87b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_46e283d6-576e-4d74-80c2-32bf56c4c5d7" xlink:to="loc_us-gaap_NonUsMember_7da4e697-4f1a-475d-b781-473ccf21f87b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_6f932919-47e0-4e48-9f46-e6017888b783" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_6c1f863d-301c-45a9-86d9-b3e1b3c0ae44" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_6f932919-47e0-4e48-9f46-e6017888b783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_bbad471a-ba9d-4071-8313-ddcdac0ef7a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_6f932919-47e0-4e48-9f46-e6017888b783" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_bbad471a-ba9d-4071-8313-ddcdac0ef7a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails" xlink:type="simple" xlink:href="sibn-20230331.xsd#MarketableSecuritiesScheduleofMarketableSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_233c493e-7dca-44ae-a38b-9dc064d4e280" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTable_ec0cd58b-2a65-4892-ad16-010459bd6a5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_233c493e-7dca-44ae-a38b-9dc064d4e280" xlink:to="loc_us-gaap_MarketableSecuritiesTable_ec0cd58b-2a65-4892-ad16-010459bd6a5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_74705183-a45d-4df4-9322-e745d7975d96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesTable_ec0cd58b-2a65-4892-ad16-010459bd6a5e" xlink:to="loc_us-gaap_FinancialInstrumentAxis_74705183-a45d-4df4-9322-e745d7975d96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e1aeea70-fc0a-4f2b-b065-96d4ca045746" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_74705183-a45d-4df4-9322-e745d7975d96" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e1aeea70-fc0a-4f2b-b065-96d4ca045746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_ab1b2be7-f2c5-4938-ad3f-0445320688b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e1aeea70-fc0a-4f2b-b065-96d4ca045746" xlink:to="loc_us-gaap_MoneyMarketFundsMember_ab1b2be7-f2c5-4938-ad3f-0445320688b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_9ec5758e-da75-4934-9841-875a6419af9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e1aeea70-fc0a-4f2b-b065-96d4ca045746" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_9ec5758e-da75-4934-9841-875a6419af9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_e003e00f-7697-4817-a72c-0c045ca273ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e1aeea70-fc0a-4f2b-b065-96d4ca045746" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_e003e00f-7697-4817-a72c-0c045ca273ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_9d2355fa-de25-4b8c-84ba-2134731791a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e1aeea70-fc0a-4f2b-b065-96d4ca045746" xlink:to="loc_us-gaap_CommercialPaperMember_9d2355fa-de25-4b8c-84ba-2134731791a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_1d2b3893-bc99-4cc0-a347-894dfce535b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e1aeea70-fc0a-4f2b-b065-96d4ca045746" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_1d2b3893-bc99-4cc0-a347-894dfce535b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesLineItems_de639f07-ad53-4fd9-8272-713a044b52a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesTable_ec0cd58b-2a65-4892-ad16-010459bd6a5e" xlink:to="loc_us-gaap_MarketableSecuritiesLineItems_de639f07-ad53-4fd9-8272-713a044b52a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValueAbstract_b7a3d8bc-e01f-40ee-94f4-aa4050ecc337" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsAtCarryingValueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_de639f07-ad53-4fd9-8272-713a044b52a5" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValueAbstract_b7a3d8bc-e01f-40ee-94f4-aa4050ecc337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_2bb2934c-fa15-47d4-83b8-1f886a5b0ce4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashEquivalentsAtCarryingValueAbstract_b7a3d8bc-e01f-40ee-94f4-aa4050ecc337" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_2bb2934c-fa15-47d4-83b8-1f886a5b0ce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_8d0f4cd3-b002-4bee-badb-2b54032d9a42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_de639f07-ad53-4fd9-8272-713a044b52a5" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_8d0f4cd3-b002-4bee-badb-2b54032d9a42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss_7958aab7-295b-432a-a600-54d43893e8c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_8d0f4cd3-b002-4bee-badb-2b54032d9a42" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss_7958aab7-295b-432a-a600-54d43893e8c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_a1929e5b-5e84-4751-b624-ff3a7f36ebd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_8d0f4cd3-b002-4bee-badb-2b54032d9a42" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_a1929e5b-5e84-4751-b624-ff3a7f36ebd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_19b82346-25c2-4a8c-9626-a22c92c6cf3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_8d0f4cd3-b002-4bee-badb-2b54032d9a42" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_19b82346-25c2-4a8c-9626-a22c92c6cf3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_f868ac28-984a-413a-9a1f-29d2ca3c6ff0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_8d0f4cd3-b002-4bee-badb-2b54032d9a42" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_f868ac28-984a-413a-9a1f-29d2ca3c6ff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_MarketableSecuritiesAmortizedCost_aa9c4d4a-ac54-4301-8b30-a3b564cbd124" xlink:href="sibn-20230331.xsd#sibn_MarketableSecuritiesAmortizedCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_de639f07-ad53-4fd9-8272-713a044b52a5" xlink:to="loc_sibn_MarketableSecuritiesAmortizedCost_aa9c4d4a-ac54-4301-8b30-a3b564cbd124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_60c3660a-1850-44d2-a2a6-ea041e7344c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_de639f07-ad53-4fd9-8272-713a044b52a5" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_60c3660a-1850-44d2-a2a6-ea041e7344c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/MarketableSecuritiesNarrativeDetails" xlink:type="simple" xlink:href="sibn-20230331.xsd#MarketableSecuritiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/MarketableSecuritiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_24b94b4d-d220-4c85-8a2b-214b1d7fc10f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest_a2e66887-3f53-4d03-99e7-d45730a2e42c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_24b94b4d-d220-4c85-8a2b-214b1d7fc10f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest_a2e66887-3f53-4d03-99e7-d45730a2e42c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss_f6a2790d-db95-40f5-8177-737557fe21ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_24b94b4d-d220-4c85-8a2b-214b1d7fc10f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss_f6a2790d-db95-40f5-8177-737557fe21ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestWriteoff_4c77faaa-b258-4423-a9df-995d7c0953a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestWriteoff"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_24b94b4d-d220-4c85-8a2b-214b1d7fc10f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestWriteoff_4c77faaa-b258-4423-a9df-995d7c0953a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/FairValueMeasurementDetails" xlink:type="simple" xlink:href="sibn-20230331.xsd#FairValueMeasurementDetails"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/FairValueMeasurementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_274ec5f5-5d58-4047-8554-bc833b637df6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f81370c7-a60e-4655-bdd2-6fcb29fb443b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_274ec5f5-5d58-4047-8554-bc833b637df6" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f81370c7-a60e-4655-bdd2-6fcb29fb443b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_9bb0688c-ad26-4e80-8bec-850136a3174c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f81370c7-a60e-4655-bdd2-6fcb29fb443b" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_9bb0688c-ad26-4e80-8bec-850136a3174c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_0c5f0a76-9ebc-4c38-9ec4-45e0e44b61cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_9bb0688c-ad26-4e80-8bec-850136a3174c" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_0c5f0a76-9ebc-4c38-9ec4-45e0e44b61cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_e6663e82-151b-4e8f-966f-c639fcddf1ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_0c5f0a76-9ebc-4c38-9ec4-45e0e44b61cf" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_e6663e82-151b-4e8f-966f-c639fcddf1ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a40e27e9-9c19-44f8-835a-c2a74f2ed47c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f81370c7-a60e-4655-bdd2-6fcb29fb443b" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a40e27e9-9c19-44f8-835a-c2a74f2ed47c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_196555c3-9f76-4b3e-806b-c8ab8ce1143d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a40e27e9-9c19-44f8-835a-c2a74f2ed47c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_196555c3-9f76-4b3e-806b-c8ab8ce1143d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_89539c7b-2772-4ef9-998c-ec8d66243e32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_196555c3-9f76-4b3e-806b-c8ab8ce1143d" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_89539c7b-2772-4ef9-998c-ec8d66243e32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_df2bfbe3-ead8-4ab9-90a1-83b2b35edd91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_196555c3-9f76-4b3e-806b-c8ab8ce1143d" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_df2bfbe3-ead8-4ab9-90a1-83b2b35edd91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_357b4564-975f-4ef7-8fdc-44178741fd5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_196555c3-9f76-4b3e-806b-c8ab8ce1143d" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_357b4564-975f-4ef7-8fdc-44178741fd5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_8e801c7b-e6c4-46d1-8631-4d83897ec6f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f81370c7-a60e-4655-bdd2-6fcb29fb443b" xlink:to="loc_us-gaap_FinancialInstrumentAxis_8e801c7b-e6c4-46d1-8631-4d83897ec6f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3fed2871-5fc5-406a-afbd-dad45b7b4ba9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_8e801c7b-e6c4-46d1-8631-4d83897ec6f9" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3fed2871-5fc5-406a-afbd-dad45b7b4ba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_ec1d1353-55d0-4037-8081-40d984b1b2ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3fed2871-5fc5-406a-afbd-dad45b7b4ba9" xlink:to="loc_us-gaap_MoneyMarketFundsMember_ec1d1353-55d0-4037-8081-40d984b1b2ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_38c23861-2d16-4249-8884-cba63c18187a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3fed2871-5fc5-406a-afbd-dad45b7b4ba9" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_38c23861-2d16-4249-8884-cba63c18187a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_88b5199c-e7de-4df8-98b5-1a17779077cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3fed2871-5fc5-406a-afbd-dad45b7b4ba9" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_88b5199c-e7de-4df8-98b5-1a17779077cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_cea0f405-be28-485a-925d-56ebc86925a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3fed2871-5fc5-406a-afbd-dad45b7b4ba9" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_cea0f405-be28-485a-925d-56ebc86925a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_0e1b7295-d91d-4fb4-b5f7-33d7678f31cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3fed2871-5fc5-406a-afbd-dad45b7b4ba9" xlink:to="loc_us-gaap_CommercialPaperMember_0e1b7295-d91d-4fb4-b5f7-33d7678f31cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8075497c-9020-4b48-aa39-033eaa5edcf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f81370c7-a60e-4655-bdd2-6fcb29fb443b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8075497c-9020-4b48-aa39-033eaa5edcf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_06f823f5-5a9b-4685-a135-373e1c404baa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8075497c-9020-4b48-aa39-033eaa5edcf3" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_06f823f5-5a9b-4685-a135-373e1c404baa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_e304e61c-9e67-4c6f-8011-a970cbd4c1ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_06f823f5-5a9b-4685-a135-373e1c404baa" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_e304e61c-9e67-4c6f-8011-a970cbd4c1ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/BalanceSheetComponentsNarrativeDetails" xlink:type="simple" xlink:href="sibn-20230331.xsd#BalanceSheetComponentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/BalanceSheetComponentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4beb0d20-4f3a-4ce9-8eb6-936542ad64a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ac0174f8-af7e-4aa2-9875-8e5f86365445" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4beb0d20-4f3a-4ce9-8eb6-936542ad64a2" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ac0174f8-af7e-4aa2-9875-8e5f86365445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d5bd59dd-9398-4f75-a277-abef42735297" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ac0174f8-af7e-4aa2-9875-8e5f86365445" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d5bd59dd-9398-4f75-a277-abef42735297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1bdbb5a5-9867-4f7c-bf8d-180e296d2a56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d5bd59dd-9398-4f75-a277-abef42735297" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1bdbb5a5-9867-4f7c-bf8d-180e296d2a56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ConstructionInProgressSurgicalPlacementInstrumentSetMember_89442908-d9d1-432b-950c-2c6312c2b5a2" xlink:href="sibn-20230331.xsd#sibn_ConstructionInProgressSurgicalPlacementInstrumentSetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1bdbb5a5-9867-4f7c-bf8d-180e296d2a56" xlink:to="loc_sibn_ConstructionInProgressSurgicalPlacementInstrumentSetMember_89442908-d9d1-432b-950c-2c6312c2b5a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ConstructionInProgressSantaClaraLeaseMember_b523971e-b666-4d65-9f25-a478da85b2f0" xlink:href="sibn-20230331.xsd#sibn_ConstructionInProgressSantaClaraLeaseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1bdbb5a5-9867-4f7c-bf8d-180e296d2a56" xlink:to="loc_sibn_ConstructionInProgressSantaClaraLeaseMember_b523971e-b666-4d65-9f25-a478da85b2f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7582b601-2a1f-47fd-a5cf-cd344f1b9f10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ac0174f8-af7e-4aa2-9875-8e5f86365445" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7582b601-2a1f-47fd-a5cf-cd344f1b9f10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_a041566a-7f22-43c1-933b-80d74cfc53ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7582b601-2a1f-47fd-a5cf-cd344f1b9f10" xlink:to="loc_us-gaap_InventoryFinishedGoods_a041566a-7f22-43c1-933b-80d74cfc53ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess_4321511c-b32e-4f62-972a-6e4a6c929869" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7582b601-2a1f-47fd-a5cf-cd344f1b9f10" xlink:to="loc_us-gaap_InventoryWorkInProcess_4321511c-b32e-4f62-972a-6e4a6c929869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_c287aae8-6748-461b-9b76-eea333e62b89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7582b601-2a1f-47fd-a5cf-cd344f1b9f10" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_c287aae8-6748-461b-9b76-eea333e62b89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_188c29cf-ae4c-44de-b05d-deaf86815afb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7582b601-2a1f-47fd-a5cf-cd344f1b9f10" xlink:to="loc_us-gaap_Depreciation_188c29cf-ae4c-44de-b05d-deaf86815afb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="sibn-20230331.xsd#BalanceSheetComponentsPropertyandEquipmentNetDetails"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a5d71a11-0134-4525-b0ed-a183b97f5ad0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4bd19718-a6f4-47f2-8148-c570bdfd1650" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a5d71a11-0134-4525-b0ed-a183b97f5ad0" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4bd19718-a6f4-47f2-8148-c570bdfd1650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_125de7d9-c054-44fa-9311-14d330bb72be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4bd19718-a6f4-47f2-8148-c570bdfd1650" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_125de7d9-c054-44fa-9311-14d330bb72be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_62a48284-8112-427a-a624-7b691daf38d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_125de7d9-c054-44fa-9311-14d330bb72be" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_62a48284-8112-427a-a624-7b691daf38d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_607842c2-36df-42a8-9fa2-45b474d280b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_62a48284-8112-427a-a624-7b691daf38d8" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_607842c2-36df-42a8-9fa2-45b474d280b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_87117d28-acf9-4282-877c-c3586b38fcd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_62a48284-8112-427a-a624-7b691daf38d8" xlink:to="loc_us-gaap_ConstructionInProgressMember_87117d28-acf9-4282-877c-c3586b38fcd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ComputerAndOfficeEquipmentMember_c7526cb4-bb3a-434b-82b6-54400d266c14" xlink:href="sibn-20230331.xsd#sibn_ComputerAndOfficeEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_62a48284-8112-427a-a624-7b691daf38d8" xlink:to="loc_sibn_ComputerAndOfficeEquipmentMember_c7526cb4-bb3a-434b-82b6-54400d266c14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_e8188575-0fae-44b7-9177-2cdf22c42e19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_62a48284-8112-427a-a624-7b691daf38d8" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_e8188575-0fae-44b7-9177-2cdf22c42e19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_8b1ad121-da9e-4545-80f8-fe55682db0d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_62a48284-8112-427a-a624-7b691daf38d8" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_8b1ad121-da9e-4545-80f8-fe55682db0d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8a2773ac-15b9-45da-a067-96fa282b2d6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4bd19718-a6f4-47f2-8148-c570bdfd1650" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8a2773ac-15b9-45da-a067-96fa282b2d6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_6cf1679e-43be-46ea-a653-890aaf45a64f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8a2773ac-15b9-45da-a067-96fa282b2d6f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_6cf1679e-43be-46ea-a653-890aaf45a64f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_9f6d417c-8a1a-4a11-9624-58534370ef09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8a2773ac-15b9-45da-a067-96fa282b2d6f" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_9f6d417c-8a1a-4a11-9624-58534370ef09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_aa9bb6eb-492a-446e-8396-57b4f0dd605d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8a2773ac-15b9-45da-a067-96fa282b2d6f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_aa9bb6eb-492a-446e-8396-57b4f0dd605d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/BalanceSheetComponentsAccruedLiabilitiesandOtherDetails" xlink:type="simple" xlink:href="sibn-20230331.xsd#BalanceSheetComponentsAccruedLiabilitiesandOtherDetails"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/BalanceSheetComponentsAccruedLiabilitiesandOtherDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_45d19236-00bc-42d4-a852-a6ea29a939d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_ab084f8b-d1ba-4238-b369-c745f653aa0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_45d19236-00bc-42d4-a852-a6ea29a939d0" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_ab084f8b-d1ba-4238-b369-c745f653aa0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_4bb8c2b4-490f-4e61-b0cb-f8232066714c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_ab084f8b-d1ba-4238-b369-c745f653aa0c" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_4bb8c2b4-490f-4e61-b0cb-f8232066714c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_d8a43ed6-c271-40ec-855b-5bf7ce73b8b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_ab084f8b-d1ba-4238-b369-c745f653aa0c" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_d8a43ed6-c271-40ec-855b-5bf7ce73b8b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_68eb6c70-2775-4f3f-b267-e8ec19a01a39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_ab084f8b-d1ba-4238-b369-c745f653aa0c" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_68eb6c70-2775-4f3f-b267-e8ec19a01a39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_792079b5-e0cc-46cc-a0eb-ebe9e72999bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_ab084f8b-d1ba-4238-b369-c745f653aa0c" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_792079b5-e0cc-46cc-a0eb-ebe9e72999bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_538cb5f4-2626-4649-931e-788e5180b739" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_ab084f8b-d1ba-4238-b369-c745f653aa0c" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_538cb5f4-2626-4649-931e-788e5180b739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/BalanceSheetComponentsAccountsReceivableandAllowanceforCreditLossesDetails" xlink:type="simple" xlink:href="sibn-20230331.xsd#BalanceSheetComponentsAccountsReceivableandAllowanceforCreditLossesDetails"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/BalanceSheetComponentsAccountsReceivableandAllowanceforCreditLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a24ed781-d7e9-4d25-aadb-1c0dc9ab1fb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_1c6830a3-3bc7-4dac-8bd3-7e2180919942" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a24ed781-d7e9-4d25-aadb-1c0dc9ab1fb4" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_1c6830a3-3bc7-4dac-8bd3-7e2180919942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_b7962731-dad1-404b-8a0b-b2016895eccf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_1c6830a3-3bc7-4dac-8bd3-7e2180919942" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_b7962731-dad1-404b-8a0b-b2016895eccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_7a3eb976-fdb0-4835-a1d1-c47648581ebc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_1c6830a3-3bc7-4dac-8bd3-7e2180919942" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_7a3eb976-fdb0-4835-a1d1-c47648581ebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_446232a5-eb03-441e-9749-570f7f7cfcee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_1c6830a3-3bc7-4dac-8bd3-7e2180919942" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_446232a5-eb03-441e-9749-570f7f7cfcee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_2bbce823-28ec-429e-b0dc-8ac027a97dbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_1c6830a3-3bc7-4dac-8bd3-7e2180919942" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_2bbce823-28ec-429e-b0dc-8ac027a97dbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/CommitmentandContingenciesSupplementalInformationRelatedtoLeaseExpenseDetails" xlink:type="simple" xlink:href="sibn-20230331.xsd#CommitmentandContingenciesSupplementalInformationRelatedtoLeaseExpenseDetails"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/CommitmentandContingenciesSupplementalInformationRelatedtoLeaseExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ce576fc0-f86f-4776-acfe-6eacb3d7e3b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_c7dff8ab-85c0-40c7-884e-57f32f304cbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ce576fc0-f86f-4776-acfe-6eacb3d7e3b8" xlink:to="loc_us-gaap_OperatingLeaseCost_c7dff8ab-85c0-40c7-884e-57f32f304cbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_56ee1f31-bd44-4aa1-accf-1ebbfd5cfad2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ce576fc0-f86f-4776-acfe-6eacb3d7e3b8" xlink:to="loc_us-gaap_VariableLeaseCost_56ee1f31-bd44-4aa1-accf-1ebbfd5cfad2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_0905c496-d56b-4aa3-9c56-0cb3e589416e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ce576fc0-f86f-4776-acfe-6eacb3d7e3b8" xlink:to="loc_us-gaap_LeaseCost_0905c496-d56b-4aa3-9c56-0cb3e589416e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_65433d3f-de2c-463a-bae4-7a0cfedf2b78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ce576fc0-f86f-4776-acfe-6eacb3d7e3b8" xlink:to="loc_us-gaap_OperatingLeasePayments_65433d3f-de2c-463a-bae4-7a0cfedf2b78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_d73bc47e-b056-4cbe-bb13-5338fa6c67f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ce576fc0-f86f-4776-acfe-6eacb3d7e3b8" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_d73bc47e-b056-4cbe-bb13-5338fa6c67f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_d4c74bad-f9f9-47b8-92c6-712f557d7243" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ce576fc0-f86f-4776-acfe-6eacb3d7e3b8" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_d4c74bad-f9f9-47b8-92c6-712f557d7243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_99dc619a-edb5-4579-a8b7-6d2b31c6d66f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ce576fc0-f86f-4776-acfe-6eacb3d7e3b8" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_99dc619a-edb5-4579-a8b7-6d2b31c6d66f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails" xlink:type="simple" xlink:href="sibn-20230331.xsd#CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8424328d-0cf0-4de7-89aa-3adfc8effa4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_969df7d4-83f5-421e-9df8-746f4c22b9bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8424328d-0cf0-4de7-89aa-3adfc8effa4b" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_969df7d4-83f5-421e-9df8-746f4c22b9bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_cabaa456-8d00-463a-8e4a-6f0aa52cbd53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_969df7d4-83f5-421e-9df8-746f4c22b9bf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_cabaa456-8d00-463a-8e4a-6f0aa52cbd53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_55008e24-cfce-43ca-ad9e-52ec7acfe5c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_969df7d4-83f5-421e-9df8-746f4c22b9bf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_55008e24-cfce-43ca-ad9e-52ec7acfe5c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_4a41c522-bf02-4476-b9b4-015a34f8e74e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_969df7d4-83f5-421e-9df8-746f4c22b9bf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_4a41c522-bf02-4476-b9b4-015a34f8e74e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_56505440-34e6-4392-bdee-7feeb5775b12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_969df7d4-83f5-421e-9df8-746f4c22b9bf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_56505440-34e6-4392-bdee-7feeb5775b12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_564b1272-13b6-49c3-b8b8-28664f8cd7fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_969df7d4-83f5-421e-9df8-746f4c22b9bf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_564b1272-13b6-49c3-b8b8-28664f8cd7fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_b4a10079-8052-4a16-9c0b-ab42a6784691" xlink:href="sibn-20230331.xsd#sibn_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_969df7d4-83f5-421e-9df8-746f4c22b9bf" xlink:to="loc_sibn_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_b4a10079-8052-4a16-9c0b-ab42a6784691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6c789144-dad7-41e9-83c9-62a3af3e60fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_969df7d4-83f5-421e-9df8-746f4c22b9bf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6c789144-dad7-41e9-83c9-62a3af3e60fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_4da8c39d-50f5-4cd5-b21c-3a41bbd08f29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_969df7d4-83f5-421e-9df8-746f4c22b9bf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_4da8c39d-50f5-4cd5-b21c-3a41bbd08f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_34f98e6b-466c-43b1-8994-05a269fda22e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_969df7d4-83f5-421e-9df8-746f4c22b9bf" xlink:to="loc_us-gaap_OperatingLeaseLiability_34f98e6b-466c-43b1-8994-05a269fda22e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails_1" xlink:type="simple" xlink:href="sibn-20230331.xsd#CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails_1"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://si-bone.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="simple" xlink:href="sibn-20230331.xsd#CommitmentsandContingenciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_34daf86c-4411-43c5-90ac-00011b34416d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_a3bd7231-2a70-4f43-9d9c-c4b5c9801028" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_34daf86c-4411-43c5-90ac-00011b34416d" xlink:to="loc_us-gaap_OtherCommitmentsTable_a3bd7231-2a70-4f43-9d9c-c4b5c9801028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_05a70a78-8d16-4f9f-941d-733a9c83f5e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_a3bd7231-2a70-4f43-9d9c-c4b5c9801028" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_05a70a78-8d16-4f9f-941d-733a9c83f5e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_64fb8cc2-4021-4f6b-97c5-6368cf63f18e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_05a70a78-8d16-4f9f-941d-733a9c83f5e9" xlink:to="loc_us-gaap_LossContingencyNatureDomain_64fb8cc2-4021-4f6b-97c5-6368cf63f18e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndemnificationGuaranteeMember_cf578d42-0f8b-487e-ae34-d3bf54def76c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndemnificationGuaranteeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_64fb8cc2-4021-4f6b-97c5-6368cf63f18e" xlink:to="loc_us-gaap_IndemnificationGuaranteeMember_cf578d42-0f8b-487e-ae34-d3bf54def76c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_4333806d-ffbc-44bc-9803-c2b5e410d6ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_a3bd7231-2a70-4f43-9d9c-c4b5c9801028" xlink:to="loc_us-gaap_OtherCommitmentsLineItems_4333806d-ffbc-44bc-9803-c2b5e410d6ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_LesseeOperatingLeaseLeaseNotYetCommencedLiability_a3cadbb5-3de6-42ed-9d40-313e88dbd8b5" xlink:href="sibn-20230331.xsd#sibn_LesseeOperatingLeaseLeaseNotYetCommencedLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_4333806d-ffbc-44bc-9803-c2b5e410d6ca" xlink:to="loc_sibn_LesseeOperatingLeaseLeaseNotYetCommencedLiability_a3cadbb5-3de6-42ed-9d40-313e88dbd8b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligation_fca24ce5-db40-4361-8e26-152924db3f5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PurchaseObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_4333806d-ffbc-44bc-9803-c2b5e410d6ca" xlink:to="loc_us-gaap_PurchaseObligation_fca24ce5-db40-4361-8e26-152924db3f5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_0f568204-b53a-48ba-8a2f-0b729eb65d35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_4333806d-ffbc-44bc-9803-c2b5e410d6ca" xlink:to="loc_us-gaap_LitigationSettlementExpense_0f568204-b53a-48ba-8a2f-0b729eb65d35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_d3b9527f-fce3-4fb5-819a-2d7850184b36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserve"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_4333806d-ffbc-44bc-9803-c2b5e410d6ca" xlink:to="loc_us-gaap_LitigationReserve_d3b9527f-fce3-4fb5-819a-2d7850184b36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/BorrowingsSummaryofBorrowingsDetails" xlink:type="simple" xlink:href="sibn-20230331.xsd#BorrowingsSummaryofBorrowingsDetails"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/BorrowingsSummaryofBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ab3b9f76-d47d-4a47-b81b-557e7ddef07c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_a09f40fc-8dcb-4c4f-af91-0b8a768c8cc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ab3b9f76-d47d-4a47-b81b-557e7ddef07c" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_a09f40fc-8dcb-4c4f-af91-0b8a768c8cc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_334f30b8-e740-4473-9742-e0bc766a23a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ab3b9f76-d47d-4a47-b81b-557e7ddef07c" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_334f30b8-e740-4473-9742-e0bc766a23a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount_e30015b1-49f7-472f-ac78-19e5aa9cc886" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ab3b9f76-d47d-4a47-b81b-557e7ddef07c" xlink:to="loc_us-gaap_DebtInstrumentFeeAmount_e30015b1-49f7-472f-ac78-19e5aa9cc886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_7bed3750-5abc-4639-8e71-bdd9b3264d12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ab3b9f76-d47d-4a47-b81b-557e7ddef07c" xlink:to="loc_us-gaap_LongTermDebt_7bed3750-5abc-4639-8e71-bdd9b3264d12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_14777981-2404-4ae0-8bd0-f1b467e01a66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ab3b9f76-d47d-4a47-b81b-557e7ddef07c" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_14777981-2404-4ae0-8bd0-f1b467e01a66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/BorrowingsNarrativeDetails" xlink:type="simple" xlink:href="sibn-20230331.xsd#BorrowingsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/BorrowingsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_1b94d2c5-6109-4c3b-a4ec-ce609c306312" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_05b2a325-7780-4305-b1bb-182a10ba52ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1b94d2c5-6109-4c3b-a4ec-ce609c306312" xlink:to="loc_us-gaap_DebtInstrumentTable_05b2a325-7780-4305-b1bb-182a10ba52ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8aefc798-34de-4c41-b759-b787b187f9c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_05b2a325-7780-4305-b1bb-182a10ba52ec" xlink:to="loc_us-gaap_DebtInstrumentAxis_8aefc798-34de-4c41-b759-b787b187f9c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_85aabf4c-ff7f-4baa-8a73-254f4a25f376" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_8aefc798-34de-4c41-b759-b787b187f9c8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_85aabf4c-ff7f-4baa-8a73-254f4a25f376" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_SVBTermLoanMember_ea9e8227-957f-462d-8b72-746ca9f97a13" xlink:href="sibn-20230331.xsd#sibn_SVBTermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_85aabf4c-ff7f-4baa-8a73-254f4a25f376" xlink:to="loc_sibn_SVBTermLoanMember_ea9e8227-957f-462d-8b72-746ca9f97a13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_SVBAmendedTermLoanMember_650ce17d-f357-45e6-ab95-a00598550273" xlink:href="sibn-20230331.xsd#sibn_SVBAmendedTermLoanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_85aabf4c-ff7f-4baa-8a73-254f4a25f376" xlink:to="loc_sibn_SVBAmendedTermLoanMember_650ce17d-f357-45e6-ab95-a00598550273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_SolarLoanAndSecurityAgreementMember_1054d38c-e653-4702-8508-bcbbebbae7a6" xlink:href="sibn-20230331.xsd#sibn_SolarLoanAndSecurityAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_85aabf4c-ff7f-4baa-8a73-254f4a25f376" xlink:to="loc_sibn_SolarLoanAndSecurityAgreementMember_1054d38c-e653-4702-8508-bcbbebbae7a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_274d0f25-ba58-4860-94b8-67faad778144" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_05b2a325-7780-4305-b1bb-182a10ba52ec" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_274d0f25-ba58-4860-94b8-67faad778144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ea923f93-5ae8-4222-ba5c-9ba5e66e0811" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_274d0f25-ba58-4860-94b8-67faad778144" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ea923f93-5ae8-4222-ba5c-9ba5e66e0811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_a9da7dab-2ba4-4f2c-bcfd-1f3796a6fdb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ea923f93-5ae8-4222-ba5c-9ba5e66e0811" xlink:to="loc_us-gaap_SecuredDebtMember_a9da7dab-2ba4-4f2c-bcfd-1f3796a6fdb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_bb15716f-c2c4-4772-a9c0-8e1eb9ed830b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ea923f93-5ae8-4222-ba5c-9ba5e66e0811" xlink:to="loc_us-gaap_LineOfCreditMember_bb15716f-c2c4-4772-a9c0-8e1eb9ed830b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_e556c148-a08e-496f-8e72-ec09476291c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_05b2a325-7780-4305-b1bb-182a10ba52ec" xlink:to="loc_us-gaap_CreditFacilityAxis_e556c148-a08e-496f-8e72-ec09476291c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_0ed16cf6-b442-49f2-90a3-d2e52c81d114" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_e556c148-a08e-496f-8e72-ec09476291c7" xlink:to="loc_us-gaap_CreditFacilityDomain_0ed16cf6-b442-49f2-90a3-d2e52c81d114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_431d339d-4457-4cfa-9838-363d19fab029" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_0ed16cf6-b442-49f2-90a3-d2e52c81d114" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_431d339d-4457-4cfa-9838-363d19fab029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_dd7fd065-db5e-4d70-996b-20cadf8dc843" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_05b2a325-7780-4305-b1bb-182a10ba52ec" xlink:to="loc_srt_RangeAxis_dd7fd065-db5e-4d70-996b-20cadf8dc843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_da5ce524-6b2d-4e27-851a-86ae6c5b06c3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_dd7fd065-db5e-4d70-996b-20cadf8dc843" xlink:to="loc_srt_RangeMember_da5ce524-6b2d-4e27-851a-86ae6c5b06c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_37a6df95-93b3-43b7-a1eb-323896af3f97" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_da5ce524-6b2d-4e27-851a-86ae6c5b06c3" xlink:to="loc_srt_MinimumMember_37a6df95-93b3-43b7-a1eb-323896af3f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2641e5ae-2260-4aa2-aae6-d02deb39612e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_da5ce524-6b2d-4e27-851a-86ae6c5b06c3" xlink:to="loc_srt_MaximumMember_2641e5ae-2260-4aa2-aae6-d02deb39612e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_cc46bafc-17fb-4610-b176-9ea43db1abf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_05b2a325-7780-4305-b1bb-182a10ba52ec" xlink:to="loc_us-gaap_DebtInstrumentLineItems_cc46bafc-17fb-4610-b176-9ea43db1abf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_973852c0-5eb1-4b3a-a10a-ed65554af67f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cc46bafc-17fb-4610-b176-9ea43db1abf8" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_973852c0-5eb1-4b3a-a10a-ed65554af67f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfSecuredDebt_cb8db7e1-6b81-472f-9a0d-245d60789863" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfSecuredDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cc46bafc-17fb-4610-b176-9ea43db1abf8" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfSecuredDebt_cb8db7e1-6b81-472f-9a0d-245d60789863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_87ffb6d7-9d9b-4513-a681-4d703fba1987" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cc46bafc-17fb-4610-b176-9ea43db1abf8" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_87ffb6d7-9d9b-4513-a681-4d703fba1987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_LineOfCreditFacilityAccordionFeatureIncreaseLimit_de10a46c-b75f-42a3-9286-18e4892682c9" xlink:href="sibn-20230331.xsd#sibn_LineOfCreditFacilityAccordionFeatureIncreaseLimit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cc46bafc-17fb-4610-b176-9ea43db1abf8" xlink:to="loc_sibn_LineOfCreditFacilityAccordionFeatureIncreaseLimit_de10a46c-b75f-42a3-9286-18e4892682c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_f761ac57-2429-4f7f-8a78-cbc3bc69acf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cc46bafc-17fb-4610-b176-9ea43db1abf8" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_f761ac57-2429-4f7f-8a78-cbc3bc69acf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal_7f1bd52a-72e5-45cd-80f4-4c592a7f64ca" xlink:href="sibn-20230331.xsd#sibn_DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cc46bafc-17fb-4610-b176-9ea43db1abf8" xlink:to="loc_sibn_DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal_7f1bd52a-72e5-45cd-80f4-4c592a7f64ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_DebtInstrumentAccountsReceivableBorrowingBase_5a736a44-fb98-46e8-a468-c5db29e872f8" xlink:href="sibn-20230331.xsd#sibn_DebtInstrumentAccountsReceivableBorrowingBase"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cc46bafc-17fb-4610-b176-9ea43db1abf8" xlink:to="loc_sibn_DebtInstrumentAccountsReceivableBorrowingBase_5a736a44-fb98-46e8-a468-c5db29e872f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_51fe6067-2c8c-4841-8c7a-246ac7062d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cc46bafc-17fb-4610-b176-9ea43db1abf8" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_51fe6067-2c8c-4841-8c7a-246ac7062d1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_DebtInstrumentCovenantAdjustedQuickRatioMinimum_402ec14a-30a2-40c7-bf4a-66901e369c85" xlink:href="sibn-20230331.xsd#sibn_DebtInstrumentCovenantAdjustedQuickRatioMinimum"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cc46bafc-17fb-4610-b176-9ea43db1abf8" xlink:to="loc_sibn_DebtInstrumentCovenantAdjustedQuickRatioMinimum_402ec14a-30a2-40c7-bf4a-66901e369c85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_8c8d2d51-a3de-4e75-a9db-da35c385e527" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeAmount"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cc46bafc-17fb-4610-b176-9ea43db1abf8" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_8c8d2d51-a3de-4e75-a9db-da35c385e527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_LineOfCreditFacilityContingentCommitmentFeeAmount_bec2e3ed-b148-488c-83b7-dd2d4ad1c591" xlink:href="sibn-20230331.xsd#sibn_LineOfCreditFacilityContingentCommitmentFeeAmount"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cc46bafc-17fb-4610-b176-9ea43db1abf8" xlink:to="loc_sibn_LineOfCreditFacilityContingentCommitmentFeeAmount_bec2e3ed-b148-488c-83b7-dd2d4ad1c591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_c57088d0-eb6a-45fb-9cf0-f5fa9102abc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cc46bafc-17fb-4610-b176-9ea43db1abf8" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_c57088d0-eb6a-45fb-9cf0-f5fa9102abc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_DebtInstrumentInterestRateIncreaseDueToDefault_89262a0b-fe6e-4055-9f93-5008d279a071" xlink:href="sibn-20230331.xsd#sibn_DebtInstrumentInterestRateIncreaseDueToDefault"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cc46bafc-17fb-4610-b176-9ea43db1abf8" xlink:to="loc_sibn_DebtInstrumentInterestRateIncreaseDueToDefault_89262a0b-fe6e-4055-9f93-5008d279a071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/BorrowingsDebtMaturityDetails" xlink:type="simple" xlink:href="sibn-20230331.xsd#BorrowingsDebtMaturityDetails"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/BorrowingsDebtMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_775b0a5c-5a81-445e-b8e0-9d7dfc875b60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_7f78a586-9efb-4a2e-84bf-db80aaecf941" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaturitiesOfLongTermDebtAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_775b0a5c-5a81-445e-b8e0-9d7dfc875b60" xlink:to="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_7f78a586-9efb-4a2e-84bf-db80aaecf941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_12fcc991-d11e-4659-a9f1-3145c257e551" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_7f78a586-9efb-4a2e-84bf-db80aaecf941" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_12fcc991-d11e-4659-a9f1-3145c257e551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_b07c6ba5-e530-4f67-87dd-9c2e1b34cae7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_7f78a586-9efb-4a2e-84bf-db80aaecf941" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_b07c6ba5-e530-4f67-87dd-9c2e1b34cae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_5062e7b0-c050-4287-b75d-6ddbea68b7bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_7f78a586-9efb-4a2e-84bf-db80aaecf941" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_5062e7b0-c050-4287-b75d-6ddbea68b7bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_aed0f80f-205c-4600-97de-d09ea086c565" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_7f78a586-9efb-4a2e-84bf-db80aaecf941" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_aed0f80f-205c-4600-97de-d09ea086c565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_6afd9a8c-3007-41fa-856c-7356fb7f91fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_7f78a586-9efb-4a2e-84bf-db80aaecf941" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_6afd9a8c-3007-41fa-856c-7356fb7f91fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_6e8659d6-19c4-42e2-8b6a-9e872a6e1111" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_7f78a586-9efb-4a2e-84bf-db80aaecf941" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_6e8659d6-19c4-42e2-8b6a-9e872a6e1111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockOptionActivityDetails" xlink:type="simple" xlink:href="sibn-20230331.xsd#StockBasedIncentiveCompensationPlansStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_113eba80-fd78-4fd2-a76b-394fbffeb640" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_47010022-07d9-4811-9938-7d0998970702" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_113eba80-fd78-4fd2-a76b-394fbffeb640" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_47010022-07d9-4811-9938-7d0998970702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c2a4b5ee-3aa9-40be-896d-ff7d7aba2a6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_47010022-07d9-4811-9938-7d0998970702" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c2a4b5ee-3aa9-40be-896d-ff7d7aba2a6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_209a5dc6-de1b-482a-8e18-e0b35a6380d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_47010022-07d9-4811-9938-7d0998970702" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_209a5dc6-de1b-482a-8e18-e0b35a6380d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_34516b05-2a3c-475a-97c3-65d3460c667a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_47010022-07d9-4811-9938-7d0998970702" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_34516b05-2a3c-475a-97c3-65d3460c667a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_557084ef-667e-4530-bcc7-190d1d584d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_47010022-07d9-4811-9938-7d0998970702" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_557084ef-667e-4530-bcc7-190d1d584d8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_da404719-d575-451b-a663-4f83c617412a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_113eba80-fd78-4fd2-a76b-394fbffeb640" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_da404719-d575-451b-a663-4f83c617412a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_529cede9-3d29-427a-b2ac-1fe62d23a1c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_da404719-d575-451b-a663-4f83c617412a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_529cede9-3d29-427a-b2ac-1fe62d23a1c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_12126275-c484-4a75-9540-a59d90d3814b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_da404719-d575-451b-a663-4f83c617412a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_12126275-c484-4a75-9540-a59d90d3814b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_00b23792-6fb9-47e5-8cac-5fa391bd66d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_da404719-d575-451b-a663-4f83c617412a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_00b23792-6fb9-47e5-8cac-5fa391bd66d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_394f7be3-c98c-41e1-9979-72346b7c6352" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_da404719-d575-451b-a663-4f83c617412a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_394f7be3-c98c-41e1-9979-72346b7c6352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails" xlink:type="simple" xlink:href="sibn-20230331.xsd#StockBasedIncentiveCompensationPlansNarrativeDetails"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f01f74d1-599e-499b-892a-9004948fc708" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a1a635a8-c2f5-4cd4-80a5-f2ddbbe34fea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f01f74d1-599e-499b-892a-9004948fc708" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a1a635a8-c2f5-4cd4-80a5-f2ddbbe34fea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_07c734b9-c597-4037-81d9-0499ccbdd6ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a1a635a8-c2f5-4cd4-80a5-f2ddbbe34fea" xlink:to="loc_us-gaap_PlanNameAxis_07c734b9-c597-4037-81d9-0499ccbdd6ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_cdb3c834-d250-4095-b984-58aa41d37495" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_07c734b9-c597-4037-81d9-0499ccbdd6ae" xlink:to="loc_us-gaap_PlanNameDomain_cdb3c834-d250-4095-b984-58aa41d37495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_A2018EmployeeStockPurchasePlanMember_8859342f-c4f9-43eb-897b-d11545071ebb" xlink:href="sibn-20230331.xsd#sibn_A2018EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_cdb3c834-d250-4095-b984-58aa41d37495" xlink:to="loc_sibn_A2018EmployeeStockPurchasePlanMember_8859342f-c4f9-43eb-897b-d11545071ebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_beebb42f-92f5-432d-9776-83c907d567f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a1a635a8-c2f5-4cd4-80a5-f2ddbbe34fea" xlink:to="loc_us-gaap_AwardTypeAxis_beebb42f-92f5-432d-9776-83c907d567f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6c4c4dc0-cbc4-44dd-861c-eefff6537d68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_beebb42f-92f5-432d-9776-83c907d567f8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6c4c4dc0-cbc4-44dd-861c-eefff6537d68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_9bd87c8d-e5f3-447c-93d2-684c62e114cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6c4c4dc0-cbc4-44dd-861c-eefff6537d68" xlink:to="loc_us-gaap_EmployeeStockOptionMember_9bd87c8d-e5f3-447c-93d2-684c62e114cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_59203a57-b620-4aed-938f-1240cd3b3c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6c4c4dc0-cbc4-44dd-861c-eefff6537d68" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_59203a57-b620-4aed-938f-1240cd3b3c4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_7a61f6db-0614-466d-9031-1e700fdab34e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6c4c4dc0-cbc4-44dd-861c-eefff6537d68" xlink:to="loc_us-gaap_PerformanceSharesMember_7a61f6db-0614-466d-9031-1e700fdab34e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f18f24d7-6757-43bd-a6d2-4afe80cd92c2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a1a635a8-c2f5-4cd4-80a5-f2ddbbe34fea" xlink:to="loc_srt_RangeAxis_f18f24d7-6757-43bd-a6d2-4afe80cd92c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6c0b2e23-59aa-43fd-bc33-6b0ddbc662b8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_f18f24d7-6757-43bd-a6d2-4afe80cd92c2" xlink:to="loc_srt_RangeMember_6c0b2e23-59aa-43fd-bc33-6b0ddbc662b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8e63d749-ed83-4555-8e94-e56a0ff9cd8a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6c0b2e23-59aa-43fd-bc33-6b0ddbc662b8" xlink:to="loc_srt_MinimumMember_8e63d749-ed83-4555-8e94-e56a0ff9cd8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d6a7c679-a7e4-449f-b528-3974d1b52150" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6c0b2e23-59aa-43fd-bc33-6b0ddbc662b8" xlink:to="loc_srt_MaximumMember_d6a7c679-a7e4-449f-b528-3974d1b52150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_131e44e3-f3d3-4a86-b5de-17862fdf2628" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a1a635a8-c2f5-4cd4-80a5-f2ddbbe34fea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_131e44e3-f3d3-4a86-b5de-17862fdf2628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0ae17600-16eb-460d-b667-da5cfc2979d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_131e44e3-f3d3-4a86-b5de-17862fdf2628" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0ae17600-16eb-460d-b667-da5cfc2979d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_7b24662b-5abc-44e5-b146-288869f843ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_131e44e3-f3d3-4a86-b5de-17862fdf2628" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_7b24662b-5abc-44e5-b146-288869f843ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase_a34fc2e7-affa-4e13-992a-86a36b2fffbe" xlink:href="sibn-20230331.xsd#sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_131e44e3-f3d3-4a86-b5de-17862fdf2628" xlink:to="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase_a34fc2e7-affa-4e13-992a-86a36b2fffbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_539c5cbd-d0f4-413d-974d-430609389545" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_131e44e3-f3d3-4a86-b5de-17862fdf2628" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_539c5cbd-d0f4-413d-974d-430609389545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_445905cc-3d66-4cfd-8895-88c0e63608c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_131e44e3-f3d3-4a86-b5de-17862fdf2628" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_445905cc-3d66-4cfd-8895-88c0e63608c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_148e0807-cded-4924-a69c-0062bfa703f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_131e44e3-f3d3-4a86-b5de-17862fdf2628" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_148e0807-cded-4924-a69c-0062bfa703f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval_3d85e69a-5b90-4c83-ba3e-08dde5e624c0" xlink:href="sibn-20230331.xsd#sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_131e44e3-f3d3-4a86-b5de-17862fdf2628" xlink:to="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval_3d85e69a-5b90-4c83-ba3e-08dde5e624c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods_1b9c9e8d-c741-4f92-892c-a51984bc7f33" xlink:href="sibn-20230331.xsd#sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_131e44e3-f3d3-4a86-b5de-17862fdf2628" xlink:to="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods_1b9c9e8d-c741-4f92-892c-a51984bc7f33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent_0add0772-c540-4e28-bb0f-e7488f7841b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherEmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_131e44e3-f3d3-4a86-b5de-17862fdf2628" xlink:to="loc_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent_0add0772-c540-4e28-bb0f-e7488f7841b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails" xlink:type="simple" xlink:href="sibn-20230331.xsd#StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_34b46ce6-9258-4fd1-bd2d-3f66d9fe4826" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_101e1d3d-4866-4399-b241-9ee1228a50ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_34b46ce6-9258-4fd1-bd2d-3f66d9fe4826" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_101e1d3d-4866-4399-b241-9ee1228a50ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_eeca9c36-6a19-40e3-9a4e-8a1d4ff1a67d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_101e1d3d-4866-4399-b241-9ee1228a50ff" xlink:to="loc_us-gaap_AwardTypeAxis_eeca9c36-6a19-40e3-9a4e-8a1d4ff1a67d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cd877b47-c870-4652-bf39-6879eb53698f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_eeca9c36-6a19-40e3-9a4e-8a1d4ff1a67d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cd877b47-c870-4652-bf39-6879eb53698f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_0f2343e9-12fe-481e-8bc1-99b0089d4a5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cd877b47-c870-4652-bf39-6879eb53698f" xlink:to="loc_us-gaap_PerformanceSharesMember_0f2343e9-12fe-481e-8bc1-99b0089d4a5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a6b4ac7c-6181-4bef-a657-62c9e95cfb9b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_101e1d3d-4866-4399-b241-9ee1228a50ff" xlink:to="loc_srt_RangeAxis_a6b4ac7c-6181-4bef-a657-62c9e95cfb9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6f0db6e2-d219-4bdd-b737-7fb8e7f78e72" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_a6b4ac7c-6181-4bef-a657-62c9e95cfb9b" xlink:to="loc_srt_RangeMember_6f0db6e2-d219-4bdd-b737-7fb8e7f78e72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_357b3046-7fff-44e6-8d6a-0c3fe4b0d190" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6f0db6e2-d219-4bdd-b737-7fb8e7f78e72" xlink:to="loc_srt_MinimumMember_357b3046-7fff-44e6-8d6a-0c3fe4b0d190" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_cedb9a2a-be66-499e-9648-5f8c99c9412e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6f0db6e2-d219-4bdd-b737-7fb8e7f78e72" xlink:to="loc_srt_MaximumMember_cedb9a2a-be66-499e-9648-5f8c99c9412e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9553f8b2-57a6-43e0-98ad-02dc535eae11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_101e1d3d-4866-4399-b241-9ee1228a50ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9553f8b2-57a6-43e0-98ad-02dc535eae11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_7c20a08f-5066-43f5-88e9-bc0144041907" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9553f8b2-57a6-43e0-98ad-02dc535eae11" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_7c20a08f-5066-43f5-88e9-bc0144041907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_a60a3554-6b25-4261-bd6d-5b8428e93480" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_7c20a08f-5066-43f5-88e9-bc0144041907" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_a60a3554-6b25-4261-bd6d-5b8428e93480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_2ed75875-7d67-4e20-94cf-08639a7948fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_7c20a08f-5066-43f5-88e9-bc0144041907" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_2ed75875-7d67-4e20-94cf-08639a7948fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMinimum_896f8e16-91b6-4dee-a6b1-b22289b98d81" xlink:href="sibn-20230331.xsd#sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMinimum"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_7c20a08f-5066-43f5-88e9-bc0144041907" xlink:to="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMinimum_896f8e16-91b6-4dee-a6b1-b22289b98d81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMaximum_4c45b926-a933-4161-832f-aef1c9b457e7" xlink:href="sibn-20230331.xsd#sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMaximum"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_7c20a08f-5066-43f5-88e9-bc0144041907" xlink:to="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMaximum_4c45b926-a933-4161-832f-aef1c9b457e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMinimum_ffb13bdb-0f8b-4627-98fd-20c5dea92a1d" xlink:href="sibn-20230331.xsd#sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMinimum"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_7c20a08f-5066-43f5-88e9-bc0144041907" xlink:to="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMinimum_ffb13bdb-0f8b-4627-98fd-20c5dea92a1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMaximum_30559e9e-b9e2-455f-962c-b708e509becb" xlink:href="sibn-20230331.xsd#sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMaximum"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_7c20a08f-5066-43f5-88e9-bc0144041907" xlink:to="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMaximum_30559e9e-b9e2-455f-962c-b708e509becb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_15e8bf90-3cfa-4af7-9ab3-ed4cab4605d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_7c20a08f-5066-43f5-88e9-bc0144041907" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_15e8bf90-3cfa-4af7-9ab3-ed4cab4605d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_aef93d62-98e6-4f96-8cb7-1735a0691a8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_7c20a08f-5066-43f5-88e9-bc0144041907" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_aef93d62-98e6-4f96-8cb7-1735a0691a8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1bc4a0e3-169a-43ba-b0a8-a0c6d71271b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_7c20a08f-5066-43f5-88e9-bc0144041907" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1bc4a0e3-169a-43ba-b0a8-a0c6d71271b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityandPerformanceBasedRestrictedStockUnitActivityDetails" xlink:type="simple" xlink:href="sibn-20230331.xsd#StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityandPerformanceBasedRestrictedStockUnitActivityDetails"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityandPerformanceBasedRestrictedStockUnitActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2a06705c-d718-4a52-9c30-6eacd778b474" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_732391ea-c2ec-4a0f-b9da-428f7701a1fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2a06705c-d718-4a52-9c30-6eacd778b474" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_732391ea-c2ec-4a0f-b9da-428f7701a1fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_ffde45d5-5734-42fe-827a-9a3c38b3de05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_732391ea-c2ec-4a0f-b9da-428f7701a1fc" xlink:to="loc_us-gaap_AwardTypeAxis_ffde45d5-5734-42fe-827a-9a3c38b3de05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7c5875b3-7ad4-4995-975d-d5e3ab2a6910" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_ffde45d5-5734-42fe-827a-9a3c38b3de05" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7c5875b3-7ad4-4995-975d-d5e3ab2a6910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_41923c6e-1651-4f22-8557-a08d2fe080c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7c5875b3-7ad4-4995-975d-d5e3ab2a6910" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_41923c6e-1651-4f22-8557-a08d2fe080c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_2f4c8b38-a117-4a0b-890b-1dfe81aa053f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7c5875b3-7ad4-4995-975d-d5e3ab2a6910" xlink:to="loc_us-gaap_PerformanceSharesMember_2f4c8b38-a117-4a0b-890b-1dfe81aa053f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_74dca812-8bb1-4794-866c-44e01669f802" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_732391ea-c2ec-4a0f-b9da-428f7701a1fc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_74dca812-8bb1-4794-866c-44e01669f802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5792a651-a9a6-495f-ab68-f948d4e3c6f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_74dca812-8bb1-4794-866c-44e01669f802" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5792a651-a9a6-495f-ab68-f948d4e3c6f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_94d4c874-0211-4943-bdaf-fcb7db966c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5792a651-a9a6-495f-ab68-f948d4e3c6f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_94d4c874-0211-4943-bdaf-fcb7db966c5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_35eec8f3-023e-4be8-b168-2a84dafe4e84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5792a651-a9a6-495f-ab68-f948d4e3c6f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_35eec8f3-023e-4be8-b168-2a84dafe4e84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_9b3235b7-1bb8-4529-95f5-7a7ac9107a6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5792a651-a9a6-495f-ab68-f948d4e3c6f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_9b3235b7-1bb8-4529-95f5-7a7ac9107a6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_de671f21-9005-4535-abe4-cd8a8764e561" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5792a651-a9a6-495f-ab68-f948d4e3c6f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_de671f21-9005-4535-abe4-cd8a8764e561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_024822f9-f1d6-489d-940b-c8ece9467b69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5792a651-a9a6-495f-ab68-f948d4e3c6f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_024822f9-f1d6-489d-940b-c8ece9467b69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_492f3459-73d7-49fe-9e56-c0d1d8df9124" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_74dca812-8bb1-4794-866c-44e01669f802" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_492f3459-73d7-49fe-9e56-c0d1d8df9124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_31a1f639-86a6-4bd7-8087-f44e738321ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_492f3459-73d7-49fe-9e56-c0d1d8df9124" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_31a1f639-86a6-4bd7-8087-f44e738321ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_55d7e1b1-209e-4b4a-a544-0e20c146c969" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_492f3459-73d7-49fe-9e56-c0d1d8df9124" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_55d7e1b1-209e-4b4a-a544-0e20c146c969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_b88c24f6-2439-44f7-8145-21c527819423" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_492f3459-73d7-49fe-9e56-c0d1d8df9124" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_b88c24f6-2439-44f7-8145-21c527819423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_83421257-b2f2-4664-a7e8-9698e9269d0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_492f3459-73d7-49fe-9e56-c0d1d8df9124" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_83421257-b2f2-4664-a7e8-9698e9269d0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ea33795a-7c04-4651-bcb2-6aeec198c327" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_492f3459-73d7-49fe-9e56-c0d1d8df9124" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ea33795a-7c04-4651-bcb2-6aeec198c327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="sibn-20230331.xsd#StockBasedIncentiveCompensationPlansStockBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0577cf8d-67d5-4e11-bb73-f9c28f2f8137" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9256da42-530a-4740-97db-a13989510b20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0577cf8d-67d5-4e11-bb73-f9c28f2f8137" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9256da42-530a-4740-97db-a13989510b20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_bc484471-837b-4b23-b8d8-a7b15cbdc585" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9256da42-530a-4740-97db-a13989510b20" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_bc484471-837b-4b23-b8d8-a7b15cbdc585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5079c327-3c5d-490f-b0cc-2d727beb3fd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_bc484471-837b-4b23-b8d8-a7b15cbdc585" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_5079c327-3c5d-490f-b0cc-2d727beb3fd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_f2e06678-4591-42de-a55c-85e6ec9800a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5079c327-3c5d-490f-b0cc-2d727beb3fd2" xlink:to="loc_us-gaap_CostOfSalesMember_f2e06678-4591-42de-a55c-85e6ec9800a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_804b96da-4952-4b4c-8aac-2a7946ceb718" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5079c327-3c5d-490f-b0cc-2d727beb3fd2" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_804b96da-4952-4b4c-8aac-2a7946ceb718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_9fe41d07-6b88-4fc4-8caf-e24d5ea71e43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5079c327-3c5d-490f-b0cc-2d727beb3fd2" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_9fe41d07-6b88-4fc4-8caf-e24d5ea71e43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_04e15553-88bc-46d9-a351-8be8449fd534" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5079c327-3c5d-490f-b0cc-2d727beb3fd2" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_04e15553-88bc-46d9-a351-8be8449fd534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d1ab7e8b-83fc-453d-acb8-35b148f8b427" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9256da42-530a-4740-97db-a13989510b20" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d1ab7e8b-83fc-453d-acb8-35b148f8b427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_966bb8f3-49bf-432a-bd8a-843e27c7130b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d1ab7e8b-83fc-453d-acb8-35b148f8b427" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_966bb8f3-49bf-432a-bd8a-843e27c7130b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/NetLossPerShareofCommonStockComputationofEarningsPerShareDetails" xlink:type="simple" xlink:href="sibn-20230331.xsd#NetLossPerShareofCommonStockComputationofEarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/NetLossPerShareofCommonStockComputationofEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_40c16d2e-7603-409b-be34-24836b68f5ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1fb76f7e-2978-4d21-9ef3-1911d6b76c90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_40c16d2e-7603-409b-be34-24836b68f5ec" xlink:to="loc_us-gaap_NetIncomeLoss_1fb76f7e-2978-4d21-9ef3-1911d6b76c90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d9cb0c04-898a-4b98-ab5f-b4ceaf688cb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_40c16d2e-7603-409b-be34-24836b68f5ec" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d9cb0c04-898a-4b98-ab5f-b4ceaf688cb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a4c693a0-b75e-4790-968f-bb9ca1087e92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_40c16d2e-7603-409b-be34-24836b68f5ec" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a4c693a0-b75e-4790-968f-bb9ca1087e92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_4d5f4426-0ca8-4a20-9736-9a22fe2bc293" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_40c16d2e-7603-409b-be34-24836b68f5ec" xlink:to="loc_us-gaap_EarningsPerShareBasic_4d5f4426-0ca8-4a20-9736-9a22fe2bc293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_fbdb8b15-95d4-4e49-b618-0f3e6c41464e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_40c16d2e-7603-409b-be34-24836b68f5ec" xlink:to="loc_us-gaap_EarningsPerShareDiluted_fbdb8b15-95d4-4e49-b618-0f3e6c41464e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/NetLossPerShareofCommonStockAntidilutiveCommonStockEquivalentsExcludedfromComputationofEarningsPerShareDetails" xlink:type="simple" xlink:href="sibn-20230331.xsd#NetLossPerShareofCommonStockAntidilutiveCommonStockEquivalentsExcludedfromComputationofEarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/NetLossPerShareofCommonStockAntidilutiveCommonStockEquivalentsExcludedfromComputationofEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_13fd58e8-2d4b-4256-bd7b-6244b0137dfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_37dc9d4a-366e-49ad-ac1a-b38d9a9110d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_13fd58e8-2d4b-4256-bd7b-6244b0137dfa" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_37dc9d4a-366e-49ad-ac1a-b38d9a9110d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e40455d0-ef04-4d68-bc29-102be82d835d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_37dc9d4a-366e-49ad-ac1a-b38d9a9110d3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e40455d0-ef04-4d68-bc29-102be82d835d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_96c464c6-ed8b-4ed3-aec1-a9434be820d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e40455d0-ef04-4d68-bc29-102be82d835d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_96c464c6-ed8b-4ed3-aec1-a9434be820d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_6a696385-7759-45fa-a890-6998d1abde6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_96c464c6-ed8b-4ed3-aec1-a9434be820d1" xlink:to="loc_us-gaap_EmployeeStockOptionMember_6a696385-7759-45fa-a890-6998d1abde6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_5ab261a5-6356-4b18-8e9d-1813a7305788" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_96c464c6-ed8b-4ed3-aec1-a9434be820d1" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_5ab261a5-6356-4b18-8e9d-1813a7305788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_EmployeeStockPurchasePlanSharesMember_1d433f02-4b94-46d6-b0cb-e4d63492fd7c" xlink:href="sibn-20230331.xsd#sibn_EmployeeStockPurchasePlanSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_96c464c6-ed8b-4ed3-aec1-a9434be820d1" xlink:to="loc_sibn_EmployeeStockPurchasePlanSharesMember_1d433f02-4b94-46d6-b0cb-e4d63492fd7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_CommonStockWarrantsMember_58ea6d71-8f07-4a0f-8e83-63d9cb76fee4" xlink:href="sibn-20230331.xsd#sibn_CommonStockWarrantsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_96c464c6-ed8b-4ed3-aec1-a9434be820d1" xlink:to="loc_sibn_CommonStockWarrantsMember_58ea6d71-8f07-4a0f-8e83-63d9cb76fee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_d7c863e4-2e30-4538-b34a-bba04a6d85c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_37dc9d4a-366e-49ad-ac1a-b38d9a9110d3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_d7c863e4-2e30-4538-b34a-bba04a6d85c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_5f8ee1e3-38f9-4bef-9a17-9af5ba093116" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_d7c863e4-2e30-4538-b34a-bba04a6d85c5" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_5f8ee1e3-38f9-4bef-9a17-9af5ba093116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/RelatedPartyTransactionDetails" xlink:type="simple" xlink:href="sibn-20230331.xsd#RelatedPartyTransactionDetails"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/RelatedPartyTransactionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_caae2550-97f8-4e0e-bc4b-78d46cd1d8a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_04736edc-b879-4d28-949a-b96a029ed575" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_caae2550-97f8-4e0e-bc4b-78d46cd1d8a8" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_04736edc-b879-4d28-949a-b96a029ed575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_35850a3c-3664-48e0-b5d3-57a03b09f423" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_04736edc-b879-4d28-949a-b96a029ed575" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_35850a3c-3664-48e0-b5d3-57a03b09f423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_b47d507d-00a4-487a-b57b-24f67eb69a7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_35850a3c-3664-48e0-b5d3-57a03b09f423" xlink:to="loc_us-gaap_RelatedPartyDomain_b47d507d-00a4-487a-b57b-24f67eb69a7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_6ab5cb50-923d-452e-b8c8-1507f7b887b2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AffiliatedEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_b47d507d-00a4-487a-b57b-24f67eb69a7f" xlink:to="loc_srt_AffiliatedEntityMember_6ab5cb50-923d-452e-b8c8-1507f7b887b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_ac0b5f75-d85e-474b-9cbe-61a2f4fb0e99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_04736edc-b879-4d28-949a-b96a029ed575" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_ac0b5f75-d85e-474b-9cbe-61a2f4fb0e99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_75072c70-f932-4bb6-9075-1cf0a684daee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_ac0b5f75-d85e-474b-9cbe-61a2f4fb0e99" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_75072c70-f932-4bb6-9075-1cf0a684daee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_DevelopmentAgreementMember_a431be9a-492b-4d2d-bea4-c306a820773c" xlink:href="sibn-20230331.xsd#sibn_DevelopmentAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_75072c70-f932-4bb6-9075-1cf0a684daee" xlink:to="loc_sibn_DevelopmentAgreementMember_a431be9a-492b-4d2d-bea4-c306a820773c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_28885571-a734-45d4-8d30-6009f4e1eb75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_04736edc-b879-4d28-949a-b96a029ed575" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_28885571-a734-45d4-8d30-6009f4e1eb75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_18965389-1bea-4e14-9715-cc41516f9352" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_28885571-a734-45d4-8d30-6009f4e1eb75" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_18965389-1bea-4e14-9715-cc41516f9352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_RelatedPartyTransactionTermOfAgreement_df5f7da2-4216-41c5-b812-4d8358bd2567" xlink:href="sibn-20230331.xsd#sibn_RelatedPartyTransactionTermOfAgreement"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_28885571-a734-45d4-8d30-6009f4e1eb75" xlink:to="loc_sibn_RelatedPartyTransactionTermOfAgreement_df5f7da2-4216-41c5-b812-4d8358bd2567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense_148353e2-520f-410c-a05d-ab428b73593c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_28885571-a734-45d4-8d30-6009f4e1eb75" xlink:to="loc_us-gaap_RoyaltyExpense_148353e2-520f-410c-a05d-ab428b73593c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrent_5ee01009-d380-44d1-84ff-647b8b2ae288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToAffiliateCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_28885571-a734-45d4-8d30-6009f4e1eb75" xlink:to="loc_us-gaap_DueToAffiliateCurrent_5ee01009-d380-44d1-84ff-647b8b2ae288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="sibn-20230331.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_13630991-1310-44e6-868e-74f7d8b577b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_54697e21-2f64-4c18-8ae6-b7b6a7bbdcb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_13630991-1310-44e6-868e-74f7d8b577b7" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_54697e21-2f64-4c18-8ae6-b7b6a7bbdcb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>image_101.jpg
<TEXT>
begin 644 image_101.jpg
MB5!.1PT*&@H    -24A$4@    @   +7" (    _FI8/    34E$051X7NW)
MH0$   C#,/Y_&FQ/0*1NRTS:U!\
L                      # ?^AH/^$  (Y'EPQZ0[$     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>image_103.jpg
<TEXT>
begin 644 image_103.jpg
MB5!.1PT*&@H    -24A$4@    @   "H" (   !2<3@R    +$E$051X7NW)
ML0$ , C#,/Y_NJS^H SREF@FO=0?            GZ"CW80%.>XL17DE'50
+    245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>image_107.jpg
<TEXT>
begin 644 image_107.jpg
MB5!.1PT*&@H    -24A$4@  ";     #" (   #'QBQ7    /$E$051X7NW9
MP0T   @",?9?6G_&&4B;>[ #24:2)$F2)$F2)$F2FCIO @       '1QB (
;      "U%G9JEAA\BH\!     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>image_111.jpg
<TEXT>
begin 644 image_111.jpg
MB5!.1PT*&@H    -24A$4@  #*4    "" (   "\2AD<    -TE$051X7NW&
ML0T   C#L/[_-&R($SK8RI D(TF2)$F2)$F2)$F2)$FJ[;P%          "@
6V *5;FI5)92X-P    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>image_116.jpg
<TEXT>
begin 644 image_116.jpg
MB5!.1PT*&@H    -24A$4@   E0    ," (    KN+3-    9TE$051X7NW;
MN0T (0P 0?IOFKN0IP-V1A:24P(V8LPQHC/_ X"*N;B2T!GQ RC9XQ=V7@P
M[]K>_W6I.2\&@'=M[_^Z $"!^ &0(WX Y(@? #GB!T#.]?NM,P!474GH# !5
9&@! S@<P7S'P"9*M@@    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>image_117.jpg
<TEXT>
begin 644 image_117.jpg
MB5!.1PT*&@H    -24A$4@   J,    ," (   #9*",M    :4E$051X7NW;
M,0K (!1$0>]_:6.I^2!)I\L,BV!K\RI;;\V^KH\# $[7)R5FMIG2 W"#M?3\
M\7Y+ #C/4J[Y @"$47H 2*;T )!,Z0$@F=(#0#*E!X!DY<NX;08 MRDQL\T
;X#;J!0#)'N$9?FA$)HIL     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>image_118.jpg
<TEXT>
begin 644 image_118.jpg
MB5!.1PT*&@H    -24A$4@   R(    ," (    189[2    ;TE$051X7NW<
M.PI (0Q%0?>_Z;S7"'Y*DRHS7 1;JU,Y8@Q+6_P' -!7+*Y0L)?)+ #H;<\L
M4IV/#0!TLE7!>@$ ((O, @ H(;,  $K(+ " $C(+ *"$S ( *'']_&0O P"8
AKE"PEP$ 3,H  *#$!_1PX;OJJKAI     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>image_120.jpg
<TEXT>
begin 644 image_120.jpg
MB5!.1PT*&@H    -24A$4@   28    ," (   ! YH=I    7TE$051X7NW9
ML0T (0P#0/9?FO\22(TI<J<(*6UD5XPY1M.9_P,)<U&"V&=4CI2]<HV=AX$[
MMM2M2S?G8>".+77K MRF<A"E<A"E<A"E<A!5?JOZ#+Q0@MAGX 7)@Z@/:M3\
1C2,K@=,     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>image_121.jpg
<TEXT>
begin 644 image_121.jpg
MB5!.1PT*&@H    -24A$4@   H0    ," (   !TJ3N$    9DE$051X7NW;
M*PX (1!$0>Y_Z=DU)'S\M* J'1(TXBE&C6&!U7\ \*Y:7)&PGHDQP-OV&!-R
M/@L +]F*L%X @'YB# !A8@P 86(, &%B# !A8@P 8=?_5^L9 $Q7)*QG #"I
8 @"$?0RZ56='Z>!7     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>image_124.jpg
<TEXT>
begin 644 image_124.jpg
MB5!.1PT*&@H    -24A$4@    @   -W" (   " \8Q5    5TE$051X7NW)
MH0$ , S#L/[_]$K-1@MDEF@FO=0?
M                                     , ?.MI-6"MGP("_(CP'
) $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>image_126.jpg
<TEXT>
begin 644 image_126.jpg
MB5!.1PT*&@H    -24A$4@    @   &7" (    !*H;^    .4E$051X7NW)
MH0$   C#,/Y_&FQ/0*1NRTS:U!\                              /@.
8'>TG'*#85;95YRFM     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>image_128.jpg
<TEXT>
begin 644 image_128.jpg
MB5!.1PT*&@H    -24A$4@    @   (W" (    IWHV-    14E$051X7NW)
ML0T , S#L/S_=+-TT L!J,WF3'JI/P
D             /"AHQV#!89YVI/GX3/1     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>image_130.jpg
<TEXT>
begin 644 image_130.jpg
MB5!.1PT*&@H    -24A$4@  #)P    #" (   #C\&-+    14E$051X7NW:
M,1$   @#L?HW#1N' QB2^Z$BFJ0D29(D29(D29(D29(D2;>--0$
D +CFU 4          /!( WPG]M"JR(E%     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>image_136.jpg
<TEXT>
begin 644 image_136.jpg
MB5!.1PT*&@H    -24A$4@  "<$    #" (   #>3<+Q    .TE$051X7NW9
M,1$   @#L?HW#1O@@>1^J(<F*4F2)$F2)$F2)$EZWC@3        X#T?*@
:     ,!J,78,L("VB3<     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>image_142.jpg
<TEXT>
begin 644 image_142.jpg
MB5!.1PT*&@H    -24A$4@    @   /(" (   !K;2WU    7$E$051X7NW)
ML0T , S#L/S_=+/JA *A-ILSZ:7^
M                                            <!HZVI^PME&(\/V(
.._78     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>image_143.jpg
<TEXT>
begin 644 image_143.jpg
MB5!.1PT*&@H    -24A$4@    <   !8" (   "VZ'JF    )4E$051X7F-@
M0 +_80!9<%1T5'14=%1T5'14=-B(PEG(8#"( @#IXVC")DJ&+     !)14Y$
$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>image_144.jpg
<TEXT>
begin 644 image_144.jpg
MB5!.1PT*&@H    -24A$4@    @   *'" (    S%)[X    24E$051X7NW)
ML0T , S#L/S_=+/JA"*@-ILSZ:7^
H                  #N0T?[$Q8)X8L;;?V8%0    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>image_146.jpg
<TEXT>
begin 644 image_146.jpg
MB5!.1PT*&@H    -24A$4@  #*L    "" (   "B@RFO    -TE$051X7NW&
ML0D   S#L/S_=+N5OA"0\. D(TF2)$F2)$F2)$F2)$DJZKP%          "@
6R@+F"((]+9/#70    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>image_149.jpg
<TEXT>
begin 644 image_149.jpg
MB5!.1PT*&@H    -24A$4@    @   1H" (   "WU@*5    9DE$051X7NW)
ML0$ , C#,/Y_NJS^H SREF@FO=0?
M                                                         +Y"
81[L)"RNL >A7NLJ2     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>image_154.jpg
<TEXT>
begin 644 image_154.jpg
MB5!.1PT*&@H    -24A$4@  #)L    *" (    F(RGZ    PDE$051X7NW=
ML0V , Q%0>^_-#10()>1C1/=Z744&>!;(BX H$!$4P        "<Q X,
M       PA8LN          " *2+_O$F2)*W7)C\M29(D29(D29(D2=JQ=P5.
M'R1)TGIM\M.2)$F2)$F2)$F2I!U[5N#/)@P          ,!_7'0!0(E\3%T4
M         ">Q P- B7QZ510         )[$# P          3.&B"P
:    8(H;RB=+F\#-]S$     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>image_156.jpg
<TEXT>
begin 644 image_156.jpg
MB5!.1PT*&@H    -24A$4@  #*P    "" (   ! 7S+6    -TE$051X7NW&
ML0D   S#L/S_=+N5OA"0\. D(TF2)$F2)$F2)$F2)$GJZKP%          "@
6S0(R1X8Y5GXBLP    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>image_158.jpg
<TEXT>
begin 644 image_158.jpg
MB5!.1PT*&@H    -24A$4@  #)T    ," (   #]9+J@    ODE$051X7NW:
M,1' ,  #,?,GG6Y-&?0'Z7XP"&\[DB1)DB1)DB1)DB1)DJ3?>WTF
M     7Y=            +7Y=            +7Y=            +7Y=
M        +7Y=            +7Y=            +=N.)$F2)$F2)$F2)$F2
M).GW_+HD29(D29(D29(D29(DJ=7]==T)          ! @%\7          !
6RP,]6!.@E&^DX0    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>image_159.jpg
<TEXT>
begin 644 image_159.jpg
MB5!.1PT*&@H    -24A$4@  #)L    ," (   #P>LKG    P$E$051X7NW<
MP0D , P#,>^_=/IH.T/\D#C($B9)1I(D29(D29(D29(D29*TV_4O
M    VRRZ            6EAT 0          M+#H @          :&'1!0
M        T,*B"P          H(5%%P          0(LD(TF2)$F2)$F2)$F2
M)$G:S:)+DB1)DB1)DB1)DB1)DEIZBZ[_K L          (!E%ET
8   M#LGXT=,^7:G>     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>image_160.jpg
<TEXT>
begin 644 image_160.jpg
MB5!.1PT*&@H    -24A$4@  #)H    ," (    ?N*'9    P$E$051X7NW<
MP0D , P#,>^_=/IH.T/\D#C($B9)1I(D29(D29(D29(D29*TV/4O
M    J\RY            *IAS 0          5##G @          J&#.!0
M        4,&<"P          H((Y%P          0(4D(TF2)$F2)$F2)$F2
M)$E:S)Q+DB1)DB1)DB1)DB1)DBIZ<Z[_I@L          (!-YEP
8   5#D:7L_&B+)65     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>image_162.jpg
<TEXT>
begin 644 image_162.jpg
MB5!.1PT*&@H    -24A$4@  #)T    #" (    ,,@AU    14E$051X7NW:
M,1$   @#L?HW#1N' QB2^Z$BFJ0D29(D29(D29(D29(D2>>--0$
D 'C KPL          ."7!G=F_<E3H8PA     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>image_163.jpg
<TEXT>
begin 644 image_163.jpg
MB5!.1PT*&@H    -24A$4@  #)H    #" (   #N[A,,    1$E$051X7NW:
MP0D   @#L>Z_M#[$&?21<- EFJ0D29(D29(D29(D29(D28>-70
C $ZY<P$          +S07Y/FX(%FH0<     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>image_164.jpg
<TEXT>
begin 644 image_164.jpg
MB5!.1PT*&@H    -24A$4@    @   %(" (   #B0B@$    -DE$051X7NW)
ML0T , S#L/S_=+/JA *A-ILSZ:7^                        P%GH:'_"
5 FJ"I2Z_YI=R     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>image_166.jpg
<TEXT>
begin 644 image_166.jpg
MB5!.1PT*&@H    -24A$4@    @   "G" (   "C)XKG    +4E$051X7NW)
ML0T , S#L/S_=+/J@0(9J,WF3'JI/P           /Y"1[L)"_!;(%$:=9FZ
,     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>40
<FILENAME>image_169.jpg
<TEXT>
begin 644 image_169.jpg
MB5!.1PT*&@H    -24A$4@    @   %'" (    3%)K1    -DE$051X7NW)
ML0T , S#L/S_=+/JA"*@-ILSZ:7^                        P'7H:'_"
5 E&)F3KYV20      $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>41
<FILENAME>image_171.jpg
<TEXT>
begin 644 image_171.jpg
MB5!.1PT*&@H    -24A$4@    @   "G" (   "C)XKG    +4E$051X7NW)
ML0T , S#L/S_=+/J@"X!J,WF3'JI/P           +Y 1SL&"_G0+$4W2-7F
,     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>42
<FILENAME>image_172.jpg
<TEXT>
begin 644 image_172.jpg
MB5!.1PT*&@H    -24A$4@    <   !7" (   !'OLAS    )4E$051X7F-@
M0 +_80!9<%1T5'14=%1T5'14= B*PEG(8#"( @"R5U_+U>[1YP    !)14Y$
$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>43
<FILENAME>image_176.jpg
<TEXT>
begin 644 image_176.jpg
MB5!.1PT*&@H    -24A$4@  "ZP    +" (   !.:W:=    ITE$051X7NW:
MP0D , P#,>^_=/M/.D -$O<*9 /G          ! N<P#          "T,8(!
M         *">$0P          /7F"":1)$F2)$F2)$F2)$F2OFZ;M_TC29(D
M29(D29(D29(D?=7VN@$         0!4C&           ZAG!          !0
LSP@&         (!Z1C           -2[K*MI&"P-,84     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>44
<FILENAME>image_177.jpg
<TEXT>
begin 644 image_177.jpg
MB5!.1PT*&@H    -24A$4@  "Z<    #" (   !:V \'    0DE$051X7NW:
M00T   @#L?DW#3^"A25M[C$12S*2)$F2)$F2)$F2)$E21>=-           H
AX?4"         $"?!6DE2BG7/-0!     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>45
<FILENAME>image_179.jpg
<TEXT>
begin 644 image_179.jpg
MB5!.1PT*&@H    -24A$4@  "Z(    #" (   "\\<1#    0DE$051X7NW:
MP0D   @#L>Z_M/[$$102[M$AFJ0D29(D29(D29(D29*DFXTU 0        #@
A*C<7           >:*!,)TRMO#QM     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>46
<FILENAME>image_189.jpg
<TEXT>
begin 644 image_189.jpg
MB5!.1PT*&@H    -24A$4@  "Z0    #" (   "Q[[0$    0DE$051X7NW:
MP0D   @#L>Z_M/[$$102[M$AFJ0D29(D29(D29(D29*DRXTU 0        #@
A-F<7          #>:(MF-3Z"*R.)     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>47
<FILENAME>image_193.jpg
<TEXT>
begin 644 image_193.jpg
MB5!.1PT*&@H    -24A$4@  "Z$    #" (   !7QG]     0DE$051X7NW:
M00T   @#L?DW#0^"ASW:7#(32S*2)$F2)$F2)$F2)$E29^<7          !:
A^;@          -!N 5EV'E5_]1]0     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>48
<FILENAME>image_196.jpg
<TEXT>
begin 644 image_196.jpg
MB5!.1PT*&@H    -24A$4@  "Z,    #" (   !3,Z]]    0DE$051X7NW:
MP0D   @#L>Z_M/[$$102[M$AFJ0D29(D29(D29(D29*DLXTU 0        #@
A,$\7          !^:/QK+D5 NV,^     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>49
<FILENAME>image_200.jpg
<TEXT>
begin 644 image_200.jpg
MB5!.1PT*&@H    -24A$4@  #(4    #" (    X2\EI    14E$051X7NW:
ML1$ , @#,>^_-.DX:D(IW1<>PDE*DB1)DB1)DB1)DB1)DK2NC0D
D , '?RP          ( ;#[&[5G$0Y B7     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>50
<FILENAME>image_207.jpg
<TEXT>
begin 644 image_207.jpg
MB5!.1PT*&@H    -24A$4@  ";L    "" (   #T>@0%    ,$E$051X7NW%
MP0D   @#L>Z_M#[$*9IP<$E&DB1)DB1)DB1)DMHZ?P       ( ^"P2\RTO3
/L"XR     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>51
<FILENAME>image_210.jpg
<TEXT>
begin 644 image_210.jpg
MB5!.1PT*&@H    -24A$4@  !P,    #" (   #P<3=K    -4E$051X7NW8
MP0T   @",?9?6G_&&4B;>S #24:2)$F2)$F2*CMO @    "4\H0"     /T6
4M/;LMF6) DP     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>52
<FILENAME>image_214.jpg
<TEXT>
begin 644 image_214.jpg
MB5!.1PT*&@H    -24A$4@    @   #W" (   "OJ8(0    ,4E$051X7NW)
MH0$ , S#L/[_]$J-A@MDEF@FO=0?                  !_Z&@W80%L"MR^
0V,R;G     !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>53
<FILENAME>image_22.jpg
<TEXT>
begin 644 image_22.jpg
MB5!.1PT*&@H    -24A$4@  #BX   ,'" (   ";YMD%  "  $E$051X7NS=
M>9C<5;DG\.Y..DLG84L@B\HJ8<T-ZPC,B.N%RY*+C"""@"";*"& "++-,"KS
M*(@B D)$H@RK!H)X$5=644!E$1%(2&152" +G7UIIJ9Z\KNGWEJZJKIZP7P^
M?_A0==[O]_R2ZKI_G.?<3E,3             -3H[;SX+@            !T
MJ> J:N<+             *C 550             ZN0J*@            !U
M<A45            @#JYB@H           ! G5Q%!0           *!.KJ("
M            4"=740$           "HDZNH             -3)550
M        ZN0J*@            !U<A45            @#JYB@H
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M])GLX2J+,:A7_-DJ(XTL6+!@UJQ9TZ=/_^QG/[OAAAO&T?*F3)FR9LV:M H
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MV;&'KJ+F3)\^/6Y6HZ...BJ65B&+QX6>E#QU;;OWVI<QOMN+"A\<
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MW_\^)JMV[KGGQKHR8K*,&"L2 UVI*9L.%^N%+V.7 ZETN*08*%+3,
M    T*/"99[^=;,G>[C*8JP'S)LW[[_\E_\2-UYK\\TW?^FEEV*FT*NOOKK5
M5EO%Y%J[[;;;W+ES8Z9>O__][^,&A9YZZJF8J4OL+7+===?%3"W2JKC6,](=
M*XBQ,MYXXXV8+&/X\.$QW)6>^Y1//_WTV%7DYS__>8QUY:<__6D6/_[XX^-R
MH62K2@XYY)"8K,[2I4M'CAP9Z\J(X3)BK$@,=*6F;#I<4D]_&;L<2*7#)<5
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M11DQ5B0&&BIN5E%/?!D/2L2U(FE;23%0I/)VDR=/CHV)+W[QBS$
M  !T0W8YI^!EX4R?R1ZNLAAKD%=??;6UM35NELBM+EZ\.,:ZLF3)DD&#!L6N
MQ,"! U]YY948J\ZD29.RGIUWWCEI+>&3G_QDS-<H-G;E>]_[7JRH*,W&M9Z1
M[EA!C)7R^NNO#QTZ-"9+&3!@0$V_"K?7/N6Y<^=NL,$&L;'0>]_[WN7+E\?D
M6NWM[>]ZU[LZ)X<,&3)GSIPX44:Z1>[EBR^^F/M;2M\,;KCAAEA1QC'''-,9
MR7W1.O_:"XI*B15EQ%B1&&BHN%E7^O;+F+:5% .U>/#!!V-=D8<??CC&
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M_G>_^UWGFTE':84=9<58D1AHJ'2C_O]E3-M*BH%:C!T[-M85>=>[WA5C
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M+BW,EQ-C]8J]U:G0T ^_C&E;23%0H]S/0+G;J,<==]S*E2MC
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MC#/.B--%8J9(#)018T5BH K5QZN?+*F7OXRQL4@,U"+W9XEU11Y\\,$8 P
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M16*@1@VLZE*Z5TDQ4$:,%8F!*E0?KWZRLM[Y,L;&(C%0BS%CQL2Z(GXK*@
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MZ;SSSKO]]MOGSIT;\P#T@'OOO??C'__XZ-&C6UM;<_^G^-!##WWPP0?C$
M        T&VNH@(           !0)U=1 0           *B3JZ@
M    U,E55             #JY"HJ             '5R%14           "
M.KF*"@           $"=7$4%            H$ZNH@(           !0)U=1
M 0           *B3JZ@             U,E55             #JY"HJ
M         '5R%14           " .KF*"@           $"=7$4%
M    H$ZNH@(           !0)U=1 0           *B3JZ@
MU,E55             #JY"HJ             '5R%14           " .KF*
M"@           $"=7$4%            H$ZNH@(           !0)U=1 0
M         *B3JZ@             U,E55             #JY"HJ
M     '5R%14     B!8O7GS//?=<<LDEG_SD)W?===?WOO>]&V^\\:"\#3?<
M<+OMMMMGGWU..^VT:=.F/?OLLS%,/_/BBR_>=---4Z9,.>"  [;??OO<1]G6
MUM;2TC)LV+!--MEDVVVWW6^__4XYY90?_O"'SS__? P#     '3%550
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M(X\\\K777HO;5"=VE?>-;WPCAFL4&[L2\VO%N=X2GP,     WE'"29=C+P
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M/OOL1AMM%)ISIDV;%D>K%KN*#!HTZ$]_^E.,U26MC6NU2'LR<:@N#2\$
M@+X23KH<>P$   # NN+BBR_.S@<S7_[RE^-<U6ZZZ:;0%B>J$THZQ:%>%Q\H
M+PY58=*D2;$E[W__[_\=1[ORVFNOC1DS)O0,&##@@0<>B*-UN??>>UM:6D+_
MX,&#__SG/\?1ZJ0][WO?^]*7F:VVVFK1HD4Q6;NT,Z[5(NW)Q*&Z-+P0
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MI VYEW?<<4?Z3NKJJZ^.X1JE;7&M%FE/)@[5I>&%     -!7PDF78R\
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M[ZFGGHJCY:7!N/;VV\\___QZZZV7SF2..^ZX.-V5-![7:I'V9.)05[J3!0
M (#^+QQ_.0L#    @'7%\N7+2_Y^S4Z''W[XBR^^&#.](CY*7ASJ=?&!\N)0
M1:^^^NJFFVX:*YJ:A@T;]L033\3I,J9-FQ;S>9=<<DD<;:BO?_WK<<N\ZZZ[
M+HZ6EP;C6MZ/?O2C="95Z_7H-!O7:I'V9.)05[J3!0   (#^+QQ_.0L#
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M7NYYXFAY:3"NK;5\^?*==]XYG<SLM--.N=48*",-QK5:I#V9.-25[F0!
MH/\+QU_.P@    !@W?+'/_YQZ-"AV4%A91,F3#CGG'-^^]O?KEFS)A8U3MPU
M+P[UNOA W?,O__(O4Z=.7;5J5=RF*[F/(';ES9DS)XXVU////Q^WS)LX<6(<
M+2\-QK7$K%FS1HP8D0YG3C[YY#A=1IJ*:[5(>QHB;@      [WSA^,M9&
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M.W/,O/>][XUS%<5\7ASJ=?&!\N)0+>;/GQ_K\D:/'AU'"QU__/$QT]0T<.#
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M*(W'M5KD?E:WVVZ[M"WSD8]\)/?W\W;C]DI[,G$(     -9MX>C,.1H
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MS8,'#W[@@0?B:-72JKC6#==<<TW:7"P&:A&[\N)0O>KK3%.=1HP8$8<
MH!=E1U4%+PMG     (!_3MGY8.;22R^-0]59OGSYAS_\X5C7U'3JJ:?&T:[$
MBKPXU.OB ^7%H2K\XQ__V&.//6)1WL8;;SQW[MP8Z,I--]W4W-P<JL:-&]>=
MWW'[Y)-/CADS)G2VM+1,GSX]CM8B;8MKW7/XX8>GY4&<KD7LRHM#]:JC<_7J
MU6FJT_CQX^,<     /2B[*BJX&7A#     #PSRD['\PT-S=?<LDE'1T=<;2B
MA0L7[KOOOK&KJ6GDR)&OO_YZG.Y*;,F+0[TN/E!>'*IHV;)EUUUW7?&O&NW4
MTM+RTY_^-&:J<_755^?BH;"MK>V[W_UNK1]E;OZJJZ[*94/;@ $#IDV;%J=K
ME!;&M>YYZZVWMMYZZ[0_%:=K$;ORXE"]ZNA<M&A1FNKTH0]]*,X!    0"_*
MCJH*7A;.      #_G++SP> #'_C ???=%Z=+6;9LV;777CMZ].A8D;_5.F/&
MC!BH0BS*BT.]+CY07AQ*='1T+%JTZ*677GKTT4>ON>::XXX[;L,--XSYM08,
M&)#[:XP5M9@^??J0(4-B;U/3Q(D3?_SC'Z]<N3(&BN1F<I.Y^5C1U#1TZ- [
M[[PS!FJ7=L:U;GO\\<<'#QZ<;I&)H[6(77EQJ%YU=.9^HM)4I]-..RW. 0
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MG$TWW33W;8US     -"[L@.K@I>%,P      0%_JZ.C8====LS/]3GXE*@
M  #]079@5?"R< 8      .A+W__^][,#_4X?_O"'.SHZXAP     ]+KLS*K@
M9>$,      #09YY]]MGAPX=G!_HY&VVTT2NOO!+G     * O9,=6!2\+9P
M    @+[Q\LLO;[;99MEI?DY;6]M##ST4YP    "@CV0G5P4O"V<      ( ^
M\/333V^YY9;947[.T*%#?_&+7\0Y     .@[V>%5P<O"&0      H _LM]]^
MV3E^SMBQ8Q]]]-$X!     !]*CN_*GA9. ,      /2!M]YZ:X\]]N@\NO_
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M!0           " G1U$!            R,E15             !R<A05
M        @)P<104            @)T=1 0           ,C)450
M    <G(4%0           ("<'$4%            ("='40$           #(
MR5%4             ')R%!4           " G!Q%!0           " G1U$!
M            R,E15             !R<A05            @)P<104
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MK0HOO_SRTDLOG38I:FEIN>>>>V(TK_WVVR_T+^3:*@    #0),*@S]0/
M * 'CZ*^\LHKRRVW7/J5S $''! K:Y<VC-<ZLV#!@AUWW#'MT.:;W_QFC';!
M6V^]M?SRRX<E8@@     Z#W"H,_4#P    "@!X^B%E_^^M>_3K^2NNRRRV)Q
MC=)N\5IG+K_\\K2\S8HKKCASYLP8[9I33STUK!(3     $#O$09]IGX
M #U[%+7H&]_X1OK%S) A0R9,F%!:79NT6[S6H9DS9XX<.3(M;_/#'_XP1KML
M\N3)@P</3E>)"0    "@]PB#/E,_     ( >/XHZ=^[<;;?=-OUZ9J.--NK*
MWT*:MHK7.G3NN>>FM6V&#ATZ;=JT&.T.G_WL9].%XF4     H/<(@SY3/P
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M7&:99=),YDM?^E),=R8MC]<J>.:99]*JS.&''QZC      !ELJ%BR<O2#
M  ! WY)-3E,Q5+5.F]QXXXUI)G7]]=?'=(?2VGBM@FNOO3:MRIQ[[KDQ"@
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M1QR1YC,C1HSX^]__'M-ETI)XK8)*?Q7KK%FS8A0     H$PV5"QY69H!
M .A;LLEI*H:J5E.3V;-GCQHU*BW);+/--G/GSHT%I=)\O%;!@ $#TJK,_/GS
M8Q0     H$PV5"QY69H!     .A;LLEI*H:J5FN3%UYX8:FEEDJK,L<>>VQ,
METK#\5H%E8ZB+EBP($8!     ,ID0\62EZ49     ("^)9N<IF*H:CF:7'_]
M]6E5ZC>_^4U,)])DO%;!TDLOG59E9L^>':,      &6RH6+)R](,     $#?
MDDU.4S%4M7Q-OOSE+Z>%F>666V[2I$DQO5B:C-<J&#ER9%J5>>>==V(4
M *!,-E0L>5F: 0    #H6[+):2J&JI:OR:Q9LS;;;+.T-C-Z].CWWW\_%K1*
M8_%:!956>>FEEV(4     *!,-E0L>5F: 0    #H6[+):2J&JI:[R?///S]\
M^/"T//.=[WPGIENEF7BM@L]\YC-I5>:QQQZ+40    " ,ME0L>1E:08
MH&_))J>I&*I:5YI<=]UU:7FF7[]^O_WM;V,ZUUI?__K7TZK,K;?>&J,
M &6RH6+)R](,     $#?DDU.4S%4M2XV&3MV;-HAL\(**[S^^NLAG ;"I4JN
MO?;:M"KS@Q_\($8!     ,ID0\62EZ49     ("^)9N<IF*H:EUL\MY[[VVR
MR29ID\PG/O&)^?/GI^'T:OKU#CS__/-I5>9+7_I2C (     E,F&BB4O2S,
M     'U+-CE-Q5#5NM[DV6>?'39L6-HG<\HIIZ3)]%+Z]0XL7+API9562@O;
M;+[YYC$*     % F&RJ6O"S-      #T+=GD-!5#5>N6)M=>>VW:)]/2TG+W
MW7=GL?124MV)KW[UJVEAF_[]^T^?/CU& 0    !*94/%DI>E&0    " OB6;
MG*9BJ&K=TJ3HT$,/35ME5EYYY<F3)[=ETJ^75G?D][__?5J8N?GFFV,4
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M\K(T P    "P),OFI+6*C5K%4&=B?2[3IT]?;[WU>J)SFQ=>>.'@@P\>,&!
M6*)Z@P8-^L8WOC%ERI38NCK''7=<[-CJY)-/CE$     H+ZR>5W)R](,
M ,"2+)N3UBHV:A5#G8GU>3WQQ!.#!P_NB<Z929,FC1LW;N.--TY7Z=3'/_[Q
M"R^\\,TWWXSM:O'NN^^.&C4J=!X]>O2L6;-B%     "HKVQD5_*R- ,
M0"]PT44793/?'IWT3IPX\:<__>F11QZYVVZ[K;ONNLLMM]R@08,&#ASXD8]\
M9)UUUADU:M0^^^PS;MRX6V^]];777HO%>;W[[KO''7?<FFNN65QH[;77/OGD
MDYU#!0   (!F$&:2/3Z@!            &")X2@J             #DYB@H
M          ! 3HZB @           )"3HZ@             Y.0H*@
M       Y.8H*            0$Z.H@(           "0DZ.H
M .3D*"H             .3F*"@           $!.CJ("            D).C
MJ             #DY"@J             #DYB@H           ! 3HZB @
M         )"3HZ@             Y.0H*@             Y.8H*
M    0$Z.H@(           "0DZ.H             .3D*"H
M.3F*"@           $!.CJ("            D).CJ             #DY"@J
M             #DYB@H           ! 3HZB @           )"3HZ@
M        Y.0H*@             Y.8H*            0$Z.H@(
M  "0DZ.H             .3D*"H             .3F*"@           $!.
MCJ("            D).CJ             #DY"@J             #DYB@H
M          ! 3HZB @           )"3HZ@             Y.0H*@
M       Y.8H*            0$Z.H@(           "0DZ.H
M .3D*"H             .3F*"@           $!.CJ("            D).C
MJ             #DY"@J             #DYB@H           ! 3HZB @
M         )"3HZ@             Y.0H*@             Y.8H*
M    0$Z.H@(           "0DZ.H             .3D*"H
M.3F*"@           $!.CJ("            D).CJ             #DY"@J
M             #DYB@H           ! 3HZB @           )"3HZ@
M        Y.0H*@             Y.8H*            0$Z.H@(
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MMUU2"KU&O)5[VW?=]]]_?_CPX>G^=]AAAQA*?.I3GTK#@P</GCU[=@P!
MT#>DDZ),#%&9*3I]0;R5?9<   !H%9Z2FNN1*=M<*H::QNS9LV^]]=8CCCAB
MN^VV6WGEE8<,&3)@P(!EEUWV8Q_[V&<^\YEQX\;==MMM;[SQ1BRK[+777KOJ
MJJO&CAW[\8]_?)555AD^?'A+2TOQG\5_'SUZ=/'KQ:O%3"SK&0L7+KSWWGN/
M//+(K;;:ZB,?^4CQK2VSS#)KK;76GGON>>:99_[UKW^-!67FSY]_QQUW%']]
MMMQRR^677W[@P('%7YSUUU]_UUUW/?OLLY]ZZJE8T&2>>^ZY[";LUZ_?Q(D3
MLTL___G/DSOT0Q,F3$@:=+-77GGE\LLO/_300]ONMV'#AO7OWW_$B!%KK+'&
MIIMN6KSE3CSQQ)_][&?%;<?*+FC(HDWU06@2DR=//N^\\_;99Y_B9[#X2S%X
M\.!55UUU\\TW/_#  Z^^^NK77W\]%M0BWL=-_%VW70\__'#8?_&VC*'%YLZ=
M.W3HT#3\R4]^,H8     Z#/225$FAGK DC$%-45?U*!%EXS[IWN9H@,  -1?
M>$IJKD>F;'.I&.H9<=4R:7C6K%GGG'/.<LLM%T/M20O;M7#APMMNNVV7779I
M]P?6!"TM+<5D,1^[="8V*I.&[[GGGE&C1L5$J3WVV.,O?_E+6I6ZX88;UEEG
MG5A3:N^]]W[VV6=C9=/XUK>^E6WU4Y_Z5'IISIPYRR^_?/)6/G#TT4>GL6Y1
MO#UNN>66'7?<L9K;H\WJJZ\^=NS8&V^\,???]=BH17OZ@Q"[E(D%[8DU96)!
MF5A0)@U/F3+EJ*..&C!@0 PE!@T:5+SWWGSSS;2P [$^E[:?M-73QH\?'Q>N
MN[@G     )8@<1C4*H:Z3QVFH/5DBE[_17OZ_HE=RL2"]L2:,K&@3"PHDX;[
M^!0=  "@@;(GH)*7I9F&R3:7BJ$JY"A/2]J5)9][[KE--MDD7JXL6:0=$R9,
M&#UZ=*RIP@X[[-#!2=!RL;Y,6VSAPH4GG'!"-5.,HH$#!UYQQ16EZRR:.7/F
M@0<>&*,5#!TZ]+>__6WHT SFSIV[P@HK9/O\Q2]^$0+''GML\CX^L.RRR\Z:
M-2LDN^+))Y_<=MMMXS)5*^[GJ*..*C:)?3O4D$7K\T&(Q65B07MB39E84"86
ME,F2CSWVV.JKKQXO5S!RY,@J_T:!6)E+?89HCJ("    T*/B,*A5#'63^DQ!
MZ\84/?:J6KY%ZW/_Q.(RL: ]L:9,+"@3"\ID25-T  " !LJ>@$I>EF8:)MM<
M*H:JD*,\+6E76^S))Y^L\B]#S92N4^+RRR\?-&A0+*C:X,&#RT^"5A*+RRQJ
M/8<Z=NS8>*$S/_G)3[)59LV:]8E/?"(F.C1PX,![[KGGPXTVAQMNN"';X?++
M+S]GSIP0>/;99Y,W\:'KKKLN)'.[Z**+BK\X<8%<8NO*&K)HW3X(L;),+&A/
MK"D3"\K$@C)ML3_^\8_#A@V+USJT[+++/O/,,Z6KM2.6Y5*?(9JCJ     #T
MJ#@,:A5#W:%N4]"Z,47ONMBZLKK=/[&R3"QH3ZPI$PO*Q((R;3%3=   @,;*
MGH!*7I9F&B;;7"J&JI"C/"UI5S'SZJNOMOL#93H65UKLE%-.B=%"H5^_?CON
MN..%%U[XQ!-/O/'&&W/GSBW^L_COQ:]4^CDOQ3ZQ=7MB69EBYHPSSFC[]\&#
M!Q]VV&&WW7;;2R^]-'OV['?>>>?YYY__R4]^LM566Y46_9\! P84=]BVRG[[
M[=?VQ?(.SSWWW,477SQJU*C2ZO^SSCKKS)PYLV2[C;;KKKMFVSOVV&/CY58[
M[+!#\B8^L--..\5<+L<==UQLW?JK^KG/?>Z&&VYXYIEGIDZ=.F_>O+?>>FO"
MA G77GOM 0<<4+P:"Q:+W2MHR*+U_"#$FC*QH#VQIDPL*!,+RA0S+[_\<G;J
M??3HT3_^\8^+O^;%7_GB+\7KK[_^X(,/GG3222NNN&)IW?_9?OOM%RQ8$)<L
M%6MRJ<\0S5%4     'I4' :UBJ$NJ^<4M&Y,T3,]O6@][Y]84R86M"?6E(D%
M96)!F46FZ    $T@>P(J>5F::9AL<ZD8JD(7RQ>UMY/B<VGQZ3U[N?766__G
M?_[GG__\Y^*S_;QY\Z9-F_:'/_SARU_^<OGC?6S=ZNRSSPZQH@TVV*#8)$83
M]]]__WKKK1?+"H7B3F*T,[%%H?"G/_VII:6E^"_;;KOM\\\_'PM:%7\1SCKK
MK%A9*.RRRR[%JY===EG;RPXZS)\_O]VAR1EGG!&CC?/WO_\]_7VL] =DK[WV
MVN0=?*C2>Z_>::>=%IL6"F/&C'GQQ1=C-#%Y\N3/?_[SL:Q5C+:G(8LV]H,0
MZZO;<Q!;U-XDUK=^M]EIIYT*K7^7P/777Q\+%ILR9<H^^^P3BPN%JZ^^.D8[
M%.MK?PL]QU%4     'I4' :UBJ&N:>P4M(>8HF=Z>M'&WC^QOKH]![%%[4UB
MO2DZ  ! <PA/2<WUR)1M+A5#5>AB^:+V=G+555>U_<N**Z[8P6/MS3??W':@
M,Q,3BQ;=?OOMY2=6QXP9\]Y[[\5HF9DS9XX>/3K4%KL5>\9HAT*'HBVVV*+X
MSZVVVNK==]^-Z5)?^]K78G&A\-!##[7]\=-J.GSQBU\,Y6NOO?;"A0MCKD%.
M.NFD;&/%7^UX>;'B[]>($2.2-_&!;W_[VS%:BUMNN25V+!0..." 3O^0;IM3
M3STU%K=W$P8-6;3A'X107JABS^5BB]J;Q/K6'U!5_&?Q[GKJJ:=BNM3LV;.W
MVVZ[4/[QCW\\YCH4R@NUOX4&:ILV9H8-&];!'S0__OCCTW#1DT\^&4,
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MWWYQO?9T^VBI&@U9M'D^"+$FUQT86]3>)-;7WF%1UYK$REIJ>TC<4-TYB@H
M  #01\3!4*L8JEWS3$&[BREZ/1=MGOLGUN3Z=,06M3>)];5W6-2U)K&REEH
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M&%JL?,I9_-3'$     !]6!@?M8FA7)ID"MI%INB+&K1HD]P_INAM8F4MM0
M $NP\)347(],V>92,507<1/=M(W33S\]]BT4;KWUUIBK0K$J-BH4BOUCKH)8
M6?L;C/6-Z-!%VVZ[;;;T::>=%B]WP=Y[[YV\K0]LLLDF,5?JY)-/CC6%PGWW
MW1=S5;C@@@O2)M_\YC=C8K&&+-HD'X1--]TT%-YXXXTQU*%1HT:%#H7:;^-8
M7WN'15UK,FC0H%";;XI:']MMMUVZU>666V[!@@4QM%CZL\/:O/#""S$$
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MBX;=%CW__/,Q!    $#?%B9(;6*H"QH^!<W-%#UHR*(-OW],T=OTHBDZ  !
M/66//R4O2S,-DVTN%4-U$3?1W=LX[[SSX@*%PKKKKGOOO??&:.*!!QY8?_WU
M8UFA<.ZYY\9H9V*+VM]@K&]$A]S2 VW''W]\O-Q-=M]]]^3-?6"KK;:*N3*G
MGGIJ+&O] ]9__>M?8S3QZ*./;K+))FG)P($#QX\?'W,5-&31AG\03COMM-BE
M4/C*5[XR:]:L&%WLMMMN6VVUU8JQ_OW[/_+(([&X]MLXUM?>85'7FH0_I5UH
M'666ST___.<_%W]ST]@SSSP3,CUJSIPY@P</3C?0\1\H#S\R:>655XX)
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M*E:6^NA'/_K@@P_&XI[W_OOO#Q\^/-W)WGOO'4.)XFV9AE=<<<6%"Q?&$
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M\3_5 'U5^,;HNR0             U7(4%0           ("<'$4%
M    ("='40$           #(R5%4          #X_^S==WP4=?['\4D/)"0@
M> 1$4!&[6! TAB@!1$%%$96BPN&I)P_PSG*>$BF*!1L(V!!/O0=W6!#;#^Y
M3A3%@CE:J$?OD4@[I"4A)+^Y73+.O+=D9U.6A-?S#QX,^_Y\OC.;[V2=>7R=
M!0  86(I*@                   ,+$4E0                   "$B:6H
M                    "!-+40$                  ! FEJ("
M           @3"Q%!0                  0)A8B@H
M ( PL105                    86(I*@                   ,+$4E0
M                  "$B:6H                    "!-+40$
M         ! FEJ("                   @3"Q%!0
M0)A8B@H                  ( PL105                    86(I*@
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M0(0\_OCC<H;.FS=/0V6^^.(+"0\9,D1#H3$_UD>.'&E^Q%NMTM+2^'\_
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MD$UF9J8]'!<75_'GA;_^^NOVGBDI*;FYN1H"     *!6LZZ+'9O.#
M ("0Y.?GMVC1PKKI9AHV;)B&0F;O8]%0  <.'/CDDT^Z=.D2%16E+3QB8F)&
MCQZM94"9Y<N7RZ)J<W/%BA6:"\I>[J6)8]LOO_SB]^FP7G7JU-FS9X_6 #6'
MSNF:=H9Z??/--W(43SWUE(;*'#IT*"$AP1[.R,C04%BRL[/M;9LW;[Y]^W8-
M 0    !0>UD7Q8Y-9P8       ! ^4I*2JZYYAKKCIOIHHLN"O(=P>6RM[)H
MJ#RYN;F=.W?6+F7Z]^]?D3U$[;9BQ8KNW;LG)R<G)25==]UU;M>AEOJ;PYHX
MMDV8,$$/P.F55U[1&J#FT E=T\Y0KY$C1\I1S)T[5T-EOOSR2PD/'3I40V$I
M*BIJW;JUO;/YX6O^AX'F      "HI:PK8L>F,P,       "@?./'C[=NMYEB
M8V,7+%B@(3?LW2P:"LT[[[P3Z.&.??KT*2XNU@*@,NAL"W<"1TJ;-FVL/8^+
MB[,=QU$77'"!U@ UAT[HFG:&>G7JU,E^"(F)B86%A1HJ,V+$"'O8],477V@H
M7#DY.3$Q,?;F+[WTDH8      *BEK,MAQZ8S P       * <>7EY]>K5LVZW
MF08.'*@AE^S=+!H*V9(E2]+2TK2=Q^]__WM- Y5!IUH%)G#U6[APH;7;T='1
M8\>.M1W'KW)R<K02J"%T-M>H,]2KJ*BH;MVZ]D/HT*&#AFS,5^WA^/CX@P</
M:J@"[KKK+GO_Y.3DK5NW:@@     @-K(NAQV;#HS         ,K1KU\_ZUZ;
MX5FXMGKU:@VY9&]HT9 ;:]>N_<UO?J,=/=Y^^VU- Q6F\ZQB$[B:#1PXT-KM
M;MVZ%145-6[<V'8H1]U]]]U:"=00.IMKU!GJ]>VWW\HA#!\^7$-E"@H*$A,3
M[>',S$P-5<R*%2NBHJ+L0_3MVU=#      #41M:UL&/3F0$        0S*I5
MJZ*CHZU[;:;NW;MKR#U[0XN&7/K^^^\3$A*TJ><;C=>N7:MIH&)TGE5X E>;
M@P</IJ:F6KO]R2>?F/_XR"./V [EJ.3DY'W[]FD]4!/H;*XY9ZCEZ:>?ED.8
M/7NVALI\_?77$@ZR;C5L7;MVM0]A_N?!BA4K- 0     0*UC70L[-IT9
M     ,'T[]_?NM'F-7/F3 VY)SV]-.3>J%&CM*E'UZY=-0I4C$ZRRIC U>.O
M?_VKM<]I:6F'#Q\V_W'-FC7RO$.O-]]\4^N!FD"G<LTY0RU77765??_CXN(.
M'#B@H3)///&$/6SZ\LLO-51ATZ=/EU'NN.,.#0$     4.M8%\*.36<&
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MA86%YJ> /7SEE5=JJ)+<=---]H%,+[SP@H8      *A=K*M@QZ8S P
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MY#1KUDQ?#B M+2W$Y_)J95BJYPRMT4M1Y\^?K[T,P_P/!LT!     %"+6)?
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M0S89&1GV<')R<NB?6>%YZ:67["-ZS9@Q0W,      -06UO6O8].9 0
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MH&&?1%H3ULS4%NZ;:+W[#J45:Z*5;FJKB.Y0M=NP88/N4U@*"@JT=8#_SP$
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MJN7Y\^=KJ,Q?__I7"9N??1JJ2K[/FKWCCCLT!     ! K6-="#LVG1D
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M:PX59G^3O30! $ U,C_N6[=N;?]@ZM2I$X^2!0     </ZPK8L>F,P,
M   @)/GY^2U:M+!NNIF&#1NF(528_1WVT@0  -4H.SO;_JET\LDG__333QH"
M     *#VLBZ*'9O.#        (!0+5VZ-"4EQ;KO9GKSS3<UA(JQO[U>F@
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M-_?**Z_DSELELFYK6C0! $ 5\WX F1_QBQ<OUM<      #C.R*U:[ML"
M    56+FS)F9F9GZKPB-=1\S1%H/ $!E:]^^_8P9,_1? 0     X+LF]66[4
M @       #CF6/<Q0Z3U         ( J(_=FN5$+        X)ACW<<,D=8#
M         *J,W)OE1BT       " 8XYU'S-$6@\         J#)R;Y8;M0
M                  @52U$!                   0)I:B @
M        ($PL104                  $"86(H*                  "
M,+$4%0                   &%B*2H                   #"Q%)4
M                A(FEJ                     @32U$!
M       0)I:B @                  ($PL104                  $"8
M6(H*                  " ,+$4%0                   &%B*2H
M              #"Q%)4         )7F\\\_O^***_1? 0 XAF5F9IJ?7_JO
M       @9"Q%!0       % )EBQ9DI65Q0U& $"-X_WPZM"A0VYNKKX&
M  !"<'3M*4M1 0       (2GJ*AHZ-"A,3$Q<K?1+ROCEC8"W-NU:U="0H)]
M7L7'Q^_8L4-S "*DH*! 3M)KK[U60S89&1GV<&QL[+Y]^S04 JN#^5F6G9UM
M?JYI @      !&5=7#LVG1D         \&_KUJUMV[:U[C.:;KCA!@W9V).N
M:"/ O;%CQ^K$,HS1HT=K#D"$S)DS1\[0YY]_7D-E#AX\&!\?;P^GIZ=K*#3F
M)Y>]SR677+)Y\V8- 0    " P*S+:L>F,P,         ?BQ8L*!)DR;63<;H
MZ.@GGWRRI*1$<S96V"UM!+AWWGGGZ<0RC+/..DMS "+D\<<?ES-TWKQY&BKS
MQ1=?2'C(D"$:"HWYR35RY$CS4\QJE9:6EI.3HSD      !" =4WMV'1F
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M8L0(>]CTQ1=?:"A<.3DY,3$Q]N8OO?22A@      @(UU$>W8=&8
MX'_R\O+JU:MGW54T#1PX4$,NV;M9- 14P,*%"ZVI%1T=/7;L6-M<^U5.3HY6
M C6$SN8:^%NTJ*BH;MVZ]D/HT*&#AFS,5^WA^/CX@P</:J@"[KKK+GO_Y.3D
MK5NW:@@      )2Q+J(=F\X,         /Q/OW[]K%N*AF=5W^K5JS7DDKVA
M14- !0P<.-":6MVZ=2LJ*FK<N+%MNAUU]]UW:R500^ALKH&_1;_]]ELYA.'#
MAVNH3$%!06)BHCV<F9FIH8I9L6)%5%24?8B^??MJ"       E+&NH!V;S@P
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MX?X0(N7FFV^V[W9T=/3>O7LU5,;W*=VS9LW24&5;O'BQ#&KJWKV[Y@
M.+Y95\V.36<&        P/&K7;MVUFU$B]M'> :AK3TT5 6:-V\N@]:K5Z^@
MH$!S(3ATZ%!R<K)T:]&BA>8JU=Z]>V5$5]\&[B4=3 ,'#M104%]]]95T./WT
MTS54O4:.'&GMS$477:0O^_/++[\D)279#N*HQQY[3*/E:=:LF31IU*A1<7&Q
MYD*P:=,F>Q]]V28B@QXC9Y!4&4'W.1!MX;Z)UE?[J22UAOM#B)233CK)OML7
M7GBA)FQZ]NQI#T='1YLGKX8JV_KUZ^V#>EUVV66: P    #@^&9=-3LVG1D
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MNQHU:N0L(SI\// O$6T=IJ&@R:/X(M+9J(J*"FUG645%19J+=OOMMVM->G2
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MO4,HO29:Z:4V0W1"61?4K:C???>=MK:L(X\\4G,      -1MSE5SU,OH#
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M#3?(;&?-FJ6A&K'W"MMGO88RZ:]__:M,P+9JU2K- 0    !0MSE7S5$OHS,
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M>^RQY@3VW'//)(>HS-:V<.%"#672(X\\(A.P?QIJ"       <"LJ
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MO+Y]^YK3:-JT:555E89J_.$/?S##-OL8TU F_?:WOS5'MW\"+EBP0$,
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M"PM??_UU#0$ 4$N\^NJK]L\RY^=:X\:-/_OL,PT!     (!XG OJJ)?1&0
M      "(8_KTZ:U;MW86&0L*"NZZZZ[JZFK- 0"0Q^R?7/;/+_NGF/,3;9]]
M]IDV;9KF      !  LXU==3+Z P         Q+=\^?)>O7HYZXRVL\XZ2T,
M .2Q,\\\T_Q!UK-GSV7+EFD(       DYEQ61[V,S@        ! 0I65E8,'
M#S8_U%@3  #D,>?GE_VS[.:;;[9_KFD"       D)8O#42\         P*4Y
M<^8<?_SQ+# " &J=R \O^Z?8[-FS]3T      .#"S_>><BLJ        @/2-
M'S_^V&./U7\% ""/'7/,,>^^^Z[^*P      <(U;40$
M . 3MZ("                  # )VY%!0                  @$_<B@H
M                  "?N!45                    /G$K*@
M         'SB5E0                   #XQ*VH
M\(E;40$                  . 3MZ("                  # )VY%!0
M                @$_<B@H                   "?N!45
M        /G$K*@                   'SB5E0                   #X
MQ*VH                    \(E;40$                  . 3MZ("
M              # )VY%!0                  @$_<B@H
M      "?N!45                    /G$K*@                   'SB
M5E0                   #XQ*VH                    \(E;40$
M             . 3MZ("                  # )VY%!0
M    @$_<B@H                   "?N!45                    /G$K
M*@                   'SB5E0                   #XQ*VH
M            \(E;40$                  . 3MZ("
M  # )VY%!0                  @$_<B@H                   "?N!45
M                    /G$K*@                   'SB5E0
M          #XQ*VH                    \(E;40$
M . 3MZ("                  # )VY%!0                  @$_<B@H
M                  "?N!45                    /G$K*@
M         'SB5E0                   #XQ*VH
M\(E;40$                  . 3MZ("                  # )VY%!0
M                @$_<B@H                   "?N!45
M        /G$K*@                   'SB5E0                   #X
MQ*VH                    \(E;40$                  . 3MZ("
M              # )VY%!0                  @$_<B@H
M      "?N!45J$.<$SX1+<@/^3]#      " N,QEC;BT  "0"M]% 0    #(
M0W*USJ5[MBU>O/AWO_M=DR9-&C=N;/_EVV^_U0028-?YX)SPB6A!?LC_&0(
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MTE[$V+ESYUY[[64V'#Y\N(;@E[EC'1JJ)70S:NV&($!Z3.334<&*,0
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M7=Q/7DM$Z[T[]]QST_F<.VWG8@<&Z\PSS]096-;Z]>LE9KXK;SDNN>02-S$
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MS,*(SIT[?_311QHU3)DR9?_]]]<RR[KGGGLTFHJVR,"*:U!DN @-N:-=LGL
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M/U][6=9''WVDN5"H5:M6FK.LM6O7:BX5;1'$YFLB/Z2<8=Q'TM:O7U]S
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M[&#;?__]-10MP*,B*.8HK!@#     %"[.-?@42^C,SGC3,ZDH0S3X3,P 1W
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M:45B*O[1F2U!IYUV6HSM[[!W[@$''""]#SWTD-:%*8^C(D'F6H*8,08
MH+)PKL1#O@RMJ2#.4/S1.+\TUQU-B4F;X]'^9"24)2G$<<LMMVA#X ^O^_3I
M\_KKKR]:M&CKUJW%Q<6___[[]]]___333Y]^^NE2G)&1\?SSSVMN*&F)2_O#
M:$.@Q7PL39HTN>ZZZZ9.G;IRY<K\_/R\O+R??OKIW7??'3!@0)TZ=8R^_Z]Q
MX\;+EBW3U839LV?/F6>>J<T!F9F9O7OW?N655Y8N7;I]^W:[<O/FS7/FS'G\
M\<>///)(IVS2I$E&4V2ZUDB/-S;M3S9=WS['''/,(X\\\L477_SRRR\%!07F
MHFW;M@4/H?/..R_\/3RLP!L,N']C70      $%>EGL?0HGBTW_#33S]%?(/8
M.G7J7'+))>^]]YY=D)>7EY^?OV+%BH\^^NB::ZYIV+"A4_;22R^5N1B/K/3W
MWW^O4:.&6?#66V])C0\//OB@F1F4D9'1M6O7L6/'SIT[=^/&C45%1?:_\^;-
M&S=N7+=NW>REVF!9]]UWGT9'HFWN:$KYTQ&XID$!6A2/]@=H43S:;["?GN%W
M*_;JU6OFS)GV<6OO;ONXM9^Y#1HT, O./OML#0IUPPTWF/5!]IG!/FF,&3/F
M^^^_7[]^?7%QL;V*U:M7VT^36VZYI4F3)E)?OWY]>Q@:'4:Z7-(4+RKRT95%
M>8#VZKIW[SYZ].@OO_QRPX8-]KI*2DKL\\POO_PR;=JTX<.'GW#""=IC6:>>
M>JJ;MT\NIZ,B$>:*3,P8 P    "0_IR+\9 O0VLJB#,4?S3.+\UU1U-BTN9X
MM#\9"65)"C']XQ__R,K*TC9W,C(R)DR8H(EAM"T>[0^C#8&6DI*2/__YS[K
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M %1+YKE1EP$     @!21JW4NW5&].$\ AU8@#;"#      ! =;-W[]X##CC
MG!49,6*$%@% M62>&W49      !($;E:Y](=U8OS!'!H!=( .P@      %0W
M7W_]M3DE8ENR9(D6 4"U9)X;=1D      $@1N5KGTAW5B_,$<&@%T@ ["
M    5#=#A@PQIT3:MFVK%0!079FG1UT&      !21*[6N71']>(\ 1Q:@320
MX XRVP$     59)>"@*57[MV[<R#_.]__[M6 $!U99X>=9D[9@(   "01/K2
M$P"J$SD9<F9$]>(\ 1Q:@320X XRVP$     59)>"@( @*HK\=< 9@(   "0
M1/K2$P"J$SD9<F9$]>(\ 1Q:@320X XRVP$     59)>"@( @*HK\=< 9@(
M  "01/K2$P"J$SD9<F9$]>(\ 1Q:@33 #@(         !#%C#     ! &I*K
M=2[=4;TX3P"'5B -L(,          $',& ,     D(;D:IU+=U1QSA'ODO8C
M%38:=!D         H#IAQA@     @#0D=]QQ^QVJ..>(=TG[ 0
M      " 0>ZXX_8[5''.$>^2]@,                  (/<<<?M=ZCBG"/>
M)>T'                   &N>..V^\                   #@%K>B @
M                P"=N104                  (!/W(H*
M        G[@5%0                   #YQ*RH                   !\
MXE94                    ^,2MJ                    /")6U$!
M              #@$[>B @                  P"=N104
M     (!/W(H*                    G[@5%0                   #YQ
M*RH                   !\XE94                    ^,2MJ
M             /")6U$!                  #@$[>B @
M    P"=N104                  (!/W(H*                    G[@5
M%0                   #YQ*RH                   !\XE94
M            ^,2MJ                    /")6U$!
M  #@$[>B @                  P"=N104                  (!/W(H*
M                    G[@5%0                   #YQ*RH
M          !\XE94                    ^,2MJ
M /")6U$!                  #@$[>B @                  P"=N104
M                 (!/W(H*                    G[@5%0
M         #YQ*RH                   !\XE94
M^,2MJ                    /")6U$!                  #@$[>B @
M                P"=N104                  (!/W(H*
M        G[@5%0                   #YQ*RH                   !\
MXE94                    ^,2MJ                    /")6U$!
M              #@$[>B @                  P"=N104
M     (!/W(H*                    G[@5%0                   #YQ
M*RH                   !\XE94                    ^,2MJ
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M6J5U\,O<MA%I0^K,G#ES\.#!N;FY.L3HFC9M:K>\]=9;>7EY&N<:!R$
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M/@XZZ*!//OE$UQV=]G.5!-?TT(DN.SM[UJQ9VN^%)L:C_2@WNNG9^
M (F1:9;*-.<R>/!@9_1BT*!!6ETEZ.-,TI[2T"3%(NB\\\[3[6M9O7OWUCHD
MB6[KE![/3SSQA(XFP#Y]_?KKKUH=9O;LV=V[=]?F?;0Z.@["JD%WH9=C
M  "22Z]/ K3(L'OW[O7KUW_WW7=//OGD66>=I9W[U*A1X_777]?F*+0YY@"
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MDK2G-#1)L4!*Z-&<HN,Y,S-3QV%96[=NU3HOOO[Z:S--%Z.J,_<^QP    "
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MRY8MD_4^\, #6A23M%O>MUXX3?25J1'>0[0_22?A%)[6'*U:M9+&(/O[6@H
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MM*@<[-BQ0];KZ3,3RR(]=JWP3A-]96J$]Q#M3])).%6G-5/$.["MP(WF6@H
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M?P)J?S(2M"(F;;:LWW[[38O<6;APH6995J=.G;0NG9Y!VI:,V1C!E @
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M^O[[[S=MVE186*B=^VBGN_4ZM-EC>T2:Z"M3([R':+_WA' 1C][DBG9: P
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M7R&??/*)]@3T[=LW_-U-HM%F%^LU:;/']H@TT5>F1G@/T7[O">%2>%H#
MJ@-]M1V@1>5,5^]K !H1+Z3JS6AI1+R0JGJU93X<7>;.XL6+Z]2I8^8X[KGG
M'K/27&1^WR6S/84AVE\)$[39LDI+2[7('?LDH%F693]9M"Z=GD$Z"(];#P
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M?+C6Q:,1\=8KM-EC>T2:F(H?;661AJ$5WJ7PM 8   !4!_IJ.T"+RIFNWM<
M-")>2-6;T=*(>"%5]6K+?#BZS(O\_/SV[=N;:8XSSSQS[]Z]90FORVP/JJ37
M\MI?X0G:;%E+ER[5(G?>?/--S;*L2RZY1.O2Z1FD@_"X]0       ,+)/$-:
M3#J8'S[>IT\?7>Q=:6EIZ]:MG4Q'Q,F@:#(S,Z4]+R]/BV*:/W^^)%@>-[4V
M>VR/1D-]Q6I$O)!QX\9I@V4-&S9,ZUR[[[[[-,ZRGG[Z::V+1-OB#=X'78&O
M5>S>O?NXXX[3(,L:,&" EGHT9LP8#;6LUUY[3>O*P8@1(W3%OF[R"WKWW7<U
MR]>F3@IS#,N7+]?%WN7GYYN90;5KU]:Z*+33Q99)[M[Y]--/-<O%&(3V>T\H
M\QX2\7DW9\X<K8M'(^*M5VBSQ_:(TN%'6UGY/+04GM8   " ZD!?;0=H43G3
MU?L:@$;$"ZEZ,UH:$2^DJEYMF0]'EWFT<.'"VK5KFX&.AQYZJ"SA=569:WGM
MK_ $;;:L]]Y[3XO<>?CAAS7+LD:,&*%UZ?0,TD%XW'H       #A9)XA]9,.
M>7EY=>O6=8;UX8<?:H4O#SWTD)/IR,G)V;)EBY9&4;]^?6E?MVZ=%L7T^NNO
M2X+E<5-KL\?V:#345ZQ&Q M9N'"A-B1VY_$%%UR@<9:U>/%BK8M$V^(-W@==
M@:]5_/6O?]44RVK3ILW.G3NUU*.('P9W^^VW:UTY^/+++W7%'F\3-SWXX(.:
MY6M3)X4YANG3I^MB[W;MVF5F!C5MVE3KHM!.%ULFN7OGB2>>T"P78Q#:[SVA
MS'N(O9&UP;(V;]ZL=?%H1+SU"FWVV!Y1.OQH*RN?AY;"TQH   !0'>BK[0 M
M*F>Z>E\#T(AX(55O1DLCXH54U:LM\^'H,N]>>.$%,]!1HT8-F6S13A>JS+6\
M]E=X@C;ONU?8A_[]^VN697WUU5=:ET[/(!V$QZT'       03N894C_I,&'"
M!&=,+5JT\/KI0M&L6[>N1HT:3K)C].C16AJ%/1CI]?J6>'?>>:<D6!XWM39[
M;(]&0WW%:H2+D$,..41:<G-S"PH*M,X%N\ONE30[7^NBD$;+Q>"]TA5X7T7$
MCWG*R<F9.W>NED9A-NJRLK*6+5N:!;8N7;IHD6N+%R\VH]JW;Z\5^Q05%9EW
MGP<U;MS8WW/_O//.DR@KTH.M&.88?$]DFU:M6F5F!G7NW%GKHM!.%ULFN7MG
MP( !$F6Y&(/0?N\)9=Y#LK.SM<&RBHN+M2ZFG3MW:D2\]0IM]M@>43K\:"LK
MGX=6EKK3&@   % =F"^/'5I4SG3UO@:@$2Y"JMB,ED:X"*F25UOF&'29+P,'
M#C0S'<V;-S>_U#87JLRUO/97>((V6U;OWKVUR(62DI*&#1M*5-VZ=:/-':7)
M,\CL"M(*        CV2>(?63#ITZ=7+&=-]]]^GB!$2\1^VHHX[2NBB./OIH
MZ7WCC3>T**8.'3I(@N5Q4]>L65/:_=T0)B33\CBJ((UP$7+__?=KCV6]\\X[
M6N>"W:5!EF7G:UT4VNEB\%[I"CRN8M6J50T:-- (RWKJJ:>T-#JS49>5E=UU
MUUUF0=#*E2NUSAW9N4.'#M4*PZ677FH6!T5\VX#8MFW;%OX<L2(]V(IACJ%;
MMVZZV+OWWW_?S RZYIIKM"X*[72W99*U=PH*"NK5JZ=![L9@TG[O"67>0YHT
M::(-EK5ITR:MBVG9LF4:$6^](OSP3OQ'0#K\:"OSOD=<2N%I#0   *CRS)?'
M#BTJ9[IZ7P/0"!<A56Q&2R-<A%3)JRUS#+K,E[R\O';MVIFQ$6F;"U7F6E[[
M*SQ!FP-_]K]MVS:MB^>++[[0(,NZ[+++M&Z?-'D&F5U!6@$      ."1S#.D
M>-)A_OSYSH R,S-7KUZM%0EX[[WWG'#3-]]\HZ61].O73QK=3^O8EBY=*NU!
M6A=3HT:-I#W:.RX4%A::9?7KU]<*@UD9I!4N:(2+D/7KU^?DY$A7SYX]M<Z%
ML\XZ2W+L9#M?ZZ*07LO%X+W2%7A915%1D7F+MN.BBR[2TIC,7EU65O;SSS]G
M9669-;9[[[U7ZURP#[^##CK(S(G]W@R??_ZY61P48[HV&O,]E4U:5U',,61D
M9"Q8L$ K/+KBBBO,S*")$R=J713:Z6[+)&OO3)HT25,"M"X>[?>>4.8])/QW
M/+;ITZ=K74S//_^\1L1;KRB/'P'I\*.MS/L><2F%IS4   "@RC-?'CNTJ)SI
MZGT-0"-<A%2Q&2V-<!%2):^VS#'H,K_FSY]?JU8M,SF<]KA09:[EM;_"$[0Y
M8,*$"5H73\0/ OKBBR^T;I\T>0:974%: 0      X)',,Z1XTN&&&VYP!G3.
M.>?HXL24E)0T:];,R7<,'CQ82R,9/GRX-'KZW!Q[+=(>I'4QA7_^5[2YZ35K
MUIAE1QYYI%88S,H@K7!!(]R%W'SSS=IF65.G3M6ZF#[YY!.-L"P[6>NBTV9W
M@_=$5^!E%1&WDGTP;-^^74MC,MMU6< UUUQCUEB!#YBSCR6MBV?DR)%F2->N
M7;4B3/B]MIF9F4N6+-&ZZ';MVA7^\61!6EI19!A]^O31"B]6KEQ9NW9MR:Q3
MITY>7IZ61B&]ENLMD_C>*2HJBO9&(%H:C_9[3RCS'G+999=I@\>3C.VTTT[3
MB'CK%>7Q(R =?K25>=\C[J7PM.;(S\^_\\X[6[=NG9V=;?][UUUWV><K+0(
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M+#B!DY&186_/&.]2O&;-FN[=NVM_X"^QW7P"6U!JGT%F>Y!6)(8I$0
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M>?..'#G2T-"@F=;SYZ: OSNUQ5/<#FN-C8TK5Z[LV;.GZ6_^-#L^?^D"
M_(]Q12MN[[;:J-V[=P=>&]'5,4F>]_+Q5UM;NV/'CJE3IPX<.# K*\MLS.:Y
MS<W-+2HJ6K-F3;3_#-B-_],>Q"41      "2C5SU:LU+8   6&IJ:JPIQZ]W
M[]Y:!                *"ML>X(LBW::P  :*D;-VY84X[?Z-&CM0@
M          ! 6V/=$61;M-<  -!2V[9MLZ8<OR5+EF@1
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M!EGW!=D6[34 @*1F315^/7KT>/[\N1:%45M;.VC0(.FP<.%"K0,
M      #0-EGW!=D6[34 @*1F3166W-S<<^?.:9U=<W/ST:-'<W)R)#MPX, O
M7[YH-0               ("VR;HUR+9HKP$ )#5KJA %!06;-V^NK*Q\_?IU
M4U-3<W-S?7W]TZ=/SYX]NWSY\CY]^FC@GW^Z=^]>6UNK P
M  !HLZR[@VR+]AH 0%*SIHH6*B@H>/7JE78'                T)99-PC)
M(@                   . 6MZ("                   @1MR*"@
M            @!C]NA75_Q\                    @6MR*"@
>        @!C]!QBBAPY;"Q!;     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>54
<FILENAME>image_222.jpg
<TEXT>
begin 644 image_222.jpg
MB5!.1PT*&@H    -24A$4@   %0    ," (   !SU T,    ,TE$051X7F-@
M8/@_TA <(#%''ACU_$@%HYX?J6#4\R,5,&!6@\,>C7H>['D$<^2!$>UY (EI
2X)[X$91Y     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>55
<FILENAME>image_224.jpg
<TEXT>
begin 644 image_224.jpg
MB5!.1PT*&@H    -24A$4@  !M,    #" (   !N[F?B    -4E$051X7NW8
ML1$   @",?9?6CO/ 2B3^X(92#*2)$F2)$F25.F\"0    !0XGD$     /H6
4K7^=]UI.&D8     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>56
<FILENAME>image_225.jpg
<TEXT>
begin 644 image_225.jpg
MB5!.1PT*&@H    -24A$4@   $P    ," (   !'K<P0    ,DE$051X7F-@
M8/@_7!$<(#&'+QCUY' !HYX<+F#4D\,%,&!6+\,&C3!/(IC#%XP(3P(  HCQ
1?U0SJ_X     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>57
<FILENAME>image_228.jpg
<TEXT>
begin 644 image_228.jpg
MB5!.1PT*&@H    -24A$4@  ":\    #" (    18_8R    /$E$051X7NW9
MP0T   @",?9?6G_&&4B;>[ #24:2)$F2)$F2)$F2:CIO @       !3QA@(
;      "=%B6OCQ_3"*Q7     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>58
<FILENAME>image_23.jpg
<TEXT>
begin 644 image_23.jpg
MB5!.1PT*&@H    -24A$4@  #C(   4]" (   !@1:F2  "  $E$051X7NS=
M=YQ4U?W_\85=EH[4L#0%(TB1B HJ8A)-%!1!000E%@P"4I2BV "CL2%$""4:
M0J1HHJ#^0()14*1'@1@[BJ&K%"G2RP*[R^]F][MWSKSOG3MW=J?M[NOY1QZR
MY[P_MYVY<X=\F$U) 0                   ")TVD%G
M     &%I4RIMJ0                   "@ ;4HUVU)U!
M     # $&D_=6D^]Q@                    !;H/'4K?74:PP
M          "P!1I/W5I/O<8                     6Z#QU*WUU&L,
M                L 4:3]U:3[W&                     %N@\=2M]=1K
M#                    + %&D_=6D^]Q@                    !;H/'4
MK?74:PP                   "P!1I/W5I/O<8
M6Z#QU*WUU&L,                    L 4:3]U:3[W&
M     %N@\=2M]=1K#                    + %&D_=6D^]Q@
M          !;H/'4K?74:PP                   "P!1I/W5I/O<;B([ '
MA::E@>AIT:*%+KA<_?OWUZD                  !139@>=CM&6"OBQ8L4*
M76WY*E6J=.C0(0T                  % <F1UT.D9;*N!'SYX]=;497GCA
M!0T                  % <F>US.D9;*A#6[MV[T]/3=;496K9LJ1D
M             (HCLWU.QY*A+=4IL$^>- ;$QNC1HW7Q.?SK7__2&
M            Q8[9.Z=CM*4"WK*SLQLU:J2+S^'66V_5)
M    Q8[9.Z=CM*4"WMYYYQU=>6[*EBV[9\\>#0,                 4+R8
MO7,Z1ELJX*USY\ZZ\D(8,V:,A@$                 *%[,QCD=HRVUP/;L
MV3-OWKQ1HT9U[=JU=>O6=>K4J5*E2IDR9=+2TJS_L/YH_= :LB98TW;OWJUY
M% 7??OMM:FJJKKP0SC[[[)R<'"T!),C1HT<7+5HT>O3HGCU[MFO7[LPSSZQ:
MM6IZKMJU:S=MVK1MV[:]>O6:.''BRI4K#Q\^K'D                 <&,V
MSND8;:F1.G#@P*1)D]JU:U>Z=&G=H="LR6W;MITP8<+^_?NU8K0-'CQ8-Y^2
M,G+D2)T7"2WGIE:M6ENV;-&D/UHK-$W&F'7>= \\+5BP0$M$2"M&J$R9,GE=
MT1=<<,%UUUTW;-BP&3-FK%V[5C<3CM;U;<.&#5K+S:Q9LS3I1F.>HK[RM9:;
M)%SV)T^>M$YOITZ=RI<OKX5"2TU-M>Y13SSQA)_5HN%8TFT#
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M2F>$$Y^5KT4=$K+L,S,S/?KF+9,F3=*,FT.'#G7LV%'#N72J@P8<-!!.8;(
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MFS@O^T&#!IDI<=%%%V5E96G&T\:-&\N6+2MU=)*#S'?20#B%R0(
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MG29,F* 9W[ITZ6*6TF$'<[(K#43/O??>JQLSA%W5                  K
M[-+1,=I2G;9OW^[]C9C6Z)$C1S06SM&C1]/3T[66(2TM;=NV;1KSIW/GSG:=
M"RZXP*CJXI9;;M%\A+1B.'_]ZU^UA"<SJV.QUZ=/'W,'Y#>AO_?>>^:HAVG3
MIIG!@M&B#AH(8?GRY9H,5KY\^;U[]VK,,'?N7,TX?/'%%QKS].233]K9@K51
MQG/E:[EP8K?L]^_?[_WUMY8M6[9HS#=KS\U2.NQ@3G:E@2A9N7*E;LEA]>K5
M&@,               !0.&:+CH[1ENKTV&./Z9:"773119KQQ_S5\*X>??11
MS?CP[;??IJ:FYE5HTJ3)%U]\$5Q5F;^5OF#,:K_^]:_-/[JRMKALV3*M$IJ9
MU;$8.W#@@-GP9YW/G)P<<X+UQ[///MO8P9!:MVYM!@M&BSIH((2LK*PJ5:IH
M.-@SSSRC,8-5H7[]^IH)-G#@0(V%9A5LT*!!7K!"A0K[]^_7&>'$>>6;I1*[
M[)][[CESLM-99YVEF4ALWKS9K*;##N9D5QJ(DAX]>NB6''KV[*DQ
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ME_W0H4/-F:X\EFXLZ.8=-&#P.<W5]==?;\9==>W:56,
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MRV6VM+[YYILZ[$.B5KX9U[%<\5GV?NY1H7J"8T0W7U!:%P
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M?/WUUQHS[-BQX\8;;S0CUHW+VDF=%X(9=*4!'_S$;[KI)G.:JQX]>F@,
M            0.&8+3HZ1EMJBK\#__.?_URY<F5-YNO<N?/LV;.W;MV:F<OZ
MC]=??_V&&VXH5:J43LU5I4J5J5.GZC8<-.90L6)%S80P<N1(#?MVVL>>V'3#
M/JQ8L2(]/5T+Y=/9!:)%/26V+55_&FTM6[:T%F=.3D[P043')9=<HMO+==99
M9_G\PLX\FG>(S\KW3[?J0]27_<*%"^O7KZ^%\I4N7;ICQX[6;>>SSSX[<.!
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MM6YHC1HU&C%BQ(X=.[2<&PW'F&[><.K4J?[]^VL@U[WWWIN5E:4!
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MT'CJUGKJ-08                   #8 HVG;JVG7F,
M  " +=!XZM9ZZC4&                    V *-IVZMIUYC
M        @"W0>.K6>NHU!@                   -@"C:=NK:=>8P
M             ( MT'CJUGKJ-08                   #8 HVG;JVG7F,
M                  " +=!XZM9ZZC4&                    V *-IVZM
MIUYC                    @"W0>.K6>NHU!@                   -@"
MC:=NK:=>8P                   ( MT'CJUGKJ-08
M  #8 HVG;JVG7F,                   " +=!XZM9ZZC4&
M        V *-IVZMIUYC                    @"W0>.K6>NHU!@
M             -@"C:=NK:=>8P                   ( MT'CJUGKJ-08
M                  #8 HVG;JVG7F,                   " +=!XZM9Z
MZC4&                    V *-IVZMIUYC                    @"W0
M>.K6>NHU!@                   -@"C:=NK:=>8P
M ( MT'CJUGKJ-08                   #8 HVG;JVG7F,
M      " +=!XZM9ZZC4&                    V *-IVZMIUYC
M            @"W0>.K6>NHU!@                   -@"C:=NK:=>8P
M                 ( MT'CJUGKJ-08                   #8 HVG;JVG
M7F,                   " +=!XZM9ZZC4&                    V *-
MIVZMIUYC                    @"W0>.K6>NHU!@
M -@"C:=NK:=>8P                   ( MT'CJUGKJ-08
M      #8 HVG;JVG7F,                   " +=!XZM9ZZC4&
M            V *-IVZMIUYC                    @"W0>.K6>NHU!@
M                 -@"C:=NK:=>8P                   ( MT'CJUGKJ
M-08                   #8 HVG;JVG7F,                   " +=!X
MZM9ZZC4&                    V *-IVZMIUYC
M@"W0>.K6>NHU!@                   -@"C:=NK:=>8P
M     ( MT'CJUGKJ-08                   #8 HVG;JVG7F,
M          " +=!XZM9ZZC4&                    V *-IVZMIUYC
M                @"W0>.K6>NHU!@                   -@"C:=NK:=>
M8P                   ( MT'CJUGKJ-08                   #8 HVG
M;JVG7F,                   " +=!XZM9ZZC4&
MV *-IVZMIUYC                    @"W0>.K6>NHU!@
M     -@"C:=NK:=>8P                   ( MT'CJUGKJ-08
M          #8 HVG;JVG7F,                   " +=!XZM9ZZC4&
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M[Z*SY[$V=.A0/34I*6/&C-%YT="I4R?=4DK*A D3=%YR&SY\N!S"]==?KY.
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M>-X]K%?]K%FSK'= W8"#]8G/^MQG9G6&C_/@%.>_GXF4[D$DG+<LG>%@3B[
M>[>'.-S>3T=X@,G9AU!XN@<%DIQO*UK"00,^)/D=P*1[4Z#CS1.?UZ.(YV<]
MK>5@3H[G6UXAQ?,<NHK/6[;."\>CI^7))Y_4V2%H,E\\S[G6<C GQWG=QN[_
MXO&0\(\,9GT=,T=U)(ZL1[W ?N1+34TMS/]E&SN??_YYV[9M=7=]N.RRRSR>
MQIPT[Y WS5K6#SWTD,\U;=T"K.48O)W31XX<L1X+=&H(Y<N7?^>==Z1"*!IV
ML&=.G#BQ;-FR.AS:U5=?7; O!=1"!5WYRY8M:]RXL=8*IURY<J-'CP[[>)I'
MPP7B<UMQ.)RH.WSX<*U:M72?4E*F39NF4Z,G5%^1/"N8PCYM6"O?HUG$E?.3
MF\??PA?L?B7NO?=>K1N)K5NW#APXL&+%BEK7AS/..*, ?<;OO__^11==I+7"
M.>^\\S[YY!.MY<;Z4*%AA[!+\<477]2,@]DL:!6L7+FRSG!3I4H5GP<2D?A?
MQT*:-&F2[D=*2M>N775>"(L7+[93UL.9_7/71SK__\3Y[KOOSHM8SSEA_Q(A
M*BOMKW_]JV8<S)4V9\X<U^_U=!7VRX87+ESHLW].U*Q9<^;,F5HN7JRW-F?C
MM77OU7F^C1LW3JKE6;!@@4[U+=G.[9HU:[ITZ6)W7?MGK7.ME2_A[Z'>XGP)
M,C,SQXX=Z^??6CC5KEU[Q(@1KB_89'A.\/;MM]]>>^VUNDE_K#?$ 0,&?/SQ
MQUK44P(?C*VW;]>>>)^J5JTZ:-"@4,\ .KM G >H,QQDOD_)]J';\N]__[M^
M_?HZ'(+U3FH=@K&=!-!]RC^6[.SLX<.'^_P+A#P%_O2=)R&O*2V7Q$M1DY[\
MM*4V:=+$C%BG46<$HRTUZJS;1:]>O9P/DWZDIZ>/&3-&*T9(BWJ>25>:C[Q"
M%,7A99A'\P[VS*^__KI%BQ8Z')JQD:A)^#(K -T/!WMFW/Z6.$^Q66/ZTP)Q
MOO/J# >9[U,2GO8B][!W.EZG4<.1B,5[KFZC0)Q+76@@?ZGDY.3\[G>_^__L
MG7G\#\4?Q\=7<E.)#I4CE1(=2*YTZ%:44%&ZZ'+\"J4B4HG(D4A)=**0;BE%
M)4<BN9);CMSW%5_[>]O]6O-YS>SNS.Y^=O=+SS]ZZ+OO]VO>,SL[QWYF9]1?
M?10L6'#<N'&IVGK$,I;V 4:@0W9?EAIEZ[%JU:JKKKH*19W)R,AHUZX=S0$M
M=[RL4 X\T;^?\0$FK(/89*&%@&WIK^]V(IKFW5#.8)+7(00'D_>%9WN+#I%T
M*^@L@ ZN9(L6@ >#T,RO363/HTWT<SU4$; MH^SR@A!]&8I$UF6CG1=I6I8:
M?9FCBH!M&7&]3>M//$XD8<K *^,U_BI>B0IZNHH5*W8XCD.4+U\>31/ &V^\
M00\&QJI,[MRYQ=&8$^@L8)CCE7OOO1<O>/'ZZZ_;J>S:M>NRRRY#"U=H3#E^
M_/C#@3J#G@*6&6SFH0@U'SX^F4(5_9I/94Z-LN+X6TKMVK4W;=J$N@+HY@O/
M=B2R[(0.M9(8BODK75H_NIH_?SXF:3)\^' T-:%@/*<3%2M61#=7-F_>C!*,
M+5RX$.U,J('UMX@0&#)D"$JKX?+U"05VT447U:E3Y_;;;Z]7KU[UZM6EH=:J
M50M%7=FP84.#!@U0Q1S/45'?<LLM% \-C*C>BH<4,W/HH[(^2>6;UYDS9Z);
M*BU:M$ ?@;9MVQKF!RYWWWTW7G.%ADU!?I4!HK^/H4 /)L;!&$6(=@[8$P:J
M%?P'0]*EHHKGR]!-L7]=N^..._"R0"@U[9%''D$? :NF[=^_7Z5:VA0I4@03
MXUB[=BU5"?0QR[-FS9J4_5:M6C5OWIR>2E@\P4,]%.I& LTZ,!3&ZM>OCW;*
ME"U;%N48._/,,^U)IA9)*]L___SSAAMNP 1,J*6M6K5JW;IUJ8D@&^F8OTV;
M-JAH$GL?ZD+TMV#9LF72#0G*E"ESTTTWW7___:U;MW[PP0>I!Z04G<9U!0L6
MA"\$8A\G>+)@P8)33ST5T],'=1V(=V#<KU\_Q<^(/4%I$S3RA3BY0 L!L%<A
M:9-N8M*D2?GRY<-KKAQWW'%SYLQ)32U2," S+]372X?*GOB;?<?X3*%0@JLB
MNKGBN2Q5',-4JE0)C5+Y;UEJZ&!Z^M!S&N0@,Y1S+4DIZ*^O$!;1/(86Z"Q@
MF<V8,4-EFL:3FDXX8!KZ!*QF/L (!"RS*-\2&T=6'<._^N*_P9XZL0_V(BM&
M]-0A'7TNIN$+L:H#Z&!6%1K<2G?8<4?]US0@QK&T#S!M';+ULM0H6X\__OC#
MWQN2A@T;6L?$X06%<K")^/V,;S ]'<0F"RT$+#/??;>4R)IW0RV#"5^'$!Q,
MVQ?)[%;04P =G,DN+0 /INTK]2B?1QM4T4=WKH?^ I99E%U>0# .?73+$(BR
MRT8[+]*T+!4M]-$M<_07L,PBKK?I_HE')#E3!EX3K_%7\4I4..T^>-]]]Z%I
MW'3HT &C-$^PK5&CQJNOOOK;;[^M7KUZ[]Z]]%_Z-_W%:6->TD%I&>@F0#;/
M/?><]6_JV)HV;?KYYY\O6;)D]^[=6[9LF3]_/@W[+K[XXE2G@QQSS#'V)RGU
MZ]>W_B@JS)LW[[777I/^!%ZJ5"F5=@'=! RS1[?_EP;N- *C&/[ZZZ]M)I2+
M3S[YY/;;;Y>V%T6+%O4\D Y "<V:3P_V0P\]A!)FZ35ITN3CCS]>N' AA;US
MYTXJQG'CQCWVV&/27N>BBR[R/ @8?7SA/A2.,COADIF9><899V <FL=S^^#/
M/__$)$V<5F/00U0Q%7&3,]US;_D='"T*%2H$JTQL5JQ8 0&(JT]..^TTL!&A
MC*"T A]\\(&X]).J4/OV[:=,F6*-JWBHV1&_**5:!V8N3)X\^9133@&%DTXZ
MJ4^?/N)FEGOV[/GPPP_%BI21D3%FS!@PYEF[=BV4C_@!"DU4/#?PH^H*.N)(
MY?WWWR<=_AM$ZE8HYBI5JM2J5>N\\\YSF1'Q&WP&(?K[&!8__/ #A,',)5QH
M)V/:M&FV"SRDC1HUXO2R^.:;;W@;)]JV;6O9TWWT_% RK)KVY)-/7IN*O336
MAFH:]1>WW'(+_T=Z%JB?/?_\\\\YYQQI3:.A*B9VB)]^^DE<@$B#AZ%#AU(-
M06O#H%[F\<<?%Q\!XLLOOT3K]$.M.L;!V LOO(!V:GSUU5>H9>+O[/A$E2U5
MOXX=.XKB5&>Z=>LFSMQV[=HE[OI,C0R86<3>ASH1_2V8/GWZB2>>R#M2 %3"
MU,NCJ0F-WVA4S]M;5*U:%2SC'2=X0LV@V*T7*%"@6;-FHT>/7K!@P=:M6ZD;
MHO_2C(#Z]#ONN$/:6#&U 7^\ V.[@^"AI*EE'CY\.#U-FS9MHB=N_?KULV;-
MHC:*.B.Q,;=!=1,T\H4XN4 + ;#W)(&3[J5+E]J_,-%SU+=O7[H+="\HC%6K
M5E&;\/333TN/<: !F[_/#T(!HS'S0N-#^W^I87GPP0>IDZ*ZO7W[]M!GW_$^
M4ZB2X*J(#JYX+DM]]MEGT<=K>_O_EJ6&#J9G0D\<5?*OO_[Z[[__IA$1S4:I
M\OSRRR]4_M+7;@T:-$!=95#+M22EH+^^0BA$]AA:H)N 88Z=BA0I@A>\P)3"
M -,PB;*:^0"3%S B?TM\A-4Q_*LO_AOL99?!7I3%B#XZI*//Q31\(59U !W,
MJF+_&$=<>>65 P8,H)G:A@T;J*C7K%DS9<J4%UYX07S53- ?J1'#-%R)=RSM
M TQ8A^R[+#7*UN///_^4=A#4)]YQQQW4/U(O256"9G94-VB61_6'?Y7T^../
M&[),83(.1/Q^)@B8G@YBDX46 D:POELDRN;=4,M@PM<A! <3]D4RNQ5T$T '
M![)1"\"#:>NG'O'S:(/^)FF=ZZ&S@!%MEQ<<#,(DK67($W&7C79>1+DL-:UE
MCLX"1N3U-H*?>(!$31EX0;S&7\4K42']X9]X^>67T316NG;MBB$R=M999_WX
MXX]HRC%APH0SSSP3W12.41-!"<;HH<W(R*!_5*Y<F=HO=#"A!X9&+>AYZ+S4
M@0,'6O_KHD C"6F_2Z,E-/4")1BC=ME^V&@P2H,M]#D$C>QI3);J?9 R9<K0
M0 >MG4%_S9K_Q!-/H+]Y5I3+/EOTG'?JU$G<[HNRH]6<@3O3C%Q*C-D)R&>?
M?08!6'S__?=H&BK\2C6>M]YZ"TT=./_\\\&79AIHY(KXJ^%EEUV&1LZ(9W-3
MGX1&@:&Q5,.&#2$AZM<IL]33HS6'. IY[[WWT,B!CS[Z2.R\FS=O[MZ/TH2*
MQA;@11,JZI[1U!F[+;6AJ3@:>4&C,7$[4AJCV(>;E"Q9LG___C1.XKUH,#%X
M\&#I +=8L6(!G\I8[F.(S)T[%\)@YA(TM)-A[X-(_2PTB2U;MDR5/(A*!FFX
M:2_(JU.G#EY6()2:)MV!DFJ:O2,OS9QI*#QJU"BJ +Q7OW[]X&T"=2*<\&%&
MCAPIOG=X\LDG=^_>C::IC!\_7CSBH42)$@%KL@^D=UEQ!2% <RT:JZ"6.?3R
M?%TEDJBR7;QX,<U50)/&QM2M."WTI"9+?#6COJ(Q]C[4B.,64+,/$T4:=-'$
M%>T$>O;LR7L1CSSR"!H)1#-.4(1FSA#,====1QTWVG%0]UVK5BWP8FK#YA@'
MQM)E9-6K5W=)FOCGGW]NO_UV=#-!4QGHH^;E"8IJRB9PTDVWLF;-FLS<(]QI
M&;UA;BU_\\TWHS-C-$Y#TZC 4!C[^NNOK7]04_SHHX]*5]);A#+[CO&9,F39
M1PM7XJJ*YYY[+OAVZ=(%C5PY[[SS0('HU:L7VCG#'SA V<'+Z80+.0NT< 8]
M=7Q#!T-AK%FS9N[/SI@Q8^ 3%.*55UY!.S5 A^F7!OKK*P0GKL?0!B7,'J%&
MC1KV_U:L6)%D?_WUU]6K5__[[[^;-V^FV!YXX %QN(O280!)L,BK67 @$A;Y
M6^(COHZ!C9.9+BBJ*9O,8L]V@[UXBQ']->M Z& T(<6#HHQ-FC3)^C'N]--/
M=SE=>M>N7<V;-T=GQFC2AZ:NQ#N6#@[$P +<%Q3R)842^B+H'VWK07.W4J5*
MH82Y9<#??_^-UH<@+YKWV;W&V+%C4[T/@CX.1/Q^)D0P^6 !H%;8?7>\S;LA
MRV"V6X<0' S"X6;I@J*1=RN&+ :T<"";M@"8MF;J,3Z/Z!SY7 ]T6+1=7BA@
M!!&688Q=-K6EXE'U#S[X(-HITZI5*UN'*@!>3H5+,XO(RMP"=%CD]3:6GW@2
M-67@U? :?Q6O1(7TAW]B].C1:!H?7WSQA3AJI&JT4^&X\!T[=E2M6A5\28TT
MT=054" NO/!"9BY)\?PF1KI*^N>??[:6AZLHW'///>!>LF1)IS4'3H "<<TU
MUUC_Z-Z].UH+4'+28ZP;-VZ,ILZ@LT[-'S%B!#HS=N>==ZHL*QDU:I2XB$'K
M\%;P93J12XDW.P&QOZ[C*5JTJ+AQ8[A\]]UWF*K)VV^_C:8R=N_>+:X[G#)E
M"MJY8B]2M%'?%'/-FC7@2RQ:M CM@K%TZ=(*%2I *@T;-J1^'4U3D:[+5#R%
M;?CPX6(/VJU;-[23L6+%B@(%"H O#4'0SAEQ6JB[@9\A6_2<-V]>RH+U[_;M
MV[NL>5JP8(&XOQU3+CTIL=S'<-FP80.$8>%2DA84K=WI-VK4"*Y*7[+T[-D3
MS$3XCU]_^>47O*Q *#6-D@81JFGV6KTJ5:K,G#D3?0[1NW=OWI&>.[0PC''C
MQD$'D9&1,7#@0+1S@"\E&YK,HUV:X=\GVE 3BG9>T-!%'$$1],"JK\6T2539
M?O_]][ @GIZ:MFW;NC]?$R=.Y%V8612*4YW8^U CIEMP^>67\_;ERI53WRK@
MAAMNX'T]OZ*)9IR@R.S9LR$2FOMX[@]MF)OX0L:9PK YQH$Q37O!EYF]C^*C
MT;%C1W16R*^1ALF%!8KJR"9STOWNN^\R<XO*WW__':U3H6;JDDLN ?=++[T4
M[:("(B%*ER[-S&)YXXTWT%H@X.P[QF?* MQ9-JF*XAO,\N7+HY$S\^?/!W<+
M"AY-G>'GVC0'P<OIA LY"[1P!CUU?$,'(E$\.&+9LF6P TWNW+E7"X=^J,"+
M6*"%%^BOKQ"0&!]#&U!@YE#*^D?1HD5=?M(8.7*D]0.S#5J$ :_/XJAFP>'#
ML(CR+?'14,=X Q<S75!41S:9Q9[M!GNQ%R.X,YTZD XPFI#B0=%#/\:==MII
M+EM,65 #!><1,7/5D>(4STC 6#HX$  +<%]0R)<42NB+H'^TK8?T\*[[[[]?
MY2=:>R=R:SX(H+6,B-_/A ND'C  U JU[XZ]>3=D&<QVZQ"" S$PV<WR 8I&
MVZU8@ )3RUKV;0$@::W4XWT>P3?ZN1XO8A%EEQ<*$$"491AOERW^ E6@0 'W
MM:%.4&WG3R\<-FP86J3"I7F0*,O<@A>QB++>QO(33]*F#+P47N.OXI6HJ%.G
MSN$@.*9.G8JF,;%QX\:33CH)PCOGG',V;=J$I@YLV+!!/'CWY)-/]ES<PP/N
M%OGRY7-966^S;MTZ\7@C:S&!HL*J5:O$;0@G3IR(=JZ NTW+EBW1U(&]>_=:
MJ]J!\>/'HZD#Z*E<\]>N72L>8TT#"_5UD*^^^BJXY\F39_'BQ6CG /@RY<BE
MQ)Z=(%#?(%V!I_CJ.0COO/,.IFKRV6>?H:D,:M; ,6?.G+MV[4([5ZCQ 1'J
M5M'( 1KU@B]UQBHC(77FSY\/&ZW1:+M'CQYH)T-<ETD-E$J'/6'"!+'OU#IN
MVU[]R:.^<+!RY<K@J[N!GR';")/N3JY<N3(R,@8-&H36 M*=X<>,&8-V:L1R
M'T.'ZK:XB(U8OGPYFJ;"?_TICE;??/--3BR+=NW:@1E <U%[#=_EEU^.E]4(
MI::]]MIK($(US7J":(CLOJ:0KO+KO\7/K:9,F2*VSUH;=-%\0YSP/_744VB7
M3JCFB ?-TQ.!=E[0H$5<2<S,)\)S):)(HLKVDT\^@2/I*5/T1[03Z-.G#^]%
M5*M6#8T<B+T/C>46B!VWUJZ]5--XWQDS9J!%*F)RH8\3U.G4J1,$,W+D2#1R
M@"99\*$M6J02X\"8IFGB-\&4])X]>]#4&?%S7K20 2Z*7IZ@J+)L8B?=U@?N
MGW_^.9K*^.FGG]"?,=T#A<,"XS@$/5QHZH#OV7>,SY0-N+-L4A7%WWN8N7T@
MVCG0I4L7=#:AWD?QE2X-6?EW1_:IB]' A9P%6CB#GCJ^H<.'4;9L695?["Q^
M_/%'WI>9.[*CD0(@PO1+ _WU%8(0[V-H ^Z$M8']*:><XOF!&2R7Q,MAP.O'
M4LV" V'81/"6^"BI8[R!BYDN**HLF]ABSUZ#O204(_@RY3J0)C":D.)!49.,
MC S%T=&B18M@"1I3/N<M"6/IX$  +,!]02%?4BBA+X+^$;8>X\:-0T]S'TKU
MWE]\P6*#IC)$]_2]GPD=/NG@ :!6>'UW$IIW0Y9!IKR*("'K$((# 3#A9OD#
M14VBZ59LP)VI92W[M@!\NEJIQ_X\\EZQS/5 A$78Y84%GW2491A[E[UFS1KX
MY8[HUZ\?VBG _Q1.3X1G%K@$(RUS&Q!A$=;;6'[B2>"4@9?":_Q5O!(5XF9L
M%EH'**>51Q]]%(/3[^RES9#ZBS9#]BP1'3MV1#L'ZM:MB\XFZ@K777<=^"KN
M1&@#[A8T7N>/"?9D[MRYXMBK8L6*:.< .#+EFM^L63-PI/'Q@@4+T,Z9 P<.
M5*]>'41H*H)V#H C4XY<2NS9"<*GGWX*Z5J\\\X[:!HVTET2F?+Z17'=8;ER
MY=#(E1T[=HCU?_;LV6CG@/@[I>_E<5*H"L%'+13MT*%#T<Z!UU]_G?=E9O>)
M1@(K5ZX4C["_ZJJKM);14.<M+A6Z[[[[T$[&OGW[Q'.9)T^>C'9>2)>O,>63
M2K[]]EOT9$R]\'EBN8]I C)B,6W:-+3C6+ITJ;V8]<8;;\3+#DU0TZ9-T2Z5
M7KUZV<8T),#+"H15T^Z__WX0L:#,JJP>+EFRI&5?J% A>,KH.1)'WK5KU^9M
M5!#/$+_KKKO0*)W\^>>?$ !Q_?77HYTK$R9,*%^^/*J8'T#__///:.U%HLJ6
M'@&8V5)E4,R4N*%1BQ8MT,B!>/O0N&Y!M6K5>&.*0>4YM:%VPUY*?NRQQ^[=
MNQ<M4DGW.$$+\;-R]\.A -AQ$"^G$N/ 6.S]J9;.FC4+[5Q9L6(%?(:!%C)X
M>W4O3U!463;)DVZ:"*.=,^)976^^^28:10*$87'VV6=[-@4\_F;?,3Y3-N#+
MLD]5+%NV+#BJ?ZI^P047@*]-__[]T5K&\.'#;9?2I4OCY33#Q9L%6CB#GCJ^
MH<.'09,CO.P*;"=3N'!AW8]PC#!* _WU%8(0^V-H@<XFU"2J;*,P?OQXW@LO
MAP&O'TLU"PX?@TTT;XF/DCK&&[B8Z8*BRK))+O9L--A+0C&BIW(=2!,834CQ
MH*B)UBFH,)TGNG;MBD8RDC"6#@ZDS@+<%Q3R)842^B+H;Q)-ZW'111>!8\Z<
M.=4_73/,#SG$!5(6:"HCRO<SH<,G'3P U#()I>].0O-N.&10?15!$M8A! <"
M8,+-\@>*FD33K=B .U/+6O9M ?ATM5*/_7GD76*9Z_$*-M%T>6'!)QUE&<;>
M91,-&C0 Q_/..P^-%.#S\LPSS^!E 2[!2,O<AE>PB:;>QO(33P*G#+P.7N.O
MXI6H$'^=M=B\>3.:Q@'5 '$3/GHVT$X!^R@B&U)6^4+( GR96:'_^><?M'.@
M?__^Z*^I $?W,MG1QNZ NX6/G=[NNNLN5%'X%-X"W=1J_I(E2\0M]^Z]]UZT
M\T)<S)0K5ZZ5*U>BG0QP9&J12TE"=H) XS9(UX*>5C0-F_ONNP]3-5%\D,5N
MR7TQBLC//_\,"GGSYE7_[J%>O7K@_OCCCZ.17S9MVB1VV'W[]D4[9QYXX %P
MI]$_&J5"7>855UP!7H4*%5*\(SSGGW\^Z!0L6%"E;/_XXP]P]+&!'U&I4B70
M8>9Z(,452//FS4-GQMY^^VVT\R*6^Y@^I+_-NQ^6\?###]N6DR9-PLN&,7GR
M9$XL"_>A+4TDBA<O;EG2C<;+:H15T\1Y$5&F3)DM6[:@J8S33CO-<JE5JQ9<
M:MBP8:KJP0CGSY\/9IZ(-5!W26A /OSP0PB >/KII]&.@]JB;=NV+5^^_,LO
MO^S4J5.Y<N70WQQT-6G21/V;6I[DE.UOO_U&_0ZO0*-9Q3&8(6MIU9NI>/O0
M6&Z!^,E$G3IUT,@+ZZ@L@IY]O":0UG&"+G9K8Z.UE@ZV[L;+'#$.C/D/(6S\
M;?\/AWGA91F\O;J7)RBJ)IOD23=S& \X(9Y;%]= ",*PH#X.[;S0G7W'^$SQ
M@"_+/E51/+:)!K1H)&/APH7@R$.3)G204;]^?=O%W^8$0>#BS0(MG$%/'=_0
MX<-8MFP97G9ER) AO#O3__7+"*,TT%]?P3=)> PMP->B5:M6:">#QOR\%UX.
M UX_EFH6'(C!(H*WQ$=/'>,-7,QT05$UV807>W89["6D&,&1J=6!]('1A!0/
MBIJ(IP:Y\,PSSX![@P8-T$@@(6/IX$#J+,!]02%?4BBA+X+^)A&T'M*M*'Q4
M">G;3J96#I&]GTD'?-+! T MD^!]=T*:=T.60:U5!$E8AQ <"( %JS,V*&H2
M0;?" ^Y,+6O9MP7@TU5//0G/(^\2RUP/%"PBZ/)"A$\ZLC),0I=-_/###^C)
M&/T1[5SYY9=?;-^<.7.JK,#A4HNNS'E P2*">AO+3SS)G#+P.GB-OXI7HD(\
M)M7"QTJ+=-"A0P>,S&M%BQ-CQHQ!(9V/A-!3<_LB^!++A\+8L6/!O7SY\FCD
M"K@SLP/VL3Y#W,R9*3_>Z*96\]NW;X]NC,V<.1/MO-B_?[^],LFF>_?N:"<#
MO)A:Y%*2D)T@7'SQQ9 H,P_+0+LT4*5*%4R8L0(%"J"= ^(!W%J'_QJR_;0I
M)#1RID2)$N#^_OOOHY$O,C,SK[WV6A!OUJP9VKDBKI8;/'@P&J4BCE28VE<[
M(N*2(T+E6Y:A0X>"E^X&?H;#1I@Y<N10?S!IE #NQ*A1H]#.E;CN8_H0)W[N
M\:Q9L\:^$>*R2XO%BQ>GZAV$VB6TXQ@T:)!M.7KT:+RL1B@U;>_>O>*DFND<
M"[YQX\;U)K"'C3AX)9HT:<+;J'#@P 'Q6;CMMMO0+IVT;=L6 F#F&[2<SHC;
M+?/DSY__KKON\CS+R8GDE.VZ=>M./_UT4!@X<"#:.;![]VYQIJ3>RL78A\9U
M"]Y]]UTPUDV44CSII).*F*A\C9V^<8(/Q,9*:QWPYLV;>5^\S!'CP%B:](0)
M$]!.@0\^^( 7P<LR>'MU+T]05$TVR9/NTTX[36L/?OZ$(XN:-6NB421 &,S\
MYLK':Q;=V;>T8D?S3/& (\L^55'\$HFI'1KUTDLOV?;B>7,T7*'Q&_JDLF/'
M#O[4Q>G3IZ-%FN'BS0(MG$%/'=]$0?<:,J)X>@8/*##]TD!_?07?).$QM$!/
M<X:^?/ERM,N&A%+-@@,QL*C>$A\]=0S50WJ0451--LG%GHT&>PDI1G13JP/I
M Z,)*1X49:QRY<IHY,J($2- 0>77M(2,I8,#2;, ]P6%?$FAA+X(^D?5>MQQ
MQQW@Q3376%C03%#Z6SS:R8CL_4PZX),.'@!JA=1W)Z1Y-V09U%I%D(1U",&!
M %BP.F.#HE%U*SS@SM2REGU; #Y=]=23\SSZ(Y2Y'BBPJ+J\A."[#)/095N<
M=]YYX*N[BKU)DR:V;]VZ=?%RV/@N<QY08%'56^GH/=T_\4@3C7W*P(O@-?XJ
M7HD*\?=I"\6]B]+-&6>< 8%10[!GSQZT4V#W[MT%"A0 M1(E2J"= ^!(=.G2
M!8V<H9$Q^FLJ+%JT"-SI848C5\"=.9R/[ G5#?$<U?SY\ZM\H ->3*WFBQ\#
M^3[/3CR^UO-L*0OP8FJ12TE"=GRS8\>.G(>.H^6YY99;T#0-2,<!BEF6KCO4
M[9;NN><>4'CXX8?1R(&-&S>"+S%W[ERT\P5_0+G%N>>>J_6SMW2UG'L/NG/G
M3G&_;6IF-VS8@*8*//;88R#%U+;Q:]VZ-7CI;N!'S)HU"T2(A@T;HITS8A/-
M]"M8+/<QK?!#9YN77GH)[0[QQ!-/V&;??/,-7C:A5H@3RX+&;6AWB,S,3/O,
M!9H,: V">4*I:3-FS  1XJJKKD([36A<)(Y<B=]^^PU-O9@S9PZJ,/:___T/
M[=+)E5=>B1'H4[APX1HU:K1HT>+33S^E$2"FH4RBRO;66V\%=Y<EE2)3IDP!
M]]RY<__[[[]H)R/&/C3&6R!NF%>A0@4T"H^TCA-\4*A0(0@F3?OVQ3@P%I.F
M.8Z_63#,]?"R#-Y>W<L3%%633?*D6Z6AX!$_22]3I@P:10*$0=Q^^^UHI(#N
M[%NLV)$]4SS@R+)553SGG'/ \<477T0C 2H<V_ZUUUX35Z8.&C0(?5(9/GRX
M;5RJ5"F\G'ZX8+- "V?04\<W46S=NA4RXGXL@Q108/JE@?[Z"KY)R&-HR HA
M^+PI(812S8(#,;"HWA(?/74,U4-ZD%%433;)Q9Z-!GL)*4;P8FIU('U@-"'%
M@Z+Z^R!,GSX=%$X__70T$DC(6#HXD#0+<%]0R)<42NB+H'\DK0<]X-2C@5>Q
M8L443U<#:#X(4DRM'")[/Y,.('*FEF4G4"NDOCLAS;LARZ#6*H(DK$,(#@3
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M%Z9_D(Y-CQX]4$NM'*)Y/Y,F('*FEF4G4"N,OCLYS;LARZ#6*H(DK$,(#@3
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M<@7]PU! "U?067_493-[]FS48JQRY<IH)X ^"EF05@-_>Q<;YAXDJ.7PJA1
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M4E KC+Y;^N#'TKP;L@SJ-GWH'X8"6J093#ZD %!4OV0,F0A:N(+.RN[9M 7
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M<6 L_6$LRB\Z,&V_DPL 115DC[!)MQ&22' P",:>?_YY-%)#.O^2SKYC?*8
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MFLK@[=/]?B9T(&FFEF4G4"N8&D\2FG<CC RB?QP* 3GRNA4;=%9SY^VS5PL
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MWKRY>L43R9\_?]>N774_/C%B'1A/FS;MP@LO1%TOJ >?,&$":BD0RN0"[;Q
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MN65RTPL_%UY5R8-=6_[OK47?8RHM><88JS0Q8L2(F-9$AY_;V;-G-_WJTV#
M@ $3)TY,7G\VIBQ8L"!&Y'*OOOKJFH7+TH&/H7GM.07//??<&6><D3PK:WK]
M-B=9V(<<<LBMM]X::Y6AVL\3VB(Y@<D3U.1>5^)[[IM*'IA...&$6;-FQ7)E
MZ\ GQLDC[.3)DW?999>XF6*&#ATZ:=*D_$77"FU_<1%#6Q+S2^H4+[KK*U2D
M[>)FFD@'/_OLLP<==%"+-YFLK[Z;TP[75*S2DIA?4CLLQ7(T_2FH^^^_/P:U
M9.3(D>D*2<T8T8[2>U*.MN3FI8M4U9UWWKG77GO%S3=15U=WW'''O?/.._G$
M&-%$:B/EI@0QOQ(5JJT=+L-8J#RQ2OMJSV56<7&3[?(N<0E==8UYLA<+M23F
M-XA!+8GY55;MTQBKE"T6JJ8:6>HQJ"4QOQGM\%RZ[>)^E"T6*FG&C!GCQX\O
M_>Y08L\]]WSLL<?2B3&BB71PF2E!S&\0@UH2\YMQXXTWIG_ZMJCDM5[RBB]\
ME7@,:B(=''34^S-9Q3TH6RS4( :5)U9IK6K?WNNS'V#,KXT*U= U'E;B<$M"
M>EJGN /$S;<DYI?4#M=CT)ZO]6)$2V)^@QC4DIA?!>UY#IO3(0_9I?WUKW]-
M?Q*TT48;5;!KO#W/>8QH2<QO$(-:$O.;T<X?\33J\)<,Z?IQ+#T:1VI8\MKC
MNNNN.^:88_;99Y_/?.8SZZVW7G+Q).<N>2P<-FS8B!$CDDOWK+/.NOGFFV?/
MGAV3*VK.G#G77GOMA D3DE657+1KK;56\F"3_#?Y=_*7Y.]77WUUM?>A$RFL
MMN97W;1IT\X___QD!H</'SY@P(">/7OV[=LW>>*2O)(\Y913FGMZU[&>?_[Y
M2RZYY+###DO67K((D]68[/; @0.WW'++,6/&_.N__NNO?_WKM]]^.Z:UP8(%
M"ZZXXHI__,=_3)[R#AHT*-EB<I:25;?SSCL??_SQ=]QQ1UN^[Z3]#Z<:DJ>Y
MO_G-;Y*S\7=_]W=;;[WUAAMNV*]?O^18UEUWW4TWW30Y4<D!GGGFF;???ON\
M>?-B<C6]^NJKEUYZZ9>^]*5D[I*]2B8NF<'/?>YSW_SF-Y-;5NEORVNCY%YT
MP047)!?75EMMM<$&&_3ITR>Y>2;WS/WVV^\'/_A!V[\F-CF3O_SE+\>-&Y<<
MSL8;;YP<6E(_V=:7O_SE'_[PAX\__GB(?_GEE\,-(7GBU<;OM'[QQ1?_XS_^
MX]!##TU6;W*,R=VX<3>2-?#%+W[QM--.2UXY5+9QL.NIA7FDLTL>@_[XQS^>
M=-))R6/WD"%#&F^_R6-Z\FB^S3;;)+?E8X\]]F<_^UGUNF.[L X_MZ^\\LK%
M%U^\__[[)Z^ED]ML<HM(_IN\SOGG?_[G&VZX(?3!)R]IPOTA>11.!V35@8^A
M>>T\!6^^^>9___=_)Z]K&F_+6VRQ1?+<+'D$3\[DYIMO_C=_\S=?_>I7D]%;
M;KFE_/\30G.J_3RAC3[ZZ*-''WWTRBNO3)[=[;777LDC>_(@E9S_'CUZ).=_
ML\TVVW''';_VM:\E+^"3"6K[]V'G=> 3XV0577[YY4<<<41RB37.2++IY!_)
MJZ1D4I)YO^>>>RIUI%5]<=%V7G173W)?_<E/?G+((8<DUU1R8VF'5]\=>$VU
MG:5(*TR?/CUY]I*\1$V>.R5+);F9-[Y[.7+DR".///*ZZZY[[[WW8@[-<QD6
MU4F767BED*N-=XF[ZAKS9._3P&FLK_FEWG:=^KET!;WVVFO)1"?G8?OMMV]\
MX$LF>N.--QX[=NS$B1/S/Z'3Y3WXX(.GGGIJ\IB8/#(F9R!9#,EKNL]^]K,'
M'WSPQ1=?_,HKK\2$"NFH]V<^M=S>.U"7?UAIA4_Y':#]K\=.^EJOIM3".>RH
MA^R.4@OGO$:TYT<\>1WUDJ'TVSNEQJ"R"JO-JH-/O6NNN2;<$,KYOD!JC7D$
MFM/TRTK'CAT;@P  @$^?\$HAYUUB    @$ZH]-L[I<:@L@JKS:J#3[W##CLL
MW!!./_WT&$3-,X] <PX__/!P?SCAA!-B$   \.D37BGDO$L,    T F5?GNG
MU!A45F&U677PZ;9@P8*^??N&&\*T:=-B'+7-/ (E;+WUUN'^\)O?_"8& 0
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MO?*7\+AQX^)P2?/GSQ\^?'CJ'O")RRZ[+,91?>81J*H==M@AW"5^\8M?Q"
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M>EIJ#             #R"HVGQ5I/2XT!            0%ZA\;18ZVFI,0
M          #(*S2>%FL]+34&             'F%QM-BK:>EQ@
M   @K]!X6JSUM-08             .05&D^+M9Z6&@,           " O$+C
M:;'6TU)C             )!7:#PMUGI::@P             \@J-I\5:3TN-
M 0           $!>H?&T6.MIJ3$             R"LTGA9K/2TU!@
M      !YA<;38JVGI<8             (*_0>%JL];34&#1G[MRYO_SE+X\Z
MZJC/?>YS0X8,J:NKZ]6KUP8;;+#--ML<<L@A9Y]]]@,//+!BQ8J8!@
M     '1FA<;38JVGI<:@J=FS9Q]]]-%]^_8M+)UF#!@PX-O?_O833SP12P!T
M'C-FS#CDD$/666>=M==>._G'*Z^\$B.@>=8/         -#UI!L%XYBV5#*Y
MYYY[!@T:5%@TY8E5 #J)&3-F#!PX,'U#2^Z!K[[Z:HR#8JP?         *!+
M2K=#Q#%MJ93O[KOO[M&C1V'%E"T6 N@D#C[XX'A'R^7&C1L7XZ 8ZP<
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MQJ!18958+5##XH7J4@4          "JM=(=2J3%H5%@E5@O4L'BANE0!
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MPS&AB<:P]KR^:F0>LXK;**G%MM2I4Z>&E/_S?_Y/#%I3+;>E5NJ1JQ,]/P$
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M)6VWW7:A0N(G/_E)C&O>Y,F3\XG) HO#Q:0VM4J,:$G,K^@C5Z=^?@(
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MSA$C1H3<O/_\S_^,T<5,GCPYG_*9SWPF#C<CM9U58D1+8GZ#MC]R=8'G)P
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M+RM6K%A__?53!3Y1HB]S\N3)^;!APX;%X9)26U@E1K0DYK?YD:OH]=49GY\
M         !TBW200QVJV+?7UUU__U:]^=<())^RSSS[;;+/-)IMLTK]__V[=
MNA5VMR6Q8DMB?BXW;]Z\&)31J%&C8M%<KM4_:[MHT:)8*Y?[VM>^%N.J(&XU
MX^DM>AZ>>>:9&%>VHE^5-WKTZ!A73$RKQ$170RU< EG7ZD<??11+9-^-K&IG
M=<6<5AU[+)&Q2$S.F)ZWTTX[Q4*YW'///1?CRC-GSIQ8JXP=JYV9K:_$B8WY
M[7)]U<(\5LG$B1/#GB0'&X-6FSU[=O[FF?QCUJQ9C7^?,&'"FC5R7_G*5]9,
M+1@W;EP^[.233X[#):6VL$J,:$G,;_,C5]'K*^N:S.O YR<         0(=(
M-PG$L5IK2UV^?/DUUUSSMW_[MYG:[XJ*I5L2\W.Y9&=B4$:;;;99+%II9?94
MM5'<:L;36_0\O/'&&S&N;#-GSHSE<KFA0X?&N&)B6B4FNH(Z^R402V3?C:QJ
M9W7%G%8=>RR1L4A,SIB>M\DFF\1"N5R^F2^KA0L7QEIE[%CMS&Q])4YLS&^7
MZZL6YK%*IDR9$G>E^2\03?]@_:Z[[IK_^^VWWY[*_D3?OGV3PTREKK)HT:*Z
MNKI\V..//QXC2DIM8948T9*8WZKUDU;T^JJL]GE^ @        !TB'230!RK
MJ;;4N^ZZ:YMMMBGL4-O$ZBV)^=DK--6_?_]8M-*VV&*+N-4JB%O->'**GH=W
MWWTWQI5MWKQYL5PNM\XZZ\2X8F):QF.IJBYP"<02K2J22>VLKIC3JF./)3(6
MB<D9T_/2'7AY"Q8LB''E6;ER9:Q5QH[5SLS65^+$QOSL%>JS%ZF%>:R>K;;:
M*NS,!1=<$(,:C!DS)A]ST447Y?^^;-FR9 &D"GSBQAMO3*6N,GGRY'Q *QYV
M4^57B1$MB?G9*P1%KZ_*:L6) @         ZBW230!RKG;;4L\\^N[ KE1 W
MT)*8G[U"4SUZ](A%*VV]]=:+6ZV"N-6,)Z?H>6C+-[TM6[8LELOE>O;L&>.*
MB6D9CZ5ZNL8E$$NTJD@FM;.Z8DZKCCV6R%@D)F=,SZOX68VURMBQBN]#JV>V
MOE7['\3\[!7JLQ>I^#F,M5K:@:HZ[;33PL[LO//.,:B^_JVWWNK>O7L^YK77
M7DN/'G'$$:D"GSCTT$/3 8W&C1N7#SCII)/B<$M2Y5>)$2V)^=DK!$771F6U
MS_,3         *!#I)L$XEAZ-(ZTHY-//KFP'RE]^O09-V[<+W[QBR>??'+N
MW+E+EBR)F:O%S.R'$_.S5VBJ'=H^>O7J%;=:!7&K&4].SYX]8WXNMVS9LAA7
MMJ5+E\9R99^*F);Q6*JDRUP"L42KBF12.ZLKYK3JV&.)C$5B<L;TO*+WKG9N
M9ZR=F:UOU?X',3][A?KL16IA'JOGJ:>>BGO3I.LT<<455^1'=]IIIS#ZN]_]
M+I7]B7[]^BU>O#@=LVC1HO3WSC[VV&/IT7*DRJ\2(UH2\[-7"(JNC<HJ\^("
M         #JC=)- '$N/QI'V<N>==Q9V(N7@@P^>,V=.C&Y&3,Y^.#$_>X6F
MBOY([D<??13C:EX\AHPG9^VUUX[YN=S\^?-C7-DZ]L>X*ZXK70*Q1*N*9%([
MJROFM.K88XF,16)RQO2\?OWZQ4*YW+OOOAOCRA9KE;%CM3.S]:W:_R#F9Z]0
MG[U(+<QC56VYY99A?RZ\\,(0L]=>>^5'SS___#"Z>/'B=,MIHYMOOCD=,WGR
MY/Q0ZWZ8/E5[E1C1DIB?O4+099Z?           =(MUR$,?2HW&D72Q?OGS8
ML&&%G5AMPH0)*U>NC-'-B_G9#R?F9Z_0U&:;;1:+YG(+%BR(<34O'D/&D[/Y
MYIO'_%SN]==?CW%EFSES9BQ7=K=03,MX+!77Q2Z!6*)513*IG=45<[(?>S+C
ML43&(C$Y8WK>D"%#8J%<;M:L63&N/$N6+(FURMBQVIG9^DJ<V)B?O4)]]B*U
M,(]5=<HIIX3]V6677=(![[SS3OIK05]^^>7T:*-QX\:E"GQB_/CQS06<=-))
MZ:$RI6JO$B-:$O.S5PBZS/,3         *!#I%L.XEB'MZ7^[__^;V$/5ALR
M9$B)'RLO*I;(?C@Q/WN%ID:-&A6+YG)OO/%&C*MY\1@RGIS==MLMYN=R4Z=.
MC7%E>_KIIV.Y7&[WW7>/<<7$M(S'4G%=[!*()5I5))/:65TQ)_NQO__^^[%$
MQB(Q.6-ZWLX[[QP+Y7+//OMLC"O/W+ES8ZTR=JQV9K:^$B<VYF>O4)^]2"W,
M8U4]\<03<8?6[%V^ZJJK\G_?<<<=4ZD%__5?_Y7*_L2  0.6+5O6.+IHT:+T
MUZD^]MAC:V:7)55[E1C1DIB?O4+099Z?           =(MUR$,<ZO"WU&]_X
M1F$/5COOO/-B7$MBB>R'$_.S5VCJZU__>BR:RTV9,B7&U;QX#!E/SH0)$V)^
M+G?333?%N+*E?U(Y+UE+,:Z8F);Q6"JNBUT"L42KBF12.ZLKYF3_1>S9LV?'
M$AE/8$S.F)YW^.&'QT*YW/_\S__$N/+,F#$CUBICQVIG9NLK<6)C?O8*]=F+
MU,(\5MMG/O.9L$L77WQQ?G3__??/__V<<\Y)Y15\\,$'??KT217XQ/_^[_\V
MCJ:7S="A0]?(+%NJ\"HQHB4Q/WN%H,L\/P$         .D2ZY2".=7A;ZN<^
M][G"'JSVQ!-/Q+B6Q!+9#R?F9Z_0U*677AJ+YG*__O6O8US-B\>0\>1<?OGE
M,3^7.^NLLV)<V<X\\\Q8+I?[S__\SQA73$S+>"P5U\4N@5BB544RJ9W5U;U[
M]Y"U<.'"&%32U*E30X5<QA,8DS.FYYU__OFQ4*NZI1O=====L589.U8[,UM?
MB1,;\[-7J,]>I!;FL=I./OGDL$NC1HUJ''KWW7=[]>J5__OTZ=/73"TX\, #
M4P4^<=111S4.C1LW+O_'$T\\<<V\<J4*KQ(C6A+SLU<(NLSS$P        "@
M0Z1;#N)8A[>E#AX\N+ 'J\V;-R_&M226R'XX,3][A::*_F;T22>=%.-J7CR&
MC"?GV6>?C?FYW%>^\I485[:O?O6KL5PN-VW:M!A73$S+>"P5U\4N@5BB544R
MJ9W5M<XZZX2LV;-GQZ"2?O.;WX0*N8PG,"9G3,_[\Y__' OE<D<<<42,*\]%
M%UT4:Y6Q8[4SL_65.+$Q/WN%^NQ%:F$>J^WQQQ\/N]2M6[=9LV8E0[_\Y2_S
M?]QVVVUC9LIUUUU7R&^PP08;?/311XL6+:JKJ\O_\=%''XV9Y4D57B5&M"3F
M9Z\0=)GG)P        ! ATBW',2Q#F]+37^36=[RY<MC7$D??/!!+)']<&)^
M]@I%;;;99J%L_HO<6F':M&GI4J7[;"HHO=%&,:(EPX8-"Q7Z]>NW>/'B&%>&
M)"O)#=62^C&N&2$QE_U8*JN+70*Q1*N*9%4CJVO(D"$A,>NWWIYZZJFA0B[C
M"8S)&=/SEBU;UK]__U"JL5$OAI:AZ$_)QZ!B:F1FZRMQ8F-^]@KUV8O4R#Q6
M6]-U\A__\1_)W[_TI2_E_W+&&6?$M)3PO:J-[KWWWLF3)^?_Y]"A0V-:V5)5
M5XD1+8GYV2LTU36>GP          '2+=)Q#'.KPM=="@084]6&WNW+DQKJ27
M7GHIELA^.#$_>X6B3COMM%@WEWOEE5=B7'G./OOL=)V)$R?&B.I(;[11C&A)
MV/-&-]]\<XPK0Y(5"^5R2?T8UXR8F?U8*JN+70*Q1*N*9%4CJVN''78(B3?=
M=%,,*FG$B!&A0B[C">S=NW=(;UT#8F+\^/&A5.+^^^^/<2U9O'CQVFNO'0N5
M=UPU,K/UE5C8,3][A?I6%:F%>:RVDTXZ*>S5Z-&CWW___3Y]^N3_,G7JU)BV
MIOWVVR]5X!/'''/,N''C\O_SA!-.B#EE2U5=)4:T).9GK]!4UWA^ @
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M4/X7G<Z>/;OHEQ8GE<OIWRTA5LQ^WF)^]@HE=.#SDZ%#AZ;3\Y*K.X8"
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M:IYY!         "@4;J')(YI2P6@JBZZZ*+"(TV#XX\_/@91\\PC
M  "-TCTD<4Q;*@#-*3Q"Y'*OO_YZ'"[/W__]WZ?K)"9/GAR#J*;TR3>/
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M*3Q"K+;))IO<>NNM,6Y-*U:L^+__]_\.&C0HY&Z]]=8+%RZ,T51?F(B<>00
M        H W2S21Q3%LJ ,TI/$*L:<2($>>>>^X]]]PS>_;L18L6K5BQ8MZ\
M>2^]]-(MM]SR_>]_?]BP83$AE]MTTTU???75N ':19R,U<PC          "M
MD.XGB6/:4@%H3N$1HFU&C!CQQAMOQ.JTES@?K64> 0        "HUY8*0.L\
M^NBCX\>/[].G3^&A(J,D][333ENZ=&DL33LRCP          5%"ZL22.:4L%
MH+2Y<^=>=MEE^^^_?]^^?0N/&2W9<,,-3SSQQ%FS9L5R=!#S"         !
M1:3;2^*8ME0 RO3AAQ_>???=/_G)3XXZZJC==MMMJZVV&CQX\%IKK=6]>_?D
MO\F_1XX<>>BAAYY[[KD//?301Q]]%/.I#>81         ("V*#2>%FL]+34&
M             'F%QM-BK:>EQ@             @K]!X6JSUM-08
M     .05&D^+M9Z6&@,           " O$+C:;'6TU)C             )!7
M:#PMUGI::@P             \@J-I\5:3TN- 0           $!>H?&T6.MI
MJ3$             R"LTGA9K/2TU!@            !YA<;38JVGI<8
M        (*_0>%JL];34&             #D%1I/B[6>EAH#
M@+Q"XVFQUM-28P            "05V@\+=9Z6FH,             /(*C:?%
M6D]+C0$           ! 7J'QM%CK::DQ             ,@K-)X6:STM-08
M            >87&TV*MIZ7&             ""OT'A:K/6TU!@
M    Y!4:3XNUGI8: P           ("\0N-IL=;34F,             D%=H
M/"W6>EIJ#             #R"HVGQ5I/2XT!            0%ZA\;18ZVFI
M,0            #(*S2>%FL]+34&             'F%QM-BK:>EQ@
M       @K]!X6JSUM-08             .05&D^+M9Z6&@,           "
MO$+C:;'6TU)C             )!7:#PMUGI::@P             \@J-I\5:
M3TN- 0           $!>H?&T6.MIJ3$             R"LTGA9K/2TU!@
M          !YA<;38JVGI<8             (*_0>%JL];34&
M  #D%1I/B[6>EAH#            @+Q"XVFQUM-28P            "05V@\
M+=9Z6FH,             /(*C:?%6D]+C0$           ! 7J'QM%CK::DQ
M             ,@K-)X6:STM-08             >87&TV*MIZ7&
M     ""OT'A:K/6TU!@             Y!4:3XNUGI8: P           ("\
M0N-IL=;34F,             D%=H/"W6>EIJ#             #R"HVGQ5I/
M2XT!            0%ZA\;18ZVFI,0            #(*S2>%FL]+34&
M         'F%QM-BK:>EQ@             @K]!X6JSUM-08
M .05&D^+M9Z6&@,           " O$+C:;'6TU)C             )!7:#PM
MUGI::@P             \@J-I\5:3TN- 0           $!>H?&T6.MIJ3$
M            R"LTGA9K/2TU!@            !YA<;38JVGI<8
M    (*_0>%JL];346/LH[$&[B[L")<V?/[]/GS[I)=2[=^]WWGDGQ@$=9.G2
MI>$B_=*7OA2#4D:/'IT.[MFSY\*%"V,0     % STF_H=:"X6Y\R/BZ!&N?C
M$@  VD'Z.60<TY8*Y;ODDDOB&LKE+K[XXA@'=) __>E/X0K]]W__]QBTVN+%
MBWOW[IT.'C5J5 P"     &I)^@V]#A1WZU/&QR50XWQ< @! .T@_AXQCVE*A
M?#OLL$-<0[G<-MML$^. #G+VV6>'*_211QZ)0:O=<\\](?BTTTZ+00    !
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M[@O!IY]^>@P"     &I,^CV].%92.C$O!I74ZL2NQ,<E=&UQ07?.B]W')0
MM(_TT\@XIBT5RK'33COEETVO7KU2BVB5$2-&Q!SH/.*"[IRWQ[WWWCM]"'W[
M]EVV;%D,6NVLL\Y*!R?NN>>>& 0     U)CT>WIQK*1T8EX,*JG5B5V)CTOH
MVN*"[IP7NX]+  !H'^FGD7%,6RJTZ*FGGLJOF>[=NU]RR26I153PV&./Q4SH
M).)J[H2WQ^7+E]?5U:4/8<\]]XQ!*<EH.KAW[]Z+%R^.00    ! C4F_K1?'
M2DHGYL6@DEJ=V&7XN(0N+Z[F3GBQ^[@$ (!VDWXF&<>TI4*+CCGFF/R:.>"
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M=L<==TCY\.'#-129U%KN#\$KX\>/EY7/FS=/0]4^_?13"8\9,T9#
M .HCV1OTTU!,TF2[.QFX76(E?](T.7^DT(JZYDBTA?LF6N_#[1(GN%T"  "
MU#-_I-0Q'DN-3KM85H,&#39MVJ0YEQYXX 'M:UFS9\_6G /F/U0-B/*OWX16
M6E:_?OTT%)F\(VP,'>;.G2OE9YUUEH92:^O6K9F9F8'U+%NV3!,AIDZ=:AS!
M4?:I\NVWWVJT-O?==Y\VLJQ%BQ9ISH'ITZ>;3738X,FD:7(5:%G4-4>B+=PW
MT7K+:M>N765EI>8BFS9MFG3HV[>OAB*36LO](7CE%[_XA;GLC(R,??OV::C:
MN''CS+!M_OSY&@(       !0'\G>H)^&8I(FV]T)Q^T2OV1/FB;GCY9%77,D
MVL)]$ZWG=HECW"X!  ! ZID_4NH8CZ5&IUTL:\"  1IRKT.'#M*V29,F965E
MFG.@M+0T/S]?NG7LV%%S$4BA;>S8L1J*;-.F35KOLL/Z]>NEW'YYJ:'4LM<?
M6$R/'CUT.)P??OBA<>/&QD$<=?_]]VNT-O;A2Y,6+5H</GQ8<P[(9T>'#9Y,
MFB97@5194=<<B;9PWT3K+>O..^_44%3OO_^^=#CEE%,T%)G46NX/P2MMV[8U
ME]V]>W=-&*Z^^FHSG)&185^\&@(       !0'YE[@P$:BDF:;'<G'+=+K)1,
MFB;GCU194=<<B;9PWT3KN5WB&+=+    D'KF3Y4Z5H<>2]60 W&65X5;R<,/
M/ZPAEXJ*BK2I9=D__6O.,?D]('ZK5JW27#A:9EEOO?66AB(K+B[6>I<==N_>
M+>4%!04:2J$C1XZ<>.*)@<5,GCQ9$Q'<<LLMP6.H=L())[C:K5BQ8H6VL*RA
M0X=J+J$\F31]K@*MB>EKA;9PWT3K+6OJU*D:BNKKK[^6#JU:M=)09%)KN3\$
M3VS8L$&6/6+$" T9[$O2#$??E $     99YLO   @ !)1$%4  !0GYA[@P$:
M<B]]MKL3B]LEJ9DT?<X?K8GIZM 6[IMH/;=+G.%V"0   #QA_E2I8SR6&IW9
MP6_.G#D:<FGBQ(G:U+(>>N@AS3DV9LP8;6=9SSSSC.;"T3++6K-FC88B*R\O
MUWJ7'4I+2Z4\(R-#0RDT=^[<P$H:-FSX_???:R*"3S_]U#B(H'???5>CD4V8
M,$'K+>O11Q_57$)Y,FGZ7 5:$]/7"FWAOHG66]9''WVDH:B^^^X[Z6"?P!J*
M3&HM]X?@"?DM2+;77GM-0]5"-V6&#Q^N(0        #UE&P/^FG(O?39[DXL
M;I>D9M+T.7^T)J:K0UNX;Z+UW"YQAMLE    \(3Y4Z6.\5AJ=&8'O__\YS\:
M<NFFFV[2II;UCW_\0W..O?[ZZ]K.LH8-&Z:Y<+3,LG;LV*&AJ+0^$1TTD4+F
M+ZVP/U,Z'-599YUE',11EU]^N>8B"WMNO/WVVYI+J/29U).K0&MB.OVTA?LF
M6F]9&S=NU%!4H4]X6VZ6H95N:CTT?/AP6?:6+5LT5"UT4^;O?_^[A@
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M3UNX;Z+U,7VIT19NEJ&5;FJ]LG___LS,3'/-0X<.U9"A1X\>9KAMV[::
M     %!_F=N# 1IR+WVVNQ.(VR7>3NK)^:,U,5T=VL)]$ZWG=HD#W"X!  "
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MA)\;3M2/26.^"K0FIM-/6[AOHO7N.U3%UT0KW=0FB2XHY39LV*!K @
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MW+E39PV1\-_5XH0GDZ;/5: U,9U^VL)]$ZUWWZ$JOB9:Z:8V271!*<<^"P
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MX?X<UGKW':KB:Z*5;FH]<?;99YNK/>ZXXRHK*S54[?;;;S?#MO7KUVL(
M    0+TFFX1^&G(O?;:[X\?M$ITR^9.FS_FC-=PN<5_K"6Z7    P$/FSY8Z
MQF.IT>DB$K&,29,F:5/+&C-FC.8<&SUZM+:SK,F3)VLN'"US?X!:[T6'.-UZ
MZZV!J0</'JS#[MFO]TX\\<3@\50;.G2H1FL*^\MQ'GGD$<TEE">3IL]5D)&1
M(57[]^_74%1%1472P7)_#FN]^PY5\3712C>UJ;=W[U[YQ$6_<D\]]50SW+9M
M6TT         J._,3<( #;F7/MO=\>-VB4Z9_$G3Y_SA=HF?5KJI33UNEP
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M\]=.^7W]]=<: @       %#?R3ZAGX9BDB;;W7'B=DF51Y.FR?G#[1(_;I<
M    SID_7NH8CZ5&IXM(T#*V;=N6FYLKG0<.'*@Y!RZ^^&+I8W>V^VLN JFU
MW!^@UGO1(6;F+V3)R,C8N'&C)N+P[KOO&L<4],DGGVC48*\A.SM;2F+[)1K=
MNG4SFRQ8L$ 3U3R9-$VN@FNNN49J1XX<J:'(UJY=*^5^FJN-UKOO4!5?D^;-
MFTMMI'^*75I::L8*"@HTD60E)25965GF&@8-&J0APRFGG&*&V[1IHPD
M    QP!SGS! 0S%)D^WN>'"[Q,^32=/D_.%VB1^W2P    #GS)\P=8S'4J/3
M121N&7???;>VMJPY<^9H+JIY\^9I"\NR.VLN,BUV?X!:[T6'F(T8,2(PZ4]^
M\A,=CL_APX=/..$$X[".&C9LF$9KNN...Z0D(R.CJ*A(<U'-GCW;[-"E2Y?*
MRDH-&3R9-!VN@D<??51J"PL+-129_=F4<C_-U4;KW7>HBJ])Z"\)BK11M6G3
M)C-VQAEG:"+)YL^?;R[ -G[\> U5V[)EBX2ON^XZ#0$        X!LA6H9^&
M8I4.V]WQX'9)@">3IL/YP^T2/VZ7     ,Z9/V'J&(^E1J>+2-PR]N[=&_HB
M_.233_[NN^\T&L'NW;L[=^XL'>R>Q<7%&HU,RBWW!ZCU7G2(36EI:;-FS0*3
MOO'&&YJ(6]C?]M*H4:-]^_9IU&"? RU:M) J^\5_65F91B.P^W?HT,$L?_[Y
MYS54DR>3IL-5L'#A0BEOT*#!NG7K-!?.DB5+[+"4^VFT-EKOOD-5?$T&#APH
MM9]]]IF&?&0W[8HKKM!$DH5>5LN7+]=0M5=>>47"4Z=.U1        " 8X!L
M%?II*%;IL-T=,VZ7F#R9-!W.'VZ7^'&[!    '#._ E3QW@L-3I=1$*7,7?N
MW(R,#.G?NW?O_?OW:S3$@0,'[-? 4FMW<_M/)Z6#Y?X M=Z+#K$Q7X =?_SQ
M%145FHC;M]]^&_9U^+///JO1FMY\\TVML:PA0X8<.7)$HR%*2DHNO/!"L_"L
ML\XJ+R_77 A/)O7\*K"/KGW[]M)D\.#!T?_ALFW]^O5MVK2QPSUZ])!RR_TY
MK/7N.U3%U^2WO_VMU$Z9,D5#/K?<<HL9>_+))S619'W[]C47T*Q9LRBGJ*S6
MMG;M6@T!        . ;(5J&?AN+@^79WS+A=(CR9U//SA]LE?MPN 0   )PS
M?\+4,1Y+C4X7D>AEC!LW3B>PK)-..FGAPH4:-7SPP0>GG'**EEG6XX\_KM':
M: OW!ZCU7G2(C?EJ[=Y[[]7A!+GXXHN-(SNJ9\^>F@LQ:M0H+?/]>]Q___O?
M&C5\]MEG7;MV-4NRL[-7K%BAN0@\F=3SJV#TZ-':Q;)NN^VV@P</:K3:K%FS
MVK9M:\<R,S.7+%FBQ>[/8:UWWZ$JOB;RCWHMWVY7Z/[%YY]_;G]RS=CJU:LE
MDU1E966YN;GF J+_^V/Y;3NM6K72!        (!C@[E5&*"A^'B^W1T;;I>$
M\F12S\\?;I=4<;L$    <,/\(5/'TN&QU. *8J+MXJ/=G=$N;HP=.U;;^7XO
M1I\^?29.G+A\^?+__O>_Y>7E]I_V"]=)DR;U[=LW[+\HM5\K:NMPM*PV6I\>
M'6*FK2,X[;33M-*QFVZZ2=LYH%U\[KGG'LU95DY.SN#!@Z=/GVZ_OBTN+JZH
MJ-BU:]<77WPQ>?+DBRZZ2,+VJ?+<<\]IWZ@\F33%5X$(_7TZ?O9?/OSPPTN6
M+-FQ8X=]R'OV[+$/?\J4*?WZ]0MD'GOLL:IPYY7.$4(+:J/U/AJJC=8;#ATZ
M=/SQQTO^LLLN^^BCC_;OWV]_\->O7__$$T\T;=K4#%QRR27:*,D^^. #<P&V
M<>/&::C:IDV;)#QDR! - 0       *B/9&_0.6WDDK?;W<[I?!%PNT0D>U)O
MSQ]NEU1QNP0   !PP_PA4\=X+%5H=V>TBTLOOOAB7EZ>-G4L-S?7^<M:+:Z-
MUJ='AYAIZPC29)_%-G[\^*RL+$T[TZ!!@VG3IFE'!SR9-)570:@%"Q;$<,@C
M1HSPE^M B)JS.2H16N^CH=IH?4W///.,%D1E?[Z6+U^N79(L=$MNV;)E&JKV
M\LLO2WCRY,D: @       % ?R=Z@<]K(/6^WNQW262/@=DGJ)_7V_.%V216W
M2P    #'S!\R=8S'4H5V=T:[N/?55U^9OR3%N3Y]^JQ:M4K;1:;UM='Z].@0
M,VT=0?KLL]B6+EW:O7MW+:C-22>=M&C1(NWEF">3INPJ"&O^_/D%!07:.H*L
MK*Q''GDD4*O#(8QYG)8(K??14&VTOJ;*RLJKKKI*:R*P/P*OOOJJMDB^@0,'
MFLMHVK1IZ*_.";CYYIO-L,T^QS0$        H#Z2O4'GM%%,O-WN=D(GCH#;
M)9Y,ZNWYP^T2;I<     #ID_9.H8CZ4*[>Z,=HG5/__YSP$#!F1D9.@$(>Q,
M__[]9\V:I2UJHXUJH_7IT2%FVCJ"M-IGL=FO)&?,F''NN>=J63@=.W9\[+''
M2DI*M(M+GDQ:E9*K()+UZ]?_\I>_S,S,U)EJZM>OW]*E2\U"380PPPY+A-;[
M:*@V6A_"_J0_^."#^?GY6EG3Z:>?OGCQ8BU.OD.'#C5NW-A<R>677ZXA@WU:
MFN&6+5M65E9J"        $!]9.X-NJ*-XN#A=G>M= 41<+NDRJ-)JSP]?[A=
MPNT2    P GSYTP=2X?'4B&V;=OVP@LO#!LVS'Z)V[IUZX8-&]JO)^T_[?^V
M_\;^^^>>>V[KUJU:AF/ NG7K)DV:-'3HT)X]>[9HT2(W-S<K*\O^C\Z=.U]R
MR25CQHQY[[WWHOQKR-AX,JF'5\&&#1NF3)DR9,B0KEV[VM/9QYN7E]>F39O^
M_?N/'#ERQ8H56E#O[-V[U_X(W'###:>??GK+EBUS<G+LCX#]H>C5J]===]TU
M9\X<=BL         P"$/M[OK,4_N7'@RJ8?G#[=+N%T"    1!=\\#3<HZ?1
MQ@                   (" X(.GX1X]C38&                    ! 0?
M/ WWZ&FT,0                   " @^.!IN$=/HXT! (!0P>^=       '
M]&45    @+I/?^X'  ! W:0_YSD3O4.T,0  $"KXO1,     X("^K (   !0
M]^G/_0   *B;].<\9Z)WB#8&  !"!;]W @     <T)=5     .H^_;D?
M=9/^G.=,] [1Q@                   (" X(.GX1X]C38&
M        ! 0?/ WWZ&FT,0                   " @^.!IN$=/HXT!
M                 <$'3\,]>AIM#                     @(/G@:[M'3
M:&,                   ! 0/#!TW"/GD8; P                    *"
M#YZ&>_0TVA@                    0$'SP--RCI]'&
M    @(#@@Z?A'CV--@8                    $!!\\#??H:;0Q
M            ("#XX&FX1T^CC0$                    !P0=/PSUZ&FT,
M                    " @^>!KNT=-H8P                   $! \,'3
M<(^>1AL#                     H(/GH9[]#3:&
M ! 0?/ TW*.GT<8                   " @."#I^$>/8TV!@
M          0$'SP-]^AIM#$                    @(/C@:;A'3Z.- 0
M                  '!!T_#/7H:;0P                    ("#YX&N[1
MTVAC                    0$#PP=-PCYY&&P,        0IWGSYEUXX87Z
MMP  I+&^??O:W[_T;P$      'R"#YZ&>_0TVA@       " F'WYY9?]^_=G
M\PT 4.?XOWGUZ]>OJ*A(QP      P#$O^.!IN-WO:&,         8E!14?'
M P]D9F8ZV7P+[M"YI(T ]_;LV9.;FVN>5SDY.;MV[=(< (^4E97)17K999=I
MR-"G3Q\SG)65M7__?@TY$.A@?R\;.7*D_7U-$P      X!AF;#^$V:F.-@8
M      # K:U;M_;JU2NX[V99@P</UI#!3+JBC0#W)DR8H">698T;-TYS #RR
M:-$BN4(??_QQ#54[>/!@3DZ.&2XL+-20,_9W+K//__M__V_SYLT: @
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MH6JEI:6YN;EFN$^?/AJ*R<B1(\VV'3ITV+%CAX8      ,"QQ-PKT#$>2P4
M      #B5%E9^=.?_C2XT699/7KTB/)+EFMEM@K0$!"?J5.GZDE6TS///*,U
M0-VA)W3=_"HZ=NQ8.8K%BQ=KJ-K"A0LE_, ##V@H)A45%=VZ=3,[#QPXT/[>
MISD      '#,,#<*=(S'4@$      ( X39PX,;C+9EE965E??/&%AMPPNP5H
M"(C/.>><$SB[LK.SC7/MJ+///EMK@+I#3^BZ^55TP( !YB'DY>65EY=KJ-J8
M,6/,L.V]]][34*R6+EV:F9EI-G_JJ:<T!       CAGF+H&.\5@J
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M)DW-%:3%(;0@'*T)H04AM"!$()FD2TDK8\)CJ;5:MFR9]K(L^WNBY@
M0+UF[@SH&(^E @       #&8,F5*<&?-)S<W-U'/,TEG/PTEW]_^]K><G!Q=
MAV/V!V3:M&G:M#;:Q;UKKKFFI*1$^T:F]2'\L8\__KA1HT8Z%E6S9LU6KUY=
M<S:/S9@Q(["\YLV;EY652>"KK[XRCB#HE5=>D63,)DV:Y/!-<&NEK2/S9-*4
M74%:&4(+PM&:$%H00@M"^&/)NY2T+":)^C(>79U^++6\O#STQ+:_)VH.
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MY:4DM9;[0_#*^/'C9>7SYLW34+5//_U4PF/&C-%0HBU8L$ FM?WF-[_1'
M    J+_,;0$=X[%4        P*TKKK@BN*U6[<LOO]1<K+2UCX:2X($''M!9
M+6OV[-F:<\!\;\Z *&_XEQ#??/.-S/C00P]IJ#;2P=:N7;O*RDK-139MVC3I
MT+=O7PVEUM:M6S,S,P/K6;9LF29"3)TZU3B"HQHT:/#MM]]JM#;WW7>?-HKU
M,>[ITZ>;3738X,FD:7(%:5G4-4>B+=PWT?J47TI2:[D_!*_\XA>_,)>=D9&Q
M;]\^#54+???N^?/G:RC15JY<*9/:!@T:I#D      %!_F=L".L9CJ0
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M&#%"0P;[DC3#T9]A392=.W>:D_IU[MQ9<P      H/XRMP5TC,=2 0
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M3;3>?8>J^)IHI9M:K[SWWGNRYBE3IFBH6DE)B7PS&C)DB(:2@W=+!0
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MO(:J;=FR1<+777>=AI*IO+P\])UH[>^)F@,      /6:N3.@8SR6"@
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M>QXZ=$AS  #40?9WM&[=NIG?Y@8,&,!;S (     <"PS-PITC,=2 0
M@/CMW+FS8\>.P;TVRQHU:I2&  "H@T:.'&E^@VO?OOU___M?#0$     @&.)
MN5>@8SR6"@!P*_B= P    #J"'UADQRK5JTJ*"@PYWWNN><T! ! G3)UZE3S
M6UN3)DU6KERI(0      <(PQMPMTC,=2 0!N!;]S     $ =H2]LDF;)DB5-
MFS8-S)N9F?GFFV]J" " .N(?__B'_;TL\'VM29,FGWSRB88      ,"Q)[!=
M8(7;@8\V!@! J.!W#@    "H(_2%33(M6[:L39LV@:DS,C(>?OCARLI*S0$
MD,;L[USV]R_[NUC@.UKKUJV7+EVJ.0      <$P*[!A8X7;@HXT!
M<&O+EBV]>O4*[KM9UL]__G,- 0"0Q@8/'FQ^(SOGG',V;]ZL(0      <*PR
M]PUTC,=2 0      @(2KJ*@8.7*D^8N/-0$ 0!H+?/^ROY?==]]]]O<U30
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MEEH#            @+S"X&FQT=-2:P            "05Q@\+39Z6FH-
M         /(*@Z?%1D]+K0$           ! 7F'PM-CH::DU
M ,@K#)X6&STMM08             >87!TV*CIZ76             ""O,'A:
M;/2TU!H             Y!4&3XN-GI9: P           ("\PN!IL='34FL
M            D%<8/"TV>EIJ#0            #R"H.GQ49/2ZT!
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M&,H8-FQ8-MRE2Y<%"Q;$4!GR'=(7^C%CQJ0O^C$!    K$KF/7J1Z^>EU@
M  "@HYDY<^:..^Y8N&J6) <==% ,9623S:53ITX[[+##V6>?/6G2I+@]*.G@
M@P^.QU.2''KHH3'7 8P?/SX^$4DR=NS8F /:R(,//AC.T)_^]*<Q5.?##S_L
MUJU;-CQTZ- 8*D_ZLI[M\\4O?O&--]Z((0   *"D[)OKN&8L%0    #RGGKJ
MJ8$#!^:OF%5555UXX84U-34QEU&XOM8RMMYZZ_'CQR]:M"AN&(I98XTUXC&4
M)-75U3'7 :3G3GPBDF2++;:(.:"-_/"'/PQGZ..//QY#=>Z[[[X0/OOLLV.H
M/.G+^@477)"^Q.=;#1@PP/\' @   !7)O$<O,GI::@T     .HXGGGBB;]^^
M^<MEG3MWON666V*HGL+UM9;4OW__<>/&^:!A5JEW[][QZ$F2/GWZQ%Q)L7XU
MO'K\Z*./QL=0YZ&''HII6*W$8WHU/$-KC1@Q(OLHTA]?RY8MBZ$ZYYY[;C:<
MNO?>>V.H$C???'-V,K6ZNCK]N1%#    0 ,R[]&+7)HHM08     '<2T:=.R
M,ZFI:ZZY)H;*DVV2%T,K5BQ?OOR##SZ8/7OVI$F3;KGEEG/..6?????MV;-G
MK,SXPA>^X'9NE';  0?$XR9)#CSPP)@K*=87.X#;N5&C1L7'4.?88X^-:5BM
MQ&-Z-3Q#4TN6+ DO>7OOO7<,90P?/CP;[MJU:]/O(_[+7_XRV[.ZNGKJU*DQ
M!    !23?4\=UXRE @   ,"<.7,VVFBCPI6R)#GWW'-CJ&S9/GDQU(!%BQ;=
M?OOM^^RS3Z=.G6*+G,Z=.X\=.S:609WITZ>' >OT/Y][[KF8*RE;7BLFVK</
M/OB@Z%UC:_7LV7/^_/FQ!E8?\9A>W<[06O_\YS_#H_CQCW\<0W4^^NBC[MV[
M9\/#A@V+H489,V9,MNV&&V[X]MMOQQ    !03_8-=5PSE@H   ! !U=34_.5
MKWRE<)DL2;;;;KL2GR.\2ME6>3&T*E.G3MUKK[UBESK''7=<4_:03[?GGGMN
MY,B1??KTZ=V[]P$''%#I3.J*8L=P3+1O5U]]=7P *[OBBBMB#:P^X@&]NIVA
MM2ZXX(+P*!YZZ*$8JO/  P^$\#GGG!-#C;)TZ=(A0X9D.Z<OONDO!C$'
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MJU>ON%;2FFNN^>RSSZZ\M2)B6:.TSAFZ6H^E+EFRI/Z!G?["$',   " L50
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MK;5J:FIBJ,[))Y^<#2=->*5HA/OOOS]L/?7M;W\[Y@   *##R[YWCFO&4@$
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M6-&T)K&RDMK6=^>==X:]_<4O?A%#=6;/GAW"JQP0;U[IOH4=2$V<.#'F
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MK,]H)V?H*J4_W[([D!H[=FP,U7G]]==#^+###HNAEI0^;^$92T^E]-R).0
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M;]_\Y;+.G3O?>NNM,403%*Y%UHD) &@5?_[SG],7^OSKT1IKK/'HHX_&$
M -" S%7>(I=Y2ZT!    0(?RY)-/#APX,'_%K*JJZL<__G%-34W,T2B%:Y%U
M8@( 6ECZLIZ^N*<O\?D7HP$#!DR:-"GF    @(9EKO(6N<Q;:@T     .IHW
MWWQSQQUW+%PU2Y*O?>UK,42C9)_56C$! "WLH(,.RKX2[;###F^\\48, 0
M "5EWUS'-6.I     ! L7;ITS)@QV<_VC0D:I7 MTA,+0!O)OP:E+_3?__[W
MTQ?]F     !6)7.5M\AEWE)K     -!A39TZ]<M?_K)+9\VH<"VR3DP 0 NK
M?0%*7^*??OKIN 8   "4I_1EWE)K     -#!W7WWW<.'#X]?I3R%BX_EB?4
MT-QVVVVWB1,GQJ\"    E2A]7;?4&@    ! HQ4N/I8GU@,     T/Z4OJY;
M:@T     H-$*%Q_+$^L!     &A_2E_7+;4&     -!HA8N/Y8GU      "T
M/Z6OZY9: P           ("\PN!IL='34FL             D%<8/"TV>EIJ
M#0            #R"H.GQ49/2ZT!            0%YA\+38Z&FI-0
M      #(*PR>%AL]+;4&             'F%P=-BHZ>EU@             @
MKS!X6FSTM-0:             .05!D^+C9Z66@,           " O,+@:;'1
MTU)K             )!7&#PM-GI::@T             \@J#I\5&3TNM 0
M         $!>8?"TV.AIJ34             R"L,GA8;/2VU!@
M  !YA<'38J.GI=8             (*\P>%IL]+34&@            #D%09/
MBXV>EEH#            @+S"X&FQT=-2:P            "05Q@\+39Z6FH-
M             /(*@Z?%1D]+K0$           ! 7F'PM-CH::DU
M     ,@K#)X6&STMM08             >87!TV*CIZ76             ""O
M,'A:;/2TU!H             Y!4&3XN-GI9: P           ("\PN!IL='3
M4FL             D%<8/"TV>EIJ#0            #R"H.GQ49/2ZT!
M        0%YA\+38Z&FI-0            #(*PR>%AL]+;4&
M 'F%P=-BHZ>EU@             @KS!X6FSTM-0:             .05!D^+
MC9Z66@,           " O,+@:;'1TU)K             )!7&#PM-GI::@T
M            \@J#I\5&3TNM 0           $!>8?"TV.AIJ34
M    R"L,GA8;/2VU!@            !YA<'38J.GI=8             (*\P
M>%IL]+34&@            #D%09/BXV>EEH#            @+S"X&FQT=-2
M:P            "05Q@\+39Z6FH-             /(*@Z?%1D]+K0$
M      ! 7F'PM-CH::DU             ,@K#)X6&STMM08
M>87!TV*CIZ76             ""O,'A:;/2TU!H             Y!4&3XN-
MGI9: P           ("\PN!IL='34FL             D%<8/"TV>EIJ#0
M          #R"H.GQ49/2ZT!            0%YA\+38Z&FI-0
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M[__^][]/#]=8V03MZK6RM)-..BD<Y^E!\LPSSV0SV=7LUU/+EBVKWZ%^#
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M*7GMM=>V;=NFY?R)X%X9KL6+%SM?$?-EDC![JS29RLO+3SGE%'N,:Q@
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MDYT?^VK>MK9OWZZAR3D_L54CJLN'>V6&6K1H(0,P#1PX4,+LK=($
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MSS]?2G7OWEV#DI!$4Y\^?30H,]I!P.MAKJZHH9,QQ&E0%N3)VD_;A@T;I,=
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M?/%%*V;//??TF'M.M78^.T^OD=GK[H=KI^'ROGQ%3 >7BGE^/OGD$ZT"
M         -EA?[]2V^RMVI(+:]>NK5^_?F),82LL+%RY<J7VFHI6"7ZN-#_[
M%7;;;3=-,(PU:]9HG&]I?U.SYJ0:N2LM$;R(Y@>O4)E9$<T,DANZ76QZ1$F'
M&Z-!P;E^,?'.G3LU+OMT$&$<G= .@G>A^;FHD#D=08P&A2WG:_^##S[0Z)C^
M_?LO6[9,HY/0Y.#G3?.#5Z@,J4@F\N21J5&C1IJ9P9>Y5U14:*UT3^QIIYTF
M=;IUZZ9!,3U[]K1BKKWV6FU.KC;/9]?;5MJONT^NG>;D7AD-^V%^\<47M]]^
M>\>.'>T_=#KTT$/+R\NU$             !D@?W-2FVSMVI++HP8,2(QH.RX
M__[[M==4M$3P<Z7YV:^P[[[[:H)A+%Z\6.-\6[1HD98SC';MVFF<@^:D&KE3
M*)M4-#]XA<K,BFAFD-S0[4K3(V(ZW!@-"FZ???;1HH:Q;MTZC<L^'4081R>T
M@^!=:'XN*F1.1Q"C06'+[=HO*RMKW[Z]1AM&24F)>9W7Z.0T/_AYT_S@%2I#
M*I*)/'ED:MNVK:89QI(E2S3.GTV;-FFM=$_LV+%CM9!A3)X\6<*^^>8;J[5.
MG3ISY\Z5@&1J^7QVO6W]\,,/&A<JUTYS<J^,AOTPXS\QI];[[[]_Z*&'VIO$
MO__][^IE             " K[.]4:IN]55MRX>"##TX,*#LZ=NRHO::B)8*?
M*\W/?H4CCSQ2$PQCVK1I&N>;?=^&Y:BCCM(X!\U)-7*G#1LV:(G@130_>(7*
MS(IH9I#<T.U*TR-B.MP8#0K._EE]EFSO[W&E@PCCZ(1V$+P+S<]%A<SI"&(T
M*&RY7?MCQHS14,-HV[:MQ_>;N](2P<^;Y@>O4!E2D4SDR2-3CQX]-,TPOOON
M.XWS9]FR95HKW1-;45'1H4,'*77^^>=+V,477VRUGG322=+JH9;/9]?;5MJO
MNT^NG>;D7AD-^V':?UY>7G[333?96^TNN>02>S              9(G]G4IM
ML[=J2^0F3YYL#:9>O7K+ER_7B("2?;GJ1Q]]I*&>-#_XN=+\[%<H*2G1!,-X
M[;77-,ZWT:-':SG#N."""S3.07."?]WJTJ5+M42JPW?2_. 5*C,KHIE!<D.7
MS]-#(_*,#C=&@X(;/'BP%C6,J5.G:ESVZ2#".#JA'03O0O-S42%S.H(8#0I;
M;M>^^7,--8Q[[[U7XU+1$L'/F^8'KU 94I&TY<\CTZ!!@S3',-Y\\TV-\V?F
MS)E:*X,3^^"##TJI^O7KKUZ]V@I8OWY]HT:-K-9WWGG'EIU"+9_/?_C#'S0A
M@]?=I_RY5T;#?IC:5EDY=.A0>X"E:]>N&@H             66!_IU+;[*W:
M$KF++KK(&DR_?OVT.;B*BHIV[=HECK#*.>><HZ&>-#_XN=+\[%<8.7*D)AC&
M;;?=IG&^W7KKK5K.,!Y]]%&-<R@H*)"L39LV:9"G:=.F204CU>$[:7[P"I69
M%=',(+FARY_IH3DY/2U^Z'!C-"BXX<.':U'#^,<__J%QV:>#"./HA'80O O-
MST6%S.D(8C0H;+E=^ZY?//W55U]I7"I:(OAYT_S@%2I#*I*V_'EDNN^^^S0G
MK=V9<6^__;;6RN#$KEFSIG[]^E+M@0<>L +LU]Y]]]TWT#^;J>7S><2($9I@
M&/?<<X_&A2I_[I71L!^FML4<<\PQ]IBX%BU::!P             9(']G4IM
ML[=J2[0V;=K4N'%C:S#OO?>>1J3EKKON2AQAE>+BXC5KUFAH<IH?_%QI?O8K
M?/?==YJ0V<Z5W_WN=UK.,&;,F*%Q#DV:-)&LI4N7:I"GEUYZ22H8J0[?2?.#
M5ZC,K(AF!LD-7?Y,#\W)Z6GQ0X<;HT'!N7X3^G777:=QV:>#"./HA'80O O-
MST6%S.D(8C0H+1X%<[OV6[9LJ:&&8?_H2I^TA.,P4]+\X!4J0RJ2GKQZ9/KX
MXX\UQ\=FUF3NO/-.K979B75^ON;^^^]?45$1;^W<N;/U\Z!;*FOY?';])T.#
M!@W2N%#ES[TR&O;#U+:8UU]_W1X35U14I'$             D 7V=RJUS=ZJ
M+=$:-6J4-9*V;=L&^L J#TN7+JU;MV[B(*L\_/##&IJ<)@<_5YH?287V[=M+
M2J-&C;9NW:IQ/IA9]F^YC3/K:YP;\]64Q*"?)7;##3=(!</'X0O-#UZA,K,B
MFADD-QOR9'I(EI'KTY*2#C=&@]*RSS[[2-F>/7MJD&\S9LRPE^K<N;-&)&'/
MBM.(C&D'P;O0_%Q4R)R.($:#TN)=,(=KO["P4()-965E&N=IX\:-6L+M,+UI
M?O *E2$524]>/3*5EI;:]\C&-6_>/+U1G7KJJ5+*R.S$?O'%%UK.,,:,&6,V
MC1\_WOI)45'1RI4K-=D3\WG???>5E&;-FJ7WNL^=.]=>Y\ ##]2(*GERK\R0
MO5-S#FAS%7N8ML6L6+'"'A/7IDT;C0,           " ++"_4ZEM]E9MB5:/
M'CVLD=QZZZW:G '7+0X''720QB6GR<'/E>9'4N'VVV_7',-XZZVW-,X',TL+
M&8997^/<_/*7OY3$UUY[38,\'7+((5+!\''X0O.#5ZC,K$A149'DIK=U(RQY
M,CTT+<@IS0D=;HP&I>7&&V_4NH8Q?_Y\C?-'7M\A0X9H1!+VK#B-R)AV$+P+
MS<]%A<SI"&(T*"W>!7.X]ENT:*'1AA%T+^"<.7.TA-MA>M/\X!4J0RJ2GGQ[
M9#KOO/,TQS ^^>03C4MEW;IUSGNED?&)/?SPPZ6@>9CFSP<,&&#])(V/^60^
MWW3339IC&!]]])'&^?#PPP_;BUQ]]=4:425/[I49LG<Z:]8L;:YB#].VF-+2
M4GM,7+=NW30.             ++ _DZEMME;M25"]F\"+2@H6+1HD49DX)UW
MWDD<I,UGGWVFH4EH9O!SI?F15%BV;%EQ<;%D]>W;5^-\..&$$Z2.6=FLKW%N
M!@X<*+F!WO6?-6N6I,=I7"J:'[Q"969%FC5K)KG)/IYPV[9M]K F39IH1!CR
M9'I(HA'DE.:$#C=&@]*R<.'">O7J2>5;;KE%XWPPIU#KUJWM=?Q_1+$]*TXC
M,J8=!.]"\W-1(7,Z@A@-2HMWP1RN?>>_4C!-F#!!XSP]]=136L+M,+UI?O *
ME2$524,>/C)]^.&'FF 8O__][S4N%?NGP-II7$#///.,%#3/FWE$]DONQ(D3
M-2T5YK,Y]YP?&7O..>=HG \''WRPO<CX\>,UHDJ>W"LS9._TV6>?U>8J]C!M
MBUFR9(D])N[22R_5.             #( OL[E=IF;]66"%UQQ176,$XZZ21M
MSLS.G3O;M&F3.,XJ)24E&IJ$9@8_5YH?586KKKI*TPQC[-BQ&N?I@P\^T!*&
M85;6N"3NO?=>R0WT=:OFRR3I<1J7BN8'KU"961'G%V<GV[RU>/%B>UB7+ETT
M(B3Y,#TT,\@IS0D=;HP&I>N22RZ1RHT:-3+G@\:E,G3H4'N17KUZ:41R]L0X
MC<B8=A"\"\W/187,Z0AB-"@M*0OF:NW__O>_UX14*4['''.,EDARF!XT/WB%
MRI"*I"$_'YGL'^ :5U!0,'/F3(U+;LN6+6W;MI4B<1H:T-:M6_?88P^IV;)E
M2^O/7;MVU1P?F,^F/_[QCY)EON[3IDW3.$_OO?>>O4*G3ITJ*BHTR"8?[I49
MLO=[RBFG:',5>YBVQ;SXXHOVF+CWWW]?XP             @"^SO5&J;O55;
MHK)MV[:F39M:PWC]]=<U(F.N7S/:L&'##1LV:*@;S0Q^KC0_J@KKUJUS[B\Y
MX( #?OKI)PU-8O7JU1T[=I0*9LVU:]=J:!+.#U&K4Z?.W+ES-<[-Y,F3S6!)
MC]/05#0_>(7*S(KT[=M7<C___',-BI']&:>==II&A"0?IH?D&D%.:4[H<&,T
M*%TK5ZYT?JKN;W_[VYT[=VIH<E]^^:5\"_8''WR@0<G9$^,T(F/:0? N-#\7
M%3*G(XC1H+2D+)BKM3]Z]&A),6+WXJ5+EVIH$F^\\8;FQVA<*IH?O$)E2$6"
MRMM'IO'CQVN.81Q[[+%E964:FL2UUUZK^54T-+BKK[Y:B]H\_OCCFN #\]ED
M7C2:-V\NB3U[]MR^?;N&)F'.JWWWW=>>_O333VM0=?EPK\R0O5_3?__[7XV(
ML<=H6V5E>7GY88<=9H\QF2>SM+140P$            @"^QO5FJ;O55;HO+"
M"R]88]AKK[W\[V#P;\&"!:Z[&WUN1-"TX.=*\R.L\/[[[Q<4%$CNKW[UJTV;
M-FFHPY8M6WKV["FY9K5 'ZI77EZ^SS[[2)%^_?IY?Q26:=Z\>?$O5W6^Z6[X
M/GR+Y@>O4)E9D6NNN49R'WOL,0V*N>"""^QA?_O;WS0B/#F?'I)N!#FE.:'#
MC=&@#+SVVFM:W3#./OMLG[MMOOKJ*]DA]-O?_E:#/-ESXS0B8]I!\"XT/Q<5
M,J<CB-&@M/@IF).UOW'C1N<.-B/6[^;-FS7:8<J4*;OMMILFQVAH*IH?O$)E
M2$6"RN='IO/..T]S#,.\HZ6\W9O^_O>_Q^-/.>64Z@5^IM'!S9DSQ_6@3.:D
M\C/MG9C/<:Z;:\\\\TSS\4]#'<P3)9\7V[5K5S^[*G-^K\R0O6LCMI?4]1/T
M[3':5EGYIS_]R1X0EXVMZ@            #@ROYFI;;96[4E*D<??;0UANNN
MNTZ;0W+""2<D#K5*MV[=-,Z-I@4_5YH?;85APX9ILF'LO__^'W[XH8;:?/SQ
MQQTZ=- TPWC@@0<T-)5;;[U5JQC&Q1=?O'7K5@VM\NZ[[^Z]]]YF6-VZ=2=/
MGJS)00X_3O.#5ZC,K(A\!JH1V[GBW+3QY9=?%A86VL.F3Y\N,>'*[?30_""G
M-"=TN#$:E)DA0X9H!X9QQ!%'F'-#0VU*2TOON^^^!@T:V+-:M6JU<N5*#?5D
M3X_3B(QI!\&[T/Q<5,B<CB!&@]+BLV!.UO[(D2,U,^;@@P_^]MMO-;I*147%
M\\\_WZA1(S.R?OWZFNQYF*XT/WB%RI"*!)7/CTP;-FPXX( #-,TP^O;M^\,/
M/VATE;5KUYK/ _%(\PHV=^[<ZMD_TYRTN!Z4Z?+++]=0WYC/<;?<<HLFQSXS
M=?;LV1IJ\_GGGQ]TT$'V%//Y9^K4J1J71&[OE1FR]Q[7NG5K\T'1(\S^\P4+
M%IQ\\LGVUKB! P?:PP             @J^SO5VJ;O55;LBG1JZ=?_.(7FNG;
MX,&#M9P/\5S]:2K5>\Z7"G9WWGFG)AA&G3IU>O7J-6+$B"E3IOSXXX^EI:7F
M?Z=.G3IRY,BCCS[:]7/%;KWU5BWM@_,;6N/,']Y]]]V3)T]>L6)%65G9FC5K
MID^?_MACC_7NW=N*&3IT:*7;V= ^'#0A%<V/T:!4--]FQXX=>^VUE\2?<LHI
MGW[ZZ:9-F\R3/V_>O <??'#WW7>W!YQXXHE:* NBG!Z:XYL6BH0.PC<M%- 5
M5URA%6.?1MFG3Y_APX=__?77RY8M,Y>,.7,6+5KTSCOO7'WUU2U:M)#X)DV:
MF+-+2SM(ED]:Q9,FIZ+Y^5$A0]I!5'0<U46Y]N/,*Z$YC34_QISAIYUVVO//
M/S]KUJSUZ]>;D:M7K_[JJZ_,"V.7+EVLL%=>><66Y$Y[#7[^-3]&@U+1_'1I
MW21R]<AD]_WWW[M^@&C#A@W/.><<\V)E!I@7KLV;-YNWO#%CQEQRR25[[KFG
M%?;LL\]6^CA>[=6?M]YZ2PO%9/)O/YC/%O,VI F&4514U*]?OY=>>LD\R6O7
MKC5O6ZM6K3)O88\^^NBQQQXKP>:UY:FGGM*ZGJ*\5X9+QF#IVK7K/??<\]%'
M'RU9LF3KUJWVIG7KUL5/W:FGGNK\K&LC]H&O?CYH%@            #"8G_+
M4MOLK=J238E>/>5JCX7^-)7J/>=+!?'LL\^Z?BB73\7%Q4&W"]B-'S^^7KUZ
M6C25*ZZX(IZN#0[5>_.5(C0_1H-2T?SJ'GGD$4WP9+Y>4Z9,T2K9$=GTT$S?
MM% D=!"^::'@A@X=6K=N7:WK6XL6+;[^^FLMZD8S_=$JGC0Y%<W/CPH9T@ZB
MHN-PB&SM6S9NW-B]>W<MY$.=.G6>>.*)2A\G4[OTD2(T/T:#4M'\=&G=)'+U
MR"2^^^Z[^(>=!W7++;?$*VB#0_4._=JY<^<^^^PCI8X]]EB-"XCY;'GHH8?2
M>-*+,\_&J%&CM*(/D=TKPZ7CR-AEEUVV;=LV[08             LLG^KJ6V
MV5NU)9L2O7K*U1X+_6DJU7O.EPI.,V;,L'__KW^]>O7Z[KOOM%Q X\:-:]*D
MB99.HEZ]>O?<<X^5J\T.MG[\I@C-C]&@5#2_NHJ*BC/..$-SDC#/P(LOOJ@E
MLBF:Z:')OFFA2.@@?--":9DT:9)\P;%/__,__[-LV3(MEX0F^Z-5/&ER*IJ?
M'Q4RI!U$1<?A)IJU;[=Y\^8++[Q0RWEJUJR9]0W7VN90O3=?*4+S8S0H%<U/
ME]9-(E>/3$X__OCC"2><H-')%1<7CQ@QPDK79@=;5\'<====4NK55U_5H."8
MSY8OOOCBT$,/U<Q4]M]__PD3)F@MWZ*Y5X;KFV^^N?KJJYT?HI\&<^%_\,$'
MV@$             9)_]O4MML[=J2S8E>O64JST6^M-4JO><+Q62^?>__]VG
M3Q_7+P 59LQQQQWW[KOO:HETS9LW[[SSSDOYN5:]>_?^XHLO[(D:X6 /]IDB
M-#]&@U+1?(?R\O+;;[^]<>/&FEE=Y\Z=)TZ<J,F1R/;TT"J^::%(Z"!\TT+I
MVK%CQPLOO-"M6S?MP$UA86'__OW'CQ^O53QI%7^TBB=-3D7S\Z-"AK2#J.@X
MDLOVVG?ZX(,/CC_^>*WNT+!APRNNN&+5JE56HD8XV#KQFR(T/T:#4M'\=&G=
M)'+UR)3,JZ^^:O^V>E=UZM0Y_?33IT^?;D_4( =[<" K5JPH*BJRZK1JU:JL
MK$R#TL5\CC.?<T:/'GW$$4=HOIO]]MMOZ-"AFS=OUBH!17"OS 9SV&/'CC7G
M0X<.'724J9A'<=)))[WWWGL5%15:%P             B87\34]OLK=J"7=JR
M9<N>>>:9DI*2(XXXHE6K5@T:-"@H*##_:_[9_(GY\Z>>>FKITJ6:%H:%"Q<^
M]MAC9YYYYD$''61V5UQ<7+]^_=:M6Q]WW'%#A@R9.G6J)NQRUJU;9YZ!<\\]
MMW/GSBU:M"@J*C+/@'DJ>O3H\:<__6GLV+$YWV20P^D!5[-FS7KXX8?-57/(
M(8?LN>>>YIRI5Z]>LV;-#CC@@*.//OK/?_[S/_[QCY]^^DG3@("B7_LS9\X<
M/GSXP($#NW3I$K\C%!86FI/\L,,..__\\Y]__OGUZ]=K#FJ.3S_]](8;;NC=
MNW>;-FW,.YUYX6K:M.F!!Q[8OW__8<.&S9\_7Q-J..:S9>[<N2-'CCSGG'.Z
M=>O6O'ES\U28K[[YAXX=.YYXXHFWW7;;__M__Z^\O%S3,E-S[Y4+%BP8/7KT
M33?==/KIIYN#;]NVK7GA3?R29AB[[[Z[^?-^_?I=?_WUYH-BYGMY 0
M     "!#]O<TM8UMJ0    "05Q*_I/%K&@           (#\X_V>IE<;
M "!BB5_2^#4-            0/[Q?D_3JPT     $+'$+VG\F@8
M   @_WB_I^G5!@    "(6.*7-'Y- P           )!_O-_3]&H#     $0L
M\4M:6K^FV=,!  !J-'W0 0       ) ?O/\>SZL-     !"QQ"]I:?V:9D\'
M  "HT?1!!P       $!^\/Y[/*\V     $#$$K^DI?5KFCT=  "@1M,''0
M      #YP?OO\;S:       12_R2QJ]I             /*/]WN:7FT
M@(@E?DGCUS0             ^<?[/4VO-@    ! Q'ZTT38
MR+7$QE.WK:=>;0                   ( EL?'4;>NI5QL
M      !@26P\==MZZM4&                    6!(;3]VVGGJU 0
M             );$QE.WK:=>;0                   ( EL?'4;>NI5QL
M                  !@26P\==MZZM4&                    6!(;3]VV
MGGJU 0                   );$QE.WK:=>;0                   ( E
ML?'4;>NI5QL                   !@26P\==MZZM4&
M    6!(;3]VVGGJU 0                   );$QE.WK:=>;0
M         ( EL?'4;>NI5QL                   !@26P\==MZZM4&
M                6!(;3]VVGGJU 0                   );$QE.WK:=>
M;0                   ( EL?'4;>NI5QL                   !@26P\
M==MZZM4&                    6!(;3]VVGGJU 0
M );$QE.WK:=>;0                   ( EL?'4;>NI5QL
M      !@26P\==MZZM4&                    6!(;3]VVGGJU 0
M             );$QE.WK:=>;0                   ( EL?'4;>NI5QL
M                  !@26P\==MZZM4&                    6!(;3]VV
MGGJU 0                   );$QE.WK:=>;0                   ( E
ML?'4;>NI5QL                   !@26P\==MZZM4&
M    6!(;3]VVGGJU 0                   );$QE.WK:=>;0
M         ( EL?'4;>NI5QL                   !@26P\==MZZM4&
M                6!(;3]VVGGJU 0                   );$QE.WK:=>
M;0                   ( EL?'4;>NI5QL                   !@26P\
M==MZZM4&                    6!(;3]VVGGJU 0
M );$QE.WK:=>;0                   ( EL?'4;>NI5QL
M      !@26P\==MZZM4&                    6!(;3]VVGGJU 0
M             );$QE.WK:=>;0                   ( EL?'4;>NI5QL
M                  !@26P\==MZZM4&                    6!(;3]VV
MGGJU 0                   );$QE.WK:=>;0                   ( E
ML?'4;>NI5QL                   !@26P\==MZZM4&
M    6!(;3]VVGGJU 0                   );$QE.WK:=>;0
M         ( EL?'4;>NI5QL                   !@26P\==MZZM4&
M                6!(;3]VVGGJU 0                   );$QE.WK:=>
M;0                   ( EL?'4;>NI5QL                   !@26P\
M==MZZM4&                    6!(;3]VVGGJUU5J)DY*$)CAH@H,F
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MJPP;-DSCTJ6E'33!01,<-"$[M-=0'73000\\\,"Z=>NT5P"YILLU]A=J&@0
MR+7^_?OK]=HP!@P8H'$ 8G2U.&@"@+S'K3!*G.ULT!/JH EPHV?--RT$( .Z
MP!PT(7)SYLSIW;NW#BN(HJ*BDTXZZ9577MF^?;M61ZW$TU%N9?NM7@     1
ML#_/:UL-W9;ZRU_^,C'N*ITZ==*XD&A/P<^5Y@>OD![M-0M:MV[]^NNO:\<
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MDU=9^^%"5N>>D:V%1X[QF&I"/IJ= 4SGYG5!KA,T2A%@4>6RMK9;N7D&1>L
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M(G5P(R-S+_[6 F #"301&73,R "F<//*(-<Q=-]A486R=K=;%?T,PGXKC#;
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M3HVX?%A+^3,L,<W$9#!BW+AQV+,J+5NV_-WO?C=ITB3,R0;LKHDAS?*$*;O
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M!S9OJ -8-%)9+%&N2'9N!X.P!T489%K@2,;9JT3;8_-9$U_M'$/C$QAKE>M
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M59@F@<^1<HT>/3KR-Y:Z.G3H(-7;R/ODJ@C$ UXN%?[& IF<Y<*(RO3$$T_
M>8E=-08E ]IU# UI9B=,M.V.>*2V:M4*2C5KUFSMVK48Z@-93KY&. +UV9Z1
M<Y2S7!BA $OH%,%,G5R9_]$@J,QAV;)ER["$9G\P63.]%"RJ5M;_S+6U$X!$
M1ZW_ $M$*J)%_78V*",SN6!HP+%$N2)KUJR1?SOE<M]PB:$*CCGF&"CEE.M
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MQ5<8 "0Z:G-&"S9@J F+\];*G/'(\2Z,R)CPKH8=2U./'CV\GEQ]]=5X.(;
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M<Q1:GLJ3[IB%+= ?',RWLDK[!MIOY&&'$7DP7[^"$=@(S=72A_6V,#BO[C2
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M"DU4" T5*<;A2)I=S(MMO%,M6[8L^97ZXX\_'L)./OGD^.@!!QP 1S,X''.
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M#C^B\60+87QR-L?$"#U8!B$]T+RR%3$^82)R9 0C%& )Y2)-,VG#$H.@PN%
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MSSWW2$GI\*QI,R,;YM=@4![,E[S[[KNI/R37I4N78XXYYJ&''A(!R%\-;@
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MEDA4)(%BW#MN&A5D6$NM6OU,]9DRORIVPP:M5A:'A;F%C<%&':=+ERX;-FS
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M"195*&O50QS3%/H/PA*)BL1*<#N;9,EU[J91P=4ODNZ/.:9/GXZUXAK(G;P
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MV]D82ZYS-]'I",(2"D72^C&'> F#54HPSCZOO_XZ]-RL6;/KKKO._[\]>O3
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M7'#!!=#MRR^_C$%Q]MY[;[F"J(D1B=A\97JP2B1,5H-5=-@\@)A?@D%Q,#_
MYL>H@:6:K\#/+TM.,0;%P?RF3-ZY0=4/J3%R/[A-WHI;<K5TZ=(Q8\:<?OKI
M8@2WW'++33;9I$V;-EMOO77OWKU_^<M?CALWKLK?ZLC%].G31XT:=>*))XI5
ME#B6UJU;BSE+3#=B<7#&&6?<?__]RY8MPYSTU.*0KE^__O777[_SSCM%A^)N
MWW777;?99IMV[=JU:-&B4Z=.7;MV[=FSYRFGG#)RY,A__.,?_VG\LK<JS9DS
M1PS422>=M.>>>WJG20R4V*]XD39TZ-#)DR=C0C9FSIQYZZVWGG;::>+YM\46
M6X@V6K9L*?ZC1X\>1QUUU+!AP_[W?_\WK4.FVE+@F63&C!FWW'*+N/MZ]>HE
MCD@4%Y?]YIMOOM-..QU\\,&__O6O__SG/R]:M C3"BW?TVV#3"\YW[GGGNLO
MAXX\\DC<7)LF3IPX9,B0PPX[3+Q6$8/F/3K%0^388X\=/GSXM&G3,"%LB8P1
MFG)\I/+>L1:G^F1R617GB+=P?5JP8,%]]]TW:-"@_???7YSW33?=M'GSYN)_
MQ7^+?Q'_?L\]]\R?/Q_3JF-FI6'8AQ]^>//--__H1S\2<\5FFVTFIEEQ4&(]
M(%8%EUQR219O415R;L]E(L*E6-AB3*SB1HP8<=QQQXEUG7@$I'Y^L8,\>K"3
ML7=I<KGV5)B?6ZI7R-G)E^DC+)>'<M:LO;ER5,@W0S)E;%:1GL,-,**@CV-C
M(^SF]RK;Y#':(_5G5KY3>NJ'DZY"/L2CY74[9RW?Z]P>\&,.,6>*%R.[[+)+
M__[];[KIIMFS9V,"98Q79I4X@)8_1DTNU8KZ_++\%">3[YU;$T,:_>HU:AL1
M$1%1L:U8L4+^BPF//?881M2-\J*P$480$1$1469P*9;'8@P[R*,'(B(R@&^&
MV$QZ#C? ""(B(B(B(B([1+]ZC=I&1$1$5&QWW'&'OQ;:=MMMO_[Z:XRH&^5%
M82.,("(B(J+,X%(LC\48=I!'#T1$9 #?#+&9]!QN@!%$1$1$1$1$=HA^]1JU
MC8B(B*C8>O;LZ:^%A@T;AIOK27E1V @CB(B(B"@SN!3+8S&&'>31 Q$1&< W
M0VPF/8<;8 01$1$1$1&1':)?O49M(R(B(BJP29,F^0NA%BU:S)\_'R/J27E1
MV @CB(B(B"@SN!3+8S&&'>31 Q$198UOAEA.>@XWP @B(B(B(B(B.T2_>HW:
M1D1$1%1@ P<.]!="_?OWQ\UUIKPH;(011$1$1)097(KEL1C##O+H@8B(LL8W
M0RPG/8<;8 01$1$1$1&1':)?O49M(R(B(BJJ18L6M6[=VE\(/?_\\QA19\J+
MPD88041$1$29P:58'HLQ[""/'HB(*%-\,\1^TG.X 480$1$1$1$1V2'ZU6O4
M-B(B(J):5%[?.,Z2)4MP<\FP8</\F)UWWGG#A@T846>D,6N $41$1$24&5R*
MY;$8PP[RZ(&(B!*3)W"^&5*[I-/8 ".(B(B(B(B([!#]ZC5J&Q$1$5$M*J]O
M'.?O?_\[;BY].TBG3IW\F#%CQF!$_9'&K %&$!$1$5%F<"F6QV(,.\BC!R(B
M2DR>P/EF2.V23F,#C" B(B(B(B*R0_2KUZAM1$1$1+6HO+YQG".//!*V;MBP
MX8033O #MMYZZU6K5D%,'9+&K %&$!$1$5%F<"F6QV(,.\BC!R(B2DR>P/EF
M2.V23F,#C" B(B(B(B*R0_2KUZAM1$1$1$1$1$1$1$1$1$1$1$1$1$1$OO('
M3\,^>AJUC8B(B(B(B(B(B(B(B(B(B(B(B(B(R%?^X&G81T^CMA$1$1$1$1$1
M$1$1$1$1$1$1$1$1$?G*'SP-^^AIU#8B(B(B(B(B(B(B(B(B(B(B(B(B(B)?
M^8.G81\]C=I&1$1$1$1$1$1$1$1$1$1$1$1$1$3D*W_P-.RCIU';B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(?.4/GH9]]#1J&Q$1$1$1$1$1$1$1$1$1$1$1$1$1
MD:_\P=.PCYY&;2,B(B(B(B(B(B(B(B(B(B(B(B(B(O*5/W@:]M'3J&U$1$1$
M1$1$1$1$1$1$1$1$1$1$1$2^\@=/PSYZ&K6-B(B(B(B(B(B(B(B(B(B(B(B(
MB(C(5_[@:=A'3Z.V$1$1$1$1$1$1$1$1$1$1$1$1$1$1^<H?/ W[Z&G4-B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(E_Y@Z=A'SV-VD9$1$1$1$1$1$1$1$1$1$1$
M1$1$1.0K?_ T[*.G4=N(B(B(B(B(B(B(B(B(B(B(B(B(B(A\Y0^>AGWT-&H;
M$1$1$1$1$1$1$1$1$1$1$1$1$1&1K_S!T["/GD9M(R(B(B(B(B(B(B(B(B(B
M(B(B(B(B\I4_>!KVT=.H;41$1$1$1$1$1$1$1$1$1$1$1$1$1+[R!T_#/GH:
MM8V(B(B(B(B(B(B(B(B(B(B(B(B(B,A7_N!IV$=/H[81$1$1$1$1$1$1$1$1
M$1$1$1$1$1'YRA\\#?OH:=0V(B(B(B(B(B(B(B(B(B(B(B(B(B(B7_F#IV$?
M/8W:1D1$1$1$1$1$1$1$1$1$1$1$1$1$Y"M_\#3LHZ=1VXB(B(B(B(B(B(B(
MB(B(B(B(B(B(B'SE#YZ&??0T:AL1$1$1$1$1$1$1$1$1$1$1$1$1$9&O_,'3
ML(^>1FTC(B(B(B(B(B(B(B(B(B(B(B(B(B+RE3]X&O;1TZAM1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$OO('3\,^>AJUC8B(B(B(B(B(B(B(B(B(B(B(B(B(R%?^
MX&G81T^CMA$1$1$1$1$1$1$1$1$1$1$1$1$1$?G*'SP-^^AIU#8B(B(B(B(B
M(B(B(B(B(B(B(B(B(B)?^8.G81\]C=I&1$1$1$1$1$1$1$1$1$1$1$1$1$3D
M*W_P-.RCIU';B(B(B(B(B(B(B(B(B(B(B(B(B(B(?.4/GH9]]#1J&Q$1$1$1
M$1$1$1$1$1$1$1$1$1$1D:_\P=.PCYY&;2,B(B(B(B(B(B(B(B(B(B(B(B(B
M(O*5/W@:]M'3J&U$1$1$1$1$1$1$1$1$1$1$1$1$1$2^\@=/PSYZ&K6-B(B(
MB(B(B(B(B(B(B(B(B(B(B(C(5_[@:=A'3Z.V$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1^<H?/ W[Z&G4-B(B(B(B(B(B(B(B(B(B(B(B(B(B(E_Y@Z=A'SV-VD9$
M1$1$1$1$1$1$1$1$1$1$1$1$1.0K?_ T[*.G4=N(B(B(B(B(B(B(B(B(B(B(
MB(B(B(A\Y0^>AGWT-&H;$1$1$1$1$1$1$1$1T?]G[[[CI*C2MH_7##,,#$D)
MH@1!Q8 )$5%164%1GU7111<%07U9T[J&=0V@K#EB0 5S]F$5Q#7@ZIHQ@2XF
M$!&0*" @*'F&,##,O+7=SW2?N:JZ0G?/=-/\OG_P4<Y]7W6ZJKJ&*@[=
M    ,?&%IVY+3[W&                    @)CXPE.WI:=>8P
M         $!,?.&IV])3KS$                    @)K[PU&WIJ=<8
M                $!-?>.JV]-1K#                    (B)+SQU6WKJ
M-08                   #$Q!>>NBT]]1H#                    8N(+
M3]V6GGJ- 0                   #'QA:=N2T^]Q@
M ("8^,)3MZ6G7F,                   ! 3'SAJ=O24Z\Q
M        (":^\-1MZ:G7&                    ! 37WCJMO34:PP
M              "(B2\\=5MZZC4&                    Q,07GKHM/?4:
M P                   &+B"T_=EIYZC0$                    Q\86G
M;DM/O<8                   " F/C"4[>EIUYC
M0$Q\X:G;TE.O,0                   " FOO#4;>FIUQ@
M       0$U]XZK;TU&L,                    B(DO/'5;>NHU!@
M             ,3$%YZZ+3WU&@,                   !BX@M/W9:>>HT!
M                    ,?&%IVY+3[W&                    @)CXPE.W
MI:=>8P                   $!,?.&IV])3KS$                    @
M)K[PU&WIJ=<8                    $!-?>.JV]-1K#
M     (B)+SQU6WKJ-0:H%B9Q  !Y=$E$050                   #$Q!>>
MNBT]]1H#                    8N(+3]V6GGJ- 0
M #'QA:=N2T^]Q@                   ("8^,)3MZ6G7F,
M      ! 3'SAJ=O24Z\Q                    (":^\-1MZ:G7&
M             ! 37WCJMO34:PP                   "(B2\\=5MZZC4&
M                    Q,07GKHM/?4: P                   &+B"T_=
MEIYZC0$                    Q\86G;DM/O<8                   "
MF/C"4[>EIUYC                    0$Q\X:G;TE.O,0
M     " FOO#4;>FIUQ@                    0$U]XZK;TU&L,
M            B(DO/'5;>NHU!@                   ,3$%YZZ+3WU&@,
M                  !BX@M/W9:>>HT!                    ,?&%IVY+
M3[W&                    @)CXPE.WI:=>8P                   $!,
M?.&IV])3KS$                    @)K[PU&WIJ=<8
M    $!-?>.JV]-1K#                    (B)+SQU6WKJ-08
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M?OKI6H=DZ<YUT(;:-7OV[!X]>NB<PJA;M^X))YPP9LR839LV:;H?3C\
M &J"WFRG3X,&#?[\YS__\,,/NDDWVNR@#4 ">NHD<-)))U545&AS2!KJ1_N1
M/KJO';0!      # P?MA@M=8UMI___WC\ZZRSS[[:!T\Z1[<ILZ![->H42/=
MOY%/PM ZI(GNZXR>S\.'#Z]7KYY.*%D[[KCCI9=>.GGR9-U,8IQ^      #4
M!+W9K@%GGGGFRI4K=<.>-"*C3T6P;=%3)['[[KM/FT/21#_:CQJCNYZ=#P
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MP<DGG\RBP!JE9W,FSF?7SR@=-FR8U@5PZ:67:E#(5\3IMZW3PQ_R!
MU Z]>8O0(D]E965GG7661D2T;MUZS9HUVN"@;2$G )CT9'(8.7*D]B3+C-4Q
MU"+S0' X      ! 0-X/$[S&LE"7+EUB$RXL+(S/ODJG3IVT9]NG+S)-!TM#
MTQ0+9(2>S;5^/L^?/S\O+T_FL/ONNV_>O%E+ ]BR9<M>>^TE:5J$G"9'GQ,
M     +*3WKQ%:)&?LK*R0P\]5%,BA@P9HM4.VA-^ D",GDP.=>O6_?;;;[4M
M*6:LCJ$6F0>"PP$       +R?IC@-99M)D^>')MM?G[^@P\^&)^]X:NOOM+.
M;9R^PC0=+ U-4RR0$7HVU_KY?,\]]^@,+.O66V_5NL!&CQXM:5J!G"9'GQ,
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M\_3EI>E@:6B:8H&,T+.YUL_G_/Q\G8%EK5JU2NO"^/SSS\TT'49.,P\])P
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M?34W >U,RC:Z+#7%"V],!J]C     +9;>D<1H47!W'???1H4<?[YYVMI==K
M4[[:?8!0F5LWI.9\=*RR<N[<N8T;-S9K8LX[[SRM]F.VZY@;L]Z5-KC1'@=M
M<- &ATKC#6B? ^>>>^Z;;[YI'_J-&S>N6;-FYLR9CSWVV,$''UR]Z;\*"@KL
M-TAT*Z>??GKT-YT),V;,>/CAAUV?1.VVVV[!_XUTC*9$7H+Y)77-FS>_Z**+
MWG[[;?M,+BDIL4]F^U6\_OKK_?KU<UWY;;^S9L^>K9M)K);?0=KF4)F^IU4
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M1/\C+R_ODDLN6;-FC?946;1HD7W25N_^KPX=.G@_1C-E]ATD"59:GU8!
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M&S9LT")/9GN45H2D<4D%:D3X$.V/2/W"F\'K6)3]1Y1##CE$VNUW$W_'
M .0\N1&(TB)/965E9YUUED9$M&W;-LBW8&M;!$_Y:N<!0L9O2-/.G(:.&>;,
MF=.H42.S..;BBR_6Z@3,+AT+P&S/8(CV1]QPPPU:E\"IIYZJS1'!$^Q377J'
M#1NF19ZD/6JOO?8*]9$?TZ=/=RYP[]*EB]95EPWO(.F-2OUI50Q/C0
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MAPX==!O!OF7,-F7*%.VTK(LNNDCK@GGLL<<D*C\_?^7*E5H7\=%''TFQ;>#
M@5H7S+WWWJM9Z=[5R2DI*;GGGGN<?TD34$%!P8477KAZ]6K-#4;C_/9)>@_*
M+;?<HEE^$W#2?LMZ_/''M<C3K%FS)*%ERY9:5#-DNP<>>*!6>))V*_S>$QJ7
M5*!&A _1_I0OO!F\CID2O<V#_QTJ    @&V4W@:DK%^_?JM6K=+->-((GO+5
MR@.$++DA33MS#CKFQMYUSB7%45=<<8565V<6ZU@ 9GL&0[3?LEY[[34M2DR^
M!3Z)A!4K5DB[[_M72+OMOOONTZ)@!@P8H%F6]<DGGVA=-KV#I-%*^6F5X*D1
M     "!7F?>Y.F:.ZDA&F=\[4[]^_35KUFA% O_YSW_B+\GPQAMO:&DP&I34
MCM*(D"':'+(]$0VUK!]^^$&+/*U;MTX2\O/SM:BZD2-'2HL5_KNM33?==)/&
M6=;##S^L=6ZTS;+>>><=+4J-;B!-QR[&]2O7#SKHH("?2S%BQ AMMJQ1HT9I
M73"??_ZY9B5^Z]UQQQU::EG#A@W3NF#>?_]]S4KWKDY%>7GYO__][W[]^B5Z
M1N^M9<N6X\:-T]  -,AOGZ3WH+S^^NN:Y3<!)^VWK(D3)VJ1IU]__542[)\I
M6E0S9+NI?TR%5H2D<4D%:D3X$.U/^<*;P>N8:?#@P=H6<<TUUV@I    @-RB
MMP'):M"@P9___.>P3^>B-(NG?+7R "%+;DC3SIR CB7PXHLOFETF[Y=@5NI8
M &9[!D.TW[)FS)BA18F5E95I?\B$C1LW2KOO^U=(N^V##S[0HF#NO/-.S;(L
M^S>U+IO>0=J6\M,JP5,C     $"N,N]S=<P<U9&,.OWTTV,3._?<<W78TP$'
M'!!_555./OEDK0M&@Y+:41H1,D2;0[8GHJ&6M73I4BWRM'GS9HWPFYM]-+7!
MLO[YSW]J76!CQX[5.,L:-&B0UKG1-LN:-V^>%J5&-^"W?T)YXHDG-#WR76FS
M9\_6T@1<#\>D29.T+AA[[VE6XB^<.O/,,[74LI);?%GI]DU55EIW=;ILW+CQ
M7__ZUT477>3\@BIO>7EY(T:,T#@_FN*W3])[4&;,F*%9?A-PTG[+6K!@@19Y
M<CZ7M\)/(SFRT>+B8JWP).U6RM/6N*0"-2)\B/:G?.'-X'7,5%)2TKES9VGL
MU*G3NG7KM!0   ! ;I$;@8 :-6JTZZZ['GC@@2>==-)MM]TV?OSXTM)2C0Y,
MTWG*5RL/$%SW0.W?D*:=.0$=2^S\\\\W&V-VW'''A0L7:G45LU+' C#;,QBB
M_9:U;-DR+?*D_>E(T I/VFQ9<^?.U:)@7GOM-<V*? BTUF73.TC;4GY:)7AJ
M!     #(5>:MKHZ9HSJ2.<N7+R\L+(Q-;,*$"5KAR?5?V=:I4^?GGW_6T@ T
M**D=I1$A0[0Y9'LB&FI923S^U@B_N77KUDT;+.O[[[_7NL"^^^X[C;.L(X\\
M4NO<:)MEK5BQ0HM2HQOPVS_!V3NM?OWZFFY9HT>/UM+$7 ]'P.\V<K+/'\U*
M\,S1UJ5+%RT-_TD>,?9%0[/2MZMKB'WJWG'''4<<<41^?KY./8&P7S^G_7[[
M)+T'9<F2)9KE-P$G[0]_?I:7EVM$^&E$+5RX\!__^,=55UW5JU>O??;9IU6K
M5@T;-LS+R]/TQ#31DS:';'?2N*0"-2)\B/:G?.'-X'5,E)24#!X\>-===RTH
M*+!_M4\5_G8!    V![H+42$%M4PW3Q/^<+?&";Q ,%U#X3=;DPJ-Z3I94Y
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MOU=*D6Z>IWQ)W6QJ1%)[(+TR<D-J3D#'/,V<.;-!@P9F>\S@P8.U.L*LT;$
MS/8,AFA_^#>@]J<C02L\:;-E;=JT28N"6;APH6995ILV;;0NF]Y!VI;4!00
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M]MM:G=JV*L,?,E<:$3Y$^[?!!&T.V6Y:N7*E9EF6_6;1NFQZ!VE;"B\?
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MF?*V<N99A_;7>H(V6]8;;[RA1<'<?OOMFF59=]UUE]9ETSM()Q%R[P$
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M.G7D291V!I SSSJTO]83M+EJW7 2^O7KIUF6]=EGGVE=-KV#=!(A]QX
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M,]E)>P+(F6<=VE_K"=H<\>233VJ=']=O3_KXXX^UKDJ6O(/,KBBM
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M7^L)VFQ9)YYX8O0_'GSP0:UVL'>XZ[</#1PX4$O=9/P=9/9&:45J>&H$
M ,A5YGVNCIFC.E);NG?O'IO#-==<H\-I<MQQQ\5?:I6##SY8Z]S<>..-VFE9
M%UQPP88-&[2TRIMOOMFZ=6N[K$Z=.I,F3=+FD'M;/@G/BCS8W;IUJY1]_?77
MA86%9MD//_P@-2:S,DHK M"(,"'#AP_79LO:???=O?\)]:>??MJA0P=MLZQ[
M[KE'2_UH1)C)!Z0;"+")+5NV.!_'6XD_ =&7&:)CAJ%#AYJ548<==IA]7FFI
MH:RL[*Z[[I+OFM]YYYV#KYY<NW:MZ_K%7KUZ+5JT2*NKK%JURGX/1BOMK<^9
M,Z=Z]W]I3\W3&50Y^NBC/_GD$ZUVLW'CQJ>??KIERY8:$5GA^OKKKVN#)XT(
MO$^2.RAVU^677Q[[BRC7+^#3'C_:'SZA,JF0AQYZ2'LB#CSPP.^__UZKJU14
M5#S__/,-&C2P*^O5JZ?- ;9KJHDK?\9_G%4F=3B"R]1US-:N73NS/6:WW7;3
M4@    "Y16\#(K2HANGFDYJ 1H0)R8VG?!H1)B2#-Z1I9TY&QU(V9<J4HJ(B
M<Q,Q6AI,;CSKT/Y:3]!FRYH]>W;TZ59>7IZ]/ST^O7CAPH4]>_;4_L@_60_R
M;751F7T'F>U16I$:GAH!     '*5>9^K8^:HCM2D^%8][;WWWMH9V+GGGJMQ
M 6A*Q-JU:W?==5<MM2S[-V^__?9)DR8M6[9L\^;-*U>N_.&''QY]]-$>/7K$
M:H8-&U;I]GIU&YZV;-FRTTX[2<)))YTT<>+$DI*2LK*RN7/GWGOOO4V:-#$+
MCC_^>,DQ1X.0]B@M\J/]U;E^V7=>7MZ11QXY<N3(R9,G__+++_8+M'^=,F7*
M0P\]U+U[=]</OKWQQALUVHVV!:,IGK39C_975@X>/%B+TD<W5MVEEUZJ#9$/
MJ#CVV&-'C!CQ[;??+EFRQ#[5[;-NP8(%;[SQQM_^]K<6+5I(?>/&C>TS4Z,]
MS9HUR_7#*8N+B\\ZZRQ[0W:!O='2TE+[5'_[[;<OO/!"\]-DGWWVV<H >UZW
M6@-TD]79%S1[C[WXXHO3IDVS]Z3]<LK+RU>O7KUHT:()$R8\\L@C P<.3/0I
MF_9I__###^OV'+3-C_8;@A^4>?/FO?ONNW_YRU_,DR'Z#5]&W__1S3AH@Q_M
MC] B/]H?N>K:I[W61=COB-Z]>S___/,S9\Y<LV:-7;EBQ8IOOOG&O@CON^^^
ML;(Q8\883>YTJ]6EZ\IORLB/,VT(1E,"R]1U3!8'Q]B_KZ4     MF7ZA_Z0
M-"Y9FNM'^R.TR(_V5Y?E3_FT/T*+_&A_=9FZ(4V13,"7]H?WZ*./:FB$U@6S
M33SKT/XL2-!A![OFF6>>B?UOTZ9-+[SPPK???GONW+FEI:7V:3QKUJQQX\;U
M[]^_N+C8Z/L_S9LWGSU[MFS46VV^@Z0K($T)C*=&     (!<9=[GZI@YJB,U
M*;Y53UFR+-4V?OSX@H("K?9SZ:671MMUP*'ZUEP\_/##VN.I7KUZDR=/EA M
M\B/M45KD1_L=GGWV6=>/%0RHJ*CHJ:>>TM $M#D83?&DS7ZTO[+2]8E\NNC&
M'(8-&U:G3AUM"ZQ%BQ;??ONMA@8P;=JTZ*<4A'7##3=$$W3 H?H&:\1__O.?
M,\XX(XEKA;<==MCAE5=>T8VYT4X_VE]=T@?%W@G1[]C2 ;\M5KJU>-/^""WR
MH_T1Z]:MZ]*EBY8&8+^%'W_\\<H T]!-.J3ERB]J_\>95@2C*6%DY#KF_-+
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M0X8,"?7OI0/*I7<03XT      #G)^]F.UQ@  ,F9-V]>_ =,1/OV[;4(
M            P+;&7!2D8RQ+!0#4A(\__CC^ R;BZ*./UB(
M    VQIS49".L2P5 % 3[KOOOO@/F(C++KM,BP                !L:\Q%
M03K&LE0 @(C_8+"LA0L7ZG P?_SC'\T<VTLOO:1%                 +8U
MYJ(@'6-9*@! Q'\P6-:H4:-T.("5*U?6JU?/S"DL+%RS9HW6 =LE\ZT!  "
M=-$_=0$  &S'](]*   @1^D? @  J$7>/Y*\Q@  VZ'X#P;+ZMFSIPX',&S8
M,#/$UJ]?/RT"ME?R[@   $!:Z)^Z    MF/Z1R4  )"C] \!  #4(N\?25YC
M (#M4/P'0\2''WZH%9YFS9I57%QL)N3EY4V>/%GK@.V5^>X   ! NNB?N@
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M^>?EY>7:#P               ""'Q!>>NBT]]1H#
M8N(+3]V6GGJ- 0                   #'QA:=N2T^]Q@            #\
M__;N/<C.LKX#^ EDDY"K)$3D$D**5&X2PIVQ,"W@%<'B%;! $2Q8L(*7@*D6
M!"LXZBA> "D*@UJI2@O%$4$!;S@HA("%4"$@*$&B@4"R)"3DTM/=X7V?_>U[
MWG/>/7MV-^'S^2-#]G=YGCWGS8%AOK,!    ,GGPM"AZ6E8#
M@$P>/"V*GI;5             ""3!T^+HJ=E-0            #(Y,'3HNAI
M60T             ,GGPM"AZ6E8#            @$P>/"V*GI;5
M     ""3!T^+HJ=E-0            #(Y,'3HNAI60T             ,GGP
MM"AZ6E8#            @$P>/"V*GI;5             ""3!T^+HJ=E-0
M          #(Y,'3HNAI60T             ,GGPM"AZ6E8#
M@$P>/"V*GI;5             ""3!T^+HJ=E-0            #(Y,'3HNAI
M60T             ,GGPM"AZ6E8#            @$P>/"V*GI;5
M     ""3!T^+HJ=E-0            #(Y,'3HNAI60T             ,GGP
MM"AZ6E8#            @$P>/"V*GI;5             ""3!T^+HJ=E-0
M          #(Y,'3HNAI60T             ,GGPM"AZ6E8#
M@$P>/"V*GI;5             ""3!T^+HJ=E-0            #(Y,'3HNAI
M60T             ,GGPM"AZ6E8#            @$P>/"V*GI;5
M     ""3!T^+HJ=E-0            #(Y,'3HNAI60T             ,GGP
MM"AZ6E8#            @$P>/"V*GI;5             ""3!T^+HJ=E-0
M          #(Y,'3HNAI60T             ,GGPM"AZ6E8#
M@$P>/"V*GI;5             ""3!T^+HJ=E-0            #(Y,'3HNAI
M60T             ,GGPM"AZ6E8#            @$P>/"V*GI;5
M     ""3!T^+HJ=E-0            #(Y,'3HNAI60T             ,GGP
MM"AZ6E8#            @$P>/"V*GI;5             ""3!T^+HJ=E-0
M          #(Y,'3HNAI60T             ,GGPM"AZ6E8#
M@$P>/"V*GI;5             ""3!T^+HJ=E-0            #(Y,'3HNAI
M60T ADO^[Z<&X@           -!YY1F>LAJ=LVC1HK>^]:V3)T^>-&E2_1\>
M?OCAV %L$C[TH0_EG[.UVBZ[[!([1IB1\^F4OFZ%X@           -!YY1F>
MLMK0R&_0GLF3)\^<.7.OO?8Z\L@C__5?__766V_M[NZ.AXT,BQ8MFC9M6GKY
MZ=.G/_+(([&/ZM)7M9'MM]]^Z=*E<;*ZN+>9.,]+PRM?^<KT,3C[[+,W5']X
M.B3>=81].J77*!0'          " SBO/\)35AD9^@\$V8<*$TTX[[;[[[HM'
M#K>CCSXZWK56>]O;WA;[J"Z^K T<<<01Z]>OC\,5Q:7-Q'E> NZ___[P&/SR
ME[_<4/WAZ9!XW1'VZ13OT4\<            .J\\PU-6&QKY#3KF7>]ZUU-/
M/14/'CZ3)DV*5^SY::^QC^KBR]K89S_[V3A<4=S83)SG)>!3G_I4^@QLO?76
MZ]:MVU#]X>F0>-V1_>D4KU5T?P          H-/*,SQEM:&1WZ"3MMEFFYMN
MNBF>/4PF3)@0[U>K39PX,?:->/%[&+ZG*!,OU%A75]<==]P1YZN(&YN)\[P$
M''#  >DS<,HII_1^/?WB,.I[V?\W*)].<;[HH &(2P=I+0          4$EY
MAJ>L-ESR.R5B4^+YYY]?O'CQG7?>^?G/?_ZUKWUMG'S1YIMO_JUO?2L.#X<W
MO_G-\7*UVI%''AG[1KSX/92^3<,E7C&QXXX[+ENV+ ZT(5T>:[ST_/&/?QPU
M:E3Z5-QPPPV]I?2+?8>:2 <SL:E4^>"@?#K%^:*#!B N':2U          !
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MM\4:+R6WWGIK^C#4+5JT*&U(2^G7FTH',[&IU( '6Y<>,8@'Q:6#M!8
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MNN*I_1QZZ*'IR+'''AL[!D]Z4"8VM2T>4/&(.%QQO)&XM(6U(^0) 0
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M%L2^CGG^^><G39J4GG[))9?$ID&5GI6)36V+!U0\(@Y7'&\D+FUA[; _(0
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M#GTRI)V]8D<#P_6$I+J[N\\YYYP==]RQJZNK_NM'/_K1YYY[+C8!
M ,#&($W1Q)I8:B/Q^ Y<(!Y0_8@X7WW#AO:6''[XX6'V5[_Z56SJ\?WO?S]M
M._+((V-'QZ3GQEI[CCWVV'1Y$+L;N.:::^)DK39^_/C''W\\MC9P[;77QOD>
ML:^9.+_Q;%BR9$G_'\_YQC>^L=)?''_GG7>&OWK^IIMNBDV)18L6I<UUM]UV
M6VSJ@'!HK]C4MGA Q2,Z],F0=O:*'0T,RQ.2ZN[NWG???=/9N@,..$ R%0
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M%UYX86P"          #8=*4!JE@32P5HW>VWWYY_:/98N'!A; (
M -ATI0&J6!-+!6C=W+ES\P_-6FWGG7>.'0           )NT-$,5:V*I *U[
MU:M>E7]HUFH?_O"'8P>,,.D3"P  F[#XG\(      $#'E/\O^K(: +!1R_\U
M#P  F[3XG\(      $#'E/\O^K(: +!1R_\U#P  F[3XG\(      $#'E/\O
M^K(:             &3RX&E1]+2L!@            "9/'A:%#TMJP$
M      ! )@^>%D5/RVH             D,F#IT71T[(:             &3R
MX&E1]+2L!@            "9/'A:%#TMJP$           ! )@^>%D5/RVH
M            D,F#IT71T[(:             &3RX&E1]+2L!@
M  "9/'A:%#TMJP$           ! )@^>%D5/RVH             D,F#IT71
MT[(:             &3RX&E1]+2L!@            "9/'A:%#TMJP$
M      ! )@^>%D5/RVH             D,F#IT71T[(:             &3R
MX&E1]+2L!@            "9/'A:%#TMJP$           ! )@^>%D5/RVH
M            D,F#IT71T[(:             &3RX&E1]+2L!@
M  "9/'A:%#TMJP$           ! )@^>%D5/RVH             D,F#IT71
MT[(:             &3RX&E1]+2L!@            "9/'A:%#TMJP$
M      ! )@^>%D5/RVH             D,F#IT71T[(:             &3R
MX&E1]+2L!@            "9/'A:%#TMJP$           ! )@^>%D5/RVH
M            D,F#IT71T[(:             &3RX&E1]+2L!@
M  "9/'A:%#TMJP$           ! )@^>%D5/RVH             D,F#IT71
MT[(:             &3RX&E1]+2L!@            "9/'A:%#TMJP$
M      ! )@^>%D5/RVH             D,F#IT71T[(:             &3R
MX&E1]+2L!@            "9/'A:%#TMJP$           ! )@^>%D5/RVH
M            D,F#IT71T[(:             &3RX&E1]+2L!@
M  "9/'A:%#TMJP$           ! )@^>%D5/RVH             D,F#IT71
MT[(:             &3RX&E1]+2L!@            "9/'A:%#TMJP$
M      ! )@^>%D5/RVH             D,F#IT71T[(:             &3R
MX&E1]+2L!@            "9/'A:%#TMJP$           ! )@^>%D5/RVH
M            D,F#IT71T[(:             &3RX&E1]+2L!@
M  "9/'A:%#TMJP$           ! )@^>%D5/RVH             D,F#IT71
MT[(:             &3RX&E1]+2L!@            "9/'A:%#TMJP$
M      ! )@^>%D5/RVH             D,F#IT71T[(:             &3R
MX&E1]+2L!@            "9/'A:%#TMJP$           ! )@^>%D5/RVH
M            D,F#IT71T[(:             &3RX&E1]+2L!@
M  "9/'A:%#TMJP$           ! )@^>%D5/RVH             D,F#IT71
MT[(:             &3RX&E1]+2L!@            "9/'A:%#TMJP$
M      ! )@^>%D5/RVH             D,F#IT71T[(:             &3R
MX&E1]+2L!@            "9/'A:%#TMJP$           ! )@^>%D5/RVH
M            D,F#IT71T[(:             &3RX&E1]+2L!@
M  "9/'A:%#TMJP$           ! )@^>%D5/RVH             D,F#IT71
MT[(:             &3RX&E1]+2L!@            "9/'A:%#TMJP$
M      ! )@^>%D5/RVH             D,F#IT71T[(:             &3R
MX&E1]+2L!@            "9/'A:%#TMJP$           ! )@^>%D5/TRH
M            M"2&4L52 0           !B &$H52P4           !@ &(H
G=<.&@B\!            0%7_!SD'YIZR(E01     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>59
<FILENAME>image_240.jpg
<TEXT>
begin 644 image_240.jpg
MB5!.1PT*&@H    -24A$4@  #*8    "" (   !7?:(?    -DE$051X7NW%
ML0D   S#L/S_=#N4_I!!PN D(TF2)$F2)$F2)$F2)$DJ[_P!          "H
5M\:-;%/'5H3T     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>60
<FILENAME>image_241.jpg
<TEXT>
begin 644 image_241.jpg
MB5!.1PT*&@H    -24A$4@  #)L    #" (    !+'@R    1$E$051X7NW:
MP0D   @#L>Z_M#[$&?21<- EFJ0D29(D29(D29(D29(D2;>-70
C *YY= $          'S1Z37MV394R^H     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>61
<FILENAME>image_245.jpg
<TEXT>
begin 644 image_245.jpg
MB5!.1PT*&@H    -24A$4@   /,    ," (    X4!RD    1TE$051X7NW8
ML0W , P$,>V_=-Q% 3Q!#B2^T !7:68>L\Q>GQ-"E$V3LFE2-DW*IDG9-"F;
FIKD_@F;_G;*MN2U[3PA1-DT'8$MQ&0XN=88     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>62
<FILENAME>image_248.jpg
<TEXT>
begin 644 image_248.jpg
MB5!.1PT*&@H    -24A$4@  !J,    5" (   !-* /\    T$E$051X7NW8
ML0W 0 @$0?IOVL[A"X#3C#9"HH&K#P    "XK_H!     #C(T@<     "2Q]
M     )"@+WU5DB1)DB1)DK8W]=O\D21)DB1)DK2MZ74#     *ZQ] $   !
M DL?     "2P] $   !  DL?     "2P] $   !  DL?     "3H2U^5)$F2
M)$F2I.U-_39_)$F2)$F2)&UK>MT     @&LL?0    "0P-('      DL?0
H  "0P-('      DL?0    "0X >*!03X^"N'RP    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>63
<FILENAME>image_252.jpg
<TEXT>
begin 644 image_252.jpg
MB5!.1PT*&@H    -24A$4@  "Z\    #" (   !)#T_S    0DE$051X7NW:
M00T   @#L?DW#3^"!4B;>TS$DI0D29(D29(D29(D29)TNK$F           <
AYPT#         , ?#<F!@?&CI3)_     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>64
<FILENAME>image_283.jpg
<TEXT>
begin 644 image_283.jpg
MB5!.1PT*&@H    -24A$4@    @   1G" (   !&@+!     9TE$051X7NW)
ML0T , S#L/S_=+/J@B(#M=F<22_U!P
M                                                         ( ?
9T-%NP@(%>?7E<W\5L     !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>65
<FILENAME>image_288.jpg
<TEXT>
begin 644 image_288.jpg
MB5!.1PT*&@H    -24A$4@    @   #<" (   #"PG?E    /DE$051X7NW)
M(0[ ,!# L/[_TS<P5J_CE6*8K/5E9O;T:J"!!AIHH($&&FB@@08::*"!!AIH
=H($&?L<<7#8>/DLX\D)SKJX     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>66
<FILENAME>image_289.jpg
<TEXT>
begin 644 image_289.jpg
MB5!.1PT*&@H    -24A$4@   9,    ?" (   "M>[<A    F$E$051X7NW<
ML0G ,! $P>^_:1N<*E'F7YAA*U!P@1":F4?2DKCDJ( >RP7T6"Z@QW(!/98+
MZ+%<0(_E GKF?%$BZ:^X9+FD17')40$]E@OHL5Q C^4">BP7T&.Y@![+!?18
M+J#'<@$]E@OHL5Q C^4">BP7T&.Y@![+!?18+J#G6Z[S?S-)6IOEDM3+<DGJ
=9;DD]7)##Q2]?[!'I&&$* \     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>67
<FILENAME>image_296.jpg
<TEXT>
begin 644 image_296.jpg
MB5!.1PT*&@H    -24A$4@    @   %$" (   "5@.A_    6TE$051X7NW)
ML0V   "$0/9?6A/M^-@9;:#D8#JN? E\"7P)? E\"7P)? E\"7P)? E\"7P)
M? E\"7SY!KC,ZRZ8@BF8@BF8@BF8@BF8@BF8@BF8@NEW.!YZ$4Z#6/=/XC76
-T0    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>68
<FILENAME>image_297.jpg
<TEXT>
begin 644 image_297.jpg
MB5!.1PT*&@H    -24A$4@    <   &1" 8   "I&JDY    "7!(67,  $SE
M  !,Y0%USO"5    3$E$051XG.W)L0G 0 P$P>N_1H$*42#C_/D"[#E8+I@D
MV5/=_3Z$$$(((8000@@AA!!"""&$$$(((8000@@AA/"'6%5[:F8V>]F'\ $D
3PJ<4&0'K      !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>69
<FILENAME>image_298.jpg
<TEXT>
begin 644 image_298.jpg
MB5!.1PT*&@H    -24A$4@    @   #D" (    JZ_(E    /TE$051X7NW)
M(0[ ,!# L/[_TS<P5J]\4F.8K/5E9O;T:J"!!AIHH($&&FB@@08::*"!!AIH
>H($&[AYS\,_Q .,V.^]^2(<A     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>70
<FILENAME>image_299.jpg
<TEXT>
begin 644 image_299.jpg
MB5!.1PT*&@H    -24A$4@   3(    *" (   "X^D7F    1DE$051X7NW8
ML0G ,! $P>^_:3N0/W(!VF"&!55P/&AF'DF1CGV!#+.$'+.$'+.$'+.$'+.$
EG/E_T4JZE5E*N;Y9[MD$*E[^ :#ID^1' @    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>71
<FILENAME>image_302.jpg
<TEXT>
begin 644 image_302.jpg
MB5!.1PT*&@H    -24A$4@    @   "D" (    EL_A)    .$E$051X7NW)
MH1' ,!# L.R_]!>410WK!5G07NO+S.SIU4 ##3300 ,---!  PTTT$ #/X\Y
7N#$>=F]2REI]E[H     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>72
<FILENAME>image_303.jpg
<TEXT>
begin 644 image_303.jpg
MB5!.1PT*&@H    -24A$4@    @   'D" (   ",G/F1    ;TE$051X7NW)
M,0J   "%4.]_Z8+:OK0%#>GH W5<[2782["78"_!7H*]!'L)]A+L)=A+L)=@
M+\%>@KT$>_D8N&S77: "%:A !2I0@0I4H (5J$ %*E"!"E2@ A6H0 4J4($*
A5* "%:A _1N.AUZ$$R4<V(I.JG-Z     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>73
<FILENAME>image_304.jpg
<TEXT>
begin 644 image_304.jpg
MB5!.1PT*&@H    -24A$4@    <   "A" (   "$=3)W    ,4E$051X7NW(
M(1( , S#L/S_TQGPE70CXQ94<FF[*^YPX<*%"Q<N7+APX<*%B]_MRP$9KO,;
0@IHET@    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>74
<FILENAME>image_309.jpg
<TEXT>
begin 644 image_309.jpg
MB5!.1PT*&@H    -24A$4@    @   #>" (   "/"M;N    0$E$051X7NW)
M(0[ ,!# L/[_TQT:J7=L4DD,D[4'ZPRO>7QJH($&&FB@@08::*"!!AIHH($&
?&FB@@0:NCSWX<3QTURH!F@NMCP    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>75
<FILENAME>image_314.jpg
<TEXT>
begin 644 image_314.jpg
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-E@    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>76
<FILENAME>image_315.jpg
<TEXT>
begin 644 image_315.jpg
MB5!.1PT*&@H    -24A$4@    <   !0" 8   #5V6^<    "7!(67,  $SE
M  !,Y0%USO"5    +DE$051XG.W)H0T 0 S#P&R<_5&>IJ#%#VS)Z"0I?2<0
B!$$0!,$-;:<?F*/O\ &4J$@X:-RQ @    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>77
<FILENAME>image_316.jpg
<TEXT>
begin 644 image_316.jpg
MB5!.1PT*&@H    -24A$4@    <   !Z" 8   !S[DG,    "7!(67,  $SE
M  !,Y0%USO"5    ,DE$051XG.W)H0T , P$L=]_B*R:TI041Y5/.N0DZ?DL
F$$(((8000O@?5E7/+^Q'Z_  WV'GZN%<R=$     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>78
<FILENAME>image_317.jpg
<TEXT>
begin 644 image_317.jpg
MB5!.1PT*&@H    -24A$4@    <   &O" 8   "7:L_D    "7!(67,  $SE
M  !,Y0%USO"5    GDE$051XG.W6L0D#(!"%X5O)H5Q)<!H'< $[%[!R "]H
M2".'10B)A/_!P^)KY*HG(J)6:ZWS!4$0!$$0!$$0!$$0!,'_1^^]6FVMJ>@A
M9XPQJM7>^X5' $$0!$$0_#R&$-3JVD/OSZSKT)J2I90G6M=)*8$@"((@"((3
M<\ZZ=Z[%A7K(3] YIWOGCQ=>=UL0!$$0!,$OXQA#][YRG%D/QR,HQ>DZ-&8
+    245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>79
<FILENAME>image_322.jpg
<TEXT>
begin 644 image_322.jpg
MB5!.1PT*&@H    -24A$4@    <   "B" 8   "-@]>.    "7!(67,  $SE
M  !,Y0%USO"5    24E$051XG.W5L0T ( P#06^>+)5ELDRHD*"A P%Z2ZZN
M<6=)JEYWKS$"01 $P9_0S.X:!((@"(+'</F"( CNP(BHWLR<L19Y"QM&IUF]
0*QG5^     !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>80
<FILENAME>image_323.jpg
<TEXT>
begin 644 image_323.jpg
MB5!.1PT*&@H    -24A$4@    <   !1" 8    >A;PY    "7!(67,  $SE
M  !,Y0%USO"5    +DE$051XG.W)H0T 0 S#P&R<_5&>IJ#E+]F2T4E2^DX@
B"((@"((;VDX_,$=_X0-8 &0<\PWXUP    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>81
<FILENAME>image_326.jpg
<TEXT>
begin 644 image_326.jpg
MB5!.1PT*&@H    -24A$4@  !%4    +" (    QRB4(    9$E$051X7NW7
MP0T , @#,?9?NOU#%RBQ=2\D!D@=  " #-4/    2]D_  ! "OL'  !(T?=/
ME21)DB1M:.JW^2-)DB1)/S:];@   !O9/P  0 K[!P  2&'_    *>P?   @
6Q04X45:'&D*N80    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>82
<FILENAME>image_327.jpg
<TEXT>
begin 644 image_327.jpg
MB5!.1PT*&@H    -24A$4@   #0    5" (   "&ZEHO    3$E$051X7NW4
M(0X , Q"4>Y_Z<U#%:)%\%)%LN2KX04##TD:Y^(XX.P4;_IF[=2TQ6B<JW&N
KQKDX3K^?M5.\Z9NU4],6HW&NQKFBXS[#87DB'.PC+@    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>83
<FILENAME>image_329.jpg
<TEXT>
begin 644 image_329.jpg
MB5!.1PT*&@H    -24A$4@    <   !0" (   !:N_C+    %DE$051X7F-@
B& 6C8!2,@E$P"H8?   &X  !</KY<     !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>84
<FILENAME>image_330.jpg
<TEXT>
begin 644 image_330.jpg
MB5!.1PT*&@H    -24A$4@    @   "D" (    EL_A)    .$E$051X7NW)
MH1' ,!# L.R_]!>410WK!5G07NO+S.SIU4 ##3300 ,---!  PTTT$ #M\8<
7_#@>)4(]WYW6X?\     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>85
<FILENAME>image_332.jpg
<TEXT>
begin 644 image_332.jpg
MB5!.1PT*&@H    -24A$4@    <   !0" 8   #5V6^<    "7!(67,  $SE
M  !,Y0%USO"5    (4E$051XG&-@8&#XCP>/2HY*CDJ.2HY*CDJ.2HY*#G=)
5 .Z\+>_46Y7W     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>86
<FILENAME>image_337.jpg
<TEXT>
begin 644 image_337.jpg
MB5!.1PT*&@H    -24A$4@   X8    ," (   "QTC1Y    >TE$051X7NW<
ML0T (0P$0?IO^C_#DBG@+)C1!A0 LB/6@E=\DB1I5%L?VG"O_@PD25(V*RDO
MJHL/ $S29S9<K%]_ & &0QH @# K*0  8592  #"K*0  (1920$ "+.2\HKS
M+S1)DI2MQG0=X6KG,Y D2=EJ3-<1   2?FZF?*U-WALG     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>87
<FILENAME>image_338.jpg
<TEXT>
begin 644 image_338.jpg
MB5!.1PT*&@H    -24A$4@   S,    ," (   #9#70$    >$E$051X7NW<
ML0W , A%0>^_=-(&/$"^X$ZO<6\+*I\#6SR2) 7VU6<7S-5?@B1)"=G,6*K<
M?0#(TT<7#-:O/P"$,:L  %+8S   4MC,  !2V,P  %+8S   4MC,V.+^/T:2
JI(3*M"HGF.M^"9(D)52F53D! /"?%UB)>3+8>0UJ     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>88
<FILENAME>image_339.jpg
<TEXT>
begin 644 image_339.jpg
MB5!.1PT*&@H    -24A$4@    @   #K" (   #;O4#P    /DE$051X7NW)
ML0' ( S ,/Y_&J8N-;D :;37'JQ_^,SCR@@CC##""".,,,(((XPPP@@CC##"
="".,,.+ML0<'[*82&9/P@4D     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>89
<FILENAME>image_342.jpg
<TEXT>
begin 644 image_342.jpg
MB5!.1PT*&@H    -24A$4@  #CX   8M" (   !(1U$:  "  $E$051X7NS=
M>9P4U=GV<1^&&1 $V1D005!9-&Y1!(E!$J/QB1I$P U$E.4EBBA1,'%+%(V8
MB!LF:C0&8R3&B,2XQ V5N"!NB5M$140@B.S(XL LO)699]ISKCK54S7=4U/=
M\_O^X4>[[NL^IZM/5_5,3GIV^1\                   "@+NVLMHL> 0
M                 +)*MZZF_AL                   #('%M7 0
M            $!.VK@(                  " F;%T%
M  ! 3-BZ"@                  @)BP=14                    Q8>LJ
M                    8L+650                   ,2$K:L
M          "("5M7 0                  $!.VK@(
M " F;%T%                  ! 3-BZ"@                  @)BP=14
M                   Q8>LJ                    8L+650
M         ,2$K:L                   "("5M7 0
M$!.VK@(                  " F;%T%                  ! 3-BZ"@
M                @)BP=14                    Q8>LJ
M        8L+650                   ,2$K:L                   "(
M28YM75VR9,F]]]X[:=*D8X\]MD^?/FW;MMUUUUT;-6KD_=/[=^\1[W'OJ%?S
MR2>?:!C9\.677S[VV&-77775T*%#^_;MV[ESYY8M6Q96:MVZ]9Y[[NF]"H,&
M#1H[=NSTZ=,?>NBAQ8L7:XN,L0SJ5!)>8@!UA.MG_-Y\\\V9,V>.'#GRD$,.
MZ=:MV^Z[[UY04-"L63/OA'?ITL5[\/CCCQ\_?ORT:=/FS)FS:-&BLK(R;0$
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M!QYXH%&C1L8(_S5HT* 5*U9HJ>VMM][JW[^_!'?QC1+TN)_1PT&K?<)7 @
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M              #X)''KZOCQXXW-%99##CEDQXX=&O I*RM+\[=WQXP9HX$
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M^(%VK[1V[5HMK8GW2J7B<BCH<;]4I9-6^Z2I/.644XQ.;J>??KK&
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M=-!JG_"5WD7#:*R\J]8]]]RS=>M6C=49G8%-JZ/XX0]_J.U\A@P9HC$
M         (!J2=FZ>LLMM^BN!]NCCSZJF1"\E#:RW7KKK9HQ:+5-JZ/(O(DQ
M$0>M#L'\4^].Z?]^>E;D]S*0R"]_^4NC3:"?_>QG5A>75+$>L"7A)<Z6J5.G
MZNP-)YYXH@8JS9DS)U7SWGOO>8_LO__^1DX]\\PSVJ+2]==?7U70HT<//1;
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M3W\*?VU)0[O;M+I6GGSRR<&#!W?LV+&PL+"XN'CHT*'SYLW3(@
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M#9[)]5-+;5H=1:0FQI@9T;XNZ]>OWW///359*]['L$LOO50'B$([VK0:
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MUZY=-5--2VU:'46D)L:8#EKM$[Y2+%BP8-BP835^&VZ-]MMO/VT=CC:R:34
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M6VSW4&-,!ZWV"5_IM&+%BIMNNND[W_E.FHM,C5YXX07M&X)VL6DU
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M/:S2:I_PE>EMVK3IKW_]Z\2)$WOW[FV,'\J4*5.T70C:Q:;5
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M__4S(?=0>UBEU?&JJ*B8/W_^F#%CFC1IHC,S[+GGGIH,0;O8M!H
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MPRJMKC_>BNK7KY_.KU)149%6AZ!=;%H=45E9V<2)$[5II<F3)Z?9T P
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M>UBEU9E)M;W[[KOU6 CKUZ\WIO:UPPX[3$M#T"XVK8YB_OSYVL[GQ1=?U!@
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M?WO<<<<Y_U\$YYQS3J2-PIJ/0GNE]<(++VC>Y\477]08              !
MM41O7?6L6K5JPH0)05^F&(:7/>^\\[[XX@MM'5%)2<DEEUR2R4P*"@HNN.""
MK5NW:NMPM%T4VBN*+5NV3)LV+6CS:"0]>_;T6BU?OES'J$G,RT##4=2BCQD)
M8\V:-3UZ]- NE;0TG"2\Q%EQVVVWZ80JWW?KUJW3TK2..^XX[;+++M_^]K>U
M+BW-1U$7?4P__O&/M=0E:;LPP]/646BO:KE[TM:O7^]-?M===]5P:-[%8?+D
MR1LW;M364<1Y#]5DG=&!=^Y\^^VWITR9TJ5+%RV-J&/'CK-FS:JHJ- !TM(N
M46BOFIQ[[KG:PC!ITB0-                &)*^=;7*RI4KK[KJJMZ]>^OF
MB+3Z].DS;=JT&K^>+9+//OML\N3)Q<7%.EA:[=JUFSAQXN+%B[5=%-HT"NT5
MW>;-F^^XXXYO?>M;C1HUTNYI%145#1PX\.JKKW[GG7>T:42Q+0-M$44M^IB1
MD/[][W^W:M5*&]6J54H27N(,+5^^7">WRRZ#!@W2NIK<?OOMVF6776ZXX0:M
M2TOS4=1%']/:M6M;MFRIU3X)W(49DK:.0GM5R_63MG[]^ADS9O3MV_=_7-_N
MZ>1="@X[[+ [[[QSRY8MVJZVXKF':K[.Z,#5*BHJ7GCAA4LNN<0[@04%!1I+
MZX ##I@^?7KM-@IKKRBT5TU*2TLG3)B@72J=?_[Y965E&@
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M^NUO?_O^^^]K/MF>?_[YH4.'>JNHL+#0>R[#AP]_\<47M0@
M ,#GZXVK.;%U%0  9->L6;/,W:L''GC@ZZ^_KD4               ! EK!U
M%0" !JVBHJ)OW[[F[E7/X8<??L,--SS__/-+ER[=LF4+?P(>
M    V<+650  &KKWWW^_>?/FLGO5;^;,F9H$                (F+K*@
MV#E[]FSOUJ^;56UL704              $#FV+H*  #^ZW>_^UVC1HUTOZJ!
MK:L               #('%M7 0# _WGFF6<Z=>JD6U:KL745
M    F6/K*@  ^-J&#1NNO/+*5JU:Z<95MJX"               @&]BZ"@
MU/;MVY]XXHG)DR<???317;MV;=FR9:-&C=BZ"@              @,RQ=14
M                   Q8>LJ                    8L+650
M         ,2$K:L                   "("5M7 0
M$!.VK@(                  " F;%T%                  ! 3-BZ"@
M                @)BP=14                    Q8>LJ
M        8L+650                   ,2$K:L                   "(
M"5M7 0                  $!.VK@(                  " F;%T%
M              ! 3-BZ"@                  @)BP=14
M       Q8>LJ                    8L+650                   ,2$
MK:L                   "("5M7 0                  $!.VK@(
M             " F;%T%                  ! 3-BZ"@
M    @)BP=14                    Q8>LJ                    8L+6
M50                   ,2$K:L                   "("5M7 0
M            $!.VK@(                  " F;%T%
M  ! 3-BZ"@                  @)BP=14                    Q8>LJ
M                    8L+650                   ,2$K:L
M          "("5M7 0                  $!.VK@(
M " F;%T%                  ! 3-BZ"@                  @)BP=14
M                   Q8>LJ                    8L+650
M         ,2$K:L                   "("5M7 0
M$!.VK@(                  " F;%T%                  ! 3-BZ"@
M                @)BP=14                    Q8>LJ
M        8L+650                   ,2$K:L                   "(
M"5M7 0                  $!.VK@(                  " F;%T%
M              ! 3-BZ"@                  @)BP=14
M       Q8>LJ                    8L+650                   ,2$
MK:L                   "("5M7 0                  $!.VK@(
M             " F;%T% *"N//?<<\.&#>O4J5-145''CAV'#!GR]--/:Q$
M  &XCP       ""_\1LP )G@&@( .8VMJT ZNT2G+8#\I:L_!&V1OW;LV#%V
M[%A]_I7..><<[Z@&HENX<.',F3/'C!G3KU^_O??>NWW[]DV:-"DL+&S=NG67
M+EUZ]>IUZ*&'#AHTZ*RSSIHV;=KLV;-?>^VU]>O7:Y=<IF<V!&UAT-(0M 4
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M/W_^1Q]]=,\]]^RUUUZV7Y[%9H*&[96FQ)HSQ9[=3 F:Q#()N=-5.FRX9-B
M%Y:69"*?LC(INK^$79%@)J]R';8ZS->)YH(+DPXRY1C I<-^U(EF(X-R+2'P
M93\"?W0,7ZL3S>[ I(-,.<;\N''C"K[KZNKJ@PXZZ)%''IDR9<J"!0M6KERI
MUC-J ZJ=TK%C1RR]%K8D2<<I _M1)YIA!K B2;IO0V%1/P*??[(2/<BQ>0=8
MA21QUY784LFP 4/$!TZHL!^2B.>EQ!V5V*0?>1Y=S;/,Z]*ERYHU:S!0)W&/
MK@9R!Z;L8Z9<JWHB(M/_/;5:)_?'\CRZJF9GG,8LBKNX"MRD29/R_^A W[Y]
M9\^>C;%,1JV)^_?OCZ4UK5JU4FMEC-EA7O+00P_AGYRI"UK5G]6K5^^^^^[X
MFC,UHMY^^VWL>B%8BR1W4N_4J9,Z0:JSLEI2+UZ\>,J4*==??WWW[MV]Q06]
M>O7ZQ>VK,C IP8S=HX\^6L_^[>OJI<<??QPSF<R##SZ(137KK;?>].G3,6.'
M>0EF_(C#>PQ0LHYZM?'Q3WXT;MSXO__]+S:<%U8AP8Q&-9=GM.2HE3HF"U$3
M0HL6+7(UW'OOO5@B!%J7K3!C@3$)9B*$7:FJ.O/,,_4O,0*__OKK'__X1\QX
M-6S8\,TWW\1D(5B+!#-VF)1@)GS)FH54L7WWW1?_6@BV%!!LIGP#-1#8%4F4
M"Z3*')E80H(9/[ N"6;LDK6/HE_#!"A9FQHS$<*N2##C!FN18$:"&0EF[# I
MB7CD+UBP(/\_665MM-%&-]QP@SIWJ#-C]A^NKKCBBMS=^3QWV'78MM?]]]^/
M 4UU=;6Z/,2,E^K5;W_[6TP6:C=PV+P$,VZP%DDFH+-;LB:QA-[I*AWV0X(9
M/[ N2<135B9=]Y>P'Q+,V,7DL,5P^2ZXL!9)] ,X$-B/,FWD."PA9LZ<:7O
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M9I(BSEMY7'KII=A 5=5EEUV&Y3*9>^^]%\M)/OC@ TQ*5#%,2NZ[[SY,>F%
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MF)2X_#)F5:$N%6'APH5''GDD-B-IUJP9AD.#;4LPXP9KD6#&CQ1/8AB08,:
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M\((++A@_?KQ:@JQ8L4*M#+[YYILQ8\8<>>21YH) #;E//OD$6\IKJZVV@DJ
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MSVP__?33+;?<,FC0H.KJ:FQ TJ)%B[///KO$1G5KUJQY_/''-]ED$VS),&#
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MWD>.YGNO8-):+JKEPF',-MV]* W*C%;W6%^3_7A+FWD%C3 D'#:!W<H"
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M7L&DM5Q4RX7#F&VZ>U$:E!FM[K&^)OOQEC;S"AIA2#AL_%7]K2P       "
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M$IJ?#Q7R^ES.A8M"[@R_F$V;-C5ITD1*77/--1*V;-FR6K5JQ0/>>NLM"0B
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MF16C$:EHOO<*)JWENEJXAS';S%[%:5!FM+K'^IKL,3T24H6P;F4!
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M<@6/,1-C-"(5S?=>P:2UO%0+\3!FF]FQ. W*C%;W6%^3/:9'PJL0RJTL
M    @!RQC2Q=+2\O7[]^_8\__OC%%U^,&3/FYIMO/O'$$VO7KJV9AHX=.V:X
M?*1___Y:U+(./_QPNP\::B@M+;WKKKOJU*EC9C5KUJRDI$1#'1Y\\$$S*ZY#
MAPY??_VU1E>JJ*AX^NFGZ]:M:T<F/"::D-R:-6L2_AK[N...6[!@@4976KER
MY447712+M'?\N^^^JYK]"\U)1?/SLT(DLR+!CT!_F1V(T0C7[KOO/JUE67ON
MN6?UCP#\Z*./VK9MJVF6=<\]]VAH*EHB@WWQA?;&LHX^^NAOOOE&XQQ>>^VU
MG7?>67)OO_UVC:L4^J04H_GY5B%_S^5P+PHY,OP2^L]__J-UHSIUZJ2A@=,^
M1;^7.?:7@H*"O_SE+_;+JCF5YL^?W[5KUZK9O["'03593IKOTV&/"_>B,&#
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M$0 0B<R=.U?FBCWVV$.# /BAHJ*B8\>.<L8%\,A5          " <+%T%0
MP&>///)(?/5)BQ8M-F_>K!$A,5;%;*41 !")?/#!!S)7''/,,1H$P \C1XZ4
MT^W88X^MJ*C0.           @&T+2U<!  !\UJ%#A_@"E$&#!NGF\!@+8[;2
M" "(1.Z]]UZ9*ZZXX@H- I"Q;[_]MEZ]>N:YUJA1HT6+%FD<          #
M-H>EJP   'Z:,&%"? %*86%A3BU ,=;&;*41 /*<>8+/GS]?-[OSQS_^T:QC
M&SUZM 8!R,S"A0MWWWUW\T0K+BZV[R(T#@          8%O$TE4    _]>G3
M)[X&I7OW[KHY5,;RF*TT D">,T_P4:-&Z6875JQ84;MV;;-.45'1ZM6K-0Y
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M  "XHJNZDCOAA!-RY,M_M6>I:#Z ?*-G=;H..." !0L6:'4
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M704                  $! 6+H*                  " @+!T%0
M              %AZ2H                    "PM)5
M    !(2EJP                    @(2U<!                   0$):N
M @                  (" L704                  $! 6+H*
M          " @+!T%0                    %AZ2H
M   "PM)5                    !(2EJP                    @(2U<!
M                   0$):N @                  (" L704
M         $! 6+H*                  " @+!T%0
M  %AZ2H                    "PM)5                    !(2EJP
M                  @(2U<!                   0$):N @
M        (" L704                  $! 6+H*                  "
M@+!T%0                    %AZ2H                    "PM)5
M                !(2EJP                    @(2U<!
M       0$):N @                  (" L704                  $!
M6+H*                  " @+!T%0                    %AZ2H
M               "PM)5                    !(2EJP
M      @(2U<!                   0$):N @                  (" L
M704                  $! 6+H*                  " @+!T%0
M              %AZ2H                    "PM)5
M    !(2EJP                    @(2U<!                   0$):N
M @                  (" L704                  $! 6+H*
M          " @+!T%0                    %AZ2H
M   "PM)5                    !(2EJP                    @(2U<!
M                   0$):N(H^5E)0\]=13%UQPP8$''MBR9<OBXN*BHJ(F
M39JT:]?N#W_XPRVWW/+QQQ]OWKQ9TP         @"3YU!*IA&70;      "
M:RQ=15Y:M&A1OW[]:M>N;7Y,EE##A@TOOOCB29,FF>ESYLSYPQ_^T*!!@_KU
MZ]M_F3MWKKDU9^5IMP$      ("\D.&GCDB&#S:W)>:)H-L       !<RZVE
MJ^9''IFH7;OV+KOLLM=>>QUYY)&77'+)B!$CIDR9HHTA;[WWWGM-FS;55SV5
M>/J<.7,:-VYL;K*K??_]]T8+N2A/NXWJF2]H,BU;MER^?+EF>J=U4]%\
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MS*P<\\PSSVBH:P\]])"6B[K^^NLUU#5S[7[CQHVW;-FB$0Y\L+F-,5]'W08
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M\\R,&3,T,PRK5JT:-V[<H$&#3C_]]/;MVS=OWKQ.G3JU:]>V!XS=V^...V[
M@ 'OOOMN)BLCT[!QX\:77W[YDDLNB1U#NS\U:M2PAY/=0_L VKU]]=57ERQ9
MHFG;D(0C_/OOOS>_DM)T[KGG&MG>F'5TFT<Y.)PJ*BK>?__]2R^]]."##V[4
MJ)$]D!HT:&!/C">==-)MM]WV[;??:H)#>7GYFV^^:8_&@PXZJ''CQK&9K6W;
MMMVZ=1L\>+#Y>;U? IM. 0   *3!?CL??P^UPPX[S)DS)[[IN>>>,]Y@_2K#
M[\KP)!_?!"U:M.B))Y[HV[?O$4<<8;^1K%NW;D%!@?VG_?=.G3K9/[>WVC&:
MMDW+ZB=[.D S_C0@VP(;(7I<PCXRHT>/U@Y95I,F3;9LV:*A2=BGL[GZ\(LO
MOI@T:9)1;"M[*ENZ=*DF)W?888?%<__YSW_JYMS@^Z>+V]O'-1===)$Q1GYA
M'\.OO_[:C#&WFC^W;=Z\V5G!&08      !#9?I:N3I\^7:M$'73001KJ6EE9
MV6.//=:^?7LMFDBC1HVNO/)*KY^E:A4',WC%BA677799C1HU-,A0LV;-RR^_
MO*2DQ$Q,3R[L?C4NN. "K]4DWKV*BHJ77GJI2Y<N.R3Z?L"$6K9LV;=OWQ=?
M?''CQHU:KBK-=-"$5)8O7_[@@P\>=]QQSF]]2JA>O7I77WVUU]<N1FLYF,$;
M-FP8,F2(\__T^^+DDT\VVS+-G#E3HY/0S.Q(UN+8L6/-3:8GGWS2C'3/+*+;
MW,G9X31^_/@##CA (ZHZX803Y&-WT^C1HUNW;JTY59URRBGVQ44SO0M@.@4
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MO&#G^_E.V<FP,WEV)C"&KF9E9;5ITT8N4#5MVM2-WX;*'7":$3GK'F_L3N(
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M7\5&]L>.=^K4:<:,&6*1Q"ED5E:6^%/\7;PB7M<=/69FS!QF-#"@!S,:&-#
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MFF#>SC=7]AP@JUA?!6\(F#W$XQ(3$[6/H5>,GC6T9\\>M5(<LN!*>&YNKG:
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M$K"H:"9/G@RSJ%"A@NL?\+S"=Z006P,G^Y:T[!:V<'IZNNZO106QW^;DY&#
M3B[#:1;YP^XD#B]8Y!+F/=$!*PK3/884R^$T-35UY,B1M6O7#@D)$7^*-ZZX
M?A%"1$1$1.2W+ERX$!H:JG[8WKQY,U:XI'L;O^#@X-.G3V.I.=C+$Z<P1>^
M%87IG@3]\LLO6&?:WKU[L9VB=.S8$>LT,&.TY+JPA?4FF+=^2NC&E3T9)JUD
MO2' ]A O24A(T'UZ^_;MVZ'RT*%#ZM3P\/#T]'0H4.7DY$1&1DK-\FF_H@]S
M/W?N'!18(LTJ'U88P;PGKB[J[H=6?S95@72Y9LN6+4V:-,&5,4?\W+D8/$U$
M1$1$1$1$Y%"*AJX*:]:LP5YV8\>.Q5))K5JU,.!I9BZAYNEMC>SL;"PR@BV,
MMJ<_KSY66(&]3'33W11N_\[)/3A[$XL-Q#[SX8<?=NG2Q=*P0EW8V@CFW=J!
M7;MPX4+9LF5A+M.F3<,Z24I*2L6*%=7B%2M68(5O20MN;0L?/'BP0H4*<EPU
M<N1(K+:3:W":.7ZU.]EL-BQR"?.>Z( 5A>D>0SS+Y.&4B(B(B(@,R8]+;MRX
M,4XVDI24%!X>+GU:SV?FWGNZL)$G3F&*W@$K"M,]"3IUZA36F7;BQ ELIRAU
MZM3!.@W,&"VY+FQAO0GFW;HP@BVL+ 8FK62](<#V$.]IV[8M+I^B3)@P <KD
M$?,]>_:$J2 N+DYJEF_8L&%0]N]__UN=VK)E2YAJE32K?%AA!/-N_1 !W?W0
MLTKNY9J<G)RY<^?&QL;B*IG3K5NW__[WO]B4B(B(B(B(B*A Z1JZ*K1LV1+;
MV>_+>.G2)2PM$!$1@0%/BXV-Q;GJP9A;FP);&#4)L-5782\3W70W15)2$M9Y
M$\[>Q&++UJ]?W[AQ8VSA+NQN!//6.YCQZ*./PEQNOOEF%[^-FS5KEEI9HT8-
M9S<H]1EIP2UOGT6+%LEQE3B>?_/--UA=M'GEE?S="?/>[Z![#/$LDX=3(B(B
M(B(R)#^Z9^K4J3C9!.WYJ6(?1:?[F&]#V,CH!$0+\][OH'L25)0+*0D)"=A.
M42(C([%. S-&2ZX+6UAO@GGK'?**U@235K+>$&![B/=,F# !ET]1VK9M"V7W
MW'./.O6?__PG3 5SY\Z5FN73#O-][+''U*ECQHR!J59)L\J'%48P;[V#ENY^
MZ%DE_7)-3D[.LF7+[KSS3C>^NQX>'KYPX4+L2$1$1$1$1$1D5^J&KHX;-P[;
MV7W\\<=86B X.!BK/:U2I4HX5ST8<VM38 NC)@&V^BKL9:*;[J8H^C?[+<'9
MFUALE>YE[J+ &1C!O/4.9OSTTT\X&T5Q\8"JYLV;JV6OO?8:3O8Y::G=V3[Q
M\?%R!U5T=/39LV>A6"Z 288"8'?"O/<[Z!Y#/,ODX92(B(B(B%S;N'&C^C&[
M;-FR+K[P[(+<1+9V[5HL-0&[&)V :&'>^QUT3X**<B$E*RL+VRE*2$@(UFE@
MQFC)=6$+ZTTP;[U#7M&:8-)*UAL"; _QGFW;MN'R*4I04%!"0H):DYF96;Y\
M>77J@0,'I 8Z3ITZ)36[[N#!@VJ-S6:[\<8;U4F;-FV2&KA#FD\^K#"">>L=
MM'3W0\\*F,LU)T^>?.>==W1O ^Q"F3)EYL^?C[V(B(B(B(B(B$KAT-7UZ]=C
M.[L! P9@:0$?7+T*#0W%N>K!F%N; EL8-0FPU5=A+Q/==#=%4:ZGNP%G;V*Q
M'4:.'(E)N["PL#Y]^LR?/W_7KET7+ES(R,C 9 %,FIZU"O/6.YATVVVWP8QZ
M]>J%178__OBC6B/>W].G3V.%STE+[<[VN7KUZJVWWBHW477ITN7:M6MRL3Q5
M?MU08.Q.F/=^!]UCB&>9/)P2$1$1$9%KNC=,]11QWH3S,P&[&)V :&'>^QU"
M0D(PH"A965E89UIF9B:V,W<>A!FC)=>%+:PWP;SU#GE%:X))*UEO"+ ]Q'MR
M<W.CHZ-Q$15ER9(E:HU\T;MV[=I2VJDF39I(S?+)MVO=L6.'^GI45%31'U4D
MS2<?5AC!O/4.6KQ<XP9<0R-B(Q=]Z#,1$1$1$1$1!9Y2-W3UV+%CV,ZN:=.F
M6%I ]YE!, +,-W AW-H4V,*H28"MO@I[F>BFNRF*\A0S-^#L32RVL&[=.HS9
MQ<7%:>_$Z0R&S<U:AGGK'4Q:N' AS"@H*$C\[&-=X5]&/OC@@SBY.$A+[>;V
MV;]_OWR;#=FKK[XJ5\J3Y-=="YC="?/>[Z![#"F6PRD1$1$1$;D@SO3#P\/Q
ML[OGA(:&7KAP >=J!+L8G8!H8=[['2I6K(@!14E,3,0ZTXKW<?#8PGH3S%OO
MD%>T)IBTDO6& -M#O$IW//W @0/5@A=>>$%]?<B0(5+4*3FBZMFSIUHP:=(D
M]?6__.4O4M1-TGSR8841S%OOH,7+-6Z0M]7V[=LG3)C0L&%#^46MEBU;YN;F
M8B,B(B(B(B(B*MU*W=#5I*0D;&=7M6I5+"U0JU8MK%:4Y.1DK/,^7 BW-@6V
M,&H28*NOPEXFNNENBE.G3F&=-^'L32QV=G9VW;IU,:8H\?'Q-IL-JYW#O(E9
M \Q;[V!29F:F]EX4+[[X(I1=NG0I+"Q,+7#OB8T>)RVR^]MGP8(%<A]54%#0
MM]]^JY;)DZ2T*X&T.V'>^QUTCR'%<C@E(B(B(B(79LR8@1_</>WMM]_&N1K!
M%D8G(%J8]WZ'VK5K8T!13IX\B76FG3AQ MLI2FQL+-9I8,9HR;7$.2^VL-X$
M\]8[Y!6M"2:M9+TAD/80;_ODDT]P$14E)B9&'0LHWT)UQ8H5A=/Z=)].%AX>
M?O7J54=!^_;MU=<_^NBCPFEW2//)AQ5&,&^]@Q8OU[A!WE:.5\1!<NW:M2U;
MMI0G@=6K5Q=N0T1$1$1$1$2E7:D;NIJ3DX/M[$)"0K"T@'R13N7C 8L.N!!N
M;0IL8=0DP%9?A;U,=-/=%+_^^BO6>1/.WL1B?_/--YA1E)HU:[IXF+LN;&%B
MU@#SUCN8-WKT:)A7I4J5TM/3Y9JWWWY;G5J_?GU+(R^]1UKD(FV?08,&R:U4
M5:M6/7_^O*-&?KUPVJE VITP[_T.NL>08CF<$A$1$1&1"\V;-\</[I[6L&%#
MG*L1;&%T J*%>>]WZ-"A P849=^^?5AGVMZ]>[&=HG3JU GK-#!CM.1:5ZY<
MP1;6FV#>>H>\HC7!I)6L-P32'N)MERY="@H*PJ6TW_!23#U]^K3Z2DA(R.7+
MES&O)S,S4_>Y/8[QA8F)B<'!P>J+YI^TXX(TDWQ8803SUCMH\7*-&^1M);^>
MFYO[RBNOR%-E0X<.E8N)B(B(B(B(B$K=T-7$Q$1L9U>^?'DL+3!X\&"L5I0]
M>_9@G??A0KBU*;"%49, 6WT5]C+1[:]__2MF%&7ERI58YTTX>Q.+_?CCCV-&
M4=Y\\TVL,X(M3,P:8-YZ!_-.GCPI7UYW^."##]0"F\U6KUX]==([[[PCI8N3
MM+Q%VCYI:6FWW'*+W$W5O7MWQSTYY!<Q[T0@[4Z8]WX'_SF<$A$1$1&1,S__
M_+/Z<3TD).3<N7-88=&Z=>ND,X#KOO_^>RQU"?-&)R!:F/=^A_CX> PHRO+E
MR['.M*5+EV([11$GJEBG@1GK3P,_<^8,MC!:?2W,6^^05[0FF+22]09_WD.P
MP@_<<<<=N)2*,G'B1#'I@P\^4%\Q,U17U:M7+ZE9OF>>>49,^O333]576K1H
M@4FW2#/)AQ5&,&^]@Q8OU[A!WE8X+2]ORI0I<H&J6;-F6$I$1$1$1$1$I5NI
M&[IZY,@1;&=7HT8-+"TP??ITK%:43S[Y!.N\#Q?"K4V!+8R:!-CJJ["7B6ZZ
M3PQ\XXTWL,Z;</8F%EOW.4T[=^[$.B/8PL2L >:M=[#DP0<?A-G)U]G7K%FC
MOAX6%G;ITB4I6IRDY2WJ]OGUUU_+E2LG-U1-GCPYSZUY!=+NA'GO=_"?PRD1
M$1$1$3GSY)-/JA_7>_?NC9.ML]ELL;&QU\\!"@P8, !+7<*\T0F(%N:]W^&]
M]][#@**,'S\>ZTQ[[;77L)VBS)PY$^LTM+>K3$U-Q2*7]NW;!QT4H]77PKSU
M#GE%:X))*UEO\)\]!#/%O65TB2V#2ZDH[=JU$Y/Z].FCOO+ZZZ]CTCG=M\!Q
M6VCY>3ZC1X_&I%NDF>3#"B.8M]Y!BY=KW"!O*YQFUZ5+%[G&(28F!NN(B(B(
MB(B(J'0K=4-75Z]>C>WL.G3H@*4%=!\U]?+++V.=]^%"N+4IL(51DP!;?17V
M,M%-][<4CSSR"-9Y$\[>Q&)7K5H5,XJ2D)" =4:PA8E9 \Q;[V#)A@T;<'Z*
MLFG3)L?4!QYX0'UQX,"!A:/%25I8#VR?#S_\4&ZH"@X._N&''^17,.E$(.U.
MF/=^!_\YG!(1$1$1D:[4U-2(B CUX_K77W^-%6Z9/'FR=!*0+RPL+#$Q$4N=
MP[S1"8@6YKW?X==??\5 T08$:[^D*NS?OQ_K-"(C(R%UYLP9+')IR9(ET$$Q
M6GTMS%OOD%>T)IBTDO4&_]E#,%/<6T:7?$]H55!0T/GSYV^XX0;UE1T[=F#2
MN:-'CTK-KCMRY(A\">B''W[ I%ND.>3#"B.8M]Y!BY=KW"!O*YQF]_GGG\LU
M#F7+EL4Z(B(B(B(B(BK=2MW0U=&C1V,[NQ$C1F"II%:M6E#?OGU[+#)M__[]
M<JM;;KD%*YR04PY880*V,-$DD%9?A;W,=:M=NS:DJE2I8O49<PYP ^";;[X9
M*_3($0>LT @-#<6,HF1G9V.=2RDI*=C"Q*P!YJUWL*I)DR8PQX<??EB\?NK4
MJ>#@8/7%'W_\$9/%1UI8SVR?1Q]]5.ZINNFFF^1_8LR)0-J=,.^3#GYR."4B
M(B(B(EWSYLU3/V#7K%G3O?-]K3-GSL@GH:IITZ9AJ7,8-G$" C#ODPYUZ]:%
M2(4*%=+3T['.!)$26>@F^F.='O%N0M#J\T-TKRABD1',6^^05[0FF+22]1(_
MV4,@I?C!EM'*S<V-CH[&!564O_WM;^K?8V)B;#8;)EUJT*"!U"Q??'R\^O?(
MR,B<G!R,N46:0SZL,()YZQUT\7*-2E[RE)04G%Q +L-I=N?/GY=K'%P\^(Z(
MB(B(B(B(2J?2-7359K-IA[(Y+%NV#*LE8\:,P8"B'#MV#.O,F3!A@MQG[-BQ
M6.&$G'+ "A.PA8DF@;3Z*NQEKMLKK[R",47Y_OOOL<Z$:=.FR4V>?_YYK- C
M1QRP0B,F)@8SBG+AP@6L<^GPX</8PL2L >:M=[!JYLR9,,?0T-"S9\^^^NJK
MZBO-FC7#6+&2%M8SVR<U-;51HT9R6UT8<R*0=B?,^Z2#GQQ.B8B(B(A(U^VW
MWZY^P'[MM==P<A'<=]]]TH?W?+?>>BO6.8=A$R<@ /,^Z0"G+0Y??/$%UID@
M4MA(441_K-/3M&E3""Y?OAR+7&K1H@5T4$RL/L"\]0YY16M2MFQ9R'IJ?+;;
M_&0/P9B5K>I+ P8,P 6U/UI'_?NCCSZ*&2-//_VTU"Q?4%"0^O<^??I@QEW2
M'/)AA1',6^^@BY=K5/*2'SQX$"<7D,MPFEU65I9<X]"Z=6NL(R(B(B(B(J+2
MK70-7=6]@BE$1$1<O7H5JR6___Y[2$@(I,:-&X=U)F1D9%2O7EWN8_XV#W+*
M 2M,P!8FF@32ZJNPE[EN)TZ<T-YU<L"  5AG0O/FS>4F&S9LP H]<L0!*S2T
MOYX1-F[<B'4N??#!!]C"Q*P!YJUWL"HU-57[3, Q8\;(.^&L6;,P5JRD)?78
M]MFW;U]X>+C<60LS3@32[H1YGW3PD\,I$1$1$1%IB5,G]=-U4%#0B1,GL*((
MOOKJ*^G#^W5;MV[%4B<P:>($!&#>)QW.GCT;%A8&J1X]>F"="7?==1?T$9U%
M?ZS3T[=O7\A:&DQV\.!!B#M@G1',6^^05[0F5:I4@:RS^YN*4TZY+#(R$BL\
MQ$_V$ @J5K:J+RU>O!@7M+!%BQ9AQLC77W^-70K[\,,/,>,N;&U].V/>>@==
MO%RCDI=\_OSY.+F 7(;3[$Z?/BW7. P;-@SKB(B(B(B(B*AT*T5#5R]>O!@;
M&XN][,S<\'+HT*&0JE"APLF3)['.R)0I4^0F'3MVQ KGY* #5IB +<PU"9C5
M5V$OT]V&#Q\.P:"@H'W[]F&=2W!1N''CQB8?YB6G'+!"X['''L.,HCSWW'-8
MYU*7+EVPA8E9 \Q;[^"&9YYY!F8JWXLB(B+"Q:.OBH6TI)[</G/GSI4[:V'
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MF%3^=\6R4Z=.,V;,V+5KES@5%:>!XD_Q=_&*>%UW&)GH@ZTU,*.! 3V8T<"
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M],R9,UCG!&0=MFS9@G7.:9_K]-133V&1AM^N/E98@;W,=?O]]]^UF\+D\Z1
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MUHRV<-A$P_;B/J]AAPX=#AX\J*4!%186CAHURGP<T]/3S3]'CQX=8,\Q
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M6AIS.J=H<O2D5U[6C.9=M"@8B9N_PEH1D#5;6%BHAVWP]Y5V\I=_'N;/M10
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MPL)"<[FN7KWZS3??[->O7W9VMB7WAYHU:ZY9LT8&#2SQ[Y!K%]NX&04
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MY6Y=:44PF@^[@Q[VXJF<,F5*9F:F'O:O6[=NO_[ZJV4H9Q+Y#KEVL8V;40
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M\Q<,<^;,T0H                 0$RP=15 \GOTT4<]^U;KU:MWZ- AK0
M                Q 1;5P$DO[9MVWJVKHX=.U8/ P                !B
MA:VK )+<HD6+//M64U-3-V_>K!4 CO#\L@    !QI*]3 0! 4M.7 @    #\
MT]?3 %!NL7450)(;,&" YS5<[]Z]]3  "\M;'@   "!N]'4J  !(:OI2
M (!_^GH: ,HMMJX"2&;;MFW+S,STO(:;/W^^5@"PL+SE 0   .)&7Z<" ("D
MIB\%     /BGKZ<!H-QBZRJ \LKZXFSGSIUZV&7LV+&>FA-..*&DI$0K
M               QQ-95 .659>>J\>Z[[^IAUT>N5JE2Q5,S??ITK0
M            Q!9;5P&45Y:=JT;W[MWE:$E)R>677^XIJ%NW[KY]^Z0&
M             !!C;%T%4%Y9=J[^[JJKKOKZZZ_W[=NW:]>NCS[ZZ.RSS[8>
MG3%CAN8!                 #''UE4 Y95U9VI@/7KT*"DIT3P
M        (.;8N@J@O-(-JGZT:M5JQXX=&@8                 Q -;5P&4
M5[I'U9?>O7OOW+E3DP                " .&'K*H#RZI=??GGMM==&C!AQ
MP047G'+**<<??WRF2YTZ=<X^^^S;;[]]\>+%F@$                 Q!5;
M5P$                  ! C;%T%                  ! C+!U%0
M             #'"UE4                   #$"%M7 0
M    $"-L704                  $",L'45                    ,<+6
M50                   ,0(6U<!                   0(VQ=!0
M            0(RP=14                    QPM95
M    Q A;5P$                  ! C;%T%                  ! C+!U
M%2A_C& T                  ! 8BCW6U=W[MSYSCOOW'GGG7WZ].G8L6.]
M>O6J5*F2GIZ>E955ITZ=%BU:=.C0X>*++QX^?/C33S_]Q1=?[-FS1ULXMW;M
MVBNNN*)RY<J5*E4R_V/=NG5: 423[E3UHH&X*BPL_/CCCR=.G-BW;]_33S_]
MA!-.J%6K5H9+M6K56K5JU:-'CUMNN67&C!D__OBCA@$
MR:6\;EW-S<V=/'ERY\Z=S7GJKKU@3CKII.NNN^[99Y_]]==?M:\-:]>NK5&C
MAK5AK5JUUJ]?KW5 U%B7GT\:B).%"Q<.'CRX8L6*.C__ZM2I8T;FS)E34%"@
M[0                  Y5_YV[JZ=NW:&V^\,2LK2[>\A:1-FS;_^,<_%B]>
MK,/XU[MW;^UB&%=>>:76 5&CZ\^+!F)NS9HU7;MVU6DYD9&1<>&%%[[XXHL'
M#AS0[@                " <JL\;5W=NW?OF#%C,C(R=(];)#1ITF34J%'+
MER_74;U4JE1)PX91N7)EK0-B19=CO+>N3IHT*5*;RTW5JE4;-FS8M]]^J\,
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M8L6*C(P,F4E*2LKLV;.UU#_SEWK<N''2Q$U+ ]*PPWBBT9,IYZ<#
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MW?1P0-9@"/%$HR=3SD\'                P+$LX;:N%A<7-VG21'=I&<:
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MXOD5\R=F:U4;A23HZ7@4%14]\<03K5NWUA:^5*]>_99;;@GAI
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MTUFZ=*DV,HP;;[Q1Z^QY]-%'I55*2LK.G3NUSHN_)<&GK@(
M  #'@L3:NNKSJ\]-";B34J?H<">9AAW&?7KEE5>TJ6&L7+E2ZWPYZZRS/)';
M;KM-#R<JRXG^KD&#!EH1C'0P+5RX4(L"VK9MFW2H4*&"%I5UWWWW2<0T?OQX
MK;/G@P\^T%Z16$X1=/CPX7???;=OW[XY.3DZ41OJU*GSYIMO:M-@M$N\KXE,
MQNE:E;@1ZNE,F3)%&QG&K%FSM,Z>18L6:2_#F#MWKM9Y&3ERI,9<1HP8H:4
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M=.K421LY7_,>A86%VLLP^O;MJW6^%!04C!PYLE&C1FEI:>:?YI5DWRH
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M0+GPV6>?F>M63\PP+KOL,BWU16-A7)-$6*L:=ACWR,G)T4:&<?CP8:T#
M            @*A)K*VKIB%#ANB^*M<'@N[9LT=+XTJGZ' GF88=Q@,[<.!
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ME!<OO_RRGIAAU*A10^M\T5BHUR1!UJJ&'<8].G7JI(T,8].F35H'
M         %&3<%M7BXN+3SSQ1-U:91@#!P[4TKC2^3G<2:9AA_&@-F[<F)J:
M*D,\^>23GH*2DI)FS9IY#DV8,,&2CKKKKKO.,J\_W'___5H7C+9P?ADU[[Q#
MJ?,F_?KUTX!AO/[ZZUIGSP\__*"]@DT@2LPG#7/5I:>G9V9F%A86ZF'G?O[Y
M9STQPTA+2],Z7S06ZC5)D+6J88=QCT&#!FDCPUBZ=*G6 0
M $#4)-S65=.T:=-T:Y5A9&=G[]Z]6TO#MGCQ8AFH0X<.6N2+I R'.\DT[#!N
MA_>7K;=KU\YS=-Z\>9Z?9V9F;M^^W1*-NE-//=4RKS^8CX76!:,MG%]&S3OO
M4.J\R0,//*"!D'9#NKWYYIO:*]@$HL0Z@9]^^DD/.U=86&CMZ5:A0@6M\T7A
M?U)_  "  $E$051CH5Z3!%FK&G88]Y@R98HV,HS9LV=K'0
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M3[<SSSQ3ZWS16*C7)$'6JH8=QJT:-FPHK3IUZJ1%MGW__??65JU:M=(*
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M@M;Y$JE?L019JY$Z'=///_^<EI9FK3'=====4F:'.9;UR<2T>/%B+0(
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MJ6U+ERYMV+"A]+SVVFNU+B")&PXWHG7KUDWB7WWUE1:YO//..]:RGCU[:D5
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MS29::F$^ES[PP /FPK.FZM:M:W]7L:EQX\;6N$?3IDVU%
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ME"E3EBQ98CY2145%YA ;-FPP5Z/Y"-:J54OJ*U>N;$Y#6P<D^VL]S)]K*0
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M]G2L%BU:=/+))VL+&ZZZZJHM6[9H.QMNO_UV[>4R<N1(+04
M  "0=,K?UE6WC1LWCAT[MF7+EKKU*: __>E/#S_\<&YNKK:S07L%HWE?BHN+
MQXT;EY.3H^&R6K5J]?GGGVO8(>NN._/!7;-FC5;$S_SY\\\__WS+&?N6G9T]
M;-BP[=NW>X):X<4RB-V(T+R+%@6C>3]>?OEEZ[?,^V0^=KUZ]5JY<J4UJ$5>
MK,4QLWKUZO'CQYN/;&9FIDXHF&;-FMUQQQWKUJW3I@Y%_%<LEFO56\1/Q^/0
MH4.S9LTZ[;33M)<OZ>GIO7OW7K!@@7:Q+3\_OUV[=M*V??OV!04%6@H
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M                  ! ]+%U]9CPZ*./>O:MUJM7[]"A0UH!
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MO7KML<<>YYY[[I@Q8S0'                  "@>GAT%0
M     !GAT54                   !DA$=7 0                  D!$>
M704                  $!&>'05                    &>'150
M             &2$1U<!                  "0$1Y=!0
M    0$9X=!4                    9X=%5                    9(1'
M5P$                  ) 1'ET%                  ! 1GAT%0
M             !GAT54                   !DA$=7 0
M    D!$>704                  $!&>'05                    &>'1
M50                   &2$1U<!                  "0$1Y=!0
M            0$9X=!4                    9X=%5
M    9(1'5P$                  ) 1'ET%                  ! 1GAT
M%0                   !GAT54                   !DA$=7 0
M            D!$>704                  $!&>'05
M    &>'150                   &2$1U<!                  "0$1Y=
M!0                  0$9X=!4                    9X=%5
M            9(1'5P$                  ) 1'ET%
M  ! 1GAT%0                   !GAT54                   !DA$=7
M 0                  D!$>704                  $!&>'05
M            &>'150                   &2$1U<!
M  "0$1Y=!0                  0$9X=!4                    9X=%5
M                    9(1'5P$                  ) 1'ET%
M          ! 1GAT%0                   !GAT54
M  !DA$=7 0                  D!$>704                  $!&>'05
M                    &>'150                   &2$1U<!
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MN^^VJ^G+\+&'*^&@::$$I7*"*9HQ>V3J8WQJXHALIT1*!#PZAYA%S6KH'C@
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MG>J'//27OI"ICYL8346&*))45KP"NVQ^)DP&*YY-TAW?W+/EX3[&NNNN:W?
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MA\-EFSU[MK;A.'WZ]-&XS$V=.E5Z=?;99VN0Q8R,'5SZ.=<8_/],51#^GY>
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M=I$R?_Y\&,QKK[V&C<[;O7LW-+[]]MNQD:<R,S-'C!@AID=*2HKXWR>??#+
MBA.B. -O-S]LY$R(N]FX.8O'$LZ*Q,W3-V MQ]5X$<. C>Q@WGV%(,3018P"
MU4N4$.RK%/0>+\XF#)9P603#SN+*U[!0KF-\]]UWUH_<%2M6%">PV-2ES9LW
MIZ>G0^6//_X8VUF(N00I8<Z<.=@NH'GSYF$)9[-4_I$*/[$#W[AQ([;3$Q_"
M:]:L"47\L*E&-!Q/@^;M^;X?%+SAAANPA1O;MV\O6;(DU$Q+2W.^A O4KET;
MJLGUQ3D:!BP.'#@@IIE4P.2""R[ @$M8T?%4-&#>?05#^*Y3R8W]RI0I@XW"
M _HMK"E:N#M/ X9#F"U*<3F%_*+PB&R ;$)0FQ5+N"R"89?Q E6%!-])5G9V
M-C;56[]^O76/+3X\8#L]R"9$:J85^J<+;]^\A7O&+7;(?_[SG\4'@)24%/&\
MGGGF&=TR7(="OP;.R\)$1!2$HK)T==^^?>W:M<-"/I4K5SYX\" &+,1)N_5?
MX5QSS36N[B&_<N5*.-Z+LR]LI"<'_;"% UC"69&X>?H&K.6XFI@ME2I5@FS[
M]NW/G3N'335.G#AQP047R/')DR=C(PTYY8<M+*9/GXX9W_6%WW__'9MJ?/;9
M9YCWP79V,.^^0A"V;-F2:/X7G++[[[\? X4'!^>#C1P(97<79[,%2[@L@F%G
M<7&BV+!A0TS:?=E66'"4/M@H9-B!%UUPKLJ-,S(RCA\_CBT"&C-FC%Q!&#]^
M/#:R@$B"@W'*NG?O#O'ERY=C(Q^X4M.[=V]LX9U??_U5[LMO[=JUV,Z!LV?/
MRM=>/_WT4VP1,N4O$(F9+SY:8%,]S/M@(P=".=P4Q,[+95BU:A762DCP]DZQ
MKEB?W>K5J['1>5.G3H7&[[SS#C;R3F9F9NO6K:''MFW;\C(E%1$P^?VPD0,A
M[F8+XN@L'DLX*Q(W3]^ M1Q7XT4, [:S@WGW%8(00Q<Q"E0O44)0KU(H>[PX
MFS!8PF41##N+1]5U#+%!K8LPQ#EO<.=H?FO6K*E5JQ;4O.>>>["=RK%CQZS_
M(JY^_?J!IZ7L\.'#%UYX(500-8\>/8I-+18N7 A!H7/GSL[7M3SZZ*.8/P^;
M:D3#\31H'I[O&[!<0L*KK[Z*C9P1!^*N7;MBN82$H4.'8E/' FSQ!,?WHA-S
M#)/GB?K8VB6LZ'@J&C#OOH(A3->IQ+M#;NPG=K/8+CRPXT*:HH6[\S1 /"&$
MV:(4EU/($&U'9 /$$X+:K%C"91$,NXP7J"KX_>4O?\&F&EE965=<<07F$Q*^
M_?9;;*I1B#.MT#]=>/OF+<0S[LS,S)8M6\I!H4.'#F?/GL6FCH5X#9R7A8F(
M*#CQOW15')ZG3)EB_=#@)SYYSYPY$S,:__K7OS#ONV61P\]2XF /PQ"?P[!1
M0'+6#ULX@"4<%XF/IV_ 6FZJ*2]J]^W;-R\O#YM:B ]M<"^'9LV:.;^-@1ST
MPQ86)T^>5,[_RRZ[3 P&6UNL7KVZ3)DR&/;!IG8P[[Y"<'KV[(D=GQ?*:;;G
M<' ^V"B@T'=W<39;L(3+(AAV'!>O@_5'D<11==:L6=BTL,$@_;!1R+ #+[K@
M7(7V??KT<?[=U;9MV^!W2(L7+[YOWSYL9R%'_+!%0,.'#X>X[M=.X<?(7GGE
M%6SAJ4LOO53N+B'857WRZL J5:HXWR+.[=BQ0[F48>+$B=A4#\,^V"B@T \W
M!;'S<AG>>NLMJ"-F#C:*H(X=.\J#24]/#_!!U/H#?YLV;<)&WADQ8@1TY_?4
M4T]A4Z)XA%/?!QL%Y,ENUB\^SN*QA.,B\?'T#5C+335>Q/##IG8P[[Y"<&+E
M(D:!ZB5*</DJA;['B[,)@R5<%L&PXWA47<>8-&F2=:U,R9(EQ?FCP[M/&<1>
M[OWWWR]5JA14Z]RYL_/]V-RY<ZWC$1/,]J:#!;Z;GK9OWQZRHIKS6P_>====
M$!?$QWLG+\7KK[_N;]^K5R]S@?^%K?4*_7@:"J_.]PU0+<'W3GGYY9>=;!'9
M\>/'K[KJ*JSENZGA@0,'L+5CRY8MPXKGU:E3!UMK3)@P </GB?K8VB6LZ&8J
M^F'>?05#F*Y3G3AQ0F[LUZ5+%VP7'MAQX4W1PMUY^D&%A!!FBU)<3B%9M!V1
M_:!"0E";%4NX+()AE_$"587Z]>LG^-ZPXH7"UA;B]5?>-5]\;,"F>H4[TPKW
MTX7G;][".N-^XHDGY*#AF6>>P::.A7@-G)>%B8@H./^W:M7'^&,,+UT5']?$
MAZW??OMMQ8H5[[[[[H ! \J7+X_Y\Y*3DQW^LQ6#.+)B%=\_%EFY<B4VE8A/
M&&/&C(%?ULC(R'!XCF>0XW[8P@$LX:9('#Q] ]9R6>W99Y_%O.\?46W>O!F;
M2I8O7W[QQ1?+D924E#5KUF [/3GKARU4WGSS38SY7'+))3___#.V/D^\FS[X
MX /_R62)$B4P[*QK&>;=5PC.UU]_C1W[B.V%30L5CL\'&TG"M+N+I]F")5P6
MP;";^/CQXS&<D"#.I74_.U)8<(@^V"ADV(%'713QN8J!A(1.G3K]][__Q786
MWWSS394J52#[XHLO8CL52"4X&*<,_HUR@N^"M?7RC?A0(0Z.<C,GSRL4K[SR
MBMR=<-MMMV$C!^2EA(\__C@^[)$>/7I((_T_KJX?8=@'&TG"=+B)E9?+<---
M-T&=EU]^&1M%RKESYV!M@?(?_1O@9["J5JV*+3QE_9%*/S$,;$H4CW#J^V C
M29AVLX8X.(O'$FZ*Q,'3-V ME]5X$2/!6=<RS+NO$)Q8N8A1H'J)$@*^2F':
MX\73A,$2+HM@V$T\JJYC?/[YY\J-TKQY\T\__=3)/WL3>W)1Q'H;*J%UZ]:N
M;MHGO/KJJU@E(:%>O7J!;VSVPP\_-&C0 &,)">/&C<.F>N(MXU_+ KIW[R[>
M2MCZ//$$!PT:Y&\I#F?;MFTSI_\79@(JW.-I*+PZWS= -4/GSIV___Y[;*UR
M]NQ9L7,3)V58PK=BZ8LOOL" 2W#;-H/S&Z;^_OOOB:I_!2HJNUVL9H5%74[%
M B\J&,)TG4J\-^7&?JY^YCX4V/%YA3)%"W'GZ8<E0I@M2G$YA4"T'9$+/-JL
M6,)E$0R[C!>H*LR9,\?_'TE)24.'#@WPFU&[=NWJTJ6+.?V_Q >& "FK0I]I
MA?CI(AQOWD(YX]9=@Q5[6FSJ6(C7P'5#XF5A(B(*3%JY&@5+5_$X%D[B<XS;
M?Z+G-V3($*SE^RC9K5NW\>/'_^<__]FS9X_XO'[JU*F=.W=^]=57CSSR2.7*
ME:%]V;)E%R]>C*4M(&4+\S[8R [FS:+YZ1NPD \VLH-Y"_'4,..[<=T--]PP
M;=HT\?E5G'2)E^+0H4/B9?G;W_YF_:D=\2Z;-&D2UC6#B"W,^^3DY(@-A$U]
MQ+;KW;OW!Q]\L&G3IN/'CXN6AP\?7K5JE?@DVJ1)$Z/9QQ]_+(74L%?W@_?#
M*B$3YQNP8L-OZM2IV#2"<#3AY&IW%RNS!?,^V,@.Q,6;%UL$)&<S,S/Q80><
M7S7V!';O&!:R@WEGL(J=HCQ7=17$$^_2I<L;;[SQPP\_[-V[5QR+<W-SQ>3<
MO7OWPH4+1X\>;;W=B'#%%5>(EP@[\,&F=C!O)GJQKIKMU:N7^$@@AIJ5E?7+
M+[^(;52N7#FY0<^>/;&0U\21&E8!5JA00?>: #D50*-&C3#IV+WWWHOE'##B
M^$ XV1YN,*!1B"^7CIB?,#/%1SXQ<[!=I(CWN#R8A("_ +AKURYHW+=O7VSD
M*;BJ:Q!_QZ9$L0\G>CC9[F9UHODL'O,^V,@.YLVB^>D;L) /-K*#>0M>Q #8
MJ_O!^V&5D$7G18R"8%^?X+C:X\7*A,&\#S:R _$XOHZQ;MVZBRZZ"+OW$>>5
MXF/_E"E3?OKII_W[]Y\Y<T:<^8KM*S[WBGWU6V^])1[5K8J^ZZZ[@OL%U;_\
MY2]8R[=7O/SRRR=,F+!Z]>I]^_:)LP;QOVO6K'GSS3<[=NR8J%K\]]QSSV%I
M.UNV;%'>6C@M+>W..^\41R[10!S%Q 85Y]2S9\\>/'BP.*4UFHD7JL#!3,->
M+2)Y//50*.?[2G(I*W$R*YZX.*JN7[]>O"!BHXC)>>S8L=]^^VW1HD7BV"IF
MH.Y.SV+"B-F+_;EGO9.<GWB_8%.]=NW:83XA053&=@Y@%3N8=U_!@(4LPG2=
MRGK"+DR?/AW;A0=V;!;Y*1KAG2?&G,$JCL7E%+(J]",R)NU@W@<;V?$V;H4!
M7T0^7Q/'T <??%!\'MZ^?;MXJXH9)0[W7W[YY1UWW"$^ $BY_R,^*FS=NA6[
M"2@:9EIA?;H(TYLW,F?<,MTU6-$I-G4F]&O@NB'QLC 1$07F7Z3J9_PQSI>N
MBD]UCS[Z:!#_ELLP=NS8Y.1DK.N8^%PE/I1@415,VL&\#S:R@WF+J'WZ!BSD
M@XWL8%[EM==>*U:L&":=$6^Q]]Y[#RM:8,P.YL\[>?)DJU:ML+4#8IS^WU'"
M!RRP2P<1):SBA7'CQD$O%2I4<'AB'"8PGC );G<7$[,%\S[8R [$0_G*1]!=
MUPL@8E_Y^&'WCF$A.YAW!JLX4&3G:A 5='KV['GZ]&FL?AZVMH-Y"^O/S016
MHD2)U:M78Y4PN.>>>Z#KN7/G8B,52.D4XEI,?" \'!YN,*91B"^7CO7?XM]]
M]]W8*(*LW_VL6K4*&YWWP0<?0..__>UOV,A3M6K5@A[]:M>NC4V)8A].]/!P
MN)L-(&K/XC'O@XWL8-XB:I^^ 0OY8",[F%?A10P9=ND@HH15O!"%%S$*@GU]
MW INCQ<3$P;S/MC(#L3C^SJ&.%=]_/''==]_NY6>GO[FFV]B'VY,F3)%>><Y
MAU)34UVM19"M7[^^1HT:6-&!9Y]]UE\!'[ P=Z@6L>.IMX(^WU?ZZ:>?^O;M
M&_3!5$?,ST\__10["XH8(59/2*A9LZ:K&Z:^_/++6,+EXE<#5K&#>?<5#%A(
M)1S7J=Y]]UU()24E1>P.UE$X12.Y\\2P,UC%C?B;0DJ%>T3&O!W,^V C.][&
MK3#@B^3FYHKW+S[@@/B0$.!NH#I1,M,*Z]-%.-Z\!1$YXY;IKL'6#?86IZ%?
M ]<-B9>%B8@H,/\B53_CC_&Y=%5\JN[<N;/X+.+VZJ?2DB5+X!;N#MURRRW.
M/_EAV [F?;"1'<RK1.?3-V A'VQD!_,:*U:L:-&B!8;MU*M7S^'OLV#2#N8E
MF9F9 P8,P$! %2M6%)]3_7%\S,+<FZ.($E;QPI$C1^#W(R)YJ5U)'HSG0M_=
M1?]LP;P/-K(#\1"_\FG4J!&VL!/A>8C=.X:%[&#>&:SB3-&<J\*J5:L&#QX<
MQ!>-AE*E2HT>/3KP[SIAQ@[F+?+S\ZV_.*-3K%BQ?_SC'U@B/#9OWIR4E"3W
M?OWUUV,C%3D20"&NQ<0'/.7V<(-YC4)\N72NN>8:N;V8+1LW;L1&$=2]>W=Y
M/.7*E;/^II7AOOONDQL+&S9LP$:>>NRQQZ!'OS__^<_8E"CVX43WE-O=;&#1
M>1:/>1]L9 ?S*M'Y] U8R <;V<&\!B]B&,R].8HH814O1.%%C()@7Q^'0M_C
M1?^$P;P/-K(#\;B_CE'@N^=HOW[]@EX$D."[6=2?_O0G\;;"TNZ)#](=.W;$
M#ARX_/++UZ]?C^7<V+=O7X\>/;"N7FIJZH0)$XPX/FPA=15(9(ZGW@KZ?#^
M_?OWO_SRR\V:-9/+!D>,[>Z[[_[]]]^QCV#EY^=;5XT,'3H4VP6T8\<.J"!J
MNEK\:H ZMC#OOH(!"ZF$XSK5G7?>"<$N7;I@HS"+MBD:L9TGYIW!*F[$ZQ12
M*JPC,E:Q@WD?;&3'V[@5!LY'\O+RQ&>M1-6]AW6Z=^^^=^]><WE'HF>F%<JG
MBW"\>?W"?<8MTUV#??KII[&I,Z%? ]<-B9>%B8@HL#A<NIJ2DE*Z=.EJU:HU
M;=I4?&(;-&C0JZ^^^NVWWYXZ=0K["TU.3L[4J5.5O[UK)4;5IT^?A0L78I6
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MJT1$1$1$1$1$1$21=N3(D>'#AZ>EI=E^/RTW*"PX)@H6OK(AP-)$%"D+%BS
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MZ]=7J% !O\@];_SX\1AP!@MI8,P-#TM18/!2ZV L-N&S4L$,45!P8JE@QHW
M=P<<,&  !BCVX696P4SXW7'''3@(E;IUZV+2SL\__XQ5-(H7+W[RY$G,VY$7
M*7;HT $?5N'[+DK,F3,G)24%-X!9X\:-'=YO59:=G=VR94NL95:L6+%9LV9A
M,@;A$U/!3%1Z_?77<=SG5:I4:>/&C1@@(B(BDG#I*A$1$1$1$1$1$9'W=N_>
MG9&1@5_AGM>^?7NW=Z(R8"T-C+GA82D*#%YJ'8S%)GQ6*I@A"@I.+!7,N)&5
ME77???=A19_^_?MG9V=C@&(?;FD5S(3?C!DS<! :Z]:MPW! +[[X(I;0$\/
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M[$GC]==?QZ3%H$&#,*;RX(,/8M)"=(<Q"\QH=.O6#9,6*U:LD"/XL-?DO@+
MF!W,JS1IT@1C9@L7+L2,Q?777X\Q/0RK8,:!9Y]]%JM83)DR!6-F$R=.Q(Q9
M\>+%CQPY@C$+C&EX,A7E1W4BOY6#LW7K5NS58LR8,1C3P[ *9MS 6BJ8L8C1
M?2DG50"8B;B;;KH)QZ1RX8478M+RBEE_9_SCCS^6&^B4*%'BU*E3D!7^\(<_
M&&U:M6J%#SL@=:*%&3U,:H2RNXZJPU,HRI0I@[UJ>/A#\.?.G</J&F7+EL6P
M&094(K]GP[ *9LS$2U2E2A7,6%QQQ1685#EQXH2\]GWJU*G8PH$U:]9(/6L-
M'3H4DT1$1%14<>DJ$1$1$1$1$1$14:AZ]>J%W\JJ[-RY$Y/N85'O8$\:S9HU
MPZ2%DS52!0Y^+%L0W6', C,:3NYZ>^S8,3F"#WM-[BL C-G!O,JP8<,P9K9C
MQP[,6%Q\\<48T\.P"F8<J%.G#E:Q6+AP(<;,YLV;AQF+-]]\$V,6F-'P9"K*
MC^I$?BL'Y^C1H]BKQ<TWWXPQ/0RK8,8-K*6"&8L8W9=R4@6 F8B;.G4JCDEC
MPX8-D!TW;IS<8-.F3=#@Q(D3MO<0];/>Y3$O+Z]RY<I&@Q=??!$:."'UH(49
M/4QJA+*[CJK#4RB*%2N&76J(#8WA8.7FYF)UC924% R;84 E\GLV#*M@QN*Y
MYY[#C,KJU:LQ:?'VVV\;[2M4J'#V[%ELX8"35TGHW;LW)HF(B*BHXM)5(B(B
M(B(B(B(BHE!=>NFE^*VLRL&#!S'I'A;5P)A*$)%MV[9!2NG++[_$I(IHADD5
MT2DFS3"@4KER90]75'@%1ZF!,3N85_GHHX\P9G;BQ G,6-2L61-C>AA6P8R=
MM6O78@F5C1LW8M)L_?KUF+'HVK4KQBPPH^+55,2Z*I'?RL$1+PCV:M&B10N,
MZ6%8!3-N8"T5S)C%[KZ4DRH S$3<D2-''*XR'#5J%&0[=.A@/-JH42-XU*]G
MSYY2#:U^_?I!\,<??Y0;_/SSS]# ";F"#F;T,*D2RNXZV@Y/H7 XJ83\_'P,
M!\O)6]A/# _#9AA0B?R>#<,JF+'8OW]_:FHJQBSNN^\^3%HT;][<:#]\^'!\
MV!DQ'JE;K=:M6V.2B(B(BBHN724B(B(B(B(B(B(*5?7JU?%;697,S$Q,NH=%
M-3"F$D3DO??>@Y32BA4K,*D"O[&K,VG2)$R:84"E?__^&(L".$H-C-G!O,KR
MY<LQ9I:=G8T9BS)ERF!,#\,JF+'CY&:3PJ%#AS!IMG?O7LQ8%"]>W/8MC!D5
MKZ8BUE6)_%8.&O9J4;ER9<SH85@%,VY@+17,F,7NOI23*@#,%(8N7;K@L%3:
MM&DCIPX<.)"4E&0\^L033\B/&N3[,@:0GIZ>DY,C!X</'VX\6J]>/?DAYZ0>
MM#"CATF54';7T79X"H5XPV*7&EE961@.UKESY["Z1MFR93%LA@&5R._9,*R"
M&95[[[T78Q:IJ:F!__G<LF7+Y/:;-V_&%LZ<.G5*KJ/C:HTO$1$1Q3<N724B
M(B(B(B(B(B(*5=FR9?%;615/OM''HAH84PDB,G#@0$@I_?+++YA4$<TPJ2(Z
MQ:09!E3"_7.ZP<%1:F#,#N95]N[=BS$+S%BX^BH!PRJ8L7///?=@"953ITYA
MTLS)W=2$[[[[#I-F&%#Q:BIB797(;^6@8:\6)4N6Q(P>AE4PXP;64L&,6>SN
M2SFI L!,87CCC3=P6"IB$^S9L\=(39HT27YTZ=*E4LG_)R(B*+?4^?>__RT'
MZ]>O;SP4] T=I?):F-'#I$HHN^MH.SR%HFK5JMB?AH<K:!TN@A0R,C(P;(8!
ME<COV3"L@AD5A_?W??'%%S$IZ=^_O]&R2Y<N^+!C#A<<IZ>G8Y*(B(B*JO/+
M5DU+5;ETE8B(B(B(B(B(B,B%XL6+X[>R*D'_[*P,BVI@3"6(2,>.'2&E9'L7
M,3_1#),JG3IUPJ09!E06+ER(L2B H]3 F!W,JYPX<0)C%IA1P8P>)E4P8T?^
MA>L LK.S,6GFY&YJPFNOO89),PRH>#45L:Y*Y+>R+"LKZ_OOOW_EE5?NN^^^
MSIT[-VS8L&+%BB5*E)!O[NB<J^^M,*R"&3>PE@IFS&)W7\I)%0!F"L/.G3MQ
M6!IOO_VVD;KNNNN,OV=D9 3XV?<V;=I(-;2&#!EB1'[^^6?YH1]^^$&JYX)<
M1 <S>IA4"65W'6V'IU!<?/'%V)_&OGW[,!PL)[>;]6O6K!F&S3"@$OD]&R95
M,*-QY9578M*B>O7JNLEV_/CQM+0TH^6,&3.PA6,Y.3E2GUIBIXU)(B(B*JJX
M=)6(B(B(B(B(B(@H5(G.;D*&L:!@40V,J001J5V[-J243I\^C4F5S,Q,3*K4
MJ5,'DV884-FQ8P?&H@".4@-C=C"O K_FK(09%<SH85(%,W9JU:J%)50P9I&7
MEX<9E0$#!F#2# ,J7DU%K*L2^:WL-W?NW%MOO55>"N,)[$8/DRJ8<0-KJ6#&
M+';WI9Q4 6"FD+1HT0)'IM*S9T]_>S%_2I0H8?Q]\.#!YGHFHT:-DFIHB9VS
M$7GQQ1>-OU>J5"DW-U>JYX)47@LS>IA4"65W'6V'IU!<>^VUV)_&IDV;,!RL
MC1LW8G6-ZZZ[#L-F&%")_)X-DRJ8T?CJJZ\PJ?+11Q]ATN?--]\TVE2I4D6W
MPM6)_/Q\J4.MI*0D3!(1$5%1Q:6K1$1$1$1$1$1$1*$J.G==+5.F#*24'"Y,
M<7@OL7+ERF'2# ,J#F]>&&$X2@V,V<&\"F94,*."&3U,JF#&CL,)Z97NW;OC
M",PPH.+55,2Z*IA1P8P*9O26+EUZZ:678MXCV)D>)E4PXP;64L&,F<.I&X7[
M4LRH8$8%,WI%9%)Y:.3(D3@RE924%/^=)C_[[#/Y[[-GS\:*D@T;-LB- UBU
M:I4_TJI5*^./]]UWG[F>"U)M+<SH85(EE-VUP_>X5VP/3Z%XZ*&'L#^-Q8L7
M8SA8BQ8MPNH:\BU^E3"@@AD5S*A@1@^3*IC1$.<7#1HTP+!%NW;M,.G3K%DS
MH\V($2/P83<<WG4U-345DT1$1%14<>DJ$1$1$1$1$1$14:C*EBV+W\JJA'(?
M(P,6U<"81XH5*X8]J6!,P^'-F42GF#3#@,JY<^<P%@5PE!H8LX-Y%<RH8$8%
M,WJ85,&,'8<3TBN-&C7"$9AA0,6KJ8AU53"C@AD5S&B,'CTZN-]M=PC[T\.D
M"F;<P%HJF#%S.'4QIA')?2EF5#"C@AF-HC.I/+1FS1H<F<;''W\LVM]]]]W&
M7\J4*6.[C[KPP@NE&EK///.,:+Q[]V[YCU]^^266<TRNHX,9/4RJV+X4 3A\
MCWO%]O 4BG???1?[TPCEM^;!].G3L;K&Y,F3,6R& 17,J&!&!3-ZF%3!C-Z$
M"1,PK+)\^7((+EFRQ'A4[&Q#N=.P(-XR4F]:Z>GIF"0B(J*BBDM7B8B(B(B(
MB(B(B$)5O7IU_%96)3,S$Y/N85$-C'G$X5*,_/Q\3*HX_!G<E)043)IA0 4S
MT0%'J8$Q.YA7P8P*9E0PHX=)%<S824Y.QA+A5*5*%1R!&094,!,LK*N"&17,
MJ&!&Y;GGGL.818D2)1Y\\,'Y\^<?.'  ?IT9FZK([0/#I IFW,!:*I@QB^]]
M*694,*-2I":5MVK7KHV#4[GMMMMR<W,K5*A@_.766V_%6A://?:85$.K:=.F
M!>;?(B]9LN3ITZ>QG&-2;2W,Z&%2!3-N1-OA*11KUZ[%_C1>>>45# =+E,+J
M&NO7K\>P&094,*."&17,Z&%2!3-ZITZ=*E>N'.8M^O7K!\%[[[W7>/3JJZ^&
M1]T2PY!ZTZI9LR8FB8B(J*CBTE4B(B(B(B(B(B*B4#G\+>.#!P]BTCTLJH$Q
MCSC\ =P8_9'KR,-1:F#,#N95,*."&17,Z&%2!3-V2I<NC27"R?8G;C&@@IE@
M85T5S*A@1@4S%G/FS$E,3,2868,&#39MVH3)\["U"F;T,*F"&3>PE@IFS.)[
M7XH9%<Q8%+5)Y:VA0X?BX%3*EBT[=^Y<^2_3IDW#6A:+%R^6(P'\\LLOW;IU
M,_[O#3?<@+7<D IK848/DRJ8<2/:#D^A$#LB)\LBA0$#!F X6 ,'#L3J*N7+
ME\_+R\.P&694,*."&17,Z&%2!3,!/?KHHYBW2$E)V;=OGQ$Y=NQ8R9(EC4>_
M^.(+J5XP]N_?+_6FU;IU:TP2$1%14<6EJT1$1$1$1$1$1$2AZM6K%WXKJ[)S
MYTY,NH=%-3#F$8<W<G-X6[7,S$Q,JM2M6Q>39AA0P4QTP%%J8,P.YE4PHX(9
M%<SH85(%,W9JU*B!)51LU[5X!3M6P4RPL*X*9E0PHX(9,_'R-FS8$#-F:6EI
MFS=OQJ0$ RJ8T<.D"F;<P%HJF#&+[WTI9E0P8U8$)Y6W%BY<B(/3:-JTJ?'?
M*2DIQXX=PUH68NM4J5)%JJ'US#//B)K&_YTR90K6<D,JK(49/4RJ8,:-:#L\
MA:A?OWXX=)5V[=IA,EB77WXY5E>YYYY[,&F!&17,J&!&!3-ZF%3!3$#B+,/)
MO7Z?>^XY(S)^_'CC[V+&.OS'$@'LV+%#ZDJK=^_>F"0B(J*BBDM7B8B(B(B(
MB(B(B$(U9,@0_%969=VZ=9AT#XMJ8,PCG3IUPIY4#ATZA$F5@P</8E+ERBNO
MQ*09!E0P$QUPE!H8LX-Y%<RH8$8%,WJ85,&,G;9MVV()E5.G3F$R/+!C%<P$
M"^NJ8$8%,RJ8,9LU:Q8&+!Y^^&&,F6% !3-ZF%3!C!M82P4S9O&]+\6,"F;,
MBN"D\E9.3DZ%"A5P?':Z=^^.A30&#!B 8974U%3COY.3DQW.9QVIL!9F]#"I
M@ADWHNWP%*+//OL,AZY2HD2)K*PL#+LG)G!:6AI65W%RHU#,J&!&!3,JF-'#
MI IF[-QRRRU8PJ)JU:K&-KKXXHN-OX\<.=)4*RAKUJR1NM(:.G0H)HF(B*BH
MXM)5(B(B(B(B(B(BHE!-G#@1OY55^?;;;S'I'A;5P)A'!@\>C#VI_/+++YA4
MV;9M&R95[K__?DR:84 %,]$!1ZF!,3N85\&,"F94,*.'217,V+GCCCNPA,K^
M_?LQ&1[8L0IF@H5U53"C@AD5S)@YV2W8[OTPH((9/4RJ8,8-K*6"&3,G+UI"
MS.Y+,:."&3,GKT^<32K/W7WWW3@^.V^]]196T9@Y<R:&[73JU FKN(0553"C
MATD5S+@1;8>G$&5E965D9.#H598N78IA]U:L6(%U5:I7KYZ=G8UA"XRI8$8%
M,RJ8T<.D"F;L+%Z\&$NH?/CAAZ+QHD6+C+\D)R?OWKT;R[FW8,$"J1^M=]]]
M%Y-$1$145''I*A$1$1$1$1$1$5&H''Y5_*]__0N3[F%1#8QY9/+DR=B3RO+E
MRS&I(IIA4L7V)X8QH(*9Z("CU,"8'<RK8$8%,RJ8T<.D"F;LC!LW#DNH;-FR
M!9/A@1VK8"986%<%,RJ84<&,6<N6+3%@87NW10RH8$8/DRJ8<0-KJ6#&++[W
MI9A1P8Q9$9Q4GOOTTT]Q?'9^^^TWK*)Q]NS94J5*83Z@5U]]%:NXA!55,*.'
M217,N!%MAZ?0O?#""SAZE6>>>0:3[CW__/-85V7TZ-&85,&8"F94,*."&3U,
MJF#&@39MVF 5BU:M6HF6=]UUE_&7ZZ^_'@L%9?KTZ5(_6IZL;R8B(J+XP*6K
M1$1$1$1$1$1$1*$Z>_:L_*NX.J^]]AHFW<.B&ACSR(X=.[ G%2>_WRJ(9IA4
M^?777S%IA@$5S$0''*4&QNQ@7@4S*IA1P8P>)E4P8\?AJO'9LV=C,CRP8Q7,
M! OKJF!&!3,JF#%+3T_'@$5.3@[&S#"@@AD]3*I@Q@VLI8(9L_C>EV)&!3-F
M17!2>2XS,[-$B1(X1#W_:C;G;KKI)BP1T/;MV[&$2UA1!3-ZF%3!C!O1=G@*
MW>'#A\N7+X]/P*)QX\:8=*]%BQ98UZ)BQ8K'CAW#I HF53"C@AD5S.AA4@4S
M#DR;-@VKJ'S]]=?R_L&K>?CJJZ]*G:B)?L^=.X=)(B(B*JJX=)6(B(B(B(B(
MB(C( YT[=\;O9BV&#Q^.,?>PJ ;&O./D9G@.%^F^\<8;F+1PLI@&,RJ8B0XX
M2@V,V<&\"F94,*."&3U,JF#&3FYN;L6*%;&*Q?CQXS%I9]>N75#DHHLNPD86
M$%'"3+"PK@IF5#"C@AFSY.1D#%AD9F9B3'+\^'$,J&!,#Y,JF'$#:ZE@QB*.
M]Z684<&,61&<5.'0JU<O'*+>BR^^B/F IDZ=BB7TFC9MBGGWL*@*9O0PJ8(9
M-Z+M\.0))[L:8<F2)9AT8]6J55A1Y>VWW\:D!B95,*."&17,Z&%2!3,.9&=G
MUZA1 PM9E"U;UOCO.G7JY.7E8:&@//+((U(G:EVZ=,$8$1$1%6%<NDI$1$1$
M1$1$1$3D@3%CQN!WLQ:>_!PG%M7 F'?>?OMM[,QBX,"!&%,9/'@P)BW>>><=
MC%E@1@4ST0%'J8$Q.YA7P8P*9E0PH^?DSL1!+)YXX($'L(I%OW[],&;'NBIK
MQ(@1V,@"(DJ8"1;65<&,"F94,&/FY'?#MV[=BC')RI4K,:"",;TP338#UE+!
MC$4<[TLQHX(9LRB<5)A4P4QAFS1I$@Y1;_WZ]9@/Z.C1H\6*%<,J&I[\B#P6
M5<&,'B95,.-25!V>/)&3DW/II9="[U9]^O3!I!OB-<&*%FW;MLW-S<6D!H95
M,*."&17,Z&%2!3/.C!X]&@L%)-ICB6#U[MT;JUO\]:]_Q1@1$1$585RZ2D1$
M1$1$1$1$1.2![=NWXW>S%HT:-<*8>UA4 V/>.7WZ=.7*E;$_LV;-FF%,Q?:F
M@U6J5#ESY@S&+#"F@IGH@*/4P)@=S*M@1@4S*IC1LYTVPMFS9S%64"#^*+<I
M5ZZ<_.BZ=>OD1Y4J5JSH=IWBU5=?#466+U^.C2P@HH298&%=%<RH8$8%,V:U
M:M7"@,6T:=,P)GGVV6<QH((QO3!--H/<1@<S%G&\+\6,"F;,HG!285(%,X5M
M__[]24E).$J5^O7K8]B!+EVZ8"&-E2M78M@]+*J"&3U,JF#&I:@Z/'EEV[9M
M9<J4@0%8_?333YAT9NW:M;:3-CT]_==??\6D'N95,*."&17,Z&%2!3/.'#ER
M)"TM#6MII*2DB!T%E@A6PX8-L0,+5]N.B(B(XAZ7KA(1$1$1$1$1$1%YX[++
M+L.O9\V2DY-/GSZ-,9>PJ ;&//7NN^]B?V:)B8E[]NS!F-F! P=L5R=,GCP9
M8RH84\%,=,!1:F#,#N95,*."&17,Z#5HT ##%H<.'<*8Y<>1K8OY^O3I(S=0
MFCU[-J0"V+!A TS.MFW;8B,5.:*#F6!A717,J&!&!3-F[=NWQX#%55==A;'S
MQ+ZB?/GR&%#!I%[X)IN?W$8',RKQNB_%C IFS*)P4F%2!3-1H$.'#CA*E>'#
MAV/2@?'CQV,AE9HU:V(R*%A7!3-ZF%3!C'O1<WCRT.>??RX^T,ICL&K2I(GR
MGP<$EIV=;7M7UV+%BGWSS3>8# A+J&!&!3,JF-'#I IF'+O__ONQEL:MM]Z*
MX6")<QS;B=&N73N,$1$14='&I:M$1$1$1$1$1$1$WOCPPP_Q&UJ+)4N68,PE
MK*B!,4_EY>5U[MP9NS1[Z:67,&;V\LLO8\:L:]>N^?GY&%/!I IFH@..4@-C
M=C"O@AD5S*A@1J]7KUX8MMBP80/&"@IFSIPIM[GQQANAP;9MVVQO,-:Z=6M(
MZ8CI?<455T!\_OSYV$X%4DJ8"1;65<&,"F94,&/V^../8T!EZM2IF/0MNQ2;
M!IMJ8%@O?)/-3VZC@QF5>-V78D8%,V91.*DPJ8*9*#!NW#@<I<J//_Z(20=@
MJ;?.'__X1TP&!>NJ8$8/DRJ8<2]Z#D_>>O_]]V$85GW[]G6XYS'<=]]]6,4L
M,3'QG__\)\;L8!45S*A@1@4S>IA4P8QCFS9M$J\5EE-9N' AAH.U>/%BK&X1
MQ.8C(B*B^,:EJT1$1$1$1$1$1$3>R,K*RLC(P"]IS<:-&X<QE["B!L:\MF?/
MGFK5JF&ODC)ERNS:M0MCY^W=NS<]/1TSDAHU:CC_ 5,,JV F.N H-3!F!_,J
MF%'!C IF])Y__GD,6WSZZ:<8*R@8,&" W&;\^/'8HJ#@G7?>D=LH/?WTTQBS
MR,_/A^Z$:Z^]%MMI0% ),\'"NBJ84<&,"F;,YLV;AP&5Y.3DAQYZ:.7*E9F9
MF6?/GMVT:9/8'U:I4@7;Z6''>F&=; 5>O&B&N-R78D8%,V91.*DPJ8*9*+!E
MRQ8<I46E2I5R<W,QZ4R+%BVPG(57:RNQK@IF]#"I@IF@1,GAR7-___O?4U)2
M8#R@;]^^#N^]*CY"WWOOO9@W2TU-G39M&B8=P$(JF%'!C IF]#"I@ADWKK[Z
M:BQGT;!A0[?+BP,8.W8L=F!6O7KU[.QLC!$1$5'1QJ6K1$1$1$1$1$1$1)Z9
M,&$"?D]KUK-G3\RXA!4U,!8&Z]>OKU"A G8L:=FRI?*GK@\<.-"N73ML+:E4
MJ=+&C1LQIH=Y%<Q$!QRE!L;L8%X%,RJ84<&,GI/;<=U[[[V06K-F#2R.V;IU
M*[3Q&SITJ-Q,:?CPX:=/G\;D>;___OM55UT%D3IUZAPY<@2;:D!6"3/!PKHJ
MF%'!C IFS/+S\YLT:8(9-VZ^^6;\DPIVK!?NR2:WT<&,7OSM2S&C@AFS*)Q4
MF%3!3'1HW+@Q#M2L?__^F'',=IEXN7+EO%JLAJ55,*.'217,!"L:#D_AL&#!
M@HH5*\*H0*-&C6S7+G___?=-FS;%I%F5*E6"NS=P@7?;&C,JF-'#I IFW'#R
M#P!>>>45C(6@1X\>V('9Q(D3,4-$1$1%'I>N$A$1$1$1$1$1$7DF.SN[?OWZ
M^%6MI'CQXB=.G,"8'N9#AAV$9N/&C?7JU<,^)%6J5!DY<N2Z=>O$LSYY\N1_
M__O?4:-&!;[%8(,&#39OWHP]F6$F6%@WS+#[$'A;.4REK&SOSY>8F/C<<\_M
MVK4K)R=G[]Z]$R=.A&4Q-]QP Q8]+S\_?]BP87)CI5JU:CWYY).+%BWZ_???
ML[*R3ITZM7W[]NG3I]]]]]WB[0F-Q01>NW8M]B2!]D'#NBJ8<2E,I?P^^>03
M;.18APX=SIPY@W]U  =AYNUDD_\>'&EH"C&Z+PU3*;]"GU3XF'MRM4(T8L0(
M')G95U]]A1G'Q!X2RYG=<<<=F'$,:[GG;34_N:9#A7)XBHQ]^_9==]UU,#:K
MEBU;CADSYL<??SQPX$"6C_@/\4S_^M>_MF[=&EM;].G3Y^#!@]BW'N9=BLY2
M">[G7N!_ )":FGKX\&',!.OX\>/662IKV+"A.-IBC(B(B(H\+ETE(B(B(B(B
M(B(B\M+<N7/QVUJS*5.F8$8/PR'##D)V^/#AOGW[8C?!NOWVVX\>/8I]6& L
M6%@WS+#[$'A;.4REK.;-FY>4E(09QTJ7+FU["\E)DR:5*E4*DT%IUJS9SIT[
ML0,SS 0+ZZI@QJ4PE3+\\8]_Q'8.=.O6[=2I4P5!#0E'8.;M9,.'W9.&IA:+
M^](PE3(4[J3"Q]R3JQ6B9<N6X<@D:6EI9\Z<P8P;=>K4P:*2&3-F8, QK.6>
MM]7\Y)JN1/CP%$F??/))HT:-<)1>:-*DR9=??HG]V<$J+D5GJ03W<^^]]][#
M$I*[[KH+ R%X__WWL0-)8F+B@@4+,$-$1$3$I:M$1$1$1$1$1$1$GALX<"!^
M9RMIUJP9!O0P'#+LP"/??//-)9=<@IVYT;QY\]FS9V-=#0P'"^N&&78? F\K
MAZF4TOCQXQ,3$S'F0%I:VKQY\["<RHX=._KV[1M<+WYERI1YX847 OQVLP&3
MP<*Z*IAQ*4RE##DY.4.&#,&F>LG)R2-&C,C-S?7'\6$'S/TK>#C9L(5[<K4
M8FM?&J92AL*=5/B8>W*U0I2?GQ_@!KW_P]Y]QT=5Y?\?OZ1#0N@"D2H6!!8$
MVX)B W55Q,6"91%$1>6GKA5$5BQ@5Q18%2SK(K;5%<M75\H*%L""%$$!Z2!%
MZ25 2(#PNSMCAI/WM'NG99*\GG_LP\V\/Y]SYMX[R;TSASM__O.?M<"EVVZ[
M39N6R,C(V+ESIQ8XINW<BVTW+[.G6XG\\Y1@]JOUM==>._GDDW7&D>K4J=.;
M;[[I>SF[HKU<2LY6EOMCKZ"@H&[=NMJEQ+1IT[0@"FW:M-$!##?==),6
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MM NBLW[]>ON@TNL0R_K[W_^NT4C91W+'CAUU@!)UZM19L6*%U@   )1@Z2H
M        Q,777W\=XIYYHT:-T@(     B)%>O7K)-4BU:M6V;]^NN4B-&#%"
M^OM4KU[]N^^^TP(    #2U<!        (%ZF3IT:;/5JM6K5EBY=J@4
M$ NS9\^6:Y!KK[U60Y&RKV7L*QKI[Y63D_/EEU]J 0  0&DL704       "
M.)HY<V:]>O7TXUR/UJU;)]674P,   "H2#IW[FQ>@-C7)IJ(B'T5TZI5*[.S
M3_WZ]6?/GJT%    ?EBZ"@        #QM6S9LK9MV^J'NA[MV[>/X5=V @
M (!/[]Z]?9<>'3ITT(<CLFW;-OLJQKBF.<3^^<J5*[4    @$):N @
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M8?IPB5Z]>OEBJ:FIRY8MTX1[QLB6?2W3MV_?-6O6: @  , 9EJX"
M0-E8M6K5K;?>FIV=[?WT5Q\&    @-+,]:.U:]=>N7*E)@X>?.:99\Q8KUZ]
M-!$1;S?[^N6O?_WKZM6K]6$    W6+H*         &5IQXX=+[SP0OOV[?4!
M     "C-7)-J:]"@P8LOOKAFS9I]^_9MW[Y]RI0I/7KT, .YN;GKUJW3+A'I
MT*'#Z-&C[>L7?0   , ]EJX"              "4 ^:R5"?>>NLM;0$  ) $
M6+H*              !0#NC2U."J5*GRQ!-/:#T  $!R8.DJ
M  ! .7#--=?DY>7I,E4_C1LW?O_]][48   @:;!T%0              H-Q8
ML&#!RR^_W*]?OU-//34O+Z]JU:II:6DU:]9LTZ;-U5=?_<X[[Q04%&@-  !
M,F'I*@                   !*$I:L                   !($):N @
M                ($%8N@H                  ( $8>DJ
M        $H2EJP                   $@0EJX"                   @
M05BZ"@                  @ 1AZ2H                    2A*6K
M                2!"6K@(                  "!!6+H*
M      " !&'I*@                   !*$I:L                   !(
M$):N @                  ($%8N@H                  ( $8>DJ
M                $H2EJP                   $@0EJX"
M       @05BZ"@                  @ 1AZ2H                    2
MA*6K                    2!"6K@(                  "!!6+H*
M              " !&'I*@                   !*$I:L
M      !($):N @                  ($%8N@H                  ( $
M8>DJ                    $H2EJP                   $@0EJX"
M               @05BZ"@                  @ 1AZ2H
M       2A*6K                    2!"6K@(                  "!!
M6+H*                  " !&'I*@                   !*$I:L
M              !($):N @                  ($%8N@H
M     ( $8>DJ                    $H2EJP                   $@0
MEJX"                   @05BZ"@                  @ 1AZ2H
M               2A*6K                    2!"6K@(
M     "!!6+H*                  " !&'I*@                   !*$
MI:L                   !($):N @                  ($%8N@H
M             ( $8>DJ                    $H2EJP
M     $@0EJX"                   @05BZ"@                  @ 1A
MZ2J @U8X6@"@+.@KTX\6     $ Y-VG2I--..TU_B@JG<^?.]K[6GP(
M  "HN%BZ"B#&Z^&6+5MV\<47Y^;F5J]>W?Z/Y<N7:P) 1/25Z4<+     )1G
ME?SZ>O[\^6>>>287.Y6$=T>?<<89\^;-T\<         5$3)M73UT.H;E[01
M #?T%>5'"X);MFQ9G3IUS-IZ]>JM6+%"<TAZYDZ,1E965OWZ]8\ZZJA.G3K=
M>..-8\:,F3MWK@X&9W3C^M$"    Q(V>BI41G18JD,I\?5U45'3???>EIJ;Z
MGKLFHK-ERY;,S$QCTUH9&1F;-FW27!3,YM%(AFOJ!&RN@\86L_?[X,&#[6-
M$^7$WKU[97-=<,$%&C*<<LHI9C@M+2T_/U]#        0$7$TE4 X5]Z6A!<
MCQX]M-BR+KGD$LTAZ>E>C*G6K5L_^>23V[9MTU$1DFY'/UH   " N-%3L3*B
MTT(%4FFOK]>N77OBB2>:S_JBBR[24'1&C!AA]O<:/GRXYJ*@W6,JP=?4"=A<
M-GLOF_U/..&$7W[Y14/EP1=??&$^$9N]LS148L^>/1D9&6:X8\>.&@(
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MMG#APBI5JIAC777551I*)M.G3S=G:[O__OLU5&+OWKU965EFN'/GSAH"
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M"W-S<\VQ,C(R-FW:I+DD8!^ZV=G9YE0[=>JD(<-99YUEANW70D%!@88
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MW*I5JW14RXK'%^ <]-SALF[=NKY1WG[[;0G<?OOMQBQ^5[-FS3U[]D@R&CJ
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M6EJ:[W8FEUQRB?>'_AT6+ESXW'//M6O7KG3U_S1OWMS5AVH'$[MW3#___'/
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M_\\F;5E961]]])$6A"--DN%02?#?E(.!YJ")0.SI'7;88695MV[=["EI#@
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MW8OA-75 2;6Y3+*>WLOA+[0$>.:99V1NDR9-TE");[[Y1L(///" AJ+ U3H
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M<DWME9R;RU1<7*S=/1>YFDNX_/S\U-14<U977765A@QR/]3##S]<$P
M $!EXENW:K[=5UF6KFK" 6WAIHE6NJGUR<G)T2ZQUJQ9,QW5C]9$]%Q"TP'<
M#Z'U\>]05GLGX!?M;=NV37..::]P3]R?UKOI,'GRY)8M6VI]I+1[.%KOOH,3
M?_G+7V24HX\^.L32ZA=>>,&7S,O+V[=OGR82PICO(1IR0^Y-XI6=G;UITR:-
M!E(!#A5MX;*)%EO6CAT[.G?NK#\M<=AAA_WZZZ_:!0   (FE9VD>&HJ:#A#K
M(2KSV?CV[=O//_]\+0ZB2I4J'3MV?.ZYYQQ>YOC3CH[GZ:7%+LOC)-YW737O
M2#I\^'!]V '_RW;+<T/-:":I[3PTY$:4U]0^R;FY3$E[U]7//OM,9O7""R]H
MJ,2N7;ODR._9LZ>&        @,J$I:ON: LW3;323:V/_%/^>*A5JY:.ZD=K
M(GHNH>D [H?0^OAW**N]$W#<"&XYXZ.]PCUQ?UKON,.##SZHE='1 <+1>O<=
MG/CFFV]T&,N:,&&"YDJ8-_6Y__[[]>%$,29[B(;<&#)DB+;S>.VUUS3JIV(<
M*MK"91,MMJP.'3KHCTKKVK5KK#X[!   0&3T%,U#0U'3 6(Z!&?CMG'CQKGZ
MZI6TM+2__.4O\^?/UT;A:".7\]1BE^5Q$O"?X$;S/H;IBR^^\/7,R,APNX[3
MRVQBBN:[++27AX;<B.::VB=I-Y=I[]Z]VMJR<G)R-!=K.F3"K5RY4N<$
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MF"5>FHB:#N!^"*U/2(>RVCM3ITXUDUY77WVUYL(Q[[IATEPX6A^N0YLV;;3
MLK[XX@O-A?3RRR]KBW#C^M-Z]QW<RL_/MU_C,NB]]]YK[OT77GA!R\J",<%#
M-.38!Q]\H+T\<G)R0GR%?04[5+2%RR9:[*#\M==>TQK+JEZ]^K)ERS0*  "
M^-"S,0\-14T'B,40G(V;X1!7Z,'LW;O7[&!KT:*%AOQ(B>5@GJ98O1D5<Y==
M=IDYG*UMV[8:<FS>O'F^/BDI*:M6K=)$%#[ZZ"-CFH=\_?77&@U)ZSTTY%AD
MU]1>Y6)SF5JW;BW=[.-'0PFT:]<N>?>O>_?N&C(<>>219KAAPX::
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MKW*QN7SL:U7_FP?;QX_F$FCRY,DRGV>>>49#)=:L62/A*ZZX0D,QQ=4Z
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M1'--?;#\;"Z?6;-F:2_+BNV=8MWR?X)SYLS14(EQX\9)>,R8,1J*':[6 0
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MJ<O+YO*Y^.*+I<]33SVEH03:NW>O_%O0T+<HMB^3S7#]^O4U$5-<K0,
M * <2:ZEJ_JFFF/:R$-#X6B]AX;"T7K#OGW[_#^HN."""Z9/GYZ?GU]86+AL
MV;*GGGJJ1HT:9N"<<\[11H9;;KG%#'NEI*1TZ=)EY,B1LV?/7K=N75%1D=U_
MU:I5'WWTT1UWW%&O7CW)Y^;FVG/0UJ5)B4/:)20M#D?KDZ.#*6%[Q[1X\>*
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M4VM9$&6XN8+QOVWPU5=?K:'$&CITJ$QIUJQ9&BHQ=NQ8"3___/,:BBFNU@$
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M-=>88=N"!0LT%%-<K0,      * <8>GJ(5KOH:%PM-[/@0,''GSPV"&-'P
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M_///0]R7,6'B]V94--:O7R\WLNW?O[^&4"GUZ]?//##L%]?:M6LU!#]<K0,
M     *"\8.DJ "2%_/Q\\^.Z\>/':P(     @ IGU*A1Q@)%*RTM;<Z<.1I"
M)?/]]]^GIJ::!\8SSSRC(0        #E&4M7 2 IC!X]VO=Y3%Y>WKY]^S0!
M     $"%4UQ<?,XYYQAK%*T.'3IP45R9V7N_;=NVYB'1I4N7,KDK,
M (#X8>DJ "0%\U.9!QYX0!\&     *""VK!A0].F38V5BM:0(4,TA$IC\.#!
MYL'0N''C7W_]54,         RCF6K@) V9LQ8X;O(YG4U-2U:]=J @    "
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MY\<0#2G_P@$    -+OZ+/70KHZL -93_OP!^^<M?QH=S'[F:__<0K[KJJI@
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MJZ_>>NNM9YYYYL$''_R^][UOV+!AO7.&#!DR=NS8,\XXX]%''XTU
M    [UY&5P$           "H$Z.K             -2)T54
MZL3H*@            !U8G05            @#HQN@H           ! G1A=
M!0           *!.C*X"            4"=&5P$           "H$Z.K
M         -2)T54             ZL3H*@            !U8G05
M    @#HQN@H           ! G1A=!=Y..A,+@#+%)U6!6            .]2
M1E<!0W7O9DN6++GKKKO..>><SWWN<_OMM]^VVVZ[Q19;-#<W]^G39\B0(;ON
MNNN^^^[[R4]^\EO?^M9UUUWWAS_\8?GRY;$%U1"?5 5B08?FSIW[F<]\9L"
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M$H^US(.=,V?.$4<<T:]?O[Y]^QYVV&'ESJV^W>4-U$[<5L-L#         "
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MV\9HDKSZZJLQE\WJU:MCK\Z>((5B?9D=8G&9Y;43MU7IQHK>+=WU)@X
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M+>%;W_I6K']'C'8FUI?9H4:O'EU7W8TUPIMX2TO+OOON&SI\Z$,?,KT*
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M?^I3G]JPP=_$=&=B?9D=:O3JT755WUBWOXE/GCPY=&@S9<J4& 4
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MR ]G+ EB?3%=?_6HD9INK YOXOG>>..-O?;:*W3>>^^]5ZQ8$:,
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MC[_LLLM>?/'%6-!@&O;5HZ8;J^>;^!MOO''&&6=LO_WVZ;V1?CWSS#/-K0(
M        FS*CJP            #4B=%5             .K$Z"H
M    =6)T%0           ( Z,;H* /#ND0        ! "?&_,4,W,;H* /#N
M$?^U P        #>$?\;,W03HZL  .\>\5\[         . =\;\Q0S<QN@H
M          ! G1A=!0           *!.C*X"            4"=&5P$
M      "H$Z.K             -2)T54             ZL3H*@
M  !U8G05            @#HQN@H           ! G1A=!0           *!.
MC*X"            4"=&5P$           "H$Z.K             -2)T54
M            ZL3H*@            !U8G05            @#HQN@H
M      ! G1A=!0           *!.C*X"            4"=&5P$
M  "H$Z.K             -2)T54             ZL3H*@            !U
M8G05            @#HQN@H           ! G1A=!0           *!.C*X"
M            4"=&5P$           "H$Z.K             -2)T54
M        ZL3H*@            !U8G05            @#HQN@H
M  ! G1A=!0           *!.C*X"            4"=&5P$           "H
M$Z.K             -2)T54             ZL3H*@            !U8G05
M            @#HQN@H           ! G1A=!0           *!.C*X"
M        4"=&5P$           "H$Z.K             -2)T54
M    ZL3H*@            !U8G05            @#HQN@H           !
MG1A=!0           *!.C*X"            4"=&5P$           "H$Z.K
M             -2)T54             ZL3H*@            !U8G05
M        @#HQN@H           ! G1A=!0           *!.C*X"
M    4"=&5P$           "H$Z.K             -2)T54
MZL3H*@            !U8G05*I=T)A8           # IFTC&UUM:6FY__[[
M+[WTTJ.//GJ???;999==!@\>W"MGX,"!N^VVVZ&''OJ-;WSC^NNO?_;99V,Q
M&X.Y<^=^YC.?&3!@0/_^_=-O7GSQQ9AH)'%2M4 L !K5QO7B P
M&Z^-9G3UP0<?G#AQ8M^^?>-L8&E#A@Q)2W[QBU^L6+$BMJ,AS9T[=]"@0?D7
M<?#@P?/FS8NYAI&_U:)B00W$)3.+C6 3MM&]^           P,9K(QA=??[Y
MYP\\\,#\B:)R]>K5ZV,?^]A/?_K3-]]\,W:GD8P?/SY>O"0YZJBC8JYAQ+T6
MB 4U$)?,+#:"3=A&]^(#           ;KT8?7;WLLLOZ].D3YXDJ-7#@P--.
M.^WQQQ^/R] 8^O?O'Z]9D@P8,"#F&E7<>EW&0^.2F<5&L G;V%]\
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MH:0D.?_\\V,NLY_\Y">A6TQ -83;K+ONM+B)G!AB0_&\G%ACBU?+]0(
M    @(U'(XZN'G;887$H*4D>>NBAF,OLK;?>&CAP8'ZWF(!JR+_'NO%.BYO(
MB2$V%,_+B36V>+5<+P          V'@TXNCJSCOO'(>2DN3UUU^/N7(<<\PQ
M^=WBPU -^?=8-]YI<1,Y,<2&XGDYL<86KY;K!0          &X]&'%WMV[=O
M'$I*DK5KU\9<.:Z[[KK\;O%AJ(;\>ZP;[[2XB9P88D/QO)Q88XM7R_4"
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MM==.G#CQPQ_^</H2E#Y'FIJ:TJ_I]Z-'CTY_GCZ:9F)9S=3M"0L
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M00;=_BJ11<77JRQ77WUUKUZ]8J/,>O?N?<TUU\2F)<3B FVQ^CQA 0
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M3MN[[KJK<.!XS)@Q*U>NC-$"+2TMHT>/#K5IM[1GC'8H=$CJ]80%
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M0X>FG6.TM%">U.L)FR]]^YX\>?(..^S0W-P\<N3(29,FK5BQ(H8
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MSCFQ+$GNNNNNF,O@CCONB(V2Y-QSSXVY$F)EO9ZP[4:.'!G*VZ0_CU$
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M0UK77?'KK[]JG&<+%R[4=)95ITX=C7.CQ5(ZWS2%AYT
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M>#1IAM+&:/:4\FL*#TE*="N1@";UD#;CNV++EBV:SJV/<*7%/*R_DZ9(*0D
M              "00&F>NAHU8<*$&C5JZ$R<B(<??EBCX]"2:4SE\3@MR74Z
M5&:5*U=.%AKENNAT9F+YI<OVO+=[]^ZM)2/*ER]_]MEGO_#""Y,G3UZV;-FF
M39NTY Y:TO.BH[2PS^*9HBL1H4'>:):4\F@*_TG,Z??\\\\W:]9,$\5G6K!+
M+KG$^\LOM;S_E72E23.4-D:SIY1?4WA(4G);B<0TJ8>TIO76,I9EVGF-\VSS
MYLV:+GYS+;28A_5WTA0I)0$                2*/U35XTOO_RRH*! )^-8
M5H<.'30T#BV9QE2>5:M6:2[+JERYLH2Y?H1ZV[9M$I8-KHOV/@4P?;IL;WM[
M[-BQ6BRB8\>.2Y<NU>@XM+"W1<=H89_%,T57(D*#O-$L*>71%"DEB9H]>_;=
M=]]]Z*&':L8X:M>N/6/&#,WB1DNFL9)VFC1#:6,T>TKY-86')"6TE4A*DWI(
MN^NNNVH9RS+MO,9YMG+E2DUG656J5-$X-UK,P_H[:8J4D@
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MCQY:QK+>>NLMC?/LC3?>T'2699HXC7.CQ3RLOY.F2"D)
MD$!(IZ[:)\W,G3M7_^S?^O7K[3FC*E2HH'%Q:$G+^O333S7(F_ONNT]S6=:
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MN^ZZ-6O6:)D=%BU:U*9-F^*E_Z=>O7H)2MGUZ=-'"T?>8S=ITB0-M=FR9<N
M 0,J5*A@+[7WWGO[FK/;MV]?>_&HYLV;SYHU2T-M)DR8T*!! WN1<N7*39DR
M1>/BL!>,T@@W0X8,T6(1C1HU^NFGGS1ZA\+"PA$C1E2J5,E$[K+++EK8VZ)C
MM+#/XIFB*Q&A0=YHEI3R: H/2;2 91UWW''3IT_7.(<//_QPK[WVDK+WWGNO
MQCG(NSFMR*1#Y_Q+4^G,R6P/2[Q6]L@HC4C;77?=I<NPK,LNNVSCQHT:NL,'
M'WRP[[[[FK R9<J,'S]>"_M<R4!:B7 >KT<??53+6U;=NG43OUW[RR^_//#
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M"R^\X/H*9X_*ER_O?1:O%DY&RT=H4#):WJ96K5H:'5&G3AT-!0
M    0!ZSS5P-T]35J#_^^./AAQ]NV+"ASH+QKZ"@X((++EBR9(DNPQM-MV/N
MSO;MVV^^^>:=W-Z9%T^[=NU^^^VWXNF]^O;;;^43VQZ=<\XY2Y<NU71^3)PX
M\8@CCM"\R=2M6_>++[[07 Y:+!DM;[-^_?I++KE$"R14K5JU#S_\,%I<_^90
M?&G)XX44SPA=AF>:*$*#DM'R$1J4C)8O*OK^^^\OO_SR>.].]J)2I4H///#
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M[2VWW%*[=FUSQ,U_36?-O%4               "($C9U-2@Z<=5MZBH
M               28^JJ)SIQE:FK                    _C%UU1.=N,K4
M50                   /^8NNJ)3EQEZBH  &&B_30              "A.
MG[4#P6'JJB=:B:G&  "$B?;3              "@.'W6#@2'J:N>:"6F&@,
M$";:3P,             @.+T63L0'*:N>J*5F&H,                  #@
M'U-7/=&)JTQ=!0                  \(^IJY[HQ%6FK@(
M     /C'U%5W.E,U&2T/                    !Z:NNM.IJ<EH>0
M             #@P==6=3DU-1LL#                  # @:FK[G1J:C):
M'@                    Y,704                  $".,'45
M            .<+450                   .0(4U<!
M  "0(TQ=!0                  0(XP=14                    YPM15
M                    Y A35P$                  ) C3%T%
M          ! CC!U%0                   #G"U%4
M  #D"%-7 0                  D"-,704                  $".,'45
M                    .<+450                   .0(4U<!
M          "0(TQ=!0                  0(XP=14
M   YPM15                    Y A35P$                  ) C3%T%
M                  ! CC!U%0                   #G"U%4
M          #D"%-7 0                  D"-,704
M $".,'45                    .<+450                   .0(4U<!
M                  "0(TQ=!0                  0(XP=14
M           YPM15                    Y A35P$
M ) C3%T%                  ! CC!U%0                   #G"U%4
M                  #D"%-7 0                  D"-,704
M         $".,'45                    .<+450
M .0(4U<!                  "0(TQ=!0                  0(XP=14
M                   YPM15                    Y A35P$
M         ) C3%T%                  ! CC!U%0
M #G"U%4                   #D"%-7 0                  D"-,704
M                 $".,'45                    .<+450
M         .0(4U<!                  "0(TQ=!0
M0(XP=14                    YPM15                    Y A35P$@
MI/[UKW\-26;!@@5:K+08-FR8;JW#BA4KM!B0]^;,F;-ITR;]5_BW??OV&3-F
MZ+\BW.@[X$N>GS ??OBA;JW#K%FSM!A06E %@#SQPP\_:-UV&#-FC!8#$ [<
MX@A<?MX;6;9LV;AQX]Y[[[WGGW_^F6>>>?755T>/'FW.QJU;MVHHTL" ' @$
M31P !"C/[U&D_T0F_0R!R_,I0/$P=14 PFCSYLUERY:UDBFMMPY_^^TWW50'
MTT^M6;-&2P)Y;/+DR1T[=MQMM]T*"POU;_#/-+!ERI2Y[+++_OSS3_T;0HF^
M [YPPAQZZ*&ZP0[??ONM%@-*"ZH D"<NO_QRK=L.M]]^NQ8#$#1N<81$7MT;
MF3AQXJ677EJO7CWM)W8H7[Y\RY8M[[CCCA]__%$+PS\&Y$ NT<0!0!CD\SV*
M])_(I)\A<'D^!2B!V+Q5^U354$Q=-:?=!QGRX8<??OKII^8*9\Z<.1LW;M0E
M(90^__SS[MV[MVW;]JJKKOKUUU_US_",/5E"F<M([:,<*E:LN'W[=BU9*GS\
M\<>ZM0[F&EN+(;^E,W)8MFR9IBM1%BY<V*5+%S-X,U6C5:M6^F>DY.677XZV
M-OOLLT\I_HUC:4+? 5_R_(19OWY]04&!;G!Q)L"$:4F@5* * /GCZ*./UNKM
M\/;;;VLQ ,'A%D>HY,F]D<F3)S=KUJQ8WY#,-==<HUG@!P-R(&=HX@ @//+Y
M'D7Z3V32SQ"X/)\"E$!XIZX.&#! #U$FF.VJ6[?N>>>=9RZYUZU;ITM%"!06
M%EY__?7VH[;OOOOFPX]Z,XX]6:(]_?33]F/GJGGSYEJLM'C@@0=T:QTZ=>JD
MQ9#?TADY3)LV3=.5$-NV;7OLL<<J5:H4VY8;;KA!@Y"26VZY);97"PH*'GWT
M48U R-!WP)<\/V&^_OIKW5J'^O7K:S&@M* * 'G"7"Y5J%!!J[?#O'GSM"2
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MTT\_78. THLJ (30+;?<(A7SS#//U""??OKI)\E9MFS9S9LW:UPIE8U="J2
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M<'D^!<BI!$Q=G3IUJFZZ99U[[KD:Y\'OO_]>O7IUS96PGRM*^"S6N/[ZZ[5
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MMGSUU5<\SK*V;=ORXI(SCO4OD6G>>.,-7HJ=%UN>/7LV7;IT_@6?>^XY'J$
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M_/$'C[,F,3%1/(E&Z-B)AP;6J%$CMKC^GG*:Y?OGNS2(&#Z>0D=E*0NX3OQ
M!JU5*MUW8=JV;<L"HIXX<\B8,2,-53Q.852M;!-\X7CH5D_E!FG8?T7N)9]
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MWQ<OM7;LV)$'!48'+.)'2$/X)J^A:+K$X.?&*0[I1SW=NG5CY?B2'\\;,&"
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MS!R"ID%%'#ITB+T4I$^?/CS(,?4;9)*'R8=AUR,I,_A/KT><DR=/=NS8T?R
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M&L6[-/I$ZR4&MT]Q2#SJV;U[]P<??-"@08.2)4MJ_3IGSIS4KSMTZ#!CQHQ
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M1/$E!ISBB!11=FZ$)ACZ;2'ITJ4[?_X\CP, B$!(<1!E2I0HP9KTYY]_SH,
M "!ZX=;5\"A8L" ;4,FCCS[*XT ]8\>.915W]]UW\R"($*A- %M.G3I5MVY=
M?9?)F#'CPH4+>1S(T*5+%WW55*Y<.7*O%BCN[-FS]]UWGWYO/_744]C;  #N
MP:0=(&:A^P, F(CB2PPXQ:&^Z#LW,GKT:/WFD#IUZO @ (#(A!0'T>3,F3/Z
MQYPT6[=NY7$  !"]<.MJ>#SRR"-L0+WMMMMHH.5Q$%9[]NRI=<.^??OXGRVX
M=.E2T:)%6=W-FC6+QX'[4)L 'MNV;5N9,F7T_25'CARK5JWB<2 )Y;2[[[Y;
M7T'=NW?G0>#8@0,']-\NI EP__[]>1   -R 23M S$+W!P!P6Q1?8L I#L5%
MY;D1=B<N&3]^/ \" (A,2'$037[YY1?6GC-FS'CUZE4>!P  T0NWKH9'GSY]
M] -JIDR9\+TS#WSQQ1?^??[;;[_Q/ULP?/AP7;U=AQ=^R(+:!/#2S)DSX^/C
M]?VE8L6*NW;MXG$@U=&C1TN6+*FOIM=??YT'@0-???55UJQ9_;LW1XX<<^?.
MY4$  *"#23M S$+W!P!P6W1?8L I#F5%Y;F1@P</IDZ=6M?<?-FR9<.GM $@
M.B#%093!N0(  ,"MJ]R??_[Y2K*WWGJ+_RV >?/F9<B0P3^:QL7%S9\_GP>!
M"[IUZ^;?[9]\\@G_<S#;MFW+G#FSOP22-FW:#1LV\#CP!&H3P$L'#AS(G3NW
MUEEHQ._2I<O%BQ=Y$"C@T*%#M]]^NSZY39X\F0=!2-A%P0<??/#@P8,\"
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M , Z7&( \%C.G#E9;]+DSY__YY]_YM$  !$%*0ZBV^C1HWGC%E2O7ITO!@
MT06WKJ8@/MAA19X\>7[ZZ2=>%KAL\.#!O";L:]&BQ?[]^WG1X#G4)@    "
MXC!I!XA9Z/X  -;A$@. ETZ=.L6[4_(7M#MUZD1_XM$  !$%*0ZB7H<.'7@3
M%[SXXHM\,0  B"ZX=34%*P]VZ*5)D^;))Y\\=NP8+P@\L6[=NHX=.V;)DH57
M3#!ITZ9MV;+EVK5K>8D@#VH3     $!QF+0#Q"QT?P  BW") <!+&S=N]/>F
MA(2$>^ZY9_#@P2=.G.!Q   1""D.HEZ%"A7\C3R0*5.F\,4  ""ZX-;5%'[_
M_?=NW;I5KEQ9_TT?)BXNKEBQ8JU:M1HS9LS??__-BP#/7;ER9?GRY7W[]JU7
MKUZ! @7$;RWYY<^?OV7+EA,G3L2T7EFH30      Q6'2#A"ST/T! (+")08
M+U$/FCESYI(E2[9LV4(3%?YG (!(AA0'4>^KK[[Z-)BC1X_RQ0  (+K@UE5C
MY\^?W[1IT_???S]CQHSITZ?/FC5KT:)%JU>OWK=OWZ5+EW@TJ.3"A0M;MVY=
ML6(%5=G,9%2/&S9L^/???WDH* ^U"0    "@.$S: 6(6NC\ @ E<8@
M    ,(=;5P$                         P".X=14
M         #R"6U<!                         , CN'45
M               \@EM7 0                        # ([AU%0
M                    /();5P$                         P".X=14
M                         #R"6U<!                         , C
MN'45                           \@EM7 0
M  # ([AU%0                          /();5P% @CESYHP,9MNV;7PQ
M (@QR!4 D6[=NG6\TPH6+%C %X/HA<0NU\<??\QWMV#/GCU\,0!0"<96 ( 0
M8!8*88&&! "*.'+DR.+%B[_]]MN)$R>.&S?N\\\_GS]__O;MVR]=NL1#P1H<
M9T$(T&P  , --*F[<.$"_U?/7;UZ=?/FS?Q?W8%;5P% @MMNN\T7S+)ER_AB
M !!CD"L (MTSSSS#.ZW@]==?YXM!]$)BER@Q,3%UZM1\=PL\.QD! *'!V H
M$ +,0B$LT)  0*[5JU=WZ-"A2)$B//7<D"Y=NNK5J_?LV7/]^O5\83"%XRP(
M 9H-  "$U]JU:YLT:9(E2Y9KUZ[QOWEN\^;-<7%Q3S_]]#___,/_%FZX=14
MO';V[-E4J5+QR7M*%$!A?$EO_?333X\__GB=.G6>>^ZY_?OW\S\#@,LB)5<
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M7[^^<N7*4%!D6#]_E-T++[Q@K^&--][ "!NQM_(SL<\[[SR,2T9^*/0--]R
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MQZ P39@P 7:@9,F2:]>NQ3A/\(:+BA4K8H1$2W;2LE&]HP!0/LS%)U?HZLE
M_A,BR E:.K:NX2EL\I<FM]UV&P;9G'_^^698F3)ES%=Q+5FR)&\%![WRRBM8
M,B_[=QR5*U?V\Q"7X -9V[9MH89.G3IA4(HF3IP(=18N7#BEZ^3$WRZ_9.>+
M+[[ N/!E;5:)3V)7+IK9NYW\LK:KK[X:@SS-G#D3:BA2I,CNW;LQSD7KUJVA
M>*H[8'GLL<>@*J%ERY88Y^+ZZZ^'LMX]6>,HHV54M821F953N).QFB<KH;!Q
M+!K'5HUG8D@4'J#X-([R)9Y,WH1W#@<K5ZZ$XL+TZ=,QSIT\F4EZ_T-"Q[BO
M"F>A=ID^"]4RKXC5\"H?B&SK2/%<N:>]5UG>NTR9.[XDHMKY.$R3PCAQE'-\
M)>YOO_V&<>YB=4K*,T:%D](P#JC&=588TD[L0%=J#4,^ZS9Q2*VJQ&&],V/&
M#'MQH5"A0DN6+,&X9.QOTC-UZ- !@]R%D3DU=A6-FP9RPZ:4RK1\B1&?UM,[
M$*A-W=%,?1,NOPNW:]<.XWR+;,\].,Y4SS[[;(Q+EW7=JOU2U;A<NBJF4&(W
MX(\79RG&^>/X]-J! P=BG,W^_?OE*^@__/!#C$O1C3?>"'4:*5Z8#V P-O7J
MU0OC<K5OWQY##>.^^^[#.*7$J(R;-(Q&C1IAG+L#!PZ\]-)+\)QV4[5JU<Q+
M0]SLWKV[>O7J6,RF8,&"8G@8/GQXVH]H-D6S(2V-*2]RC-R?R=-8YYB...((
MJ&W8L&$8%*TQ8\; +AUYY)$8E(Q(&J5+EX9ZQ)P;XSQ=>^VU4$.0,3@-)Y]\
M,NS G7?>B4')''/,,?8:_#R"2TMVTK)1O:. G?)A+E:Y0E=/MM.5$[1T;"W#
M4P3DBZO..><<##K$_C.D=;>5F!Z("8"M@H.2GJ'V]X_X?$-0\(%,OL-[Y,B1
M&)2B1Q]]%.H\[;33,,B36%I##<*F39LP+GS9F55BE=B5BV;V;G?666?!)IYX
MX@D,\B2:"VKXYS__B4'NZM:M"\6??_YY#/+'\>$KHG=AG(N&#1M"V3?>> .#
M;#2.,EI&54L8F5DYA3L9GWFR*@H;QZ)Q;-5X)H9$X0&*2>,H7^+)'#>1TFQ$
M_F%23&_\W*EED7^Z,%]WX"WZ<5\5SD(M^6 6JF5>$9_AE1TI$=>5>]I[E<V]
MRY*YXTLBJIV/PS0IC!-'N<\^^PQVLERY<ACD*5:GI#QC5#@I#>. :EQGA2'M
MQ&ZG,;6&(9]UFSBD5E7BL-Z1GZS?NG5K#/)!OFG*_QN]0\J<&KN*QDW;.39L
M2JE,RY<8\6D]O0.!VM0=S=17&#%B!%9M&,\\\PS&^1;9GGOXXHLO<*N^?[_V
M(]:7KLIW(1<K5BPG)P?C_#GJJ*.@-F'4J%$89R-/%\0A]S-=\+!OW[Z*%2M"
MM<+$B1,QU+<F39I@=8;Q]--/8URN.G7J8*AAC!\_'N.4DG\B-7S?)B(2XMBQ
M8QT?B"T4+U[\VV^_Q3(2^3'4C@H5*B1.Z:%#AZ9Z*X\E@@UI:4PQK\+HU.??
MEIT[=\I7I:?]RA)5Y.=LMVG3!H.26;QX,5221M(0TPZH),@8G*IITZ;!UH6%
M"Q=BG*?MV[?#=5I^7B*C)3M%OU'MHX"=\F$N/KE"8T^VTY43HN_8"4W#4P1Z
M]^X-^U.K5BT,.L2Z=[-2I4I;MVZU_EU^V]?UUU]O*X>^_/)+>[#/;A]P(-NV
M;9M\QLV9,P?C4B2_]R#5\^BMM]Z"&D1GPZ#P96U6B4]B#TD$LW?+ :>7M4V:
M- GC/,GW[M]ZZZT8Y$)T%2@KS)\_'^/\$1D&ZS*,SIT[8YP3T1-$DT)9[Q-*
MXRBC950UA929U5*XD[&:)RNAL''L-(ZM&L_$,*@]0#%I'.5+/%GP3?3MVQ=J
MN."""S#(D_P=[YMOOHE!3J(<]U7A+-0N'\Q"HY]7Q&IX94=*Q'7EGMY>97GO
MLLO$\<42P<YKGR:%=.(H)[_MVN/^>5FL3LG@,T8/(1U0C>NL,*27V('>U*I6
M_NLVVE.K*G%8[_SZZZ]R]_CRRR\Q+ID]>_84*U8,ZO$_5PPI<VKL*AHW;1>\
M8;5\B1&3UM,[$(21NB.8^B9<KCS^YIMO,"X5T>RYAZ>>>@HW9A@C1HS N'05
ML+'^,2Z7KHKI+_SE9YQQ!@;YLW?OWL*%"T-MPM=??XVA-J^__CK$-VS8$(-2
M-&O6+*A3$*V=ZAEN5[Y\>:S1,,:-&X=QN4,OQN5N_>^__\90=98N78J;S)7T
M6SDQ+^G5JY?C-WJF,F7*3)TZ%8NY$-U)_GW4C8ALT:+%^^^_+Q9[6%$RH6Y(
M5V->==556,#'[2!NQ(@"58G3<]>N71@7+>L5SY94'X(EB'D&5))JTG#\(?_'
M'W_$N-#(-^:><LHI&)2,F/% )6+UA4%Y:<E.6C:J=Q0 RH>Y^.0*73T9:,D)
M6CJVKN$I J^\\@KLDEB8.;Z;6_RQ5HR8P=L_DI_][_TZC$LOO=2*;-"@ 7[L
M(N! )F;%4+QHT:)[]NS!N!3)E^U^\,$'&.1)?K)C>G<\!Y2U624^B3T\H<[>
M[1SS\[IUZS#.DWSO_N#!@S'(A7Q?;+ERY=)^.ZW]X= 6GSLC?RM=JE2I_?OW
M8]PA&D<9QZ,6]JAJ"2DSJZ5P)V,U3U9"8>/8Z1I;-9Z)(5%X@.+3.,J7>++@
MF[CLLLN@!C_/[K)LW;JU@/33Q>+%BS'.163COBJ<A=IE^BQ4R[PB5L,K.U(B
MKBOW]/8JRWL7R+CQQ2[4G8_#-"FD$T<Y^1&G*3V6.U:G9/ 9HX>0#JBN=59(
MTDOL0'MJ52B?=9LXI%95XK#>N?_^^Z&X:*(TOC(5?1OJ26FN&$;FU-A5-&X:
M!&_8Z+_$B$_KZ1T(0DK=H4Y]3?+-/Z(/I/WJ#TL$>^Y!GJD*2Y8LP;AT%;"Q
M_C$NEZ[*;VCU>2&Y3#095&7Z\\\_,=1&K H@WOL167X\^^RS4*=PW'''89QO
MZ]:MP^IR.=Z/XGB?<9"M^R&_U-(D/ZQ8))IY\^:-'#FR??OV\FP/G'[ZZ;_]
M]AO4X.V[[[X[Z:23L")/1Q]]])@Q8["B9,+;D);&%).S2I4J89D SZ@?-6H4
M5!5V)_1#_ALG3YZ,0<ETZ=(%*DDU:<@_Y!<K5BSX&.Q33DZ._-1WN #+C\&#
M!T,E2<<M+=E)RT;UC@) [3 7GURAL2<#+3E!2\?6,CQ%0_[6PW#J":+_GW#"
M">:G-6O6A.\CY*<D5JM6S1Y@MVC1(OLZ=M"@01CA0CX!4QK(GGGF&2@N)C,8
ME**-&S="G<+RY<LQSI-\X6^_?OTP*&19FU7BD]C#%M[LW>[MM]^&2D2ZP"!/
M>_?N+5Z\.%0B=A[C7,CWQ9Y[[KD8Y,_^_?M+E"@!M1F^T\[SSS\/!;TOZ-<X
MRF@952UA9&;E%.YDK.;)2BAL'(O&L57CF1@2A0<H/HVC=HGG*/@FY-=M^[D
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M9\^>6)UAB!2,<;F4;]V/TT\_'3>9EA(E2H@SZJ.//DHCJ\I6KU[]W__^UWI
M6E*GGGKJUJU;L18?U&Y(2V..M[T!V5*V;%F,\TV,QU";&+,Q*%KCQHV#73KB
MB",PR =YC9%JTI!_R%<[!GOKT*$#;#V]6T!.//%$>R5GGGDF1DBT9*?\L=&4
M1@&@=IB+3Z[0V).!EIR@O(_YH65XBDS)DB5A/^&-V'OW[CWJJ*/,CXX\\DCQ
M?^V?"N^]]U[>"@Z:-V\>A"5RWP-B7VK>>>>=&.$B^$!VW'''00U#AP[%H!3)
MU^PV;]X<@SS]_OOO4(.P=NU:C M9UF:5^"3V**F=O=M=<,$%4+9W[]X8Y&GT
MZ-%00X,&#3#(G0B&XJ^^^BH&^>/XS##1:!CG LX%8>3(D1ADHW&4T3*J6L+(
MS,HIW$GEK1UDGJR$PL:Q:!Q;-9Z)(5%X@.+3.&J7>(X";D*^!J)2I4H8Y$G^
MZ>(___D/!OD6WKBO!&>A=OE@%JI\I/-#^4:##*_L2/%<N:>]5]G<NY**^?CB
M3>W.QV&:%,:)HYS\WJ>2)4NF](+76)V2 6>,WL(XH!K766%(.[&#N*76(/)9
MMXE#:E4B#NN=[MV[V\L*Y<N73RG]6N2YXK///HM![L+(G!J[BL9-@X -J^5+
MC/BTGMZ!((S4+5,[]4VX7!#?M6M7C M,^9Y[^."##[ ZPWCNN><P+H#X7KHJ
M']$B18K(EP+XY'C 1HT:A7$VO_WV&\2+-MF\>3/&I:A*E2I0K9'B,Z7!V6>?
MC=491M^^?3$NE^/6QXX=BW%*.6[4IX(%"S9JU*ACQX[OO__^MFW;L&H5YLV;
M)R8E-6O6Q&U+@MR>F%"T(2V-^>233V)=AM&D21.,\V?W[MWRVT6__OIKC(M6
M[]Z]89=:M6J%0<G(:XPTDH;\B.\PQF W1Q]]-&P]U8<')'+O#X9;?)+.P!(N
M?5M+=M*RT<A& 3OEPUQ\<H7&GFRG*R<X]C$M'=NGM(>GR!Q[[+&PS_?>>Z\]
M8/CPX=9';[[YIOTCTX\__F@K_3^.[RB\_OKKK0#1,K_^^BM&N @XD.W:M4N^
M.W/:M&D8EZ*V;=M"G:DNS^3E4/7JU3$H?%F;5>*3V+50,GNWJURY,A1TS ,>
M[KCC#JCANNNNPR 7CK>&SIDS!^/\$=N%J@S?SW#=LV=/T:)%H:SWGF@<91PW
M'?:H:@HI,ZNE=B<=6UO+/%D)M8UCT3BV.AX@GP*>B6%0>X!BTCC*EWBRX)OH
MW[\_U'#^^>=CD"?YIXN77WX9@U*G?-Q7@K-0NWPP"W7,%6'/*QPWJF5X94=*
MQ'7EGO9>97/O\B^>XXM/2G;>L9_XI&2:%-*)H]QSSST'.YEJOG)L:BVG9/ 9
MHX>0#JC&=588TD[L=G%.K:G*?]W&\7SW24EJ524.ZYW33CO-7M9(]^&(CG/%
M;[[Y!N-<A)0Y-785C9NV"]ZP6K[$B$GKZ1T(0DK='I1,?86WWGH+"R1[<D=
MJO;<PWWWW8=U&<9//_V$<0$4L+'^,1:7KLJ/#A:C%P;Y\_???\OO61!6K%B!
MH3;OOOLNQ->O7Q^#4B>?8,+\^?,QSI^<G!QY%!1^_/%'#,WEN'7'AWXIY+A1
MF0BK4:/&*:><<L455XBYW?#AP[_]]EO_K[\,:/_^_9]]]EGKUJWE'W0MXJ18
MLF0)EDQ1P UI:4S'3.3_9W+P]==?0U7B[TW[ G]5Q#04]JI/GSX8E(R8 4 E
MJ28-QQ_RIT^?CG'A6+]^/6Q:>.&%%S NF4F3)D$E26=@"9>^K24[:=EH9*.
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MI&7V+G3MVA7*&KF7O_?KUT]^F,JR9<O$MLSK$L0>3IX\N56K5E#6_Q<-(KU
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MFI]FH7;R2!?2O,).WF@&#:]!Y(..%.K@I406]JZ,'E^T['STTZ38GC@///
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M;,G,N.ZZZ_;MVX=QH8G7I:LK5ZZTMX5I]>K5&$=$1$1$1$1$F># @0,5*E2
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M&Q5*M_A11_1]NDH]DMHC0X8,T'ZZ%"I4J'OW[F3(PYQ/))_^F6>>29\^/3Z
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M ?A= 62A4"BJN'CQ(HT[LA$E2Y;D/QQ1@AV*P//>>^]A%HIBOGI!]IW&.+U
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M&E56C;EP<=-1W#"1XI,1+<9/0\L:2E98OGPY9NJG1(D2(2MDB>658EQ8=%]
MI/,6P8D76>T8/YJ!A;\8)T.&#"',9JNPM\=H6.]%/G>XT^I'JBK:'^5\NJK[
M/77)DB51+J*,&#$"'QG>0TD3879^MEG;*S-NW#A,&>RPD'W[]L&Y(&O6K$$A
M!O[$:17^C@]2:G_^^>>$"1/(&^;7VX!*E2KMV;,'<C"G:]>ND(GYQG>[9,F2
M!?)?O'@Q"@6#U")D8O<E^;U3U%X6#0:I)_Z*%O.K'(R8.'$BY!-./W<"N->
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M]MMO*">/CS_^&%ZO0H4**&29K%FS0FYV#Q5_Z:67((>6+5NBD"GB.\\''WP
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MKB]?OHS)&*)1,[BDZ@0@W>'TN2!J%F"1)5H9B8\.OV(?>. !R,'6"00[=NR
MY(K_\C6VBU+_P60,45U[H<5B&A&,H*5X*9Y_Y1Y<ZR:I1/4P#XK$T@F WX'\
MU%-/49'OOOMN]9])DR9MU:K5PH4+M9<GMV?;MFW]^_?G+V=4_$[%Q(D3 Q]B
M1ARV8)1.)HA<)92RKB'86O$]/T>.'/"2LVQ>6@WPFY>(Q8L7^_R?;K!-3(^F
M88+I70!?2[&D'W0'FG.QN8JL\D9$->GBJ$;U2:HQN8N;(I$^D1*^D@DG6HR?
MAO9)&DI4^5I":A1;US=19V,>^Q]D\=F6W;MW+R:[@Y3RJD@Q+CY)SIM&!"=>
M6*2T8_QH!FIZ>,^B18O2.&5=Z\<??YQ4O=;TUZ]?W[=O'W5FW0EPXHTWW@A\
M2+C(<J?5CU15M#_*_'35YS\GF5<NBG^*K77KUGW[]ATW;MR8,6/Z]^_?K%DS
M]1H7EE*E2H6PH]'HH1DR9*"'4@@Z?OSX8<.&=>_>G;1,LF3)0(S^0B/DVK5K
MF&^HD,;D3W<@VK9M:\O&F'#@P %MP8:%U"5YSU32(4.&3)X\^;///ALT:! I
M!?[D83)XFIJP#K4:Y-.C1P\4"A4:+>RW_+I0 8.^=O@O23X9Y,!C?F"XRJ%#
MA_+GSX\I[T#C-%.F3.G2I8._ITV;EMQ92MZG3Q_XB:PC/D,>U)GYES?9U&X1
M7=?*!#)[,V;,\!G<D@"0L/G68>F=9^G2I?Q*.0NI-5Z]4$.H\0RI._B)#"0^
M0P_2HI!0@S1DY<J5.W?N3%J4=.FD29/H_4EG-FK4*$N6+"BM*!TZ='#;N6A4
M.OYT] (%"O3JU6OBQ(GD';9OWSYCQHSLKV^^^2;FPA%^;S&'HES=&E9)2$@@
M1US=D*1!*E2]388<'?;O/$%/D@B_="&,!2G]T E5%I,VVE&D-+U*O#66<SYJ
MI+PXG[%C[V@T(:LGU*]?G\W$8A6Q2!P^*G/GSH5\R+"BD!THJF=W2RO^:MFQ
M8P?*N0;=VP"M.!(LHT>/QBS\6+FNRXB-&S=";C1([7XK6;1H4<@$R)X].Z9A
MB%+-X(:J$X9<AU-%;M0LQB++LC(^>8\.LV*O7KW*WQ2V=NU:E#-&]\ &@.PC
M)@LD2FO/%U(LQA*I"%J6E^+Y5^[!M6Z21O0.<RO(*IT JG#7NP\<.-#G'SN\
M^B)/1G<E58,&[T\__83/,"4.6S"J)Q.$K1(*7M<0;ZWXGL]#<1DFLP,EQQP5
MA1Q^^HE&&?O'+[_\$A.[ [Z68DP_& TT)V)S#?'EC:!JXG%.HVJ(KS&?O,5-
M\<B=2 E?R809+<9/0_N$#Z7>O7MK">O5JV?^/0//SIT[@RHNDR\I?<++RR+%
MN/B$.V\LD9IXX9'2CG&B&;IUZP;OV;QY<_K[EBU;^-)1A9 YX%M9@P3(4<=G
MA(TL=]J-GZ[Z_--2#1HT8(MMA;1ITPX8,,!*@*1+: \E:M:L:>OL:(L\^NBC
M\* 77G@A4DZGRO'CQVO4J %/L0)Y5$;;98+"FPWS8RILL7KU:LB<IVC1HIB,
M(_R7?.NMMR 'GM]^^PV3Z;%W[UXR,YC8F#)ERI#7JZ;E3QI7U8I+V+5K%[P>
M\<\__Z"<32Y<N,!?T&D$6=.-&S>J"7_ZZ2?\F8-R#GP:XH;.\_///X,O8D[Y
M\N6W;]^NIN6O4:/W"<Q>GQLW;I"S5;5J54AN"WJ3H-<PR:)KUZ[XNL98C/3"
M[RU!V;!A0[9LV> I1MQSSSW:5#N9-OPY$&W@&!%^Z4(8"U+ZH4.J+/9LM*-(
M:7J->&LLAWS42'EQ*J$Y]F%&$U)Z K\23VX "IDB=_A<O'A1VR"K4J%"A9LW
M;Z*<':@1V0P5_UP)"KF,].G3LR^<(4,&NW:$OU*0>/OMMU'.#A,F3( ,2Y8L
MB4*FG#]_WF1N1<5\%BE*-8,;JDXD$AU.#8E1LS"++,7*J$AY=)@5RQ]]D9"0
M8&L@=]>[]PU8NG0I)N.(QMKSA12+ 1&)H&5Y*9Y_Y2K<Z2:Q1.DPMXB4TCD-
M1:_0KY0[I\CX_ MU0=?L61HW;FQR_I 1\=F",3R9H$1HE5#PNH9X:\7W?!Y;
M>XUX-F_>C#GZ0Z=UZ]:Q0YO:"U.Z!KZ68D\_A#;00HC-6027-[*JB<<AC<HB
MN,94I"QN2D'B1$KX2B;\:#%^&MHG<"B-'#E22_O((X_8W4*OTJY=.^85D#QY
M\F "#F'EY9%B7 0[;T!$)EYTD=*.\: 9>//]P0<?J#]1E^"C5!,J5JRX9<N6
MP.PC@RQWVJ6?KJHL6+"@4J5*3(48DCMW[IX]>X8P1\!C_:&DR%JU:D7>)V81
M(=Y\\TWV<6W:M(FLTZE">7[YY9>\FV)$P8(%APP9 F=-6^?<N7-)[AQKK[%K
MURZ4"Y4Q8\9 YCS-FC7#9(%$Y"5KU:H%.0#T".NG9%^\>)'4*W]D"$ &;^+$
MB>QD-+]K9-Z\>4S&DOGFFV_@]?+GSX]"(?'OO_]V[MR9W_K,DC5K5NK,K"_R
MX8<?HA 'A7_,<Q#W=)Y#APY15P^ZX%VR9,G)DR>SN@66-PB['@:9R7?????!
M!Q_DJ\*(5*E2-6K4:/;LV9B7FZ!:LC(,[[OO/HO';4:DMUCAS)DS+[WTDGEG
M2)<N'1D=]E#W+,:;/A7_NN_5JU>9AR 1*5TX8T%D/W1.E<68C1:#R*9GB:O&
M<LA'C8@7!UAW[",530CN"02],S@\??OV12%K2!D^\&$015C:=$-H7+Y\&1Q@
MLMW[]NU#.9=!U<Z^\_OOOX\2P>#OZGKEE5=0R":=.G6"/%NW;HU"IOS^^^^0
M X_YK%F4:@8W5)U@I#B<@)2H6;!%%F]E- 0_.OR*'3]^/"0O5:H4"IEB98Z>
M>CXFTR/J:L\77BRF$MD(6K"7XOE7KL*=;A(0C</<.H)+)P#='<CL#>_+ER\O
M6[8L2@1";@^I2O//,HR(VQ:,R<F$B*\22EG7$&.M='L^$,)M%8#N:93ITZ<O
M6;*D]L_$Q,2]QO<=RT6WEF)5/U@?:"''YH#(\CJAFE@<TJB R!K3D+BX*1@I
M$RD143+A1XN^>&IHGY"A-&W:-*TR[[__?G(G4,(:AP\?3ITZ=>#K_#_UZ]?'
M!'H(**\)XHV+%.=-);(3+X"4=HQYS<!_F_OCCS]JOY(VKE.G#@CP4*SZW7??
M.6'W562YTTD8M#^ZY=-5E1T[=@P;-JQ)DR:E2I4B>TSJDBHB5ZY<)4J4:-"@
MP8 ! W[YY9>(;QSG'TJ1&/6DHD6+UJY=FU3 _/GSPXR@7 7U[*5+EW;OWKUJ
MU:KWW'-/FC1I2,=1_\N9,^?__O<_<D$Z=NPX>O1HN[Z+1V0Y=>K4I$F3&C=N
M3#['W7??K?;)0H4*/?'$$WW[]N5WH_+3<#2N3Y\^#6(2@>"*:-2H$0J% 6G,
M$2-&U*U;MUBQ8MFR9:,:(\^ :J]MV[8S9\XT=]]C@SU[]@P<.)"&<-Z\>=.F
M39LR9<I,F3*1'B/GLG___NO7K\<$$86\/3*<O7OW5CLM.0WT='J'#!DRY,F3
MA\P;Z7#Z==:L64%C&/= /M/@P8.??/))&GID':@X- SSY\__V&./D8.[:M4J
M3. :J#E(C=>K5X]J7AT.]/[4+JU;MYXZ=6H4-8%=!/1#IU699Z-#0T#3\WB-
MY4YXQ][I:$)P3X!H]N&''T8)FP@;/FO6K($#C>SN\N<AKYC-4+%Y>J)'_"!>
M,\0#;G X8R]JYA%L95@D/CH&B,_:BW@$+<Q+\?PKCQ"([6$>2Z6C0<&.$<6_
M;HU"/M^*%2MZ].A1O7IU&J3ITJ6C\M* O??>>\F!'#ERY,&#!S&!NXFE%A0&
M'S((6R64M:XAS%HY2K5JU6", Q]]]!&FB6_DZ@=^H#D=F\LM;S0BI<;D+FZ*
MQ T3*1*)GX;V21I*$I%;7O'&19;SYG-@XH5%2CO&E6;@V;IU:[]^_:@O%2A0
M@)QPJG"*1JEQR5(,&C3(H9-6 2GN=!1\NNKAX1$:X9\RXC1D,N$-0S@[P</#
MPT,NGBKS\/"0R^+%BT$+B0E?P^3HT:.Y<N5B7_N==]Y!(9M05 _[PLN5*W?]
M^G64\_#P\+B#^Z-F#P\/*7C^E8='#-.C1P]VF"B63Y#R\/"("LQOLG[HH8<B
M^ZF*AX>'AX>'AX>'1RPAQ9WV/EWU\(A9FC9M"GK$51/6MV[=RIPY,[PA>R:V
MAX>'A_OQ5)F'AX<;J%"A JN%VK5KAQ(NX^K5JQ4K5F3?V>YUZCSGSY\O7KPX
MFV?6K%EW[]Z-<AX>'AX,+H^:/3P\).+Y5QX>L4K-FC79D4+T[=L7A3P\/**6
MV;-GPQC72)LV[9X]>S"!AX>'AX>'AX>'A\<=I+C3WJ>K'AZQR9DS9U*E2@6J
M9.O6K2@G#WH9>+V4*5->NG0)Y3P\/#Q<C*?*/#P\W,#JU:N3)DVJ*2)R K=O
MWXY"KN'JU:L-&S9D%*?2LF7+&S=NH)P=KERY I>8)"8FAGD;CH>'1\SC_JC9
MP\-#(IY_Y>$1JV3)DH4=+,3<N7-1R,/#(VHY?OPXC'&-<>/&H;2'AX>'AX>'
MAX>'!X,4=]K[=-7#(S89,V8,Z)%*E2JAD%1&C1H%;UBM6C44\O#P\' WGBKS
M\/!P"5VZ=&%U4;ERY=SYL<*%"Q=JU*C!OFJ;-FW"?-6S9\_"R4EITJ19O'@Q
MRGEX>'@$XOZHV</#0R[Q[%]Y>,0J!P\>9 >+RN'#AU'.P\,CFLF7+Q^.<T5I
MT:(%RGEX>'AX>'AX>'AX<(AWI[U/5ST\7,>^??NJW.' @0/XLP6N7;M6J% A
M4"5SYLQ!.:G K#HQ=NQ8%/+P\/!P-YXJ\_#P< GD_E6J5(E51SUZ]$ AV1PZ
M=(B]>Y="SO???Q^%;+)]^_82)4HPY5:R9,FR>O5JE//P\(@MXB1J]O#PD$O<
M^E<>'C',K%FSF#%]FQPY<J"0AX='E-.\>7,8Z?_[W__.GS^/<AX>'AX>'AX>
M'AX>'.+=:>_350\/US%]^G1-!:Q;MPY_ML#PX<,9-7(;MQT><_CPX>3)D[-O
MF"E3)N^*;0\/C^C"4V4>'AZNXL2)$\6*%6.5TEMOO85"\OCFFV\R9LRHO5N6
M+%GFSY^/0C:9-6M68F(B4V*E3)DR>_;L03D/#X^8(QZB9@\/#S<0A_Z5AT=L
MTZM7+V9 WZ9.G3HHY.'A$>7T[=N7'>;ITJ7;NG4K"GEX>'AX>'AX>'AXZ"'>
MG?8^7?7P<!W=NW?7M, 77WR!/P=C^_;MZ=.G9S2)DB)%BDV;-J&<5+IV[<J^
M(=&G3Q\4\O#P\' WGBKS\/!P&T>.'+GOOOM8O31ITB04D@$$NK5KUX[(I9R'
M#AW*D2.'FB<%L%VZ=+EZ]2H*>7AXQ"+Q$#5[>'BXA'CSKSP\8ILGGGB"'3C$
M.^^\@T(>'AZN8<>.'=W\O/ONN_B; 0L6+$B=.K4VQI,E2[9PX4(4\O#P\/#P
M\/#P\(@#HL6=]CY=]?!P'=6J5=,40>/&C?%G4TZ?/EVX<&$MN<K''W^,<E+9
MO'ESRI0IV3<L5JS8E2M74,[#P\/#Q7BJS,/#PYV</W^^4:-&FFJ:-6L62LB@
M5*E2ZOODRI5K^O3I^',8+%^^/$6*% \\\,#*E2OQ-P\/C]@EYJ-F#P\/5Q%O
M_I6'1PQ#XT4;RRK??_\]"GEX>+@&\M+5H9HM6S;\38\A0X8D2Y:,'>.??OHI
M"GEX>'AX>'AX>'C$!]'B3GN?KGIXN [VJB\:B;_]]AM*&+!UZ]8B18HP:N0V
MG3MW1CFI;-^^O4"! NP;IDZ=>LV:-2CGX>'AX6(\5>;AX>%R)DV:I+J4!PX<
MP-^$<^7*E82$A,R9,P\>//CRY<OX<]ALV+#AQHT;^%</#X^8)K:C9@\/#W<2
M5_Z5AT=,<OSX<? !B/W[]Z.<AX>':WCNN>?4H9HT:5)S>T=C^?'''P\8WHHR
M:- @E//P\/#P\/#P\/"(&Z+%G?8^7?7P<!=[]NP!=9 I4Z;Y\^>C7"#__OMO
MOW[]TJ9-"VE??_WU6[=NH;0,SIT[]\LOOW3NW)D]7)I(E2K5XL6+4=K#P\/#
ME7BJS./_V+OS^"KJJP_ MPF!* @B((HH4,2-*EJ5BG5%JM:Z8G%?ZD85M76C
M5(M::ZTKN.]:;&NK57E!W+5UWW!!$45%15&@@B"RR)[XCJ2FDW-SDUP((83G
M^<./9K[GS&3N+^.=RV$"*Y$OO_SR_///CU]=$29,F'#]]=?/G3LW;@!8*@WU
MKAFH_[R_@I7:(X\\$MX&M&K5*H: ^F3SS3<O_X'-]<"GCS_^^/333R\N+D[]
M<'_KCW_\8XP" ,"J9&5Y.VUT%>J7>^^]-UP1ROSXQS^^YIIK7GSQQ:E3I\Z?
M/W_!@@7_^<]_WGKKK=MOO_V((XYHT:)%R#=OWOS..^^,W5>0-FW:A,,KL\$&
M&SS]]-,Q#5 ON90! -0'#?*N&0!8WBZZZ*+P9J!7KUXQ!-0;\^;-:]2H4?D/
M;./&C7_[V]\^]]QS[[WWWJA1HT:,&''AA1?NN...!04%J1_K;Q46%MYZZZVQ
M'0  K$I6HK?31E>A?KGBBBO"=6$I].G3Y]-//XVM5Y"9,V?&XUORF[5//OGD
M9%-, ]1++F4  /5$P[MK!@#JP($''AC>#_SF-[^)(:#>>/GEE\//;$VT:]?N
MR2>?C+T  & 5LQ*]G3:Z"O7.J%&C3CSQQ#777#->)*K3N''C@PXZZ/777X\=
M5ZBWWGJK_ B;-6NVZZZ[7G'%%=.G3X\Y@'K,I0P H/YH8'?- $ =Z-2I4WAC
M</?==\<04&_<<,,-X6>V:D5%1<<<<\P77WP1&P$ P*IG)7H[;705ZJG%BQ>_
M^.*+?_C#'_;88X\.'3ID/Z6YW 8;;'#000?=?OOM]7.(ZO///Q\^?/@SSSPS
M=NS8Y)N*FP%6!BYE  #U38.Y:P8 ZL"==][YMXJF39L60T"]\<8;;_3OW[][
M]^[IWW,:%!86=NG2Y>"##[[QQAL___SSV (  %95*]';::.KL'*8-V_>N^^^
M^])++SWQQ!/#EWC\\<='CQ[]U5=?Q2@   "L8MPU P! PS-W[MPQ8\8D[^V'
M#1LV=.C0$2-&)&_X7WGEE0D3)BQ<N#"F 0" E/K_=MKH*@            !U
MQ.@J             '7$Z"H             =<3H*@            !UQ.@J
M             '7$Z"H             =<3H*@            !UQ.@J
M         '7$Z"H             =<3H*@            !UQ.@J
M     '7$Z"H             =<3H*K5OW+AQ\^;-BU]=)964E+SSSCOQJP
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M[B@J*BH?Q^S8L>.''WX80RPQ9LR8)DV:E)^K1HT:/?OLLS$$
MJP"CJRR-:Z^]MGP0,['99IM-FC0IADBY[+++TF?L^]___MRY<V,(
M    &CJCJ^3MNNNN2T]A=NS8<>K4J3%$124E)1MMM%'ZO T<.#"&
M    H*$SNDI^A@X=6E!04#Y_V;1IT]&C1\<0E;GFFFM2DZN99LV:39LV+88
M          "@03.Z2AY>??75XN+B]/SE???=%T/D,&O6K.;-FZ?/W@477!!#
M            T* 97:6FID^?WJ%#A_3DY2]^\8L8HDK[[;=?^@1V[-BQM+0T
MA@           *#A,KI*31UXX('IL<M6K5I]\<47,425KKCBBO0Y3#S__/,Q
M!             V7T55JY($''@@SEW_^\Y]CB.J,'#DRG,;?_>YW,00
M       -E]%5JC=GSIP--M@@/7"YQ19;^$WW2R$YD^G3F.C1HT<, 0
M    0,-E=)7JG7'&&6'@<NC0H3%$S;1LV3)])E=???7%BQ?'$
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M^<]_QE!N\^?/O^RRRUJT:!&:U$3;MFW/.>><Y,S$IC73K5NWT/"66VZ)(0
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M5LMWUG,I)-]FV.]&&VT40_G+'NKMW+ES#%5I_OSYC1HU"DU>>^VUF,LR8,"
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MKXVAW 8/'EQ86!@ZY)(D]]IKKZ%#ARY>O#@V6BJ''')(W$<F\_[[[\<<
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M/GUZLB9#DR>??#+F:L/X\>,/.>20L*]R5UUU52RHSM2I4[,/OG___C$'
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M?+SRRBN-&C5*G\"\GAQ<J8\__KA/GS[) :^QQAH[[+##77?=%1,
M  "P,C"Z2B4>>^RQ].1EXNVWWXXA*O.?__QGO?762Y^Z@0,'QA
M  "LJHRN4KGMMMLN/7_9MV_?F"#+@@4+>O3HD3YO1Q]]= P!          #
M*LSH*I4;.7)D04%!^0AF<7'Q>^^]%T.D+%BPX( ##DB-K68..^RPQ8L7QQP
M          "LPHRNDM/IIY^>'L3LWKV[0<Q<YLR9TZM7K_3I.O;88YTN
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MZZ^_?N[<N7$#            D(/150            #JB-%5
M .J(T54             ZHC150            #JB-%5             .J(
MT54             ZHC150            #JB-%5             .J(T54
M            ZHC150            #JB-%5             .J(T54
M        ZHC150            #JB-%5             .J(T54
M    ZHC150            #JB-%5             .J(T54
MZHC150            #JB-%5             .J(T54             ZHC1
M50            #JB-%5             .J(T54             ZHC150
M          #JB-%5             .J(T54             ZHC150
M      #JB-%5             .J(T54             ZHC150
M  #JB-%5             .J(T54             ZHC150            #J
MB-%5             .J(T54             ZHC150            #JB-%5
M             .J(T54             ZHC150            #JB-%5
M         .J(T54             ZHC150            #JB-%5
M     .J(T54             ZHC150            #JB-%5
M .J(T54             ZHC150            #JB-%5             .J(
MT54             ZHC150            #JB-%5             .J(T54
M            ZHC150            #JB-%5             .J(T54
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M__[[!04%Z66P[[[[QE#=2A],F9@ 5C;QIWK9?JY_^M.?IELE%[&Q8\?&$
M  W72CFZ>L<==Y3?RJZSSCJ+%BU*OOC!!Q]\K^)?T"QSZZVWQOJ56?SVENUS
M@7*Q:2VUA14BKN85M)Z;-FT:CV.9GRUQ^^VWI[O%S31TZ5??&@  8-FEWUM.
MG3HU;JZ9#S_\,-VG3*M6K6(NAW15Y\Z=WW___9CXYINCCSZZ/#-HT*"X^3OW
MWGMO>>S""R^,F[]SZZVWEL?*Q,1RYFZ16I=^]:V!55;Z4EGFT4<?C:&Z%8XG
M8V7"RB_^5"_;S_6##SX8NAUYY)$Q!   0,.U4HZN_OC'/RZ_CSW[[+/+O[[K
MKKNF[G#_JWOW[JG2E5[\]I;M<X%RL6DMM845(J[F%;2>PX,NRGSYY9<QEX\7
M7G@AW2UNIJ%+O_K6    ]41RFQ/?IV8R145%,9=#NFK//?>,FY=(_QWF_???
M/V[^S@]^\(.RS%IKK35GSIRX^3LE)24;;KAA><-,G;^O=K=(K4N_^M; JFG:
MM&E-FC1)KX&6+5N6/?%A!4H?3YF8 %8V\:=ZV7ZN%RQ8T+QY\W2WQHT;?_'%
M%S$'  !  [7RC:Z.'3NV_"8V.<@//_RP?-,__O&/U!WN_XP>/3K58.46O[=E
M^UR@7&Q:6=OD- X<.+!7KU[KK;?>ZJNOWJ1)DW777?<'/_A!GSY];KCAAH\^
M^B@6++.)$R?>=MMMQQQSS';;;9?LJVG3I@4%!<D_DW_OT:-'\O5D:Y*)9<O-
MO'GSA@T;]LM?_K)[]^YMV[8M+BYNU*C1FFNNN=EFF^VSSS[GGW_^ P\\,'GR
MY%C64+SQQAN77GKI 0<<T+5KUY8M6S9NW+BHJ"CY]C?::*,]]MCCG'/.>?31
M1Y?Q(3&5>O[YY\\^^^Q==]VU;.&5G?,N7;KLN^^^%U]\\3OOO!,+:K:>ZT#X
MT*W,FV^^&7/YF#9M6KI;W%SGLE^=9&ULO/'&O7OW'CQX\,<??QP+ZLKGGW\^
M:-"@9)%TZ- AN6@DUZMV[=IML<46AQYZZ.VWWSYITJ18L+1FS)@Q?/CPY,=_
MO_WV2RX%R=5IM=562RX.R>Z2RV-RP3SWW'.?>.*)*O[4/"_I5[^>K(&Z5.L7
MX15U60, :& 6+5H4WZ=F,LG[\)C+(5UU]=57Q\U+O/KJJ^69Y-U:W+Q$>G;S
MZ*./CILK^MWO?E<>SM3Y^VIWB^X6W2W6+G>+B2NNN"*L@8,//CB&ZEPXI,S*
ML#(;S'*JM]?AAJ$!KY.Z_^P]69.AX>677QY#    -% KW^CJ&6><47X'V[-G
MS_2F^?/GMVK5*G6'^U^GG')*.E9SL5&66%"96),E%E04TTNEVK]A'PLJ'M5+
M+[VT\\X[QT1%!04%AQ]^>'J2>*F5EI8^\, #N^ZZ:[((XVZR)/M-DDD^=JE.
M;)0E'9X[=^XEEUS2LF7+&*I,>57<D"6UAYQB32V)N\EMX<*%M]QRRV:;;19;
M5&:MM=8Z[;33:F6>.%D&=]UUUZ:;;AKWD667779Y[KGGTK4QD<_W6XLZ=.@0
MCR.3N>JJJV)N>8J[SQ(+:J:&KT[R([S__ON__?;;Z=H8RI(.+T7)].G33S[Y
MY$:-&L502N/&C9/_+TR9,B5=F)=ITZ9=>^VUO7J'!?\C   X_TE$053U*BHJ
MBMTKTZQ9L^1_7DOQHQ$;+97POX"X.4LZG$NLR1(+LL2"+.GPTEV$<UE1ES4
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M0C,$FS7;K6"HHUB,L M)3T_'!B&.'#F"=<H.'3J$<4)D9F9BG1ELL]MX!W
MEX;HW;LWY@K1J%$CW5\?FAX.=]6J50M']3+]7K.C1X]BG3+,<FE71][>O7N'
M#1M6J5(E?#Z23ITZ89LU;%;8,^X>'=.KD%AD!_OU$SRAA2Q9LL3T?G%G,#TH
M;-9L-X6)CC(Q0C\$^_43 D5Q6B,B(B)*/(6%A7?==9?\7NBJJZ[B)UI%"U>+
MIK!?/\$36@A7BX$P0C\$^_43 B78:I&?NJH.M\:-[8GBZ11K\S V:[;[8(1^
M"/9'(R%0PIPGGO#LGQ _=96(B(B(B(CB5TS?NKILV3)YF>K_8 PM<HALT:)%
M6&H'(QRMR3%",P2;-=NM8*BC6(RP"S']C)!0_H*YH*  XX1(24G!.C/89K?Q
M#N  ;@SQ]MMO8Z@0Y<J5V[1I$Y;:,3T<[CKWW'-Q5"_3H4,Y$S#+C5T=1;FY
MN4\^^61:6AH^*R]CKMZR90OV6,!FA3T3@T<'^_43/"&$//744]@9&AP@*&S6
M;#>%B8XR,4(_!/OU$P*9GKWNLIK6B(B(B!+,V;-GX<\F6[5JQ?M6HXZK18#]
M^@F>$$*X6C2%$?HAV*^?$,CT['57)%>+IO>EA?+#Z(>A^CL?^_43W(5;X\;V
M1/%T,ATZE$./69K[!YLUVWTP0C\$^Z.1$,CT8+DK7LX34Z=.G<)0(=+3T[&.
MB(B(B(B($DY,W[IJ^H&I;NG6K1N.9P<C'*W),4(S!)LUVZU@J*-8C+ +,?U(
M@(*" JQ39GJ!(S4U%>O,8)O=QCN  X0\Q*9-F\J5*X>A0LR8,0-+%9A>PW*7
MU;$P'3K6+I]%W<J5*ZM4J8)/S&O<N'%8;0$[%?9,#!X=[-=/\#@-&3QX,+9Y
MI:6E&:\I;[WUU@\__'#PX,'\_'SL+(:=:N/Z8;-FNRE,=)2)$?HAV*^?$,CT
M['67U;1&1$1$E$B*BHKZ]>LGOPMJW;HU[UN-'5PM^F&_?H+':0A7BU8P0C\$
M^_43 IF>O>Z*Y&HQ*RL+AQ?BQ(D36*</0_5W/O;K)[@+M\:-[8GBZ60Z=!3G
M86S6;/?!"/T0[(]&0B#3@^6N>#E/3.7FYF*H$!4K5L0Z(B(B(B(B2CBQ>^OJ
MD2-'2I<NC:M5]Q@K^8,'#^*H06&$HS4Y1FB&8+-FNQ4,=12+$78A&1D9V"#$
MX<.'L4[9H4.',$Z(S,Q,K#.#;78;[P .$-H0)T^>;-2H$28*T:=/'RQ58_JE
M186%A5@7!J8WX!HS -:I"?W+K6+6EU]^F924A,]-B"Y=NF"I!>Q4V#/N'AV/
MHVT V*^?X'$4LGCQ8NSQZMJUZ_[]^[': C8KC"O#9LUV4YCH*!,C]$.P7S\A
M4!2G-2(B(J)$,F#  /D-%>];C4%<+?I@OWZ"QU$(5XM!8(1^"/;K)P1*L-5B
MW;IU\<D(X>SKRP"&ZN]\[-=/<!=NC1O;$\73*=;F86S6;/?!"/T0[(]&0J"$
M.4_"=.W]X,&#&"I$_?KUL8Z(B(B(B(@23NS>NCIQXD1<JKKMA1=>P%&#PG[]
M-7GH"WMLUFRW@J&.8C'"+J1&C1K8(,2>/7NP3MGNW;LQ3HA:M6IAG1ELL]MX
M!W" T(;X\Y__C'%"7'+))7EY>5BJIGKUZA@GQ-&C1[$N#*I5JX8#"_'33S]A
MG1K3/]'&HKAUVVVWX7,3HEZ]>EAG 3L5]HR[1R<_/Q^S%+8!8+]^@D<_Y/3I
MT[5KU\8>(?KV[6M,[%AM#?OMQ@78K-EN"A/U,T-_:?.XL1F!HCBM$1$1$26,
M@0,'RN^FVK1IP_M68Q-7BQY'SR(01MB%<+48!%>+D=&B10M\,D+LWKT;Z_1A
MJ/[.QW[]!'?AUKBQ/5$\G6)M'L9FS79/S$P:V*^?$"AASI,P77O?N7,GA@K1
MLF5+K",B(B(B(J*$$[NWKC9IT@27JF[3_:M-[-=?DQ\_?APC-$.P6;/="H8Z
MBL4(NY#6K5MC@Q#KUJW#.F5KUZ[%."&NOOIJK#.#;78;[P .$,(0LV;-PBPA
MRI0ILW[]>BQ5UJI5*TP48N_>O5@7!J97V+.SL[%.S?[]^S$KA%T=:V;/GHW/
M38BLK"RLLX"="GO&W:-C^@?T6&0'^_43//HAGWWV&38(4:U:M2#?]F@*(^S&
M!=BLV6X*$_4S0W]I\[BQ&8&B.*T1$1$1)8;APX?+;Z7:M&F3FYN+110;N%KT
M.'H6@3#"+H2KQ2"X6HR,6V^]%9^,$*%<)/3#4/V=C_WZ">["K7%C>Z)X.L7:
M/(S-FNV>F)DTL%\_(5#"G"=ANO9N^IN=SIT[8QT1$1$1$1$EG!B]=77%BA7^
M!6I*2LJ! P>P0I/55W=]\<476&H-F_6_TF7?OGT8H;FPQV;-=BL8ZB@6(^Q"
M^O;MBPU"S)DS!^N4??#!!Q@GQ'WWW8=U9K#-;N,=P &<#K%UZ]:,C S,$F+Z
M].E8JJ-/GSZ8*,2:-6NP+@QZ].B! POQSW_^$^O4;-JT";.<[NK0&1-I<G)R
M:FIJ6EJ:XP_$E>W:M0N?FW>2Q#H+V*FP9]P].MNW;\<LA6T V*^?X-$/,682
M;!!B].C16&<'(^S&!=BLV6X*$Z/QTN8QVPRLT!?%:8V(B(@H 8P:-4I^'W7U
MU5?SOE47<;4(N%K$"+MQ 39KMIO"1*X68]7##S^,3T:(9<N689T^#-7?^=BO
MG^ NW!HWMB>*IU.LS</8'+>3!O;K)P1*F/,D3-?>ERY=BJ%"//+((UA'1$1$
M1$1$"2=&;UV5OPR]2Y<N^+"^HJ*B6K5J_;'J+7;//?=@J;6DI"1HU_VUS;IU
MZR!!:"[LL5FSW0J&.HK%"+N029,F88,0?__[W[%.V<B1(S%.B"E3IF"=&6RS
MVW@'< !'0YPZ=>JRRR[#("%Z].B!I9HF3)B H4*\^^Z[6!<&SS__/ [LZ-<\
M/A]]]!%F.=K5KI"W8=NV;?BPOKR\/#G3ITR9,EAG 3L5]HR[1V?)DB68I; -
M /OU$SSZ(:8_=ZM6K<(Z.QAA-R[ 9LUV4['PTN8)SU.+XK1&1$1$%._&CATK
MOXGB?:NNDW<O5XL>KA;UQP78K-ENBJO%>/'BBR_BDQ%BWKQY6*</0_5W/O;K
M)[@+M\:-[8GBZ11K\W#"3!K8KY\0*&'.DS!=>Y\S9PZ&"O'22R]A'1$1$1$1
M$26<6+QU-3<W-ST]W;] 7;!@ 58X\LPSSTC+WM^EI:4=/GP82RUD9F9"^[Y]
M^[ HJ/?>>P\2A.;"'ILUVZU@J*-8C+ +R<[.QH;0[E2^[;;;,$Z(C1LW8IT9
M;+/;> =P $=#//300Y@B1+UZ]7)R<K!4D^F7\@P:- CKPN#++[_$@35O*Y?!
M)P/Y8%&DR-O@RL==G#AQ0L[TJ5*E"M99P$Z%/>/NT3'];0H6V<%^_02/?HBQ
MD[%!B$.'#F&='8RP&Q=@LV:[J5AX:?.$YZE%<5HC(B(BBFL3)TZ4WT'IWK<J
M]^)C5$S>2UPM>KA:U!\78+-FNRFN%N/%IY]^BD]&"&,FQSI]&*J_\[%?/\%=
MN#5N;$\43Z=8FX<39M+ ?OV$0 ESGH3IVOO++[^,H4(L7+@0ZXB(B(B(B"CA
MQ.*MJ].G3_>O3JM5JZ;[M3)6]NW;EYR<+*U\?_?**Z]@J05C8Z!7]T,4A@P9
M @E"<V&/S9KM5C#442Q&*(34KET;6LJ5*W?RY$FL4V!T&;V09N1CG05H% H;
MKPL'T!]B[MRY&.&]_7KUZM58:D%NQ,<\GNK5J\L%AE:M6F&1LHT;-\I1#1HT
MP(IB!04%\MWJ/A4K5G3VLW_KK;="E#![LI$A;\,SSSR##^O;N7.GG.G3LF5+
MK+. G0I[QMVC8_H%55AD!_OU$SSZ(:FIJ=@@Q.G3I[$NJ)R<'(RP&Q=@LV:[
MJ5AX:?.$YZEYHC>M$1$1$<6OUUY[[9QSSO&_YVG;MJW6?:L>NX4G^<A[B:M%
M#U>+7"U:PW[]!%.)M%K<OW^_/+K/X,&#L4X?ANKO?.S73W 7;HU+VQ.MTRG6
MYN&$F32P7S_!5&*<)V&Z]O[XXX]CJ! '#AS .B(B(B(B(DHXL7CK:HL6+?RK
MTY$C1^+#(3!=5S=LV!#K+#1JU AZY\R9@T5!-6W:%!*$YL*^5*E2T.[L$@.
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MWXU%FB!0Z.]\[-=/<!=NC=O;$ZW3*7;FX<28-+!?/R&X^#I/(G#M_?;;;X?
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7"/E_=4\<U/U%)FX     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>90
<FILENAME>image_343.jpg
<TEXT>
begin 644 image_343.jpg
MB5!.1PT*&@H    -24A$4@  #DX   ,)" (   !P"[P%  "  $E$051X7NS=
M:9C<99DN\$JG.TLG84N@DZBL$M9,6$?@''$=&)8,,H(( H)LHH0 LLAV#D?E
M7 JBB( 0D2B'50-!',255110640$$A)9%1+(UMF7YM143VK>?JK^U56=[DI%
M?K\/7NEZG_M^_^GJXL-<SW1R_0            "@D;R]6BZ>
M ,!:%5==BU\#            0/U9=04           "@05EU!0
M *!!674%            H$%9=04           "@05EU!0           *!!
M674%            H$%9=04           "@05EU!0           *!!674%
M            H$%9=04           "@05EU!0           *!!674%
M        H$%9=04           "@0376JFNN]\1J*(@_*+VAN;EY^/#A6VZY
MY2Z[[++??ON=?_[Y4Z=.?>655^+=            0(VLNO+.$G]0^M)..^UT
MQ157O/766_$A            @.I8=>6=)?Z@]+V! P=.F#!A_OSY\5$
M      " [EAUY9TE_J#4R^C1HZ=,F1*?!@           *BHL59=2\6%P0PQ
M!E6+/TP9TLC<N7.G3Y\^9<J4SW[VLQMNN&$<S39QXL15JU:E50
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MKOT!MMQRRU6K5L7+:O3XXX_'WBJD#?&L+Z7W5GEU/3^,\=4ZZOK@
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MXL QQQP33I-T>6&^@ICLJ=A;A0KQ!OPPIFUEQ4"-\C\#6=NNQQUWW/+ERV,
M          !81UAU+6/0H$'Q@A(K5JR(L>HL7[X\=I5H;6V-L1)77WUU<?[L
ML\^.QV^_O7+ERO>\YSU):QF3)T^.L>ZD\7CV]MO3IDVK9E%XFVVVR5H 3<?B
M6=](;^R9YN;F_-]ZBRVVV'GGG??;;[_SSS]_ZM2IK[[Z:KRI1FOK+0[VWW__
M6)IM[-BQ^:>*%=5)>\+1HX\^FIZ6NNZZZT+DN...*YX^_OCCX32)EA?F*XC)
MGHJ]5:@<;[0/8]I65@STR,]^]K.##CJHK:VMI:5EY,B1'__XQW_]ZU_'(0
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MD_G/9EM;6^>+FVVV6=FM]*[1,F(@6TR6B(%$E6-9JHPWR(<Q;2LK!@
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M#/2>GMVRMCZ,:5M9,= C#SSPP*&''CIRY,@! P:,'CWZL,,.>_CAA^,0
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M!@\>_/+++\?,:GOLL4?G6%-3TXLOOAB/JW#666=UO3#:>^^]8Z9$.A_/JO#
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MN>^^^S[^\8^WM;6UM+3D_PM\Z*&'/O300W$(          !8IUAU!0
M     *!!674%            H$%9=04           "@05EU!0
M *!!674%            H$%9=04           "@05EU!0           *!!
M674%            H$%9=04           "@05EU!0           *!!674%
M            H$%9=04           "@05EU!0           *!!674%
M        H$%9=04           "@05EU!0           *!!674%
M    H$%9=04           "@05EU!0           *!!674%
MH$%9=04           "@05EU!0           *!!674%            H$%9
M=04           "@05EU!0           *!!674%            H$%9=04
M          "@05EU!0           *!!674%            H$%9=04
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MYX\\\LB6EI9X<2T..." AQ]^.%;7(C9FR%_4T=$1PS6*I=V)^=7B7+W$YP
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MB!?D<N/&C5NV;%D<K4):\N*++X:?EJ+##CLL)FN7%L:S6J0]17&H1WJ]$
M  #JR:HK     -#GMMIJJW39KM/KK[\>YVIQ^.&'IVWQN#II0U$<JKOX0 5Q
MJ K///-,;"G8=MMMXVA%M]UV6ZS(Y4:-&K5X\>(XN@86+ERXR2:;Q&MRN4LO
MO32.5B%MR']YYYUWIJ^DKKGFFABN4=H6SVJ1]A3%H1[I]4(     J">KK@
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MM:]]+5Y9<,,--\31;&DPGE7AV&./31N*1HP8\=IKKX7A=" <U23M*8I#
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M^\<K<[G/?_[S<;2B-!O/JC9Y\N2TIZBIJ>E7O_I5<2P]2M(U2WN*XA
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MGS^_M;4U7I;+39HT*8YV)XW'LQH]_?33^9^KM+#HRU_^\MN]=U?:4Q2'
M ."=QZHK     % /Z?;>_???'X]KMVC1HK2S4UM;6YRK*.8+XE#=Q0<JB$.U
MN/ONNV-=P5Y[[15'2RQ>O/@][WE/3.9RW_[VM^/H&OOF-[\9K\GEMMABBZ5+
ME\;1[J0-\:QVUUUW75I8U+]__P<>>"!])29KD?84Q2$     >.>QZ@H
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M>."!_OW[A_[1HT?/GCT[CE8G[8EG/?744T\-&C0H;2X5,[6(705QJ*?ZHA,
M    ZL.J*P    !0#^FF7=Y!!QT4)VHQ8\:,P8,'A\[6UM;V]O8X6E%HZ!2'
MZBX^4$$<JLZL6;,VWWSSV%5P^NFGQ^F*[KWWWI:6EE"RR2:;O/#""W&T1M.G
M3Q\Q8D1H'CAPX(,//AA'JY96Q;,U<.VUUZ;-I6*@%K&K( [U5,\ZTU2G8<.&
MQ2$     Z&-670$   " >H@;<[G<99==%H>JLW3IT@]_^,.Q+I<[]=13XVAW
M8D5!'*J[^$ %<:@*?__[W_?88X]85+#QQAO/FC4K!KIS\\TW]^O7+U2-'CUZ
M37Y'[U-//35RY,C0V=34-&7*E#A:B[0MGJV9PP\_/"T/XG0M8E=!'.JI'G2N
M7+DR374:,V9,G ,   " /F;5%0    "HA[@QE_O/_SODI9=>VM'1$4<KFC=O
MWK[[[AN[<KGAPX>_\<8;<;H[L:4@#M5=?*"".%31DB5+KK_^^M)?E=JIJ:GI
M)S_Y2<Q4YYIKKLG'0V%K:^MWOO.=6M_*_/S55U^=SX:V_OW[3YX\.4[7*"V,
M9VMFP8(%6V^]==J?BM.UB%T%<:BG>M Y?_[\--7I0Q_Z4)P#    @#YFU14
M    J(>X,;?:!S[P@?OOOS].E[-DR9+KKKNNK:TM5A2V9J=.G1H#58A%!7&H
M[N(#%<2A1$='Q_SY\U]^^>7''GOLVFNO/>ZXXS;<<,.87ZU___[Y;V.LJ,64
M*5,&#1H4>W.Y<>/&_>A'/UJ^?'D,E,C/Y"?S\[$BEQL\>/!==]T5 [5+.^/9
M&GOBB2<&#AR87E$41VL1NPKB4$_UH#/_$Y6F.IUVVFEQ#@    #ZF%57
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MM;6U]>&''XYS     %!'5ET!     ("WGWGFF2VWW#+=<QT\>/#/?_[S. <
M    ]675%0      >'N__?9+]UQ'C1KUV&./Q2$     J#NKK@      P-L+
M%BS88X\].O=</_"!#[SZZJMQ @    #6!JNN      # ?YHW;]X'/_C!*ZZX
MHJ.C(YX!    P%IBU14           " !F75%0           ( &9=45
M        @ 9EU14           " !F75%0           ( &9=45
M    @ 9EU14           " !F75%0           ( &9=45
M@ 9EU14           " !F75%0           ( &9=45            @ 9E
MU14           " !F75%0#^/WMW'EYG6>8/_) V:;K04@NT[&5'6<J.I: @
MRW@!@@XS((M@<4$&4%00AJV R# HB&RRX^"@" AZE1%$5D%9A);*)E*!(O17
MA+:4IFE3VO1WS&D/;^^3DYSW9#EOVL_G#R[,^[WOYSGID^AY>IL
M   99=05            @(PRZ@H           ! 1AEU!0           ""C
MC+H"            D%%&70$           #(**.N             &2445<
M            ,LJH*P      F39SYLR[[[[[S#///.200W;:::>UUUY[V+!A
M]?7UC8V-(T>.W&RSS7;<<<?]]MOOV]_^]@TWW/#XXX_/F3,GM@      ^BRC
MK@      O2=7K=BH30RU9]UUUWWWW7=C97JQ;V=B?7IOO_WVI9=>.F[<N%56
M625V[\SFFV]^S#''_,___,_TZ=-C7P    "@3S'J"@    #0>^)(9L5BHS8Q
M5,;^^^_?VMH:BU.*33L3Z].8.G7JL<<>V]C8&)M69>NMMS[CC#.>?OKIN P
M    T!<8=04     Z#UQ#+-BL5&;&"KO!S_X02Q.*7;L3*ROS+QY\TX__?2&
MAH;8KCN,'CWZM--.^_.?_QQ7!0     RS*@K     $#OB=.7%8N-VL10>?7U
M]4\\\42L3R-V[$RLK\#DR9,WV623V*C-ZJNO?N211UY__?5_^,,?ID^?WM34
MM&C1HMFS9[_^^NOYJO_]W__]]K>_/6[<N%566256MB<N#     !DF%%7
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MK,(FK[SRRJJKKIH,%QUWW'$Q74:R*CXK;YMMMDD6%KWZZJLQ"@    !@U!4
M    H+;BR&>;&*I8Y4UNO?769#CI]MMOC^GV)$OBL_)&C1J5+"R:/7MVC (
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MK3CRV2:&*E9=DR]_^<O)PJ+APX=/FS8MII=))N.S\D:-&I4L+'KOO?=B%
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MW713LD]175W=_???7XPE'R6J._?5KWXU65O0KU^_.7/FQ"@     L-(SZ@H
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MF[&X6N^___[))Y^\_OKKYQ<:/7KT&6><8<X5     &K"J"L
M&674%0           (",,NH*            0$89=04            @HXRZ
M @           )!11ET!            R"BCK@            !DE%%7
M         #+*J"L             &674%0           (",,NH*
M    0$89=04            @HXRZ @           )!11ET!
MR"BCK@            !DE%%7             #+*J"L             &674
M%0           (",,NH*            0$89=04            @HXRZ @
M         )!11ET!            R"BCK@            !DE%%7
M     #+*J"L             &674%0           (",,NH*
M0$89=04            @HXRZ @           )!11ET!            R"BC
MK@            !DE%%7             #+*J"L             &674%0
M         (",,NH*            0$89=04            @HXRZ @
M     )!11ET!            R"BCK@            !DE%%7
M #+*J"L             &674%0           (",,NH*            0$89
M=04            @HXRZ @           )!11ET!            R"BCK@
M          !DE%%7             #+*J"L             &674%0
M     (",,NH*            0$89=04            @HXRZ @
M )!11ET!            R"BCK@            !DE%%7             #+*
MJ"L             &674%0           (",,NH*            0$89=04
M           @HXRZ @           )!11ET!            R"BCK@
M      !DE%%7             #+*J"L             &674%0
M (",,NH*            0$89=04            @HXRZ @           )!1
M1ET!            R"BCK@            !D5+9&77.U$[<"9<R<.7/ @ ')
MP]/0T/#..^_$'% +"Q8L"%^A^^^_?PPEC!LW+AGNW[__W+ES8P@  & ED'QS
M5$-Q6RL?5T\      *6,NBX5MP)E7'KII?'TY'(77WQQS &U\/###X<OSXLN
MNBB&EFEN;FYH:$B&QXX=&T,    KA^2;HQJ*VUKYN'H"     "AEU'6IN!4H
M8ZNMMHJG)Y?;8HLM8@ZHA7/..2=\>3[QQ!,QM,S]]]\?PO_YG_\90P   "N'
M\/ZH5N*V5CZNG@      2AEU72IN!=KSQS_^,1Z=91Y]]-&8ACXEGNF^^8UQ
MSSWW3+Z$P8,'?_#!!S&TS%EGG94,Y]UWWWTQ!   L'(([X]J)6YK)>/JB158
M/-,K_=<[     *ED:]2U5+S]:A-#U>J)GJS8QH\?GSPV24<==51,0Y\2SW0?
M_,;8TM(R<.# Y$O89Y]]8BAA]]UW3X;KZ^OGS9L70P   "N'Y/NC^*Q#R<*B
M&.I0U84K'E=/K,#BF5[IO]X!    2,6H:S?W9 7V_OOO#QX\.'ELD@8.'#A[
M]NQ8 WU'/--]\!OC[W__^_ 2SC___!A:9O[\^0,&#$B&QXT;%T,    KC>3[
MH_BL0\G"HACJ4-6%*QA73ZS8XIE>N;_> 0   $C+J&LW]V0%=O755R?/3*DK
MKK@BUD#?$0]T'_S&>-YYYX67T,&O=WSPP0=#^,PSSXPA  " E4;R_5%\UJ%D
M85$,=:CJPA6,JR=6;/% K]Q?[P    "D9=2UFWNR MMAAQV*!Z:^OCYQ?)8:
M,V9,K(&^(Q[H/OB-<:^]]DKNO[&QL:6E)8:6F3!A0C*<=__]]\<0  # 2B/Y
M_B@^ZU"RL"B&.E1UX0K&U1,KMGB@5^ZO=P    #2,NK:S3U944V:-*EX6NKJ
MZBZ]]-+$\?G04T\]%2NACXBGN:]]8URX<.&@08.2^]]CCSUB*"'_-!EN:&AH
M;FZ.(0  @)5&\BU2?-:A9&%1#'6HZL(5B:LG5GCQ-*_$7^\     5,&H:S?W
M9$5UW'''%4_+?OOMMW#API$C1R9.T%)?^<I78B7T$?$T][5OC(\]]EC8_]EG
MGQU#RRQ8L*"QL3$9WGWWW6,(  !@99)\BQ2?=2A96!1#':JZ<$7BZHD57CS-
M*_'7.P    !5,.K:S3U9(34W-P\;-JQX6NZZZZ[\!T\]]=3$"5IJR) A<^?.
MC?70%\33W->^,7[O>]\+^W_@@0=B:)E''GDDA#N8BP4  %@9)-\BQ6<=2A86
MQ5"'JBY<8;AZ8F403_/*^O4.    0'56ZE%7J-!/?O*3XO$;-6K4!Q]\D/_@
M*Z^\DO\R^?!<+G/===?%>N@+XE'N:]]L]]EGG^3FZ^OKY\V;%T/+G'ONN<EP
MWH,//AA#    *Y/D6Z3XK$/)PJ(8ZE#5A2L,5T^L#.)17EF_W@$   "HCE%7
MZ-RX<>.*Q^\___,_BQ_?<\\]$P=SJ9UWWCE1"GU&/,I]ZIOM!Q]\,'CPX.3F
M=]UUUQA*^-2G/I4,#Q@P8/[\^3$$  ! !9)OKXIBB ZY>F)E$(^R;Q0
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M# $  %"Q\":K((:ZH.;W!CW'U5-!3R]:\R,4RG,5[+E4;)&^2:QW]00   !
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M=PP!  "01O)-5E$,52L+]P8]Q-53KE<6S<(1BI6=[;E=L47Z)K&^C:LG
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M,00  $ :R?=913%4E8S<&_0$5T^Y7EDT(T<H5.4ZW',YL47Z)K'>U1,
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MJ\EPWM2I4V,(  " JH0W7 4QE%YV[@VZA:NGN&3/+YJ=(Q1K7#VEKP4
MHZZ5BIOHCFU<?OGEL6DN-V'"A)BKV-EGGQW;Y7)77GEES+4GEJ5_@;&^%AVJ
M]N4O?[FXZ$$''10?I]?:VCIZ].@/7\DRAQ]^>(PNK]U?9O>][WTOYKI531;-
MSOFOJZL+57/GSHVA#DV9,B5TR*4_O;$^?8<E76L2*]/4]K+9LV>'/[6.OVPW
MVVRS9'B===:)"0   *J5?,-5%$/I9>?>H%NX>HI+]ORBV3E"KIX*8F6:6@
M   PZEJIN(GNV,9SSST7FW;MLONSG_UL;)?+O?#""S'7GEB6_@7&^EITJ,[<
MN7.'#!E27/3NN^^.B:I\][O?3;R4I08,&#!SYLP836CWYOJPPPZ+N6Y5DT6S
M<_Z'#AT:JMY\\\T8ZM MM]P2.N32G]Y8G[[#DJXUB95I:GO9Q(D3PU9_^,,?
MQM RTZ=/#^%._]H/  " RH7W7 4QE%YV[@VZSM5331;-SA%R]500*]/4 @
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MG78Z\<03[[GG'C.C    U%8-[PU6;#6Y!:K)HC4\0JZ>7#T!    D)915P
M           RRJ@K             !EEU!4           " C#+J"@
M     $!&&74%@(KD  " %4[\W_T K+CB?P<   !TG_@.!(#N9M05 "H2WZP
M  !]7_S?_0"LN.)_!P   '2?^ X$@.YFU!4 *A+?K    'U?_-_] *RXXG\'
M    =)_X#@2 [F;4%0           (",,NH*            0$89=04
M       @HXRZ @           )!11ET!            R"BCK@
M  !DE%%7             #+*J"L             &674%0           (",
M,NH*            0$89=04            @HXRZ @           )!11ET!
M            R"BCK@            !DE%%7             #+*J"L
M        &674%0           (",,NH*            0$89=04
MX/^S=]_Q5=39_\?'5" A]*6+BBB"(HJ@B*@4L0&*K 547!1=>>CN6M8""K@6
MD%40L&'WH6O']H-=L*#8$>D(+-(14)2B$" )(?<WWWO)W<G[ELS<.D->SS]\
M8/(^9V9NYI-P3S[<"P  X%)L=04                  (!+L=45
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M$\7\ =JA0X=APX;-F3-'CP=$U:]?/[V?#*-___Z:.WA-F#!!K]\PQHT;ISD
M*3=KUBQ9F__\YS\U5&[/GCTY.3G6<.?.G354&?,GN+7#22>=M&'#!@T!
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MWWS3^EN<@H("\WN%A@    #G4CQ*TD: #8Q*<!#3>]I3WR?3-23Q,2<!  !
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MT.>??R[G?__]]VNHW-Z]>W-S<ZWA+EVZ:,BAX<.'6QL>>NBA/__\LX8
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M?8R4/]=++$8E0<D^:!I7C2_<?:L)&[2%\R9:G_+EH_7.+R&QO#LD\3$G 0
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MJ(QT,%+^7"\A&)6DYJ#N635:$]-W#&WAO(G6IWSY2*WA_!)2QN5#$A]S$@
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M;EKOO(,O04UBP*@DQ0=-[ZJQTAKGMQRCD@32DTBY^(<D/N8D    J$K8Z@H
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MUT0KG=2FV/'''V\]SSIUZD1Y6:;KKKO.&C;B^-'@R,R9,^6XIK_\Y2^: P
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ME 0 . @P)P$  $#5Q%97 ("'E965]>K5RSK0.?'$$_?MVZ<YQ,WZ( =H @"
MY#!_LK=KU\[Z,ZA'CQZ\I@L   !BP"@) .!US$D   !09;'5%0#@;5NV;&G1
MHH5UK#-BQ @-(6[61SA $P  ),?PX<.M/X":-V_^TT\_:0@   "PAU$2 ,#3
MF),   "@RF*K*P# \Y8L65)04& =[CSSS#,:0GRL#V^ )@  2(+)DR=;?_K4
MK%ESX<*%&@(   "<8)0$ / HYB0   "HRMCJ"@ X&,R>/;M6K5K!^4YF9N;;
M;[^M(<3!,CT[0!,  "3:6V^]9?Y,#_[HJ5FSYM=??ZTA    P#E&20  SV%.
M @  @"J.K:X @(/$W+ES&S=N')SR9&1DW'___65E99I#3((/;) F  !('/,G
MN/ESW/QI'ORYTZA1HSESYF@.    B!6C) " 5S G 0   'QL=04 '$Q^_/''
MCAT[!F<]I@LOO%!#B(GU40W0!   B7/!!1=8?^ATZ-!APX8-&@(   #BPR@)
M . )S$D     'UM= 0 'F9*2DN'#AUO?Q$<3B(EEC,8#"P!(NN"/&_-G^IUW
MWFG^?-<$    D B,D@  [L><!    /"QU14 <%!:M&C1&6><P>\G$B@X2@O2
M!   B1/X66/^-%^X<*%^#@   $@T1DD  #=C3@(   #XV.H* #B(S9@QHVO7
MKOI1V!.8G=FG]0  Q.&TTTZ;/GVZ?A0   !()D9)  !W8DX"    ^-CJ"@
MPM*MK)71>@               " 1V.H*  #"T*VLE=%Z
M(!'8Z@H  ,+0K:R5T7H                @$=CJ"@
M )=BJRL                   !<BJVN                    <"FVN@(
M                 ,"EV.H*                    EV*K*P
M         %R*K:X                   !P*;:Z @
MP*78Z@H                   "78JLK                    7(JMK@
M                 ' IMKH"                  # I=CJ"@
M         )=BJRL                   !<BJVN
M<"FVN@(                  ,"EV.H*                    EV*K*P
M                 %R*K:X                   !P*;:Z @
M        P*78Z@H                   "78JLK
M7(JMK@                   ' IMKH"                  # I=CJ"@
M                 )=BJRL                   !<BJVN
M        <"FVN@(                  ,"EV.H*
MEV*K*P                   %R*K:X                   !P*;:Z @
M                P*78Z@H                   "78JLK
M        7(JMK@                   ' IMKH"                  #
MI=CJ"@                   )=BJRL                   !<BJVN
M                <"FVN@(                  ,"EV.H*
M        EV*K*P                   %R*K:X                   !P
M*;:Z @                  P*78Z@H                   "78JLK
M                7(JMK@                   ' IMKH"
M      # I=CJ"@                   )=BJRL                   !<
MBJVN                    <"FVN@(                  ,"EV.H*
M                EV*K*P                   %R*K:X
M      !P*;:Z @                  P*78Z@I4+49EM,!-O'*>      "@
M:K+.+L+2 @" $WQ'!0    "@RF*K:_JM6K7JHHLN*B@HJ%FSIOF'U:M7:P(1
M\-#%P#H*#$L+W,0KYPD      *HFZ^PB+"V(PZVWWFKMW+IU:TT P$''^GU/
M/P<       YJ[MKJ:AU2Q*.@H*!%BQ;MV[?OTZ?/ P\\\,DGGQ06%NK!W&'5
MJE7UZM6SGGR#!@W6K%FC.83@H8N-]1$+2PO<Q"OG"0      JB;K["(L+8C#
MD4<>:>U\QQUW: (V6!]#1[01@)1@&0(     4&4=G%M=0^7EY5U__?7??_^]
M'C+=^O7KI^=J&/W[]]<<0O#0Q48?LA!:X"9>.4\      % U66<786E!K)8N
M72J=O_[Z:PW!!GD8[=-& %*"90@     0)555;:Z!EUZZ:7;MFW3 Z=/S9HU
M]13]KTJK.83@H4L(?03=/1_TRGD"      #XDCEX&3UZM+5MPX8-]^_?KR'8
M8'T8'=%& %*"90@     0)55Y;:ZFAHW;OS!!Q_HL=,D+R]/S\\P\O/S-8<0
M/'0)H8^@N^>#7CE/        7S('+R>??+*U[9 A0S0!>ZP/HR/:R)7TI#UR
MVD@JO2>\=E=X]\P!     $"<W+75-91U;!&D(8NBHJ)-FS9]]]UWCSSRR%EG
MG:65Y3(S,U]YY14M3H?>O7OKR1E&GSY]-(<0/'0)H8]@U/65=EXY3P
M %_2!B\__?33(8<<8FT[=>I4#2%6U@<V2$,>H9?AV0M! ND]X;6[PKMG#@
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MDT^RL[/E?+*RLH8,&?+QQQ]OW;K5^O'MV[=_]]UW$R=.[-&CA_7C0H\!
M  "0*CJGB'M2\<DGGTC#5:M6:0CQD4<X0$,>H9?AV0M! ND]X;*[@A$Q
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MX=C>3@DX.Z<I4Z;8[R1NOD)M]IGVZM7KG7?>.73HD#8R:%E4W-\546.)&
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MI-R*Z>U4*F>W;-DRJ3KOO/-R<W,UYV!GKKSR2JG54#!2XK(J 5@B!@
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M_])++^GAL.2G]FO4J''X\&$-16)V\--$0IQ]]MDZ#]]C0N2G]LVCYI\#
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M^^^EQ-:[=V_-Q9,.'XM+]]ACCVG(G3Y]^FBO:)]QZY*,=<XYYV@B$NE@>;^
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M0\T%HV6QN)U*]^P&#!B@:<LJ7[[\???=MV_?/DW'@@X6[5T1)RP1 P    "
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MK2RBE=XGK_7>.R22SC42^Q;]ZJNOM L       BKS"Q9:(M(36*^V*6](DU
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M*7G.SI-%BQ:=>>:9.F\7>]"U(!;7,)$BSIPE8@      RBJVND:FP\=A CJ
M]R&TWGN'0N]-EBQ9H@66U:M7+\W%DPX?:<Y.6F]9(T>.U) [/7OVU%Z6]=57
M7VFNL/"DDT[2G&5E9F9J+A)M$8O3UT0RB3C/H _634]/UQP       BFC"U9
M:(M(3;[\\DLM"/&)/6X\]MACVBO2! +NN.,.L^I7O_J5)L):MFR96>YW[;77
M:LZUZZZ[3MM9UHH5*S07C):YO@BE1:?KHR%WM$M4?;2%ER9:Z:76M'CQ8FUD
M6??==Y_FXD\G$>T9F9+G[+RRWYP;-VXL,V_>O+GFBI.\%8MKF$@19\X2,0
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M1[M$)0%G%W#PX$%[K!X]>M2J54M;A]:@08-[[[UWZ]:MVLZ%^-T5)<02,0
M    ""6YMKJBC%F[=NW8L6-[]^Y]P047U*E3IT*%"JFIJ?9OFC5KUJ5+EV'#
MAOW[W__.S\_7LL32];!@*Z$K5JP8/GSX-==<8\^\1HT:]EE4K%BQ08,&EUUV
MV0,//!"KQ;Z5*U>.'CVZ>_?NK5JUJE>OGGVYTM+2:M6J=?[YY]]RRRUOO/'&
M_OW[M:;LVK!APZ1)D_[ZU[_:E_W<<\]MV+!AI4J5S)?)?B'L/[_VVFOMEV#Z
M].GN=TL#      !/6++P^_KKK__RE[]<=MEE#1HTJ%BQ8FIJZ@DGG'#&&6=T
MZ]9MY,B1Z]>OUP*/_OG/?YI+'^7*E=NY<Z>&8F3[]NWCQX_OUZ_?11==9+^F
ME2I52DE)L7^U?V__B?WGK[[ZZK9MV[0,Q[)]^_:]^.*+??KT:=FR9=VZ==/3
MT^W;V'[%V[1I<]===TV?/KTDNP-7K5HU:M2H&V^\\=QSS[7?'.SF]A=([=JU
MFS1ITKY]^S_]Z4]OO_WV[MV[M>P8D<BSR\O+FS=OWLLOOVR_*!T[=FS>O'G]
M^O6K5*E2OGSY&C5JG'+**>><<T[/GCU'C!CQ^>>?EWQI/:YW1<FQ1 P
M $QL=<7QSEP:\],$D@8O$P      **OZ]^]O+GU<?/'%F@" XY[Y/JG'
M  ! F<965QSOS*4Q%LB2'"\3       HD_+S\T\\\41SZ6/X\.$: H#CGOD^
MJ<<      $"9QE97'._,I3$6R)(<+Q,      "B3YLZ=:ZY[V%:N7*DA #CN
MF>^3>@P      )1I;'7%\<Y<&F.!+,GQ,@$     @#+I_OOO-]<]FC5KI@D
M $O$       <Q]CJBN.=N33& EF2B^'+9+8"     !Q7]%M$( DT;][<O$O_
M_.<_:P( P!(Q    C@7Z5T\ 0(RPU17'._U+!W_M2&(Q?)G,5@    " XXI^
MBP@  (X1,?P?NMD*    B"']JR< ($;8ZHKCG?ZE@[]V)+$8ODQF*P    #
M<46_100  ,>(&/X/W6P%    Q)#^U1, $"-L=<7Q3O_2P5\[DA@O$P
M   <MU@B!@    #@N,565QSOS*4Q%LB2'"\3         !RW6"(&     ."X
MQ597''?,M3 WM!ZE9Z=!CP$         RC26B $     .&ZQU17''=W*&HG6
M P                " 1&&K*XX[NI4U$JT'                  ")PE97
M''=T*VLD6@\                  !*%K:X                   !(4FQU
M!0                  0))BJRL                   "2%%M= 0
M            D*38Z@H                  ( DQ597
M    )"FVN@(                  "!)L=45                    28JM
MK@                   $A2;'4%                  ! DF*K*P
M             )(46UT!                  "0I-CJ"@
M    @"3%5E<                    D*;:Z @                  ($FQ
MU14                   !)BJVN                    2%)L=04
M             $"28JLK                    DA1;70$
M     )"DV.H*                  " ),565P                   "0I
MMKH"                   @2;'5%0                   $F*K:X
M              !(4FQU!0                  0))BJRL
M      "2%%M= 0                  D*38Z@H                  ( D
MQ597                    )"FVN@(                  "!)L=45
M                28JMK@                   $A2;'4%
M      ! DF*K*P                   )(46UT!                  "0
MI-CJ"@                  @"3%5E<                    D*;:Z @
M                ($FQU14                   !)BJVN
M        2%)L=04                  $"28JLK
MDA1;70$                  )"DV.H*                  " ),565P
M                 "0IMKH"                   @2;'5%0
M         $F*K:X                   !(4FQU!0
M0))BJRL                   "2%%M= 0                  D*38Z@H
M                 ( DQ597                    )"FVN@(
M         "!)L=45                    28JMKL<I*Q(M )*8WKX.6@
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MMV_/RLK*S<W=O7OWFC5K_OG/?S[TT$._^M6OM*8X'2DT;L*R05]"+_<
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MFDB49<N6I:>GRV124E+>?OMMC8:6GY__R"./2!,_C8;&35@VF*^@GR8
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MQAEG2#<-H:R3&X![     $"RT6]:?#0424Y.SH477JA=?!YXX %-.VB-]PD
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M-@&6N1+VC7/ ,?HM6- ;:<.&#35JU# /!=Q\\\U&M3=F'SU6AA04%,R>/7O
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MU%-/U7E8UJA1HS073SJ\@Q:XX_+5L;^$K[ONNN7+EYNU&G(PPU&4[-FS9^#
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M)!VLHO5&^XOQE5=>T;2#/=PMM]RB+2RK3Y\^&@VFU+^"I-R*Z1(-      !
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M9(FL>^NMM^I07!)W[(]>-&U,J%,K[$LTGZ(GX4I\6HMHV[:M!,/<K^LH
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M#J69+L]IKH1>86E%0D<@M2KE)9BY [HMKD6+%M6K5\^,1PP;-DRG0\P9W1:
M&:_$$LW;/P UGXH&G8A+PXZS??MV'0IFY<J5VN4XK5JUTKE,>@1I+*$G$
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M3Q5IV#+N14L3JM4*OY(A0X9HP'%>>>45G0MLXL2)6N<X%UQP@<[%HC&_G4^
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M.G7JF,W1-!- M7F!K_D*;]!PR/CQXW7.3\Q/-YHZ=:K.[98ACR S%:83
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MK_D*;]"PX_3NW3O\+P\\\(!.1W$/>,Q/!QHX<*".QE+ICR S&Z83R>$\"0
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M+_ UGP$-NCE*9'+LV+&YN;FZV5NO7KW6KEUK+&6G8AY!&@Y&6P+C/ D
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M                @(%+70$ %>3>>^^52UVOO/)*'0(
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MJJM%BQ:3)T_6N?)V[MSY?__W?\V:-9/L 0<<4%!0H-,
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MT4=WZ-"A>?/F=>O6S<K*<O_I_GNW;MW./OOL.^ZXX\LOORPI*=$\
M          3#I:X                   #(4%SJ"@
M@ S%I:X                   #(4%SJ"@                  @ S%I:X
M                  #(4%SJ"@                  @ S%I:X
M          #(4%SJ"@                  @ S%I:X
M  #(4%SJ"@                  @ S%I:X                   #(4%SJ
M"@                  @ S%I:X                   #(4%SJ"@
M            @ S%I:X @$SG^-$                 @.J"2UTKW]*E2W__
M^]\W;-BP08,&[K\L6[9,)P!4"]=>>ZUY=6;'CAUU(L-DSK.3>=QBT@
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MDGKUZNG^.4[]^O5U+N/I]Y !5Y[I#GG+R<F9-FV:YFUHHQ_-HP8X\L@CS?O
M11==%/ZZ^<5*5'YG_RLESTZ:C[50 K0T1;4                 ,E!F7>H:
M3:]F"M$AP_;MV]>L63-]^O3[[[__Y)-/UN1NM6K5>N&%%S1<&<XXXPS=.<?I
MTZ>/SF4\_1[BWDR517?1T*Y=N\V;-VL@"6:Y;D/-\Y___,=]4C7O%6^]]59X
MD_G%\B$?9C!"A^**'TS)LY/F8RV4 "U-42T               " #%3=+G45
MLV?//NJHHS0?DI.3,W7J5 U4N 4+%C1JU,C<,?<_%RY<J',9S_P6PG0B ^@N
MEM>W;U\-),%LUFVH>1Y__''S+I&7EU=45!3>9'Z]?,B'&8S0H;CB!U/R[&3&
MPW0B(5J:HEH                 &:B:7^KJ*BXN/O?<<[4BI&7+EC___+,&
M*MS"A0O////,^O7KUZM7[XPSSK"]DBQ#Z,&UO)DJANYBE''CQFDF46:M;D/-
MT[MW;_,N85Y7;7[=2/@S@Q$Z%)=O,/EG)W.). O9TM(4U0(
M  #(0-7_4M>RT-6N1QQQA+:$#!\^7*>1$#VR]C=3!=!=C%*[=NV9,V=J+"%F
MK6Y##5-04)";FVO>)9Y]]MG(5O/K1LB?&8S0H;@2#@9G+I'"A;0T1;4
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M<^?.E26^^>8;'4J4-(?ID#UMC**!\G0Z(;[/#!KPVZLX*O<> @
M     ,!7#;K4=?7JU5H4TJ1)$YG4B2B1R84+%W;JU$DW>TM@"2\:B!*9_.:;
M;UJU:J6;/?SZU[^>.W>NL8XG32;$]X*VU#*7EDU77GFEN34B+R_/O95E. BS
M1+?Y<6^RP8,'UZE3QRP)J';MVG?==9<V^M&6*.&QTM+2X<.'NT\.NCF6G)R<
M\>/'EU^GK+"P<,"  3KJH6[=NN^\\XXT6/GDDT_VVV\_[?7C'OD[[[PS)7?.
M4:-&F<TM6K1PCZ$.)<ILCM A>]H810/EZ71"? ^^!OSVRDNEWT,
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M;R\//_RP6=6@08/BXF(=2H)9'J%#2=,%+)?0L&7<BY9:UF;(/00
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M9G^$#B5-%[!<0L.6<2]:&KBVTN\AA86%AQUVF,2[=>O&U:X
M  " EVI^J>N<.7...NHHS8?DY.0$?)](389<==55.A?+IDV;S)1NWLV<B3_I
M1?,A7W[YI<YYB_[<^<LOOUR'O$G6L?\6*D#PW9LX<:(Y;'KUU5=U.A8SHMO\
MF-D5*U;HYKB>>>89,^[Z^../=<B/-#BA:[O7K5NG<QX>?OAAS5LVW'___1(_
MYYQS="C*\N7+L[.S)3ADR!"=\S-Y\F0I<9\N5J]>K7-Q]>_?WVPXZ:23=")I
M9G^$#B5-%[!<0L.6<2]:&JPV$^XAPX</EVS8L&'#=!0               !
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MR-L''WP@<=MWYPU"E@C3H:3I I9+:-@R[D5+@]5FPCTD)R='@F'NUW44
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M625,AY*F"U@NH6'+N!<M#5";(?>0@H*";MVZ2;!+ER[Y^?DZ"@
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M9>S8L6:D4:-&";R_<D#F0A$ZE#1=P'()#5O&O6AI@-H,N8<
M    L,6EKOYT^33L@"Y@OX3F[1O*DBO1I$VVPB2Y>UNW;NW4J9-9$M&S9\^2
MDA)SV-QJ?MW7L&'#S&Q$;FYNOW[]GG[ZZ9DS9ZY?O[ZHJ$B3NVG2<@?*JF9#
M!5S(F).3HZM&.?'$$\W(@ $#=")US(4B="AINH#E$AJVC'O1T@"U&7(/ 0
M             &"+2UW]Z?)IV %=P'X)S=LWE"57HDF;;(5)?O<6+%B0EY=G
M]D3<<,,-YJ2YR?QZ?.^__[X9C.C;MV_T&\=ZT;#-#H1IOBHTQ/QX>KG^.-TV
M;=J4G9UM[L#$B1-U*'7,A2)T*&FZ@.42&K:,>]'2 +69< \!
M    D  N=?6GRZ=A!W0!^R4T;]]0EER))FVR%28EN_?,,\^8/1%965D???11
M9,S<9*3CV;%C1_OV[<U@V) A0TI+2W7:F^8#[T"$YJM"0^O6K37@.)LW;]:Y
M='KNN>?,U6O7KKUERQ8=2AUSK0@=2IHN8+F$ABWC7K0T0&TFW$,
M        )(!+7?WI\FG8 5W ?@G-VS>4)5>B29MLA4G5[@T:-,BLBFC>O/FZ
M=>O",^;7RZ<]O?/..V8JK%6K5D5%13H:EU8$WH$(S5>%AAX]>FC <5:M6J5S
MZ?2'/_S!7/W44T_5B90RUXK0H:3I I9+:-@R[D5+ ]1FPCT$
M    0 *XU-6?+I^&'= %[)?0O'U#67(EFK3)5IA4[5YA8>&!!QYHMD6<=-))
MNW;M*DMHK0LNN,!,A8T>/5KG_&A%X!V(T'Q5:!@\>+ &'&?V[-DZES;;MV]O
MT*"!N?HCCSRB0REEKA6A0TG3!2R7T+!EW(N6!JBM]'L(
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MGCU[%H>RD#RB*K$H3<RGB?FULGHS)#^M1(BO]]=N2! V>E<5_CR. @
M    159=2XB]E8DM9<5PFIC/HF$EHY)5]^[=BX&RZNOK/WSX$%NR$\]+$_.;
MTM/3$WNK;)Z=G3UQXD2LJ$#A_^S]^_=7*OB+QR,KB 0QGX^&X-:M6V$)M2J-
MC8WCX^.Q=)V'#Q\F4X5;/3\_'X>RD#RE*K$H3<RGB?EU,GDSQ*$T(5[2W[DA
MP<&#!V-144M+2QP%          "*K+J6$'LK$UO*BN$T,9]%PTI&):N6EY<O
M7KP8,QNHJ:EY_/AQK,A4/#)-S&_*CQ\_6EM;M]@\/S_?U]<72LIK:&AX^?+E
M[WC\;)VUIU44"6(^'PWKC8V-'3MV+"8K<.G2I:FIJ5A7ROGSYY/![N[N.)&1
MY"E5B45I8CY-S*^3R9LASJ6)^0W\A1L2# P,Q*ZBP<'!. H          !19
M=2TA]E8FMI05PVEB/HN&E8Q*DI:6EF[>O+EW[]Z87*NMK>WMV[<QG+5X:IJ8
MWZSQ\?&ZNKJM-[]^_?KTZ=/)GI+V[-G3W]\_/3V]&HP3ZR0.J302Q'P^&DI:
M7%Q\].C1\>/'8[Z4VMK:"Q<NO'GS)K9LX.?/GX7GGVQX\.!!',I(\I2JQ*(T
M,9\FYDO9^ILACJ:)^8W]T1NRWNSL;$='1ZCM[.R<FYN+HP          0%&^
M5EW9'KY__SXR,G+ERI6VMK;&QL9=NW;5U]<W-S>?/'GRZM6KKUZ]6EY>CIGM
MY>[=N\D]MOAQ-28F)H:'AR]?OMS>WEYXAG5U=;6UM0<.'.CL[.SM[1T='9V9
MF8D92IF<G+QSYTY/3T]'1T?A 1:N94U-34-#0VMK:U=7U[5KUYX\>?+UZ]<8
M*^O%BQ?)?^C":_/SY\]QB/_)^9OA3]R0DF9G9P<&!@X=.E3H+_QZX\8->ZX
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M            R*ERJZX             D!-670$           #(*:NN
M         .2455<             <NK_JZZKOP,           " 7+'J"@
M         $!.674%            (*?^ Z9#0D8+T92      $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>91
<FILENAME>image_344.jpg
<TEXT>
begin 644 image_344.jpg
MB5!.1PT*&@H    -24A$4@  #E@   5:" (   "S<0+)  "  $E$051X7NS=
M=YQ4U?W&\74;':EA:0I&D"*Q@8J81*."(BB(H,2"(B!%*8H-,!H;2L10HB%$
MBB8*Z@\D& 5!>E2(L:,8JH4.TI:RPI;?93<[G'GNE#.[4W<^[S_RDKWG^9Y;
MSMRY0[[,IIP$                    Q),".RF: P
M &)*.U[]H!$6                    \44[7OTXT0BK6P
M     (!H,?I@;?M::80%                  ! [!E]L+9]K33" @
M            (/:,/EC;OE8:80$                  !![1A^L;5\KC;
M                  "(/:,/UK:OE498                    Q)[1!VO;
MUTHC+                    &+/Z(.U[6NE$18                   "Q
M9_3!VO:UT@@+                  " V#/Z8&W[6FF$!0
M    0.P9?;"V?:TTP@(                  "#VC#Y8V[Y6&F$!
M           0>T8?K&U?*XVP                    B#VC#]:VKY5&6
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M"0                  2L?H@[7M:Z41%CCAG7?>T:7F2[ERY7;MVJ5A
M              !0"D8?K&U?*XVPP F=.W?6I>;',\\\HV$
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M(['L"ZS/0YRL_)R<G.>>>\XY9 V'J$6+%F/&C-F^?;M.4$P#D:1S P
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M7V!Q.5*BN_('#1ID1L1YYYV7FYNKF8#6KU]?KEPYJ:.#7&2\FP:"*4T6
M            0!ESH@W6NJ^51E@OX\:-TYD,%2I4V+ESIV;\^_'''RM5JJ15
M#,\]]YQFK(T9,T;+^?+\\\]K,D1:T8^6+5ONW[]?PQ;,(KHM*N0[4$>/'EWT
M\Z>??MK\>0!KUJSQ+EE"6M=% [[<====&C.DIJ8N7+A0,]Z&#1NF,6^U:M7*
MR<G1F(6E2Y=ZBG3KUDTW6XC:LB^PN!Q%HK/R9\V:98YW6[1HD68LN)OU=82+
MC'?30#"A9I<M6]:]>_>LK*S,S,QZ]>K=<,,-'WSP@0X"
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MZ,H?/GRX.=AMW+AQFK'6I4L7LY1N=C$'^Z2!\+G[[KMU,D/050T
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MO.P+XF;EGW?>>>9(MQX]>F@FDG1Z%PV$2=VZ=74FE_KUZVL,
M    0$(Q^F!M^UIIA#UNW;IU.H'+V+%C-6;'"6HM%V<'-.;'3S_]5*=.G:*4
MYYLU7WGE%>]ZJF'#AKFYN5K+CEG'^>-___O?:M6JF3_TJ7GSYOOV[=-:OI@I
MW19A+5JT\$Q=KERYW;MWZXB"@NW;MV=D9!C[Z%?OWKTU'"*MZ*(!_QYXX $-
MNVS8L$%CAJU;MZ:GIVO&VZ1)DS3F1_OV[3VI__SG/[HYF.@O^P+7RHS)RO_A
MAQ_,83X]]MAC&HLDG=Y% P;+83[9O PS,S,U!@               ""A&'VP
MMGVM-,(>-WWZ=)W Y<TWW]28'2>HM5Q>>NDEC?GQZJNO>E)]^O0I^N%//_U4
MNW9MHYX/<^;,\:YDRRQ2]).%"Q<&;9%T=.C0P:8-T8SHMDA:NG2I.?5--]VD
M(XIUZ];-'.F/IT&SQ+2BBP;\LUG205?=]==?KQEO9Y]]MF9\6;=NG7.'*8J<
M?_[YNME"])=]@:^5&?V5;QZX/S-FS-!8).GT+AHP6 [SZ6<_^YD9]ZE.G3H:
M P               )!03K3!6O>UT@A[W*!!@W0"EU6K5FG,SLJ5*[66RUUW
MW:4Q/W[YRU]Z4I]\\HGGYT&_ ;1]^_9&F1"813P_?/[YY\V?^S-X\&"CDF_F
M>-T623?>>*,Y]8H5*W1$L7???=<<&<#X\>,U' HMYZ(!_Q8O7JQAEZ"K;M&B
M19IQ^?###S7F<N^]]WK&3YLV33=;B/ZR+_"S,J.\\H<.'6H.\RG THT$G=Y%
M P;+83Y=<\TU9MRGKEV[:@P               ! 0C'Z8&W[6FF$/>Z**Z[0
M"5PV;MRH,3L;-FS06BX=.G30F"]??OFE)W+AA1>:FYS=.ZGX2S=]<K:N6[?.
MC%@RBY@_M^D>=OSE+W\Q4V[F8-T6,3MV[,C,S/3,V[)E2QUAR,_/;]RXL;&;
M?C5KUDS#H=!R+AKP;\V:-1IVL6D2=8Y(8]YNO?56S7@[<N1(C1HUB@8[_^'\
M44<$$Y-E7^!_949SY5]YY97F,)_6KEVKL4C2Z5TT8+ <YM.\>?/,N$\+%BS0
M&                ("$XFEJM>]KI1'VN#/..$,G<-F]>[?&[.S<N5-KN31O
MWEQCO@P8,, 3>?GEEV5KT)ZY>^ZY1R(VS KFSX\=.V;30)R>GKYX\6(S*,S!
MNBUBGGKJ*7/>"1,FZ AO3S[YI#D^@"5+EFC8FM9RT8!_V[9MT["+3=ONN''C
M-.:M?/GR/_[XH\8,TZ=/]PR^]]Y[=;.%F"S[ O\K,YHKW[DSF,-\VK%CA\8B
M2:=WT8#!<I@_-]]\LUE!].[=6P,                 $HW1!VO;UTHC['&>
M;ZP,H 3?9%GD\.'#6LNE9LV:&G/)SLZN4J5*T?A:M6KEY.3(@'_\XQ_>557)
MOH_3K"";]N[=:]-#[,P;X%LYS9&Z+3+R\O(:-6KDF;1BQ8K[]NW30=ZV;=N6
MGIY^8D?]Z]&CAX:M:2T7#?AWZ- A#;LXUT5C+LZ9<<Z/)KV-'3M68X;SSS^_
M:-A))?IRUE@M^X* *S-J*]^Y,YC#?'+N,!J+))V^I+2N!>?J^^N%O>...XX>
M/:H!                 (GF1!NL=5\KC;#'E2]?7B=P.7;LF,;L'#UZ5&NY
M5*Q846,N+[SP@F?\_???KYL+"G)S<QLV;&A4]6':M&D:"\:,Z[:"@K5KU]JT
M$9]QQAE[]^[5<"%SF&Z+C+???MN<]/;;;]<1OG3MVM5,^9.1D;%MVS8-V]%:
M+AKPSV;55:A006.^W''''9KTUJ1)D_S\?(T5^OCCCSW#VK=OKYLMQ&K9%P1;
MF=%9^1&]-96,3E]26M?:_/GSK[WVVCIUZCBOM:RLK&[=NBU:M$@' 0
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M+UFRY$0A.S%?]@4AKLP(K?S!@P>;PWQ:OGRYQB))IW?1@,%R&
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M].C 7S0;6.7*E9V+E9.3HZ6]:2S"='K#P($#=;1A\.#!&@
M  "0:(P^6-N^5AIAK>S9L^>/?_SCA1=>F)J:JB7\<P:W;=MVW+AQ>_?NU8J^
M:-XE.AV!]G16:\.'#]=:A71<B6C1@!*Z$38]/;URY<I965EGG756QXX=APP9
M,G7JU-6K5WOO<J0<.7*D9LV:LDN9F9F!OU[432JX16?9%UCLB8=.;"WL*S\G
M)^?EEU_NT*%#N7+EM*A_C1LW'C%BQ-:M6[6<+QJ.,)W><.S8L?[]^VN@T-UW
MWYV;FZL!                 (G&Z(.U[6N-<2-LPMFQ8\>L6;-&C!C1I4N7
M<\\]-RLKJW+ERFF%BEH2G1\ZFT:.'#E[]NR=.W=J'@ B(#L[>_[\^8\__GCW
M[MTON.""^O7K5ZU:-:-0C1HU&C5JU+IUZ]MNNVW<N'&K5JW2<$)9LF1)MV[=
MZM2IXQR:<\MUCC?27WX,                (&J,/EC;OE8:80$
M         !![1A^L;5\KC;                    "(/:,/UK:OE498
M                Q)[1!VO;UTHC+                    &+/Z(.U[6NE
M$18                   "Q9_3!VO:UT@@+                  " V#/Z
M8&W[6FF$!0                  0.P9?;"V?:TTP@(
M "#VC#Y8V[Y6&F$!                   0>T8?K&U?*XVP
M        B#VC#]:VKY5&6                    ,2>T0=KV]=*(RP
M              !BS^B#M>UKI1$6                    L6?TP=KVM=((
M"P                  @-@S^F!M^UIIA 4                  $#L&7VP
MMGVM-,("                   @]HP^6-N^5AIA 0
M$'M&'ZQM7RN-L                    (@]HP_6MJ^51E@
M      #$GM$':]O72B,L                    8L_H@[7M:Z41%@
M             +%G],':]K72" L                  (#8,_I@;?M::80%
M                  ! [!E]L+9]K33" @                  (/:,/EC;
MOE8:80$                  !![1A^L;5\KC;                    "(
M/:,/UK:OE498                    Q)[1!VO;UTHC+
M     &+/Z(.U[6NE$18                   "Q9_3!VO:UT@@+
M          " V#/Z8&W[6FF$!0                  0.P9?;"V?:TTP@(
M                 "#VC#Y8V[Y6&F$!                   0>T8?K&U?
M*XVP                    B#VC#]:VKY5&6                    ,2>
MT0=KV]=*(RP                   !BS^B#M>UKI1$6
M    L6?TP=KVM=(("P                  @-@S^F!M^UIIA 4
M         $#L&7VPMGVM-,("                   @]HP^6-N^5AIA 0
M                $'M&'ZQM7RN-L                    (@]HP_6MJ^5
M1E@                   #$GM$':]O72B,L                    8L_H
M@[7M:Z41%@                   +%G],':]K72" L
M (#8,_I@;?M::80%                  ! [!E]L+9]K33" @
M        (/:,/EC;OE8:80$                  !![1A^L;5\KC;
M              "(/:,/UK:OE498                    Q)[1!VO;UTHC
M+                    &+/Z(.U[6NE$18                   "Q9_3!
MVO:UT@@+                  " V#/Z8&W[6FF$!0
M0.P9?;"V?:TTP@(                  "#VC#Y8V[Y6&F$!
M       0>T8?K&U?*XVP                    B#VC#]:VKY5&6
M             ,2>T0=KV]=*(RP                   !BS^B#M>UKI1$6
M                    L6?TP=KVM=(("P                  @-@S^F!M
M^UIIA 4                  $#L&7VPMGVM-,("                   @
M]HP^6-N^5AIA 0                  $'M&'ZQM7RN-L
M     (@]HP_6MJ^51E@                   #$GM$':]O72B,L
M            8L_H@[7M:Z41%@                   +%G],':]K72" L
M                 (#8,_I@;?M::81%6982C :0K/;LV;-^_?K//__\HX\^
M6KUZ]:9-FPX>/*B#     " QZ8=A%PV4+7JT+AI <MBQ8\>T:=/NN...L\\^
MNT&#!A4K5LS(R*A5JU:S9LVNN^ZZ1Q]]=,6*%<>.'=-8(M.E[Z(!%PVX:
M  MEZ4U9WQI=-("2*DO+)H'H@G;10-)@02*:](7GH@&$B9YH%PT <4D7KHL&
M@-@Q^F!M^UH3KQ'VQQ]__.<__SEJU*@>/7JT:=.F7KUZ)Y]\LO,H6;Y\^3IU
MZC1MVK1UZ]8=.W:\]]Y[ITR9\N&''^[?OU]+(&GH#=M% T@:Z]>OGSQY<N_>
MO9U/I%6K5M6542@K*^M7O_K50P\]-'_^_)]^^DE+ /XM7KRX5Z]>O_G-;P8,
M&/#]]]_K9D38\N7+WPK=UU]_K84"6K9LF1E?M6J5C@AFP8(%9H4 5J]>K>%B
M++:(VKIUJUZ,4GCWW7>==?+?__[7>9K5F0"@3'.>O:^[[CKGJ;M*E2K.?VS8
ML$%'(/+TTXZ+!LH6/5H7#2#^A/=.LGGSYO[]^Y<O7UZ7@LO))Y_<KU^___SG
M/UHB,>GAN6C 10,N&@" 8N&]DZ/,*'MORKK?+AI Z,K>LDD@>HI=-) $6)"(
M/EU;+AJ(L.1YS-,3[:(!("[IPG71 ! [1A^L;5]KPC3"[MBQ8]RX<>W:M7-V
M55^%P9QQQAF]>_=^Z:67MF[=JG51INE2<-$ RKHM6[8\]MAC9YYYIBZ%8&K4
MJ#%HT*!UZ]9I1<!;?G[^D"%#S,53OW[]/7OVZ#A$4K5JU<Q+8&GBQ(E:R#_G
M;I"6EF;&+[KH(AT4T($#!^P?:<:.':MY%EM4C!X]VCS#873**:?<>..-DR9-
MRL[.UED!H&Q9OWY]S9HUS7M@[=JU-V[<J.,08>8E\$D#98L>K8L&$&?">R=Y
M[[WWG+A9S89624QZ5"X:<-& BP8 H%!X[^0H,\KDF[+NKHL&$*(RN6P2B)Y9
M%PV4=2Q(Q(0N*1<-1%)2/>:9A^F3!H"XI O710- ['B:6NW[6A.@$=9Y[[SS
MSCMM_AV5C5:M6HT<.9)_:Y4D]/*[: !EUU=??77##3>DIZ?K(@B%$^_3I\_N
MW;NU.E#LV6>?U763DO+,,\_H.$3,A@T;] +8^>"##[26?\ZM0.(___G/=5!
MRY8MDPH!+%VZ5/,LMJCHWKV[GN)PJU:MVH,//D@[+( RK&O7KGKO2TGIUJV;
MCD.$Z35PT4#9HD?KH@'$F3#>218N7"C_I,V2%DI,>E0N&G#1@(L& *!0&._D
M*#/*ZINR[JZ+!A"*LKIL$HB>61<-E&DL2,2*+BD7#4124CWFZ7&Z: "(2[IP
M730 Q([1!VO;UQK7C;"'#AT:,6)$9F:FONS"H5&C1@\^^. 77WRALZ+LTD7
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ML>C!)]GA)Z*PW$EV[-@A?]G8L&'#G)P<'5=LQ(@1YF#=7":8!UBRP]1\Z!4
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M*1G=CU"X[V,ZPL4<7(*W]0"B<,\O"/$ X[//(5QT/THD/M]KM(2+!BPDQ-W
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MJ^I#=3;*R6XH%Y2E(NBOKV"6>"JF SH+.&8S9LQ0F=#QY+R.2?!*^D0L<E'
M4 0<LS@?-5L'5I'#OX;BOS&A.BD9$\:6F>BI0^8Z9;Q2*,1B#Z"#76QH)"S=
M),@?]==S0((#[RA@$#KDZH6P<38I/__\<[BG*TV;-G7.UL,?%/+!)>9G.Q'!
MJ^H@MF-H(>"8A>[6I<36YEMJ"4SY.@=38 2A2&=?@YX"Z.!-[FH->#""4#'$
M63==4$4?W;DA^@LX9G%V@J; @/31S4P@SMX<[8+(T$)8M-!'-\_17\ QB[D
M9_K-D4@BTPIW46L>Y76M"2^$]=I8\=9;;T73I.G<N3-&:9\%7*=.G>>??_['
M'W_\XX\_=N[<2?^E?]-?O'8>)AV4EH%N F3SQ!-/./^F[JUERY8???31DB5+
MMF_?OF'#AOGSY]- \*RSSLKIM)=##CG$_2"F<>/&SA]%A7GSYKWPP@O2]^OE
MRI53:1303<"R^W7W?VDH3Z,QBN'77W_=9$.I>/_]]Z^[[CII8U&B1(G (_P
ME%"NSPY4J^^\\TZ4L'.O18L6[[WWWL*%"RGLK5NW4C:.&S?NOOONDW8Y9YYY
M9N!)RN@3"O]A<9S)R1#9V=DGG' "!J1YXGD(?OGE%[RDC=>:#ZI-9^=$W+Q-
M]P1A?HM*AZ)%B\):%I<5*U9  .(:E^...PYL1"@A**W VV^_+2XVI;+4J5.G
M*5.F.*,K'FI_Q,];J?B!F0^3)T\^YIAC0*%4J5)]^_85=^O<L6/'.^^\(Q:D
MK*RL,6/&@#'/ZM6K(7_$#U]HWA*X,2$55] 1QRMOO?46Z?"?0E+_0C'7J%&C
M7KUZIYYZJL\$B=_!- KQWT>#?/WUUQ )L]>*H9V,:=.FN2Y03YLU:\;I[>/S
MSS_G;;SHT*&#8T^W,O!C35.%[<$''[PD)^YB7!<J;-1W7'WUU?P?J3I0GWO:
M::>=?/+)TL)&8U:\V'Z^_?9;<:4C#22&#AU*A02M+8MZG/OOOU^L!<0GGWR"
MUC%"+3P&Q-A33SV%=FI\^NFGJ&4S8,  -%4@59E,Y?#11Q\5Q:GP=._>79S+
M;=NV3=SEFAH<,'-(O#_U(OY;,'WZ]*...HIWI  HAZG'1U,;&M314)^W=ZA9
MLR98)CMF4(<:1K&O+U*D2*M6K4:/'KU@P8*-&S=2WT3_I?D"=?377W^]M/EB
M:M.!9(?-;I?!0Y>FMGKX\.%4K?[^^V^J>G_]]=>L6;.HL:+N26S>75#=!HU"
M(4X]T$( [ -)X91\Z=*E[ALIJE#]^O6CNT#W@L+X_???J7%X^.&'I>=7T"@N
MW)</!L&8[!31T-']7VIG[KCC#NJSJ(1OWKS9^ P]V9J%*BDND.C@2^!"V,<>
M>PQ]@K;V_V\A;$;!J]I0[:,"_]EGG_WVVV\T6*))*Q6D[[__GNZ%]#%=DR9-
M4%<9U K*4A'TUU<P2&P5TP'=!"Q[<%6\>''\(0B\DCGP2C9Q%KDH8!P"5NR/
MF@^P(H=_#<5_8\+<-2:,,S/11X?,=<IXI5"(Q1Y ![O8N&_WB LNN&#@P($T
MN5N[=BUE^*I5JZ9,F?+44T^)CZP)^B,U:'@-7Y(=>$<!(] A]RZ$C;-)^>67
M7Z2]!G64UU]_/76:U'52V:#Y(!42FAM20>*?1]U___V6+%%X&0]B?K83';RJ
M#F([AA8"5K1N723.-M]22V#*USF8 B\?BG3V->@F@ X>Y+K6@ <CT(\AYKKI
M@OXV&9T;HK. %6\G:!",QB:CF<D3<V^.=D'$N1 VHWF.S@)6[ 4XAC='0%+3
MBCP<^)L'>YM1+0>S2%<5$,\^^RR:)DJW;MTP1,9.//'$;[[Y!DTY)DR84*%"
M!713.'A.!"48HQJ;E95%_ZA>O3HU7NA@0[6%1C#HN?_ V4&#!CG_ZZ- HPII
M[TLC)S0- B48HT;9K6DT/*6!%_KLA\;Z-#[+Z;V7BA4KTJ 'K;U!?[7Z[/+
M P^@OWUXEL^V853)NW3I(NY>1LG1:LO G6E&+B7!Y)CBPP\_A$@<OOKJ*S0U
M"K\PCN?55U]%4P]..^TT\*7I!QKY(KZ,//?<<]'(&_&X<^J9T"@R-*)JVK0I
M7(AZ=THL]?=HS2&.1=Y\\TTT\N#==]\5N_#6K5O[]Z8TRZ(1!GC1+(LZ:33U
MQFU476B6CD9!T)A,W'*51BKNV2YERY8=,&  C99X+QI2#!X\6#K,+5FR9,3J
MF<A]-,O<N7,A$F:O=4,[&>X6C]3G0O-X[[WWYI3<BTH::=SIKOQKT* !_JR
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MU0LJ]OP)D,.&#4.+G'#7W$N<>>[ BSC$68 3>7.4X+0B#P?^YD'""V$;-&@
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M7@(1_T51V=G9XF=SQ-2I4]%4C8X=.Z*6PEM>&I.)WRQ*7YGX(ZZ(*E.FC-:
M3UR75JQ8,33R)9'[& -BR6?>0\.N7;NZ-B-'CL2?.<J6+?NOW'Z\CF(\XXPS
M' /RVK5K%_ZLAJG"=O?==X/(L<<>&^Z+,9XSSSP39(GGGGL.[8*8-FV:N-EG
MP8(%=9<Y&F'ITJ40"4$M3TL9S9LW;]"@P8DGGDA#:_2QN?322]>O7X_7T"$E
MF4PC0_$30-TUV:U:M0(%^@L:>9!@?YK@+7CPP0?!GMEC\LZ=.V_=NA6M(R.V
MG*;&#!&1+@C.FS<O=>(1ZQ=/@L/FOGW[HJG:9,<4>.VP4P\ 115D4SXE_^Z[
M[]#(ES5KUH "57DTBA$(AOCBBR_02 WU&7J"-0M MUQ5('_ZZ2=T8VS1HD5H
MQ]&K5R_7TCEF2_S:(5^^?#ZMZ)8M6_AOP%1ZS$S Q;L/M/ %G37=4P@D)\2>
M1J# ]/,$_?45HI">BFG)LB(7O;Y5!!(8HL@9!()AL3QJ/JB*'*H;JMTHJB";
M\FS/76/"]&0F^BB4A!C F Q%A:*,S9DS!XU\V;1I$R@$OIY+S\#;(!A!A!N$
M0J&D4$)?!/UC:5*>?OII<"&Z=^^.=FJ,&S<.M=3R(9YG.QD%HU=+N!>H9:);
M3T^;;\D2J+5*(0WK'$P!8;!H)<<%16/I:P!P9VI)R^VM 8:ND.I4U<W0P.5"
MS U!@<72":832(5*9J:D-W>YXXX[P+UTZ=(J+YVSL[/+E2OG>H5XT18.+M*]
MJ.0Y  HLE@*<R)NC-$PK_ET&J[RN->&%L.)YU@X;-FQ T]AIV;(EAL78>^^]
MAW;*C!@Q N48N^666]!.!KHQIK7AEI49!;3P!9T9FS]_/AJI,7KT:-126ZJ%
M/@I)D!:#*5.FH)T:BQ<O1BVU[0K01R%R*2E)3G0>>N@AO+!-Z$*ECG1$3BQ?
MOAQ-98AGFC=IT@2-?)DV;1HHY,N7S^N\-I%FS9J!^SWWW(-&^DR=.A5D:9:R
M8,$"M NB=>O6H.._*.JSSSX#>Q9A,W9+-E C[KOO/K3+R:^__@HN>?0W)B1J
MUZX-.NW;MT<C7\2!;ZU:M=#(FZ3N8PR(:^:8Q^E"6[=N=4]%K%2IDO_>AS5J
MU,@IN1=I0_3QQQ^[!@,&#,"?E3%5V&K6K DZ7OOCJC-QXD30=%BR9 F:^C)W
M[EQQA271IDT;-(V%4:-&82@*=7/9LF44<%96%GHR5KERY4V;-J&#&NG)9)J.
M@B\)ZI[=PY_1[#!PX$ T\B"I_C396S!FS!ATV$^I4J4>?_SQE2M7HD\$,C1F
MB(YX[UR*%2M&98.R%WWT27#8++WT^^^_CW89 Z\==NH!H*B"K#0KTC,EIZ8>
MC7P17[HPA4S('!A*T$I*']1GZ-)[&D_- M!-X5Y(@T^J0)YXXHG@^,PSSZ 1
MQ__^]S_7LE^_?O277;MVB7O>^SS$Y \W*%>N'/X<%URP^T +7]!9TSV%0'(*
M%2J$%D&  M//$_375XA"JBHFNC%&S10:Y7(@@2&*G$$@&.8Q&5<A8D=VH!8Y
M5#=4NU%403;EV9Z[QH3IR4STB3$3?,"8#$6%HIKG=Q'__/,/2@3%)KW7B0R\
M#8(1!&6"#R@42@HE]$70/Y8F17S:PR)\3"(>-\^" G"(Y]E.1L&XU1+N!6J9
MZ-:E[4 B;;XE2V#T50K1%= B%C (0V&@:"Q]#8#.:NZYO37 H!52G:JZ&1JX
M7(BY(2BP6#K!= ))4,G,E/3F+N(1CDQM SO^[7G!@@6]MIHR#A?F7E3R'  %
M%DL!EK8>F7YS)+UHS-,*=U&K^KK6A!?"5JE2!5-IH_LN.1.(:T0(JL-HIXQT
MTX[:M6NCG0QT8VS+EBUHY OZFU! "U_067\$YC)[]FS48JQZ]>IH)X ^"DF0
M%H/ S9F]H#Q'+8_GJ@#Z*$0N)27)B<Y--]V$%[:)83-I\8TCLU<UH9T'YYY[
M+OCZO[ 4&31H$"B<<<89:.3-22>=!.Z#!P]&(WTNN^PRD UWB$.U:M5 Q__$
M9VE)Z-BQ(]HI0P48Y1A[[+''T"XG_%MAAXH5*Z)1$-G9V>+! 1]]]!':^7+]
M]=>#@M:BI:3N8PQ\^NFG$!)!@Q"TLZP^??JX!D.'#L6?<W+EE5=R>ON0[L_J
MKG(^^NBCH[14I@I;X<*%02?P<ZM Q-T]F4[S:-G[W;[RRBO\9F,NE&]KUZY%
MAU@03Q\FWGGG';23(>Z.[!#ZS(B49#*5X1(E2H![SYX]T<Z7?_[Y)W_^_""B
M/G=*JC]-]A;LW+GSV&./13>.K*RL"RZXX.677_[KK[_069\,C1F,T+1I4X@-
M./WTTY]^^NG0J_JL1(?-TDOK[N(0!;QVV*D'@*(*LM*L2,^47+<\[-Z]&R44
M,B%S8"B,K5FS!HW44)^A2^^I;DZZ:-4L -T4[H4T^*0*Y,,//PR./B<PK%RY
M,L_^O>KI'[_]]IOS]UMNN26G!FO8L&%.UW^A>8%K%GAB1N;@@MT'6OB"SIKN
M,;!\^?(WWWRS??OV]>O7KU2I$O7[-$ET;Y\*J!@$^B>A$(5454QT8\Q_:)<&
MXB]R!L%08GG4?% 5.50W=+M15$$VY=FN.Y))=DR8GLQ$GQ@SP0>,R5!4**K_
M;LZ2B:!%3J3W6K>XND09>!L$(PC*!!]0*)042NB+H+_^/0K1I(C?I;,(SQQ6
MKUZ-6D$!N,3P;">C8+C*"9>"6B:Z=6D[D$B;;\D2J-L2HK\)!;2(!0S"4!@H
MJI\_EDP$+7Q!9V7W7-T:8*P*J4Y5W72)?VZ(_K%T@O$00V:FIS=W$7?[DFY'
M!5Q^^>6N?935VS'D.8#^L11@:>L1^KXK(KVH;F)=PDTKW$6M>937M2:\$%:Z
M@H28-FT:FL;.\<<?CV$QMF+%"K139MFR92AG'WN-=C+0C3&MP[*MS"B@A2_H
M'&H$YD -&6JI;5B-/@I)D!8#LZ@,1-!'(7(I*4E.=!HT:( 79JQ$B1)H9QII
M+28>??11-)4A/=-\[-BQ:.>+N-?FK;?>BD8>;-Z\.8_0Y<^8,0/M-%FX<*$H
M*UT+Z(]T4=34J5/1;C\T/BA>O#C8$Q]__#&:*L-OE>32NW=OM,N)>%8U3=O0
M*(A??OD%1+*RLG0/_JA<N3*(J"]:2NH^QL.//_X((1$E2Y8$LYT[=[I[-%('
MO6O7+C  ;K_]]IR2>WGWW7?!C-]"LD>/'O"K%D8*V]RY<T$D1&$3X4^O<%'<
M:#8[._O]]]^7GCA/%"A00/=$"8.("\0)JK!HYX&TPZ(,#_=-?THR6=QBN5"A
M0KI%2'PZDS=OWFW;MJ&=C 3[T\1O ;4PZ"F#,O.""RX8.'"@[M8(+AD:,YAB
MX\:-5:M6A?"DG'WVV<\^^ZSBSOT\"0Z;I9=V%Z[% %X[[-0#0%$%66E6I&=*
M3F,>- H")10R(7-@*(SI;NSMHCY#E]Y3LWC5+ #=%.Z%-/BD"N3,F3/1TWO'
M(/X$*YKON'_G-UUPH,Z(VG_.=1];MFSA/^'XX8<?T"(NN&#W@1:^H+.F>^:@
M]N355U\]]]QSQ<Y7%Y0. OV34(A"JBHFNH7J*>(AP2)G$ PEED?-!U610W5#
MMQM%%60/O&Q'"85,,$5Z,A-]8LP$'S F0U&AJ/Z[.4LF@A8YD=YKLR@.O V"
M$01E@@\H%$H*)?1%T#^6)D7ZB77H9PXA-C-SB>'93D;!*)43+@6U0A4&0-H.
M)-+F6[($ZK:$Z&]" 2UB 8,P% :*ZN>/)1-!"U_06=D]5[<&&*)"JE-5-Q.<
M&Z)_J'8/)?3#,$B<F9F>WMSE[;??!@7*!_]WJ4N7+N7/U0SQO#'./ ?0/Y8"
M+&T]0M]W1:07-4O@M&+_FM:]X&\>)+P0MFW;MIA*FTSOWZN"N#,?$64WYK5K
MUZ(<8T6+%D4[&>@65 =$T#]V!70.-0)S6+=N'6HQ1O<+[0301R$)TF)@EK)E
MR^)5!=!'(7(I*4E.=.K4J8,7]MC<T2POO/ "7M5FUJQ9:"ICX<*%Z*F_\9*X
MUV;__OW1R(-OOOD&? \]]- 0O3+0OGU[D*5B$**"BV]S#SGD$)^],VD\!/;,
M'E3I+L;B.>*((U!1X2B!BRZZ"%QT-R8DWGGG'1 Y]=13T<B7;=NVY<V;%T0H
M5]'.@Z3N8SRL7+D2HF+V0K'L[&S>C(;+[J]4W_F?I(A[<3%9E;STTDN=GZB
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M#S'7;M.FC>../PCDO)J2"X#^-F@4!/KG9/;LV<XVM[H\^NBCC@+^()#S@OM
MH[#H/MN) EY;&12R02,U4$63V-I\2S^!Z)\.A0QQP/0U^',0X.Z 1F&)K37
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M"F68]!1[- H"_67$,_ V",:A# IY,V[<.''K!R_HCC_]]-.N+_XLP%U'U05
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M5UP1'A9VVVVW6$3-LXY %G/GSNW6K5MXN'CNN>=B'0  0#GAG47!1\T
M]265@\V::Q6$I9/$SR9].@E=V2NOO/*%Y5Y[[;5X<P:+%R_><LLMP\/"__M_
M_R_6T9&L(]!I[K___O!8T;=OWX\^^BC6 0  E!/>7!1\U P   !07U(YV*RY
M5D%8.DG\;-*GD]"5C1\_OG@M/_[XX_'F#"ZYY)+4X\''?(UHY[..0*?Q< $
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M$TY8NG1IK*;C64>@TSS\\,/A0:-;MV[WW7??0RD3)DR(;0   $W"&XJR8C\
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M+             #5E\K!9LVU"L("            4'VI'&S67*L@+
M      #5E\K!9LVU"L("            4'VI'&S67*L@+             #5
ME\K!9LVU"L("            4'VI'&S67*L@+             #5E\K!9LVU
M"L("            4'VI'&S67*L@+             #5E\K!9LVU"L("
M        4'VI'&S67*L@+             #5E\K!9LVU"L("
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M          #0!:5RL%ESK8*PE#%@P( 0L'OWW7=C$5!5X2(M",("
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MUGW[]NW6K5ORW^3?0X<.37Z>W)K4Q+8.4_&%;H?:O 3^]K>_77SQQ0<>>.#
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MK,0.QX82Q<K.O+AJ9!TSBM/;E"4(^YG/?";=DCREQHH5U7X0MH+/65WBE0D
M        L.I(Y6"SYEIK(@@;XQ7Y'7+((;G^3'SL+]%<-F'"A(S?M5:TXG8^
ML73ITA_]Z$>?RO!%AJW9>^^]WWGGG3BW \0-YY$E"/OSG_^\5Z]>L3.SWKU[
M7WGEE7%H*V)SB>:R"BYT^\3I^770)?#@@P\V-#3$V]JTYIIKAN^2[#2==FK%
MSA*QH26QIT1L6%&L;I>R(;:GGGIJXXTWCFT9C!DSIGE"O*'$BAML6:>M;&,E
M=C@VE&@NZ\R+JT;6,;LXO4UE@["3)DT*+?_G__R?6+2B&@_"5NHYJPN],@$
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ML?ZG/_UI:1;VJJNNBCTK&C]^?+%XT*!!\>8VI;:S3*PH)_97XCFK/EZ9
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M7[1H4;+TJ0$?N^&&&U*MRXP?/[Y8T+YGV]06EHD5Y<3^_!."%B^NRFK?L0(
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MBFTKVG???5,#/G;TT4>/'#FR^#^//_[XV)-':O RL:*<V)]_0JGZ>&4"
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M;18;<HH3\Q^TV)]_0HMJX97)W+ES3SKII&01>_;LF3Q\G7;:::UE]P$
M  " 54TJ!YLUUUK-(.SX\>/3$8IF#0T-TZ=/CZ6M^-WO?A?[F\2Z<F)__@FM
MF3ES9NDW-7[QBU_,]5?+'WOLL?!WS^^XXXY8U&'2VVT6*S*8,V?.QAMO'.9L
ML<46;[WU5BQMQ:Q9L[;::JLP(9GYSCOOQ-+6A?9"N^Y+!=79)1!'M&M(7K5P
M:I5^]6;RB/K22R_%NI8\_/##27%H;Q9+V[3WWGN']D<>>206-;GMMMO290<<
M<$"L:&R\YYY[TC7-OO"%+RQ>O#B6MN*<<\Z)_<O%TE;4PLHV5N*LCOWY)S2V
M=T@MK&/'.?[XX^,^I63\:M+D:,3.Y9+YL3JG.#'_08O]^2>TJ.JO3.;-FS=D
MR)!T;V*WW79;L&!!+ 4         5CW%4&OV7&LU@[#OO__^NNNN&Y(0B<]_
M_O/SYLV+U24F3)BP^NJKQ^8FL;2<V)]_0AMNO/'&.+U0^-K7OI8Q<?+XXX^'
MH_3%+WXQ%G6D]*:;Q8IL_OC'/Y9^]UZRUG/GSHVE)3[XX(.A0X>&WF1:WJ^'
M#!,*[;TOE5)GET <T:XA[5#U4^NCCS[:=---PY"O?.4K2Y<NC:4KFC)E2O,?
M%B_-A!5R'KT?_. 'H?WRRR^/14V^\8UOI,LNNNBB6-%DU*A1Z;)F26_9.Y6X
M^NJK/]64[MUBBRWBB#SWJ^HKVUB)LSKVYY_0N!)#:F$=.\C##S\<]VFYS3??
M/%:WXM)++XW-RR7S8W5.<6+^@Q;[\T]H375?F9Q\\LGIWJ+33CLME@(
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MIYUB&B*#9)^ON.**Q@S!D;C)#"TMBE-R&CMV;/?NW>/0S-9;;[TGGG@B#NT
M<<.9Q4&M^,4O?M'BEYAFU+MW[ZNNNBH.;45LSB9.Z6!=XA*(_4UB43FQO](Z
M\]0J=<\]]_3HT2,.+>?88X]M;H\WE%AQ:RWXZ4]_&GO:E!RK"1,FQ"DK>OKI
MIYN_MC:O0P\]M/EOK,<;,MR14IVYLK&YG-A?B0F-%1I25"/K6'$//?10W*U"
M8<"  ;F^S/7""R^,(W)&:8OBE')B?_X)S>*4/*KRRF3333>-@YH,&C0HE@(
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MK&O3RR^_'"8D,W-%:8O"G+)B?_X)S>*4G#K_E<D))YP09S7YX0]_&$L!
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MY6"SYEIK+@@+0'V8.G5J"%!NOOGFL8B:9QT!         .@TJ1QLUERK("P
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M 8C2V<?$IIMN^LHKK\2B5KS\\LO;;+--F/#-;WXSUM'QPBI81P
M:EPJ!YLUURH("T 4XH^)C3?>^)9;;HEU*UJR9,G__;__=[WUU@N]6V^]]=RY
M<V,U'2\L1,$Z @        !0VU(YV*RY5D%8 **0@"P:/'CPN>>>>_?==T^?
M/GW>O'E+EBR9-6O6BR^^>//--__@!S\8-&A0;"@4-MEDDY=??CEN@$X1%V,Y
MZP@         0&U*Y6"SYEH%80&(8@JRO08/'OSZZZ_'Z726N![M91T!
M     .@<J1QLUERK("P T2.//#)JU*C>O7O'1&1F2>^IIYZZ<.'".)I.9!T!
M         .A:4CG8K+E605@ 6C9SYLQ++[UTO_WVZ].G3PQ(MF[]]=<_X803
MIDV;%L=1)=81         ("N(I6#S9IK%80%H(P//OC@KKON^LE/?G+DD4?N
MMMMN6VZYY08;;+#::JMUZ]8M^6_R[R%#AAQRR"'GGGON@P\^^.&''\9^:H-U
M!         "@QJ5RL%ESK8*P             %1?*@>;-=<J" L
M  ! ]:5RL%ESK8*P             %1?*@>;-=<J" L           ! ]:5R
ML%ESK8*P             %1?*@>;-=<J" L           ! ]:5RL%ESK8*P
M             %1?*@>;-=<J" L           ! ]:5RL%ESK8*P
M     %1?*@>;-=<J" L           ! ]:5RL%ESK8*P             %1?
M*@>;-=<J" L           ! ]:5RL%ESK8*P             %1?*@>;-=<J
M" L           ! ]:5RL%ESK8*P             %1?*@>;-=<J" L
M      ! ]:5RL%ESK8*P             %1?*@>;-=<J" L           !
M]:5RL%ESK8*P             %1?*@>;-=<J" L           ! ]:5RL%ES
MK8*P             %1?*@>;-=<J" L           ! ]:5RL%ESK8*P
M         %1?*@>;-=<J" L           ! ]:5RL%ESK8*P
M %1?*@>;-=<J" L           ! ]:5RL%ESK8*P             %1?*@>;
M-=<J" L           ! ]:5RL%ESK8*P             %1?*@>;-=<J" L
M          ! ]:5RL%ESK8*P             %1?*@>;-=<J" L
M  ! ]:5RL%ESK8*P             %1?*@>;-=<J" L           ! ]:5R
ML%ESK8*P             %1?*@>;-=<J" L           ! ]:5RL%ESK8*P
M             %1?*@>;-=<J" L           ! ]:5RL%ESK8*P
M     %1?*@>;-=<J" L           ! ]:5RL%ESK8*P             %1?
M*@>;-=<J" L           ! ]:5RL%ESK8*P             %1?*@>;-=<J
M" L           ! ]:5RL%ESK8*P             %1?*@>;-=<J" L
M      ! ]:5RL%ESK8*P             %1?*@>;-=<J" L           !
M]:5RL%ESK8*P             %1?*@>;-=<J" L           ! ]:5RL%ES
MK8*P             %1?*@>;-=<J" L           ! ]:5RL%ESK8*P
M         %1?*@>;-=<J" L           ! ]:5RL%ESK8*P
M %1?*@>;-=<J" L           ! ]:5RL%ESK8*P             %1?*@>;
M-=<J" L           ! ]:5RL%ESK54.PA:J)^X*M&GV[-F]>_=.GT*]>O5Z
M^^VW8QU0)0L7+@P7Z9>^]*58E#)LV+!T<8\>/>;.G1N+     (#:D/XTKXKB
M;JUB_*X$:IS?E0  4!]2.=BLN59!6,CDDDLNB>=0H7#QQ1?'.J!*_OSG/X<K
M]#_^XS]BT7+SY\_OU:M7NGCHT*&Q"     "H&>E/\ZHH[M8JQN]*H,;Y70D
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M!P^./=!UQ!.Z:SX\[K777NF[T*=/GT6+%L6BY<X\\\QT<>+NN^^.10    !
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M??'%%XWM'Q7MP)T;,6*$-K6L7KUZK5V[5J.&[=NWWW###5H6H-%(?%G4WZM
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M6];77W^MN>BTV/TA^*6RLK)APX;FSH-O31U-KUZ]S'!^?OZA0X<T!
M *!^,>\*AFC(JW2XUYT,/"L)2O:BZ7#^2*U5UYXCTA;NFV@]STH<XUD)
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MSCOOE/(A0X9H*#JIM=P?@E_&C!DC.Y\[=ZZ&:GSRR2<2'CERI(8
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M=P       (!Z0V__!6C(O?2YUYT0/"M)\:+I<_YHC?NK@V<E2:(;2CF>E0
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MY[#6N^]0'5\3K713ZXMSSSW7W.WQQQ]?556EH1IWW'&'&;:M6[=.0P
M  #J+[E#&*0A]]+G7G?\>%:B2R9_T?0Y?[2&9R7N:WW!LQ(   #4;\8<K-.Y
M5@9AH])-)&(;X\>/UZ:6-7+D2,TY-F+$"&UG61,G3M1<)%KF_@"UWH\.<;KM
MMMM"2P\8,$!?=L_^(?.DDTXZ>CPU!@T:I-':(O[6H4<??51S">7+HNES%61D
M9$C5OGW[-!13<7&Q=+#<G\-:[[Y#=7Q-M-)-;>KMV;-'/G&QK]S33CO-#+=I
MTT83         .HU\PYAB(;<2Y][W?'C68DNF?Q%T^?\X5E)D%:ZJ4T]GI4
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MUR3\MR]%NSNV<>-&,W;FF6=J(LGFS9MG;L V9LP8#=78O'FSA&^XX08- 0
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M;K&%WS3Y[+//[$^N&5NU:I5DDJJ\O#PW-]?<0.Q_9BV_QJAERY::
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MUG;&&6<L6K1(BY/OX,&#C1LW-G=RY957:LA@GY9FN$6+%E5551H"
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M/M[KKL=\>6SARZ(^GC\\*^%9"0   . [8P[6Z5PK@[
M  #PGS$'ZW2NE4%8                    ^,^8@W4ZU\H@+
M         /QGS,$ZG6ME$!8                   #^,^9@G<ZU,@@+ ( +
M%@     @"OT)"@   $!]I#\)    H%[0_]OG'V,.UNE<*X.P  "XH/\O
M  !00W^" @   % ?Z4\"    J!?T__;YQYB#=3K7RB L   NZ/\+      #4
MT)^@     -1'^I,     Z@7]OWW^,>9@G<ZU,@@+
M_QESL$[G6AF$!0                  @/^,.5BG<ZT,P@(
M     ,!_QARLT[E6!F$!                  #@/V,.UNE<*X.P
M            \)\Q!^MTKI5!6                    /C/F(-U.M?*("P
M                  #\9\S!.IUK91 6                    _C/F8)W.
MM3(("P                   /\9<[!.YUH9A 4                  (#_
MC#E8IW.M#,("                  # ?\8<K-.Y5@9A 0
M    X#]C#M;I7"N#L                    /"?,0?K=*Z505@
M          #XSYB#=3K7RB L                    _&?,P3J=:V40%@
M                 /XSYF"=SK4R" L                   #_&7.P3N=:
M&80%                  " _XPY6*=SK0S" @                  P'_&
M'*S3N58&80$                  . _8P[6Z5PK@[
M  #PGS$'ZW2NE4%8        (!7FSIU[\<47Z]\" )#&BHJ*[.]?^K<
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MDY-CA@L+"S7DC/V=R^SS__[?_]NT:9.&        $L>8@W4ZU\H@+
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M[:FLK$Q#<:NHJ"@H*# 7RLG)V;ESI^8       #<,^9@G<ZU,@@+
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M:=2H48RWJK6_^YAAV[)ERS244!'?9=G;EUP      ("0T%"K\[E6!F$!
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MU9#!OB3-<.RIV439L6.'N6A0ITZ=- <      ."&,0?K=*Z505@       #
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MWT3KW7>HCJ^)5KJI]<N[[[XK>YXT:9*&:I26ELHWHX$#!VHH.7A'6
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MTAI/IY^V<-]$Z]UWJ(ZOB5:ZJ4T2W5#*)6H0=M^^?=K:LIHW;ZXY
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M]PHR:8W[TV_OWKW:PGT3K7??H3J^)EKIIC9)=$,IEZA!V(@G9__^_34'
M  #@AC$'ZW2NE4%8        P*,A0X;H!)!E+5RX4'->:>L #27:X,&#=4G+
MFC%CAN8<FSY]NK:SK%MOO55S ?;?:]2R'GOL,<W515NX_[AIO?L.U0EJ$H_%
MBQ>'EL[*RMJV;9LF7)H[=ZYQ-$>]]]Y[&JWMEEMNT1K+>O/--S674+XLZN\5
M9-(:RSITZ)"&8MJR98NV<'\.:[W[#M7Q-=%*-[6^./?<<\W='G_\\3'>#_N.
M.^XPP[9UZ]9I*&GFSY\OJ]ONOOMNS0$      +AAS,$ZG6ME$!8       #P
MZ*FGGM()(,MZXXTW-.>5M@[04**-'S]>E[2LD2-':LZQ$2-&:#O+FCAQHN8"
MNG;MJE'+6KITJ>;JHBW<?]RTWGV'Z@0UB<=MM]T66GK @ 'ZLGM5554GG732
MT>.I,6C0((W6-F[<.*VQK$<??51S">7+HOY>0::,C RIVK=OGX9B*BXNE@Z6
M^W-8Z]UWJ(ZOB5:ZJ4V]/7OVR"<N]I5[VFFGF>$V;=IH(IEFS)AAKAXT9LP8
MS0$      +AAS,$ZG6ME$!8       #PZ.]__[M. %G6N''C-.>5M@[0D"<Q
M&JY<N=)\-2CV)%9L/_WI3[6=97WYY9>:"VC9LJ5&+6O7KEV:JXNV"#O,.FF]
M^P[5"6KBV;Y]^_+S\T-+SYHU2Q.>_/&/?S0.Z(C<W-S=NW=KU!!QI/+G/_^Y
MYA+*ET7]O8),!04%4K5ERQ8-Q31MVC3I8+D_A[7>?8?J^)IHI9O:U)LY<Z;L
M]NFGG]90C6W;MDFXSI'TQ++W)ANPS9X]6W,       !N&'.P3N=:&80%
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M^_?7D.'44T\UPZU;M]9$DIUUUEGF!FSV6:<A        EXPY6*=SK0S" @
M     -Y-G#A1QH#R\O(.'CRH.4^D<Y"&/*FSX3WWW&-F@F;/GJVYF.;.G:LM
M+,ONK#G#+W_Y2RVHJR3<Q1=?K"VB'&8,6N^^0W6"FG@S=.C0T*(_^M&/].7X
M'#ITZ,033S0.ZXC!@P=KM+8[[[Q32C(R,HJ+BS47TZQ9L\P.G3MWKJJJTI#!
MET7]NH),CSWVF-06%A9J*#K[LRGE09JKB]:[[U =7Y..'3M*;;1)XHT;-YJQ
M,\\\4Q-)-F_>/',#MC%CQFBHQN;-FR5\PPTW:"B9*BHJPM]MU_Z>J#D
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M6K9LF89JO/SRRQ*>,F6*AI)IZ=*EL@%;8M]\&@      _'<*#;4ZGVME$!8
M      "(2_?NW642*%'32-(V2$.>.&DX9\Z<C(P,,VGKV;/GOGW[-!IF__[]
MA86%4FMWJ_,=,;___OOPF44KL&YI::FFPRQ;MJQ)DR9:'*#1NFB]^P[5"6KB
M@3DA=\())U165FHB;M]\\TV#2(.2DR=/UFAM$2>5!PX<>/CP88V&L<\!>;O?
M<\XYIZ*B0G-A?%G4ERO(9!]=NW;MI,F  0-BOY>M;=VZ=:U;M[;#W;IUDW++
M_3FL]>X[5,?7Y#>_^8W43IHT24,!M]YZJQE[ZJFG-)%D145%Y@:..^ZX&*>H
M[-:V9LT:#273A D39 /V=T,- 0      N'=T#-;Q7"N#L        $!<GGKJ
M*1D&NO[ZZS7DB;0-TI G#AN.'CW:3 :=?/+)"Q8LT*CA_???/_744[7,LIYX
MX@F-1C)^_'BM#.C2I<L77WRAZ1I5554OO?12X\:-[61>7IX6QSS,B+3>?8?J
M!#7QP!RGN^^^^_3E!+GTTDN-(SO"R23<\.'#M2SP%JW__.<_-6KX]--/SSKK
M++,D.SM[^?+EFHO"ET5]N8),(T:,T"Z6=?OMMQ\X<$"C-6;.G-FF31L[EIF9
MN7CQ8BUV?PYKO?L.U?$UD?=YM0+CR.$#II]]]IG]R35CJU:MDDQ2E9>7Y^;F
MFAN(_9:T'3MV-,,M6[;41))=<\TUY@9L3S[YI(8       #<,^9@G<ZU,@@+
M        Q&7GSITRO?2#'_S@X,&#FJN+V2&5=!^UC1HU2@L"OV"]5Z]>X\:-
M6[9LV;___>^*B@K[S^7+EX\?/[ZHJ*A!I#<*'3%BA+:.PO[0]>W;5^L#,C(R
MKKKJJI=>>FG-FC7???>=G=RU:]?2I4N??/+),\\\,Q1[]=57C:+(=%7W'W^M
M#]!07;0^#MHZBM-//UTK';OYYINUG0/:)>#>>^_5G&7EY.0,&#!@VK1IJU:M
M*BDIJ:RLM"^NSS__?.+$B9=<<HF$[=/LV6>?U;XQ^;)HZJ\@T]Z]>]NW;Z^]
M+,O^RT<>>63QXL7;MV^W#WGW[MWVX4^:-*EW[]ZAS..//UX=Z;S2-<)H05VT
M/D!#==%Z@_V%XH033I#\%5=<\>&''^[;M\_^X*];M\[^&M*T:5,S<-EEEVFC
M)'O__??-#=A&CQZMH1H;-VZ4\,"! S643/;'33YB]J5D7SN: P      <"\T
MU.I\KI5!6        "!>-]UTDSD/9)LS9XZ&ZB(=4D;W$>:%%UZ(^!ZK#N7F
MYKJ='?S^^^_/.^\\;>1 @P8-IDR94NW@@ZE+.B@16A^@H;IH?1RT=11I,@AK
M&S-F3%96EJ:=L3_14Z=.U8X.^+)HZJ\@T_SY\ST<\M"A0X/E^D*8VJLY*A%:
M'Z"ANFA];1,F3-""F.S/U[)ER[1+DH7/3"]=NE1#-5YZZ24)3YPX44/)%/X^
MN[_\Y2\U!       X$EHJ-7Y7"N#L        $"\_OG/?V9D9)@C0?W[]]=0
M7<SR5-)]1/+EEU\6%15II0.]>O5:N7*EMG.@M+3T?_[G?[1=3,V:-9LU:U:P
M7%\+4WLU1R5"ZP,T5!>MCX.VCB)]!F%M2Y8LZ=JUJQ;4Y>233UZX<*'V<LR7
M15-_!9GFS9M74%"@K:/(RLIZ]-%'0[7Z<AAC':<E0NL#-%07K:^MJJKJFFNN
MT9HH[(_ *Z^\HBV2KU^_?N8VFC9M>OCP80W5N.666\RPS3['-)1,/_G)3\S5
M[>^ JU>OUA       ( GQARLT[E6!F$!      " !) WA<W(R%B[=JV&8C++
M4TGW$=W?__[WOGW[RLAO1':F3Y\^,V?.U!8NS9T[]X<__*%V#].H4:.A0X>:
MOY5;$V&,19R6"*T/T%!=M#X.VCJ*M!J$M1T^?'CZ].GGGW^^ED72H4.'QQ]_
MO+2T5+NXY,NBU7Y<02'KUJW[Q2]^D9F9J2O5UKMW[R5+EIB%F@ACAAV6"*T/
MT%!=M#Z,_4E_Z*&'\O/SM;*V,\XX8]&B15J<? </'FS<N+&YDRNOO%)#!ONT
M-,,M6K2HJJK24-*L6;.F08,&Y@8&#1JD(0       *^.CL$ZGFME$!8
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M[KMGSYZ=RG'28]?MM]]N?K-KW+AQDLY8      #PW\F8@W4ZU\H@+
M ) 8X\:-,V>#LK*REBU;IB$  (Y9GWWVF;RU\)@Q8S0$       0!V,.UNE<
M*X.P        0&)4555==MEEYGA0]^[=#QX\J#D  (Y!]G>T+EVZF-_F^O;M
MR]OH @    " Q#+F8)W.M3(("P       "3,CAT[.G3H8 X)#1\^7$,  !R#
MA@T;9GZ#:]>NW;___6\- 0      Q,>8@W4ZU\H@+        )!(*U>N+"@H
M,$>%GGWV60T! '!,F3)EBOFMK4F3)BM6K- 0      ! W(PY6*=SK0S" @!<
M,&]V P   , Q1W_(29K%BQ<W;=HTM&YF9N8;;[RA(0  CA%_^]O?[.]EH>]K
M39HT^?CCCS4$      "0",8<K-.Y5@9A 0 NA&YV P   ,"Q2'_(2::E2Y>V
M;MTZM'1&1L8CCSQ2556E.0  TIC]G<O^_F5_%PM]1VO5JM62)4LT!P
MD"#&'*S3N58&80$ +H3N=P,   # L4A_R$FRS9LW]^C1P]S 3W_Z4PT! )#&
M!@P88'XC.^^\\S9MVJ0A      " Q#'F8)W.M3(("P       "1+967EL&'#
MS%\GK0D  -)8Z/N7_;WL_OOOM[^O:0(      ""AC#E8IW.M#,("
MR55<7'S))9<P" L ..8$OWG9W\56K%BAKP$      "2!,0?K=*Z505@
M   @%>;,F5-45*1_"P! &KOHHHMFSYZM?PL      ) TQARLT[E6!F$!
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M==IKI0@+                  " Z#-ZL$Y[K11A 0
M$'U&#]9IKY4B+                    *+/Z,$Z[;52A 4
M     $#T&3U8I[U6BK                    "(/J,'Z[372A$6
M            T6?T8)WV6BG" @                  (/J,'JS37BM%6
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M+#$QT0RGI:5IR!G[;=W<\^M?_WKGSIT: @      I>YT#=9QKY4B+
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MNAS>H;;L[&QYR[OBBBLT9.C:M:L93DA(*/YGI3_[[+/FSI24E/3T= T!
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MU.OSSS^7IS!AP@0-%<C*RJI4J9(9[MJUJX:*9_WZ]3$Q,>8AA@P9HB$
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MBR^J5*FBCX54O7KU;[_]MO#1 M"QL)3.'5JNB[#9V=G^%[;]%P;- 0    "
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MS%KNGT*T?/WUUW+FX\>/UU"![.SL2I4JF>&>/7MJJ*3-F3/'/*+7U*E3-0<
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MG/9KK[VFH0+^K=G1HT=K* (R,S/EN);G0Y<U!P      (L#HP3KMM5*$!0
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M:-FYB73&_95Y^/!A7>%^B<Z[WY!?O"4ZZ68V0O2$2EU)%6$#7IS]^O73'
M    B(#3-5C'O5:*L        *B@1H\>K247RUJ\>+'FPJ6K/304EMFS9^M>
MCSY]^FC4<,LMM^B 9:U:M4ISD:<G85F;-V_6D#-SY\[5798U9,@0S>7G#QLV
M3'.6-6?.',TY]OKKK^LZR[KUUELU5PQ???75[W[WN]C86#V,Q\*%"W7 C\ZX
MO )UV.5X1"U=NM1W5O'Q\7OW[M6$2^^__[[Q1$_[Y)-/-%K8[W__>YVQK+??
M?EMS)2HJ!RT[-Y'.6%9N;JZ&0MJ]>[>N<']YZ[S[#?G%6Z*3;F:CHFW;MN;9
MUJA1(R\O3T,%1HX<:8:M8KQ3A&'1HD5R=-L?__A'S0$     @ @P>K!.>ZT4
M80$      %!!/?'$$UIRL:RWWGI+<^'2U1X:<B\K*ZM9LV:ZU^/33S_5M&'Z
M].DZ8%G_^<]_-!=Y>A*6]>&''VK(F8<??EAW6=;DR9,UEY__Y)-/:LZR)DZ<
MJ#G')DR8H.LLZ^FGG]9<L:U<N;)UZ]9ZI'#[@IH(28==CD?4\.'#?6=U[;77
MZL/NY>7EG7766:>?:H& O6K3C!DS=,:R'GGD$<V5J*@<M.S<1/[M\,S,3 V%
ME)Z>+ALL]Y>WSKO?D%^\)3KI9K;T'3IT2+YPH>_<<\\]UPPW;-A0$Y$T9\X<
M\^A>4Z=.U1P      (@ HP?KM-=*$18        5U'__^U\MN5C6C!DS-!<N
M7>VA(??&CAVK2ST&#!B@T<("_J+GN^ZZ2W.1IR=A65.F3-&0,X,&#=)=EO79
M9Y]I+C]_[=JUFBNJAA7:====I^LL:]VZ=9HK"?OW[S_[[+/E6.>==Y[F_,B(
MY?(*U&&7XY&3F9F9G)SL.ZOWWGM/$V%YZ*&'C.=Z2E)2TH$#!S1J"%BI'#QX
ML.9*5%0.6G9NHI24%)G:O7NWAD)ZY9579(/E_O+6>?<;\HNW1"?=S):^^?/G
MR]G^\Y__U%"!O7OW2KC(2GK)LL]-3L"V8,$"S0$     @ @P>K!.>ZT480$
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M=\G9KEJU2D,%_)O*]EVOH4CZV]_^)B=@V[MWK^8      $ $&#U8I[U6BK
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MSKO?D%^\)67S#@WHR)$C\N[3KU\_#1F:-V]NANVW&TU$6.O6K<T3L-E7G88
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MO__][\VPS;[&-!1)O7OW-H]NOQ&O7[]>0P      ()).UV =]UHIP@(
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M9+ O2S-<ITZ=O+P\#47,A@T;8@K_QQA#A@S1$       B+#3-5C'O5:*L
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M7BM%6         "1I477HN@\         *!B,'JP3GNM%&$!
M       0?48/UFFOE2(L                    HL_HP3KMM5*$!0
M            0/09/5BGO5:*L                    (@^HP?KM-=*$18
M                  #19_1@G?9:*<("                   @^HP>K-->
M*T58                    1)_1@W7::Z4("P                  @.@S
M>K!.>ZT480$                  !!]1@_6::^5(BP
M  "BS^C!.NVU4H0%                  ! ]!D]6*>]5HJP
M        B#ZC!^NTUTH1%@                   -%G]&"=]EHIP@(
M             "#ZC!ZLTUXK15@                   !$G]&#==IKI0@+
M                  " Z#-ZL$Y[K11A 0                  $'U&#]9I
MKY4B+                    *+/Z,$Z[;52A 4                  $#T
M&3U8I[U6BK                    "(/J,'Z[372A$6
M    T6?T8)WV6BG" @                  (/J,'JS37BM%6
M         $2?T8-UVFNE" L                  (#H,WJP3GNM%&$!
M               0?48/UFFOE2(L                    HL_HP3KMM5*$
M!0                  0/09/5BGO5:*L                    (@^HP?K
MM-=*$18                   #19_1@G?9:*<("                   @
M^HP>K-->*T58                    1)_1@W7::Z4("P
M    @.@S>K!.>ZT480$                  !!]1@_6::^5(BP
M          "BS^C!.NVU4H0%                  ! ]!D]6*>]5HJP
M                B#ZC!^NTUTH1%@                   -%G]&"=]EHI
MP@(                  "#ZC!ZLTUXK15@                   !$G]&#
M==IKI0@+                  " Z#-ZL$Y[K11A 0
M$'U&#]9IKY4B+                    *+/Z,$Z[;52A 4
M     $#T&3U8I[U6BK                    "(/J,'Z[372A$6
M            T6?T8)WV6BG" @                  (/J,'JS37BM%6
M                 $2?T8-UVFNE" L                  (#H,WJP3GNM
M%&$!                   0?48/UFFOE2(L                    HL_H
MP3KMM5*$!0                  0/09/5BGO5:*L
M (@^HP?KM-=*$18                   #19_1@G?9:*<("
M       @^HP>K-->*T58                    1)_1@W7::Z4("P
M            @.@S>K!.>ZT480$                  !!]1@_6::^5(BR
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M:M4J,ZP/.Q;V$G/01T,AA3V(,X]Y,?AH" A7.?W[DIXH-P4J*NX"
M     !6<T8-UVFLM3T78F3-GFC\8]O?44T_I#% &Z)5*K2$__]9;;Y77Y+__
M_:^&#$>.'#'#^K!C82\Q!WTT%%+8@SCSF!>#CX: <)73OR_I67)3H*+B+@
M          !0P1D]6*>]UO)4A.W0H8/OI\()"0G&SXA/:=NVK<X 98!>J=0:
M\O/;M6LGK\GWWW^OH0@PCZB/A60.^F@HI+ '<>8Q+P8?#0'A*J=_7]*SY*9
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M^^]__]N^7'6R&,K4>V5H(T:,D.O<ODC6K%EC9LQ'S3^WG3AQPG^#?PP
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MC,4\=.A0CY^&FY:63B+,:V6PNG?OKE.Q+/=,S*VR*:Y/GSY>P@
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M8$_CQ1=?//_\\^VMFK"+5D\DY&MEL-JT::/S2'2_9VZ537'VQ<Y+&
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MJKPLYL<>>TQ2; \\\(#&!2I_KI6!>/CAAW7XE/;99Y^^??O^ZU__LJ^#6@L
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M9OK)#58%6QMATNDZ-,B_A.^(W_499Y];M)9E77#!!1J7B*99UHH5*S0H.SI
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M.@<==)!&[)(GU\HLF8/::T W[V*&Z3;'TJ5+S9B8IDV;:AP
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MTH<??FA6:-.F34E)B089\N%:F25SW#///%,W[V*&Z3;'*Z^\8L;$C!HU2N,
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M>^XY#2HK'ZZ563+'M?WWO__5"(<9H]M*2W?LV''DD4>:,39[9Q87%VLH
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M;KMV[;ST<49^K<R2.;3E=*\F_(H ,T:WE9;^^<]_-@-B<M$<#P
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M+HEHKY59,D>/:=*DB7V7F"+,_/G<N7//..,,<VM,KUZ]S#
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M/H5PK<P%>]HC1XZTUT.K5JUTENG8K^*TTT[[\,,/2TI*M"X
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M?+-]EYA]]S              Y#^C#]9K7RN-L     "0%\Q&6-T&
M     )6 T0?KM:^51E@     R LTP@(           "HY(P^6*]]K33" @
M $!>H!$6            0"5G],%Z[6NE$18     \D+VC;!F!0  @/)+[W(
M        5!I&'ZS7OE8:80$    @+V3?_&%6    *+_T+@<       ! I6'T
MP7KM:Z41%@    #R0O;-'V8%  " \DOO<@        !4&D8?K->^5AIA 0
M " OT/P!            H)(S^F"]]K72" L     >8%&6             "5
MG-$'Z[6OE498     ,@+-,("            J.2,/EBO?:TTP@(   ! 7OC9
MH-L             H!(P^F"]]K72" L                  (#H&7VP7OM:
M:80%                  ! ](P^6*]]K33" @                  ('I&
M'ZS7OE8:80$                  ! ]HP_6:U\KC;
M  "(GM$'Z[6OE498                    1,_H@_7:UTHC+
M         *)G],%Z[6NE$18                   #1,_I@O?:UT@@+
M              " Z!E]L%[[6FF$!0                  0/2,/EBO?:TT
MP@(                  "!Z1A^LU[Y6&F$!                   0/:,/
MUFM?*XVP                    B)[1!^NUKY5&6
M $3/Z(/UVM=*(RP                   "B9_3!>NUKI1$6
M        T3/Z8+WVM=(("P                  @.@9?;!>^UIIA 4
M             $#TC#Y8KWVM-,("                   @>D8?K->^5AIA
M 0                  $#VC#]9K7RN-L                    (B>T0?K
MM:^51E@                   !$S^B#]=K72B,L
MHF?TP7KM:Z41%@                   -$S^F"]]K72" L
M     (#H&7VP7OM::80%                  ! ](P^6*]]K33" @
M            ('I&'ZS7OE8:80$                  ! ]HP_6:U\KC;
M                  "(GM$'Z[6OE498                    1,_H@_7:
MUTHC+                    *)G],%Z[6NE$18                   #1
M,_I@O?:UT@@+                  " Z!E]L%[[6FF$!0
M    0/2,/EBO?:TTP@(                  "!Z1A^LU[Y6&F$!
M           0/:,/UFM?*XVP                    B)[1!^NUKY5&6
M                 $3/Z(/UVM=*(RP                   "B9_3!>NUK
MI1$6                    T3/Z8+WVM=(("P                  @.@9
M?;!>^UIIA 4                  $#TC#Y8KWVM-,("
M   @>D8?K->^5AIA 0                  $#VC#]9K7RN-L
M         (B>T0?KM:^51E@                   !$S^B#]=K72B,L
M                HF?TP7KM:Z41%@                   -$S^F"]]K72
M" L                  (#H&7VP7OM::80%                  ! ](P^
M6*]]K33" @                  ('I&'ZS7OE8:80$
M ! ]HP_6:U\KC;                    "(GM$'Z[6OE498
M        1,_H@_7:UTHC+                    *)G],%Z[6NE$18
M              #1,_I@O?:UT@@+                  " Z!E]L%[[6FF$
M!0                  0/2,/EBO?:TTP@(                  "!Z1A^L
MU[Y6&F&5E8XFN&B"BR8      #*EOW&Y: (  %'3:Y6+)@! ^:%G-!=-
M    *,OH@_7:UTHCK-*_DG'1!!=-<-$$    P#%[]NQSSSVW3ITZ>^ZYI_V'
M.7/F: 0 %_V-RT43 )0W7!\CQ,[/$;U6N6@" )0?>D9ST83\L&'#AH\__OB1
M1QZYX((+.G3HT*I5JX8-&U9S[+777@<??/"IIYYZW777O?CBBS-FS-!DP,#M
M$P    !DS^B#]=K76OX:85>N7%E45&3^I4FU:M66+U^N<9DR*R>D"2Z:X*()
MN:<SR%3UZM4;-6K4NG7K8X\]]JJKKGKZZ:<G39JD@P'(&WH,6Y9]_M0@ $#>
MF#U[=OWZ]<WS=L.&#>?.G:MQ ,HRCYJ$- % N<+U,4+L_-PQ]VI"FH"4=/=Y
MIH4 !$&/-!=-B-KGGW_>MV_?6K5JZ423:]2HD9WR]MMOKU^_7LNA<N/V*4_D
M^FDR    @%PS^F"]]K66OT;8QQY[S/R])6;0H$$:ERDM[:()+IK@H@FYIS,(
MU"&''/+PPP^O7KU:1P40-3U<G;]TTR  0-[HT:.'GK@MJV?/GAH'H"P];%PT
M 4"YPO4Q0NS\W-'=ZJ()2$EWGV=:"$ 0]$AST83HS)PY\\033]3Y^5&M6K73
M3COM]==?W[)EBU9'I<3M4Y[(]=-D     +EF],%Z[6LM?XVPAQYZJ/[B8EEM
MVK31N(#H2/[_CD;S_5?(GLX@!YHT:?+66V_IP "BLVW;-CU0+:M5JU8:!P#(
M&WONN:>>N"VK3ITZ&@<@)3V*HO@5#$" N#Y&B)T?&MW+7+Q\TMWGF18"D -Z
MX.7-H3=HT*#JU:OKY#*UUUY[77/--1,G3M1A4,EP^Y0G0GZ:#    "!P1A^L
MU[[6<M8(^\477^AO+;N,&S=.HX.@P_C_.QK-]U\A>SJ#G+GAAAMT;  16;=N
MG1ZBEG7**:=H' "$2,]*4=P7!4A?3-8O)^'W,-:N75OC *2D1U'6QR8 7_0(
MS/H8Y/H8(7:^F^Z.K%=XC!8-J&SEH;O/,RT$( ?TP,N/0^_::Z_5:3D*"PO/
M/??<)YYXXLLOOUR\>/&&#1NV;MWZRR^_S)PY\U__^M?MM]]^U%%':4Y9.A(J
MF4!NGS2?=>53^$^3 >0G/05P.D46=#&QG !47'J^B^Z,9_3!>NUK+6>-L'W[
M]M6=O<LEEURBT4'08?R_NYKOOT(NZ)P<&K1+<7'Q\N7+?_SQQ[???OO66V]M
MV;*E9AKNN.,.S0<0A04+%NCQ:5G777>=Q@% B/2LE/SVHUS0%Y/URSGKK+.T
MHF6=??;9&@<@)3V*LCXV ?BB1V#6QR#7QPBQ\]UT=V2]PF.T:$!E*S/=H0X-
M A */13SX&#\V]_^IG-R].W;=^G2I1KM\N677YYTTDF:O(M&HY()Y/9)\UE7
M/H7_-!E ?M)3 *=39$$7$\L)0,6EY[OHSGA&'ZS7OM;RU B[;MVZA/^2,J9&
MC1JK5Z_6G*SI,/[?7<WW7R$7=$X.#4JBI*3D[;??;M*DB>8[[+4T8<($S0$0
MNG'CQNGQ:5G_]W__IW$ $"(]*WF^_<A/^F*R?CE3ITZM6[>N6=#^WVG3IFD<
M@)3,@RA&(P#DDAZ!61^#7!\CQ,YW,_=&C$9D1(L&5+8RTQWJT"  H=!#,>J#
M\8<??JA6K9I,J:"@X!__^(>&)K=CQXZ[[KI+BL1H*"J90&Z?S/08C4!RD3Q-
M!I"?]!3 Z119T,7$<@)0<>GY+KHSWNXV6,]]K>6I$?;IIY_6/5W6XX\_KCE9
MTS'\O[N:[[]"+NB<'!J4TI(E2UJT:*$E',<>>ZQ& PC=L&'#Y-@L*"A8MFR9
MQ@% B.2\9/F\_<@W^F*">#G3IDT[YYQS:M>N7:M6K;/..LOODQ( I;DY-@%X
MIT=@$,<@U\<(L?.%KN\@5GAISLI69KI#'1H$(!1Z*$9],";\P,Z! P=JG ?7
M7'.-%HKZU2$?9'_[I*N*=>5')$^3 >0G/?XYG2(+NIA83@ J+CW?17?&,_I@
MO?:UEJ=&V X=.L1W<6%AH;'#=SK\\,,U)VLZAO]W5_/]5\@%G9-#@]+Y^NNO
MM<0NDR9-TF@ X;KLLLODP.S4J9,& 4"XY+QD^;_]R"OZ8LKYRP$J##TR.3:!
M<.D1R#&(BD77=T K7(L&5+8RTQWJT"  H=!#,=*#<>[<N7OLL8?,YX ##MBZ
M=:N&>K!MV[:##CI(JFD0X)\L*M:5+Y$\30:0G_3XYW2*+.AB8CD!J+CT?!?=
M&6]W&ZSGOM9RTP@[<>+$^/XM*"AX[+''C!V^VU=??:69V=$!_+^[FN^_0B[H
MG!P:Y,'99Y^M51P///" A@((T8X=.QHW;BP'YBNOO*)Q ! N.2]9&=U^Y ]]
M,>7\Y0 5AAZ9')M N/0(Y!A$Q:+K.Z 5KD4#*EN9Z0YU:!" 4.BA&.G!^/##
M#^ML+.N>>^[1.,]>>^TUJ:81@'^RJ%A7WD7U-!E ?M*#G],ILJ"+B>4$H.+2
M\UUT9SRC#]9K7VNY:82]^NJKX_OWC#/.V+IU:Z-&C8Q]OM,55URAF=G1 ?R_
MNYKOOT(NZ)P<&N3!<\\]IU4<7;MVU5  (1HQ8H0<E<V;-]^V;9O& 4"XY-1D
M973[D3_TQ93SEP-4&'ID<FP"X=(CD&,0%8NN[X!6N!8-J&QEICO4H4$ 0J&'
M8J0'XUEGG:6SL:P)$R9HG&?;MFW;:Z^]S&H: ?AGKBC6E2]1/4T&D)_TX.=T
MBBSH8F(Y :BX]'P7W1G/Z(/UVM=:/AIA-VW:5+=NW?C^???==^T?WGSSS<8^
MWZEV[=KKUZ_7_"SH /[?7<WW7R$7=$X.#?)@ZM2I6L71IDT;#040HF.//5:.
MRK?>>DN# "!T<FJR,KK]R!_Z8LKYRP$J##TR.3:!<.D1R#&(BD77=T K7(L&
M5+8RTQWJT"  H=!#,=*#\< ##]396-;2I4LUSH_>O7N;U70SX)^YHEA7WD7X
M-!E ?M*#G],ILJ"+B>4$H.+2\UUT9SRC#]9K7VOY:(1]Z:67XCNW<>/&L0\U
MG#5KECWMW7M]EV>??5;SLZ#5_;^[FN^_0B[HG!P:Y,&*%2NTBJ-^_?H:"B L
M]FE0#LF>/7MJ$ !$0<Y.5D:W'_E#7TPY?SE A:%')L<F$"X] CD&4;'H^@YH
MA6O1@,I69KI#'1H$(!1Z*$9Z,-:J54MG8UE;MV[5.#^>?_YYLYIN!OPS5Q3K
MRKL(GR8#R$]ZY',Z119T,;&< %1<>KZ+[HP7;VKUWM=:/AIA.W?N'-^YM]YZ
M:_SG)YUTDK';=SKZZ*.-U&QI=?_OKN;[KY +.B>'!GFP=>M6K>(H+"S44 "A
M^.:;;^3O<]NU:[=V[5J- X HF&>G&(TH5_3%E/.7 U08>F1R; +ATB.08Q 5
MBZ[O@%:X%@VH;&6F.]2A00!"H8=BI =C04&!SL:R5JU:I7%^C!\_WJRFFP'_
MS!7%NO(NPJ?) /*3'OF<3I$%74PL)P 5EY[OHCOC&7VP7OM:RT$C[+1IT^)[
MUI[G[-FSXYM>>^TU8[?O-GGR9*- 5K2T_W=7\_U7R 6=DT.#/$CVB;"-&C72
M4/\6+5KTW'//]>W;][>__6V3)DUJU:I54%!@_]?^<Z=.G>R?VUOM&$W+F<V;
M-[_[[KM77765_>NQ_0*K5Z]>M6K5>O7JM6W;]NRSS[[SSCL_^."#)4N6:)H?
M@0^1;_LPSTV:-.FAAQ[JT:/'(8<<LM=>>U6K5JVPL-#>_P<==-!IIYW6OW__
M4:-&9?GQ -YEMACLEV 'FP?C?OOMMW#A0@GSQ3[K/OWTTY=??OE11QW5HD4+
M>PZQF=A_[MBQXZ677CIDR)#QX\=OW[Y=,_-59OLVA;Q:.?/FS7OTT4=[]NS9
MIDT;>S+V2ZM1H\:^^^Y[TDDGW7KKK9]__KDFY$ %V,/A+_OP7V,*2Y<N'31H
MT#GGG+/__OO;EXRBHJ*F39L>=MAAO7OW?O[YYQ<O7JP)?I@GJ!B-R,[JU:O?
M>^\]>YEU[][=7G+V]<X^!.Q%:+^$0P\]M%NW;G?<<<=__O.?#1LV:&9&],4$
M_7("E&^W!#E=9J;P#^=@A;RD/0KM[8NQ+U[V)<R^D-F7LYHU:\;>P=:M6]L3
M>/#!!Z=.G:H)Y>K8+!?R<QT&?K_A%M00^;D#<WH@ZQ&8Q\=@^/=@Y?W"E%,Y
M798!TO4=T K7HHG*3IX\^?;;;[?/&[%KHKV+[%.*?2;IU:O7DT\^.6?.'$W(
M6OC'2(!TASHT*'21W)97PBM1[K S2\O__7F=.G5T-I;UW7??:9P?\I1$-_L7
MX>EW_OSYSSSSS"677!*[![;?XBI5JM2M6[=Y\^;V(K=O@V^YY9977GEEVK1I
MFEGA!/7K0&;,%174NJKPHGV:+-RG2OM8_LUO?G/NN><^^NBC\^;-TX2P!+ZP
M(SQ?13BT*"DI^?CCCZ^^^NKV[=OOO??>]BZUKS7V1?F,,\ZXYYY[9LR8H0DN
M]B^ (T>.M-^7(X\\LG[]^K$7TJI5JZY=NS[PP -97J02RI^]5YKC.QD][,O#
MZ30_;S@KTMDC8[J80EQ.@>__?% >UT#N1'(3'LE?4*00PCH/?(@(EW&NUXR>
M[T(\XXEX4ZOWOM9RT A[PPTWQ/?LR2>?;&[:LF6+?3MH[/F=KKGF&C,L&UK:
M_[NK^?XKY(+.R:%!'DR=.E6K..P[=0WUS/Z%P3Z_V+\?[I'HRTJ$?2ZV(^UX
MK9*.%G(Q@S=MVC1PX$#[S*5!B<2S=(.+,4*&0R23ZWVH)5*RS[::[W+KK;>:
M*3-GSM2(LAYYY!$S/@7-3,2^]@P;-LR^O&ER(O8OL====YW?2[Y6<3&#LUD,
MIY]^NKFU7;MV?J=J>OOMMT\\\40OJ\AF3]C^I?355U_=N'&C%LHEG8>+&9S-
MOG7+MY7SPP\__/[WOT_[?AU\\,%OO/&&F9B:YKN8P>5N#[N%O.Q#>(U:Q<4,
M7KER9;]^_>R;?@TRV#?Q]HW6LF7+S,04-#\CL2\R2V'%BA5#AP[MUJV;_0N&
M)B=2NW9M^P[3[\XLS=G+T0@7B?<NU[<$,5K(Q0S.Q3)+*.3#.5BA+>G2?'W[
M2IW5^_KKK]N7+1W Q7ZCQXT;9^9J1!8'469T^)3R]FXY;]=A9O<;NL'%&"'#
M(43>[L!<',B:GY$PKX\AW(.YE:\+DT[(11-<-,'%#,[%L@R03B4C[A4N-*'L
M+OKO?_][P@DG:$19]KW<11==9/9\9"R28R1P.E&'!H4EG-MR4:FN1+G&SBPM
MY_?GIOWWWU]G8UF//?:8QD4APM.O_?Z^\\X[QQUWG)?35$RS9LWZ]NW[YIMO
M;MZ\6<L9-,U%$Q+1'!=-<-$$%S,XLU\'=(.+,4("&IV1^/V&;DCGS#//+#N=
MW:9/GZ[126AFZ*)]FASC\51I'VB___WOITR98N9JD(L9G$%*9@L[F0C/5R$,
MK55<S. Q8\8<?OCA&E'6J:>>^OWWWYM9IN'#A[=LV5)SRCKKK+,2_E,3O_)M
M[^7B3D;S,Y+VU[=<R-L;S@IS]LB 3B@C[N6D$2YF< ;[7W_J8M9/1G-<-,&S
M\K4&<BUW-^$IA/,7%%K(Q0S.8)V7AC)$,A$NX]RM&4W+B/N,E[T]#+HMB7QO
MA"TN+F[0H$%\K]F_/TB O6*,O;I3O7KU['4LD9G1TAX6O=!\_Q5R0>?DT" /
MGGWV6:WBN/;::S74F\F3)W?JU$G+>7#LL<>F^"W"3?-=XI'3IDT[Y)!#='-R
M80Z14 C[4#-3\O)H_Z"##C)3'GSP08TH*Y!'^S%CQXYMW;JUIJ53O7IU>Y+>
MS^.:[Q*/S'(QK%NW[K>__6UL4_?NW=>L62,!'BU8L$!Z:KVK4Z?.U5=?_>VW
MWVK1W-#A7>*16>Y;D6\K9_#@P45%1;HYN5-..>7GGW\VADI*,UWBD>5Q#YO"
M7_;AO$;-=XE'?O755_:ML&Y.HG'CQAX_,D$S,Y+B]=K3[M.GC[U;-,>#:M6J
M/?300UHQ)2V1$??+T0@7B?<HA%N"&,UWB4?F:)F)\ _G (6\I$OS[^V+6;QX
M<=>N7;5H<@4%!3?==-..'3MBZ;HYTX,H8SI\2GEXMYS/ZS#C^PW=X)+]$''Y
MO -S="!K9D9"NSZ&<P]F*H\7)IV'BR:X:()+/#)'RS) .HF,I%T\FK!K%Y64
ME P8,*!*E2JZ.8D]]]QS].C196O[$_XQDB,Z18<&A2*TV_*X2G@ERAUV9DQY
MOS\WV4>6SL:RVK9M:Y]O-31<$9Y^)TZ<V+%C1RWM6;UZ]?KUZV<7T;H.C7;1
MA$0TQT437#3!)1Z9\:\#NL$E'IF01F>D,C?"1OXTN=3_J;*HJ&CPX,'Q=-WL
M8@SE.R7CA9U0A.>K<(;6?)=8F'WAN/GFF_?PUH926%@X;-BPLN.4;MBPH7?O
MWAJ:1(T:-4:,&"$5?,FKO5>:LSL9S<R(]]<;B'R^X:PP9X_,Z%0RXIZY1KC$
M(S/;__I3EWC]%#3'11.\*7=K(*=R>A.>3&A_0:'Y+O'(S-9Y.$,D%.$RSNF:
MT>B,9/D"$]K=!NNYKS7?&V&'#Q\>WV7UZ]??LF6+!"3[1-*77WY9(C.C==,M
M>C?-]U\A%W1.#@WRP/[U6*LXQHP9HZ$>///,,_;MFM;RS/ZET?U;1#*:[!(+
ML\\"'O]90%R80[B%LP\U+:6TC_;MRZVD''7441I45I:/]F/LWU'OO??>/;S]
MCII0MV[=5JU:I743T4R76%@@BV'-FC4GGGBBO1)T@V<__OACTZ9-=23_M&YN
MZ*@NL;! ]FU,'JX<^90XCYHU:^;EWQ!KFDLLK)SNX;B0EWV8KU$S76)AX\>/
MKUFSIFY+R;Y=EL\M2$C3,I+BOEE#_>O5JY?W;Q'2Y(RX7XY&N$B\%^'<$L1H
MLDLL+'?+S!3RX1PXG8=_OI9TJ8<18V'AO'TQWW__?69OXGGGG1?[,G'=$/H;
MJL.GE(=WRQKD7X[683;W&[K!)?LAXC3"OQSMP-P=R)J6D1"NCV'>@\65TPN3
M#N^B"2Z:X!(+R]VR#)#.("/N%2XTP=E%]J*][+++=$,ZA86%F?V]7"3'2.[H
MY!P:E'MAWI;':17_RMV5*'=T0OY5@)U9 >[/3>9G1IK^_O>_:VA8HCW]#ATZ
MU.,GSZ6EI1T:Y*()B6B.BR:X:()++"R;7P=T@TL\,B&-SDAE;H2-_&ERQJ?*
M_OW[QRKH!I>R _I(R69ABPC/5V$.K9DNI<Y\^O;MJQO2>>JII^*C;-JTZ?CC
MC]>(E,K%?;YFNL3"<G<GHVD92?OK6[!T>/]R=,-9,<X>V=!)9,2]G#3")1:6
M\?[7G[KLGDIRFN.B">F4TS60.[F^"4\HS+^@T&276%C&ZSR<(42TRSC7:T:#
M,N(^XV7/:6C=2;<ED>^-L.8_GKONNNMTLR/A/^'MTJ6+QF5$ZR99$REHOO\*
MN:!S<FA0.E]^^:66<'3JU$E#/;C]]MNUD//](,<==]R0(4.^_?;;)4N6%!<7
MV_^U_VS_)-FG/=MUM'0BFN9BQ_STTT\)ORTEM3"'$*'M0TU(*>VC_0$#!FB.
M9<V?/U_C#%D^VB]UKE)_^M.?--JY?E]\\<7__.<_9\V:M6[=NHT;-\Z=.W?T
MZ-'77W]]PK_%./+((U>O7JW5733-I33HQ9"Q9<N6-6G21$:I7;OV%5=<\<X[
M[_SXXX]KUZ[=OGV[_=^9,V>^]MIKO7OW3G;#I*5S0T=U*0UTW^;ARK'O6>/_
M:]_&77;991]\\('][JQS3)\^_=UWW[W@@@L2_IU"PX8-TWZWLN:XE);G/1P3
M\K(/^35JFHL=,V_>O/CO /9%?/#@P9,G3UZ^?+E]R5B\>/&X<>/Z]^]OKY:R
M>;\ZYIACXI_ODHSF9"3%?;.&.AHT:&#OMY$C1RY<N'#3IDU;MFRQKWU??/&%
M??E(^$U5O7KUTKI):&9&W"]'(UPD/JW0;@EB-,VE-,?++"[DPSD7=!Z.W"WI
MTB0CFDK#>OMB9LR8D?":8E_([/?+OJC9ES;[)+E^_7K[;#EBQ C[C&I^Z,L-
M-]Q0FNA%Z3 YIL.GE(=WRQKDB'P=9GF_H1M<LA\B3B,<D>_ G![(FI.17%\?
M0[X'BRF_%R8=WD437#3!I33'RS) .GQ&W"M<:(*SB^Z^^^[X_YY\\LE//OGD
ME"E35JQ88>^BGW_^><*$"??==]]^^^UG).UD_]!>SSI&2I$<(SFE,W-H4(Z%
M?%L>I_F.BGTERAV=C:-2[<R*<7]NLB_!.AM'U:I57WWU58W.O6A/O__[O_^K
MA9RA>_3H,7SX</NBLVK5JJU;M]JKRUYC+[[XXOGGGY_B.ZFTND.#7#0A$<UQ
MT00737 IS?K7 =W@LGLVB6AT1BIS(VRT3Y.]GRKMV_X//_SPLLLN,QLRGGWV
MV5(/[YJ.ZBTERX5MBO!\%?+0FN92:MRHVW/HTZ?/!Q]\8 ^]>?/F-6O6V&_W
M4T\]U;Y]^[))O[*O-?&O^^C9LV?LA^X*TZ9->_SQQQ/>5+1LV=)7OV-I7NZ]
MG-[):$Y&TO[Z%BP=WA'Y#6?%.'MD26>0$?=RT@B7TNSVO_[4I<QLDM <%TU(
MJ?RN@1P)X2;<+>2_H- TE]+LUGDX0YBB7<8AK!D-RHC[C)>]73VMO])M2>1U
M(^R<.7/V, ZM9/_*QWX7C1V[FWVCJ:'^:=$D:R(%S?=?(1=T3@X-2LF^$TWX
M5^VU:M7Z[KOO-#J=!QYX0 M95NO6K3_[[#,--8P=._;  P_4- ]?%>JF)2S+
MOI.V3^[Q_^W0H8-=]NNOO[9/_?89Q#XWV7.[_/++S24:HZ5WD3 KZ"&BVH<'
M'WRPY-YSSST:E%+;MFVE@NW11Q_5N.3,?^QKOQS=G,A?__I78[2=3CGE%/OZ
MI*&[V!>M.^^\T_UUA">??'+:W[N$5+""7@S9L*_3,L3O?O>[9<N6:9S!OI:?
M<,()DF7E8&Y>Z"2"WK?YMG)FS)@1OXGITZ?/BA4K-&<7^S[/'K%L]J]:M6JU
M=NU:C4Y.\RO$'@YYV4?R&N.D@N6\@UVZ=+&<#TM(\<AGY<J5YYQSCB9;UO//
M/Z^A*6F^MYV6@I:SK"NNN"+UJG[OO??,QW(Q@P8-TC@/I(B5]<N)T:(^RT9U
M2Q"G)4)<9B$?SKF@\PAW29<FFD!H;U^I\\'V+5NVU!+./Y-=N'"A1N]B9_7K
MUR]^H1DU:E39[%]I3HC*X]VR,<Y.^; . [S?*,WQ$!)@Y<<.#.U +DTT 8W(
MB!;U63:2>[ *<&&*T=GXGX_FA[XL Z13\;\W$M*BEC5^_/B"@@+[#\V;-T_Q
M+:B;-FVZ\LHK-=FR!@P8H*$I17*,Y)3,*D:#<BG"VW)-KGQ7H@#I5"K9SJR0
M]^=;MFS99Y]]=$*[].[=>\&"!9J32Q&>?A/^B[O.G3NG&-JV=.G2"RZX0-,<
M&IJ(YGC+$EK"?Q'-#_37@1@)2Q&9D";[3#>=?OKI4NKHHX_6(,_LWV?C=0X]
M]%#=')%HGR;_?_;N.]Z*XOP?^-*D@P**(BAB 0M@"8HMB*)^8T>C(J(&B:B_
MKYI$@X6H6 $+B:)B+[%$\6N-&BN6B%&0B(J@*$A7Z0A(E_,;SL(Z][-[=F?V
MS.[LV?MY_Y&7X3S/,[.SL[-SS]U[3KRE<L&"!6>==98;6:]>O:^^^JIJ]@:8
M$P7S34]LB^N5Q:8+00/[G__\Q]VH=^G2I=3\$:W<<,,-F.DXW;MW%Z_><\\]
M[O\-J;!NW;K AY:NO?9:# V5M=%+<R=3".H 1F0 =C$;&\Y\K!YF06><$L>K
M"XN:'G^(*146#DMH%LG-'##"RB;<XAL4+BQA>IX7DF_"XC2V,F<P1RTK"34D
M^%H)F7X0=N# @=Z8AGS(J)@]39LVE<9_HTLNN01#]6%1_;.+^?H5DH!]*L*@
M$M:O7__,,\]LO?76F%_\:>W%%U_$A"@OO_QR#=_B(JY;<68QU&?Y\N5B;D"N
MJ"9J8F@HJ" \\, #[G]LN>66(1MQ,13N3SL>C-A$CG$9;,+B&/J7W8X=.V)0
M::7^GEAT'D-+\_YN4KC\\LOQ99^1(T=*36W4NW=OE3]0>/;99_V?T'/]]==C
M7"A(=XQ.AG),F#!!+B[LN>>>8A^ <3XBYJBCCH)<#$H%],$Q.K89G#E'''&$
M^Q\WW7031ON(U?O,,\^L6F"#TT\_'4-+P^3*'^&4I[V58Y1!NE/\_B^G^'F$
MD7_'LG+ERGWWW1?2NW;MBG&A(-U1&+1P4.U/?_H31@29/GTZ?#Q;W;IUQ4\^
M&!=%KN#"B%BPJ$Y9BUL"#U1PTIIF*5_."8%NI#RE"[X..&F=/M>IIYX*Z4*_
M?OW$+0Q#?;R/2&_7KEW5 AM@=(HJ<;<LM;-!%N:AP?V&2XYQ&6Q"?M7)Q@"F
M>2$7@CJ $;%@49VR5O9@^;@QN: S,?J#^:E/2X.@)X[^: 3"HL4)(_ZW=>O6
MTZ9-P^BJQ(VR9\^>D-ZF31OU=]6M7"-)@RZY,"@Q=K?ED%L-[T0&04^JVV#F
M<G]>"-JBR\2:UK=OWT\^^033$F!Q^0W\9%QQQA7O'5===14FJYU6S%'+ EA"
MOPCF&_UQP"7'A$<&PF3-=-DKK[R"M1QGS)@Q&*=@W;IU8H/A%;GKKKLPPA*[
MOTTN9ZD<.G2H&W_DD4=6+; !1D?!?*,3V^)Z9;%I%Z0[FS;J>^^]=^27, 1^
M=-SHT:/=ST-5J?"[W_T.TMNV;:LRNUP9'+TT=S*%H Y@1 9 #[.PX<S'ZF$<
M],0).MX8L*C1\2\$U<<(!5A"ITB>YD#YK&S"[;Y!X8(*CNEY7DBX"8O3V,J<
M*02-)T:D9=,SK1O@:R5D]T%8,6/DF_=##SV$$9+SSS]?&O^-6K1HL7KU:@S5
MA$7USR[FZU=( O:I"(,V6;-FS8(%"[[^^FMQB5Y^^>6!?]KH%/]BP/M"!W4+
M%RYLV;(EE&K?OOVB18LPM 31-]$T5-AZZZU%90PM#=(%]W.JQ22<-&D21E<%
M#Y;ARYO(,2Y33=@=0__O]ISBIU1B7 GR'Q#+Q**DN%D7=U_Y.]\C)^'<N7.;
M-6LF-;6!N'^O6[<.0TL8/GPXI->K5V_JU*D85QJD.^8F0YD&#1HD%Q?$C1^#
M2A"S!?[Z$"-2(7? 96ILLSES7!=>>"&&EB!NB^[?VH)1HT9A: F86?DCG.:T
MMW6,,DAWBM^F)/[WI9=>PM @[[__/N8[CM@A8%QIF!PU:)'D4ATZ=%!YN,3U
M[W__6\X5+KOL,@R* A6<L@_'A465R]K=$G@@W4EKFJ5Y.2='[D/Z4[I@[_0)
M;[SQ!F86/R=#?1#\<\"#H2FJN-UR(9/ST-1^PR/'N PV(;^:D0%,[4)V87+0
M*,6 197+VMJ#^1>E2KPQN>2>Q.L/YJ<^+0W"?NB/1B L6E2S9DV5=5N8,F4*
MO&LOO/WVVQ@7Q-8UDC3HD@N#DF%]6RYG5<\[D4%R'ZK;8.9U?UXH[I#]EYA?
MY\Z=;[[YYN16,XO+[[QY\_P?(R>:7K5J%8:6YO^@/HP( BF*60!+Z!?!?*,_
M#KCDF/#(0)BLF2Y;OWZ]_Z.\SCCC#(Q3\,(++W@5&C5J%/YIA:FQ^]OD\I?*
M"R^\$/,WP= HF&]N8EM<KRPV[8%T5X,&#4(^\=<CUEOY/1F7^QW-BA7FS)GC
M_VKC]]Y[#^."9'/T4MO)N##9-[VS0.Y>1C:<.5@]D@ ]<7S'&P\6-3?^+CD@
M)"P<EE NDK,Y4"8KFW#K;U"X(-TQ/<\+239A<1I;F3,N2%',2H+W4*OZ<ZW9
M?1!6_H&J29,FRY<OQPC))Y]\(HW_+T:.'(FAFK"B_MG%?/T*2< ^E:=3IT[W
MW7>?RM/N?O_[O_^+Y93?J?<$_JBI_F18H<2 U*Q94^7O8D>-&B5GX<N;R#$>
M(TU8'T.Q*8=$];]@Z-RY,^1Z%/^>6/ZFUW;MVN'+/N><<X[4R ;B9\C)DR=C
M7&GKUZ\_\, #H8BX.V)<:9#K,C(9RK2_[P]ZPK^U$\"G*>#+J9 [X#$RMIF=
M.6+WMFS9,@PM;>+$B?[?C^ZSSSX85P(DNBIZA-.<]K:.40:YKO_YG__!N-+\
M;YV+/0 &E0:Y3M2@19)+W7WWW?AR*/BLM:9-FZY8L0*#0LGI+HR(!8LJE[6^
M)7!A<E$*TRS-RSDY<A_2G](%>Z=/V&NOO2"Q5JU:Z@^,"JM7K_:_(^/"T'15
MUFZYD-5Y:&2_X9%C/*::D%_-S@"F<R&[(-<)&J48L*AR65M[L'S<F%QR3^+U
M!_.+TIR6!D$W'/W1"(1%B\X]]UR,*^V  PZ ],&#!V-0$%O72-*@/RX,2H;U
M;;F<4CWO1 ;)?:AN@YGC_;DP;MRX^O7K8[=*Z-BQXQ577#%Z]&C%#]U19''Y
M[=^_/V2)G?!GGWV&<:%FSIQ9NW9MN0A&!)'CU;, EM O@OE%IGX<<,DQX9&!
M,%DS'0P;-@RJB<DV;]X\C(LB?VJIUBXE479_FUS^4KETZ5+Y05X9AD;!_"(C
M$]OB>F6Q:0_DNJZZZBJ,*^'XXX_'Y"+U"N*^#[E#AP[%H""9';UT=C(NR'5\
MTSL+Y.YE9\-9Z:M'$J ;CN]XX\&B14;&WR4'A(2%PQ+*17(V!\ID91-N_0T*
M%R87&9SGA22;L#B-K<P9EQROGI4$Z3E8U>=:L_L@[-%''^T-J,H/5/OLLX]T
M"C;JT:,'QFG"BOIG%_/U*R0!^Z1/;*3..NNL$2-&?//--UA=F;CD_)\"+79L
M&*? ^WYPCZBL\K=T+LAU773111@79-&B17(6OKR)'.,IOXDLC*'_\[0[=^Z,
M04'$Y(%$6??NW3$AB/Q-KY%_Z/;MM]_"*B_T[=L7XZ*\^.*+4*1.G3JS9\_&
MN!(@UU7^9"A?Z]:MY>*"UE]"CQT[5L[%EU,A=\!3_MAF>>:(=1CCHIQQQAE8
M1?E#83&MJ*)'.+5I;_$899#K^N"##S"N-/_7.8D?HC"H-,AU0@=-A5QJ^O3I
M^'*HAQ]^6$YW]'_V@W2G[,-Q85&ULEG8$K@@UY7"-$OM<DZ4W(?TIW3!WNE[
M\\TW(<N)M4C^XQ__P"I%&)>N"MHMNZ1&,C0/R]]OR.08CZDFY%>S,X I7,@>
MR'6"1BD&+*I6UN(>+!\W)I?<DWC]P?RB-*>E0= -1W\T F'1(JWWW/[RE[]
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M7?!5<%(Y?6^__3:D"'WZ],$X-;?<<@O64KB(DE81NV53I YN8&0>EK_? -A
M DW$!ATS,H I7,@RR'4,78-85*&LW3U8GFY,<"".PN #S$]]6AH$W7#T1R,0
M%G6<D2-'8E"HV;-G0X4F39I@4%5VKY&D06=<&&1:IK;EL4%SE7@GR@XXBDH9
MS.JP/P?+EBV[^>:;_;\G5E2[=NW^_?NK?VF>Q>4WL.G>O7MC7&*P[5B3 4OH
M%\'\!'X<P 8T.XG)FNF!?OWK7T--]<^D?.RQQ[RL9LV:K5RY$B-LL/O;9+-+
MY;777HNU]$\ZYIN8V(&+AL7U*IVF 20*SSWW' :5!M^V'*/"@@4+(+V"]OF0
MZ*2RDY%!KJ-_964?'*"1#6=%KQ[)@3XXAJ83%C4Q_C*L'JO;6$*A2"[G0&R!
MHY'T)CQ3;U!@FNEY7DBFB< 3E\XT#FPZZ3DCP[85KOJ$_/(8K/)SK5E\$%;^
MA/_Z]>LO6;($(TKX\,,/I;/PBQ=??!%#E6$M_;.+^?H5DH!]*L*@4*M7KW[\
M\<>WWGIKK.(XXB=/E>\?&3Y\.&;&^KA^SZ!!@[!<\9.3,"X(ICF.\=].80,F
MFLC.&'[ZZ:>8YCA3IDS!.,FMM][J1;I?8_'FFV]*V1O4J5,GY U$W6]ZO?WV
MVZ7:&SWZZ*,8I^:##S[ 6LJK#::9F Q&G'_^^=BSXK?N#A@P(.1$9 KVWL38
M9GGFO/#""QBD9O#@P5C+<<0_8IP/YE3^"*<S[>T>HPS3'&?TZ-$8%&K>O'E0
M0>S6,*@TR'4TMQ_&06=4_IA>!NF.H</!H@IEL[,E* 3U/YUIEL[EG'%P^+I3
MNN"KX*1R^FZ\\49($88.'8IQ:MYXXPVLI7 1):TB=LNF2!W<P,@\+'^_ ;"!
M!)J(#3IF9 !3N)!ED.L8N@:QJ$)9NWNP/-V8\# 4!A]@?NK3TB#HAJ,_&H&P
MJ.-\\<47&!1JZ=*E4*%FS9H85)7=:R1IV)4B##(M4]ORV*"Y2KP390<<1:4,
M9G78GP=:MV[=*Z^\TJM7+_]G':EHV;*EXCMU%I??VVZ[#4/5WA(T!=N.-1FP
MA'X1S$_@QP%L0+.3F*R9'NCIIY_&HLK[C0,..,!+N?CBB_%E2^S^-MGL4OG\
M\\]C+?V3CODF)K;%]<IBTP#3'&?2I$D85-KJU:LQ7[/"RI4K(;V"]OF8ELI.
M1@:YCOZ5E7UP@$8VG!6]>B0'>V!H.F%1$^,OP^JQNHTE%(KD<@[$9F43GJDW
M*##-]#PO)-.$Q6EL9<[(L&V%JSXATG.PJL^U9O%!6/E#:\XZZRQ\.53'CAVE
M$['1,<<<@W'*L);^V<5\_0I)P#X589""^?/G'W+((5C(<3;??/,OO_P2HZL2
M)Q?3'.?__N__,$[9R)$CL9SC].W;%^."8)KC3)TZ%8/*@PV8:")38[CSSCM#
MXI A0S!(TK5K5R]2W$(*Q2^B:M:LF51@@Y ;B>XWO08.UT<??81Q:L3IPUK*
M'\^):28F@Q%CQX[%GFW2M&G3/_SA#Q,G3L2<C,%^FQC;+,^<R)6VE.>>>PYK
M.4ZO7KTPS@=S*G^$TYGV=H]1AFF.,WWZ= P*Y7_?S='90F"F3FX2H#,-&C3
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M^6-I_,1/E%@KJ@/IR/YNN90LS,/R]QL &TB@"4\6!C"%"UF&F3JY(;"H0MG
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MGS.Q7&F8KP:KA,)D-5A%7VIC&&G]^O5MVK2!5BZZZ"*,"_7MM]]"!5%3Z^&
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M$#8_<.'GTD^5#&=SY<QG['?E])RJ+9RR^I,6\_4K4*;@Z>0)S3L\WSSC1&7
MRXD7%"4#YYFAF89%#96E<N IJ9R3@OVNG)Y7$WONN2><H*^__AJ#+(&..88F
M#Q8U5):(*AJN"]E>&;*\=!-5-W Q.ME>/8B(JA5<H*O9$HT'GZ/#QP/+T:$1
M40CI.5C5YUKY(&Q^X,+/I9\J&<[FRIG/V._*Z3E56SAE]2<MYNM7H$S!T\D3
MFG=XOGG&B<J EQ,O*$H&SC-#,PV+&BI+Y<!34CDG!?M=.3VO)EJW;@TG:,F2
M)1AD"73,,31YL*BALD14T7!=R/;*D.6EFZBZ@8O1R?;J0414K> "7<V6:#SX
M'!T^'EB.#HV(0DC/P:H^U\H'8?,#%WXN_53)<#97SGS&?E=.SZG:PBFK/VDQ
M7[\"90J>3I[0O,/SS3-.5 :\G'A!43)PGAF::5C44%DJ!YZ2RCDIV._*Z7DU
MT:!! SA!:]:LP2!+H&..H<F#10V5):**ANM"ME>&+"_=1-4-7(Q.ME</(J)J
M!1?H:K9$X\'GZ/#QP')T:$040GH.5O6Y5CX(FQ^X\'/IITJ&L[ERYC/VNW)Z
M3M463EG]28OY^A4H4_!T\H3F'9YOGG&B,N#EQ N*DH'SS-!,PZ*&RE(Y\)14
MSDG!?E=.SZL)/#U9.D'8,T-]PZ*&RA)11<-U(=LK _8UV[TERC>\&GD]$A%E
M!B[0U6R)QH//T>'C@>7HT(@HA/0<K.ISK7P0-C]PX>?23Y4,9W/ES&?L=^7T
MG*HMG++ZDQ;S]2M0IN#IY G-.SS?/.-$9<#+B1<4)0/GF:&9AD4-E:5RX"FI
MG)."_:Z<GE<3>'JR=(*P9X;ZAD4-E26BBH;K0K97!NQKMGM+E&]X-?)Z)"+*
M#%R@J]D2C0>?H\/' \O1H1%1".DY6-7G6OD@;'[@PL^EGRH9SN;*F<_8[\KI
M.55;.&7U)RWFZU>@3,'3R1.:=WB^><:)RH"7$R\H2@;.,T,S#8L:*DOEP%-2
M.2<%^UTY/:\F\/1DZ01ASPSU#8L:*DM$%0W7A6RO#-C7;/>6*-_P:N3U2$24
M&;A 5[,E&@\^1X>/!Y:C0R.B$-)SL*K/M6;Q0=C%BQ>_\,(+@P8-.O[XXW?;
M;;=MMMFF?OWZ]>K5:]6JU1Y[[-&C1X^KKKKJS3??7+Y\.68FZ8<??A@V;-AQ
MQQVW_?;;-VS8L&[=NJ(_G3IU.NVTTQY\\,$Y<^9@0GE&CQY]Q157=._>?=MM
MMVW0H$'MVK4WWWSSG7?>671@R) A$R=.Q(3*6?JG3Y]^[[WWGGGFF?ONNV_+
MEBW%T=6J5:MITZ9MVK01Y_?88X^]_/++'WOLL4F3)F%F&6;/GOW  P_T[=NW
M:]>N8D:),UBS9DWQO^*_]]]_?_'OXE41@VG)6+]^_=MOOWW^^>?OO??>S9HU
M$R>W29,F8EX===11UUUWW5=??84)/NO6K7OUU5?//??<O?;:JWGSYG7JU!'3
M8Z>==CKLL,,&#Q[\Z:>?8D("IDV;]M>__O6DDT[JT*'#%EML(8Y"7*=BNHI)
M*Z:NF,"8H EGLXGY/'[\^)MNNJEGSYZ[[[Z[Z/-FFVWF#MTNN^QRY)%'#APX
M\+777ENS9@VF:<)^F^AYH'0.IZ*EO&Z;DOY-$*>L_J3%?/T*5E30:ISRK,#3
MF=@)S=0ZMG+ERN>??UZ<37=_(H;7W7V) 1>;$S'X+[WTTG???8=I"4CY=!=2
M/.-),'[BTI^64Z9,N>>>>W[_^]__ZE>_:MNVK6C+/03QWUVZ=#G[[+.'#Q_^
MP0<?B 4',\U)>E_GE_XX>Y+^800O)],75!8FC!&9^@&M4('[1IQGAF8:%@TJ
M^]EGGUUYY97B?N2^62'&2IPU<?F<?/+)(T:,F#IU*B:4S>**89S=MWI2WF-@
MO\OH>;@\S9!"BLLCGI[$3E ,V#-#?<.B066YQ!F7@^VZR[^ B];;MV]_XHDG
MBHVTV$YC0GZE?PH2W0#CNA"T,F0']M5T;U.[!RDROH"8DO*>2E'%_40CLSZD
M_D4^S5VZ%=;'/%#ZTSCI]X@"I7\GK5SIOV/I9_QFE+6[;?9E9(FV=>5FY/ S
M @\LZ-#2_Z&>%[466Y>2+9DZ7N-WM-1(S\&J/M>:H0=A%RQ8<,<==XA529Q[
M7,."-&K4Z.*++XZW:F M'SEXX<*%__N__RLF 09)Q)2]X((+YLZ=*R?&L'[]
M^B>??'+777?%!GP..>20]]]_7\[%B*"EWR)Q:,\]]]Q!!QTD)AMVM(36K5N+
M>\/33S\MKDDLIT8T*BY7L3E0:53<DT2DB,<J4;"0CQP\:M2HSIT[8T151QQQ
MQ.>??RYGR9YZZJD==M@!<ZHZYIAC K<^I6"^CQP\8<*$$TXX(7)(Q30>.7*D
MG*@%RY4QG\7-X[[[[A,K.%8,TJQ9LS_^\8]:"PN6B&7MVK58MX2D#R<AV#,?
M3/#!!!\Y.,UUVY0T;X( 2RN<#H#Y^A6,P$[XR,'97(U!:K,""\62J74,J_C(
MP2M6K!@Z=*CX"02#@GA9^(*/U(*2U$ZW'Y;6[[PIV \?.3C>B2LEA6GI]^RS
MSXHM?>2>RB6.]+333GOBB2=^^NDG+%059OK(P>GLZSQ6QMF5W \CF!:+RA*:
MT(1)609_0*N4?2/V*9;(F88)5<?JPP\_[-:M&T94)<[:Z:>?/F7*%#DQ'HLK
MAG%VW^I);8^!A6*)G*6>/,V00BK+(U;1T:]?/RQG%+872^3DP00N<?JP9SYR
M< ZVZP7E!5Q<N6)3_<477\BY&.0C!\>(#X0Y/IB@S,HI2&(#C&FQ1"XXIF##
M.M27[A3N006%8Y&#S2X@IJ2VIRIH#E>E_$3CE^:0!E)<Y)WR=ND8%R7DCRNN
MO_YZC"X!,S=)<\RQEH\<G/(T3NX]HA!6[J29@@?I(P<G](XEYOO(P69O1HG>
M;3$_BMEU!E_PD<IK2&>)CF3KRLW(X6<-'EC50_O_[-UYO-7$V0?P "([6,2=
MQ0VU6G=1J?M2;>OV6E[<JU6KU;>MK;4J8EVK@%5;08M[]:-5L:W;1^M:W*F*
M*$4+J*""@(BRRA4!D;S#"<2YO^2<S"23F3F'W_>/?EK.\SR9F4PFD]/<>RT_
MU)=Z48=IG:VA2Y<NF)]PP047R"GOO?<>1C1W]=57R_$U8&::\BXE3,YB=@&L
MIKS^QK!*@AQL]HYF7PL)?E:%%R_"CAX]^J233FK;MBV.L0*Q\;WJJJNP8A:L
MDA!'BK:)W2U^7,7ZZZ\_;MPXZ3AZ9LR8<< !!V#1ZL2*>>ZYYW[]]==1.G[L
MTQQ]\\TW^_3I@^U3MM9::XE'(%$$Z]8DSD7?OGVQEH+O?O>[-=Y\2L+\A"A,
MW [//__\%@KW0D$\A8K%L?EQPJ:FIF.//19#JVC7KMWCCS\.%:K!Y(0X<NC0
MH6W:M,&/J_O>][XW<^9,Z5"JL%#>^?S\\\_W[MT;:V41R]'@P8,5O]/$Y%P4
MCV6A.R7!-B5@0@(F),21-M=M(^S?! $653@= //U*QB!C4B(PGQ>C6.69P66
MR$5QD;&SCF%^0APY8<*$;;;9!C^N+L<A,ED^W4E85*?Q9F$[$N+(W"<NE9UI
M*9LZ=>H/?O #K*BF<^?.9YYYYAMOO(%%5\&$A#C2VKXN8G^<8Z4^C&!T+K4[
M6.J$L<FW![2PKO:-V)I<:L^T,.THT;^+[=/%%U_<JE4K_+B*3ITZ/?WTT\UK
MZW&X8ACG\*L>RWL,+)&+XNEKI!D2VEH>,5F'^MM4^>#Q<LD\LYC )4X?MBDA
MCJSW[7I$=P$76VNQP8[3\>,$Z5!YXE-A3@(FJ+%_"LK; &-T+ODZE0,>6(?B
MTFWG'A0J]"6.-+N &&%Y3Q7J#%<=/='([ ]IDNXBGWN7CG%92GH_P_Z88Y6$
M.-+R-"[U.Z)J[-])/83=2X@CR_O&$C,3XDBS-Z.R[[:8EL7L.H,?)$CE55E;
MHFMS=>5ZTGT/8<=6=<W^0WW9%W68UMD:5%Z$W6*++>04,4LQHCF#+\*6>BEA
M6A:S"V"J4OL;P_R$.-+L'<V)^*56]?=:O7@1%H=67__^_;7^0 /F)T1AHT:-
M:M^^/7Y6D]@!PP]_*Q)+WH8;;HCE%!QUU%'1W_W!#[R9H]=??[WB#Q=FPM+5
MW7SSS>+9#/.5B1UV\LVG:C Y(:S<@$\^^63\(,N--]X8'V71HD5[[[TW1M0D
MAGWDR)'?-+0ZS$R(PN G112))]@<OQ 1J^B<_8@8<W&[:J'VKENJ P\\<.[<
MN5@W =-RR;RK6>M.2; U"9B0@ D)49C-==L4;) ^W9L@P'(*IP-@OGX%([ 1
M":'WJW$,2^C3FA68G(M7ZQAF)D1A;[[YIN(/P,5T#Z$",_5IG>XD+*?3>+.P
M'0E16)$3!VQ.R]B[[[Z;;]L/L.XJ&)<0A=G<USD9YUC9#R,8E$N-);3L"6.-
M;P]H8;WM&[$IN=28:1%,6+5].O744_&#+#GV/Q&W*X9Q;K_JP4Q]6GL,3,XE
M<Y8VV P)+2Z/F*E#\6VJW/!XN61.'DS@$J</6Y,0A=7[=CV2>P$?.'!@5 $_
M2&A^0.WX5)B3@ E9G)R"4C? &)1+YH)C"AY8A\K2;>T>%"KT)0HSN( 8A(?4
MI[6G"A6.&(75UQ.-#)NE3W=(0>Y%/L<N'>.RE/1^!D;HTQUSS$^(PBQ/X[*_
M(TIR<B?U$W8L(0HK]1M+3$N(PLS>C"S<;3$GB]EU!C](D,HKL;E$5^/PRO6A
M^]["CE6Z9OFA/K1R48=IG:TA\T78<>/&0<HNN^R"0<T9>1'6PJ6$"5G,+H#
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M+5LF_E/LG>Z]]U[Q+%#M6Q4LO0K&)81V]W5.QCEFX6$$@W*IMH1:F#!V>/B
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M.<'(D2,QM K,S#K[L5FS9G7MVA5RQ=Q;MFP9AE8Q;-@P2&_;MNW[[[^/<55
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MTDT0([)@OGZ%,F";--=2'U;C?(K/"D@/"IQ03]8Q2 PJ?_)CZM2I&%< 'J#
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M74B=!KK7<DR,.=;*^^"$$6H\Z4Y)L"GZHX3Y^H.38]VVPX>;($9DP7S]"F7
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MXG_?;KOMI-1OW'OOO5+V"EVZ=%FR9$GT:5-3D_PK8T>/'MT\NRJ'EU*JLA=
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M"T.'#L6<(/CK7_^*<27#%BBT/)4GW2D)=DQ_E#!?OT)HJ$ANC703Q'S]"F7
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M=BQK-%0X'#&S"_@UUUR#M33'IW/GSI ^??IT#*KIGGON@0J!0AL<GH*"\FV
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M$!HJDELCW00Q7[]"&;!-^JW"_/(K>#(K&F\=DQ,C&%$8'D#A$)Z<[C!7X^W
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MQS ^2QMLACA?'B$]T#R_I3(^>2)R9 0C%& )Y2(--H$C<GLB&%& &RZI2@
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M]-'RWRW*M.&&&YYSSCG3IDW#<EFP4/,1*VE?5XW-<0:6'T8,+J&6)XP%=?&
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MLG4!>^ZT[])[L*KOM?)%V(:%/5^=^D[J<)9PGE 6G#&<,XT.S[?U,XZ'M]X
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M49_@#$S9^3+YQ&&M #DXW;499L8ITT]4L 4!<G"Z[QD-##A8)4 .SFBFQOP
M.;CL>CC(S'MSGX%SQ"H!<G"ZHY '\Q.)G<*,#>Q8*)'@Z6!$ ,2K,S.G8Z$
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M7()#Q#)\N8.PJ$+C,2$ $VK#Z$2X$5:V>/'B7KUZ82N+:]BPX<B1(_UT?#E
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M#"H._N) @@HK5JR =&/]!L?-:VP)O?\OOOABC%/SX(,/0JFZ=>NN7+D2X\)
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MYLV;8U!M;=JT@13=/?777GLM5'#4.GS???>%K%:M6NG^S6C/G#ESY#H'''
M1H214SP8H0!+)"IB&+98O\V8GWV%RAM;VK9M"Z7\GSA,8,:,&7*IZ+=G,CG+
M@Q$EPP,H',*2R^TF:CS ?,T*F*R9KNC@@P^&HYQ]]MGBWQ<N7"C_F;])DR9A
MIGVV;-G2M&E3Z51V\CZ P% %H7\P"(,BY37)\B&28;Y^!1G64JM6/6-^N4BP
M9G93ZD L$5>$CW.^L,6)VHPE%(H$/V5KTJ3)QHT;,4Z!R!*Y4$W4Q[@PD.4H
MM-Q"> Z.<^JIIV*0 K&6:-FR)902JXYBSZ,E(W_6;!ZCDFW$U+W0,LAR[&@#
M1L3!?+4*YC_>L?G>,S/(R"#+43N+*AFF0LE-]6"$,DNF[*S9_,1AA (LD:B(
MKY(^47'3[AR?)0..G.4IQYDZE"4]G(#Z>W-+SE'.\F"$ BRA4P0S=7)EE@SL
MF*R97@P652MKSYP.B8Y:^P&62%1$B_KCG!=+;GLWI:N#)>**I/N]R?>__WTH
MY<0UP#;!1_XWO_F-^/=33CG%_Y<;;K@!TR3PNV,]$R=.'#-FC/]_]]MO/TR+
M%"SHE/-=&@T/D,8A*JP#L81.$<S4R8V 1=7*6K**2\#^J<T#C734KDLL+)JH
M+):(*V+)4XS)FNGIDO;!JNYKM64C[&Z[[0;]F&S9 :"FD^CR8(FX(GOLL0<F
M.,[2I4LQ+M+LV;.Q1-QQ049=:H#<YM6K5^/+<98M6R97$';??7<,JNV;W_PF
MI#SSS#,8%*E+ERY0P5&[7K_^]:\QS7'^\8]_8)R">^^]5RYR^>678T08.<6#
M$0JP1*(BAF&+]=N,^=E7J+RQY;KKKH-2PKQY\S!.S4TWW237&3QX,$84(6=Y
M,*)D> "%0UARN=U$C0>8KUDAQ5LNP@,// !'$0O-Q8L77W_]]?Z_''KHH9AF
MJ_[]^TNG4D/EUW* C1LW-FO6# MI7L&\)ED^1#+,UZ\@PUIJU:IGS#=&/@LS
M:V8WI0[$$G%%^#CG"UN<J,U80J$(/.:>YYY[#N,4B"PLY#BB/L:%,;,.R1J<
M@E/XV\0)Q@WQ1A4+.<X/?_A#C-O%DI$_:S:/4<V;-T_PO;7NA99AFAUMP(@X
MF*]6P?S'.S;?>V8&&1FFJ9U%E0Q3H5*<X"R9LK-F\Q.'$0JP1*(BO@K[1$4Z
MCQH8D8@E XZ<Y2G'F3I4CCTL1R:8_M3?F^=XCC(YRX,1"K"$3I&TIC!+!O:T
M3@= 34>M5?;,Z9BIUGZ )12*R,&9/LYYL>2V=Q-=G2 LH5 DK>]-Q.T1?'@=
MA0989="@0=#^[MV[KUV[5KR;\_]EVK1IF%9;GSY]I ([77KII?WZ]?/_[Y57
M7HDYD2KL+HV&!TCC$!76@5A"ITCP(<UQALUQ%2='5N34YK'J<@,L$5?$DJ<X
MHRY-1MH'J[JOU9:-L*U:M8)^+/;V>].F37)8])9S.=*#$0JP1%R1X(8/X;77
M7L.X2(\\\@B6B#LNR*A+#9 ;H_M+XX3-FS?+%83V[=MC4&UGG746I$1/&&#6
MK%F0[L&X, L6+ ANZD_VAQ@Z=^XL%YDX<2)&A)%3/!BA $LD*F(8MEB_S9B?
M?87*&UOFSY]?OWY].<:)^_G"8L2Q]MY[;[F.^N@A9WDPHF1X (5#6'*YW42-
M!YBO62'%6R["^O7K1;R<+HAW)O)]-7KT:$RSU=___G?I/&HH?B$A>_KII[%*
M <9%RFN2Y4,DPWS]"C*LI5:M>L9\8^2S4.\!7X(ULYM2!V*)N")\G/.%+4[4
M9BRA4&3QXL7R)^^>WKU[8YR"DTXZ">J(RJ(^QH4QLP[)FMPPW\,//XQQ<4)_
M3WS$/C]+1OZLV3Q&"6/&C,&X.+H76H9I!;FW 2/B8+Y:!?,?[UA^[QD89&28
MIG8653),A4IQ@K-DRLZ:S4\<1BC $HF*^"KL$Q7I)&I@1"*6##AREJ_L9NI0
M.?:P>F0H]??F.9ZC3,[R8(0"+*%3)*TIS)*!/:W3 7*D!R/"V#.G0ZZCUGZ
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M7F@/)MO1!HR(@_DZ%4Q^O&/SO6=RD/%@LLY95/PP%2KU"2[W*3MK-C]Q&*$
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M)12*8$+VC[-Y-MSV;EA78X0"+*%<)-GW)N)-C7AKXT6*L73.G#FULW?"G'(
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M5/B;6NLH[VNU92.L</_]]\M]%*M1HT9BJ0U%,"@.I'LP* [F%ZQ;M^Z((X[
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M>YS-PS;%P?P"#(J#^<7]Y2]_Z=6K5]VZ=;%$@/<WGEY\\44LH<_D.B05V+(
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M""B;@("@[#,"PS+Y71,F?.9]<Y//33))9G@]_^!AN>>\[YV;FTOOAT,"
M      "0?<8<K.U<*X.P                    R#YC#M9VKI5!6
M             &2?,0=K.]?*("P                   "RSYB#M9UK91 6
M                    V6?,P=K.M3(("P                  @.PSYF!M
MYUH9A 4                  $#V&7.PMG.M#,("                   @
M^XPY6-NY5@9A 0                  D'W&'*SM7"N#L
M     ,@^8P[6=JZ505@                   !DGS$':SO7RB L
M            LL^8@[6=:V40%@                   -EGS,':SK4R" L
M                 (#L,^9@;>=:&80%                  ! ]AESL+9S
MK0S" @                  (/N,.5C;N58&80$                  )!]
MQARL[5PK@[                    #(/F,.UG:NE4%8
M    9)\Q!VL[U\H@+                    ++/F(.UG6ME$!8
M          #99\S!VLZU,@@+                  " [#/F8&WG6AF$!0
M                0/89<["V<ZT,P@(                  "#[C#E8V[E6
M!F$!                  "0?<8<K.U<*X.P                    R#YC
M#M9VKI5!6                    &2?,0=K.]?*("P
M  "RSYB#M9UK91 6                    V6?,P=K.M3(("P
M        @.PSYF!MYUH9A 4                  $#V&7.PMG.M#,("
M               @^XPY6-NY5@9A 0                  D'W&'*SM7"N#
ML                    ,@^8P[6=JZ505@                   !DGS$'
M:SO7RB L                    LL^8@[6=:V40%@
M -EGS,':SK4R" L                  (#L,^9@;>=:&80%
M      ! ]AESL+9SK0S" @                  (/N,.5C;N58&80$
M             )!]QARL[5PK@[                    #(/F,.UG:NE4%8
M                    9)\Q!VL[U\H@+                    ++/F(.U
MG6ME$!8                   #99\S!VLZU,@@+                  "
M[#/F8&WG6AF$!0                  0/89<["V<ZT,P@(
M     "#[C#E8V[E6!F$!                  "0?<8<K.U<*X.P
M            R#YC#M9VKI5!6                    &2?,0=K.]?*("P
M                  "RSYB#M9UK91 6                    V6?,P=K.
MM3(("P                  @.PSYF!MYUH9A 4                  $#V
M&7.PMG.M#,("                   @^XPY6-NY5@9A 0
M    D'W&'*SM7"N#L                    ,@^8P[6=JZ505@
M          !DGS$':SO7RB L                    LL^8@[6=:V40%@
M                 -EGS,':SK4R" L                  (#L,^9@;>=:
M&80%                  ! ]AESL+9SK0S" @                  (/N,
M.5C;N58&80$                  )!]QARL[5PK@[
M  #(/F,.UG:NE4%8                    9)\Q!VL[U\H@+
M         ++/F(.UG6ME$!8                   #99\S!VLZU,@@+
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M&1[:        D [&'*SM7&OE&X1=LV9-86&AN=12O7KUGW_^6>M@,$]73-J
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MAS_\X9MOOM%=QJ+-'MH ^-!+Q\=99YU56EJJS0%I:"+:C_31<^VA#0
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MF#'CA!-.T/ZP@H*"]]]_7QMBT<X@!P (O9C*Z]6KES:DP$S6;<@@\X7@Y0
M     !7'F(.UG6NM3(.P(T>.U%66\AY[[#'MJ>3T)TS3NI*&IBD6KCESYIQS
MSCEUZM2I7;OVV6>?S3!BQ=&+...7<<S/81TZ=*C66;CFFFLT*."/PX57V>G+
M'_ "      #D/GWP"].BN$I*2BZ\\$*-"-MOO_W6KU^O#1[:%O   )->3!Z/
M//*(]B3+C-5MR"#SA>#E        %<>8@[6=:ZU,@[#MV[>/+J\4%!08BRT[
MM6W;5GLJ.?T)T[2NI*%IB@4R22_BS%[&BQ8M<F^;<@ ''GC@UJU;M=3"MFW;
M#C[X8$G3(E1I\NIS 0    ! U:,/?F%:E$A)2<EQQQVG*6&#!@W2:@_M"7X
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M_['''GM<??75Z]>OUYXR2Y<N=2_:\MV_:M6J5?PE.%-VWT&2X*1[I0L
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M_/-FNQ/\;_*DW0EXZKPT+JE C0@>HOUAJ=]OLW43BQHT:) T1@P<.%!+ 0
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M+]=[[[WWQ!-/S,O+T^/V$?2+^;3?XH2D]T59OGRY9ED<@TF;@U^9V[=OUXB
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MB5J=VKY"P5^RF#0B>(CV5\($;0[8;EJS9HUF.8[[9M&Z7'H':5L*/SX
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M3RWUH9T6)R2]+THHJ6,P:7/ ]@B-L AY]]UWM2>L5Z]>W@\@\:/-%OLU:7/
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MBM *      "0)KO&8*WG6K,_"'O--==$5PW...,,W9R:[=NW-VW:U%B7V&G
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M)-J?\01M+G/##3=HJ8^2DI*33CI)^QW'?8VTM+Q<> >9C1%:D1I6G
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MA>3<7R?1_AQ(T,T>D;);;KE%-UC8;[_]XGS941P9>P=IIQU-L<:*$P
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MF)SCZR3:GP,)NMDC6CEBQ(C"PD+=[*][]^XK5JPP=A5,9MY!VFQ'4ZRQX@0
M    0-2N,5CKN58&87?1%,."!0OZ]^^?\!\9=^G2Y;///C,;M<+#+/:S8\>.
M.^ZXHTZ=.MI<7ILV;:9,F:+-85J:B/:':5$BVN_OW__^]ZFGGIJ7EZ<1'FY-
MUZY=WWSS38V(2U/L:(H_[4Q$^X,G!*([\[%MV[;1HT<?<\PQVA]+04%!KUZ]
M)D^>K"G!C1\_WOR*^9C<&]0YYYPC'P^@11YF<09\]]UW0X<.[=:M6Z %WX@#
M#SQPT*!!"Q<NU-"X-"41[?=G\Z*X3CGE%/.>XUY"4N#>,XW4&*0^(>T/TZ)$
MM+^\=]]]UWT1M<>C5JU:UUQSS<\__QQMU H/8R>^4K_;QY3)/\*TPHZF)"63
M-[&-&S>V;=M6,MNU:U=45*2E     '97\L@0E,8E2W,3T?XP+4I$^_U5]*I@
M*$T'KT6):+^/3#[)IDX/*!'M3]:77WXIJVU:$5 NKY-H?PXDZ&8/LWC6K%GG
MG'/.'HF^_:Q-FS9CQXXU&Y.3@7>0IMC1%&NL. $     $!4=:K6?:\W"(&SE
M]?WWWS_QQ!/GGW_^X8<?OL\^^Q06%M:H46/????MVK7KX,&#9\R8H0UIM6[=
M.G?O_?KU:].F3>/&C:M7K^[NW3V,#ATZ7'OMM6^__79I::GV5"K+ER]_]MEG
M!PP8</SQQ[L_5\V:-?/R\MQ?W?]V?\?]_:>??MK^PS*1M+ESYS[\\,/N==ZV
M;=L&#1JX5UI^?G[#A@T/.NB@SIT[_^E/?WKQQ1=_^NDG;4O-U*E3;[KIIBY=
MNC1MVM2]L-T][KGGG@<??'"O7KV&#Q\>=$(TNTI*2K[ZZJO1HT??>..-O_G-
M;XXYYI@##SS0/8'N#U6M6K5:M6JYE_211QYYYIEGNB?S^>>?_^Z[[S0B-\B+
MXAY\_?KU6[=NW:-'CR%#ALR>/5OJ5Z]>+:NT=>K4D9K*8LZ<.2-&C#COO/,.
M.^RPR-V^H*# ?3NT:]?NXHLO?N&%%]:O7Z\]Z5-!=_OL_A&629FYB6W<N/&O
M?_WK_OOO[X:[O[KO=_Y. @    "2PZI@9IYD*Z]''WW47''2S4G9?=9),F_1
MHD5___O?SSWWW$,..63//?=T+V;WW#9MVK1+ERZ#!@T*]*^[+56E=Q K3@
M    1!ASL+9SK0S" @#28.'"A>;?2;A:MFRI10                #@SYB#
MM9UK91 6 ) &[[__O@S"GG+**5H$                 /Z,.5C;N58&80$
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M/=C<7JLB+,"&+OR_H%MOO35.].JWO_WMB!$CT@W5_TVY__[[XQQLJ-+O#@
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M]5__];;;;CMAPH2--MIHT*!!U3^K?Y\Z=>J'/O2A\\\_?^;,F2M7KHQY
M      " /DEZL+F]5D58             ,J7]&!S>ZV*L             "4
M+^G!YO9:%6$!            *%_2@\WMM2K" @           %"^I >;VVM5
MA 4           "@?$D/-K?7J@@+            0/F2'FQNKU41%@
M     (#R)3W8W%ZK(BP             Y4MZL+F]5D58             ,J7
M]&!S>ZV*L             "4+^G!YO9:%6$!            *%_2@\WMM2K"
M @           %"^I >;VVM5A 4           "@?$D/-K?7J@@+
M    0/F2'FQNKU41%@           (#R)3W8W%ZK(BP             Y4MZ
ML+F]5D58             ,J7]&!S>ZV*L             "4+^G!YO9:%6$!
M            *%_2@\WMM2K" @           %"^I >;VVM5A 4
M  "@?$D/-K?7J@@+            0/F2'FQNKU41%@           (#R)3W8
MW%ZK(BP             Y4MZL+F]5D58             ,J7]&!S>ZV*L
M          "4+^G!YO9:%6$!            *%_2@\WMM2K" @
M %"^I >;VVM5A 4           "@?$D/-K?7J@@+            0/F2'FQN
MKU41%@           (#R)3W8W%ZK(BP             Y4MZL+F]5D58
M         ,J7]&!S>ZV*L             "4+^G!YO9:%6$!
M*%_2@\WMM2K" @           %"^I >;VVM5A 4           "@?$D/-K?7
MJ@@+            0/F2'FQNKU41%@           (#R)3W8W%ZK(BP
M        Y4MZL+F]5D58             ,J7]&!S>ZV*L             "4
M+^G!YO9:%6$!            *%_2@\WMM2K" @           %"^I >;VVM5
MA 4           "@?$D/-K?7J@@+            0/F2'FQNKU41%@
M     (#R)3W8W%ZK(BP             Y4MZL+F]5D58             ,J7
M]&!S>ZV*L             "4+^G!YO9:%6$!            *%_2@\WMM2K"
M @           %"^I >;VVM5A 4           "@?$D/-K?7J@@+
M    0/F2'FQNKU41%H !I])(#            .N^I >;VVM5A"W!G#ESWO_^
M]X\9,V;TZ-'5OSSQQ!-Q E@O?/:SGTV[F]MOOWV<&& &SKM3^KKU* 8
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M6]]*'XD1(T8L7;JT\U+Z\:ZA!M)@31SJ5>_!EKP[I?%.<:)/XM(6K04
M      :4I >;VVM=WXJP5<N6+3OJJ*/BB@Y;;+'%BR^^& -KW>S9LP\]]-!1
MHT:-'#GRO>]];]&>V0 17]R"7Z:U(]YB-Q=??'',]%6Z-EYCP_.>][PG?232
MUG7Z\2316!JLB4.]:AAL_MTI/:*7@XJ*2UNT%@          &%"2'FQNKW4]
M+,*NZ>C"[KGGGG%+A]-//SU.TR?QE2W^95H+XBUV,W3HT%FS9L58GZ1KXS4V
M,(L7+QXV;%CZ2%QUU56UJ^G'DU!C:; F#O6JS\%\Z1$M/"@N;=%:
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M1 P7C-<3EV:O'0A/2'M[^QEGG+'UUENWM;5-FC1I^O3IBQ<OCD,
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MR) 0/.:88^)<(]=??WU84GV[F#MW;ISKU1%'')%N.."  ^)$T]+]-7&H:?&
M@D?$<,%X/7%IWMJ!\(2<?OKI(=MI^O3I<10          #9X20\VM]>ZSA=A
M7WGEE6>???;>>^_]^M>__HYWO",F7S-DR)!KKKDFANN(X<JKK]+33S\=YYH0
M#^CU<^Q1S%<J6VZYY>K5J^-<?5=<<478L.^^^\:A^D*V4OQ36 L*W=[QQQ^?
MSM>,'3LVYY]!3R/Q6G]Z_/''TZ.KSCGGG#C42-A0];=_^[=QJ+[PBY#[L.%G
M/_M9B+_E+6^)0]V<<<89(57UP ,/Q+E&5JY<N<466X0]7_K2E^)<?<N7+Z\^
M)VG\XHLOCD--2_?7Q*&FQ0,*'A'#!>/UQ*5Y:P?"$S)ITJ00[%3]>!P%
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M4A.'FA8/*'A$#!>,UQ.79JP=.$_(XL6+IT^?OM566PT9,J3Z9_5;6PL6
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M@V.@U3;>>.-X:C<77711&AD[=FP??C=SIO2@FCC4M'A P2-BN&"\GK@T8^T
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M-K?7J@C;@WA\/]Q /*#X$3%??,.:YI;$9)'L6M.JVVMO;]]AAQW2;34'''#
MJE6KUO3IK(]__.-IJM,7O_C%.-=(7)%] S4QORYL./KHHV.@4GG@@0?B7+]Y
MY9571H\>G9Y^Z:67QJ&62L^JB4--BP<4/"*&"\;KB4LSUI;^A
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MJAUVV"%.)%:O7KWYYING\YV_&+A?I<?5Q*&FQ0,*'A'#!>/UQ*5Y:TM\0@
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MF;9@JV;/GAV'            Z*ND!YO;:U6$!<@R??KTM 7[YC>_.4X
M      #0A*0'F]MK580%R++==MNE1=A33STU3L! DCZN  "P'HL_"@,
M .NRI >;VVM5A 6 ]5!L!P  P'HJ_B@,      "LRY(>;&ZO51$6 -9#L1T
M  #KJ?BC,       L"Y+>K"YO59%6             #*E_1@<WNMBK
M        E"_IP>;V6A5A 0           "A?TH/-[;4JP@(           !0
MOJ0'F]MK580%            H'Q)#S:WUZH("P           $#YDAYL;J]5
M$18           " \B4]V-Q>JR(L             .5+>K"YO59%6
M      #*E_1@<WNMBK              E"_IP>;V6A5A 0           "A?
MTH/-[;4JP@(           !0OJ0'F]MK580%            H'Q)#S:WUZH(
M"P           $#YDAYL;J]5$18           " \B4]V-Q>JR(L
M     .5+>K"YO59%6             #*E_1@<WNMBK              E"_I
MP>;V6A5A 0           "A?TH/-[;4JP@(           !0OJ0'F]MK580%
M            H'Q)#S:WUZH("P           $#YDAYL;J]5$18
M  " \B4]V-Q>JR(L             .5+>K"YO59%6             #*E_1@
M<WNMBK              E"_IP>;V6A5A 0           "A?TH/-[;4JP@(
M          !0OJ0'F]MK580%            H'Q)#S:WUZH("P
M $#YDAYL;J]5$18           " \B4]V-Q>JR(L             .5+>K"Y
MO59%6             #*E_1@<WNMBK              E"_IP>;V6A5A 0
M         "A?TH/-[;4JP@(           !0OJ0'F]MK580%
MH'Q)#S:WUZH("P           $#YDAYL;J]5$18           " \B4]V-Q>
MJR(L             .5+>K"YO59%6             #*E_1@<WNMBK
M        E"_IP>;V6A5A 0           "A?TH/-[;4JP@(           !0
MOJ0'F]MK580%            H'Q)#S:WUZH("P           $#YDAYL;J]5
M$18           " \B4]V-Q>JR(L             .5+>K"YO59%6
M      #*E_1@<WNMBK              E"_IP>;V6A5A 0           "A?
MTH/-[;4JP@(           !0OJ0'F]MK580%            H'Q)#S:WUZH(
M"P           $#YDAYL;J]5$18           " \B4]V-Q>JR(L
M     .5+>K"YO59%6             #*E_1@<WNMBK              E"_I
MP>;V6A5A 0           "A?TH/-[;4JP@(           !0OJ0'F]MK580%
M            H'Q)#S:WUZH("P           $#YDAYL;J]5$18
M  " \B4]V-Q>JR(L             .5+>K"YO59%6             #*E_1@
M<WNMBK              E"_IP>;V6A5A 0           "A?TH/-[;4JP@(
M          !0OJ0'F]MK580%            H'Q)#S:WUZH("P
M $#YDAYL;J]5$18           " \B4]V-Q>JR(L     'XU)Y,   (W241!
M5        .5+>K"YO59%6             #*E_1@<WNMBK
ME"_IP>;V6A5A 0           "A?TH/-[;4JP@(           !0OJ0'F]MK
M580%            H'Q)#S:WUZH("P           $#YDAYL;J]5$18
M      " \B4]V-Q>JR(L             .5+>K"YO59%6             #*
ME_1@<WNMBK              E"_IP>;V6A5A 0           "A?TH/-[;4J
MP@(           !0OJ0'F]MK580%            H'Q)#S:WUZH("P
M     $#YDAYL;J]5$18           " \B4]V-Q>JR(L             .5+
M>K"YO59%6             #*E_1@<WNMBK              E"_IP>;V6A5A
M 0           "A?TH/-[;4JP@(           !0OJ0'F]MK580%
M    H'Q)#S:WUZH("P           $#YDAYL;J]5$18           " \B4]
MV-Q>JR(L             .5+>K"YO59%6             #*E_1@<WNMKQ=A
M 0           & @B(W7.A1A 0           !A88N.U#D58
L  :6V'BMHQ(_              #K@O\'T1TFWJC(?GX     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>92
<FILENAME>image_345.jpg
<TEXT>
begin 644 image_345.jpg
MB5!.1PT*&@H    -24A$4@    @   #=" (    )GJ1     /TE$051X7NW)
M(0+ (!# ,/[_Z9N8(\--(!K9KO5E9O;T:J"!!AIHH($&&FB@@08::*"!!AIH
>H($&?AYS<.=X  E*)P2: FP*     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>93
<FILENAME>image_45.jpg
<TEXT>
begin 644 image_45.jpg
MB5!.1PT*&@H    -24A$4@   !0    ," (   #M;@JL    )DE$051X7F-@
M8/A/*H(#)";I8%0SB8 RS9C12!!123."23J@2#, 6^]GM5DG9R\     245.
%1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>94
<FILENAME>image_48.jpg
<TEXT>
begin 644 image_48.jpg
MB5!.1PT*&@H    -24A$4@    @   "6" (   !L 5[O    *TE$051X7NW)
ML0T , S#L/S_=+/JA :@-ILSZ:7^          !^AXYV#!:Z\F$"5H&*+P
*  !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>95
<FILENAME>image_53.jpg
<TEXT>
begin 644 image_53.jpg
MB5!.1PT*&@H    -24A$4@    @   'G" (    *"(L_    0$E$051X7NW)
ML0T , S#L/S_=+/J@0(9J,WF3'JI/P
?      #P&SK:35A:!A(RC *;UP    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>96
<FILENAME>image_54.jpg
<TEXT>
begin 644 image_54.jpg
MB5!.1PT*&@H    -24A$4@   @     #" (   !J$2 J    )TE$051X7NW5
M,1$   P",?R;;K=>/9#<#S@@R4B2>CIO M#$ 0"46N% ^+Y+1RO$     $E%
&3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>97
<FILENAME>image_56.jpg
<TEXT>
begin 644 image_56.jpg
MB5!.1PT*&@H    -24A$4@   %@    5" (   !-,;[1    5TE$051X7NW5
ML0D , S$0.^_= )!E3\3V#I</:11DSIZJ@];&0*&0 ]1M>)2W_+-R$N_;25#
MP! P! P!0\ 0Z"'RRQUYJ6_Y9N2EW[:2(6 (& *&@"%P 19_+=Y5KK"2
) $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>98
<FILENAME>image_58.jpg
<TEXT>
begin 644 image_58.jpg
MB5!.1PT*&@H    -24A$4@  !$<    ," (    /E$1E    ?DE$051X7NW<
M,0Z , P$0?__TXGHL/R"BV>T34(/NH8Z59*DQ,:%)$F+^AL/)4DAC0M)DA9E
MU4C2*P$ WZH!  !(9M4   #9K!H  "";50,  &2S:@  @&Q6#0  D,VJ 4@U
M__,L2=*>VC>QG0#(,=_ODB3MJ7T3VPD  "#-!;C<0WYAA03R     $E%3D2N
#0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>99
<FILENAME>image_61.jpg
<TEXT>
begin 644 image_61.jpg
MB5!.1PT*&@H    -24A$4@   @<    ," (   !YFXF&    9DE$051X7NW:
M,1+ ( @ 0?[_Z:1$!AI;W)UK-&T8&N.+D%;6+B3-G=I':4OM0M*<K:!G BZU
M*9(V!5PR-@ D6P& 9"L D&P% )*M $"R%5BKOTB2-%8&IYQ@D?[K2QHK@U-.
8 +SM!P,-JFGH&MCG     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>100
<FILENAME>image_64.jpg
<TEXT>
begin 644 image_64.jpg
MB5!.1PT*&@H    -24A$4@    @   !?" (   !:YA&3    +TE$051X7NW)
MH0T , S$P.R_]%=56)W2(!^TJR9)WM0<X  '., !#G"  ^[(Q\8XLZ^$BH4$
..4IH     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>101
<FILENAME>image_76.jpg
<TEXT>
begin 644 image_76.jpg
MB5!.1PT*&@H    -24A$4@  ":X    #" (   #^H9T,    /$E$051X7NW9
MP0T   @",?9?6G_&&4B;>[ #24:2)$F2)$F2)$F2.CIO @       +1PA0(
;      "%%@?!B";*[!>K     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>102
<FILENAME>image_77.jpg
<TEXT>
begin 644 image_77.jpg
MB5!.1PT*&@H    -24A$4@    @   /'" (   ":.Y\@    7$E$051X7NW)
ML0T , S#L/S_=+/JA0;49G,FO=0?
M                                            #D%'^PP6:0B(\/I6
..1P<     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>103
<FILENAME>image_90.jpg
<TEXT>
begin 644 image_90.jpg
MB5!.1PT*&@H    -24A$4@  !^,    #" (   #'DSH:    .$E$051X7NW8
M,1$   @#L?HW#1N' EB2^Z$:FJ0D29(D29(D2=)Q8TT      ."<IQX
7 #XUA1T&_V8[B_4     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>104
<FILENAME>image_91.jpg
<TEXT>
begin 644 image_91.jpg
MB5!.1PT*&@H    -24A$4@   %,    ," (   "1"!9U    ,4E$051X7F-@
M8/@_HA <(#%'&!CU^<@#HSX?>6#4YR,/,&#6>,,;C?I\)*=V=($1 P#-@\*\
0%#V-MP    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>105
<FILENAME>image_93.jpg
<TEXT>
begin 644 image_93.jpg
MB5!.1PT*&@H    -24A$4@  !XX    #" (   #CBK7:    -TE$051X7NW8
M,1$   @#L?HW#1N' EB2^Z$:FJ0D29(D29(D2;IOK D      !]<U0
6/&OZ$K8E"FA4+     !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>106
<FILENAME>image_95.jpg
<TEXT>
begin 644 image_95.jpg
MB5!.1PT*&@H    -24A$4@   $T    5" (   ",MO1]    3$E$051X7NW5
ML0T , P"0?9?.NG!"_C-R152BJ^B=X-\@&HGBW=*A$N^Y9N-EZ:-J)TL[61I
K)XMWYE^T\9)O^6;CI6DC:B=+.UFN='[VU=,.6!E"%P    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>107
<FILENAME>image_96.jpg
<TEXT>
begin 644 image_96.jpg
MB5!.1PT*&@H    -24A$4@   %4    #" (   !M0-3G    %DE$051X7F/X
BS\ P0A$80*D1"T:Z_P$SQU3(DU/5.     !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>108
<FILENAME>image_97.jpg
<TEXT>
begin 644 image_97.jpg
MB5!.1PT*&@H    -24A$4@   %P    5" (   !$VAZK    5DE$051X7NW5
ML0T , S#L/S_=+O;NB 1D<E %RV=IS(YR"C(*""CS)R[EEN_67^-MO., HP"
MC *, HP"C (R2G_CZZ_EUF_67Z/M/*, HP"C *, HX /= ()$;W1OT0
(245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>109
<FILENAME>picture1.jpg
<TEXT>
begin 644 picture1.jpg
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MO\TIYI&2=BY0[?G_\4,D2)!@L\>61(*6#[Y3]7I7J8= : (;H##24RI<(5H
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MM$_EQ%X*VD,9UG2,![/E=%A $$AV9 O6?LD?6[CZ?Q;&=TCW68AWAFSQT&U
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MZ.EUFJM6([]=ED-.]^!-A(H=E02QHW(++>5$NR,J#@EB?1OV4W)G4#V&WG'
MDTNRGXVRA^:G0HHDB,>UNXYHVK']2ESVVKO4[/Z#5:]WJSA/I,^?,%(35V@?
MQ+BXPK3$ZU-SO>GJ;UYK!Z\T_8PXYZILSX5HUW#)N/[?UA^%W-0"5X;H,9C7
MF/"Y;![/(HZ4?<PPG<GF)J'M3@,10;ANI(6\L-W#P%4CYH7A&#[CG*@ZK'*G
MIM7 E1#:BO&YTK(%(GFTST+^#E([3(E.+BK!/F<Z)U=-AY)E?>;.5>U3HSD
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MUS)^8>XCZ ,I4[@4WWGR&X_L&_;E($)-&--2N1-1H)N1>#"H5!=FBHPRDU^
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M^XK4!V\3""!$U?H[PKTL]16DS7 C@:<$LX6K2_1'MS'_%@+B#IT>"S 625"
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MFZ0?3H)XM83<K^C>4*Q_7>\\L<+3-27E*BT?)DG)#X1U9_(:"G=_M1,FB\8
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M?A,3#R;YW-WX^R<JR^T+Q,WK#4I7<+ARQRTCNGE(N3OJR;WBA(^X3 ")"/2
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5/R" :UO2Z%&^     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715577944960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Apr. 26, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38701<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">SI-BONE,&#160;INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">26-2216351<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">471 El Camino Real<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Santa Clara<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">95050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">207-0700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001&#160;per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SIBN<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,184,049<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001459839<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715578009072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 22,969<span></span>
</td>
<td class="nump">$ 20,717<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent', window );">Short-term investments</a></td>
<td class="nump">62,997<span></span>
</td>
<td class="nump">76,573<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance for credit losses of $450 and $400, respectively</a></td>
<td class="nump">22,600<span></span>
</td>
<td class="nump">20,674<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">17,790<span></span>
</td>
<td class="nump">17,282<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">2,045<span></span>
</td>
<td class="nump">2,365<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">128,401<span></span>
</td>
<td class="nump">137,611<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">16,629<span></span>
</td>
<td class="nump">15,564<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">3,672<span></span>
</td>
<td class="nump">4,002<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">374<span></span>
</td>
<td class="nump">375<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">149,076<span></span>
</td>
<td class="nump">157,552<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">5,331<span></span>
</td>
<td class="nump">6,279<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities and other</a></td>
<td class="nump">9,896<span></span>
</td>
<td class="nump">13,511<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities, current portion</a></td>
<td class="nump">1,401<span></span>
</td>
<td class="nump">1,388<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">16,628<span></span>
</td>
<td class="nump">21,178<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term borrowings</a></td>
<td class="nump">35,938<span></span>
</td>
<td class="nump">35,171<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, net of current portion</a></td>
<td class="nump">2,525<span></span>
</td>
<td class="nump">2,871<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">TOTAL LIABILITIES</a></td>
<td class="nump">55,117<span></span>
</td>
<td class="nump">59,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 6)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>STOCKHOLDERS&#8217; EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.0001 par value; 5,000,000 shares authorized; no shares issued and outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.0001 par value; 100,000,000 shares authorized; 35,106,163 and 34,731,577 shares issued and outstanding, respectively</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">461,886<span></span>
</td>
<td class="nump">455,172<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">300<span></span>
</td>
<td class="nump">232<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(368,230)<span></span>
</td>
<td class="num">(357,105)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">TOTAL STOCKHOLDERS&#8217; EQUITY</a></td>
<td class="nump">93,959<span></span>
</td>
<td class="nump">98,302<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</a></td>
<td class="nump">$ 149,076<span></span>
</td>
<td class="nump">$ 157,552<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715578537520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts</a></td>
<td class="nump">$ 450<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock authorized (in shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock authorized (in shares)</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock issued (in shares)</a></td>
<td class="nump">35,106,163<span></span>
</td>
<td class="nump">34,731,577<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock outstanding (in shares)</a></td>
<td class="nump">35,106,163<span></span>
</td>
<td class="nump">34,731,577<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715577952128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 32,708<span></span>
</td>
<td class="nump">$ 22,439<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of goods sold</a></td>
<td class="nump">5,924<span></span>
</td>
<td class="nump">2,983<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">26,784<span></span>
</td>
<td class="nump">19,456<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="nump">27,313<span></span>
</td>
<td class="nump">25,605<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">3,291<span></span>
</td>
<td class="nump">3,580<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">7,473<span></span>
</td>
<td class="nump">7,139<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">38,077<span></span>
</td>
<td class="nump">36,324<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(11,293)<span></span>
</td>
<td class="num">(16,868)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Interest and other income (expense), net:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">932<span></span>
</td>
<td class="nump">73<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(838)<span></span>
</td>
<td class="num">(561)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">74<span></span>
</td>
<td class="num">(54)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(11,125)<span></span>
</td>
<td class="num">(17,410)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Changes in foreign currency translation</a></td>
<td class="num">(22)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Unrealized gain (loss) on marketable securities</a></td>
<td class="nump">90<span></span>
</td>
<td class="num">(248)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (11,057)<span></span>
</td>
<td class="num">$ (17,658)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share, basic (in usd per share)</a></td>
<td class="num">$ (0.32)<span></span>
</td>
<td class="num">$ (0.52)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share, diluted (in usd per share)</a></td>
<td class="num">$ (0.32)<span></span>
</td>
<td class="num">$ (0.52)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average number of common shares used to compute basic net loss per share (in shares)</a></td>
<td class="nump">34,916,106<span></span>
</td>
<td class="nump">33,792,326<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average number of common shares used to compute diluted net loss per share (in shares)</a></td>
<td class="nump">34,916,106<span></span>
</td>
<td class="nump">33,792,326<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715575205344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Stockholders' equity, beginning of period (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,674,085<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity, beginning of period at Dec. 31, 2021</a></td>
<td class="nump">$ 134,420<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 429,914<span></span>
</td>
<td class="nump">$ 352<span></span>
</td>
<td class="num">$ (295,849)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options, net of shares withheld (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,798<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options, net of shares withheld</a></td>
<td class="nump">169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sibn_StockIssuedDuringPeriodSharesRestrictedStockUnits', window );">Issuance of common stock upon vesting of restricted stock units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">163,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">5,507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Net unrealized gain (loss) on marketable securities</a></td>
<td class="num">(248)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(248)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(17,410)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17,410)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Stockholders' equity, end of period (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,872,363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity, end of period at Mar. 31, 2022</a></td>
<td class="nump">$ 122,438<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">435,590<span></span>
</td>
<td class="nump">104<span></span>
</td>
<td class="num">(313,259)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Stockholders' equity, beginning of period (in shares) at Dec. 31, 2022</a></td>
<td class="nump">34,731,577<span></span>
</td>
<td class="nump">34,731,577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity, beginning of period at Dec. 31, 2022</a></td>
<td class="nump">$ 98,302<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">455,172<span></span>
</td>
<td class="nump">232<span></span>
</td>
<td class="num">(357,105)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options, net of shares withheld (in shares)</a></td>
<td class="nump">120,266<span></span>
</td>
<td class="nump">120,266<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options, net of shares withheld</a></td>
<td class="nump">$ 520<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">520<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sibn_StockIssuedDuringPeriodSharesRestrictedStockUnits', window );">Issuance of common stock upon vesting of restricted stock units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">254,320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">6,194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation</a></td>
<td class="num">(22)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Net unrealized gain (loss) on marketable securities</a></td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (11,125)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,125)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Stockholders' equity, end of period (in shares) at Mar. 31, 2023</a></td>
<td class="nump">35,106,163<span></span>
</td>
<td class="nump">35,106,163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity, end of period at Mar. 31, 2023</a></td>
<td class="nump">$ 93,959<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 461,886<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="num">$ (368,230)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_StockIssuedDuringPeriodSharesRestrictedStockUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period Shares Restricted Stock Units</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_StockIssuedDuringPeriodSharesRestrictedStockUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715575374576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (11,125)<span></span>
</td>
<td class="num">$ (17,410)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">6,194<span></span>
</td>
<td class="nump">5,507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,086<span></span>
</td>
<td class="nump">713<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Accounts receivable credit losses</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Accretion (amortization) of discount on marketable securities</a></td>
<td class="num">(615)<span></span>
</td>
<td class="nump">244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of debt issuance costs</a></td>
<td class="nump">81<span></span>
</td>
<td class="nump">51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on disposal of property and equipment</a></td>
<td class="nump">190<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(2,019)<span></span>
</td>
<td class="nump">1,603<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="num">(536)<span></span>
</td>
<td class="num">(3,178)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="nump">311<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(745)<span></span>
</td>
<td class="nump">2,086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued liabilities and other</a></td>
<td class="num">(3,625)<span></span>
</td>
<td class="num">(3,171)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(10,753)<span></span>
</td>
<td class="num">(13,512)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sibn_ProceedsFromMaturityOfMarketableSecurities', window );">Maturities of marketable securities</a></td>
<td class="nump">30,000<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchases of marketable securities</a></td>
<td class="num">(15,718)<span></span>
</td>
<td class="num">(45,334)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(2,579)<span></span>
</td>
<td class="num">(2,274)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="nump">11,703<span></span>
</td>
<td class="num">(22,608)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from debt financing</a></td>
<td class="nump">36,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of debt financing</a></td>
<td class="num">(35,275)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payments of debt issuance costs</a></td>
<td class="num">(40)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from the exercise of stock options</a></td>
<td class="nump">520<span></span>
</td>
<td class="nump">169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">1,205<span></span>
</td>
<td class="nump">169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="nump">97<span></span>
</td>
<td class="num">(139)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash and cash equivalents</a></td>
<td class="nump">2,252<span></span>
</td>
<td class="num">(36,090)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValueAbstract', window );"><strong>Cash and cash equivalents at</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Beginning of period</a></td>
<td class="nump">20,717<span></span>
</td>
<td class="nump">63,419<span></span>
</td>
<td class="nump">63,419<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">End of period</a></td>
<td class="nump">22,969<span></span>
</td>
<td class="nump">27,329<span></span>
</td>
<td class="nump">$ 20,717<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental disclosure of non-cash information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Unpaid purchases of property and equipment</a></td>
<td class="nump">$ 887<span></span>
</td>
<td class="nump">$ 241<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_ProceedsFromMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Maturity Of Marketable Securities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_ProceedsFromMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715580424064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The Company and Nature of Business<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">The Company and Nature of Business</a></td>
<td class="text">The Company and Nature of Business<div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SI-BONE, Inc. (the &#8220;Company&#8221;) was incorporated in the state of Delaware on March&#160;18, 2008 and is headquartered in Santa Clara, California. The Company is a medical device company that has pioneered a proprietary minimally invasive surgical implant system to fuse the sacroiliac joint for treatment of musculoskeletal disorders of the sacropelvic anatomy. The Company introduced its first generation iFuse implant in 2009 in the U.S., in 2010 in certain countries in the European Union, and in 2015 in certain countries in the rest of the world. The second generation iFuse implant, iFuse-3D, was introduced in 2017 followed by iFuse-TORQ in 2021 and iFuse Bedrock Granite in 2022.</span></div><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks and Uncertainties</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company is subject to uncertainties related to liquidity, the ability to meet covenants and access to funding for its capital needs as the financial service industry has experienced disruptions characterized by the bankruptcy, failure, collapse or sale of various financial institutions. The Company&#8217;s cash and cash equivalents are primarily invested in deposits and money market accounts with two major financial institutions in the U.S. Deposits in these banks may exceed the federally insured limits or any other insurance provided on such deposits, if any. The Company had accounts with Silicon Valley Bank (&#8220;SVB&#8221;). On March 10, 2023, California regulators shut down SVB and the FDIC was appointed as SVB&#8217;s receiver. On March 26, 2023, the FDIC announced that it had entered into a purchase and assumption agreement with First-Citizens Bank &amp; Trust Company (&#8220;First-Citizens&#8221;) under which all deposits of the former Silicon Valley Bank were assumed by First-Citizens.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">First-Citizens acquired the rights as lender under the Company&#8217;s Loan and Security Agreement as amended. To date, the Company has not experienced any losses on its deposits of cash, cash equivalents and marketable securities and continues to have access to these funds.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company is subject to continuing risk and uncertainties resulting from the COVID-19 pandemic. The COVID-19 pandemic has impacted our supply chain and also caused delays or cancellations of our procedures. Continuing or future outbreaks of COVID-19 or other public health concerns could contribute to health systems diverting resources to respond to COVID-19 which could lead to scheduling delays or cancellations of our procedures. Continuing or future outbreaks could also cause or exacerbate supply chain shortages.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As such the Company's future results of operations and liquidity could be adversely impacted by a variety of factors related to uncertainties in the financial services industry and new or ongoing impacts of the COVID-19 pandemic, including those discussed in the section titled "Risk Factors" in this report. As of the date of issuance of these condensed consolidated financial statements, the extent to which the COVID-19 pandemic, economic disruption that has resulted from the pandemic and measures taken to stabilize economies during the pandemic, global supply chain issues and uncertainties of the financial services industry may materially impact the Company's financial condition, liquidity, or results of operations remains uncertain.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715583844112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="margin-bottom:12pt;margin-top:9pt;padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Principles of Consolidation</span></div><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (&#8220;U.S. GAAP&#8221;) and applicable rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;) regarding interim financial reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP have been condensed or omitted, and accordingly the balance sheet as of December 31, 2022 has been derived from the audited consolidated financial statements at that date but does not include all of the information required by GAAP for complete financial statements. These unaudited interim condensed consolidated financial statements have been prepared on the same basis as the Company&#8217;s annual financial statements and, in the opinion of management, reflect all adjustments that are necessary for a fair statement of the Company&#8217;s consolidated financial information. The results of operations for the three months ended March 31, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any other interim period or for any other future year. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements should be read in conjunction with the audited financial statements and related notes thereto for the year ended December 31, 2022 contained in the Company&#8217;s Annual Report on Form 10-K filed with the SEC on March 2, 2023.</span></div><div style="margin-bottom:12pt;margin-top:9pt;padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates </span></div><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Significant accounting estimates and management judgments reflected in the condensed consolidated financial statements primarily includes the fair value of performance-based restricted stock unit awards. Estimates are based on historical experience, where applicable and other assumptions believed to be reasonable by the management. Actual results could differ from those estimates. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s significant accounting policies are disclosed in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2022. The Company updated the accounting policies related to the property and equipment and revenue recognition, as follows:</span></div><div style="padding-left:72pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Property and Equipment </span></div><div style="padding-left:72pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Construction in progress includes assets that have not yet been placed into service including the cost of individual components of an instrument tray. Once an instrument tray is placed into service, the Company transfers its carrying value into machinery and equipment and begins depreciating the cost of the instrument tray over its useful life. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Leasehold improvements are amortized over the lesser of their useful lives or the life of the lease.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Upon the sale or retirement of these assets, the cost and related accumulated depreciation are removed from the consolidated balance sheet and the resulting gain or loss is recognized in the consolidated statement of operations. Maintenance and repairs are charged to operations as incurred.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:72pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Revenue Recognition</span></div><div style="padding-left:72pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company&#8217;s revenue is derived from the sale of its products to medical groups and hospitals through its direct sales force and third-party sales agents and resellers throughout the U.S. and Europe. The Company receives payment for its implants consumed during the surgery and does not receive additional or separate consideration for the use of the instrument tray furnished by the Company for the surgeon&#8217;s use. The Company identifies the instrument trays as a lease component and the implants as a non-lease component in its arrangements with its customers. The Company determines that the non-lease component is qualitatively predominant, and as such, elected the practical expedient to not separate the lease and non-lease components. Therefore, the overall arrangement is accounted for under Accounting Standards Codification (&#8220;ASC&#8221;) 606, Revenue from Contracts with Customers (&#8220;ASC 606&#8221;).</span></div><div style="padding-left:72pt;text-align:justify"><span><br/></span></div><div style="padding-left:72pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In accordance with ASC 606, the Company recognizes revenue when control is transferred to the customer, in an amount that reflects the consideration the Company expects to be entitled to in exchange for the goods or services. Under the revenue recognition standard, the Company applies the following five step approach: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when a performance obligation is satisfied. As it relates to product sales where the Company's sales representative delivers the product at the point of implantation at the hospital or medical facilities, the Company continues to recognize the revenue upon completion of the procedure and authorization by the customer, net of rebates and price discounts. This represents the majority of the Company's consolidated revenue. The Company also generates a small portion of revenue from the sale of products through distributors and to certain hospital or medical facilities where the products are ordered in advance of a procedure. The performance obligation is the delivery of the products and therefore, revenue is recognized upon shipment to the customers, net of rebates and price discounts. The Company accounts for rebates and price discounts as a reduction to revenue, calculated based on the terms agreed to with the customer. Historically, there had been no significant price discounts. Sales prices are specified in either the customer contract or agreed price list, which is executed prior to the transfer of control to the customer. For certain hospitals and medical facilities, the Company has agreements in place consists of either a master services agreement or an agreed price list, which defines the terms and conditions of the arrangement, including the pricing information, payment terms and pertinent aspects of the relationship between the parties. The Company also has agreements in place with its distributors, which include standard terms that do not allow for payment contingent on resale of the product, obtaining financing, or other terms that could impact the distributor&#8217;s payment obligation. The Company's standard payment terms are generally net 30 to 90 days.</span></div><div style="padding-left:72pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segments</span></div><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's chief operating decision makers are the Chief Executive Officer (&#8220;CEO&#8221;) and Chief Financial Officer (&#8220;CFO&#8221;). The CEO and the CFO review financial information presented on a consolidated basis, accompanied by information about revenue by geographic region, for purposes of evaluating financial performance. The Company has one business activity and there are no segment managers who are held accountable for operations, operating results or plans for levels or components below the consolidated unit level. Accordingly, the Company has determined that it has a single reportable and operating segment structure</span><span style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company derives substantially all of its revenue from sales to customers in the U.S. Revenue by geography is based on billing address of the customer. International revenue accounted for less than 10% of the total revenue during the periods presented. Long-lived assets held outside the U.S. are immaterial. Following table summarizes the Company's revenue by geography:</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.527%"><tr><td style="width:1.0%"/><td style="width:64.870%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.392%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.843%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.395%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,072&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,708&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,439&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No recently issued accounting standards are expected to have a material impact on the Company&#8217;s consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715577910112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Marketable Securities</a></td>
<td class="text">Marketable Securities<div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company's marketable securities were available-for-sale and were classified based on their maturities. Marketable securities with remaining maturities at the date of purchase of three months or less are classified as cash equivalents. Short-term investments are securities that original maturity or remaining maturity is greater than three months and not more than twelve months. Long-term investments are securities for which the original maturity or remaining maturity is greater than twelve months.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the marketable securities:</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.666%"><tr><td style="width:1.0%"/><td style="width:36.560%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.242%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.242%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.921%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.486%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,602&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,602&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,978&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,964&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,945&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,938&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,820&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,830&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,008&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,997&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,610&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,599&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.527%"><tr><td style="width:1.0%"/><td style="width:36.620%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.244%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.244%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.667%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.084%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.029%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,002&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,002&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,002&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,002&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,636&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,535&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,918&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,921&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,914&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,911&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,674&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,573&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,676&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,575&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost of the Company's available-for-sale securities approximates their fair value. Unrealized losses are generally due to interest rate fluctuations, as opposed to credit quality. However, the Company reviews individual securities that are in an unrealized loss position in order to evaluate whether or not they have experienced or are expected to experience credit losses. During the three months ended March 31, 2023 and 2022, unrealized gains and losses from the investments were not material and were not the result of a decline in credit quality. As a result, the Company did not recognize any credit losses related to its investments and that all unrealized gains and losses on available-for-sale securities are recorded in accumulated other comprehensive income (loss) on the condensed consolidated balance sheets as of March 31, 2023 and December 31, 2022.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company elected to present accrued interest receivable separately from short-term and long-term investments on its condensed consolidated balance sheets. Accrued interest receivable was $0.1&#160;million as of March 31, 2023, and was recorded in prepaid expenses and other current assets. The Company also elected to exclude accrued interest receivable from the estimation of expected credit losses on its marketable securities and reverse accrued interest receivable through interest income (expense) when amounts are determined to be uncollectible. The Company did not write off any accrued interest receivable as of March 31, 2023 or December 31, 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2176304<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (b)<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715577910112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurement<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurement</a></td>
<td class="text">Fair Value Measurement<div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Carrying amounts of certain of the Company&#8217;s financial instruments, including cash equivalents, accounts receivable, accounts payable and accrued liabilities, approximate fair value due to their relatively short maturities and market interest rates, if applicable. The carrying value of the Company&#8217;s long-term debt also approximates fair value based on management&#8217;s estimation that a current interest rate would not differ materially from the stated rate. There were no other financial assets and liabilities that require fair value hierarchy measurements and disclosures for the periods presented. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the fair value of the Company&#8217;s marketable securities measured at fair value on a recurring basis based on the three-tier fair value hierarchy:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.888%"><tr><td style="width:1.0%"/><td style="width:45.201%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.775%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Marketable securities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,602&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,602&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,964&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,964&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,938&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,938&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,830&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,830&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,566&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,033&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,599&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Marketable securities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,002&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,002&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency bonds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,921&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,921&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,911&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,911&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,537&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,038&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,575&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715664043424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">Balance Sheet Components</a></td>
<td class="text">Balance Sheet Components<div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023, inventory consisted of finished goods of $16.3&#160;million and work-in-progress of $1.5&#160;million. As of December 31, 2022,  inventory consisted of finished goods of $15.6&#160;million and work-in-progress and components of $1.7&#160;million.</span></div><div style="margin-bottom:9pt;margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment, net:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:9pt;margin-top:12pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.916%"><tr><td style="width:1.0%"/><td style="width:66.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.697%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.589%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.700%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,920&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,682&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,854&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer and office equipment</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">976&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,631&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,631&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,912&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,771&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation and amortization</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,283)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,207)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,629&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,564&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023, construction in progress pertains to the cost of individual components of a custom instrument set used for surgical placement of the Company's products that have not yet been placed into service of $4.0 million and construction costs related to the Company's lease for research and development and warehouse space in Santa Clara and software costs of $3.7 million. Depreciation expense was $1.1 million and $0.7 million for the three months ended March 31, 2023 and 2022, respectively.</span></div><div style="margin-bottom:9pt;margin-top:12pt;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accrued Liabilities and Other</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:9pt;margin-top:12pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.916%"><tr><td style="width:1.0%"/><td style="width:66.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.697%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.589%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.700%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and related expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,487&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued royalty</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Accrued professional services </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Others</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">761&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">973&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,896&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,511&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">        Accounts Receivable and Allowance for Credit Losses:</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The movement in the allowance for credit losses was as follows:</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.916%"><tr><td style="width:1.0%"/><td style="width:66.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.697%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.589%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.700%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -URI https://asc.fasb.org/topic&amp;trid=2122208<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715580421424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-top:9pt;padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Leases</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a non-cancelable operating lease for an office building space, located in Santa Clara, California which expires in May 2025 and a building used for research and development and warehouse space in Santa Clara, California which expires in </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">October 2026. The Company also has non-cancelable operating leases for its office building spaces in Gallarate, Italy and Knaresborough, United Kingdom, which expire in August 2027 and December 2025, respectively. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company also leases vehicles under operating lease arrangements for certain of its personnel in Europe which expire at various times throughout 2023 to 2027.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental information related to lease expense and valuation of the lease assets and lease liabilit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ies are as follows:</span></div><div><span><br/></span></div><div style="padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:60.833%"><tr><td style="width:1.0%"/><td style="width:56.662%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.763%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.311%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.764%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Operating lease expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Variable lease expense</span></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cash paid for amounts included in the measurement of operating lease liabilities</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Leased assets obtained in exchange for new operating lease liabilities</span></div><div><span><br/></span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Weighted average remaining lease term (in years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.83</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.05</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.77%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.77%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments under non-cancelable operating leases as of March 31, 2023 was as follows:</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.861%"><tr><td style="width:1.0%"/><td style="width:71.044%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.756%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:4.5pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,195&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,005&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">530&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,256&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(330)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,926&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr></table></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023, the Company had no operating lease liabilities that had not commenced.</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purchase Commitments and Obligations</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has certain purchase commitments related to its inventory management with certain manufacturing suppliers wherein the Company is required to purchase the amounts forecasted in a blanket purchase order. The contractual obligations represent future cash commitments and liabilities under agreements with third parties and exclude orders for goods and services entered into in the normal course of business that are not enforceable or legally binding. These outstanding commitments amounted to $1.8 million and $0.8 million as of March 31, 2023 and December 31, 2022, respectively.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indemnification</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into standard indemnification arrangements in the ordinary course of business. Pursuant to these arrangements, the Company indemnifies, holds harmless, and agrees to reimburse the indemnified parties for losses suffered or incurred by the indemnified party, in connection with any trade secret, copyright, patent or other intellectual property infringement claim by any third-party with respect to the Company&#8217;s technology. The term of these indemnification agreements is generally perpetual. The maximum potential amount of future payments the Company could be required to make under these agreements is not determinable because it involves claims that may be made against the Company in the future, but have not yet been made.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into indemnification agreements with its directors and officers that may require the Company to indemnify its directors and officers against liabilities that may arise by reason of their status or service as directors or officers, other than liabilities arising from willful misconduct of the individual.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has not incurred costs to defend lawsuits or settle claims related to these indemnification agreements. No liability associated with such indemnifications has been recorded to date.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Contingencies</span></div>From time to time, the Company may become involved in legal proceedings arising in the ordinary course of its business. The Company is not presently a party to any material legal proceedings that, if determined adversely to the Company, would have a material adverse effect on the Company.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715583866528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Borrowings</a></td>
<td class="text">Borrowings<div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Term Loan</span></div><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the outstanding borrowings from the term loan as of periods presented:</span></div><div style="margin-bottom:12pt;margin-top:9pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.583%"><tr><td style="width:1.0%"/><td style="width:66.962%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.558%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.575%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.405%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal outstanding and final fee</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,720&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Unaccreted value of final fee</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(683)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(456)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding debt, net of debt issuance costs and unaccreted value of final fee</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,938&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,171&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Classified as:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term borrowings</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,938&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,171&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The outstanding debt is related to a term loan pursuant to the Loan and Security Agreement dated August 12, 2021 (the &#8220;Effective Date&#8221;), entered into by the Company with Silicon Valley Bank (&#8220;SVB&#8221;). Pursuant the agreement, SVB provided an aggregate principal amount of $35.0&#160;million to the Company (the &#8220;SVB Term Loan&#8221;). </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 6, 2023, the Company entered into a First Amendment to Loan and Security Agreement (the &#8220;Amendment&#8221;) with SVB, which amended the Company's SVB Term Loan pursuant to which the Company had a term loan facility in an aggregate principal amount of $35.0&#160;million (the &#8220;Original Loan Agreement&#8221; and with the Amendment, collectively the &#8220;Amended Loan Agreement&#8221;).  Upon entry into the Amended Loan Agreement, the Company borrowed $36.0&#160;million pursuant to a term loan (the "Term Loan"), which was substantially used to repay in full the $35.0&#160;million term loan facility outstanding under the Original Loan Agreement and secured a revolving credit facility in an aggregate principal amount of up to $15.0&#160;million (the "Revolver"). On March 14, 2023 all of SVB&#8217;s assets and liabilities, including all of SVB&#8217;s rights as the lender pursuant to the Amended Loan Agreement, were assigned to Silicon Valley Bridge Bank.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 27, 2023, all of Silicon Valley Bridge Bank&#8217;s assets and liabilities were assigned and assumed by First-Citizens Bank &amp; Trust Company (&#8220;First-Citizens&#8221;). The Amended Loan Agreement also includes an uncommitted accordion term loan in an aggregate principal amount of up to $15.0&#160;million, which accordion may be approved by First-Citizens solely in its discretion, upon the Company&#8217;s request. The Term Loan matures on December 1, 2027 (the &#8220;Term Loan Maturity Date&#8221;). Interest on the Term Loan will be payable monthly at a floating annual rate set at the greater of the prime rate as published in the Wall Street Journal plus 0.5% or 6.75%. Commencing on July 1, 2025, the Company will be required to make monthly principal Term Loan amortization payments. A final fee payment of 2% of the original principal amount of the Term Loan is due upon the earlier of the Term Loan Maturity Date, termination, acceleration by First-Citizens following an event of default, or prepayment of the Term Loan. The Company may elect to prepay the Term Loan in whole prior to the Term Loan Maturity Date subject to a prepayment fee equal to 2% of the principal amount of the Term Loan prepaid at such time. No prepayment fee would be due if the Term Loan is refinanced by First-Citizens. Pursuant to the terms of the Amended Loan Agreement, revolving loans may be </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">borrowed, repaid and reborrowed until the maturity date, which will be July 6, 2025 (the "Revolver Maturity Date"). Borrowings under the Revolver are based on 80% of eligible domestic accounts receivable borrowing base. Interest on the outstanding balance of the Revolver will be payable monthly at a floating annual rate set at the greater of the prime rate as published in the Wall Street Journal or 6.25%. Interest on borrowings is due monthly and any principal balance is due on the Revolver Maturity Date, provided that when Revolver Advances are outstanding, in the event the Company does not maintain an adjusted quick ratio of at least 1.5 to 1.0, then falling below such threshold will allow First-Citizens to apply accounts receivable collections to outstanding Revolver borrowings. The Company will pay a total commitment fee of $187,500 on account of the Revolver payable in installments, but fully earned at close. The Company will also be required to pay a fee of $150,000 if it terminates the Amended Loan Agreement or Revolver prior to Revolver Maturity Date. No termination fee would be due if the Revolver is replaced with a new facility with First-Citizens. No amounts were outstanding under the Revolver as of March 31, 2023.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounted for the Amended Loan Agreement as a debt modification. Accordingly, the remaining unamortized debt issuance costs related to the Original Loan Agreement together with any lender fees incurred in connection with the entry of the Amended Loan Agreement are amortized to interest expense using the straight-line method over the new term of the loan through December 2027.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective interest rate related to the First-Citizens Term Loan for the three months ended March 31, 2023 and March 31, 2022 was 8.6% and 6.3%, respectively. </span></div><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">         The table below summarizes the future principal and final fee payments under the Fist-Citizens Term Loan as of March 31, 2023:</span></div><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.388%"><tr><td style="width:1.0%"/><td style="width:84.912%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.888%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,920&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total principal and final fee payments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,720&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Amended Loan Agreement contains customary events of default, including bankruptcy, the failure to make payments when due, the occurrence of a material impairment on First-Citizens's security interest over the collateral, a material adverse change, the occurrence of a default under certain other indebtedness of the Company and its subsidiaries, the rendering of certain types of judgments against the Company and its subsidiaries, the revocation of certain government approvals, violation of covenants, and incorrectness of representations and warranties in any material respect. In addition, the Amended Loan Agreement contains a financial covenant which requires the Company to maintain, at all times when the Financial Covenant Measuring Period is in effect, certain net revenue levels as agreed upon by the Company and First-Citizens. If the Company does not comply with the various covenants under the Amended Loan Agreement and an event of default occurs under the Amended Loan Agreement, the interest rate on outstanding amounts can increase by 3% and First-Citizens may, subject to various customary cure rights, decline to provide additional advances under the Revolver, require the immediate payment of all amounts outstanding under the Amended Loan Agreement, and foreclose on all collateral. </span></div>On March 10, 2023, the Company violated one of the terms of the credit facility by opening bank accounts with another financial institution and transferring funds from SVB. The Company entered into a letter agreement with Silicon Valley Bridge Bank waiving enforcement of this covenant and providing the Company the right to hold a portion of its cash at other financial institutions. A future violation of any covenants could result in a default under the Amended Loan Agreement that would permit First-Citizens to restrict the Company&#8217;s ability to further access the Revolving Line of Credit for loans and require the immediate repayment of any outstanding loans under the agreement. As of March 31, 2023, the Company was in compliance with all debt covenants, provided, however, that in order to access future credit advances under the Revolving Line of Credit, the Company will be required to transfer certain cash management accounts back to First-Citizens.  As of March 31, 2023, the Company had cash management accounts with a financial institution other than First-Citizens and instructed its customers to direct payments to these separate operating accounts. Until such operating accounts are closed and the funds moved back to cash collateral accounts held at First-Citizens, the Company will be unable to obtain credit advances under the Revolver.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715580447360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Incentive Compensation Plans<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Incentive Compensation Plans</a></td>
<td class="text">Stock-Based Incentive Compensation Plans <div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the stock option activity for the three months ended March 31, 2023:</span></div><div style="margin-bottom:9pt;padding-left:72pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.444%"><tr><td style="width:1.0%"/><td style="width:62.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of <br/>Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted- <br/>Average <br/>Exercise <br/>Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,903,341&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$8.82</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(120,266)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.33</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled and forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,284)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.36</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,767,791&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023, the unrecognized compensation cost related to stock options is insignificant and is expected to be recognized over a period of approximately 0.4 years.</span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no stock options granted during the three months ended March 31, 2023 and 2022. </span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Early Exercise of Unvested Stock Options</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Early exercises of stock options under the Company's 2008 Stock Option Plan are subject to a right of repurchase by the Company of any unvested shares. The repurchase rights lapse over the original vesting period of the options. The Company accounts for the cash received in consideration for the early exercised options as a liability included in accrued liabilities, which is then reclassified to stockholders&#8217; equity as the options vest. As of March 31, 2023 and December 31, 2022, the Company had no shares subject to repurchase. </span></div><div style="margin-top:18pt;padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Units (&#8220;RSUs&#8221;)</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs are share awards that entitle the holder to receive freely tradable shares of the Company&#8217;s common stock upon vesting. RSUs generally vest over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfMTEwOQ_b006b137-1392-4dc1-aa98-21e5cfe1c1eb">two</span> to four years based upon continued services and are settled at vesting in shares of the Company's common stock. Certain RSUs vest based upon continued services and the achievement of financial milestones. The grant date fair value of the RSUs is equal to the closing price of the Company&#8217;s common stock on the grant date. As of March 31, 2023, the unr</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ecognized compensation cost related to the RSUs was $41.5 million, which is expected to be recognized over a period of approximately 2.8 years. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company granted performance-based restricted stock unit awards subject to market and service vesting conditions to certain executive officers under SI-BONE's 2018 Equity Incentive Plan (&#8220;PSUs&#8221;). The shares subject to PSUs vest over a three-year performance period. The actual number of PSUs that will vest in each measurement period will be determined by the Compensation Committee based on the Company&#8217;s total shareholder return (&#8220;TSR&#8221;) relative to the TSR of the Median Peer Companies (as defined in the award agreement).  The grant date fair value of each stock award with a market condition was determined using the Monte Carlo valuation model. The table below summarizes the assumptions used to estimate the grant date fair value of the PSUs granted:</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.833%"><tr><td style="width:1.0%"/><td style="width:41.073%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.379%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.320%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.320%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.320%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.320%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.320%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.324%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility of common stock</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.0%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.0%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.9%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.7%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility of peer companies</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.0%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141.0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.2%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152.5%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Correlation coefficient of peer companies</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.15)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.13)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0%</span></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023, the unrecognized compensation cost related to the PSUs was $4.1 million, which is expected to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">be recognized over a period of approximately 2.4 years.</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes RSU and PSU activity for the three months ended March 31, 2023:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.222%"><tr><td style="width:1.0%"/><td style="width:38.258%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.475%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.258%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.475%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.258%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.475%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.258%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.982%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.261%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">RSUs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PSUs</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,794,928</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$22.72</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,596</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$19.50</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,044,344</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.69</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255,458</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.33</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(228,388)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.97</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,932)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.50</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled and forfeited</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86,107)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.70</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,524,777</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.82</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385,122</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.74</span></td></tr></table></div><div style="margin-top:18pt;padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s 2018 Employee Stock Purchase Plan (the &#8220;ESPP&#8221;) allows eligible employees to purchase shares of the Company's common stock through payroll deductions at the price equal to 85% of the lesser of the fair market value of the stock as of the first date or the ending date of each six month offering period. The offering period generally commences in May and November. On March 26, 2020, the Company's Compensation Committee approved the amendment of the terms of future offerings under the ESPP which, among other things, increased the maximum number of shares that may be purchased on any single purchase date, provided for automatic enrollment in a new offering, and provided that the offering which commenced in May 2020 be twelve months in duration and consist of two purchase periods. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the ESPP shares is estimated using the Black-Scholes option pricing model, which is being amortized over the requisite service period. The Company did not issue any shares under ESPP for the three months ended March 31, 2023 and 2022. As of March 31, 2023 and December 31, 2022, total accumulated ESPP related employee payroll deductions amounted to </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.2 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $0.3 million, respectively, which were included within accrued compensation and related expenses in the condensed consolidated balance sheets. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the detail of stock-based compensation expense amounts included in the condensed consolidated statements of operations:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.305%"><tr><td style="width:1.0%"/><td style="width:59.159%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.879%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.690%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.879%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.693%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,594&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">752&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">633&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,194&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,507&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715580793776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share of Common Stock<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Share of Common Stock</a></td>
<td class="text">Net Loss Per Share of Common Stock<div style="margin-bottom:12pt;margin-top:12pt;padding-left:24.75pt;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the computation of basic and diluted net loss per share:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:61.388%"><tr><td style="width:1.0%"/><td style="width:55.687%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.931%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.942%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except share and per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,125)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,410)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares used to compute basic and diluted net loss per share</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,916,106&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,792,326&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share, basic and diluted</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.32)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.52)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because the Company has reported a net loss in all periods presented, outstanding stock options, restricted stock units, ESPP purchase rights and common stock warrants are anti-dilutive and therefore diluted net loss per common share is the same as basic net loss per common share for the periods presented. The following anti-dilutive common stock equivalents were excluded from the computation of diluted net loss per share for the periods presented:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">            </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.527%"><tr><td style="width:1.0%"/><td style="width:59.025%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.315%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.843%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.317%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,767,791</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,963,360</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,909,899</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,309,284</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESPP purchase rights</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,226</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,264</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock warrants</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,122</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,122</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,930,038&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,452,030&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715580253904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transaction<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transaction</a></td>
<td class="text">Related Party Transaction <div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 24, 2020, the Company entered into a joint development agreement (the &#8220;Development Agreement&#8221;) with SeaSpine Orthopedics Corporation (&#8220;SeaSpine&#8221;), which merged with Orthofix Medical, Inc., to develop a next generation device for sacropelvic fixation. Mr. Keith Valentine, who serves as the President, Chief Executive Officer and a member of the board of directors of SeaSpine, also serves as a member of the Company's Board of Directors since August 2015. On April 27, 2021, Addendum No.1 to the Development Agreement was entered into by and between the Company and SeaSpine to extend certain obligations as described under the Development Agreement to a consultant of the Company.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the development plan, SeaSpine shall use reasonable efforts to assist in the development of the potential product offering, including licensing certain existing intellectual property to be incorporated into such product. Under the terms of the&#160;Development Agreement, the Company agreed to make monthly payments to SeaSpine to reimburse for full time resources employed by SeaSpine responsible to conduct the development activities. For the three months ended March 31, 2023, the Company did not incur any</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> reimbursement charges from SeaSpine. For the three months ended March 31, 2022, the Company expensed approximately $6,000 of the reimbursement charges from SeaSpine. The reimbursement charges were recorded within research and development expense in the condensed consolidated statements of operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain intellectual property developed pursuant to the project plan will be owned by the Company, certain intellectual property developed pursuant to the project plan will be owned by SeaSpine, and other intellectual property developed pursuant to the project plan will be jointly owned by SeaSpine and the Company. The Company also agreed to provide SeaSpine a royalty-free, worldwide, perpetual, non-exclusive license of certain of the Company's intellectual property incorporated into the product to be developed. The Company also agreed to pay SeaSpine a product royalty, in an amount specified in the Development Agreement, for each resulting product sold for a period of 10 years beginning on the initial market launch. The term of the Development Agreement shall continue until the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expiration of all royalty terms, unless earlier terminated by either party, as provided for by the Development Agreement. The Company recorded $0.06 million of royalty for the three months ended March 31, 2023. No royalties were recorded for three months ended March 31, 2022.</span></div>The outstanding liability to SeaSpine as of March 31, 2023 and December 31, 2022 was approximately $0.06 million and $0.1&#160;million, respectively, and was recorded within accrued liabilities and other in the condensed consolidated balance sheet.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI https://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715580244944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income TaxesIn determining quarterly provisions for income taxes, the Company uses the annual estimated effective tax rate applied to the actual year-to-date profit or loss, adjusted for discrete items arising in that quarter. The Company updates its estimate of its annual effective tax rate at the end of each quarterly period. The estimate takes into account annual forecasted income (loss) before income taxes, the geographic mix of income (loss) before income taxes and any significant permanent tax items. The Company did not have provision for income taxes for the three months ended March 31, 2023 and 2022. The Company continues to maintain a full valuation allowance against its net deferred tax assets due to the uncertainty surrounding realization of such assets.<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for the uncertainty in income taxes by utilizing a comprehensive model for the recognition, measurement, presentation and disclosure in financial statements of any uncertain tax positions that have been taken or are expected to be taken on an income tax return. There had been no changes in the estimated uncertain tax benefits recorded as of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 31, 2023</span> compared to December 31, 2022.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715580855552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (&#8220;U.S. GAAP&#8221;) and applicable rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;) regarding interim financial reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP have been condensed or omitted, and accordingly the balance sheet as of December 31, 2022 has been derived from the audited consolidated financial statements at that date but does not include all of the information required by GAAP for complete financial statements.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text">These unaudited interim condensed consolidated financial statements have been prepared on the same basis as the Company&#8217;s annual financial statements and, in the opinion of management, reflect all adjustments that are necessary for a fair statement of the Company&#8217;s consolidated financial information. The results of operations for the three months ended March 31, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any other interim period or for any other future year.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Significant accounting estimates and management judgments reflected in the condensed consolidated financial statements primarily includes the fair value of performance-based restricted stock unit awards. Estimates are based on historical experience, where applicable and other assumptions believed to be reasonable by the management. Actual results could differ from those estimates.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><div style="padding-left:72pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Property and Equipment </span></div><div style="padding-left:72pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Construction in progress includes assets that have not yet been placed into service including the cost of individual components of an instrument tray. Once an instrument tray is placed into service, the Company transfers its carrying value into machinery and equipment and begins depreciating the cost of the instrument tray over its useful life. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Leasehold improvements are amortized over the lesser of their useful lives or the life of the lease.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Upon the sale or retirement of these assets, the cost and related accumulated depreciation are removed from the consolidated balance sheet and the resulting gain or loss is recognized in the consolidated statement of operations. Maintenance and repairs are charged to operations as incurred.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="padding-left:72pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Revenue Recognition</span></div><div style="padding-left:72pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company&#8217;s revenue is derived from the sale of its products to medical groups and hospitals through its direct sales force and third-party sales agents and resellers throughout the U.S. and Europe. The Company receives payment for its implants consumed during the surgery and does not receive additional or separate consideration for the use of the instrument tray furnished by the Company for the surgeon&#8217;s use. The Company identifies the instrument trays as a lease component and the implants as a non-lease component in its arrangements with its customers. The Company determines that the non-lease component is qualitatively predominant, and as such, elected the practical expedient to not separate the lease and non-lease components. Therefore, the overall arrangement is accounted for under Accounting Standards Codification (&#8220;ASC&#8221;) 606, Revenue from Contracts with Customers (&#8220;ASC 606&#8221;).</span></div><div style="padding-left:72pt;text-align:justify"><span><br/></span></div><div style="padding-left:72pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In accordance with ASC 606, the Company recognizes revenue when control is transferred to the customer, in an amount that reflects the consideration the Company expects to be entitled to in exchange for the goods or services. Under the revenue recognition standard, the Company applies the following five step approach: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when a performance obligation is satisfied. As it relates to product sales where the Company's sales representative delivers the product at the point of implantation at the hospital or medical facilities, the Company continues to recognize the revenue upon completion of the procedure and authorization by the customer, net of rebates and price discounts. This represents the majority of the Company's consolidated revenue. The Company also generates a small portion of revenue from the sale of products through distributors and to certain hospital or medical facilities where the products are ordered in advance of a procedure. The performance obligation is the delivery of the products and therefore, revenue is recognized upon shipment to the customers, net of rebates and price discounts. The Company accounts for rebates and price discounts as a reduction to revenue, calculated based on the terms agreed to with the customer. Historically, there had been no significant price discounts. Sales prices are specified in either the customer contract or agreed price list, which is executed prior to the transfer of control to the customer. For certain hospitals and medical facilities, the Company has agreements in place consists of either a master services agreement or an agreed price list, which defines the terms and conditions of the arrangement, including the pricing information, payment terms and pertinent aspects of the relationship between the parties. The Company also has agreements in place with its distributors, which include standard terms that do not allow for payment contingent on resale of the product, obtaining financing, or other terms that could impact the distributor&#8217;s payment obligation. The Company's standard payment terms are generally net 30 to 90 days.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segments</a></td>
<td class="text">Segments<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's chief operating decision makers are the Chief Executive Officer (&#8220;CEO&#8221;) and Chief Financial Officer (&#8220;CFO&#8221;). The CEO and the CFO review financial information presented on a consolidated basis, accompanied by information about revenue by geographic region, for purposes of evaluating financial performance. The Company has one business activity and there are no segment managers who are held accountable for operations, operating results or plans for levels or components below the consolidated unit level. Accordingly, the Company has determined that it has a single reportable and operating segment structure</span><span style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</span>The Company derives substantially all of its revenue from sales to customers in the U.S. Revenue by geography is based on billing address of the customer. International revenue accounted for less than 10% of the total revenue during the periods presented. Long-lived assets held outside the U.S. are immaterial.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Standards and Recent Accounting Standards Not Yet Effective</a></td>
<td class="text"><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No recently issued accounting standards are expected to have a material impact on the Company&#8217;s consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715581881232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock', window );">Schedule of Revenue by Geography</a></td>
<td class="text">Following table summarizes the Company's revenue by geography:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.527%"><tr><td style="width:1.0%"/><td style="width:64.870%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.392%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.843%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.395%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,072&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,708&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,439&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph a<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715580321568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesTextBlock', window );">Schedule of Marketable Securities</a></td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the marketable securities:</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.666%"><tr><td style="width:1.0%"/><td style="width:36.560%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.242%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.242%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.921%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.486%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,602&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,602&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,978&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,964&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,945&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,938&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,820&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,830&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,008&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,997&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,610&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,599&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.527%"><tr><td style="width:1.0%"/><td style="width:36.620%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.244%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.244%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.667%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.084%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.029%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,002&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,002&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,002&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,002&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,636&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,535&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,918&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,921&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,914&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,911&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,674&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,573&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,676&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,575&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715580339936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurement (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Marketable Securities Measured at Fair Value on Recurring Basis</a></td>
<td class="text"><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the fair value of the Company&#8217;s marketable securities measured at fair value on a recurring basis based on the three-tier fair value hierarchy:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.888%"><tr><td style="width:1.0%"/><td style="width:45.201%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.775%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Marketable securities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,602&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,602&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,964&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,964&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,938&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,938&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,830&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,830&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,566&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,033&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,599&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Marketable securities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,002&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,002&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency bonds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,921&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,921&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,911&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,911&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,537&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,038&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,575&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715582741168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment, Net</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment, net:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.916%"><tr><td style="width:1.0%"/><td style="width:66.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.697%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.589%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.700%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,920&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,682&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,854&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer and office equipment</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">976&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,631&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,631&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,912&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,771&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation and amortization</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,283)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,207)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,629&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,564&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities and Other</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:12pt;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accrued Liabilities and Other</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:9pt;margin-top:12pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.916%"><tr><td style="width:1.0%"/><td style="width:66.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.697%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.589%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.700%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and related expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,487&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued royalty</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Accrued professional services </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Others</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">761&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">973&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,896&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,511&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock', window );">Schedule of Accounts Receivable and Allowance for Credit Losses</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The movement in the allowance for credit losses was as follows:</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.916%"><tr><td style="width:1.0%"/><td style="width:66.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.697%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.589%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.700%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715580306848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Summary of Information Related to Lease Expense and Valuation of Lease Assets and Lease Liabilities</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental information related to lease expense and valuation of the lease assets and lease liabilit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ies are as follows:</span></div><div><span><br/></span></div><div style="padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:60.833%"><tr><td style="width:1.0%"/><td style="width:56.662%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.763%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.311%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.764%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Operating lease expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Variable lease expense</span></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cash paid for amounts included in the measurement of operating lease liabilities</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Leased assets obtained in exchange for new operating lease liabilities</span></div><div><span><br/></span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Weighted average remaining lease term (in years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.83</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.05</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.77%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.77%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Future Minimum Lease Payments Under Non-Cancelable Operating Leases</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments under non-cancelable operating leases as of March 31, 2023 was as follows:</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.861%"><tr><td style="width:1.0%"/><td style="width:71.044%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.756%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:4.5pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,195&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,005&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">530&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,256&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(330)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,926&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715580241520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Outstanding Borrowings</a></td>
<td class="text"><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the outstanding borrowings from the term loan as of periods presented:</span></div><div style="margin-bottom:12pt;margin-top:9pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.583%"><tr><td style="width:1.0%"/><td style="width:66.962%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.558%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.575%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.405%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal outstanding and final fee</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,720&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Unaccreted value of final fee</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(683)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(456)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding debt, net of debt issuance costs and unaccreted value of final fee</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,938&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,171&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Classified as:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term borrowings</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,938&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,171&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Future Principal and Final Fee Payments</a></td>
<td class="text">The table below summarizes the future principal and final fee payments under the Fist-Citizens Term Loan as of March 31, 2023:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.388%"><tr><td style="width:1.0%"/><td style="width:84.912%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.888%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,920&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total principal and final fee payments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,720&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715575376640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Incentive Compensation Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Activity</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the stock option activity for the three months ended March 31, 2023:</span></div><div style="margin-bottom:9pt;padding-left:72pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.444%"><tr><td style="width:1.0%"/><td style="width:62.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of <br/>Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted- <br/>Average <br/>Exercise <br/>Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,903,341&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$8.82</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(120,266)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.33</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled and forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,284)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.36</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,767,791&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sibn_ScheduleOfShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Share-based Payment Award, Equity Instruments Other Than Options, Valuation Assumptions</a></td>
<td class="text">The table below summarizes the assumptions used to estimate the grant date fair value of the PSUs granted:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.833%"><tr><td style="width:1.0%"/><td style="width:41.073%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.379%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.320%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.320%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.320%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.320%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.320%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.324%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility of common stock</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.0%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.0%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.9%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.7%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility of peer companies</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.0%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141.0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.2%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152.5%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Correlation coefficient of peer companies</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.15)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.13)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Schedule of Restricted Stock Unit Activity</a></td>
<td class="text">The table below summarizes RSU and PSU activity for the three months ended March 31, 2023:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.222%"><tr><td style="width:1.0%"/><td style="width:38.258%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.475%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.258%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.475%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.258%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.475%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.258%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.982%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.261%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">RSUs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PSUs</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,794,928</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$22.72</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,596</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$19.50</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,044,344</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.69</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255,458</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.33</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(228,388)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.97</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,932)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.50</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled and forfeited</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86,107)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.70</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,524,777</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.82</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385,122</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.74</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock', window );">Schedule of Performance-based Restricted Stock Unit Activity Arrangement</a></td>
<td class="text">The table below summarizes RSU and PSU activity for the three months ended March 31, 2023:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.222%"><tr><td style="width:1.0%"/><td style="width:38.258%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.475%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.258%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.475%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.258%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.475%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.258%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.982%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.261%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">RSUs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PSUs</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,794,928</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$22.72</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,596</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$19.50</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,044,344</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.69</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255,458</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.33</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(228,388)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.97</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,932)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.50</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled and forfeited</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86,107)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.70</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,524,777</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.82</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385,122</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.74</span></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock', window );">Schedule of Stock-Based Compensation</a></td>
<td class="text"><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the detail of stock-based compensation expense amounts included in the condensed consolidated statements of operations:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.305%"><tr><td style="width:1.0%"/><td style="width:59.159%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.879%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.690%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.879%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.693%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,594&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">752&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">633&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,194&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,507&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_ScheduleOfShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Share-based Payment Award, Equity Instruments Other Than Options, Valuation Assumptions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_ScheduleOfShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of number and weighted-average grant date fair value for nonvested performance shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715580304064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share of Common Stock (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Computation of Basic and Diluted Net Loss per Share</a></td>
<td class="text"><div style="margin-bottom:12pt;margin-top:12pt;padding-left:24.75pt;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the computation of basic and diluted net loss per share:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:61.388%"><tr><td style="width:1.0%"/><td style="width:55.687%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.931%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.942%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except share and per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,125)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,410)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares used to compute basic and diluted net loss per share</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,916,106&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,792,326&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share, basic and diluted</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.32)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.52)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Anti-dilutive Common Stock Equivalents Excluded from Computation of Diluted Net Loss per Share</a></td>
<td class="text">The following anti-dilutive common stock equivalents were excluded from the computation of diluted net loss per share for the periods presented:<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">            </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.527%"><tr><td style="width:1.0%"/><td style="width:59.025%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.315%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.843%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.317%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,767,791</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,963,360</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,909,899</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,309,284</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESPP purchase rights</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,226</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,264</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock warrants</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,122</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,122</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,930,038&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,452,030&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715580217760">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Narrative (Details)<br></strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>activity</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sibn_NumberOfBusinessActivities', window );">Number of business activities</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_NumberOfBusinessActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Business Activities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_NumberOfBusinessActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715577661776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Revenue by Geography (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 32,708<span></span>
</td>
<td class="nump">$ 22,439<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">30,450<span></span>
</td>
<td class="nump">20,367<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 2,258<span></span>
</td>
<td class="nump">$ 2,072<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715577608512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Marketable Securities - Schedule of Marketable Securities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValueAbstract', window );"><strong>Cash equivalents</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Carrying value</a></td>
<td class="nump">$ 15,602<span></span>
</td>
<td class="nump">$ 8,002<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract', window );"><strong>Short-term investments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">Amortized Cost</a></td>
<td class="nump">63,008<span></span>
</td>
<td class="nump">76,674<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(29)<span></span>
</td>
<td class="num">(108)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Aggregate Fair Value</a></td>
<td class="nump">62,997<span></span>
</td>
<td class="nump">76,573<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sibn_MarketableSecuritiesAmortizedCost', window );">Total marketable securities, Amortized Cost</a></td>
<td class="nump">78,610<span></span>
</td>
<td class="nump">84,676<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestments', window );">Total marketable securities, Aggregate Fair Value</a></td>
<td class="nump">78,599<span></span>
</td>
<td class="nump">84,575<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValueAbstract', window );"><strong>Cash equivalents</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Carrying value</a></td>
<td class="nump">15,602<span></span>
</td>
<td class="nump">8,002<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. treasury securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract', window );"><strong>Short-term investments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">Amortized Cost</a></td>
<td class="nump">35,978<span></span>
</td>
<td class="nump">48,636<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(21)<span></span>
</td>
<td class="num">(105)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Aggregate Fair Value</a></td>
<td class="nump">35,964<span></span>
</td>
<td class="nump">48,535<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract', window );"><strong>Short-term investments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">Amortized Cost</a></td>
<td class="nump">2,945<span></span>
</td>
<td class="nump">2,914<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Aggregate Fair Value</a></td>
<td class="nump">2,938<span></span>
</td>
<td class="nump">2,911<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract', window );"><strong>Short-term investments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">Amortized Cost</a></td>
<td class="nump">18,265<span></span>
</td>
<td class="nump">22,206<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Aggregate Fair Value</a></td>
<td class="nump">18,265<span></span>
</td>
<td class="nump">22,206<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. agency bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract', window );"><strong>Short-term investments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">Amortized Cost</a></td>
<td class="nump">5,820<span></span>
</td>
<td class="nump">2,918<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Aggregate Fair Value</a></td>
<td class="nump">$ 5,830<span></span>
</td>
<td class="nump">$ 2,921<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_MarketableSecuritiesAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amortized cost for marketable securities included in cash equivalents and investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_MarketableSecuritiesAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost excluding accrued interest, before allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715578530928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest', window );">Credit losses on investments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss', window );">Accrued interest receivable</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestWriteoff', window );">Accrued interest writeoff</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of accrued interest on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL120267853-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=SL121698322-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL120267856-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestWriteoff">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of writeoff of accrued interest on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), recognized by reversing interest income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3D<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL120267862-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestWriteoff</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest, of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>140
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715574503968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurement (Details) - Recurring - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities</a></td>
<td class="nump">$ 78,599<span></span>
</td>
<td class="nump">$ 84,575<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities</a></td>
<td class="nump">15,602<span></span>
</td>
<td class="nump">8,002<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">U.S. treasury securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities</a></td>
<td class="nump">35,964<span></span>
</td>
<td class="nump">48,535<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities</a></td>
<td class="nump">2,938<span></span>
</td>
<td class="nump">2,911<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">U.S. agency bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities</a></td>
<td class="nump">5,830<span></span>
</td>
<td class="nump">2,921<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities</a></td>
<td class="nump">18,265<span></span>
</td>
<td class="nump">22,206<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level&#160;1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities</a></td>
<td class="nump">51,566<span></span>
</td>
<td class="nump">56,537<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level&#160;1 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities</a></td>
<td class="nump">15,602<span></span>
</td>
<td class="nump">8,002<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level&#160;1 | U.S. treasury securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities</a></td>
<td class="nump">35,964<span></span>
</td>
<td class="nump">48,535<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level&#160;1 | Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level&#160;1 | U.S. agency bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level&#160;1 | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level&#160;2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities</a></td>
<td class="nump">27,033<span></span>
</td>
<td class="nump">28,038<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level&#160;2 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level&#160;2 | U.S. treasury securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level&#160;2 | Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities</a></td>
<td class="nump">2,938<span></span>
</td>
<td class="nump">2,911<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level&#160;2 | U.S. agency bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities</a></td>
<td class="nump">5,830<span></span>
</td>
<td class="nump">2,921<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level&#160;2 | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities</a></td>
<td class="nump">18,265<span></span>
</td>
<td class="nump">22,206<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level&#160;3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level&#160;3 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level&#160;3 | U.S. treasury securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level&#160;3 | Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level&#160;3 | U.S. agency bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level&#160;3 | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>141
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715577693312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Inventory, finished goods, gross</a></td>
<td class="nump">$ 16,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Inventory, work in process, gross</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">27,912<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,771<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">1,100<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=sibn_ConstructionInProgressSurgicalPlacementInstrumentSetMember', window );">Construction in progress, surgical placement instrument set</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=sibn_ConstructionInProgressSantaClaraLeaseMember', window );">Construction in Progress, Santa Clara Lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 3,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=sibn_ConstructionInProgressSurgicalPlacementInstrumentSetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=sibn_ConstructionInProgressSurgicalPlacementInstrumentSetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=sibn_ConstructionInProgressSantaClaraLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=sibn_ConstructionInProgressSantaClaraLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>142
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715575278080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components - Property and Equipment, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and Equipment, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 27,912<span></span>
</td>
<td class="nump">$ 25,771<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: Accumulated depreciation and amortization</a></td>
<td class="num">(11,283)<span></span>
</td>
<td class="num">(10,207)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">16,629<span></span>
</td>
<td class="nump">15,564<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and Equipment, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">17,070<span></span>
</td>
<td class="nump">14,920<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and Equipment, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">7,682<span></span>
</td>
<td class="nump">7,854<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=sibn_ComputerAndOfficeEquipmentMember', window );">Computer and office equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and Equipment, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">1,139<span></span>
</td>
<td class="nump">976<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and Equipment, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">1,631<span></span>
</td>
<td class="nump">1,631<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and Equipment, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 390<span></span>
</td>
<td class="nump">$ 390<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=sibn_ComputerAndOfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=sibn_ComputerAndOfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>143
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715577430560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components - Accrued Liabilities and Other (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued Liabilities and Other</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation and related expenses</a></td>
<td class="nump">$ 7,487<span></span>
</td>
<td class="nump">$ 11,365<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedRoyaltiesCurrent', window );">Accrued royalty</a></td>
<td class="nump">996<span></span>
</td>
<td class="nump">818<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued professional services</a></td>
<td class="nump">652<span></span>
</td>
<td class="nump">355<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Others</a></td>
<td class="nump">761<span></span>
</td>
<td class="nump">973<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities and other</a></td>
<td class="nump">$ 9,896<span></span>
</td>
<td class="nump">$ 13,511<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedRoyaltiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedRoyaltiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>144
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715575312160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components - Accounts Receivable and Allowance for Credit Losses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward', window );"><strong>Accounts Receivable, Allowance for Credit Loss [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Balance at beginning of period</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="nump">$ 264<span></span>
</td>
<td class="nump">$ 264<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">150<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs', window );">Write-offs</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Balance at end of period</a></td>
<td class="nump">$ 450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of direct write-downs of accounts receivable charged against the allowance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>145
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715575314416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitment and Contingencies - Supplemental Information Related to Lease Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease expense</a></td>
<td class="nump">$ 394<span></span>
</td>
<td class="nump">$ 409<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease expense</a></td>
<td class="nump">76<span></span>
</td>
<td class="nump">104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease expense</a></td>
<td class="nump">470<span></span>
</td>
<td class="nump">513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Cash paid for amounts included in the measurement of operating lease liabilities</a></td>
<td class="nump">398<span></span>
</td>
<td class="nump">408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Leased assets obtained in exchange for new operating lease liabilities</a></td>
<td class="nump">$ 21<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term (in years)</a></td>
<td class="text">2 years 9 months 29 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 18 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="nump">5.77%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.77%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>146
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715578058304">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Aggregate Future Minimum Lease Payments (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract', window );"><strong>Aggregate Future Minimum Lease Payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">Remainder of 2023</a></td>
<td class="nump">$ 1,195<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2024</a></td>
<td class="nump">1,517<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2025</a></td>
<td class="nump">1,005<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2026</a></td>
<td class="nump">530<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2027</a></td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sibn_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour', window );">Thereafter</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total operating lease payments</a></td>
<td class="nump">4,256<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(330)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">$ 3,926<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Liability, to be Paid, After Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>147
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715580794416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sibn_LesseeOperatingLeaseLeaseNotYetCommencedLiability', window );">Operating lease liabilities that had not commenced.</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PurchaseObligation', window );">Purchase commitments related to inventory management and training materials</a></td>
<td class="nump">1,800,000<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_IndemnificationGuaranteeMember', window );">Indemnification Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Costs to defend lawsuits or settle claims</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationReserve', window );">Liability associated with indemnifications</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_LesseeOperatingLeaseLeaseNotYetCommencedLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Lease Not Yet Commenced, Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_LesseeOperatingLeaseLeaseNotYetCommencedLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_IndemnificationGuaranteeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_IndemnificationGuaranteeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>148
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715577914832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Borrowings - Summary of Borrowings (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal outstanding and final fee</a></td>
<td class="nump">$ 36,720<span></span>
</td>
<td class="nump">$ 35,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Less: Unamortized debt issuance costs</a></td>
<td class="num">(99)<span></span>
</td>
<td class="num">(73)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFeeAmount', window );">Unaccreted value of final fee</a></td>
<td class="num">(683)<span></span>
</td>
<td class="num">(456)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Outstanding debt, net of debt issuance costs and unaccreted value of final fee</a></td>
<td class="nump">35,938<span></span>
</td>
<td class="nump">35,171<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term borrowings</a></td>
<td class="nump">$ 35,938<span></span>
</td>
<td class="nump">$ 35,171<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFeeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the fee that accompanies borrowing money under the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFeeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>149
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715573699168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 06, 2023 </div>
<div>USD ($) </div>
<div>quick_ratio</div>
</th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th">
<div>Aug. 12, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=sibn_SVBTermLoanMember', window );">SVB Term Loan | Term loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="nump">$ 35,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfSecuredDebt', window );">Proceeds from (Repayments of) Secured Debt</a></td>
<td class="nump">35,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Effective interest rate during the period (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sibn_DebtInstrumentInterestRateIncreaseDueToDefault', window );">Contingent interest rate increase due to default</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=sibn_SVBAmendedTermLoanMember', window );">SVB Amended Term Loan | Term loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfSecuredDebt', window );">Proceeds from (Repayments of) Secured Debt</a></td>
<td class="num">$ (36,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sibn_DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal', window );">Final fee as percentage of aggregate principal amount (percent)</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=sibn_SVBAmendedTermLoanMember', window );">SVB Amended Term Loan | Term loan | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=sibn_SVBAmendedTermLoanMember', window );">SVB Amended Term Loan | Term loan | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">6.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=sibn_SVBAmendedTermLoanMember', window );">SVB Amended Term Loan | Term loan | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sibn_LineOfCreditFacilityAccordionFeatureIncreaseLimit', window );">Accordion feature, increase limit</a></td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sibn_DebtInstrumentAccountsReceivableBorrowingBase', window );">Accounts receivable borrowing base (percent)</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Fixed interest rate (percent)</a></td>
<td class="nump">6.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sibn_DebtInstrumentCovenantAdjustedQuickRatioMinimum', window );">Adjusted quick ratio threshold | quick_ratio</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=sibn_SVBAmendedTermLoanMember', window );">SVB Amended Term Loan | Line of Credit | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Revolving credit facility, aggregate principal amount</a></td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeeAmount', window );">Total commitment fee, amount</a></td>
<td class="nump">187,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sibn_LineOfCreditFacilityContingentCommitmentFeeAmount', window );">Contingent fee, amount</a></td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=sibn_SolarLoanAndSecurityAgreementMember', window );">Solar Term Loan | Term loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Effective interest rate during the period (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_DebtInstrumentAccountsReceivableBorrowingBase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Accounts Receivable Borrowing Base</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_DebtInstrumentAccountsReceivableBorrowingBase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_DebtInstrumentCovenantAdjustedQuickRatioMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Adjusted Quick Ratio, Minimum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_DebtInstrumentCovenantAdjustedQuickRatioMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Fee Amount As Percentage Of Aggregate Principal</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_DebtInstrumentInterestRateIncreaseDueToDefault">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Interest Rate Increase Due to Default</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_DebtInstrumentInterestRateIncreaseDueToDefault</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_LineOfCreditFacilityAccordionFeatureIncreaseLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Accordion Feature, Increase Limit</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_LineOfCreditFacilityAccordionFeatureIncreaseLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_LineOfCreditFacilityContingentCommitmentFeeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Contingent Commitment Fee, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_LineOfCreditFacilityContingentCommitmentFeeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the fee for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfSecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from long-term debt wholly or partially secured by collateral. Excludes tax exempt secured debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfSecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=sibn_SVBTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=sibn_SVBTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=sibn_SVBAmendedTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=sibn_SVBAmendedTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=sibn_SolarLoanAndSecurityAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=sibn_SolarLoanAndSecurityAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>150
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715575340144">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Borrowings - Debt Maturity (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MaturitiesOfLongTermDebtAbstract', window );"><strong>Future principal and final fee payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">Remainder of 2023</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2024</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2025</a></td>
<td class="nump">8,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2026</a></td>
<td class="nump">14,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2027</a></td>
<td class="nump">13,920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total principal and final fee payments</a></td>
<td class="nump">$ 36,720<span></span>
</td>
<td class="nump">$ 35,700<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaturitiesOfLongTermDebtAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaturitiesOfLongTermDebtAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>151
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715578739904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Incentive Compensation Plans - Stock Option Activity (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, beginning of period (in shares) | shares</a></td>
<td class="nump">1,903,341<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares) | shares</a></td>
<td class="num">(120,266)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Canceled and forfeited (in shares) | shares</a></td>
<td class="num">(15,284)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, end of period (in shares) | shares</a></td>
<td class="nump">1,767,791<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted-Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, beginning of period (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 8.82<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share) | $ / shares</a></td>
<td class="nump">4.33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Canceled and forfeited (in dollars per share) | $ / shares</a></td>
<td class="nump">21.36<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, end of period (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 10.23<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>152
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715574376032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Incentive Compensation Plans - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th">
<div>May 31, 2020 </div>
<div>purchase_period</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock options granted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase', window );">Early exercise of stock options, share subject to repurchase (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation cost, expected period for recognition (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation cost, expected period for recognition (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized compensation cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Performance period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Performance period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation cost, expected period for recognition (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized compensation cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=sibn_A2018EmployeeStockPurchasePlanMember', window );">2018 ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Purchase price of common stock as a percent of fair market value (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval', window );">Employee stock purchase program offering period interval (in months)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods', window );">Number of purchase periods in offering interval | purchase_period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation and related expenses for employee payroll deductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=sibn_A2018EmployeeStockPurchasePlanMember', window );">2018 ESPP | Performance Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Performance period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Purchase Periods</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Offering Period Interval</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Early Exercise, Common Stock Subject To Repurchase</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligations incurred for employer-related costs classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherEmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=sibn_A2018EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=sibn_A2018EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>153
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715578827456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Incentive Compensation Plans - Valuation Assumptions for Stock Options (Details) - Performance Shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Black-Scholes option-pricing model assumptions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility of common stock, minimum (percent)</a></td>
<td class="nump">58.00%<span></span>
</td>
<td class="nump">48.90%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility of common stock, maximum (percent)</a></td>
<td class="nump">73.00%<span></span>
</td>
<td class="nump">58.70%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMinimum', window );">Expected volatility of peer companies, minimum (percent)</a></td>
<td class="nump">33.00%<span></span>
</td>
<td class="nump">24.20%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMaximum', window );">Expected volatility of peer companies, maximum (percent)</a></td>
<td class="nump">141.00%<span></span>
</td>
<td class="nump">152.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMinimum', window );">Correlation coefficient of peer companies, minimum</a></td>
<td class="num">(15.00%)<span></span>
</td>
<td class="num">(13.00%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMaximum', window );">Correlation coefficient of peer companies, maximum</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rate, minimum (percent)</a></td>
<td class="nump">3.90%<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free interest rate, maximum (percent)</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">1.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Black-Scholes option-pricing model assumptions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield (percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Black-Scholes option-pricing model assumptions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield (percent)</a></td>
<td class="nump">1.30%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Correlation Coefficient Of Peer Companies, Maximum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Correlation Coefficient Of Peer Companies, Minimum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Peer Companies, Maximum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Peer Companies, Minimum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>154
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715578785216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Incentive Compensation Plans - Restricted Stock Units Activity and Performance-Based Restricted Stock Unit Activity (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding, beginning of period (in shares) | shares</a></td>
<td class="nump">1,794,928<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">1,044,344<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(228,388)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Canceled and forfeited (in shares) | shares</a></td>
<td class="num">(86,107)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding, end of period (in shares) | shares</a></td>
<td class="nump">2,524,777<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding, beginning of period (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 22.72<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">15.69<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share) | $ / shares</a></td>
<td class="nump">22.97<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Canceled and forfeited (in dollars per share) | $ / shares</a></td>
<td class="nump">21.70<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding, end of period (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 19.82<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding, beginning of period (in shares) | shares</a></td>
<td class="nump">155,596<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">255,458<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(25,932)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Canceled and forfeited (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding, end of period (in shares) | shares</a></td>
<td class="nump">385,122<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding, beginning of period (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 19.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">12.33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share) | $ / shares</a></td>
<td class="nump">19.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Canceled and forfeited (in dollars per share) | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding, end of period (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 14.74<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>155
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715577959344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Incentive Compensation Plans - Stock-Based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 6,194<span></span>
</td>
<td class="nump">$ 5,507<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of goods sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">137<span></span>
</td>
<td class="nump">123<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Sales and marketing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">2,910<span></span>
</td>
<td class="nump">2,594<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">752<span></span>
</td>
<td class="nump">633<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 2,395<span></span>
</td>
<td class="nump">$ 2,157<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>156
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715575318832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share of Common Stock - Computation of Earnings Per Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (11,125)<span></span>
</td>
<td class="num">$ (17,410)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average number of common shares used to compute basic net loss per share (in shares)</a></td>
<td class="nump">34,916,106<span></span>
</td>
<td class="nump">33,792,326<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average number of common shares used to compute diluted net loss per share (in shares)</a></td>
<td class="nump">34,916,106<span></span>
</td>
<td class="nump">33,792,326<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share, basic (in usd per share)</a></td>
<td class="num">$ (0.32)<span></span>
</td>
<td class="num">$ (0.52)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share, diluted (in usd per share)</a></td>
<td class="num">$ (0.32)<span></span>
</td>
<td class="num">$ (0.52)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>157
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715575331328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share of Common Stock - Antidilutive Common Stock Equivalents Excluded from Computation of Earnings Per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Common stock equivalents excluded from computation of diluted net loss per share (in shares)</a></td>
<td class="nump">4,930,038<span></span>
</td>
<td class="nump">4,452,030<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Common stock equivalents excluded from computation of diluted net loss per share (in shares)</a></td>
<td class="nump">1,767,791<span></span>
</td>
<td class="nump">1,963,360<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Common stock equivalents excluded from computation of diluted net loss per share (in shares)</a></td>
<td class="nump">2,909,899<span></span>
</td>
<td class="nump">2,309,284<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=sibn_EmployeeStockPurchasePlanSharesMember', window );">ESPP purchase rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Common stock equivalents excluded from computation of diluted net loss per share (in shares)</a></td>
<td class="nump">134,226<span></span>
</td>
<td class="nump">61,264<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=sibn_CommonStockWarrantsMember', window );">Common stock warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Common stock equivalents excluded from computation of diluted net loss per share (in shares)</a></td>
<td class="nump">118,122<span></span>
</td>
<td class="nump">118,122<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=sibn_EmployeeStockPurchasePlanSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=sibn_EmployeeStockPurchasePlanSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=sibn_CommonStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=sibn_CommonStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>158
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715578530672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transaction (Details) - SeaSpine - Joint development agreement - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Reimbursement charges expensed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sibn_RelatedPartyTransactionTermOfAgreement', window );">Term of product royalty sales period (in years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RoyaltyExpense', window );">Royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToAffiliateCurrent', window );">Outstanding liability to SeaSpine</a></td>
<td class="nump">$ 60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_RelatedPartyTransactionTermOfAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Related Party Transaction, Term Of Agreement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_RelatedPartyTransactionTermOfAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToAffiliateCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payable due to an entity that is affiliated with the reporting entity by means of direct or indirect ownership. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e603758-122996<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToAffiliateCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=sibn_DevelopmentAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=sibn_DevelopmentAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>159
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140715575429072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>160
<FILENAME>sibn-20230331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:sibn="http://si-bone.com/20230331"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="sibn-20230331.xsd" xlink:type="simple"/>
    <context id="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i0e136d89ad474fdeb683220221498c6a_I20230426">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
        </entity>
        <period>
            <instant>2023-04-26</instant>
        </period>
    </context>
    <context id="ibc8dabdb27e24a31aa334795682f86fb_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9dcf850d9d0446dea538750874891e18_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia1ad2c138559410ba21a1f7abb1d4ffd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i73f03223216c40f18e39597ffaec1ef4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib60e72c3aa6e4ad28de9ed0584387b84_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i02dda049bbb449b7a4908baa63bfc3c0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id0c350aefbd0469a8c27d16d7649c977_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i205f14e8b1cc49a7aedfb949e6e0c598_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="idd89d2d32f7e4eadb653b6c699a1da65_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="idb828f727d314174b2f1a4710790fde9_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i061a1d4685fa4917a427a6f03c1beeb4_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i64e08c97777d48b3a2279b29a42ce726_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i930a39bf4a65491ca6af24ed50e20906_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i954439b3925043e3949da7080d9256e2_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i883fe34ebc0c4092a483d977c3f8d429_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0aa2d78b45474cb8b1a7e306265bc187_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0422532f98d04beb985b3c54535d2911_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i429ed22eade94b3e88f8ed51a9a289e9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i25ff20079ccb48899ea84d72b50e16e7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i58ceb493d83949bb8045aa75c1c8bdc3_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i84b72a6f51f6449f84a5d5b3cc309664_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id37cd14c22ad42eb8a735baa4d08d8b0_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie59f6758cf1b4684be0a81c20e471c4b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iad9213ed4f734769974b00e30b313acc_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8247ae5acd7b41e9a09b537937c10239_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia8f402bebac44ff39653d91d5f80e030_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7459a99379124552878485552b9000b8_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i37f453d1957c4f60a0e5d364ba1d84c7_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie621378e8af644ff959fd17071edec6f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1d986d6c5754440c896f37265133c6f7_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if6d7b650f421439ea4f82d9dcaa13596_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ibad906d7939f45519af713f88d015ade_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6706d03c32974a768210dd2966cd849e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic034056cf84142f3a1464896584f8499_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i44dd3ae16d4d45c8bb7f34c32c3afa5b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia13be74212cd4cbdac029edf9dc0a7af_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0f387eb12eb641d8acf7a18c1539123f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib0cbf148284f4875b34513e22dea1727_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8559cf2d961048048b5f1dcd580f39ee_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib2d6675789b842e3bc0f882dee4352c3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib008684c4f9b4e4782d069220bea736d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifdfec2a876ef4b7eb0d2a97b4c97ad16_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic260793641a14f2695a83d42d27f0e29_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i93f63117979e431d8fafecd7bb59dfac_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie7af7e18c08648e8a31cfe8e93a21d37_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if55d28f6c32e42e4a57e446914b3a62c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i412cc8ac40b4449d8130d9a574e1630c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i70c37c2527cc48178344c05517b09dbd_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i05b7a065321d4879b2ff02286b48fe5d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6e5ed5afd4274c968b88749c12c77e79_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8ad3e05b47f148779fa5695c98e40dcf_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0c92d73d84f74de3a6513213ff796c66_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0cfde19be5044c3fb1effae06f724c64_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic660e995acfe4b2a9f4faedc08362fa8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="idb816e01e7874d0a96715509b31cb35a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7c6fdeac85ad413ca0c0dedf070a75fe_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3a100bced9af4ad5bd35f338bc5a32f8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="idbcaeebb6db24dffb245482694bd9c7a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i402c694c2fe74b3ca22ce9842744aa6d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie4f6a87d519949ebb36b48d5adde8532_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ibcc50bab28c64661b1b3e2f3166b18ac_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i127926870dbf443f939ff61f15decebe_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i165bfa53062b4b66b55877948006f464_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i599fe7f797b64b16986fe58ad0b1dea9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i18026ebb41a3463a83e4df8c40ad564c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3a9913b7b1e5449cb00f06f2ff1eb7b7_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2d0dee683e5841eb84e260a32f3255fe_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0d93d5c546664a5d81e0bd4ff383fd5e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i593bc48b8f4243ddb04b45abc6ea214d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib2a471609df94d37a930d6f5d6e15098_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5a286c1bf0564b09a30caa94533124d2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1c06318063df438297ac590b6ad0fc1d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i02f410de75d14cdeaee8f125e8343cbd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2648a4f0afd74ba895a75a8524bd2b05_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia89f5e43abc74a268ac2cf0241b3f413_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic3ad078aff0542a4a095dda948ebfa96_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idf18e06ec7af4f8894d706876e2614db_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic8afde8ae10a47ca88a2373bafb3dfac_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3f7ab8e31a7c40be87fc6165468887e2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9c0adbda751147eea7396bd575122c5e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i386cd3185459468682f42288ddfd4237_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if245b8c2654f417395c08edfa479ab82_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6d1b210afd954f47bea17adf2f027ac5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id88038b7e8b941bc8a88b3faa056a48f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i59372acb82174f63bc0cbb959bab7cb7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0994310adbdc4a3fb6f259424a3dda9b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7a30c099351643919a25ea1474e284b5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7b6ddb9d49374251b145ed8c06d3ea23_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1b54f88e74024fb4a2091106b2085b42_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib87aa61e8c5640999864db57e9a5de97_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i238fa20d4bac4223a52c0c5dd3a10b39_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1e71d795db204f3b8f094023c24425b3_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iee9e604e937b47a2a28b7c87d255fe22_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8ca79707ebe549c1bb352a2ebd78915f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i20591f6aa1e240348d149ac3850df479_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i95acc83c9a7845c6a6530d0b489719b9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sibn:ComputerAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9201dd932d9848bdbbe7c5a345ef8038_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sibn:ComputerAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if93177d48de1415e9f17d96b9723fe38_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9a70cc88c75d4e89898c6b1352acaacc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4ab4226e44904229bd0ee82536c2fdcd_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i1ef76ab501ca47529edb5647153de4b2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if3464bbb971c4eefb3b4e6d7ae410bb8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sibn:ConstructionInProgressSurgicalPlacementInstrumentSetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i368a721c855a4a1190ec9dcdc696598a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sibn:ConstructionInProgressSantaClaraLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0948ce79deee4391b59b52520a368e51_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:IndemnificationGuaranteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8c1e121f074342c9bd40478fa2984c46_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:IndemnificationGuaranteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if8e560c29f77458f868e82a8beb02128_I20210812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SVBTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-12</instant>
        </period>
    </context>
    <context id="i7fe2d63d0e5c43bdbdf07781f3c546f9_I20230106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SVBTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-06</instant>
        </period>
    </context>
    <context id="i1bf81bb780c3454a8a17edba536c3cca_D20230106-20230106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SVBAmendedTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-06</startDate>
            <endDate>2023-01-06</endDate>
        </period>
    </context>
    <context id="icb70f81572e248629f7b7f231c74cec6_D20230106-20230106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SVBTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-06</startDate>
            <endDate>2023-01-06</endDate>
        </period>
    </context>
    <context id="i75a6a55921b94e788965c7b88a1250c0_I20230106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SVBAmendedTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-06</instant>
        </period>
    </context>
    <context id="i76321e3f57544d228615f7521f589bc2_I20230106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SVBAmendedTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-06</instant>
        </period>
    </context>
    <context id="i40ef43333c0442bf888482c8ace88dd4_D20230106-20230106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SVBAmendedTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-06</startDate>
            <endDate>2023-01-06</endDate>
        </period>
    </context>
    <context id="id912f88617b74e8f9c3530bd836870bf_D20230106-20230106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SVBAmendedTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-06</startDate>
            <endDate>2023-01-06</endDate>
        </period>
    </context>
    <context id="ibd2e135759a24184955191e8a1e9cc3c_I20230106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SVBAmendedTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-06</instant>
        </period>
    </context>
    <context id="idbafe1e8ab4043a896784415b82016d4_D20230106-20230106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SVBAmendedTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-06</startDate>
            <endDate>2023-01-06</endDate>
        </period>
    </context>
    <context id="iead9b266d2d14baba4281492cf7acebc_D20230106-20230106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SVBAmendedTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-06</startDate>
            <endDate>2023-01-06</endDate>
        </period>
    </context>
    <context id="ia93eb97347d343fb94b99ed9c40ef16b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SVBTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7d10f967602a4f5e83faefa1d251c9a3_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SolarLoanAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6a9db0b913fe48aea9fd168fc919ec8d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iaea4309f7d894f26aa578b17d53f7daf_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iae333c43aa6f438893c3e83047c6ba3e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iafee48dbb8fc4bfc960af6aa6244917f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iaf9a24c75b524dfa94a49c4ab5a022c0_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iac4ffd9b01074e8fa63dc6df8b863046_D20220101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sibn:A2018EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i73253fc85d9d4718b307a6aeea2b9c06_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="if5a58a2d117b40d8a0d022c115299b14_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i542cba4badbf402198062c358fb44a47_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i0fd34d1ccf7c424faab3f807a548673b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="idce254121fa64dda9831a0bf7d7be47d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic31c0bf439854ab39758877476c132a4_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9878b683aeef427ebf14f59132cf0f4a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2829f82cc061453792f3357c0e3b2d45_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0c44b4d86d814a99aa4f0201bc819c63_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0491eac20c484a99bcfa28ef410f4825_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sibn:A2018EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i78f562b20b2e4096bb55d93c2515d6b4_D20200501-20200531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sibn:A2018EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-01</startDate>
            <endDate>2020-05-31</endDate>
        </period>
    </context>
    <context id="i2a36228c84c94fdd90258ab5546be250_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sibn:A2018EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id0b8dd5bc1a74d16976adc6fe0963e3c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sibn:A2018EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i017405027da74f35a1e9b7624aa42eb3_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ibaf29913eb3446079f07610b7349c5a2_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i90358afa0410497b9f081e97dbf0db01_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iff0a36e596f44a779c08847487b58a42_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie75cc149b1a34a578c7e33c33a5bb53e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia11934861f834ff494d0a96536ea4362_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ica097e93dc6e43ceb0f401463e05eced_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7d77a44aec9a441e8285b555ea83a233_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3ae664fc28564f66ac4064ddbcbd566e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i727673cf2e684c87b5b941e19e9dead2_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib3a30c8bb4fa4da191e1db1a2cdf4ad3_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i58b615af0c5645a8bab43631dc6ce435_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iba2a746fe9d742cd9ce6866ca1f467ca_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">sibn:EmployeeStockPurchasePlanSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3834751827fd42c693830e07acfee079_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">sibn:EmployeeStockPurchasePlanSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i785a9d69422049969f551e00c09cd4fe_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">sibn:CommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5cfef6391a45463393b78121e9c5bed4_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">sibn:CommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i42f2ba3e6b0746d58d9b74e3cf027cd7_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sibn:DevelopmentAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7bf5dda5bf324c4fa4a20b1e527679ae_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sibn:DevelopmentAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5e73e5a0115b4970b15363db24e13c22_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sibn:DevelopmentAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7a94faa120a0446aa696de6aeda19c4b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sibn:DevelopmentAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="activity">
        <measure>sibn:activity</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="quick_ratio">
        <measure>sibn:quick_ratio</measure>
    </unit>
    <unit id="purchase_period">
        <measure>sibn:purchase_period</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80L2ZyYWc6ZjdlOWM4ZDZiNjgzNGI3ZWFhMWFhMTZjYTFjNWU3ZTkvdGFibGU6YmYyNmZjZjM2MGRmNDk0NTkyM2RmZDhjMmNjZjk1ZGMvdGFibGVyYW5nZTpiZjI2ZmNmMzYwZGY0OTQ1OTIzZGZkOGMyY2NmOTVkY18xLTEtMS0xLTY4MzE2_ca95f64f-b7f0-4a1e-8c9d-39515f82346b">0001459839</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80L2ZyYWc6ZjdlOWM4ZDZiNjgzNGI3ZWFhMWFhMTZjYTFjNWU3ZTkvdGFibGU6YmYyNmZjZjM2MGRmNDk0NTkyM2RmZDhjMmNjZjk1ZGMvdGFibGVyYW5nZTpiZjI2ZmNmMzYwZGY0OTQ1OTIzZGZkOGMyY2NmOTVkY18yLTEtMS0xLTY4MzE2_0f2f5a2a-f77b-4d5e-b087-d75a5f38e30b">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80L2ZyYWc6ZjdlOWM4ZDZiNjgzNGI3ZWFhMWFhMTZjYTFjNWU3ZTkvdGFibGU6YmYyNmZjZjM2MGRmNDk0NTkyM2RmZDhjMmNjZjk1ZGMvdGFibGVyYW5nZTpiZjI2ZmNmMzYwZGY0OTQ1OTIzZGZkOGMyY2NmOTVkY18zLTEtMS0xLTY4MzE2_d32b5c4d-a2f4-4ea0-9a8a-ee5216b18c3e">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80L2ZyYWc6ZjdlOWM4ZDZiNjgzNGI3ZWFhMWFhMTZjYTFjNWU3ZTkvdGFibGU6YmYyNmZjZjM2MGRmNDk0NTkyM2RmZDhjMmNjZjk1ZGMvdGFibGVyYW5nZTpiZjI2ZmNmMzYwZGY0OTQ1OTIzZGZkOGMyY2NmOTVkY180LTEtMS0xLTY4MzE2_9ba50e0d-05f7-4dff-963e-d02cec47ed74">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80L2ZyYWc6ZjdlOWM4ZDZiNjgzNGI3ZWFhMWFhMTZjYTFjNWU3ZTkvdGFibGU6YmYyNmZjZjM2MGRmNDk0NTkyM2RmZDhjMmNjZjk1ZGMvdGFibGVyYW5nZTpiZjI2ZmNmMzYwZGY0OTQ1OTIzZGZkOGMyY2NmOTVkY181LTEtMS0xLTY4MzE2_ed667950-66e2-4feb-ac8f-26c60001e5c7">false</dei:AmendmentFlag>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="iaea4309f7d894f26aa578b17d53f7daf_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfMTEwOQ_b006b137-1392-4dc1-aa98-21e5cfe1c1eb">P2Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <dei:DocumentType
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGV4dHJlZ2lvbjplNzg5M2Y0OWYwOTE0NDU0YjQ5YTI4MTcxZmZiODJlY18yMTUx_e738e308-4ede-4992-84a6-91705df250e6">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGV4dHJlZ2lvbjplNzg5M2Y0OWYwOTE0NDU0YjQ5YTI4MTcxZmZiODJlY18yMTQy_f1e5b190-406f-42c6-881a-a0f1cd668abf">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGV4dHJlZ2lvbjplNzg5M2Y0OWYwOTE0NDU0YjQ5YTI4MTcxZmZiODJlY18yMjk_42b5efc8-49bf-42ba-81f3-ea6e325d863e">2023-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGV4dHJlZ2lvbjplNzg5M2Y0OWYwOTE0NDU0YjQ5YTI4MTcxZmZiODJlY18yMTUy_5295dec7-0899-4102-9e2c-47594d12d542">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGV4dHJlZ2lvbjplNzg5M2Y0OWYwOTE0NDU0YjQ5YTI4MTcxZmZiODJlY18yMTUz_137f7f41-b60d-4607-bdf6-ab2e4c046322">001-38701</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGV4dHJlZ2lvbjplNzg5M2Y0OWYwOTE0NDU0YjQ5YTI4MTcxZmZiODJlY18yMTQ3_e975d30c-b296-425c-a99c-bc67e518a6e8">SI-BONE,&#160;INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGFibGU6ZWE0MmQwYThmYTVmNGZkMGE4NmQwZTJmZWRmMWM2NjIvdGFibGVyYW5nZTplYTQyZDBhOGZhNWY0ZmQwYTg2ZDBlMmZlZGYxYzY2Ml8wLTAtMS0xLTY4MzE2_4950ccab-c645-45da-9eb3-d2753b7fbeb6">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGFibGU6ZWE0MmQwYThmYTVmNGZkMGE4NmQwZTJmZWRmMWM2NjIvdGFibGVyYW5nZTplYTQyZDBhOGZhNWY0ZmQwYTg2ZDBlMmZlZGYxYzY2Ml8wLTItMS0xLTY4MzE2_af3d9fe8-5c49-47b0-8ff7-cb01209b46ca">26-2216351</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGFibGU6MzVhODJlOGJiOTM5NDBjOThjMDAwNmNmZDNjNTRjYjkvdGFibGVyYW5nZTozNWE4MmU4YmI5Mzk0MGM5OGMwMDA2Y2ZkM2M1NGNiOV8wLTAtMS0xLTY4MzE2L3RleHRyZWdpb246NmE0ODRhNmVjMmMxNDUzMzk4YTEwYmQ0MTUzZGY1NWRfNA_c36327e5-6540-4358-95b3-a5dd438dbc15">471 El Camino Real</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGFibGU6MzVhODJlOGJiOTM5NDBjOThjMDAwNmNmZDNjNTRjYjkvdGFibGVyYW5nZTozNWE4MmU4YmI5Mzk0MGM5OGMwMDA2Y2ZkM2M1NGNiOV8wLTAtMS0xLTY4MzE2L3RleHRyZWdpb246NmE0ODRhNmVjMmMxNDUzMzk4YTEwYmQ0MTUzZGY1NWRfOA_83b18137-1267-43c6-8abb-61b639f2ca25">Suite 101</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGFibGU6MzVhODJlOGJiOTM5NDBjOThjMDAwNmNmZDNjNTRjYjkvdGFibGVyYW5nZTozNWE4MmU4YmI5Mzk0MGM5OGMwMDA2Y2ZkM2M1NGNiOV8wLTAtMS0xLTY4MzE2L3RleHRyZWdpb246NmE0ODRhNmVjMmMxNDUzMzk4YTEwYmQ0MTUzZGY1NWRfMTI_52a3107c-334b-48de-b9a5-0834c7622e4d">Santa Clara</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGFibGU6MzVhODJlOGJiOTM5NDBjOThjMDAwNmNmZDNjNTRjYjkvdGFibGVyYW5nZTozNWE4MmU4YmI5Mzk0MGM5OGMwMDA2Y2ZkM2M1NGNiOV8wLTAtMS0xLTY4MzE2L3RleHRyZWdpb246NmE0ODRhNmVjMmMxNDUzMzk4YTEwYmQ0MTUzZGY1NWRfMTY_a84438ea-8d09-4763-a586-336645ea5601">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGFibGU6MzVhODJlOGJiOTM5NDBjOThjMDAwNmNmZDNjNTRjYjkvdGFibGVyYW5nZTozNWE4MmU4YmI5Mzk0MGM5OGMwMDA2Y2ZkM2M1NGNiOV8wLTItMS0xLTY4MzE2_575fe8b2-1999-4bf2-87cc-c2bedb3be137">95050</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGV4dHJlZ2lvbjplNzg5M2Y0OWYwOTE0NDU0YjQ5YTI4MTcxZmZiODJlY18yMTQz_d07fddc6-78cc-4f8f-90ca-6f22dbb1ac3e">408</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGV4dHJlZ2lvbjplNzg5M2Y0OWYwOTE0NDU0YjQ5YTI4MTcxZmZiODJlY18yMTQ0_5bbd69ea-be46-4843-ba4d-da13aa43921d">207-0700</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGFibGU6Y2Q0OTViYWY0MWU4NGE0MWJmYzk2NTcwMzI4YjQxMjgvdGFibGVyYW5nZTpjZDQ5NWJhZjQxZTg0YTQxYmZjOTY1NzAzMjhiNDEyOF8xLTAtMS0xLTY4MzE2_2c3224e4-cf8c-4413-8f21-c2559681252d">Common Stock, par value $0.0001&#160;per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGFibGU6Y2Q0OTViYWY0MWU4NGE0MWJmYzk2NTcwMzI4YjQxMjgvdGFibGVyYW5nZTpjZDQ5NWJhZjQxZTg0YTQxYmZjOTY1NzAzMjhiNDEyOF8xLTEtMS0xLTY4MzE2_c8250bc9-0ac7-4acb-b760-ec5de918365c">SIBN</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGFibGU6Y2Q0OTViYWY0MWU4NGE0MWJmYzk2NTcwMzI4YjQxMjgvdGFibGVyYW5nZTpjZDQ5NWJhZjQxZTg0YTQxYmZjOTY1NzAzMjhiNDEyOF8xLTItMS0xLTY4MzE2_d39b9441-bfb6-4eed-9e14-254b621a5bec">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGV4dHJlZ2lvbjplNzg5M2Y0OWYwOTE0NDU0YjQ5YTI4MTcxZmZiODJlY18yMTU0_653b2098-5e9c-4a71-92f1-f97d465d33bb">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGV4dHJlZ2lvbjplNzg5M2Y0OWYwOTE0NDU0YjQ5YTI4MTcxZmZiODJlY18yMTQ4_de72f556-90ae-454c-b9b8-566204955c28">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGFibGU6N2E0NDljZTBmZmE1NDMwMGEyZmZkMzk0MWE5ODc4YmIvdGFibGVyYW5nZTo3YTQ0OWNlMGZmYTU0MzAwYTJmZmQzOTQxYTk4NzhiYl8wLTYtMS0xLTgxNTcw_79f43289-368d-42d9-bfe2-14cd258c5f0d">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGFibGU6N2E0NDljZTBmZmE1NDMwMGEyZmZkMzk0MWE5ODc4YmIvdGFibGVyYW5nZTo3YTQ0OWNlMGZmYTU0MzAwYTJmZmQzOTQxYTk4NzhiYl8xLTEtMS0xLTY4MzE2_37ed8036-cacb-4342-a53b-1ad0cb6112a2">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGFibGU6N2E0NDljZTBmZmE1NDMwMGEyZmZkMzk0MWE5ODc4YmIvdGFibGVyYW5nZTo3YTQ0OWNlMGZmYTU0MzAwYTJmZmQzOTQxYTk4NzhiYl8xLTQtMS0xLTY4MzE2_18c0330a-571e-49a1-bdf5-8b1d754dd7ff">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGV4dHJlZ2lvbjplNzg5M2Y0OWYwOTE0NDU0YjQ5YTI4MTcxZmZiODJlY18yMTU1_21f3a433-9a23-4608-b6c2-69cacfa8904d">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i0e136d89ad474fdeb683220221498c6a_I20230426"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xL2ZyYWc6ZTc4OTNmNDlmMDkxNDQ1NGI0OWEyODE3MWZmYjgyZWMvdGV4dHJlZ2lvbjplNzg5M2Y0OWYwOTE0NDU0YjQ5YTI4MTcxZmZiODJlY18yMTMx_2f87b60a-407d-43d1-8a55-58c664eeb099"
      unitRef="shares">35184049</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMy0xLTEtMS02ODMxNg_5c4bbb87-8272-49c6-973e-4c8fc88ab24a"
      unitRef="usd">22969000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMy0zLTEtMS02ODMxNg_f3135688-e2c8-4478-b15a-45135d94f997"
      unitRef="usd">20717000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfNC0xLTEtMS02ODMxNg_0cc3314d-46bc-4c8c-a543-da07ff514f2a"
      unitRef="usd">62997000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfNC0zLTEtMS02ODMxNg_b568e745-2552-4ebb-ac50-f7d30ebd0f1f"
      unitRef="usd">76573000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfNS0wLTEtMS02ODMxNi90ZXh0cmVnaW9uOjQ0NGY4NzRkMWE4MTQ4NjY4YzAyNzkwYTE3ZmRlMjA4XzY3_91e8cd95-4e7b-4b02-9aa5-c55693376f90"
      unitRef="usd">450000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfNS0wLTEtMS02ODMxNi90ZXh0cmVnaW9uOjQ0NGY4NzRkMWE4MTQ4NjY4YzAyNzkwYTE3ZmRlMjA4Xzc1_cb57d70f-f5ef-4c56-a9df-0c6bef1cef2c"
      unitRef="usd">400000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfNS0xLTEtMS02ODMxNg_30509cd7-cd75-4385-8595-17d2e38a8606"
      unitRef="usd">22600000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfNS0zLTEtMS02ODMxNg_d2251587-1132-404b-baf5-20731070c2cf"
      unitRef="usd">20674000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfNi0xLTEtMS02ODMxNg_9b648083-b400-44a0-bc71-35c53b77b335"
      unitRef="usd">17790000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfNi0zLTEtMS02ODMxNg_b764b7b2-3399-4c76-aa24-401e0b81f061"
      unitRef="usd">17282000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfNy0xLTEtMS02ODMxNg_ef4b37a5-e1d6-4b3e-89d7-f04710105808"
      unitRef="usd">2045000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfNy0zLTEtMS02ODMxNg_4ea9d469-7441-4d1f-925a-d9e5fb397963"
      unitRef="usd">2365000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfOC0xLTEtMS02ODMxNg_aa1747d7-1fcd-4b48-8b3f-3891b2e6d8ca"
      unitRef="usd">128401000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfOC0zLTEtMS02ODMxNg_a83322ba-e587-4ca7-adc1-e62e10a3c17d"
      unitRef="usd">137611000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMTAtMS0xLTEtNjgzMTY_f9739bfb-0ae2-4e4b-9006-a80533f4c057"
      unitRef="usd">16629000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMTAtMy0xLTEtNjgzMTY_c8982c4f-235e-4f1f-8c56-4bbe76db286d"
      unitRef="usd">15564000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMTEtMS0xLTEtNjgzMTY_1913a477-aa83-4d7d-878a-a73dcba477df"
      unitRef="usd">3672000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMTEtMy0xLTEtNjgzMTY_bf93a173-6f12-446d-b5b6-e0acb150cb47"
      unitRef="usd">4002000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMTItMS0xLTEtNjgzMTY_e65fd43b-be03-4aa6-8bb8-5856054519a9"
      unitRef="usd">374000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMTItMy0xLTEtNjgzMTY_0b0b52f0-4517-40c9-89ea-f5caaa2093e8"
      unitRef="usd">375000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMTMtMS0xLTEtNjgzMTY_b7e1ccae-be59-40e4-9b02-f42fcbfc917f"
      unitRef="usd">149076000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMTMtMy0xLTEtNjgzMTY_5d4ce0f1-ae14-4657-a280-70b102229aa5"
      unitRef="usd">157552000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMTctMS0xLTEtNjgzMTY_a2f64653-0cc8-4b88-971d-23820e3255ef"
      unitRef="usd">5331000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMTctMy0xLTEtNjgzMTY_06128036-9190-4b5f-9c6a-7b7b4bf09e03"
      unitRef="usd">6279000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMTgtMS0xLTEtNjgzMTY_24eda7de-f2d1-46d6-8944-5b41844b5a1a"
      unitRef="usd">9896000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMTgtMy0xLTEtNjgzMTY_cb3c342f-450a-4fb0-b7da-4c33d4c463ff"
      unitRef="usd">13511000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMjAtMS0xLTEtNjgzMTY_ba812f00-558e-435c-98de-d5b720d29890"
      unitRef="usd">1401000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMjAtMy0xLTEtNjgzMTY_26e37e48-26cb-4d2c-9241-21d7d6265cd1"
      unitRef="usd">1388000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMjEtMS0xLTEtNjgzMTY_02f1fbca-1bc4-452d-b4be-fdd569d30353"
      unitRef="usd">16628000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMjEtMy0xLTEtNjgzMTY_4ab6628f-82d2-406d-9bea-54f890c62ad2"
      unitRef="usd">21178000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMjItMS0xLTEtNjgzMTY_e0ef90d5-8675-46d2-9f8e-53aa17021fe2"
      unitRef="usd">35938000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMjItMy0xLTEtNjgzMTY_3413528f-822d-43d2-ac0a-4edd96d735e1"
      unitRef="usd">35171000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMjMtMS0xLTEtNjgzMTY_a3389924-224a-44cf-a2a8-df6ebbe1341b"
      unitRef="usd">2525000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMjMtMy0xLTEtNjgzMTY_5bc6972b-a0d6-4ba8-8524-e2038d9f9d64"
      unitRef="usd">2871000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMjQtMS0xLTEtNjgzMTY_9e4d2748-c915-4828-b0f0-33827101c64a"
      unitRef="usd">26000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMjQtMy0xLTEtNjgzMTY_d9a1063d-9563-4139-922c-22d2bc45a8ee"
      unitRef="usd">30000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMjUtMS0xLTEtNjgzMTY_f7323dad-a168-4602-a945-17cb274c84ff"
      unitRef="usd">55117000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMjUtMy0xLTEtNjgzMTY_6a7c6bc9-346e-4adf-a525-a78575da80c3"
      unitRef="usd">59250000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMjctMS0xLTEtNjgzMTY_cf5aa13d-3873-4574-9daa-999a6179b182"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMjctMy0xLTEtNjgzMTY_5e1c3179-1b83-4525-92e0-041a1bf670b2"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzAtMC0xLTEtNjgzMTYvdGV4dHJlZ2lvbjpmODNmZjZiODJmYTA0ODJmYjVjZjJiYzIyMGE5OGU4Y18yMg_6c7427cf-2e2f-4d68-a6d8-15d8ee8c6a09"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzAtMC0xLTEtNjgzMTYvdGV4dHJlZ2lvbjpmODNmZjZiODJmYTA0ODJmYjVjZjJiYzIyMGE5OGU4Y18yMg_bbf62bd9-f206-42d7-a706-bb7a0e1ed30f"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzAtMC0xLTEtNjgzMTYvdGV4dHJlZ2lvbjpmODNmZjZiODJmYTA0ODJmYjVjZjJiYzIyMGE5OGU4Y18zNg_5fcbe3bd-abb3-429c-9656-6c42349289a1"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzAtMC0xLTEtNjgzMTYvdGV4dHJlZ2lvbjpmODNmZjZiODJmYTA0ODJmYjVjZjJiYzIyMGE5OGU4Y18zNg_87abbe23-e6d2-410e-ab32-d14a42fd1bcc"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzAtMC0xLTEtNjgzMTYvdGV4dHJlZ2lvbjpmODNmZjZiODJmYTA0ODJmYjVjZjJiYzIyMGE5OGU4Y181OA_2c889b7a-12b5-4adc-8996-b1e65f142825"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzAtMC0xLTEtNjgzMTYvdGV4dHJlZ2lvbjpmODNmZjZiODJmYTA0ODJmYjVjZjJiYzIyMGE5OGU4Y181OA_3afcd7e9-d31d-448f-b406-8da5e564180d"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzAtMC0xLTEtNjgzMTYvdGV4dHJlZ2lvbjpmODNmZjZiODJmYTA0ODJmYjVjZjJiYzIyMGE5OGU4Y181OA_e6a3a326-245a-47e2-abdd-ef516115ae18"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzAtMC0xLTEtNjgzMTYvdGV4dHJlZ2lvbjpmODNmZjZiODJmYTA0ODJmYjVjZjJiYzIyMGE5OGU4Y181OA_f1626f23-cf96-4121-aedd-c381fee418b2"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzAtMS0xLTEtNjgzMTY_3e6c3ebe-9b9e-4728-bfae-59ba97b2a5fe"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzAtMy0xLTEtNjgzMTY_31b013e8-5386-465e-826c-9b4d1494f943"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzEtMC0xLTEtNjgzMTYvdGV4dHJlZ2lvbjo0ZjhkNzFkNjk4NzQ0MjU0OGViNDAwMDg4YjM4OGU5Yl8xOA_3b11cac9-9a04-4e71-9e7c-fb3ea7ababb2"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzEtMC0xLTEtNjgzMTYvdGV4dHJlZ2lvbjo0ZjhkNzFkNjk4NzQ0MjU0OGViNDAwMDg4YjM4OGU5Yl8xOA_d81311d2-b249-4008-8e0f-78e6d68b7b87"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzEtMC0xLTEtNjgzMTYvdGV4dHJlZ2lvbjo0ZjhkNzFkNjk4NzQ0MjU0OGViNDAwMDg4YjM4OGU5Yl8zMg_1168a993-1e59-4b7a-b817-66f732f71587"
      unitRef="shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzEtMC0xLTEtNjgzMTYvdGV4dHJlZ2lvbjo0ZjhkNzFkNjk4NzQ0MjU0OGViNDAwMDg4YjM4OGU5Yl8zMg_93a41026-b275-4589-ac2a-566342b82366"
      unitRef="shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzEtMC0xLTEtNjgzMTYvdGV4dHJlZ2lvbjo0ZjhkNzFkNjk4NzQ0MjU0OGViNDAwMDg4YjM4OGU5Yl81NA_091172c4-5422-45c6-b002-9aa357af6404"
      unitRef="shares">35106163</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzEtMC0xLTEtNjgzMTYvdGV4dHJlZ2lvbjo0ZjhkNzFkNjk4NzQ0MjU0OGViNDAwMDg4YjM4OGU5Yl81NA_b28a15f0-80f5-411e-ad91-270863d61383"
      unitRef="shares">35106163</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzEtMC0xLTEtNjgzMTYvdGV4dHJlZ2lvbjo0ZjhkNzFkNjk4NzQ0MjU0OGViNDAwMDg4YjM4OGU5Yl82MQ_7c2e3748-05d1-4af7-ac00-b8b52ce1db52"
      unitRef="shares">34731577</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzEtMC0xLTEtNjgzMTYvdGV4dHJlZ2lvbjo0ZjhkNzFkNjk4NzQ0MjU0OGViNDAwMDg4YjM4OGU5Yl82MQ_d1757cdf-ee30-47ec-90f4-492edf56f15f"
      unitRef="shares">34731577</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzEtMS0xLTEtNjgzMTY_d7f19ad7-df49-4bc6-8b62-754847bb5465"
      unitRef="usd">3000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzEtMy0xLTEtNjgzMTY_eb867319-fa09-4651-a9e0-f378abf25771"
      unitRef="usd">3000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzItMS0xLTEtNjgzMTY_7163b525-8073-4746-a471-120c6a105b87"
      unitRef="usd">461886000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzItMy0xLTEtNjgzMTY_09e6663d-10fc-4ed8-88c0-f6d4f9c55bbe"
      unitRef="usd">455172000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzMtMS0xLTEtNjgzMTY_5485ae3e-04a1-4cfd-b10f-823004e9edd5"
      unitRef="usd">300000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzMtMy0xLTEtNjgzMTY_0da1f53d-a2c2-4a42-b05c-70408d6c38e5"
      unitRef="usd">232000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzQtMS0xLTEtNjgzMTY_d309500c-f23d-4c5d-8bae-e2f715fc4469"
      unitRef="usd">-368230000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzQtMy0xLTEtNjgzMTY_70ec4f6d-0ee7-4c0c-9ad6-d9c606a914c5"
      unitRef="usd">-357105000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzUtMS0xLTEtNjgzMTY_b9015112-72c2-412e-b97f-82497039a588"
      unitRef="usd">93959000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzUtMy0xLTEtNjgzMTY_791fd52b-a751-443a-9595-244c6dded0ec"
      unitRef="usd">98302000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzYtMS0xLTEtNjgzMTY_9cd0a78f-6513-4eaf-a2d3-64544d31fe2a"
      unitRef="usd">149076000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xNi9mcmFnOjVlNWUzODE0MmRlOTQ1ZTE5NWVlYTRhODliMDM4OTM1L3RhYmxlOjdkZTgyY2FmM2VlYTQ3YWZiZTljMDczOTAxMzM0MTQ2L3RhYmxlcmFuZ2U6N2RlODJjYWYzZWVhNDdhZmJlOWMwNzM5MDEzMzQxNDZfMzYtMy0xLTEtNjgzMTY_9235377c-2baa-4347-aa8b-9f1a8a21e805"
      unitRef="usd">157552000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMi0xLTEtMS02ODMxNg_2404ee11-3490-4625-8f37-f215391f791e"
      unitRef="usd">32708000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMi0zLTEtMS02ODMxNg_cd8ad697-0c18-4389-80c8-1103f69f42cb"
      unitRef="usd">22439000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMy0xLTEtMS02ODMxNg_31ea5a77-3cdd-435e-a0e0-dba4973d1ea8"
      unitRef="usd">5924000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMy0zLTEtMS02ODMxNg_3cfefbf1-ddf0-4cbc-a941-b79160fa0689"
      unitRef="usd">2983000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfNC0xLTEtMS02ODMxNg_fe4d1c44-704b-4458-9278-9548b0153aa2"
      unitRef="usd">26784000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfNC0zLTEtMS02ODMxNg_b67f8b43-6fbd-41de-b9e1-186752e93f7f"
      unitRef="usd">19456000</us-gaap:GrossProfit>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfNi0xLTEtMS02ODMxNg_620a1ba7-511e-4ff3-b752-78b229142d3d"
      unitRef="usd">27313000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfNi0zLTEtMS02ODMxNg_086b8601-9557-4594-bcc6-d9a0fdcbc2eb"
      unitRef="usd">25605000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfNy0xLTEtMS02ODMxNg_72a1cac4-686b-4b7a-bf60-72a6e1b002c2"
      unitRef="usd">3291000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfNy0zLTEtMS02ODMxNg_62449af6-fb41-44d2-99d8-11ff4603b90a"
      unitRef="usd">3580000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfOC0xLTEtMS02ODMxNg_1b56a693-3ab7-4c36-a269-3fc9879be236"
      unitRef="usd">7473000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfOC0zLTEtMS02ODMxNg_b9701a4a-dc99-40ac-b376-6cb3aa5425eb"
      unitRef="usd">7139000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfOS0xLTEtMS02ODMxNg_d194d74e-b47f-4ca5-9637-4cf5321ca920"
      unitRef="usd">38077000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfOS0zLTEtMS02ODMxNg_baf1cfde-4ed7-48cd-9e07-b308d3cd1ea1"
      unitRef="usd">36324000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMTAtMS0xLTEtNjgzMTY_575a8d99-2b90-4284-ba37-6e7157ea76fa"
      unitRef="usd">-11293000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMTAtMy0xLTEtNjgzMTY_d1bae251-0970-4471-9dc7-7bb2aac6a568"
      unitRef="usd">-16868000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMTItMS0xLTEtNjgzMTY_76975a96-0762-473a-b042-6f5ed04b502c"
      unitRef="usd">932000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMTItMy0xLTEtNjgzMTY_30ea8b4f-4175-45cb-a0e4-ab1fb6e4af75"
      unitRef="usd">73000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMTMtMS0xLTEtNjgzMTY_5e945932-89b1-42d9-959a-a7b64751569b"
      unitRef="usd">838000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMTMtMy0xLTEtNjgzMTY_7fd167ca-1fcb-4115-8d14-281e9443bed7"
      unitRef="usd">561000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMTQtMS0xLTEtNjgzMTY_8d3f61b5-7962-427c-9dd1-3d0ff5b0c961"
      unitRef="usd">74000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMTQtMy0xLTEtNjgzMTY_af7b5b4e-1e82-49f1-a34e-f277490ed51b"
      unitRef="usd">-54000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMTUtMS0xLTEtNjgzMTY_c659b1dd-58c3-4035-9c61-fd009f3c7a49"
      unitRef="usd">-11125000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMTUtMy0xLTEtNjgzMTY_790808bf-ea33-4870-9f96-753e4492d563"
      unitRef="usd">-17410000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMTctMS0xLTEtNjgzMTY_a6a1a371-b582-4442-8db6-0540595f5151"
      unitRef="usd">-22000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMTctMy0xLTEtNjgzMTY_74452b3c-ab53-4137-b9f2-33818adce841"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMTgtMS0xLTEtNjgzMTY_41c7b522-6cdd-4b9c-b0ee-551d131c6259"
      unitRef="usd">90000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMTgtMy0xLTEtNjgzMTY_712c889a-4190-40b9-bdd7-3bca123a3394"
      unitRef="usd">-248000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMTktMS0xLTEtNjgzMTY_0324ac71-e465-4d78-95dc-18df2e62d94f"
      unitRef="usd">-11057000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMTktMy0xLTEtNjgzMTY_7a0ff8b6-0cd8-4e09-ab50-cba2cbcdd813"
      unitRef="usd">-17658000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMjEtMS0xLTEtNjgzMTY_4bdef36a-9d62-40c3-8760-dfd8bd535a5a"
      unitRef="usdPerShare">-0.32</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMjEtMS0xLTEtNjgzMTY_b2a1e2f8-b646-4ddc-9b5f-8a5b2108cf6c"
      unitRef="usdPerShare">-0.32</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMjEtMy0xLTEtNjgzMTY_9b67ed2f-2bb1-4372-b80a-49b761f9afe5"
      unitRef="usdPerShare">-0.52</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMjEtMy0xLTEtNjgzMTY_f7c53151-bad7-43f9-a148-29f999bac2e7"
      unitRef="usdPerShare">-0.52</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMjMtMS0xLTEtNjgzMTY_a180c728-3f47-486d-995e-be86a427d55d"
      unitRef="shares">34916106</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMjMtMS0xLTEtNjgzMTY_d61bfe58-9ae2-48c9-8282-becaee9d4a90"
      unitRef="shares">34916106</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMjMtMy0xLTEtNjgzMTY_82428667-fad5-4bb0-9c80-2bd78af9ec12"
      unitRef="shares">33792326</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8xOS9mcmFnOjBhMzlhYmVjYTNhNzRhOTk5MTRkMTY4MTcwYTNjODY0L3RhYmxlOjQ3OTMwOGFjZjRlMjQwNzNiYmU2ZTFhYmMyOGI5ODRiL3RhYmxlcmFuZ2U6NDc5MzA4YWNmNGUyNDA3M2JiZTZlMWFiYzI4Yjk4NGJfMjMtMy0xLTEtNjgzMTY_ebf0e2e3-a8f1-4a90-85bb-56254b0f281c"
      unitRef="shares">33792326</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ia1ad2c138559410ba21a1f7abb1d4ffd_I20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMi0yLTEtMS02ODMxNg_8e9b8e5b-bd51-4c50-aa2e-b91aa23a38b4"
      unitRef="shares">34731577</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ia1ad2c138559410ba21a1f7abb1d4ffd_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMi00LTEtMS02ODMxNg_2c01a858-b43d-4190-858e-e75c7d1844b6"
      unitRef="usd">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i73f03223216c40f18e39597ffaec1ef4_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMi02LTEtMS02ODMxNg_d2299e22-4656-4edf-999a-b88a4363f268"
      unitRef="usd">455172000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib60e72c3aa6e4ad28de9ed0584387b84_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMi04LTEtMS02ODMxNg_713aa2a8-30f2-4ddb-b5d4-8a18bd2c0abe"
      unitRef="usd">232000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i02dda049bbb449b7a4908baa63bfc3c0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMi0xMC0xLTEtNjgzMTY_8ef24a24-c5eb-437a-ba93-9199de828bd9"
      unitRef="usd">-357105000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMi0xMi0xLTEtNjgzMTY_9c5b8b91-5a45-4259-a7ef-2a22ead31ce7"
      unitRef="usd">98302000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="id0c350aefbd0469a8c27d16d7649c977_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMy0yLTEtMS02ODMxNg_516b6943-d91d-43ec-817d-603e0dd8b601"
      unitRef="shares">120266</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i205f14e8b1cc49a7aedfb949e6e0c598_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMy02LTEtMS02ODMxNg_af17e3d3-9f15-4f37-88cc-bba15284088a"
      unitRef="usd">520000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMy0xMi0xLTEtNjgzMTY_5ae2db9f-7194-4c26-9139-8b33029de05b"
      unitRef="usd">520000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <sibn:StockIssuedDuringPeriodSharesRestrictedStockUnits
      contextRef="id0c350aefbd0469a8c27d16d7649c977_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfNC0yLTEtMS02ODMxNg_eb8663ed-5737-46ee-ad09-6128a51fe4f4"
      unitRef="shares">254320</sibn:StockIssuedDuringPeriodSharesRestrictedStockUnits>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i205f14e8b1cc49a7aedfb949e6e0c598_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfNS02LTEtMS02ODMxNg_009c077b-96a2-4fb3-b802-e1cc3f47b8d6"
      unitRef="usd">6194000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfNS0xMi0xLTEtNjgzMTY_7185957a-141d-4112-8622-b82441686993"
      unitRef="usd">6194000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="idd89d2d32f7e4eadb653b6c699a1da65_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfNy04LTEtMS02ODMxNg_9d3a0d72-72fb-426c-aade-c8b8c1fe749c"
      unitRef="usd">-22000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfNy0xMi0xLTEtNjgzMTY_a4e64e2d-6b83-4b90-990c-49f27cff8bde"
      unitRef="usd">-22000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="idd89d2d32f7e4eadb653b6c699a1da65_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfOC04LTEtMS02ODMxNg_9592373e-fffe-46e6-bc2e-ad27ab227889"
      unitRef="usd">90000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfOC0xMi0xLTEtNjgzMTY_05ce7305-f4a7-4e0f-b941-9f29f693d106"
      unitRef="usd">90000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="idb828f727d314174b2f1a4710790fde9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfOS0xMC0xLTEtNjgzMTY_8f0d4df1-49a3-4a84-b514-7dcbaeea2573"
      unitRef="usd">-11125000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfOS0xMi0xLTEtNjgzMTY_7b78e745-12e0-450e-a1e9-4f5669d93508"
      unitRef="usd">-11125000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i061a1d4685fa4917a427a6f03c1beeb4_I20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMTAtMi0xLTEtNjgzMTY_2697b472-7b25-4e00-ab2b-2825cd315d29"
      unitRef="shares">35106163</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i061a1d4685fa4917a427a6f03c1beeb4_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMTAtNC0xLTEtNjgzMTY_20b107b2-7a0f-4d2f-bceb-a4a67aaf3f5a"
      unitRef="usd">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i64e08c97777d48b3a2279b29a42ce726_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMTAtNi0xLTEtNjgzMTY_edd66c96-21e8-4ff5-8097-6a89340c77a0"
      unitRef="usd">461886000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i930a39bf4a65491ca6af24ed50e20906_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMTAtOC0xLTEtNjgzMTY_a245e2e0-c759-480f-9b4f-528418778fa5"
      unitRef="usd">300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i954439b3925043e3949da7080d9256e2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMTAtMTAtMS0xLTY4MzE2_56f6a8bd-c345-4242-9632-c2b97d53fb41"
      unitRef="usd">-368230000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMTAtMTItMS0xLTY4MzE2_4b0b24e2-feef-4728-a768-a51668bfb878"
      unitRef="usd">93959000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i883fe34ebc0c4092a483d977c3f8d429_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMzItMi0xLTEtNjgzMTY_95840e9e-efb1-48d6-a132-58af4f5727ad"
      unitRef="shares">33674085</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i883fe34ebc0c4092a483d977c3f8d429_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMzItNC0xLTEtNjgzMTY_547a52e3-a3ce-4fe4-9e58-aea1efe87481"
      unitRef="usd">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0aa2d78b45474cb8b1a7e306265bc187_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMzItNi0xLTEtNjgzMTY_22a8d334-73fb-4813-97d9-d871004cd77c"
      unitRef="usd">429914000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0422532f98d04beb985b3c54535d2911_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMzItOC0xLTEtNjgzMTY_ab116e70-bc5b-486b-a4cc-227045e11c5e"
      unitRef="usd">352000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i429ed22eade94b3e88f8ed51a9a289e9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMzItMTAtMS0xLTY4MzE2_6746b2de-4078-4216-aa6e-b31cb325647f"
      unitRef="usd">-295849000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i25ff20079ccb48899ea84d72b50e16e7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMzItMTItMS0xLTY4MzE2_c25dc590-84f7-42c4-a4af-e1a49aa04cf0"
      unitRef="usd">134420000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i58ceb493d83949bb8045aa75c1c8bdc3_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMzMtMi0xLTEtNjgzMTY_c4046b90-cd3e-40e9-92cd-eef48f92f26f"
      unitRef="shares">34798</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i84b72a6f51f6449f84a5d5b3cc309664_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMzMtNi0xLTEtNjgzMTY_329e9ddb-e349-471a-bc7f-a88773596ef8"
      unitRef="usd">169000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMzMtMTItMS0xLTY4MzE2_80c6fda3-ad63-431c-a4ec-c99b5f761231"
      unitRef="usd">169000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <sibn:StockIssuedDuringPeriodSharesRestrictedStockUnits
      contextRef="i58ceb493d83949bb8045aa75c1c8bdc3_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMzQtMi0xLTEtNjgzMTY_fd1ce5f5-3711-42d0-a199-7530c14cb0a3"
      unitRef="shares">163480</sibn:StockIssuedDuringPeriodSharesRestrictedStockUnits>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i84b72a6f51f6449f84a5d5b3cc309664_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMzUtNi0xLTEtNjgzMTY_9758561b-fb28-49d7-a95a-919292884d5d"
      unitRef="usd">5507000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMzUtMTItMS0xLTY4MzE2_dd82003b-11b3-465e-8983-c2d4f44de1fc"
      unitRef="usd">5507000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="id37cd14c22ad42eb8a735baa4d08d8b0_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMzgtOC0xLTEtNjgzMTY_fa90a910-dd7d-4173-8354-9c468da0cb8c"
      unitRef="usd">-248000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMzgtMTItMS0xLTY4MzE2_13a9ac70-bff8-4422-a5ec-c6ea4d6ff967"
      unitRef="usd">-248000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="ie59f6758cf1b4684be0a81c20e471c4b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMzktMTAtMS0xLTY4MzE2_ee601db8-3bb3-499f-acb1-96e3baadfa3a"
      unitRef="usd">-17410000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfMzktMTItMS0xLTY4MzE2_0fc05bd4-e9ef-49dc-81f3-f5584ae1b4ad"
      unitRef="usd">-17410000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="iad9213ed4f734769974b00e30b313acc_I20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfNDAtMi0xLTEtNjgzMTY_1158adb6-174a-4167-b9cc-0d5db75c4f03"
      unitRef="shares">33872363</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="iad9213ed4f734769974b00e30b313acc_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfNDAtNC0xLTEtNjgzMTY_c6e1871b-3a92-4a63-92f5-20381c8fb437"
      unitRef="usd">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8247ae5acd7b41e9a09b537937c10239_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfNDAtNi0xLTEtNjgzMTY_25ac893d-1136-4f4c-b0fc-8ca67599e9db"
      unitRef="usd">435590000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia8f402bebac44ff39653d91d5f80e030_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfNDAtOC0xLTEtNjgzMTY_6ea3507a-523e-49dd-8977-2a2184efbb6b"
      unitRef="usd">104000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7459a99379124552878485552b9000b8_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfNDAtMTAtMS0xLTY4MzE2_ff4a9e0c-fc86-4cda-965d-08357e309959"
      unitRef="usd">-313259000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i37f453d1957c4f60a0e5d364ba1d84c7_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yMi9mcmFnOmFkMjhlZTA1N2Q4MTRhMTg5NDU5YjQ5Yjk2NGQyMGQ4L3RhYmxlOjJlMGFlZGVmYTgzYTQyYzNhN2E3YjkxMmE1OTUzNzJlL3RhYmxlcmFuZ2U6MmUwYWVkZWZhODNhNDJjM2E3YTdiOTEyYTU5NTM3MmVfNDAtMTItMS0xLTY4MzE2_02addfad-fe79-40bb-9432-8604e810603f"
      unitRef="usd">122438000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMy0xLTEtMS02ODMxNg_3327638c-cfee-4412-9343-3c2abedf4883"
      unitRef="usd">-11125000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMy0zLTEtMS02ODMxNg_4b3630fc-9e3a-4f5d-97eb-3f9ac293b531"
      unitRef="usd">-17410000</us-gaap:NetIncomeLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfNS0xLTEtMS02ODMxNg_a3effe8f-dad3-40d1-bbe9-497c1aa15453"
      unitRef="usd">6194000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfNS0zLTEtMS02ODMxNg_7e968ef2-fdec-4bb1-9cee-5bb12ac93f98"
      unitRef="usd">5507000</us-gaap:ShareBasedCompensation>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfNi0xLTEtMS02ODMxNg_41990c3c-b9e2-4a02-b8fb-631c0d6dd0c6"
      unitRef="usd">1086000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfNi0zLTEtMS02ODMxNg_c1877551-ea33-46d0-9df3-b4cb3df9a0a5"
      unitRef="usd">713000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfNy0xLTEtMS02ODMxNg_a0efc564-0526-4612-820c-f9d1174d907d"
      unitRef="usd">50000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfNy0zLTEtMS02ODMxNg_a24ad7a3-ad8b-416c-8f9a-39f22deaab1e"
      unitRef="usd">0</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfOC0xLTEtMS02ODMxNg_8cbf87e3-fe4a-4fc4-b63a-a0056f4c4680"
      unitRef="usd">615000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfOC0zLTEtMS02ODMxNg_f4c5b145-769c-4db8-9bdf-a1e81a611f93"
      unitRef="usd">-244000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMTAtMS0xLTEtNjgzMTY_aff00ae7-5011-43d0-bc5a-b74231aa2ec1"
      unitRef="usd">81000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMTAtMy0xLTEtNjgzMTY_d22ef1f8-4aeb-453f-bd34-21c58541936e"
      unitRef="usd">51000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMTItMS0xLTEtNjgzMTY_4e08f946-3e2a-40ed-bb86-fcb13821509e"
      unitRef="usd">-190000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMTItMy0xLTEtNjgzMTY_0e7a46cb-ad53-4488-b0c4-4337a717b87d"
      unitRef="usd">-31000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMTQtMS0xLTEtNjgzMTY_f126d060-5b8f-4ea8-a350-2f622b3663e0"
      unitRef="usd">2019000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMTQtMy0xLTEtNjgzMTY_f48d9f27-75e4-42f1-9a8e-44b3de4cf946"
      unitRef="usd">-1603000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMTUtMS0xLTEtNjgzMTY_c9e20b8c-db07-4994-a288-1feea4063a17"
      unitRef="usd">536000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMTUtMy0xLTEtNjgzMTY_68a1a092-85d4-4fc7-ac0b-91754d72134b"
      unitRef="usd">3178000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMTYtMS0xLTEtNjgzMTY_3431e226-54e2-4605-b075-806a3a359046"
      unitRef="usd">-311000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMTYtMy0xLTEtNjgzMTY_29f49387-a170-4265-977e-03d9322c8b1d"
      unitRef="usd">-12000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMTctMS0xLTEtNjgzMTY_64e8bc35-86c2-4cc4-b497-b584e8949ad1"
      unitRef="usd">-745000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMTctMy0xLTEtNjgzMTY_0c5f0b87-87f5-433a-9101-5556cf73190a"
      unitRef="usd">2086000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMTgtMS0xLTEtNjgzMTY_af502278-93f2-49e0-a366-91feb1443b96"
      unitRef="usd">-3625000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMTgtMy0xLTEtNjgzMTY_b2883dd5-6cd1-44ac-b855-87b85b16d91d"
      unitRef="usd">-3171000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMTktMS0xLTEtNjgzMTY_31a56737-d723-423c-9a35-1b3eefa58d0d"
      unitRef="usd">-10753000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMTktMy0xLTEtNjgzMTY_7008d54e-d9c2-492b-be82-6587db3b16a2"
      unitRef="usd">-13512000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <sibn:ProceedsFromMaturityOfMarketableSecurities
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMjEtMS0xLTEtNjgzMTY_f39c5949-7165-4d23-84cd-1a0e4843de2a"
      unitRef="usd">30000000</sibn:ProceedsFromMaturityOfMarketableSecurities>
    <sibn:ProceedsFromMaturityOfMarketableSecurities
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMjEtMy0xLTEtNjgzMTY_69ed9a54-a0b3-4af5-9db1-5e843068d853"
      unitRef="usd">25000000</sibn:ProceedsFromMaturityOfMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMjMtMS0xLTEtNjgzMTY_887b70a7-68e3-4c44-86bd-db3fa256ad29"
      unitRef="usd">15718000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMjMtMy0xLTEtNjgzMTY_c021cdc9-a814-4c51-9a81-5614e42e6666"
      unitRef="usd">45334000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMjQtMS0xLTEtNjgzMTY_aed40589-b40a-45dd-bbce-580bb4f279a2"
      unitRef="usd">2579000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMjQtMy0xLTEtNjgzMTY_9c8abf9c-2c28-47f1-bed7-58224882a89c"
      unitRef="usd">2274000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMjUtMS0xLTEtNjgzMTY_3c7b6294-573a-4d5c-93ac-605016d1e7b8"
      unitRef="usd">11703000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMjUtMy0xLTEtNjgzMTY_6d771cb3-4a7c-4ded-9d94-a49af51f1b92"
      unitRef="usd">-22608000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMjgtMS0xLTEtNjgzMTY_5251325d-61ae-43c9-a605-b4646c386964"
      unitRef="usd">36000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMjgtMy0xLTEtNjgzMTY_607054c3-367f-4f51-b0d4-b6bf31f9c781"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMjktMS0xLTEtNjgzMTY_fee74b5c-5632-4817-9a8c-f2fe2c3a8a56"
      unitRef="usd">35275000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMjktMy0xLTEtNjgzMTY_70f36e1c-6589-4337-a63e-5df2bf0e4e5e"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMzAtMS0xLTEtNjgzMTY_98e643c6-17a8-4a21-8482-9f37aa9906a8"
      unitRef="usd">40000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMzAtMy0xLTEtNjgzMTY_9f5cc358-c22a-44fb-8a42-166806ad7ea3"
      unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMzMtMS0xLTEtNjgzMTY_046a6e65-7735-49f6-8b5e-931badc5f078"
      unitRef="usd">520000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMzMtMy0xLTEtNjgzMTY_4e21d307-f182-4dfc-b225-b36fde10a1c0"
      unitRef="usd">169000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMzYtMS0xLTEtNjgzMTY_092e8926-c08b-42d2-aad1-1b5e83e51fb3"
      unitRef="usd">1205000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMzYtMy0xLTEtNjgzMTY_18ac6acb-6325-4890-8879-04aacf3edf52"
      unitRef="usd">169000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMzctMS0xLTEtNjgzMTY_f9c436c4-fd0d-43e1-a782-51807b3297f7"
      unitRef="usd">97000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMzctMy0xLTEtNjgzMTY_a65ad3e0-cd75-4ca1-8d3d-1ef99e0dca1d"
      unitRef="usd">-139000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMzgtMS0xLTEtNjgzMTY_a36b2732-8c31-474a-8fa0-6856c8b5233e"
      unitRef="usd">2252000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfMzgtMy0xLTEtNjgzMTY_bc5055e3-cfda-4941-9d60-fcd5bcf09d0a"
      unitRef="usd">-36090000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfNDAtMS0xLTEtNjgzMTY_fb14c958-63cd-442c-af17-5ef27e6e955a"
      unitRef="usd">20717000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i25ff20079ccb48899ea84d72b50e16e7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfNDAtMy0xLTEtNjgzMTY_4341f613-74d2-4561-99bb-39b85ea5dd0b"
      unitRef="usd">63419000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfNDEtMS0xLTEtNjgzMTY_f2e89c15-9bf6-41c6-bbb8-6d8cdc6eaad4"
      unitRef="usd">22969000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i37f453d1957c4f60a0e5d364ba1d84c7_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfNDEtMy0xLTEtNjgzMTY_15347db3-9948-4fe1-aea5-02d29f326cbd"
      unitRef="usd">27329000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfNDctMS0xLTEtNjgzMTY_9f300a74-ebca-4392-b036-cea01e195f13"
      unitRef="usd">887000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8yNS9mcmFnOmY4NDg2Y2VjZDFjMjQzMDE5ZTg0OWIyYzA2ZDE5NDcxL3RhYmxlOjdiMDVkY2E4NzUxNjQzYTdiZGM1YzIyZjQ4MTBhMjYyL3RhYmxlcmFuZ2U6N2IwNWRjYTg3NTE2NDNhN2JkYzVjMjJmNDgxMGEyNjJfNDctMy0xLTEtNjgzMTY_a38854a8-aa16-4766-b1a9-54618c67dbe6"
      unitRef="usd">241000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:NatureOfOperations
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zMS9mcmFnOmRkZjEzNWUzODVmNDQ5OGQ4MzIxZTczYjFlYTEzMDhmL3RleHRyZWdpb246ZGRmMTM1ZTM4NWY0NDk4ZDgzMjFlNzNiMWVhMTMwOGZfMjI3OQ_09adfe0d-2885-4a30-9ae5-d52c1146c3d3">The Company and Nature of Business&lt;div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;SI-BONE, Inc. (the &#x201c;Company&#x201d;) was incorporated in the state of Delaware on March&#160;18, 2008 and is headquartered in Santa Clara, California. The Company is a medical device company that has pioneered a proprietary minimally invasive surgical implant system to fuse the sacroiliac joint for treatment of musculoskeletal disorders of the sacropelvic anatomy. The Company introduced its first generation iFuse implant in 2009 in the U.S., in 2010 in certain countries in the European Union, and in 2015 in certain countries in the rest of the world. The second generation iFuse implant, iFuse-3D, was introduced in 2017 followed by iFuse-TORQ in 2021 and iFuse Bedrock Granite in 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Risks and Uncertainties&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company is subject to uncertainties related to liquidity, the ability to meet covenants and access to funding for its capital needs as the financial service industry has experienced disruptions characterized by the bankruptcy, failure, collapse or sale of various financial institutions. The Company&#x2019;s cash and cash equivalents are primarily invested in deposits and money market accounts with two major financial institutions in the U.S. Deposits in these banks may exceed the federally insured limits or any other insurance provided on such deposits, if any. The Company had accounts with Silicon Valley Bank (&#x201c;SVB&#x201d;). On March 10, 2023, California regulators shut down SVB and the FDIC was appointed as SVB&#x2019;s receiver. On March 26, 2023, the FDIC announced that it had entered into a purchase and assumption agreement with First-Citizens Bank &amp;amp; Trust Company (&#x201c;First-Citizens&#x201d;) under which all deposits of the former Silicon Valley Bank were assumed by First-Citizens.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;First-Citizens acquired the rights as lender under the Company&#x2019;s Loan and Security Agreement as amended. To date, the Company has not experienced any losses on its deposits of cash, cash equivalents and marketable securities and continues to have access to these funds.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company is subject to continuing risk and uncertainties resulting from the COVID-19 pandemic. The COVID-19 pandemic has impacted our supply chain and also caused delays or cancellations of our procedures. Continuing or future outbreaks of COVID-19 or other public health concerns could contribute to health systems diverting resources to respond to COVID-19 which could lead to scheduling delays or cancellations of our procedures. Continuing or future outbreaks could also cause or exacerbate supply chain shortages.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;As such the Company's future results of operations and liquidity could be adversely impacted by a variety of factors related to uncertainties in the financial services industry and new or ongoing impacts of the COVID-19 pandemic, including those discussed in the section titled "Risk Factors" in this report. As of the date of issuance of these condensed consolidated financial statements, the extent to which the COVID-19 pandemic, economic disruption that has resulted from the pandemic and measures taken to stabilize economies during the pandemic, global supply chain issues and uncertainties of the financial services industry may materially impact the Company's financial condition, liquidity, or results of operations remains uncertain.&lt;/span&gt;&lt;/div&gt;</us-gaap:NatureOfOperations>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNC9mcmFnOmQzZTgyM2VlNTNhMTRkYjc5ODNhZDFhYTIzNmQyZTMzL3RleHRyZWdpb246ZDNlODIzZWU1M2ExNGRiNzk4M2FkMWFhMjM2ZDJlMzNfMTA0NDE_cce14ca6-d9ca-4db4-b12b-ad3479f2bf46">Summary of Significant Accounting Policies&lt;div style="margin-bottom:12pt;margin-top:9pt;padding-left:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (&#x201c;U.S. GAAP&#x201d;) and applicable rules and regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;) regarding interim financial reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP have been condensed or omitted, and accordingly the balance sheet as of December 31, 2022 has been derived from the audited consolidated financial statements at that date but does not include all of the information required by GAAP for complete financial statements. These unaudited interim condensed consolidated financial statements have been prepared on the same basis as the Company&#x2019;s annual financial statements and, in the opinion of management, reflect all adjustments that are necessary for a fair statement of the Company&#x2019;s consolidated financial information. The results of operations for the three months ended March 31, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any other interim period or for any other future year. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying condensed consolidated financial statements should be read in conjunction with the audited financial statements and related notes thereto for the year ended December 31, 2022 contained in the Company&#x2019;s Annual Report on Form 10-K filed with the SEC on March 2, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:9pt;padding-left:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Significant accounting estimates and management judgments reflected in the condensed consolidated financial statements primarily includes the fair value of performance-based restricted stock unit awards. Estimates are based on historical experience, where applicable and other assumptions believed to be reasonable by the management. Actual results could differ from those estimates. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Significant Accounting Policies &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s significant accounting policies are disclosed in the Company&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2022. The Company updated the accounting policies related to the property and equipment and revenue recognition, as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Property and Equipment &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Construction in progress includes assets that have not yet been placed into service including the cost of individual components of an instrument tray. Once an instrument tray is placed into service, the Company transfers its carrying value into machinery and equipment and begins depreciating the cost of the instrument tray over its useful life. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Leasehold improvements are amortized over the lesser of their useful lives or the life of the lease.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Upon the sale or retirement of these assets, the cost and related accumulated depreciation are removed from the consolidated balance sheet and the resulting gain or loss is recognized in the consolidated statement of operations. Maintenance and repairs are charged to operations as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company&#x2019;s revenue is derived from the sale of its products to medical groups and hospitals through its direct sales force and third-party sales agents and resellers throughout the U.S. and Europe. The Company receives payment for its implants consumed during the surgery and does not receive additional or separate consideration for the use of the instrument tray furnished by the Company for the surgeon&#x2019;s use. The Company identifies the instrument trays as a lease component and the implants as a non-lease component in its arrangements with its customers. The Company determines that the non-lease component is qualitatively predominant, and as such, elected the practical expedient to not separate the lease and non-lease components. Therefore, the overall arrangement is accounted for under Accounting Standards Codification (&#x201c;ASC&#x201d;) 606, Revenue from Contracts with Customers (&#x201c;ASC 606&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In accordance with ASC 606, the Company recognizes revenue when control is transferred to the customer, in an amount that reflects the consideration the Company expects to be entitled to in exchange for the goods or services. Under the revenue recognition standard, the Company applies the following five step approach: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when a performance obligation is satisfied. As it relates to product sales where the Company's sales representative delivers the product at the point of implantation at the hospital or medical facilities, the Company continues to recognize the revenue upon completion of the procedure and authorization by the customer, net of rebates and price discounts. This represents the majority of the Company's consolidated revenue. The Company also generates a small portion of revenue from the sale of products through distributors and to certain hospital or medical facilities where the products are ordered in advance of a procedure. The performance obligation is the delivery of the products and therefore, revenue is recognized upon shipment to the customers, net of rebates and price discounts. The Company accounts for rebates and price discounts as a reduction to revenue, calculated based on the terms agreed to with the customer. Historically, there had been no significant price discounts. Sales prices are specified in either the customer contract or agreed price list, which is executed prior to the transfer of control to the customer. For certain hospitals and medical facilities, the Company has agreements in place consists of either a master services agreement or an agreed price list, which defines the terms and conditions of the arrangement, including the pricing information, payment terms and pertinent aspects of the relationship between the parties. The Company also has agreements in place with its distributors, which include standard terms that do not allow for payment contingent on resale of the product, obtaining financing, or other terms that could impact the distributor&#x2019;s payment obligation. The Company's standard payment terms are generally net 30 to 90 days.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Segments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's chief operating decision makers are the Chief Executive Officer (&#x201c;CEO&#x201d;) and Chief Financial Officer (&#x201c;CFO&#x201d;). The CEO and the CFO review financial information presented on a consolidated basis, accompanied by information about revenue by geographic region, for purposes of evaluating financial performance. The Company has one business activity and there are no segment managers who are held accountable for operations, operating results or plans for levels or components below the consolidated unit level. Accordingly, the Company has determined that it has a single reportable and operating segment structure&lt;/span&gt;&lt;span style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company derives substantially all of its revenue from sales to customers in the U.S. Revenue by geography is based on billing address of the customer. International revenue accounted for less than 10% of the total revenue during the periods presented. Long-lived assets held outside the U.S. are immaterial. Following table summarizes the Company's revenue by geography:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.527%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No recently issued accounting standards are expected to have a material impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNC9mcmFnOmQzZTgyM2VlNTNhMTRkYjc5ODNhZDFhYTIzNmQyZTMzL3RleHRyZWdpb246ZDNlODIzZWU1M2ExNGRiNzk4M2FkMWFhMjM2ZDJlMzNfMTA0NDI_145fdeae-d8de-48c5-8d3c-a94cc871b2e9">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (&#x201c;U.S. GAAP&#x201d;) and applicable rules and regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;) regarding interim financial reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP have been condensed or omitted, and accordingly the balance sheet as of December 31, 2022 has been derived from the audited consolidated financial statements at that date but does not include all of the information required by GAAP for complete financial statements.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNC9mcmFnOmQzZTgyM2VlNTNhMTRkYjc5ODNhZDFhYTIzNmQyZTMzL3RleHRyZWdpb246ZDNlODIzZWU1M2ExNGRiNzk4M2FkMWFhMjM2ZDJlMzNfMTA0NDM_63bf4a8b-2a2c-422e-b699-aa13bce07db3">These unaudited interim condensed consolidated financial statements have been prepared on the same basis as the Company&#x2019;s annual financial statements and, in the opinion of management, reflect all adjustments that are necessary for a fair statement of the Company&#x2019;s consolidated financial information. The results of operations for the three months ended March 31, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any other interim period or for any other future year.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNC9mcmFnOmQzZTgyM2VlNTNhMTRkYjc5ODNhZDFhYTIzNmQyZTMzL3RleHRyZWdpb246ZDNlODIzZWU1M2ExNGRiNzk4M2FkMWFhMjM2ZDJlMzNfMTA0NDY_30671c4e-b645-4a05-97c6-3ed901c56643">Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Significant accounting estimates and management judgments reflected in the condensed consolidated financial statements primarily includes the fair value of performance-based restricted stock unit awards. Estimates are based on historical experience, where applicable and other assumptions believed to be reasonable by the management. Actual results could differ from those estimates.</us-gaap:UseOfEstimates>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNC9mcmFnOmQzZTgyM2VlNTNhMTRkYjc5ODNhZDFhYTIzNmQyZTMzL3RleHRyZWdpb246ZDNlODIzZWU1M2ExNGRiNzk4M2FkMWFhMjM2ZDJlMzNfNTQ5NzU1ODQ2NzA5_9f9d5ec1-1ef8-4066-a718-a1f90f80be7d">&lt;div style="padding-left:72pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Property and Equipment &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Construction in progress includes assets that have not yet been placed into service including the cost of individual components of an instrument tray. Once an instrument tray is placed into service, the Company transfers its carrying value into machinery and equipment and begins depreciating the cost of the instrument tray over its useful life. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Leasehold improvements are amortized over the lesser of their useful lives or the life of the lease.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Upon the sale or retirement of these assets, the cost and related accumulated depreciation are removed from the consolidated balance sheet and the resulting gain or loss is recognized in the consolidated statement of operations. Maintenance and repairs are charged to operations as incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNC9mcmFnOmQzZTgyM2VlNTNhMTRkYjc5ODNhZDFhYTIzNmQyZTMzL3RleHRyZWdpb246ZDNlODIzZWU1M2ExNGRiNzk4M2FkMWFhMjM2ZDJlMzNfNTQ5NzU1ODQ2NzEw_aad9eaf8-71c9-4958-ba15-14d3969ff89f">&lt;div style="padding-left:72pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company&#x2019;s revenue is derived from the sale of its products to medical groups and hospitals through its direct sales force and third-party sales agents and resellers throughout the U.S. and Europe. The Company receives payment for its implants consumed during the surgery and does not receive additional or separate consideration for the use of the instrument tray furnished by the Company for the surgeon&#x2019;s use. The Company identifies the instrument trays as a lease component and the implants as a non-lease component in its arrangements with its customers. The Company determines that the non-lease component is qualitatively predominant, and as such, elected the practical expedient to not separate the lease and non-lease components. Therefore, the overall arrangement is accounted for under Accounting Standards Codification (&#x201c;ASC&#x201d;) 606, Revenue from Contracts with Customers (&#x201c;ASC 606&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In accordance with ASC 606, the Company recognizes revenue when control is transferred to the customer, in an amount that reflects the consideration the Company expects to be entitled to in exchange for the goods or services. Under the revenue recognition standard, the Company applies the following five step approach: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when a performance obligation is satisfied. As it relates to product sales where the Company's sales representative delivers the product at the point of implantation at the hospital or medical facilities, the Company continues to recognize the revenue upon completion of the procedure and authorization by the customer, net of rebates and price discounts. This represents the majority of the Company's consolidated revenue. The Company also generates a small portion of revenue from the sale of products through distributors and to certain hospital or medical facilities where the products are ordered in advance of a procedure. The performance obligation is the delivery of the products and therefore, revenue is recognized upon shipment to the customers, net of rebates and price discounts. The Company accounts for rebates and price discounts as a reduction to revenue, calculated based on the terms agreed to with the customer. Historically, there had been no significant price discounts. Sales prices are specified in either the customer contract or agreed price list, which is executed prior to the transfer of control to the customer. For certain hospitals and medical facilities, the Company has agreements in place consists of either a master services agreement or an agreed price list, which defines the terms and conditions of the arrangement, including the pricing information, payment terms and pertinent aspects of the relationship between the parties. The Company also has agreements in place with its distributors, which include standard terms that do not allow for payment contingent on resale of the product, obtaining financing, or other terms that could impact the distributor&#x2019;s payment obligation. The Company's standard payment terms are generally net 30 to 90 days.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNC9mcmFnOmQzZTgyM2VlNTNhMTRkYjc5ODNhZDFhYTIzNmQyZTMzL3RleHRyZWdpb246ZDNlODIzZWU1M2ExNGRiNzk4M2FkMWFhMjM2ZDJlMzNfMTA0Mzg_2fa2e9d5-e36f-4960-9a5a-3094e1948748">Segments&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's chief operating decision makers are the Chief Executive Officer (&#x201c;CEO&#x201d;) and Chief Financial Officer (&#x201c;CFO&#x201d;). The CEO and the CFO review financial information presented on a consolidated basis, accompanied by information about revenue by geographic region, for purposes of evaluating financial performance. The Company has one business activity and there are no segment managers who are held accountable for operations, operating results or plans for levels or components below the consolidated unit level. Accordingly, the Company has determined that it has a single reportable and operating segment structure&lt;/span&gt;&lt;span style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;The Company derives substantially all of its revenue from sales to customers in the U.S. Revenue by geography is based on billing address of the customer. International revenue accounted for less than 10% of the total revenue during the periods presented. Long-lived assets held outside the U.S. are immaterial.</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <sibn:NumberOfBusinessActivities
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNC9mcmFnOmQzZTgyM2VlNTNhMTRkYjc5ODNhZDFhYTIzNmQyZTMzL3RleHRyZWdpb246ZDNlODIzZWU1M2ExNGRiNzk4M2FkMWFhMjM2ZDJlMzNfNDAxMw_e0477b33-eca7-45c8-b8e1-277ff3fe41d9"
      unitRef="activity">1</sibn:NumberOfBusinessActivities>
    <us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNC9mcmFnOmQzZTgyM2VlNTNhMTRkYjc5ODNhZDFhYTIzNmQyZTMzL3RleHRyZWdpb246ZDNlODIzZWU1M2ExNGRiNzk4M2FkMWFhMjM2ZDJlMzNfMTA0Mzk_0f086fab-1237-42de-bd85-95e778c7d76a">Following table summarizes the Company's revenue by geography:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.527%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie621378e8af644ff959fd17071edec6f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNC9mcmFnOmQzZTgyM2VlNTNhMTRkYjc5ODNhZDFhYTIzNmQyZTMzL3RhYmxlOjkxZTZhMmNiYTIyMTQ2MWU5ZmVjMDRjYzgyNjg3NWZjL3RhYmxlcmFuZ2U6OTFlNmEyY2JhMjIxNDYxZTlmZWMwNGNjODI2ODc1ZmNfMy0xLTEtMS02ODMxNg_f9c1cbe7-c9a6-42c1-a32b-d6e489655e2e"
      unitRef="usd">30450000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1d986d6c5754440c896f37265133c6f7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNC9mcmFnOmQzZTgyM2VlNTNhMTRkYjc5ODNhZDFhYTIzNmQyZTMzL3RhYmxlOjkxZTZhMmNiYTIyMTQ2MWU5ZmVjMDRjYzgyNjg3NWZjL3RhYmxlcmFuZ2U6OTFlNmEyY2JhMjIxNDYxZTlmZWMwNGNjODI2ODc1ZmNfMy0zLTEtMS02ODMxNg_a3f71fab-b38c-49d5-af21-1dcc62d47588"
      unitRef="usd">20367000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if6d7b650f421439ea4f82d9dcaa13596_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNC9mcmFnOmQzZTgyM2VlNTNhMTRkYjc5ODNhZDFhYTIzNmQyZTMzL3RhYmxlOjkxZTZhMmNiYTIyMTQ2MWU5ZmVjMDRjYzgyNjg3NWZjL3RhYmxlcmFuZ2U6OTFlNmEyY2JhMjIxNDYxZTlmZWMwNGNjODI2ODc1ZmNfNC0xLTEtMS02ODMxNg_2bbb215e-c1e4-4d9f-b7cb-1ddcec6f34aa"
      unitRef="usd">2258000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibad906d7939f45519af713f88d015ade_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNC9mcmFnOmQzZTgyM2VlNTNhMTRkYjc5ODNhZDFhYTIzNmQyZTMzL3RhYmxlOjkxZTZhMmNiYTIyMTQ2MWU5ZmVjMDRjYzgyNjg3NWZjL3RhYmxlcmFuZ2U6OTFlNmEyY2JhMjIxNDYxZTlmZWMwNGNjODI2ODc1ZmNfNC0zLTEtMS02ODMxNg_a69a34e6-43ca-4407-9830-2e86cd37b952"
      unitRef="usd">2072000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNC9mcmFnOmQzZTgyM2VlNTNhMTRkYjc5ODNhZDFhYTIzNmQyZTMzL3RhYmxlOjkxZTZhMmNiYTIyMTQ2MWU5ZmVjMDRjYzgyNjg3NWZjL3RhYmxlcmFuZ2U6OTFlNmEyY2JhMjIxNDYxZTlmZWMwNGNjODI2ODc1ZmNfNS0xLTEtMS02ODMxNg_0afe52be-7b95-4177-bbb4-f5b18050ac44"
      unitRef="usd">32708000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNC9mcmFnOmQzZTgyM2VlNTNhMTRkYjc5ODNhZDFhYTIzNmQyZTMzL3RhYmxlOjkxZTZhMmNiYTIyMTQ2MWU5ZmVjMDRjYzgyNjg3NWZjL3RhYmxlcmFuZ2U6OTFlNmEyY2JhMjIxNDYxZTlmZWMwNGNjODI2ODc1ZmNfNS0zLTEtMS02ODMxNg_901e7c1a-9b2d-40b1-8568-eb1d9d2e7e5f"
      unitRef="usd">22439000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNC9mcmFnOmQzZTgyM2VlNTNhMTRkYjc5ODNhZDFhYTIzNmQyZTMzL3RleHRyZWdpb246ZDNlODIzZWU1M2ExNGRiNzk4M2FkMWFhMjM2ZDJlMzNfMTA0NDg_7ec9271c-623b-4db9-b3f7-de5dea4f637d">&lt;div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No recently issued accounting standards are expected to have a material impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RleHRyZWdpb246NjU3MWQxNzBhMzg2NDZmODg0YWExYmM3YWE1ZThiNmJfMjAzNQ_5e6317c7-b57c-40eb-96e6-e02bfc8b656e">Marketable Securities&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All of the Company's marketable securities were available-for-sale and were classified based on their maturities. Marketable securities with remaining maturities at the date of purchase of three months or less are classified as cash equivalents. Short-term investments are securities that original maturity or remaining maturity is greater than three months and not more than twelve months. Long-term investments are securities for which the original maturity or remaining maturity is greater than twelve months.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the marketable securities:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;   &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.666%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.560%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.242%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.242%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.921%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.486%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. agency bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.527%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.506%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.244%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.506%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.244%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.667%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.029%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. agency bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(108)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(108)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amortized cost of the Company's available-for-sale securities approximates their fair value. Unrealized losses are generally due to interest rate fluctuations, as opposed to credit quality. However, the Company reviews individual securities that are in an unrealized loss position in order to evaluate whether or not they have experienced or are expected to experience credit losses. During the three months ended March 31, 2023 and 2022, unrealized gains and losses from the investments were not material and were not the result of a decline in credit quality. As a result, the Company did not recognize any credit losses related to its investments and that all unrealized gains and losses on available-for-sale securities are recorded in accumulated other comprehensive income (loss) on the condensed consolidated balance sheets as of March 31, 2023 and December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company elected to present accrued interest receivable separately from short-term and long-term investments on its condensed consolidated balance sheets. Accrued interest receivable was $0.1&#160;million as of March 31, 2023, and was recorded in prepaid expenses and other current assets. The Company also elected to exclude accrued interest receivable from the estimation of expected credit losses on its marketable securities and reverse accrued interest receivable through interest income (expense) when amounts are determined to be uncollectible. The Company did not write off any accrued interest receivable as of March 31, 2023 or December 31, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:MarketableSecuritiesTextBlock
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RleHRyZWdpb246NjU3MWQxNzBhMzg2NDZmODg0YWExYmM3YWE1ZThiNmJfMjAzNg_31f65b63-8939-4bbf-b58f-71eeee2216e0">&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the marketable securities:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;   &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.666%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.560%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.242%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.242%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.921%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.486%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. agency bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.527%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.506%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.244%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.506%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.244%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.667%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.029%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. agency bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(108)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(108)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:MarketableSecuritiesTextBlock>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="i6706d03c32974a768210dd2966cd849e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfMy0xLTEtMS02ODMxNg_c2ab2fd1-f718-4713-ac94-aae5f989dd58"
      unitRef="usd">15602000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="i6706d03c32974a768210dd2966cd849e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfMy03LTEtMS02ODMxNg_6adeed34-d8ce-4a1c-b63d-44810729aee9"
      unitRef="usd">15602000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfNi0xLTEtMS02ODMxNg_7fcdef46-448c-4630-b34e-0bd4ec3d3599"
      unitRef="usd">15602000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfNi03LTEtMS02ODMxNg_8bfc4c0e-8536-477a-8877-3f768a31f8b6"
      unitRef="usd">15602000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="ic034056cf84142f3a1464896584f8499_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfOC0xLTEtMS02ODMxNg_bba76562-33d7-4b13-b17a-772bf734db80"
      unitRef="usd">35978000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ic034056cf84142f3a1464896584f8499_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfOC0zLTEtMS02ODMxNg_217f82a4-7022-4e88-87ae-310f398bf810"
      unitRef="usd">7000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ic034056cf84142f3a1464896584f8499_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfOC01LTEtMS02ODMxNg_26d8eb29-92ea-4744-a06f-1ea940588895"
      unitRef="usd">21000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ic034056cf84142f3a1464896584f8499_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfOC03LTEtMS02ODMxNg_a8c4393f-0db0-4e07-9d0b-f61de643a112"
      unitRef="usd">35964000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="i44dd3ae16d4d45c8bb7f34c32c3afa5b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfOS0xLTEtMS02ODMxNg_2e8ce314-6772-4889-842e-1ce57dfe1591"
      unitRef="usd">2945000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i44dd3ae16d4d45c8bb7f34c32c3afa5b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfOS0zLTEtMS02ODMxNg_b219d6ec-81b4-4943-900d-a0a0248854c6"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i44dd3ae16d4d45c8bb7f34c32c3afa5b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfOS01LTEtMS02ODMxNg_681e318a-6853-48ab-9b40-a6f75af21701"
      unitRef="usd">7000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i44dd3ae16d4d45c8bb7f34c32c3afa5b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfOS03LTEtMS02ODMxNg_1363533b-5714-4beb-bd1b-318e1fef0134"
      unitRef="usd">2938000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="ia13be74212cd4cbdac029edf9dc0a7af_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfMTAtMS0xLTEtNjgzMTY_4341b131-64af-4d32-b59a-8009bc66ee75"
      unitRef="usd">18265000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ia13be74212cd4cbdac029edf9dc0a7af_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfMTAtMy0xLTEtNjgzMTY_823fece8-501e-4778-a993-d520c7371077"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ia13be74212cd4cbdac029edf9dc0a7af_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfMTAtNS0xLTEtNjgzMTY_583e0ee4-0e4b-480f-a35a-030360f8e463"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ia13be74212cd4cbdac029edf9dc0a7af_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfMTAtNy0xLTEtNjgzMTY_5aa3fa1d-ee9c-41f0-8530-cd25ab90f050"
      unitRef="usd">18265000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="i0f387eb12eb641d8acf7a18c1539123f_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfMTEtMS0xLTEtNzY0OTc_bed85484-e396-495b-a8f2-f542d6cd0c71"
      unitRef="usd">5820000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i0f387eb12eb641d8acf7a18c1539123f_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfMTEtMy0xLTEtNzY1MDQ_b7106117-55ed-4532-9864-b23d78e301ac"
      unitRef="usd">11000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i0f387eb12eb641d8acf7a18c1539123f_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfMTEtNS0xLTEtNzY1MTI_c8badb0d-793e-4acf-90ca-22af4802768d"
      unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i0f387eb12eb641d8acf7a18c1539123f_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfMTEtNy0xLTEtNzY1MTk_8cd14dfb-e665-40a7-82c9-61bd123511ab"
      unitRef="usd">5830000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfMTEtMS0xLTEtNjgzMTY_0c659509-5617-4e96-a232-2cb9b628f0b5"
      unitRef="usd">63008000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfMTEtMy0xLTEtNjgzMTY_67a30989-43a6-4fd3-b80e-ddf011d51252"
      unitRef="usd">18000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfMTEtNS0xLTEtNjgzMTY_e3e32550-75f6-47ae-bb07-206cc75a3e75"
      unitRef="usd">29000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfMTEtNy0xLTEtNjgzMTY_36532f56-8052-4745-b6d5-e737f19de915"
      unitRef="usd">62997000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <sibn:MarketableSecuritiesAmortizedCost
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfMTUtMS0xLTEtNjgzMTY_c90e6ec1-1d4f-47b7-b7a1-b084fb5046ec"
      unitRef="usd">78610000</sibn:MarketableSecuritiesAmortizedCost>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfMTUtMy0xLTEtNjgzMTY_f1ed1d8a-d42e-4c73-a8a3-79309774d8c3"
      unitRef="usd">18000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfMTUtNS0xLTEtNjgzMTY_65e1ae79-d2d2-480f-994e-f3956afa8019"
      unitRef="usd">29000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmNjMDM5NWIxYzhkOTQxYzBiMzRlZTM1YzI2ZWRiNDY2L3RhYmxlcmFuZ2U6Y2MwMzk1YjFjOGQ5NDFjMGIzNGVlMzVjMjZlZGI0NjZfMTUtNy0xLTEtNjgzMTY_0debcf1f-b8eb-4b6c-92c2-979770b0f1bc"
      unitRef="usd">78599000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="ib0cbf148284f4875b34513e22dea1727_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfMy0xLTEtMS02ODMxNg_c8a561cb-db30-4f10-9faa-2cb5dd85d77b"
      unitRef="usd">8002000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="ib0cbf148284f4875b34513e22dea1727_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfMy03LTEtMS02ODMxNg_1f0fa78c-c8e1-45e1-97e4-80dafd41a9df"
      unitRef="usd">8002000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfNS0xLTEtMS02ODMxNg_7be93a11-51b2-4a59-9e6e-f6aea08eedde"
      unitRef="usd">8002000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfNS03LTEtMS02ODMxNg_48c159af-a73b-425a-8fa6-e4cd57b05b60"
      unitRef="usd">8002000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="i8559cf2d961048048b5f1dcd580f39ee_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfNy0xLTEtMS02ODMxNg_e3f0e871-f0fe-4fad-acbf-785177c853f4"
      unitRef="usd">48636000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i8559cf2d961048048b5f1dcd580f39ee_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfNy0zLTEtMS02ODMxNg_78278715-8d63-48de-b8e9-69083148e5fd"
      unitRef="usd">4000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i8559cf2d961048048b5f1dcd580f39ee_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfNy01LTEtMS02ODMxNg_d1412a7f-db79-4f89-8005-1c3debfc5566"
      unitRef="usd">105000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i8559cf2d961048048b5f1dcd580f39ee_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfNy03LTEtMS02ODMxNg_264f3d8f-90c4-4762-95ba-00a13b133a65"
      unitRef="usd">48535000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="ib2d6675789b842e3bc0f882dee4352c3_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfOC0xLTEtMS03Mjg3NQ_9f3bbd79-aacb-4ad8-9f8f-5ae0d176721c"
      unitRef="usd">2918000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ib2d6675789b842e3bc0f882dee4352c3_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfOC0zLTEtMS03Mjg4Mw_9b41a286-ccf8-41ea-b50d-3fc23faca45f"
      unitRef="usd">3000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ib2d6675789b842e3bc0f882dee4352c3_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfOC01LTEtMS03Mjg5MA_beec5929-3410-4dde-a7a3-704024d2fe98"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ib2d6675789b842e3bc0f882dee4352c3_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfOC03LTEtMS03MzUxMg_182d5650-edb4-48e1-9fb6-3e598721f15c"
      unitRef="usd">2921000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="ib008684c4f9b4e4782d069220bea736d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfOC0xLTEtMS02ODMxNg_2e130ee1-6ae1-4f3a-95c5-487a447823fc"
      unitRef="usd">2914000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ib008684c4f9b4e4782d069220bea736d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfOC0zLTEtMS02ODMxNg_0e3995fb-4eed-4b86-b825-178ed96ef139"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ib008684c4f9b4e4782d069220bea736d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfOC01LTEtMS02ODMxNg_b2efc6ae-e798-45b2-9765-b5d06a6e03f7"
      unitRef="usd">3000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ib008684c4f9b4e4782d069220bea736d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfOC03LTEtMS02ODMxNg_ae98fa82-495f-41f4-ad8e-1adb261811a0"
      unitRef="usd">2911000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="ifdfec2a876ef4b7eb0d2a97b4c97ad16_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfOS0xLTEtMS02ODMxNg_4cd999da-94c6-4971-9de8-81e7621bac3a"
      unitRef="usd">22206000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ifdfec2a876ef4b7eb0d2a97b4c97ad16_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfOS0zLTEtMS02ODMxNg_dc20d3d1-bfea-441a-9a1d-41e7aff7f570"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ifdfec2a876ef4b7eb0d2a97b4c97ad16_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfOS01LTEtMS02ODMxNg_e4d12e99-b886-46a9-b0c3-b16fdae16194"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ifdfec2a876ef4b7eb0d2a97b4c97ad16_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfOS03LTEtMS02ODMxNg_947297ee-23af-4b9a-848d-bbe6a31132bd"
      unitRef="usd">22206000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfMTAtMS0xLTEtNjgzMTY_742682bd-ac19-4483-a7c7-b52a09604c0e"
      unitRef="usd">76674000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfMTAtMy0xLTEtNjgzMTY_04175ca1-57b1-4e69-a558-f8bf033e1cb2"
      unitRef="usd">7000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfMTAtNS0xLTEtNjgzMTY_09e74a5c-5d39-48ad-84ce-2a2ffe0bba38"
      unitRef="usd">108000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfMTAtNy0xLTEtNjgzMTY_09a1ebb8-ed14-4440-a4f5-59a0bbfdb5e6"
      unitRef="usd">76573000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <sibn:MarketableSecuritiesAmortizedCost
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfMTQtMS0xLTEtNjgzMTY_b3fb3fc5-b74a-4c9d-8dee-2dbb630e5629"
      unitRef="usd">84676000</sibn:MarketableSecuritiesAmortizedCost>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfMTQtMy0xLTEtNjgzMTY_825fff2e-5459-497d-adb1-aff5badd11b2"
      unitRef="usd">7000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfMTQtNS0xLTEtNjgzMTY_91a9c24a-ddcd-4d6b-b0d3-cdaba9e57f32"
      unitRef="usd">108000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RhYmxlOmQ3Y2RkZWJmYmUwMzQ5MDhhYzYyODZiNzE1NGIzZjk3L3RhYmxlcmFuZ2U6ZDdjZGRlYmZiZTAzNDkwOGFjNjI4NmI3MTU0YjNmOTdfMTQtNy0xLTEtNjgzMTY_2650619a-ff6c-491a-8ca1-3fd9ab034e34"
      unitRef="usd">84575000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RleHRyZWdpb246NjU3MWQxNzBhMzg2NDZmODg0YWExYmM3YWE1ZThiNmJfMTE3Ng_0c4d2210-5f12-45dc-96f8-904ddcb6931c"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RleHRyZWdpb246NjU3MWQxNzBhMzg2NDZmODg0YWExYmM3YWE1ZThiNmJfMTE3Ng_d6cbf766-0380-47f7-85fa-99ff44965bf4"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RleHRyZWdpb246NjU3MWQxNzBhMzg2NDZmODg0YWExYmM3YWE1ZThiNmJfMTYyMg_1d568e93-b0a9-453a-99ec-091e71f8ac6b"
      unitRef="usd">100000</us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestWriteoff
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RleHRyZWdpb246NjU3MWQxNzBhMzg2NDZmODg0YWExYmM3YWE1ZThiNmJfMTk3Ng_95b54ce0-8454-4e8d-a85c-9af201206e7d"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestWriteoff>
    <us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestWriteoff
      contextRef="ic260793641a14f2695a83d42d27f0e29_D20220101-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl8zNy9mcmFnOjY1NzFkMTcwYTM4NjQ2Zjg4NGFhMWJjN2FhNWU4YjZiL3RleHRyZWdpb246NjU3MWQxNzBhMzg2NDZmODg0YWExYmM3YWE1ZThiNmJfMTk3Ng_95bd4262-ff71-4ef6-ad63-db4551f5b93c"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestWriteoff>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RleHRyZWdpb246ODAyZTVhMmUyMmUyNDVkNzlkNjQ2NDE0NGQyNTQ5NGZfODA0_af0ca707-0aae-43af-aae9-cf576431686f">Fair Value Measurement&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Carrying amounts of certain of the Company&#x2019;s financial instruments, including cash equivalents, accounts receivable, accounts payable and accrued liabilities, approximate fair value due to their relatively short maturities and market interest rates, if applicable. The carrying value of the Company&#x2019;s long-term debt also approximates fair value based on management&#x2019;s estimation that a current interest rate would not differ materially from the stated rate. There were no other financial assets and liabilities that require fair value hierarchy measurements and disclosures for the periods presented. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the fair value of the Company&#x2019;s marketable securities measured at fair value on a recurring basis based on the three-tier fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.888%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.775%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. agency bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:17pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:20.25pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. agency bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RleHRyZWdpb246ODAyZTVhMmUyMmUyNDVkNzlkNjQ2NDE0NGQyNTQ5NGZfODA1_674cb34c-b8a2-4c18-b2b9-95b989493999">&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the fair value of the Company&#x2019;s marketable securities measured at fair value on a recurring basis based on the three-tier fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.888%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.775%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. agency bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:17pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:20.25pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. agency bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i93f63117979e431d8fafecd7bb59dfac_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfNC0xLTEtMS02ODMxNg_42128dad-2fac-48af-9c68-9d695c4afda6"
      unitRef="usd">15602000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ie7af7e18c08648e8a31cfe8e93a21d37_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfNC0zLTEtMS02ODMxNg_943d2687-512d-4a45-8d61-428c11ef4105"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="if55d28f6c32e42e4a57e446914b3a62c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfNC01LTEtMS02ODMxNg_760a9e52-3833-49c9-a0b5-d25b85459e9c"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i412cc8ac40b4449d8130d9a574e1630c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfNC03LTEtMS02ODMxNg_4ac75fe3-186b-4cf2-9182-b88495d2a207"
      unitRef="usd">15602000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i70c37c2527cc48178344c05517b09dbd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfNS0xLTEtMS02ODMxNg_c90a40f8-7313-4dc9-b340-096370986d1d"
      unitRef="usd">35964000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i05b7a065321d4879b2ff02286b48fe5d_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfNS0zLTEtMS02ODMxNg_60be0c3e-836b-47c0-bd22-730607fddc57"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i6e5ed5afd4274c968b88749c12c77e79_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfNS01LTEtMS02ODMxNg_015a622c-dc7f-4e99-9b38-2bec391927fe"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i8ad3e05b47f148779fa5695c98e40dcf_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfNS03LTEtMS02ODMxNg_a86f4219-45d3-456e-8857-9e0920027ee8"
      unitRef="usd">35964000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i0c92d73d84f74de3a6513213ff796c66_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfNi0xLTEtMS02ODMxNg_06093f00-0bf2-404c-9f14-35e19b51cc2f"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i0cfde19be5044c3fb1effae06f724c64_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfNi0zLTEtMS02ODMxNg_a42bf910-9361-40b6-85ba-fedb04340954"
      unitRef="usd">2938000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ic660e995acfe4b2a9f4faedc08362fa8_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfNi01LTEtMS02ODMxNg_be788c12-727a-4687-948e-0243c7a6ef97"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="idb816e01e7874d0a96715509b31cb35a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfNi03LTEtMS02ODMxNg_0c687d18-9856-4926-a80e-cc9cd9cc04d1"
      unitRef="usd">2938000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i7c6fdeac85ad413ca0c0dedf070a75fe_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfNy0xLTEtMS03NjY1Mg_cf3e04dd-cd83-4548-af70-e2c5bad419ab"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i3a100bced9af4ad5bd35f338bc5a32f8_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfNy0zLTEtMS03NjY1OA_fe98ffe2-babb-4f4e-b12d-6baa9b2a03ac"
      unitRef="usd">5830000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="idbcaeebb6db24dffb245482694bd9c7a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfNy01LTEtMS03NjY2MQ_65634cd1-0f6c-429e-9305-5b36303c9ff6"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i402c694c2fe74b3ca22ce9842744aa6d_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfNy03LTEtMS03NjY2NA_542cd3bd-7d19-4397-b041-91a962d836fd"
      unitRef="usd">5830000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ie4f6a87d519949ebb36b48d5adde8532_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfNy0xLTEtMS02ODMxNg_1fb19a7b-59c7-4c53-8b93-ef940d502fa8"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ibcc50bab28c64661b1b3e2f3166b18ac_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfNy0zLTEtMS02ODMxNg_9a275b71-ce6a-49c9-a657-8b06c58b73c4"
      unitRef="usd">18265000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i127926870dbf443f939ff61f15decebe_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfNy01LTEtMS02ODMxNg_979df010-8841-4a02-a2b4-dd909b88e2e5"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i165bfa53062b4b66b55877948006f464_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfNy03LTEtMS02ODMxNg_bdaba7dc-3328-4246-8173-6c0846f73b0d"
      unitRef="usd">18265000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i599fe7f797b64b16986fe58ad0b1dea9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfOC0xLTEtMS02ODMxNg_36f11580-f24f-4c74-99bf-2d3a1f670bf0"
      unitRef="usd">51566000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i18026ebb41a3463a83e4df8c40ad564c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfOC0zLTEtMS02ODMxNg_5237f28d-a77e-4e8c-86a0-7ef44f00d37a"
      unitRef="usd">27033000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i3a9913b7b1e5449cb00f06f2ff1eb7b7_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfOC01LTEtMS02ODMxNg_b0bf1d77-5348-4cf1-8c12-40f484fd95d9"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i2d0dee683e5841eb84e260a32f3255fe_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfOC03LTEtMS02ODMxNg_e5556894-db7d-44a0-bb67-57787034bc57"
      unitRef="usd">78599000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i0d93d5c546664a5d81e0bd4ff383fd5e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfMTQtMS0xLTEtNjgzMTY_fc4b5074-7d76-472d-98a8-7e55da3566fd"
      unitRef="usd">8002000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i593bc48b8f4243ddb04b45abc6ea214d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfMTQtMy0xLTEtNjgzMTY_3a7ed1c0-e563-469e-8630-88a64e46fe3b"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ib2a471609df94d37a930d6f5d6e15098_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfMTQtNS0xLTEtNjgzMTY_7959a18d-6dfc-48ad-bb20-5b13ded86363"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i5a286c1bf0564b09a30caa94533124d2_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfMTQtNy0xLTEtNjgzMTY_1dd05afa-49d7-4505-bf17-119583e2ece8"
      unitRef="usd">8002000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i1c06318063df438297ac590b6ad0fc1d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfMTUtMS0xLTEtNjgzMTY_2402b7f8-65c5-40ca-ba3c-bca7d7a4618d"
      unitRef="usd">48535000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i02f410de75d14cdeaee8f125e8343cbd_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfMTUtMy0xLTEtNjgzMTY_5926c1d8-bc47-48cd-8a8a-8a0f8bbdeedd"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i2648a4f0afd74ba895a75a8524bd2b05_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfMTUtNS0xLTEtNjgzMTY_745d8d26-0d07-4e89-8174-6de51d912986"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ia89f5e43abc74a268ac2cf0241b3f413_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfMTUtNy0xLTEtNjgzMTY_fb6e4bd6-4659-4215-b3b9-e0ff411248e2"
      unitRef="usd">48535000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ic3ad078aff0542a4a095dda948ebfa96_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfMTYtMS0xLTEtNzI5OTk_fc4e6027-8b0a-4544-90aa-70995b9dcebd"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="idf18e06ec7af4f8894d706876e2614db_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfMTYtMy0xLTEtNzMwMDc_dab73579-5be3-4d5d-a55e-cb31b42fa3bf"
      unitRef="usd">2921000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ic8afde8ae10a47ca88a2373bafb3dfac_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfMTYtNS0xLTEtNzMwMjI_156e8d28-3393-4b57-b76e-cb489388c777"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i3f7ab8e31a7c40be87fc6165468887e2_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfMTYtNy0xLTEtNzMwMzY_ce2f7a79-f348-4cae-994f-c2dde054ebf7"
      unitRef="usd">2921000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i9c0adbda751147eea7396bd575122c5e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfMTYtMS0xLTEtNjgzMTY_6bb51a64-9086-4284-acd8-85d8cb8c10ff"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i386cd3185459468682f42288ddfd4237_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfMTYtMy0xLTEtNjgzMTY_baae9988-504e-426a-afe2-109cc898e90f"
      unitRef="usd">2911000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="if245b8c2654f417395c08edfa479ab82_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfMTYtNS0xLTEtNjgzMTY_128caad0-28c5-4ec9-8326-af0e8131993b"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i6d1b210afd954f47bea17adf2f027ac5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfMTYtNy0xLTEtNjgzMTY_64d54764-bd62-4176-9e52-4c1f5542b0e9"
      unitRef="usd">2911000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="id88038b7e8b941bc8a88b3faa056a48f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfMTctMS0xLTEtNjgzMTY_53f78d8e-dcbf-4a19-838c-076277772d55"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i59372acb82174f63bc0cbb959bab7cb7_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfMTctMy0xLTEtNjgzMTY_5a02c3db-95d4-4dee-aed7-ee22c0144c77"
      unitRef="usd">22206000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i0994310adbdc4a3fb6f259424a3dda9b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfMTctNS0xLTEtNjgzMTY_b9d27be8-5ac0-40cb-9da7-64b0081282e7"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i7a30c099351643919a25ea1474e284b5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfMTctNy0xLTEtNjgzMTY_ab297aca-5fe9-48c4-83df-e9824e981fd9"
      unitRef="usd">22206000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i7b6ddb9d49374251b145ed8c06d3ea23_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfMTgtMS0xLTEtNjgzMTY_df2d81da-1ea2-4208-bbde-b8414423fa12"
      unitRef="usd">56537000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i1b54f88e74024fb4a2091106b2085b42_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfMTgtMy0xLTEtNjgzMTY_ea11cc1a-9558-441b-b05c-e84b524ad0b5"
      unitRef="usd">28038000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ib87aa61e8c5640999864db57e9a5de97_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfMTgtNS0xLTEtNjgzMTY_85a9f726-32a5-490a-b914-2e022567229a"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i238fa20d4bac4223a52c0c5dd3a10b39_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80MC9mcmFnOjgwMmU1YTJlMjJlMjQ1ZDc5ZDY0NjQxNDRkMjU0OTRmL3RhYmxlOjAwNDEzOTRmZWI2ZTQyZDI4YjUyYjViM2MzYzczZTMwL3RhYmxlcmFuZ2U6MDA0MTM5NGZlYjZlNDJkMjhiNTJiNWIzYzNjNzNlMzBfMTgtNy0xLTEtNjgzMTY_64cecdc8-97ec-49bb-875e-e5b7ef6824cb"
      unitRef="usd">84575000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RleHRyZWdpb246NThjZmNhNzJmMzk5NGQ5NWJkYjAxNGIyNzgyMWY1ZmRfNzk5_6f1de833-6a1c-4a29-8d83-9b70d25a5d29">Balance Sheet Components&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventory&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March 31, 2023, inventory consisted of finished goods of $16.3&#160;million and work-in-progress of $1.5&#160;million. As of December 31, 2022,  inventory consisted of finished goods of $15.6&#160;million and work-in-progress and components of $1.7&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:12pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and Equipment, net:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:12pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.916%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.697%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer and office equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Accumulated depreciation and amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,283)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,207)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March 31, 2023, construction in progress pertains to the cost of individual components of a custom instrument set used for surgical placement of the Company's products that have not yet been placed into service of $4.0 million and construction costs related to the Company's lease for research and development and warehouse space in Santa Clara and software costs of $3.7 million. Depreciation expense was $1.1 million and $0.7 million for the three months ended March 31, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:12pt;text-indent:24.75pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accrued Liabilities and Other&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:12pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.916%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.697%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation and related expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued royalty&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Accrued professional services &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Others&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;        Accounts Receivable and Allowance for Credit Losses:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The movement in the allowance for credit losses was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.916%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.697%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <us-gaap:InventoryFinishedGoods
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RleHRyZWdpb246NThjZmNhNzJmMzk5NGQ5NWJkYjAxNGIyNzgyMWY1ZmRfOTQ_b627b33a-f1a5-4012-b798-122214e48bdc"
      unitRef="usd">16300000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryWorkInProcess
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RleHRyZWdpb246NThjZmNhNzJmMzk5NGQ5NWJkYjAxNGIyNzgyMWY1ZmRfMTIx_5c8319b1-22aa-497e-91a1-9882441238ed"
      unitRef="usd">1500000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryFinishedGoods
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RleHRyZWdpb246NThjZmNhNzJmMzk5NGQ5NWJkYjAxNGIyNzgyMWY1ZmRfNTQ5NzU1ODE0OTA2_12814891-fe1c-46b8-9962-da8ccfcc77a9"
      unitRef="usd">15600000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryWorkInProcess
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RleHRyZWdpb246NThjZmNhNzJmMzk5NGQ5NWJkYjAxNGIyNzgyMWY1ZmRfNTQ5NzU1ODE0OTIx_4bfdb5cd-95e5-427c-a73b-05c4a4f277dc"
      unitRef="usd">1700000</us-gaap:InventoryWorkInProcess>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RleHRyZWdpb246NThjZmNhNzJmMzk5NGQ5NWJkYjAxNGIyNzgyMWY1ZmRfODAw_31ab423f-27db-4361-9abf-f82651328eef">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and Equipment, net:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.916%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.697%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer and office equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Accumulated depreciation and amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,283)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,207)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i1e71d795db204f3b8f094023c24425b3_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmI2ZjQ0YjVkNDhjNDRmNzBiNDQ5YmM5ZTVkZGQ2ZDhmL3RhYmxlcmFuZ2U6YjZmNDRiNWQ0OGM0NGY3MGI0NDliYzllNWRkZDZkOGZfMi0xLTEtMS02ODMxNg_b2380bbb-0c3d-4d36-a566-09410f062189"
      unitRef="usd">17070000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="iee9e604e937b47a2a28b7c87d255fe22_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmI2ZjQ0YjVkNDhjNDRmNzBiNDQ5YmM5ZTVkZGQ2ZDhmL3RhYmxlcmFuZ2U6YjZmNDRiNWQ0OGM0NGY3MGI0NDliYzllNWRkZDZkOGZfMi0zLTEtMS02ODMxNg_5c0614b8-2cc0-47fd-8fa8-e5ed8beab124"
      unitRef="usd">14920000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i8ca79707ebe549c1bb352a2ebd78915f_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmI2ZjQ0YjVkNDhjNDRmNzBiNDQ5YmM5ZTVkZGQ2ZDhmL3RhYmxlcmFuZ2U6YjZmNDRiNWQ0OGM0NGY3MGI0NDliYzllNWRkZDZkOGZfMy0xLTEtMS02ODMxNg_f0eba209-e021-4699-8262-3c33000ab0d1"
      unitRef="usd">7682000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i20591f6aa1e240348d149ac3850df479_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmI2ZjQ0YjVkNDhjNDRmNzBiNDQ5YmM5ZTVkZGQ2ZDhmL3RhYmxlcmFuZ2U6YjZmNDRiNWQ0OGM0NGY3MGI0NDliYzllNWRkZDZkOGZfMy0zLTEtMS02ODMxNg_b34d1037-a901-40da-963c-1647050c2dad"
      unitRef="usd">7854000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i95acc83c9a7845c6a6530d0b489719b9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmI2ZjQ0YjVkNDhjNDRmNzBiNDQ5YmM5ZTVkZGQ2ZDhmL3RhYmxlcmFuZ2U6YjZmNDRiNWQ0OGM0NGY3MGI0NDliYzllNWRkZDZkOGZfNC0xLTEtMS02ODMxNg_7c8d6bfb-24b0-4917-a318-aadc87e69e39"
      unitRef="usd">1139000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i9201dd932d9848bdbbe7c5a345ef8038_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmI2ZjQ0YjVkNDhjNDRmNzBiNDQ5YmM5ZTVkZGQ2ZDhmL3RhYmxlcmFuZ2U6YjZmNDRiNWQ0OGM0NGY3MGI0NDliYzllNWRkZDZkOGZfNC0zLTEtMS02ODMxNg_35246d50-fca4-431c-831c-d23c955acdb9"
      unitRef="usd">976000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="if93177d48de1415e9f17d96b9723fe38_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmI2ZjQ0YjVkNDhjNDRmNzBiNDQ5YmM5ZTVkZGQ2ZDhmL3RhYmxlcmFuZ2U6YjZmNDRiNWQ0OGM0NGY3MGI0NDliYzllNWRkZDZkOGZfNS0xLTEtMS02ODMxNg_514a951b-c0c8-4dda-9af2-a7c25ec95c22"
      unitRef="usd">1631000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i9a70cc88c75d4e89898c6b1352acaacc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmI2ZjQ0YjVkNDhjNDRmNzBiNDQ5YmM5ZTVkZGQ2ZDhmL3RhYmxlcmFuZ2U6YjZmNDRiNWQ0OGM0NGY3MGI0NDliYzllNWRkZDZkOGZfNS0zLTEtMS02ODMxNg_e6beb51a-f750-4b69-98e1-c71b528a4e75"
      unitRef="usd">1631000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i4ab4226e44904229bd0ee82536c2fdcd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmI2ZjQ0YjVkNDhjNDRmNzBiNDQ5YmM5ZTVkZGQ2ZDhmL3RhYmxlcmFuZ2U6YjZmNDRiNWQ0OGM0NGY3MGI0NDliYzllNWRkZDZkOGZfNi0xLTEtMS02ODMxNg_f6f8bc14-1868-4c5f-8185-d1f58e747180"
      unitRef="usd">390000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i1ef76ab501ca47529edb5647153de4b2_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmI2ZjQ0YjVkNDhjNDRmNzBiNDQ5YmM5ZTVkZGQ2ZDhmL3RhYmxlcmFuZ2U6YjZmNDRiNWQ0OGM0NGY3MGI0NDliYzllNWRkZDZkOGZfNi0zLTEtMS02ODMxNg_c78c614b-eeac-4aa6-bc0b-a9815b34612c"
      unitRef="usd">390000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmI2ZjQ0YjVkNDhjNDRmNzBiNDQ5YmM5ZTVkZGQ2ZDhmL3RhYmxlcmFuZ2U6YjZmNDRiNWQ0OGM0NGY3MGI0NDliYzllNWRkZDZkOGZfNy0xLTEtMS02ODMxNg_cfaabbb4-9522-48c5-91d5-52304d29a9ea"
      unitRef="usd">27912000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmI2ZjQ0YjVkNDhjNDRmNzBiNDQ5YmM5ZTVkZGQ2ZDhmL3RhYmxlcmFuZ2U6YjZmNDRiNWQ0OGM0NGY3MGI0NDliYzllNWRkZDZkOGZfNy0zLTEtMS02ODMxNg_c695f151-e584-45a1-94af-ecbd6e3c952e"
      unitRef="usd">25771000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmI2ZjQ0YjVkNDhjNDRmNzBiNDQ5YmM5ZTVkZGQ2ZDhmL3RhYmxlcmFuZ2U6YjZmNDRiNWQ0OGM0NGY3MGI0NDliYzllNWRkZDZkOGZfOC0xLTEtMS02ODMxNg_5039b973-1340-4c25-9a3b-94ef46f923de"
      unitRef="usd">11283000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmI2ZjQ0YjVkNDhjNDRmNzBiNDQ5YmM5ZTVkZGQ2ZDhmL3RhYmxlcmFuZ2U6YjZmNDRiNWQ0OGM0NGY3MGI0NDliYzllNWRkZDZkOGZfOC0zLTEtMS02ODMxNg_87878a74-a11b-4b2e-82ee-476d0983dcfb"
      unitRef="usd">10207000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmI2ZjQ0YjVkNDhjNDRmNzBiNDQ5YmM5ZTVkZGQ2ZDhmL3RhYmxlcmFuZ2U6YjZmNDRiNWQ0OGM0NGY3MGI0NDliYzllNWRkZDZkOGZfOS0xLTEtMS02ODMxNg_8de07f30-6423-4877-b326-1dd6349b4c66"
      unitRef="usd">16629000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmI2ZjQ0YjVkNDhjNDRmNzBiNDQ5YmM5ZTVkZGQ2ZDhmL3RhYmxlcmFuZ2U6YjZmNDRiNWQ0OGM0NGY3MGI0NDliYzllNWRkZDZkOGZfOS0zLTEtMS02ODMxNg_b9a91b62-d3be-4b9a-b8f6-9de989f4c1b1"
      unitRef="usd">15564000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="if3464bbb971c4eefb3b4e6d7ae410bb8_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RleHRyZWdpb246NThjZmNhNzJmMzk5NGQ5NWJkYjAxNGIyNzgyMWY1ZmRfNDE3_eaa1676a-c424-4390-8dcd-08c7edb1fe26"
      unitRef="usd">4000000.0</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i368a721c855a4a1190ec9dcdc696598a_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RleHRyZWdpb246NThjZmNhNzJmMzk5NGQ5NWJkYjAxNGIyNzgyMWY1ZmRfNTEz_d0926211-95e3-4314-a7ca-9ea443bee339"
      unitRef="usd">3700000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:Depreciation
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RleHRyZWdpb246NThjZmNhNzJmMzk5NGQ5NWJkYjAxNGIyNzgyMWY1ZmRfMTA5OTUxMTYyODczOQ_88dceaf6-7c71-4cb7-b9ed-cfc299bd469f"
      unitRef="usd">1100000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RleHRyZWdpb246NThjZmNhNzJmMzk5NGQ5NWJkYjAxNGIyNzgyMWY1ZmRfMTA5OTUxMTYyODczMA_48a77428-60a1-4f5a-9481-6f3d04563a73"
      unitRef="usd">700000</us-gaap:Depreciation>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RleHRyZWdpb246NThjZmNhNzJmMzk5NGQ5NWJkYjAxNGIyNzgyMWY1ZmRfNzk3_effed613-03ad-43d6-bfa9-9c2d3f341c39">&lt;div style="margin-bottom:9pt;margin-top:12pt;text-indent:24.75pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accrued Liabilities and Other&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:12pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.916%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.697%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation and related expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued royalty&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Accrued professional services &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Others&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmJjYjZjNWYyODljNTQ5ODU4NmQyNWU2YTgwNGY2NGQ5L3RhYmxlcmFuZ2U6YmNiNmM1ZjI4OWM1NDk4NTg2ZDI1ZTZhODA0ZjY0ZDlfMi0xLTEtMS02ODMxNg_9d70bcfc-4f0a-47e9-becb-735e268b7b73"
      unitRef="usd">7487000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmJjYjZjNWYyODljNTQ5ODU4NmQyNWU2YTgwNGY2NGQ5L3RhYmxlcmFuZ2U6YmNiNmM1ZjI4OWM1NDk4NTg2ZDI1ZTZhODA0ZjY0ZDlfMi0zLTEtMS02ODMxNg_fb9c4802-e6ba-47c9-b912-f981f29c8698"
      unitRef="usd">11365000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmJjYjZjNWYyODljNTQ5ODU4NmQyNWU2YTgwNGY2NGQ5L3RhYmxlcmFuZ2U6YmNiNmM1ZjI4OWM1NDk4NTg2ZDI1ZTZhODA0ZjY0ZDlfNC0xLTEtMS03NjgxMQ_2295bc35-f641-47ee-9e25-9a236acea697"
      unitRef="usd">996000</us-gaap:AccruedRoyaltiesCurrent>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmJjYjZjNWYyODljNTQ5ODU4NmQyNWU2YTgwNGY2NGQ5L3RhYmxlcmFuZ2U6YmNiNmM1ZjI4OWM1NDk4NTg2ZDI1ZTZhODA0ZjY0ZDlfNC0zLTEtMS03NjgxOA_edf931e1-9781-4fe2-ade4-5269e71d84b3"
      unitRef="usd">818000</us-gaap:AccruedRoyaltiesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmJjYjZjNWYyODljNTQ5ODU4NmQyNWU2YTgwNGY2NGQ5L3RhYmxlcmFuZ2U6YmNiNmM1ZjI4OWM1NDk4NTg2ZDI1ZTZhODA0ZjY0ZDlfNC0xLTEtMS02ODMxNg_f47291f0-42e1-470d-8234-d42cff89ab31"
      unitRef="usd">652000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmJjYjZjNWYyODljNTQ5ODU4NmQyNWU2YTgwNGY2NGQ5L3RhYmxlcmFuZ2U6YmNiNmM1ZjI4OWM1NDk4NTg2ZDI1ZTZhODA0ZjY0ZDlfNC0zLTEtMS02ODMxNg_f93d3af1-7b96-4ecc-9574-341b4ad5511b"
      unitRef="usd">355000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmJjYjZjNWYyODljNTQ5ODU4NmQyNWU2YTgwNGY2NGQ5L3RhYmxlcmFuZ2U6YmNiNmM1ZjI4OWM1NDk4NTg2ZDI1ZTZhODA0ZjY0ZDlfNi0xLTEtMS02ODMxNg_01c43c2e-2d1b-4bfa-8144-a4692c5c3b37"
      unitRef="usd">761000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmJjYjZjNWYyODljNTQ5ODU4NmQyNWU2YTgwNGY2NGQ5L3RhYmxlcmFuZ2U6YmNiNmM1ZjI4OWM1NDk4NTg2ZDI1ZTZhODA0ZjY0ZDlfNi0zLTEtMS02ODMxNg_934978ce-bd75-41c4-b700-e2a960da1887"
      unitRef="usd">973000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmJjYjZjNWYyODljNTQ5ODU4NmQyNWU2YTgwNGY2NGQ5L3RhYmxlcmFuZ2U6YmNiNmM1ZjI4OWM1NDk4NTg2ZDI1ZTZhODA0ZjY0ZDlfNy0xLTEtMS02ODMxNg_64d6899a-5367-4a65-8cc6-177bc2162fad"
      unitRef="usd">9896000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOmJjYjZjNWYyODljNTQ5ODU4NmQyNWU2YTgwNGY2NGQ5L3RhYmxlcmFuZ2U6YmNiNmM1ZjI4OWM1NDk4NTg2ZDI1ZTZhODA0ZjY0ZDlfNy0zLTEtMS02ODMxNg_a63ee103-7fde-45e4-86d2-0895782d0677"
      unitRef="usd">13511000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RleHRyZWdpb246NThjZmNhNzJmMzk5NGQ5NWJkYjAxNGIyNzgyMWY1ZmRfNzk4_c78258f4-dc55-424e-9591-690a0df70599">&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The movement in the allowance for credit losses was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.916%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.697%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOjUyMjI4YzE2MTI5MjQwMjViMmVmOTU3ZjQ4ZGRmNjg4L3RhYmxlcmFuZ2U6NTIyMjhjMTYxMjkyNDAyNWIyZWY5NTdmNDhkZGY2ODhfMi0xLTEtMS02ODMxNg_a2d419c1-66c8-4916-b98b-ddae14c84f06"
      unitRef="usd">400000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i25ff20079ccb48899ea84d72b50e16e7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOjUyMjI4YzE2MTI5MjQwMjViMmVmOTU3ZjQ4ZGRmNjg4L3RhYmxlcmFuZ2U6NTIyMjhjMTYxMjkyNDAyNWIyZWY5NTdmNDhkZGY2ODhfMi0zLTEtMS02ODMxNg_919c8edc-d574-4eb4-a446-de8e8e87604b"
      unitRef="usd">264000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOjUyMjI4YzE2MTI5MjQwMjViMmVmOTU3ZjQ4ZGRmNjg4L3RhYmxlcmFuZ2U6NTIyMjhjMTYxMjkyNDAyNWIyZWY5NTdmNDhkZGY2ODhfMy0xLTEtMS02ODMxNg_7fab38a0-3fda-4437-ac2e-88a32836c76a"
      unitRef="usd">50000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="ic260793641a14f2695a83d42d27f0e29_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOjUyMjI4YzE2MTI5MjQwMjViMmVmOTU3ZjQ4ZGRmNjg4L3RhYmxlcmFuZ2U6NTIyMjhjMTYxMjkyNDAyNWIyZWY5NTdmNDhkZGY2ODhfMy0zLTEtMS02ODMxNg_ccd55c25-0f94-45f5-8a7f-981ee74b8640"
      unitRef="usd">150000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOjUyMjI4YzE2MTI5MjQwMjViMmVmOTU3ZjQ4ZGRmNjg4L3RhYmxlcmFuZ2U6NTIyMjhjMTYxMjkyNDAyNWIyZWY5NTdmNDhkZGY2ODhfNC0xLTEtMS02ODMxNg_0557ac33-9996-4e97-8fc4-291ba87ad72a"
      unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="ic260793641a14f2695a83d42d27f0e29_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOjUyMjI4YzE2MTI5MjQwMjViMmVmOTU3ZjQ4ZGRmNjg4L3RhYmxlcmFuZ2U6NTIyMjhjMTYxMjkyNDAyNWIyZWY5NTdmNDhkZGY2ODhfNC0zLTEtMS02ODMxNg_522e2979-24f0-43ce-a952-be1e01ef1eea"
      unitRef="usd">14000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOjUyMjI4YzE2MTI5MjQwMjViMmVmOTU3ZjQ4ZGRmNjg4L3RhYmxlcmFuZ2U6NTIyMjhjMTYxMjkyNDAyNWIyZWY5NTdmNDhkZGY2ODhfNS0xLTEtMS02ODMxNg_7f5ada53-437a-4cbc-ae50-abfb0ed56531"
      unitRef="usd">450000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80My9mcmFnOjU4Y2ZjYTcyZjM5OTRkOTViZGIwMTRiMjc4MjFmNWZkL3RhYmxlOjUyMjI4YzE2MTI5MjQwMjViMmVmOTU3ZjQ4ZGRmNjg4L3RhYmxlcmFuZ2U6NTIyMjhjMTYxMjkyNDAyNWIyZWY5NTdmNDhkZGY2ODhfNS0zLTEtMS02ODMxNg_fa5116e1-70bf-4c58-a323-ec215481e8a4"
      unitRef="usd">400000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RleHRyZWdpb246YjEzZTdjNDg3MjczNDdhN2I3MjgyZmJjNjFlOGY0ZThfMzE2Nw_2e5a732a-01dc-4a64-91ff-3f1e92f3fcf8">Commitments and Contingencies&lt;div style="margin-top:9pt;padding-left:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a non-cancelable operating lease for an office building space, located in Santa Clara, California which expires in May 2025 and a building used for research and development and warehouse space in Santa Clara, California which expires in &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;October 2026. The Company also has non-cancelable operating leases for its office building spaces in Gallarate, Italy and Knaresborough, United Kingdom, which expire in August 2027 and December 2025, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company also leases vehicles under operating lease arrangements for certain of its personnel in Europe which expire at various times throughout 2023 to 2027.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental information related to lease expense and valuation of the lease assets and lease liabilit&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ies are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:60.833%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.662%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.311%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.764%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Operating lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;409&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Variable lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;513&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Cash paid for amounts included in the measurement of operating lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Leased assets obtained in exchange for new operating lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Weighted average remaining lease term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.83&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.05&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.77%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.77%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments under non-cancelable operating leases as of March 31, 2023 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.044%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.756%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-right:4.5pt;text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(330)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March 31, 2023, the Company had no operating lease liabilities that had not commenced.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;padding-left:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Purchase Commitments and Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has certain purchase commitments related to its inventory management with certain manufacturing suppliers wherein the Company is required to purchase the amounts forecasted in a blanket purchase order. The contractual obligations represent future cash commitments and liabilities under agreements with third parties and exclude orders for goods and services entered into in the normal course of business that are not enforceable or legally binding. These outstanding commitments amounted to $1.8 million and $0.8 million as of March 31, 2023 and December 31, 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Indemnification&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company enters into standard indemnification arrangements in the ordinary course of business. Pursuant to these arrangements, the Company indemnifies, holds harmless, and agrees to reimburse the indemnified parties for losses suffered or incurred by the indemnified party, in connection with any trade secret, copyright, patent or other intellectual property infringement claim by any third-party with respect to the Company&#x2019;s technology. The term of these indemnification agreements is generally perpetual. The maximum potential amount of future payments the Company could be required to make under these agreements is not determinable because it involves claims that may be made against the Company in the future, but have not yet been made.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has entered into indemnification agreements with its directors and officers that may require the Company to indemnify its directors and officers against liabilities that may arise by reason of their status or service as directors or officers, other than liabilities arising from willful misconduct of the individual.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has not incurred costs to defend lawsuits or settle claims related to these indemnification agreements. No liability associated with such indemnifications has been recorded to date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Legal Contingencies&lt;/span&gt;&lt;/div&gt;From time to time, the Company may become involved in legal proceedings arising in the ordinary course of its business. The Company is not presently a party to any material legal proceedings that, if determined adversely to the Company, would have a material adverse effect on the Company.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RleHRyZWdpb246YjEzZTdjNDg3MjczNDdhN2I3MjgyZmJjNjFlOGY0ZThfMzE2OA_502d5c3c-e8b9-4366-8214-48384cc1aa4f">&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental information related to lease expense and valuation of the lease assets and lease liabilit&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ies are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:60.833%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.662%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.311%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.764%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Operating lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;409&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Variable lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;513&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Cash paid for amounts included in the measurement of operating lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Leased assets obtained in exchange for new operating lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Weighted average remaining lease term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.83&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.05&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.77%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.77%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RhYmxlOjI3YmY3MzkxYjk3NjQwOWRhYTA4MDlhZTRhZTdiNzFmL3RhYmxlcmFuZ2U6MjdiZjczOTFiOTc2NDA5ZGFhMDgwOWFlNGFlN2I3MWZfMi0xLTEtMS02ODMxNg_aaddb893-6815-430e-8630-294c92251620"
      unitRef="usd">394000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RhYmxlOjI3YmY3MzkxYjk3NjQwOWRhYTA4MDlhZTRhZTdiNzFmL3RhYmxlcmFuZ2U6MjdiZjczOTFiOTc2NDA5ZGFhMDgwOWFlNGFlN2I3MWZfMi0zLTEtMS02ODMxNg_893d59e0-0a9a-42ca-afd2-00f24827a401"
      unitRef="usd">409000</us-gaap:OperatingLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RhYmxlOjI3YmY3MzkxYjk3NjQwOWRhYTA4MDlhZTRhZTdiNzFmL3RhYmxlcmFuZ2U6MjdiZjczOTFiOTc2NDA5ZGFhMDgwOWFlNGFlN2I3MWZfMy0xLTEtMS02ODMxNg_ccd18e87-3055-454f-9649-3455ffe11a43"
      unitRef="usd">76000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RhYmxlOjI3YmY3MzkxYjk3NjQwOWRhYTA4MDlhZTRhZTdiNzFmL3RhYmxlcmFuZ2U6MjdiZjczOTFiOTc2NDA5ZGFhMDgwOWFlNGFlN2I3MWZfMy0zLTEtMS02ODMxNg_5b81dd7b-ce80-4888-a4c7-02e412a0fefd"
      unitRef="usd">104000</us-gaap:VariableLeaseCost>
    <us-gaap:LeaseCost
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RhYmxlOjI3YmY3MzkxYjk3NjQwOWRhYTA4MDlhZTRhZTdiNzFmL3RhYmxlcmFuZ2U6MjdiZjczOTFiOTc2NDA5ZGFhMDgwOWFlNGFlN2I3MWZfNC0xLTEtMS02ODMxNg_d2130155-5fb2-4c23-9b16-54077f9ee9e1"
      unitRef="usd">470000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RhYmxlOjI3YmY3MzkxYjk3NjQwOWRhYTA4MDlhZTRhZTdiNzFmL3RhYmxlcmFuZ2U6MjdiZjczOTFiOTc2NDA5ZGFhMDgwOWFlNGFlN2I3MWZfNC0zLTEtMS02ODMxNg_142170c5-af16-42d6-ada9-7cddc6836914"
      unitRef="usd">513000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RhYmxlOjI3YmY3MzkxYjk3NjQwOWRhYTA4MDlhZTRhZTdiNzFmL3RhYmxlcmFuZ2U6MjdiZjczOTFiOTc2NDA5ZGFhMDgwOWFlNGFlN2I3MWZfNi0xLTEtMS02ODMxNg_2ee8d62c-38cb-44b6-bf85-343f9aa4af0f"
      unitRef="usd">398000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RhYmxlOjI3YmY3MzkxYjk3NjQwOWRhYTA4MDlhZTRhZTdiNzFmL3RhYmxlcmFuZ2U6MjdiZjczOTFiOTc2NDA5ZGFhMDgwOWFlNGFlN2I3MWZfNi0zLTEtMS02ODMxNg_30ab6905-8e48-430a-afd8-9a9026a5c73c"
      unitRef="usd">408000</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RhYmxlOjI3YmY3MzkxYjk3NjQwOWRhYTA4MDlhZTRhZTdiNzFmL3RhYmxlcmFuZ2U6MjdiZjczOTFiOTc2NDA5ZGFhMDgwOWFlNGFlN2I3MWZfNy0xLTEtMS02ODMxNg_a9976fca-7fa4-41c3-a647-418ae2e2a9a2"
      unitRef="usd">21000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RhYmxlOjI3YmY3MzkxYjk3NjQwOWRhYTA4MDlhZTRhZTdiNzFmL3RhYmxlcmFuZ2U6MjdiZjczOTFiOTc2NDA5ZGFhMDgwOWFlNGFlN2I3MWZfNy0zLTEtMS02ODMxNg_7265b068-9e47-4d44-822f-129bcc08f8d7"
      unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RhYmxlOjI3YmY3MzkxYjk3NjQwOWRhYTA4MDlhZTRhZTdiNzFmL3RhYmxlcmFuZ2U6MjdiZjczOTFiOTc2NDA5ZGFhMDgwOWFlNGFlN2I3MWZfMTAtMS0xLTEtNjgzMTY_dc5c189c-b194-4cc0-a911-b745fb531968">P2Y9M29D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RhYmxlOjI3YmY3MzkxYjk3NjQwOWRhYTA4MDlhZTRhZTdiNzFmL3RhYmxlcmFuZ2U6MjdiZjczOTFiOTc2NDA5ZGFhMDgwOWFlNGFlN2I3MWZfMTAtMy0xLTEtNjgzMTY_98294459-d168-44c8-9e73-94d152050b22">P3Y18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RhYmxlOjI3YmY3MzkxYjk3NjQwOWRhYTA4MDlhZTRhZTdiNzFmL3RhYmxlcmFuZ2U6MjdiZjczOTFiOTc2NDA5ZGFhMDgwOWFlNGFlN2I3MWZfMTEtMS0xLTEtNjgzMTY_55835157-4608-4d51-9d57-0dfabf214b1c"
      unitRef="number">0.0577</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RhYmxlOjI3YmY3MzkxYjk3NjQwOWRhYTA4MDlhZTRhZTdiNzFmL3RhYmxlcmFuZ2U6MjdiZjczOTFiOTc2NDA5ZGFhMDgwOWFlNGFlN2I3MWZfMTEtMy0xLTEtNjgzMTY_59fd8934-50e1-46d0-a2f3-d06f2673ede8"
      unitRef="number">0.0577</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RleHRyZWdpb246YjEzZTdjNDg3MjczNDdhN2I3MjgyZmJjNjFlOGY0ZThfMzE2Ng_a1fee7c8-a78e-47d8-8042-de34154fd271">&lt;div style="margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments under non-cancelable operating leases as of March 31, 2023 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.044%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.756%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-right:4.5pt;text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(330)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RhYmxlOjA1OTg0YmRkMDNjNTRmNDNiY2IxNDBkMjBiZjY1NGYzL3RhYmxlcmFuZ2U6MDU5ODRiZGQwM2M1NGY0M2JjYjE0MGQyMGJmNjU0ZjNfMS0xLTEtMS02ODMxNg_66e0f960-6b15-4570-8880-900ae6d20029"
      unitRef="usd">1195000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RhYmxlOjA1OTg0YmRkMDNjNTRmNDNiY2IxNDBkMjBiZjY1NGYzL3RhYmxlcmFuZ2U6MDU5ODRiZGQwM2M1NGY0M2JjYjE0MGQyMGJmNjU0ZjNfMi0xLTEtMS02ODMxNg_796b2dd0-31ac-4318-b372-c1945653cb62"
      unitRef="usd">1517000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RhYmxlOjA1OTg0YmRkMDNjNTRmNDNiY2IxNDBkMjBiZjY1NGYzL3RhYmxlcmFuZ2U6MDU5ODRiZGQwM2M1NGY0M2JjYjE0MGQyMGJmNjU0ZjNfMy0xLTEtMS02ODMxNg_5c5df93a-a1cf-4c1e-aaf9-284e217fd147"
      unitRef="usd">1005000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RhYmxlOjA1OTg0YmRkMDNjNTRmNDNiY2IxNDBkMjBiZjY1NGYzL3RhYmxlcmFuZ2U6MDU5ODRiZGQwM2M1NGY0M2JjYjE0MGQyMGJmNjU0ZjNfNC0xLTEtMS02ODMxNg_8eb2b002-6975-49e6-9d4f-b05f3c9ddbeb"
      unitRef="usd">530000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RhYmxlOjA1OTg0YmRkMDNjNTRmNDNiY2IxNDBkMjBiZjY1NGYzL3RhYmxlcmFuZ2U6MDU5ODRiZGQwM2M1NGY0M2JjYjE0MGQyMGJmNjU0ZjNfNS0xLTEtMS02ODMxNg_16685a58-3da3-44b9-9543-fc886590cb12"
      unitRef="usd">9000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <sibn:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RhYmxlOjA1OTg0YmRkMDNjNTRmNDNiY2IxNDBkMjBiZjY1NGYzL3RhYmxlcmFuZ2U6MDU5ODRiZGQwM2M1NGY0M2JjYjE0MGQyMGJmNjU0ZjNfNi0xLTEtMS02ODMxNg_ce23f90f-b1e9-4306-b82e-b80a7d148e09"
      unitRef="usd">0</sibn:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RhYmxlOjA1OTg0YmRkMDNjNTRmNDNiY2IxNDBkMjBiZjY1NGYzL3RhYmxlcmFuZ2U6MDU5ODRiZGQwM2M1NGY0M2JjYjE0MGQyMGJmNjU0ZjNfNy0xLTEtMS02ODMxNg_ca90a65c-f743-441e-9621-61b2c069eaa7"
      unitRef="usd">4256000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RhYmxlOjA1OTg0YmRkMDNjNTRmNDNiY2IxNDBkMjBiZjY1NGYzL3RhYmxlcmFuZ2U6MDU5ODRiZGQwM2M1NGY0M2JjYjE0MGQyMGJmNjU0ZjNfOC0xLTEtMS02ODMxNg_4d76a572-08ad-4c47-a0e2-58746a9d478f"
      unitRef="usd">330000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RhYmxlOjA1OTg0YmRkMDNjNTRmNDNiY2IxNDBkMjBiZjY1NGYzL3RhYmxlcmFuZ2U6MDU5ODRiZGQwM2M1NGY0M2JjYjE0MGQyMGJmNjU0ZjNfOS0xLTEtMS02ODMxNg_458ae51a-a070-4384-9676-02ae6476169c"
      unitRef="usd">3926000</us-gaap:OperatingLeaseLiability>
    <sibn:LesseeOperatingLeaseLeaseNotYetCommencedLiability
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RleHRyZWdpb246YjEzZTdjNDg3MjczNDdhN2I3MjgyZmJjNjFlOGY0ZThfOTMz_6f2ac838-ba47-487d-90ff-bffba944cf9d"
      unitRef="usd">0</sibn:LesseeOperatingLeaseLeaseNotYetCommencedLiability>
    <us-gaap:PurchaseObligation
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RleHRyZWdpb246YjEzZTdjNDg3MjczNDdhN2I3MjgyZmJjNjFlOGY0ZThfMTUyOA_6d294686-29aa-46f6-b5fc-1534bb4dca81"
      unitRef="usd">1800000</us-gaap:PurchaseObligation>
    <us-gaap:PurchaseObligation
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RleHRyZWdpb246YjEzZTdjNDg3MjczNDdhN2I3MjgyZmJjNjFlOGY0ZThfMTUzNQ_a3a8fe57-e3d0-4d27-aa39-bd1fd9758ec8"
      unitRef="usd">800000</us-gaap:PurchaseObligation>
    <us-gaap:LitigationSettlementExpense
      contextRef="i0948ce79deee4391b59b52520a368e51_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RleHRyZWdpb246YjEzZTdjNDg3MjczNDdhN2I3MjgyZmJjNjFlOGY0ZThfMjY3OQ_811adb18-d357-4600-bba3-8fe317376d8a"
      unitRef="usd">0</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationReserve
      contextRef="i8c1e121f074342c9bd40478fa2984c46_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80Ni9mcmFnOmIxM2U3YzQ4NzI3MzQ3YTdiNzI4MmZiYzYxZThmNGU4L3RleHRyZWdpb246YjEzZTdjNDg3MjczNDdhN2I3MjgyZmJjNjFlOGY0ZThfMjc3OQ_b5b7aa76-f7a5-4735-b587-05be6e979ff1"
      unitRef="usd">0</us-gaap:LitigationReserve>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RleHRyZWdpb246OGViMzFkNTMyOTA1NGYxOTk0YzkzNzE3MzdmYWViNjdfNTk5Mw_0a60ed76-8df4-4b4e-8793-f52629961330">Borrowings&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Term Loan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the outstanding borrowings from the term loan as of periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:9pt;padding-left:36pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.583%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.962%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.575%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal outstanding and final fee&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Unamortized debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Unaccreted value of final fee&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(683)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(456)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding debt, net of debt issuance costs and unaccreted value of final fee&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Classified as:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term borrowings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The outstanding debt is related to a term loan pursuant to the Loan and Security Agreement dated August 12, 2021 (the &#x201c;Effective Date&#x201d;), entered into by the Company with Silicon Valley Bank (&#x201c;SVB&#x201d;). Pursuant the agreement, SVB provided an aggregate principal amount of $35.0&#160;million to the Company (the &#x201c;SVB Term Loan&#x201d;). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 6, 2023, the Company entered into a First Amendment to Loan and Security Agreement (the &#x201c;Amendment&#x201d;) with SVB, which amended the Company's SVB Term Loan pursuant to which the Company had a term loan facility in an aggregate principal amount of $35.0&#160;million (the &#x201c;Original Loan Agreement&#x201d; and with the Amendment, collectively the &#x201c;Amended Loan Agreement&#x201d;).  Upon entry into the Amended Loan Agreement, the Company borrowed $36.0&#160;million pursuant to a term loan (the "Term Loan"), which was substantially used to repay in full the $35.0&#160;million term loan facility outstanding under the Original Loan Agreement and secured a revolving credit facility in an aggregate principal amount of up to $15.0&#160;million (the "Revolver"). On March 14, 2023 all of SVB&#x2019;s assets and liabilities, including all of SVB&#x2019;s rights as the lender pursuant to the Amended Loan Agreement, were assigned to Silicon Valley Bridge Bank.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 27, 2023, all of Silicon Valley Bridge Bank&#x2019;s assets and liabilities were assigned and assumed by First-Citizens Bank &amp;amp; Trust Company (&#x201c;First-Citizens&#x201d;). The Amended Loan Agreement also includes an uncommitted accordion term loan in an aggregate principal amount of up to $15.0&#160;million, which accordion may be approved by First-Citizens solely in its discretion, upon the Company&#x2019;s request. The Term Loan matures on December 1, 2027 (the &#x201c;Term Loan Maturity Date&#x201d;). Interest on the Term Loan will be payable monthly at a floating annual rate set at the greater of the prime rate as published in the Wall Street Journal plus 0.5% or 6.75%. Commencing on July 1, 2025, the Company will be required to make monthly principal Term Loan amortization payments. A final fee payment of 2% of the original principal amount of the Term Loan is due upon the earlier of the Term Loan Maturity Date, termination, acceleration by First-Citizens following an event of default, or prepayment of the Term Loan. The Company may elect to prepay the Term Loan in whole prior to the Term Loan Maturity Date subject to a prepayment fee equal to 2% of the principal amount of the Term Loan prepaid at such time. No prepayment fee would be due if the Term Loan is refinanced by First-Citizens. Pursuant to the terms of the Amended Loan Agreement, revolving loans may be &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;borrowed, repaid and reborrowed until the maturity date, which will be July 6, 2025 (the "Revolver Maturity Date"). Borrowings under the Revolver are based on 80% of eligible domestic accounts receivable borrowing base. Interest on the outstanding balance of the Revolver will be payable monthly at a floating annual rate set at the greater of the prime rate as published in the Wall Street Journal or 6.25%. Interest on borrowings is due monthly and any principal balance is due on the Revolver Maturity Date, provided that when Revolver Advances are outstanding, in the event the Company does not maintain an adjusted quick ratio of at least 1.5 to 1.0, then falling below such threshold will allow First-Citizens to apply accounts receivable collections to outstanding Revolver borrowings. The Company will pay a total commitment fee of $187,500 on account of the Revolver payable in installments, but fully earned at close. The Company will also be required to pay a fee of $150,000 if it terminates the Amended Loan Agreement or Revolver prior to Revolver Maturity Date. No termination fee would be due if the Revolver is replaced with a new facility with First-Citizens. No amounts were outstanding under the Revolver as of March 31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounted for the Amended Loan Agreement as a debt modification. Accordingly, the remaining unamortized debt issuance costs related to the Original Loan Agreement together with any lender fees incurred in connection with the entry of the Amended Loan Agreement are amortized to interest expense using the straight-line method over the new term of the loan through December 2027.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effective interest rate related to the First-Citizens Term Loan for the three months ended March 31, 2023 and March 31, 2022 was 8.6% and 6.3%, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;         The table below summarizes the future principal and final fee payments under the Fist-Citizens Term Loan as of March 31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.388%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total principal and final fee payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Amended Loan Agreement contains customary events of default, including bankruptcy, the failure to make payments when due, the occurrence of a material impairment on First-Citizens's security interest over the collateral, a material adverse change, the occurrence of a default under certain other indebtedness of the Company and its subsidiaries, the rendering of certain types of judgments against the Company and its subsidiaries, the revocation of certain government approvals, violation of covenants, and incorrectness of representations and warranties in any material respect. In addition, the Amended Loan Agreement contains a financial covenant which requires the Company to maintain, at all times when the Financial Covenant Measuring Period is in effect, certain net revenue levels as agreed upon by the Company and First-Citizens. If the Company does not comply with the various covenants under the Amended Loan Agreement and an event of default occurs under the Amended Loan Agreement, the interest rate on outstanding amounts can increase by 3% and First-Citizens may, subject to various customary cure rights, decline to provide additional advances under the Revolver, require the immediate payment of all amounts outstanding under the Amended Loan Agreement, and foreclose on all collateral. &lt;/span&gt;&lt;/div&gt;On March 10, 2023, the Company violated one of the terms of the credit facility by opening bank accounts with another financial institution and transferring funds from SVB. The Company entered into a letter agreement with Silicon Valley Bridge Bank waiving enforcement of this covenant and providing the Company the right to hold a portion of its cash at other financial institutions. A future violation of any covenants could result in a default under the Amended Loan Agreement that would permit First-Citizens to restrict the Company&#x2019;s ability to further access the Revolving Line of Credit for loans and require the immediate repayment of any outstanding loans under the agreement. As of March 31, 2023, the Company was in compliance with all debt covenants, provided, however, that in order to access future credit advances under the Revolving Line of Credit, the Company will be required to transfer certain cash management accounts back to First-Citizens.  As of March 31, 2023, the Company had cash management accounts with a financial institution other than First-Citizens and instructed its customers to direct payments to these separate operating accounts. Until such operating accounts are closed and the funds moved back to cash collateral accounts held at First-Citizens, the Company will be unable to obtain credit advances under the Revolver.</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RleHRyZWdpb246OGViMzFkNTMyOTA1NGYxOTk0YzkzNzE3MzdmYWViNjdfNTk5NQ_03ac9479-494d-4937-b0a3-b07f9e9c1607">&lt;div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the outstanding borrowings from the term loan as of periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:9pt;padding-left:36pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.583%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.962%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.575%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal outstanding and final fee&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Unamortized debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Unaccreted value of final fee&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(683)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(456)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding debt, net of debt issuance costs and unaccreted value of final fee&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Classified as:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term borrowings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RhYmxlOmFiY2M3Y2JlODkxNjQ2NTJiMzlhODcyMTNiZTZlNDk2L3RhYmxlcmFuZ2U6YWJjYzdjYmU4OTE2NDY1MmIzOWE4NzIxM2JlNmU0OTZfMi0xLTEtMS02ODMxNg_9afcefdf-8e06-453c-b16a-749ad3325d2a"
      unitRef="usd">36720000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RhYmxlOmFiY2M3Y2JlODkxNjQ2NTJiMzlhODcyMTNiZTZlNDk2L3RhYmxlcmFuZ2U6YWJjYzdjYmU4OTE2NDY1MmIzOWE4NzIxM2JlNmU0OTZfMi0zLTEtMS02ODMxNg_1498691a-5890-416e-b57a-2ed9be174ebb"
      unitRef="usd">35700000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RhYmxlOmFiY2M3Y2JlODkxNjQ2NTJiMzlhODcyMTNiZTZlNDk2L3RhYmxlcmFuZ2U6YWJjYzdjYmU4OTE2NDY1MmIzOWE4NzIxM2JlNmU0OTZfMy0xLTEtMS02ODMxNg_29fa9ed6-7677-49e3-aa4e-2fce7a97fa68"
      unitRef="usd">99000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RhYmxlOmFiY2M3Y2JlODkxNjQ2NTJiMzlhODcyMTNiZTZlNDk2L3RhYmxlcmFuZ2U6YWJjYzdjYmU4OTE2NDY1MmIzOWE4NzIxM2JlNmU0OTZfMy0zLTEtMS02ODMxNg_90d4b1d3-7005-41e2-94d7-ea12c923aabf"
      unitRef="usd">73000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentFeeAmount
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RhYmxlOmFiY2M3Y2JlODkxNjQ2NTJiMzlhODcyMTNiZTZlNDk2L3RhYmxlcmFuZ2U6YWJjYzdjYmU4OTE2NDY1MmIzOWE4NzIxM2JlNmU0OTZfNC0xLTEtMS02ODMxNg_f9f166ca-fa15-4c6a-9777-369b65d14013"
      unitRef="usd">683000</us-gaap:DebtInstrumentFeeAmount>
    <us-gaap:DebtInstrumentFeeAmount
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RhYmxlOmFiY2M3Y2JlODkxNjQ2NTJiMzlhODcyMTNiZTZlNDk2L3RhYmxlcmFuZ2U6YWJjYzdjYmU4OTE2NDY1MmIzOWE4NzIxM2JlNmU0OTZfNC0zLTEtMS02ODMxNg_6b58161d-e8b7-4cb0-b42e-d492eb5862bf"
      unitRef="usd">456000</us-gaap:DebtInstrumentFeeAmount>
    <us-gaap:LongTermDebt
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RhYmxlOmFiY2M3Y2JlODkxNjQ2NTJiMzlhODcyMTNiZTZlNDk2L3RhYmxlcmFuZ2U6YWJjYzdjYmU4OTE2NDY1MmIzOWE4NzIxM2JlNmU0OTZfNS0xLTEtMS02ODMxNg_7b574425-71f6-448d-a5fb-c8af9c16e2a8"
      unitRef="usd">35938000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RhYmxlOmFiY2M3Y2JlODkxNjQ2NTJiMzlhODcyMTNiZTZlNDk2L3RhYmxlcmFuZ2U6YWJjYzdjYmU4OTE2NDY1MmIzOWE4NzIxM2JlNmU0OTZfNS0zLTEtMS02ODMxNg_2774bd0a-d2ed-487d-b939-9c1fd0514fea"
      unitRef="usd">35171000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RhYmxlOmFiY2M3Y2JlODkxNjQ2NTJiMzlhODcyMTNiZTZlNDk2L3RhYmxlcmFuZ2U6YWJjYzdjYmU4OTE2NDY1MmIzOWE4NzIxM2JlNmU0OTZfOC0xLTEtMS02ODMxNg_6b8a35b2-afe2-4d93-82e5-9c1f5ae3d8dd"
      unitRef="usd">35938000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RhYmxlOmFiY2M3Y2JlODkxNjQ2NTJiMzlhODcyMTNiZTZlNDk2L3RhYmxlcmFuZ2U6YWJjYzdjYmU4OTE2NDY1MmIzOWE4NzIxM2JlNmU0OTZfOC0zLTEtMS02ODMxNg_f6255995-a6cb-42b3-a01a-3cdcec28bd67"
      unitRef="usd">35171000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="if8e560c29f77458f868e82a8beb02128_I20210812"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RleHRyZWdpb246OGViMzFkNTMyOTA1NGYxOTk0YzkzNzE3MzdmYWViNjdfMTcwMg_606146a7-7c61-437e-b50b-6724254fd321"
      unitRef="usd">35000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i7fe2d63d0e5c43bdbdf07781f3c546f9_I20230106"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RleHRyZWdpb246OGViMzFkNTMyOTA1NGYxOTk0YzkzNzE3MzdmYWViNjdfMTA5OTUxMTY0MTIxMg_5a491a40-7350-4fb3-9394-91e114f4d19d"
      unitRef="usd">35000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromRepaymentsOfSecuredDebt
      contextRef="i1bf81bb780c3454a8a17edba536c3cca_D20230106-20230106"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RleHRyZWdpb246OGViMzFkNTMyOTA1NGYxOTk0YzkzNzE3MzdmYWViNjdfMTA5OTUxMTY0MTMzNg_5beaf468-844a-430c-a9cc-5379fd838cbd"
      unitRef="usd">36000000</us-gaap:ProceedsFromRepaymentsOfSecuredDebt>
    <us-gaap:ProceedsFromRepaymentsOfSecuredDebt
      contextRef="icb70f81572e248629f7b7f231c74cec6_D20230106-20230106"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RleHRyZWdpb246OGViMzFkNTMyOTA1NGYxOTk0YzkzNzE3MzdmYWViNjdfNTQ5NzU1ODI4MTU3_4ef0a0d8-8305-454d-95fb-0c6ce826a501"
      unitRef="usd">-35000000</us-gaap:ProceedsFromRepaymentsOfSecuredDebt>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i75a6a55921b94e788965c7b88a1250c0_I20230106"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RleHRyZWdpb246OGViMzFkNTMyOTA1NGYxOTk0YzkzNzE3MzdmYWViNjdfNTQ5NzU1ODI4MTcy_71a76ae9-c579-4f60-abeb-3388e4abb460"
      unitRef="usd">15000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <sibn:LineOfCreditFacilityAccordionFeatureIncreaseLimit
      contextRef="i76321e3f57544d228615f7521f589bc2_I20230106"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RleHRyZWdpb246OGViMzFkNTMyOTA1NGYxOTk0YzkzNzE3MzdmYWViNjdfMTA5OTUxMTY0MTM1MQ_6e6c4d4f-db88-4847-bac9-017f0fe5e05d"
      unitRef="usd">15000000</sibn:LineOfCreditFacilityAccordionFeatureIncreaseLimit>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i40ef43333c0442bf888482c8ace88dd4_D20230106-20230106"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RleHRyZWdpb246OGViMzFkNTMyOTA1NGYxOTk0YzkzNzE3MzdmYWViNjdfMTA5OTUxMTY0MTM2Ng_23a99057-a28b-453c-a33a-a0349e5524fa"
      unitRef="number">0.005</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="id912f88617b74e8f9c3530bd836870bf_D20230106-20230106"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RleHRyZWdpb246OGViMzFkNTMyOTA1NGYxOTk0YzkzNzE3MzdmYWViNjdfMTA5OTUxMTY0MTM3Mg_fb5bf095-0b45-4023-96b2-7936ddd9b490"
      unitRef="number">0.0675</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <sibn:DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal
      contextRef="ibd2e135759a24184955191e8a1e9cc3c_I20230106"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RleHRyZWdpb246OGViMzFkNTMyOTA1NGYxOTk0YzkzNzE3MzdmYWViNjdfNTQ5NzU1ODI4MTk2_1d015cfb-6e4d-4b36-968a-b629d5c57ab3"
      unitRef="number">0.02</sibn:DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal>
    <sibn:DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal
      contextRef="ibd2e135759a24184955191e8a1e9cc3c_I20230106"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RleHRyZWdpb246OGViMzFkNTMyOTA1NGYxOTk0YzkzNzE3MzdmYWViNjdfMTA5OTUxMTY0MTM4MA_13f38c3b-2554-47e1-b06a-b7f34a2eebe3"
      unitRef="number">0.02</sibn:DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal>
    <sibn:DebtInstrumentAccountsReceivableBorrowingBase
      contextRef="idbafe1e8ab4043a896784415b82016d4_D20230106-20230106"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RleHRyZWdpb246OGViMzFkNTMyOTA1NGYxOTk0YzkzNzE3MzdmYWViNjdfMTA5OTUxMTY0MTM4NA_81932a3d-f917-4fea-86b0-57c1c01295bf"
      unitRef="number">0.80</sibn:DebtInstrumentAccountsReceivableBorrowingBase>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i76321e3f57544d228615f7521f589bc2_I20230106"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RleHRyZWdpb246OGViMzFkNTMyOTA1NGYxOTk0YzkzNzE3MzdmYWViNjdfMTA5OTUxMTY0MTM4OQ_d5d06836-ff88-4455-ac10-7050a7e7f19f"
      unitRef="number">0.0625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <sibn:DebtInstrumentCovenantAdjustedQuickRatioMinimum
      contextRef="idbafe1e8ab4043a896784415b82016d4_D20230106-20230106"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RleHRyZWdpb246OGViMzFkNTMyOTA1NGYxOTk0YzkzNzE3MzdmYWViNjdfMTA5OTUxMTY0MTQxNA_321d5a90-c167-4b4f-9fc5-a19ae76a6b55"
      unitRef="quick_ratio">1.5</sibn:DebtInstrumentCovenantAdjustedQuickRatioMinimum>
    <us-gaap:LineOfCreditFacilityCommitmentFeeAmount
      contextRef="iead9b266d2d14baba4281492cf7acebc_D20230106-20230106"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RleHRyZWdpb246OGViMzFkNTMyOTA1NGYxOTk0YzkzNzE3MzdmYWViNjdfMTA5OTUxMTY0MTM5Ng_e748cdfd-cb8e-43f9-a7ce-7bfddba39bee"
      unitRef="usd">187500</us-gaap:LineOfCreditFacilityCommitmentFeeAmount>
    <sibn:LineOfCreditFacilityContingentCommitmentFeeAmount
      contextRef="iead9b266d2d14baba4281492cf7acebc_D20230106-20230106"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RleHRyZWdpb246OGViMzFkNTMyOTA1NGYxOTk0YzkzNzE3MzdmYWViNjdfMTA5OTUxMTY0MTQwNQ_faa4031a-307d-41b6-9594-c25319d9da6e"
      unitRef="usd">150000</sibn:LineOfCreditFacilityContingentCommitmentFeeAmount>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="ia93eb97347d343fb94b99ed9c40ef16b_D20230101-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RleHRyZWdpb246OGViMzFkNTMyOTA1NGYxOTk0YzkzNzE3MzdmYWViNjdfNDU3MA_3d45719a-c956-4a2d-9b72-8d64ed3ce6e2"
      unitRef="number">0.086</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i7d10f967602a4f5e83faefa1d251c9a3_D20220101-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RleHRyZWdpb246OGViMzFkNTMyOTA1NGYxOTk0YzkzNzE3MzdmYWViNjdfNDU3Nw_2b89edf2-3093-48ee-a5f2-8747ea409590"
      unitRef="number">0.063</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RleHRyZWdpb246OGViMzFkNTMyOTA1NGYxOTk0YzkzNzE3MzdmYWViNjdfNTk5Ng_0fa17355-610d-4daa-a44d-cb1773576813">The table below summarizes the future principal and final fee payments under the Fist-Citizens Term Loan as of March 31, 2023:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.388%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total principal and final fee payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RhYmxlOmUwOWYzZGIxNjdhNTQ3YTlhYWFmN2FjNjkxZDg3YWY2L3RhYmxlcmFuZ2U6ZTA5ZjNkYjE2N2E1NDdhOWFhYWY3YWM2OTFkODdhZjZfMS0xLTEtMS02ODMxNg_6e2ff7d6-1c3f-4bf8-b484-7486fb7587ee"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RhYmxlOmUwOWYzZGIxNjdhNTQ3YTlhYWFmN2FjNjkxZDg3YWY2L3RhYmxlcmFuZ2U6ZTA5ZjNkYjE2N2E1NDdhOWFhYWY3YWM2OTFkODdhZjZfMi0xLTEtMS02ODMxNg_3f8218f6-106d-47e1-a8c2-3c55f7cb8a1d"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RhYmxlOmUwOWYzZGIxNjdhNTQ3YTlhYWFmN2FjNjkxZDg3YWY2L3RhYmxlcmFuZ2U6ZTA5ZjNkYjE2N2E1NDdhOWFhYWY3YWM2OTFkODdhZjZfMy0xLTEtMS02ODMxNg_d253af3a-ed04-4781-9f60-62ccab8532af"
      unitRef="usd">8400000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RhYmxlOmUwOWYzZGIxNjdhNTQ3YTlhYWFmN2FjNjkxZDg3YWY2L3RhYmxlcmFuZ2U6ZTA5ZjNkYjE2N2E1NDdhOWFhYWY3YWM2OTFkODdhZjZfNC0xLTEtMS02ODMxNg_7ca7da02-4099-4561-92f9-7eab57c0bac2"
      unitRef="usd">14400000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RhYmxlOmUwOWYzZGIxNjdhNTQ3YTlhYWFmN2FjNjkxZDg3YWY2L3RhYmxlcmFuZ2U6ZTA5ZjNkYjE2N2E1NDdhOWFhYWY3YWM2OTFkODdhZjZfNS0xLTEtMS02ODMxNg_1e05d167-7de0-48e2-addc-1a0c8f447089"
      unitRef="usd">13920000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RhYmxlOmUwOWYzZGIxNjdhNTQ3YTlhYWFmN2FjNjkxZDg3YWY2L3RhYmxlcmFuZ2U6ZTA5ZjNkYjE2N2E1NDdhOWFhYWY3YWM2OTFkODdhZjZfNy0xLTEtMS02ODMxNg_3a58e74f-6210-484d-8685-fefdd9766d07"
      unitRef="usd">36720000</us-gaap:DebtInstrumentCarryingAmount>
    <sibn:DebtInstrumentInterestRateIncreaseDueToDefault
      contextRef="ia93eb97347d343fb94b99ed9c40ef16b_D20230101-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl80OS9mcmFnOjhlYjMxZDUzMjkwNTRmMTk5NGM5MzcxNzM3ZmFlYjY3L3RleHRyZWdpb246OGViMzFkNTMyOTA1NGYxOTk0YzkzNzE3MzdmYWViNjdfNTQ5NzU1ODI4MTQy_c6b78ed2-3867-41f1-a0de-35a785c6ddba"
      unitRef="number">0.03</sibn:DebtInstrumentInterestRateIncreaseDueToDefault>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfNDAyNg_d7d47278-68c2-47d2-9775-eb00d1c2dbaa">Stock-Based Incentive Compensation Plans &lt;div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the stock option activity for the three months ended March 31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:72pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of &lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted- &lt;br/&gt;Average &lt;br/&gt;Exercise &lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,903,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$8.82&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:1pt;padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(120,266)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.33&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canceled and forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,284)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.36&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,767,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.23&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March 31, 2023, the unrecognized compensation cost related to stock options is insignificant and is expected to be recognized over a period of approximately 0.4 years.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no stock options granted during the three months ended March 31, 2023 and 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Early Exercise of Unvested Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Early exercises of stock options under the Company's 2008 Stock Option Plan are subject to a right of repurchase by the Company of any unvested shares. The repurchase rights lapse over the original vesting period of the options. The Company accounts for the cash received in consideration for the early exercised options as a liability included in accrued liabilities, which is then reclassified to stockholders&#x2019; equity as the options vest. As of March 31, 2023 and December 31, 2022, the Company had no shares subject to repurchase. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:18pt;padding-left:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Stock Units (&#x201c;RSUs&#x201d;)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RSUs are share awards that entitle the holder to receive freely tradable shares of the Company&#x2019;s common stock upon vesting. RSUs generally vest over &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfMTEwOQ_b006b137-1392-4dc1-aa98-21e5cfe1c1eb"&gt;two&lt;/span&gt; to four years based upon continued services and are settled at vesting in shares of the Company's common stock. Certain RSUs vest based upon continued services and the achievement of financial milestones. The grant date fair value of the RSUs is equal to the closing price of the Company&#x2019;s common stock on the grant date. As of March 31, 2023, the unr&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ecognized compensation cost related to the RSUs was $41.5 million, which is expected to be recognized over a period of approximately 2.8 years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company granted performance-based restricted stock unit awards subject to market and service vesting conditions to certain executive officers under SI-BONE's 2018 Equity Incentive Plan (&#x201c;PSUs&#x201d;). The shares subject to PSUs vest over a three-year performance period. The actual number of PSUs that will vest in each measurement period will be determined by the Compensation Committee based on the Company&#x2019;s total shareholder return (&#x201c;TSR&#x201d;) relative to the TSR of the Median Peer Companies (as defined in the award agreement).  The grant date fair value of each stock award with a market condition was determined using the Monte Carlo valuation model. The table below summarizes the assumptions used to estimate the grant date fair value of the PSUs granted:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.833%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.073%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.320%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.320%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.320%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.320%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.320%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility of common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.9%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.7%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility of peer companies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.2%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152.5%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Correlation coefficient of peer companies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.15)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.13)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.00&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March 31, 2023, the unrecognized compensation cost related to the PSUs was $4.1 million, which is expected to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;be recognized over a period of approximately 2.4 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes RSU and PSU activity for the three months ended March 31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:24.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.222%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.258%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.258%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.258%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.258%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.982%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;PSUs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,794,928&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$22.72&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,596&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$19.50&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,044,344&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.69&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255,458&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.33&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(228,388)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.97&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25,932)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.50&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canceled and forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(86,107)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.70&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,524,777&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.82&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;385,122&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.74&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:18pt;padding-left:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s 2018 Employee Stock Purchase Plan (the &#x201c;ESPP&#x201d;) allows eligible employees to purchase shares of the Company's common stock through payroll deductions at the price equal to 85% of the lesser of the fair market value of the stock as of the first date or the ending date of each six month offering period. The offering period generally commences in May and November. On March 26, 2020, the Company's Compensation Committee approved the amendment of the terms of future offerings under the ESPP which, among other things, increased the maximum number of shares that may be purchased on any single purchase date, provided for automatic enrollment in a new offering, and provided that the offering which commenced in May 2020 be twelve months in duration and consist of two purchase periods. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the ESPP shares is estimated using the Black-Scholes option pricing model, which is being amortized over the requisite service period. The Company did not issue any shares under ESPP for the three months ended March 31, 2023 and 2022. As of March 31, 2023 and December 31, 2022, total accumulated ESPP related employee payroll deductions amounted to &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$1.2 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and $0.3 million, respectively, which were included within accrued compensation and related expenses in the condensed consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-Based Compensation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents the detail of stock-based compensation expense amounts included in the condensed consolidated statements of operations:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.305%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.879%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.690%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.879%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.693%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of goods sold&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales and marketing&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfNDAyOA_b54e8933-e5bf-4a97-a807-a3891cdb6a68">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the stock option activity for the three months ended March 31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:72pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of &lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted- &lt;br/&gt;Average &lt;br/&gt;Exercise &lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,903,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$8.82&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:1pt;padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(120,266)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.33&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canceled and forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,284)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.36&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,767,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.23&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOjRjNzUxYjQ1NWMzZTRmNzdhYjczNjE0NGU2MWFiZWU4L3RhYmxlcmFuZ2U6NGM3NTFiNDU1YzNlNGY3N2FiNzM2MTQ0ZTYxYWJlZThfMS0yLTEtMS02ODMxNg_7e8544c7-c354-41d3-ac2c-aa2823d440f9"
      unitRef="shares">1903341</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOjRjNzUxYjQ1NWMzZTRmNzdhYjczNjE0NGU2MWFiZWU4L3RhYmxlcmFuZ2U6NGM3NTFiNDU1YzNlNGY3N2FiNzM2MTQ0ZTYxYWJlZThfMS00LTEtMS02ODMxNg_827b7e64-faae-4a2b-9443-9209cdc98e89"
      unitRef="usdPerShare">8.82</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOjRjNzUxYjQ1NWMzZTRmNzdhYjczNjE0NGU2MWFiZWU4L3RhYmxlcmFuZ2U6NGM3NTFiNDU1YzNlNGY3N2FiNzM2MTQ0ZTYxYWJlZThfMy0yLTEtMS02ODMxNg_ffb989b1-ec66-4069-8b7c-d0e9683ca8e4"
      unitRef="shares">120266</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOjRjNzUxYjQ1NWMzZTRmNzdhYjczNjE0NGU2MWFiZWU4L3RhYmxlcmFuZ2U6NGM3NTFiNDU1YzNlNGY3N2FiNzM2MTQ0ZTYxYWJlZThfMy00LTEtMS02ODMxNg_8463f5fd-d08a-4c9b-b76a-a1faeb92bf50"
      unitRef="usdPerShare">4.33</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOjRjNzUxYjQ1NWMzZTRmNzdhYjczNjE0NGU2MWFiZWU4L3RhYmxlcmFuZ2U6NGM3NTFiNDU1YzNlNGY3N2FiNzM2MTQ0ZTYxYWJlZThfNC0yLTEtMS02ODMxNg_a46354fc-d99a-4dea-869c-7fe2b46ce8a5"
      unitRef="shares">15284</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOjRjNzUxYjQ1NWMzZTRmNzdhYjczNjE0NGU2MWFiZWU4L3RhYmxlcmFuZ2U6NGM3NTFiNDU1YzNlNGY3N2FiNzM2MTQ0ZTYxYWJlZThfNC00LTEtMS02ODMxNg_aa1e9203-19c2-4ab3-865d-8e22468e5830"
      unitRef="usdPerShare">21.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOjRjNzUxYjQ1NWMzZTRmNzdhYjczNjE0NGU2MWFiZWU4L3RhYmxlcmFuZ2U6NGM3NTFiNDU1YzNlNGY3N2FiNzM2MTQ0ZTYxYWJlZThfNS0yLTEtMS02ODMxNg_31c353c2-d087-49c3-a7d1-e436850d69f4"
      unitRef="shares">1767791</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOjRjNzUxYjQ1NWMzZTRmNzdhYjczNjE0NGU2MWFiZWU4L3RhYmxlcmFuZ2U6NGM3NTFiNDU1YzNlNGY3N2FiNzM2MTQ0ZTYxYWJlZThfNS00LTEtMS02ODMxNg_8fa139b2-8074-4265-9398-4d5db9b49333"
      unitRef="usdPerShare">10.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i6a9db0b913fe48aea9fd168fc919ec8d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfMjc5_a8aef1dd-5689-436f-ac0a-97a78c52ee86">P0Y4M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfMjk1_43447d02-bf2e-4929-bd4c-6036949e8d2a"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfMjk1_b205a52b-b3af-44dc-a46d-2fa410a6967c"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase
      contextRef="ibc8dabdb27e24a31aa334795682f86fb_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfODc2_4943d8fd-70f0-4137-9514-c6eef222210c"
      unitRef="shares">0</sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase>
    <sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase
      contextRef="i9dcf850d9d0446dea538750874891e18_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfODc2_66680961-7825-425a-b076-60bc7be612ae"
      unitRef="shares">0</sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="iae333c43aa6f438893c3e83047c6ba3e_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfMTExNQ_be506648-2bdb-4a78-b2c6-25dbd934e492">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="iafee48dbb8fc4bfc960af6aa6244917f_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfMTA5OTUxMTYzODUyNQ_463185be-7545-4208-afb7-baf42b7f4202"
      unitRef="usd">41500000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="iaf9a24c75b524dfa94a49c4ab5a022c0_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfMTA5OTUxMTYzODU5Ng_8ebb04cf-b0f5-4c54-9f87-023db060447d">P2Y9M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="iac4ffd9b01074e8fa63dc6df8b863046_D20220101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfNDAyOQ_2be96ab5-77f8-4ea9-91fc-0d3f4aa4b46d">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <sibn:ScheduleOfShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValuationAssumptionsTableTextBlock
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfNDAzMA_aaebd7de-6ad9-4c32-8bb2-06d5c41821e0">The table below summarizes the assumptions used to estimate the grant date fair value of the PSUs granted:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.833%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.073%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.320%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.320%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.320%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.320%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.320%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility of common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.9%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.7%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility of peer companies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.2%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152.5%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Correlation coefficient of peer companies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.15)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.13)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.00&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</sibn:ScheduleOfShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="i73253fc85d9d4718b307a6aeea2b9c06_D20230101-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmZjNjRjNWI2MDI2YzRkOGFhOWI1MTRkNGVlOWQxYThlL3RhYmxlcmFuZ2U6ZmM2NGM1YjYwMjZjNGQ4YWE5YjUxNGQ0ZWU5ZDFhOGVfMS0xMy0xLTEtNjgzMTY_6279dd35-18e3-4c0d-ad7e-24338c6bf67c"
      unitRef="number">0.580</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="i73253fc85d9d4718b307a6aeea2b9c06_D20230101-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmZjNjRjNWI2MDI2YzRkOGFhOWI1MTRkNGVlOWQxYThlL3RhYmxlcmFuZ2U6ZmM2NGM1YjYwMjZjNGQ4YWE5YjUxNGQ0ZWU5ZDFhOGVfMS0xNS0xLTEtNjgzMTY_49062d06-8581-42b4-aab7-0ea135e5ce9c"
      unitRef="number">0.730</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="if5a58a2d117b40d8a0d022c115299b14_D20220101-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmZjNjRjNWI2MDI2YzRkOGFhOWI1MTRkNGVlOWQxYThlL3RhYmxlcmFuZ2U6ZmM2NGM1YjYwMjZjNGQ4YWE5YjUxNGQ0ZWU5ZDFhOGVfMi0xNy0xLTEtNzk1NDg_5f151f95-5eb9-4aa3-a87b-8da0d35dc8c4"
      unitRef="number">0.489</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="if5a58a2d117b40d8a0d022c115299b14_D20220101-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmZjNjRjNWI2MDI2YzRkOGFhOWI1MTRkNGVlOWQxYThlL3RhYmxlcmFuZ2U6ZmM2NGM1YjYwMjZjNGQ4YWE5YjUxNGQ0ZWU5ZDFhOGVfMi0xOS0xLTEtNzk1NTE_53b91c4e-23c9-4066-8f42-0d6eed039a7b"
      unitRef="number">0.587</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMinimum
      contextRef="i73253fc85d9d4718b307a6aeea2b9c06_D20230101-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmZjNjRjNWI2MDI2YzRkOGFhOWI1MTRkNGVlOWQxYThlL3RhYmxlcmFuZ2U6ZmM2NGM1YjYwMjZjNGQ4YWE5YjUxNGQ0ZWU5ZDFhOGVfMi0xMy0xLTEtNjgzMTY_7efa34d1-01b0-486d-a582-93f6441dfb8b"
      unitRef="number">0.330</sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMinimum>
    <sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMaximum
      contextRef="i73253fc85d9d4718b307a6aeea2b9c06_D20230101-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmZjNjRjNWI2MDI2YzRkOGFhOWI1MTRkNGVlOWQxYThlL3RhYmxlcmFuZ2U6ZmM2NGM1YjYwMjZjNGQ4YWE5YjUxNGQ0ZWU5ZDFhOGVfMi0xNS0xLTEtNjgzMTY_90f80049-5402-430e-8217-90e2b7b80106"
      unitRef="number">1.410</sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMaximum>
    <sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMinimum
      contextRef="if5a58a2d117b40d8a0d022c115299b14_D20220101-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmZjNjRjNWI2MDI2YzRkOGFhOWI1MTRkNGVlOWQxYThlL3RhYmxlcmFuZ2U6ZmM2NGM1YjYwMjZjNGQ4YWE5YjUxNGQ0ZWU5ZDFhOGVfMy0xNy0xLTEtNzk1NDg_89b5f8fa-15a1-4816-ad81-ce42575fe225"
      unitRef="number">0.242</sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMinimum>
    <sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMaximum
      contextRef="if5a58a2d117b40d8a0d022c115299b14_D20220101-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmZjNjRjNWI2MDI2YzRkOGFhOWI1MTRkNGVlOWQxYThlL3RhYmxlcmFuZ2U6ZmM2NGM1YjYwMjZjNGQ4YWE5YjUxNGQ0ZWU5ZDFhOGVfMy0xOS0xLTEtNzk1NTE_b38a832b-289b-43bb-be2a-4a7812ac66d7"
      unitRef="number">1.525</sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMaximum>
    <sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMinimum
      contextRef="i73253fc85d9d4718b307a6aeea2b9c06_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmZjNjRjNWI2MDI2YzRkOGFhOWI1MTRkNGVlOWQxYThlL3RhYmxlcmFuZ2U6ZmM2NGM1YjYwMjZjNGQ4YWE5YjUxNGQ0ZWU5ZDFhOGVfMy0xMy0xLTEtNjgzMTY_17083d61-e1a5-4b99-aad9-10530407ec02"
      unitRef="number">-0.15</sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMinimum>
    <sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMaximum
      contextRef="i73253fc85d9d4718b307a6aeea2b9c06_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmZjNjRjNWI2MDI2YzRkOGFhOWI1MTRkNGVlOWQxYThlL3RhYmxlcmFuZ2U6ZmM2NGM1YjYwMjZjNGQ4YWE5YjUxNGQ0ZWU5ZDFhOGVfMy0xNS0xLTEtNjgzMTY_ae6581e4-775b-4a1b-bcf3-9de3a8c4147b"
      unitRef="number">1.00</sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMaximum>
    <sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMinimum
      contextRef="if5a58a2d117b40d8a0d022c115299b14_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmZjNjRjNWI2MDI2YzRkOGFhOWI1MTRkNGVlOWQxYThlL3RhYmxlcmFuZ2U6ZmM2NGM1YjYwMjZjNGQ4YWE5YjUxNGQ0ZWU5ZDFhOGVfNC0xNy0xLTEtNzk1NDg_05758aba-b142-48d3-b4de-fff77473712c"
      unitRef="number">-0.13</sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMinimum>
    <sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMaximum
      contextRef="if5a58a2d117b40d8a0d022c115299b14_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmZjNjRjNWI2MDI2YzRkOGFhOWI1MTRkNGVlOWQxYThlL3RhYmxlcmFuZ2U6ZmM2NGM1YjYwMjZjNGQ4YWE5YjUxNGQ0ZWU5ZDFhOGVfNC0xOS0xLTEtNzk1NTE_b4e45f41-84cb-4a5d-b189-64ec37b4accb"
      unitRef="number">1.00</sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="i73253fc85d9d4718b307a6aeea2b9c06_D20230101-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmZjNjRjNWI2MDI2YzRkOGFhOWI1MTRkNGVlOWQxYThlL3RhYmxlcmFuZ2U6ZmM2NGM1YjYwMjZjNGQ4YWE5YjUxNGQ0ZWU5ZDFhOGVfNC0xMy0xLTEtNjgzMTY_25a34dcc-9435-4777-85d9-096292110a3d"
      unitRef="number">0.039</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="i73253fc85d9d4718b307a6aeea2b9c06_D20230101-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmZjNjRjNWI2MDI2YzRkOGFhOWI1MTRkNGVlOWQxYThlL3RhYmxlcmFuZ2U6ZmM2NGM1YjYwMjZjNGQ4YWE5YjUxNGQ0ZWU5ZDFhOGVfNC0xNS0xLTEtNjgzMTY_0bbeef21-fd68-43b4-9be6-6d46b602f1ce"
      unitRef="number">0.050</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="if5a58a2d117b40d8a0d022c115299b14_D20220101-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmZjNjRjNWI2MDI2YzRkOGFhOWI1MTRkNGVlOWQxYThlL3RhYmxlcmFuZ2U6ZmM2NGM1YjYwMjZjNGQ4YWE5YjUxNGQ0ZWU5ZDFhOGVfNS0xNy0xLTEtNzk1NDg_a0a44856-29ac-4dd9-a6cb-8e56b91958a4"
      unitRef="number">0.004</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="if5a58a2d117b40d8a0d022c115299b14_D20220101-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmZjNjRjNWI2MDI2YzRkOGFhOWI1MTRkNGVlOWQxYThlL3RhYmxlcmFuZ2U6ZmM2NGM1YjYwMjZjNGQ4YWE5YjUxNGQ0ZWU5ZDFhOGVfNS0xOS0xLTEtNzk1NTE_0f129aee-ceae-41af-92ea-59fffafdd1c7"
      unitRef="number">0.012</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i542cba4badbf402198062c358fb44a47_D20230101-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmZjNjRjNWI2MDI2YzRkOGFhOWI1MTRkNGVlOWQxYThlL3RhYmxlcmFuZ2U6ZmM2NGM1YjYwMjZjNGQ4YWE5YjUxNGQ0ZWU5ZDFhOGVfNS0xMy0xLTEtNjgzMTY_31204922-ae1c-4735-a10c-76c3a4d76cc4"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i0fd34d1ccf7c424faab3f807a548673b_D20230101-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmZjNjRjNWI2MDI2YzRkOGFhOWI1MTRkNGVlOWQxYThlL3RhYmxlcmFuZ2U6ZmM2NGM1YjYwMjZjNGQ4YWE5YjUxNGQ0ZWU5ZDFhOGVfNS0xNS0xLTEtNjgzMTY_df180238-e292-4ce0-a06f-39bb84341e8b"
      unitRef="number">0.013</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="idce254121fa64dda9831a0bf7d7be47d_D20220101-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmZjNjRjNWI2MDI2YzRkOGFhOWI1MTRkNGVlOWQxYThlL3RhYmxlcmFuZ2U6ZmM2NGM1YjYwMjZjNGQ4YWE5YjUxNGQ0ZWU5ZDFhOGVfNi0xNy0xLTEtNzk1NDg_a1fb451e-ac87-4be5-91ed-814f11766990"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ic31c0bf439854ab39758877476c132a4_D20220101-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmZjNjRjNWI2MDI2YzRkOGFhOWI1MTRkNGVlOWQxYThlL3RhYmxlcmFuZ2U6ZmM2NGM1YjYwMjZjNGQ4YWE5YjUxNGQ0ZWU5ZDFhOGVfNi0xOS0xLTEtNzk1NTE_542b1e23-0f21-43bb-9e32-28df85ff7cc5"
      unitRef="number">0.010</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="i9878b683aeef427ebf14f59132cf0f4a_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfMzg0ODI5MDcxMjk5NA_b5cc05bd-2d8e-4b2e-b36b-4218e88a8dab"
      unitRef="usd">4100000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i73253fc85d9d4718b307a6aeea2b9c06_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfMzg0ODI5MDcxMzA2NQ_4846fa77-2186-48fa-b375-edd6ffa8fd00">P2Y4M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfNDAzNA_398517f9-8f04-45a4-a505-35561478bf27">The table below summarizes RSU and PSU activity for the three months ended March 31, 2023:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.222%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.258%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.258%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.258%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.258%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.982%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;PSUs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,794,928&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$22.72&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,596&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$19.50&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,044,344&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.69&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255,458&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.33&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(228,388)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.97&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25,932)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.50&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canceled and forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(86,107)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.70&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,524,777&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.82&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;385,122&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.74&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfNDAzNA_5147c52e-c22c-42c2-a6a0-e0865c551406">The table below summarizes RSU and PSU activity for the three months ended March 31, 2023:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.222%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.258%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.258%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.258%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.258%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.982%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;PSUs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,794,928&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$22.72&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,596&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$19.50&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,044,344&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.69&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255,458&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.33&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(228,388)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.97&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25,932)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.50&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canceled and forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(86,107)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.70&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,524,777&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.82&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;385,122&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.74&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i2829f82cc061453792f3357c0e3b2d45_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmE2MGEzYzg4MGNlZjQzMjM5MTU4MzMyMjI4OTFjNGRjL3RhYmxlcmFuZ2U6YTYwYTNjODgwY2VmNDMyMzkxNTgzMzIyMjg5MWM0ZGNfMi0yLTEtMS02ODMxNg_38ae9fc6-3f8d-47c7-84be-bc46a8733994"
      unitRef="shares">1794928</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i2829f82cc061453792f3357c0e3b2d45_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmE2MGEzYzg4MGNlZjQzMjM5MTU4MzMyMjI4OTFjNGRjL3RhYmxlcmFuZ2U6YTYwYTNjODgwY2VmNDMyMzkxNTgzMzIyMjg5MWM0ZGNfMi00LTEtMS02ODMxNg_56f7ac1c-f373-4bfa-9469-cb34d179725d"
      unitRef="usdPerShare">22.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i0c44b4d86d814a99aa4f0201bc819c63_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmE2MGEzYzg4MGNlZjQzMjM5MTU4MzMyMjI4OTFjNGRjL3RhYmxlcmFuZ2U6YTYwYTNjODgwY2VmNDMyMzkxNTgzMzIyMjg5MWM0ZGNfMi02LTEtMS02ODMxNg_938aabce-5dc8-4b5d-9bba-b99e7a96f9c2"
      unitRef="shares">155596</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i0c44b4d86d814a99aa4f0201bc819c63_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmE2MGEzYzg4MGNlZjQzMjM5MTU4MzMyMjI4OTFjNGRjL3RhYmxlcmFuZ2U6YTYwYTNjODgwY2VmNDMyMzkxNTgzMzIyMjg5MWM0ZGNfMi04LTEtMS02ODMxNg_9032f142-3f8c-4410-982e-0d1cf01d83c8"
      unitRef="usdPerShare">19.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="iaf9a24c75b524dfa94a49c4ab5a022c0_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmE2MGEzYzg4MGNlZjQzMjM5MTU4MzMyMjI4OTFjNGRjL3RhYmxlcmFuZ2U6YTYwYTNjODgwY2VmNDMyMzkxNTgzMzIyMjg5MWM0ZGNfMy0yLTEtMS02ODMxNg_46c0615c-2c4a-416c-924e-6c05774e4346"
      unitRef="shares">1044344</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="iaf9a24c75b524dfa94a49c4ab5a022c0_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmE2MGEzYzg4MGNlZjQzMjM5MTU4MzMyMjI4OTFjNGRjL3RhYmxlcmFuZ2U6YTYwYTNjODgwY2VmNDMyMzkxNTgzMzIyMjg5MWM0ZGNfMy00LTEtMS02ODMxNg_8a3cd8f4-b1a3-4215-bf0f-705cf9cf1c9c"
      unitRef="usdPerShare">15.69</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i73253fc85d9d4718b307a6aeea2b9c06_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmE2MGEzYzg4MGNlZjQzMjM5MTU4MzMyMjI4OTFjNGRjL3RhYmxlcmFuZ2U6YTYwYTNjODgwY2VmNDMyMzkxNTgzMzIyMjg5MWM0ZGNfMy02LTEtMS02ODMxNg_644f05c1-070b-4f46-8564-b43459bc23d4"
      unitRef="shares">255458</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i73253fc85d9d4718b307a6aeea2b9c06_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmE2MGEzYzg4MGNlZjQzMjM5MTU4MzMyMjI4OTFjNGRjL3RhYmxlcmFuZ2U6YTYwYTNjODgwY2VmNDMyMzkxNTgzMzIyMjg5MWM0ZGNfMy04LTEtMS02ODMxNg_cfbb8f86-a290-4b7a-9ab2-c4bd0a08f958"
      unitRef="usdPerShare">12.33</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="iaf9a24c75b524dfa94a49c4ab5a022c0_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmE2MGEzYzg4MGNlZjQzMjM5MTU4MzMyMjI4OTFjNGRjL3RhYmxlcmFuZ2U6YTYwYTNjODgwY2VmNDMyMzkxNTgzMzIyMjg5MWM0ZGNfNC0yLTEtMS02ODMxNg_885e8ee8-663e-410e-8e15-961789ea44c6"
      unitRef="shares">228388</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="iaf9a24c75b524dfa94a49c4ab5a022c0_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmE2MGEzYzg4MGNlZjQzMjM5MTU4MzMyMjI4OTFjNGRjL3RhYmxlcmFuZ2U6YTYwYTNjODgwY2VmNDMyMzkxNTgzMzIyMjg5MWM0ZGNfNC00LTEtMS02ODMxNg_e265b819-0d47-42c2-980d-db4e1dd490e9"
      unitRef="usdPerShare">22.97</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i73253fc85d9d4718b307a6aeea2b9c06_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmE2MGEzYzg4MGNlZjQzMjM5MTU4MzMyMjI4OTFjNGRjL3RhYmxlcmFuZ2U6YTYwYTNjODgwY2VmNDMyMzkxNTgzMzIyMjg5MWM0ZGNfNC02LTEtMS02ODMxNg_4c8ceffd-eb98-4be4-945c-bb1b03671712"
      unitRef="shares">25932</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i73253fc85d9d4718b307a6aeea2b9c06_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmE2MGEzYzg4MGNlZjQzMjM5MTU4MzMyMjI4OTFjNGRjL3RhYmxlcmFuZ2U6YTYwYTNjODgwY2VmNDMyMzkxNTgzMzIyMjg5MWM0ZGNfNC04LTEtMS02ODMxNg_724b49c5-ef4a-461a-bc2a-d3ed6666fa80"
      unitRef="usdPerShare">19.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="iaf9a24c75b524dfa94a49c4ab5a022c0_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmE2MGEzYzg4MGNlZjQzMjM5MTU4MzMyMjI4OTFjNGRjL3RhYmxlcmFuZ2U6YTYwYTNjODgwY2VmNDMyMzkxNTgzMzIyMjg5MWM0ZGNfNS0yLTEtMS02ODMxNg_a63fb141-48ba-4f12-9e70-272927c63810"
      unitRef="shares">86107</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="iaf9a24c75b524dfa94a49c4ab5a022c0_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmE2MGEzYzg4MGNlZjQzMjM5MTU4MzMyMjI4OTFjNGRjL3RhYmxlcmFuZ2U6YTYwYTNjODgwY2VmNDMyMzkxNTgzMzIyMjg5MWM0ZGNfNS00LTEtMS02ODMxNg_26378df8-9223-472e-9817-aeba3f6837d0"
      unitRef="usdPerShare">21.70</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i73253fc85d9d4718b307a6aeea2b9c06_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmE2MGEzYzg4MGNlZjQzMjM5MTU4MzMyMjI4OTFjNGRjL3RhYmxlcmFuZ2U6YTYwYTNjODgwY2VmNDMyMzkxNTgzMzIyMjg5MWM0ZGNfNS02LTEtMS02ODMxNg_2f8448be-3cd9-4769-be19-741d82fe04f2"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i73253fc85d9d4718b307a6aeea2b9c06_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmE2MGEzYzg4MGNlZjQzMjM5MTU4MzMyMjI4OTFjNGRjL3RhYmxlcmFuZ2U6YTYwYTNjODgwY2VmNDMyMzkxNTgzMzIyMjg5MWM0ZGNfNS04LTEtMS02ODMxNg_b25ed0c0-6be7-454b-8479-6cf203c24d1b"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="iafee48dbb8fc4bfc960af6aa6244917f_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmE2MGEzYzg4MGNlZjQzMjM5MTU4MzMyMjI4OTFjNGRjL3RhYmxlcmFuZ2U6YTYwYTNjODgwY2VmNDMyMzkxNTgzMzIyMjg5MWM0ZGNfNi0yLTEtMS02ODMxNg_418e381d-2bc7-4191-ae97-dd971906a9ed"
      unitRef="shares">2524777</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="iafee48dbb8fc4bfc960af6aa6244917f_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmE2MGEzYzg4MGNlZjQzMjM5MTU4MzMyMjI4OTFjNGRjL3RhYmxlcmFuZ2U6YTYwYTNjODgwY2VmNDMyMzkxNTgzMzIyMjg5MWM0ZGNfNi00LTEtMS02ODMxNg_d4875571-0bc9-4b16-8a2d-876fe52f4710"
      unitRef="usdPerShare">19.82</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i9878b683aeef427ebf14f59132cf0f4a_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmE2MGEzYzg4MGNlZjQzMjM5MTU4MzMyMjI4OTFjNGRjL3RhYmxlcmFuZ2U6YTYwYTNjODgwY2VmNDMyMzkxNTgzMzIyMjg5MWM0ZGNfNi02LTEtMS02ODMxNg_50d868ae-cce9-4c3d-aa3d-c60a6a699c9d"
      unitRef="shares">385122</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i9878b683aeef427ebf14f59132cf0f4a_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmE2MGEzYzg4MGNlZjQzMjM5MTU4MzMyMjI4OTFjNGRjL3RhYmxlcmFuZ2U6YTYwYTNjODgwY2VmNDMyMzkxNTgzMzIyMjg5MWM0ZGNfNi04LTEtMS02ODMxNg_0d7ab66f-9d7d-43c1-80e6-c97f419b3c6c"
      unitRef="usdPerShare">14.74</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="i0491eac20c484a99bcfa28ef410f4825_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfMjc0MA_a6ca75e5-17b8-4599-b258-61d6c085b586"
      unitRef="number">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval
      contextRef="i0491eac20c484a99bcfa28ef410f4825_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfNDAzNQ_fc2dde6d-97c4-44dc-82a3-9a827ca49e66">P6M</sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval>
    <sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval
      contextRef="i78f562b20b2e4096bb55d93c2515d6b4_D20200501-20200531"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfMzI4OQ_e29e798d-7d11-4cb1-a0db-6e983e40cf7f">P12M</sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval>
    <sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods
      contextRef="i78f562b20b2e4096bb55d93c2515d6b4_D20200501-20200531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfMzMxOQ_d07ba8b3-9de4-452d-95e3-3eac62331505"
      unitRef="purchase_period">2</sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods>
    <us-gaap:OtherEmployeeRelatedLiabilitiesCurrent
      contextRef="i2a36228c84c94fdd90258ab5546be250_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfMzcxMg_f9a5889d-e446-48a7-8157-f9df87fcc6cb"
      unitRef="usd">1200000</us-gaap:OtherEmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OtherEmployeeRelatedLiabilitiesCurrent
      contextRef="id0b8dd5bc1a74d16976adc6fe0963e3c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfMzcxOQ_22f346c0-7a1d-422d-a3b4-182d7af91603"
      unitRef="usd">300000</us-gaap:OtherEmployeeRelatedLiabilitiesCurrent>
    <us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RleHRyZWdpb246NmUxOWRhOTMxNmI0NDM4Mjg3OGNjMDc1ODQ3ZGI3MDlfNDAzMQ_2cd55a1d-d6e3-44d0-b579-d406ea2f86aa">&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents the detail of stock-based compensation expense amounts included in the condensed consolidated statements of operations:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.305%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.879%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.690%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.879%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.693%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of goods sold&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales and marketing&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i017405027da74f35a1e9b7624aa42eb3_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmRiYzQwNDFjMzEyYjRjYTU4MTczYjViZmMyYmE5YjM3L3RhYmxlcmFuZ2U6ZGJjNDA0MWMzMTJiNGNhNTgxNzNiNWJmYzJiYTliMzdfMy0yLTEtMS02ODMxNg_7ad0a5a7-1fed-44c9-ac70-6a855c8bcaa3"
      unitRef="usd">137000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ibaf29913eb3446079f07610b7349c5a2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmRiYzQwNDFjMzEyYjRjYTU4MTczYjViZmMyYmE5YjM3L3RhYmxlcmFuZ2U6ZGJjNDA0MWMzMTJiNGNhNTgxNzNiNWJmYzJiYTliMzdfMy00LTEtMS02ODMxNg_2ea6b2f2-78d1-403c-b1de-640805b53e31"
      unitRef="usd">123000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i90358afa0410497b9f081e97dbf0db01_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmRiYzQwNDFjMzEyYjRjYTU4MTczYjViZmMyYmE5YjM3L3RhYmxlcmFuZ2U6ZGJjNDA0MWMzMTJiNGNhNTgxNzNiNWJmYzJiYTliMzdfNC0yLTEtMS02ODMxNg_438e1e29-2bd7-4e57-9c5f-b5b0041a337c"
      unitRef="usd">2910000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iff0a36e596f44a779c08847487b58a42_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmRiYzQwNDFjMzEyYjRjYTU4MTczYjViZmMyYmE5YjM3L3RhYmxlcmFuZ2U6ZGJjNDA0MWMzMTJiNGNhNTgxNzNiNWJmYzJiYTliMzdfNC00LTEtMS02ODMxNg_4da9be45-212b-45f0-b254-a2a057620607"
      unitRef="usd">2594000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie75cc149b1a34a578c7e33c33a5bb53e_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmRiYzQwNDFjMzEyYjRjYTU4MTczYjViZmMyYmE5YjM3L3RhYmxlcmFuZ2U6ZGJjNDA0MWMzMTJiNGNhNTgxNzNiNWJmYzJiYTliMzdfNS0yLTEtMS02ODMxNg_0814a797-b6fe-475f-9cf1-134eb16d7d02"
      unitRef="usd">752000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia11934861f834ff494d0a96536ea4362_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmRiYzQwNDFjMzEyYjRjYTU4MTczYjViZmMyYmE5YjM3L3RhYmxlcmFuZ2U6ZGJjNDA0MWMzMTJiNGNhNTgxNzNiNWJmYzJiYTliMzdfNS00LTEtMS02ODMxNg_89e4a118-56e3-4c5e-a5bf-0d7a53412a59"
      unitRef="usd">633000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ica097e93dc6e43ceb0f401463e05eced_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmRiYzQwNDFjMzEyYjRjYTU4MTczYjViZmMyYmE5YjM3L3RhYmxlcmFuZ2U6ZGJjNDA0MWMzMTJiNGNhNTgxNzNiNWJmYzJiYTliMzdfNi0yLTEtMS02ODMxNg_690a5c67-1e3b-4f95-b968-f240fab135b0"
      unitRef="usd">2395000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i7d77a44aec9a441e8285b555ea83a233_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmRiYzQwNDFjMzEyYjRjYTU4MTczYjViZmMyYmE5YjM3L3RhYmxlcmFuZ2U6ZGJjNDA0MWMzMTJiNGNhNTgxNzNiNWJmYzJiYTliMzdfNi00LTEtMS02ODMxNg_efc79a26-be55-4e56-9654-d8817c2a1672"
      unitRef="usd">2157000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmRiYzQwNDFjMzEyYjRjYTU4MTczYjViZmMyYmE5YjM3L3RhYmxlcmFuZ2U6ZGJjNDA0MWMzMTJiNGNhNTgxNzNiNWJmYzJiYTliMzdfNy0yLTEtMS02ODMxNg_3005aed0-6133-417d-b3d7-37d6400adaa6"
      unitRef="usd">6194000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81Mi9mcmFnOjZlMTlkYTkzMTZiNDQzODI4NzhjYzA3NTg0N2RiNzA5L3RhYmxlOmRiYzQwNDFjMzEyYjRjYTU4MTczYjViZmMyYmE5YjM3L3RhYmxlcmFuZ2U6ZGJjNDA0MWMzMTJiNGNhNTgxNzNiNWJmYzJiYTliMzdfNy00LTEtMS02ODMxNg_12313a37-71f9-46df-99c6-315a2186678c"
      unitRef="usd">5507000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81NS9mcmFnOjk5MTU2Yjk5YWQ0ZTRlOTU4NTFkMDVkYjVlZjhkZTVmL3RleHRyZWdpb246OTkxNTZiOTlhZDRlNGU5NTg1MWQwNWRiNWVmOGRlNWZfNjI5_4cc6bedc-d7db-4bf0-b715-221441f1cc44">Net Loss Per Share of Common Stock&lt;div style="margin-bottom:12pt;margin-top:12pt;padding-left:24.75pt;text-indent:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the computation of basic and diluted net loss per share:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;padding-left:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:61.388%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.687%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.931%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.942%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands, except share and per share data)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,410)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average shares used to compute basic and diluted net loss per share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,916,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,792,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss per share, basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Because the Company has reported a net loss in all periods presented, outstanding stock options, restricted stock units, ESPP purchase rights and common stock warrants are anti-dilutive and therefore diluted net loss per common share is the same as basic net loss per common share for the periods presented. The following anti-dilutive common stock equivalents were excluded from the computation of diluted net loss per share for the periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;            &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.527%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.025%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.317%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,767,791&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,963,360&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,909,899&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,309,284&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ESPP purchase rights&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134,226&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,264&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock warrants&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,122&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,122&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,930,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,452,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81NS9mcmFnOjk5MTU2Yjk5YWQ0ZTRlOTU4NTFkMDVkYjVlZjhkZTVmL3RleHRyZWdpb246OTkxNTZiOTlhZDRlNGU5NTg1MWQwNWRiNWVmOGRlNWZfNjI3_184481ec-e012-4676-90bd-918ddc7e1108">&lt;div style="margin-bottom:12pt;margin-top:12pt;padding-left:24.75pt;text-indent:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the computation of basic and diluted net loss per share:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;padding-left:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:61.388%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.687%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.931%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.942%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands, except share and per share data)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,410)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average shares used to compute basic and diluted net loss per share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,916,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,792,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss per share, basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81NS9mcmFnOjk5MTU2Yjk5YWQ0ZTRlOTU4NTFkMDVkYjVlZjhkZTVmL3RhYmxlOjNiNDg0Yjg2NjVjMzQ2MTk5NjRkZGNjMjQ5MWYyOWQzL3RhYmxlcmFuZ2U6M2I0ODRiODY2NWMzNDYxOTk2NGRkY2MyNDkxZjI5ZDNfMy0xLTEtMS02ODMxNg_d9b8f20c-fd61-418d-970a-f1c5716c8b41"
      unitRef="usd">-11125000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81NS9mcmFnOjk5MTU2Yjk5YWQ0ZTRlOTU4NTFkMDVkYjVlZjhkZTVmL3RhYmxlOjNiNDg0Yjg2NjVjMzQ2MTk5NjRkZGNjMjQ5MWYyOWQzL3RhYmxlcmFuZ2U6M2I0ODRiODY2NWMzNDYxOTk2NGRkY2MyNDkxZjI5ZDNfMy0zLTEtMS02ODMxNg_30919542-3fc0-4728-a7b3-aec7be63f83a"
      unitRef="usd">-17410000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81NS9mcmFnOjk5MTU2Yjk5YWQ0ZTRlOTU4NTFkMDVkYjVlZjhkZTVmL3RhYmxlOjNiNDg0Yjg2NjVjMzQ2MTk5NjRkZGNjMjQ5MWYyOWQzL3RhYmxlcmFuZ2U6M2I0ODRiODY2NWMzNDYxOTk2NGRkY2MyNDkxZjI5ZDNfNS0xLTEtMS02ODMxNg_4dffa458-7720-46db-b3f7-646ac481778d"
      unitRef="shares">34916106</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81NS9mcmFnOjk5MTU2Yjk5YWQ0ZTRlOTU4NTFkMDVkYjVlZjhkZTVmL3RhYmxlOjNiNDg0Yjg2NjVjMzQ2MTk5NjRkZGNjMjQ5MWYyOWQzL3RhYmxlcmFuZ2U6M2I0ODRiODY2NWMzNDYxOTk2NGRkY2MyNDkxZjI5ZDNfNS0xLTEtMS02ODMxNg_e5946455-a44b-49ce-9262-66b4addbf777"
      unitRef="shares">34916106</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81NS9mcmFnOjk5MTU2Yjk5YWQ0ZTRlOTU4NTFkMDVkYjVlZjhkZTVmL3RhYmxlOjNiNDg0Yjg2NjVjMzQ2MTk5NjRkZGNjMjQ5MWYyOWQzL3RhYmxlcmFuZ2U6M2I0ODRiODY2NWMzNDYxOTk2NGRkY2MyNDkxZjI5ZDNfNS0zLTEtMS02ODMxNg_2d51b2b4-b9da-4988-be1b-6e7f5c188b27"
      unitRef="shares">33792326</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81NS9mcmFnOjk5MTU2Yjk5YWQ0ZTRlOTU4NTFkMDVkYjVlZjhkZTVmL3RhYmxlOjNiNDg0Yjg2NjVjMzQ2MTk5NjRkZGNjMjQ5MWYyOWQzL3RhYmxlcmFuZ2U6M2I0ODRiODY2NWMzNDYxOTk2NGRkY2MyNDkxZjI5ZDNfNS0zLTEtMS02ODMxNg_4d4755d7-6518-4465-8213-b05de271c3c6"
      unitRef="shares">33792326</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81NS9mcmFnOjk5MTU2Yjk5YWQ0ZTRlOTU4NTFkMDVkYjVlZjhkZTVmL3RhYmxlOjNiNDg0Yjg2NjVjMzQ2MTk5NjRkZGNjMjQ5MWYyOWQzL3RhYmxlcmFuZ2U6M2I0ODRiODY2NWMzNDYxOTk2NGRkY2MyNDkxZjI5ZDNfNy0xLTEtMS02ODMxNg_20a9feb2-a793-4d2d-b2fa-91f13ba162cf"
      unitRef="usdPerShare">-0.32</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81NS9mcmFnOjk5MTU2Yjk5YWQ0ZTRlOTU4NTFkMDVkYjVlZjhkZTVmL3RhYmxlOjNiNDg0Yjg2NjVjMzQ2MTk5NjRkZGNjMjQ5MWYyOWQzL3RhYmxlcmFuZ2U6M2I0ODRiODY2NWMzNDYxOTk2NGRkY2MyNDkxZjI5ZDNfNy0xLTEtMS02ODMxNg_899498eb-858e-49f3-8bb7-2a199de5573a"
      unitRef="usdPerShare">-0.32</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81NS9mcmFnOjk5MTU2Yjk5YWQ0ZTRlOTU4NTFkMDVkYjVlZjhkZTVmL3RhYmxlOjNiNDg0Yjg2NjVjMzQ2MTk5NjRkZGNjMjQ5MWYyOWQzL3RhYmxlcmFuZ2U6M2I0ODRiODY2NWMzNDYxOTk2NGRkY2MyNDkxZjI5ZDNfNy0zLTEtMS02ODMxNg_031c3b0a-f332-40bf-8e4e-1799b524ab4f"
      unitRef="usdPerShare">-0.52</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81NS9mcmFnOjk5MTU2Yjk5YWQ0ZTRlOTU4NTFkMDVkYjVlZjhkZTVmL3RhYmxlOjNiNDg0Yjg2NjVjMzQ2MTk5NjRkZGNjMjQ5MWYyOWQzL3RhYmxlcmFuZ2U6M2I0ODRiODY2NWMzNDYxOTk2NGRkY2MyNDkxZjI5ZDNfNy0zLTEtMS02ODMxNg_e8b6fd90-3af6-4a01-8b02-79088d2e9dc9"
      unitRef="usdPerShare">-0.52</us-gaap:EarningsPerShareBasic>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81NS9mcmFnOjk5MTU2Yjk5YWQ0ZTRlOTU4NTFkMDVkYjVlZjhkZTVmL3RleHRyZWdpb246OTkxNTZiOTlhZDRlNGU5NTg1MWQwNWRiNWVmOGRlNWZfNjI4_fc229622-073b-4bc8-a634-cf76ff7ead1b">The following anti-dilutive common stock equivalents were excluded from the computation of diluted net loss per share for the periods presented:&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;            &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.527%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.025%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.317%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,767,791&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,963,360&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,909,899&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,309,284&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ESPP purchase rights&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134,226&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,264&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock warrants&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,122&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,122&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,930,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,452,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i3ae664fc28564f66ac4064ddbcbd566e_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81NS9mcmFnOjk5MTU2Yjk5YWQ0ZTRlOTU4NTFkMDVkYjVlZjhkZTVmL3RhYmxlOjllNDM0YWZjOGY5OTQ0OGE4ZmM1MWU1YzMwNGRkMmRiL3RhYmxlcmFuZ2U6OWU0MzRhZmM4Zjk5NDQ4YThmYzUxZTVjMzA0ZGQyZGJfMi0xLTEtMS02ODMxNg_04e17424-f602-4cb0-842f-b22e33c9f03f"
      unitRef="shares">1767791</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i727673cf2e684c87b5b941e19e9dead2_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81NS9mcmFnOjk5MTU2Yjk5YWQ0ZTRlOTU4NTFkMDVkYjVlZjhkZTVmL3RhYmxlOjllNDM0YWZjOGY5OTQ0OGE4ZmM1MWU1YzMwNGRkMmRiL3RhYmxlcmFuZ2U6OWU0MzRhZmM4Zjk5NDQ4YThmYzUxZTVjMzA0ZGQyZGJfMi0zLTEtMS02ODMxNg_66667e4c-a498-4980-b1fb-9150301a56d7"
      unitRef="shares">1963360</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib3a30c8bb4fa4da191e1db1a2cdf4ad3_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81NS9mcmFnOjk5MTU2Yjk5YWQ0ZTRlOTU4NTFkMDVkYjVlZjhkZTVmL3RhYmxlOjllNDM0YWZjOGY5OTQ0OGE4ZmM1MWU1YzMwNGRkMmRiL3RhYmxlcmFuZ2U6OWU0MzRhZmM4Zjk5NDQ4YThmYzUxZTVjMzA0ZGQyZGJfMy0xLTEtMS02ODMxNg_bcbe3a8b-3677-4521-a08f-3117367c12ad"
      unitRef="shares">2909899</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i58b615af0c5645a8bab43631dc6ce435_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81NS9mcmFnOjk5MTU2Yjk5YWQ0ZTRlOTU4NTFkMDVkYjVlZjhkZTVmL3RhYmxlOjllNDM0YWZjOGY5OTQ0OGE4ZmM1MWU1YzMwNGRkMmRiL3RhYmxlcmFuZ2U6OWU0MzRhZmM4Zjk5NDQ4YThmYzUxZTVjMzA0ZGQyZGJfMy0zLTEtMS02ODMxNg_fdab15d1-4a0e-4ff6-a62d-19c354a9cae7"
      unitRef="shares">2309284</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="iba2a746fe9d742cd9ce6866ca1f467ca_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81NS9mcmFnOjk5MTU2Yjk5YWQ0ZTRlOTU4NTFkMDVkYjVlZjhkZTVmL3RhYmxlOjllNDM0YWZjOGY5OTQ0OGE4ZmM1MWU1YzMwNGRkMmRiL3RhYmxlcmFuZ2U6OWU0MzRhZmM4Zjk5NDQ4YThmYzUxZTVjMzA0ZGQyZGJfNS0xLTEtMS02ODMxNg_2e777825-9a0c-42cf-be46-e757977f8dbe"
      unitRef="shares">134226</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i3834751827fd42c693830e07acfee079_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81NS9mcmFnOjk5MTU2Yjk5YWQ0ZTRlOTU4NTFkMDVkYjVlZjhkZTVmL3RhYmxlOjllNDM0YWZjOGY5OTQ0OGE4ZmM1MWU1YzMwNGRkMmRiL3RhYmxlcmFuZ2U6OWU0MzRhZmM4Zjk5NDQ4YThmYzUxZTVjMzA0ZGQyZGJfNS0zLTEtMS02ODMxNg_b3b2d313-67d8-4dea-88f1-5183ad92e266"
      unitRef="shares">61264</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i785a9d69422049969f551e00c09cd4fe_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81NS9mcmFnOjk5MTU2Yjk5YWQ0ZTRlOTU4NTFkMDVkYjVlZjhkZTVmL3RhYmxlOjllNDM0YWZjOGY5OTQ0OGE4ZmM1MWU1YzMwNGRkMmRiL3RhYmxlcmFuZ2U6OWU0MzRhZmM4Zjk5NDQ4YThmYzUxZTVjMzA0ZGQyZGJfNi0xLTEtMS02ODMxNg_c1543bac-0b7a-41cc-b429-9c67d2dde01a"
      unitRef="shares">118122</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i5cfef6391a45463393b78121e9c5bed4_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81NS9mcmFnOjk5MTU2Yjk5YWQ0ZTRlOTU4NTFkMDVkYjVlZjhkZTVmL3RhYmxlOjllNDM0YWZjOGY5OTQ0OGE4ZmM1MWU1YzMwNGRkMmRiL3RhYmxlcmFuZ2U6OWU0MzRhZmM4Zjk5NDQ4YThmYzUxZTVjMzA0ZGQyZGJfNi0zLTEtMS02ODMxNg_b1eb7dcf-13e5-44bf-9114-f47aaa31de52"
      unitRef="shares">118122</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81NS9mcmFnOjk5MTU2Yjk5YWQ0ZTRlOTU4NTFkMDVkYjVlZjhkZTVmL3RhYmxlOjllNDM0YWZjOGY5OTQ0OGE4ZmM1MWU1YzMwNGRkMmRiL3RhYmxlcmFuZ2U6OWU0MzRhZmM4Zjk5NDQ4YThmYzUxZTVjMzA0ZGQyZGJfNy0xLTEtMS02ODMxNg_4a7f4bc1-ada2-4331-8967-5010a323ad2c"
      unitRef="shares">4930038</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81NS9mcmFnOjk5MTU2Yjk5YWQ0ZTRlOTU4NTFkMDVkYjVlZjhkZTVmL3RhYmxlOjllNDM0YWZjOGY5OTQ0OGE4ZmM1MWU1YzMwNGRkMmRiL3RhYmxlcmFuZ2U6OWU0MzRhZmM4Zjk5NDQ4YThmYzUxZTVjMzA0ZGQyZGJfNy0zLTEtMS02ODMxNg_d9adeb17-ed08-4625-bcfb-3384cd582ba4"
      unitRef="shares">4452030</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81OC9mcmFnOjJmZjdiMzc2YmI5ZjRhYzU5MGMzZTQ3NDBhYzNjYWJjL3RleHRyZWdpb246MmZmN2IzNzZiYjlmNGFjNTkwYzNlNDc0MGFjM2NhYmNfMjgwMA_6db20705-36b1-421e-90e0-0520167b824f">Related Party Transaction &lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 24, 2020, the Company entered into a joint development agreement (the &#x201c;Development Agreement&#x201d;) with SeaSpine Orthopedics Corporation (&#x201c;SeaSpine&#x201d;), which merged with Orthofix Medical, Inc., to develop a next generation device for sacropelvic fixation. Mr. Keith Valentine, who serves as the President, Chief Executive Officer and a member of the board of directors of SeaSpine, also serves as a member of the Company's Board of Directors since August 2015. On April 27, 2021, Addendum No.1 to the Development Agreement was entered into by and between the Company and SeaSpine to extend certain obligations as described under the Development Agreement to a consultant of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the development plan, SeaSpine shall use reasonable efforts to assist in the development of the potential product offering, including licensing certain existing intellectual property to be incorporated into such product. Under the terms of the&#160;Development Agreement, the Company agreed to make monthly payments to SeaSpine to reimburse for full time resources employed by SeaSpine responsible to conduct the development activities. For the three months ended March 31, 2023, the Company did not incur any&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; reimbursement charges from SeaSpine. For the three months ended March 31, 2022, the Company expensed approximately $6,000 of the reimbursement charges from SeaSpine. The reimbursement charges were recorded within research and development expense in the condensed consolidated statements of operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain intellectual property developed pursuant to the project plan will be owned by the Company, certain intellectual property developed pursuant to the project plan will be owned by SeaSpine, and other intellectual property developed pursuant to the project plan will be jointly owned by SeaSpine and the Company. The Company also agreed to provide SeaSpine a royalty-free, worldwide, perpetual, non-exclusive license of certain of the Company's intellectual property incorporated into the product to be developed. The Company also agreed to pay SeaSpine a product royalty, in an amount specified in the Development Agreement, for each resulting product sold for a period of 10 years beginning on the initial market launch. The term of the Development Agreement shall continue until the &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;expiration of all royalty terms, unless earlier terminated by either party, as provided for by the Development Agreement. The Company recorded $0.06 million of royalty for the three months ended March 31, 2023. No royalties were recorded for three months ended March 31, 2022.&lt;/span&gt;&lt;/div&gt;The outstanding liability to SeaSpine as of March 31, 2023 and December 31, 2022 was approximately $0.06 million and $0.1&#160;million, respectively, and was recorded within accrued liabilities and other in the condensed consolidated balance sheet.</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i42f2ba3e6b0746d58d9b74e3cf027cd7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81OC9mcmFnOjJmZjdiMzc2YmI5ZjRhYzU5MGMzZTQ3NDBhYzNjYWJjL3RleHRyZWdpb246MmZmN2IzNzZiYjlmNGFjNTkwYzNlNDc0MGFjM2NhYmNfMTMyMg_a5011924-a32b-4ad9-96d0-6b84a9ca09a4"
      unitRef="usd">6000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <sibn:RelatedPartyTransactionTermOfAgreement
      contextRef="i7bf5dda5bf324c4fa4a20b1e527679ae_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81OC9mcmFnOjJmZjdiMzc2YmI5ZjRhYzU5MGMzZTQ3NDBhYzNjYWJjL3RleHRyZWdpb246MmZmN2IzNzZiYjlmNGFjNTkwYzNlNDc0MGFjM2NhYmNfMjE5OQ_73b16295-e0f0-4185-b383-e25499ba96bc">P10Y</sibn:RelatedPartyTransactionTermOfAgreement>
    <us-gaap:DueToAffiliateCurrent
      contextRef="i5e73e5a0115b4970b15363db24e13c22_I20230331"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81OC9mcmFnOjJmZjdiMzc2YmI5ZjRhYzU5MGMzZTQ3NDBhYzNjYWJjL3RleHRyZWdpb246MmZmN2IzNzZiYjlmNGFjNTkwYzNlNDc0MGFjM2NhYmNfMTA5OTUxMTYzMDkzOQ_1fa0bc52-4e8d-4f7b-a7b7-170cacedacf3"
      unitRef="usd">60000.00</us-gaap:DueToAffiliateCurrent>
    <us-gaap:RoyaltyExpense
      contextRef="i42f2ba3e6b0746d58d9b74e3cf027cd7_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81OC9mcmFnOjJmZjdiMzc2YmI5ZjRhYzU5MGMzZTQ3NDBhYzNjYWJjL3RleHRyZWdpb246MmZmN2IzNzZiYjlmNGFjNTkwYzNlNDc0MGFjM2NhYmNfMjUyOA_cd76ef3e-65cb-40ae-bc64-b91db02893eb"
      unitRef="usd">0</us-gaap:RoyaltyExpense>
    <us-gaap:DueToAffiliateCurrent
      contextRef="i5e73e5a0115b4970b15363db24e13c22_I20230331"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81OC9mcmFnOjJmZjdiMzc2YmI5ZjRhYzU5MGMzZTQ3NDBhYzNjYWJjL3RleHRyZWdpb246MmZmN2IzNzZiYjlmNGFjNTkwYzNlNDc0MGFjM2NhYmNfMjY0MQ_1fa0bc52-4e8d-4f7b-a7b7-170cacedacf3"
      unitRef="usd">60000.00</us-gaap:DueToAffiliateCurrent>
    <us-gaap:DueToAffiliateCurrent
      contextRef="i7a94faa120a0446aa696de6aeda19c4b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl81OC9mcmFnOjJmZjdiMzc2YmI5ZjRhYzU5MGMzZTQ3NDBhYzNjYWJjL3RleHRyZWdpb246MmZmN2IzNzZiYjlmNGFjNTkwYzNlNDc0MGFjM2NhYmNfNTQ5NzU1ODE2ODgx_780dde2a-1108-4672-b4f1-ba1bc273782a"
      unitRef="usd">100000</us-gaap:DueToAffiliateCurrent>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl82MS9mcmFnOmQyOGUyMzliY2IyMzQyN2I5MzIyYTIzYzYwM2QwOGRmL3RleHRyZWdpb246ZDI4ZTIzOWJjYjIzNDI3YjkzMjJhMjNjNjAzZDA4ZGZfMjQzOA_ce65716f-3018-469c-9b0b-3c492b9ee61e">Income TaxesIn determining quarterly provisions for income taxes, the Company uses the annual estimated effective tax rate applied to the actual year-to-date profit or loss, adjusted for discrete items arising in that quarter. The Company updates its estimate of its annual effective tax rate at the end of each quarterly period. The estimate takes into account annual forecasted income (loss) before income taxes, the geographic mix of income (loss) before income taxes and any significant permanent tax items. The Company did not have provision for income taxes for the three months ended March 31, 2023 and 2022. The Company continues to maintain a full valuation allowance against its net deferred tax assets due to the uncertainty surrounding realization of such assets.&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for the uncertainty in income taxes by utilizing a comprehensive model for the recognition, measurement, presentation and disclosure in financial statements of any uncertain tax positions that have been taken or are expected to be taken on an income tax return. There had been no changes in the estimated uncertain tax benefits recorded as of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;March 31, 2023&lt;/span&gt; compared to December 31, 2022.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2eee4a74d9f049d7a2c1ca2683d9d687_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl82MS9mcmFnOmQyOGUyMzliY2IyMzQyN2I5MzIyYTIzYzYwM2QwOGRmL3RleHRyZWdpb246ZDI4ZTIzOWJjYjIzNDI3YjkzMjJhMjNjNjAzZDA4ZGZfNTM5_2bc03212-876e-457f-98af-303df4e8d1e0"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i98922e161396461cb3686ce9a8571fb1_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyOGFhNTA1YTJlYTQ2MDc5ZGE0ZTUwODIwMDIyNjdiL3NlYzo5MjhhYTUwNWEyZWE0NjA3OWRhNGU1MDgyMDAyMjY3Yl82MS9mcmFnOmQyOGUyMzliY2IyMzQyN2I5MzIyYTIzYzYwM2QwOGRmL3RleHRyZWdpb246ZDI4ZTIzOWJjYjIzNDI3YjkzMjJhMjNjNjAzZDA4ZGZfNTM5_f6e6f6ca-95ee-416d-9894-04980c11a8d6"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>161
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M$;^HBFG.5_6G4M5F+=JV;OF>WUI%;2M,[:Y2ARMYPV9]:Q:0&NQ^6:BWT(W
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MDHKC_?4[4K)B>[:+/>S!)H_D??SN/O+$V4:J9UT@&G@M1:7G7F%,?3T<ZK3
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M=Q5<-6;5&- -]@Q;-'G<+Y-$9!M==$5S'$B*===<N0N1^[10*T5T+;>AX;\
M!#)&Y+S-[]',^KOZ'8E_NP[UCE8XEVL6YN2$!G1X(AT8&J<?X2#B9TL%I$98
M$L#/Y_Y*IK^JXZ,W#97R:WZ?$@2O8.FE0_>T>V5SG]Y4'(ZG]SV@[#42C,FP
M@NAD=+D<")_>H:2;Z&I^;Y&Y&%W%7TN%NO5T +^O'-JSO2$#W8NLN[\ 4$L#
M!!0    (  2#HE;46X1WY@H  $<>   9    >&PO=V]R:W-H965T<R]S:&5E
M=#$S+GAM;,59VW(;-Q+]%11C)W+5A.)%E.2;JB0[KHW+WKALQZFMK7T 9T 2
M,68P 6;(:+]^3S<P-XJD-_NR+Q(Y S2Z3W>?[@9?[*S[ZC=*5>+/W!3^Y6A3
M5>6S\W.?;E0N_=B6JL";E76YK/#5K<]]Z93,>%-NSF>3R>5Y+G4QNGG!SSZX
MFQ>VKHPNU <G?)WGTMW?*6-W+T?34?/@HUYO*GIP?O.BE&OU256_EA\<OIVW
M4C*=J\)K6PBG5B]'M]-G=Q>TGA=\T6KG>Y\%6;*T]BM]^3E[.9J00LJHM"()
M$O^VZI4RA@1!C3^BS%%[)&WL?VZDOV';8<M2>O7*FM]T5FU>CJY'(E,K69OJ
MH]W]345[%B0OM<;S7[$+:V=7(Y'6OK)YW P-<EV$__+/B$-OP_7DR(99W#!C
MO<-!K.5K6<F;%\[NA*/5D$8?V%3>#>5T04[Y5#F\U=A7W=Q9AQVZ6/L7YQ7D
MT=/S-.Z]"WMG1_;.Q7M;5!LO?BHRE0WWGT-JJ\RL4>9N=E+@>^G&8CY-Q&PR
MFY^0-V^-F[.\^1%YK]6R$J^U3XWUM5/BG[=+7SD$PK\.&1MD71R61<GQS)<R
M52]'B'ZOW%:-;K[_;GHY>7Y"TXM6TXM3TK_AAI-[#VO6"12?E<O%.RL+\7FC
MQ,H:PR]$)9=&Q6S4_U9>5'B-O/65+#):L.QDK)S-^7U%P@P)DU[8E2B5TS;S
M@D\N*I4]$_!BNFG=*%ZK5.5+Y9HG,W&F"\BRM<<Y_HGXX'21ZE*:P>'X)U:Z
MP-.54N*1F%\F5[,)?5@D5Y.)>*>\?R9^+61N707U,^0BO*V]KV61*I%:7WEQ
M]O3I$W%V-7]"*]/4*6@HMM+4BI3OY)]=7F/-V<7B\HGXI:<%R4Q$ 7+$\D,'
MD)KU2=&L\=/Y=?@PO9J*5T9ZKU<:ZR5L>&>+]8^,:P_PA[L^[WDG:@-F-)*.
MKJR0/?>4M2-%*WI.CN, (&T_J;1VNKH7MVNG%/BU$AD+N*W7X!LQG;&;IN*,
MMGW_W?5L-GG^TVJEF#\%6$;QP^GS)XD@ESOLU06.6=[S2:]L7LKB'D16;<0G
M;70*]OTBC5'WXDX67\59%/KIRUTC:2P^M/I"A&Q42P06(;CL5F<$%TQ8X]T:
M2N!I$S>(@;I@%SV:+\83\*0Q1/G1]$:AOD$DMDV,3HM?"O%6%C7*D[@,\9L,
M1 SLE>*-=D#L%IIF#"0>GL*YKT"[J3D\XO7E+A&[C48&25I!CNW._\&+@>(#
M+X==?6TW,AO$Q$JF< =4TL5?A;*O^B].KSF\6876O&@(&\^VT);6S 0)8TP(
M(A,"I8\$[#PH#3[YM<3Y>.+N ^RMV =[AKX*V81%C^:7/4OZD/7!80M'+;2C
M)XT?=F Z7R\I\2J-,+X7M0_YYE0I&<Q5;0R?O1=_#Y'O9W -$QQO.X(H0^DI
MCBCV<=S6FBWM!-MDNOIK_JQ+4OG1](%71Q]9KG*CD "!OZ<7D;]A,6V/R3J]
M>@[2\UY%[C-:+DD'K7P"-5)3!_9^N,E1?T1[V6*CV/A]ECKFUQVRCH[5ZR)
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MRQ.: <!2S6K-:K[5"CH+(*O)//FSM+'6V'*!IT&C /%3* Y>9"&,<7C!$15
M7Y?WZJ OWYTF2ZF-+YHM_71>=U-MT9>/#N_8Q87>$6"71$\F>]P(S1,  +S;
M0 BWA(*/D*((R)!]JGQ<DS'%-0J>N.>9-DHIC22:&@.<D)>^'E)^0N,A Y<-
MM,^=>OTK!H;059, !"C07<$TOL.% ;)K+:A9X^J20_UHRAY1\/$DJE""75"#
MVEA3?T>ZA6VOV,V32P.&FDNL&5A.>&,5%":9@=LQY&0&$GI6B4VG>$!NZS;2
MH;;O=U<66V?GK;/1HZB9W8CBH:M8\!+N>LZE*)=N(<9Y;].#K NFKY/?=E3R
MH'<#%F3?BOOM_KK@V?WI709L!K'O+G (85Q 7;]7T1>"DKU4VN[JN*7+&7!#
M U6CHYQ][+7<-I=XSP#G 4T0SOU.-Q=STO:["WCO?ONW[CU$X. RUI2-ZV9T
M;-O:VLIP,+]+O"NZ?G8$K;=M>734412FNQX(1F'O ^Y7;%O_T=6^NQ$B+^O=
M"O>:+<KK%'K$>9><=$$%!H<3#A.JD#DM6_""F#-]H 0\]#\E[27HTX9*7Y_P
M!HS"@1!R6737?G_QV-/-Z^.=8?:NN"_H!YW"$H&E4*G:7ZC-09ZW8W?')%4U
M!EQB3L 2EP,KI?#. P2<';$XG>!?V'+'$</H/5=6$:Q),(LC;$6S(5YA!8$$
ME^0"@J-JRN;)*&%C:)>_N:)([WD.S%CBATFB\$F0SD;P-Q[A:= 80=X1@Y8<
M3=BA+XUGO4_%I= K^B".O02\YKX:=[/=-_<K]ZEYM]Q]L =@KR3@KQ!+V!J%
MD]' ?0)I!U;5].%YH2R4*GI<"PXIA0O@_5(IVP[P@.Y_(B[_!%!+ P04
M"  $@Z)6P14B/; #  #C"   &0   'AL+W=O<FMS:&5E=',O<VAE970Q-2YX
M;6R=5FV/XC80_BNCM*INI1Q)' BP!:1ENU4K]4YH:7L?JGXPR4"L3>R<[2Q[
M_?4=.Y!E6Z"G?B%C>^:99]YL9GNEGTR):.&EKJ29!Z6US6T4F;S$FIN!:E#2
MR5;IFEM:ZEUD&HV\\$9U%;$XSJ*:"QDL9GYOI1<SU=I*2%QI,&U=<_UEB97:
MSX,D.&X\BEUIW4:TF#5\AVNTOS4K3:NH1RE$C=(()4'C=A[<);?+H=/W"K\+
MW)L3&5PD&Z6>W.+G8A[$CA!6F%N'P.GSC/=850Z(:'P^8 :]2V=X*A_1?_2Q
M4RP;;O!>59]$8<MY, F@P"UO*_NH]C_A(9Z1P\M59?PO[#O==!1 WAJKZH,Q
M,:B%[+[\Y9"'$X-)?,& '0R8Y]TY\BQ_X)8O9EKM03MM0G."#]5;$SDA75'6
M5M.I(#N[^$AU_T49 RO4L"ZY1E!;N%=U32E;6Y4_S2)+?IQVE!\PEQTFNX"9
MP@<E;6G@0198O+6/B%]/DAU)+ME5P ]<#R!-0F Q2Z_@I7W0J<=++^ ]<"V%
MW)T&_<?=QEA-/?+GN7@[N.%Y.#<WMZ;A.<X#&@R#^AF#Q7??)%G\_16RPY[L
M\!KZ_ZS05<SSC/_;$?Q:(EB^J1 V;IP/HRS^0@.6CG)5-ZWE?MS(E*9%Y,!E
M 86H6HL%2')1.1<-N3#.Q2UA:L0W'0-4[[SL"^Y^&+P3DGRHUA">"0%?<FQL
MA^%=](A0T!S<P,>CJV_A79*$"1O=>'$<#I/X!C[Y<<7B/7]&3;=/9VN@->3?
MJD,H^%4Q0#H,ITD6)G$&:1J.IRQ,6?;*H%<,S\ 1IWB0LIM.&)&PQ)P3#9]1
MRG[#Y1<HN:$KL%':F?!7#I047E7.@U %>7+%E*03 EW QI(CZG,POGBJ<86A
MW)&2U2)W4-U)*X6E_8?U:@5-2[FG:PZT2Y#Q7/.N!SKE/=>:2W?B,V_%>Q\*
MW:U>EUC3O:I<'<XE[ CE\R:ZMC&\)EMS2,YE=4+U^O^*=N ;<ZLJZDD7[UM6
M;]CCYU8\\PI= 'MBZAJI:EW3;;6JSW7QE;I?)/357;T^K0PDX3@;4_\D)$VS
M-$RS&![/%@M8.(VGX60Z)2DEB4V&Y^N74',RZL8L"5DV/([S/TJ9)!.:$-9_
MJ9_3.(S3"4G#$2,IAG-7673R\-2H=_YY-93!5MKN#>IW^Q?\KGNX7M6[YY^R
MLQ.4@PJW9!H/QO1@ZNY)[196-?X9VRA+CZ(72_H7@MHIT/E6*7M<. ?]_YK%
MWU!+ P04    "  $@Z)6/D.(@=D%  #K#@  &0   'AL+W=O<FMS:&5E=',O
M<VAE970Q-BYX;6RM5VUO$SD0_BNC@#A."DF:EH*@K=06T*%3CXH"]^%T'YS=
MV:RIU]ZSO4WR[^\9[TO3%WIPXDNRNYYYYIE7VP<KYR]#R1QI71D;#D=EC/6K
MZ31D)5<J3%S-%BN%\Y6*>/7+::@]JSPI568ZG\WVIY72=G1TD+Z=^Z,#UT2C
M+9]["DU5*;\Y8>-6AZ.=4?_AHUZ643Y,CPYJM>0+CI_K<X^WZ8"2ZXIMT,Z2
MY^)P=+SSZF1/Y)/ %\VKL/5,XLG"N4MY>9\?CF9"B UG41 4_J[XE(T1(-#X
MI\,<#29%<?NY1W^7?(<O"Q7XU)D_=1[+P]'+$>5<J,;$CV[U&W?^/!>\S)F0
M?FG5RNY".&M"=%6G# :5MNV_6G=QV%)X.?N&PKQ3F"?>K:'$\HV*ZNC NQ5Y
MD0::/"17DS;(:2M)N8@>JQIZ\>@C&Q4YIW/EXX8^>66#2O$ZF$; B] TZZ!.
M6JCY-Z!VZ<S96 9Z:W/.;^I/06O@-N^YG<P?!#Q3?D*[.V.:S^:[#^#M#K[N
M)KS='_4UT%_'BQ ]WOZ^S^\6=N]^6&F;5Z%6&1^.T!>!_16/CIX\VMF?O7Z
M]-Y >N\A]!]+T/^$H@^6WO'"-VA+FN^E@,_&%$NF4U?5RFZ(;60/76VC(T5?
M'1Y0_5?HZAH]&DDM/7-Z>BIZ3QZ]G,]GK]]L21SW$FEMY_6O*/58T@6KBQI,
MZ8./)89-KK, L[YV7B5R3SNL7K!7'].JU%E)%?LEF"6PA%'H-9T)CC)C>F^S
M"5QQ/5F0M[R.M&3+G0&LZ(P)$XX0$ \.!A\(,&E]0F>HP]]9\+\H P= 0HP[
M2LD.I$**U3FRKW.LC^FTU%S0VS5GC4P=^E 4,.%)V1P$*JX6>'%%4ELXY7-Y
MR;7'K'(^R$OO[9B4"=N6;JMW&?HET$D/]&8 "MK"L^-FB4F"K.X\GTBNCVNO
M#<U?I$2COXYSL,Z;BOYPDQV)E>#>FSI:@<&-6EALDE,+CBMF>Z-FY/N078@B
M[#!#B$/$;D%N8?12M?T'U)Q#YO4"N WFAW^ 0ZK #&J8O KO-P,QH?/&AT:U
M@K*P7::U479\S2J4RAAJ F.#4<%9M3!,7* 48DAV0M"(G+9W@#JCM8M2$,I0
M[5W>9+)0L-=V.8969IH<CV20?.QC>.J=YS5PY0."B"T)Z6I:C)JE.26P+ !=
M'_31#@T*OK,TH<]#H)"0*O2<[HW:S79.W9J+F4I=,E4RN,V&:K41V>3Z=N8\
MZVJ!J+9-4C2(6<36C._!-3Y#87)5&[<!).IAT,1RC31I"2I0D+(4H=NA3#NS
MCIK#A+#5M@Z5(-CRDH+#AD+8#N!\OQ_<]"?7.5DGB<H:Z;+-->5D(BL5AD2@
MPKMJX/?]UN:WAN$:9Z( (54C%VN-PP$C>H_WQ[/9K,_"=Q'X]$W!%5H,2RB
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MQ.4H/9:XC;(7 :P7#EMR]R(&AOOMT;]02P,$%     @ !(.B5H'<"MKO P
M" D  !D   !X;"]W;W)K<VAE971S+W-H965T,3<N>&ULC5;;;N,V$/V5@0H4
M+9"-'#N[7:2V@23;HGE8(-A;'XH^C,61Q(8BM21E)_OUG2$MQ4:S21\2BQ3/
MF3,WCI8[Y^]"2Q3AOC,VK(HVQOZB+$/54H?AU/5D^4WM?(>1E[XI0^\)50)U
MIIS/9F_*#K4MULNT=^O72S=$HRW=>@A#UZ%_N"+C=JOBK!@W/NBFC;)1KI<]
M-O21XN?^UO.JG%B4[L@&[2QXJE?%Y=G%U;F<3P>^:-J%@V<03S;.W<GB1JV*
MF0@B0U44!N2?+5V3,4+$,K[N.8O)I  /GT?VWY/O[,L& UT[\Z=6L5T5;PM0
M5.-@X@>W^X/V_KP6OLJ9D/[#+I]=+ JHAA!=MP>S@D[;_(OW^S@< -[.O@.8
M[P'SI#L;2BK?8<3UTKL=>#G-;/*07$UH%J>M).5C]/Q6,RZN;VSE.H)/>$]A
M649FE/VRVJ.O,GK^'?0"WCL;VP"_647J&%^RDDG.?)1S-7^6\#WZ4UB<G<!\
M-E\\P[>8W%LDOL6+[L$['2KCPN )_KK<A.BY(/Y^RN7,>/XTHS3)1>BQHE7!
M71#(;ZE8__C#V9O9K\_H/9_TGC_'_F(Z_C_ZQG)Q1O)<,]HV\'5 SROS +UW
M6RT]%8![&G3&1,&<0&P)KEW7HWV (5!(&VCM@ 8H1,UM0 JHKBEUD\# \QY@
MWQO-KZ++D"H*Y('0OXKNE9(C;+C6$=@FIX%MH?J'ZYLQ(D-Q=CSK!1VI"X">
M);)L;9D.XRC_%#X="NR%-S D3.+ U6D]:GY":4P*R2HY2UBUA\$AKYW*9B;*
MB'=BQ;)O6%5NL'&D9^5487)B'\>?Q+>?84/RZHG@-N0:CWVK*^[F^Z3V)2 ;
M4R#^!MU87>L*60 +[= 2/XEC*6C'P5%:@7416MS28\[_D_*T(<)BZXF@R^U,
MTL[ S<C!&;LQR>"'^;&=BA':#E(J#F0*1/X#A'HP!K9H!LRWK^'K'VW%\6_X
M0(@I2Y:G#E^AY+V4#CN"(1#OJX'&2AH8XX4S<@ &[SG\2BJ#)Y#1WS(Y1S$,
M+#6CC_7M,_;HZ"$A*ST*QH:+*FKF%0O(OG7<XZV,H*W$1I&9:#CQCM,A]D^@
M(Y2+A8=5/(%T+7 8LM\<-/5X\[#!6EN.@^;J"7PF88)XD"IZU):"T;N0^$/N
M@93)#9%-!6FED9 IZ;[G$L^MMZ'QG5@^\(WEQL';%!K&M*@RDW50M6B;5-^Y
M+Z8N/Q:S(4NUY$P<]U(>F&0?%\E35V!Y,)TZ\DV:P0%26O*@FG:G,7^9I]OC
M\?R-P,8:+AXP5#-T=OK+ZP)\GKMY$5V?9MW&19Z<Z;'E3Q7R<H#?U\[%<2$&
MIH^?];]02P,$%     @ !(.B5K+OGK-^#   02,  !D   !X;"]W;W)K<VAE
M971S+W-H965T,3@N>&ULI5IK;QLW%OTKA JT":#*LIU7\S#@N$Y;8-L8\687
MB\5^H&8HB<W,<$IR[*B_?L^]E\,9R9*2[GY)QC/DY7V>^Z!>WSO_*:R-B>IS
M737AS60=8_ORY"04:U/K,'.M:?!EZ7RM(_[TJY/0>J-+WE17)V?S^;.36MMF
M<O&:W]WXB]>NBY5MS(U7H:MK[3=O3>7NWTQ.)_V+#W:UCO3BY.)UJU?FUL2/
M[8W'7R>92FEKTP3K&N7-\LWD\O3EV],Y;> 5_[#F/HR>%8FR<.X3_?%+^68R
M)XY,98I()#3^NS-7IJJ($OCX(Q&=Y#-IX_BYI_Z.A8<P"QW,E:O^:<NX?C-Y
M,5&E6>JNBA_<_<\F"?24Z!6N"OROND]KYQ-5="&Z.FT&![5MY'_].2GB:S:<
MI0UGS+<<Q%S^J*.^>.W=O?*T&M3H@47EW6#.-F25V^CQU6)?O+@5:RBW5+=V
MU=BE+703U651N*Z)MEFI&U?9PIJ@'O5/CU^?1!Q-!$Z*=,Q;.>;LP#'GZE?7
MQ'50UTUIRNW])V Y\WW6\_WV["C!7[6?J?/3J3J;GYT?H7>>]7#.],X/T-LG
M\+\O%R%Z^,U_]@DL])[LIT?!]#*TNC!O)HB68/R=F5Q\^\WIL_FK(]P^R=P^
M.4;]XJT.-I#-;HAV$S5Y^#XFCY/Y^]H@+ I7M[K9D.A=H[O21E.JPL%039"G
M (V4FEXO;:.;PNI*!1QJ$)XQJ+6^,VIA3*,@:JL]UMF&"?L2JPU<.J[5RC3&
MZZK:T!?3$C4]*+WU%G3;"FK'W@C&/C;,R"V=P[)>UL;#.]6C;[]Y<78V?_5Q
M=CM3/UU>WO#?IZ\>*]V 9MO"?'I1&>4[(D<OO5EU%2N)*1'Y6U-TWD:;5EQ_
M+M:Z61EUY>K:!@:=_J#;ZZM\!"AI7Q+'MHG@IQZI!,([3]+,U&50K?&UC21"
M!U5Z'.I"XFFJ"N,C(%,MG8N-8P&]<N#+C^C91E"7>(EK'154JQIZ15KTYH_.
MDJX7&Y55,;+%8$$B+:Q,145L&? )*J2*A:[83)(&-*OH1U.8>@%V4HR=@7(0
MPA &0 I?\*[F_2.?^8*G0 86A):H18<'!]&A ,A:5%T)6E756V@L_EA8EA.?
M%#EN94!IWUFS(V'V-(?9TZ/Q<3,X)7BZRN(="+;CQ!!LL/\08;W__)^1YB1:
M@J[)D 0+L!.]N9*P)L\]??Z*O+SI0&V_71JX1HH[U]J&5 Z):]T@,].2*65@
MRJ1L(%W^CLPD6P?'A,>$0+F$;*/54EL_G-$;=9>K S*/;#]3!%/ .>19M@,J
M$I]BF4XBJG'MC5&UI!A#*48A013KG"%2Z,3,I87OVZ8$4E!5T'/7GQ(=M*S,
MYQ82$U_IF(W1GLA3^.\&R#F%&4O>;%(D]Q8&O]:5#[\ON]AYH7K,6Y]E;WUV
MU,$^!I;C.D1;$V;N<]&_1H$U+YXF88B/>_W',MR0R6S<"-P/D)1B-XS<B11<
MZT]0<3Z*@2F@.&S%M.)7RR7YG)B&P)621DTY@ST!ZXUXKZJL7MAJP//2AJ)R
M@?2+A6".<)E./K0G)P;&IO1\*%@.<N3-G6DZPVO(?1#7095(-/"880\G/':*
MV5;5-<J'VXH9:>[WKEP)'RDB)=L2\;^"),BW=1\%C+P"&ART=[KJ6 7@D<,0
MR>%[*GTID:(BLGPH2M/B$_#,@N][Y,0P&SD.A9OL@->L+=92ZJY8)]X:$)RJ
M>\2 &>=KDE0B8^P("U-90_E&@A*M1W -KU](^AJ4@[Q;Q(XSL<0QU%F1+\"-
M?)^O* MG[1Z+N^<Y[IY_(4L0(L'ON8Z K[?$R[[H^U_H<-J)OI,FQA+RNQ7D
M"X/ADDMSQ'"&(*#;()5+IJA0A7*Z<8KJ4%N8M+5WRL(%QF?"PSM;D@(IM;K&
M]'%&!Q,3$KM>;V;J/54,#S\H)* ])T['X$\+FP"30 8RDO:>JT_Q.]Y6ZV(-
M]7A1ALG*H+\69H5#488 F>#6<5<,J1VVN7)WA,<XK MFV54(_:69J;_!E\S:
MP45L#;7>]0%.;EE3G/Y)#GQG!/U1!D":= +")).ZD_*-UX!NST-%U&?J8YM3
M-'P6Z[R)@,-14H1#B@FG@QQ2M58ZE<E=W<GS(#6UM)[BH79;U=A6[.^4=AFY
M*#Q(;RLJ0L$3H#*0Z4#; 8_^W *5@=Q6.A_R\ S9EI)=H\4IB/462"*J1&'M
M5Q*_H]2MV8$[CQKF6!"^R$'XXFCP?$C ^T$$.%2B_64BG )WBY8>Y6UX6 R+
ME9?L;/"I$H'+]41M2D; E7==*Z@.*&IMU!6%+MZNUKRIA',@YQ$=+G"21N/:
M^O)[9&( A'S3JYR.J NL*@JH1,EUDC4Y"S.>=(0NL[$X9&S#SMOJ#1N5RA-B
M =$ MXE2G2&*RG$*0TY=]8&9R_=$"I5AR6J#H* 5I'(0)[)ELGTNI[I@#L7K
MLO.-A=.6/<CW//=[F0O79)-T84<X'(=,NK0IL>T<P/ZG)40'L,L!DA7 JQK7
M?+^[$M%A&2H\=8V"&USW,*+QW ;FV&:I1*^""JDQ":OII+VT@_H#(&PCUZ9(
MT0CY$AT<PBNF#BY  <5ZJDRJ "(7:C3BZK-L:5.=1>;)ALBXQ&3V'"XLH[1P
M/H$VX1\7_8.HQ&&J55)U+"WN:(B"MKTIJ2J ]"77-W'<4E_>#BWUL_FSJ>I#
MC^,(*8_G+DFE5[TZQ]MI6T]BIGYY.&](:[8S3\:W(8A1AG#U&KVK2+ ^.7F!
M+,; Q #W2,AY4O")$5,5%C)8#GX^/EAZB=Q90$FQD@- TO3#A]Z[5\Z502*(
MTR>L\C$-$4QFW(]0*B1U;TO+M55?V;FJ<O=DFB4%:HBFI>_>(=.^5(].'_<1
ML^DE81.(+O5(!8_.=I:.JD3E%I5=)80?$@A3PL[SQT,,2-]&NM92VJ BI3KA
MT9/'U&.ZHG?7!VMZJWSUN>3JCYX^'HR_;7M]@!(Y0\!3 (B4/-*Q,>5DMF-"
M]X3&4LV.M/]=2%^\:?.4#IHO#54,/J28%1H)#5IG);<F $II7C[VZ8+\HL\F
M2UVD#F;;\M+P=,+H(/?8?3JJ2](()?5VB2,4;]0W,=!T*)B]_5,825@\^$)C
MHG0]B]RJB(FH_>*FB.#$CG004LG^.ZC&S<Y4X+N=>4!B=1M%D2]=&B;RF2K0
M/$QQ7R5B^#&6C'/RD(]3O@6;:&<6'=J3U->Y/)H[KNZ1O3-5*G8 0:8?@)9W
MXE%+<K%>K2+,88_C%E1<9#.R23I!\E,/SZ,Z9%2XL6'#.E7,.Q 6OM9H(X4+
MJLNTY<@N2980/O4J['G,X!0U?E6D"C:WA1S<  .J9+P1,&2T&?,[4S_G[K':
M3$5Z=#FE-#<-.HQ1 _U CEN.0'XM]@F 8:H*V$+&<K<Y/F\ /AK5"%]"M0(?
MU+3:8DT*-Y]-T47Y2JCM!K!:2I?0YY0="\S4.YI=[GA9ZO._$-8T@V6F\MB%
M>RW).T&:M2241I !Y(<4,FQDT9K#TI5FF8J4;*!&;@3LU@A]5!%,=UI*(BI#
M\CS'F^8R<Z!)_:Z5RBM(?LR#N#2NAQO#TO&>C,V$40!;L^NA! F'=).KLG&P
M9T.FL7.?/Q-O,J26VHF2T3W[?L__:)K$H^D>7D:A.D54DWTEW_+\I5E-AR'_
MZ!B940#P=9ITC?C,Y6U_]( 56QJ@7--+L*-E^/QP\T*A?SXGC_QAKDJ4P<=:
MKQ]RZ_7#T:[IULA :E^_]74[=T1!ZV]R>PD%E@A9OI"AD6%J*CDJ>-TU!R)E
MUO=+P "4VU>)5]?OMZZ&9/V[/ Y[L/[=^Z&B9):NW^>6 !\)SNB>>?\-34IP
M@FUZMPU'>$[S79N5OF:\6R^H9>L!'1_1W:R\;N&E=.?$\<,^V/G6!;F0,#0P
M$14-+(TRRW:04'R@Q%>++E!T![D0MVG>)+@J4W) !MLE3=8\)3O'W]:FRK=V
M/((CEH:F?CHR6A[8>XK#-*NO(%_%[T8#I@7]-.#AK($GB[QAQHU%NK%Z"(BY
MI"PEH&P4+$!FP(9^YCI,&#.+O9@R7J.2YU@XG,Z'*_7Y%\8(!<@BW"Y+Q_><
M>_LBXD56[O_^&[#G7XC7:YZ!P[_WWKI_#2=;M_G>-7@N$DK^QM6A<&M#Z+8O
M9</ K!]=AT0G8T9*,73#08$@\+7=]'SIDN<+EW4GHU\U(&^N^+<;/--MHOS
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M#JBV3[:&D573F];24*=KIAG]M4!E'6A_(Z4Y&/: _L_*XE]02P,$%     @
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ME@(LA1IFE+%MMLJ_A &+4\9I4:NGE$(M@,7!S=JE%@*J)MR"P@T8K'S91>L
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M+#[?7'.)[V6A:0'.SY6RCQU2T+W )W\#4$L#!!0    (  2#HE;>0CAJB@,
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MQ.<]_6"(8HHJ%HKG=A!9<*7'&GN8Z,D3A"G0YY><J^W"7*":98-_4$L#!!0
M   (  2#HE:ZU9_63 4  "(>   9    >&PO=V]R:W-H965T<R]S:&5E=#(Y
M+GAM;*V9[V_:.!C'_Q6+FTZ;M);8SB]Z@+11[>ZDJU2-=??:!0/1DI@Y!M;[
MZ\\):9S$C@EJWK0D/,^3[]=.GH]-IB?&?V0[2@7XE<1I-AOMA-C?C<?9:D<3
MDMVR/4WE-QO&$R+D(=^.LSVG9%TD)?$8.8X_3DB4CN;3XMPCGT_90<112A\Y
MR Y)0OC+9QJSTVP$1Z\GOD;;G<A/C.?3/=G2)15/^T<NC\95E764T#2+6 HX
MW<Q&G^#= @=Y0A'Q/:*GK/89Y%:>&?N1'_R]GHV<7!&-Z4KD)8C\=Z0+&L=Y
M):GC9UET5%TS3ZQ_?JW^I3 OS3R3C"Y8_&^T%KO9*!R!-=V00RR^LM-?M#3D
MY?56+,Z*O^!4QCHCL#ID@B5ELE201.GY/_E5#D0M ;H=":A,0'T3<)F "Z-G
M986M>R+(?,K9"? \6E;+/Q1C4V1+-U&:3^-2</EM)//$_('P'U20YYB")5T=
M>"0BFH$;L)3WR_H@S[(-,,>\OY?GHCC[(*.?EO?@_;L/X!V(4O!MQPX92=?9
M="RDPOPZXU6IYO-9#>I6<PLP_ B0@[ A?6%/OZ>K*ATUT\=R7*K!0=7@H*(>
M[JBW(-D.T)^'Z$ABF@JCH7,%UUPA?PCOLCU9T=E(/F49Y4<ZFO_^&_2=/TSV
M!BK6,(LKL]A679KE_"5*MT":/5"3U7.^7^3G[>$XAY[OR($^UCWH4:%3"VIH
M<RMMKG4BECO&Q8V@/)$WV)%F(NF:#G?(Z1BH6,.R5UGVK-/Q*9&6H__H&BQ8
M)DQ6S_E>;:!][#AA:SKTJ,#W ]<\'WXESK>*>THE,N)"W9\2%<:9\+4+P[8V
M/20PZPHJ74%?7?^P+*-&88%VU1LT:2DSQ,#:T#;$A96XT#ZCVRVG6R(H^$(B
M#KYW/6:A/J]H,@E:"O6HP/<";)8XJ21.K!*_,4%BB9>JWV=5O_\(+M^1$UU3
MZ$.GI5R/"ET_\,W*H:- YKQ!>\^Q+Z_1M.!-VK>'(2QTO<#K\%"#,;1Z>& I
M?2D]@,VABZ'6(M<VN:&J-2TKQ,*W,Q8."MFAJC4-*\S"MW*V+.!= *TAK)NT
M4*$66K$V?[I=W@(A^VAVX"^UA\BH=%#<#E6M:5P!%WH#+3*@%=U7VQZH6M.V
M0CFTL_QR6X<ZI[$W"=HT-X2YH8^[&KMB.NP-]<[%!M2!W0:F(:1C%005T:$=
MZ;W6&U!']0V";76&(.AT 47Q'-J!WIM[.I3E%/MN6Z4>YH8>[I")%+N1G=T+
MQO>,YS*?60?T[!6NWF@-5*WI5W$>P8%:#1J4]4-5:]JN;:>M:.W1:LH"]1L,
M35RO=1L:HV#'TXP4F9&=S'T:#=*AVU[?6D.:TA24T04H]VDT98U&#VEW05-,
MQZ8!*7*B"WO5GET&Z9M1-,%MCABC(.P0J3B'[)Q;L"2A?!7)3<*>["DW"K26
MN/II&ZA:T[#B)@J&:C)6 %]M>Z!J3=N*R>C"-OMRD]%9"T/D:UU&#T,(.1WK
M&:28C.Q,[M5F=-!J;<86TOP%4'$8VSG<J\U@??/;UF8-:6I3S,3VO7'?)E.6
MN32[AC#+[&+%.&QG7+%](EN:KEZZ%S/V&M<^<$-5:SJN_6Z,!^HSV,K?JVT/
M5*UI6R$9VY%\N<]@G;5>B+1G18^2N.OXK1$K)F,[D_MT&:R3%K8W)H:8CO4"
M5BC&O7\^MK09?3MYHXG38[KZC,(FMF\W>_>90'O1X858FUT]"DU0>S$SKKW
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M.\SIU@-E NA])B7N)R9!=X_&OP%02P,$%     @ !(.B5GGT,D7S!@  94
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M[=BTV5(-J=0T/@@F[Q*9)Y(;5* JQ>"AK9DM+6M:X4IP\ [<,UDL3'P#J,K
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MI7Y909@ /;_B7+UU3/'NWNKL'U!+ P04    "  $@Z)6,U$.( ,#  "L"0
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MB/)N4&X4+^S7<LF5_O;:Y5I?IT 8 _T\XUSM-\9!?4$;_0-02P,$%     @
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MNPS2!.#_3 C].#"EOWOID]]02P,$%     @ !(.B5J,P"5N#!@  7C,  !D
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M%J[,!9#$"F6IBSTO=#-"F1/U[=I$1'V^4BEE,!%(KK*,B)<1I'PS<'QGN_!
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M'6LM5XT;B_JC<;VJ(2*N1<1G$$&>WA81NT0,HY:(V"$B'@W=(@:UB,&OB"@
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M%2"_GU,JMC?J <7[E.$_4$L#!!0    (  2#HE;PU2*=%0,  $ )   9
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M!2ME1BBL.1)EGF/^SSUD[+"T7.MUX)'L4JD'[&A1X!UL0/Y1K+FZLQN4A.1
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M,,;>#Y3=@-\74IKMQ!JHNLG@/U!+ P04    "  $@Z)6MI[/(SX"  ")!0
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M][ 0]:AU^RM,KYTT)VJ3BXF,+F@VJKMJ.K;-P#1,UOH"PBYR9R\_@G$<YD<
MP_)@#C".8V%Y_J?Y]-#Y. SSUO,B/9330SF.Y4-&]H/E\7-2<_EGFJ9QG"38
MBHY&7@<C;-V2!'[\:I@W8&!Y(-.?K36^VWB%[*\#;$_W50@V4[P2L9GB:PV(
M?]V D:;^W<;R  /;!:QV(+\_#]24GQ/'L*N8-^P)QI$TQ1"H17^-)@FR.@E\
M_/N#/25QG*9^!#"_@SC&$'@:<01S !XP)([M>W#G?12MWE/1^O^7P]]02P,$
M%     @ !(.B5I>*NQS     $P(   L   !?<F5L<R\N<F5L<YV2N6[#, Q
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M4$L! A0#%     @ !(.B5@=!36*!    L0   !               ( !
M &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    "  $@Z)6*4SBM^X    K @
M$0              @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4
M"  $@Z)6F5R<(Q &  "<)P  $P              @ ', 0  >&PO=&AE;64O
M=&AE;64Q+GAM;%!+ 0(4 Q0    (  2#HE9@-UA+YP4  +H?   8
M      " @0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M"  $@Z)6:KLO13L&   "&0  &               @($J#@  >&PO=V]R:W-H
M965T<R]S:&5E=#(N>&UL4$L! A0#%     @ !(.B5M!.2V=' P  [0H  !@
M             ("!FQ0  'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4
M Q0    (  2#HE8X"K%I<04  $<5   8              " @1@8  !X;"]W
M;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4    "  $@Z)6 [*5[[D&  !(
M+0  &               @(&_'0  >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL
M4$L! A0#%     @ !(.B5O+JF')P!P  HB@  !@              ("!KB0
M 'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    (  2#HE;JEKQ5
MF <  ,T1   8              " @50L  !X;"]W;W)K<VAE971S+W-H965T
M-RYX;6Q02P$"% ,4    "  $@Z)6\A5R]U(-  "()   &
M@($B-   >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @ !(.B
M5GSR^O=:!@  LQ   !@              ("!JD$  'AL+W=O<FMS:&5E=',O
M<VAE970Y+GAM;%!+ 0(4 Q0    (  2#HE8Q6$/P5P0  /L*   9
M      " @3I(  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%
M  @ !(.B5@9JGD;U!   : L  !D              ("!R$P  'AL+W=O<FMS
M:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4    "  $@Z)6?J*7SJ4'  #4$@
M&0              @('T40  >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+
M 0(4 Q0    (  2#HE;46X1WY@H  $<>   9              " @=!9  !X
M;"]W;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @ !(.B5HL#R%F2
M"0  E1@  !D              ("![60  'AL+W=O<FMS:&5E=',O<VAE970Q
M-"YX;6Q02P$"% ,4    "  $@Z)6P14B/; #  #C"   &0
M@(&V;@  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    (  2#
MHE8^0XB!V04  .L.   9              " @9UR  !X;"]W;W)K<VAE971S
M+W-H965T,38N>&UL4$L! A0#%     @ !(.B5H'<"MKO P  " D  !D
M         ("!K7@  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4
M    "  $@Z)6LN^>LWX,  !!(P  &0              @('3?   >&PO=V]R
M:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    (  2#HE;$LIIXD@(  )4%
M   9              " @8B)  !X;"]W;W)K<VAE971S+W-H965T,3DN>&UL
M4$L! A0#%     @ !(.B5J0A(O:> P  R0@  !D              ("!48P
M 'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    "  $@Z)6<&(/
M9FX#  "X"   &0              @($FD   >&PO=V]R:W-H965T<R]S:&5E
M=#(Q+GAM;%!+ 0(4 Q0    (  2#HE8/R&OV# 0  + )   9
M  " @<N3  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%     @
M!(.B5CZ<F%#N P  9@D  !D              ("!#I@  'AL+W=O<FMS:&5E
M=',O<VAE970R,RYX;6Q02P$"% ,4    "  $@Z)6DRY<37@#  !/"   &0
M            @($SG   >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4
M Q0    (  2#HE94I0,E: 4  (T/   9              " @>*?  !X;"]W
M;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ !(.B5MY".&J* P
MD @  !D              ("!@:4  'AL+W=O<FMS:&5E=',O<VAE970R-BYX
M;6Q02P$"% ,4    "  $@Z)6!FA_GP@"   V!   &0              @(%"
MJ0  >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    (  2#HE;/
MD"2(_ (  -<*   9              " @8&K  !X;"]W;W)K<VAE971S+W-H
M965T,C@N>&UL4$L! A0#%     @ !(.B5KK5G]9,!0  (AX  !D
M     ("!M*X  'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    (  2#HE9VC)C)KP(  +<'   9              "
M@47&  !X;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @ !(.B
M5C-1#B # P  K D  !D              ("!*\D  'AL+W=O<FMS:&5E=',O
M<VAE970S-2YX;6Q02P$"% ,4    "  $@Z)6VQP)],X#  !H#0  &0
M        @(%ES   >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0
M   (  2#HE;WV1E3Q@(   0(   9              " @6K0  !X;"]W;W)K
M<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @ !(.B5J9K@#@S P  6PH
M !D              ("!9],  'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q0
M2P$"% ,4    "  $@Z)6 #%Q8M0"  #U!P  &0              @('1U@
M>&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    (  2#HE:C, E;
M@P8  %XS   9              " @=S9  !X;"]W;W)K<VAE971S+W-H965T
M-# N>&UL4$L! A0#%     @ !(.B5B!AR0N< @  R0@  !D
M ("!EN   'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"% ,4    "  $
M@Z)6\/7J"!\#  #C"0  &0              @(%IXP  >&PO=V]R:W-H965T
M<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    (  2#HE;*FRS" 0<  *@]   9
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M970T-RYX;6Q02P$"% ,4    "  $@Z)6Q>R_I<,#  #6$@  &0
M    @('8_0  >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    (
M  2#HE8;.:Z@$P,  %D*   9              " @=(! 0!X;"]W;W)K<VAE
M971S+W-H965T-#DN>&UL4$L! A0#%     @ !(.B5K:>SR,^ @  B04  !D
M             ("!' 4! 'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6Q02P$"
M% ,4    "  $@Z)6*OTVN4,#  #,%   #0              @ &1!P$ >&PO
M<W1Y;&5S+GAM;%!+ 0(4 Q0    (  2#HE:7BKL<P    !,"   +
M      "  ?\* 0!?<F5L<R\N<F5L<U!+ 0(4 Q0    (  2#HE8&$")_)00
M *DA   /              "  >@+ 0!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4
M    "  $@Z)6.(-O)L0!   -'@  &@              @ $Z$ $ >&PO7W)E
M;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    "  $@Z)6@(3XG< !
M'@  $P              @ $V$@$ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08
1    .@ Z ,T/   G% $    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>162
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>163
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>164
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>160</ContextCount>
  <ElementCount>251</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>45</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Disclosure - The Company and Nature of Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/TheCompanyandNatureofBusiness</Role>
      <ShortName>The Company and Nature of Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Marketable Securities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/MarketableSecurities</Role>
      <ShortName>Marketable Securities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Fair Value Measurement</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/FairValueMeasurement</Role>
      <ShortName>Fair Value Measurement</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Balance Sheet Components</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/BalanceSheetComponents</Role>
      <ShortName>Balance Sheet Components</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Borrowings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/Borrowings</Role>
      <ShortName>Borrowings</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Stock-Based Incentive Compensation Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/StockBasedIncentiveCompensationPlans</Role>
      <ShortName>Stock-Based Incentive Compensation Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Net Loss Per Share of Common Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/NetLossPerShareofCommonStock</Role>
      <ShortName>Net Loss Per Share of Common Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Related Party Transaction</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/RelatedPartyTransaction</Role>
      <ShortName>Related Party Transaction</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://si-bone.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://si-bone.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Marketable Securities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/MarketableSecuritiesTables</Role>
      <ShortName>Marketable Securities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://si-bone.com/role/MarketableSecurities</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Fair Value Measurement (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/FairValueMeasurementTables</Role>
      <ShortName>Fair Value Measurement (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://si-bone.com/role/FairValueMeasurement</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Balance Sheet Components (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/BalanceSheetComponentsTables</Role>
      <ShortName>Balance Sheet Components (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://si-bone.com/role/BalanceSheetComponents</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/CommitmentsandContingenciesTables</Role>
      <ShortName>Commitments and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://si-bone.com/role/CommitmentsandContingencies</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Borrowings (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/BorrowingsTables</Role>
      <ShortName>Borrowings (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://si-bone.com/role/Borrowings</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Stock-Based Incentive Compensation Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/StockBasedIncentiveCompensationPlansTables</Role>
      <ShortName>Stock-Based Incentive Compensation Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://si-bone.com/role/StockBasedIncentiveCompensationPlans</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Net Loss Per Share of Common Stock (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/NetLossPerShareofCommonStockTables</Role>
      <ShortName>Net Loss Per Share of Common Stock (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://si-bone.com/role/NetLossPerShareofCommonStock</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Summary of Significant Accounting Policies - Revenue by Geography (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/SummaryofSignificantAccountingPoliciesRevenuebyGeographyDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Revenue by Geography (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Marketable Securities - Schedule of Marketable Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails</Role>
      <ShortName>Marketable Securities - Schedule of Marketable Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Marketable Securities - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/MarketableSecuritiesNarrativeDetails</Role>
      <ShortName>Marketable Securities - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Fair Value Measurement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/FairValueMeasurementDetails</Role>
      <ShortName>Fair Value Measurement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://si-bone.com/role/FairValueMeasurementTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Balance Sheet Components - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/BalanceSheetComponentsNarrativeDetails</Role>
      <ShortName>Balance Sheet Components - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Balance Sheet Components - Property and Equipment, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails</Role>
      <ShortName>Balance Sheet Components - Property and Equipment, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Balance Sheet Components - Accrued Liabilities and Other (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/BalanceSheetComponentsAccruedLiabilitiesandOtherDetails</Role>
      <ShortName>Balance Sheet Components - Accrued Liabilities and Other (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Balance Sheet Components - Accounts Receivable and Allowance for Credit Losses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/BalanceSheetComponentsAccountsReceivableandAllowanceforCreditLossesDetails</Role>
      <ShortName>Balance Sheet Components - Accounts Receivable and Allowance for Credit Losses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Commitment and Contingencies - Supplemental Information Related to Lease Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/CommitmentandContingenciesSupplementalInformationRelatedtoLeaseExpenseDetails</Role>
      <ShortName>Commitment and Contingencies - Supplemental Information Related to Lease Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Commitments and Contingencies - Aggregate Future Minimum Lease Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails</Role>
      <ShortName>Commitments and Contingencies - Aggregate Future Minimum Lease Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Commitments and Contingencies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/CommitmentsandContingenciesNarrativeDetails</Role>
      <ShortName>Commitments and Contingencies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Borrowings - Summary of Borrowings (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/BorrowingsSummaryofBorrowingsDetails</Role>
      <ShortName>Borrowings - Summary of Borrowings (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - Borrowings - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/BorrowingsNarrativeDetails</Role>
      <ShortName>Borrowings - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - Borrowings - Debt Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/BorrowingsDebtMaturityDetails</Role>
      <ShortName>Borrowings - Debt Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - Stock-Based Incentive Compensation Plans - Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockOptionActivityDetails</Role>
      <ShortName>Stock-Based Incentive Compensation Plans - Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - Stock-Based Incentive Compensation Plans - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails</Role>
      <ShortName>Stock-Based Incentive Compensation Plans - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - Stock-Based Incentive Compensation Plans - Valuation Assumptions for Stock Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails</Role>
      <ShortName>Stock-Based Incentive Compensation Plans - Valuation Assumptions for Stock Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - Stock-Based Incentive Compensation Plans - Restricted Stock Units Activity and Performance-Based Restricted Stock Unit Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityandPerformanceBasedRestrictedStockUnitActivityDetails</Role>
      <ShortName>Stock-Based Incentive Compensation Plans - Restricted Stock Units Activity and Performance-Based Restricted Stock Unit Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - Stock-Based Incentive Compensation Plans - Stock-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockBasedCompensationExpenseDetails</Role>
      <ShortName>Stock-Based Incentive Compensation Plans - Stock-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - Net Loss Per Share of Common Stock - Computation of Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/NetLossPerShareofCommonStockComputationofEarningsPerShareDetails</Role>
      <ShortName>Net Loss Per Share of Common Stock - Computation of Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - Net Loss Per Share of Common Stock - Antidilutive Common Stock Equivalents Excluded from Computation of Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/NetLossPerShareofCommonStockAntidilutiveCommonStockEquivalentsExcludedfromComputationofEarningsPerShareDetails</Role>
      <ShortName>Net Loss Per Share of Common Stock - Antidilutive Common Stock Equivalents Excluded from Computation of Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - Related Party Transaction (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/RelatedPartyTransactionDetails</Role>
      <ShortName>Related Party Transaction (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://si-bone.com/role/RelatedPartyTransaction</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="sibn-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://si-bone.com/role/IncomeTaxes</ParentRole>
      <Position>50</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty in us-gaap/2022 used in 1 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. sibn-20230331.htm 4</Log>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept DueToAffiliateCurrent in us-gaap/2022 used in 3 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. sibn-20230331.htm 4</Log>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 -  sibn-20230331.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" original="sibn-20230331.htm">sibn-20230331.htm</File>
    <File>a-confidentialmarkupxsvb_x.htm</File>
    <File>letteragreement.htm</File>
    <File>sibn-20230331.xsd</File>
    <File>sibn-20230331_cal.xml</File>
    <File>sibn-20230331_def.xml</File>
    <File>sibn-20230331_lab.xml</File>
    <File>sibn-20230331_pre.xml</File>
    <File>sibn-ex311_331202310xq.htm</File>
    <File>sibn-ex312_331202310xq.htm</File>
    <File>sibn-ex321_331202310xq.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="536">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="30">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>167
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "sibn-20230331.htm": {
   "axisCustom": 0,
   "axisStandard": 17,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 536,
    "http://xbrl.sec.gov/dei/2022": 30
   },
   "contextCount": 160,
   "dts": {
    "calculationLink": {
     "local": [
      "sibn-20230331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "sibn-20230331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "sibn-20230331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "sibn-20230331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "sibn-20230331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "sibn-20230331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 390,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 1,
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 6
   },
   "keyCustom": 21,
   "keyStandard": 230,
   "memberCustom": 10,
   "memberStandard": 33,
   "nsprefix": "sibn",
   "nsuri": "http://si-bone.com/20230331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://si-bone.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Fair Value Measurement",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://si-bone.com/role/FairValueMeasurement",
     "shortName": "Fair Value Measurement",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Balance Sheet Components",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://si-bone.com/role/BalanceSheetComponents",
     "shortName": "Balance Sheet Components",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Commitments and Contingencies",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://si-bone.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Borrowings",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://si-bone.com/role/Borrowings",
     "shortName": "Borrowings",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Stock-Based Incentive Compensation Plans",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://si-bone.com/role/StockBasedIncentiveCompensationPlans",
     "shortName": "Stock-Based Incentive Compensation Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Net Loss Per Share of Common Stock",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://si-bone.com/role/NetLossPerShareofCommonStock",
     "shortName": "Net Loss Per Share of Common Stock",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Related Party Transaction",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://si-bone.com/role/RelatedPartyTransaction",
     "shortName": "Related Party Transaction",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Income Taxes",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://si-bone.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "18",
     "role": "http://si-bone.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "menuCat": "Tables",
     "order": "19",
     "role": "http://si-bone.com/role/SummaryofSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "ibc8dabdb27e24a31aa334795682f86fb_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "ibc8dabdb27e24a31aa334795682f86fb_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Marketable Securities (Tables)",
     "menuCat": "Tables",
     "order": "20",
     "role": "http://si-bone.com/role/MarketableSecuritiesTables",
     "shortName": "Marketable Securities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Fair Value Measurement (Tables)",
     "menuCat": "Tables",
     "order": "21",
     "role": "http://si-bone.com/role/FairValueMeasurementTables",
     "shortName": "Fair Value Measurement (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Balance Sheet Components (Tables)",
     "menuCat": "Tables",
     "order": "22",
     "role": "http://si-bone.com/role/BalanceSheetComponentsTables",
     "shortName": "Balance Sheet Components (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Commitments and Contingencies (Tables)",
     "menuCat": "Tables",
     "order": "23",
     "role": "http://si-bone.com/role/CommitmentsandContingenciesTables",
     "shortName": "Commitments and Contingencies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Borrowings (Tables)",
     "menuCat": "Tables",
     "order": "24",
     "role": "http://si-bone.com/role/BorrowingsTables",
     "shortName": "Borrowings (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Stock-Based Incentive Compensation Plans (Tables)",
     "menuCat": "Tables",
     "order": "25",
     "role": "http://si-bone.com/role/StockBasedIncentiveCompensationPlansTables",
     "shortName": "Stock-Based Incentive Compensation Plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Net Loss Per Share of Common Stock (Tables)",
     "menuCat": "Tables",
     "order": "26",
     "role": "http://si-bone.com/role/NetLossPerShareofCommonStockTables",
     "shortName": "Net Loss Per Share of Common Stock (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "ibc8dabdb27e24a31aa334795682f86fb_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "sibn:NumberOfBusinessActivities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "activity",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)",
     "menuCat": "Details",
     "order": "27",
     "role": "http://si-bone.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Summary of Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "ibc8dabdb27e24a31aa334795682f86fb_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "sibn:NumberOfBusinessActivities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "activity",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Summary of Significant Accounting Policies - Revenue by Geography (Details)",
     "menuCat": "Details",
     "order": "28",
     "role": "http://si-bone.com/role/SummaryofSignificantAccountingPoliciesRevenuebyGeographyDetails",
     "shortName": "Summary of Significant Accounting Policies - Revenue by Geography (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "ie621378e8af644ff959fd17071edec6f_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:MarketableSecuritiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "ibc8dabdb27e24a31aa334795682f86fb_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Marketable Securities - Schedule of Marketable Securities (Details)",
     "menuCat": "Details",
     "order": "29",
     "role": "http://si-bone.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails",
     "shortName": "Marketable Securities - Schedule of Marketable Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:MarketableSecuritiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "ibc8dabdb27e24a31aa334795682f86fb_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "ibc8dabdb27e24a31aa334795682f86fb_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "ibc8dabdb27e24a31aa334795682f86fb_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "ibc8dabdb27e24a31aa334795682f86fb_I20230331",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - Marketable Securities - Narrative (Details)",
     "menuCat": "Details",
     "order": "30",
     "role": "http://si-bone.com/role/MarketableSecuritiesNarrativeDetails",
     "shortName": "Marketable Securities - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "ibc8dabdb27e24a31aa334795682f86fb_I20230331",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i2d0dee683e5841eb84e260a32f3255fe_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Fair Value Measurement (Details)",
     "menuCat": "Details",
     "order": "31",
     "role": "http://si-bone.com/role/FairValueMeasurementDetails",
     "shortName": "Fair Value Measurement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i2d0dee683e5841eb84e260a32f3255fe_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "ibc8dabdb27e24a31aa334795682f86fb_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryFinishedGoods",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Balance Sheet Components - Narrative (Details)",
     "menuCat": "Details",
     "order": "32",
     "role": "http://si-bone.com/role/BalanceSheetComponentsNarrativeDetails",
     "shortName": "Balance Sheet Components - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "ibc8dabdb27e24a31aa334795682f86fb_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryFinishedGoods",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "ibc8dabdb27e24a31aa334795682f86fb_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Balance Sheet Components - Property and Equipment, Net (Details)",
     "menuCat": "Details",
     "order": "33",
     "role": "http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails",
     "shortName": "Balance Sheet Components - Property and Equipment, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "ibc8dabdb27e24a31aa334795682f86fb_I20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "ibc8dabdb27e24a31aa334795682f86fb_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Balance Sheet Components - Accrued Liabilities and Other (Details)",
     "menuCat": "Details",
     "order": "34",
     "role": "http://si-bone.com/role/BalanceSheetComponentsAccruedLiabilitiesandOtherDetails",
     "shortName": "Balance Sheet Components - Accrued Liabilities and Other (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "ibc8dabdb27e24a31aa334795682f86fb_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i9dcf850d9d0446dea538750874891e18_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Balance Sheet Components - Accounts Receivable and Allowance for Credit Losses (Details)",
     "menuCat": "Details",
     "order": "35",
     "role": "http://si-bone.com/role/BalanceSheetComponentsAccountsReceivableandAllowanceforCreditLossesDetails",
     "shortName": "Balance Sheet Components - Accounts Receivable and Allowance for Credit Losses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Commitment and Contingencies - Supplemental Information Related to Lease Expense (Details)",
     "menuCat": "Details",
     "order": "36",
     "role": "http://si-bone.com/role/CommitmentandContingenciesSupplementalInformationRelatedtoLeaseExpenseDetails",
     "shortName": "Commitment and Contingencies - Supplemental Information Related to Lease Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "ibc8dabdb27e24a31aa334795682f86fb_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Commitments and Contingencies - Aggregate Future Minimum Lease Payments (Details)",
     "menuCat": "Details",
     "order": "37",
     "role": "http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails",
     "shortName": "Commitments and Contingencies - Aggregate Future Minimum Lease Payments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "ibc8dabdb27e24a31aa334795682f86fb_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "ibc8dabdb27e24a31aa334795682f86fb_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "sibn:LesseeOperatingLeaseLeaseNotYetCommencedLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Commitments and Contingencies - Narrative (Details)",
     "menuCat": "Details",
     "order": "38",
     "role": "http://si-bone.com/role/CommitmentsandContingenciesNarrativeDetails",
     "shortName": "Commitments and Contingencies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "ibc8dabdb27e24a31aa334795682f86fb_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "sibn:LesseeOperatingLeaseLeaseNotYetCommencedLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "ibc8dabdb27e24a31aa334795682f86fb_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Borrowings - Summary of Borrowings (Details)",
     "menuCat": "Details",
     "order": "39",
     "role": "http://si-bone.com/role/BorrowingsSummaryofBorrowingsDetails",
     "shortName": "Borrowings - Summary of Borrowings (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "ibc8dabdb27e24a31aa334795682f86fb_I20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DeferredFinanceCostsNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i7fe2d63d0e5c43bdbdf07781f3c546f9_I20230106",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - Borrowings - Narrative (Details)",
     "menuCat": "Details",
     "order": "40",
     "role": "http://si-bone.com/role/BorrowingsNarrativeDetails",
     "shortName": "Borrowings - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i7fe2d63d0e5c43bdbdf07781f3c546f9_I20230106",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "ibc8dabdb27e24a31aa334795682f86fb_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - Borrowings - Debt Maturity (Details)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://si-bone.com/role/BorrowingsDebtMaturityDetails",
     "shortName": "Borrowings - Debt Maturity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "ibc8dabdb27e24a31aa334795682f86fb_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i9dcf850d9d0446dea538750874891e18_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - Stock-Based Incentive Compensation Plans - Stock Option Activity (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockOptionActivityDetails",
     "shortName": "Stock-Based Incentive Compensation Plans - Stock Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i9dcf850d9d0446dea538750874891e18_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - Stock-Based Incentive Compensation Plans - Narrative (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails",
     "shortName": "Stock-Based Incentive Compensation Plans - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i73253fc85d9d4718b307a6aeea2b9c06_D20230101-20230331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - Stock-Based Incentive Compensation Plans - Valuation Assumptions for Stock Options (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails",
     "shortName": "Stock-Based Incentive Compensation Plans - Valuation Assumptions for Stock Options (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i73253fc85d9d4718b307a6aeea2b9c06_D20230101-20230331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i2829f82cc061453792f3357c0e3b2d45_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - Stock-Based Incentive Compensation Plans - Restricted Stock Units Activity and Performance-Based Restricted Stock Unit Activity (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://si-bone.com/role/StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityandPerformanceBasedRestrictedStockUnitActivityDetails",
     "shortName": "Stock-Based Incentive Compensation Plans - Restricted Stock Units Activity and Performance-Based Restricted Stock Unit Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i2829f82cc061453792f3357c0e3b2d45_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - Stock-Based Incentive Compensation Plans - Stock-Based Compensation Expense (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockBasedCompensationExpenseDetails",
     "shortName": "Stock-Based Incentive Compensation Plans - Stock-Based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - Net Loss Per Share of Common Stock - Computation of Earnings Per Share (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://si-bone.com/role/NetLossPerShareofCommonStockComputationofEarningsPerShareDetails",
     "shortName": "Net Loss Per Share of Common Stock - Computation of Earnings Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - Net Loss Per Share of Common Stock - Antidilutive Common Stock Equivalents Excluded from Computation of Earnings Per Share (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://si-bone.com/role/NetLossPerShareofCommonStockAntidilutiveCommonStockEquivalentsExcludedfromComputationofEarningsPerShareDetails",
     "shortName": "Net Loss Per Share of Common Stock - Antidilutive Common Stock Equivalents Excluded from Computation of Earnings Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i42f2ba3e6b0746d58d9b74e3cf027cd7_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - Related Party Transaction (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://si-bone.com/role/RelatedPartyTransactionDetails",
     "shortName": "Related Party Transaction (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i42f2ba3e6b0746d58d9b74e3cf027cd7_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i883fe34ebc0c4092a483d977c3f8d429_I20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i883fe34ebc0c4092a483d977c3f8d429_I20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxExpenseBenefit",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - Income Taxes (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://si-bone.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxExpenseBenefit",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000007 - Disclosure - The Company and Nature of Business",
     "menuCat": "Notes",
     "order": "7",
     "role": "http://si-bone.com/role/TheCompanyandNatureofBusiness",
     "shortName": "The Company and Nature of Business",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000008 - Disclosure - Summary of Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://si-bone.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - Marketable Securities",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://si-bone.com/role/MarketableSecurities",
     "shortName": "Marketable Securities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20230331.htm",
      "contextRef": "i98922e161396461cb3686ce9a8571fb1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 45,
   "tag": {
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://si-bone.com/role/SummaryofSignificantAccountingPoliciesRevenuebyGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "sibn_A2018EmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A2018 Employee Stock Purchase Plan [Member]",
        "label": "A2018 Employee Stock Purchase Plan [Member]",
        "terseLabel": "2018 ESPP"
       }
      }
     },
     "localname": "A2018EmployeeStockPurchasePlanMember",
     "nsuri": "http://si-bone.com/20230331",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sibn_CommonStockWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock Warrants [Member]",
        "label": "Common Stock Warrants [Member]",
        "terseLabel": "Common stock warrants"
       }
      }
     },
     "localname": "CommonStockWarrantsMember",
     "nsuri": "http://si-bone.com/20230331",
     "presentation": [
      "http://si-bone.com/role/NetLossPerShareofCommonStockAntidilutiveCommonStockEquivalentsExcludedfromComputationofEarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sibn_ComputerAndOfficeEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Computer And Office Equipment [Member]",
        "label": "Computer And Office Equipment [Member]",
        "terseLabel": "Computer and office equipment"
       }
      }
     },
     "localname": "ComputerAndOfficeEquipmentMember",
     "nsuri": "http://si-bone.com/20230331",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sibn_ConstructionInProgressSantaClaraLeaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Construction in Progress, Santa Clara Lease",
        "label": "Construction in Progress, Santa Clara Lease [Member]",
        "terseLabel": "Construction in Progress, Santa Clara Lease"
       }
      }
     },
     "localname": "ConstructionInProgressSantaClaraLeaseMember",
     "nsuri": "http://si-bone.com/20230331",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sibn_ConstructionInProgressSurgicalPlacementInstrumentSetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Construction in Progress, Surgical Placement Instrument Set",
        "label": "Construction in Progress, Surgical Placement Instrument Set [Member]",
        "terseLabel": "Construction in progress, surgical placement instrument set"
       }
      }
     },
     "localname": "ConstructionInProgressSurgicalPlacementInstrumentSetMember",
     "nsuri": "http://si-bone.com/20230331",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sibn_DebtInstrumentAccountsReceivableBorrowingBase": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Accounts Receivable Borrowing Base",
        "label": "Debt Instrument, Accounts Receivable Borrowing Base",
        "terseLabel": "Accounts receivable borrowing base (percent)"
       }
      }
     },
     "localname": "DebtInstrumentAccountsReceivableBorrowingBase",
     "nsuri": "http://si-bone.com/20230331",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sibn_DebtInstrumentCovenantAdjustedQuickRatioMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Adjusted Quick Ratio, Minimum",
        "label": "Debt Instrument, Covenant, Adjusted Quick Ratio, Minimum",
        "terseLabel": "Adjusted quick ratio threshold"
       }
      }
     },
     "localname": "DebtInstrumentCovenantAdjustedQuickRatioMinimum",
     "nsuri": "http://si-bone.com/20230331",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "sibn_DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Fee Amount As Percentage Of Aggregate Principal",
        "label": "Debt Instrument, Fee Amount As Percentage Of Aggregate Principal",
        "terseLabel": "Final fee as percentage of aggregate principal amount (percent)"
       }
      }
     },
     "localname": "DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal",
     "nsuri": "http://si-bone.com/20230331",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sibn_DebtInstrumentInterestRateIncreaseDueToDefault": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Interest Rate Increase Due to Default",
        "label": "Debt Instrument, Interest Rate Increase Due to Default",
        "terseLabel": "Contingent interest rate increase due to default"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateIncreaseDueToDefault",
     "nsuri": "http://si-bone.com/20230331",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sibn_DevelopmentAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Development Agreement",
        "label": "Development Agreement [Member]",
        "terseLabel": "Joint development agreement"
       }
      }
     },
     "localname": "DevelopmentAgreementMember",
     "nsuri": "http://si-bone.com/20230331",
     "presentation": [
      "http://si-bone.com/role/RelatedPartyTransactionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sibn_EmployeeStockPurchasePlanSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plan Shares [Member]",
        "label": "Employee Stock Purchase Plan Shares [Member]",
        "verboseLabel": "ESPP purchase rights"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanSharesMember",
     "nsuri": "http://si-bone.com/20230331",
     "presentation": [
      "http://si-bone.com/role/NetLossPerShareofCommonStockAntidilutiveCommonStockEquivalentsExcludedfromComputationofEarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sibn_LesseeOperatingLeaseLeaseNotYetCommencedLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Lease Not Yet Commenced, Liability",
        "label": "Lessee, Operating Lease, Lease Not Yet Commenced, Liability",
        "terseLabel": "Operating lease liabilities that had not commenced."
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedLiability",
     "nsuri": "http://si-bone.com/20230331",
     "presentation": [
      "http://si-bone.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sibn_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Liability, to be Paid, After Year Four",
        "label": "Lessee, Operating Lease, Liability, to be Paid, After Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityToBePaidAfterYearFour",
     "nsuri": "http://si-bone.com/20230331",
     "presentation": [
      "http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sibn_LineOfCreditFacilityAccordionFeatureIncreaseLimit": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of Credit Facility, Accordion Feature, Increase Limit",
        "label": "Line of Credit Facility, Accordion Feature, Increase Limit",
        "terseLabel": "Accordion feature, increase limit"
       }
      }
     },
     "localname": "LineOfCreditFacilityAccordionFeatureIncreaseLimit",
     "nsuri": "http://si-bone.com/20230331",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sibn_LineOfCreditFacilityContingentCommitmentFeeAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of Credit Facility, Contingent Commitment Fee, Amount",
        "label": "Line of Credit Facility, Contingent Commitment Fee, Amount",
        "terseLabel": "Contingent fee, amount"
       }
      }
     },
     "localname": "LineOfCreditFacilityContingentCommitmentFeeAmount",
     "nsuri": "http://si-bone.com/20230331",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sibn_MarketableSecuritiesAmortizedCost": {
     "auth_ref": [],
     "calculation": {
      "http://si-bone.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total amortized cost for marketable securities included in cash equivalents and investments.",
        "label": "Marketable Securities, Amortized Cost",
        "totalLabel": "Total marketable securities, Amortized Cost"
       }
      }
     },
     "localname": "MarketableSecuritiesAmortizedCost",
     "nsuri": "http://si-bone.com/20230331",
     "presentation": [
      "http://si-bone.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sibn_NumberOfBusinessActivities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Business Activities",
        "label": "Number Of Business Activities",
        "terseLabel": "Number of business activities"
       }
      }
     },
     "localname": "NumberOfBusinessActivities",
     "nsuri": "http://si-bone.com/20230331",
     "presentation": [
      "http://si-bone.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sibn_ProceedsFromMaturityOfMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Maturity Of Marketable Securities",
        "label": "Proceeds From Maturity Of Marketable Securities",
        "terseLabel": "Maturities of marketable securities"
       }
      }
     },
     "localname": "ProceedsFromMaturityOfMarketableSecurities",
     "nsuri": "http://si-bone.com/20230331",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sibn_RelatedPartyTransactionTermOfAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related Party Transaction, Term Of Agreement",
        "label": "Related Party Transaction, Term Of Agreement",
        "terseLabel": "Term of product royalty sales period (in years)"
       }
      }
     },
     "localname": "RelatedPartyTransactionTermOfAgreement",
     "nsuri": "http://si-bone.com/20230331",
     "presentation": [
      "http://si-bone.com/role/RelatedPartyTransactionDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "sibn_SVBAmendedTermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SVB Amended Term Loan",
        "label": "SVB Amended Term Loan [Member]",
        "terseLabel": "SVB Amended Term Loan"
       }
      }
     },
     "localname": "SVBAmendedTermLoanMember",
     "nsuri": "http://si-bone.com/20230331",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sibn_SVBTermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SVB Term Loan",
        "label": "SVB Term Loan [Member]",
        "terseLabel": "SVB Term Loan"
       }
      }
     },
     "localname": "SVBTermLoanMember",
     "nsuri": "http://si-bone.com/20230331",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sibn_ScheduleOfShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Share-based Payment Award, Equity Instruments Other Than Options, Valuation Assumptions",
        "label": "Schedule of Share-based Payment Award, Equity Instruments Other Than Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Share-based Payment Award, Equity Instruments Other Than Options, Valuation Assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://si-bone.com/20230331",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Correlation Coefficient Of Peer Companies, Maximum",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Correlation Coefficient Of Peer Companies, Maximum",
        "terseLabel": "Correlation coefficient of peer companies, maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMaximum",
     "nsuri": "http://si-bone.com/20230331",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Correlation Coefficient Of Peer Companies, Minimum",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Correlation Coefficient Of Peer Companies, Minimum",
        "terseLabel": "Correlation coefficient of peer companies, minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationCoefficientOfPeerCompaniesMinimum",
     "nsuri": "http://si-bone.com/20230331",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Peer Companies, Maximum",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Peer Companies, Maximum",
        "terseLabel": "Expected volatility of peer companies, maximum (percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMaximum",
     "nsuri": "http://si-bone.com/20230331",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Peer Companies, Minimum",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Peer Companies, Minimum",
        "terseLabel": "Expected volatility of peer companies, minimum (percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeerCompaniesMinimum",
     "nsuri": "http://si-bone.com/20230331",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Purchase Periods",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Purchase Periods",
        "terseLabel": "Number of purchase periods in offering interval"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods",
     "nsuri": "http://si-bone.com/20230331",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Offering Period Interval",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Offering Period Interval",
        "terseLabel": "Employee stock purchase program offering period interval (in months)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval",
     "nsuri": "http://si-bone.com/20230331",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Early Exercise, Common Stock Subject To Repurchase",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Early Exercise, Common Stock Subject To Repurchase",
        "terseLabel": "Early exercise of stock options, share subject to repurchase (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase",
     "nsuri": "http://si-bone.com/20230331",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "sibn_SolarLoanAndSecurityAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Solar Loan and Security Agreement",
        "label": "Solar Loan and Security Agreement [Member]",
        "terseLabel": "Solar Term Loan"
       }
      }
     },
     "localname": "SolarLoanAndSecurityAgreementMember",
     "nsuri": "http://si-bone.com/20230331",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sibn_StockIssuedDuringPeriodSharesRestrictedStockUnits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period Shares Restricted Stock Units",
        "label": "Stock Issued During Period Shares Restricted Stock Units",
        "terseLabel": "Issuance of common stock upon vesting of restricted stock units (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockUnits",
     "nsuri": "http://si-bone.com/20230331",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "srt_AffiliatedEntityMember": {
     "auth_ref": [
      "r477",
      "r553",
      "r585",
      "r586",
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Affiliated Entity [Member]",
        "terseLabel": "SeaSpine"
       }
      }
     },
     "localname": "AffiliatedEntityMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://si-bone.com/role/RelatedPartyTransactionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r245",
      "r246",
      "r247",
      "r248",
      "r309",
      "r436",
      "r457",
      "r478",
      "r479",
      "r496",
      "r507",
      "r512",
      "r549",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails",
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails",
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r245",
      "r246",
      "r247",
      "r248",
      "r309",
      "r436",
      "r457",
      "r478",
      "r479",
      "r496",
      "r507",
      "r512",
      "r549",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails",
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails",
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r245",
      "r246",
      "r247",
      "r248",
      "r301",
      "r309",
      "r336",
      "r337",
      "r338",
      "r412",
      "r436",
      "r457",
      "r478",
      "r479",
      "r496",
      "r507",
      "r512",
      "r542",
      "r549",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails",
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails",
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r245",
      "r246",
      "r247",
      "r248",
      "r301",
      "r309",
      "r336",
      "r337",
      "r338",
      "r412",
      "r436",
      "r457",
      "r478",
      "r479",
      "r496",
      "r507",
      "r512",
      "r542",
      "r549",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails",
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails",
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r212",
      "r213",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r498",
      "r511",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://si-bone.com/role/SummaryofSignificantAccountingPoliciesRevenuebyGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r212",
      "r213",
      "r464",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r498",
      "r511",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://si-bone.com/role/SummaryofSignificantAccountingPoliciesRevenuebyGeographyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r11",
      "r510"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock": {
     "auth_ref": [
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss [Table Text Block]",
        "terseLabel": "Schedule of Accounts Receivable and Allowance for Credit Losses"
       }
      }
     },
     "localname": "AccountsReceivableAllowanceForCreditLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r215",
      "r216"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net of allowance for credit losses of $450 and $400, respectively"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Accretion (Amortization) of Discounts and Premiums, Investments",
        "negatedTerseLabel": "Accretion (amortization) of discount on marketable securities"
       }
      }
     },
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r14"
     ],
     "calculation": {
      "http://si-bone.com/role/BalanceSheetComponentsAccruedLiabilitiesandOtherDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued liabilities and other",
        "totalLabel": "Accrued liabilities and other"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsAccruedLiabilitiesandOtherDetails",
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities, Current [Abstract]",
        "terseLabel": "Accrued Liabilities and Other"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsAccruedLiabilitiesandOtherDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r14"
     ],
     "calculation": {
      "http://si-bone.com/role/BalanceSheetComponentsAccruedLiabilitiesandOtherDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees, Current",
        "terseLabel": "Accrued professional services"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsAccruedLiabilitiesandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedRoyaltiesCurrent": {
     "auth_ref": [
      "r14",
      "r483"
     ],
     "calculation": {
      "http://si-bone.com/role/BalanceSheetComponentsAccruedLiabilitiesandOtherDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Royalties, Current",
        "terseLabel": "Accrued royalty"
       }
      }
     },
     "localname": "AccruedRoyaltiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsAccruedLiabilitiesandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r64",
      "r132"
     ],
     "calculation": {
      "http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedTerseLabel": "Less: Accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r23",
      "r24",
      "r25",
      "r136",
      "r453",
      "r462",
      "r463"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r22",
      "r25",
      "r94",
      "r399",
      "r458",
      "r459",
      "r524",
      "r525",
      "r526",
      "r532",
      "r533",
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r6",
      "r510"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r345",
      "r346",
      "r347",
      "r532",
      "r533",
      "r534",
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r87",
      "r88",
      "r311"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r340"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r137",
      "r217",
      "r223",
      "r225",
      "r228"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsAccountsReceivableandAllowanceforCreditLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r137",
      "r217",
      "r223"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]",
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsAccountsReceivableandAllowanceforCreditLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": {
     "auth_ref": [
      "r227"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff",
        "negatedTerseLabel": "Write-offs"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsAccountsReceivableandAllowanceforCreditLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r29",
      "r280",
      "r386",
      "r527"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortization of debt issuance costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Common stock equivalents excluded from computation of diluted net loss per share (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/NetLossPerShareofCommonStockAntidilutiveCommonStockEquivalentsExcludedfromComputationofEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r52"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/NetLossPerShareofCommonStockAntidilutiveCommonStockEquivalentsExcludedfromComputationofEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/NetLossPerShareofCommonStockAntidilutiveCommonStockEquivalentsExcludedfromComputationofEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r52"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/NetLossPerShareofCommonStockAntidilutiveCommonStockEquivalentsExcludedfromComputationofEarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r105",
      "r115",
      "r134",
      "r154",
      "r196",
      "r205",
      "r209",
      "r221",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r362",
      "r364",
      "r377",
      "r510",
      "r547",
      "r548",
      "r588"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "TOTAL ASSETS"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r128",
      "r139",
      "r154",
      "r221",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r362",
      "r364",
      "r377",
      "r510",
      "r547",
      "r548",
      "r588"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "terseLabel": "Marketable securities"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/FairValueMeasurementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://si-bone.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://si-bone.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedTerseLabel": "Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Fair Value to Amortized Cost, after Allowance for Credit Loss [Abstract]",
        "terseLabel": "Short-term investments"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails",
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityandPerformanceBasedRestrictedStockUnitActivityDetails",
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r47",
      "r48",
      "r49"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Unpaid purchases of property and equipment"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r46",
      "r130",
      "r481"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsAndShortTermInvestments": {
     "auth_ref": [
      "r522"
     ],
     "calculation": {
      "http://si-bone.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.",
        "label": "Cash, Cash Equivalents, and Short-Term Investments",
        "totalLabel": "Total marketable securities, Aggregate Fair Value"
       }
      }
     },
     "localname": "CashCashEquivalentsAndShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r41",
      "r46",
      "r50"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "End of period",
        "periodStartLabel": "Beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r41",
      "r95"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r519"
     ],
     "calculation": {
      "http://si-bone.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "sibn_MarketableSecuritiesAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash Equivalents, at Carrying Value",
        "terseLabel": "Carrying value"
       }
      }
     },
     "localname": "CashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashEquivalentsAtCarryingValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Equivalents, at Carrying Value [Abstract]",
        "terseLabel": "Cash and cash equivalents at",
        "verboseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashEquivalentsAtCarryingValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://si-bone.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r71"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial paper",
        "verboseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/FairValueMeasurementDetails",
      "http://si-bone.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r20",
      "r109",
      "r120"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 6)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r66",
      "r242",
      "r243",
      "r465",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r532",
      "r533",
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r5",
      "r75"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Stockholders' equity, end of period (in shares)",
        "periodStartLabel": "Stockholders' equity, beginning of period (in shares)",
        "terseLabel": "Common stock outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r5",
      "r510"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.0001 par value; 100,000,000 shares authorized; 35,106,163 and 34,731,577 shares issued and outstanding, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r26",
      "r141",
      "r143",
      "r148",
      "r450",
      "r454"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r92",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction in progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r504",
      "r506",
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate bonds",
        "verboseLabel": "Corporate bonds"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/FairValueMeasurementDetails",
      "http://si-bone.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r31",
      "r437"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of goods sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of goods sold"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r74",
      "r153",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r274",
      "r281",
      "r282",
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Borrowings"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/Borrowings"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r1",
      "r2",
      "r3",
      "r106",
      "r107",
      "r114",
      "r157",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r264",
      "r270",
      "r271",
      "r272",
      "r273",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r387",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r3",
      "r107",
      "r114",
      "r285"
     ],
     "calculation": {
      "http://si-bone.com/role/BorrowingsDebtMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://si-bone.com/role/BorrowingsSummaryofBorrowingsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-Term Debt, Gross",
        "terseLabel": "Principal outstanding and final fee",
        "totalLabel": "Total principal and final fee payments"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BorrowingsDebtMaturityDetails",
      "http://si-bone.com/role/BorrowingsSummaryofBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r97",
      "r99",
      "r258",
      "r387",
      "r492",
      "r493"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Aggregate principal amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFeeAmount": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://si-bone.com/role/BorrowingsSummaryofBorrowingsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the fee that accompanies borrowing money under the debt instrument.",
        "label": "Debt Instrument, Fee Amount",
        "negatedTerseLabel": "Unaccreted value of final fee"
       }
      }
     },
     "localname": "DebtInstrumentFeeAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BorrowingsSummaryofBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "auth_ref": [
      "r16",
      "r97",
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average effective interest rate during the reporting period.",
        "label": "Debt Instrument, Interest Rate During Period",
        "terseLabel": "Effective interest rate during the period (percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r16",
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Fixed interest rate (percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r18",
      "r157",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r264",
      "r270",
      "r271",
      "r272",
      "r273",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r387",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r18",
      "r76",
      "r77",
      "r78",
      "r79",
      "r96",
      "r97",
      "r99",
      "r113",
      "r157",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r264",
      "r270",
      "r271",
      "r272",
      "r273",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r283",
      "r387",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss": {
     "auth_ref": [
      "r218",
      "r233",
      "r234",
      "r235"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of accrued interest on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss",
        "terseLabel": "Accrued interest receivable"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/MarketableSecuritiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestWriteoff": {
     "auth_ref": [
      "r236"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of writeoff of accrued interest on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), recognized by reversing interest income.",
        "label": "Debt Securities, Available-for-Sale, Accrued Interest Writeoff",
        "terseLabel": "Accrued interest writeoff"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAccruedInterestWriteoff",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/MarketableSecuritiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest": {
     "auth_ref": [
      "r233"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount excluding accrued interest, of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Allowance for Credit Loss, Excluding Accrued Interest",
        "terseLabel": "Credit losses on investments"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/MarketableSecuritiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss": {
     "auth_ref": [
      "r233"
     ],
     "calculation": {
      "http://si-bone.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "sibn_MarketableSecuritiesAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost excluding accrued interest, before allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, before Allowance for Credit Loss",
        "totalLabel": "Amortized Cost"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest": {
     "auth_ref": [
      "r541"
     ],
     "calculation": {
      "http://si-bone.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount excluding accrued interest, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Excluding Accrued Interest",
        "terseLabel": "Aggregate Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleExcludingAccruedInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent": {
     "auth_ref": [
      "r541"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount excluding accrued interest, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Debt Securities, Available-for-Sale, Excluding Accrued Interest, Current",
        "verboseLabel": "Short-term investments"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r98",
      "r550"
     ],
     "calculation": {
      "http://si-bone.com/role/BorrowingsSummaryofBorrowingsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "negatedLabel": "Less: Unamortized debt issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BorrowingsSummaryofBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r44",
      "r62"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r44",
      "r194"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/SummaryofSignificantAccountingPoliciesRevenuebyGeographyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r299",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/SummaryofSignificantAccountingPoliciesRevenuebyGeographyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r313",
      "r341",
      "r342",
      "r344",
      "r348",
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "Stock-Based Incentive Compensation Plans"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]",
        "terseLabel": "Disclosure of Compensation Related Costs, Share-based Payments [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DueToAffiliateCurrent": {
     "auth_ref": [
      "r0",
      "r101",
      "r122",
      "r530"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payable due to an entity that is affiliated with the reporting entity by means of direct or indirect ownership. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Due to Affiliate, Current",
        "terseLabel": "Outstanding liability to SeaSpine"
       }
      }
     },
     "localname": "DueToAffiliateCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/RelatedPartyTransactionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r149",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r171",
      "r173",
      "r175",
      "r176",
      "r177",
      "r181",
      "r368",
      "r369",
      "r451",
      "r455",
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net loss per share, basic (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://si-bone.com/role/NetLossPerShareofCommonStockComputationofEarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r149",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r173",
      "r175",
      "r176",
      "r177",
      "r181",
      "r368",
      "r369",
      "r451",
      "r455",
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net loss per share, diluted (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://si-bone.com/role/NetLossPerShareofCommonStockComputationofEarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r178",
      "r179",
      "r180",
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net Loss Per Share of Common Stock"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/NetLossPerShareofCommonStock"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r378"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of exchange rate changes on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r14"
     ],
     "calculation": {
      "http://si-bone.com/role/BalanceSheetComponentsAccruedLiabilitiesandOtherDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued compensation and related expenses"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsAccruedLiabilitiesandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Unrecognized compensation cost, expected period for recognition (in years)"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "auth_ref": [
      "r580"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation cost"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock options",
        "verboseLabel": "Stock Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/NetLossPerShareofCommonStockAntidilutiveCommonStockEquivalentsExcludedfromComputationofEarningsPerShareDetails",
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r75",
      "r126",
      "r144",
      "r145",
      "r146",
      "r158",
      "r159",
      "r160",
      "r162",
      "r168",
      "r170",
      "r183",
      "r222",
      "r289",
      "r345",
      "r346",
      "r347",
      "r353",
      "r354",
      "r367",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r399",
      "r458",
      "r459",
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/FairValueMeasurementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r370",
      "r371",
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/FairValueMeasurementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r272",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r371",
      "r409",
      "r410",
      "r411",
      "r492",
      "r493",
      "r504",
      "r505",
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/FairValueMeasurementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r370",
      "r371",
      "r372",
      "r373",
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/FairValueMeasurementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurement"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/FairValueMeasurement"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r272",
      "r302",
      "r307",
      "r371",
      "r409",
      "r504",
      "r505",
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level\u00a01"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/FairValueMeasurementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r272",
      "r302",
      "r307",
      "r371",
      "r410",
      "r492",
      "r493",
      "r504",
      "r505",
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level\u00a02"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/FairValueMeasurementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r272",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r371",
      "r411",
      "r492",
      "r493",
      "r504",
      "r505",
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level\u00a03"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/FairValueMeasurementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Fair Value, Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/FairValueMeasurementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r272",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r409",
      "r410",
      "r411",
      "r492",
      "r493",
      "r504",
      "r505",
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/FairValueMeasurementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r374",
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/FairValueMeasurementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r219",
      "r220",
      "r224",
      "r229",
      "r230",
      "r231",
      "r232",
      "r237",
      "r238",
      "r239",
      "r283",
      "r288",
      "r366",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r490",
      "r536",
      "r537",
      "r538",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/FairValueMeasurementDetails",
      "http://si-bone.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "verboseLabel": "Furniture and fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "negatedTerseLabel": "Loss on disposal of property and equipment"
       }
      }
     },
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r28"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r30",
      "r154",
      "r196",
      "r204",
      "r208",
      "r210",
      "r221",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r377",
      "r489",
      "r547"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r240",
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r155",
      "r350",
      "r351",
      "r352",
      "r355",
      "r357",
      "r359",
      "r360",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r156",
      "r169",
      "r170",
      "r195",
      "r349",
      "r356",
      "r358",
      "r456"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax provision"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued liabilities and other"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventory"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedTerseLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndemnificationGuaranteeMember": {
     "auth_ref": [
      "r67",
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An agreement (contract) that contingently requires the guarantor to make payments to the guaranteed party in compensation for that party's or parties' loss or injury attributable to specified events or actions, such as a patent infringement action against an entity that relied on certain representations as to ownership rights made by a software vendor.",
        "label": "Indemnification Agreement [Member]",
        "terseLabel": "Indemnification Agreement"
       }
      }
     },
     "localname": "IndemnificationGuaranteeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r98",
      "r111",
      "r147",
      "r193",
      "r385"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedTerseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryFinishedGoods": {
     "auth_ref": [
      "r520"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.",
        "label": "Inventory, Finished Goods, Gross",
        "terseLabel": "Inventory, finished goods, gross"
       }
      }
     },
     "localname": "InventoryFinishedGoods",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r138",
      "r482",
      "r510"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcess": {
     "auth_ref": [
      "r521"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.",
        "label": "Inventory, Work in Process, Gross",
        "terseLabel": "Inventory, work in process, gross"
       }
      }
     },
     "localname": "InventoryWorkInProcess",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r34",
      "r192"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]",
        "terseLabel": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r370"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Investments, Fair Value Disclosure",
        "terseLabel": "Marketable securities"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/FairValueMeasurementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r61",
      "r104",
      "r112",
      "r123",
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for investments in certain debt and equity securities.",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "terseLabel": "Marketable Securities"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/MarketableSecurities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r397",
      "r509"
     ],
     "calculation": {
      "http://si-bone.com/role/CommitmentandContingenciesSupplementalInformationRelatedtoLeaseExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total lease expense"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CommitmentandContingenciesSupplementalInformationRelatedtoLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Summary of Information Related to Lease Expense and Valuation of Lease Assets and Lease Liabilities"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CommitmentsandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Future Minimum Lease Payments Under Non-Cancelable Operating Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CommitmentsandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r398"
     ],
     "calculation": {
      "http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total operating lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r398"
     ],
     "calculation": {
      "http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r398"
     ],
     "calculation": {
      "http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r398"
     ],
     "calculation": {
      "http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r398"
     ],
     "calculation": {
      "http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r584"
     ],
     "calculation": {
      "http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "Remainder of 2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r398"
     ],
     "calculation": {
      "http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r13",
      "r154",
      "r221",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r363",
      "r364",
      "r365",
      "r377",
      "r488",
      "r547",
      "r588",
      "r589"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "TOTAL LIABILITIES"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r10",
      "r108",
      "r118",
      "r510",
      "r529",
      "r539",
      "r582"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r15",
      "r129",
      "r154",
      "r221",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r363",
      "r364",
      "r365",
      "r377",
      "r510",
      "r547",
      "r588",
      "r589"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeeAmount": {
     "auth_ref": [
      "r12"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the fee for available but unused credit capacity under the credit facility.",
        "label": "Line of Credit Facility, Commitment Fee Amount",
        "terseLabel": "Total commitment fee, amount"
       }
      }
     },
     "localname": "LineOfCreditFacilityCommitmentFeeAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r12"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Revolving credit facility, aggregate principal amount"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LitigationReserve": {
     "auth_ref": [
      "r20",
      "r543"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.",
        "label": "Estimated Litigation Liability",
        "terseLabel": "Liability associated with indemnifications"
       }
      }
     },
     "localname": "LitigationReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.",
        "label": "Litigation Settlement, Expense",
        "terseLabel": "Costs to defend lawsuits or settle claims"
       }
      }
     },
     "localname": "LitigationSettlementExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r3",
      "r107",
      "r116",
      "r271",
      "r286",
      "r492",
      "r493"
     ],
     "calculation": {
      "http://si-bone.com/role/BorrowingsSummaryofBorrowingsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "totalLabel": "Outstanding debt, net of debt issuance costs and unaccreted value of final fee"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BorrowingsSummaryofBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r72",
      "r157",
      "r276"
     ],
     "calculation": {
      "http://si-bone.com/role/BorrowingsDebtMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BorrowingsDebtMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r72",
      "r157",
      "r276"
     ],
     "calculation": {
      "http://si-bone.com/role/BorrowingsDebtMaturityDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BorrowingsDebtMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r72",
      "r157",
      "r276"
     ],
     "calculation": {
      "http://si-bone.com/role/BorrowingsDebtMaturityDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BorrowingsDebtMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r72",
      "r157",
      "r276"
     ],
     "calculation": {
      "http://si-bone.com/role/BorrowingsDebtMaturityDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BorrowingsDebtMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": {
     "auth_ref": [
      "r531"
     ],
     "calculation": {
      "http://si-bone.com/role/BorrowingsDebtMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.",
        "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year",
        "terseLabel": "Remainder of 2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BorrowingsDebtMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r135"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term borrowings"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BorrowingsSummaryofBorrowingsDetails",
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r18",
      "r73"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r68",
      "r69",
      "r244",
      "r245",
      "r246",
      "r544",
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]",
        "terseLabel": "Loss Contingency Nature [Axis]"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r68",
      "r69",
      "r244",
      "r245",
      "r246",
      "r544",
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment [Member]",
        "terseLabel": "Machinery and equipment"
       }
      }
     },
     "localname": "MachineryAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MarketableSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Marketable Securities [Line Items]",
        "terseLabel": "Marketable Securities [Line Items]"
       }
      }
     },
     "localname": "MarketableSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MarketableSecuritiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in marketable security.",
        "label": "Marketable Securities [Table]",
        "terseLabel": "Marketable Securities [Table]"
       }
      }
     },
     "localname": "MarketableSecuritiesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MarketableSecuritiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.",
        "label": "Marketable Securities [Table Text Block]",
        "terseLabel": "Schedule of Marketable Securities"
       }
      }
     },
     "localname": "MarketableSecuritiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/MarketableSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MaturitiesOfLongTermDebtAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maturities of Long-Term Debt [Abstract]",
        "terseLabel": "Future principal and final fee payments"
       }
      }
     },
     "localname": "MaturitiesOfLongTermDebtAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BorrowingsDebtMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money market funds",
        "verboseLabel": "Money market funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/FairValueMeasurementDetails",
      "http://si-bone.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r184",
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "terseLabel": "The Company and Nature of Business"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/TheCompanyandNatureofBusiness"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r151"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r151"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r41",
      "r42",
      "r45"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r27",
      "r45",
      "r110",
      "r121",
      "r127",
      "r140",
      "r142",
      "r146",
      "r154",
      "r161",
      "r163",
      "r164",
      "r165",
      "r166",
      "r169",
      "r170",
      "r174",
      "r196",
      "r204",
      "r208",
      "r210",
      "r221",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r369",
      "r377",
      "r489",
      "r547"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://si-bone.com/role/NetLossPerShareofCommonStockComputationofEarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Adopted Accounting Standards and Recent Accounting Standards Not Yet Effective"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "International"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/SummaryofSignificantAccountingPoliciesRevenuebyGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Supplemental disclosure of non-cash information"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r196",
      "r204",
      "r208",
      "r210",
      "r489"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r391",
      "r509"
     ],
     "calculation": {
      "http://si-bone.com/role/CommitmentandContingenciesSupplementalInformationRelatedtoLeaseExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease expense"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CommitmentandContingenciesSupplementalInformationRelatedtoLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r389"
     ],
     "calculation": {
      "http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r389"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating lease liabilities, current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r389"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liabilities, net of current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r390",
      "r393"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Cash paid for amounts included in the measurement of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CommitmentandContingenciesSupplementalInformationRelatedtoLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r388"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r396",
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CommitmentandContingenciesSupplementalInformationRelatedtoLeaseExpenseDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r395",
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term (in years)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CommitmentandContingenciesSupplementalInformationRelatedtoLeaseExpenseDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Aggregate Future Minimum Lease Payments"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r14"
     ],
     "calculation": {
      "http://si-bone.com/role/BalanceSheetComponentsAccruedLiabilitiesandOtherDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Others"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsAccruedLiabilitiesandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r133"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Other Commitments [Line Items]",
        "terseLabel": "Other Commitments [Line Items]"
       }
      }
     },
     "localname": "OtherCommitmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherCommitmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about obligations resulting from other commitments.",
        "label": "Other Commitments [Table]",
        "terseLabel": "Other Commitments [Table]"
       }
      }
     },
     "localname": "OtherCommitmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r90",
      "r91",
      "r93"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 3.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.",
        "label": "Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Unrealized gain (loss) on marketable securities",
        "verboseLabel": "Net unrealized gain (loss) on marketable securities"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r90",
      "r91",
      "r93"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Changes in foreign currency translation",
        "verboseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]",
        "terseLabel": "Other comprehensive income (loss):"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherEmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r14"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligations incurred for employer-related costs classified as other, payable within one year or the normal operating cycle, if longer.",
        "label": "Other Employee-related Liabilities, Current",
        "terseLabel": "Accrued compensation and related expenses for employee payroll deductions"
       }
      }
     },
     "localname": "OtherEmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherIncomeAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income and Expenses [Abstract]",
        "terseLabel": "Interest and other income (expense), net:"
       }
      }
     },
     "localname": "OtherIncomeAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r19"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedTerseLabel": "Payments of debt issuance costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for purchase of marketable security.",
        "label": "Payments to Acquire Marketable Securities",
        "negatedTerseLabel": "Purchases of marketable securities"
       }
      }
     },
     "localname": "PaymentsToAcquireMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedTerseLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance Shares"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails",
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityandPerformanceBasedRestrictedStockUnitActivityDetails",
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r4",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r4",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r4",
      "r510"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.0001 par value; 5,000,000 shares authorized; no shares issued and outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r522"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-Term Debt",
        "terseLabel": "Proceeds from debt financing"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfSecuredDebt": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from long-term debt wholly or partially secured by collateral. Excludes tax exempt secured debt.",
        "label": "Proceeds from (Repayments of) Secured Debt",
        "negatedTerseLabel": "Proceeds from (Repayments of) Secured Debt"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfSecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r37",
      "r86"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from the exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r65"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsNarrativeDetails",
      "http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r63",
      "r131"
     ],
     "calculation": {
      "http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsNarrativeDetails",
      "http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]",
        "verboseLabel": "Property and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsNarrativeDetails",
      "http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r65",
      "r119",
      "r452",
      "r510"
     ],
     "calculation": {
      "http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails",
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r65",
      "r466",
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r65"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "verboseLabel": "Schedule of Property and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Long-Lived Tangible Asset [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsNarrativeDetails",
      "http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r150",
      "r226"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Accounts receivable credit losses",
        "verboseLabel": "Provision"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsAccountsReceivableandAllowanceforCreditLossesDetails",
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.",
        "label": "Purchase Obligation",
        "terseLabel": "Purchase commitments related to inventory management and training materials"
       }
      }
     },
     "localname": "PurchaseObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r308",
      "r402",
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/RelatedPartyTransactionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "auth_ref": [
      "r125",
      "r402",
      "r403",
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party transaction.",
        "label": "Related Party Transaction [Axis]",
        "terseLabel": "Related Party Transaction [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/RelatedPartyTransactionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction between related party.",
        "label": "Related Party Transaction [Domain]",
        "terseLabel": "Related Party Transaction [Domain]"
       }
      }
     },
     "localname": "RelatedPartyTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/RelatedPartyTransactionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": {
     "auth_ref": [
      "r100"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
        "label": "Related Party Transaction, Expenses from Transactions with Related Party",
        "terseLabel": "Reimbursement charges expensed"
       }
      }
     },
     "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/RelatedPartyTransactionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/RelatedPartyTransactionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]",
        "terseLabel": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r308",
      "r402",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/RelatedPartyTransactionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r400",
      "r401",
      "r403",
      "r404",
      "r405"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "Related Party Transaction"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/RelatedPartyTransaction"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-Term Debt",
        "negatedTerseLabel": "Repayments of debt financing"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r89",
      "r124",
      "r596"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units",
        "verboseLabel": "Restricted stock units"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/NetLossPerShareofCommonStockAntidilutiveCommonStockEquivalentsExcludedfromComputationofEarningsPerShareDetails",
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails",
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityandPerformanceBasedRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r7",
      "r80",
      "r117",
      "r461",
      "r463",
      "r510"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r126",
      "r158",
      "r159",
      "r160",
      "r162",
      "r168",
      "r170",
      "r222",
      "r345",
      "r346",
      "r347",
      "r353",
      "r354",
      "r367",
      "r458",
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r190",
      "r191",
      "r203",
      "r206",
      "r207",
      "r211",
      "r212",
      "r214",
      "r298",
      "r299",
      "r437"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://si-bone.com/role/SummaryofSignificantAccountingPoliciesRevenuebyGeographyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r300",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r56"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.",
        "label": "Revenue from External Customers by Geographic Areas [Table Text Block]",
        "terseLabel": "Schedule of Revenue by Geography"
       }
      }
     },
     "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r394",
      "r509"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Leased assets obtained in exchange for new operating lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CommitmentandContingenciesSupplementalInformationRelatedtoLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RoyaltyExpense": {
     "auth_ref": [
      "r32"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.",
        "label": "Royalty Expense",
        "terseLabel": "Royalties"
       }
      }
     },
     "localname": "RoyaltyExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/RelatedPartyTransactionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accrued Liabilities and Other"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r52"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/NetLossPerShareofCommonStockAntidilutiveCommonStockEquivalentsExcludedfromComputationofEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r52"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Anti-dilutive Common Stock Equivalents Excluded from Computation of Diluted Net Loss per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/NetLossPerShareofCommonStockTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r18",
      "r76",
      "r77",
      "r78",
      "r79",
      "r96",
      "r97",
      "r99",
      "r113",
      "r492",
      "r494",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Outstanding Borrowings"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BorrowingsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Computation of Basic and Diluted Net Loss per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/NetLossPerShareofCommonStockTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r370",
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Marketable Securities Measured at Fair Value on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/FairValueMeasurementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r72"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]",
        "terseLabel": "Schedule of Future Principal and Final Fee Payments"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BorrowingsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r65"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsNarrativeDetails",
      "http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r102",
      "r103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/RelatedPartyTransactionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": {
     "auth_ref": [
      "r83",
      "r84",
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Activity [Table Text Block]",
        "terseLabel": "Schedule of Stock-Based Compensation"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r310",
      "r312",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails",
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityandPerformanceBasedRestrictedStockUnitActivityDetails",
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockBasedCompensationExpenseDetails",
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r82"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Schedule of Restricted Stock Unit Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r82",
      "r84",
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of Stock Option Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.",
        "label": "Secured Debt [Member]",
        "terseLabel": "Term loan"
       }
      }
     },
     "localname": "SecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r212"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segments"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingAndMarketingExpense": {
     "auth_ref": [],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.",
        "label": "Selling and Marketing Expense",
        "terseLabel": "Sales and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingAndMarketingExpenseMember": {
     "auth_ref": [
      "r28"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling and marketing expense.",
        "label": "Selling and Marketing Expense [Member]",
        "terseLabel": "Sales and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Performance period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Canceled and forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityandPerformanceBasedRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Canceled and forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityandPerformanceBasedRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "verboseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityandPerformanceBasedRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityandPerformanceBasedRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r325",
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Outstanding, end of period (in shares)",
        "periodStartLabel": "Outstanding, beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityandPerformanceBasedRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Number of Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityandPerformanceBasedRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r325",
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Outstanding, end of period (in dollars per share)",
        "periodStartLabel": "Outstanding, beginning of period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityandPerformanceBasedRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityandPerformanceBasedRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityandPerformanceBasedRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityandPerformanceBasedRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract]",
        "terseLabel": "Black-Scholes option-pricing model assumptions"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend yield (percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum",
        "terseLabel": "Expected volatility of common stock, maximum (percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum",
        "terseLabel": "Expected volatility of common stock, minimum (percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum",
        "terseLabel": "Risk-free interest rate, maximum (percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum",
        "terseLabel": "Risk-free interest rate, minimum (percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails",
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityandPerformanceBasedRestrictedStockUnitActivityDetails",
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockBasedCompensationExpenseDetails",
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period",
        "negatedTerseLabel": "Canceled and forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Canceled and forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "verboseLabel": "Stock options granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r317",
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding, end of period (in shares)",
        "periodStartLabel": "Outstanding, beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number of Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r317",
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding, end of period (in dollars per share)",
        "periodStartLabel": "Outstanding, beginning of period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted-Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Equity Award [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails",
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityandPerformanceBasedRestrictedStockUnitActivityDetails",
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock": {
     "auth_ref": [
      "r81"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of number and weighted-average grant date fair value for nonvested performance shares.",
        "label": "Share-Based Payment Arrangement, Performance Shares, Activity [Table Text Block]",
        "terseLabel": "Schedule of Performance-based Restricted Stock Unit Activity Arrangement"
       }
      }
     },
     "localname": "ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "Purchase price of common stock as a percent of fair market value (percent)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r51",
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r21",
      "r75",
      "r126",
      "r144",
      "r145",
      "r146",
      "r158",
      "r159",
      "r160",
      "r162",
      "r168",
      "r170",
      "r183",
      "r222",
      "r289",
      "r345",
      "r346",
      "r347",
      "r353",
      "r354",
      "r367",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r399",
      "r458",
      "r459",
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r158",
      "r159",
      "r160",
      "r183",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r4",
      "r5",
      "r75",
      "r80",
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised (in shares)",
        "verboseLabel": "Issuance of common stock upon exercise of stock options, net of shares withheld (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r21",
      "r75",
      "r80"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Issuance of common stock upon exercise of stock options, net of shares withheld"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r5",
      "r8",
      "r9",
      "r57",
      "r510",
      "r529",
      "r539",
      "r582"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Stockholders' equity, end of period",
        "periodStartLabel": "Stockholders' equity, beginning of period",
        "totalLabel": "TOTAL STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "auth_ref": [
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "terseLabel": "Balance Sheet Components"
       }
      }
     },
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r219",
      "r220",
      "r283",
      "r288",
      "r366",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r536",
      "r537",
      "r538",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/FairValueMeasurementDetails",
      "http://si-bone.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "auth_ref": [
      "r486",
      "r504",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB).",
        "label": "US Government Agencies Debt Securities [Member]",
        "terseLabel": "U.S. agency bonds"
       }
      }
     },
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/FairValueMeasurementDetails",
      "http://si-bone.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "auth_ref": [
      "r486",
      "r504",
      "r506",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).",
        "label": "US Treasury Securities [Member]",
        "terseLabel": "U.S. treasury securities",
        "verboseLabel": "U.S. treasury securities"
       }
      }
     },
     "localname": "USTreasurySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/FairValueMeasurementDetails",
      "http://si-bone.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r53",
      "r54",
      "r55",
      "r185",
      "r186",
      "r187",
      "r188"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r392",
      "r509"
     ],
     "calculation": {
      "http://si-bone.com/role/CommitmentandContingenciesSupplementalInformationRelatedtoLeaseExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease, Cost",
        "terseLabel": "Variable lease expense"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CommitmentandContingenciesSupplementalInformationRelatedtoLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r172",
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted-average number of common shares used to compute diluted net loss per share (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://si-bone.com/role/NetLossPerShareofCommonStockComputationofEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r171",
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted-average number of common shares used to compute basic net loss per share (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://si-bone.com/role/NetLossPerShareofCommonStockComputationofEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 7
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a)(5))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "https://asc.fasb.org/subtopic&trid=2176304",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/subtopic&trid=2209399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "https://asc.fasb.org/subtopic&trid=2324412",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL121698322-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL120267853-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL120267856-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL120267862-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "https://asc.fasb.org/topic&trid=2122745",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1403",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r513": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r514": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r515": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r516": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r517": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r518": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "210",
   "URI": "https://asc.fasb.org/topic&trid=2122208",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r599": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r601": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r602": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r603": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r604": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r605": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907419&loc=d3e10037-110241",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907907&loc=d3e13051-110250",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>168
<FILENAME>0001459839-23-000063-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001459839-23-000063-xbrl.zip
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M!*1(:0]HYNTU[UEP=:Q@'F+>S0$&DQ!D E=FL)F]@$[!I*EP'1AAAHS2C;C
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MMJ !75Z5(67GB2$":S4!>I?ZTEPCQH!_ER EE0&K?S9@]37GO1K*SI#,EN8
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ME<D87V%[L10,@AEN=@.=B33B!?NZ<5V84FXBWT_NFYYJ,A\B _AV0NEJMZQ
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M&U+#^7: *O/@+,-[ZFK816E!$WI%@\SH;0FLH4*W[57XYH*$2\JRIC)IFQJ
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MYJ:M2,] "Q\2,X44FWCA6<UHSDF]#'XX5KHHH,MW-119UM\TWW7N*Q-Q[XA
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M6N8-SET"EW6C-TWHA>9G+G4?8BGXNKP56C39ND:S=J9RI3<(R=G%OM$(!L:
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M8[>L2Q_OV/(2 T$F*>^13_M&L(B"!F?)#0(IJI\4"(:7T/NTGI=>^EZ[Z>E
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MWQ%!]61HL%9]0)!@>&RBAJGF]/2W+XER0:[GUCQ8^$#M,@/WQ.A:Z/%:-VS
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M1*JI .@4/<;L Y6[CO37\Z?<;T5F6.%;7:Q][ 'M><J#6WAL&ZYU<*Q N-:
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M'=!8B-?P(&(>A$S18L;HEU61KO!/%C=-"K$'-FB8I;6T,UO<V/"00:<ABFT
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M=7NSD=RNFC[B_(%2XGHF0$#27E\,$QMW/DF1N'.,._;)[1>[K&0F:=\4Y@;
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M)Y<I4,EF'"2P(5<;Q5:",2+=XOHZ6434)WRA@MKX-F@&S*9"BS=S"=@'2.I
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M(6*FRR()()%Y\N19GO.<+$W@HK'0J7N+EH32$N9.;](@"_5/IO *8Z8H(6@
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M>GAXTK9 \Q!DUHF2%A>R1NT=V);M2+@U+2H6#H;CF%L DH^M$$+T;\85@Y7
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ME.F;X8 9U%,K2K342&@I6[J@Q"EHLLV$758/>ZP?*GAG2Q=SA*&N/J5Q1:U
M!2'E%01%7L69((HW\$_@"C"-0NSR9X]M>/S7<BK!Z)&**5%Z_ARKQ:RL YQ'
M M,R2 K.*^;7]@?6;%O;QP #E6%D.I!Q]PAN<K96#.2APQB:AFUIW6R3;:TW
M*^J#^\V\;)M<&&TF"CE368UE9\WOLK2XO2-!49J-[2QY)&,"J-<\WV0DC*I>
M^GB9.VG[[%7?4A_Q>\M]>=]K]N7]LB_?DS3M]TTG?,3'EVX93D^H,V^4[.HB
MT3Y^M>E;^3[T./M&B57Z1'74?>3:6GK^X/(U\+-52=+]58%$6:Q":=,.E-6!
MLCI0ECN$FT?]87N GSG=;"3;=89* 4\*4!?<GE:=LK%VV#7Z \]M#9IFCTW(
MZ"42 \B3$Y'W8AQ)5LG$- :EF"<',61>DS8;&<7&;E>/VR5W^^NF?3;GANHR
M9)U6%]PZTHF4?C,A]''_?"_8F-J_:V#4BF1AB@1-1XT1<4&>3%Q8>M^+4EMS
M4&P9NAGY0S K8^E-9!2>E07C.5,?9NBADXL:"MFF NP9#'AA%SHFW@7;3U7-
MWZ(O-O<F<8$\;H9C3(U%?).!UXP<[E(O/1I8%N5?3>MS&,LD4@V7-!:S(0%M
M8);F9=6+^)4W8;Q7P.%9:C-0AEQL@E$S<\ @&NS8 _;>+8>F^#7(#U D;Z47
M+\]/\R30QW@(J:Y4"'PKV/RTX@=<V9UW4=^U4=\&R:B*.)_\Q"BU4+4BND1$
M1_#NY+Z?I3 /,O-P6T1XWB<$7R2'J5J<QTE:JMZJ?4\ 5PX3\<<!VQ]<X54D
M%I(41W$G8FZ+$RPX\*H=8Q&Z'?^?%)E=<-:&0/@&:TO-.R63F37%XMN,6P'9
MZ%,[VB=;8)9!J[*/$4<[5AP2N65?RESWQT0TH4U+8%/RI'64R *9KG:TD]1;
M VS40F_1UZP8_DYMDLYFK:.373 JHKQC;WPA[(TU K)RW%@V,V[NICQ?TDJ9
M%"1?8C);E9(7O.UKXW9QAPM1<[N45IO2PD3,F321%S*(&Y&A=^E#HG[43)#^
MF*7=#GFY8VOM#DWA4&UUL#^H*1M%M# DOH-%<GE)'.0'-%BLJMH%?R,4WIC:
M.2(Q1Y1(&EUIV_%*(BPJ+;*\1"?:#CU!QQ[XV*.WG'Y3ZUOA#Q1)",N/2CD1
MM^D\"AB&IV"@%LYUJX*QS1BAXY+A(,M?23)TFE31E1B6/+:Q&%6LZKRXG;5,
M+5AUG_!)K5>&9#-AH_TIE'N;ZH]=-1YI4V[<8>K3A"=L:2\Y5)91+8)<&2S7
MD15G0*7SY2'U?@:IP+MAH>O"^W*7%CF*F8D\#(\I[M!O##TLJ77=M>WQ(D7*
M00*[D@A52ZK9//'&018B1#128#GZW<44AC$&O_#J&_81SGT5HI11K'?H6"C9
M:I"J8Q7-VH($_0CFJSM4<YH]9%78\OD]P*8M/^3?.;SGW6&/TPR"E%S"K$:-
MP)<@883MAK4VI=P-G/6ELI":X7&=W M9#Z+,#^J'"8<JR'GGP+P,?K6* V,W
MO8H%K#-C5_F0\+T1!A(U+)"#A(H/QW9H9#V2AJ,S^**44(%+J4UG4V)EO1M4
M.8=N$(&ZWL@Y/=[:<73P!(5W1(>8TR$O!^FM9"=W2KF&@C"6C_*8N5B44;PD
MSLNY+UUANKSGB,$N&*+7B..+5*M39X1V,)!"NT*M)J!64>_ X["1();\W(LL
MS(+)W.YJ[>LZ$0E3)VQT4" 6?1Z-O7$L N1902TG;$0#%I-8?U6>/DM3K+>2
M&XE*"A^$F"D5C8C[.S'^*F-6G.PQ"M\W59WD@3:@<M2=U0T]U=L0)CI0F OY
MZBNY-9W!8^.MH_#__BDZ/!634)P?#(X/SH\&)T>CX>E1(":GPQ,ACH48_K_#
MP9\Z$/=K W$[B<9NEWZQS+,@43)-"#[69D@]);69Q^J,4(H3KL3"XD'2(GC.
M%WRVEPOIC(+4FJ4=]\-U[$+BSD'9Z'^L$!4F_D[ $J3D]@3=C2(CY-,L$].H
MF+KF-KP2F4H=EZF*^2,R*L)'N4$^/+!H1E&H_HDT>$&L_@+YPC)S^1<A1*FM
M[3('."V5SVE)WJU([B)6O\U@O>/2.W-/>G]M3OTTZ,1FAM%ZC'Y;W*9=3*]!
M@O[EG@2M**!=77=>%IQZWK N0C)MJ&6H=DN;&M<2JZX54:,P9>X(4R..H:G;
M;35RVV2Y*4HXS!DD1(AMU]P@!<?C0\"RKYHW#18-A*LC*BF_C? TM9[5R5VC
MW.7NR-VQC&56F I+[&,X8],$^7PTUPZ:1^!")OM(+V!;8DL*QQK/3F]/\H#
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M'G"82C(!KJ]6I[/AG:WW4P63#3GA\'5E=;:O2I<KSZ1J.KS12),5Y*:&6_&
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M%$90HX2 [?3D29$EL$U88C!GD<#=P(V;K)PFA82B[N<L,\0S2"2["),D +Q
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M[6N(+QMH!=Q42A>PC\(>@G$0 F3#GL0IMX8A#V!&)"I),2T'?U13'FP3 ]9
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MGJ-#$B%U&O@_GX)Q-(G&'HYK0S"SO<>V]L9K*Q.'6(GR[N)_O"\?VR)8.*6
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M+=Z> Q+V)DB^NB!<OJ8;&BE6E#BB_E&IU<OB6K6P<&+J*@Q2;4Y?W\.N%+,
M+#%L#()J W<IMZG(FYE2EL',GV V#*I<"OO/<JPUK\N@WYY45%A S_K: EB1
MD\<3\,O5YU]NO(_O5()^NZNU#F#LV/H-G%G 0\ZY?A'9U'N?!KKUZ(8,9T_*
M\M9YFQIZXH#!.=C NCQMC_%I+^BUIQDK\GW4/Q^LWH@7]T$4!Z,HCN:+-A5Z
MW[LI1G]8C8.8;H\[-25AQ#V 5'<FBYHO76MU32:MH*>Q)^\H+=:9L#L<W;,A
MBYH?CJOHYM*\B[+<Z75I:5XN% 6=RW.S4YFM^'7I*B-W,MFM*J\N% <C[[*T
MN+V#:<H1>C='OX""HFCV(INBI2UGF1@+/ Z53IT&7Q&W1Q>!*KT+[M%U!;]U
M*EKUM'T/W3%)!PF#A(E/A+<WZ-$IX,5H@ 1L@."K:/[("#[&NJH(C(@@AO>-
MDG$T@W_)BJI2N95ERUAGGG?!/]W#GSC@7-4L+A>\+#>UE?=P%XWOI-2,A%?D
MX#6CCQPA?R8WD!35I9=2M!?D+NNXEF8TQ%D3H2HL-"3'L+.P.)$W$IV>GCXK
M*K&PG@<V3SX/N'K11,PJ5W6S7\<>E>;1!SD&0<[A9_ED(:<0M=RG8$'3#B+L
M?>>"=8M0![VC"/M2M43-/4T;U<G3UJ);@37;0 9(82_ 9C#6CL_:'BL3'M*,
MK)IQ,(OF: 44V2S-1=YGHP*OU@9#,/Z:I ^Q"&^9YIT"AMT:U-9@?A<\2NG[
MDL&:3"EKML=9@6D3F&GX@ YG6A,JWTV2,JEW-_UZ^DGI[$3CRR/Z >[TY2'M
MIKXV]3_#OY&3X8;Z12R\=VF1>5_NTB)'*?Z Y5#J)_@'_.(MPD8R#E6=G5&!
M&3S$V_O+\/3(/S\_Z)^=M1@0Q,C:!?F'F9@I.0+A>;A+8_1O49 P?=+SEQQM
MTV!!/ 8C)*R0.:IPPS#P\T5TVPJ8A.QK@P>R@(,*>]2#J19AJ1QS=I!:G,WB
M:$S(HS +'A2/!YT]I!-'"TMGXG$%.M*O-6KI-JF>=I1)9$\1H.3HJ*)3A0('
M@5Z1>NP ]BA[_G%3&"&XA06YY:A/-:#0K4%M#>1A#]Y=,</9?!>!EA&)]TL4
MQYCD5VIQ[R^#8Q^&B?_?>TR894OO]=@*D%^3<3J=1G-,P5^,X1=AJS;*ZE),
ME01GC0%R',USY ,CZ[83VKK02ABK%T;Y.!/XM4\GW&V&G5C@.(2S9D%:/"_&
M=UK)3+)T:O0%>AU!0VB2>[6 A'<SO]FVZGO7$_;OTB1>>-'$;Y!D>ZGHS,Q1
MW<RR]#X*!2U5D\[OEJ N_"RFV%[(/OVTU'J-:^1[(L H*VZ'NLAS\)5^,4+F
MLB2'12%.LVX!FO7UP4\U&UOJ<<)X\6I0;"(,V3S$I2&WCX1<96_^]N?C\Y_4
M-@C9#*JUJ9,)'^QZEZQ+[[_&%:EI[N8]8'(,:3&/E?^-VT![V+1.-C*!#'OA
M$5Z<?C_OW.WZ HPXLJT ?(QRW-"[W+1 N0P"JWFD2Q#LSL.,1B[!C [/5\.,
M/JO@0[N1D$KG00J)+(E[!'F9:;.&Q>U[%W +.]EEY9]1?UO1SR*9!1$I ;@4
M[$FC;VH/9GL(1Y>BIB\]X.,()#'@Y'XU,4$'=-/=,@Q&<+@;WI:<7WB=28%/
M2"IC^"68%QEFQ3%,^(@@S]8*1XZJ%-NN[;JQ2[ON_&3UKOL$"\M'V:?,R0U(
M"!04P73&M@T:]K0IX5O?&Q5SBCW&(L^90Y<^EL9-@[!K<T@_!\$ H8BC>Y'!
MGLEP-A*\9R2A)!@X@ONAMR%BV673C&*):L 1!>@68D1][[CGO2ER>%D8Y-M@
MD9M0/.W)F9YZG<KJX4[,?;7_0@HZ3:H_]_8N>CPYC3IF%A?Y2B6S4>K2WVXD
M=]A\:+:U6]_TJA%8LQ&\=P(D)B+3V/?V+GOUC(M<L+<]2Q_GQ30WEY'9;<GR
M"/;AM*YP-UL*6+IQ7- RZT645OU;,0F*>.Y]1E&IW@U]X!G*(SV6XG)Y77D_
M7D4WK[#;^CG4^KG"V@5#K[)VZ8_*I;-/X^PZ;*(*&YS62<K,9]6*W2<]=T#/
M=> P.CQ:?1C] ALBF*?9PMZ#O\Y2<J3 U0+URQ>U>T)=+SE<$ P2J%%R5VHZ
M/+C42.5ZTO&XR#)!IP3L?RL+-(9G1TE!MR)_W+M2'>GEYJXUQHZF4Q%&\+08
M]_="GU?D>-8!CJ"9\&YXX@5++=,MG1I\BFVD6]OT>OUVRVD5:*7Q5(GN7\VQ
MLAD%2$5WGAS55*?^J*PYG\BRN%)S5L7R>XE'5FE&HB0Y.QB<>_?'&]97?4_S
MANK!>%8_&,\:Z2RW/<]/!]!O0I:R!C\_/#\^.#XZ/SGK'^U$0SUIB)90E)A>
M!L<G@X/^R3JFEZ-!_^!H=TPOS\P+>M _/3]Z'O:4)S.E;-CBBE]L!:-*G79[
MF0G=ZJ8Y/#X:G@[V80!'Y^>/87EY- _0><<#U/$ ;;W^OJ4LQZ _Z%\L\4O;
M=A%W.2651@+]T[/5+N)G<9_&]VBHOH>_MV!KUDO^7R  L5127I6>D_.Z].C/
M2M)S\L3 AB/2\[A2]B>6DS,92^J%(BPX%IQ.NJQMPSZ%6]YC(ZYJW>:%0EJ:
M#%=Y4WL%1GQJO?44T JC_>+;6(A0QDVZV5\IY[)\M2__FRL6H7#Y B#<;20X
MSQ"%B'F3_RIE/+NZC(:9K^> MYPB?<+A!7K1[;-KM.SL&@[J$1[S6=FQ/7GA
M9]>ZX#A&[:*$/F9@EP9,,,-590_/Y<]AO#*'6/Y!MW<;T@\6M(%J-;C&DZHU
MEF=9#<P=SSAUO,EZM^5A]&X!&FH*$;>8;(IOX= 5&@%ITRFF$7EVDJ02'W=
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M[11)#&?89T]KK4 K5="&)_9PUPY0*S!8F$6<D$J](UE#_:0J7ZBP5F.@A^N
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M>[4]]&G9XL',+9SAYY==<YO (0>/$UE4!6QPM%A8\$>R<T.R[\JAF&_SSH3
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M;,#!U&4IG3'8>X4[ZEH591Z'7,ZEE,&/0X%]9JG0FJWSL)M:K?/F;T_;.G]
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M:9Z[C7#T?LF"/&IFTVL+22,&#%S8*NX0$;4@(;F&;F1/*.NU;?X>D- YD+3
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MTL(!^2;J+N8-2PU> BU[2/\P5\RX4:E*:?04K/QLK13JQ.49@K9SP4BPT6@
MB&]Y[R !QUV<505.@M9/<4,$4Q>4TZWMB73G!8Y?/"PO<*"EWZU@<V[3B,U(
M^>RT'2F;OWTS2(>NUVX$RJ>S\YTQPS58_?SNN82Z.Q_Z8:J@?<HB;=X)C\-^
M[Z!H?'EIH=]Z2QV?NY=_WN6%N^K\A]]51!&WYZYZ7!#W".;.T\$W6P6;59#;
M[1KV;_65<_'R&Y=![N0,=5'XX:V*JD2Q7V.3!=?.Z:^-XIZ:R$/&W_0EJZ)5
MHKT-FLB-YG@!7YEPWY%VK?$&%&;VP/O"RIK20+-@E%II3X/Q/ALZ3_,I$]2X
M*&):T$$>47O^9JZ8&H>49:H+XJ3*%>,D5%AQ=#'.2&M&S$+7K=V&<L<+I!<Y
M]Y(8(J?Z[&"XXU)>X<T*'>UW<0=J&X;!DMYE[A7'N6G-C;.( [;V-!F8@M-Q
MI).3D0%^S+1):A [7,=IZ!"N;B&9&J?%HLK3N+AU^G$%\C#)D"BS18_ FE$P
M13&X-4%23#4V@M(:0<A<7D26-LY':SY$=5TR3;R0"UCJ29"[9&C$@0%CBIP5
M*^;&+LJ\TN>SI@IBS,J*"+#C)*&#/ DB2JV:ZX^ST)H%A0>QE)(M[=)"\EDW
M6<80/3A4$B6L@+JQVV:J;C!=EF-V#FP<9=6LJ_LN19XX^L&X"SIX<;8ZK.1.
MQ:5C;*@!0!L<;6]X2\B&"<&3*E7BK8(5.E8&C1EH$.5HC3KFX88I.)5RT6IU
M!!MXK3"B)9(RTYX1A@D>8"(573OND>!<R1EC9&IA<'7C!+0GP-0,4QBDH@AR
MQ ]'65XHYR"H0Q##7(%A\99JF15[9OA.]DSPC?"7$?[R;<-?&LW8?<,;1OC+
M"'\9X2\C_&6$OXSPEQ'^\AW 7QZE4CCT6N=\8ZWSK*/6>=;MG)\\%J<QE%IG
M9\>Z<S2\ABT' 4TQVXN+2H*U2'[DM%(YG5%C0+RYA488:*A5E'()1.C'+:!M
M;4-,E^;2@BM=FLQF[@5+*BS$W)+)!#.?[C/-.C9.06L*.GC83H2'K<7,B/4!
MIF*&9W-V!BI7P)S=$"&3;I9F<L=5 !8!F1ZG8T*H/?@X5F!/XH+E: I5EHER
MDVRT%1)<R+055L&:&KN1_:I*$@8:8,X3EW^4N4Q,V+EZDQ$W7N8E&>;N4'YS
M&PCG1YT%LXZC#(6;,AQ>K I@:;Z\]9EIT'(A$B!&L#'8=9ZFF(.6O<)Z!_D:
MZ;3R@DH.FNP*OS..?D>_RU+7&^%T3F\0_V%;6"0IJAM93+K9H69D>2WD<3=Z
M5K9WV&5!9("(AB[ U(RST?9[#):CL% .XK0L'"B'P5P*8H2J\DX_!N*+4N\/
M< =U-X"P\@6?N;R)I[5N L#")QPJXV2T.U[B0I=:^&BPA1HY;M&N/'/C;W?4
M<S+PJ"?<W.'908]\TDF/?'GQC0<]NQH\7YFN0#RW;'U;"#>+^ OZX1>.,#A#
M%VN4Z@T2N='MVUT0CPE_IET^%$K*<J)4UZ5R)/G',Q&;I"0(969A9YK$JB(L
MZ?,\^Z+MJS]VV79-@0.Q1N_CY.CG.0X<'G8\;O37XY])Y8K[UFQ7E3=1,??R
MD!:Y'FC<#'*Q5RA;C]L)P80D2^%>= I;ZE:-W3J=,P-KG5HZTQ;3PPZGI-7K
M%H/''L4!A:)Z)]'NX2BJ8.[:,2G0V?S<MB\"0=RPM&>("-2*M_4F0KPER2\A
M67% T53.&!07WSBR>X[M#?V7+8?4WC"P\O78WC"V-XSM#6-[P]C>,+8WC.T-
MWT%[PS?'[OE 5IN&;WYRUF:AM'^K3^?CG/.+XY?=])<=BATGG8H=QT=?%1<,
MYHU/.XA&3SN)1@][X_[>^**#8N*BFV+B&WWC8:4H+";[;!)-65J-NS\L!D57
M!S>D+"PS'E+=$55!X'TLX>!;XCU0[12IXD0_92S>=D'K*-?O,V,9EUO=K%NN
MHBI4- =_./+:= 'ZZ[6ZRY([K F^QQ&?5"DU.S N+&9<6)&!#X&EL%R-"+L-
M-?226G(*6<0=J5/U)2ZPCJ@2HK3#!8TXQHQF;BV);-X^4VHKH5KYMCTQ[H<M
M^X&J-0M%B6I=-,!LLQ<%,4JK!45<T\RU8D@KE7/#H*Z/LV@24ITY;&DJ5W#9
M@$7B_J5&2H*.(AN1H61F*G;DKZEW2A\@S-2!%W!8<".%['O8RD/=AVZ.'*X[
MSL#F[LZ);<<Q QOK8R#-O,R<#=+'AG:)9,3A6W!$9_?40R)5'20"]!09N%S!
MJ7.GS,88)Z%=3F.ZQLPY?M%ZT#>F^[:./&'GR+#;1J*Q;61WK[P0RA4S%)7&
MX\H0?*%-9<I2\L1=F6-MCIE'! D9&D[,N)<W-N<1<\5F'X_L*_9DWV9)1'/0
M.*ML39=:Z9V#SPF8QO'O[(]J> V&?9IZ%FP4U QY7")?-W0-IUXPS[!O/D[#
MI.)=PY,Q3D#[,#,4R9;;F=CL77_[@6XUL2;;C@1AQ[<S"=MCG(G63+AKF]4H
M$H';W'-G$X>4[M>(S1]->R3$ZZM@C?GI_IV04_[>@/T0M=D/>:[<\@ <D5W]
MJ]?,\4[J*AQO.,W^>W>1Q0L7@3/N_0XW!!M4'4;]M?<NQ5%&I1+'^K8:\@QV
M$O.M)IP6  ?&V01W(L/!%V=-CW$*VL1R18%&U*4'@A,PJI;:]Z@W$QLDWPH)
MGO*8L'P&*HE'8AY959/FZ3F.?QNX!^<#7!_6NT9WP>)&Q)(A^V-@C)8_1_S8
M:FT$&3JGC9/>U8IX>XD*C;6A:C('XQR8.7C':YHS013$E*4"^Z(BL1YLY0N-
M/:K+RN$<14QJIL-0.  "K3@'EVL>'&/A82>2@0).-N<X 3 3]F!@R9V"(:V\
MUNGP=<I%#4B]O="88]V\"61\G]>+=G16-SO,O4JO+C9ZS*<=F;O3SLS=(POF
M9Y<ONMM GBEE.)1FC/YN?-XQTN>'G.*+S7JSSQH4P?(YVA$4_0/O(JI)PDW_
M*DL7L>CPZ3^Q1_)_*WCC<LU_^]W16T(B%$DK=DE6/KY_:Z,XR. Z3C!HN<.+
MKK6N%PZBH/=0ZT(+:PHE"2(@6Y@^^/@.7A/&&C/>2ZD\:C+6);HP^<@:LWTB
MW RV[PD43R*<%,D!'%)_3YP-3P>6/-#TM:"PJ?+P-LN0A0/G0MR0,?&WI:BK
M TL<ZIH4AJ9BCE-8R1C#:"U$6V>/_OJ7L\N?=8\)[*.H"DL;S(:W*ORLG?#Z
M[<;Y:&^&C*/Z.^:-J0TU#YJ9&Q[?0],%C#B[$6?W;>/L+NIKNV\<U8BS&W%V
M(\YNQ-F-.+L19S?B[+X#G-TC.A+.2-)]P T)-V-#PAZ=D;^CV'HPCS&G)@FT
M&DD>9HJRM(CG+#R5Q+2/M3)5<9OE)8R?:%)!^ 8+/L30>BQ%=9#E!;C6O#(C
M^$J2%43#'"FCI.9E"]\J?ODUR2_10NH4_H(8MC#*7T&JHVNZS6+,273!D6"0
M59Z3HB"B89#AMD#H%L\(G$$ZO?,YQMPG5669&))GQ9 =^JX\*O_9=\1K:0K,
M%\:9Z" 8IJ%R4VEZW?)P-D2]ZM2W#?9AHA6N#,Z263]Q4]5E4L&PC3/1H5X+
M"UJWJ[IV7UO[+B7:K 6:Q&]JZ4W#_DS]]&"G2#3:&*IQ$C8EKPFH<(NCQ6JR
MO'@=I6:#*\+E3-6N1!_C-%^$J+F'K9+C,9.J&Y@F):*W]W&2P"X91[\U^DND
MLZ5D_[Y*=D](67LZN]RCY_=9.A@N.R?Q?':^R<4^.^D0ZCCI=+%?G W7Q>YZ
M[X:+?3H[W^YA7ZME7):Z;>N#X%QF ]T!;[Z$:E5BX=$B&;J%YAD9 LZ1_M/E
M[-@H 8_N?Y?4,CF3?IT?-X#C$.T\=RS<JJ:+C\>I@^IIL,IK$5H6-X4_<D1@
MZ"7F8X%X2TL@QK@TL([WF"&8%R?D%]TV^QJ" 6[0%'5KPLN;#O(6'*<)K)H$
M8W]X%X%KG.42K[;Z6&M@-!Q/AFC"-QKV1_OWU,\\G^YJI!WGH;-5I=5:_)@9
M>3$[D^G@WJP:HIXP*Z.NQ=?K6K00*Y*GDSB,+5".+H<Y*G"VFO!:SBJ-T]"A
M@)UA,W=%H6N&W1ZJ5-Z;?U;QBF)8/IUAF%$VQQX#C:Q$3!0WCFZ,U]:-D;!Z
MG()V<LZH>8'1"6$_X/J-V3;]D2HME>9U"(,=:V$PG1::T"B+@$M-MH<G:?2/
MVN._@"@87,JU"O*I0^E#B1QAGHE+RB*0]4'=*;!,2=W*.#XKB\IO2B!17GL!
MMQ]17)U2 XB'@UAX[7OS2D:=0"RTH,V(%VH5Y 2:0[X$U+3CB,+I**4Q9EBS
M7)*/%[)5ZLLJA_TR3D';0:I!@FQB3O.%6(_TW$OB92P:8-A9"D:+30U\W CK
MG.U1*+H\[!&5%.J>A*I&ZK).5]6E9]DS0W=ZH S=\?$+G>?9#SQTH([ 3:FW
M7?T[3WC[!L"#,F#_]E^?@B]*H!H?5%H0(F._*=IWAO;H23@];TS2]@Z$)^W:
MW!WW/^'M.YD)8)+@#LG:6\2)TK*%Q%+BJ0#/"6;B^EC-BSB*@SQ6A<;/R(^0
M!(:_&P8(1A VS,(*JP2,'H$#I>15(,RGE@XE^.( \ZUP(M&I\9U6".'9\^D&
M1?2\@2RLIP7HCB965''^S+04>.;PU* 0*SRM[RU4A">2#P^J78DD0U>PQ+T-
M7RX*F&U2)L),+YUGA88:P6D'#@H?=_="*FE<1_C*ICGT20AYQ4?L)%+"D:.%
M9"4%2D] MX%S%3_>E8Z %0\;L)8@$BTST5DR>'8\G!4,=N37V ="+$ 0N SI
M%$N\+^.=Q/,2B29?$\7LOY_XRPX;<*I0"3I@;@ITTR1%K H<@15/F(]NVR(F
M3N"<B^*19X8+=7KA>TQ1N$H"B6\:O DP4G'.8]6VS0?9 R?4#SL4"SP?D@7&
M5BRPP+Q>:1^6-1"81$BM%4-S7#0WA-T*O#5J@N)OXP5X]QWQ\3F'QS[QF[A@
M=BP=Y#&M<$D1D9PPK!RYJ6^8V);HM\8![J0[E60KT7OVW4037,>R3$P]L!2E
M-\\P_LA(8Y6A0!R7P$NLBAI=%JQ\RA/B!7_-8+.F> _D-&,Z67BW1-VM23J:
MR"H:8T&13S9')2_:*-[[6*7,6^'H3[M5%8II=3!*Q8! "^5]0 Z8$B^.5YF)
M0-X(41HA2KU##X8$4;H<%@1EA"B-$*41HC1"E$:(T@A1&B%*WP%$Z?$T+0]H
MEWSBG*WQD5KMDAW23&?=TDSGA^1=.FM' /9O]?LBG=!W0/ATUL&[=/:,O$O/
MEI8_EK3\54A) 8BJ;;S+6?I?LNPS9^^NT4KOT9/ZI!'$56FE3!3S[%-N[DD.
MXL?5HNI'&/Q#]8@CV5[!OQLTPN5ILWZ#73&G/3:";ELNYWU.U[36:5M(8P@E
M)T/E"/.DF?Y;[&0+X\YVQ1U-=%-?I_X9* .G &7RA2(TN!/&9WQ*$HQ+B2ZM
MF35D 2#G>T&%[%!<#UFMV[TN9'&W6ME^U^?'*NQ15&/;"OTT4JMV4JO&94QI
M\2AVM"*Q%H1MBQ$5?5"-"KY=KKW)RZ.I%\$><]JDW\9Y47I72Y5&E,=_0_)P
M2 SX&E8YI_!'[:J-,\!C'F:LWJ&L9@<65"B$= KH>EZ\(EBJF?<):Y,T$[Z5
M]]P@9.AIV;ZBURW:\\DN=IBU.K :A>N^<!<^8?=@X0_6Q JA=^MH,"3MMUF5
M;VO#>^+'[WF&X9!?9CEV^I8JY4)<AM5K!+VNO?)>)=:QW5UZVT/<C;\W;''N
M9Q-N[L5;/SZ9PIRGY6V/S:?;3+QI<GJXG^E;1!ZV2W&QNMN(#=FF]WJVTN@2
M'I5,@F;$U;T\6J$E=KMH3-_!YB.5];*_F6.U-\CJO@?N=L-=Q%^\R87>Y]XD
MHQE=D(A(BLS4,JWC%'2P<AA-WVZU<6Y>P9F(>:+N@SP/TK+'UJ?G,IK>HTT$
M>=_4^'B3<3/_O@L]*-O.F_J"O7?*) 3"6SB#%;//+ SS#%P&T4M=J"7&+$$,
M@?^'*E/X3XC4:*?0 -S"X&(CI?"QZT?+E>X2K'%<HXC=3XQ_Q:F'NP5YI!\+
MGX@Q@$LU];U54A5NYC6KRI^RQ4^K+/RL2OUJQ<RKB=G4.CMYM,-;%56)(N ;
MQ:-D#\@2T,KP)B\D^L3&Q.@.NQ+K\27,-_PMH1ZQ0JG/E+4F&2]]<896\.4I
MU++4/XU[8#,;+@9)&9EF3Y+WF^!O$>-'> U-,-0D"B<7L> '0 4854Q;<F&!
MM,\%WD(1/NW3?=8UPR<RPSC6=*_.08:1D5VA%=GAN4UGIR9[D>F#+1Z'\8HP
MGV%62".NN93NXJ,A30+-167&$MYZ7P3%8_JCAP:7>#$TN,2[M*ARG)SG!DE\
MM8[D#P>:^&^E5G3RFB!=&WHG&1SC?,)6Q.V9QX54UM#429.W,</X#=S401KS
MH=XZ3V :8%;$D<4.?-J]="XY@A#&9J^U&AL::5E5WBI+P#PHYPS#9R&>$)]M
MYR).X9LQ? H.6D9=YPS'J+@3(C;7LD];$Q.^6BSB)*;^> ?9Z3=?W/S&>6!L
M5"\606@$&5T%N<-VI)];HM(!+.\!=J1?,1T-(T(;RX9J(0&BUR-G?1)UI6CC
M>O!1EA?<)E[<"G<*G8F%_,Y\7ZF9AW>S5&6-V^'OJ2I#]W6N7.A+^^;:Z&=$
M[//:[5>C,)VSV$K4^22NRD?[.KQ#1"9'-):-)ZIW&%6F\'5#[%%':L\X-;]I
M4?<\;GG7SH"C_9AYAVW@PR'M #;P;VC2V5 91+5>WY;5L+Y)UFC3?(H'7*\Q
M6Y4,UI&?:Q:.+#7"WN*:.1Q!A"K&)4>'A%9\-.&)CQQ"8*-A^:*O6CQ*-+@I
MA*BKG/S M%Y7JV2M;^YB^0EO$A15D-B7KU;X:AC0_!8G"5ZA$<^PQZME70VE
M@^9CP)VH#&<D%E%J-Y"CD7QEN =R$2#5TCT>H RO7B6!!J>@6[L*8M+Z(3K=
M;(T,'1A"8;;4 MX[F&GLSI9+1O9ZSB^I0F/,"MP'3EPP%T2)_)D4LRJ2:W*>
MK7ZA1MV8TE/F>D*]67,G) :FQ8-S.U<*Z1S![<?YA=,;"W?$HH2&M*5JM#<G
M4K>X: <#4(VVK+X[&(736"%"61F4C67&@1B\]<.VR+.#.4\&[BE'0S*DXDHT
MC*'XI2WCHS&8@K&D"'85LQ\9MUU8"FQQR^KER>C(95PM#0YSYKT)F! #OYAK
ML]4XLTW?"*_;&H%#CZ.YO6;X;-%K]T*[F)W+M!$#C(_)"=?I(UP='1F\[Y&S
MQ)AP5 &G=$9,=AK_ 2._4K1]<&+*O&(';U'E:5S<,@)0)VL<JAED.9>DR#W\
M "SRB6YGP"P9)GLFQ_(7W43$)'.-7%#L)K)@F=12)%%%]BC-TI\<P*4LMFGW
M!>>8Y'/$S3K&P5AZ#9[$G'>"EII."7X$=%_?.<* R!O..3"",CK+."BVKF18
M,!Z3ZV&"BH2G.6^(*' >9OJKN0;L&GA+?%%Y9T)5QW#6<CZR,'D^W\:?2X)Q
M)G0($N&,U@XW Y?K)V]ZSGI8;!M7BTSE!1]@!BLJI%GZ;9V+T /A"8H*YU6T
M/S7(R?>0V'HYM,26UKT\<%YK1,B."-EO&R'[HKZV^T9 C@C9$2$[(F1'A.R(
MD!T1LB-"]D= R)[OA9 =B[^UVL!O$+]2#$N1;IO UM_$VR1?L+Q)OU8!9F\=
MN7-&#5#_B01-AE8-ZZ+ZC]+803C.,(#8W:(,A)747-&69'V7S*A587[+E&]U
MHBD.ZO7KZIL+<1@E R#*IRR=<V7*"3@9=3?7SUEQG18P5XQKA(&=[&T7L^-C
M;Q**C-H=HB?P>T+)U%_(^V__9>F@6F-H-,IV=?,^Z282@JKIL]4;(9X<ME49
M8,W]G2U>ZSW@5/O<5HJUN[X<^],V*QJ_*#DW_,PTK(2YPIZY,,@CWWNORI(S
MY*_HS[[W]G^]5QE+MK&](C,#KPZN Q?V57X7@P%",Y3 16E'$LT:&P"A<,0B
MF345:_>V1!^)Z439/9*%C=0"GC B"]!F7'L'BV<._\!WD'7-J<;)S91K>51'
M>X1YJXVX-Z>F ?V.^U@\N"^^:XW,C]+5G(W,%+>84Y65K)^Y>IQJPDW3VE/X
M]6EM40!N>71]+7P%(L1[R%MP)?+.Z6NLGP%I)#.&;ZJ^Q$7I9>35F1PO%02+
M(LL+KRKLM()O&*>X8D.$,]$98-;B[@?;,W5X=$#BX!<#]XP&V#71L&&X6%I]
MM2TF=%@?X.6U"H+B0$B'*U9Z)N=2W-E6<H$K@TL<%[>ZA]>IH&N]T*!DS4/1
M()B+VV2ZWZ@(%9<5EZ?K"W&+?S5#(\,TKQTW95-@]C1W&2 ,U&RNHC4&85 5
MW))!8E(A!5O;'W?2>-ZI^[;</[!A5.+"/ E7W-07%59"^JO+LP&?"EEB6=>M
M%+'+E6OK>*W&*3)^72.4H6E!]$U]A(FJ4Y>,NAZ\D]56/$ALN.<*$;]\^_'1
MOHED#N," HV3QG7+C2_N>@MAT4H1D.G_/]U*YQ>3*$NC C*6QEF%.@QI265J
MJ\Y#;37XOG@ZBGMOG6'W0"4+NJ!RVAH>._'U/PP!,VH1T^BKY2K)L(WM'OO.
M\.]SE2JD!]8%<6F>U^WB^N,N#0Y],>E916/'57G=F5'C<BYH;AQV5[S\7F[Q
M$XIJ'LW.]O%53V8O>R*)NJ!:Q&Y+?SX[/MI($_6R@[SH95<]ZN2P/%&]T34]
M&_1U*&#?_E#&YQU<8.?=Q<X#SW''XKIXCL5UWL$%=OX47&"M&W?LX_/.?7SH
M-W[1<>,7SW'COM[XV1;70<L'C^%[.YM=G*[:2L3UHL*UPOA01;,G*1SM]]A;
M2EQOC9?[*KM3*>H[3'Y7I7>-S5J5F@Y5-?E_$%48>!V/_YL*"FZS-=CS$>3<
M)8VLD?B-H CB*]*Y=U:!-UG2H'*VH1D,_'IU]8$ZB5'L+TXH)>*BS\?1;XW^
M/"CB F)RT5#X9Q7D$!LEV'E/OGT2%"6AD;'MG;5_$$X3Y/JKOA:\Y"Y#;HWG
M\ ,"K[K <H*B$06K)H]ST:%]"9%JQ#VU<U7>8]-_&VS=#+(%*J"_AV$PA&PL
MV/C7OYR_^+D.7XBRD()UVD'C)+0G 9>R9D3C5EA'>,Z7%.Z2184@S"VY*3?$
M'+B+:/!U#L9<S$R!I%N0.&.<@-8$.*+L;]4\KS")<+*K"?YQSWJQUSCU>6YL
M&RACDA$@!>L*O%>2O"$#X0R=[YT<G9Q)X;B9_L$^<\*_91X:!10SEL1=KTMS
MRQ9DD6L4SA3]'_&VY'!AJ@.C,#^4)=3C9ONW_ZHM%&.&8(/%2R2WT'IO"'P(
MJYRL6!MBJ-.K3NW-7 J\" 0S=#0;K/+L3TVN(JEESBT.<T]I^L:F9VFQ":<3
MI97EN S;LOR:JX=$M'(!V3LD*PY]#UZ[UWVFA83-')'6;7,2R7XXRM &ZQVD
M*;I[KH,.PX*);TO.\C2UJ^,]^R%>'O_\G__YG_#_3W=UCCSI0+=!OD&Z9BUA
MJ2.3BB(:*EQ;J*B&[,9[1I4"[J3+<KEIE8$=-T[D_PE2LH''<A3@NFT=$,*/
MTYK\@T5?'L<:IBJQXL=7/!ZO5:B6<SB 3N$IAVD<8)1.K<V3B(G]0-A%[CC9
M M!<C5MAW_$5$/E>E:)O0:;Y^'@H^*SC%XRU^I!GI9QD8*??@<-'379HPS]H
ML/LU7N.1$J$C4&L$:GW;0*V=W?8C4&L$:@UG?8Q K1&H-0*U1J#6"-0:.%!K
MF_?\V,\ZG_M@)$BGECMQF&W1 P2,8:7M[X7:F/I3BT66<WOFBD,Q!'TME/!O
MUMK\[V#4(V3U(@18"C\,E:9.[&KDI*]AEM<V7YK/.B,]@]SH0#)01L.I#409
M4M#=9U4245K#H?.D@A86(SFO*ZR1FNL&V9X5H@"XQM^9(S;H .PO9E@<M=?F
MSK-TQZIUK(6Y)V'/G#PUC/5R153ST5U<*).EQ49?S#T1\]0"\V=".)DQZ9^T
MV]Z980EI #:_O,OP@W/*[X[_Q6\O\UJI TP?/Q&RPW6]MS3HPLM3&W*29/?T
M2MV7,E? %';SR60P.I[+3!Q5]+U@#G?-4A7YF.-;J+@4)CX5P1DB0T29OVJ>
MQ*'IO*[U@#>:KP\-!WD,I^9LX*R: \2X?1!,1S<5N]8F0R 0DGF=:C(O+%1A
M%9(V)=8TP9 21HLHBN?,9W4MF!)83^_AHDB^[V(AD(\5'#3U$_6=8S-1MBCO
M \WQ&3<*,\$=6#E=OK&+<SIK=B,1&Y64'+NM>U&J56%HFH7_SB7QDCR_@ J(
M[/8^(+3%?,UX/Y$ N+_-"N>KYFLUI1/,H^.!8[C'.@:&-Z903 K$S@(K-*P.
MC<5"X"Z.#6_Q2G)EB\=QB4N +>0]VM2Y!?OPK@>C>QO/R0; Q"7!O7# U3"_
M6YX=&R@436L*MHL :+(L:(E0#8+T&1D45Y55KAQ@0NU="%@C9V>3 B[PDOB?
M51P%A@JUCIK!TP^<Y:RP:.8Z5V>S#M(E),#LVJPDX+*VV:JVIA7GE?P^"Y!4
ME5MU]L9./"--?+^)]9.A)-8EK_X>_ CF*H6U85R8?C65WR)"EV"V6-]W*M:6
M&-B3.-;L281$R2YH]CTQXY]K+*7+20YQK8-B/FBA6K/% G9V7O@-S!$KL-;4
M0*R'872J<]:I]C?B;A'=A88./UVZ/IJUF.QV%PQV(\=$7.\U8U)_8N1R43%A
MI1#>BD8, >_8F*%'=(,XOK*[):]A08@*.&&R!\?!VG-7'S\*Z3JX6MCI4+:L
MKH6UVN&?#W"\07=P0 ;V;"BS)9/U-LN71L?F*H3SFLN$Q!OBH.7[-;GM'H\-
ML.@4.5(0Z:R[UYBNG0&YX%)\U.TX%[-3NLK%[%),N"'5)D1Q'6LLD9IAA:!.
MU:)%) '?"HE[M?61I0NO:P&#2Y6&21410T7MC0)AO*_RH@JX.2_P7L<,D9TV
M3@%RGNS3L5^-]/8,?Z:/4Y@*YXG89%,LH8.'P/LSBU,MK]OJ#:2@ =W7,/MI
M[G9%L]N%;^_=\#.L:]^W#V:_/0D*JR)FI9FZU=BPC3Z[89^5C@3=:RV#A&_;
MW3[<)8GBC#D\(W735'B"QO*>1 =O%*CJC/ $I)XX1#L6HHL?%5-/&![D, V*
M0M$);>8@H?ABR:Z\+)>H-C&B/"?GHG/>P3 @]7QKVAS,N'!_AZ0?0TP3.$O\
M3T&[X_O"P'%"!I7*5'2#?Z2(A^F8R+F!YPJ97II SM0KE=VG<+7;>%6+7#J6
MUZ9V[AUJ-4Z*)>QX47PZ6@2U^7_<K? )]2I ,01X4=9:7,6I!J%CH%NH9,/O
MN0U=5JS\# -)=SZ:#@P[6.@G:?$AZ=U<ZW%W: KJ;YF#3Y5+CV<P!_,V\Z[2
MM?F2S\@$_F>6N^P!IBT>_\S<X:Y9:7!$'Y\YG:SU>.G <@&/2!F=[Y,[[_>$
M/Q_8"?\NQ8 \RT6GXUI!/)_V2J8U\TC\"]>8>3C<1S=9IM/U^6?%Y38CP>FC
MLJEB>B235<4X(T29 GDK#GLP)XLFH.@&^^!VU<07K]6\1)H=7O&+C-*YK6 I
MA$4&KYVC6@U2IN.E699D+00^XCK4#_=6ILNDRS%KMY C3Z07<GX#G^(Q, @Q
M4E-@?J32ICQ,@G@IRE]Q>I<EF)DW<I"HD?@W.%O10KR-%W!6=2DFGHN"C.TW
M#0JCQ 0K)U'R(.8YUN8IB%,?G\&7IO:R+42CJPKH0W60I77'84]I+O8A9^S7
M7NSJ8GCVB*#*Z8R]*D19H&??_XWAT%FCS@(]FRMQ800-N+0FWQ!E YLS;LKZ
M%0Y9CF^+ADJK5BGK]*&*0ZZS.ZJ#64<@G?7,!.XJ6YR" Q<SG44[ W3@7?)=
M[(G+@>V)C[ /*&[L]]C$B Y"86M_A4=N UDJ+$%<T#<BHB??(H.-AU1,+'&1
M@B@KGM?"8^\,F4)K!0 I^LZI[/F@!S!AH!Y$N-4'JL;(-<'35XY67%,GK2%9
M980RB=<)-ME=G"6!V <S3TX@$4T-]9:X[AOW3GM/C"H:8W/V]]^<?7)47]M]
M-]^.S=EC<_;8G#TV9X_-V6-S]MB<_0TW9S_2L1YFW_;Y[+0[<.[):R,!:5/O
MD1*N[JP575=)=B #+G6M4&DSX_^_O>;F8\)C$>?4)DC]LY1?T9&;SHQFRU42
MNZS!]5K"Y<QS&*U];AJ+X3>*J9)\*>4B4S.$;7&!O2?8/$CTOO>W,7;$U"N1
M,?%=:V8SITN0@L:HRBGN;(64N5HAN8E44SAM=!_D6.L36>Q:\)NK)346YI62
MWIZ<ZF$['^DITSF#ZSUY)@G=!^"PLZ+\Z56282[;S1KTFK?94[/S@'TP&PS5
M8!JK+<*DD=4X;U,3GW<R$[\\.205\\5)!Z'IR?=$Q?S\T[P!R7.%)PUGYE=9
M4<1@N7UO7I4Z0\GMP\1T4^<XI&Y+W6G^) [^(63%%S'XL:I'_K]M81K# H9,
MC?>T9F>PJV9GTT!/"^;TJ,_Y$NR*[9T;YB"]I1:Q*TVL]\-NKWKS0XMTN%&$
M&:X)#[RH2M:V:RH!_Q\>*W*"'H8/;:5Y?>)W>*HDUT'.P. NR[6X2S?Q7:*(
MV%!K=6'?R,GIBZ.?3DY?'GE_W"N(QDJ(KB# ^P@!6N"]2H(\\+U75][+\Y?G
MNYJH>S($.NH>L@7H:6@Z^W!-;!ZGTFH"+F&"C;B"VDVC+"\$.8R9#&J5G:^=
M!,,+@[_)J<:]J*B-*P\I:A\GHKU&)6]2[Z=V6U9-[DAS42(M.7P1@NH"=9 H
MU\(@;,[JL'P6-9.%"?:;([)Y'/KVT+O+&=>J:R:_@03%OBC('62"W908EP-)
M6'2GNAPD>"N"[U#XZ6[$N'AD"'\\C  >YNC%#Q# ]QTC;[,@J.$X9,/Z@T;O
M.Z/DGI;+,R$1QN#].]A=#PS>FS'R8/?F/(@3I2P)CM!]6.]K#.&[ALU$[J1R
M2F-8"]:/CT_.O?^9>1_B- W"!*5*@\_P5$'D>Q]N,Y7&7WSOZO_S7IP?G5P2
MX4BN7#ULD>L=![]K\%>:/8IC,U?\?9A&M*T(3$_^]]G'V0\6W RK0G^Q2Y'P
MV>KS)U2?W[:&?G_SZ]6G=_]XX[WZXQ]O?K_Z_=/'KVW]Z9J?%_T5O1LG*@9(
M4>:",AA]J(6&6OQMG1+:I$/VW#P;YT/GV;B8#4<@X)0;4UX3TQ7ERWK&TX&Q
MOE-KWRL4:J%3(MY'89&T6*#H8  A_4WJFUXRXB!S>+H>25CA3; )DUW,!.XN
ME&G]3=.__=<G>><^)T.(XJ8TWCO!5-XG.TU)HEE)T#'0/W 9/U=-.E+TY_05
M"@*3D5:%@\ FGK0<)A>QSF%6Y3SG^JH6! 9_O,_R]">8?5A)5;Y**F891?R2
M*I7WYI]5O%H:(JFX\/7UG8Z]/ZOH9BEL<=H\^F 9P=5,;["-$:Q<ML3D6&*@
MUYHDRU"ZPEVK0BVJ9(\7J/.[:O29=!X*86F#T8-2W?9O.%Q%23E<N4#4O  ^
M0Q$D2M,M4&%#4_*56?C9IRD3)@W?6Y(\#__;='!V,&W8[DX86V338A;!6-5>
M2U81/BLSK>ABR<7LI T^E7=0S7?HXBIM+DCY#$>?\*ZRLO#GRRQ5Q(?S*BAN
M:2W<H;HIY[V1PS9-56YR@00DK)$:UJ@,&\V6$I1TT?FYG!YMV^2%^#""LV?N
ML 4,$3-]$,(?1R]8NY.[F++N5OH3["%8XQ@@)TRC6)CXJ.)%)L!%=MW=&>D8
MNSW6*K?&\FN:6]K)=>TL68#)[=1PMZA%+#!+=RG+.]U,Y:K6%N ,8,_L%T1=
M>G^DRE )=) (@.5B$@%)^);W"JD()L<G6H^*!:@<#.9M^Y;($EP76*4NX%R%
MBOB;<*X,#+1;"1<-A9& *BCOO/X)<Z3X "&NE<GE^7],#?M._1%XQ4="*0A3
M'7]ABA0&>B-WWA1&-F;.3:E[.2QSK6E=[QMJ',H1.WTYNSCOS9]]*ZL_N,OB
M2-NX**OF)9KPE)T%.&.L.603:!<E>2)YB14$L*N1FL,?>>7C$=/\W?]PLS;/
M'\/[?3+? J\/;X/"?/F7#);=WU1TH]SOXY2AO1:1-"0-H@?'3G@SJWR09@[B
MF.WHOL^^X5GU:;WAR1Q.*GIQ59:)M7=U!LGM+]AQ;RTHZ;!*!68?/.VJ/9^]
M//\F(XC!,*%B!$%C_PK,W T?';^8,^*W( UNA/5)TC#D1>AOP G)6;N>HPZT
M!&\,%<%>SFZ=N<"Z<):1FI*3\G>%-#UYSO 1_BE1&KA[VU#EN41E0>%P;OGL
M%SAD(0GSJV,"L\RL ZRIC9GN%-P\HN/9Z[U&'H&11^ [Y1$XKJ_MOG'B(X_
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M9[4L$1@S%!"F-&VO&*@D"(;Z&B95$2-()L\6J _S:I(K9;9=(SG!VFRP" C
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MI1008X='RXDU*-,J_JF(O2RT;"(T4.GDA 594.E8U(&H(DG&4E)$[FE*D4C
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M2JY+!N._I9]$EM08/6)'"[T@*);\+B[JRU?6 AU5= .<,D8'PBP*O"%"0ZQ
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MV&T#3/;!.=42E.O#Y!+C*Z6"\?4*Z::IL%/!]J@6KY* ]DLBH]EJ>6=FV[M
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M]3RPGG]0UG.#@[=I5NO >AY8SP/K>6 ]#ZSG@?4\L)Y_ -;S&MV]#9E(D4K
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M.$("6\4#)[$<:WB0NKL]M^_\_%P[J;5?CA$I!*\3B0UI\!&U;4:6NB^"181
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M(P=;.]QZY8M^VJG7&+4>S3SIGM T48)K1O:G5<&:4DVT?[(]HN-')FE#6:R
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ME#E)P6 ,>6E*=!</&E3LR/(9_<FFH=98*US=C,'\,WV-":F%*HGM<)-28"S
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M 6\:,15$T7 2UU:W3;/A-.["5T"_%=-X/E^:N*ULU3K?6$.^QA5W:NHKDB)
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M_?0)1KKP.I2-0,(3G=X8Z)H%D6(&$\]_570$=:@ULP#6=ZKR!2SV^&M9Y;C
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M&/ KX&E3V"M-(1R8I]9FGR<5E6?)*][IR'#<)C:TF)PJR),8K4FTIU!&"F^
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MEO*0L5J6L7+CGRVM4LLQ<A%N-20)A4#!O#4JO;'JC*<,O=_J?4<B!KV?BF3
MK-H0Z0626A@B,^&LDDQM1LD-JHH0S#(P:/Z6T@EFL"9*Y+O"*9A (FBD@]W#
M0+0& J9_BR+'VCQ!^@4^E>B_B.31'BYR:I@3PY@B[%BI0DAH@5'&HLC"F :(
M<UQZ-\I1(*"X"^8^0FA]U_D;1L-6.1/8L9/D*WS3S:8SYSCUI:@A"MH:,J56
M0K+(-T>>B2#+A:9%EXNY6EF^;DVU#0:Y[R?G$W/4-;O$,[YB.;C>Y!,YXSZZ
M&GF=[<3YMG/\YM!.X[Q*9(\6*0P**<SS;%8E-[1UD%((+0O?4P$S@(6ZCD>
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M>F<GSEMYYKP#JARQ+RPZ7.N]EP,?0D,2J3'8XL;F6-QYIXL65]/O4DT21"S
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M$&H,@3L4,)2OWAYJ.C0&5YUSU:%A&Y3X(_PC=\-@'##JCS/!9J;,1:9-ME#
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M@?D@]\:O<N.TW4(U32<4VJ:;IZF.TBGT/*JC#<V9LFR1U-*2-9J+(VITW%O
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MDN<H_>\H]N?\/Y-L&O[M_P-02P,$%     @ !(.B5J?D&,X&#   ?C\  !,
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MFLZQ8M[]'2QAXX'PST./K4J_ A^=B^O'!=Z-9Z-5^\MT\QOY-_\%4$L#!!0
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M@G_W6?/+)OGDC ;^RV)F9409,SADRFF?4<TQCXI0)NS*2P1,@W&MJ/[CMVM
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M&JQ5&XRD8@$*\.=2DYL>@**/P1&CI B165 =D"=&2\N<EL9CL10 >CI-;GJ
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M_8/61*+!5@/(,2:0U!%)@9&5E&G'#5D@ZW[.P#D;6QQ1D&#1(-!AF986P*F
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M"Y6HNX0X,1,^P4@DJ<!>6 3JAN?*Z]1+$LQ81*3S<H%P8B>T81/\.]BVT1X
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MVF_EV,7DA@D1G@Q6RN=@46E__K5"5VZL>[P2V/M&O]?.?6,"P1/C/>SS"]3
MY2B7K_FMW(KO0)&["/XVL8QG(IZ$7MB#<.WU]D[SO_X#"_3['\ JN[UN:]B!
MD5QCS%%W0BS+/#4A 0M,M6 ".TN%$BYHH[C$T=Z96MKHFB10?<A?;/1<V?8R
ME8^MC)/\Z=\CN]$[?4MV3O=I<^B/-T\/WNCC[>//H^TWKX]:>^MX?^^O]O[>
M>]+<</S@S28ZV/MPMKVQ==;<V!JUCGW^EK;:^U]ZO'E\=+0/UUH?-T<''S=1
MZWB=;G_<.6J]^8";&X>CYL;ZJ'F\3_?;ZOPM.1CM?W3B8,^Q[;U6I[71[C0W
M/I^W-M[CUILMM UC;&]LTN;'@\[^\2&,USSU;_YF_M]_M0](^]0>G[1;7PYY
MD^S#O?MGVWOPOHT/:/_X/=_?VV+-/7=^T#G(MS=@[EB-FGL?SC^!.JL"12IC
MP8>,:4TRQ8S(-):(^T@X"F+E)4;9^U)@74+AY?<QJYKJYXKJ'YW&U0T29W>2
M^"\I@;;1ZX9?'V.F'V$OTW[V[^-#Z$&3? +N\WX(ZFPHVJ#=GO2*P4JC+%P=
MP O.!R]B?AY\-BB&SX]!O1]]BCAPBS7*&!(Q2T&G3"EL,H,B=EX(96Q<>?E?
M_Z$E$[_?RZ.FBMOZ0>+K_8?UG;W-G;?[C9W-=]L[>XUW'W9V/ZRW]AI[VPW0
M!?>2PH=I8WNG@?DO_M?&]NO&WK\W&U?4Q L5<?W57KJ<\G2_FU!FS0DP?IBT
M[Q6-P5%H_#,AA49E1S7*#ON-)R#"=^7[-BO?T'42]/!+UH%W'J7',F]&V2B8
M(@O=YT:2QY\_,6)YB Y4!FT315J3I?-_LV!$H(1[)6A8>=E,*=8-BE<;:<]_
M3GF8!S1^&-%O[\S1PA9'_I4NGCQY>.X7@-&T^\]/ GX8?>)$<Q^<S)#2.F,8
MD4P'XC(FN68>$\\9&4M -E<2<&]GO;6[5<JYV8K 1]-JOR[*!A=8/9%EL>AU
M&I\N_C0&O2O?YHAS3',W4D@[[R?W;N-U#C8@8*8-Q8O&8XKTR@F<7E>][?FQ
MC2^?,)511H8S*Y#/DALYLSZ*S*0V) XQ00E)P0.<4253&.TZXU@X;,3B0>CX
MZ%BW$P[+<I3N(/59>':8]YY^"EIR3Y'++-$"%$3N,J,U?'5"!HX5Z(EJY>7N
M5O;G=FMSM7+Q;;5>K3U<2;SN$J)/X;24#\*N7S;/C1LT$N0;O=BXQ(6&Z3=V
M3X)+43G?R+N-?-!OO#HJ;9U?9^CWO^GVOUL%'+MAQ[.L?7G3]>7],/]\6D!H
ML<:)_!% ,+C(U8, \3W#8K6&J)CZL%2N"?2P8<=H<Q^.3'" G)PG++C*I-HA
MWMKR:K=7OL+I\%-PNF\J]^A)Y&BJ RW &"R3*<MRT%>]87=0C%[U_'7W#*S
MI?2?03@I>J=IG 7UR[S.[9L/(HW=[+P_V]\[ZNSO_=UIO3GXW'RSR5KPV\'>
M7YV#CSN=YL<F:1UOC9_Y&][%NP=[)VD=HX.-/X^VWQP<M3[NHX-RG$,"O[6;
MG8/VP9O]\_TO^Z395F=O]]8'S5UT_G9OGS6_;))/3'/DG+&9$XQGC'L#AJ:E
MF2>24RNC#5:LO-P(;7-FBO!UA7%".E^ABFN<\=L$Q-:HO O][Z6B922*/7.^
M-4[NJ<JB%]B^>6ILW[J.[292KV-0&7=,9TQ:E*D89>8L J5'6R:<67E)1$8(
M%I3?;R#]G"!X2B3^IL%>(O$O);.M5+Y>4?V[/3@*XX]_#8N\[_,R'VM\4RQ5
MEVL,N]$K&MO%H>GF7\KOOU[;KJDR!K$FR-SOZ=;:SMKN6F-<$U14&W:-DL>.
MD5]OX]5W!7^?7"?4C/V@3D@?J&5]ETX(U@)GCZ$3,O9=IL0CZH3/10-<][X(
M_?[XGW3L-5Y@0=?\\O=1<I-LO_DKW]YK\M;&G\?;>T?',/X9C-0YV&@=M_9V
MCO>//]\0=+TO,#?6['Q@^YTMWOSR&37?-/GVFR:L99WL$Q"8I GO;^7;?]]6
MZ][2G7;X]P[,Q9]8PD2KLXFV-V!]G;^/FYTFS/W#%QB3[>]MGNUWWJ/D/ 3!
MB5L?=V)K_9.C@A(9>"8X0QFC7&6:@U)HN/>,*F\=YBLOF<2-S7;C%:!9M]?8
M":9]4URN/KZ_]S:^D!I?GA1?MM<_*6JQPE1FF @)^)+R-8RUF<!64!V),P3P
M97>8#T(#WW8[/QV:O(*/V\5>[VR1;<5%1)+FWM8G3@S%2+J,4F8SIGS(K#8\
M0XHR)P4 F7G $M,=F,:KMBG,[/"DU(:WBW=%[S3ONJ7V/"PF-NU_,HJ!* HF
M4QXE4TXD\:0$()<0C ?#!<(K+U^!R@2PZ^:WD.FQ71<S-/GF2Y5[UP-B:1_D
M)Y4/KR:4;Q+*#:<%ESP&94F&=<H%L9%D2CJ7.6*#M]0&D+PK+S5''#T??\48
MN5+ [:0 'IV?F'8CG =7UMG#SV!BA_XC>B#F?XN Y!J)YK['NW"EC.I)(JS\
M04NY'HJ<P5Y>QG3_N]\8A'8X.>IU0Z-;>F]6&X!_[6'"C(8I@@',\>%))GLK
M<%M.]L7CY'\]$.L>4:PD[7T=-GAA!<E/Y5A\^>21C-Z#<245L'\65<PT<B83
MD1!O+38N)>$RI&Z*@5\?4W%.S5K;[Q(]+'!<XJ<@@SYQ:[W0H(S:P 28-HQF
MUC"?>8.I,8QJ@L&T(4AF",CFP6E7#^#&3YZ7(>4/I0,L2E[&'5LORF=F4"EU
MV2VH490"*!3!-TZ&17^8LHL&O0;<4881,/G%_IITH92"NNX&+QY4*'U?X>?3
MXI0B:U3@'\$IJM:4F'XX@= URN]_](?#"6R-*?K(X81Y4T.KN?G@QB'"%\,N
M8%.Z:^7E7CYHEQESP;BCAFL;4.>_0U]?]-47IM08=T<=VVO_TO_U&:U]DBI9
M CZ<NZ-T0'$#^-C940Z_7&%V2V# WJVD/Z)"-A8;(TQL26(+J9!5/I=]\AYM
M[_V=[W_<1\V/'U@+YM3\^%=G_\MGTMIS9\TO6PP4L_/F\>'-1)'C@XWWO/7Q
MKZ,#N'ZP=XA@7>?[G8/C[;U]W/JR_@76D+<VX-VO88XWTZ*(HX2PP#(7%:C:
M#--,18(S1SC70F'"B:_*' !KR]9]JXT34S1.37L8&O^)U@!Y<&6VGJ1V/D=?
M2YY:.'I_<I0>,\N*5];X_ !\WKR.STX1CJS3&3).9LPXFUDI4!8<]T%C105W
M*3W_SU:-I3_->#?'$JVJ!;D9.DKR;N&C1D^'R#><X9YJJUFJ<(H6+.T0?*8#
M9AGAS J"#;<!$'D/S*"6Z7OS3^--NV=-NU&=VO9M__CCM]IY@ $V UMSJ^M3
M3EIHV%'#'07WN=%);3K.CD+* BSMRN*RL.47_&OCR/0;,6^#DF;:;;B8:GB3
MH?K/,$^:&UBG-HQO@#$O+%6:L@2KRL^QO7K%S)U03K)AT^54^=GP<!44Y73K
M29'.KDK?,&F4M?G]QB\P'M!8HS\$U;%_U$O5-9/:R\&1&=R<^YFY/LLTQ>KA
M\1I^76V8KF_\0JHU6J!4N&Z/807I_O+6U'D.9C$>)Y4S]\M)E),T_4%#HX8W
MH_Y:I0-4?S]^^/K5L"A@+E5!=1*8 S,8]A>2S_Q4)23Z)#BU!&F5\:!!@3,2
M9YI$G$4M/1/<4VKMRLO]T/_9XNEO%=P_C/S.9Q,O*-_=:+1ZLUEU[YFQS<1.
M@)-T\L$ >$]H T<I>MVD&+5'C0!*TJBQE=:2&E^>AL:&&9BJ?OH&5[T<XZHS
M<&<(=S+$QT6(PW:58KR;[35^20Q(_DXH61O?,#C*^S!C<U+6(CXRBZWF>\$Y
M0__7:WSQT1N^38J++K8V[>R85SX[YOB>??)!DLBYR#0R(6.<N<QJ"[Q2B'2&
M ^>.J+N9XP]%8I>!1<Z>1\YDV<^,00-/-(TV+"0TC'/ H(O47KCD6472"N_\
MM0$$DMUYH=\!S@YO*2;Z&'"U#NS!*.G ,!HHCFG/#AN'1>]L<#2YN@8J<2BG
MYD/,NV4WD3+3Y;_^0Q$"J[QG@N5E_/ODMF_><._T)O<E-7A\[SU3G=R9=ROQ
M@XG-R$2QOZK-KRT\)C5F61 OV9HDY$>"9(2N:4VF'R1;4^AAP:SO&94G]>0Q
M GKU%CS:%CRLQG_:L1M@#K/Q'[Z]F_D^AIMT9FN\Z"LVT^3)F2U_O0;N\@+W
M23J0%:\ >0Y[Q>@.]W]Y4XE6;GS30D<"6B09G.WC@[T_.P>=3=S::)XUW\ [
M.P>?RU3WCYM\>\.EU/>;:?$4U@%CM]K--S#NW@?4_+)^MI_J_SOOOVRGJ,#>
M9];Z<I3OE[7\^^-(P.%YBC!\DCHR2I3. $@^8\3KS,9 ,LR<)UPY'I%?>=FZ
M2S=_BAC7;.E;_/ZHF1,S6]QN9;)4JOB%W5)]'9LD2P7,1^=6Y8;^.>S#F_O]
MI>I!_J3LZ7;$G<K@P3X0F4O!=D89R0RG-L/&(V<%QL20>WN8/YEPOJO]0(7L
M,RP*>1AI;-[MD?CNNKZ:"8PF6_FFW,E7U48N5S_FI^8&[Z]S ZP<;#TR&4 E
M';EB<&K,RC-EL9><>2]CO+>?\^-P@Q^]]4%Y\W/OS=N*7W' IHJN.]W&>;PK
MI%<&\D"W[/;*.-RP7SEO8:'5.09W](3N%>6[VJ/T\K,<7IV\PEU86B_Y8T_S
M?JFK=DW7Y::=W VI#UZZ.9T[YTWA^XU4?I[[NRL"*HU(_F)^_87\^LN?=^5:
M)*?L)/Y6HMVS=/;WCT*[?>&6_P6@6?K<JWZM7W=I7P]B[L,J9A@=NV'5SR9&
M-K,@V>.KR0E-EE(P_E2>#?Y$<*2&49II0VCJ.*XR*QS)A :]-QJE46KJ<?XC
M)6]Z?AA+RB>LBGT3(RBSN?N-WG!0,N/$E7LW!4,*C&'Y>[]Q-4>\3(P8X^KK
MHCK>M#'LYA6F5L.N7,=>%# 57FGCF631!RL4)>4YLDPK)\SX[&%&Q IP+I>#
M.=?_U\I6Z_4=R6&7Y\R71]/WMR\7<!VG8:F9[Y75&VE T = "X:QT+/#\.;Y
M)Q*5M )4-X:D!T/.XTP9SC,.VR]8"!9IO?*2\E6LV"I*!V->!_#+U 8<\&/]
MI,C;E80@HCHAY_Z@Z-4S74]ZE?+PHDC'X.:GX=8IKY=AR%) H\M'C.WWVL/!
M[4>^=3#L]YY.*U<FSQP5E^KC8<AL$<SGS$2@W1>F?69&_97?GN (6ZRF7[5Y
MZ^R<>XY 6?_S[68ZM^35=FMOL[6W^Q!FE^8[!\68L.VI=.5' LURC= ?"X=^
M[1I9XU7!\53CEHJND4>(LM(UIAXVZMTUSN@K-<Y/:.%]KS'X;<?RLO56N9V]
M>%WU?X;M9MX!L_^1F,/C(.F,M^S;DJ+:L_6=O<96]GJKM=YZM;7^M@%ZV_9.
M<SV=D?4 5!I+@U)\W-OSX(Z=*-(49K01]\6L;E'/X[74O7>),3[:$K]6#?V'
MF9NY-(Z*9'7\Q[?U/4Q77FX-0J>!08DU-Q6S680M:A _ HA?7[@@RY:85:'3
M#P%\.KVO2]9U/Y.JP?M]X&7W@'+>9/=#,64\1);N_X8)6*/*=Z"*2+T.X,%N
M"DO IU+5*/-I_C1M8!"AL7L4PJ!_%9UFH4=\R_M< _W[^,,O'[IFZ', ]*\U
MTU\*H(KE8_KE(WGB3C7/GR*FZ'MY_A55L!<;VR>A>DV_K!=*0;(B',%CJ83U
M;:]?"X5EPHI:*"PA4('4^9()A=H2>!142<>'/T@JO"K39/HIBZ:,.!_UVO"V
M_G\W-O\9YH-1+1.6!R=JF;"$0$V$+FJ94*/* U"%/U0FF/Y1XW6[=U:;!$L$
M_IK]+R%0$TW+FOW7J/( 5%&IRG8 <QKT&O?(@;O"B+4,6!X<J&7 $@(U$;;Z
M.1E0IV[,!G1"CK-S2)V=L\0@;IJN.2REZ46YR4;>=\-^/Q66I&C,>M>T1_V\
M-+\NA7"2TE4]8KIG)_2'[9NQG)J%+PN2$%SS\$6$'49BS,1IS<27&<;O4^UV
M/BA+NTJ&##^T)]\3/V_W^L-4<+AN>\/!^"2#QD[>_UPSZ:5! EISZ04%GAYS
M:59SZ66&,>C,@P)@4W+H=T7/!9^8<LV"EP;"3\V"YZ30:@EK2)>T4' KV][[
M]^;.=U8)_LR>UQ)G1OP(\[J\[CG ^&TX-.U*G2@/W:GUB>6!+26U2;>8P%,5
M\ZV4);Q>L^!EAG1RI#5>&S?H%37W71ZP4EISWX4$'L%U[/HYP/A#M^J6&-(A
MD;NF'<H(=%4><K5/;?*W?>B'='&L)]=L>GFP0/QDEFE-PK,"'JNCT\\!QALA
MFC(]Z,-):F,;NGFON,*>:U:\-)"N6?&B D_6(>CG .,F/ .:<@R@(%_)"ZI9
M\-) N&;!"PH\BL8LF-<L>)EAO%T>)+/5K4Y+@*%JYKLTL*V9[Z(";]*+6-3,
M=YEAO'E^E-M\4"N\RP-2\8T"T\FZ)B]GMT[(T(^;AWA[^)H%S I?Q,K+W:TW
MK?6]#SN;NS436!J@"OTU)G#O4:.W4G97[C\JZN['CH?]01Y'#WON[L.EZH>^
M_R%RG0+'4*A^&O?Q)6Q-\A^<T.U<[H<-\^AGKGT+<9^P&* \J Q/X^ WC%8F
M#\WPY+>GW]*[SW[;?;=9'N33VM[;;.QLOEG?V=AJO6F\WM[Y"!^SM]O;_Y.^
M[^ZM[VTV[SP;[@=YV'7JD4]P^-U])V7F_53 6@ ,VJ/&3CCI%8-&K]MXW2LF
M"94H>U\><FGR;C^=.WEF"I^U>[W/X_.-QPV"UAKK[?:5[XW>^!3?<E57&\O!
M.P>](@GP1C0.?AN/7IWB.[AK2NF(9]<>^NNO3 =XPF3*$SV'12,.!\,BG>IY
MT2"A=[W9]>4)S1/J7VW881_>W.\WTD&@@W X6DTG-?=/TL',IR%]]L,TQ_3\
M^$O#I5,X4ZND_FJC7Z;"P+:X=(3T23HZ.@W;'Q:'(75L\+V3ZD5%R#MV6/3+
MJ3=\@.4!156S6VTX@$VY(X,BS6^\AM4JG69M=PT TO/EMXUB>-A8]_!L>79I
MV1?BEY77&^LKOS;,23IEVK33@[ 37P'6U.7M/.-XZ(>K6)-W3WMM@.WG;N^L
MZJDQ[%:?B[S_&?9NV'6@80)&7F0T5;B<=Q(NIL.H8Y6 FK![T.B8$:!$.D<\
M82%<&5Z%(*!@Z7Y,QV[TTN6C/)R.9S+H-6R YP$7 .J [3Z/,10)06+1ZY2G
MC%_'ZJ^/!P@(]Z5^7KURMNT</MI1>=AMC0S5F>.-?J\3 %[]1+VCWC!1,PA/
MF!=,\RN[5.XCT"QPBJ$[2J?$IBXN!/T.X%\M/^+?)S^=Y>WVS=_Z1[UAV]_\
M%2 &G.;FKR=MT[WY6^HZX/(3F,[-*^ZN@0%Y0_?6KP/0O<+MUQ6]XSMF49YL
M#$ATQRMM:">LN[4:@'7GCML!*WU^QS)[@[3MICWY';#VRKOS[C!<N9*0N L,
MO^3+U0G.0'(52.!R1:+]')#&%!-*J)BK:0]@\P^/&MW> +ZTOP;EL2P:CS[!
MBW336:_P(.4J=O*5$4!VF,\@0X&<JZ.$T\23M*@^WR5P$XM)#+L_M D0B2^8
M*R=8W\N63+\_[)R,1<BEA(35PA1]Z+LBMR&Q-Q^J_>L'5XG#^P1M8Y /VO#(
M& Q7L^TGH$@O'E]^Q(Y&:Y/7?7._JW6'),H'Y2XF*+<!#U(KPT%O]>J]INS)
M4;'#=KMWEKP,#SW<_%I#RE(#_@:;RY[D5..[^5RY>^*B=/CIIW!]NS!;*^W#
M4D#:O)V2A@'))U2>/L/&AZ*?>'"Z::)J=?+SJY@]ID?0E$KL 8SIPF1[)PEU
MT\GL%X3A7-+I$J"=.<D'I4#^9Y@7)4J 3$WW>/@ED64: G0"&+E7C-*8H.@.
MBN$88^#.)$G-6%[#JHKQT$G@7WWS[S4F/2TF5<*S0H52$S/ _P^[)7Z "I5
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M+JWLBC!7:_LC/W_1[75?ISRQY%Y*_5)VTOD(P[Y?*4,],/ORA]PZY8WUELA
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M H7)<RL)\D2K='X'GF*?E#GR)-6D_+A%-S4I/RHIWU"3B A4!J8R(IS-F"=
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MR$E$$'(8&$Q3F7,H@?0P "$]=UP:8:18*0?>S)[+7I85V8CGNT<?$>)2*T4
M\BQNQ&3<-A()P'FZ;!,$8FDC/I&]*&^JU=Q4BFB*(.81W5)&.B85T!9KP#@G
M%!N)">=K&ZAVW#V6\^[AH.Y:+TO>EJW9EFAO\R-4" EL*6 4X[@M;=R@$.)(
MY#1A0@=.(7TR5\O"KKK*,)XW5*LVE,%2(Q8@D#!$G$/( ^T4 EA R8GCB$A2
M9^V#O(LXN07,):MW6T[;C&OMWX9X]Z^/PF)/4DX5R%*Y0!U$2AX)(Y$S#%N/
M7/RG/1PNXUKK-Y1#@@GK O">P.1$MD#!0 %5V+O >(B@%W&-=@5!7286[]K?
MT;?7[<3/3GUL^L7WSN[AZ7L1B?>6Y>F;D<S&4Y ] G>3NCEWGA,!*>T$<"$9
M=4SDE])P# 2CD@IC&.4LBDV+TNCEI)@M=>1EV;RO;,YYZ[R1/)Y6*NX0J)*W
M#@&M/ 2!"*E-P/$40^V2S7;<N&O7]<O-V+6T++K7.=6%BSWJ6'U:C'0OAP<]
M4D7XZ0J\B0NPTW]53W].@K,\\%JL\"$0)R;==)<P)5X0E --!0((0\LU@JSR
M%E&.NE+FS)G/6(J75A$^2_$C2/$<!8'*<YYR:B(8;*KL(8&4-E(0[FA0EC%C
M?)3BE+Y.X!9)<3L"AEI&1*P=GXQ[*:ZB,ZA2==O!R>G0'_M^67SQG:(??_?9
MDO%(I.1B-:J<P*]FUV*G6HH_!V6YYT?[X5!_RTAV)R1;K #"J&3:$P\@U0A0
M&QPP$=2 C(L%J5?>N63HN,*OFTT=ST9XE\9%LO ^K/#.TQ"G46"1AFAL,4AW
MJ8&!S (!*92.6R)]%%Y,[DU!LBWDT2B(\Z&PQ>A%&D%^>A3"4<9QQI_FP>NM
M'^G8([>MA_U4879F4;;J-<DZU?+ ;+&<B"-0,0@M"#@B&K7, 6FT![X*70PV
MGDPJ,A$NN_B*8@4_9Z/(<Y#J'V<B6:K;(=5S%$5 ;VG@#D#O193J*-]*.PZ<
MLAQRK5 4]!17);H(+M88?!*I7F[UD77!;LM6GJX R2UR8>;B!$]A#JG<QL>#
M7IS'<ON_XV)TEN%J>7"U6);$*(@80AB(2J-"V .C1#*'4"4@49I)N;:A2%<Q
MM2HU"G)9DE6TI63)?V#)GR<J"@7'4O%4P1"@E&@099P!3*GESGD7B4R4?-DE
M<%GFE,>J3G)?6\LJUE'K;.YMW8'6W+)D23V]OY(X)VXP-CT_7:[[(=Y5D_FD
M@/<_3SA!S^8H>("B=)M]EP^&ASP8WB^6N;4.:B$#X P10+T.0&-' *>,4D=0
M\%BO;2"JNE L*V)G>=+TQ*:MC*L95UM+L3.N/BJNSA%NA0DC0EB C=: QI,1
M:"T-4 %IJ3'R$K*(JTQT&5M6#-73XVI%R7\9Z?BE$^?>C)-RYEW6QQT_;(1Q
MXU]F^,O&99_@+1Y[1!G&%0L_]AUM4_B4[I_%F>KT!Z-TT7\8_]SO%+%G1\,J
MWGLXZ@Q"9W3L2Q\%78]=D5R?4<B=[Y?U3]745Q[14/1UWQ;QP3)EOZDJ<*UW
MKIV,ID>$QRZ?#LHJ./+7H>_I="7MMZ^%&QU/(&?FJ69+P(M'M(E=&(^N?^1$
M#X^*?K57^.5CYTD7@2[,S/5[:/:_:605D"DLM6:0:>PUY5 HIZF/\(IA1%4N
MS$>4"IO4#QU/"W"=ZB,/S-#KST"'./I?=>^K/BO7?KD\9W'"9A=H?FYOZNJ3
M;GIQY7P?[(#?]_>VNYV=O5??V99MZ>ZK_;VM[;V#[:U._.E@_\^=K<W#[:0J
MQW]VM_<.#SK[KSO[;[;?;A[NQ :5'OUJ?_?-V^U_Q\=V_M[N_+E_<-#^<?ZT
MTX\ ,QC'=[BRV_'?K$^ ?ER#D>N<^N'DMY-X4HS*GU=@3.\F6/GSG?OZ T=(
M=4I= &1U,L:A]O1IZ7^=_/";*\K3GC[[M>A7':X>^JW!Q@95DP=LWE24OJ_^
MN $!P=898PD'&HM5\\4-1*Q7$#%WT->?<;ZN$+WV8[B.KOWL>Z]%=)UA]D.O
M_?YG JF'Z"RA^+:OO4*UFRQC)%D^M[Q+RQNLK#?Z4]3:G(PU4G,C 5VD'(^C
MT:F;P*HVR1X/O>_LQG;'96<[,CM7(="N'MKC#D'=:SW+SWFMR?Q:+VH:J[7*
MR8)YBY6\>;3WF;)5G#6\DOM_55KFBTZ+F^ZM_^+[XVMN,CVL1W^%[;!W'O_S
M,;-*A;%''!'%*4?6$"ZY]4I+)E PZ.-6Y;Y"$(';^;&:#?AZ.#A)Y=-3%_XI
M1L>OQF6<#S_<_F9[XS2/FV7IX_]WU16153#![A],3+"_'^^>]X[?G_S]Z?WA
MWO'>^=OC_<//;/?P[>?=P_=T]]!^C7__M+_U'EZ88/\B^X>[7V/_/GWX]+:W
M^^FOKWOG>\7[DW?XP^'KV&8W]GV'[6^]+19,L'$,N^>;]/T_>R>Q7V=[6YMD
M%_^G^'#XH;?[S^M4!8:^3WFB_OA/V"UJ\^ON <3[6[O?]HX^8@JI]P@!0A4$
ME*=;Z8$($#!B1*$@%(J 2G!70+DJ(0]+"G;ZX7&\:"Q\ID"(O?=4"^I4@%0Y
MH;%%5F,NB5..2U$!(9X (<Y V'8@/)\#0NND=EP) "V2@!*I@(16 H0@"5P%
MBJV)I!UW*7GPJ,\'1,'VT?15:9DO+5Y5:J6LO'A'@X$KTP9V+_+.XE,2ZK0$
M^^&/M  I@,$/OQ36EP=Q*?)QL;3CXFR!-Q/D-=-" &*=B\<%\T!##X$SFBI!
M7/Q8IG+6"M,6Y7[)EQ7;3@NS.#^*.,^S/V*##R8@X%R(:K U%FA%$3!1_^4P
M:,BEBNROJ^2]<TH^N#BWCSJM2LMEWOK$K.6W/O\8#LJR<SH<A)E,$_F>UY.2
MN6I-WE1+DN%^67"_]VJ!O05/';*4IBPY!E#*)%!8Q/\P*@U$C&B-(]SSKI#W
MIF\K9O7,HO\TQ"^+_L.(_CS3,UP$:2@!/)BHN"&7;G=[!)#D@F&O2!!A;0.I
M+F7WOLGSM*+?/GZU*BVSJ6\1&_=/_5"/4D"__W::(O3+7V^P]=UBPFXE&;>)
M"OIA"\8C=K)]^WQ56KXHO>P@GNYE%9Y^HH>??1*Y^ZAGSYN&+5T#._"]7O*Z
M]MWN9/:W:[S+K&QIK&PQ#(5CJ)'1 K!4=9&&0(")= P(:3!6B&)'7%3(1)>@
M-A5UR5F(VZY697E^%'F>U[*@Y$;RN$J*,0$H4Q08:U/*/PV#L\9BGZ(I6)=?
MD?&O;?+</D*T*BV7F7RH]<3MK2]]=;$E<3?GO_C>X#1=5/XA]O8BO*</$%U<
M+T&$^ZV+!<B OVS 7XR'$%C'@]I2$%?0 &J$!B9P".+?N4>I+KO%:QND&\E<
MZQVH.1ZB/?PM2_1C2?0\A>.84J4#!\'0E S18:"42P&Q(5 .B5%0)XEF\MYU
M87)(1&M;OBC3VQ^^[U-RFD3@M#LI^D4Y&E8Y8[(%[O%B(.I%B("_>6D),N8O
M&?/W%^,BD&%<<T4 T29EZB<<Q,-; 1*LDD(9CPE?VQ!=*K(5[AG+]/*#&[),
M/YI,+P0\* &1IAHXJQ2@4%M@B." 1ZC6FE',DBE.=-'2[C5E'M>^ECFDX8KL
M-(-1)'N#A<"&^]]A>L&!<4OG@]/ D^:P*/-IL;33XF"! 3JDJ!/4 T-%B Q0
M,Z X25PP,((C"U 81JU?=J$0RTW(^O21L4NT\KU@ %@Z><P \)  L$ 7=4 V
M.)\JVD>QE]8!Y:&(G!%*1VRZV(A2"<8N6=K-QAP?NV(M<V:M181,1:T[83@X
MF1#*0?\^1/*9WK"X4QW0^S/):PJ"3D^4BWKD^4Q9VNW:P\V%^BE,,"V=4@";
ME&4*2PJ,CJR2>X&8\%KPD.JGH"Y6BX;%VQ< S5>MGB40+(%19B!X(B"8*_CA
MD-$>,P2@$A$(J$! .2N , 9K;;EF7$8@X%W)%]/-K0H0M(^PK4K+;*5<1,J=
ME+C8EZ/**ST8'?MAIZC0JO-38[#\N=OI^]$2KF.UY<95OE351EE;Y<B.J1#5
MHI/#.1[-?+_3_Q+G/07MU1QKLA*92MV)2NTLZ%2"JZA5*0Z@X!A0030PD&+
M _,.4L,@3L6*R;(J%:^HXO2\Q77IQO8LKLL2USG-AT"OI:$!4"08H,R:E#"0
M FTBK/*XB$&PM8T5B*MJ'Y-9E98OZC;4E'$U2LH+NP7UR(;N>1"OYWX:7I>Q
M^P[8O;MHOO:*LLBD@%0& 8J= HHI#;0PG J&&%=F;4.2^YBL\JVF%DOH ]"L
M+*'WDM Y=B6"0UQ8#5"(Q(HBQ(!TB (L491=2HQW8FV#\<7+ARV2T/8QEE5I
M^:)L6?O7VX"S7>OQPE+3*NP-^H/++L0,Z#\"Z'\M4"[I2.#(,"!4LFYA88%R
M#@'B8 C,0*LXBNKRLK*S9N/6,Z5=USG^L_0N57KGZ)@.PC!#/4!>1NE5 0%-
MXJ\!"T$5](ZAJ#"Q1>F]LXL_L['VM<Q>_$78V_.C3F]07A,2^K#7"5:XVN"=
MQ_]\#K^'"W^->S''NSW$0?AN@<9:SI1!S@$F+0$4$@:4Y0@$!Z$*Q I-517X
MBO!B'KP[FR9:$_AZ@V4QPUV&N\?C^AGN'@[NYLVP"DHH30!>DPAW4D"@@N)
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MN-7UD(>,:7].6/J@UIBR,/WOFV+>3A>X:O8N+6^VQ"P+9_=>+5ABO)&<$^\
M$U&+H-Q[H!U4@",L-4/!TT#7-C"C77)_J+T:FMK"C%97FG^,I^;5>%&KD8_
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MI-0YKF^3MOPV0WY14[=Y,ACW1TO2[-K2]$$]$2M6%>\VZ?^WO/4G)G+<I@(
M>NIB>2M: >".A4BOK  @)0F>4&\LM!0JK*DD3@EA29".8E5EE$$(YPH ;4@M
M<[ZS4 % ,4FA5Q[X8!"@TG&@$<& 21UH8 (+[=8V".ER0;M0+M91^;%B9>U(
MDWH#!CR@W+>N\.CM<V?=;? K"G:+N;-^#.ERFM0'P+#Y]/R,"LVP)T 3ZP$-
MG@+EF03::^2#EX)*=%5Z_@Q=&;I> G1!K;$3TM H*-0::9 6GD"..3,627$?
MZ,II_Y:(:_/5F;"6CA *! DF<C-$@!). 2=%W /4NGCZK&W$LZ>K$,WHEM'M
M9:(;Q9@1')1TD!IOE&2&6$892=7+$,K$[-$ ;"%_O4&(>P&!L2P!&$\EDZP%
M& M(F4?(,I_*R^$,7AF\G@]XW26Y?#R]O</8:^<5-<1+&:1W#&FEL53^.VIE
M3B[_- :T^>3R7%!NL(N*)Q024(PXT)I[8$@J*XT9IR*L;6#%NI(N)F>^<QGB
MC'$9XUHPZCM '&8A8 B%LM90*97R6E(GL&'0)WJ0U<^V(-M<UGF+F;-,02!I
M$!'9+$T5+P/P2%.E==1  US;0(1V*5XLF[$Z%.Z1';"MKK]^M;3OE.6X\L .
M0AQC%6-=)FGLC$_CC_Z;']JBK#ZM_SPX35N@[';Z?E3]M7+J=;X6H^-CWW,_
MY+!=8LGV9^^69=)Z0Q5Q,E4K,D9&=4MKP2RRTCA+/FY%R,40002J'VZJT%Y!
M;]H$WFV-AW'JWL11#%SMJZT^W*]7?+O9"BY[;9<'S;L+7EM+822=$9FM(XEX
M>@44M@Y$"*4R*!PPCYPS K-0\K[ ?#5</67YRF<NZE6<'_XM+U.[E^DNOF-J
M!-8\,!0XI2I(JIE+5DI+H.*<W@#'UU#A13S^6_?&_AHXSF3X3H@[[XLA6'GE
MG &>4 6H0!H8*P+04@I!F.(^R,B%^:*&G^6XW7*<X38O4UZFI[ +>>^I%M2I
M *ER0N.HGFC,4UR5XU+D4[%UI^*"B4A"RX/3!&C'": $6:"IM\ J95@0O++J
MK<2QF*/P[V<$^N++41Q)^G 8?QP6=N3=I$$$@5M=>'G(*/WG!*8/:O0I"]/_
MOL7G[72!JV;OTO)F@\_R@/:O!8-/<,AZ%A@@ B% L8- (Z6 8 1:1*V!FB2<
M)5TJEV6*;Y$_\9G+^8]QV[Q,>9GR,N5ERLN4E^G%+5/VV=^T<!4U!T:7/HWQ
MY-3W2YW88':^9]MC7J:\3.VS:CR"XW33?1J7HQ/?'Y6'@XODABDWX$Z_R:M7
MV3@JW'PU YMO_7_'15F,_($??BFLK^TA;[T='/6KMU1FYAR1N#PKR+L%)ZP2
M3#*.# @&2Y!\!D KIH%""BLL)77,K6VP+H.B]?;FC H9O/,RY65Z\C-VZ6[8
M?,:NTAF[X-)U3F((B0$(&0(H9QY()0FPV-% J?,HV%4Y9'.1E]QR95N^A)B"
M/3^*9]/0QZZ<>]?I#<JR$X^K$SW\[$<ZE04IO1T/(_C?+F-F-MZN@O$V+U->
MIKQ,>9F>/OV"(\(Z1"W&VE'LC=2",*,U=5 Z:> ME)]K\C!491@NU3"H"P!L
M?M%%+YUL48DIHZ9R,#W?+O2F>"KNAT/][<U@F :P.1H-"S.NSL/#P9NH.?5'
M6<^YDYYSM)";)F@%M4(0."<<H$@0( FC0%G*I=/0&AG5'$P7[\_=.65#%OV,
MT'F9?A"AEV">R@B]$@B]8(E"1"MM4_JP$"2@%&.@6;I<P'T\H'D(BHO60W0.
M5+F-#2 I_CDP)7MC\C+E9<K+E)<I+]/*+]-=2+YG*G#!I W(1/6;&@^U1!9#
M3P6RU/PXR8_DHF;U?T:&D3W'R^/KGQ<S87K/(7)& F*2YUBI +0U""CNB=':
M!4WTV@8278H6[ZC=GK)G26ZQ)#^<NIXE^0$E>4[SAL%"9AP%7OF0 BTMD"@0
M$!B35/L(TJDJ5/LE.3O@+V3[-J7U=O70'D_JZN&G=K@WN4";(JTD[@PW&*>8
M@"H?Z(I6W;MZ&>YVTU\[A1'QC@9!J.!*"6H@] 0:@HBVMLJH>W-6QUQU[S$
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M)O1FZ$^*\4FYT__B&\]G1K [(-BD6.,,@DEK@A2>@!!/(T"#I<!PHH&&D/%
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M)42IO@0+6/O28EQ%U#IZ=/]T&&W)>+&<8D3/J:S5U<?'[_ZHZ/>3&SCEO:V
M^!YFSI<0PJV<#9+!>&)"2KGSFA$I&)2"2H4\DA]WTMF)\(-R\GP"+NL$W-M:
MO*,152QJ%9. $^L I=@"'9  S <L//>*L7@"8M@5Z-ZVS'Q9H[62CED(&$*A
MK#542J6\EM0);!B,RKD7E:2C+.FK).GSD8&$HL 1 5$IPH R'KFN,@80922+
MT.X<-&L;G'0I6I;+-]/:AW'L1D9[ X5Y6-_+51/XE$#W/P]F)K_#;FTWP!LK
MG3;.Q$,=4TV0UH10H1B7.$@>3 7P#VU>S0"_/("_H@IEBN*SB %E @<460Z,
M,9'9.6F=Y5YK1ZLTGVIIT=^KXI;.<)CA\!(<$A$H(PXI)BP-'&KHF2.<&HV<
MI+;FN[>(5\QPV!XXG(]O9/& <X9$EDLEH"%%Z$2:"R!V6 6"N34NPJ'H$KPR
M</C<+I[D#K?E:L]JZD=7F_T/QJ>G/9]R1>A>)\Z9[0W*\;"ZKQUG#E3.@*)?
M8V\4]GMX A8=.R1*MAN,4T'7I63&OJT!ZV%Z^?REX?E;"][U3W4\ADYOKOK7
MN7_4][,VDCY K-)I$3%J^]NI[[MB%#&JW.G;\7#HW>_CT=Y@]-Z/WL3%RUSP
M3EQP,5H[\CT(M:# &ZL!)0H# PD'UFN(?-0" B)K&U(N*UR[1:IOEMZ'NJN6
MI?>AI'<^?II(R:B60&O$ 16< X.T BR"L+0\*GF>1TV.HA9)[W-C3BWM\"]5
M3>\)8YDA9"=Z>%3T:U4<7P8Q&ZF.'RX;KQ"\";!P JS#8]_1U@Y.XG>?I5B4
M_F 4WZZC>A([4\2>'0VCUG*JA]7-O=&Q+WU$-3V."./3W"0Z6=8_5?8%G?[<
M9#B(#Y:C^(<J3=[Z')V;F9RF1SC%WY\.RB+)RJ]#WXOJT!?_V]?"C8XG^#KS
M5+W!?X47CV@3NS >7?_(S"KP%BV"6)B9NA\;_S+#7S;F6/#,?]/(*@176&K-
M(-/8:\JA4$Y3SZ#$,)X<7)B/6*Y-'CH>7B@)1QZ8H=>?@0YQ]+_JWE=]5J[]
M<GG.XH0UO64T#N>ZN7W\R5S0MJO)/-@!O^_O;7<[.WNOOK/GVM+=O?W#[8/.
MX7[GU?[>UO;>P?96^NE@_\^=K<W#^,OKG;W-O5<[FW]V#@[C'W:W]PX/.C^]
MFTC@SW<?X?6[ZKL;[_:;+1*5A3<^]K2BN/3UX;LW/HFOL$M0G>92 ^A$L?;#
M?M1<*[M-^;1TZGQW2J?>?O[P:?M\[Y]WY_M;?T<Z\Q?;_R/2H?.=;Q\.[?G[
M3Z_C=V]'BG5\$JE1S__[;7RW.S68\@]_O#W9/=Q%'PYWZ=X_[^'>UF?Z82O2
MGOC,WOE>L?O/W\?Q\Z_[?WP(NY]VR/Y?'Z'2+GCH (ZL"%!-(%#:,^!8)+0H
ME01RI*:^17_LW69R+S!CI*0>>:@-U2PHA;@@5ANGN$&8KW5\Y*BG:1,/Q[X^
MI5[59U1E(JCG/AU(OX_+N/9E.:%:S6K/[=WX6=.!:J7J=;JQ$[<\.CZ-RU$1
MSBZ95S!=%VSY%I9;GB<7$-BWZYV?4I+(E!(5P]^:2:Q^0[_]W/FJRW2K;# \
M'0RKD[OH5SDEJV,[S>]6/(6_)C809VU7#^UQ36&1[':BO,MJ-8JR<^RU^^\X
MD@0_K%]RH/LCW7G5TT/=[;R*$Q4&PWZAUSNS2QD?U)T3[Q)KC:K-EZ)*.%Y_
M-CK6H\YQ[-YI7#!?O597=J)AX4=Z>-:)YU)2A7IGJ2RS+B-3Z)3CN$;I7<7)
M:2IIWBG/RL@^.J-!)XPC;ZE&INUP4/0*;3N?!I'?))]79Q0/P5%E<HI#/AF7
M=MP;E)]]SS<6V\I2638$J'[%J>_%_L;QZTA"SN;&U1\-!VYLTU2,RLB&AN6H
M<^3[#5!TBM>I-Y-.QMF*4ZDF4_]N_6"]6_\1P>IZ7^3U.OT;58-1''TY:;D]
M3MV(V^M=/[ZU6Z]%]1S[[G-1,9R0N<[7P;#GZMZ7/K&Y:_O9K7\%9*O;;)N+
M059?*N)4]GJ#KW62J[KQX?[;O^J/,:K[5[WR=^^&*5'I'T,=%63?M,#KUYYE
MC?0UE*]BT#,"J5H@D-4;?TT*>&%O<3Z]+<K/934C[_K-0BT6Q;SZ,&\5WB#\
M?R[#<Y3I<FP^I4P?4>S&LX/K5)0^;H_X0:_X[[B(#.:L6VU#;:)(CL[2)R<^
MY4P;?/%1A1C54Q05E CQM1CWDRI<"6T2+5O;/#K]*B5NW)7I93/:AQ]6H!)G
M*4Y:!(T$*/Y;BE3S_;1SHVP/QTVV7'NLDYX>/SNOMW!ZE]']SZF%C1T-NNC%
M8Z>;-,*>/DT9=R.7UKT**+_H83$8ES-?7O3C.HW&U<LOX4.5GEK\5EY_<;?2
MOR+2Q3U>U  71;86-.<K=:>>F),(C1$)]?!SG+.DQHW3PU^+T7%G]#5.I?X4
M>WAUCV;A)J)\\]+ZCV4][C*^X"PE:_%IS=+$^@B##>0F#Y:+RWB2'HO?DM9^
M$!L-Z\^JXA'3I'<12\JQ/9YV/F))2$]<ALUC[>8&<1!W102ESM_Q2^- ?X^=
MZOS4'&4'?_\^.<;6._O-Z=1!,!U,F,P>.G'?'8WCSAM$""^/Q\G5]#6>4'__
M7LUA&MCKK9U7%:CIT]-T**3#INPTWU MU=!;'X^8X<Q783[YJNDK=+\_&%<;
MJSJ^BE$UIHI\5ZL7=[">>C[JK5V6XY-J W;TT=!7JG(]]M?IU "OHF9['C7L
M>NS_5Y^<_M8Y',;-/)VUR7Q<;C\]X:/ Q#7Y>ES$'L=9O-@_S0&0W(ZQP54S
M_=4G*T#J8"T/E[]A"M;+11Q\*\3I=![FVV^'=W-+HVV4W&$C(Y4MKH*B*,EI
MZNL%&%TA_G\.8M?3)CCP=CQ,\+<YW0)I+YZD%Z3#>=!)9I7N[$LJ).L/1I?0
M+/T]$I>R3J:4%GEVM1/(=*^ FH0C%8(DTU5B :DO":XK9&IX>X6^Q_J+GP'C
M&BD2))?7G]QW.KBNTSM7^Q!LYC"=6\-X[%?S.G\PEN/>J#K8)EG=7^W_O;,%
MD.K$%SI_4M@&*^?_7&V$2-'2R16!=AQ/I!1N<):.LZ+>7KI7QD[H<3+3N7@$
MGU6 ;1-$]WJUZIKV1WKV-"5$=LEUL!X',^UV.D7&M<HU'E46H^J):6?BYS7V
MGXY-+_7)ZUZ$L#CP.,ITM [&O7HO#0LSCH0O;::Z34W1XTXM*OMUFB-?QJ[8
M>LO%7TX3*XT_3K^M!K/ZG;VH>*0/2WL<^]U+SR]OB/577$Q?:N2_Z3@FD]2C
M2Q-='@_B>A[Y+ IK&YME?=S/X-7_EI/IK?=ZO1Q3TTFU3Z><L)EX$\'&Q5U1
M^L0X)EL\'D2Z8EL^-HPO"?'/Z62?(9>7A:LA.@NLL+R@A>G;^W'L:1_WCP9I
M/]3?-STF%^0NJ6C-+?G88! W1XKL&9?EC!+M:R=@Y%R]^->UQ/D[K^ONKM6-
MBM3OJ'N/UCN;T^]RC>X]+<(U-;S?P=S>;6I#C-)I$N>D%IIKAI(TOT$"DPL^
M?*& UPN6OF:"35/LJ<X.KQ,7C-*J/_M^)8NCBLZ?^\E[XX=1X.J9\C-?>]0;
MF-3I63E*@V[.GLO+..$KWUG&1%=/=&+P-4FMEG!^%TZ?3Y-9^0VZL]I(W )7
M[]"A/XE=*2]Z-2?HO\P9F>YD,:5K=U9ZT^]/9+/&#VY</8C 5H0B OAHL]8(
MXNYY$S>\C5OA,'[3[[V!_?S$!M>]5Q.#ZU_G'P[C9_COWM[AWO'NX=O/[S]9
MMK^U=_QAZW5\W\[YWLE?9Q\.=\\7#*Y;>[W8C_,/_\3WX^UO>W^\+?;./]-=
M_/KS[C^OCW<_[>(/6__I[9[OA=W#3;BWM?TQ$C!$K>; J10]X@P%!F$#M$M7
M:%)%1<KG+:[042Z@DD$&3YUS!C%DXG[DRB+H'9JWN!Z,3TZ2E2W*P,Q:="X6
MHS-9C1^PO-[<F<N=1Q8Z';R*4I1JS.L4$9\"991!WGBAK[34?L=6="DZKFV6
MH=]U6538\R;B4(H9K97#B(=O(H3:XK17@^&KZ0FP$#.Z5,.9>#(S]@-C3#71
M^V$.7\[J_[YLC-GYB"@+SFL/G'0>4&E9RA%H@5;46BF0P5Y=Y:6Y%$OP0W$"
MM99I?.02IY$;Z<:AD%X\=!4=JLPCM9DZ'?-)(3VM3#87X'1Z(2H3.U>_ZLA!
M^IY*?C:K7:6G]I/*$/;'YN:;J>FDTITB-8FMDF8\'/<:8M+8DR9:17K]P66U
M>9(X*1&/DTAID@A/#5?;KZ9?$=^DAQ6'3%:G87$R,R4U,8R?5=PP$I&38I2&
M,#$H),Y9]:D[-?6'P6!4!W!,-;)9Z]\TQ+PF=\G(V$]_2K,X](T1(_+KZ53,
MK,7%"J97UUWI3JRS@VH,O8G)M%<M4WF<++FZK-U(UI^8V!V"*J,9KIAE]>(X
MF*CZS;#+F3USPT[1HWH@%6$VE6'/UU:1FIO[RN+5K-#L\&<'6XTSV9/3QNWY
MD;\Z>F7^F'MH!G0)WC,F[6WM?N0D,ALM#< :6T#C# /#E4IA>,18#]/MJBLP
MZ5+ TD3,[@E(@T;#BTL6]WLZL!O?P[R-3_<C\^E=LWW[KCN!I\%ID9QXE?]1
M]_51U:0;-VKH)2M2VL?:I?.Y?O1"?GVRQB6FEK:P3CZ*X<5W3+77><?#U6.>
M$9':VG2U)E1Y3(^3.W7H??)!C([+3F6K;"SCC9"3!F%&TU[6SHSD[TV179/>
M3;XEJH[&5P;-2M&??,V9U\/T^H22\SA"*KO-G/NA7N$Z'<'BYXT9(KWU"J&^
M@4>UQ=MXMYB^NVSV\GAB>QDFTUKE/^Y_BDIO!9RU:VD&I*_;V%-S3'T<I9GW
MR7\WMZ:QP>+1D* TGF87AI3Y[;M9"]7;ZH!,LO@Z;ML.@N#_Q?XD4\NTF_&L
MG48N='"]96ZEMU^.3"3\A48FRA^,3,Q!AJWJ[J,$&39 >&.4X94F@1M5_#F3
M "%2QL^8LA)3Y8."!ELDJ(:!!:S5LS()/##5?%?Z_; =%R_93I\ZBO%IR.7[
MCP1R@2Q-E)*F,$;(@!*6 ^*=@L@RSNE"&*,UW#KJ('*6TH"Y<4@+98.,9)$)
MAN?)Z+NZ2/-TJCO?MYVM5/S3C9:<19F_<?HJ)E-S[OJQY.ZYBG#4+"61U^0]
MJD[_"QVV4?;*&6)=Q1GISY%L3I?B<C#&A&'7)8MJDIK(1K(RG-0!*K$OL;T?
M37Q7=0C3Q !P^9IW/?:CVK%_]3,+WI\Y9\=E=G5=CX;^BX_;L[Y'FRZ"E9=]
M+U.;0D./UR]9=V<,*)<G9F;F/HW=4=V/1C>YH&EWH9FSP4V5JMZ$;B7UY8ON
MC7V34:Q22/HVBJ5.+QY.<Y=TZE+GZ8)=)T6HNG)]1K"2XE$_$7?-<1';#JO
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MP2Z&$LLPIXOAX"#V?<=V&T?V*/9+*,-U\)1"BIY:K8!><J>BPX%:HQSW1ME
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M\OQH=[G(_DPY_3K5^)KWYQQ%RFM?N-A?D[7;R(A@.X>#QK#7&.Y%^.!@F"\
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MGO#?"]/_9RQ0]$"Z<&9+<44-21AQ&C-=P %IRC@*G/J4M+$.UF=5BGDK0;P
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M6^T-^.[>?K.]]:L)S]B",;6^;<!XMT2K'0Y:ZWO?M\$LWUS?NRHKT-+ B?%
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M9-9#4<>6AW<E-[7F%1=.N^)AN,<YU_B9;PP:>Z->XT5.3;TQ_#F"^XM/>>&
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M1!@7EN'U2LZCYXFLO/-<J/D/U>I^$+WHN.JS[7EF!-?F]/F>!O#X]'F#;1W
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MH.#1H+0&^VE/DP2-HTXGT]]UR,U960#!<4D"84HD*\G*"'Z<DPS< [$"N0U
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MFK5OS-K22VD8,\%I^ <'11($!>?!*&H(I77T:_U9>Z%W8'12&R*0#9RGP+9
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M@_3;>/O""8R;/@ R")T.$-RH'.,X)&&=2".D 2I.'M/+8 0L6SUIL_%YLM5
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M%V_!'8EB+P[SBC3A1[\'C7%6,O7#V=H?-MC5;N,ZFMPUFMP]QKTO3SZ\[GL
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M'C0(;OB-!-=,4S:B9S4M/K]6@N=[VDIP57>WTUW//7Z/IZURKB_PH4#"?)\
MX2KOA?"+ESY\O=@FT_CQL<7V'??,3.>),Z0O>\/CTWME2 ]ZI\.SQTB-O;BX
MW[#K_W9R>?D8DQT.NLD^UF0W&[;+D.XRI.\^_$'E\G89TEV&]$-MST67(?V
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MHR\S+T?("J168YF+9: 6 >WAI 2!@>]7]ZIEPUV> MJ%6'@K-I)K["&ID/L
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MUCYYKQX7^WM* W\XO&LCDNZ0GOB0SOSC6PHH=X>T]4."FW3G+LC=(>V%7O:
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MB\!*\HB$,4RLF;@/A_U5Z<37L?ZC2,F%U.T6&7_2&UH9WW:E*\_#&H!M L_
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M^4*-03>T,P5%CNKDG[\",[&,91ZX4O[I102?!KVLG)?LPR=01SJ?EPG(62=
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M!MP_ QL21T&<CG54G"I](K:RSKRJV#N+ -*]G&SN0*[<&9FX9Z7*2KVZ1>#
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M)GB+7$,9ZFS.D,/=Z<#E<C;Q#K\\S8)Y;A3 7RGX(_@?_D<46K!?E.CVBWA
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M71),*!81);#SSK:H%-05$<4,_L-]N:U7&B)@NHV"+T3OPHTMJ0@5MH_@0]>
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MAJ"2^9G1\W 9%=6B-KIWN$F/LPKA&Z4.Z9.4EZH04<Q<(A%E4P\>#\?R)$D
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M]]PQ$<C&]%.1&QS)?*:?BGE[*Y)J.'R^^)KADWK$IF LRGUY=T5C3D]/17
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M@E1C!YN)J6(6N/"%D6R)*61UJ!@*-T.9B?E%TWN8$:K)9 R-47(ZTAF.E8$
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MBU(LYAM A52IO.4TFH50N,-,-OP1>^-YB9]S+\9]YPOC!'8MQVLQB9H=P&H
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MGDEZ_AEV[>S'3*C_:P7YN:KHI/QLU 56AMX]U/+=]ZXJH3'W7=/&0P*K9($
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M< P&_H&]GROBU6P.53*S.D8ACXW#3!.*#9XO6J VJ&PS&X-X,4@[%Q2;QP(
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MR;GP(F<Q2^)+ 2:UKB4ZD@0<(V.E9RV/2W-)R2I&0)%+$#2 LP(4,5,I! 3
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M,:>R0T--$/"#?9S$WX]9)-,4AT'?"V_42[T:)V>IU%Q++Y&+N]%%D@B[\D]
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M?-C>;$P<VV"['066%(&D=%ULTA4#<WXRT"C%1@EXC6B[Q_0;!%AW8 )&2.U
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M(&G0.=4<J#VK!_58'Z<"< LTO-]L?%ABD+9N.'=P:V?^/';="2+_/4Z.823
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M]<YRSJ5C3B-M 6EPWX,W# :>/[FFU':![K?#$(>C,S)T;\OOQQ\J06J-=_K
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M<<:D96"LLGDOH\SVD_3A?7H#X=]4WP:2:QE4OPF'_ A:5A28*&A=0&'!:1[
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M%Z$K=9*H%Z\.'L+BB^VP$2[.TDPA ,87.L?X&.]F>QYISY?J2C>>^!^9J*,
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MDMNDI8H!FE($.)<9E$3&6GA=+73T-35BJ&7[QW^("?SGV,]ZZ +4S7@(!-/
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MJ\1]5SL]S[H.YD'8R0+RX_/VD3;8K_;>^[RI/ZD,[4E;8Q0S1 &2% ,:TQ1
MC!#&(K.NLU[G6V>+-#6BW"U@_Z+0_6XI=?Y\J-!]DWGEC#*C 0;8\>AJU&$;
M^KAJ)S7.Z1'[L>^(^9]0!0,YU*G4^0*->Q(5#,"]TZ=P+7M6Y"A7VQ#*/ZOB
MMF0/=S9K>NU_GT,:YYF.00XY X:1(:",QX!C'>M<T)PB)Z.ULY>I$>ZN?%XQ
M#-U8=A-A,(0&YC8?<-SK(K@HW\4YIH$=OC'_VG)-=]OCE#QP46]3T,#IX:#1
M#I_JO%6'';!D'$M%)0&Y)+'9MAK[C E# SJ6-&%<8H:]7//\19@:/=0^5+H.
M_*^OFN9KT4,'/W0-BYM5-2S8 S/-B6"(C1)#^ZOU!W'8^(@N :80)^$ D&.\
MA$M+?3,\-)6\Z\*/3;''J\=5M6)+>W\R@Q!B+6)N[!VDVA*,$A(@TIQDE"02
M9DXE&-VZFQK1M<D+VEKGM<P7ZZ*D.V+[YGSH1+R;U\+C.#"'G0MACRP0+LB<
MD0NBL_F1,T*XJ+J?%\+IK3.S0_RD6/58UB9<M?GAO\]5:9J\6Y=(P#PCFJ?8
ML(O  %&, "=8@C23,4<ZPW'FE83*J_>ID<TV/T*TD;2NZOKSY5]Z>IKZC8:;
M1348Q@,3T7GP]L\_X0-3Z(P43GV_38X*'UB.9JWP:J2O7_Q3L7@RQ/BN5'*^
M^LA$'5;6YF=!,)<QBQ/ <IM$F&3F;QS% &<$9@0+F?GZQ7?T-C7"V@@;-=)&
M:W%]W>&[$'8CI6"X#4Q"1R$;( ..$R;!W.&[^AK9'=Y![7UW>)>7>F8@+VV8
MX>K9YDA>72ZE+<;W8"EK6T8]4Y"D-A].KJ'UAT@5R%F& 5$*)X1G":5H]J1*
M7CCG)3_9J<^LV.UZP$NC'1_GM?SU"KT1_L+&]'FF,#^-OAO%A$5T8)Y9"WL1
MU>*^1''06O7N,(5*CGZZPW$3ICL#L)=$W?W-WK:,6CZJQG][69\>_76^NGOW
M6*V*>U5>%XNY>-[.BSC-,AVSU)@T-FE7(CC()<0@P501H6.<0*^D77[=3]#:
ML=*OB[3XI\KP1-_9\!D(T^$MH1K.-E:E$3WZS<@>K86/?FW$'X:H^B$7SE[R
MZ7QL ZH', <LJCZM]#6QE%:E,=UVSK0^5=6CDC.<9)RD@@*5J<3F+(M!CK,8
M:)T33)F6&?(Z8CK>U=0(:R-I5%E1HWDM9>U/6M5B>SJ4=H#L:D&%@&YPRVF-
MVLNSZD;0D';2*3""V4='.QK9+CJE\+X]=/(-_SNO]X5XK&TJ\^HLQES2A!B3
MAF%A+!S" 1.I 'FL!>%:QPHYE8MYW?#4J& M6YV)T_VVZ@56I^^E^B(P\(QV
M4][KGNF0IKUNE%XT--K=T2'Q=V^)#OY^9/_HMOK;SLW4*U_N#]]4*>:5NB[G
M0GTI%@M=E/;%&5(TB:%( $D1!X@@!9BF&A!%D:1*:Y5EH_A3]U9A:O2Q%ANL
MXR36@D>UY",Y5/?_(MS,DVF/\\ D>;;#]D5;TK2ZV+W6/Q!C\_+;&:9RS)N-
MY%M[A?=7X/?A17[V  7S.C]?DI$75'N:N'K^M#2SK5[<]PJM;HJW6F$_MM3)
M$XY)EN< (6DL9!83P'+*0"(SLZ9R#GD^3G!2+_&GMI#^_&COD^S]1K.;&6GE
M[#?T Z^:@P_H]%?,!H)H!X.H!B%:&12VZ^D&"//75Q]0]*L%)VK1F<(2>M:P
MOO7RV4_XW\?2>=; !%LVSY/B;?:@1@JMYJM',]_LK=RWAWE9MU!]6EZK<E[(
MF4I@#&-;U$92>XYDMIP4D1APE">0<HE3F,^6ZM:FW+L9;^=Y4G G.LT;.MT3
M?SAJ?<?,5%C8Q A+&>E&B7-.KH?_ ,;98889S]_-\KA9 '?T;CP9MIK;+-Z-
M[A-8^WR'Z:V7.V=Y?Q\KG"_\H?>"[AU[!BC/^;*_<!N_V,NJ>KQO)#6R*6$H
M]2_%PC1C/=V^&&Z_5JJTC;/E7%4_S9?S^\?[&<1<*YPD@+&$6A=]"1@D&"B2
M\YR0E,38Z8KD+968VC9P+7GTM!'=FO0/1O1(K&6_B.X;Z:/O'I3I>+ER7/7>
M]'/I7@A_+Q_!]-?&G6B&'31LYL/VT]H"$EE$(@M)]&[[<;6H_ X^*=G>1M7=
M_>X_K1?:_-_]B;DG1YC V#:VFI7$&F I3-.X2:[PEK*-D[MA NAO4D-,09:>
M):2J2NU$*;V?5V)1V.BE348#P:""&": 9T0 1"0&%&44""J98 3J5,9>-:!.
M]3@UN^@G5OY=K6K?]&J3==JS'--)E-VVZD&Q&]B<:&1]0=A;>8<I8.2*3J@*
M1"?[&[>$D*OZ>S6 G%^<[.7@JUO./YNF5^\-8VZ4FE&=Q5D2,T"DU@!9MUO*
M8P%PIB&FL5(*ZME#O2'^NF+E:C(7AR=5\YGSKQ4<;OJ_<+?@ZG:^K#.8UAM*
M*T-];BJ+Q8*5E?U1<X8ZUA%JR"\KR9A,(2% $1LFQX4"G- $I$@FB@M"8A6W
M7]:'I?RO_%VMU1OIJU)+^5_Q>YK,#7?0+V3ZAQ?^]]Y[7F0U1)'%:,?LF< 5
MP !C_M:W!"%5^GU<) PPB&]P@>XN6S]CT];WV%JPV\!%0K",(2<@1J0N90Q!
MGB<Q8 H1EA"=8^&5$^-(/U/;O/[8LS+/,1C=%J< X R\7E@)7^Q'!XGF/(%#
M( X]ULNHM'9"U==,<^KQOFD#O]ZIQ:(Y(WN><82TA#$".#;V.,H5 ;F0%*!$
M86+V>VE,L%^:P-WFIS;5&PFC6L3VP-LQY\T1^+KG^OF@##S%O?#HD=#OD-IG
M)/![T=S("?L.J;*?H._@4_U6Z4]+4=IB%^]5\^>GY:40Y:.2N[6AA(Z9TDP"
MG7"S9(N, 9Y)!G)*D$WUD"<Y]%FR73J=VJ1N)8P66Q%K9Z/"VE=^2[H3YF[K
M>V@D!V:"M;C1=VN!O[<>6FML!ZGCY0-1(#O J<M1C0(?$%Y;"%[O]BS?IZI*
MJ9>U>=:M/[?;F^K]H_K9F"<WOZG%D_JI6*[NJAG6,F78;"$(RS1 C'/ 8*9
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M_9I/W%[J$UUFM@M*;1Q0:I_3^C]-[DW+8X:VS*YESG@=J3!+5"H0YPJH6!"
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M#[I4^AX'##2FKJ<(;S]2@Q\^;%2TAPXU,UI?^IW!:WVM=MQBOZNS5#6Z1NM
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M/C:N#)YY0=W&R(VZPB,_,'4UUN5:8K"&^O-N]M7@P5E^*(7*%>K6Z;@)0[V
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M^2/4*P;D& 1G!8'L-3IZ%,@QM0Z%@1Q]UG^2?S:8+Z[OBJ5JW9(H,W,Y26,
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MW/2B$VN!9AY^;0\Z*>E$R^%\I=M#_'2QV/4Q ^_O7R=8$I5E.@9"D1A G&>
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M=O&)LC87+V1-B]4*:^[!,RTADWL@BI=H76L@;:9HW/A](#0U5$('D'I@4YB
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M^$MUE,)T=;*N_YWE9_-9M:PX2Y45GZ5WFEDH*#(H9@-XI, !&4],NY RW_1
MV%[EV(^3,VZ=QY/@J)4R.K _&R244YT<7A_OM3[69VXX^#I'. CFT<68H\'&
ML#KP\J1Y,_N3HJJ1*CH U;O+==<LG7<I%"EM5E'6AGUR]B1G$(6-D"B@0"4Q
M6-GZ8NX!,L9N5&NCX?NEBP>)NP/$W)@4=$Y_\/5BVFH067M0M*\@YE3[^35R
MEU3P&U_%W?=,NTG#V/>U@V#E($%W )2CG-=7UN'X79CF5[-GX<N4?*R)QF*,
MU'4ZH29W3H7:!%40*!30CEOO-W?1[W7W\3 IXX;V \&FA=A[0$]*IR>GQV&%
MY^7==8#= C_C;#G]BO71OQ-\/5\NW^#J;?D8ODU\4C+(K$"6^E0HALJH"9"M
MYM;%5%P>X#YV%Q+'#?:'0MN :NH A>]Q%:8SS"_"8D:!P_(&N\^Q3--T-1&)
M">:$(3^2!5#%*W#9U6(]U,H4YGWS&[CO4S5NAF @K#561@?PNB^HB?$&16$&
M6(U-R"-,Y W*6.?LN>(L]W36#Q[*C9L8& @^!PJ[@\S2]V+;B71.U<0%>*$<
MG?$"R4/T&KRVRB;#ZQCH)RZI'.?IV+%RE8>KI1G,GG+<T;NU,C[C:IK(J[[%
M2:O91[>7&'X0T@:6GG(JDA966+0.G!2<+%2H%BH2?F)TQA?)BFJ=,'Z2J4C'
MQ_,_Z*/K-(+G\].X*J?']YO(+PLF&&*00A;@VM47#I@FI[$XVJM"<XR*16R=
MWMR)P+%358UQ=,_''TQ9';A@MS-RM.O?+M8"S>N<RSM<K,=A3QC+VD0E(0E&
MT3,:!Y$)6[F2(G.EO=OTQ,WA.=''*!L[]34P]@903W>@.Q^X?G2Z^CQ?3/\+
M\X09$8U"#H7+6FVA271.9[#,126"\[:T[^K=1-'8B;(G!=E!ZN@47*^6RU/B
M1$HM8B9C'&TM& LJ0N#!0G%%A)!]8:%U?=7CU(R=#QL!5'NHH5- W7P>(A6F
M#*.MD0VC\"8%K.6QH4YU9BIK&Z-J?0'T'9+&3G^- *U]%=(!OFY<=#UZP'./
M7$7IZI-6ZRVC@9Q*!EXQKX6SR&7KR3I;D#5VGFQ@G+563%]8NW?.2Q4U2H>
M/&M04@6( 1,XEG,JQ _'UIG\#>2,6T;SE-@Z2!$]8NKBF+<\"D]\$ <UIUPB
M;8U @N+$E5+9%F%;QXR/D#)N$O;IL;2' GK$T:TSW:..(GE(SM21^:GV(,4
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M )%'WVNX"WV/RAL5,JC,Z0\E%=E13A*+K@3&T6G=&CS;TC;NF+R!8#6(8CH
MW'O\BK-3K,-4:[E+E=/?IZO/STZ7*XH]%G>Y$UYS';@ 9E*J=T$%?%8&4HHJ
M%6&-8ZT')^U&X;B3YP8"WX!*Z@""'_!3W4CO\<M\L<%QC%D835)S3)$A]UJ
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M$5+&Q5,C1<_;2[T#\*R?9Z65:Q/[!UQ\G28Z[6_,@[G9&$H?N7SX1Q=!%?*
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ML*0[1,O%AJ(C4\CB)>B Q(6HXVZ"3N#I3S0&F>-\8+STX)L>KN'O0&8/<7<
MFK6EQ%R9N+"1P>=@<X@@8E"@BDAD'DL&3I;7FV!*;OX:SSTB^H+*/IJ=MQ1S
M!SAY/9W5'HKU:] 7',3(M>6F0!))U3G( H)/#!QRC!ZSDZSY\)Y[5(Q[# V
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M#PVH95W>8BPXFS/YF0+K7KP4L'GJXI #CUO^TPMP#Q3DU%!;U?+#?Q8SS8Q
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M5IF5C<QR4$Q9[B%K6]L$Z<X.QM2EWTXFPZWBHK>[:7<J1Q[:<1+!_1" .JW
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MD8];@F6RJ"&NIT&H&7><=@^7U?@@&;NT>G^_MM!AK^_K]2K#+^%L)K/3:'P
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M>,[\MI;@-6=\I+A UZJ3&!TH+3R0"#4%NC8DBFIM,*V'<QZ+MHGVE9V2&AX
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M=K'+ V^$E)_^Y13WFLS>_P%02P,$%     @ !(.B5C/8 XT$!@  3"$  !H
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M2P$"% ,4    "  $@Z)6GTM6 F]P @#@[A8 $0              @ $@N0(
M<VEB;BTR,#(S,#,S,2YH=&U02P$"% ,4    "  $@Z)6,]__55,-   ZAP
M$0              @ &^*04 <VEB;BTR,#(S,#,S,2YX<V102P$"% ,4
M"  $@Z)6KOZ<3$ :  "U^   %0              @ % -P4 <VEB;BTR,#(S
M,#,S,5]C86PN>&UL4$L! A0#%     @ !(.B5CX*0$DH,P  #S8" !4
M         ( !LU$% '-I8FXM,C R,S S,S%?9&5F+GAM;%!+ 0(4 Q0    (
M  2#HE;=!G[ K[8  "B6!P 5              "  0Z%!0!S:6)N+3(P,C,P
M,S,Q7VQA8BYX;6Q02P$"% ,4    "  $@Z)6*J5-L,1H   XPP0 %0
M        @ 'P.P8 <VEB;BTR,#(S,#,S,5]P<F4N>&UL4$L! A0#%     @
M!(.B5E<!FVEH"   EC(  !H              ( !YZ0& '-I8FXM97@S,3%?
M,S,Q,C R,S$P>'$N:'1M4$L! A0#%     @ !(.B5A* 8SJ5"   @3,  !H
M             ( !AZT& '-I8FXM97@S,3)?,S,Q,C R,S$P>'$N:'1M4$L!
M A0#%     @ !(.B5C/8 XT$!@  3"$  !H              ( !5+8& '-I
M8FXM97@S,C%?,S,Q,C R,S$P>'$N:'1M4$L%!@     +  L [P(  )"\!@
!  $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
